data_1eub_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1eub _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.481 ' HA ' HD23 ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.469 0.652 . . . . 1.03 109.727 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.499 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 6.3 tp 39.41 30.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 1.04 111.178 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HD3' ' CD2' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -118.4 88.75 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.023 . . . . 0.77000000000000002 109.776 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.595 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 13.4 t90 -153.52 -65.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.41999999999999998 111.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.48 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 17.8 t -105.02 59.97 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.44 111.207 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 114' ' ' SER . 10.9 mmtm -154.57 53.45 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.035 -1.041 . . . . 0.48999999999999999 110.379 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 59.2 ttp -72.97 -15.67 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.29999999999999999 110.393 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 15.3 p-10 -142.78 140.42 31.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.14999999999999999 110.416 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 12.8 tp -158.23 166.39 32.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.379 -0.826 . . . . 0.13 109.841 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.5 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.6 OUTLIER -107.57 162.94 13.5 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -0.983 . . . . 0.12 110.081 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.581 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 36.5 p90 -157.63 164.02 37.65 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.376 -0.93 . . . . 0.33000000000000002 110.887 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.24 146.46 45.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.422 -0.799 . . . . 0.54000000000000004 110.301 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.615 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 4.2 pt -106.31 117.46 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.33000000000000002 110.574 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 2.9 m -162.82 42.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.27000000000000002 110.04 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 11.3 t-20 -40.63 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.79 -0.764 . . . . 0.40999999999999998 109.311 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.57 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 7.8 t80 -178.92 178.46 0.76 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.409 -0.807 . . . . 0.40000000000000002 109.78 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.544 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -130.56 51.08 6.9 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.45000000000000001 110.126 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.57 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 46.7 Cg_endo -75.85 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.125 1.592 . . . . 0.35999999999999999 110.639 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -99.58 -2.09 36.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.25 109.938 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.559 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -110.47 168.76 9.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -0.8 . . . . 0.39000000000000001 109.879 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.48 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -116.97 169.08 9.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.47999999999999998 110.25 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -43.28 -32.96 0.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.40000000000000002 109.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.9 m -67.98 -47.93 67.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.46000000000000002 109.84 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.559 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 9.5 mp0 -63.07 -58.83 5.95 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.137 -0.977 . . . . 0.46999999999999997 109.745 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 133' ' ' GLU . 10.9 t -45.68 -36.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.042 -1.096 . . . . 0.31 108.042 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.4 tt0 -57.84 -42.06 83.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.096 -1.076 . . . . 0.47999999999999998 108.096 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 5.9 tttt -72.53 -51.1 21.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.448 -0.901 . . . . 0.64000000000000001 108.732 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.67 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -44.92 -60.08 2.24 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.137 -0.977 . . . . 0.41999999999999998 110.223 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.628 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -67.47 -52.82 34.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.34000000000000002 110.974 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.07 -71.67 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.931 -1.105 . . . . 0.46999999999999997 110.159 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtp? -39.49 -61.29 0.82 Allowed 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.809 -0.557 . . . . 0.46999999999999997 110.508 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.41 -37.16 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.693 -1.254 . . . . 0.25 108.305 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.2 -36.67 74.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.743 -0.836 . . . . 0.34999999999999998 108.743 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttmm -58.03 -41.39 83.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.228 -0.92 . . . . 0.69999999999999996 108.923 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.79 -48.42 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.592 -0.692 . . . . 0.60999999999999999 109.4 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.609 ' CH2' HG13 ' A' ' 262' ' ' ILE . 57.0 t-105 -55.01 -38.05 67.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.39000000000000001 109.157 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -73.5 -34.0 65.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.305 -0.872 . . . . 0.34999999999999998 108.936 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -44.18 89.45 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.35999999999999999 109.251 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 26.9 m -72.93 -32.2 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.634 -0.826 . . . . 0.5 109.753 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 148' ' ' VAL . 15.3 t -152.0 134.18 8.54 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.51000000000000001 110.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.29 59.83 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.951 1.501 . . . . 0.31 110.158 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -76.72 136.04 39.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.17999999999999999 110.414 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -82.35 120.45 25.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.17000000000000001 109.92 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.558 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.5 p90 -131.6 133.99 45.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 0.14000000000000001 110.521 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.481 ' O ' ' CG2' ' A' ' 119' ' ' THR . 6.3 m -140.02 128.9 23.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.364 -0.835 . . . . 0.14999999999999999 110.11 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.569 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -96.67 81.85 3.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.20000000000000001 109.972 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.423 HD11 HG21 ' A' ' 154' ' ' THR . 0.2 OUTLIER -82.26 89.1 6.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.094 -1.004 . . . . 0.22 110.109 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.465 ' CD2' ' N ' ' A' ' 158' ' ' ASP . 5.1 p-80 -48.45 -24.43 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.32000000000000001 109.963 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.465 ' N ' ' CD2' ' A' ' 157' ' ' HIS . 3.0 t70 -42.29 -27.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.497 -0.752 . . . . 0.33000000000000002 109.811 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 124.55 26.33 1.46 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.72 -1.352 . . . . 0.28000000000000003 109.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 119' ' ' THR . 51.7 mt -119.85 70.93 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -1.215 . . . . 0.29999999999999999 109.725 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -124.35 143.48 50.56 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.15 -0.62 . . . . 0.20000000000000001 110.598 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.424 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.9 OUTLIER -108.1 -43.78 4.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.10000000000000001 109.965 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -119.86 156.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.259 -0.901 . . . . 0.10000000000000001 109.84 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 199' ' ' ALA . 3.1 ptt? -156.85 153.01 27.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.515 -1.365 . . . . 0.11 111.602 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.556 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 4.1 tt -101.24 116.69 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.10000000000000001 109.316 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.498 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 12.9 p -162.64 148.64 12.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.578 -1.326 . . . . 0.10000000000000001 111.364 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.571 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.3 p90 -67.79 117.15 9.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -0.823 . . . . 0.089999999999999997 109.411 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -75.38 142.76 29.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.91 -0.876 . . . . 0.20000000000000001 110.91 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.595 ' N ' ' CD1' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -134.54 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.754 -0.851 . . . . 0.55000000000000004 109.124 178.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 11.7 tmtt? 1.08 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.375 0.607 . . . . 0.84999999999999998 112.428 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 171' ' ' GLU . 14.3 tt0 -146.16 23.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.326 -0.859 . . . . 0.70999999999999996 110.11 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.433 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 12.1 m170 -96.89 -67.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.41999999999999998 110.267 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 124.6 5.96 6.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.649 -1.38 . . . . 0.33000000000000002 109.649 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -121.51 -82.62 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -1.226 . . . . 0.33000000000000002 110.217 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.46 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 65.3 m-85 -102.48 154.6 18.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.27000000000000002 110.016 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.2 m-30 -96.56 105.74 24.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.34000000000000002 110.039 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.469 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 43.7 Cg_endo -73.17 -66.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.929 1.489 . . . . 0.46999999999999997 110.823 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.565 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -49.47 135.39 18.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.34999999999999998 110.634 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.492 ' OD1' ' OD2' ' A' ' 202' ' ' ASP . 7.6 p30 179.56 83.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.241 -0.912 . . . . 0.20000000000000001 110.398 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.491 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 41.47 -156.59 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.688 -1.365 . . . . 0.25 109.688 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.6 Cg_endo -76.45 6.35 4.07 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.123 1.591 . . . . 0.44 110.308 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 181' ' ' PRO . 1.5 t -41.06 165.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.56999999999999995 110.738 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.62 76.18 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.536 -1.025 . . . . 0.48999999999999999 110.536 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.516 ' CD2' ' OD1' ' A' ' 202' ' ' ASP . 3.3 tt 179.78 89.28 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.358 -1.084 . . . . 0.40999999999999998 110.058 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.581 HD12 ' CZ ' ' A' ' 214' ' ' TYR . 1.3 tt -106.2 -21.66 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.787 -1.196 . . . . 0.29999999999999999 111.533 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.539 ' CB ' ' OE1' ' A' ' 223' ' ' GLU . . . -152.59 108.86 3.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.473 -1.392 . . . . 0.20000000000000001 112.247 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.1 OUTLIER -106.48 125.74 51.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 0.16 109.73 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.544 ' N ' ' OE2' ' A' ' 223' ' ' GLU . . . -115.54 150.62 36.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.16 -0.963 . . . . 0.23000000000000001 110.613 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.433 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.6 m-30 -107.53 165.33 12.99 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.937 . . . . 0.38 110.471 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 43.4 Cg_endo -71.18 137.81 32.11 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.012 1.532 . . . . 0.40000000000000002 109.901 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 41.2 Cg_endo -67.53 74.5 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.041 1.548 . . . . 0.32000000000000001 110.807 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.62 -92.66 1.97 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.913 -1.675 . . . . 0.32000000000000001 108.913 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.37 -159.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.001 1.527 . . . . 0.46999999999999997 110.17 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.32 2.63 12.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.63 110.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 15.71 19.66 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.287 -0.883 . . . . 0.53000000000000003 110.094 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -86.55 167.0 38.42 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.438 -1.465 . . . . 0.25 109.438 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 45.93 24.23 1.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.354 -1.499 . . . . 0.10000000000000001 109.354 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.76 93.83 3.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.208 . . . . 0.10000000000000001 110.192 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 164' ' ' MET . . . -75.74 105.13 6.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.089999999999999997 109.925 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 166' ' ' SER . 10.3 m170 -119.24 122.18 41.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.089999999999999997 110.237 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 203' ' ' ASP . 29.7 m-85 -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.10000000000000001 110.455 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.9 OUTLIER -48.78 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.282 -0.886 . . . . 0.14000000000000001 108.789 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -36.33 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.901 -0.72 . . . . 0.17999999999999999 111.694 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 202' ' ' ASP . 66.2 m-20 -77.62 2.08 17.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.812 -1.18 . . . . 0.23999999999999999 111.075 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 202' ' ' ASP . 28.6 mm-40 -97.32 -170.78 2.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.997 -1.065 . . . . 0.41999999999999998 110.548 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.414 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 96.5 m -121.37 146.52 46.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.46999999999999997 110.367 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.503 ' C ' ' CG2' ' A' ' 208' ' ' THR . 0.9 OUTLIER -145.05 145.42 31.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.887 . . . . 0.27000000000000002 109.663 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.54 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -163.7 -177.97 5.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 111.159 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -125.54 30.26 5.8 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.72 0.772 . . . . 0.60999999999999999 108.999 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -126.93 -175.69 3.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.569 -0.707 . . . . 0.78000000000000003 110.375 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.475 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -82.38 61.32 5.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.91000000000000003 110.135 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 212' ' ' LYS . 3.5 pttt -170.0 106.26 0.34 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.957 . . . . 0.93000000000000005 110.157 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 96.16 -162.47 22.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.363 -1.495 . . . . 0.79000000000000004 109.363 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.581 ' CZ ' HD12 ' A' ' 185' ' ' LEU . 83.7 m-85 -81.56 127.33 32.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -1.18 . . . . 0.68999999999999995 109.986 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 218' ' ' LEU . 16.5 m-80 -89.25 119.25 29.57 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.095 -1.003 . . . . 0.40000000000000002 108.939 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.67 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.6 OUTLIER -41.39 -36.59 0.86 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.515 -0.874 . . . . 0.17000000000000001 110.214 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 5.0 m-85 -52.55 -47.04 67.01 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.468 -1.308 . . . . 0.28000000000000003 107.468 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.557 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 11.5 tp -78.5 -72.1 0.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.617 -0.72 . . . . 0.46000000000000002 110.835 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.558 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -46.8 -61.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.936 -1.103 . . . . 0.39000000000000001 110.23 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -54.35 -52.86 60.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.17000000000000001 111.207 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -54.79 -29.48 54.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.352 -1.467 . . . . 0.10000000000000001 109.043 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.596 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.0 t60 -77.17 -52.21 9.65 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.423 0.63 . . . . 0.20999999999999999 109.895 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' A' ' 188' ' ' ALA . 19.0 tp10 -58.38 -53.87 53.39 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.28000000000000003 109.01 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.564 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 2.4 m-85 -53.99 -46.61 71.77 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.304 -0.872 . . . . 0.17999999999999999 108.84 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.404 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -49.83 -31.85 17.3 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.315 -1.914 . . . . 0.20999999999999999 108.315 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.577 ' NE2' ' NE2' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -86.54 -68.38 0.75 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.385 -1.068 . . . . 0.17000000000000001 110.402 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.538 ' CA ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -38.74 -39.64 0.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.574 -0.704 . . . . 0.33000000000000002 111.108 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.475 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 4.6 tp -98.19 -34.18 10.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.086 -1.009 . . . . 0.53000000000000003 110.356 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -75.58 -88.85 0.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.107 -1.197 . . . . 0.40999999999999998 110.107 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.5 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -177.68 -170.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -1.088 . . . . 0.45000000000000001 110.878 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.521 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -39.23 -64.91 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.556 -0.715 . . . . 0.62 110.823 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.577 ' NE2' ' NE2' ' A' ' 226' ' ' HIS . 1.3 m80 -166.92 -177.44 3.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.45000000000000001 110.096 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 232' ' ' HIS . 24.1 p 179.92 60.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.768 . . . . 0.38 109.406 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.596 ' CB ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -148.12 26.4 0.98 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.47999999999999998 111.415 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.524 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.6 OUTLIER -34.34 -51.09 0.97 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.38 111.173 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 46.8 Cg_endo -83.94 -49.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.72 1.379 . . . . 0.28000000000000003 111.644 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.34 103.16 0.17 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.193 -1.479 . . . . 0.23999999999999999 111.424 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.596 ' CB ' ' CB ' ' A' ' 234' ' ' LYS . . . -149.84 167.84 25.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.287 -1.125 . . . . 0.28000000000000003 110.532 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -73.3 58.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.326 -0.99 . . . . 0.40000000000000002 108.326 178.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.59 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 24.7 mmm -140.42 -34.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.45000000000000001 110.813 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.596 ' CG ' HG23 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -58.11 170.54 0.71 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.047 -1.033 . . . . 0.56999999999999995 110.243 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.1 Cg_endo -68.72 -7.55 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.544 1.286 . . . . 0.76000000000000001 110.046 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.596 HG23 ' CG ' ' A' ' 241' ' ' PHE . 1.2 tp -98.66 142.48 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 0.89000000000000001 109.57 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.557 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 16.1 p90 -131.93 -21.29 2.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.246 -0.908 . . . . 0.78000000000000003 111.257 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.55 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER 4.25 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 112.999 0.74 . . . . 0.60999999999999999 112.999 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.549 ' CE1' ' O ' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -66.36 115.9 6.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.571 -1.331 . . . . 0.73999999999999999 109.619 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 250' ' ' SER . 0.2 OUTLIER -61.46 174.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.81000000000000005 110.358 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -46.74 -34.28 6.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.822 -1.311 . . . . 0.56000000000000005 109.822 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -148.73 51.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.044 -1.268 . . . . 0.37 110.572 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 247' ' ' THR . 83.6 p -102.07 13.19 35.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.44 109.875 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 1.7 t60 -173.65 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.53000000000000003 109.959 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.549 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 2.5 t80 179.9 177.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.38 110.193 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.533 ' SD ' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -75.33 48.94 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.891 . . . . 0.19 110.451 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.669 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -44.46 -47.89 26.11 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.17 -1.048 . . . . 0.28000000000000003 108.17 177.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.7 Cg_endo -72.52 51.04 1.75 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.054 1.555 . . . . 0.48999999999999999 110.662 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.562 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.4 m-20 -53.4 -30.23 38.93 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.118 -0.989 . . . . 0.48999999999999999 109.399 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.56 ' CB ' ' CB ' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -50.59 -42.64 56.04 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.228 -0.92 . . . . 0.31 109.897 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.592 ' N ' ' HB3' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -81.78 -33.46 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.248 -1.019 . . . . 0.14000000000000001 108.248 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 97.0 t -62.26 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.544 -0.862 . . . . 0.17000000000000001 109.727 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.9 tm0? -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.295 -0.878 . . . . 0.26000000000000001 109.597 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.12 -65.29 1.29 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.19 109.919 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.609 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -78.35 -20.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.22 110.615 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 1.7 tm0? -66.25 -21.15 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.839 -1.144 . . . . 0.39000000000000001 108.513 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t -104.11 -42.54 5.51 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.383 0.611 . . . . 0.46999999999999997 110.897 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -79.18 -48.42 14.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.47999999999999998 111.254 -178.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.475 ' HB3' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -84.55 -7.46 59.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.40999999999999998 110.542 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -50.73 -98.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.001 -1.64 . . . . 0.46000000000000002 109.001 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.65 133.89 13.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.839 1.442 . . . . 0.57999999999999996 110.037 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -94.7 161.06 23.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.484 -1.446 . . . . 0.64000000000000001 109.484 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.595 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.148 -1.207 . . . . 0.94999999999999996 110.134 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.53 ' CA ' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.337 -0.616 . . . . 1.03 109.337 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 36.3 40.08 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.694 -0.629 . . . . 1.04 111.545 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HD3' ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -126.85 81.94 2.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.77000000000000002 109.496 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.601 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 15.6 t90 -151.64 -70.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.134 -0.979 . . . . 0.41999999999999998 111.16 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 13.2 p -102.4 77.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.44 111.098 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -169.31 51.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.48999999999999999 110.326 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 5.6 ttt -85.37 -13.38 49.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.29999999999999999 110.42 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.467 ' O ' HD12 ' A' ' 118' ' ' LEU . 6.5 p-10 -143.96 109.62 5.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.208 -0.933 . . . . 0.14999999999999999 110.043 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -138.24 -168.4 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.13 110.658 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.51 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -130.59 176.95 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.12 110.321 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 155' ' ' ARG . 36.7 p90 -174.43 -169.24 0.43 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.27 -0.894 . . . . 0.33000000000000002 110.918 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -127.87 156.46 42.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.54000000000000004 110.037 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.633 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 2.7 pt -122.77 95.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.33000000000000002 110.436 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 4.2 m -149.9 56.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.982 . . . . 0.27000000000000002 110.812 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 1.0 OUTLIER -44.34 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.40999999999999998 109.306 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 167' ' ' PHE . 11.9 t80 -178.69 -173.95 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.40000000000000002 109.69 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.514 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 2.6 m -136.35 53.89 8.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.45000000000000001 110.774 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -78.26 -86.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.981 1.517 . . . . 0.35999999999999999 109.922 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.47 0.04 41.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.895 . . . . 0.25 109.699 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.541 ' CE ' HG21 ' A' ' 134' ' ' VAL . 2.6 ptm -121.77 147.99 45.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 0.39000000000000001 109.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -92.78 169.36 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.47999999999999998 110.118 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' THR . 11.2 t-160 -43.51 -33.64 1.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.40000000000000002 109.622 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 2.5 m -57.98 -54.6 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.46000000000000002 109.23 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.52 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.6 OUTLIER -58.1 -54.35 47.99 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.542 -0.863 . . . . 0.46999999999999997 108.913 179.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.541 HG21 ' CE ' ' A' ' 129' ' ' MET . 10.5 t -45.25 -34.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.169 -1.049 . . . . 0.31 108.169 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -63.44 -41.58 98.67 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.435 -0.95 . . . . 0.47999999999999998 108.435 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.586 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 2.6 ttmt -70.5 -49.54 47.33 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.922 0.868 . . . . 0.64000000000000001 108.999 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.64 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -44.77 -59.6 2.44 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 121.149 -0.969 . . . . 0.41999999999999998 110.206 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.633 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.54 -53.59 33.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.34000000000000002 110.775 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.12 -72.69 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.994 -1.067 . . . . 0.46999999999999997 110.167 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -38.47 -61.89 0.65 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.85 -0.531 . . . . 0.46999999999999997 110.427 178.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.23 -38.86 12.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.678 -1.264 . . . . 0.25 108.413 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.3 OUTLIER -69.43 -31.92 70.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.34999999999999998 109.063 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -61.29 -43.85 98.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.208 -0.933 . . . . 0.69999999999999996 108.699 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 7.5 t -69.58 -46.56 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.915 -0.772 . . . . 0.60999999999999999 108.915 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.597 ' CH2' HG13 ' A' ' 262' ' ' ILE . 53.9 t-105 -54.72 -37.1 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.485 -0.76 . . . . 0.39000000000000001 109.012 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 149' ' ' THR . 56.5 m -74.93 -33.17 61.93 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.915 . . . . 0.34999999999999998 108.711 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.9 OUTLIER -57.85 -43.12 85.68 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.094 -0.706 . . . . 0.35999999999999999 109.094 179.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 29.5 m -74.64 -33.98 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.438 -0.789 . . . . 0.5 109.903 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.501 ' N ' HG21 ' A' ' 148' ' ' VAL . 13.1 t -148.3 129.46 7.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -0.982 . . . . 0.51000000000000001 110.216 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.43 59.17 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.968 1.51 . . . . 0.31 110.582 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.49 HD23 ' CD1' ' A' ' 266' ' ' TYR . 11.6 mt -80.25 171.31 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.17999999999999999 110.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -122.79 136.64 54.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.17000000000000001 110.463 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 6.8 p90 -154.91 145.02 21.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.14000000000000001 110.316 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 119' ' ' THR . 2.8 m -143.99 142.95 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.14999999999999999 110.14 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -93.74 86.51 5.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.20000000000000001 110.12 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -92.62 85.14 5.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.22 110.419 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 159' ' ' GLY . 45.5 p-80 -56.88 -19.12 15.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.32000000000000001 109.873 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.521 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 2.4 t0 -43.4 -26.14 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.494 -0.754 . . . . 0.33000000000000002 109.776 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.75 21.87 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.95 -1.26 . . . . 0.28000000000000003 109.95 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.51 ' O ' ' CB ' ' A' ' 119' ' ' THR . 14.8 mt -125.63 64.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.035 -1.273 . . . . 0.29999999999999999 109.274 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -115.86 137.0 52.51 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.254 -0.579 . . . . 0.20000000000000001 110.594 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.522 ' CB ' HD22 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -101.34 -51.79 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.10000000000000001 110.034 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 3.1 pt -120.01 -177.33 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.10000000000000001 109.229 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.1 ptp -174.88 139.54 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.5 -1.375 . . . . 0.11 111.836 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -90.35 118.71 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.10000000000000001 109.443 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.54 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 29.5 p -169.83 162.45 9.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.722 -1.236 . . . . 0.10000000000000001 111.291 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 167' ' ' PHE . 0.1 OUTLIER -75.19 150.46 38.67 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.471 -0.768 . . . . 0.089999999999999997 109.24 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -111.9 131.59 10.32 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.754 -1.212 . . . . 0.20000000000000001 110.986 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.594 ' O ' ' C ' ' A' ' 170' ' ' LYS . 12.4 pt -125.74 101.31 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.629 -0.924 . . . . 0.55000000000000004 109.358 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.594 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 2.08 78.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.462 0.649 . . . . 0.84999999999999998 112.202 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -4.48 10.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.70999999999999996 110.135 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 9.1 m-70 -83.94 -153.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.923 . . . . 0.41999999999999998 110.186 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.4 36.64 1.7 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.244 -1.542 . . . . 0.33000000000000002 109.244 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' PHE . 15.0 p-10 -140.87 -146.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -1.093 . . . . 0.33000000000000002 110.205 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 174' ' ' ASP . 28.5 m-85 -45.84 169.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.27000000000000002 110.046 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -86.31 127.12 62.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.34000000000000002 110.43 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.53 ' CG ' ' HA ' ' A' ' 170' ' ' LYS . 44.6 Cg_endo -79.01 -79.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.885 1.466 . . . . 0.46999999999999997 110.497 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.2 p90 -58.91 149.83 25.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.34999999999999998 110.307 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.483 ' OD2' ' O ' ' A' ' 177' ' ' PRO . 1.6 p30 178.89 78.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.20000000000000001 110.491 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.535 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 42.63 -160.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.522 -1.431 . . . . 0.25 109.522 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 182' ' ' SER . 52.0 Cg_endo -78.23 9.34 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.019 1.537 . . . . 0.44 110.483 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 181' ' ' PRO . 40.5 m -46.9 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.56999999999999995 110.575 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.87 74.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 111.149 -0.78 . . . . 0.48999999999999999 111.149 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 4.0 tt 179.56 90.45 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.22 -1.164 . . . . 0.40999999999999998 110.379 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.473 HD12 ' HB3' ' A' ' 205' ' ' GLU . 6.3 tt -109.18 -21.48 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.29999999999999999 111.179 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.432 ' C ' ' OE2' ' A' ' 223' ' ' GLU . . . -150.1 105.56 3.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.665 -1.272 . . . . 0.20000000000000001 111.775 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -107.08 122.54 46.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.16 109.632 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.55 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -114.64 134.07 55.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.23000000000000001 110.399 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.448 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.1 m-30 -79.63 174.78 5.56 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.38 110.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.495 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.6 Cg_endo -72.77 130.72 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.089 1.573 . . . . 0.40000000000000002 109.458 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.4 Cg_endo -71.22 77.28 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.95 1.5 . . . . 0.32000000000000001 110.457 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.13 -90.01 0.51 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.686 -1.245 . . . . 0.32000000000000001 110.217 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.5 -179.98 4.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.46999999999999997 111.014 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -58.92 -14.83 10.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.815 . . . . 0.63 110.133 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.97 53.3 0.7 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.538 0.685 . . . . 0.53000000000000003 109.937 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -133.97 -178.52 15.67 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.392 -1.483 . . . . 0.25 109.392 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.554 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 43.56 26.14 0.64 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.67 -1.372 . . . . 0.10000000000000001 109.67 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 196' ' ' GLY . 3.7 m-20 -79.28 87.95 4.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.10000000000000001 110.22 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.66 97.1 1.67 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.089999999999999997 110.027 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 52.3 m170 -112.97 134.19 54.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.089999999999999997 110.69 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.7 m-85 -101.1 135.92 41.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.905 . . . . 0.10000000000000001 110.296 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.3 OUTLIER -46.58 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.265 -1.013 . . . . 0.14000000000000001 108.265 178.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.09 -26.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.827 -0.749 . . . . 0.17999999999999999 111.826 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 202' ' ' ASP . 1.0 OUTLIER -78.06 3.59 14.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.499 -1.376 . . . . 0.23999999999999999 110.749 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 202' ' ' ASP . 21.6 mm-40 -100.27 -174.55 2.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.008 -1.058 . . . . 0.41999999999999998 110.107 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 144.27 47.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.46999999999999997 110.439 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.487 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -141.4 134.11 28.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.27000000000000002 109.488 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.492 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -142.34 171.12 14.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.062 . . . . 0.29999999999999999 110.508 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -129.24 25.95 5.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.573 -0.899 . . . . 0.60999999999999999 108.573 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -69.3 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.78000000000000003 110.357 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.583 -0.698 . . . . 0.91000000000000003 109.518 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -95.8 157.86 15.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.449 -0.782 . . . . 0.93000000000000005 110.022 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.25 -174.55 37.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.101 -1.6 . . . . 0.79000000000000004 109.101 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -67.31 114.96 6.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -1.228 . . . . 0.68999999999999995 109.902 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 218' ' ' LEU . 45.5 m-80 -84.37 120.33 26.14 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.985 -1.072 . . . . 0.40000000000000002 109.001 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.64 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -41.18 -36.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.17000000000000001 110.397 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.586 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 3.9 m-85 -52.4 -47.64 66.13 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.279 -1.378 . . . . 0.28000000000000003 107.279 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.16 -73.04 0.29 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.812 -0.631 . . . . 0.46000000000000002 110.422 178.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.558 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.2 -62.78 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.136 -0.978 . . . . 0.39000000000000001 110.566 -179.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -51.81 -50.69 60.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.026 -1.047 . . . . 0.17000000000000001 111.263 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.9 -37.52 76.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.342 -1.474 . . . . 0.10000000000000001 108.829 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.574 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 6.6 t60 -63.68 -59.29 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.197 0.522 . . . . 0.20999999999999999 109.606 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.489 ' O ' ' OG ' ' A' ' 227' ' ' SER . 3.0 tp10 -54.3 -39.44 66.97 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.252 -1.018 . . . . 0.28000000000000003 108.252 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.2 m-30 -56.33 -61.32 2.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.435 -0.79 . . . . 0.17999999999999999 109.057 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -45.07 -30.39 2.55 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.669 -1.772 . . . . 0.20999999999999999 108.669 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 1.6 m80 -81.36 -78.27 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -1.156 . . . . 0.17000000000000001 111.115 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.554 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -37.9 -37.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.584 -0.697 . . . . 0.33000000000000002 112.47 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.47 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 11.5 tp -100.6 -36.72 9.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.717 -1.239 . . . . 0.53000000000000003 111.278 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -75.82 -86.88 0.31 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.171 -1.172 . . . . 0.40999999999999998 110.171 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.53 HD11 ' CA ' ' A' ' 110' ' ' THR . 0.5 OUTLIER -172.57 -170.18 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -1.154 . . . . 0.45000000000000001 110.661 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.509 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.2 t0 -43.08 -60.79 1.51 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.62 110.77 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.513 ' CD2' ' HE3' ' A' ' 234' ' ' LYS . 0.8 OUTLIER -166.97 -175.56 3.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.45000000000000001 110.359 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.445 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER 179.59 61.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.488 -0.758 . . . . 0.38 109.698 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.587 ' CB ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.79 23.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.47999999999999998 111.26 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.532 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -34.51 -47.43 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.647 . . . . 0.38 110.926 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 41.2 Cg_endo -90.78 -45.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.82 1.432 . . . . 0.28000000000000003 111.987 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.31 102.02 0.15 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 118.829 -1.653 . . . . 0.23999999999999999 111.991 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.589 ' HB1' ' N ' ' A' ' 258' ' ' ASP . . . -150.46 166.47 30.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.334 -1.098 . . . . 0.28000000000000003 110.257 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.574 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.3 53.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.972 . . . . 0.40000000000000002 109.21 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.565 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 5.2 mtt -137.3 -30.63 0.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.45000000000000001 110.372 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -47.49 171.27 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 0.56999999999999995 110.6 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -70.29 -2.83 11.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.511 1.269 . . . . 0.76000000000000001 110.454 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 6.4 tt -110.66 153.93 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.89000000000000001 109.919 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' A' ' 246' ' ' TYR . 32.5 p90 -128.35 -20.61 3.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.78000000000000003 110.935 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.51 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.6 OUTLIER 2.75 -67.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.717 1.006 . . . . 0.60999999999999999 113.717 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -72.56 119.57 16.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.339 -1.476 . . . . 0.73999999999999999 109.833 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 250' ' ' SER . 21.6 p -63.12 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.81 . . . . 0.81000000000000005 110.424 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.84 -20.64 57.57 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.722 -1.351 . . . . 0.56000000000000005 109.722 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -158.07 40.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -1.226 . . . . 0.37 110.507 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 247' ' ' THR . 4.6 m -63.79 -13.0 40.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.44 109.781 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.2 OUTLIER -171.13 -48.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.53000000000000003 110.329 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.572 ' CD2' ' HG2' ' A' ' 253' ' ' MET . 4.7 t80 -179.1 178.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.38 110.777 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.572 ' HG2' ' CD2' ' A' ' 252' ' ' PHE . 6.8 ptp -68.14 55.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.424 -0.797 . . . . 0.19 110.263 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.638 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -44.11 -47.97 23.25 Favored Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 108.021 -1.103 . . . . 0.28000000000000003 108.021 177.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.9 Cg_endo -74.31 50.53 2.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.129 1.594 . . . . 0.48999999999999999 110.698 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.538 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.1 m-20 -50.87 -32.27 19.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.069 -1.019 . . . . 0.48999999999999999 110.008 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.553 ' O ' ' HA3' ' A' ' 261' ' ' GLY . 51.8 m-20 -54.17 -46.47 72.35 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.24 -0.984 . . . . 0.31 109.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.589 ' N ' ' HB1' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -72.96 -36.32 67.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.491 -0.929 . . . . 0.14000000000000001 108.491 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 74.1 t -63.88 -82.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.17000000000000001 110.266 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.3 tp60 -56.62 -43.09 79.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.276 -0.89 . . . . 0.26000000000000001 109.495 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.76 -69.86 0.45 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.496 -1.042 . . . . 0.19 110.496 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.597 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -72.86 -22.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.777 -1.425 . . . . 0.22 110.032 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 6.0 tt0 -59.98 -23.17 63.4 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.98 -1.088 . . . . 0.39000000000000001 108.208 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.1 t -103.6 -43.0 5.49 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.406 0.622 . . . . 0.46999999999999997 110.913 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.52 ' CB ' ' HG2' ' A' ' 112' ' ' LYS . 54.7 mt -75.31 -52.49 10.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.47999999999999998 111.187 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.49 ' CD1' HD23 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -82.61 -1.36 50.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.40999999999999998 109.959 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.31 -108.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.226 -1.55 . . . . 0.46000000000000002 109.226 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.453 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.6 Cg_endo -75.91 84.29 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.702 1.369 . . . . 0.57999999999999996 110.223 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.69 174.48 1.06 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.64000000000000001 109.48 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.601 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.94999999999999996 110.117 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.171 0.51 . . . . 1.03 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.513 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 39.49 27.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 1.04 110.88 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -114.94 72.76 0.8 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.0 . . . . 0.77000000000000002 109.781 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.612 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.0 t90 -143.85 -65.09 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.41999999999999998 110.474 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.437 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 13.4 t -103.06 60.31 0.78 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.44 110.537 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 3.8 mmtp -146.01 85.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.146 -0.971 . . . . 0.48999999999999999 110.302 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 152' ' ' ASN . 34.1 ttp -112.99 -20.78 11.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.29999999999999999 110.28 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 11.3 p30 -144.97 129.48 17.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.169 -0.957 . . . . 0.14999999999999999 110.106 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -152.32 -175.73 5.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.13 110.662 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 1.0 OUTLIER -126.39 155.44 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 0.12 109.992 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.631 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 46.1 p90 -148.61 159.46 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.33000000000000002 110.776 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -116.9 151.33 36.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.51 -0.744 . . . . 0.54000000000000004 109.873 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.624 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 2.0 pp -113.51 115.19 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.33000000000000002 110.983 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.6 m -160.56 41.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.313 -0.867 . . . . 0.27000000000000002 110.19 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 2.3 t-20 -40.78 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.40999999999999998 109.491 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.559 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 2.7 t80 -179.39 -163.45 0.05 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.43 -0.794 . . . . 0.40000000000000002 109.57 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -152.84 47.87 0.41 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.063 -1.023 . . . . 0.45000000000000001 110.436 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -73.73 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.956 1.503 . . . . 0.35999999999999999 110.311 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.95 -5.21 56.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.25 109.755 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.525 ' HB2' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -115.96 172.07 7.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.39000000000000001 110.068 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.7 177.67 5.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.47999999999999998 109.993 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 4.7 t60 -45.53 -36.92 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.40000000000000002 110.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 5.7 t -63.59 -50.58 68.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.46000000000000002 109.595 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 129' ' ' MET . 51.9 mp0 -59.87 -62.74 1.65 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.255 -0.903 . . . . 0.46999999999999997 109.378 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 13.1 t -44.02 -37.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.478 -0.934 . . . . 0.31 108.478 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.517 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.77 -42.04 78.69 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.319 -0.993 . . . . 0.47999999999999998 108.319 178.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 42.2 tttt -74.69 -47.52 31.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.005 0.907 . . . . 0.64000000000000001 108.577 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.677 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -47.64 -60.71 2.36 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.333 -0.854 . . . . 0.41999999999999998 110.001 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -68.25 -51.36 46.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.34000000000000002 111.095 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.54 -72.1 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.963 -1.086 . . . . 0.46999999999999997 110.277 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -40.95 -59.33 1.47 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.693 -0.629 . . . . 0.46999999999999997 110.437 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.86 -37.16 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.691 -1.256 . . . . 0.25 108.012 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -69.85 -40.74 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.499 -0.751 . . . . 0.34999999999999998 109.02 178.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -52.67 -37.47 58.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.06 -1.025 . . . . 0.69999999999999996 108.565 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 89.0 t -72.75 -45.17 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.351 0.596 . . . . 0.60999999999999999 109.572 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.597 ' CH2' HG13 ' A' ' 262' ' ' ILE . 26.1 t-105 -58.72 -44.37 90.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.39000000000000001 109.333 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 149' ' ' THR . 58.8 m -69.11 -33.4 73.43 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.137 -0.977 . . . . 0.34999999999999998 108.745 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -56.12 -44.92 79.61 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.35999999999999999 109.302 179.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.2 m -76.24 -30.83 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.5 109.778 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.513 HG21 ' CD1' ' A' ' 151' ' ' LEU . 12.7 t -151.8 114.7 2.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.51000000000000001 109.944 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.91 59.96 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.826 1.435 . . . . 0.31 110.52 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.58 HD23 ' CD1' ' A' ' 266' ' ' TYR . 65.7 mt -76.27 165.91 24.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.17999999999999999 110.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.442 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -91.58 128.05 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.17000000000000001 110.147 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 5.8 p90 -147.41 125.34 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.14000000000000001 110.234 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.47 ' O ' HG21 ' A' ' 119' ' ' THR . 6.0 m -128.59 139.85 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.14999999999999999 110.439 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.631 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -106.5 87.11 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.20000000000000001 109.931 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -95.38 89.52 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.22 110.05 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 158' ' ' ASP . 3.4 p-80 -49.12 -23.78 1.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.32000000000000001 109.916 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.471 ' HB3' HD21 ' A' ' 156' ' ' LEU . 3.0 t0 -42.76 -32.77 0.64 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.625 -0.672 . . . . 0.33000000000000002 109.644 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.56 32.79 0.37 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.81 -1.316 . . . . 0.28000000000000003 109.81 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 119' ' ' THR . 17.7 mt -126.79 67.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.236 . . . . 0.29999999999999999 109.271 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -125.76 149.63 48.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.657 -0.652 . . . . 0.20000000000000001 110.906 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.453 ' O ' ' O ' ' A' ' 196' ' ' GLY . 3.7 t70 -113.19 -38.05 4.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.10000000000000001 109.623 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.531 ' CG2' ' HA3' ' A' ' 197' ' ' GLY . 6.6 pt -125.17 172.81 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.10000000000000001 109.382 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 1.2 ptp -171.88 141.51 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.808 -1.183 . . . . 0.11 111.222 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.575 ' HB ' ' CE2' ' A' ' 224' ' ' PHE . 2.8 tt -93.87 117.23 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.389 -0.819 . . . . 0.10000000000000001 109.563 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.491 ' HB3' HG23 ' A' ' 123' ' ' VAL . 69.4 p -158.53 159.59 35.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.893 -1.129 . . . . 0.10000000000000001 110.489 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.559 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 9.1 p90 -76.63 126.41 30.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.383 -0.823 . . . . 0.089999999999999997 109.709 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -88.23 117.04 4.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.148 -1.181 . . . . 0.20000000000000001 110.148 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -110.25 103.01 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.67 -0.9 . . . . 0.55000000000000004 109.264 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.579 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.82 81.12 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.329 0.585 . . . . 0.84999999999999998 112.523 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.24 -6.26 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.70999999999999996 110.048 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.464 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 13.1 m-70 -80.75 -86.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.41999999999999998 110.418 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.47 4.11 6.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.526 -1.43 . . . . 0.33000000000000002 109.526 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -113.28 -64.73 1.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.33000000000000002 110.132 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.455 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 18.7 m-85 -112.79 118.14 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.27000000000000002 110.245 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -45.78 104.29 0.39 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.34000000000000002 110.36 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.476 ' O ' HD13 ' A' ' 184' ' ' LEU . 44.4 Cg_endo -74.5 -59.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.925 1.487 . . . . 0.46999999999999997 110.374 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -89.2 161.04 16.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.34999999999999998 109.919 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.463 ' O ' ' OD2' ' A' ' 204' ' ' ASP . 0.9 OUTLIER -173.65 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.20000000000000001 111.206 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.575 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 130.9 -137.23 9.32 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.929 -1.668 . . . . 0.25 108.929 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 182' ' ' SER . 54.0 Cg_endo -72.13 -3.37 13.15 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 O-C-N 124.076 1.566 . . . . 0.44 109.664 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.443 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -50.21 -179.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.358 -0.839 . . . . 0.56999999999999995 110.158 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -82.88 73.58 2.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.278 -1.129 . . . . 0.48999999999999999 110.278 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.535 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 4.4 tt -179.96 93.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.221 -1.164 . . . . 0.40999999999999998 110.788 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 3.2 tt -109.55 -15.58 14.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.823 -1.151 . . . . 0.29999999999999999 110.719 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.475 ' HB2' ' CE1' ' A' ' 201' ' ' PHE . . . -153.15 102.81 2.66 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.774 -1.203 . . . . 0.20000000000000001 111.591 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -112.15 119.2 37.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.16 109.789 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.51 ' CB ' ' HB3' ' A' ' 227' ' ' SER . . . -110.11 151.41 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.23000000000000001 110.488 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.415 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.1 m-30 -90.64 165.53 22.41 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.38 110.686 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.7 Cg_endo -73.56 143.03 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.021 1.537 . . . . 0.40000000000000002 109.804 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -70.5 72.74 1.78 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.896 1.471 . . . . 0.32000000000000001 110.572 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.3 -101.5 2.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.433 -1.467 . . . . 0.32000000000000001 109.433 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.15 -160.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.902 1.475 . . . . 0.46999999999999997 110.28 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -6.97 26.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.993 . . . . 0.63 110.112 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.11 52.08 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.473 -0.767 . . . . 0.53000000000000003 109.772 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -127.68 172.27 18.93 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.409 -1.477 . . . . 0.25 109.409 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' A' ' 163' ' ' ILE . . . 45.69 24.63 1.25 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.33 -1.508 . . . . 0.10000000000000001 109.33 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 0.2 OUTLIER -81.47 92.83 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -1.142 . . . . 0.10000000000000001 110.233 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 164' ' ' MET . . . -69.37 98.55 1.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.089999999999999997 110.294 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.43 ' O ' ' OE2' ' A' ' 223' ' ' GLU . 19.2 m170 -102.98 138.14 40.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.089999999999999997 110.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 17.5 m-85 -107.15 133.16 52.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.10000000000000001 111.284 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 42.9 t0 -45.55 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.936 -0.764 . . . . 0.14000000000000001 108.936 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 201' ' ' PHE . 0.8 OUTLIER -40.86 -34.16 0.37 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.014 -1.053 . . . . 0.17999999999999999 111.525 -177.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.575 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 48.8 t0 -73.75 0.54 12.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.772 -1.205 . . . . 0.23999999999999999 110.46 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.522 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 10.5 mm-40 -97.42 -161.72 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.123 . . . . 0.41999999999999998 109.903 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.539 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 69.6 m -133.24 153.67 51.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.916 -1.115 . . . . 0.46999999999999997 110.835 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.539 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.8 OUTLIER -148.3 166.47 27.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.308 -0.87 . . . . 0.27000000000000002 109.796 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.3 OUTLIER -178.81 175.07 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.069 -1.019 . . . . 0.29999999999999999 110.871 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -139.01 25.75 2.49 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.565 -0.854 . . . . 0.60999999999999999 109.817 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.2 t -90.66 -88.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 0.78000000000000003 110.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 210' ' ' SER . 35.7 p -158.88 18.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.91000000000000003 110.0 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 213' ' ' GLY . 6.9 ptpt -145.69 -174.11 4.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.93000000000000005 110.133 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 44.34 -168.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.79000000000000004 109.625 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.516 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 97.7 m-85 -70.33 121.56 17.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.68999999999999995 110.195 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 218' ' ' LEU . 47.7 m-80 -87.31 116.89 25.71 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.159 -0.963 . . . . 0.40000000000000002 109.086 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.677 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -41.17 -35.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.625 -0.83 . . . . 0.17000000000000001 110.332 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.2 m-85 -52.37 -45.87 65.95 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.405 -1.331 . . . . 0.28000000000000003 107.405 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 9.7 tp -81.42 -73.16 0.39 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.435 -0.802 . . . . 0.46000000000000002 110.993 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 201' ' ' PHE . 1.6 p -45.5 -56.14 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.39000000000000001 110.325 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -60.5 -48.5 81.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.087 -1.008 . . . . 0.17000000000000001 111.114 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -56.7 -24.59 50.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.177 -1.577 . . . . 0.10000000000000001 108.406 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.606 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.3 t60 -83.33 -49.87 8.93 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.749 -0.659 . . . . 0.20999999999999999 110.325 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 226' ' ' HIS . 3.0 tp10 -61.69 -44.54 96.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.933 -1.104 . . . . 0.28000000000000003 108.782 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.575 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER -60.23 -62.16 2.07 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.472 -0.768 . . . . 0.17999999999999999 109.026 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.85 -28.86 0.73 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.918 -1.673 . . . . 0.20999999999999999 108.918 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 1.0 OUTLIER -80.91 -68.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -1.134 . . . . 0.17000000000000001 111.084 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.514 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -46.93 -38.41 10.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.51 -0.744 . . . . 0.33000000000000002 112.288 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.527 HD21 ' N ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER -100.13 -37.45 8.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.53000000000000003 110.977 -178.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.527 ' N ' HD21 ' A' ' 228' ' ' LEU . . . -74.39 -87.42 0.23 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.963 -1.255 . . . . 0.40999999999999998 109.963 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.7 OUTLIER -161.96 -176.23 5.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.45000000000000001 110.789 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 2.6 m-20 -55.17 -58.84 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.374 -0.829 . . . . 0.62 110.19 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 231' ' ' ASP . 3.6 m80 -161.6 176.15 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.45000000000000001 110.639 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 2.4 p 179.73 50.69 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.79 -0.818 . . . . 0.38 108.79 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -125.09 20.21 8.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.537 -0.727 . . . . 0.47999999999999998 110.584 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.568 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -43.12 -53.53 10.54 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 119.443 -0.903 . . . . 0.38 109.831 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 50.5 Cg_endo -86.05 -47.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.595 1.313 . . . . 0.28000000000000003 110.573 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.23 94.55 0.09 OUTLIER Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.233 -1.46 . . . . 0.23999999999999999 111.589 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.609 ' HB3' ' CB ' ' A' ' 257' ' ' ASP . . . -144.42 162.16 37.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.211 -1.17 . . . . 0.28000000000000003 110.358 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.606 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -77.61 57.73 1.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.40000000000000002 108.72 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.538 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 21.6 mmm -133.14 -35.71 1.03 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.45000000000000001 110.354 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -43.99 169.86 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.152 -0.968 . . . . 0.56999999999999995 110.366 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.5 Cg_endo -71.85 -8.09 22.35 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.763 1.402 . . . . 0.76000000000000001 109.842 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 16.1 mt -98.83 146.76 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.89000000000000001 109.699 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.575 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 36.8 p90 -128.92 -25.97 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.03 -1.044 . . . . 0.78000000000000003 110.976 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.528 HG21 ' CG2' ' A' ' 243' ' ' ILE . 0.2 OUTLIER 2.73 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.602 0.964 . . . . 0.60999999999999999 113.602 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -70.23 107.56 3.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.381 -1.45 . . . . 0.73999999999999999 109.686 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 2.2 t -65.32 -151.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 0.81000000000000005 110.252 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.462 ' N ' ' OG1' ' A' ' 247' ' ' THR . . . -84.31 -5.0 87.63 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.404 -1.478 . . . . 0.56000000000000005 109.404 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.04 30.13 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -1.155 . . . . 0.37 110.38 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -28.8 61.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.44 110.406 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 1.9 m-70 -164.82 -61.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.53000000000000003 110.425 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 2.8 m-85 -174.38 -174.4 0.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.967 . . . . 0.38 110.516 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.448 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -68.07 53.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.51 -0.744 . . . . 0.19 110.559 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.661 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.1 -47.57 43.52 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 107.963 -1.125 . . . . 0.28000000000000003 107.963 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.9 Cg_endo -73.59 51.0 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.137 1.598 . . . . 0.48999999999999999 110.979 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.1 m-20 -50.65 -32.42 19.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.018 -1.051 . . . . 0.48999999999999999 110.494 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.609 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -53.82 -54.13 42.75 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.885 -1.126 . . . . 0.31 109.136 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -66.01 -35.48 80.69 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.074 -1.05 . . . . 0.14000000000000001 108.784 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.538 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 55.2 t -63.93 -86.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.17000000000000001 110.581 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -55.0 -43.73 73.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.099 -1.001 . . . . 0.26000000000000001 109.569 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.83 -70.2 0.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.641 -0.984 . . . . 0.19 110.641 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.597 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -72.66 -21.13 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.727 -1.455 . . . . 0.22 110.296 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.561 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 0.6 OUTLIER -64.86 -20.47 66.43 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.985 -1.072 . . . . 0.39000000000000001 108.659 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 29.1 t -103.72 -41.88 5.8 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.203 -0.599 . . . . 0.46999999999999997 111.164 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.466 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -84.3 -47.09 11.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.353 -0.842 . . . . 0.47999999999999998 111.145 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.58 ' CD1' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -69.64 -20.52 63.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.40999999999999998 110.223 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -53.51 -102.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.276 -1.53 . . . . 0.46000000000000002 109.276 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.33 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.867 1.457 . . . . 0.57999999999999996 110.333 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -83.22 155.79 33.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.64000000000000001 109.388 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.612 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.206 -1.173 . . . . 0.94999999999999996 110.414 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.465 ' O ' HD22 ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.525 0.679 . . . . 1.03 109.259 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.527 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.01 55.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.682 -0.636 . . . . 1.04 111.67 178.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -140.94 77.03 1.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.193 -0.942 . . . . 0.77000000000000002 109.403 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.573 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 10.1 t90 -149.72 -69.22 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.41999999999999998 111.411 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.6 t -100.48 77.17 1.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.44 111.101 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -170.21 49.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.185 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.2 OUTLIER -75.46 -29.15 59.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.29999999999999999 110.141 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 25.0 p-10 -129.74 123.46 31.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.14999999999999999 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 3.8 mt -141.32 -178.62 5.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.13 110.364 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -122.6 150.75 42.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.12 109.829 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.637 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 40.3 p90 -145.11 -164.31 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.33000000000000002 110.692 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.1 154.2 40.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.54000000000000004 110.888 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.585 HG12 ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.48 110.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.33000000000000002 110.223 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 3.4 m -159.91 41.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.27000000000000002 110.147 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 3.4 t-20 -41.36 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.696 -0.802 . . . . 0.40999999999999998 108.993 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 6.3 t80 -179.91 -176.14 0.33 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.514 -0.741 . . . . 0.40000000000000002 109.593 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.551 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -132.52 49.77 4.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.013 -1.054 . . . . 0.45000000000000001 110.611 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.4 Cg_endo -76.78 -85.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.854 1.45 . . . . 0.35999999999999999 110.253 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.31 -0.5 38.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.25 109.622 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.526 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 3.6 ptm -123.12 133.93 54.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.39000000000000001 109.976 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -86.33 178.52 7.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.47999999999999998 110.354 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -45.74 -33.76 3.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.845 . . . . 0.40000000000000002 110.068 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.5 t -63.16 -58.3 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.46000000000000002 109.791 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.526 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 6.3 mp0 -54.46 -57.72 10.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.268 -0.895 . . . . 0.46999999999999997 109.566 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.501 HG22 ' CE ' ' A' ' 129' ' ' MET . 4.0 t -45.34 -37.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.111 -1.07 . . . . 0.31 108.111 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.477 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 9.6 tt0 -59.03 -39.97 83.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.486 -0.931 . . . . 0.47999999999999998 108.486 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.559 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 12.9 tttt -73.07 -50.37 23.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.64000000000000001 108.776 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.65 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.64 -60.61 2.1 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.163 -0.961 . . . . 0.41999999999999998 110.537 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -68.44 -50.97 48.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.34000000000000002 111.216 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.625 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.91 -71.17 0.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.957 -1.089 . . . . 0.46999999999999997 110.147 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -40.18 -58.78 1.4 Allowed 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.651 -0.656 . . . . 0.46999999999999997 110.114 178.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.75 -38.81 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.707 -1.246 . . . . 0.25 108.365 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -71.0 -34.73 71.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.846 . . . . 0.34999999999999998 108.985 178.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -56.4 -45.45 80.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.69999999999999996 108.394 178.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.68 -44.67 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.987 -0.746 . . . . 0.60999999999999999 108.987 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.59 ' CH2' HG13 ' A' ' 262' ' ' ILE . 26.3 t-105 -55.02 -36.69 65.74 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.718 -0.845 . . . . 0.39000000000000001 108.718 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -74.12 -38.42 63.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.742 -0.836 . . . . 0.34999999999999998 108.742 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -37.48 61.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.533 -0.729 . . . . 0.35999999999999999 109.045 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 34.8 m -85.45 -35.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.5 110.116 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 148' ' ' VAL . 15.3 t -153.93 127.25 4.24 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.038 -1.039 . . . . 0.51000000000000001 110.15 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.67 59.88 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.871 1.459 . . . . 0.31 110.813 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.489 HD21 ' N ' ' A' ' 151' ' ' LEU . 1.9 mm? -72.53 145.88 47.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.17999999999999999 110.086 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -91.88 133.68 35.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.17000000000000001 110.32 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.9 p90 -149.11 147.91 29.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.14000000000000001 110.237 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 119' ' ' THR . 6.5 m -152.72 133.03 13.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.14999999999999999 110.29 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 32.1 mtm180 -91.86 119.32 31.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.013 -1.054 . . . . 0.20000000000000001 110.16 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.56 108.67 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.22 110.3 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -72.17 -4.11 27.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.32000000000000001 110.091 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -30.08 69.79 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.409 -0.807 . . . . 0.33000000000000002 109.581 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.81 30.65 0.63 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.734 -1.346 . . . . 0.28000000000000003 109.734 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' A' ' 119' ' ' THR . 57.7 mt -126.68 66.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.073 -1.251 . . . . 0.29999999999999999 109.308 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -121.9 152.1 39.99 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.358 0.599 . . . . 0.20000000000000001 110.612 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.466 ' O ' ' O ' ' A' ' 196' ' ' GLY . 5.4 t70 -120.5 -40.04 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.10000000000000001 109.818 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -128.57 171.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.36 -0.838 . . . . 0.10000000000000001 110.105 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.539 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 2.3 ptp -177.14 153.99 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.539 -1.351 . . . . 0.11 111.379 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 3.6 tt -99.3 118.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.10000000000000001 109.408 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 15.1 p -162.85 144.64 10.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.752 -1.218 . . . . 0.10000000000000001 111.237 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.652 ' CE2' ' CG2' ' A' ' 169' ' ' ILE . 0.9 OUTLIER -66.42 122.83 18.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.089999999999999997 110.006 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -80.87 127.94 8.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.972 -1.251 . . . . 0.20000000000000001 109.972 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.652 ' CG2' ' CE2' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -116.07 102.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.535 -0.98 . . . . 0.55000000000000004 109.659 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.639 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.78 81.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.439 0.638 . . . . 0.84999999999999998 112.257 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 169' ' ' ILE . 1.7 mm-40 -125.95 -4.86 6.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.70999999999999996 110.267 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.524 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 8.8 m-70 -87.41 -140.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.41999999999999998 109.995 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -169.89 -36.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.399 -1.48 . . . . 0.33000000000000002 109.399 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -61.36 -61.23 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -1.104 . . . . 0.33000000000000002 110.194 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.8 116.02 17.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.27000000000000002 110.16 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -55.41 114.43 7.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 0.34000000000000002 110.071 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.518 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 42.9 Cg_endo -73.14 -79.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.907 1.477 . . . . 0.46999999999999997 110.898 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -46.59 142.95 2.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 0.34999999999999998 110.778 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 4.4 p30 179.5 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.20000000000000001 110.751 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 46.76 -167.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.38 -1.488 . . . . 0.25 109.38 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.2 Cg_endo -75.81 5.01 4.66 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.197 1.63 . . . . 0.44 110.304 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -44.57 173.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -0.797 . . . . 0.56999999999999995 110.898 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.506 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.64 76.71 0.02 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.895 -0.882 . . . . 0.48999999999999999 110.895 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.518 ' CD2' ' O ' ' A' ' 177' ' ' PRO . 0.4 OUTLIER 179.46 88.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.174 -1.192 . . . . 0.40999999999999998 110.373 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' A' ' 214' ' ' TYR . 4.6 tt -108.76 -21.13 12.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.832 -1.168 . . . . 0.29999999999999999 111.612 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.518 ' CB ' ' OE1' ' A' ' 223' ' ' GLU . . . -149.97 101.09 3.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.48 -1.388 . . . . 0.20000000000000001 111.907 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.7 OUTLIER -101.76 123.78 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.473 -0.767 . . . . 0.16 109.431 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.517 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -108.88 137.32 46.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.23000000000000001 110.65 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -80.0 173.1 8.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.38 110.369 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 48.4 Cg_endo -73.75 133.34 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.975 1.513 . . . . 0.40000000000000002 109.786 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.527 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -69.79 81.17 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.866 1.456 . . . . 0.32000000000000001 110.604 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.55 -106.63 1.78 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.292 -1.523 . . . . 0.32000000000000001 109.292 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.95 -159.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.882 1.464 . . . . 0.46999999999999997 110.337 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -63.07 -11.27 18.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.941 . . . . 0.63 110.383 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.76 56.02 0.68 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.428 -0.795 . . . . 0.53000000000000003 110.147 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.3 174.59 22.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.212 -1.555 . . . . 0.25 109.212 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.543 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 42.09 25.75 0.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.946 -1.261 . . . . 0.10000000000000001 109.946 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 196' ' ' GLY . 0.3 OUTLIER -79.38 86.16 5.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.32 . . . . 0.10000000000000001 110.005 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 165' ' ' ILE . . . -62.94 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.089999999999999997 110.002 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.519 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.4 m170 -98.79 134.01 42.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.089999999999999997 110.669 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 203' ' ' ASP . 13.3 m-30 -102.74 131.07 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -0.903 . . . . 0.10000000000000001 109.877 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.5 OUTLIER -46.3 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.544 -0.91 . . . . 0.14000000000000001 108.544 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.0 p30 -37.68 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.17999999999999999 111.53 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.551 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -77.7 3.95 12.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.762 -1.211 . . . . 0.23999999999999999 110.829 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 202' ' ' ASP . 15.6 mm-40 -100.68 -167.39 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.036 . . . . 0.41999999999999998 110.315 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.507 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 3.2 m -124.64 150.28 46.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -0.929 . . . . 0.46999999999999997 110.385 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.507 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -147.42 142.74 27.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.902 . . . . 0.27000000000000002 109.636 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.53 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -157.81 174.21 15.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.822 -1.174 . . . . 0.29999999999999999 110.984 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.5 t -130.66 41.0 3.44 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.639 0.733 . . . . 0.60999999999999999 109.384 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.9 t -109.87 -99.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.78000000000000003 110.267 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.494 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -149.59 13.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.068 -1.02 . . . . 0.91000000000000003 110.247 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.99 155.55 44.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.93000000000000005 109.858 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.81 -175.24 53.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.081 -1.608 . . . . 0.79000000000000004 109.081 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.578 ' CD1' HD13 ' A' ' 185' ' ' LEU . 67.7 m-85 -71.26 106.53 3.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 0.68999999999999995 109.931 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 218' ' ' LEU . 61.6 m-20 -75.04 119.28 18.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.154 -0.966 . . . . 0.40000000000000002 108.528 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.65 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -39.71 -37.01 0.47 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.82 -0.752 . . . . 0.17000000000000001 110.271 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.571 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.3 m-30 -52.16 -48.82 64.73 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.653 -1.24 . . . . 0.28000000000000003 107.653 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.559 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 6.8 tp -74.56 -69.81 0.44 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.856 -0.611 . . . . 0.46000000000000002 110.45 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.59 HG23 ' CZ ' ' A' ' 201' ' ' PHE . 0.5 OUTLIER -50.12 -70.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.077 -1.014 . . . . 0.39000000000000001 109.75 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -41.73 -52.55 3.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.07 . . . . 0.17000000000000001 111.248 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.47 -37.3 77.84 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.417 -1.427 . . . . 0.10000000000000001 108.977 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.562 ' HB2' ' CD1' ' A' ' 239' ' ' LEU . 5.6 t60 -64.91 -53.39 47.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.421 0.629 . . . . 0.20999999999999999 109.551 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.518 ' OE1' ' CB ' ' A' ' 186' ' ' ALA . 25.0 tp10 -57.99 -46.14 85.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.28000000000000003 109.301 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.511 ' CG ' ' O ' ' A' ' 220' ' ' ALA . 12.3 m-30 -52.57 -63.44 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.17999999999999999 109.279 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -34.46 2.73 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.913 -1.675 . . . . 0.20999999999999999 108.913 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.663 ' CE1' ' CG ' ' A' ' 240' ' ' MET . 0.0 OUTLIER -76.03 -79.02 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -1.132 . . . . 0.17000000000000001 110.839 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.543 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -35.4 -53.93 0.65 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.666 -0.646 . . . . 0.33000000000000002 111.916 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -80.59 -44.83 18.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.998 -1.064 . . . . 0.53000000000000003 110.725 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -63.58 -82.78 0.08 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.775 -1.33 . . . . 0.40999999999999998 109.775 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.478 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.5 OUTLIER -177.5 -170.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -1.076 . . . . 0.45000000000000001 110.299 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 230' ' ' LEU . 1.8 m-20 -42.22 -61.62 1.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.62 110.51 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.634 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -159.51 -175.9 5.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.289 -0.882 . . . . 0.45000000000000001 109.989 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.0 61.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.295 -0.878 . . . . 0.38 109.56 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.579 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.68 24.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.279 -0.968 . . . . 0.47999999999999998 111.502 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.548 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -35.93 -51.9 1.58 Allowed Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.987 -0.685 . . . . 0.38 111.106 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 51.1 Cg_endo -85.58 -49.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.643 1.338 . . . . 0.28000000000000003 111.291 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.19 101.25 0.14 Allowed Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.214 -1.47 . . . . 0.23999999999999999 111.581 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -143.22 -174.21 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -1.124 . . . . 0.28000000000000003 110.238 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 239' ' ' LEU . 3.1 tp -88.86 27.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.371 1.081 . . . . 0.40000000000000002 108.87 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.663 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -119.44 -6.46 10.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.872 -1.142 . . . . 0.45000000000000001 110.655 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -60.53 170.31 1.42 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 121.15 -0.969 . . . . 0.56999999999999995 111.558 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.1 Cg_endo -76.09 6.08 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.516 1.272 . . . . 0.76000000000000001 110.597 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.602 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 16.1 mt -126.89 164.88 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.337 -0.852 . . . . 0.89000000000000001 109.506 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.559 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 33.3 p90 -139.72 -29.2 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.78000000000000003 111.249 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.52 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER 3.18 -67.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 114.14 1.163 . . . . 0.60999999999999999 114.14 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -59.87 101.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.279 -1.513 . . . . 0.73999999999999999 109.816 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.516 ' N ' ' HB2' ' A' ' 250' ' ' SER . 80.6 p -50.44 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.81000000000000005 110.146 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -56.79 -26.14 53.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.463 -1.455 . . . . 0.56000000000000005 109.463 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.31 29.33 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.16 . . . . 0.37 110.014 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.521 ' O ' ' ND1' ' A' ' 251' ' ' HIS . 0.5 OUTLIER -62.8 -10.98 14.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.44 109.982 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 250' ' ' SER . 0.1 OUTLIER -174.42 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.53000000000000003 110.204 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.3 OUTLIER 179.67 -173.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.38 110.285 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.461 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 14.2 ptt? -66.55 53.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.605 -0.684 . . . . 0.19 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.664 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -47.84 -46.3 62.52 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.28000000000000003 107.833 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.9 Cg_endo -74.54 52.52 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.958 1.504 . . . . 0.48999999999999999 110.806 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.57 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 9.9 m-20 -55.78 -31.51 62.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.159 -0.963 . . . . 0.48999999999999999 110.572 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -51.35 -45.91 62.52 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.655 -1.218 . . . . 0.31 108.551 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.555 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.72 -39.47 64.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.453 -0.943 . . . . 0.14000000000000001 108.453 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.57 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 97.3 t -56.24 -76.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.17000000000000001 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.624 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 7.1 pt20 -71.05 -34.76 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.32 -0.862 . . . . 0.26000000000000001 110.567 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -44.37 -58.34 4.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.308 -1.517 . . . . 0.19 109.308 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.59 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -82.87 -23.12 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.023 -1.28 . . . . 0.22 110.89 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.624 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 0.1 OUTLIER -62.63 -20.0 64.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.462 . . . . 0.39000000000000001 108.195 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -103.18 -36.92 7.93 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.181 -0.608 . . . . 0.46999999999999997 111.125 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 48.5 mt -88.32 -46.89 8.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.139 -0.976 . . . . 0.47999999999999998 111.216 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.465 ' HB3' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -81.33 -4.76 56.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.40999999999999998 110.299 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.8 -112.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.231 -1.548 . . . . 0.46000000000000002 109.231 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.55 86.2 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.789 1.415 . . . . 0.57999999999999996 110.296 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.27 170.12 1.8 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.64000000000000001 109.575 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.573 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.94999999999999996 110.166 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.256 -0.646 . . . . 1.03 109.256 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.6 OUTLIER 32.15 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.131 0.491 . . . . 1.04 111.461 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 110' ' ' THR . 7.6 mttt -124.73 64.92 1.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.77000000000000002 110.357 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.61 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.1 t90 -123.3 -67.94 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.897 . . . . 0.41999999999999998 110.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.436 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 72.8 p -99.38 54.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.44 110.151 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 17.5 mmtt -145.31 87.15 1.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.48999999999999999 110.289 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 116' ' ' MET . 2.1 tmm? -121.34 -4.45 9.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.29999999999999999 110.052 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.14999999999999999 110.076 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.433 HD21 ' CB ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -147.29 -167.1 2.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.13 110.31 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.531 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.6 OUTLIER -133.66 156.37 48.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.12 110.473 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.644 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 46.0 p90 -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.49 -0.884 . . . . 0.33000000000000002 110.94 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 1.1 mtt85 -124.85 151.39 45.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.54000000000000004 110.114 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.645 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.2 pp -114.02 97.93 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.947 . . . . 0.33000000000000002 111.14 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 7.3 m -147.34 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.27000000000000002 110.471 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.0 t30 -44.31 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.40999999999999998 109.379 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.566 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.0 t80 -179.85 -166.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.437 -0.79 . . . . 0.40000000000000002 109.736 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -148.95 48.2 0.57 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.982 -1.074 . . . . 0.45000000000000001 110.693 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.3 Cg_endo -74.04 -87.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.998 1.525 . . . . 0.35999999999999999 110.268 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.96 -0.89 57.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.25 109.65 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.539 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -119.55 158.83 25.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.816 . . . . 0.39000000000000001 109.718 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -112.31 177.03 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.47999999999999998 110.183 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 130' ' ' THR . 1.3 t-160 -43.18 -40.12 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.40000000000000002 109.71 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 23.3 t -61.49 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.46000000000000002 109.629 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.3 OUTLIER -62.63 -60.74 3.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 0.46999999999999997 109.375 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 4.9 t -45.72 -36.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.882 -1.155 . . . . 0.31 107.882 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -58.21 -40.81 82.59 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.053 -1.091 . . . . 0.47999999999999998 108.053 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.7 tttt -72.74 -54.56 8.6 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.76 -0.83 . . . . 0.64000000000000001 108.76 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.628 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.88 -63.22 1.02 Allowed 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.958 -1.088 . . . . 0.41999999999999998 110.101 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -61.7 -55.82 26.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.213 -0.93 . . . . 0.34000000000000002 110.849 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 3.3 tttt -64.96 -73.2 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.46999999999999997 110.331 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.37 -63.06 0.53 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.686 -0.634 . . . . 0.46999999999999997 110.562 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.51 -36.92 7.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.77 -1.206 . . . . 0.25 108.665 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -72.62 -33.05 66.4 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.361 -0.837 . . . . 0.34999999999999998 108.937 178.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.226 -0.921 . . . . 0.69999999999999996 108.784 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 40.8 t -72.13 -48.28 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.589 -0.694 . . . . 0.60999999999999999 109.294 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.584 ' CH2' HG13 ' A' ' 262' ' ' ILE . 32.0 t-105 -56.71 -40.18 75.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.788 . . . . 0.39000000000000001 109.047 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.2 m -73.12 -31.23 64.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.598 -0.89 . . . . 0.34999999999999998 108.598 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -57.74 -43.22 85.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.132 -0.692 . . . . 0.35999999999999999 109.132 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.7 m -76.16 -33.0 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.618 -0.833 . . . . 0.5 109.739 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.528 ' N ' HG22 ' A' ' 148' ' ' VAL . 4.6 t -145.1 120.57 5.86 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 0.51000000000000001 110.149 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.36 58.86 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.757 1.399 . . . . 0.31 110.658 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 266' ' ' TYR . 8.8 mt -72.58 161.17 31.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.17999999999999999 110.027 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.0 OUTLIER -104.46 102.02 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.17000000000000001 110.255 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 151' ' ' LEU . 37.3 m-85 -123.3 142.86 50.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.14000000000000001 110.2 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 119' ' ' THR . 3.3 m -142.0 141.35 32.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.184 -0.948 . . . . 0.14999999999999999 110.448 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.644 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -100.06 91.64 4.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.20000000000000001 109.985 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -94.06 106.91 18.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.22 110.153 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 158' ' ' ASP . 51.1 p-80 -63.83 -29.62 70.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.32000000000000001 110.145 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.448 ' HB3' HD21 ' A' ' 156' ' ' LEU . 2.1 t0 -41.19 -30.58 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.589 -0.694 . . . . 0.33000000000000002 110.098 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.73 32.13 0.72 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.716 -1.354 . . . . 0.28000000000000003 109.716 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 119' ' ' THR . 39.9 mt -121.51 71.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.127 -1.219 . . . . 0.29999999999999999 109.513 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -138.55 156.19 47.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.888 -0.725 . . . . 0.20000000000000001 110.767 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.433 ' CB ' HD21 ' A' ' 118' ' ' LEU . 39.0 t0 -124.64 -31.08 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.439 -0.788 . . . . 0.10000000000000001 110.036 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -122.47 160.66 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.236 -0.915 . . . . 0.10000000000000001 109.912 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -165.36 140.96 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.373 -1.454 . . . . 0.11 111.6 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.554 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 3.9 tt -90.32 116.67 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 0.10000000000000001 109.538 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 3.7 p -156.1 159.88 39.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.921 -1.112 . . . . 0.10000000000000001 110.46 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.8 p90 -76.55 116.59 17.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.409 -0.807 . . . . 0.089999999999999997 109.735 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -64.16 119.69 16.83 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.434 -1.066 . . . . 0.20000000000000001 110.434 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.576 ' O ' ' C ' ' A' ' 170' ' ' LYS . 1.7 tp -117.09 97.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.639 -0.918 . . . . 0.55000000000000004 109.532 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.579 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.09 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 112.634 0.605 . . . . 0.84999999999999998 112.634 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -156.03 17.1 0.36 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.847 . . . . 0.70999999999999996 110.606 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.581 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 2.2 m170 -82.58 -90.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.41999999999999998 110.207 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -177.35 -36.73 0.06 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.42 -1.472 . . . . 0.33000000000000002 109.42 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -148.41 -65.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.33000000000000002 110.185 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.479 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 58.0 t80 -42.13 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.27000000000000002 110.403 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 174' ' ' ASP . 10.9 m-30 -47.9 104.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.34000000000000002 110.264 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 49.1 Cg_endo -79.72 -64.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.09 1.574 . . . . 0.46999999999999997 110.677 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.579 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -72.64 138.33 46.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.072 -1.017 . . . . 0.34999999999999998 111.07 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 202' ' ' ASP . 0.5 OUTLIER 178.79 78.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.071 -1.052 . . . . 0.20000000000000001 111.652 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.551 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 35.41 -153.66 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.86 -0.896 . . . . 0.25 110.86 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.6 Cg_endo -74.93 3.39 5.62 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.554 1.818 . . . . 0.44 110.361 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 184' ' ' LEU . 14.1 t -40.15 162.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.56999999999999995 110.256 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -59.13 76.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.498 -1.041 . . . . 0.48999999999999999 110.498 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 182' ' ' SER . 9.9 tp 179.76 84.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.391 -1.064 . . . . 0.40999999999999998 110.047 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 214' ' ' TYR . 0.4 OUTLIER -100.92 -25.27 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.224 . . . . 0.29999999999999999 111.07 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -150.4 105.07 3.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.68 -1.262 . . . . 0.20000000000000001 111.928 -179.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 187' ' ' HIS . 21.2 p-80 -110.65 122.55 48.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.16 109.437 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.525 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -116.29 131.3 56.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.23000000000000001 110.422 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.581 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.7 OUTLIER -73.48 169.33 18.76 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.38 110.675 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.8 Cg_endo -73.59 144.0 35.07 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.171 1.617 . . . . 0.40000000000000002 109.618 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.2 Cg_endo -70.71 81.12 1.09 Allowed 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.91 1.479 . . . . 0.32000000000000001 110.82 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.4 -107.28 2.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.466 -1.454 . . . . 0.32000000000000001 109.466 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -75.76 -162.76 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.927 1.488 . . . . 0.46999999999999997 110.731 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -57.85 -15.43 8.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.63 110.316 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.22 54.96 0.7 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.496 -0.753 . . . . 0.53000000000000003 110.251 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.4 170.09 21.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.409 -1.476 . . . . 0.25 109.409 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.495 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 41.76 27.44 0.35 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.62 -1.392 . . . . 0.10000000000000001 109.62 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 2.0 m-20 -76.75 92.12 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.239 . . . . 0.10000000000000001 110.087 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.532 ' HB3' ' CG ' ' A' ' 223' ' ' GLU . . . -74.69 98.63 3.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.089999999999999997 109.954 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.572 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 29.2 m170 -117.47 126.03 51.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.218 -0.926 . . . . 0.089999999999999997 110.688 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 203' ' ' ASP . 32.6 m-85 -93.41 141.97 27.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.10000000000000001 110.571 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.533 ' CB ' ' HG3' ' A' ' 205' ' ' GLU . 0.1 OUTLIER -49.0 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.183 -1.043 . . . . 0.14000000000000001 108.183 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.564 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 4.3 p30 -37.21 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.17999999999999999 111.604 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.551 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.7 t0 -75.56 -1.62 25.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.568 -1.333 . . . . 0.23999999999999999 110.994 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.533 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 21.4 mm-40 -94.15 -163.52 1.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.937 -1.102 . . . . 0.41999999999999998 110.379 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.424 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -125.94 150.84 47.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.46999999999999997 110.729 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.564 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -143.36 140.86 30.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 0.27000000000000002 109.295 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.501 ' O ' ' CD1' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.18 177.67 11.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 110.95 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 209' ' ' SER . 2.0 t -131.56 45.95 2.72 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.584 0.707 . . . . 0.60999999999999999 109.6 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.1 t -112.38 -105.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.78000000000000003 110.164 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 210' ' ' SER . 25.2 p -157.48 17.85 0.27 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.91000000000000003 110.268 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 213' ' ' GLY . 4.2 mttp -125.91 -86.45 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.93000000000000005 110.193 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . -49.08 -178.3 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.317 . . . . 0.79000000000000004 109.806 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.576 ' CZ ' HD11 ' A' ' 185' ' ' LEU . 94.8 m-85 -57.08 115.15 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.68999999999999995 109.992 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 218' ' ' LEU . 9.9 m-80 -82.67 116.03 21.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.008 . . . . 0.40000000000000002 109.044 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.628 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 1.2 mp -41.73 -33.38 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.436 -0.79 . . . . 0.17000000000000001 110.283 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 5.2 m-85 -53.44 -45.07 69.33 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 118.07 -1.452 . . . . 0.28000000000000003 107.431 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.583 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 20.9 tp -82.52 -71.0 0.51 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.523 -0.762 . . . . 0.46000000000000002 110.993 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.603 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -47.86 -56.61 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.39000000000000001 110.19 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -59.56 -46.92 87.51 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.968 -1.083 . . . . 0.17000000000000001 111.131 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -60.33 -23.6 64.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.164 -1.585 . . . . 0.10000000000000001 108.454 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.616 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 3.4 t-160 -80.43 -50.04 10.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.373 -0.603 . . . . 0.20999999999999999 109.373 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 199' ' ' ALA . 2.7 tp10 -62.31 -33.32 74.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.065 -1.022 . . . . 0.28000000000000003 108.442 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.535 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 6.2 m-85 -64.78 -66.87 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.669 0.747 . . . . 0.17999999999999999 108.99 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.463 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.35 -28.15 0.54 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.762 -1.735 . . . . 0.20999999999999999 108.762 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.441 ' CE1' ' HB3' ' A' ' 240' ' ' MET . 3.3 m80 -81.42 -68.07 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -1.166 . . . . 0.17000000000000001 110.842 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.525 ' CA ' ' HB2' ' A' ' 188' ' ' ALA . 0.2 OUTLIER -40.36 -42.78 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.33000000000000002 111.88 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.534 ' CD1' ' OH ' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -101.16 -37.77 8.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.885 -1.134 . . . . 0.53000000000000003 111.364 -178.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.49 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -65.09 -81.86 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.624 -0.99 . . . . 0.40999999999999998 110.624 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.479 ' HB3' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -169.85 -147.83 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -1.18 . . . . 0.45000000000000001 110.658 -178.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -86.87 -44.48 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.356 -0.84 . . . . 0.62 110.532 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -179.99 161.88 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.45000000000000001 110.284 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 p -168.67 28.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.38 109.797 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.604 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -104.3 22.45 14.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -0.779 . . . . 0.47999999999999998 111.002 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -35.25 -50.37 1.24 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.559 -0.713 . . . . 0.38 110.685 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 47.5 Cg_endo -86.73 -49.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.433 1.228 . . . . 0.28000000000000003 111.14 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.06 101.33 0.14 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.137 -1.506 . . . . 0.23999999999999999 111.544 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -145.36 173.58 11.87 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.371 -1.076 . . . . 0.28000000000000003 109.7 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.598 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -80.85 38.31 0.45 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.826 -1.171 . . . . 0.40000000000000002 109.916 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.616 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 25.6 mtp -123.01 -17.61 6.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.45000000000000001 109.746 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -56.0 170.25 0.47 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.184 -0.948 . . . . 0.56999999999999995 110.97 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 46.3 Cg_endo -73.73 -10.9 23.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.626 1.329 . . . . 0.76000000000000001 110.006 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.586 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 36.5 mt -104.84 147.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.89000000000000001 109.787 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.583 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 41.8 p90 -131.25 -24.45 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.78000000000000003 111.115 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.535 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER 2.88 -68.97 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 113.534 0.938 . . . . 0.60999999999999999 113.534 -179.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.58 ' CZ ' ' O ' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -62.72 107.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.447 -1.408 . . . . 0.73999999999999999 109.5 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.447 ' N ' ' HB2' ' A' ' 250' ' ' SER . 42.7 p -54.1 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.81000000000000005 110.215 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.04 -9.76 54.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.317 -1.513 . . . . 0.56000000000000005 109.317 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -149.27 29.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -1.18 . . . . 0.37 110.526 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.6 OUTLIER -73.84 -31.52 63.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.996 -1.065 . . . . 0.44 110.091 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.8 -60.23 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.53000000000000003 109.913 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.58 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 179.42 -175.61 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.38 110.306 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.468 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 25.9 ptt? -68.83 52.5 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.19 110.416 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.646 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.2 -46.85 44.82 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 107.912 -1.144 . . . . 0.28000000000000003 107.912 177.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.3 Cg_endo -73.81 52.3 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.956 1.503 . . . . 0.48999999999999999 110.715 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.586 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 12.4 m-20 -57.22 -28.58 63.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.371 -0.831 . . . . 0.48999999999999999 110.436 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.546 ' HB2' ' CB ' ' A' ' 238' ' ' ALA . 2.0 m-20 -51.31 -45.44 62.23 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.015 -1.053 . . . . 0.31 109.235 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.02 -34.18 50.75 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.365 -0.976 . . . . 0.14000000000000001 108.365 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 98.6 t -58.6 -74.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.899 -0.72 . . . . 0.17000000000000001 110.533 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.637 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 14.1 pt20 -69.9 -37.05 75.87 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.267 -0.896 . . . . 0.26000000000000001 109.769 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.489 ' N ' ' HG3' ' A' ' 260' ' ' GLN . . . -41.53 -53.92 4.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.466 -1.454 . . . . 0.19 109.466 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.584 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -92.1 -23.58 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.963 -1.316 . . . . 0.22 110.97 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 7.1 tp60 -54.81 -26.12 32.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.001 -1.48 . . . . 0.39000000000000001 107.947 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.1 p -103.92 -41.68 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.244 0.545 . . . . 0.46999999999999997 111.127 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 4.0 mm? -73.95 -51.85 14.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.47999999999999998 111.477 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -76.18 -9.67 58.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.40999999999999998 110.533 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -60.38 -111.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.356 -1.498 . . . . 0.46000000000000002 109.356 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 88.98 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.819 1.431 . . . . 0.57999999999999996 110.226 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.29 168.53 50.67 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.605 -1.398 . . . . 0.64000000000000001 109.605 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.61 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 1.3 m-20 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.94999999999999996 110.247 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.512 ' HA ' HD11 ' A' ' 230' ' ' LEU . 1.1 p . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.444 -0.576 . . . . 1.03 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER 30.92 38.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.208 0.528 . . . . 1.04 111.356 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -135.96 61.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.77000000000000002 109.536 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.607 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 8.3 t90 -131.19 -50.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.41999999999999998 110.682 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.464 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 28.5 t -111.89 62.85 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.44 110.928 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.464 ' HG2' ' C ' ' A' ' 114' ' ' SER . 19.5 mmmt -149.09 42.05 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.074 -1.017 . . . . 0.48999999999999999 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 2.2 ttp -72.77 -19.58 61.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.137 -0.977 . . . . 0.29999999999999999 110.837 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 5.7 p30 -138.48 113.23 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.14999999999999999 110.743 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -143.47 -179.68 6.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.13 110.261 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -124.04 173.53 8.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.12 110.078 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 14.6 p90 -167.78 179.25 4.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.128 -0.982 . . . . 0.33000000000000002 111.008 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.9 tpt85 -126.03 147.66 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.54000000000000004 109.989 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.625 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 pp -110.36 77.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.33000000000000002 110.789 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 8.3 m -125.54 42.17 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.27000000000000002 110.299 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.612 ' OD1' ' N ' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -40.33 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.567 -0.853 . . . . 0.40999999999999998 109.212 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.667 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 2.9 t80 -178.9 169.33 1.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.044 -1.035 . . . . 0.40000000000000002 110.293 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -125.23 49.69 3.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.97 . . . . 0.45000000000000001 110.481 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.1 Cg_endo -73.97 -87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.121 1.59 . . . . 0.35999999999999999 110.317 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.08 2.1 50.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.25 109.805 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.517 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -117.88 159.15 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.39000000000000001 109.829 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -109.73 175.96 5.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.47999999999999998 110.103 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 71.6 t60 -43.39 -32.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.40000000000000002 109.738 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.3 t -68.42 -59.16 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.46000000000000002 109.752 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.517 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 32.8 mp0 -51.46 -59.87 3.76 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.309 -0.87 . . . . 0.46999999999999997 109.645 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 6.2 t -46.04 -37.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.261 -1.015 . . . . 0.31 108.261 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.56 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 12.1 tt0 -57.63 -39.1 76.2 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.347 -0.983 . . . . 0.47999999999999998 108.347 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -73.84 -52.66 12.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.948 0.88 . . . . 0.64000000000000001 108.819 178.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.669 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.48 -64.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.112 -0.993 . . . . 0.41999999999999998 110.508 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -63.17 -53.73 48.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.34000000000000002 111.327 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.65 -72.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.928 -1.107 . . . . 0.46999999999999997 110.371 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -39.49 -61.84 0.75 Allowed 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.697 -0.627 . . . . 0.46999999999999997 110.494 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -45.62 -37.99 6.17 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.795 -1.162 . . . . 0.25 108.291 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.37 -37.83 74.66 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.029 -0.73 . . . . 0.34999999999999998 109.029 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttpt -55.38 -40.66 71.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.69999999999999996 108.754 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.5 -44.84 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.69 -0.632 . . . . 0.60999999999999999 109.342 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.592 ' CH2' HG13 ' A' ' 262' ' ' ILE . 29.1 t-105 -56.3 -41.5 76.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.39000000000000001 109.161 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.5 OUTLIER -71.11 -34.42 71.06 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.288 -0.883 . . . . 0.34999999999999998 108.858 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.41 -41.64 80.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.602 -0.686 . . . . 0.35999999999999999 109.625 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 28.4 m -78.24 -29.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.5 110.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 146' ' ' SER . 13.4 t -152.27 141.91 14.59 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.94 -1.1 . . . . 0.51000000000000001 110.586 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.37 58.0 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.895 1.471 . . . . 0.31 110.313 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.495 HD22 ' HB3' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -77.01 138.41 39.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.17999999999999999 110.265 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -100.16 120.52 40.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.17000000000000001 109.995 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.513 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.0 p90 -137.57 141.01 41.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.14000000000000001 110.389 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 119' ' ' THR . 2.6 m -139.58 134.5 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.14999999999999999 110.011 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.599 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 1.1 mtm180 -92.64 89.63 6.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.20000000000000001 109.731 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.23 107.65 18.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.22 110.52 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -66.61 -11.9 55.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.32000000000000001 109.79 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -54.53 -21.73 11.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.649 -0.657 . . . . 0.33000000000000002 109.515 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.56 15.78 4.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.28000000000000003 109.477 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 119' ' ' THR . 24.3 mm -106.22 78.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.119 -1.224 . . . . 0.29999999999999999 108.943 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 124.78 45.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.20000000000000001 111.018 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.443 ' O ' ' O ' ' A' ' 196' ' ' GLY . 14.8 t70 -94.08 -46.31 7.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.10000000000000001 109.393 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.533 ' CG2' ' HA3' ' A' ' 197' ' ' GLY . 12.2 pt -128.56 177.94 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 0.10000000000000001 109.302 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 163' ' ' ILE . 4.0 ptt? -177.28 154.62 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.598 -1.314 . . . . 0.11 111.242 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.54 ' CD1' ' HB2' ' A' ' 220' ' ' ALA . 3.0 tt -102.55 119.81 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.403 -0.811 . . . . 0.10000000000000001 109.547 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.479 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 5.1 p -160.57 148.23 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.10000000000000001 111.176 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.667 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 3.2 p90 -68.95 116.35 9.31 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.594 -0.691 . . . . 0.089999999999999997 109.523 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -74.42 113.38 4.06 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.367 -1.093 . . . . 0.20000000000000001 110.367 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -111.04 99.84 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -1.043 . . . . 0.55000000000000004 109.585 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.634 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.26 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.365 0.602 . . . . 0.84999999999999998 112.553 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.59 -3.51 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.70999999999999996 110.192 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -75.62 -80.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.41999999999999998 110.042 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 135.57 -39.57 1.65 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.587 -1.405 . . . . 0.33000000000000002 109.587 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -77.46 -88.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -1.158 . . . . 0.33000000000000002 110.33 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.466 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.1 OUTLIER -88.21 136.12 33.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.27000000000000002 110.274 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.94 108.46 35.26 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.34000000000000002 109.745 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 45.2 Cg_endo -77.51 -68.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.998 1.525 . . . . 0.46999999999999997 110.581 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.634 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 6.3 p90 -40.81 136.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.87 . . . . 0.34999999999999998 110.749 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.498 ' OD1' ' OD2' ' A' ' 202' ' ' ASP . 11.1 p30 179.21 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.20000000000000001 110.759 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 43.17 -158.06 0.1 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.421 -1.472 . . . . 0.25 109.421 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.6 Cg_endo -77.04 8.52 3.14 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.101 1.58 . . . . 0.44 110.304 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 184' ' ' LEU . 58.3 m -44.67 172.18 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.258 -0.901 . . . . 0.56999999999999995 110.444 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.91 73.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 C-N-CA 120.393 -0.908 . . . . 0.48999999999999999 110.893 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.522 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 3.2 tt 179.82 87.39 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.014 -1.286 . . . . 0.40999999999999998 111.002 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.51 HD12 ' CE2' ' A' ' 214' ' ' TYR . 8.3 tt -103.72 -22.61 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.686 -1.205 . . . . 0.29999999999999999 110.88 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 223' ' ' GLU . . . -150.21 100.0 2.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.72 -1.237 . . . . 0.20000000000000001 111.973 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.563 ' NE2' ' CB ' ' A' ' 200' ' ' HIS . 1.2 p80 -100.8 127.38 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.958 -1.089 . . . . 0.16 109.111 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.578 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -115.0 126.22 54.51 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.961 -1.087 . . . . 0.23000000000000001 110.651 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.471 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 2.4 m-85 -71.85 155.93 91.57 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.38 110.185 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.521 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.5 Cg_endo -72.3 141.65 35.96 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.945 1.497 . . . . 0.40000000000000002 109.93 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 64.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.32000000000000001 110.783 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.47 -103.36 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.244 -1.543 . . . . 0.32000000000000001 109.244 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.16 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.925 1.487 . . . . 0.46999999999999997 110.314 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -65.02 -9.34 21.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.63 110.373 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 59.37 0.61 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.34 -0.85 . . . . 0.53000000000000003 110.147 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -137.16 164.81 25.27 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.073 -1.611 . . . . 0.25 109.073 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 57.95 16.93 27.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.354 -1.498 . . . . 0.10000000000000001 109.354 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.455 ' OD1' ' HE2' ' A' ' 164' ' ' MET . 8.4 m-20 -81.94 88.71 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 0.10000000000000001 110.466 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.501 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -62.43 115.51 4.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.089999999999999997 109.894 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.563 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 15.0 m170 -123.44 127.79 48.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.089999999999999997 111.003 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 11.3 m-30 -96.76 132.41 42.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.10000000000000001 110.223 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.3 OUTLIER -49.98 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.97 -1.122 . . . . 0.14000000000000001 107.97 178.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.4 p30 -35.21 -28.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.17999999999999999 112.267 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 202' ' ' ASP . 0.1 OUTLIER -78.61 3.31 16.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.427 -1.421 . . . . 0.23999999999999999 110.971 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.521 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 18.0 mm-40 -97.99 -168.97 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.934 -1.104 . . . . 0.41999999999999998 110.229 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.501 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 12.5 m -122.29 151.53 41.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.46999999999999997 110.383 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.501 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.2 m-90 -148.09 141.02 24.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.306 -0.871 . . . . 0.27000000000000002 109.67 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -159.0 179.63 8.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.999 -1.063 . . . . 0.29999999999999999 110.62 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 209' ' ' SER . 3.9 t -125.28 49.84 1.85 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.807 -0.757 . . . . 0.60999999999999999 109.551 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 211' ' ' SER . 15.9 t -125.84 -144.62 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.78000000000000003 109.962 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.515 ' N ' ' OG ' ' A' ' 210' ' ' SER . 56.6 p -101.95 -27.97 12.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.91000000000000003 110.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 213' ' ' GLY . 2.2 mppt? -93.01 -176.84 4.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.93000000000000005 110.364 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 48.58 -176.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.614 -1.394 . . . . 0.79000000000000004 109.614 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.51 ' CE2' HD12 ' A' ' 185' ' ' LEU . 66.1 m-85 -79.79 118.09 21.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -1.081 . . . . 0.68999999999999995 109.606 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.503 ' ND2' HG22 ' A' ' 247' ' ' THR . 7.8 p30 -83.13 124.77 30.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.933 -1.105 . . . . 0.40000000000000002 108.818 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.669 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -42.2 -36.92 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.17000000000000001 110.522 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.8 m-85 -50.98 -47.12 61.46 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.419 -1.312 . . . . 0.28000000000000003 107.793 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.528 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 20.3 tp -77.65 -70.7 0.46 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.683 -0.689 . . . . 0.46000000000000002 110.912 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.553 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -49.18 -63.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.035 -1.041 . . . . 0.39000000000000001 109.903 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -50.93 -52.28 43.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.17000000000000001 111.287 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.89 -35.06 66.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.183 -1.573 . . . . 0.10000000000000001 108.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.602 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.6 t60 -69.11 -49.48 56.72 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.212 0.529 . . . . 0.20999999999999999 109.738 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.501 ' CG ' ' HB1' ' A' ' 199' ' ' ALA . 2.5 tp10 -64.1 -27.48 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.28000000000000003 108.777 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.416 ' HE2' ' CD2' ' A' ' 142' ' ' PHE . 5.2 m-30 -70.2 -61.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.043 -0.725 . . . . 0.17999999999999999 109.043 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -48.62 -27.72 6.28 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.802 -1.719 . . . . 0.20999999999999999 108.802 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 1.8 m80 -81.41 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -1.203 . . . . 0.17000000000000001 111.601 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.578 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -58.32 -29.82 66.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.33000000000000002 111.971 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 7.0 tp -100.21 -39.72 7.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.53000000000000003 111.623 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.456 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -78.36 -79.07 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.211 -1.156 . . . . 0.40999999999999998 110.211 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.5 OUTLIER -170.83 -166.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -1.22 . . . . 0.45000000000000001 110.846 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.0 OUTLIER -55.12 -55.92 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.62 110.573 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.573 ' CD2' ' HB3' ' A' ' 240' ' ' MET . 0.7 OUTLIER -167.25 -179.6 4.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.145 -0.972 . . . . 0.45000000000000001 110.763 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 257' ' ' ASP . 9.9 t 179.5 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.015 -0.735 . . . . 0.38 109.015 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -128.6 22.03 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -0.811 . . . . 0.47999999999999998 111.247 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.547 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -40.96 -52.38 6.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.438 -0.905 . . . . 0.38 110.101 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -87.04 -49.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.614 1.323 . . . . 0.28000000000000003 110.589 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.56 99.21 0.12 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.435 -1.364 . . . . 0.23999999999999999 111.543 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.604 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.82 162.8 35.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -1.183 . . . . 0.28000000000000003 110.103 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.592 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -72.5 58.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.40000000000000002 108.823 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.602 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 1.4 mtt -142.74 -36.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.335 -0.853 . . . . 0.45000000000000001 110.432 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -46.01 174.98 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.235 -0.916 . . . . 0.56999999999999995 110.377 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 48.6 Cg_endo -78.43 22.57 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.476 1.25 . . . . 0.76000000000000001 111.127 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.575 ' O ' ' CE1' ' A' ' 241' ' ' PHE . 12.6 mm -127.76 140.79 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.89000000000000001 109.107 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.541 ' O ' ' C ' ' A' ' 245' ' ' THR . 54.3 p90 -126.29 -31.27 2.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.145 . . . . 0.78000000000000003 110.633 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER 3.8 -78.52 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 113.152 0.797 . . . . 0.60999999999999999 113.152 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.568 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -43.82 114.79 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.7 -1.25 . . . . 0.73999999999999999 109.687 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.529 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 6.1 m -72.6 172.86 9.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.865 . . . . 0.81000000000000005 110.306 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -53.13 -22.35 13.44 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.351 -1.5 . . . . 0.56000000000000005 109.351 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 48.1 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -1.109 . . . . 0.37 110.193 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -61.03 1.87 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.44 110.465 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.676 ' CD2' ' CE2' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -133.38 -77.16 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.53000000000000003 110.649 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.676 ' CE2' ' CD2' ' A' ' 251' ' ' HIS . 23.1 m-85 -151.17 -178.03 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.38 110.948 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.468 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -66.7 58.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.672 -0.642 . . . . 0.19 110.018 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 2.6 mp -44.32 -47.08 24.92 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.066 -1.087 . . . . 0.28000000000000003 108.066 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.5 Cg_endo -72.49 46.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.894 1.47 . . . . 0.48999999999999999 111.231 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.5 m-20 -46.7 -32.74 3.77 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.576 -1.328 . . . . 0.48999999999999999 110.367 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.604 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.83 -54.62 40.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.948 -1.101 . . . . 0.31 109.241 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.546 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.88 -33.69 76.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.174 -1.01 . . . . 0.14000000000000001 108.873 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.525 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 74.2 t -67.41 -86.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.17000000000000001 110.566 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.2 tt0 -52.84 -42.18 64.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.008 -1.058 . . . . 0.26000000000000001 109.353 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.72 -70.91 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.368 -1.093 . . . . 0.19 110.368 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.592 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -72.82 -18.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.735 -1.45 . . . . 0.22 110.035 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.586 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 6.6 tt0 -64.37 -21.97 66.8 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.854 -1.138 . . . . 0.39000000000000001 108.355 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.3 p -103.7 -42.42 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.222 -0.591 . . . . 0.46999999999999997 111.502 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.474 ' HB3' ' HG3' ' A' ' 112' ' ' LYS . 7.6 mp -86.15 -46.18 10.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.47999999999999998 111.266 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.495 ' HB3' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -77.95 -14.24 59.6 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.306 -0.871 . . . . 0.40999999999999998 110.404 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.33 -94.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.889 -1.684 . . . . 0.46000000000000002 108.889 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.43 109.73 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.083 1.57 . . . . 0.57999999999999996 110.244 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -82.38 132.96 11.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.552 -1.419 . . . . 0.64000000000000001 109.552 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.607 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.94999999999999996 110.283 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 4.8 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.351 0.596 . . . . 1.03 109.851 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.5 mm? 39.12 47.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 1.04 111.118 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 265' ' ' LEU . 2.1 tptm -128.17 60.99 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.003 . . . . 0.77000000000000002 109.967 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.539 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 10.7 t90 -139.48 -65.55 0.47 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.41999999999999998 110.637 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.437 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 79.1 p -98.85 46.15 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.44 110.562 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 6.9 mmpt? -130.09 76.41 1.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.48999999999999999 110.248 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -111.85 -3.4 14.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.29999999999999999 110.173 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -159.11 125.78 4.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.14999999999999999 109.859 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.462 HD21 ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.4 -177.06 5.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.13 110.751 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -127.29 165.88 18.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.12 109.848 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.555 ' CB ' HG13 ' A' ' 163' ' ' ILE . 46.1 p90 -162.89 -176.77 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.025 -1.047 . . . . 0.33000000000000002 111.367 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -140.38 155.45 46.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.54000000000000004 110.23 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.594 HG13 ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -114.41 123.5 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.494 -0.754 . . . . 0.33000000000000002 111.134 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 1.2 m -165.86 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.27000000000000002 109.72 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 0.9 OUTLIER -39.68 -80.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.718 . . . . 0.40999999999999998 109.395 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.565 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 4.9 t80 -179.2 -159.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.432 -0.792 . . . . 0.40000000000000002 109.527 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.547 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -154.0 50.38 0.56 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.45000000000000001 110.656 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.65 -85.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.807 1.425 . . . . 0.35999999999999999 110.388 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.6 0.45 49.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.25 109.982 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.03 160.04 22.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.39000000000000001 110.168 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.7 m -106.33 168.86 8.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.47999999999999998 110.254 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -44.7 -32.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.40000000000000002 109.806 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -66.28 -49.36 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.46000000000000002 109.562 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 1.8 mp0 -60.79 -57.64 11.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.249 -0.907 . . . . 0.46999999999999997 109.17 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 133' ' ' GLU . 5.6 t -46.22 -36.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.761 -1.2 . . . . 0.31 107.761 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -56.89 -42.38 79.74 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.03 -1.1 . . . . 0.47999999999999998 108.03 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.4 tttt -71.24 -49.98 37.63 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.65 -0.87 . . . . 0.64000000000000001 108.65 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.658 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.83 -57.39 4.36 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.96 -1.087 . . . . 0.41999999999999998 109.749 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -65.11 -56.29 13.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.34000000000000002 110.734 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.602 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.61 -73.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.984 . . . . 0.46999999999999997 110.157 -179.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -36.87 -60.99 0.58 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.823 -0.548 . . . . 0.46999999999999997 110.667 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.46 -40.95 19.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.618 -1.301 . . . . 0.25 108.709 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 138' ' ' PHE . 2.5 m-85 -69.38 -32.97 72.35 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.998 . . . . 0.34999999999999998 108.774 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 17.1 tttm -56.15 -41.66 75.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.977 -1.119 . . . . 0.69999999999999996 107.977 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 148' ' ' VAL . 10.9 t -67.11 -41.91 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.537 -0.912 . . . . 0.60999999999999999 108.537 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.593 ' CH2' HG13 ' A' ' 262' ' ' ILE . 25.5 t-105 -54.9 -38.67 67.89 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.819 -0.808 . . . . 0.39000000000000001 108.819 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.7 OUTLIER -75.95 -41.23 52.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.347 -0.846 . . . . 0.34999999999999998 108.74 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 3.0 m-20 -50.47 -33.3 20.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.968 -0.753 . . . . 0.35999999999999999 108.968 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.0 m -91.16 -38.52 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.532 -0.73 . . . . 0.5 110.108 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.513 ' N ' HG22 ' A' ' 148' ' ' VAL . 14.1 t -149.43 124.15 4.78 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.51000000000000001 110.136 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.21 59.27 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.859 1.452 . . . . 0.31 110.599 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.518 ' CD2' ' O ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -73.81 139.24 45.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.17999999999999999 110.154 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 7.4 t-20 -76.62 105.49 7.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.17000000000000001 109.912 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 7.8 p90 -117.34 143.67 45.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.14000000000000001 110.479 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 119' ' ' THR . 20.5 m -141.27 145.6 35.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.927 . . . . 0.14999999999999999 110.125 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.519 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -124.84 79.87 1.82 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.706 -0.621 . . . . 0.20000000000000001 110.152 -178.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.42 114.73 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.22 110.092 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -56.42 -18.0 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.32000000000000001 109.98 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -23.25 5.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.449 -0.782 . . . . 0.33000000000000002 109.632 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.42 7.94 5.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.534 -1.426 . . . . 0.28000000000000003 109.534 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 119' ' ' THR . 8.7 mt -87.91 91.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.126 -1.22 . . . . 0.29999999999999999 109.034 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -154.98 107.07 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.968 -0.693 . . . . 0.20000000000000001 110.336 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.462 ' CB ' HD21 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -76.51 -42.74 42.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.10000000000000001 109.808 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.555 HG13 ' CB ' ' A' ' 120' ' ' TYR . 1.1 pt -118.09 171.91 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.10000000000000001 109.546 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.461 ' O ' ' CB ' ' A' ' 199' ' ' ALA . 1.8 ptp -170.08 157.28 6.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.715 -1.241 . . . . 0.11 111.188 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.54 ' CD1' ' HB1' ' A' ' 220' ' ' ALA . 2.0 tt -104.9 120.78 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.10000000000000001 109.806 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 200' ' ' HIS . 11.5 p -162.45 156.4 21.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.786 -1.196 . . . . 0.10000000000000001 111.142 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.9 p90 -73.17 118.43 16.12 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.493 -0.755 . . . . 0.089999999999999997 109.272 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -76.9 131.66 11.54 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.46 -1.056 . . . . 0.20000000000000001 110.46 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.583 ' O ' ' C ' ' A' ' 170' ' ' LYS . 2.5 tp -126.34 93.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.614 -0.933 . . . . 0.55000000000000004 109.154 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 0.87 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.358 0.599 . . . . 0.84999999999999998 112.466 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -148.69 17.22 1.01 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.343 -0.848 . . . . 0.70999999999999996 109.861 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.401 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m170 -78.96 -68.84 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.39 -0.819 . . . . 0.41999999999999998 110.306 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.72 34.86 0.42 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.446 -1.461 . . . . 0.33000000000000002 109.446 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -149.06 -69.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -1.11 . . . . 0.33000000000000002 110.091 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -123.29 174.48 7.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.27000000000000002 110.167 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.4 m-30 -98.57 110.34 56.49 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.34000000000000002 110.237 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.487 ' CD ' ' HD2' ' A' ' 170' ' ' LYS . 41.9 Cg_endo -73.33 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.968 1.51 . . . . 0.46999999999999997 110.616 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.6 OUTLIER -49.58 142.05 8.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.34999999999999998 110.575 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 182' ' ' SER . 5.5 p30 179.64 80.3 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.202 -0.936 . . . . 0.20000000000000001 110.453 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.511 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.72 -155.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.398 . . . . 0.25 109.606 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.7 Cg_endo -77.34 8.65 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.077 1.567 . . . . 0.44 110.573 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.2 t -42.75 166.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.56999999999999995 110.318 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.45 73.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.712 -0.955 . . . . 0.48999999999999999 110.712 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 1.0 OUTLIER 179.86 87.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.193 -1.181 . . . . 0.40999999999999998 110.649 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 214' ' ' TYR . 7.8 tt -103.85 -23.05 13.42 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.616 -1.234 . . . . 0.29999999999999999 110.969 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.45 ' HB3' ' CD1' ' A' ' 201' ' ' PHE . . . -151.94 106.2 3.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.524 -1.36 . . . . 0.20000000000000001 112.333 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.521 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.2 OUTLIER -101.84 133.02 47.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.16 109.229 178.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.58 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -122.09 118.72 29.38 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.134 -0.978 . . . . 0.23000000000000001 110.476 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.433 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-85 -67.86 167.48 16.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.38 110.372 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.483 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.4 Cg_endo -72.89 136.65 25.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.145 1.603 . . . . 0.40000000000000002 109.856 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.0 84.62 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.903 1.475 . . . . 0.32000000000000001 110.561 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.9 -102.22 0.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.958 -1.257 . . . . 0.32000000000000001 109.958 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.34 -163.6 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.46999999999999997 110.859 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.89 -7.28 26.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.404 -0.81 . . . . 0.63 110.152 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.46 48.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.383 -0.823 . . . . 0.53000000000000003 109.838 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -136.06 169.23 23.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.029 -1.629 . . . . 0.25 109.029 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.584 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 57.31 17.68 25.78 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.088 -1.605 . . . . 0.10000000000000001 109.088 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.86 91.31 4.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.429 -1.042 . . . . 0.10000000000000001 110.508 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.505 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -73.47 95.93 2.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.089999999999999997 109.866 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.521 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 28.7 m170 -111.93 134.45 53.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.089999999999999997 110.887 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.4 m-85 -104.51 137.6 42.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.154 -0.966 . . . . 0.10000000000000001 110.59 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.7 OUTLIER -47.03 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.14000000000000001 108.554 179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.2 p30 -36.88 -27.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.516 -0.74 . . . . 0.17999999999999999 112.046 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 203' ' ' ASP . 1.0 OUTLIER -78.79 2.93 18.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.488 -1.383 . . . . 0.23999999999999999 110.848 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.479 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 11.6 mm-40 -95.91 -168.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.942 -1.099 . . . . 0.41999999999999998 110.237 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.8 m -123.72 140.21 53.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.498 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.542 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.8 OUTLIER -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.27000000000000002 109.312 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.544 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.33 178.61 9.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.959 -1.088 . . . . 0.29999999999999999 110.792 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.407 ' OG ' ' CZ ' ' A' ' 217' ' ' PHE . 29.9 t -130.48 32.37 4.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.534 0.683 . . . . 0.60999999999999999 109.285 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -103.98 -90.87 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.78000000000000003 110.686 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -157.21 -33.97 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.462 -0.774 . . . . 0.91000000000000003 109.793 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 213' ' ' GLY . 3.5 pttt -87.91 -171.96 3.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.93000000000000005 109.932 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 45.42 -155.59 0.44 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.243 -1.543 . . . . 0.79000000000000004 109.243 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.56 ' CD2' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -94.13 126.24 39.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -1.193 . . . . 0.68999999999999995 109.931 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 208' ' ' THR . 42.6 m-80 -89.65 121.4 31.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.018 -1.051 . . . . 0.40000000000000002 108.879 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.658 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -41.59 -37.84 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.611 -0.836 . . . . 0.17000000000000001 110.375 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 217' ' ' PHE . 3.1 m-30 -51.67 -46.91 63.98 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.382 -1.327 . . . . 0.28000000000000003 107.585 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.562 ' CD1' ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.26 -73.4 0.28 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.781 -0.645 . . . . 0.46000000000000002 110.277 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.61 -65.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.39000000000000001 110.302 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -49.66 -48.87 49.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.366 -0.834 . . . . 0.17000000000000001 111.737 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.99 -41.71 92.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.185 -1.572 . . . . 0.10000000000000001 108.645 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.604 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.3 t60 -60.2 -51.26 70.33 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.377 0.608 . . . . 0.20999999999999999 109.792 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.505 ' CG ' ' HB1' ' A' ' 199' ' ' ALA . 2.0 tp10 -64.8 -29.16 70.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.092 -1.005 . . . . 0.28000000000000003 109.138 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 220' ' ' ALA . 13.8 m-30 -66.12 -64.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.447 -0.783 . . . . 0.17999999999999999 109.177 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -49.84 -26.7 8.52 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.045 -1.622 . . . . 0.20999999999999999 109.045 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -78.93 -58.7 3.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.081 -1.247 . . . . 0.17000000000000001 111.557 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.584 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.9 OUTLIER -69.22 -23.77 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.33000000000000002 111.78 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.523 ' CD2' ' OH ' ' A' ' 266' ' ' TYR . 0.8 OUTLIER -99.21 -43.82 6.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.028 -1.045 . . . . 0.53000000000000003 111.258 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -83.03 -70.86 1.33 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.184 -1.008 . . . . 0.40999999999999998 110.589 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 230' ' ' LEU . 0.4 OUTLIER -165.01 -162.11 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.241 . . . . 0.45000000000000001 110.86 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -75.01 -51.7 12.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.62 110.34 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.622 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.8 OUTLIER -162.48 172.79 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.45000000000000001 110.959 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 233' ' ' SER . 5.7 t 179.56 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.615 -0.678 . . . . 0.38 109.24 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -117.19 20.26 13.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.47999999999999998 111.005 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -30.55 -53.81 0.38 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.894 -0.503 . . . . 0.38 111.507 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.7 Cg_endo -89.49 -47.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.4 1.21 . . . . 0.28000000000000003 111.063 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.12 100.54 0.13 Allowed Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.498 -1.334 . . . . 0.23999999999999999 111.268 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -146.78 168.73 20.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.131 -1.217 . . . . 0.28000000000000003 110.518 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.604 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.7 OUTLIER -73.67 55.42 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.301 -0.875 . . . . 0.40000000000000002 109.011 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.581 ' HA ' ' CE1' ' A' ' 226' ' ' HIS . 1.9 mtt -140.87 -5.6 1.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.288 -0.882 . . . . 0.45000000000000001 111.356 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -79.71 168.82 23.4 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.932 -1.105 . . . . 0.56999999999999995 110.134 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -69.56 -4.27 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.848 1.447 . . . . 0.76000000000000001 110.665 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.605 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 50.2 mm -104.63 143.87 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.89000000000000001 109.808 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.562 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . 42.8 p90 -131.39 -28.95 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.948 -1.095 . . . . 0.78000000000000003 110.913 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.53 ' C ' ' O ' ' A' ' 244' ' ' TYR . 98.8 m 2.79 -69.63 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.412 0.893 . . . . 0.60999999999999999 113.412 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -55.81 101.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.604 -1.31 . . . . 0.73999999999999999 109.511 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.494 ' N ' ' HB3' ' A' ' 250' ' ' SER . 0.2 OUTLIER -48.09 179.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.431 -0.793 . . . . 0.81000000000000005 110.263 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.71 -29.25 25.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.446 -1.461 . . . . 0.56000000000000005 109.446 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -143.1 31.24 1.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.37 110.084 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.494 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.4 OUTLIER -59.56 -23.03 62.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.44 110.186 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 6.8 t-80 -156.21 -67.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.882 . . . . 0.53000000000000003 110.004 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.1 m-85 -168.38 -178.36 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.38 110.164 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.479 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 5.6 ptt? -72.26 54.99 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.72 . . . . 0.19 110.225 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.69 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 7.6 tp -45.03 -46.07 28.53 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 107.975 -1.12 . . . . 0.28000000000000003 107.975 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -71.58 48.19 0.99 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.76 1.4 . . . . 0.48999999999999999 110.944 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.59 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.2 m-20 -52.63 -27.14 15.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.855 -1.153 . . . . 0.48999999999999999 110.575 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.608 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -57.15 -43.76 82.78 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.578 -1.249 . . . . 0.31 109.454 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -79.57 -32.95 42.1 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.184 -1.006 . . . . 0.14000000000000001 108.548 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.59 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 54.4 t -65.43 -75.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.816 0.817 . . . . 0.17000000000000001 110.019 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -63.57 -34.1 77.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.768 . . . . 0.26000000000000001 109.612 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -49.53 -67.24 1.85 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.124 -1.19 . . . . 0.19 110.124 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.593 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -70.35 -21.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.811 -1.405 . . . . 0.22 109.895 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 20.4 tp60 -67.31 -19.44 65.47 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.028 -1.045 . . . . 0.39000000000000001 108.625 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.1 m -103.41 -38.6 7.12 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.119 -0.633 . . . . 0.46999999999999997 111.709 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.514 ' HB3' ' CG ' ' A' ' 112' ' ' LYS . 8.5 mp -97.79 -42.51 7.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.179 -0.951 . . . . 0.47999999999999998 111.166 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -72.15 -21.48 61.45 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.37 -0.831 . . . . 0.40999999999999998 109.808 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -55.6 -97.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.293 -1.523 . . . . 0.46000000000000002 109.293 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.7 108.29 2.52 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.044 1.549 . . . . 0.57999999999999996 110.258 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.17 151.43 23.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.696 -1.362 . . . . 0.64000000000000001 109.696 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.539 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 6.8 t0 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.94999999999999996 110.203 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.109 0.481 . . . . 1.03 109.71 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.534 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 5.9 mp 32.08 37.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.079 0.466 . . . . 1.04 111.454 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -121.51 42.6 3.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.77000000000000002 109.869 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.576 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 22.7 t90 -110.63 -65.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.853 . . . . 0.41999999999999998 110.106 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.478 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 31.9 t -102.36 60.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.44 110.267 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.579 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 0.0 OUTLIER -146.26 85.48 1.66 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.935 . . . . 0.48999999999999999 110.617 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 ttt -119.82 -18.33 8.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.29999999999999999 110.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 8.7 p30 -157.3 111.88 2.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.14999999999999999 109.984 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.08 -160.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.13 110.466 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -137.91 155.35 49.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.12 110.275 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.599 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 13.2 p90 -152.73 -167.6 2.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.247 -0.908 . . . . 0.33000000000000002 110.857 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.412 ' N ' ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.36 155.94 47.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.54000000000000004 110.662 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.561 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 5.6 pt -112.67 115.75 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.805 . . . . 0.33000000000000002 110.698 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 1.1 m -165.72 42.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.201 -0.937 . . . . 0.27000000000000002 110.301 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 125' ' ' TYR . 2.5 t-20 -42.28 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.40999999999999998 109.742 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 4.8 t80 -179.32 -155.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -0.795 . . . . 0.40000000000000002 109.497 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.543 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -161.26 51.47 0.36 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.45000000000000001 110.583 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -78.14 -85.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.906 1.477 . . . . 0.35999999999999999 109.963 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.93 -2.09 56.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.25 109.638 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.535 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -121.06 160.75 22.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.39000000000000001 110.137 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.14 -175.05 2.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.875 . . . . 0.47999999999999998 110.211 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -48.46 -37.49 17.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.40000000000000002 109.978 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t -60.47 -50.08 75.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.46000000000000002 109.845 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.535 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 7.7 mp0 -64.88 -63.64 1.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.194 -0.941 . . . . 0.46999999999999997 109.92 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 133' ' ' GLU . 16.3 t -42.96 -37.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.694 -0.854 . . . . 0.31 108.694 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.569 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 6.5 mt-10 -59.24 -43.23 92.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.387 -0.968 . . . . 0.47999999999999998 108.387 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.5 tttp -70.33 -47.34 61.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.416 -0.957 . . . . 0.64000000000000001 108.416 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.646 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.79 -60.71 2.07 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.31 -0.868 . . . . 0.41999999999999998 110.101 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -66.96 -52.31 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.34000000000000002 110.897 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 4.1 tttt -66.58 -73.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.84 -1.162 . . . . 0.46999999999999997 110.124 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.71 -60.8 0.79 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.754 -0.592 . . . . 0.46999999999999997 110.779 179.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.28 -38.93 13.42 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.54 -1.264 . . . . 0.25 108.341 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -70.08 -33.66 72.19 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.611 -0.836 . . . . 0.34999999999999998 108.976 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -56.31 -41.55 76.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.931 -1.137 . . . . 0.69999999999999996 107.931 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.05 -41.73 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.578 -0.897 . . . . 0.60999999999999999 108.578 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.585 ' CH2' HG13 ' A' ' 262' ' ' ILE . 27.9 t-105 -56.88 -39.21 73.94 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.818 -0.808 . . . . 0.39000000000000001 108.818 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 149' ' ' THR . 69.1 m -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.427 -0.796 . . . . 0.34999999999999998 108.854 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.89 -37.51 66.39 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.586 -0.696 . . . . 0.35999999999999999 109.359 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 26.8 m -84.82 -34.86 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.5 110.195 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.522 ' N ' HG22 ' A' ' 148' ' ' VAL . 14.4 t -152.12 131.63 6.87 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.51000000000000001 110.264 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.41 59.05 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.965 1.508 . . . . 0.31 110.808 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.625 ' CD2' ' CD1' ' A' ' 266' ' ' TYR . 3.6 mp -76.88 169.09 18.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.17999999999999999 110.014 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.64 116.42 28.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.17000000000000001 110.568 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 8.4 p90 -126.33 125.78 42.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.14000000000000001 109.723 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 119' ' ' THR . 10.7 m -125.72 133.08 52.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.197 -0.94 . . . . 0.14999999999999999 110.62 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.599 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.31 81.71 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.20000000000000001 109.877 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.526 ' CG ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -60.43 129.79 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.22 110.49 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -91.79 40.61 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.44 -0.787 . . . . 0.32000000000000001 109.921 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.464 ' OD2' HD11 ' A' ' 160' ' ' ILE . 3.2 t0 -135.55 -38.95 0.73 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.33000000000000002 109.52 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 144.2 37.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.661 -1.376 . . . . 0.28000000000000003 109.661 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.526 HD13 ' CG ' ' A' ' 156' ' ' LEU . 3.1 mp -123.82 69.45 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.29999999999999999 109.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.467 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -144.47 156.29 44.12 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.032 -0.667 . . . . 0.20000000000000001 110.111 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.5 OUTLIER -121.39 -23.52 5.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.10000000000000001 110.337 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tt -125.49 168.51 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.178 -0.951 . . . . 0.10000000000000001 110.142 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.48 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 11.9 ptp -177.3 151.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.522 -1.361 . . . . 0.11 111.645 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.546 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 5.4 tt -97.98 112.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.593 -0.692 . . . . 0.10000000000000001 110.032 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 200' ' ' HIS . 4.4 p -153.76 149.71 27.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.901 -1.125 . . . . 0.10000000000000001 110.39 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 8.0 p90 -68.64 127.53 33.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.089999999999999997 109.758 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.67 120.99 6.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.235 -1.146 . . . . 0.20000000000000001 110.235 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.569 ' O ' ' CG2' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.33 102.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.445 -1.032 . . . . 0.55000000000000004 109.135 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.578 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 26.1 tptp 1.07 84.08 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.422 0.629 . . . . 0.84999999999999998 112.532 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.46 0.76 4.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.70999999999999996 109.942 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 10.8 m-70 -74.01 -81.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.878 . . . . 0.41999999999999998 110.331 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.97 8.3 7.41 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.194 -1.562 . . . . 0.33000000000000002 109.194 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.417 ' OD2' ' CE2' ' A' ' 175' ' ' PHE . 3.1 t0 -126.3 -70.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -1.103 . . . . 0.33000000000000002 110.198 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.467 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 98.3 m-85 -107.25 144.5 33.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.27000000000000002 110.093 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -63.65 111.07 4.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.34000000000000002 110.355 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 49.7 Cg_endo -78.74 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.976 1.514 . . . . 0.46999999999999997 110.444 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.596 ' CD2' ' OD2' ' A' ' 203' ' ' ASP . 0.4 OUTLIER -94.21 178.59 5.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.34999999999999998 110.232 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.3 p-10 -180.0 -53.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.923 . . . . 0.20000000000000001 110.804 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.565 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 146.39 -134.98 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.364 -1.494 . . . . 0.25 109.364 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.11 -1.6 10.78 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 124.053 1.554 . . . . 0.44 109.809 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.427 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -57.02 -177.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.428 -0.795 . . . . 0.56999999999999995 110.296 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -81.3 76.55 2.15 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.575 -1.01 . . . . 0.48999999999999999 110.575 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 5.5 tt 179.64 94.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.273 -1.133 . . . . 0.40999999999999998 110.789 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.579 HD11 ' CG ' ' A' ' 214' ' ' TYR . 8.6 tt -112.13 -18.45 12.57 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.554 -1.258 . . . . 0.29999999999999999 111.109 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -152.11 109.56 3.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.503 -1.373 . . . . 0.20000000000000001 111.832 -179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -121.35 135.59 55.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.16 109.971 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 227' ' ' SER . . . -123.78 160.8 26.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.096 -1.003 . . . . 0.23000000000000001 110.454 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 1.1 m-30 -99.04 170.23 7.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.38 110.176 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.474 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.8 Cg_endo -71.74 128.3 14.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.562 . . . . 0.40000000000000002 109.745 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 196' ' ' GLY . 42.9 Cg_endo -69.05 68.3 1.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.873 1.459 . . . . 0.32000000000000001 110.62 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.98 -83.67 1.2 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.267 -1.533 . . . . 0.32000000000000001 109.267 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 -159.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.559 . . . . 0.46999999999999997 110.042 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.12 0.52 27.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.63 110.34 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.74 40.84 2.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.319 -0.863 . . . . 0.53000000000000003 110.326 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -108.63 -179.3 21.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.961 -1.656 . . . . 0.25 108.961 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 163' ' ' ILE . . . 38.91 27.13 0.05 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.213 -1.155 . . . . 0.10000000000000001 110.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 196' ' ' GLY . 0.8 OUTLIER -77.59 88.23 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.331 . . . . 0.10000000000000001 109.25 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 165' ' ' ILE . . . -71.72 90.24 1.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.089999999999999997 110.74 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 12.8 m170 -100.86 120.83 40.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.089999999999999997 109.909 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 203' ' ' ASP . 20.2 m-85 -89.6 135.24 33.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.156 -0.965 . . . . 0.10000000000000001 110.722 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 58.8 t0 -44.2 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.857 -0.794 . . . . 0.14000000000000001 108.857 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.9 p30 -41.76 -31.64 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.17999999999999999 111.49 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.565 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 17.1 t0 -71.15 -5.54 32.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.558 -1.338 . . . . 0.23999999999999999 110.329 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.472 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 16.6 mm-40 -93.73 -164.71 1.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.088 . . . . 0.41999999999999998 109.878 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.559 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 33.3 m -127.37 159.08 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.128 . . . . 0.46999999999999997 110.769 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.2 m-90 -150.12 142.8 24.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.27000000000000002 109.555 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -153.93 173.65 15.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.853 -1.154 . . . . 0.29999999999999999 110.795 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.8 t -128.21 29.79 5.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.781 0.8 . . . . 0.60999999999999999 108.945 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 -72.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.504 0.669 . . . . 0.78000000000000003 110.108 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.132 -0.692 . . . . 0.91000000000000003 109.132 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.43 133.17 33.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.548 -0.72 . . . . 0.93000000000000005 109.553 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.18 -171.54 38.81 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.109 -1.596 . . . . 0.79000000000000004 109.109 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.579 ' CG ' HD11 ' A' ' 185' ' ' LEU . 66.1 m-85 -75.66 113.54 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.68999999999999995 109.999 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 208' ' ' THR . 34.5 m-80 -79.87 121.97 26.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.054 -1.028 . . . . 0.40000000000000002 108.627 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.646 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -40.56 -38.01 0.8 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.329 -0.857 . . . . 0.17000000000000001 110.504 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 3.3 m-85 -52.97 -48.33 67.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.529 -1.268 . . . . 0.28000000000000003 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 40.9 tp -72.06 -71.36 0.28 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.978 -0.556 . . . . 0.46000000000000002 110.185 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.533 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -51.32 -70.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.156 -0.965 . . . . 0.39000000000000001 110.144 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -42.22 -50.21 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.876 -1.14 . . . . 0.17000000000000001 111.565 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -60.86 -34.7 75.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.309 -1.494 . . . . 0.10000000000000001 108.924 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.592 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.7 t60 -69.33 -50.83 42.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.465 0.65 . . . . 0.20999999999999999 109.792 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.496 ' OE2' ' CB ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -60.9 -44.09 97.62 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 109.181 178.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.512 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 7.4 m-85 -55.08 -62.02 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.17999999999999999 108.926 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.46 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.62 -32.03 1.9 Allowed Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.804 -1.718 . . . . 0.20999999999999999 108.804 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.578 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.41 -71.96 0.43 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -1.174 . . . . 0.17000000000000001 111.068 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.05 -44.19 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.33000000000000002 112.006 -178.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.473 ' HB3' ' OH ' ' A' ' 266' ' ' TYR . 0.8 OUTLIER -100.37 -37.41 8.87 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.784 -1.197 . . . . 0.53000000000000003 111.328 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -67.66 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.173 -1.171 . . . . 0.40999999999999998 110.173 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.8 OUTLIER -169.21 -172.62 1.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.45000000000000001 110.936 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 1.9 m-20 -53.05 -58.04 8.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.62 110.172 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.578 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -163.67 179.63 7.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.45000000000000001 111.017 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.515 ' N ' ' SD ' ' A' ' 240' ' ' MET . 1.8 t 179.53 54.35 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.083 -0.71 . . . . 0.38 109.083 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.31 23.89 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.47999999999999998 111.351 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -38.72 -47.01 3.35 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.36 -0.936 . . . . 0.38 109.346 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 43.0 Cg_endo -92.1 -47.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.029 1.542 . . . . 0.28000000000000003 110.968 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 176.83 100.9 0.14 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.725 -1.703 . . . . 0.23999999999999999 112.506 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -148.08 160.92 42.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.317 -1.108 . . . . 0.28000000000000003 109.998 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.592 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 1.0 OUTLIER -69.31 62.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.076 0.941 . . . . 0.40000000000000002 108.596 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.566 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.7 mtt -146.56 -33.98 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.59 -0.694 . . . . 0.45000000000000001 110.758 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -44.13 168.5 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.56999999999999995 110.325 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.4 Cg_endo -72.66 -12.51 26.77 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.879 1.463 . . . . 0.76000000000000001 109.817 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 5.9 tt -98.25 151.09 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.89000000000000001 109.695 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.56 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 32.6 p90 -131.89 -28.28 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.78000000000000003 111.038 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.532 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 2.45 -69.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 113.196 0.813 . . . . 0.60999999999999999 113.196 -179.009 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -67.96 104.25 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.547 -1.346 . . . . 0.73999999999999999 109.554 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.511 ' HA ' HD22 ' A' ' 218' ' ' LEU . 26.5 p -56.08 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.81000000000000005 110.352 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.4 -7.15 57.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.56000000000000005 109.495 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -149.21 27.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -1.16 . . . . 0.37 110.174 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.533 ' HB3' ' CD1' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -68.21 -13.93 62.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.44 110.339 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.0 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.53000000000000003 110.326 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -167.54 178.39 5.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.38 110.501 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.509 ' HE3' ' CE2' ' A' ' 252' ' ' PHE . 4.7 ptp -68.23 53.98 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.393 -0.817 . . . . 0.19 110.61 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.674 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -43.97 -48.34 22.22 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.131 -1.063 . . . . 0.28000000000000003 108.131 177.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -72.49 48.05 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 124.125 1.592 . . . . 0.48999999999999999 111.251 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.575 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.3 m-20 -52.77 -30.86 35.22 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.763 -1.211 . . . . 0.48999999999999999 109.761 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 238' ' ' ALA . 3.1 m-20 -50.47 -45.59 56.34 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.589 -0.844 . . . . 0.31 109.57 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -80.18 -32.31 38.71 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.379 -0.971 . . . . 0.14000000000000001 108.379 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 83.6 t -60.35 -73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.17000000000000001 110.072 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.642 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 6.2 pt20 -72.52 -31.35 65.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.331 -0.855 . . . . 0.26000000000000001 110.094 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -47.73 -57.79 7.33 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.092 -1.603 . . . . 0.19 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.585 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -83.5 -21.71 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -1.228 . . . . 0.22 110.674 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.642 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 29.6 tt0 -64.47 -20.01 65.92 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.493 -1.379 . . . . 0.39000000000000001 108.348 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 2.8 p -103.68 -38.98 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.152 -0.619 . . . . 0.46999999999999997 111.354 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.9 mp -90.88 -44.57 9.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.103 -0.998 . . . . 0.47999999999999998 111.343 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -72.92 -10.91 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.40999999999999998 110.057 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -60.75 -92.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.461 . . . . 0.46000000000000002 109.446 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 117.03 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.57999999999999996 110.332 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.06 123.72 7.88 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.446 -1.462 . . . . 0.64000000000000001 109.446 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.576 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.94999999999999996 109.93 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.533 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.403 0.62 . . . . 1.03 109.944 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.2 OUTLIER 33.15 53.76 0.41 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.909 -0.494 . . . . 1.04 111.881 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.533 ' HE2' ' CB ' ' A' ' 110' ' ' THR . 17.4 pttt -140.75 78.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.77000000000000002 109.688 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.584 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 11.6 t90 -142.27 -71.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.41999999999999998 111.017 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.472 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 95.4 p -101.13 60.67 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.44 110.489 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 114' ' ' SER . 30.3 mttp -148.72 78.72 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.48999999999999999 110.183 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.46 ' HA ' HD12 ' A' ' 151' ' ' LEU . 12.6 ttt -105.71 -13.01 15.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 0.29999999999999999 109.956 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 152' ' ' ASN . 6.4 t30 -151.86 124.64 8.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.14999999999999999 109.993 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 117' ' ' ASN . 3.2 tp -145.99 -170.2 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.13 110.258 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -122.05 158.05 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.12 110.161 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.572 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 37.0 p90 -151.06 169.2 22.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.367 -0.833 . . . . 0.33000000000000002 110.704 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -120.87 147.1 45.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -0.816 . . . . 0.54000000000000004 109.776 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.56 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.7 pp -112.87 120.45 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.116 -0.99 . . . . 0.33000000000000002 110.997 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 1.0 OUTLIER -164.77 49.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.838 . . . . 0.27000000000000002 109.416 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 124' ' ' ASN . 1.4 m120 -39.67 -84.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.696 -0.627 . . . . 0.40999999999999998 109.843 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.585 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.8 t80 179.89 -168.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.40000000000000002 109.089 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.592 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -138.61 42.71 0.6 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.707 -1.246 . . . . 0.45000000000000001 111.705 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -76.96 -83.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.484 1.255 . . . . 0.35999999999999999 110.506 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.9 m-20 -107.83 -0.9 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.25 110.053 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.56 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -126.39 89.95 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.39000000000000001 109.778 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.465 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -48.21 -179.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.47999999999999998 110.939 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -48.49 -39.27 22.54 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.40000000000000002 110.032 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -53.68 -61.2 2.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.46000000000000002 109.615 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.56 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 31.6 mp0 -54.01 -54.49 38.38 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.565 -0.854 . . . . 0.46999999999999997 109.43 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.458 HG21 ' SD ' ' A' ' 129' ' ' MET . 53.2 t -45.76 -34.41 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 132' ' ' SER . 0.7 OUTLIER -61.38 -43.21 99.25 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.776 -1.194 . . . . 0.47999999999999998 107.776 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 1.4 tttp -70.34 -56.98 5.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.64000000000000001 108.337 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.672 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -43.75 -69.94 0.12 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.186 -0.946 . . . . 0.41999999999999998 110.189 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -52.81 -59.46 4.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.34000000000000002 110.945 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 5.1 tmtt? -65.56 -74.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.978 -1.076 . . . . 0.46999999999999997 110.893 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.8 OUTLIER -38.24 -62.39 0.58 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.679 -0.638 . . . . 0.46999999999999997 110.669 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -45.89 -38.15 7.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.798 -1.161 . . . . 0.25 108.386 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -70.42 -34.87 73.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.362 -0.836 . . . . 0.34999999999999998 108.892 178.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 10.6 ttmm -58.51 -42.4 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.69999999999999996 108.961 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.86 -46.72 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.535 -0.728 . . . . 0.60999999999999999 109.094 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.6 ' CH2' HG13 ' A' ' 262' ' ' ILE . 13.3 t-105 -53.55 -41.66 66.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.777 . . . . 0.39000000000000001 108.967 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 149' ' ' THR . 14.5 m -71.76 -37.15 70.54 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.412 -0.805 . . . . 0.34999999999999998 109.02 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.66 -41.61 66.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.595 -0.691 . . . . 0.35999999999999999 109.549 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 29.4 m -79.63 -30.81 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.5 110.071 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 146' ' ' SER . 3.6 t -144.22 127.33 8.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.51000000000000001 110.339 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 59.76 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.748 1.394 . . . . 0.31 110.745 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 266' ' ' TYR . 1.4 mm? -88.72 156.01 19.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.17999999999999999 110.158 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' OD1' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -103.38 146.35 28.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.17000000000000001 110.381 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 6.9 p90 -152.49 138.6 18.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.868 . . . . 0.14000000000000001 110.384 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 119' ' ' THR . 4.2 m -143.02 135.4 27.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.14999999999999999 110.261 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.572 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -93.61 89.03 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.978 -1.076 . . . . 0.20000000000000001 110.024 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.536 ' CB ' ' HB ' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -62.97 100.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.22 110.371 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.57 ' O ' ' CD2' ' A' ' 157' ' ' HIS . 53.6 p-80 -67.14 57.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.331 -0.856 . . . . 0.32000000000000001 110.357 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 156' ' ' LEU . 10.9 t0 -154.31 -51.53 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.33000000000000002 109.904 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.41 35.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.037 -1.225 . . . . 0.28000000000000003 110.037 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 156' ' ' LEU . 72.1 mt -128.83 65.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -1.18 . . . . 0.29999999999999999 109.289 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -126.01 150.16 48.29 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.2 -0.6 . . . . 0.20000000000000001 110.568 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' GLY . 1.2 m-20 -113.27 -34.22 5.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.356 -0.84 . . . . 0.10000000000000001 109.883 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.534 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -126.03 170.38 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.10000000000000001 110.155 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.524 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 8.5 ptm -168.93 139.12 2.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.891 -1.131 . . . . 0.11 110.95 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.568 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 4.2 tt -96.88 115.44 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.401 -0.812 . . . . 0.10000000000000001 109.29 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.535 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 14.2 p -160.07 148.48 17.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.511 -1.368 . . . . 0.10000000000000001 111.065 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.601 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.0 p90 -64.55 114.75 4.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.089999999999999997 109.354 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.511 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -72.52 148.42 42.01 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.441 -1.464 . . . . 0.20000000000000001 109.441 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 170' ' ' LYS . 10.3 pt -141.41 97.46 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.752 -0.852 . . . . 0.55000000000000004 109.853 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.64 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.07 78.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.277 0.561 . . . . 0.84999999999999998 112.127 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -121.1 -5.57 9.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.70999999999999996 110.266 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 172' ' ' HIS . 19.9 m-70 -82.19 -150.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.41999999999999998 110.011 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.97 30.31 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.704 -1.358 . . . . 0.33000000000000002 109.704 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 175' ' ' PHE . 2.9 p30 -127.51 -148.21 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -1.223 . . . . 0.33000000000000002 110.176 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -49.22 153.35 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.27000000000000002 110.09 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 9.2 m-30 -80.96 112.23 30.57 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.34000000000000002 110.314 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 45.9 Cg_endo -78.41 -67.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.901 1.474 . . . . 0.46999999999999997 110.631 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -51.74 149.79 4.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.34999999999999998 110.714 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.6 p30 -174.21 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.214 -0.994 . . . . 0.20000000000000001 111.482 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.561 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 120.43 -140.32 14.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.178 -1.569 . . . . 0.25 109.178 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.29 53.88 3.13 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 124.103 1.58 . . . . 0.44 109.628 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.415 ' CB ' ' OD1' ' A' ' 179' ' ' ASP . 0.2 OUTLIER -114.4 -177.41 3.12 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.526 -0.733 . . . . 0.56999999999999995 110.055 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -72.03 65.18 1.23 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.482 -1.047 . . . . 0.48999999999999999 110.482 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 2.6 tt 179.69 93.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -1.17 . . . . 0.40999999999999998 110.846 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.583 ' CD1' ' CZ ' ' A' ' 214' ' ' TYR . 4.1 tt -114.48 -13.3 12.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.606 -1.237 . . . . 0.29999999999999999 111.352 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.32 102.62 2.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.488 -1.382 . . . . 0.20000000000000001 111.671 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.54 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -117.26 122.77 44.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.16 109.51 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.587 ' CB ' ' CB ' ' A' ' 227' ' ' SER . . . -110.52 158.66 18.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.23000000000000001 110.207 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.9 m-30 -96.0 166.79 13.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.38 110.545 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 46.5 Cg_endo -72.86 136.38 25.13 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.091 1.574 . . . . 0.40000000000000002 109.742 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 58.98 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.93 1.489 . . . . 0.32000000000000001 110.611 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -99.18 -94.62 2.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.32000000000000001 109.464 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.8 -165.89 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.965 1.508 . . . . 0.46999999999999997 110.38 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -9.07 26.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.63 110.279 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 54.56 0.66 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.42 -0.8 . . . . 0.53000000000000003 110.226 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -124.08 174.76 16.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.049 -1.621 . . . . 0.25 109.049 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.14 24.66 0.59 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.716 -1.354 . . . . 0.10000000000000001 109.716 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 1.5 m-20 -79.8 87.35 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.068 -1.254 . . . . 0.10000000000000001 109.96 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -63.73 113.25 3.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.089999999999999997 110.502 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 11.4 m170 -121.24 119.07 31.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.325 -0.859 . . . . 0.089999999999999997 110.602 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.0 m-85 -90.5 141.78 28.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.228 -0.92 . . . . 0.10000000000000001 110.677 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 24.0 t0 -52.27 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.578 -0.701 . . . . 0.14000000000000001 109.476 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.7 p-10 -35.78 -37.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.17999999999999999 112.059 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.561 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 3.0 m-20 -65.62 -14.1 60.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.725 -1.234 . . . . 0.23999999999999999 111.175 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.536 ' OE1' ' CB ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -93.13 -156.99 0.51 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.716 -1.24 . . . . 0.41999999999999998 110.325 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.513 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 3.2 m -137.16 161.43 36.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.944 -1.098 . . . . 0.46999999999999997 111.062 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.513 ' CG ' ' C ' ' A' ' 206' ' ' THR . 1.1 m-90 -149.19 149.1 30.44 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.033 -0.728 . . . . 0.27000000000000002 109.033 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.76 -174.45 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.804 -1.185 . . . . 0.29999999999999999 110.708 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -123.36 30.2 6.38 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.893 -0.723 . . . . 0.60999999999999999 109.822 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -117.21 -172.49 2.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.41 -0.806 . . . . 0.78000000000000003 110.161 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.488 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.4 OUTLIER -80.88 0.84 33.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.91000000000000003 110.236 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -113.79 149.67 34.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.158 -0.964 . . . . 0.93000000000000005 110.184 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 68.46 -173.8 32.53 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.79000000000000004 109.402 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.583 ' CZ ' ' CD1' ' A' ' 185' ' ' LEU . 76.8 m-85 -77.16 114.26 15.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.68999999999999995 110.157 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 218' ' ' LEU . 1.6 m120 -77.45 123.24 26.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.99 -1.069 . . . . 0.40000000000000002 108.653 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.672 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.6 OUTLIER -44.72 -35.18 2.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.787 -1.165 . . . . 0.17000000000000001 108.691 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.584 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 6.6 m-85 -55.74 -46.42 77.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.968 -1.493 . . . . 0.28000000000000003 106.968 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 215' ' ' ASN . 21.8 tp -74.19 -74.8 0.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.901 -0.59 . . . . 0.46000000000000002 110.742 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 222' ' ' HIS . 1.2 p -48.19 -61.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.106 -0.996 . . . . 0.39000000000000001 110.852 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -53.6 -51.15 63.93 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.79 -1.194 . . . . 0.17000000000000001 111.336 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.247 -1.533 . . . . 0.10000000000000001 108.682 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.618 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.9 t60 -77.08 -51.69 10.61 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.223 0.535 . . . . 0.20999999999999999 109.647 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.482 ' O ' ' OG ' ' A' ' 227' ' ' SER . 3.1 tp10 -59.41 -44.08 92.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.987 -1.071 . . . . 0.28000000000000003 108.341 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.467 ' CZ ' HD11 ' A' ' 165' ' ' ILE . 7.5 m-30 -53.38 -61.96 1.96 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.734 . . . . 0.17999999999999999 109.102 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -32.72 2.16 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.925 -1.67 . . . . 0.20999999999999999 108.925 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.639 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -81.97 -77.99 0.21 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -1.178 . . . . 0.17000000000000001 111.229 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.587 ' CB ' ' CB ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.73 -39.84 0.16 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.558 -0.714 . . . . 0.33000000000000002 111.937 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 266' ' ' TYR . 3.0 tp -96.41 -39.45 9.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.968 -1.082 . . . . 0.53000000000000003 110.667 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -74.73 -91.09 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.099 -1.201 . . . . 0.40999999999999998 110.099 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.647 ' CD1' ' N ' ' A' ' 230' ' ' LEU . 0.0 OUTLIER -175.93 170.44 2.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -1.118 . . . . 0.45000000000000001 111.17 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.531 ' N ' HD22 ' A' ' 230' ' ' LEU . 7.2 t70 -25.7 -70.82 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 120.992 0.425 . . . . 0.62 112.024 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.639 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -162.12 -179.83 7.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.01 -1.056 . . . . 0.45000000000000001 111.176 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.3 OUTLIER 179.46 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.467 0.651 . . . . 0.38 109.401 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.555 ' HA ' ' CB ' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -101.76 23.09 11.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.534 -0.729 . . . . 0.47999999999999998 111.472 -179.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.592 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -37.3 -66.71 0.27 Allowed Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.81 -0.756 . . . . 0.38 110.381 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 55.0 Cg_endo -76.87 -47.28 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.292 1.154 . . . . 0.28000000000000003 110.578 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.79 101.17 0.14 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.981 -1.58 . . . . 0.23999999999999999 111.936 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.582 ' O ' ' CE2' ' A' ' 241' ' ' PHE . . . -144.57 160.25 41.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -1.058 . . . . 0.28000000000000003 110.207 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.618 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -75.2 64.98 1.5 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.23 1.015 . . . . 0.40000000000000002 108.747 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.585 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 3.1 mtp -141.64 -37.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.805 . . . . 0.45000000000000001 110.011 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -47.99 170.25 0.11 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.56999999999999995 109.795 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.0 Cg_endo -70.69 -2.64 11.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.582 1.306 . . . . 0.76000000000000001 110.512 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.546 ' O ' ' CE1' ' A' ' 241' ' ' PHE . 4.3 mt -98.64 145.12 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.89000000000000001 110.054 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.538 ' O ' ' N ' ' A' ' 246' ' ' TYR . 46.9 p90 -134.65 -33.62 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.78000000000000003 110.486 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.522 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER 3.15 -68.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.646 0.98 . . . . 0.60999999999999999 113.646 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.555 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -54.0 107.79 0.3 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.355 -1.466 . . . . 0.73999999999999999 109.854 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 53.3 m -58.38 172.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.81000000000000005 110.363 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 247' ' ' THR . . . -43.15 -40.76 4.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.899 -1.28 . . . . 0.56000000000000005 109.899 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 46.74 1.64 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.254 . . . . 0.37 110.638 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 1.2 t -89.29 1.93 55.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.44 110.093 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.86 -69.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.53000000000000003 110.238 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.2 OUTLIER 179.75 178.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.38 110.47 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.501 ' O ' ' CG ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -69.04 56.16 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.768 . . . . 0.19 109.853 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.654 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.79 -46.12 50.44 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 108.0 -1.111 . . . . 0.28000000000000003 108.0 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -73.89 49.69 1.95 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.94 1.495 . . . . 0.48999999999999999 111.499 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.511 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.3 m-20 -48.82 -34.11 11.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.48999999999999999 110.689 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.567 ' CB ' ' HB1' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -54.69 -53.28 56.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.615 -1.234 . . . . 0.31 108.79 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.22 -36.43 84.13 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.498 -0.881 . . . . 0.14000000000000001 108.819 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.52 ' O ' HD12 ' A' ' 262' ' ' ILE . 78.3 t -64.73 -84.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.17000000000000001 110.753 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 11.0 tt0 -54.68 -43.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.045 . . . . 0.26000000000000001 109.395 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.0 -70.12 0.39 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.518 -1.033 . . . . 0.19 110.518 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.6 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -71.25 -24.93 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.594 -1.533 . . . . 0.22 110.005 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 5.4 tt0 -57.33 -23.36 48.25 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.998 -1.081 . . . . 0.39000000000000001 108.554 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 -43.49 5.48 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.155 -0.618 . . . . 0.46999999999999997 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.53 ' CD1' ' HD2' ' A' ' 112' ' ' LYS . 7.0 mt -73.92 -53.45 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.812 . . . . 0.47999999999999998 110.876 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.513 ' O ' ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -75.37 -8.48 56.8 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.251 -0.905 . . . . 0.40999999999999998 109.837 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.43 -106.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.097 -1.601 . . . . 0.46000000000000002 109.097 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.81 115.42 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.878 1.462 . . . . 0.57999999999999996 109.999 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.08 143.13 18.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.66 -1.376 . . . . 0.64000000000000001 109.66 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.584 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.94999999999999996 110.064 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.545 ' CA ' HD12 ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.374 0.607 . . . . 1.03 109.41 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.484 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.64 48.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.783 -0.573 . . . . 1.04 111.363 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -138.72 78.83 1.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.997 . . . . 0.77000000000000002 109.61 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.593 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 6.4 t90 -151.15 -67.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.893 . . . . 0.41999999999999998 111.176 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.466 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 35.9 t -87.79 40.68 0.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.44 110.86 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HD3' ' CD1' ' A' ' 118' ' ' LEU . 13.1 mmtt -143.31 83.69 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.48999999999999999 110.807 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.1 ttp -100.26 -21.03 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.974 . . . . 0.29999999999999999 109.391 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 1.7 p-10 -138.52 137.83 37.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.14999999999999999 109.455 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.535 HD21 ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -151.07 167.56 27.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 0.13 110.824 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -110.17 168.45 9.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.12 109.604 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.663 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 8.5 p90 -167.32 176.13 6.88 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.934 -1.107 . . . . 0.33000000000000002 111.486 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.472 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 6.2 tpt85 -123.38 152.73 41.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.698 -0.626 . . . . 0.54000000000000004 109.38 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.659 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -121.32 95.05 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.084 -1.01 . . . . 0.33000000000000002 111.16 -179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 3.5 m -141.53 50.33 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.134 -0.979 . . . . 0.27000000000000002 110.257 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 1.8 t-20 -43.33 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.40999999999999998 109.404 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 30.6 t80 179.89 175.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.40000000000000002 110.127 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -118.97 59.28 4.24 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.45000000000000001 109.964 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.8 Cg_endo -70.73 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.109 1.584 . . . . 0.35999999999999999 110.567 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.19 4.39 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.25 109.795 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.538 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -115.41 139.9 49.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.518 -0.739 . . . . 0.39000000000000001 109.83 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -78.53 167.52 21.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.47999999999999998 110.378 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 130' ' ' THR . 22.3 t-80 -43.28 -39.21 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.40000000000000002 109.751 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 8.4 t -59.32 -49.36 78.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.46000000000000002 109.709 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.5 OUTLIER -58.25 -57.62 12.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.33 -0.857 . . . . 0.46999999999999997 109.337 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 125' ' ' TYR . 4.6 t -46.42 -35.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.608 -1.256 . . . . 0.31 107.608 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.584 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -57.79 -42.37 84.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.013 -1.106 . . . . 0.47999999999999998 108.013 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.578 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 7.8 tttt -69.31 -49.66 53.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.197 0.999 . . . . 0.64000000000000001 108.397 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.609 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -48.12 -61.71 1.84 Allowed 'General case' 0 C--N 1.287 -2.138 0 O-C-N 121.245 -0.91 . . . . 0.41999999999999998 110.816 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.659 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.34 -52.25 35.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.234 -0.916 . . . . 0.34000000000000002 111.026 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.631 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.2 -71.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.46999999999999997 110.397 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -41.99 -57.55 2.39 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.527 -0.733 . . . . 0.46999999999999997 110.307 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.97 -38.51 17.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.296 -1.362 . . . . 0.25 108.345 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.663 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -71.57 -34.71 70.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.308 -0.87 . . . . 0.34999999999999998 108.994 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.421 ' CD ' ' C ' ' A' ' 143' ' ' LYS . 0.1 OUTLIER -60.63 -41.25 94.52 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.797 -0.816 . . . . 0.69999999999999996 108.797 179.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.99 -49.96 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.661 -0.866 . . . . 0.60999999999999999 108.661 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.612 ' CH2' HG13 ' A' ' 262' ' ' ILE . 29.4 t-105 -52.43 -36.24 53.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.682 -0.859 . . . . 0.39000000000000001 108.682 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 149' ' ' THR . 57.8 m -75.24 -35.39 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.475 -0.766 . . . . 0.34999999999999998 109.095 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.68 -40.15 78.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.429 -0.794 . . . . 0.35999999999999999 109.375 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 263' ' ' GLN . 20.0 m -80.37 -31.23 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.777 -0.769 . . . . 0.5 110.119 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 146' ' ' SER . 12.8 t -150.59 131.9 7.53 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.047 . . . . 0.51000000000000001 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.14 58.93 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.854 1.45 . . . . 0.31 110.545 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 266' ' ' TYR . 2.1 mm? -77.2 134.89 38.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.17999999999999999 110.284 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.435 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 1.7 m-20 -80.94 130.13 34.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 110.123 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.5 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 8.4 p90 -137.15 139.57 41.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.14000000000000001 110.268 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.471 ' HB ' HG21 ' A' ' 119' ' ' THR . 18.2 m -147.06 131.31 17.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.302 -0.874 . . . . 0.14999999999999999 110.554 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.59 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -98.65 118.23 34.91 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.695 -0.628 . . . . 0.20000000000000001 109.471 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.43 99.74 7.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.22 110.311 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 158' ' ' ASP . 11.1 p-80 -54.03 -28.77 40.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.32000000000000001 109.833 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.5 t0 -41.76 -57.21 2.41 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.475 0.655 . . . . 0.33000000000000002 109.719 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.72 37.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.616 -1.394 . . . . 0.28000000000000003 109.616 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 119' ' ' THR . 23.5 mm -128.26 67.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.146 -1.208 . . . . 0.29999999999999999 109.373 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.8 127.94 52.41 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.78 -0.575 . . . . 0.20000000000000001 110.356 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.535 ' CB ' HD21 ' A' ' 118' ' ' LEU . 29.5 m-20 -90.0 -45.16 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.10000000000000001 110.058 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.536 HG13 ' CB ' ' A' ' 120' ' ' TYR . 1.4 pp -127.02 172.84 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.10000000000000001 109.719 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.472 ' HB2' ' HB3' ' A' ' 121' ' ' ARG . 4.3 ptt? -174.39 163.51 3.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.11 111.563 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.559 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 4.0 tt -106.23 116.25 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.542 -0.724 . . . . 0.10000000000000001 109.683 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.531 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 4.8 p -157.12 141.08 16.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.598 -1.314 . . . . 0.10000000000000001 111.304 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.7 p90 -60.76 121.68 12.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.547 -0.72 . . . . 0.089999999999999997 109.913 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -90.86 126.86 8.58 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.094 -1.203 . . . . 0.20000000000000001 110.094 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.584 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.2 tt -122.88 97.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.936 . . . . 0.55000000000000004 109.457 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 7.0 tptt 0.28 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.291 0.567 . . . . 0.84999999999999998 112.401 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.66 15.18 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.70999999999999996 110.168 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.412 ' CE1' ' CE1' ' A' ' 200' ' ' HIS . 29.6 m-70 -85.08 -86.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.41999999999999998 110.302 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.48 41.72 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.422 -1.471 . . . . 0.33000000000000002 109.422 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.97 -89.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -1.112 . . . . 0.33000000000000002 110.355 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.469 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 3.5 m-85 -116.66 -171.26 1.98 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.27000000000000002 110.411 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.551 ' CD1' ' HE2' ' A' ' 170' ' ' LYS . 4.2 m-30 -90.45 109.83 36.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.34000000000000002 110.176 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 42.9 Cg_endo -75.56 -72.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.46999999999999997 110.536 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CG ' ' OD2' ' A' ' 203' ' ' ASP . 2.1 p90 -64.85 177.61 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.34999999999999998 109.936 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.8 p-10 179.13 -51.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.164 -0.96 . . . . 0.20000000000000001 111.022 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 138.29 -136.59 8.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.366 -1.494 . . . . 0.25 109.366 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.64 -5.41 16.99 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 O-C-N 124.15 1.606 . . . . 0.44 109.392 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.449 ' HB2' ' OD2' ' A' ' 179' ' ' ASP . 1.8 m -55.04 -176.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.397 -0.814 . . . . 0.56999999999999995 109.616 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -82.63 76.34 2.24 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.038 -1.077 . . . . 0.48999999999999999 110.672 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 6.6 tt 179.77 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -1.146 . . . . 0.40999999999999998 110.841 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 214' ' ' TYR . 9.4 tt -109.43 -15.59 14.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.803 -1.186 . . . . 0.29999999999999999 111.248 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.45 ' HB3' ' OE1' ' A' ' 223' ' ' GLU . . . -154.28 109.16 3.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.437 -1.414 . . . . 0.20000000000000001 111.8 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 1.1 p80 -109.77 127.04 54.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.89 -1.131 . . . . 0.16 109.862 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.542 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -104.2 130.98 51.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.459 -0.775 . . . . 0.23000000000000001 110.359 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.439 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -78.53 163.49 61.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.085 -1.009 . . . . 0.38 110.42 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.471 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.2 Cg_endo -72.73 133.43 20.26 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 124.105 1.582 . . . . 0.40000000000000002 109.933 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.484 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.7 Cg_endo -70.55 70.07 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.874 1.46 . . . . 0.32000000000000001 110.399 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.36 -105.5 2.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.564 -1.414 . . . . 0.32000000000000001 109.564 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.74 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.916 1.482 . . . . 0.46999999999999997 110.223 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -63.17 -10.95 17.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.101 -1.0 . . . . 0.63 110.175 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.63 68.79 0.8 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.499 -0.75 . . . . 0.53000000000000003 110.032 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.472 ' O ' ' O ' ' A' ' 162' ' ' ASP . . . -151.53 165.33 30.47 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.901 -1.68 . . . . 0.25 108.901 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 58.28 16.18 26.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.066 -1.614 . . . . 0.10000000000000001 109.066 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -79.24 87.5 4.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -1.113 . . . . 0.10000000000000001 110.576 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 223' ' ' GLU . . . -62.7 95.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.089999999999999997 109.59 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.569 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 19.6 m170 -97.08 141.05 30.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.089999999999999997 110.394 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.583 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 5.4 m-30 -108.0 136.84 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.10000000000000001 110.98 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 179' ' ' ASP . 59.5 t0 -50.86 86.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.786 -0.82 . . . . 0.14000000000000001 108.786 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.597 ' OD2' ' CG ' ' A' ' 178' ' ' PHE . 1.3 p30 -39.34 -32.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.17999999999999999 111.844 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.576 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -78.81 3.0 17.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.645 -1.285 . . . . 0.23999999999999999 110.715 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.499 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 9.1 mm-40 -96.63 -162.83 0.99 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.012 -1.055 . . . . 0.41999999999999998 110.126 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.92 147.5 48.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.023 -1.048 . . . . 0.46999999999999997 110.51 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.511 ' CZ2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -138.71 144.94 39.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.27000000000000002 109.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.501 ' CG2' ' C ' ' A' ' 207' ' ' TRP . 0.1 OUTLIER -160.27 177.58 10.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.93 -1.106 . . . . 0.29999999999999999 110.833 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -128.61 41.19 3.53 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.912 0.863 . . . . 0.60999999999999999 109.109 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 4.0 t -122.19 -164.79 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.502 -0.749 . . . . 0.78000000000000003 109.955 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -89.02 14.45 10.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.91000000000000003 109.889 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -130.28 163.16 27.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.93000000000000005 110.316 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 58.76 -175.26 2.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.79000000000000004 109.461 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 185' ' ' LEU . 63.0 m-85 -74.62 117.76 16.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.68999999999999995 110.144 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 218' ' ' LEU . 9.3 p30 -87.75 118.66 27.41 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.192 -0.943 . . . . 0.40000000000000002 108.709 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.609 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 1.6 mp -41.83 -32.72 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.483 -0.76 . . . . 0.17000000000000001 110.649 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.1 m-85 -50.89 -47.64 60.6 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.297 -1.372 . . . . 0.28000000000000003 107.297 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 42.1 tp -82.49 -70.16 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.423 -0.808 . . . . 0.46000000000000002 110.976 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.599 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.43 -60.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.39000000000000001 109.753 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -54.8 -48.69 72.42 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.892 -1.13 . . . . 0.17000000000000001 110.916 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.22 -29.99 66.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.328 -1.483 . . . . 0.10000000000000001 108.846 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.594 ' CE1' ' CA ' ' A' ' 240' ' ' MET . 5.4 t60 -74.75 -51.06 15.19 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.746 -0.661 . . . . 0.20999999999999999 109.523 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.523 ' CG ' ' HB2' ' A' ' 199' ' ' ALA . 2.9 tp10 -61.09 -32.9 72.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.28000000000000003 109.042 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 225' ' ' GLY . 13.6 m-30 -65.85 -64.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.42 -0.8 . . . . 0.17999999999999999 108.986 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -28.27 1.19 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.076 -1.61 . . . . 0.20999999999999999 109.076 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.63 -70.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -1.221 . . . . 0.17000000000000001 111.657 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.542 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 5.0 p -51.77 -31.17 25.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.33000000000000002 112.124 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.487 HD12 ' CG2' ' A' ' 163' ' ' ILE . 9.8 tp -99.96 -41.83 7.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.89 -1.131 . . . . 0.53000000000000003 111.157 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -74.89 -83.93 0.36 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.758 -0.937 . . . . 0.40999999999999998 110.758 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 2.0 pt? -161.13 -157.73 0.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.031 -1.276 . . . . 0.45000000000000001 110.785 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -70.74 -50.95 30.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.62 110.36 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.624 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -169.09 176.18 5.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 0.45000000000000001 110.59 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.71 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.443 -0.785 . . . . 0.38 109.316 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -138.98 22.22 2.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.47999999999999998 110.889 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -38.78 -48.47 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.464 -0.772 . . . . 0.38 110.433 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 45.6 Cg_endo -87.36 -48.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.846 1.445 . . . . 0.28000000000000003 111.372 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.506 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.28 100.43 0.13 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 118.962 -1.589 . . . . 0.23999999999999999 111.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -144.89 -161.62 1.33 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -1.143 . . . . 0.28000000000000003 109.808 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -105.66 49.84 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.341 -0.985 . . . . 0.40000000000000002 108.341 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.594 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 3.4 mtt -134.37 -21.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.374 -0.829 . . . . 0.45000000000000001 111.157 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.625 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -59.07 168.5 1.51 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.793 -1.192 . . . . 0.56999999999999995 111.035 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.7 Cg_endo -71.23 -8.65 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.684 1.36 . . . . 0.76000000000000001 109.93 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.567 ' O ' ' CE1' ' A' ' 241' ' ' PHE . 17.1 mm -101.06 139.08 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.452 -0.78 . . . . 0.89000000000000001 109.647 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.565 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 48.2 p90 -125.6 -25.56 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.78000000000000003 110.664 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.514 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.5 OUTLIER 2.45 -67.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 113.635 0.976 . . . . 0.60999999999999999 113.635 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.568 ' CD1' ' OG ' ' A' ' 250' ' ' SER . 0.1 OUTLIER -68.63 117.19 10.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.38 -1.45 . . . . 0.73999999999999999 109.289 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.496 ' HA ' HD21 ' A' ' 218' ' ' LEU . 49.3 p -47.13 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.81000000000000005 110.206 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.79 -21.16 3.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.432 -1.467 . . . . 0.56000000000000005 109.432 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.443 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 1.1 ptmm? -162.5 49.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.246 . . . . 0.37 110.665 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.568 ' OG ' ' CD1' ' A' ' 246' ' ' TYR . 1.4 m -43.77 -61.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.44 109.856 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.7 OUTLIER -147.37 4.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.53000000000000003 111.016 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.554 ' CE2' ' HG2' ' A' ' 253' ' ' MET . 92.7 t80 179.98 170.91 1.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.934 -1.104 . . . . 0.38 110.939 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.554 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -90.58 59.89 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.55 -0.719 . . . . 0.19 110.013 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.667 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.7 OUTLIER -44.41 -47.33 25.75 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.979 -1.119 . . . . 0.28000000000000003 107.979 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.2 Cg_endo -73.34 50.58 1.95 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.143 1.602 . . . . 0.48999999999999999 110.922 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.588 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.4 m-20 -55.54 -29.15 58.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.072 -1.017 . . . . 0.48999999999999999 110.633 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 238' ' ' ALA . 35.3 m-20 -54.7 -48.95 71.83 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.111 -0.993 . . . . 0.31 109.234 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.536 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.98 -33.31 63.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.57 -0.9 . . . . 0.14000000000000001 108.57 178.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 72.8 t -62.23 -82.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.811 . . . . 0.17000000000000001 110.055 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.572 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 21.4 tm0? -59.84 -41.76 92.08 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.345 -0.847 . . . . 0.26000000000000001 109.665 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.69 -64.87 1.12 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.612 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -80.21 -21.66 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.744 -1.445 . . . . 0.22 110.278 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.572 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 6.3 tt0 -60.35 -22.67 63.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.788 -1.165 . . . . 0.39000000000000001 108.158 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 31.2 t -104.09 -41.21 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.268 -0.573 . . . . 0.46999999999999997 111.092 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -79.75 -50.2 10.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.47999999999999998 111.527 -178.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.568 ' CE2' ' HA2' ' A' ' 229' ' ' GLY . 0.0 OUTLIER -78.7 -17.09 56.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.40999999999999998 110.059 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -52.88 -93.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.815 -1.714 . . . . 0.46000000000000002 108.815 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 128.49 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.017 1.535 . . . . 0.57999999999999996 110.067 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -101.02 147.7 17.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.583 -1.407 . . . . 0.64000000000000001 109.583 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.593 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.273 -1.134 . . . . 0.94999999999999996 110.054 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 6.7 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 1.03 109.967 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.516 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 45.06 23.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.187 -0.945 . . . . 1.04 111.285 179.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HG2' ' CD2' ' A' ' 266' ' ' TYR . 28.9 mtpt -123.64 74.45 1.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.051 -1.031 . . . . 0.77000000000000002 109.598 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.566 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 5.9 t90 -145.44 -67.91 0.3 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.225 -0.922 . . . . 0.41999999999999998 110.907 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.1 t -97.84 58.52 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.865 . . . . 0.44 110.835 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 114' ' ' SER . 9.5 mttm -160.03 61.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.94 . . . . 0.48999999999999999 110.43 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 7.3 tmm? -85.05 13.69 5.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.29999999999999999 110.355 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -171.82 126.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.14999999999999999 110.278 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.459 HD11 ' OD2' ' A' ' 162' ' ' ASP . 2.8 mt -151.3 -164.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.13 110.177 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -128.78 171.38 12.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.12 109.75 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 154' ' ' THR . 36.2 p90 -171.4 -172.97 1.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.09 . . . . 0.33000000000000002 111.168 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.449 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 2.3 mtm-85 -127.98 164.84 21.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.54000000000000004 110.196 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 138' ' ' PHE . 6.6 pt -128.19 70.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.33000000000000002 110.365 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.487 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 4.8 m -120.67 50.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.27000000000000002 110.793 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 6.8 t30 -44.13 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.40999999999999998 109.267 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.524 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 7.5 t80 -178.99 174.43 1.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.506 -0.746 . . . . 0.40000000000000002 109.836 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.508 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -128.74 53.78 12.23 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.45000000000000001 110.425 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 126' ' ' THR . 47.2 Cg_endo -77.14 -86.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.989 1.52 . . . . 0.35999999999999999 110.609 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.02 -1.38 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.25 110.064 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.528 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -112.19 150.52 30.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.39000000000000001 110.111 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -98.03 166.24 11.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.47999999999999998 110.069 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' THR . 17.2 t-80 -41.3 -32.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.395 -0.816 . . . . 0.40000000000000002 110.194 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -69.87 -46.32 65.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.46000000000000002 110.261 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.528 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.8 OUTLIER -67.67 -58.11 5.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.083 -1.01 . . . . 0.46999999999999997 109.528 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 13.8 t -45.07 -37.78 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.817 -1.179 . . . . 0.31 107.817 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.9 mt-10 -57.58 -45.95 84.6 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.887 -1.153 . . . . 0.47999999999999998 107.887 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 3.3 tttt -63.2 -48.94 76.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.798 0.809 . . . . 0.64000000000000001 109.011 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.67 -59.02 2.99 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.123 -0.986 . . . . 0.41999999999999998 110.155 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.624 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -66.71 -54.15 26.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.34000000000000002 110.568 -179.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -64.6 -74.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.099 -1.0 . . . . 0.46999999999999997 109.942 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.9 tmtt? -37.32 -62.7 0.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 O-C-N 122.07 -0.394 . . . . 0.46999999999999997 110.886 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.92 -36.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.686 -1.206 . . . . 0.25 108.585 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.83 -28.94 61.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.34999999999999998 109.111 178.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.93 -43.73 97.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.379 -0.971 . . . . 0.69999999999999996 108.379 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.29 -49.66 52.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.649 -0.871 . . . . 0.60999999999999999 108.649 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.603 ' CH2' HG13 ' A' ' 262' ' ' ILE . 51.3 t-105 -53.54 -31.52 46.74 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.755 -0.831 . . . . 0.39000000000000001 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 149' ' ' THR . 67.6 m -78.95 -34.25 44.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.235 -1.024 . . . . 0.34999999999999998 108.235 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -37.37 73.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.793 -0.818 . . . . 0.35999999999999999 108.793 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.1 m -80.67 -35.14 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.767 -0.773 . . . . 0.5 109.751 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.507 ' N ' HG23 ' A' ' 148' ' ' VAL . 4.6 t -147.83 127.6 6.56 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.994 . . . . 0.51000000000000001 110.389 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 54.25 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.803 1.422 . . . . 0.31 110.601 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 266' ' ' TYR . 4.1 tp -73.85 147.79 42.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.17999999999999999 110.318 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.9 OUTLIER -88.22 117.62 27.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.93 . . . . 0.17000000000000001 110.204 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 6.0 p90 -125.12 119.75 29.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.14000000000000001 110.297 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 23.0 m -120.45 170.75 9.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.14999999999999999 110.256 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.488 ' N ' ' CG2' ' A' ' 154' ' ' THR . 2.3 ptt180 -156.64 114.52 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.902 -0.719 . . . . 0.20000000000000001 110.481 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 110.67 14.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.22 109.995 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 158' ' ' ASP . 23.9 p-80 -51.86 -23.63 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.32000000000000001 109.954 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.523 ' OD2' ' CD1' ' A' ' 160' ' ' ILE . 1.1 t70 -44.24 -26.16 0.29 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.39 -0.819 . . . . 0.33000000000000002 109.666 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.72 28.9 1.01 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.543 -1.423 . . . . 0.28000000000000003 109.543 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.546 ' O ' ' HB ' ' A' ' 119' ' ' THR . 7.2 mt -115.3 81.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.2 -1.176 . . . . 0.29999999999999999 108.483 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.514 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -144.81 123.68 12.7 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.068 -0.653 . . . . 0.20000000000000001 110.828 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.459 ' OD2' HD11 ' A' ' 118' ' ' LEU . 39.4 t0 -92.29 -51.61 5.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.10000000000000001 109.697 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 120' ' ' TYR . 1.1 pt -115.82 179.43 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.307 -0.87 . . . . 0.10000000000000001 109.05 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.479 ' HB3' ' O ' ' A' ' 163' ' ' ILE . 8.2 ptp -177.82 151.6 0.71 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 0.11 111.618 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.573 ' HB ' ' CE2' ' A' ' 224' ' ' PHE . 3.6 tt -93.98 117.6 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.10000000000000001 109.374 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.487 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 4.1 p -159.31 150.57 20.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.74 -1.225 . . . . 0.10000000000000001 110.587 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.584 ' CE2' ' HB ' ' A' ' 169' ' ' ILE . 6.7 p90 -72.94 117.74 15.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.499 -0.751 . . . . 0.089999999999999997 110.168 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -67.75 118.82 10.18 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.051 -1.22 . . . . 0.20000000000000001 110.051 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.584 ' HB ' ' CE2' ' A' ' 167' ' ' PHE . 19.7 tt -118.5 101.08 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.88 -0.776 . . . . 0.55000000000000004 109.422 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.9 OUTLIER 1.93 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.331 0.586 . . . . 0.84999999999999998 112.488 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.22 -0.04 3.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.70999999999999996 110.088 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 17.3 m-70 -91.36 -154.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.41999999999999998 110.191 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -159.08 31.61 0.45 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.467 . . . . 0.33000000000000002 109.434 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -131.47 -52.84 1.01 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -1.155 . . . . 0.33000000000000002 110.125 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -136.87 175.98 9.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.27000000000000002 110.231 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -95.09 110.15 48.49 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.34000000000000002 110.255 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.534 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.2 Cg_endo -73.38 -37.96 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.984 1.518 . . . . 0.46999999999999997 110.592 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 4.4 p90 -109.73 170.19 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.34999999999999998 110.734 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -179.77 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.20000000000000001 111.142 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.564 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 159.2 -141.66 7.73 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.561 -1.415 . . . . 0.25 109.561 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.65 -3.82 13.83 Favored 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.236 1.65 . . . . 0.44 109.875 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.86 177.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.463 -0.773 . . . . 0.56999999999999995 110.019 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.51 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -74.97 79.77 0.98 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.234 -1.146 . . . . 0.48999999999999999 110.234 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 15.1 tp 179.82 91.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -1.12 . . . . 0.40999999999999998 110.888 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.577 HD12 ' CD1' ' A' ' 214' ' ' TYR . 8.0 tt -113.83 -17.38 12.06 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.461 -1.296 . . . . 0.29999999999999999 111.293 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -152.14 104.55 2.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.555 -1.341 . . . . 0.20000000000000001 111.864 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 0.4 OUTLIER -109.41 121.0 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.16 109.77 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.533 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -110.83 136.01 50.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.23000000000000001 110.413 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.698 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.8 m-30 -85.57 159.36 55.72 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.38 110.216 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.506 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 43.8 Cg_endo -70.88 140.28 38.14 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.145 1.603 . . . . 0.40000000000000002 109.588 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 42.0 Cg_endo -68.75 82.0 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.015 1.534 . . . . 0.32000000000000001 110.836 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.61 -91.23 1.12 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.17 -1.572 . . . . 0.32000000000000001 109.17 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.28 -158.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.074 1.565 . . . . 0.46999999999999997 109.981 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -82.51 12.26 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 0.63 110.323 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -117.78 -3.34 11.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.249 -0.907 . . . . 0.53000000000000003 109.982 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -68.54 171.31 37.52 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.331 -1.508 . . . . 0.25 109.331 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.487 ' O ' ' HB ' ' A' ' 163' ' ' ILE . . . 48.22 21.76 2.0 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.775 -1.33 . . . . 0.10000000000000001 109.775 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 195' ' ' TYR . 0.4 OUTLIER -81.71 85.55 6.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.317 . . . . 0.10000000000000001 110.096 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 223' ' ' GLU . . . -62.17 101.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.089999999999999997 110.033 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.572 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -112.53 120.88 43.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.837 . . . . 0.089999999999999997 110.461 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 203' ' ' ASP . 22.6 m-85 -90.67 144.37 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.10000000000000001 110.477 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 15.1 t0 -52.84 85.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.593 -0.892 . . . . 0.14000000000000001 108.593 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.8 p30 -38.19 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.17999999999999999 111.799 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.564 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -75.68 -0.65 21.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.792 -1.193 . . . . 0.23999999999999999 110.929 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 0.0 OUTLIER -101.98 -156.14 0.55 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 0.41999999999999998 110.218 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 17.5 m -133.98 156.4 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 0.46999999999999997 110.768 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -151.65 150.64 30.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.27000000000000002 109.272 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -161.05 173.18 15.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.726 -1.234 . . . . 0.29999999999999999 111.038 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.0 OUTLIER -129.84 25.35 5.31 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.716 0.769 . . . . 0.60999999999999999 108.993 178.62 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.34 -67.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.463 0.649 . . . . 0.78000000000000003 110.525 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.75 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.488 -0.757 . . . . 0.91000000000000003 109.724 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.99 -178.99 4.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 110.063 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.05 -174.7 0.17 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.539 -1.424 . . . . 0.79000000000000004 109.539 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.577 ' CD1' HD12 ' A' ' 185' ' ' LEU . 93.9 m-85 -67.36 120.13 13.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -1.109 . . . . 0.68999999999999995 109.814 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 218' ' ' LEU . 40.6 m-80 -88.17 119.5 28.63 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.974 -1.079 . . . . 0.40000000000000002 108.8 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.656 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -41.84 -36.24 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -0.863 . . . . 0.17000000000000001 110.236 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.583 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 4.6 m-85 -51.58 -44.11 62.67 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.407 -1.317 . . . . 0.28000000000000003 107.746 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 12.3 tp -83.65 -71.29 0.51 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.894 -0.594 . . . . 0.46000000000000002 111.106 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.589 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.4 p -46.31 -56.11 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.986 -1.071 . . . . 0.39000000000000001 109.817 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -59.95 -48.92 79.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.101 -0.999 . . . . 0.17000000000000001 110.873 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -57.36 -24.92 58.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.234 -1.541 . . . . 0.10000000000000001 108.556 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.586 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 3.8 t-160 -79.64 -54.89 5.44 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.95 -0.568 . . . . 0.20999999999999999 109.872 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 199' ' ' ALA . 3.3 tp10 -59.51 -50.94 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.979 -1.076 . . . . 0.28000000000000003 109.092 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 1.9 m-85 -52.82 -57.99 8.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.17999999999999999 109.163 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.02 -32.58 4.84 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.251 -1.539 . . . . 0.20999999999999999 109.251 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.64 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.0 -72.14 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.09 -1.241 . . . . 0.17000000000000001 111.001 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.533 ' CA ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -38.05 -42.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.33000000000000002 111.9 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -95.95 -38.49 10.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.878 -1.139 . . . . 0.53000000000000003 111.335 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.523 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -75.13 -87.09 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.653 -0.979 . . . . 0.40999999999999998 110.653 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 110' ' ' THR . 0.3 OUTLIER -158.69 -167.72 2.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -1.194 . . . . 0.45000000000000001 110.855 -178.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.503 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -64.41 -55.43 21.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.62 109.75 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.64 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -157.38 179.98 8.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.264 -0.898 . . . . 0.45000000000000001 110.62 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 14.2 t 179.24 50.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.38 109.381 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -131.06 21.56 4.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.47999999999999998 111.13 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.582 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -37.44 -52.86 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.38 110.708 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.2 Cg_endo -90.12 -46.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.52 1.274 . . . . 0.28000000000000003 110.873 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.01 96.11 0.1 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.295 -1.431 . . . . 0.23999999999999999 111.419 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -143.37 165.95 26.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.347 -1.09 . . . . 0.28000000000000003 110.133 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.582 ' CD2' ' HB2' ' A' ' 222' ' ' HIS . 7.0 tt -74.46 55.7 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.40000000000000002 109.736 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.586 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.6 mmm -133.7 -34.72 1.01 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.004 -1.06 . . . . 0.45000000000000001 110.32 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -42.99 168.51 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 0.56999999999999995 110.464 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.9 Cg_endo -72.89 -2.43 11.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.89 1.468 . . . . 0.76000000000000001 110.024 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.57 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 26.1 mm -106.89 149.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.89000000000000001 110.04 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.551 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 26.4 p90 -134.51 -28.3 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.78000000000000003 110.922 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.536 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 2.93 -69.52 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.495 0.924 . . . . 0.60999999999999999 113.495 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.595 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -55.17 104.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.309 -1.495 . . . . 0.73999999999999999 109.628 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.519 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 0.2 OUTLIER -52.52 -177.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.81000000000000005 110.201 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.58 -8.31 51.31 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.317 -1.513 . . . . 0.56000000000000005 109.317 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 29.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.37 110.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.482 ' HB2' ' CB ' ' A' ' 247' ' ' THR . 0.9 OUTLIER -82.35 -10.62 59.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.056 -1.028 . . . . 0.44 109.746 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.555 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -156.92 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.53000000000000003 109.785 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER 179.22 -172.27 0.15 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.38 110.407 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.466 ' CE ' ' OD2' ' A' ' 256' ' ' ASP . 19.7 ptt? -66.31 53.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.19 110.825 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.681 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.6 OUTLIER -46.22 -47.39 45.06 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 107.933 -1.136 . . . . 0.28000000000000003 107.933 177.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -72.92 50.32 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 124.076 1.567 . . . . 0.48999999999999999 111.309 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.0 m-20 -48.51 -32.48 7.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.945 -1.097 . . . . 0.48999999999999999 110.6 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.613 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -53.89 -53.54 51.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.887 -1.125 . . . . 0.31 109.233 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.541 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -67.46 -32.86 73.99 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.021 -1.05 . . . . 0.14000000000000001 108.915 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 59.2 t -66.54 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.17000000000000001 110.398 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 8.7 tt0 -53.9 -41.97 68.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.26000000000000001 109.231 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.69 -71.66 0.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.603 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -71.54 -19.48 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.707 -1.466 . . . . 0.22 110.073 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.599 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 40.3 tt0 -59.6 -26.44 65.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.543 -1.28 . . . . 0.39000000000000001 107.543 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.7 t -104.59 -42.47 5.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.411 0.624 . . . . 0.46999999999999997 110.887 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 262' ' ' ILE . 26.5 mt -69.15 -55.02 11.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.47999999999999998 111.223 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.53 ' CE2' HD22 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -81.33 -6.84 59.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.40999999999999998 110.032 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.29 -108.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.129 -1.588 . . . . 0.46000000000000002 109.129 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.74 76.84 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.733 1.386 . . . . 0.57999999999999996 110.325 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -48.19 161.04 0.51 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.64000000000000001 109.554 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.566 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.94999999999999996 110.125 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.287 0.565 . . . . 1.03 109.505 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.3 tp 35.53 30.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.817 -0.552 . . . . 1.04 111.18 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -108.59 51.53 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.945 . . . . 0.77000000000000002 110.239 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.501 ' NE1' ' HB3' ' A' ' 270' ' ' ASP . 8.0 t90 -139.79 -56.47 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.41999999999999998 110.124 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.471 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 79.5 p -90.67 49.74 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.44 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 6.4 mmtt -148.48 87.71 1.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.48999999999999999 110.174 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 35.9 ttp -123.02 -8.81 8.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.162 -0.961 . . . . 0.29999999999999999 110.098 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 7.0 p-10 -159.77 126.73 4.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.14999999999999999 109.974 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -152.98 -172.58 4.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.13 110.426 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' A' ' 161' ' ' ALA . 1.2 p -127.59 139.14 52.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.12 110.557 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.544 ' CB ' HG12 ' A' ' 163' ' ' ILE . 26.6 p90 -127.32 177.99 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.33000000000000002 111.398 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' CB ' ' A' ' 164' ' ' MET . 7.2 tpt180 -133.08 150.39 52.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.54000000000000004 109.508 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.585 HD11 ' CE2' ' A' ' 138' ' ' PHE . 3.4 pt -112.62 118.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.003 . . . . 0.33000000000000002 111.771 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 1.8 m -166.26 38.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.27000000000000002 110.079 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.541 ' OD1' ' CG2' ' A' ' 134' ' ' VAL . 0.8 OUTLIER -42.89 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.399 -0.92 . . . . 0.40999999999999998 109.116 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.538 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 4.7 t80 179.58 -171.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.885 . . . . 0.40000000000000002 109.991 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.541 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.8 53.02 3.47 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.798 -1.189 . . . . 0.45000000000000001 110.913 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.9 Cg_endo -80.38 -84.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.858 1.452 . . . . 0.35999999999999999 110.571 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.15 -3.96 57.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.25 109.95 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.507 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -123.0 160.38 26.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.303 -0.873 . . . . 0.39000000000000001 110.369 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.26 179.51 4.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.47999999999999998 109.759 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -47.02 -39.26 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.40000000000000002 110.208 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -59.96 -57.87 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.46000000000000002 110.037 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 136' ' ' LYS . 4.4 mp0 -53.69 -54.61 35.52 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.219 -0.925 . . . . 0.46999999999999997 109.607 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.541 ' CG2' ' OD1' ' A' ' 124' ' ' ASN . 2.6 t -46.16 -36.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.939 -1.134 . . . . 0.31 107.939 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 5.1 tt0 -61.2 -40.28 93.35 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.242 -1.022 . . . . 0.47999999999999998 108.242 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.581 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -72.44 -52.0 17.8 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.3 -0.96 . . . . 0.64000000000000001 108.776 178.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.657 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -44.67 -62.63 1.13 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.081 -1.012 . . . . 0.41999999999999998 110.447 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -64.32 -52.98 55.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.439 -0.788 . . . . 0.34000000000000002 111.343 -178.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.645 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -68.78 -71.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.905 -1.122 . . . . 0.46999999999999997 110.328 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.54 -59.78 0.88 Allowed 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.933 -0.479 . . . . 0.46999999999999997 110.33 178.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.22 -41.38 27.22 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.594 -1.242 . . . . 0.25 107.984 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -68.29 -27.47 66.34 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.432 -0.793 . . . . 0.34999999999999998 109.11 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 2.6 tttt -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.465 -0.939 . . . . 0.69999999999999996 108.465 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 13.4 t -73.14 -46.86 49.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.905 -0.776 . . . . 0.60999999999999999 108.905 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.584 ' CH2' HG13 ' A' ' 262' ' ' ILE . 42.3 t-105 -58.52 -42.53 87.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.9 -0.778 . . . . 0.39000000000000001 108.9 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.3 m -70.86 -32.06 68.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.431 -0.952 . . . . 0.34999999999999998 108.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -55.65 -46.87 77.41 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.107 -0.701 . . . . 0.35999999999999999 109.107 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 28.1 m -72.34 -34.62 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.448 -0.901 . . . . 0.5 109.369 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.527 HG21 ' CD1' ' A' ' 151' ' ' LEU . 1.1 t -141.37 118.69 7.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.103 -0.998 . . . . 0.51000000000000001 109.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.49 62.58 3.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.68 1.358 . . . . 0.31 111.153 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.64 ' CD2' ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -76.48 174.2 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.003 -1.06 . . . . 0.17999999999999999 109.931 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.447 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 12.5 t-20 -107.81 126.23 52.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.228 -0.92 . . . . 0.17000000000000001 109.873 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -131.37 143.03 50.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 0.14000000000000001 110.925 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 119' ' ' THR . 33.0 m -143.61 141.51 30.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.337 -0.852 . . . . 0.14999999999999999 110.38 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.443 ' NH1' ' OH ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -117.35 88.24 2.87 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.29 -0.882 . . . . 0.20000000000000001 109.935 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.54 ' CB ' ' HB ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -79.81 129.07 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.22 110.461 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -89.0 36.78 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.32000000000000001 109.965 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -34.63 2.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.511 -0.743 . . . . 0.33000000000000002 109.648 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 147.1 37.13 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.051 -1.22 . . . . 0.28000000000000003 110.051 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.54 ' HB ' ' CB ' ' A' ' 156' ' ' LEU . 1.9 mp -126.02 70.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.251 . . . . 0.29999999999999999 108.983 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -139.22 162.27 35.39 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 0.20000000000000001 110.702 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.555 ' CB ' ' CD2' ' A' ' 118' ' ' LEU . 7.0 t70 -134.18 -33.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.10000000000000001 110.458 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.557 ' CG2' ' HA3' ' A' ' 197' ' ' GLY . 0.2 OUTLIER -127.5 173.29 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.038 . . . . 0.10000000000000001 109.77 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.503 ' CB ' ' HB3' ' A' ' 121' ' ' ARG . 2.9 ptt? -176.98 159.12 1.65 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.605 -1.309 . . . . 0.11 111.754 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.56 ' HB ' ' CZ ' ' A' ' 224' ' ' PHE . 3.3 tt -103.0 116.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.10000000000000001 109.301 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 4.3 p -157.32 154.58 29.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.789 -1.195 . . . . 0.10000000000000001 111.035 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.3 p90 -75.03 122.13 23.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.089999999999999997 109.448 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -84.52 115.72 4.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.244 -1.142 . . . . 0.20000000000000001 110.244 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.577 ' O ' ' CG2' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -105.43 104.21 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -1.034 . . . . 0.55000000000000004 109.246 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.588 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.72 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.42 0.628 . . . . 0.84999999999999998 112.374 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -130.15 -2.13 4.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 0.70999999999999996 110.181 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 10.3 m-70 -84.83 178.95 7.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.41999999999999998 109.857 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.74 28.38 4.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.33000000000000002 109.683 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -121.77 -97.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.33000000000000002 110.14 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.404 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 97.3 m-85 -102.09 126.94 49.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.27000000000000002 110.022 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -54.48 109.59 1.65 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.93 . . . . 0.34000000000000002 110.301 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.461 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 42.7 Cg_endo -74.16 -66.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.015 1.534 . . . . 0.46999999999999997 110.76 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -47.72 137.75 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.34999999999999998 110.406 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.493 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 7.6 p30 179.14 81.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.402 -0.919 . . . . 0.20000000000000001 110.584 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.485 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 38.2 -152.01 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.741 -1.343 . . . . 0.25 109.741 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -82.49 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.969 1.51 . . . . 0.44 110.584 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.4 t -58.39 176.13 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.56999999999999995 110.354 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.504 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.49 70.49 0.04 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.219 -1.153 . . . . 0.48999999999999999 110.219 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.507 ' N ' ' O ' ' A' ' 182' ' ' SER . 7.4 tp 179.9 81.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.349 -1.089 . . . . 0.40999999999999998 110.175 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.558 HD12 ' CG ' ' A' ' 214' ' ' TYR . 6.4 tt -100.84 -24.34 14.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.355 -1.338 . . . . 0.29999999999999999 111.036 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.479 ' HB3' ' CD1' ' A' ' 201' ' ' PHE . . . -149.01 101.71 3.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.723 -1.235 . . . . 0.20000000000000001 112.254 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.518 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.1 OUTLIER -102.97 133.35 48.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.16 109.236 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.519 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -121.37 130.93 53.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 0.23000000000000001 110.595 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.403 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -79.14 165.15 50.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.38 110.341 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.53 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.9 Cg_endo -73.41 141.27 31.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.974 1.512 . . . . 0.40000000000000002 110.038 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 227' ' ' SER . 42.9 Cg_endo -70.08 83.25 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.911 1.48 . . . . 0.32000000000000001 110.626 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.72 -101.52 1.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.32000000000000001 109.589 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -162.49 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.942 1.496 . . . . 0.46999999999999997 110.539 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -62.0 -17.79 58.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.63 110.023 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.44 59.55 0.67 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.532 -0.73 . . . . 0.53000000000000003 110.377 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -131.22 168.16 22.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.828 -1.709 . . . . 0.25 108.828 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.557 ' HA3' ' CG2' ' A' ' 163' ' ' ILE . . . 42.78 26.61 0.46 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.67 -1.372 . . . . 0.10000000000000001 109.67 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 196' ' ' GLY . 7.3 m-20 -79.06 86.18 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.10000000000000001 109.914 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.531 ' HB2' ' CG ' ' A' ' 223' ' ' GLU . . . -62.6 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.074 -1.016 . . . . 0.089999999999999997 109.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.518 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 17.9 m170 -101.97 131.19 48.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.855 . . . . 0.089999999999999997 110.707 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 203' ' ' ASP . 42.4 m-85 -103.52 137.61 41.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.913 . . . . 0.10000000000000001 110.515 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -49.05 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.14000000000000001 108.956 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.548 ' OD2' ' CB ' ' A' ' 178' ' ' PHE . 2.6 p30 -35.95 -29.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.653 -0.654 . . . . 0.17999999999999999 111.772 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 202' ' ' ASP . 10.4 m-20 -79.12 2.27 21.4 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.607 -1.308 . . . . 0.23999999999999999 111.457 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 202' ' ' ASP . 9.8 mm-40 -93.65 -166.45 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.773 -1.204 . . . . 0.41999999999999998 110.347 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.32 140.81 52.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.46999999999999997 110.468 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.462 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -140.6 130.39 24.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.275 -0.89 . . . . 0.27000000000000002 109.737 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -138.83 176.46 8.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.021 -1.05 . . . . 0.29999999999999999 110.583 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 209' ' ' SER . 2.1 t -130.5 35.94 3.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.873 -0.788 . . . . 0.60999999999999999 108.873 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.9 t -115.26 -111.62 0.35 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.702 -0.624 . . . . 0.78000000000000003 110.065 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.517 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 t -143.88 11.23 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.91000000000000003 109.952 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 123.52 29.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 109.917 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.99 -171.7 31.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.175 -1.57 . . . . 0.79000000000000004 109.175 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.558 ' CG ' HD12 ' A' ' 185' ' ' LEU . 64.8 m-85 -69.47 122.11 18.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -1.192 . . . . 0.68999999999999995 109.687 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 208' ' ' THR . 1.1 p-10 -95.73 119.82 34.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.986 -1.072 . . . . 0.40000000000000002 108.965 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.657 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -38.45 -37.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.672 -0.643 . . . . 0.17000000000000001 111.093 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.581 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.6 m-30 -49.92 -48.39 51.73 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.439 -1.304 . . . . 0.28000000000000003 107.719 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.555 ' CD1' HD12 ' A' ' 239' ' ' LEU . 4.7 tp -79.79 -69.45 0.58 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.906 -0.588 . . . . 0.46000000000000002 110.53 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.575 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.99 -65.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.39000000000000001 109.786 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -48.53 -50.27 32.65 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.832 -1.167 . . . . 0.17000000000000001 111.564 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -63.52 -24.88 68.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.329 -1.482 . . . . 0.10000000000000001 109.052 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.614 ' CE1' ' CA ' ' A' ' 240' ' ' MET . 6.6 t60 -76.78 -54.5 6.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.281 -0.637 . . . . 0.20999999999999999 109.281 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 199' ' ' ALA . 3.2 tp10 -58.76 -47.9 83.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.181 -0.949 . . . . 0.28000000000000003 108.538 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.56 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -54.79 -55.76 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.17999999999999999 109.049 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.53 -31.52 5.07 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.848 -1.701 . . . . 0.20999999999999999 108.848 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.573 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -82.07 -76.71 0.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.241 -1.152 . . . . 0.17000000000000001 110.865 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.542 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -35.22 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.832 -0.543 . . . . 0.33000000000000002 111.834 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.54 ' HG ' ' CG2' ' A' ' 163' ' ' ILE . 0.3 OUTLIER -99.82 -41.23 7.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 0.53000000000000003 110.731 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -72.19 -79.32 0.45 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.26 -1.136 . . . . 0.40999999999999998 110.26 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 231' ' ' ASP . 0.7 OUTLIER -173.54 -163.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.253 . . . . 0.45000000000000001 110.525 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.513 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -61.55 -54.62 40.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.62 110.288 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.573 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -167.77 177.14 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.45000000000000001 111.056 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 27.7 t 179.26 51.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.748 -0.834 . . . . 0.38 108.748 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -132.41 24.66 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.47999999999999998 111.41 -178.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.549 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.1 OUTLIER -37.13 -53.61 2.03 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.491 -0.756 . . . . 0.38 110.976 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -84.27 -49.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.715 1.376 . . . . 0.28000000000000003 111.202 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.57 101.56 0.15 Allowed Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.361 -1.399 . . . . 0.23999999999999999 111.357 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -146.73 163.27 36.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.341 -1.094 . . . . 0.28000000000000003 110.246 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.581 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -69.64 58.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.40000000000000002 109.026 179.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.614 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 2.8 mtp -144.17 -37.29 0.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.45000000000000001 110.045 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -48.56 171.39 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.865 -1.147 . . . . 0.56999999999999995 110.063 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.3 Cg_endo -74.25 3.91 4.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.578 1.304 . . . . 0.76000000000000001 110.553 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.8 mt -104.8 134.58 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.89000000000000001 110.182 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.554 ' O ' ' C ' ' A' ' 245' ' ' THR . 49.8 p90 -127.87 -36.53 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.854 . . . . 0.78000000000000003 109.72 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 244' ' ' TYR . 53.7 m 1.41 -69.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 112.977 0.732 . . . . 0.60999999999999999 112.977 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.577 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -60.14 101.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.73999999999999999 109.33 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.52 ' N ' ' HB2' ' A' ' 250' ' ' SER . 38.7 p -46.79 175.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.81000000000000005 110.484 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.22 8.05 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.703 -1.359 . . . . 0.56000000000000005 109.703 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.48 28.48 1.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.156 . . . . 0.37 110.345 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.52 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.5 OUTLIER -58.52 -27.34 64.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.44 109.941 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 252' ' ' PHE . 6.9 t-160 -150.59 -55.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.53000000000000003 110.03 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER -176.94 -179.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.38 110.191 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.476 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 1.5 ptt? -68.77 54.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.418 -0.801 . . . . 0.19 110.371 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.667 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.6 mp -44.75 -47.72 28.56 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.974 -1.121 . . . . 0.28000000000000003 107.974 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.5 Cg_endo -72.89 50.13 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.962 1.506 . . . . 0.48999999999999999 110.94 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.543 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.7 m-20 -52.51 -29.77 26.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.037 -1.039 . . . . 0.48999999999999999 110.157 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.07 -51.55 63.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.118 -1.033 . . . . 0.31 109.487 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.558 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.32 -33.92 70.11 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.938 -1.105 . . . . 0.14000000000000001 108.553 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 72.2 t -62.51 -85.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.573 -0.851 . . . . 0.17000000000000001 110.22 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.4 tt0 -58.04 -43.52 86.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.26000000000000001 110.007 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.1 -63.87 1.66 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.556 -1.018 . . . . 0.19 110.556 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -80.18 -19.19 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.755 -1.438 . . . . 0.22 109.994 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.593 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 0.7 OUTLIER -59.33 -24.65 63.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.849 -1.167 . . . . 0.39000000000000001 107.849 178.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.4 p -103.9 -40.85 6.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.273 -0.571 . . . . 0.46999999999999997 111.806 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.43 ' HB3' ' CG ' ' A' ' 112' ' ' LYS . 4.9 mp -83.96 -46.85 11.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.47999999999999998 111.789 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.64 ' CD1' ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -76.08 -21.42 56.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.061 -1.025 . . . . 0.40999999999999998 110.481 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -57.7 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.165 -1.574 . . . . 0.46000000000000002 109.165 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.426 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.0 Cg_endo -75.19 95.68 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.789 1.415 . . . . 0.57999999999999996 110.062 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.8 178.26 43.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.558 -1.417 . . . . 0.64000000000000001 109.558 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.501 ' HB3' ' NE1' ' A' ' 113' ' ' TRP . 27.9 t0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.266 -1.138 . . . . 0.94999999999999996 110.138 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.521 ' CA ' HD12 ' A' ' 230' ' ' LEU . 3.1 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.6 0.714 . . . . 1.03 109.407 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.51 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.9 mp 49.2 18.36 0.24 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.386 -0.821 . . . . 1.04 111.541 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 265' ' ' LEU . 9.6 mttm -97.41 78.89 2.72 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.837 -1.164 . . . . 0.77000000000000002 109.643 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.536 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.3 t90 -165.38 -68.33 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.41999999999999998 111.36 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.525 ' O ' ' CD ' ' A' ' 115' ' ' LYS . 79.9 p -104.69 84.47 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.44 110.952 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.579 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 3.4 mptt -173.53 83.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.48999999999999999 110.312 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 116' ' ' MET . 7.7 tmm? -123.75 -8.88 7.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.29999999999999999 110.134 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 10.1 p30 -158.31 117.34 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.14999999999999999 109.941 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.515 ' CD2' ' OD2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -141.88 -178.83 5.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.13 110.611 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -119.93 170.36 9.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.85 . . . . 0.12 109.56 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 155' ' ' ARG . 41.0 p90 -165.22 -158.54 0.39 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.041 . . . . 0.33000000000000002 110.947 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -150.34 143.17 24.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 0.54000000000000004 110.138 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.623 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.7 pp -103.81 108.25 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.33000000000000002 110.866 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.5 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 15.6 m -158.76 43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.27000000000000002 110.352 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 165' ' ' ILE . 16.1 t-20 -42.68 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.40999999999999998 109.328 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.558 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.0 t80 -179.17 -168.98 0.14 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.383 -0.823 . . . . 0.40000000000000002 109.537 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.579 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -143.34 45.71 0.62 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.832 -1.167 . . . . 0.45000000000000001 111.353 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.2 Cg_endo -75.49 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.783 1.412 . . . . 0.35999999999999999 110.041 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -5.84 51.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.858 . . . . 0.25 109.655 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.507 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 1.9 ptt? -118.49 146.87 44.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.39000000000000001 109.94 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -104.07 -179.35 3.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.47999999999999998 110.149 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t-80 -43.43 -35.33 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.40000000000000002 109.872 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -66.62 -59.99 3.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.46000000000000002 110.096 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 136' ' ' LYS . 1.3 mp0 -50.72 -61.21 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.46999999999999997 109.409 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 125' ' ' TYR . 8.2 t -45.13 -37.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.28 -1.007 . . . . 0.31 108.28 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.558 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.87 -41.05 77.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.319 -0.993 . . . . 0.47999999999999998 108.319 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.577 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.2 tttp -75.09 -51.63 13.0 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.05 0.928 . . . . 0.64000000000000001 108.608 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.663 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.5 -63.47 0.95 Allowed 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.093 -1.005 . . . . 0.41999999999999998 110.418 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -61.26 -54.31 45.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.34000000000000002 111.289 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.658 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -69.62 -72.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.46999999999999997 110.485 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.1 tmtp? -37.91 -61.59 0.63 Allowed 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.899 -0.5 . . . . 0.46999999999999997 110.607 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.06 -40.32 14.78 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.69 -1.204 . . . . 0.25 108.257 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -68.28 -32.82 73.24 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.508 -0.877 . . . . 0.34999999999999998 108.947 178.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 140' ' ' LYS . 13.1 ttpp -59.53 -39.23 83.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.261 -1.014 . . . . 0.69999999999999996 108.261 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.86 -41.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.813 -0.81 . . . . 0.60999999999999999 108.813 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.587 ' CH2' HG13 ' A' ' 262' ' ' ILE . 20.6 t-105 -60.99 -39.74 90.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.047 -0.723 . . . . 0.39000000000000001 109.047 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.6 m -73.46 -34.51 65.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.412 -0.805 . . . . 0.34999999999999998 108.834 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -41.55 76.83 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.595 -0.691 . . . . 0.35999999999999999 109.291 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 35.2 m -78.35 -31.7 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.5 110.11 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.506 ' N ' HG21 ' A' ' 148' ' ' VAL . 5.7 t -148.12 135.21 10.38 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.51000000000000001 110.56 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.98 59.65 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.84 1.442 . . . . 0.31 110.377 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.604 ' CD2' ' CD1' ' A' ' 266' ' ' TYR . 1.1 mp -80.8 163.43 23.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.17999999999999999 110.5 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -107.4 110.18 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.17000000000000001 110.178 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 8.1 p90 -115.71 122.62 46.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.887 . . . . 0.14000000000000001 110.015 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.512 ' CG2' HD13 ' A' ' 156' ' ' LEU . 8.3 m -127.42 140.87 51.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.14999999999999999 110.373 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.531 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.5 82.09 1.87 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.421 -0.799 . . . . 0.20000000000000001 109.622 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.512 HD13 ' CG2' ' A' ' 154' ' ' THR . 1.3 mp -91.26 85.48 5.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.22 110.44 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' GLY . 36.6 p-80 -57.32 -19.72 24.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.32000000000000001 109.789 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.96 -26.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.481 -0.762 . . . . 0.33000000000000002 109.823 179.13 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.38 20.68 1.24 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.829 -1.308 . . . . 0.28000000000000003 109.829 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.476 ' O ' ' HB ' ' A' ' 119' ' ' THR . 12.1 mt -122.64 65.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.045 -1.268 . . . . 0.29999999999999999 109.259 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.467 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -118.96 141.45 48.65 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.198 -0.601 . . . . 0.20000000000000001 110.4 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD2' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -107.12 -47.55 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.10000000000000001 109.961 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.599 ' CD1' ' CD1' ' A' ' 228' ' ' LEU . 0.1 OUTLIER -116.34 173.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 0.10000000000000001 109.824 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.54 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 4.4 ptp -170.67 142.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.11 110.63 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 3.8 tt -92.89 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.10000000000000001 109.086 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.496 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 5.0 p -157.38 156.54 32.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.805 -1.184 . . . . 0.10000000000000001 111.262 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -74.23 118.48 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.692 -0.63 . . . . 0.089999999999999997 109.665 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -71.67 119.8 7.83 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.024 -1.231 . . . . 0.20000000000000001 110.024 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 170' ' ' LYS . 6.9 tp -116.61 97.65 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -1.063 . . . . 0.55000000000000004 109.985 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.63 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 3.7 tmtt? 0.07 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.289 0.566 . . . . 0.84999999999999998 112.388 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -162.47 24.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.70999999999999996 110.351 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -97.11 -69.59 0.75 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.41999999999999998 110.132 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.43 -35.82 1.51 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.494 -1.442 . . . . 0.33000000000000002 109.494 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -75.29 -144.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -1.171 . . . . 0.33000000000000002 110.517 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.427 ' C ' ' CD1' ' A' ' 176' ' ' TYR . 58.3 m-85 -55.65 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.27000000000000002 110.509 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 5.4 m-30 -111.01 110.94 56.52 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.34000000000000002 110.306 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.88 -68.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.929 1.489 . . . . 0.46999999999999997 110.558 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -51.21 137.58 22.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.34999999999999998 110.417 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 178' ' ' PHE . 51.6 p-10 -178.44 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.20000000000000001 110.624 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.545 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 44.44 -158.73 0.15 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.782 -1.327 . . . . 0.25 109.782 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.8 Cg_endo -74.95 7.28 2.91 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.14 1.6 . . . . 0.44 110.725 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 184' ' ' LEU . 6.4 t -42.58 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.967 . . . . 0.56999999999999995 110.36 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.98 76.51 0.02 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.418 -1.073 . . . . 0.48999999999999999 110.418 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 3.3 tt 179.9 88.13 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.222 -1.163 . . . . 0.40999999999999998 110.389 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 214' ' ' TYR . 4.8 tt -103.84 -23.22 13.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.29999999999999999 110.944 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.532 ' CB ' ' OE1' ' A' ' 223' ' ' GLU . . . -148.45 108.03 3.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.602 -1.311 . . . . 0.20000000000000001 112.126 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -105.7 118.76 37.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.16 109.529 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -107.8 141.02 40.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.23000000000000001 110.202 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 3.2 m-30 -91.04 161.51 35.12 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.38 110.32 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.5 Cg_endo -72.41 142.98 37.96 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.967 1.509 . . . . 0.40000000000000002 109.409 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.3 Cg_endo -69.64 74.41 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.849 1.447 . . . . 0.32000000000000001 110.693 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.84 -93.71 1.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.408 -1.477 . . . . 0.32000000000000001 109.408 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 -158.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.981 1.516 . . . . 0.46999999999999997 110.406 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -79.51 8.82 5.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.63 110.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.426 ' HA ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -114.67 6.98 15.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.324 -0.86 . . . . 0.53000000000000003 109.717 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -80.89 168.8 51.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.594 -1.402 . . . . 0.25 109.594 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 51.84 18.65 4.38 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.658 -1.377 . . . . 0.10000000000000001 109.658 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -79.98 92.19 5.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -1.125 . . . . 0.10000000000000001 110.339 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.532 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -72.44 97.44 2.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.942 . . . . 0.089999999999999997 109.952 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.468 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 1.4 m170 -111.13 131.99 54.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.089999999999999997 110.328 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.626 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 59.5 m-85 -103.27 136.61 42.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.992 -1.067 . . . . 0.10000000000000001 110.678 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 204' ' ' ASP . 1.0 OUTLIER -46.52 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.719 -0.845 . . . . 0.14000000000000001 108.719 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.587 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.4 p30 -36.84 -27.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.17999999999999999 111.674 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.545 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -77.69 -0.24 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.675 -1.266 . . . . 0.23999999999999999 111.217 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 12.6 mm-40 -94.82 -164.17 1.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.41999999999999998 110.303 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 m -125.58 140.48 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.46999999999999997 110.582 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.587 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.1 m-90 -135.56 142.81 45.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -0.823 . . . . 0.27000000000000002 109.43 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.543 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.83 179.93 8.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.932 -1.105 . . . . 0.29999999999999999 110.565 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.408 ' OG ' ' CZ ' ' A' ' 217' ' ' PHE . 42.8 t -124.62 43.07 3.11 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.686 0.755 . . . . 0.60999999999999999 109.251 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.8 t -131.63 -165.9 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.697 -0.627 . . . . 0.78000000000000003 110.076 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.522 ' N ' ' OG ' ' A' ' 210' ' ' SER . 8.7 t -87.64 -0.51 56.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.91000000000000003 110.14 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 149.75 28.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.93000000000000005 109.969 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.23 -164.25 33.27 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.35 -1.5 . . . . 0.79000000000000004 109.35 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.567 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.8 m-85 -84.52 120.78 26.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -1.195 . . . . 0.68999999999999995 109.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 218' ' ' LEU . 7.3 p30 -87.62 121.7 30.39 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.067 -1.021 . . . . 0.40000000000000002 108.852 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.663 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -39.89 -38.78 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.487 -0.758 . . . . 0.17000000000000001 110.867 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.577 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 4.0 m-85 -51.31 -48.87 62.22 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 118.435 -1.306 . . . . 0.28000000000000003 107.527 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.536 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 0.5 OUTLIER -73.87 -72.6 0.26 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.726 -0.67 . . . . 0.46000000000000002 110.151 178.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.626 ' CG2' ' CE1' ' A' ' 201' ' ' PHE . 0.7 OUTLIER -47.93 -69.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.39000000000000001 109.914 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -42.27 -54.79 3.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.17000000000000001 111.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -57.58 -30.72 65.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.499 -1.376 . . . . 0.10000000000000001 109.578 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.592 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.7 t60 -75.51 -43.78 47.24 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.353 0.597 . . . . 0.20999999999999999 109.686 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.532 ' CG ' ' HB1' ' A' ' 199' ' ' ALA . 22.8 tp10 -64.4 -35.97 82.63 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 108.894 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 220' ' ' ALA . 19.1 m-85 -66.93 -48.52 68.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.755 -0.831 . . . . 0.17999999999999999 108.755 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -52.47 -31.66 36.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.288 -1.925 . . . . 0.20999999999999999 108.288 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.662 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.7 OUTLIER -80.62 -78.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -1.056 . . . . 0.17000000000000001 110.674 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.561 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.9 OUTLIER -38.5 -45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.33000000000000002 111.268 -178.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 163' ' ' ILE . 6.0 mt -83.37 -46.3 12.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.53000000000000003 110.878 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -71.31 -85.14 0.19 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.363 -1.095 . . . . 0.40999999999999998 110.363 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.521 HD12 ' CA ' ' A' ' 110' ' ' THR . 2.6 pt? -176.62 -158.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -1.2 . . . . 0.45000000000000001 110.563 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.51 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 7.4 t70 -49.88 -56.1 11.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.62 110.148 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.662 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -164.69 -175.68 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.45000000000000001 109.861 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.409 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER -179.78 58.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.38 109.809 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.583 ' CB ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -152.29 27.06 0.59 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.47999999999999998 111.196 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.546 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.7 OUTLIER -37.83 -48.89 2.89 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.38 110.674 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 41.1 Cg_endo -86.81 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.913 1.481 . . . . 0.28000000000000003 112.289 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.32 99.58 0.12 Allowed Glycine 0 N--CA 1.5 2.94 0 C-N-CA 118.638 -1.744 . . . . 0.23999999999999999 112.127 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.611 ' HB3' ' N ' ' A' ' 258' ' ' ASP . . . -150.03 169.49 21.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.031 -1.276 . . . . 0.28000000000000003 110.556 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.572 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -80.19 49.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.40000000000000002 108.79 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.592 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.9 OUTLIER -133.99 -22.45 1.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.005 -1.059 . . . . 0.45000000000000001 110.915 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -60.72 172.09 0.91 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.873 -1.142 . . . . 0.56999999999999995 110.204 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 40.6 Cg_endo -67.79 -2.73 9.1 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.413 1.217 . . . . 0.76000000000000001 110.935 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.569 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.6 mp -108.04 153.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.89000000000000001 109.649 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 244' ' ' TYR . 14.3 p90 -135.78 -22.93 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.78000000000000003 111.685 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.529 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 4.0 -70.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 113.44 0.904 . . . . 0.60999999999999999 113.44 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -72.27 117.34 13.8 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.454 -1.404 . . . . 0.73999999999999999 109.77 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 218' ' ' LEU . 47.6 p -62.17 -161.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.81000000000000005 110.403 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.58 -32.61 79.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.56000000000000005 109.593 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.48 41.67 2.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -1.124 . . . . 0.37 110.517 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -63.52 -20.87 65.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.44 109.751 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 20.4 m-70 -167.9 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.786 . . . . 0.53000000000000003 109.911 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.9 m-85 -170.22 176.6 4.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.41 -0.806 . . . . 0.38 110.205 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.466 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 0.0 OUTLIER -70.56 54.38 0.15 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.19 110.043 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.663 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.2 mm? -43.82 -47.56 20.83 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.176 -1.046 . . . . 0.28000000000000003 108.176 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.663 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.21 49.81 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.015 1.534 . . . . 0.48999999999999999 110.787 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.558 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 6.2 m-20 -54.19 -29.45 45.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.48999999999999999 110.236 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 237' ' ' GLY . 55.4 m-20 -57.2 -41.2 78.92 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.31 109.339 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.611 ' N ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -78.43 -33.2 48.7 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.986 -1.116 . . . . 0.14000000000000001 107.986 178.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 83.5 t -65.55 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.17000000000000001 109.906 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.4 tt0 -58.18 -42.37 85.9 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.29 -0.881 . . . . 0.26000000000000001 109.446 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.46 -70.33 0.5 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.178 -1.169 . . . . 0.19 110.178 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.598 ' CD1' ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -73.75 -18.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.963 -1.316 . . . . 0.22 110.392 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.598 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 44.9 tt0 -65.54 -20.3 66.28 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.9 -1.12 . . . . 0.39000000000000001 108.163 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 260' ' ' GLN . 0.8 OUTLIER -103.37 -40.69 6.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.779 -0.576 . . . . 0.46999999999999997 111.145 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 112' ' ' LYS . 4.3 mm? -86.71 -45.4 11.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.185 -0.947 . . . . 0.47999999999999998 111.179 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.604 ' CD1' ' CD2' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -76.95 -13.68 59.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.40999999999999998 110.53 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -62.7 -107.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.953 -1.659 . . . . 0.46000000000000002 108.953 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.1 95.07 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.57999999999999996 110.079 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.87 171.04 37.08 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.825 -1.31 . . . . 0.64000000000000001 109.825 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.536 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.325 -1.103 . . . . 0.94999999999999996 110.13 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.5 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.643 0.735 . . . . 1.03 109.59 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 3.2 mm? 40.75 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.545 -0.722 . . . . 1.04 111.373 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 1.8 mttt -123.44 65.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.856 -1.153 . . . . 0.77000000000000002 109.939 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.61 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 19.3 t90 -123.03 -71.67 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.41999999999999998 110.573 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.412 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 22.1 t -105.15 58.33 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.302 -0.874 . . . . 0.44 110.291 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.412 ' HG3' ' C ' ' A' ' 114' ' ' SER . 39.0 mttp -141.72 59.49 1.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.48999999999999999 110.489 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.48 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.6 OUTLIER -89.9 11.2 21.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.29999999999999999 109.793 179.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -172.0 115.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.14999999999999999 109.512 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 117' ' ' ASN . 1.2 mm? -137.48 178.01 7.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.184 -0.947 . . . . 0.13 110.72 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -120.34 174.11 6.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.12 109.902 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.501 ' HB2' HG13 ' A' ' 163' ' ' ILE . 31.3 p90 -178.94 178.74 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.33000000000000002 111.425 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 1.3 ttp180 -121.05 158.51 27.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.54000000000000004 109.654 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.6 pp -125.7 98.42 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.33000000000000002 110.881 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 3.4 m -145.57 53.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.27000000000000002 110.334 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 17.9 t30 -43.39 -84.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.40999999999999998 109.623 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.56 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 8.6 t80 -177.53 -175.07 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.40000000000000002 109.917 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.51 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -139.03 52.52 4.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.45000000000000001 110.716 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.2 Cg_endo -76.26 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.819 1.431 . . . . 0.35999999999999999 109.767 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.77 -4.62 54.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.25 109.588 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.541 ' HE1' ' CG2' ' A' ' 134' ' ' VAL . 1.8 ptm -119.76 170.71 8.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.469 -0.769 . . . . 0.39000000000000001 109.955 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.91 -172.46 2.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.47999999999999998 110.34 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.5 t60 -53.09 -36.4 60.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.40000000000000002 110.03 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 6.9 t -60.83 -48.68 80.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.46000000000000002 109.336 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 136' ' ' LYS . 13.1 mp0 -62.79 -63.33 1.24 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.34 -0.85 . . . . 0.46999999999999997 109.527 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.541 ' CG2' ' HE1' ' A' ' 129' ' ' MET . 13.4 t -43.68 -38.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.611 -0.885 . . . . 0.31 108.611 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.566 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 3.0 mt-10 -56.68 -42.14 78.54 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.47999999999999998 108.246 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 2.4 tttm -73.8 -50.13 22.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.471 -0.936 . . . . 0.64000000000000001 108.471 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.665 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -46.05 -60.79 2.07 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.19 -0.944 . . . . 0.41999999999999998 110.225 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -64.74 -53.63 44.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.34000000000000002 111.018 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.82 -72.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.857 -1.152 . . . . 0.46999999999999997 110.347 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.2 tmtm? -38.65 -61.16 0.74 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.752 -0.593 . . . . 0.46999999999999997 110.655 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.59 -38.59 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.611 -1.235 . . . . 0.25 108.374 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -70.11 -32.76 70.94 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.335 -0.853 . . . . 0.34999999999999998 109.15 178.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' LYS . 4.6 tttp -59.82 -38.82 83.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.38 -0.971 . . . . 0.69999999999999996 108.38 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 16.1 t -71.91 -44.34 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 109.035 -0.728 . . . . 0.60999999999999999 109.035 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.6 ' CH2' HG13 ' A' ' 262' ' ' ILE . 13.6 t-105 -56.63 -44.93 81.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.39000000000000001 109.01 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 149' ' ' THR . 26.0 m -71.01 -35.05 71.88 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.32 -0.862 . . . . 0.34999999999999998 108.739 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -53.06 -42.43 65.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.576 -0.703 . . . . 0.35999999999999999 109.416 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 31.1 m -80.47 -32.59 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.779 -0.768 . . . . 0.5 110.198 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.487 ' N ' HG23 ' A' ' 148' ' ' VAL . 2.5 t -137.94 124.59 13.27 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.068 . . . . 0.51000000000000001 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -78.28 62.24 8.04 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.31 110.341 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -101.0 156.31 17.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.17999999999999999 110.127 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.489 ' HB3' ' ND2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -76.94 134.41 38.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.35 -0.844 . . . . 0.17000000000000001 111.341 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 7.7 p90 -135.19 121.99 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.14000000000000001 109.618 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 119' ' ' THR . 42.4 m -127.0 161.68 27.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.14999999999999999 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -142.18 68.95 1.32 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.655 -0.653 . . . . 0.20000000000000001 110.09 -178.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 93.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.22 110.038 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' ASP . 50.4 p-80 -48.51 -28.15 3.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.32000000000000001 110.083 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' HIS . 4.3 t70 -42.36 -70.27 0.11 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.576 -0.703 . . . . 0.33000000000000002 109.819 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 179.39 30.68 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.28000000000000003 109.586 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.565 ' O ' ' HB ' ' A' ' 119' ' ' THR . 20.9 mm -121.57 79.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.267 -1.137 . . . . 0.29999999999999999 108.339 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -136.14 112.02 9.53 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.097 -0.641 . . . . 0.20000000000000001 110.714 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.37 -54.36 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.10000000000000001 109.97 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.572 ' CG2' ' HG ' ' A' ' 228' ' ' LEU . 5.4 pt -111.84 175.9 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.10000000000000001 109.677 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.487 ' O ' ' HB1' ' A' ' 199' ' ' ALA . 23.2 ptm -170.35 136.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.844 -1.16 . . . . 0.11 111.122 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 220' ' ' ALA . 1.6 tt -90.24 123.44 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.447 -0.783 . . . . 0.10000000000000001 109.852 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 23.0 p -168.37 143.05 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.831 -1.168 . . . . 0.10000000000000001 110.922 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.8 p90 -58.49 117.21 4.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.372 -0.83 . . . . 0.089999999999999997 109.507 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -83.79 115.3 4.03 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.901 -1.28 . . . . 0.20000000000000001 109.901 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.574 ' O ' ' C ' ' A' ' 170' ' ' LYS . 7.0 tt -106.63 100.26 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.957 . . . . 0.55000000000000004 109.781 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.574 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 0.91 87.47 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.33 0.586 . . . . 0.84999999999999998 112.397 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -130.06 -1.75 4.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.70999999999999996 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -77.18 -86.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.41999999999999998 110.035 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.28 58.8 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.339 -1.504 . . . . 0.33000000000000002 109.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -155.16 -80.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -1.105 . . . . 0.33000000000000002 110.377 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.489 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 83.9 m-85 -115.67 103.67 10.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.27000000000000002 110.335 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.427 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.3 m-30 -40.32 98.82 0.18 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.34000000000000002 110.156 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 48.9 Cg_endo -82.67 -59.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.099 1.579 . . . . 0.46999999999999997 110.775 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CB ' ' OD1' ' A' ' 203' ' ' ASP . 10.8 p90 -50.7 163.4 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.34999999999999998 110.209 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 180' ' ' GLY . 0.9 OUTLIER 179.48 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.941 -1.099 . . . . 0.20000000000000001 111.451 179.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.555 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 141.89 -123.55 2.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.157 -1.577 . . . . 0.25 109.157 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.4 2.62 7.91 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 O-C-N 123.919 1.484 . . . . 0.44 109.768 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 177.53 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.434 -0.791 . . . . 0.56999999999999995 110.228 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -77.03 76.33 1.63 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.594 -1.003 . . . . 0.48999999999999999 110.594 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 0.6 OUTLIER 179.77 98.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -1.127 . . . . 0.40999999999999998 110.288 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.549 HD12 ' CE2' ' A' ' 214' ' ' TYR . 1.4 tt -116.74 -17.6 10.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.746 -1.182 . . . . 0.29999999999999999 111.334 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.481 ' CB ' ' OE1' ' A' ' 223' ' ' GLU . . . -157.52 105.1 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.452 -1.405 . . . . 0.20000000000000001 111.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -102.76 121.35 42.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.16 110.086 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 227' ' ' SER . . . -106.41 119.03 38.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.23000000000000001 110.075 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -69.7 170.25 10.18 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.257 -0.902 . . . . 0.38 110.401 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.511 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 46.2 Cg_endo -73.15 130.73 15.68 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.101 1.579 . . . . 0.40000000000000002 109.698 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.6 Cg_endo -69.88 74.8 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.956 1.503 . . . . 0.32000000000000001 110.572 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.01 -91.45 1.02 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.703 -1.359 . . . . 0.32000000000000001 109.703 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.0 -163.57 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.991 1.521 . . . . 0.46999999999999997 110.489 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -6.58 35.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.63 110.047 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . 0.438 ' C ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -111.55 49.7 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.423 -0.798 . . . . 0.53000000000000003 109.796 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -123.89 174.62 16.81 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.36 -1.496 . . . . 0.25 109.36 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.559 ' HA3' ' CG2' ' A' ' 163' ' ' ILE . . . 41.59 27.63 0.32 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.081 -1.208 . . . . 0.10000000000000001 110.081 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD2' ' C ' ' A' ' 195' ' ' TYR . 57.7 m-20 -79.53 90.07 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.057 -1.261 . . . . 0.10000000000000001 110.031 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 164' ' ' MET . . . -68.59 89.97 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.053 -1.029 . . . . 0.089999999999999997 109.81 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.521 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 3.1 m170 -102.92 128.31 49.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.089999999999999997 110.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.567 ' O ' ' N ' ' A' ' 203' ' ' ASP . 21.2 m-85 -96.73 132.13 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.10000000000000001 111.173 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.552 ' HB3' ' CG ' ' A' ' 205' ' ' GLU . 35.8 t0 -40.06 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.245 -0.65 . . . . 0.14000000000000001 109.245 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -36.43 -38.89 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.17999999999999999 112.161 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.555 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 14.0 t0 -73.68 -6.65 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.642 -1.286 . . . . 0.23999999999999999 111.225 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 14.7 mm-40 -84.79 -165.21 1.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.847 -1.158 . . . . 0.41999999999999998 110.176 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.55 148.26 52.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.46999999999999997 110.441 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.425 ' C ' HG22 ' A' ' 208' ' ' THR . 0.9 OUTLIER -142.24 140.36 32.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.267 -0.895 . . . . 0.27000000000000002 109.57 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -149.03 174.85 11.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.857 -1.152 . . . . 0.29999999999999999 110.748 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -129.06 24.79 5.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.794 0.807 . . . . 0.60999999999999999 109.206 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.3 t -94.6 -111.46 0.12 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.615 -0.678 . . . . 0.78000000000000003 110.03 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.531 ' N ' ' OG ' ' A' ' 210' ' ' SER . 4.4 p -141.28 8.39 2.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.134 . . . . 0.91000000000000003 110.008 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 -179.26 5.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.93000000000000005 109.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.76 -154.88 5.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.038 -1.625 . . . . 0.79000000000000004 109.038 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.549 ' CE2' HD12 ' A' ' 185' ' ' LEU . 79.0 m-85 -90.16 109.94 20.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.251 . . . . 0.68999999999999995 110.066 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 218' ' ' LEU . 32.6 m-20 -79.15 120.92 24.36 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.097 -1.002 . . . . 0.40000000000000002 108.866 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.665 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -41.26 -36.53 0.79 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.556 -0.858 . . . . 0.17000000000000001 110.718 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.576 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 4.1 m-85 -53.05 -46.92 68.74 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.315 -1.354 . . . . 0.28000000000000003 107.589 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.581 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 5.8 tp -77.27 -71.86 0.38 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.4 -0.818 . . . . 0.46000000000000002 110.683 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.547 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.3 p -48.78 -61.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.39000000000000001 110.385 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -53.06 -48.56 67.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.061 -1.024 . . . . 0.17000000000000001 111.439 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.95 -29.11 66.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.201 -1.562 . . . . 0.10000000000000001 108.743 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.596 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 4.0 t60 -77.0 -44.12 32.19 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.31 0.576 . . . . 0.20999999999999999 109.747 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.481 ' OE1' ' CB ' ' A' ' 186' ' ' ALA . 17.8 tp10 -64.58 -45.61 86.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.02 . . . . 0.28000000000000003 108.667 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.528 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 18.4 m-30 -56.35 -60.51 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.17999999999999999 109.029 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.07 -34.15 1.99 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.971 -1.652 . . . . 0.20999999999999999 108.971 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 227' ' ' SER . 0.2 OUTLIER -80.87 -70.16 0.55 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.106 -1.232 . . . . 0.17000000000000001 111.235 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.526 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.1 OUTLIER -36.66 -44.33 0.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.33000000000000002 112.017 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.572 ' HG ' ' CG2' ' A' ' 163' ' ' ILE . 1.0 OUTLIER -101.09 -37.49 8.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.661 -1.274 . . . . 0.53000000000000003 111.317 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -65.01 -85.08 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.316 -1.114 . . . . 0.40999999999999998 110.316 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -172.54 -173.28 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.245 . . . . 0.45000000000000001 110.473 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.519 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 42.0 t0 -51.35 -59.72 3.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.62 109.975 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 231' ' ' ASP . 1.6 m80 -163.82 -179.98 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.45000000000000001 110.256 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.492 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.1 OUTLIER 179.23 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.457 -0.777 . . . . 0.38 109.391 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 240' ' ' MET . 0.0 OUTLIER -137.04 21.43 3.02 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.468 -0.893 . . . . 0.47999999999999998 111.197 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.538 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -35.58 -49.66 1.38 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 120.055 -0.658 . . . . 0.38 110.635 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -88.5 -48.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.701 1.369 . . . . 0.28000000000000003 111.132 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.1 101.73 0.15 Allowed Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.409 -1.377 . . . . 0.23999999999999999 111.401 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.584 ' HB3' ' CB ' ' A' ' 257' ' ' ASP . . . -147.47 163.16 37.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.372 -1.075 . . . . 0.28000000000000003 110.463 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.18 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.074 -1.016 . . . . 0.40000000000000002 108.818 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.624 ' HB2' ' HB3' ' A' ' 234' ' ' LYS . 50.6 mtt -135.9 -34.4 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.793 . . . . 0.45000000000000001 110.437 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -43.88 169.85 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.195 -0.941 . . . . 0.56999999999999995 110.359 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.2 Cg_endo -69.35 -8.02 22.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.786 1.413 . . . . 0.76000000000000001 110.198 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.544 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 16.0 mm -103.26 159.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.89000000000000001 109.845 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 244' ' ' TYR . 16.8 p90 -138.07 -24.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.78000000000000003 111.446 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.517 HG21 ' CG2' ' A' ' 243' ' ' ILE . 0.1 OUTLIER 3.19 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.824 1.046 . . . . 0.60999999999999999 113.824 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.55 ' CZ ' ' O ' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -71.82 115.64 11.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.438 -1.413 . . . . 0.73999999999999999 110.022 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 218' ' ' LEU . 2.9 m -54.04 -174.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.81000000000000005 110.301 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.409 ' O ' ' OH ' ' A' ' 246' ' ' TYR . . . -50.83 -25.29 9.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.56000000000000005 109.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -167.46 36.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -1.135 . . . . 0.37 110.353 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.2 t -58.54 -16.19 14.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.44 110.147 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 11.2 t60 -145.55 -48.7 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.53000000000000003 110.086 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.55 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.8 OUTLIER 179.99 172.75 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.38 110.122 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 253' ' ' MET . 4.8 ptp -72.85 52.38 0.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.122 -0.986 . . . . 0.19 110.055 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.642 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.1 OUTLIER -45.24 -47.39 33.45 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 108.014 -1.106 . . . . 0.28000000000000003 108.014 177.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -73.76 51.9 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.085 1.571 . . . . 0.48999999999999999 110.905 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.562 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.7 m-20 -52.17 -31.44 31.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.129 -0.982 . . . . 0.48999999999999999 110.151 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.584 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -51.89 -51.5 56.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.945 -1.102 . . . . 0.31 109.346 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.537 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -69.48 -35.6 75.74 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.074 -1.051 . . . . 0.14000000000000001 108.553 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 73.8 t -63.41 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.17000000000000001 110.273 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 33.0 tt0 -54.03 -43.87 70.5 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.246 -0.909 . . . . 0.26000000000000001 109.902 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.04 -69.04 0.55 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.345 -1.102 . . . . 0.19 110.345 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.6 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -76.37 -19.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.786 -1.42 . . . . 0.22 110.264 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 14.3 tt0 -61.54 -23.58 66.05 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.863 -1.135 . . . . 0.39000000000000001 107.94 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 p -103.87 -42.58 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.386 0.612 . . . . 0.46999999999999997 110.691 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 75.3 mt -73.95 -52.11 13.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.422 -0.799 . . . . 0.47999999999999998 111.319 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.53 ' OH ' ' CD2' ' A' ' 228' ' ' LEU . 0.1 OUTLIER -75.6 -11.82 60.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.40999999999999998 110.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.48 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.89 -102.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.059 -1.617 . . . . 0.46000000000000002 109.059 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.52 101.65 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.86 1.452 . . . . 0.57999999999999996 110.158 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -78.82 165.71 51.37 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.587 -1.405 . . . . 0.64000000000000001 109.587 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.61 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.29 -1.124 . . . . 0.94999999999999996 110.254 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.538 ' CA ' HD12 ' A' ' 230' ' ' LEU . 1.5 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.513 0.673 . . . . 1.03 109.484 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.4 OUTLIER 39.09 30.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.643 -0.66 . . . . 1.04 111.428 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -114.35 68.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.043 -1.036 . . . . 0.77000000000000002 109.433 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.556 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 20.8 t90 -147.52 -66.85 0.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.41999999999999998 111.063 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.466 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 24.0 p -97.1 51.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.44 110.952 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 114' ' ' SER . 4.5 mmmt -148.48 85.77 1.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.48999999999999999 109.91 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 tmm? -120.86 -15.72 8.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.025 -1.047 . . . . 0.29999999999999999 110.473 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.453 ' O ' HD21 ' A' ' 118' ' ' LEU . 7.3 p-10 -153.46 114.28 4.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.14999999999999999 110.211 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -141.0 -151.87 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.304 -0.873 . . . . 0.13 110.201 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.552 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.7 OUTLIER -136.32 155.35 50.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.12 110.142 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.585 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 29.0 p90 -148.92 163.33 37.77 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.496 -0.882 . . . . 0.33000000000000002 111.055 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 151.38 35.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.48 -0.763 . . . . 0.54000000000000004 109.881 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.642 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 pp -116.91 111.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.33000000000000002 111.163 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 2.8 m -161.82 49.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.27000000000000002 110.261 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.8 t30 -42.95 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.40999999999999998 109.451 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.484 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 24.6 t80 -179.03 -176.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.40000000000000002 110.042 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.428 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -129.09 57.95 33.73 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.982 . . . . 0.45000000000000001 109.834 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 125' ' ' TYR . 47.8 Cg_endo -75.1 -88.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.275 1.671 . . . . 0.35999999999999999 110.688 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.37 -8.27 21.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.25 110.163 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.567 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.04 174.95 5.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.39000000000000001 110.204 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 132' ' ' SER . 3.0 m -115.17 167.03 11.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.47999999999999998 109.302 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 130' ' ' THR . 7.9 t-160 -43.38 -26.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.40000000000000002 109.61 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.2 OUTLIER -68.8 -45.57 70.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.831 . . . . 0.46000000000000002 110.116 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.567 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.1 OUTLIER -70.71 -50.54 35.21 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.938 -1.101 . . . . 0.46999999999999997 109.248 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 9.5 t -47.18 -36.61 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.242 -1.392 . . . . 0.31 107.242 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.565 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 1.4 tt0 -58.96 -45.88 89.42 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.474 -1.306 . . . . 0.47999999999999998 107.474 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.31 -50.36 71.98 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.068 0.937 . . . . 0.64000000000000001 108.704 178.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.649 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -46.33 -62.93 1.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.149 -0.969 . . . . 0.41999999999999998 110.718 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.642 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.73 -52.53 56.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.34000000000000002 110.7 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -65.91 -74.82 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.901 -1.124 . . . . 0.46999999999999997 110.175 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -38.48 -61.6 0.68 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.807 -0.558 . . . . 0.46999999999999997 110.66 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.96 -38.56 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.665 -1.272 . . . . 0.25 108.359 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -71.65 -28.92 64.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -0.869 . . . . 0.34999999999999998 109.156 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.02 -42.2 98.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.69999999999999996 108.416 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 4.4 t -72.31 -51.36 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.817 -0.809 . . . . 0.60999999999999999 108.817 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.595 ' CH2' HG13 ' A' ' 262' ' ' ILE . 47.8 t-105 -50.85 -34.47 28.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.523 -0.917 . . . . 0.39000000000000001 108.523 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -76.28 -36.02 58.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.45 -0.944 . . . . 0.34999999999999998 108.45 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.31 -43.23 70.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.981 -0.748 . . . . 0.35999999999999999 108.981 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 31.4 m -74.85 -35.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.703 -0.799 . . . . 0.5 109.552 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.507 ' N ' HG23 ' A' ' 148' ' ' VAL . 13.0 t -148.06 121.77 4.81 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 0.51000000000000001 110.305 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.79 60.74 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.819 1.431 . . . . 0.31 110.335 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 266' ' ' TYR . 1.1 mp -73.9 173.86 9.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.17999999999999999 110.815 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.25 121.83 46.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.17000000000000001 109.95 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 9.0 p90 -138.8 131.23 28.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.14000000000000001 110.266 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 119' ' ' THR . 7.8 m -136.84 130.58 32.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.14999999999999999 110.22 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.585 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -94.12 69.83 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.20000000000000001 109.945 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 110.64 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.22 110.11 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 158' ' ' ASP . 4.6 m-70 -67.74 -24.53 65.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.32000000000000001 110.01 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.461 ' OD2' HD11 ' A' ' 160' ' ' ILE . 4.5 t0 -42.44 -27.71 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.33000000000000002 109.646 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.86 26.52 1.25 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.614 -1.395 . . . . 0.28000000000000003 109.614 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 119' ' ' THR . 8.0 mt -116.65 74.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.203 -1.175 . . . . 0.29999999999999999 109.432 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -135.57 152.94 51.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.664 -0.648 . . . . 0.20000000000000001 110.491 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.3 OUTLIER -128.98 -35.27 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.10000000000000001 110.185 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.541 HG13 ' N ' ' A' ' 164' ' ' MET . 0.7 OUTLIER -115.21 163.21 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.291 -0.881 . . . . 0.10000000000000001 109.335 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -174.63 142.57 0.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.375 -1.453 . . . . 0.11 111.71 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 220' ' ' ALA . 6.7 tt -94.74 118.42 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.469 -0.769 . . . . 0.10000000000000001 109.777 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 9.7 p -160.94 153.4 20.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.808 -1.183 . . . . 0.10000000000000001 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.0 p90 -68.81 120.46 14.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.089999999999999997 109.727 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -81.95 129.92 9.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.529 -1.028 . . . . 0.20000000000000001 110.529 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.583 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -125.06 99.99 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.709 -0.877 . . . . 0.55000000000000004 108.94 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 1.43 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.42 0.629 . . . . 0.84999999999999998 112.475 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -163.3 24.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.70999999999999996 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 14.4 m-70 -93.29 -57.96 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.41999999999999998 110.253 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 110.86 55.34 0.51 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.65 -1.38 . . . . 0.33000000000000002 109.65 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 8.0 p-10 -176.71 -37.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -1.079 . . . . 0.33000000000000002 110.202 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.6 OUTLIER -156.05 149.07 24.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.27000000000000002 110.106 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -77.34 112.24 22.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.34000000000000002 110.138 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.1 Cg_endo -74.15 -55.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.954 1.502 . . . . 0.46999999999999997 110.625 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.596 ' CG ' ' OD2' ' A' ' 203' ' ' ASP . 3.3 p90 -79.64 162.44 25.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.038 . . . . 0.34999999999999998 110.528 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -169.51 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.019 . . . . 0.20000000000000001 110.989 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.601 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 160.48 -149.11 18.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.25 109.49 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.83 -2.05 10.85 Favored 'Trans proline' 0 C--N 1.297 -2.174 0 O-C-N 124.228 1.646 . . . . 0.44 109.765 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.519 ' CB ' ' OD1' ' A' ' 179' ' ' ASP . 20.2 t -49.88 175.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.56999999999999995 110.184 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -68.61 76.53 0.28 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.781 -0.928 . . . . 0.48999999999999999 110.781 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 177' ' ' PRO . 1.0 OUTLIER 179.35 85.94 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.199 -1.177 . . . . 0.40999999999999998 110.575 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.6 tt -105.79 -21.4 13.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.612 -1.305 . . . . 0.29999999999999999 111.664 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -146.63 109.7 4.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.526 -1.359 . . . . 0.20000000000000001 111.985 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -112.61 115.26 28.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.16 109.538 178.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 227' ' ' SER . . . -111.1 145.72 38.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.23000000000000001 110.116 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 2.2 m-30 -95.72 165.78 15.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.233 -0.917 . . . . 0.38 110.757 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -71.04 150.58 60.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.069 1.562 . . . . 0.40000000000000002 109.163 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 227' ' ' SER . 45.4 Cg_endo -72.89 76.27 2.53 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.681 1.359 . . . . 0.32000000000000001 110.5 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.07 -108.29 2.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.498 -1.441 . . . . 0.32000000000000001 109.498 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.89 -158.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.935 1.492 . . . . 0.46999999999999997 110.26 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -3.42 13.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.161 -0.962 . . . . 0.63 110.554 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.36 27.51 8.66 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.53000000000000003 110.227 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -105.35 166.72 14.51 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.136 -1.586 . . . . 0.25 109.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' A' ' 163' ' ' ILE . . . 51.43 21.04 5.85 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.937 -1.665 . . . . 0.10000000000000001 108.937 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.9 OUTLIER -77.44 88.83 3.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -1.143 . . . . 0.10000000000000001 110.267 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.516 ' HB2' ' CG ' ' A' ' 223' ' ' GLU . . . -72.96 84.98 1.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.089999999999999997 109.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 52.9 m170 -97.82 127.06 43.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.089999999999999997 110.628 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.3 m-85 -97.89 141.03 31.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.995 . . . . 0.10000000000000001 109.818 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 205' ' ' GLU . 0.2 OUTLIER -51.76 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.373 -0.973 . . . . 0.14000000000000001 108.373 178.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.596 ' OD2' ' CG ' ' A' ' 178' ' ' PHE . 1.7 p30 -34.86 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.17999999999999999 112.204 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.601 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 18.5 t0 -80.18 10.12 4.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.683 -1.261 . . . . 0.23999999999999999 110.744 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 202' ' ' ASP . 21.8 mm-40 -101.41 -162.15 0.91 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.41999999999999998 109.961 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.0 m -128.41 141.85 51.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.036 -1.04 . . . . 0.46999999999999997 110.381 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.538 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -142.41 139.03 31.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.968 . . . . 0.27000000000000002 109.9 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -144.29 172.91 12.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.975 -1.078 . . . . 0.29999999999999999 110.545 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -128.2 27.5 5.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.951 0.882 . . . . 0.60999999999999999 108.996 178.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.6 t -99.66 -99.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.69 -0.632 . . . . 0.78000000000000003 110.15 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.53 ' N ' ' OG ' ' A' ' 210' ' ' SER . 13.2 t -153.0 15.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.033 -1.042 . . . . 0.91000000000000003 110.328 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 213' ' ' GLY . 0.0 OUTLIER -133.27 -172.12 2.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.93000000000000005 109.93 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 42.69 -147.95 0.62 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.179 -1.569 . . . . 0.79000000000000004 109.179 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.596 ' CE1' HD13 ' A' ' 185' ' ' LEU . 90.8 m-85 -93.24 103.1 15.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.106 -1.232 . . . . 0.68999999999999995 109.738 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 218' ' ' LEU . 58.1 m-80 -71.65 120.27 17.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.094 -1.004 . . . . 0.40000000000000002 108.933 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.649 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -42.03 -34.7 0.75 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.564 -0.854 . . . . 0.17000000000000001 110.051 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.582 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 7.2 m-85 -54.37 -46.09 72.93 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.572 -1.27 . . . . 0.28000000000000003 107.572 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.558 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 10.2 tp -78.08 -71.15 0.44 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.775 -0.648 . . . . 0.46000000000000002 110.694 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.556 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.17 -62.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 0.39000000000000001 110.141 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -53.08 -53.63 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.067 . . . . 0.17000000000000001 111.391 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -56.44 -25.94 52.06 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.404 -1.435 . . . . 0.10000000000000001 108.965 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.574 ' HB2' ' CD2' ' A' ' 239' ' ' LEU . 6.3 t60 -78.82 -46.79 17.95 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.767 -0.583 . . . . 0.20999999999999999 109.748 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.516 ' CG ' ' HB2' ' A' ' 199' ' ' ALA . 3.7 tp10 -63.99 -38.3 90.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.28000000000000003 109.244 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 6.8 m-30 -64.33 -63.08 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.816 . . . . 0.17999999999999999 109.084 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.44 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -44.72 -31.68 2.7 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.86 -1.696 . . . . 0.20999999999999999 108.86 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.643 ' CE1' ' CG ' ' A' ' 240' ' ' MET . 0.0 OUTLIER -77.36 -74.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -1.139 . . . . 0.17000000000000001 110.639 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -39.35 -54.83 1.83 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.484 -0.76 . . . . 0.33000000000000002 111.492 -179.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.471 ' N ' ' OG ' ' A' ' 227' ' ' SER . 0.2 OUTLIER -78.79 -46.04 19.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.53000000000000003 110.785 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -60.3 -78.77 0.13 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.717 -1.353 . . . . 0.40999999999999998 109.717 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.538 HD12 ' CA ' ' A' ' 110' ' ' THR . 0.5 OUTLIER -177.76 -162.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.45000000000000001 110.08 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.5 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -55.8 -55.3 34.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.62 109.789 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.628 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -162.09 -179.96 7.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.45000000000000001 109.385 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 67.3 p -178.97 48.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.38 110.569 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -135.39 27.29 3.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.242 -0.911 . . . . 0.47999999999999998 110.559 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -39.83 -50.76 5.6 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.595 -0.842 . . . . 0.38 109.622 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 43.4 Cg_endo -90.53 -46.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.747 1.393 . . . . 0.28000000000000003 110.462 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.57 96.31 0.1 Allowed Glycine 0 N--CA 1.498 2.795 0 C-N-CA 119.065 -1.541 . . . . 0.23999999999999999 112.304 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 234' ' ' LYS . . . -145.25 160.33 41.64 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.263 -1.14 . . . . 0.28000000000000003 109.57 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.574 ' CD2' ' HB2' ' A' ' 222' ' ' HIS . 1.5 tt -68.18 57.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.40000000000000002 109.237 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.643 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -141.72 -6.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.45000000000000001 111.547 -178.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -78.21 165.23 51.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.556 -1.34 . . . . 0.56999999999999995 110.987 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 41.1 Cg_endo -68.11 -18.34 45.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.78 1.41 . . . . 0.76000000000000001 110.053 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.1 mm -90.21 136.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.934 -0.765 . . . . 0.89000000000000001 108.934 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 38.5 p90 -126.96 -30.64 2.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.942 -1.099 . . . . 0.78000000000000003 110.405 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.548 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 2.49 -70.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 113.203 0.816 . . . . 0.60999999999999999 113.203 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -53.41 105.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.556 -1.34 . . . . 0.73999999999999999 109.321 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.505 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 22.5 p -57.16 166.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.849 . . . . 0.81000000000000005 109.998 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -53.7 -19.8 10.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.092 -1.603 . . . . 0.56000000000000005 109.092 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.95 31.87 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.37 110.631 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.474 ' HB3' ' N ' ' A' ' 247' ' ' THR . 1.9 t -83.76 -22.67 31.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.05 -1.031 . . . . 0.44 109.927 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -152.41 -69.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.53000000000000003 109.873 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.64 -176.01 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.38 110.47 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -66.1 55.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.593 -0.692 . . . . 0.19 110.702 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.691 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -45.83 -46.88 40.44 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.017 -1.105 . . . . 0.28000000000000003 108.017 177.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.3 Cg_endo -71.82 48.91 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.954 1.502 . . . . 0.48999999999999999 110.966 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.551 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.8 m-20 -47.39 -32.42 4.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.887 -1.133 . . . . 0.48999999999999999 110.453 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 1.4 m-20 -50.49 -50.81 51.68 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.138 -0.976 . . . . 0.31 109.51 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.556 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -73.35 -33.01 64.87 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.169 -1.012 . . . . 0.14000000000000001 108.468 179.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 84.8 t -60.56 -81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.252 -0.979 . . . . 0.17000000000000001 110.153 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.3 OUTLIER -62.05 -42.85 99.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.238 -0.914 . . . . 0.26000000000000001 109.786 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.65 -64.92 1.1 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.396 -1.082 . . . . 0.19 110.396 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.595 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -77.49 -19.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.816 -1.402 . . . . 0.22 110.441 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.594 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 17.3 tt0 -64.37 -21.87 66.77 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.838 -1.145 . . . . 0.39000000000000001 108.317 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.0 t -104.22 -41.52 5.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.157 -0.617 . . . . 0.46999999999999997 111.487 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 9.2 mt -87.5 -45.86 10.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.227 -0.921 . . . . 0.47999999999999998 111.669 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.587 ' CG ' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.85 -8.78 57.36 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.206 -0.934 . . . . 0.40999999999999998 110.156 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -73.73 -107.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.032 -1.627 . . . . 0.46000000000000002 109.032 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 269' ' ' GLY . 46.3 Cg_endo -73.01 74.99 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.784 1.413 . . . . 0.57999999999999996 110.112 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 268' ' ' PRO . . . -61.81 -137.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.64000000000000001 109.723 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.556 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.94999999999999996 110.139 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 112' ' ' LYS . 1.7 p . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.325 0.583 . . . . 1.03 109.692 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.7 OUTLIER 37.24 28.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.706 -0.621 . . . . 1.04 111.107 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -100.22 91.05 4.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.121 -0.987 . . . . 0.77000000000000002 110.015 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.578 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 21.7 t90 -164.08 -71.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.41999999999999998 110.284 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.493 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 88.4 p -91.71 69.52 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.44 110.268 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 27.1 mttp -165.65 86.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.48999999999999999 110.465 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 5.8 ttp -123.23 -12.79 7.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.29999999999999999 110.149 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 20.3 p-10 -155.3 124.21 6.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.14999999999999999 109.84 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.493 ' CD2' ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.98 -177.82 6.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.13 110.424 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -121.44 147.14 46.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.12 109.766 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.59 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 9.6 p90 -145.01 160.71 40.94 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.254 -0.978 . . . . 0.33000000000000002 111.015 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 160.69 14.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.472 -0.768 . . . . 0.54000000000000004 110.032 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.648 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 7.6 pt -122.32 62.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.33000000000000002 110.727 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 12.1 m -110.39 48.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.995 -1.066 . . . . 0.27000000000000002 110.727 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.511 ' ND2' ' HG ' ' A' ' 216' ' ' LEU . 41.6 t-20 -43.18 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.40999999999999998 109.297 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.586 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 5.6 t80 -178.81 -175.1 0.39 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.346 -0.846 . . . . 0.40000000000000002 109.47 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.55 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -136.36 48.29 2.44 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.45000000000000001 110.805 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.586 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.8 Cg_endo -76.14 -85.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.814 1.429 . . . . 0.35999999999999999 110.343 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 1.5 m-20 -95.53 2.85 54.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.25 109.638 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.533 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -124.3 156.5 36.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 0.39000000000000001 109.75 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -110.41 176.48 5.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.47999999999999998 109.95 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -43.37 -34.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.40000000000000002 109.931 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -68.87 -50.01 53.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.46000000000000002 109.646 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 136' ' ' LYS . 5.2 mp0 -58.44 -62.09 2.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.364 -0.835 . . . . 0.46999999999999997 109.41 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 9.5 t -45.16 -39.7 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.139 -1.06 . . . . 0.31 108.139 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -54.11 -40.48 67.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.057 -1.09 . . . . 0.47999999999999998 108.057 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 17.0 tttt -74.54 -52.24 12.41 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.867 0.842 . . . . 0.64000000000000001 108.846 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.661 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -46.31 -60.81 2.1 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.962 -1.086 . . . . 0.41999999999999998 110.561 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -64.54 -54.17 36.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.34000000000000002 111.004 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.654 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 7.9 tttm -68.09 -72.76 0.16 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.94 -1.1 . . . . 0.46999999999999997 110.28 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.4 OUTLIER -38.48 -61.24 0.72 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.731 -0.605 . . . . 0.46999999999999997 110.709 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.43 -38.27 13.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.641 -1.287 . . . . 0.25 108.344 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.53 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -72.53 -28.58 62.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.31 -0.869 . . . . 0.34999999999999998 109.068 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 140' ' ' LYS . 58.7 tttt -63.4 -39.75 95.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.43 -0.952 . . . . 0.69999999999999996 108.43 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 11.3 t -75.76 -51.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.086 -0.709 . . . . 0.60999999999999999 109.086 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.605 ' CH2' HG13 ' A' ' 262' ' ' ILE . 45.2 t-105 -52.19 -34.18 44.16 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.441 -0.948 . . . . 0.39000000000000001 108.441 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 149' ' ' THR . 41.5 m -77.38 -38.41 50.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.395 -0.965 . . . . 0.34999999999999998 108.395 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.43 -43.88 62.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.862 -0.792 . . . . 0.35999999999999999 108.862 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 32.3 m -74.05 -38.52 49.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.477 -0.764 . . . . 0.5 109.55 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.524 ' N ' HG22 ' A' ' 148' ' ' VAL . 7.2 t -142.78 119.53 6.89 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.51000000000000001 110.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.41 58.57 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.663 1.349 . . . . 0.31 110.793 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 266' ' ' TYR . 59.4 mt -70.48 167.12 19.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.17999999999999999 110.043 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -105.89 103.08 12.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.892 . . . . 0.17000000000000001 110.22 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 8.6 p90 -116.08 144.68 43.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.14000000000000001 110.312 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 156' ' ' LEU . 27.7 m -147.9 130.55 15.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.14999999999999999 110.439 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.59 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -99.62 84.4 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.20000000000000001 109.904 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 154' ' ' THR . 0.5 OUTLIER -77.11 104.35 7.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.22 110.224 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' ASP . 55.8 p-80 -56.06 -27.96 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.96 . . . . 0.32000000000000001 109.948 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.454 ' OD1' HD11 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -42.12 -41.91 2.79 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.56 -0.712 . . . . 0.33000000000000002 109.941 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.73 33.22 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.733 -1.347 . . . . 0.28000000000000003 109.733 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.478 ' O ' ' HB ' ' A' ' 119' ' ' THR . 6.5 mt -121.13 71.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.064 -1.257 . . . . 0.29999999999999999 109.542 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -125.3 137.6 54.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.029 -0.668 . . . . 0.20000000000000001 110.411 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.493 ' CB ' ' CD2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.52 -34.9 8.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.10000000000000001 109.653 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.546 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -122.72 173.11 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.10000000000000001 109.052 179.347 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.537 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 3.5 ptp -177.05 144.63 0.44 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.495 -1.378 . . . . 0.11 111.656 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 1.5 tt -93.31 120.87 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.10000000000000001 109.272 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.505 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 4.3 p -163.62 142.56 8.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.735 -1.228 . . . . 0.10000000000000001 110.702 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.62 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.8 p90 -67.03 112.3 4.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.324 -0.86 . . . . 0.089999999999999997 109.618 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -60.63 143.28 48.12 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.281 -1.527 . . . . 0.20000000000000001 109.281 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.586 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.7 tt -138.15 96.91 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.972 . . . . 0.55000000000000004 109.905 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.586 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 1.06 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.382 0.611 . . . . 0.84999999999999998 112.363 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 11.83 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.70999999999999996 110.108 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.404 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m-70 -80.25 -87.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.41999999999999998 110.031 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.58 -35.2 1.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.485 -1.446 . . . . 0.33000000000000002 109.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 -87.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.33000000000000002 110.26 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -111.01 -170.01 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.27000000000000002 110.569 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -101.95 110.62 62.72 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.34000000000000002 110.349 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.445 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.1 Cg_endo -76.92 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.829 1.437 . . . . 0.46999999999999997 110.668 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.571 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -50.38 140.68 13.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.34999999999999998 110.606 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.466 ' OD1' ' OD2' ' A' ' 202' ' ' ASP . 6.0 p30 -178.74 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.932 -1.107 . . . . 0.20000000000000001 111.703 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 36.97 -157.54 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.562 -1.015 . . . . 0.25 110.562 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.462 ' HA ' ' OE1' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -78.62 43.74 1.5 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.183 1.623 . . . . 0.44 110.535 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 184' ' ' LEU . 0.5 OUTLIER -83.33 179.32 7.72 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.285 -0.885 . . . . 0.56999999999999995 109.816 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.2 68.6 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.566 -1.013 . . . . 0.48999999999999999 110.566 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 182' ' ' SER . 0.8 OUTLIER 179.64 84.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.132 -1.217 . . . . 0.40999999999999998 110.954 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.582 HD12 ' CZ ' ' A' ' 214' ' ' TYR . 0.5 OUTLIER -100.18 -24.17 14.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.964 -1.094 . . . . 0.29999999999999999 110.741 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -152.36 99.55 2.51 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.79 -1.194 . . . . 0.20000000000000001 111.788 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.539 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -100.97 124.47 46.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.051 -1.031 . . . . 0.16 109.987 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.521 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -106.08 124.49 49.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.974 . . . . 0.23000000000000001 110.333 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.4 OUTLIER -68.5 162.83 59.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.38 110.443 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.4 Cg_endo -72.26 138.58 30.63 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.40000000000000002 109.772 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.56 72.88 2.34 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.92 1.484 . . . . 0.32000000000000001 110.575 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.59 -105.95 2.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.32000000000000001 109.443 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.65 -159.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.943 1.497 . . . . 0.46999999999999997 110.396 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -63.61 -11.8 28.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.63 110.279 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.27 63.58 0.66 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.45 -0.781 . . . . 0.53000000000000003 109.997 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.19 173.89 22.46 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.097 -1.601 . . . . 0.25 109.097 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.537 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.28 25.5 0.76 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.481 -1.448 . . . . 0.10000000000000001 109.481 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 12.5 m-20 -79.04 87.44 4.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -1.209 . . . . 0.10000000000000001 110.666 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' A' ' 223' ' ' GLU . . . -62.8 98.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.089999999999999997 109.539 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.529 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 8.5 m170 -110.57 119.86 40.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.089999999999999997 111.266 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 203' ' ' ASP . 13.7 m-30 -90.62 131.93 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.10000000000000001 109.556 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -49.33 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.079 . . . . 0.14000000000000001 108.717 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -34.55 -32.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.566 -0.709 . . . . 0.17999999999999999 111.738 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.532 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 1.8 m-20 -64.1 -16.75 62.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.638 -1.289 . . . . 0.23999999999999999 110.631 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 202' ' ' ASP . 11.4 mm-40 -86.77 -176.02 5.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.002 . . . . 0.41999999999999998 110.49 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.528 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 83.8 m -122.11 154.74 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.46999999999999997 110.006 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.528 ' CG ' ' C ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -149.49 147.28 28.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 0.27000000000000002 109.756 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.32 177.55 11.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.02 -1.05 . . . . 0.29999999999999999 110.595 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 209' ' ' SER . 0.1 OUTLIER -129.06 20.28 5.88 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.729 0.776 . . . . 0.60999999999999999 109.553 178.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -89.38 -69.81 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.566 0.698 . . . . 0.78000000000000003 110.078 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.415 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER 179.41 -30.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.58 -0.7 . . . . 0.91000000000000003 109.543 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 177.61 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.548 -0.72 . . . . 0.93000000000000005 109.98 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 50.11 -161.4 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.79000000000000004 109.432 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.582 ' CZ ' HD12 ' A' ' 185' ' ' LEU . 80.1 m-85 -81.69 126.2 31.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.68999999999999995 109.473 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 208' ' ' THR . 16.8 m-80 -89.2 118.6 29.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.026 -1.046 . . . . 0.40000000000000002 108.658 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.661 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -41.37 -36.98 0.92 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.672 -0.811 . . . . 0.17000000000000001 110.334 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.57 ' CZ ' ' HG2' ' A' ' 136' ' ' LYS . 3.0 m-85 -51.24 -49.34 61.31 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.574 -1.25 . . . . 0.28000000000000003 107.833 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.507 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 12.7 tp -75.09 -70.42 0.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.791 -0.64 . . . . 0.46000000000000002 110.54 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -49.96 -68.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.39000000000000001 110.03 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -44.46 -52.96 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.978 -1.076 . . . . 0.17000000000000001 111.23 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.99 -47.71 77.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.275 -1.516 . . . . 0.10000000000000001 108.722 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.576 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.6 t60 -54.25 -52.18 62.17 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.419 0.628 . . . . 0.20999999999999999 109.942 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.541 ' CG ' ' HB3' ' A' ' 199' ' ' ALA . 3.4 tp10 -59.81 -43.7 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.207 -0.933 . . . . 0.28000000000000003 108.87 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 224' ' ' PHE . 11.6 m-30 -55.0 -62.35 1.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.17999999999999999 109.091 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.449 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.59 -32.97 1.4 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.786 -1.725 . . . . 0.20999999999999999 108.786 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -79.83 -76.46 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.195 -1.179 . . . . 0.17000000000000001 111.052 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.537 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.1 OUTLIER -34.55 -42.57 0.15 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.83 -0.544 . . . . 0.33000000000000002 112.336 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.522 ' CD2' ' OH ' ' A' ' 266' ' ' TYR . 3.1 tp -101.17 -38.74 7.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.839 -1.163 . . . . 0.53000000000000003 111.309 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 225' ' ' GLY . . . -68.29 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.762 -0.935 . . . . 0.40999999999999998 110.762 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.509 ' CD2' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -160.45 -155.34 0.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.131 -1.217 . . . . 0.45000000000000001 111.098 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 37.3 m-20 -74.4 -48.34 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.62 110.712 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.624 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -174.82 157.82 2.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -1.0 . . . . 0.45000000000000001 111.098 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 24.1 p -162.71 47.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.033 -0.728 . . . . 0.38 109.033 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.64 ' HA ' ' HB2' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -127.06 23.09 6.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.449 -0.782 . . . . 0.47999999999999998 111.001 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.534 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -43.86 -60.24 2.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.38 109.494 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.0 Cg_endo -75.97 -50.76 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.735 1.387 . . . . 0.28000000000000003 110.681 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.06 95.03 0.1 OUTLIER Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.337 -1.411 . . . . 0.23999999999999999 111.404 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 234' ' ' LYS . . . -145.77 164.93 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.426 -1.044 . . . . 0.28000000000000003 110.022 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.576 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 1.1 tp -72.14 57.33 0.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -0.916 . . . . 0.40000000000000002 109.131 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.572 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 4.3 mmm -146.86 14.46 1.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.102 -0.998 . . . . 0.45000000000000001 110.576 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -106.14 166.67 10.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.56999999999999995 110.704 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.469 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.3 Cg_endo -70.24 -7.53 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.008 1.53 . . . . 0.76000000000000001 109.981 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.596 ' O ' ' CE1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -101.41 112.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.137 -0.69 . . . . 0.89000000000000001 109.137 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 245' ' ' THR . 52.1 p90 -116.6 -31.58 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.04 . . . . 0.78000000000000003 110.731 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 243' ' ' ILE . 0.5 OUTLIER 1.89 -68.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.235 0.828 . . . . 0.60999999999999999 113.235 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -48.6 106.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.51 -1.369 . . . . 0.73999999999999999 109.524 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 70.0 p -53.8 171.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.81000000000000005 110.164 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.3 -15.23 29.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.27 -1.532 . . . . 0.56000000000000005 109.27 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.7 20.09 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.37 110.441 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.447 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -64.74 -17.88 64.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.44 109.795 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -168.36 -64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.53000000000000003 110.187 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.1 OUTLIER 179.95 -172.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.38 110.605 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.484 ' HG3' ' OD1' ' A' ' 256' ' ' ASP . 0.0 OUTLIER -66.32 56.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.716 -0.615 . . . . 0.19 110.541 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.9 OUTLIER -44.01 -47.6 22.43 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.0 -1.111 . . . . 0.28000000000000003 108.0 177.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.65 50.67 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 124.101 1.579 . . . . 0.48999999999999999 111.176 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.599 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 31.3 m-20 -53.54 -28.52 32.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.48999999999999999 110.786 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 1.7 m-20 -54.25 -47.76 71.91 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.035 -1.041 . . . . 0.31 109.436 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -76.21 -31.82 58.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.277 -0.969 . . . . 0.14000000000000001 108.442 178.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 70.8 t -61.83 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.658 -0.817 . . . . 0.17000000000000001 109.98 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -61.41 -40.96 96.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.247 -0.908 . . . . 0.26000000000000001 109.525 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.53 -66.71 0.92 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.355 -1.098 . . . . 0.19 110.355 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.605 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -76.14 -20.17 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.912 -1.346 . . . . 0.22 110.613 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 13.4 tp60 -61.37 -23.86 66.07 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.648 -1.221 . . . . 0.39000000000000001 107.969 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -103.12 -36.34 8.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.936 -0.705 . . . . 0.46999999999999997 111.672 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 265' ' ' LEU . 4.3 mm? -90.76 -46.52 8.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.973 -1.079 . . . . 0.47999999999999998 111.923 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -71.23 -18.09 62.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.964 -1.085 . . . . 0.40999999999999998 109.904 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.95 -88.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.999 -1.64 . . . . 0.46000000000000002 108.999 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.9 114.24 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.072 1.564 . . . . 0.57999999999999996 110.001 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.92 154.97 17.27 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.842 -1.303 . . . . 0.64000000000000001 109.842 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.279 -1.13 . . . . 0.94999999999999996 109.986 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.559 ' O ' ' CG ' ' A' ' 112' ' ' LYS . 1.1 p . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.505 0.669 . . . . 1.03 109.204 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 48.11 32.66 3.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 1.04 111.469 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 110' ' ' THR . 1.2 mtpt -117.75 92.88 3.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.77000000000000002 109.883 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 9.9 t90 -160.91 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.009 -1.057 . . . . 0.41999999999999998 111.307 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.483 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 87.6 p -102.23 69.23 1.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -0.998 . . . . 0.44 110.865 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 114' ' ' SER . 7.3 mttm -161.59 50.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.48999999999999999 110.352 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 3.9 ttt -74.91 -5.16 42.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.247 -0.908 . . . . 0.29999999999999999 110.427 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' CB ' ' HB3' ' A' ' 152' ' ' ASN . 29.7 p30 -156.78 149.13 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.14999999999999999 110.502 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 9.3 tp -171.15 177.64 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.13 109.857 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -110.36 158.84 18.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.008 . . . . 0.12 110.458 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 21.4 p90 -154.45 167.85 28.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.422 -0.799 . . . . 0.33000000000000002 110.329 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.464 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -130.06 144.21 51.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -0.818 . . . . 0.54000000000000004 110.102 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.591 HG22 ' CD1' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -105.18 123.85 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.346 -0.846 . . . . 0.33000000000000002 110.704 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 2.0 m -165.41 44.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.802 . . . . 0.27000000000000002 109.818 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.3 t-20 -40.11 -80.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.40999999999999998 109.539 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 7.8 t80 -179.11 178.46 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.314 -0.866 . . . . 0.40000000000000002 109.951 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.553 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -131.9 55.71 19.71 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.45000000000000001 110.576 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.6 Cg_endo -82.86 -81.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.789 1.415 . . . . 0.35999999999999999 110.517 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.77 -4.03 25.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.25 110.048 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.535 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 1.0 OUTLIER -113.76 160.98 18.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.39000000000000001 110.211 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.3 m -106.89 167.74 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.47999999999999998 109.839 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 2.0 t60 -44.29 -29.98 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.40000000000000002 109.845 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -66.71 -51.5 55.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.46000000000000002 109.654 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.535 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 10.3 mt-10 -62.16 -58.0 9.42 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.249 -0.907 . . . . 0.46999999999999997 109.18 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 125' ' ' TYR . 5.7 t -46.37 -34.76 2.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.935 -1.135 . . . . 0.31 107.935 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -59.0 -42.4 90.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.938 -1.134 . . . . 0.47999999999999998 107.938 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 47.1 tttt -68.97 -45.49 70.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.219 -1.03 . . . . 0.64000000000000001 108.219 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.666 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -49.17 -59.71 3.43 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.321 -0.862 . . . . 0.41999999999999998 109.739 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -65.39 -55.79 16.17 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.542 -0.724 . . . . 0.34000000000000002 110.509 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -64.27 -73.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.46999999999999997 110.603 -179.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -39.64 -60.27 1.0 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.633 -0.667 . . . . 0.46999999999999997 110.73 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.11 -36.86 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.521 -1.362 . . . . 0.25 108.339 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -72.33 -31.41 65.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.9 -0.778 . . . . 0.34999999999999998 108.9 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -61.29 -42.32 98.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.69999999999999996 108.655 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.3 t -73.22 -48.55 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.566 -0.709 . . . . 0.60999999999999999 109.208 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.59 ' CH2' HG13 ' A' ' 262' ' ' ILE . 43.1 t-105 -54.72 -39.38 68.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.39000000000000001 109.215 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 149' ' ' THR . 75.5 m -74.9 -35.18 62.25 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.508 -0.923 . . . . 0.34999999999999998 108.508 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.432 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.524 0.678 . . . . 0.35999999999999999 109.375 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.2 m -82.29 -32.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.419 -0.801 . . . . 0.5 110.256 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.513 ' N ' HG22 ' A' ' 148' ' ' VAL . 5.0 t -146.29 136.65 12.17 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.51000000000000001 110.557 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.93 58.44 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.972 1.512 . . . . 0.31 110.542 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.579 HD23 ' CG ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -75.63 129.54 37.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.17999999999999999 110.431 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.492 ' N ' HD12 ' A' ' 151' ' ' LEU . 64.6 t-20 -87.25 123.59 32.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.17000000000000001 109.841 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.58 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 7.5 p90 -133.11 152.97 51.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.14000000000000001 110.467 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 119' ' ' THR . 22.5 m -152.49 125.81 8.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.14999999999999999 110.319 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.584 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -92.04 105.43 17.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.20000000000000001 109.755 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 154' ' ' THR . 0.3 OUTLIER -101.76 96.97 7.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.22 110.395 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.3 p-80 -52.5 -28.34 20.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.32000000000000001 109.954 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.3 t0 -41.42 -60.7 1.22 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.587 -0.696 . . . . 0.33000000000000002 109.752 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.99 35.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.963 -1.255 . . . . 0.28000000000000003 109.963 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 160' ' ' ILE . 50.4 mt -126.09 68.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -1.205 . . . . 0.29999999999999999 109.398 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.41 55.26 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.641 -0.662 . . . . 0.20000000000000001 110.758 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.431 ' HB3' HD22 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -96.9 -51.07 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.10000000000000001 109.798 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 224' ' ' PHE . 18.5 tt -116.53 160.84 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.346 -0.846 . . . . 0.10000000000000001 109.644 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.515 ' O ' ' CB ' ' A' ' 199' ' ' ALA . 15.6 ptp -160.81 139.73 10.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.56 -1.338 . . . . 0.11 111.439 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.555 HD13 ' CE2' ' A' ' 201' ' ' PHE . 0.3 OUTLIER -93.6 113.97 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.10000000000000001 109.292 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.507 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 63.6 p -162.23 166.4 25.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.777 -1.202 . . . . 0.10000000000000001 111.36 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.616 ' CG ' ' CD1' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -79.99 136.56 36.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.55 -0.719 . . . . 0.089999999999999997 109.979 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.72 128.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.793 -1.323 . . . . 0.20000000000000001 109.793 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.56 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.1 tt -118.29 100.87 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -1.037 . . . . 0.55000000000000004 109.737 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.582 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 3.0 tmtt? -9.71 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.284 0.564 . . . . 0.84999999999999998 112.352 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 9.3 tt0 -146.16 11.85 1.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.70999999999999996 110.278 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -74.78 -75.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.41999999999999998 110.107 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 120.12 52.45 0.26 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.795 -1.322 . . . . 0.33000000000000002 109.795 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 6.5 p-10 -177.1 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -1.151 . . . . 0.33000000000000002 110.083 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.452 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.2 OUTLIER -132.03 154.72 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.27000000000000002 110.083 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.571 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 3.0 m-30 -106.48 88.98 3.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.941 . . . . 0.34000000000000002 110.168 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.463 ' O ' HD22 ' A' ' 184' ' ' LEU . 44.3 Cg_endo -72.6 -58.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.46999999999999997 109.968 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -49.12 131.49 19.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.34999999999999998 110.362 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 178' ' ' PHE . 14.8 p30 179.33 82.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.134 -0.979 . . . . 0.20000000000000001 110.804 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.475 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 35.71 -154.13 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.094 -1.202 . . . . 0.25 110.094 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -78.96 43.74 1.54 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.965 1.508 . . . . 0.44 110.2 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.1 t -80.78 176.67 9.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.103 -0.998 . . . . 0.56999999999999995 110.076 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.35 67.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.664 -0.974 . . . . 0.48999999999999999 110.664 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.517 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 0.3 OUTLIER 179.57 88.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.178 -1.189 . . . . 0.40999999999999998 110.709 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.553 HD11 ' CE2' ' A' ' 214' ' ' TYR . 4.9 tt -105.9 -19.11 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.759 -1.176 . . . . 0.29999999999999999 110.919 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.5 ' HB2' ' CD1' ' A' ' 201' ' ' PHE . . . -150.25 111.11 4.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.20000000000000001 112.074 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -114.64 125.83 54.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.84 . . . . 0.16 109.414 178.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.528 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -123.04 116.89 24.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.106 . . . . 0.23000000000000001 110.512 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -58.57 167.68 1.68 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.38 110.146 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.465 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -72.19 145.87 44.85 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.027 1.541 . . . . 0.40000000000000002 109.489 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.3 Cg_endo -72.48 86.43 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.831 1.438 . . . . 0.32000000000000001 110.35 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.49 -98.55 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.591 -1.404 . . . . 0.32000000000000001 109.591 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.61 -166.39 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.46999999999999997 110.573 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -69.67 -6.58 32.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.63 110.343 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 26.46 10.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.33 -0.856 . . . . 0.53000000000000003 109.891 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -106.34 176.94 22.02 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.082 -1.607 . . . . 0.25 109.082 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.514 ' O ' HG13 ' A' ' 163' ' ' ILE . . . 45.3 25.33 1.16 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.226 -1.55 . . . . 0.10000000000000001 109.226 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 196' ' ' GLY . 10.7 m-20 -78.79 87.49 4.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.10000000000000001 110.026 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 164' ' ' MET . . . -69.72 97.99 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.089999999999999997 109.895 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 41.4 m170 -115.27 129.47 56.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -0.876 . . . . 0.089999999999999997 110.602 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.9 m-85 -96.79 139.25 33.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.085 -1.009 . . . . 0.10000000000000001 110.365 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -47.78 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.14000000000000001 108.544 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.7 p-10 -35.48 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.013 -0.675 . . . . 0.17999999999999999 111.985 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 0.8 OUTLIER -76.66 -3.21 36.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.771 -1.205 . . . . 0.23999999999999999 111.271 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 14.5 mm-40 -91.22 -164.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.031 -1.043 . . . . 0.41999999999999998 110.171 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.446 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 16.0 m -127.88 150.95 49.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.46999999999999997 110.223 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.508 ' C ' ' CG2' ' A' ' 208' ' ' THR . 1.2 m-90 -145.9 146.25 31.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.27000000000000002 109.56 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.526 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -162.17 175.4 11.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.867 -1.145 . . . . 0.29999999999999999 111.104 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.9 t -126.58 45.24 2.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.855 0.836 . . . . 0.60999999999999999 109.037 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 211' ' ' SER . 11.0 t -127.38 -157.99 0.84 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.676 . . . . 0.78000000000000003 110.035 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.497 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 p -97.62 27.92 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.91000000000000003 110.349 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -145.09 150.13 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.93000000000000005 110.013 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.1 -176.2 12.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.174 -1.57 . . . . 0.79000000000000004 109.174 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 185' ' ' LEU . 86.7 m-85 -65.33 139.6 58.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 0.68999999999999995 109.565 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.519 ' ND2' ' CB ' ' A' ' 218' ' ' LEU . 0.6 OUTLIER -108.32 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.061 -1.024 . . . . 0.40000000000000002 108.678 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.666 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -39.08 -38.76 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.044 -0.662 . . . . 0.17000000000000001 110.801 -178.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.583 ' CZ ' ' HG2' ' A' ' 136' ' ' LYS . 2.0 m-85 -50.62 -46.66 58.25 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.302 -1.359 . . . . 0.28000000000000003 107.592 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.548 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 13.4 tp -80.72 -72.86 0.4 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.707 -0.678 . . . . 0.46000000000000002 110.908 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.56 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -46.1 -57.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.39000000000000001 110.395 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -59.36 -49.56 77.33 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.336 -0.852 . . . . 0.17000000000000001 111.385 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.23 -27.07 65.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.338 -1.476 . . . . 0.10000000000000001 108.998 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.575 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 4.0 t60 -76.53 -56.17 4.87 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.305 0.574 . . . . 0.20999999999999999 109.768 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.481 ' CD ' ' CE1' ' A' ' 201' ' ' PHE . 34.7 tt0 -58.43 -39.28 79.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.126 -0.983 . . . . 0.28000000000000003 109.015 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -60.47 -62.39 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.17999999999999999 109.005 178.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.83 -29.71 0.86 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.701 -1.76 . . . . 0.20999999999999999 108.701 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.43 -66.05 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -1.122 . . . . 0.17000000000000001 110.884 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.528 ' CA ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -40.78 -42.91 1.89 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.443 -0.786 . . . . 0.33000000000000002 111.691 -178.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 163' ' ' ILE . 0.9 OUTLIER -100.27 -37.87 8.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.772 -1.205 . . . . 0.53000000000000003 110.942 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -67.91 -85.74 0.1 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.255 -1.138 . . . . 0.40999999999999998 110.255 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.7 OUTLIER -170.23 -163.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.066 -1.255 . . . . 0.45000000000000001 111.05 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.444 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -59.03 -55.78 30.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.765 . . . . 0.62 110.329 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -161.72 -179.69 7.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.937 . . . . 0.45000000000000001 110.802 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 1.2 t 179.35 56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.714 -0.616 . . . . 0.38 109.474 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.569 ' HA ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -139.25 26.36 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.47999999999999998 110.862 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 234' ' ' LYS . 0.5 OUTLIER -34.03 -52.6 0.89 Allowed Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 120.005 -0.678 . . . . 0.38 110.273 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.505 ' CG ' ' CG ' ' A' ' 257' ' ' ASP . 50.2 Cg_endo -75.25 -56.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.634 1.334 . . . . 0.28000000000000003 110.12 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.62 37.22 0.05 OUTLIER Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.328 -1.415 . . . . 0.23999999999999999 111.655 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.573 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . . . -69.9 171.97 8.49 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.389 -1.653 . . . . 0.28000000000000003 111.009 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.21 58.79 1.29 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.938 0.875 . . . . 0.40000000000000002 109.148 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.571 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.6 mmt -138.07 -33.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.45000000000000001 110.519 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.642 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -52.62 169.93 0.26 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.56999999999999995 110.344 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.516 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 44.7 Cg_endo -72.17 -1.42 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.592 1.312 . . . . 0.76000000000000001 110.369 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 4.1 mt -111.97 141.96 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.89000000000000001 109.965 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.558 ' O ' ' C ' ' A' ' 245' ' ' THR . 22.4 p90 -130.15 -19.66 3.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.151 -0.968 . . . . 0.78000000000000003 111.201 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.558 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER 4.46 -76.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 113.006 0.743 . . . . 0.60999999999999999 113.006 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.583 ' CE2' ' HD3' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -45.49 121.09 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.498 -1.376 . . . . 0.73999999999999999 109.612 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 0.6 OUTLIER -71.14 157.96 37.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.828 . . . . 0.81000000000000005 110.228 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.87 -22.09 4.16 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.528 -1.429 . . . . 0.56000000000000005 109.528 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -131.07 31.56 4.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -1.154 . . . . 0.37 110.744 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.6 t -76.28 -69.5 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.806 -1.184 . . . . 0.44 110.114 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . 0.537 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 2.4 t60 -116.73 -60.09 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.53000000000000003 110.338 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.2 OUTLIER 179.85 -169.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.977 . . . . 0.38 110.898 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.462 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 26.0 ptp -64.92 55.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.998 -0.439 . . . . 0.19 110.658 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.698 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -45.38 -46.96 35.16 Favored Pre-proline 0 N--CA 1.484 1.238 0 N-CA-C 107.897 -1.149 . . . . 0.28000000000000003 107.897 177.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.3 Cg_endo -71.42 48.72 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.901 1.474 . . . . 0.48999999999999999 111.194 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 7.7 m-20 -49.29 -32.54 11.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.887 -1.133 . . . . 0.48999999999999999 110.325 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.548 ' O ' ' HA3' ' A' ' 261' ' ' GLY . 0.5 OUTLIER -55.96 -50.69 70.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.966 -1.093 . . . . 0.31 108.974 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.557 ' CB ' ' HB1' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -68.54 -35.13 77.0 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.257 -0.977 . . . . 0.14000000000000001 108.672 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 53.6 t -66.49 -86.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.17000000000000001 110.543 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 10.0 tt0 -53.77 -39.62 65.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 0.26000000000000001 109.631 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -45.9 -70.83 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.354 -1.098 . . . . 0.19 110.354 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.59 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -69.96 -20.65 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.22 109.89 -179.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.524 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 3.4 tp-100 -58.87 -25.99 63.83 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.722 -1.191 . . . . 0.39000000000000001 107.821 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 25.5 t -103.07 -43.05 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.308 0.575 . . . . 0.46999999999999997 110.857 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 1.6 mt -72.52 -53.06 13.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.47999999999999998 111.054 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.579 ' CG ' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -80.13 -8.1 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.40999999999999998 110.291 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.0 -100.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.103 -1.599 . . . . 0.46000000000000002 109.103 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.33 132.74 13.98 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.967 1.509 . . . . 0.57999999999999996 110.088 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -98.37 140.88 15.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.737 -1.345 . . . . 0.64000000000000001 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.59 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.244 -1.15 . . . . 0.94999999999999996 109.903 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.496 ' HA ' HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.52 0.676 . . . . 1.03 109.439 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.6 mt 40.05 31.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 1.04 111.017 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -119.97 76.68 1.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.77000000000000002 109.74 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.578 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 23.5 t90 -140.92 -71.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.41999999999999998 110.54 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 114' ' ' SER . 4.6 t -103.48 54.0 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.44 110.326 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.471 ' CD ' HD11 ' A' ' 118' ' ' LEU . 59.6 mmtt -136.54 46.65 2.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.48999999999999999 110.311 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.446 ' HE1' ' HB2' ' A' ' 152' ' ' ASN . 1.1 ttp -82.47 -15.34 52.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.296 -0.878 . . . . 0.29999999999999999 109.989 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 17.3 p30 -140.17 115.52 9.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.831 . . . . 0.14999999999999999 110.077 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.76 176.2 8.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.13 110.108 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.9 OUTLIER -123.64 162.04 23.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.12 109.992 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' A' ' 163' ' ' ILE . 16.0 p90 -164.66 167.7 18.85 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.199 -1.0 . . . . 0.33000000000000002 111.285 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -120.45 151.83 38.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.416 -0.803 . . . . 0.54000000000000004 109.875 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.632 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.5 pp -109.47 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.862 . . . . 0.33000000000000002 110.989 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 2.8 m -143.63 43.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.27000000000000002 110.396 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 4.0 t30 -42.04 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.40999999999999998 109.303 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.519 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 2.9 t80 -179.69 -167.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.40000000000000002 109.68 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.526 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.7 OUTLIER -150.97 50.07 0.66 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.45000000000000001 110.533 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -75.76 -84.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.838 1.441 . . . . 0.35999999999999999 110.508 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.71 -0.25 51.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.25 109.998 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -115.99 163.57 15.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.39000000000000001 110.007 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.17 168.68 9.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.47999999999999998 110.049 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -43.6 -32.83 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.40000000000000002 110.04 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -64.4 -46.32 83.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.46000000000000002 109.512 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 12.5 mt-10 -67.23 -57.5 6.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.138 -0.976 . . . . 0.46999999999999997 109.66 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 17.5 t -45.33 -32.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.95 -1.13 . . . . 0.31 107.95 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.7 mt-10 -63.55 -44.54 93.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.078 -1.082 . . . . 0.47999999999999998 108.078 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.2 ttmt -68.56 -49.07 62.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.24 -0.984 . . . . 0.64000000000000001 108.651 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.66 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -46.39 -59.75 2.76 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.212 -0.93 . . . . 0.41999999999999998 110.245 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.632 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.68 -53.78 30.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.34000000000000002 110.825 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.63 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.18 -73.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.46999999999999997 110.335 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtt? -38.63 -60.63 0.8 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.865 -0.522 . . . . 0.46999999999999997 110.603 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.38 -38.71 13.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.676 -1.265 . . . . 0.25 108.528 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -71.68 -29.68 64.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.368 -0.832 . . . . 0.34999999999999998 109.079 178.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 140' ' ' LYS . 6.1 ttmm -61.24 -44.91 96.5 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.19 -1.041 . . . . 0.69999999999999996 108.19 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 6.5 t -63.61 -43.35 98.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.7 -0.852 . . . . 0.60999999999999999 108.7 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.515 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 46.2 t-105 -56.35 -44.4 80.05 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.79 -0.819 . . . . 0.39000000000000001 108.79 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 149' ' ' THR . 9.6 m -64.66 -32.12 73.65 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.34999999999999998 108.886 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -62.72 -36.57 83.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.521 -0.737 . . . . 0.35999999999999999 109.334 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 263' ' ' GLN . 35.3 m -89.17 -11.56 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -0.85 . . . . 0.5 110.534 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.512 HG21 ' CG1' ' A' ' 262' ' ' ILE . 14.9 t -175.92 132.67 0.42 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.927 -1.108 . . . . 0.51000000000000001 110.247 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.04 60.1 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.866 1.456 . . . . 0.31 110.804 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -72.32 129.63 38.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.17999999999999999 109.879 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -87.19 124.73 33.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.17000000000000001 110.191 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.528 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -136.27 155.85 49.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.14000000000000001 110.508 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 119' ' ' THR . 34.5 m -152.81 132.11 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.14999999999999999 110.222 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -101.55 91.21 4.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.978 . . . . 0.20000000000000001 110.123 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.5 94.32 7.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.22 110.286 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 158' ' ' ASP . 14.3 p-80 -52.71 -25.85 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.32000000000000001 109.867 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' HIS . 1.5 t70 -41.53 -62.79 0.81 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.468 0.652 . . . . 0.33000000000000002 109.679 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.58 34.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.888 -1.285 . . . . 0.28000000000000003 109.888 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.541 ' O ' ' HB ' ' A' ' 119' ' ' THR . 22.6 mm -126.5 69.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.065 -1.256 . . . . 0.29999999999999999 109.108 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -127.91 136.9 51.99 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.001 -0.68 . . . . 0.20000000000000001 110.572 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -118.33 -35.81 3.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.10000000000000001 110.269 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.596 ' CG2' ' CD1' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -126.82 163.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.294 -0.879 . . . . 0.10000000000000001 109.511 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.526 ' N ' HD13 ' A' ' 163' ' ' ILE . 6.5 ptm -172.77 156.19 3.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.208 -1.558 . . . . 0.11 111.727 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.57 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 4.5 tt -98.43 114.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.654 -0.654 . . . . 0.10000000000000001 109.447 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.531 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 80.9 p -155.85 151.61 27.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 0.10000000000000001 110.92 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -72.45 119.15 16.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.522 -0.736 . . . . 0.089999999999999997 109.826 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -77.87 129.31 9.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.219 -1.152 . . . . 0.20000000000000001 110.219 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.5 tt -126.18 98.55 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.614 -0.933 . . . . 0.55000000000000004 109.634 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 1.2 tmtt? 1.15 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.589 0.588 . . . . 0.84999999999999998 112.589 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 20.21 0.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.70999999999999996 110.282 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -93.31 -88.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.41999999999999998 110.268 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.29 -20.96 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.325 -1.51 . . . . 0.33000000000000002 109.325 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.68 -66.91 0.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -1.062 . . . . 0.33000000000000002 110.339 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.465 ' C ' ' CD1' ' A' ' 175' ' ' PHE . 23.4 p90 -148.24 163.51 36.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.27000000000000002 110.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.0 m-30 -69.24 114.95 27.37 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.34000000000000002 110.186 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.495 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 44.1 Cg_endo -77.07 -72.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.857 1.451 . . . . 0.46999999999999997 110.784 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -54.2 146.87 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.34999999999999998 110.422 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 44.4 p-10 -178.08 76.82 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.20000000000000001 110.459 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.514 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 53.18 -169.39 0.88 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.121 -1.591 . . . . 0.25 109.121 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 182' ' ' SER . 49.3 Cg_endo -78.28 10.05 2.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.042 1.548 . . . . 0.44 110.478 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 184' ' ' LEU . 28.5 t -47.59 177.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.56999999999999995 110.915 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.503 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.02 76.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.479 -1.048 . . . . 0.48999999999999999 110.479 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.503 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 5.0 tp 179.47 87.68 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.369 -1.077 . . . . 0.40999999999999998 109.767 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.535 HD12 ' CG ' ' A' ' 214' ' ' TYR . 6.4 tt -109.84 -23.47 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.901 -1.124 . . . . 0.29999999999999999 111.42 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.447 ' HB1' ' CD1' ' A' ' 201' ' ' PHE . . . -152.5 101.84 2.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.517 -1.365 . . . . 0.20000000000000001 111.935 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 2.2 p80 -100.76 120.84 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.054 . . . . 0.16 110.016 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.511 ' N ' ' OE2' ' A' ' 223' ' ' GLU . . . -102.64 132.45 48.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.23000000000000001 110.179 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-30 -78.91 168.92 23.19 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.38 110.421 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.477 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 48.0 Cg_endo -73.68 125.47 10.05 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.994 1.523 . . . . 0.40000000000000002 109.553 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.25 68.22 1.41 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.897 1.472 . . . . 0.32000000000000001 110.6 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.36 -86.23 1.4 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.366 -1.494 . . . . 0.32000000000000001 109.366 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 -164.46 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.072 1.564 . . . . 0.46999999999999997 110.367 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . 0.434 ' ND2' ' N ' ' A' ' 194' ' ' ASN . 3.4 m120 -74.22 -0.89 18.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.63 110.386 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.89 48.67 1.19 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.53000000000000003 110.162 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -124.32 177.37 16.79 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.313 -1.515 . . . . 0.25 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 46.79 22.74 1.22 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.902 -1.279 . . . . 0.10000000000000001 109.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.88 86.58 6.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -1.211 . . . . 0.10000000000000001 109.745 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 164' ' ' MET . . . -61.58 97.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.143 -0.973 . . . . 0.089999999999999997 110.057 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.529 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 14.1 m170 -107.34 126.73 52.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.089999999999999997 110.341 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.5 m-85 -99.0 132.58 44.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.173 -0.954 . . . . 0.10000000000000001 110.529 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.6 OUTLIER -46.74 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.834 -0.802 . . . . 0.14000000000000001 108.834 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.52 -27.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.17999999999999999 111.638 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 202' ' ' ASP . 19.6 m-20 -77.17 3.15 13.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.622 -1.299 . . . . 0.23999999999999999 110.731 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 17.2 mm-40 -98.41 -167.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.934 -1.104 . . . . 0.41999999999999998 110.41 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . 0.532 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -124.94 151.72 45.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.46999999999999997 110.177 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.1 m-90 -148.95 144.52 26.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.27000000000000002 109.911 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.57 170.17 21.42 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.958 -1.089 . . . . 0.29999999999999999 110.638 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.1 t -129.58 26.98 5.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.822 -0.807 . . . . 0.60999999999999999 108.822 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -95.26 -94.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.715 -0.615 . . . . 0.78000000000000003 110.296 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.483 ' N ' ' OG ' ' A' ' 210' ' ' SER . 18.0 p -156.78 20.96 0.33 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.91000000000000003 109.8 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 213' ' ' GLY . 5.4 mttm -141.94 -177.16 5.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.439 -0.788 . . . . 0.93000000000000005 110.134 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 43.68 -166.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.385 -1.486 . . . . 0.79000000000000004 109.385 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.535 ' CG ' HD12 ' A' ' 185' ' ' LEU . 73.7 m-85 -73.75 120.54 19.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.68999999999999995 109.793 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 208' ' ' THR . 57.2 m-80 -84.52 120.05 25.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.963 -1.086 . . . . 0.40000000000000002 108.856 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.66 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -41.33 -37.2 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.17000000000000001 110.439 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 217' ' ' PHE . 3.1 m-30 -51.33 -47.79 62.59 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 118.619 -1.232 . . . . 0.28000000000000003 107.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.53 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 7.3 tp -77.0 -70.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.9 -0.591 . . . . 0.46000000000000002 110.605 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.563 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -48.89 -66.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.944 -1.097 . . . . 0.39000000000000001 109.808 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -46.57 -48.55 19.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.111 -0.993 . . . . 0.17000000000000001 111.077 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.59 -45.43 89.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.323 -1.485 . . . . 0.10000000000000001 108.764 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.588 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 2.7 t-160 -58.08 -54.52 45.99 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.415 0.626 . . . . 0.20999999999999999 109.811 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 188' ' ' ALA . 24.6 tp10 -58.5 -57.12 14.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.28000000000000003 109.156 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 3.3 m-85 -43.73 -57.89 2.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.17999999999999999 109.016 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.474 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -46.96 -35.04 7.76 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.421 -1.472 . . . . 0.20999999999999999 109.421 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.588 ' CE1' ' HB3' ' A' ' 240' ' ' MET . 0.1 OUTLIER -81.8 -67.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.095 -1.238 . . . . 0.17000000000000001 111.08 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.519 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.1 OUTLIER -38.08 -42.95 0.7 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.46 -0.775 . . . . 0.33000000000000002 111.726 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.596 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 2.1 tp -99.95 -36.72 9.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.815 -1.178 . . . . 0.53000000000000003 110.753 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.58 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -64.99 -79.71 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.3 -1.12 . . . . 0.40999999999999998 110.3 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -177.37 -152.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.45000000000000001 110.896 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -50.67 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.62 110.199 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.572 ' NE2' ' NE2' ' A' ' 226' ' ' HIS . 0.2 OUTLIER -175.19 169.15 3.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.45000000000000001 110.017 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.9 p -169.31 53.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.38 109.229 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.2 OUTLIER -139.33 25.14 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.47999999999999998 111.525 -178.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.529 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -39.39 -51.06 4.8 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.38 110.428 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 53.2 Cg_endo -81.03 -52.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.571 1.301 . . . . 0.28000000000000003 110.687 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 176.75 101.72 0.15 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.2 -1.476 . . . . 0.23999999999999999 111.508 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -139.4 177.4 7.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.261 -1.141 . . . . 0.28000000000000003 109.65 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.595 ' N ' ' CB ' ' A' ' 255' ' ' PRO . 2.0 tp -67.8 -3.98 11.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.065 -1.022 . . . . 0.40000000000000002 109.86 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.588 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 6.4 mmt -94.91 -6.81 41.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.45000000000000001 111.709 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -53.8 169.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.768 -1.208 . . . . 0.56999999999999995 110.681 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.532 ' O ' ' CG1' ' A' ' 243' ' ' ILE . 49.5 Cg_endo -80.22 43.0 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.662 1.349 . . . . 0.76000000000000001 110.055 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 242' ' ' PRO . 9.0 mt -161.01 144.38 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.797 -0.816 . . . . 0.89000000000000001 108.797 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.558 ' O ' ' C ' ' A' ' 245' ' ' THR . 53.7 p90 -124.97 -34.15 2.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.965 -1.084 . . . . 0.78000000000000003 110.057 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.558 ' C ' ' O ' ' A' ' 244' ' ' TYR . 15.7 m 2.9 -70.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.831 0.678 . . . . 0.60999999999999999 112.831 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.55 ' CE2' ' HD3' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -61.34 106.96 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.632 -1.292 . . . . 0.73999999999999999 108.977 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.458 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.2 OUTLIER -47.03 174.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.81000000000000005 110.263 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.31 -16.5 27.87 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.037 -1.625 . . . . 0.56000000000000005 109.037 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -146.89 31.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.37 110.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.453 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -56.56 -19.22 14.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.44 110.144 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -170.97 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.53000000000000003 110.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.491 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -177.92 177.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.38 111.019 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -71.32 56.68 0.24 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.64 -0.663 . . . . 0.19 110.903 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.69 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.0 OUTLIER -43.82 -47.07 20.79 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.019 -1.104 . . . . 0.28000000000000003 108.019 177.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.5 Cg_endo -71.29 50.89 1.3 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.983 1.518 . . . . 0.48999999999999999 111.085 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.556 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 15.1 m-20 -54.56 -28.77 48.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.021 -1.05 . . . . 0.48999999999999999 111.192 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.535 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -54.38 -46.3 73.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.726 -1.234 . . . . 0.31 109.396 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.563 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.07 -32.02 56.5 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.297 -1.001 . . . . 0.14000000000000001 108.297 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 66.7 t -61.25 -76.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.661 -0.816 . . . . 0.17000000000000001 110.269 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.3 tt0 -65.78 -42.26 90.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.101 -0.999 . . . . 0.26000000000000001 109.434 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.38 -63.44 1.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.129 -1.189 . . . . 0.19 110.129 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.563 ' CD1' ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -77.75 -20.49 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.762 -1.434 . . . . 0.22 110.395 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.568 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 0.0 OUTLIER -59.72 -25.98 65.25 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.795 -1.19 . . . . 0.39000000000000001 108.028 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.0 m -104.38 -33.54 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.145 -0.622 . . . . 0.46999999999999997 111.764 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 2.2 mm? -90.08 -44.99 9.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.075 -1.015 . . . . 0.47999999999999998 111.563 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.58 ' CE2' ' HA2' ' A' ' 229' ' ' GLY . 0.1 OUTLIER -85.09 -11.28 55.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.40999999999999998 110.647 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -58.3 -110.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.516 . . . . 0.46000000000000002 109.311 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.66 93.78 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.809 1.426 . . . . 0.57999999999999996 110.353 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 113' ' ' TRP . . . -79.18 156.08 41.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.44 -1.464 . . . . 0.64000000000000001 109.44 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.578 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 38.0 t0 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.244 -1.151 . . . . 0.94999999999999996 110.396 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.5 ' HA ' HD13 ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.379 0.609 . . . . 1.03 109.568 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 0.3 OUTLIER 38.21 42.53 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.577 . . . . 1.04 111.126 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HD3' HD21 ' A' ' 265' ' ' LEU . 1.2 ptpt -134.3 66.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.77000000000000002 109.303 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.594 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 12.3 t90 -140.37 -65.15 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.41999999999999998 110.822 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.468 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 36.1 t -103.69 56.41 0.74 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.44 111.09 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 114' ' ' SER . 30.4 mmtt -150.9 45.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.028 -1.045 . . . . 0.48999999999999999 110.476 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.505 ' HB2' ' CA ' ' A' ' 269' ' ' GLY . 2.0 ttp -81.66 -1.9 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.29999999999999999 110.458 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.461 ' O ' HD13 ' A' ' 118' ' ' LEU . 1.4 p30 -148.51 119.53 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.14999999999999999 110.012 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.47 ' CD2' HD11 ' A' ' 228' ' ' LEU . 1.5 tp -152.13 174.3 13.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.13 110.493 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.493 ' CB ' ' HA ' ' A' ' 161' ' ' ALA . 0.6 OUTLIER -118.2 159.46 23.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.12 110.256 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 20.1 p90 -154.35 170.22 21.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.616 -0.834 . . . . 0.33000000000000002 110.591 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 147.39 49.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.54000000000000004 110.12 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.546 HG21 ' CD1' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -107.09 125.05 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.33000000000000002 110.929 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 1.3 m -167.19 43.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.27000000000000002 109.768 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.514 ' OD1' ' CE ' ' A' ' 129' ' ' MET . 1.0 OUTLIER -40.07 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.40999999999999998 109.429 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.547 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 19.9 t80 -178.46 -178.62 0.62 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 0.40000000000000002 109.641 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -119.7 48.2 1.12 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.917 -1.114 . . . . 0.45000000000000001 110.664 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -71.28 -87.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.11 1.584 . . . . 0.35999999999999999 110.52 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -108.41 -15.09 14.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 0.25 109.909 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.583 ' CB ' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -111.24 104.95 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.39000000000000001 109.548 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -51.46 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.47999999999999998 110.593 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.58 -39.35 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.40000000000000002 110.209 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -55.45 -57.82 10.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.46000000000000002 109.668 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.583 ' CB ' ' CB ' ' A' ' 129' ' ' MET . 2.2 mp0 -55.72 -56.75 16.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.46999999999999997 109.256 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 133' ' ' GLU 0.253 5.1 t -44.47 -35.46 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.016 -1.105 . . . . 0.31 108.016 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 132' ' ' SER . 5.0 tt0 -59.47 -44.43 93.02 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.888 -1.153 . . . . 0.47999999999999998 107.888 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.569 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.8 tttp -68.22 -44.0 76.71 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.581 -0.896 . . . . 0.64000000000000001 108.581 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.642 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -47.96 -58.53 4.3 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.205 -0.934 . . . . 0.41999999999999998 109.893 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -69.92 -51.76 30.28 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.704 -0.798 . . . . 0.34000000000000002 110.701 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.623 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 10.8 tttt -64.22 -73.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 0.46999999999999997 109.993 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -39.14 -60.84 0.83 Allowed 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.837 -0.539 . . . . 0.46999999999999997 110.693 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.88 -37.4 8.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.665 -1.214 . . . . 0.25 108.519 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -73.23 -34.27 65.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.781 . . . . 0.34999999999999998 109.217 178.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -56.36 -40.68 74.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.269 -1.011 . . . . 0.69999999999999996 108.269 178.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 4.1 t -69.25 -44.58 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.893 -0.78 . . . . 0.60999999999999999 108.893 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.592 ' CH2' HG13 ' A' ' 262' ' ' ILE . 27.4 t-105 -54.71 -42.66 71.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.464 -0.773 . . . . 0.39000000000000001 109.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 149' ' ' THR . 20.0 m -70.37 -33.41 71.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.81 . . . . 0.34999999999999998 108.929 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -58.1 -36.48 72.94 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.612 -0.68 . . . . 0.35999999999999999 109.457 179.267 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 34.7 m -86.9 -29.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.5 110.634 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 146' ' ' SER . 5.2 t -153.04 135.93 9.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.869 -1.144 . . . . 0.51000000000000001 110.526 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.88 58.1 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.986 1.519 . . . . 0.31 110.644 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.49 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -80.15 136.52 36.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 0.17999999999999999 110.076 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 9.3 t30 -88.08 126.11 34.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.17000000000000001 110.391 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.79 139.52 45.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.14000000000000001 110.207 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 119' ' ' THR . 11.5 m -141.47 137.57 32.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.14999999999999999 110.369 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.53 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.6 130.77 47.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 0.20000000000000001 109.677 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.477 HD21 ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -128.43 105.7 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.22 110.193 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.507 ' CD2' ' N ' ' A' ' 158' ' ' ASP . 4.7 p-80 -54.54 -33.8 60.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.32000000000000001 110.075 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.515 ' OD2' ' CG1' ' A' ' 160' ' ' ILE . 1.3 t70 -42.25 -42.38 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.589 -0.694 . . . . 0.33000000000000002 109.869 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.57 33.77 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.442 -1.463 . . . . 0.28000000000000003 109.442 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.515 ' CG1' ' OD2' ' A' ' 158' ' ' ASP . 6.7 mt -116.15 75.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.286 -1.126 . . . . 0.29999999999999999 109.631 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.493 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -143.6 147.78 34.89 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.528 -0.732 . . . . 0.20000000000000001 110.403 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.2 OUTLIER -105.67 -18.22 14.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.10000000000000001 110.285 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tt -136.07 166.93 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.153 -0.967 . . . . 0.10000000000000001 110.077 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 199' ' ' ALA . 6.9 ptp -171.38 146.38 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.288 . . . . 0.11 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 2.4 tt -98.72 119.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.423 -0.798 . . . . 0.10000000000000001 110.082 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.44 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 14.9 p -161.8 158.58 25.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.965 -1.084 . . . . 0.10000000000000001 110.82 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 18.6 p90 -76.41 122.46 24.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.089999999999999997 110.061 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.462 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -78.19 134.8 14.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.023 -1.231 . . . . 0.20000000000000001 110.023 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.585 ' O ' ' C ' ' A' ' 170' ' ' LYS . 1.3 tt -130.17 98.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.977 . . . . 0.55000000000000004 109.702 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.588 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.4 OUTLIER 1.09 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 121.359 0.6 . . . . 0.84999999999999998 112.266 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -141.52 7.0 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.70999999999999996 110.215 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.411 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 12.8 m-70 -77.98 -51.61 10.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.41999999999999998 110.002 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 94.65 39.38 4.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.433 -1.467 . . . . 0.33000000000000002 109.433 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.24 -51.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -1.095 . . . . 0.33000000000000002 110.036 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.86 159.28 16.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.27000000000000002 110.135 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 14.5 m-30 -113.0 85.27 7.75 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.34000000000000002 110.097 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.474 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 46.3 Cg_endo -73.69 -57.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.993 1.523 . . . . 0.46999999999999997 110.386 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -57.96 135.37 56.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.34999999999999998 110.698 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.483 ' N ' ' OD2' ' A' ' 204' ' ' ASP . 3.2 p30 179.97 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.206 -0.997 . . . . 0.20000000000000001 111.602 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.2 -161.33 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.247 -1.141 . . . . 0.25 110.247 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.443 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.6 Cg_endo -80.11 44.01 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.086 1.572 . . . . 0.44 110.157 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.7 m -81.08 177.66 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.095 -1.003 . . . . 0.56999999999999995 110.231 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.74 71.32 0.03 OUTLIER Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.892 -1.283 . . . . 0.48999999999999999 109.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.515 ' N ' ' O ' ' A' ' 182' ' ' SER . 0.7 OUTLIER 179.58 95.31 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.303 -1.116 . . . . 0.40999999999999998 110.202 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.45 ' CD2' HG21 ' A' ' 219' ' ' VAL . 6.7 tt -114.0 -18.41 11.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.708 -1.245 . . . . 0.29999999999999999 111.375 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.476 ' HB2' ' HG2' ' A' ' 223' ' ' GLU . . . -151.0 105.76 3.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.493 -1.379 . . . . 0.20000000000000001 112.001 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -115.08 119.81 37.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.16 109.485 178.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.519 ' CB ' ' OE2' ' A' ' 223' ' ' GLU . . . -109.68 142.03 41.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.981 -1.075 . . . . 0.23000000000000001 110.691 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -72.56 168.94 19.34 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.38 110.327 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 189' ' ' PHE . 46.6 Cg_endo -74.69 137.87 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.40000000000000002 109.502 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.3 Cg_endo -70.8 82.1 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.85 1.447 . . . . 0.32000000000000001 110.569 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 -99.72 1.29 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.396 -1.482 . . . . 0.32000000000000001 109.396 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.94 -162.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 0.46999999999999997 110.241 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -65.58 -11.82 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.63 109.991 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.42 60.89 0.64 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.557 -0.714 . . . . 0.53000000000000003 110.058 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 162' ' ' ASP . . . -134.33 177.07 19.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.559 -1.816 . . . . 0.25 108.559 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.83 25.88 0.25 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.808 -1.317 . . . . 0.10000000000000001 109.808 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 196' ' ' GLY . 72.7 m-20 -79.71 91.77 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.962 -1.316 . . . . 0.10000000000000001 109.898 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 165' ' ' ILE . . . -67.38 111.69 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.089999999999999997 110.421 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 31.2 m170 -121.6 126.43 49.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 0.089999999999999997 110.2 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 203' ' ' ASP . 23.2 m-85 -98.1 137.63 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.939 -1.1 . . . . 0.10000000000000001 110.674 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 205' ' ' GLU . 1.1 m-20 -49.19 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.14000000000000001 108.889 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.541 ' OD2' ' CB ' ' A' ' 178' ' ' PHE . 1.4 p30 -35.94 -30.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.772 . . . . 0.17999999999999999 111.663 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 9.4 m-20 -79.06 2.07 21.92 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.59 -1.319 . . . . 0.23999999999999999 111.245 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 29.4 mm-40 -95.95 -162.51 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.982 -1.074 . . . . 0.41999999999999998 110.155 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.8 m -125.81 148.53 49.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.112 -0.992 . . . . 0.46999999999999997 110.529 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.518 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.5 m-90 -142.27 142.85 32.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.267 -0.896 . . . . 0.27000000000000002 109.785 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.531 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -155.37 174.3 15.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.954 -1.091 . . . . 0.29999999999999999 110.722 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.1 t -129.27 21.97 5.66 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.649 -0.871 . . . . 0.60999999999999999 108.649 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.4 OUTLIER -99.2 -81.47 0.45 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.712 0.767 . . . . 0.78000000000000003 110.376 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.7 p -171.77 -35.32 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.958 -0.756 . . . . 0.91000000000000003 108.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -80.06 139.81 36.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.469 -0.769 . . . . 0.93000000000000005 109.538 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.04 -154.96 32.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.935 -1.666 . . . . 0.79000000000000004 108.935 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.491 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 60.0 m-85 -93.77 117.25 29.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.243 . . . . 0.68999999999999995 109.555 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 208' ' ' THR . 46.9 m-80 -81.4 122.4 27.44 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.946 -1.096 . . . . 0.40000000000000002 109.028 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.642 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -42.28 -37.42 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.17000000000000001 109.937 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 217' ' ' PHE . 2.3 m-30 -51.98 -48.74 64.23 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.423 -1.325 . . . . 0.28000000000000003 107.423 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -73.34 -73.57 0.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.819 -0.628 . . . . 0.46000000000000002 109.906 178.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.6 OUTLIER -47.77 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.39000000000000001 110.043 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -41.61 -51.28 4.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.735 -1.228 . . . . 0.17000000000000001 111.484 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.91 -33.51 71.96 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.249 -1.532 . . . . 0.10000000000000001 109.045 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.616 ' CE1' ' CA ' ' A' ' 240' ' ' MET . 5.3 t60 -71.63 -58.6 3.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.311 0.577 . . . . 0.20999999999999999 109.564 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.519 ' OE2' ' CB ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -55.87 -25.04 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.62 -0.882 . . . . 0.28000000000000003 108.62 178.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.7 m-30 -72.11 -67.65 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.6 0.714 . . . . 0.17999999999999999 109.261 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.98 -27.25 0.99 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.646 -1.782 . . . . 0.20999999999999999 108.646 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.598 ' CE1' ' HG2' ' A' ' 240' ' ' MET . 0.0 OUTLIER -80.98 -58.41 3.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -1.085 . . . . 0.17000000000000001 110.348 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.495 ' HB3' ' CB ' ' A' ' 188' ' ' ALA . 0.4 OUTLIER -47.74 -45.39 28.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.668 -0.645 . . . . 0.33000000000000002 111.794 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.47 HD11 ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -100.54 -38.15 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.02 . . . . 0.53000000000000003 111.044 -178.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -63.96 -77.2 0.24 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.043 -1.223 . . . . 0.40999999999999998 110.043 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 1.7 pt? -177.14 -162.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.187 . . . . 0.45000000000000001 110.488 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.495 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.2 OUTLIER -62.5 -54.6 37.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.62 109.904 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.576 ' NE2' ' NE2' ' A' ' 226' ' ' HIS . 2.2 m80 -163.71 178.26 8.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.45000000000000001 110.379 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 2.5 t 179.59 60.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.38 109.122 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.57 ' HA ' ' HB1' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -144.61 22.13 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.589 -0.844 . . . . 0.47999999999999998 111.174 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.53 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -37.12 -49.13 2.19 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.759 -0.776 . . . . 0.38 110.775 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.53 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 47.1 Cg_endo -89.41 -46.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.738 1.389 . . . . 0.28000000000000003 111.586 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.66 98.88 0.12 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 118.971 -1.585 . . . . 0.23999999999999999 111.91 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.583 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . . . -149.22 165.5 31.69 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.39 -1.065 . . . . 0.28000000000000003 110.012 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.579 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -79.32 55.63 1.93 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.40000000000000002 108.837 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.616 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 14.0 mtt -137.96 -24.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.81 . . . . 0.45000000000000001 110.998 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -60.05 171.35 0.93 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.7 -1.25 . . . . 0.56999999999999995 109.962 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.8 Cg_endo -69.48 -4.69 14.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.377 1.198 . . . . 0.76000000000000001 110.128 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 10.2 mm -100.43 148.47 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.89000000000000001 109.689 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.534 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 35.0 p90 -133.35 -27.46 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.095 -1.003 . . . . 0.78000000000000003 111.174 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.523 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 3.27 -69.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.642 0.978 . . . . 0.60999999999999999 113.642 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -66.32 129.82 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.348 -1.47 . . . . 0.73999999999999999 109.676 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -161.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.81000000000000005 110.202 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . 0.474 ' O ' ' CG ' ' A' ' 249' ' ' LYS . . . -86.93 10.89 66.39 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.427 -1.469 . . . . 0.56000000000000005 109.427 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -177.59 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.37 110.37 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -32.88 73.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 0.44 110.167 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.79 -88.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.53000000000000003 110.174 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -164.18 92.59 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 0.38 110.387 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 252' ' ' PHE . 3.1 ptt? 36.09 47.77 0.48 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.544 -0.722 . . . . 0.19 111.596 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.67 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.9 tp -47.65 -44.69 56.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.862 -1.135 . . . . 0.28000000000000003 107.958 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -73.1 49.62 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.646 1.34 . . . . 0.48999999999999999 111.055 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.542 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.6 m-20 -47.48 -32.41 5.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.754 -1.216 . . . . 0.48999999999999999 110.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.547 ' CB ' ' HB1' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -55.57 -49.81 71.72 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.131 -0.981 . . . . 0.31 109.821 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.66 -32.08 63.8 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.448 -0.901 . . . . 0.14000000000000001 108.615 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 71.1 t -66.72 -82.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.17000000000000001 110.061 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.0 tt0 -55.92 -40.9 73.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.306 -0.871 . . . . 0.26000000000000001 109.247 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.29 -70.65 0.45 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.113 -1.195 . . . . 0.19 110.113 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.592 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -74.24 -21.01 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.952 -1.322 . . . . 0.22 110.342 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.558 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 47.7 tt0 -64.05 -20.36 65.88 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.904 -1.118 . . . . 0.39000000000000001 108.422 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 18.8 t -103.42 -42.45 5.7 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.249 -0.58 . . . . 0.46999999999999997 111.347 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HD3' ' A' ' 112' ' ' LYS . 4.2 mp -87.32 -45.64 10.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.141 -0.974 . . . . 0.47999999999999998 111.202 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.49 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -79.08 -5.11 53.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.40999999999999998 109.948 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.65 -72.28 0.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.608 -1.397 . . . . 0.46000000000000002 109.608 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -86.9 142.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.987 1.52 . . . . 0.57999999999999996 110.761 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.505 ' CA ' ' HB2' ' A' ' 116' ' ' MET . . . -105.46 121.76 6.95 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.498 -1.441 . . . . 0.64000000000000001 109.498 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.594 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.107 -1.231 . . . . 0.94999999999999996 110.149 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' THR . . . . . 0.575 ' CA ' ' HB2' ' A' ' 230' ' ' LEU . 1.0 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 121.482 0.658 . . . . 1.03 111.488 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.544 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 0.7 OUTLIER 40.73 48.49 2.65 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.268 -0.895 . . . . 1.04 111.471 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.513 ' HE2' ' CG2' ' A' ' 110' ' ' THR . 4.1 pttt -146.82 79.07 1.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.77000000000000002 109.113 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TRP . . . . . 0.593 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 7.6 t90 -143.89 -70.1 0.31 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.41999999999999998 111.398 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 93.6 p -96.95 63.0 1.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.44 111.015 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 114' ' ' SER . 14.2 mttm -159.59 53.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.48999999999999999 110.082 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' MET . . . . . 0.451 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -60.79 -19.89 60.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.29999999999999999 110.408 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -138.34 156.2 47.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.14999999999999999 110.446 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -166.09 -174.61 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.13 110.127 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' THR . . . . . 0.497 ' HB ' ' HA ' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -128.47 149.26 50.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.181 -0.949 . . . . 0.12 110.11 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' TYR . . . . . 0.588 ' CE1' ' HB2' ' A' ' 153' ' ' PHE . 23.1 p90 -149.87 165.12 33.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -0.922 . . . . 0.33000000000000002 111.18 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.467 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.2 OUTLIER -118.08 150.91 38.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.54000000000000004 109.89 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ILE . . . . . 0.577 HG21 ' CE1' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -115.65 124.76 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.886 . . . . 0.33000000000000002 110.543 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -168.76 43.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.27000000000000002 109.932 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.3 t-20 -40.79 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.40999999999999998 109.501 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TYR . . . . . 0.575 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.7 t80 -179.35 -164.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.40000000000000002 109.553 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' THR . . . . . 0.577 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 1.8 m -148.12 46.78 0.48 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.913 -1.117 . . . . 0.45000000000000001 110.864 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -74.03 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.896 1.472 . . . . 0.35999999999999999 110.109 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.26 -4.46 58.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.955 . . . . 0.25 109.689 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' MET . . . . . 0.508 ' CE ' HG23 ' A' ' 134' ' ' VAL . 1.2 ptm -122.85 171.87 8.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.39000000000000001 110.107 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' THR . . . . . 0.463 ' HA ' HG21 ' A' ' 126' ' ' THR . 0.2 OUTLIER -119.66 171.63 8.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.47999999999999998 109.768 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -45.74 -28.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.036 -1.04 . . . . 0.40000000000000002 109.715 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -67.31 -58.28 5.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.46000000000000002 109.464 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.4 mp0 -55.82 -55.32 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.24 -0.913 . . . . 0.46999999999999997 108.775 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' VAL . . . . . 0.508 HG23 ' CE ' ' A' ' 129' ' ' MET . 4.9 t -46.19 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.826 -1.176 . . . . 0.31 107.826 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' GLU . . . . . 0.554 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 8.1 tt0 -59.37 -42.48 91.73 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.782 -1.192 . . . . 0.47999999999999998 107.782 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.572 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 23.4 tttt -70.65 -47.59 59.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.185 0.993 . . . . 0.64000000000000001 108.456 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.677 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -49.26 -62.22 1.66 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.566 -0.709 . . . . 0.41999999999999998 110.217 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.636 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -66.89 -52.51 42.45 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.41 -0.806 . . . . 0.34000000000000002 110.842 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' LYS . . . . . 0.636 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 1.0 OUTLIER -64.52 -72.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.976 -1.077 . . . . 0.46999999999999997 110.555 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' LYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -41.5 -58.68 1.83 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.581 -0.699 . . . . 0.46999999999999997 110.383 179.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.81 -35.4 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.564 -1.254 . . . . 0.25 108.351 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.63 -39.35 64.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.443 -0.786 . . . . 0.34999999999999998 109.117 178.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -56.03 -38.82 71.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.08 -1.012 . . . . 0.69999999999999996 108.455 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.9 t -68.92 -45.28 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.112 -0.699 . . . . 0.60999999999999999 109.112 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' TRP . . . . . 0.589 ' CH2' HG13 ' A' ' 262' ' ' ILE . 50.4 t-105 -57.11 -35.31 69.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.39000000000000001 108.895 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.7 m -75.73 -39.64 56.94 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.327 -0.858 . . . . 0.34999999999999998 108.788 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -40.74 72.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.35999999999999999 109.51 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.6 m -75.78 -33.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.5 109.781 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . 0.536 ' CB ' ' HA ' ' A' ' 263' ' ' GLN . 9.9 t -147.2 147.33 28.44 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.168 -0.958 . . . . 0.51000000000000001 110.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.67 58.69 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.948 1.499 . . . . 0.31 110.222 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 152' ' ' ASN . 1.4 tm? -84.0 139.46 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.17999999999999999 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ASN . . . . . 0.455 ' N ' HD13 ' A' ' 151' ' ' LEU . 1.2 m-20 -104.26 139.2 39.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.17000000000000001 110.118 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' PHE . . . . . 0.588 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 2.1 p90 -151.24 155.95 39.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.14000000000000001 110.593 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' THR . . . . . 0.484 ' CG2' HD11 ' A' ' 156' ' ' LEU . 7.3 m -152.9 131.05 11.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.406 -0.809 . . . . 0.14999999999999999 109.943 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ARG . . . . . 0.555 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 5.2 mtm180 -96.62 82.47 3.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.20000000000000001 110.595 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.484 HD11 ' CG2' ' A' ' 154' ' ' THR . 1.6 mp -74.98 83.34 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.155 -0.965 . . . . 0.22 109.71 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.7 p-80 -42.82 -26.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.32000000000000001 110.16 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -41.14 -37.87 0.97 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.616 -0.677 . . . . 0.33000000000000002 109.768 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.38 33.71 0.3 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.879 -1.288 . . . . 0.28000000000000003 109.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ILE . . . . . 0.515 ' CD1' ' OD1' ' A' ' 158' ' ' ASP . 2.7 mp -127.83 65.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -1.223 . . . . 0.29999999999999999 109.507 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -122.36 144.38 49.06 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.232 -0.587 . . . . 0.20000000000000001 110.364 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.7 OUTLIER -107.6 -36.54 6.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.885 . . . . 0.10000000000000001 110.205 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -127.57 156.87 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.132 -0.98 . . . . 0.10000000000000001 110.001 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' MET . . . . . 0.501 ' N ' HG13 ' A' ' 163' ' ' ILE . 13.7 ptm -163.94 160.45 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.42 -1.425 . . . . 0.11 111.564 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 220' ' ' ALA . 0.8 OUTLIER -106.75 119.41 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.46 -0.775 . . . . 0.10000000000000001 109.985 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 200' ' ' HIS . 11.6 p -158.68 146.01 17.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.10000000000000001 110.389 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' PHE . . . . . 0.599 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 10.4 p90 -66.34 114.24 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.089999999999999997 109.667 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -73.49 119.81 6.74 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.225 -1.15 . . . . 0.20000000000000001 110.225 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -110.05 103.25 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.48 -1.012 . . . . 0.55000000000000004 109.311 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . 0.601 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 2.0 tmtt? 1.26 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.32 0.581 . . . . 0.84999999999999998 112.317 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 171' ' ' GLU . 1.9 tm-20 -137.17 5.21 2.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.70999999999999996 110.218 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -87.14 -87.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.978 . . . . 0.41999999999999998 110.284 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 134.13 -34.86 2.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.165 -1.574 . . . . 0.33000000000000002 109.165 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.53 -31.25 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 0.33000000000000002 110.153 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' PHE . . . . . 0.434 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 2.4 t80 -172.52 116.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.27000000000000002 110.183 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.3 m-30 -47.14 105.72 0.51 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34000000000000002 110.192 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.2 Cg_endo -74.18 -61.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.902 1.475 . . . . 0.46999999999999997 110.422 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -55.23 144.49 24.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.34999999999999998 110.64 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 2.7 p30 179.12 80.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.396 -0.815 . . . . 0.20000000000000001 110.093 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.82 -154.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.335 -1.506 . . . . 0.25 109.335 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 182' ' ' SER . 53.3 Cg_endo -79.63 11.29 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.994 1.523 . . . . 0.44 110.393 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' SER . . . . . 0.477 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 0.8 OUTLIER -45.28 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.56999999999999995 110.669 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' GLY . . . . . 0.524 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -64.71 72.34 0.07 OUTLIER Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.795 -0.922 . . . . 0.48999999999999999 110.795 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 4.4 tt 179.52 92.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.191 -1.182 . . . . 0.40999999999999998 110.322 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' LEU . . . . . 0.494 HD11 ' CE1' ' A' ' 214' ' ' TYR . 4.1 tt -110.15 -23.84 11.05 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.561 -1.256 . . . . 0.29999999999999999 111.471 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' ALA . . . . . 0.474 ' HB2' ' CD1' ' A' ' 201' ' ' PHE . . . -150.9 103.3 3.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.521 -1.362 . . . . 0.20000000000000001 112.065 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' HIS . . . . . 0.529 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 1.5 p80 -103.0 141.12 36.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.103 . . . . 0.16 109.683 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' ALA . . . . . 0.532 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -123.78 128.04 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.23000000000000001 110.478 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -75.25 169.78 18.78 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.38 110.337 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' PRO . . . . . 0.496 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.8 Cg_endo -75.08 134.51 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.119 1.589 . . . . 0.40000000000000002 109.792 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' PRO . . . . . 0.544 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 43.9 Cg_endo -70.62 73.53 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.962 1.506 . . . . 0.32000000000000001 110.431 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.87 -98.09 2.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.632 -1.387 . . . . 0.32000000000000001 109.632 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.04 -161.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.988 1.52 . . . . 0.46999999999999997 110.045 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -67.75 -9.41 43.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 0.63 110.237 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.53 55.86 0.64 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.387 -0.821 . . . . 0.53000000000000003 110.23 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.07 174.87 19.41 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.185 -1.566 . . . . 0.25 109.185 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' GLY . . . . . 0.56 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 43.55 24.63 0.43 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.971 -1.252 . . . . 0.10000000000000001 109.971 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.1 OUTLIER -78.18 92.02 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -1.22 . . . . 0.10000000000000001 110.604 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 223' ' ' GLU . . . -73.36 99.47 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.089999999999999997 109.779 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' HIS . . . . . 0.529 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.9 m170 -112.58 138.59 49.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.089999999999999997 110.388 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 203' ' ' ASP . 25.8 m-85 -105.74 137.52 43.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.10000000000000001 110.526 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.5 OUTLIER -49.47 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.092 -1.077 . . . . 0.14000000000000001 108.092 178.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.5 p30 -36.07 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.1 -0.64 . . . . 0.17999999999999999 111.967 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 202' ' ' ASP . 32.0 m-20 -80.58 6.36 12.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.739 -1.225 . . . . 0.23999999999999999 111.006 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 202' ' ' ASP . 16.8 mm-40 -97.91 -167.07 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.922 -1.111 . . . . 0.41999999999999998 110.226 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.0 143.86 50.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.46999999999999997 110.446 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' TRP . . . . . 0.475 ' HB3' HD13 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -143.17 131.38 21.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.93 . . . . 0.27000000000000002 109.409 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' THR . . . . . 0.528 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -145.08 170.5 16.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.832 -1.167 . . . . 0.29999999999999999 111.114 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' SER . . . . . 0.532 ' OG ' ' CZ ' ' A' ' 217' ' ' PHE . 17.4 t -130.92 26.71 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.81 0.814 . . . . 0.60999999999999999 108.956 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -89.09 -93.53 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.752 -0.592 . . . . 0.78000000000000003 110.272 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -155.41 18.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.91000000000000003 110.156 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.64 -176.3 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.93000000000000005 110.221 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.8 -172.24 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.256 -1.537 . . . . 0.79000000000000004 109.256 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 244' ' ' TYR . 75.6 m-85 -68.22 101.68 1.22 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -1.222 . . . . 0.68999999999999995 109.734 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 208' ' ' THR . 64.8 m-80 -76.1 117.77 18.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.047 -1.033 . . . . 0.40000000000000002 108.857 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' LEU . . . . . 0.677 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -40.17 -36.73 0.54 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.716 . . . . 0.17000000000000001 110.528 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' PHE . . . . . 0.572 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.3 m-85 -49.45 -49.79 43.75 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.335 -1.346 . . . . 0.28000000000000003 107.736 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' LEU . . . . . 0.536 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 47.5 tp -76.83 -68.64 0.58 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.7 -0.682 . . . . 0.46000000000000002 110.778 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -50.89 -66.69 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.39000000000000001 109.718 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -44.25 -49.69 9.18 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.727 -1.233 . . . . 0.17000000000000001 110.653 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -64.73 -23.1 67.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.535 -1.353 . . . . 0.10000000000000001 109.194 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.591 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 6.0 t60 -79.97 -55.7 4.78 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.186 0.517 . . . . 0.20999999999999999 109.778 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' GLU . . . . . 0.54 ' CD ' ' CE1' ' A' ' 201' ' ' PHE . 29.1 tt0 -58.75 -43.65 90.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.127 -0.983 . . . . 0.28000000000000003 108.71 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 2.7 m-85 -58.42 -60.36 3.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.86 . . . . 0.17999999999999999 109.46 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -31.33 1.94 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.18 -1.568 . . . . 0.20999999999999999 109.18 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' HIS . . . . . 0.52 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 1.4 m80 -78.58 -74.77 0.26 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.107 -1.231 . . . . 0.17000000000000001 110.679 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' SER . . . . . 0.56 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -41.18 -36.67 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.385 0.513 . . . . 0.33000000000000002 112.385 -178.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' LEU . . . . . 0.506 ' CD2' ' CE2' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -101.39 -35.06 9.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.81 -1.181 . . . . 0.53000000000000003 112.172 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -85.36 -87.52 0.94 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.97 -1.081 . . . . 0.40999999999999998 111.442 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -154.27 156.01 36.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -1.127 . . . . 0.45000000000000001 110.483 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.551 ' N ' HD23 ' A' ' 230' ' ' LEU . 1.3 m-20 -37.08 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.349 -0.844 . . . . 0.62 110.98 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' HIS . . . . . 0.594 ' N ' HD23 ' A' ' 230' ' ' LEU . 6.3 m80 -143.12 161.39 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.247 -0.908 . . . . 0.45000000000000001 110.588 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 238' ' ' ALA . 1.0 OUTLIER -165.67 35.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.38 109.937 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -103.23 20.48 17.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.47999999999999998 110.624 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' ASP . . . . . 0.589 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -41.36 -60.15 1.95 Allowed Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.291 -0.964 . . . . 0.38 109.299 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 54.7 Cg_endo -81.07 -50.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.666 1.351 . . . . 0.28000000000000003 109.742 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.37 93.49 0.09 OUTLIER Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.788 -1.196 . . . . 0.23999999999999999 111.36 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' ALA . . . . . 0.559 ' HB3' ' CB ' ' A' ' 257' ' ' ASP . . . -137.48 162.76 32.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.929 -1.336 . . . . 0.28000000000000003 110.12 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' LEU . . . . . 0.591 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -73.22 57.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.195 -0.941 . . . . 0.40000000000000002 109.275 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.0 OUTLIER -140.37 -31.04 0.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.45000000000000001 110.687 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' PHE . . . . . 0.546 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -42.0 167.22 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.56999999999999995 110.553 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.23 -5.6 17.19 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.965 1.508 . . . . 0.76000000000000001 109.605 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' ILE . . . . . 0.532 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 19.4 mt -102.78 145.67 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.89000000000000001 109.812 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 246' ' ' TYR . 45.8 p90 -128.65 -31.73 2.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.78000000000000003 110.419 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' THR . . . . . 0.531 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.4 OUTLIER 2.17 -67.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.571 0.952 . . . . 0.60999999999999999 113.571 -179.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' TYR . . . . . 0.557 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -59.4 101.99 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.478 -1.389 . . . . 0.73999999999999999 109.415 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' THR . . . . . 0.526 ' N ' ' HB2' ' A' ' 250' ' ' SER . 1.4 m -47.98 178.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.763 . . . . 0.81000000000000005 110.475 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -52.1 -20.36 6.56 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.938 -1.265 . . . . 0.56000000000000005 109.938 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.26 31.35 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.083 -1.245 . . . . 0.37 110.639 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' SER . . . . . 0.526 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.2 OUTLIER -49.65 -47.35 49.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 0.44 109.876 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -47.65 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.53000000000000003 110.022 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 179.46 -178.19 0.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.38 110.494 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' MET . . . . . 0.474 ' HG3' ' OD2' ' A' ' 256' ' ' ASP . 0.0 OUTLIER -68.32 55.52 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.19 110.595 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.692 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.8 tp -43.99 -47.61 22.29 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.061 -1.088 . . . . 0.28000000000000003 108.061 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -71.1 48.52 0.89 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.054 1.555 . . . . 0.48999999999999999 111.279 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.4 m-20 -52.64 -28.78 22.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.882 -1.136 . . . . 0.48999999999999999 111.191 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' ASP . . . . . 0.559 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.58 -52.67 62.97 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.875 -1.13 . . . . 0.31 109.523 -178.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ASP . . . . . 0.544 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.22 -32.29 68.62 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.203 -0.999 . . . . 0.14000000000000001 108.947 179.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 61.1 t -64.02 -82.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.807 -0.757 . . . . 0.17000000000000001 110.054 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' GLN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.8 tt0 -55.59 -42.43 74.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 0.26000000000000001 108.951 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -38.95 -72.4 0.21 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' ILE . . . . . 0.589 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -72.33 -22.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.34 . . . . 0.22 110.082 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 0.8 OUTLIER -57.25 -24.84 57.4 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.843 -1.143 . . . . 0.39000000000000001 108.424 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.0 -37.44 7.37 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.146 -0.622 . . . . 0.46999999999999997 111.507 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 265' ' ' LEU . 4.5 mm? -83.15 -47.98 11.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.47999999999999998 111.951 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -82.74 -9.94 59.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.40999999999999998 110.691 -179.136 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -54.62 -97.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.009 -1.636 . . . . 0.46000000000000002 109.009 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.05 116.75 4.67 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.097 1.577 . . . . 0.57999999999999996 110.246 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -67.33 134.92 31.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.749 -1.34 . . . . 0.64000000000000001 109.749 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 270' ' ' ASP . . . . . 0.593 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.94999999999999996 110.037 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.206 0.527 . . . . 0.40999999999999998 110.18 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.477 ' O ' ' CG2' ' A' ' 106' ' ' VAL . 13.8 p30 -150.31 136.2 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.26000000000000001 110.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 105' ' ' ASN . 54.9 t -156.5 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 0.33000000000000002 110.0 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.7 m-85 -92.37 114.22 61.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.65000000000000002 109.949 179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.461 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 44.9 Cg_endo -72.18 67.45 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.877 1.461 . . . . 0.83999999999999997 110.672 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.496 ' C ' ' CD1' ' A' ' 230' ' ' LEU . 1.2 mtt180 -148.64 95.14 2.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.93000000000000005 110.153 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.481 ' HA ' HD23 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -171.63 -60.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.45 -0.781 . . . . 1.03 109.727 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.499 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 6.3 tp 39.41 30.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 1.04 111.178 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' HD3' ' CD2' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -118.4 88.75 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.023 . . . . 0.77000000000000002 109.776 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.595 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 13.4 t90 -153.52 -65.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.41999999999999998 111.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.518 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 17.8 t -105.02 59.97 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.44 111.207 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 114' ' ' SER . 10.9 mmtm -154.57 53.45 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.035 -1.041 . . . . 0.48999999999999999 110.379 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.476 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 59.2 ttp -72.97 -15.67 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.29999999999999999 110.393 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 15.3 p-10 -142.78 140.42 31.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.14999999999999999 110.416 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.454 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 12.8 tp -158.23 166.39 32.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.379 -0.826 . . . . 0.13 109.841 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.5 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.6 OUTLIER -107.57 162.94 13.5 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -0.983 . . . . 0.12 110.081 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.581 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 36.5 p90 -157.63 164.02 37.65 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.376 -0.93 . . . . 0.33000000000000002 110.887 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.24 146.46 45.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.422 -0.799 . . . . 0.54000000000000004 110.301 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.615 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 4.2 pt -106.31 117.46 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.33000000000000002 110.574 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.525 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 2.9 m -162.82 42.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.27000000000000002 110.04 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 11.3 t-20 -40.63 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.79 -0.764 . . . . 0.40999999999999998 109.311 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.57 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 7.8 t80 -178.92 178.46 0.76 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.409 -0.807 . . . . 0.40000000000000002 109.78 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.544 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -130.56 51.08 6.9 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.45000000000000001 110.126 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.57 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 46.7 Cg_endo -75.85 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.125 1.592 . . . . 0.35999999999999999 110.639 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -99.58 -2.09 36.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.25 109.938 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.559 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -110.47 168.76 9.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -0.8 . . . . 0.39000000000000001 109.879 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.48 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -116.97 169.08 9.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.47999999999999998 110.25 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -43.28 -32.96 0.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.40000000000000002 109.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.9 m -67.98 -47.93 67.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.46000000000000002 109.84 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.559 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 9.5 mp0 -63.07 -58.83 5.95 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.137 -0.977 . . . . 0.46999999999999997 109.745 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.451 ' C ' ' O ' ' A' ' 133' ' ' GLU . 10.9 t -45.68 -36.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.042 -1.096 . . . . 0.31 108.042 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.468 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.4 tt0 -57.84 -42.06 83.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.096 -1.076 . . . . 0.47999999999999998 108.096 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 5.9 tttt -72.53 -51.1 21.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.448 -0.901 . . . . 0.64000000000000001 108.732 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.67 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -44.92 -60.08 2.24 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.137 -0.977 . . . . 0.41999999999999998 110.223 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.628 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -67.47 -52.82 34.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.34000000000000002 110.974 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.07 -71.67 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.931 -1.105 . . . . 0.46999999999999997 110.159 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtp? -39.49 -61.29 0.82 Allowed 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.809 -0.557 . . . . 0.46999999999999997 110.508 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.41 -37.16 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.693 -1.254 . . . . 0.25 108.305 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.2 -36.67 74.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.743 -0.836 . . . . 0.34999999999999998 108.743 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttmm -58.03 -41.39 83.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.228 -0.92 . . . . 0.69999999999999996 108.923 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.79 -48.42 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.592 -0.692 . . . . 0.60999999999999999 109.4 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.609 ' CH2' HG13 ' A' ' 262' ' ' ILE . 57.0 t-105 -55.01 -38.05 67.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.39000000000000001 109.157 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.492 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -73.5 -34.0 65.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.305 -0.872 . . . . 0.34999999999999998 108.936 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -44.18 89.45 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.35999999999999999 109.251 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.531 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 26.9 m -72.93 -32.2 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.634 -0.826 . . . . 0.5 109.753 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.503 ' N ' HG23 ' A' ' 148' ' ' VAL . 15.3 t -152.0 134.18 8.54 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.51000000000000001 110.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.29 59.83 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.951 1.501 . . . . 0.31 110.158 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -76.72 136.04 39.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.17999999999999999 110.414 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.43 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -82.35 120.45 25.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.17000000000000001 109.92 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.558 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.5 p90 -131.6 133.99 45.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 0.14000000000000001 110.521 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.481 ' O ' ' CG2' ' A' ' 119' ' ' THR . 6.3 m -140.02 128.9 23.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.364 -0.835 . . . . 0.14999999999999999 110.11 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.569 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -96.67 81.85 3.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.20000000000000001 109.972 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.423 HD11 HG21 ' A' ' 154' ' ' THR . 0.2 OUTLIER -82.26 89.1 6.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.094 -1.004 . . . . 0.22 110.109 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.465 ' CD2' ' N ' ' A' ' 158' ' ' ASP . 5.1 p-80 -48.45 -24.43 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.32000000000000001 109.963 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.465 ' N ' ' CD2' ' A' ' 157' ' ' HIS . 3.0 t70 -42.29 -27.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.497 -0.752 . . . . 0.33000000000000002 109.811 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 124.55 26.33 1.46 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.72 -1.352 . . . . 0.28000000000000003 109.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.5 ' O ' ' CB ' ' A' ' 119' ' ' THR . 51.7 mt -119.85 70.93 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -1.215 . . . . 0.29999999999999999 109.725 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -124.35 143.48 50.56 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.15 -0.62 . . . . 0.20000000000000001 110.598 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -108.1 -43.78 4.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.10000000000000001 109.965 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -119.86 156.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.259 -0.901 . . . . 0.10000000000000001 109.84 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.529 ' O ' ' CB ' ' A' ' 199' ' ' ALA . 3.1 ptt? -156.85 153.01 27.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.515 -1.365 . . . . 0.11 111.602 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.556 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 4.1 tt -101.24 116.69 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.10000000000000001 109.316 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.498 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 12.9 p -162.64 148.64 12.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.578 -1.326 . . . . 0.10000000000000001 111.364 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.571 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.3 p90 -67.79 117.15 9.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -0.823 . . . . 0.089999999999999997 109.411 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -75.38 142.76 29.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.91 -0.876 . . . . 0.20000000000000001 110.91 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.595 ' N ' ' CD1' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -134.54 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.754 -0.851 . . . . 0.55000000000000004 109.124 178.959 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 11.7 tmtt? 1.08 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.375 0.607 . . . . 0.84999999999999998 112.428 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' HG2' ' O ' ' A' ' 171' ' ' GLU . 14.3 tt0 -146.16 23.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.326 -0.859 . . . . 0.70999999999999996 110.11 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.433 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 12.1 m170 -96.89 -67.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.41999999999999998 110.267 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 124.6 5.96 6.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.649 -1.38 . . . . 0.33000000000000002 109.649 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -121.51 -82.62 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -1.226 . . . . 0.33000000000000002 110.217 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.46 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 65.3 m-85 -102.48 154.6 18.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.27000000000000002 110.016 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.2 m-30 -96.56 105.74 24.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.34000000000000002 110.039 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.469 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 43.7 Cg_endo -73.17 -66.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.929 1.489 . . . . 0.46999999999999997 110.823 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.565 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -49.47 135.39 18.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.34999999999999998 110.634 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.488 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 7.6 p30 179.56 83.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.241 -0.912 . . . . 0.20000000000000001 110.398 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.491 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 41.47 -156.59 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.688 -1.365 . . . . 0.25 109.688 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.6 Cg_endo -76.45 6.35 4.07 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.123 1.591 . . . . 0.44 110.308 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.474 ' O ' ' O ' ' A' ' 181' ' ' PRO . 1.5 t -41.06 165.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.56999999999999995 110.738 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.534 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.62 76.18 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.536 -1.025 . . . . 0.48999999999999999 110.536 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.543 ' HG ' ' CG1' ' A' ' 1' ' ' HAV . 3.3 tt 179.78 89.28 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.358 -1.084 . . . . 0.40999999999999998 110.058 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.581 HD12 ' CZ ' ' A' ' 214' ' ' TYR . 1.3 tt -106.2 -21.66 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.787 -1.196 . . . . 0.29999999999999999 111.533 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.619 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.59 108.86 3.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.473 -1.392 . . . . 0.20000000000000001 112.247 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.1 OUTLIER -106.48 125.74 51.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 0.16 109.73 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.544 ' N ' ' OE2' ' A' ' 223' ' ' GLU . . . -115.54 150.62 36.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.16 -0.963 . . . . 0.23000000000000001 110.613 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.433 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.6 m-30 -107.53 165.33 12.99 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.937 . . . . 0.38 110.471 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 43.4 Cg_endo -71.18 137.81 32.11 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.012 1.532 . . . . 0.40000000000000002 109.901 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.499 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 41.2 Cg_endo -67.53 74.5 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.041 1.548 . . . . 0.32000000000000001 110.807 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.62 -92.66 1.97 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.913 -1.675 . . . . 0.32000000000000001 108.913 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.37 -159.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.001 1.527 . . . . 0.46999999999999997 110.17 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.32 2.63 12.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.63 110.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 15.71 19.66 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.287 -0.883 . . . . 0.53000000000000003 110.094 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -86.55 167.0 38.42 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.438 -1.465 . . . . 0.25 109.438 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.536 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 45.93 24.23 1.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.354 -1.499 . . . . 0.10000000000000001 109.354 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.76 93.83 3.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.208 . . . . 0.10000000000000001 110.192 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.529 ' CB ' ' O ' ' A' ' 164' ' ' MET . . . -75.74 105.13 6.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.089999999999999997 109.925 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.47 ' HA ' ' O ' ' A' ' 166' ' ' SER . 10.3 m170 -119.24 122.18 41.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.089999999999999997 110.237 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 203' ' ' ASP . 29.7 m-85 -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.10000000000000001 110.455 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.543 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.9 OUTLIER -48.78 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.282 -0.886 . . . . 0.14000000000000001 108.789 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -36.33 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.901 -0.72 . . . . 0.17999999999999999 111.694 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 202' ' ' ASP . 66.2 m-20 -77.62 2.08 17.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.812 -1.18 . . . . 0.23999999999999999 111.075 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 202' ' ' ASP . 28.6 mm-40 -97.32 -170.78 2.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.997 -1.065 . . . . 0.41999999999999998 110.548 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.414 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 96.5 m -121.37 146.52 46.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.46999999999999997 110.367 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.503 ' C ' ' CG2' ' A' ' 208' ' ' THR . 0.9 OUTLIER -145.05 145.42 31.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.887 . . . . 0.27000000000000002 109.663 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.54 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -163.7 -177.97 5.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 111.159 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.478 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -125.54 30.26 5.8 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.72 0.772 . . . . 0.60999999999999999 108.999 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -126.93 -175.69 3.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.569 -0.707 . . . . 0.78000000000000003 110.375 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.475 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -82.38 61.32 5.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.91000000000000003 110.135 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.455 ' O ' ' HG3' ' A' ' 212' ' ' LYS . 3.5 pttt -170.0 106.26 0.34 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.957 . . . . 0.93000000000000005 110.157 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 96.16 -162.47 22.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.363 -1.495 . . . . 0.79000000000000004 109.363 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.581 ' CZ ' HD12 ' A' ' 185' ' ' LEU . 83.7 m-85 -81.56 127.33 32.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -1.18 . . . . 0.68999999999999995 109.986 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.509 ' O ' ' N ' ' A' ' 218' ' ' LEU . 16.5 m-80 -89.25 119.25 29.57 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.095 -1.003 . . . . 0.40000000000000002 108.939 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.67 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.6 OUTLIER -41.39 -36.59 0.86 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.515 -0.874 . . . . 0.17000000000000001 110.214 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 5.0 m-85 -52.55 -47.04 67.01 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.468 -1.308 . . . . 0.28000000000000003 107.468 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.557 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 11.5 tp -78.5 -72.1 0.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.617 -0.72 . . . . 0.46000000000000002 110.835 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.558 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -46.8 -61.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.936 -1.103 . . . . 0.39000000000000001 110.23 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -54.35 -52.86 60.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.17000000000000001 111.207 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -54.79 -29.48 54.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.352 -1.467 . . . . 0.10000000000000001 109.043 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.596 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.0 t60 -77.17 -52.21 9.65 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.423 0.63 . . . . 0.20999999999999999 109.895 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.544 ' OE2' ' N ' ' A' ' 188' ' ' ALA . 19.0 tp10 -58.38 -53.87 53.39 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.28000000000000003 109.01 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.564 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 2.4 m-85 -53.99 -46.61 71.77 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.304 -0.872 . . . . 0.17999999999999999 108.84 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.404 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -49.83 -31.85 17.3 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.315 -1.914 . . . . 0.20999999999999999 108.315 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.532 ' NE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -86.54 -68.38 0.75 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.385 -1.068 . . . . 0.17000000000000001 110.402 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.538 ' CA ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -38.74 -39.64 0.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.574 -0.704 . . . . 0.33000000000000002 111.108 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.475 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 4.6 tp -98.19 -34.18 10.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.086 -1.009 . . . . 0.53000000000000003 110.356 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -75.58 -88.85 0.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.107 -1.197 . . . . 0.40999999999999998 110.107 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.5 ' CD2' ' HD3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -177.68 -170.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -1.088 . . . . 0.45000000000000001 110.878 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.521 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -39.23 -64.91 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.556 -0.715 . . . . 0.62 110.823 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.532 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 1.3 m80 -166.92 -177.44 3.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.45000000000000001 110.096 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.49 ' HB3' ' O ' ' A' ' 232' ' ' HIS . 24.1 p 179.92 60.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.768 . . . . 0.38 109.406 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.596 ' CB ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -148.12 26.4 0.98 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.47999999999999998 111.415 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.524 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.6 OUTLIER -34.34 -51.09 0.97 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.38 111.173 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 46.8 Cg_endo -83.94 -49.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.72 1.379 . . . . 0.28000000000000003 111.644 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.34 103.16 0.17 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.193 -1.479 . . . . 0.23999999999999999 111.424 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.596 ' CB ' ' CB ' ' A' ' 234' ' ' LYS . . . -149.84 167.84 25.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.287 -1.125 . . . . 0.28000000000000003 110.532 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -73.3 58.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.326 -0.99 . . . . 0.40000000000000002 108.326 178.586 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.59 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 24.7 mmm -140.42 -34.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.45000000000000001 110.813 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.596 ' CG ' HG23 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -58.11 170.54 0.71 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.047 -1.033 . . . . 0.56999999999999995 110.243 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.534 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.1 Cg_endo -68.72 -7.55 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.544 1.286 . . . . 0.76000000000000001 110.046 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.596 HG23 ' CG ' ' A' ' 241' ' ' PHE . 1.2 tp -98.66 142.48 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 0.89000000000000001 109.57 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.557 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 16.1 p90 -131.93 -21.29 2.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.246 -0.908 . . . . 0.78000000000000003 111.257 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.55 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER 4.25 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 112.999 0.74 . . . . 0.60999999999999999 112.999 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.549 ' CE1' ' O ' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -66.36 115.9 6.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.571 -1.331 . . . . 0.73999999999999999 109.619 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 250' ' ' SER . 0.2 OUTLIER -61.46 174.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.81000000000000005 110.358 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -46.74 -34.28 6.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.822 -1.311 . . . . 0.56000000000000005 109.822 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -148.73 51.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.044 -1.268 . . . . 0.37 110.572 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 247' ' ' THR . 83.6 p -102.07 13.19 35.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.44 109.875 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.445 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 1.7 t60 -173.65 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.53000000000000003 109.959 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.549 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 2.5 t80 179.9 177.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.38 110.193 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.533 ' SD ' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -75.33 48.94 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.891 . . . . 0.19 110.451 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.669 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -44.46 -47.89 26.11 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.17 -1.048 . . . . 0.28000000000000003 108.17 177.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.669 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.7 Cg_endo -72.52 51.04 1.75 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.054 1.555 . . . . 0.48999999999999999 110.662 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.562 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.4 m-20 -53.4 -30.23 38.93 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.118 -0.989 . . . . 0.48999999999999999 109.399 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.56 ' CB ' ' CB ' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -50.59 -42.64 56.04 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.228 -0.92 . . . . 0.31 109.897 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.592 ' N ' ' HB3' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -81.78 -33.46 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.248 -1.019 . . . . 0.14000000000000001 108.248 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 97.0 t -62.26 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.544 -0.862 . . . . 0.17000000000000001 109.727 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.593 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.9 tm0? -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.295 -0.878 . . . . 0.26000000000000001 109.597 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.12 -65.29 1.29 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.19 109.919 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.609 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -78.35 -20.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.22 110.615 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.593 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 1.7 tm0? -66.25 -21.15 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.839 -1.144 . . . . 0.39000000000000001 108.513 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t -104.11 -42.54 5.51 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.383 0.611 . . . . 0.46999999999999997 110.897 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.448 HD13 ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -79.18 -48.42 14.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.47999999999999998 111.254 -178.753 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.475 ' HB3' HD22 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -84.55 -7.46 59.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.40999999999999998 110.542 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.476 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -50.73 -98.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.001 -1.64 . . . . 0.46000000000000002 109.001 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.65 133.89 13.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.839 1.442 . . . . 0.57999999999999996 110.037 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.466 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -94.7 161.06 23.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.484 -1.446 . . . . 0.64000000000000001 109.484 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.595 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -112.15 -62.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -1.207 . . . . 0.94999999999999996 110.134 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.518 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 81.4 tt0 46.46 29.32 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 1.2 110.177 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.79 114.21 11.01 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 1.2 110.18 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.89 75.3 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.937 1.493 . . . . 1.0600000000000001 110.333 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.997 -1.001 . . . . 0.78000000000000003 110.211 -179.986 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.592 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.551 ' HB1' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.619 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.2 t80 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.338 0.59 . . . . 0.40999999999999998 110.216 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -133.73 120.81 21.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.26000000000000001 110.046 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.523 HG11 ' CD1' ' A' ' 107' ' ' PHE . 79.0 t -135.34 -89.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.943 . . . . 0.33000000000000002 110.468 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.523 ' CD1' HG11 ' A' ' 106' ' ' VAL . 8.5 m-30 -101.77 101.0 16.01 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.65000000000000002 110.234 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.51 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 48.7 Cg_endo -75.32 -158.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.974 1.512 . . . . 0.83999999999999997 110.557 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.51 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER 70.94 82.65 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 0.93000000000000005 110.677 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.53 ' CA ' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -149.15 -64.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.556 -0.715 . . . . 1.03 109.337 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.466 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 36.3 40.08 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.694 -0.629 . . . . 1.04 111.545 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.521 ' HD3' ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -126.85 81.94 2.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.77000000000000002 109.496 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.601 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 15.6 t90 -151.64 -70.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.134 -0.979 . . . . 0.41999999999999998 111.16 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 13.2 p -102.4 77.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.44 111.098 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -169.31 51.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.48999999999999999 110.326 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 5.6 ttt -85.37 -13.38 49.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.29999999999999999 110.42 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.467 ' O ' HD12 ' A' ' 118' ' ' LEU . 6.5 p-10 -143.96 109.62 5.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.208 -0.933 . . . . 0.14999999999999999 110.043 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.522 HD22 ' CB ' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -138.24 -168.4 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.13 110.658 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.51 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -130.59 176.95 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.12 110.321 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.601 ' CZ ' ' HG3' ' A' ' 155' ' ' ARG . 36.7 p90 -174.43 -169.24 0.43 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.27 -0.894 . . . . 0.33000000000000002 110.918 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.423 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -127.87 156.46 42.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.54000000000000004 110.037 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.633 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 2.7 pt -122.77 95.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.33000000000000002 110.436 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.54 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 4.2 m -149.9 56.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.982 . . . . 0.27000000000000002 110.812 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.504 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 1.0 OUTLIER -44.34 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.40999999999999998 109.306 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 167' ' ' PHE . 11.9 t80 -178.69 -173.95 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.40000000000000002 109.69 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.514 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 2.6 m -136.35 53.89 8.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.45000000000000001 110.774 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.514 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -78.26 -86.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.981 1.517 . . . . 0.35999999999999999 109.922 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.47 0.04 41.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.895 . . . . 0.25 109.699 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.541 ' CE ' HG21 ' A' ' 134' ' ' VAL . 2.6 ptm -121.77 147.99 45.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 0.39000000000000001 109.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -92.78 169.36 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.47999999999999998 110.118 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' THR . 11.2 t-160 -43.51 -33.64 1.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.40000000000000002 109.622 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 2.5 m -57.98 -54.6 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.46000000000000002 109.23 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.52 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.6 OUTLIER -58.1 -54.35 47.99 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.542 -0.863 . . . . 0.46999999999999997 108.913 179.04 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.541 HG21 ' CE ' ' A' ' 129' ' ' MET . 10.5 t -45.25 -34.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.169 -1.049 . . . . 0.31 108.169 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.485 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -63.44 -41.58 98.67 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.435 -0.95 . . . . 0.47999999999999998 108.435 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.586 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 2.6 ttmt -70.5 -49.54 47.33 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.922 0.868 . . . . 0.64000000000000001 108.999 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.64 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -44.77 -59.6 2.44 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 121.149 -0.969 . . . . 0.41999999999999998 110.206 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.633 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.54 -53.59 33.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.34000000000000002 110.775 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.12 -72.69 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.994 -1.067 . . . . 0.46999999999999997 110.167 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.527 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -38.47 -61.89 0.65 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.85 -0.531 . . . . 0.46999999999999997 110.427 178.74 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.23 -38.86 12.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.678 -1.264 . . . . 0.25 108.413 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.3 OUTLIER -69.43 -31.92 70.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.34999999999999998 109.063 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -61.29 -43.85 98.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.208 -0.933 . . . . 0.69999999999999996 108.699 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.401 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 7.5 t -69.58 -46.56 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.915 -0.772 . . . . 0.60999999999999999 108.915 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.597 ' CH2' HG13 ' A' ' 262' ' ' ILE . 53.9 t-105 -54.72 -37.1 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.485 -0.76 . . . . 0.39000000000000001 109.012 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 149' ' ' THR . 56.5 m -74.93 -33.17 61.93 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.915 . . . . 0.34999999999999998 108.711 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.401 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.9 OUTLIER -57.85 -43.12 85.68 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.094 -0.706 . . . . 0.35999999999999999 109.094 179.026 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.523 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 29.5 m -74.64 -33.98 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.438 -0.789 . . . . 0.5 109.903 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.501 ' N ' HG21 ' A' ' 148' ' ' VAL . 13.1 t -148.3 129.46 7.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -0.982 . . . . 0.51000000000000001 110.216 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.43 59.17 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.968 1.51 . . . . 0.31 110.582 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.49 HD23 ' CD1' ' A' ' 266' ' ' TYR . 11.6 mt -80.25 171.31 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.17999999999999999 110.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -122.79 136.64 54.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.17000000000000001 110.463 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.422 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 6.8 p90 -154.91 145.02 21.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.14000000000000001 110.316 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.483 ' O ' ' CG2' ' A' ' 119' ' ' THR . 2.8 m -143.99 142.95 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.14999999999999999 110.14 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.601 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -93.74 86.51 5.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.20000000000000001 110.12 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.521 ' CD1' ' HB3' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -92.62 85.14 5.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.22 110.419 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 159' ' ' GLY . 45.5 p-80 -56.88 -19.12 15.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.32000000000000001 109.873 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.521 ' HB3' ' CD1' ' A' ' 156' ' ' LEU . 2.4 t0 -43.4 -26.14 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.494 -0.754 . . . . 0.33000000000000002 109.776 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.75 21.87 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.95 -1.26 . . . . 0.28000000000000003 109.95 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.51 ' O ' ' CB ' ' A' ' 119' ' ' THR . 14.8 mt -125.63 64.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.035 -1.273 . . . . 0.29999999999999999 109.274 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.468 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -115.86 137.0 52.51 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.254 -0.579 . . . . 0.20000000000000001 110.594 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.522 ' CB ' HD22 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -101.34 -51.79 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.10000000000000001 110.034 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 3.1 pt -120.01 -177.33 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.10000000000000001 109.229 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.473 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.1 ptp -174.88 139.54 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.5 -1.375 . . . . 0.11 111.836 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -90.35 118.71 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.10000000000000001 109.443 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.54 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 29.5 p -169.83 162.45 9.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.722 -1.236 . . . . 0.10000000000000001 111.291 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.594 ' CD1' ' O ' ' A' ' 167' ' ' PHE . 0.1 OUTLIER -75.19 150.46 38.67 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.471 -0.768 . . . . 0.089999999999999997 109.24 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.474 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -111.9 131.59 10.32 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.754 -1.212 . . . . 0.20000000000000001 110.986 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.594 ' O ' ' C ' ' A' ' 170' ' ' LYS . 12.4 pt -125.74 101.31 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.629 -0.924 . . . . 0.55000000000000004 109.358 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.594 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 2.08 78.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.462 0.649 . . . . 0.84999999999999998 112.202 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -4.48 10.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.70999999999999996 110.135 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 9.1 m-70 -83.94 -153.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.923 . . . . 0.41999999999999998 110.186 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.4 36.64 1.7 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.244 -1.542 . . . . 0.33000000000000002 109.244 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' PHE . 15.0 p-10 -140.87 -146.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -1.093 . . . . 0.33000000000000002 110.205 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 174' ' ' ASP . 28.5 m-85 -45.84 169.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.27000000000000002 110.046 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -86.31 127.12 62.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.34000000000000002 110.43 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.53 ' CG ' ' HA ' ' A' ' 170' ' ' LYS . 44.6 Cg_endo -79.01 -79.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.885 1.466 . . . . 0.46999999999999997 110.497 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.568 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.2 p90 -58.91 149.83 25.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.34999999999999998 110.307 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.483 ' OD2' ' O ' ' A' ' 177' ' ' PRO . 1.6 p30 178.89 78.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.20000000000000001 110.491 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.535 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 42.63 -160.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.522 -1.431 . . . . 0.25 109.522 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.468 ' O ' ' O ' ' A' ' 182' ' ' SER . 52.0 Cg_endo -78.23 9.34 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.019 1.537 . . . . 0.44 110.483 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 181' ' ' PRO . 40.5 m -46.9 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.56999999999999995 110.575 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.553 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.87 74.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 111.149 -0.78 . . . . 0.48999999999999999 111.149 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.524 ' HB2' ' O ' ' A' ' 183' ' ' GLY . 4.0 tt 179.56 90.45 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.22 -1.164 . . . . 0.40999999999999998 110.379 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.504 ' HB3' ' OB2' ' A' ' 3' ' ' MSB . 6.3 tt -109.18 -21.48 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.29999999999999999 111.179 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.655 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.1 105.56 3.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.665 -1.272 . . . . 0.20000000000000001 111.775 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -107.08 122.54 46.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.16 109.632 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.55 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -114.64 134.07 55.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.23000000000000001 110.399 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.448 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.1 m-30 -79.63 174.78 5.56 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.38 110.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.495 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.6 Cg_endo -72.77 130.72 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.089 1.573 . . . . 0.40000000000000002 109.458 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.4 Cg_endo -71.22 77.28 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.95 1.5 . . . . 0.32000000000000001 110.457 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.13 -90.01 0.51 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.686 -1.245 . . . . 0.32000000000000001 110.217 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.5 -179.98 4.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.46999999999999997 111.014 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -58.92 -14.83 10.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.815 . . . . 0.63 110.133 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.97 53.3 0.7 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.538 0.685 . . . . 0.53000000000000003 109.937 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.495 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -133.97 -178.52 15.67 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.392 -1.483 . . . . 0.25 109.392 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.554 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 43.56 26.14 0.64 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.67 -1.372 . . . . 0.10000000000000001 109.67 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 196' ' ' GLY . 3.7 m-20 -79.28 87.95 4.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.10000000000000001 110.22 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.473 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.66 97.1 1.67 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.089999999999999997 110.027 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.507 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 52.3 m170 -112.97 134.19 54.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.089999999999999997 110.69 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.7 m-85 -101.1 135.92 41.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.905 . . . . 0.10000000000000001 110.296 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.537 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.3 OUTLIER -46.58 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.265 -1.013 . . . . 0.14000000000000001 108.265 178.762 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.09 -26.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.827 -0.749 . . . . 0.17999999999999999 111.826 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.537 ' N ' ' O ' ' A' ' 202' ' ' ASP . 1.0 OUTLIER -78.06 3.59 14.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.499 -1.376 . . . . 0.23999999999999999 110.749 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 202' ' ' ASP . 21.6 mm-40 -100.27 -174.55 2.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.008 -1.058 . . . . 0.41999999999999998 110.107 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 144.27 47.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.46999999999999997 110.439 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.487 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -141.4 134.11 28.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.27000000000000002 109.488 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.492 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -142.34 171.12 14.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.062 . . . . 0.29999999999999999 110.508 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.456 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -129.24 25.95 5.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.573 -0.899 . . . . 0.60999999999999999 108.573 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -69.3 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.78000000000000003 110.357 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.583 -0.698 . . . . 0.91000000000000003 109.518 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -95.8 157.86 15.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.449 -0.782 . . . . 0.93000000000000005 110.022 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.25 -174.55 37.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.101 -1.6 . . . . 0.79000000000000004 109.101 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . . . . . . . . . 83.9 m-85 -67.31 114.96 6.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -1.228 . . . . 0.68999999999999995 109.902 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.494 ' O ' ' N ' ' A' ' 218' ' ' LEU . 45.5 m-80 -84.37 120.33 26.14 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.985 -1.072 . . . . 0.40000000000000002 109.001 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.64 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -41.18 -36.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.17000000000000001 110.397 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.586 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 3.9 m-85 -52.4 -47.64 66.13 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.279 -1.378 . . . . 0.28000000000000003 107.279 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.537 ' CD1' ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.16 -73.04 0.29 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.812 -0.631 . . . . 0.46000000000000002 110.422 178.581 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.558 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.2 -62.78 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.136 -0.978 . . . . 0.39000000000000001 110.566 -179.491 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -51.81 -50.69 60.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.026 -1.047 . . . . 0.17000000000000001 111.263 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.9 -37.52 76.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.342 -1.474 . . . . 0.10000000000000001 108.829 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.582 ' CG ' ' HE1' ' A' ' 3' ' ' MSB . 6.6 t60 -63.68 -59.29 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.197 0.522 . . . . 0.20999999999999999 109.606 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.489 ' O ' ' OG ' ' A' ' 227' ' ' SER . 3.0 tp10 -54.3 -39.44 66.97 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.252 -1.018 . . . . 0.28000000000000003 108.252 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.2 m-30 -56.33 -61.32 2.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.435 -0.79 . . . . 0.17999999999999999 109.057 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -45.07 -30.39 2.55 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.669 -1.772 . . . . 0.20999999999999999 108.669 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 1.6 m80 -81.36 -78.27 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -1.156 . . . . 0.17000000000000001 111.115 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.554 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -37.9 -37.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.584 -0.697 . . . . 0.33000000000000002 112.47 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.47 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 11.5 tp -100.6 -36.72 9.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.717 -1.239 . . . . 0.53000000000000003 111.278 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -75.82 -86.88 0.31 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.171 -1.172 . . . . 0.40999999999999998 110.171 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.53 HD11 ' CA ' ' A' ' 110' ' ' THR . 0.5 OUTLIER -172.57 -170.18 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -1.154 . . . . 0.45000000000000001 110.661 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.509 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.2 t0 -43.08 -60.79 1.51 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.62 110.77 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.513 ' CD2' ' HE3' ' A' ' 234' ' ' LYS . 0.8 OUTLIER -166.97 -175.56 3.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.45000000000000001 110.359 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.445 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER 179.59 61.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.488 -0.758 . . . . 0.38 109.698 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.587 ' CB ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.79 23.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.47999999999999998 111.26 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.532 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -34.51 -47.43 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.647 . . . . 0.38 110.926 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.532 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 41.2 Cg_endo -90.78 -45.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.82 1.432 . . . . 0.28000000000000003 111.987 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.31 102.02 0.15 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 118.829 -1.653 . . . . 0.23999999999999999 111.991 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.589 ' HB1' ' N ' ' A' ' 258' ' ' ASP . . . -150.46 166.47 30.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.334 -1.098 . . . . 0.28000000000000003 110.257 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.574 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.3 53.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.972 . . . . 0.40000000000000002 109.21 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.565 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 5.2 mtt -137.3 -30.63 0.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.45000000000000001 110.372 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -47.49 171.27 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 0.56999999999999995 110.6 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -70.29 -2.83 11.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.511 1.269 . . . . 0.76000000000000001 110.454 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 6.4 tt -110.66 153.93 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.89000000000000001 109.919 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.547 ' O ' ' N ' ' A' ' 246' ' ' TYR . 32.5 p90 -128.35 -20.61 3.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.78000000000000003 110.935 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.51 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.6 OUTLIER 2.75 -67.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.717 1.006 . . . . 0.60999999999999999 113.717 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.547 ' N ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER -72.56 119.57 16.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.339 -1.476 . . . . 0.73999999999999999 109.833 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 250' ' ' SER . 21.6 p -63.12 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.81 . . . . 0.81000000000000005 110.424 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.84 -20.64 57.57 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.722 -1.351 . . . . 0.56000000000000005 109.722 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -158.07 40.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -1.226 . . . . 0.37 110.507 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 247' ' ' THR . 4.6 m -63.79 -13.0 40.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.44 109.781 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.455 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.2 OUTLIER -171.13 -48.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.53000000000000003 110.329 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.572 ' CD2' ' HG2' ' A' ' 253' ' ' MET . 4.7 t80 -179.1 178.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.38 110.777 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.572 ' HG2' ' CD2' ' A' ' 252' ' ' PHE . 6.8 ptp -68.14 55.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.424 -0.797 . . . . 0.19 110.263 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.638 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -44.11 -47.97 23.25 Favored Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 108.021 -1.103 . . . . 0.28000000000000003 108.021 177.605 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.638 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.9 Cg_endo -74.31 50.53 2.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.129 1.594 . . . . 0.48999999999999999 110.698 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.538 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.1 m-20 -50.87 -32.27 19.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.069 -1.019 . . . . 0.48999999999999999 110.008 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.553 ' O ' ' HA3' ' A' ' 261' ' ' GLY . 51.8 m-20 -54.17 -46.47 72.35 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.24 -0.984 . . . . 0.31 109.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.589 ' N ' ' HB1' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -72.96 -36.32 67.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.491 -0.929 . . . . 0.14000000000000001 108.491 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.538 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 74.1 t -63.88 -82.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.17000000000000001 110.266 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.542 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.3 tp60 -56.62 -43.09 79.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.276 -0.89 . . . . 0.26000000000000001 109.495 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.76 -69.86 0.45 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.496 -1.042 . . . . 0.19 110.496 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.597 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -72.86 -22.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.777 -1.425 . . . . 0.22 110.032 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.542 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 6.0 tt0 -59.98 -23.17 63.4 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.98 -1.088 . . . . 0.39000000000000001 108.208 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.1 t -103.6 -43.0 5.49 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.406 0.622 . . . . 0.46999999999999997 110.913 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.52 ' CB ' ' HG2' ' A' ' 112' ' ' LYS . 54.7 mt -75.31 -52.49 10.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.47999999999999998 111.187 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.49 ' CD1' HD23 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -82.61 -1.36 50.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.40999999999999998 109.959 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.31 -108.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.226 -1.55 . . . . 0.46000000000000002 109.226 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.453 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.6 Cg_endo -75.91 84.29 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.702 1.369 . . . . 0.57999999999999996 110.223 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.69 174.48 1.06 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.64000000000000001 109.48 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.601 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -115.6 -69.01 0.88 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.94999999999999996 110.117 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.515 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 28.7 tt0 41.93 37.96 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.401 -0.812 . . . . 1.2 110.259 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.455 ' OD1' ' OD2' ' A' ' 270' ' ' ASP . 8.3 p-10 -131.35 94.44 26.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 1.2 110.546 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -74.35 56.03 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.918 1.483 . . . . 1.0600000000000001 110.252 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.997 -1.002 . . . . 0.78000000000000003 110.16 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.557 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.585 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.655 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.231 0.539 . . . . 0.40999999999999998 110.242 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 105' ' ' ASN . 18.7 p30 -145.14 140.85 28.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.26000000000000001 110.183 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.81 -37.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.33000000000000002 110.253 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -130.71 146.38 61.69 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.65000000000000002 110.264 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.451 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.2 Cg_endo -73.44 -160.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.83999999999999997 110.418 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.451 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 56.7 mtt180 58.72 66.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.336 -0.852 . . . . 0.93000000000000005 110.309 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.484 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.7 OUTLIER -141.91 -61.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 1.03 110.189 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.513 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 39.49 27.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 1.04 110.88 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -114.94 72.76 0.8 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.0 . . . . 0.77000000000000002 109.781 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.612 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.0 t90 -143.85 -65.09 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.41999999999999998 110.474 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.475 ' OG ' ' HB2' ' A' ' 271' ' ' GLU . 13.4 t -103.06 60.31 0.78 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.44 110.537 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 3.8 mmtp -146.01 85.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.146 -0.971 . . . . 0.48999999999999999 110.302 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.406 ' O ' ' HB2' ' A' ' 152' ' ' ASN . 34.1 ttp -112.99 -20.78 11.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.29999999999999999 110.28 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 11.3 p30 -144.97 129.48 17.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.169 -0.957 . . . . 0.14999999999999999 110.106 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.4 OUTLIER -152.32 -175.73 5.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.13 110.662 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.508 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 1.0 OUTLIER -126.39 155.44 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 0.12 109.992 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.631 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 46.1 p90 -148.61 159.46 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.33000000000000002 110.776 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.502 ' HG3' ' N ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -116.9 151.33 36.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.51 -0.744 . . . . 0.54000000000000004 109.873 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.624 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 2.0 pp -113.51 115.19 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.33000000000000002 110.983 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.6 m -160.56 41.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.313 -0.867 . . . . 0.27000000000000002 110.19 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 2.3 t-20 -40.78 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.40999999999999998 109.491 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.559 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 2.7 t80 -179.39 -163.45 0.05 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.43 -0.794 . . . . 0.40000000000000002 109.57 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -152.84 47.87 0.41 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.063 -1.023 . . . . 0.45000000000000001 110.436 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -73.73 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.956 1.503 . . . . 0.35999999999999999 110.311 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.95 -5.21 56.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.25 109.755 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.525 ' HB2' ' HB2' ' A' ' 133' ' ' GLU . 0.6 OUTLIER -115.96 172.07 7.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.39000000000000001 110.068 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.7 177.67 5.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.47999999999999998 109.993 179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.461 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 4.7 t60 -45.53 -36.92 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.40000000000000002 110.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.456 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 5.7 t -63.59 -50.58 68.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.46000000000000002 109.595 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.525 ' HB2' ' HB2' ' A' ' 129' ' ' MET . 51.9 mp0 -59.87 -62.74 1.65 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.255 -0.903 . . . . 0.46999999999999997 109.378 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.505 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 13.1 t -44.02 -37.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.478 -0.934 . . . . 0.31 108.478 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.517 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.77 -42.04 78.69 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.319 -0.993 . . . . 0.47999999999999998 108.319 178.448 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.594 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 42.2 tttt -74.69 -47.52 31.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.005 0.907 . . . . 0.64000000000000001 108.577 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.677 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -47.64 -60.71 2.36 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.333 -0.854 . . . . 0.41999999999999998 110.001 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -68.25 -51.36 46.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.34000000000000002 111.095 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.54 -72.1 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.963 -1.086 . . . . 0.46999999999999997 110.277 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -40.95 -59.33 1.47 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.693 -0.629 . . . . 0.46999999999999997 110.437 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.86 -37.16 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.691 -1.256 . . . . 0.25 108.012 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -69.85 -40.74 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.499 -0.751 . . . . 0.34999999999999998 109.02 178.559 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -52.67 -37.47 58.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.06 -1.025 . . . . 0.69999999999999996 108.565 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.413 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 89.0 t -72.75 -45.17 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.351 0.596 . . . . 0.60999999999999999 109.572 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.597 ' CH2' HG13 ' A' ' 262' ' ' ILE . 26.1 t-105 -58.72 -44.37 90.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.39000000000000001 109.333 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 149' ' ' THR . 58.8 m -69.11 -33.4 73.43 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.137 -0.977 . . . . 0.34999999999999998 108.745 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -56.12 -44.92 79.61 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.35999999999999999 109.302 179.17 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.548 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.2 m -76.24 -30.83 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.5 109.778 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.513 HG21 ' CD1' ' A' ' 151' ' ' LEU . 12.7 t -151.8 114.7 2.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.51000000000000001 109.944 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.91 59.96 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.826 1.435 . . . . 0.31 110.52 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.58 HD23 ' CD1' ' A' ' 266' ' ' TYR . 65.7 mt -76.27 165.91 24.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.17999999999999999 110.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.442 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -91.58 128.05 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.17000000000000001 110.147 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.485 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 5.8 p90 -147.41 125.34 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.14000000000000001 110.234 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.47 ' O ' HG21 ' A' ' 119' ' ' THR . 6.0 m -128.59 139.85 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.14999999999999999 110.439 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.631 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -106.5 87.11 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.20000000000000001 109.931 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.471 HD21 ' HB3' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -95.38 89.52 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.22 110.05 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 158' ' ' ASP . 3.4 p-80 -49.12 -23.78 1.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.32000000000000001 109.916 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.471 ' HB3' HD21 ' A' ' 156' ' ' LEU . 3.0 t0 -42.76 -32.77 0.64 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.625 -0.672 . . . . 0.33000000000000002 109.644 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.56 32.79 0.37 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.81 -1.316 . . . . 0.28000000000000003 109.81 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.508 ' O ' ' CB ' ' A' ' 119' ' ' THR . 17.7 mt -126.79 67.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.236 . . . . 0.29999999999999999 109.271 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.479 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -125.76 149.63 48.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.657 -0.652 . . . . 0.20000000000000001 110.906 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.432 ' HB2' HD21 ' A' ' 118' ' ' LEU . 3.7 t70 -113.19 -38.05 4.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.10000000000000001 109.623 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.531 ' CG2' ' HA3' ' A' ' 197' ' ' GLY . 6.6 pt -125.17 172.81 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.10000000000000001 109.382 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.461 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 1.2 ptp -171.88 141.51 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.808 -1.183 . . . . 0.11 111.222 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.575 ' HB ' ' CE2' ' A' ' 224' ' ' PHE . 2.8 tt -93.87 117.23 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.389 -0.819 . . . . 0.10000000000000001 109.563 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.491 ' HB3' HG23 ' A' ' 123' ' ' VAL . 69.4 p -158.53 159.59 35.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.893 -1.129 . . . . 0.10000000000000001 110.489 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.559 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 9.1 p90 -76.63 126.41 30.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.383 -0.823 . . . . 0.089999999999999997 109.709 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.473 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -88.23 117.04 4.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.148 -1.181 . . . . 0.20000000000000001 110.148 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -110.25 103.01 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.67 -0.9 . . . . 0.55000000000000004 109.264 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.579 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.82 81.12 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.329 0.585 . . . . 0.84999999999999998 112.523 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.24 -6.26 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.70999999999999996 110.048 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.464 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 13.1 m-70 -80.75 -86.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.41999999999999998 110.418 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.47 4.11 6.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.526 -1.43 . . . . 0.33000000000000002 109.526 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -113.28 -64.73 1.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.33000000000000002 110.132 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.455 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 18.7 m-85 -112.79 118.14 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.27000000000000002 110.245 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -45.78 104.29 0.39 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.34000000000000002 110.36 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.476 ' O ' HD13 ' A' ' 184' ' ' LEU . 44.4 Cg_endo -74.5 -59.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.925 1.487 . . . . 0.46999999999999997 110.374 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -89.2 161.04 16.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.34999999999999998 109.919 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.463 ' O ' ' OD2' ' A' ' 204' ' ' ASP . 0.9 OUTLIER -173.65 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.20000000000000001 111.206 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.575 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 130.9 -137.23 9.32 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.929 -1.668 . . . . 0.25 108.929 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 182' ' ' SER . 54.0 Cg_endo -72.13 -3.37 13.15 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 O-C-N 124.076 1.566 . . . . 0.44 109.664 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.443 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -50.21 -179.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.358 -0.839 . . . . 0.56999999999999995 110.158 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.534 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -82.88 73.58 2.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.278 -1.129 . . . . 0.48999999999999999 110.278 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.536 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 4.4 tt -179.96 93.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.221 -1.164 . . . . 0.40999999999999998 110.788 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.516 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 3.2 tt -109.55 -15.58 14.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.823 -1.151 . . . . 0.29999999999999999 110.719 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.665 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -153.15 102.81 2.66 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.774 -1.203 . . . . 0.20000000000000001 111.591 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -112.15 119.2 37.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.16 109.789 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.51 ' CB ' ' HB3' ' A' ' 227' ' ' SER . . . -110.11 151.41 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.23000000000000001 110.488 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.415 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.1 m-30 -90.64 165.53 22.41 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.38 110.686 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.7 Cg_endo -73.56 143.03 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.021 1.537 . . . . 0.40000000000000002 109.804 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.513 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -70.5 72.74 1.78 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.896 1.471 . . . . 0.32000000000000001 110.572 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.3 -101.5 2.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.433 -1.467 . . . . 0.32000000000000001 109.433 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.15 -160.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.902 1.475 . . . . 0.46999999999999997 110.28 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -6.97 26.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.993 . . . . 0.63 110.112 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.11 52.08 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.473 -0.767 . . . . 0.53000000000000003 109.772 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -127.68 172.27 18.93 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.409 -1.477 . . . . 0.25 109.409 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.531 ' HA3' ' CG2' ' A' ' 163' ' ' ILE . . . 45.69 24.63 1.25 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.33 -1.508 . . . . 0.10000000000000001 109.33 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.416 ' O ' ' HA ' ' A' ' 188' ' ' ALA . 0.2 OUTLIER -81.47 92.83 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -1.142 . . . . 0.10000000000000001 110.233 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 164' ' ' MET . . . -69.37 98.55 1.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.089999999999999997 110.294 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.43 ' O ' ' OE2' ' A' ' 223' ' ' GLU . 19.2 m170 -102.98 138.14 40.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.089999999999999997 110.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.634 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 17.5 m-85 -107.15 133.16 52.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.10000000000000001 111.284 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.535 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 42.9 t0 -45.55 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.936 -0.764 . . . . 0.14000000000000001 108.936 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 201' ' ' PHE . 0.8 OUTLIER -40.86 -34.16 0.37 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.014 -1.053 . . . . 0.17999999999999999 111.525 -177.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.575 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 48.8 t0 -73.75 0.54 12.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.772 -1.205 . . . . 0.23999999999999999 110.46 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.522 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 10.5 mm-40 -97.42 -161.72 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.123 . . . . 0.41999999999999998 109.903 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.539 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 69.6 m -133.24 153.67 51.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.916 -1.115 . . . . 0.46999999999999997 110.835 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.539 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.8 OUTLIER -148.3 166.47 27.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.308 -0.87 . . . . 0.27000000000000002 109.796 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.529 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.3 OUTLIER -178.81 175.07 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.069 -1.019 . . . . 0.29999999999999999 110.871 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.48 ' OG ' ' O ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -139.01 25.75 2.49 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.565 -0.854 . . . . 0.60999999999999999 109.817 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.2 t -90.66 -88.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 0.78000000000000003 110.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 210' ' ' SER . 35.7 p -158.88 18.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.91000000000000003 110.0 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 213' ' ' GLY . 6.9 ptpt -145.69 -174.11 4.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.93000000000000005 110.133 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 44.34 -168.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.79000000000000004 109.625 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.516 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 97.7 m-85 -70.33 121.56 17.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.68999999999999995 110.195 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.52 ' O ' ' N ' ' A' ' 218' ' ' LEU . 47.7 m-80 -87.31 116.89 25.71 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.159 -0.963 . . . . 0.40000000000000002 109.086 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.677 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -41.17 -35.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.625 -0.83 . . . . 0.17000000000000001 110.332 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.594 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.2 m-85 -52.37 -45.87 65.95 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.405 -1.331 . . . . 0.28000000000000003 107.405 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.575 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 9.7 tp -81.42 -73.16 0.39 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.435 -0.802 . . . . 0.46000000000000002 110.993 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.634 ' CG2' ' CE1' ' A' ' 201' ' ' PHE . 1.6 p -45.5 -56.14 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.39000000000000001 110.325 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -60.5 -48.5 81.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.087 -1.008 . . . . 0.17000000000000001 111.114 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.579 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -56.7 -24.59 50.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.177 -1.577 . . . . 0.10000000000000001 108.406 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.606 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.3 t60 -83.33 -49.87 8.93 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.749 -0.659 . . . . 0.20999999999999999 110.325 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 226' ' ' HIS . 3.0 tp10 -61.69 -44.54 96.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.933 -1.104 . . . . 0.28000000000000003 108.782 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.575 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER -60.23 -62.16 2.07 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.472 -0.768 . . . . 0.17999999999999999 109.026 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.85 -28.86 0.73 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.918 -1.673 . . . . 0.20999999999999999 108.918 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 1.0 OUTLIER -80.91 -68.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -1.134 . . . . 0.17000000000000001 111.084 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.514 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -46.93 -38.41 10.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.51 -0.744 . . . . 0.33000000000000002 112.288 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.527 HD21 ' N ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER -100.13 -37.45 8.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.53000000000000003 110.977 -178.6 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.527 ' N ' HD21 ' A' ' 228' ' ' LEU . . . -74.39 -87.42 0.23 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.963 -1.255 . . . . 0.40999999999999998 109.963 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.572 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.7 OUTLIER -161.96 -176.23 5.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.45000000000000001 110.789 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 2.6 m-20 -55.17 -58.84 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.374 -0.829 . . . . 0.62 110.19 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 231' ' ' ASP . 3.6 m80 -161.6 176.15 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.45000000000000001 110.639 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 2.4 p 179.73 50.69 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.79 -0.818 . . . . 0.38 108.79 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.575 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -125.09 20.21 8.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.537 -0.727 . . . . 0.47999999999999998 110.584 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.568 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -43.12 -53.53 10.54 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 119.443 -0.903 . . . . 0.38 109.831 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.568 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 50.5 Cg_endo -86.05 -47.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.595 1.313 . . . . 0.28000000000000003 110.573 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.23 94.55 0.09 OUTLIER Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.233 -1.46 . . . . 0.23999999999999999 111.589 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.609 ' HB3' ' CB ' ' A' ' 257' ' ' ASP . . . -144.42 162.16 37.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.211 -1.17 . . . . 0.28000000000000003 110.358 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.606 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -77.61 57.73 1.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.40000000000000002 108.72 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.538 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 21.6 mmm -133.14 -35.71 1.03 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.45000000000000001 110.354 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -43.99 169.86 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.152 -0.968 . . . . 0.56999999999999995 110.366 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.486 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.5 Cg_endo -71.85 -8.09 22.35 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.763 1.402 . . . . 0.76000000000000001 109.842 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.591 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 16.1 mt -98.83 146.76 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.89000000000000001 109.699 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.58 ' CB ' ' CH ' ' A' ' 3' ' ' MSB . 36.8 p90 -128.92 -25.97 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.03 -1.044 . . . . 0.78000000000000003 110.976 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.528 HG21 ' CG2' ' A' ' 243' ' ' ILE . 0.2 OUTLIER 2.73 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.602 0.964 . . . . 0.60999999999999999 113.602 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.539 ' CD2' ' O ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -70.23 107.56 3.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.381 -1.45 . . . . 0.73999999999999999 109.686 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.478 ' HA ' ' HB2' ' A' ' 218' ' ' LEU . 2.2 t -65.32 -151.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 0.81000000000000005 110.252 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.462 ' N ' ' OG1' ' A' ' 247' ' ' THR . . . -84.31 -5.0 87.63 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.404 -1.478 . . . . 0.56000000000000005 109.404 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.04 30.13 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -1.155 . . . . 0.37 110.38 -179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.16 -28.8 61.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.44 110.406 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 1.9 m-70 -164.82 -61.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.53000000000000003 110.425 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 2.8 m-85 -174.38 -174.4 0.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.967 . . . . 0.38 110.516 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.448 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -68.07 53.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.51 -0.744 . . . . 0.19 110.559 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.661 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.1 -47.57 43.52 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 107.963 -1.125 . . . . 0.28000000000000003 107.963 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.661 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.9 Cg_endo -73.59 51.0 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.137 1.598 . . . . 0.48999999999999999 110.979 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.522 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.1 m-20 -50.65 -32.42 19.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.018 -1.051 . . . . 0.48999999999999999 110.494 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.609 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -53.82 -54.13 42.75 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.885 -1.126 . . . . 0.31 109.136 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -66.01 -35.48 80.69 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.074 -1.05 . . . . 0.14000000000000001 108.784 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.538 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 55.2 t -63.93 -86.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.17000000000000001 110.581 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -55.0 -43.73 73.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.099 -1.001 . . . . 0.26000000000000001 109.569 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.529 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.83 -70.2 0.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.641 -0.984 . . . . 0.19 110.641 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.597 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -72.66 -21.13 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.727 -1.455 . . . . 0.22 110.296 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.561 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 0.6 OUTLIER -64.86 -20.47 66.43 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.985 -1.072 . . . . 0.39000000000000001 108.659 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 29.1 t -103.72 -41.88 5.8 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.203 -0.599 . . . . 0.46999999999999997 111.164 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.466 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -84.3 -47.09 11.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.353 -0.842 . . . . 0.47999999999999998 111.145 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.58 ' CD1' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -69.64 -20.52 63.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.40999999999999998 110.223 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -53.51 -102.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.276 -1.53 . . . . 0.46000000000000002 109.276 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.33 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.867 1.457 . . . . 0.57999999999999996 110.333 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -83.22 155.79 33.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.64000000000000001 109.388 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.612 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.4 OUTLIER -93.09 -61.64 1.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -1.173 . . . . 0.94999999999999996 110.414 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.475 ' HB2' ' OG ' ' A' ' 114' ' ' SER . 5.2 tp10 50.27 35.49 10.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 1.2 110.004 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.0 133.41 10.25 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 1.2 110.226 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.28 85.72 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.925 1.487 . . . . 1.0600000000000001 110.476 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.021 -0.99 . . . . 0.78000000000000003 110.254 -179.904 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.581 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.566 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.665 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 36.1 p90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.284 0.564 . . . . 0.40999999999999998 110.253 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -166.31 75.61 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.26000000000000001 110.148 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' HG13 ' A' ' 106' ' ' VAL . 42.1 t -126.61 -24.54 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.33000000000000002 110.565 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.11 64.99 13.7 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.99 . . . . 0.65000000000000002 110.696 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.531 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.1 Cg_endo -71.39 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.03 1.542 . . . . 0.83999999999999997 109.984 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.531 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 21.3 mtt180 70.63 82.64 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.93000000000000005 110.46 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.465 ' O ' HD22 ' A' ' 230' ' ' LEU . 1.6 p -147.8 -65.83 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.711 . . . . 1.03 109.259 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.527 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.01 55.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.682 -0.636 . . . . 1.04 111.67 178.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -140.94 77.03 1.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.193 -0.942 . . . . 0.77000000000000002 109.403 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.573 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 10.1 t90 -149.72 -69.22 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.41999999999999998 111.411 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.6 t -100.48 77.17 1.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.44 111.101 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -170.21 49.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.279 -0.888 . . . . 0.48999999999999999 110.185 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.2 OUTLIER -75.46 -29.15 59.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.29999999999999999 110.141 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 25.0 p-10 -129.74 123.46 31.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.14999999999999999 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.46 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 3.8 mt -141.32 -178.62 5.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.13 110.364 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.529 ' CG2' ' O ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -122.6 150.75 42.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.12 109.829 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.637 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 40.3 p90 -145.11 -164.31 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.33000000000000002 110.692 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.1 154.2 40.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.54000000000000004 110.888 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.585 HG12 ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.48 110.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.33000000000000002 110.223 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.534 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 3.4 m -159.91 41.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.27000000000000002 110.147 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.486 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 3.4 t-20 -41.36 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.696 -0.802 . . . . 0.40999999999999998 108.993 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 6.3 t80 -179.91 -176.14 0.33 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.514 -0.741 . . . . 0.40000000000000002 109.593 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.551 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -132.52 49.77 4.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.013 -1.054 . . . . 0.45000000000000001 110.611 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.4 Cg_endo -76.78 -85.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.854 1.45 . . . . 0.35999999999999999 110.253 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.31 -0.5 38.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.25 109.622 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.526 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 3.6 ptm -123.12 133.93 54.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.39000000000000001 109.976 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 1.4 m -86.33 178.52 7.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.47999999999999998 110.354 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.448 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -45.74 -33.76 3.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.845 . . . . 0.40000000000000002 110.068 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.5 t -63.16 -58.3 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.46000000000000002 109.791 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.526 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 6.3 mp0 -54.46 -57.72 10.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.268 -0.895 . . . . 0.46999999999999997 109.566 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.501 HG22 ' CE ' ' A' ' 129' ' ' MET . 4.0 t -45.34 -37.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.111 -1.07 . . . . 0.31 108.111 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.477 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 9.6 tt0 -59.03 -39.97 83.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.486 -0.931 . . . . 0.47999999999999998 108.486 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.559 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 12.9 tttt -73.07 -50.37 23.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.64000000000000001 108.776 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.65 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.64 -60.61 2.1 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.163 -0.961 . . . . 0.41999999999999998 110.537 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -68.44 -50.97 48.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.34000000000000002 111.216 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.625 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.91 -71.17 0.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.957 -1.089 . . . . 0.46999999999999997 110.147 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -40.18 -58.78 1.4 Allowed 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.651 -0.656 . . . . 0.46999999999999997 110.114 178.731 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.75 -38.81 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.707 -1.246 . . . . 0.25 108.365 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -71.0 -34.73 71.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.846 . . . . 0.34999999999999998 108.985 178.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -56.4 -45.45 80.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.69999999999999996 108.394 178.77 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 22.9 t -64.68 -44.67 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.987 -0.746 . . . . 0.60999999999999999 108.987 178.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.59 ' CH2' HG13 ' A' ' 262' ' ' ILE . 26.3 t-105 -55.02 -36.69 65.74 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.718 -0.845 . . . . 0.39000000000000001 108.718 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -74.12 -38.42 63.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.742 -0.836 . . . . 0.34999999999999998 108.742 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -53.1 -37.48 61.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.533 -0.729 . . . . 0.35999999999999999 109.045 178.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.529 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 34.8 m -85.45 -35.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.5 110.116 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.526 ' N ' HG22 ' A' ' 148' ' ' VAL . 15.3 t -153.93 127.25 4.24 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.038 -1.039 . . . . 0.51000000000000001 110.15 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.67 59.88 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.871 1.459 . . . . 0.31 110.813 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.489 HD21 ' N ' ' A' ' 151' ' ' LEU . 1.9 mm? -72.53 145.88 47.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.17999999999999999 110.086 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.423 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -91.88 133.68 35.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.17000000000000001 110.32 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.46 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.9 p90 -149.11 147.91 29.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.14000000000000001 110.237 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.529 ' O ' ' CG2' ' A' ' 119' ' ' THR . 6.5 m -152.72 133.03 13.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.14999999999999999 110.29 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 32.1 mtm180 -91.86 119.32 31.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.013 -1.054 . . . . 0.20000000000000001 110.16 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -117.56 108.67 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.22 110.3 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -72.17 -4.11 27.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.32000000000000001 110.091 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -30.08 69.79 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.409 -0.807 . . . . 0.33000000000000002 109.581 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.81 30.65 0.63 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.734 -1.346 . . . . 0.28000000000000003 109.734 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.471 ' O ' ' HB ' ' A' ' 119' ' ' THR . 57.7 mt -126.68 66.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.073 -1.251 . . . . 0.29999999999999999 109.308 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.472 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -121.9 152.1 39.99 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.358 0.599 . . . . 0.20000000000000001 110.612 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.404 ' CB ' HD23 ' A' ' 118' ' ' LEU . 5.4 t70 -120.5 -40.04 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.10000000000000001 109.818 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.555 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 0.6 OUTLIER -128.57 171.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.36 -0.838 . . . . 0.10000000000000001 110.105 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.539 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 2.3 ptp -177.14 153.99 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.539 -1.351 . . . . 0.11 111.379 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 3.6 tt -99.3 118.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.10000000000000001 109.408 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.534 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 15.1 p -162.85 144.64 10.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.752 -1.218 . . . . 0.10000000000000001 111.237 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.652 ' CE2' ' CG2' ' A' ' 169' ' ' ILE . 0.9 OUTLIER -66.42 122.83 18.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.089999999999999997 110.006 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -80.87 127.94 8.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.972 -1.251 . . . . 0.20000000000000001 109.972 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.652 ' CG2' ' CE2' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -116.07 102.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.535 -0.98 . . . . 0.55000000000000004 109.659 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.639 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.78 81.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.439 0.638 . . . . 0.84999999999999998 112.257 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 169' ' ' ILE . 1.7 mm-40 -125.95 -4.86 6.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.70999999999999996 110.267 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.524 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 8.8 m-70 -87.41 -140.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.41999999999999998 109.995 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -169.89 -36.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.399 -1.48 . . . . 0.33000000000000002 109.399 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -61.36 -61.23 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -1.104 . . . . 0.33000000000000002 110.194 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.8 116.02 17.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.27000000000000002 110.16 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -55.41 114.43 7.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 0.34000000000000002 110.071 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.518 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 42.9 Cg_endo -73.14 -79.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.907 1.477 . . . . 0.46999999999999997 110.898 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -46.59 142.95 2.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 0.34999999999999998 110.778 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.494 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 4.4 p30 179.5 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.20000000000000001 110.751 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.551 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 46.76 -167.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.38 -1.488 . . . . 0.25 109.38 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.2 Cg_endo -75.81 5.01 4.66 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.197 1.63 . . . . 0.44 110.304 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -44.57 173.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -0.797 . . . . 0.56999999999999995 110.898 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.552 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.64 76.71 0.02 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.895 -0.882 . . . . 0.48999999999999999 110.895 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.55 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 0.4 OUTLIER 179.46 88.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.174 -1.192 . . . . 0.40999999999999998 110.373 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.578 HD13 ' CD1' ' A' ' 214' ' ' TYR . 4.6 tt -108.76 -21.13 12.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.832 -1.168 . . . . 0.29999999999999999 111.612 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.631 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -149.97 101.09 3.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.48 -1.388 . . . . 0.20000000000000001 111.907 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.7 OUTLIER -101.76 123.78 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.473 -0.767 . . . . 0.16 109.431 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.517 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -108.88 137.32 46.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.23000000000000001 110.65 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.446 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -80.0 173.1 8.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.38 110.369 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 48.4 Cg_endo -73.75 133.34 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.975 1.513 . . . . 0.40000000000000002 109.786 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.527 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -69.79 81.17 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.866 1.456 . . . . 0.32000000000000001 110.604 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.55 -106.63 1.78 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.292 -1.523 . . . . 0.32000000000000001 109.292 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.95 -159.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.882 1.464 . . . . 0.46999999999999997 110.337 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -63.07 -11.27 18.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.941 . . . . 0.63 110.383 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.76 56.02 0.68 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.428 -0.795 . . . . 0.53000000000000003 110.147 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.3 174.59 22.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.212 -1.555 . . . . 0.25 109.212 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.543 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 42.09 25.75 0.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.946 -1.261 . . . . 0.10000000000000001 109.946 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.455 ' N ' ' O ' ' A' ' 196' ' ' GLY . 0.3 OUTLIER -79.38 86.16 5.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.32 . . . . 0.10000000000000001 110.005 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 165' ' ' ILE . . . -62.94 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.089999999999999997 110.002 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.519 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.4 m170 -98.79 134.01 42.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.089999999999999997 110.669 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.59 ' O ' ' N ' ' A' ' 203' ' ' ASP . 13.3 m-30 -102.74 131.07 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -0.903 . . . . 0.10000000000000001 109.877 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.5 OUTLIER -46.3 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.544 -0.91 . . . . 0.14000000000000001 108.544 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.0 p30 -37.68 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.17999999999999999 111.53 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.551 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -77.7 3.95 12.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.762 -1.211 . . . . 0.23999999999999999 110.829 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.513 ' N ' ' O ' ' A' ' 202' ' ' ASP . 15.6 mm-40 -100.68 -167.39 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.036 . . . . 0.41999999999999998 110.315 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.507 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 3.2 m -124.64 150.28 46.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -0.929 . . . . 0.46999999999999997 110.385 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.507 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -147.42 142.74 27.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.902 . . . . 0.27000000000000002 109.636 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.53 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -157.81 174.21 15.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.822 -1.174 . . . . 0.29999999999999999 110.984 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.5 t -130.66 41.0 3.44 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.639 0.733 . . . . 0.60999999999999999 109.384 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.9 t -109.87 -99.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.78000000000000003 110.267 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.494 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -149.59 13.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.068 -1.02 . . . . 0.91000000000000003 110.247 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.99 155.55 44.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.93000000000000005 109.858 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.81 -175.24 53.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.081 -1.608 . . . . 0.79000000000000004 109.081 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.578 ' CD1' HD13 ' A' ' 185' ' ' LEU . 67.7 m-85 -71.26 106.53 3.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 0.68999999999999995 109.931 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 218' ' ' LEU . 61.6 m-20 -75.04 119.28 18.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.154 -0.966 . . . . 0.40000000000000002 108.528 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.65 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -39.71 -37.01 0.47 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.82 -0.752 . . . . 0.17000000000000001 110.271 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.571 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.3 m-30 -52.16 -48.82 64.73 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.653 -1.24 . . . . 0.28000000000000003 107.653 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.559 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 6.8 tp -74.56 -69.81 0.44 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.856 -0.611 . . . . 0.46000000000000002 110.45 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.59 HG23 ' CZ ' ' A' ' 201' ' ' PHE . 0.5 OUTLIER -50.12 -70.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.077 -1.014 . . . . 0.39000000000000001 109.75 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -41.73 -52.55 3.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.07 . . . . 0.17000000000000001 111.248 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.47 -37.3 77.84 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.417 -1.427 . . . . 0.10000000000000001 108.977 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.583 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 5.6 t60 -64.91 -53.39 47.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.421 0.629 . . . . 0.20999999999999999 109.551 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.518 ' OE1' ' CB ' ' A' ' 186' ' ' ALA . 25.0 tp10 -57.99 -46.14 85.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.28000000000000003 109.301 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.511 ' CG ' ' O ' ' A' ' 220' ' ' ALA . 12.3 m-30 -52.57 -63.44 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.17999999999999999 109.279 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -34.46 2.73 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.913 -1.675 . . . . 0.20999999999999999 108.913 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.663 ' CE1' ' CG ' ' A' ' 240' ' ' MET . 0.0 OUTLIER -76.03 -79.02 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -1.132 . . . . 0.17000000000000001 110.839 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.543 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -35.4 -53.93 0.65 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.666 -0.646 . . . . 0.33000000000000002 111.916 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.531 ' CD1' HG22 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -80.59 -44.83 18.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.998 -1.064 . . . . 0.53000000000000003 110.725 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.478 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -63.58 -82.78 0.08 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.775 -1.33 . . . . 0.40999999999999998 109.775 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.507 ' CD1' ' C ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -177.5 -170.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -1.076 . . . . 0.45000000000000001 110.299 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 230' ' ' LEU . 1.8 m-20 -42.22 -61.62 1.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.62 110.51 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.634 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -159.51 -175.9 5.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.289 -0.882 . . . . 0.45000000000000001 109.989 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.0 61.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.295 -0.878 . . . . 0.38 109.56 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.579 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.68 24.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.279 -0.968 . . . . 0.47999999999999998 111.502 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.548 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -35.93 -51.9 1.58 Allowed Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.987 -0.685 . . . . 0.38 111.106 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.548 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 51.1 Cg_endo -85.58 -49.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.643 1.338 . . . . 0.28000000000000003 111.291 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.19 101.25 0.14 Allowed Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.214 -1.47 . . . . 0.23999999999999999 111.581 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.579 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -143.22 -174.21 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -1.124 . . . . 0.28000000000000003 110.238 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.596 ' HG ' ' O ' ' A' ' 239' ' ' LEU . 3.1 tp -88.86 27.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.371 1.081 . . . . 0.40000000000000002 108.87 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.663 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -119.44 -6.46 10.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.872 -1.142 . . . . 0.45000000000000001 110.655 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -60.53 170.31 1.42 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 121.15 -0.969 . . . . 0.56999999999999995 111.558 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.54 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.1 Cg_endo -76.09 6.08 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.516 1.272 . . . . 0.76000000000000001 110.597 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.602 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 16.1 mt -126.89 164.88 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.337 -0.852 . . . . 0.89000000000000001 109.506 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.559 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 33.3 p90 -139.72 -29.2 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.78000000000000003 111.249 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.52 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER 3.18 -67.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 114.14 1.163 . . . . 0.60999999999999999 114.14 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.544 ' N ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -59.87 101.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.279 -1.513 . . . . 0.73999999999999999 109.816 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.516 ' N ' ' HB2' ' A' ' 250' ' ' SER . 80.6 p -50.44 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.81000000000000005 110.146 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -56.79 -26.14 53.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.463 -1.455 . . . . 0.56000000000000005 109.463 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.31 29.33 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.16 . . . . 0.37 110.014 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.521 ' O ' ' ND1' ' A' ' 251' ' ' HIS . 0.5 OUTLIER -62.8 -10.98 14.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.44 109.982 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 250' ' ' SER . 0.1 OUTLIER -174.42 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.53000000000000003 110.204 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.435 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.3 OUTLIER 179.67 -173.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.38 110.285 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.461 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 14.2 ptt? -66.55 53.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.605 -0.684 . . . . 0.19 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.664 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -47.84 -46.3 62.52 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.28000000000000003 107.833 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.664 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.9 Cg_endo -74.54 52.52 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.958 1.504 . . . . 0.48999999999999999 110.806 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.57 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 9.9 m-20 -55.78 -31.51 62.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.159 -0.963 . . . . 0.48999999999999999 110.572 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.543 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -51.35 -45.91 62.52 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.655 -1.218 . . . . 0.31 108.551 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.555 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.72 -39.47 64.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.453 -0.943 . . . . 0.14000000000000001 108.453 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.57 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 97.3 t -56.24 -76.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.17000000000000001 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.624 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 7.1 pt20 -71.05 -34.76 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.32 -0.862 . . . . 0.26000000000000001 110.567 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -44.37 -58.34 4.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.308 -1.517 . . . . 0.19 109.308 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.59 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -82.87 -23.12 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.023 -1.28 . . . . 0.22 110.89 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.624 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 0.1 OUTLIER -62.63 -20.0 64.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.462 . . . . 0.39000000000000001 108.195 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -103.18 -36.92 7.93 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.181 -0.608 . . . . 0.46999999999999997 111.125 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.487 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 48.5 mt -88.32 -46.89 8.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.139 -0.976 . . . . 0.47999999999999998 111.216 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.465 ' HB3' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -81.33 -4.76 56.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.40999999999999998 110.299 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.8 -112.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.231 -1.548 . . . . 0.46000000000000002 109.231 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.55 86.2 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.789 1.415 . . . . 0.57999999999999996 110.296 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.27 170.12 1.8 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.64000000000000001 109.575 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.573 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 -108.82 -61.35 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.94999999999999996 110.166 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.471 ' HA ' ' HB2' ' A' ' 114' ' ' SER . 1.9 tm-20 54.07 30.64 12.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 1.2 110.259 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.7 102.04 0.34 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 1.2 110.465 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 274' ' ' ASN . 46.2 Cg_endo -73.72 -7.3 19.96 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.035 1.545 . . . . 1.0600000000000001 110.335 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 273' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.969 -1.015 . . . . 0.78000000000000003 110.35 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.583 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.568 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.631 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.258 0.551 . . . . 0.40999999999999998 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -93.62 108.82 20.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 0.26000000000000001 110.162 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 15.9 t -79.15 -118.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.33000000000000002 109.918 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 77.6 m-85 -108.52 122.19 41.07 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 120.774 -1.204 . . . . 0.65000000000000002 110.313 -179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.9 56.72 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.896 1.472 . . . . 0.83999999999999997 110.465 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.492 ' C ' ' CD1' ' A' ' 230' ' ' LEU . 49.0 mtt-85 -141.14 85.78 1.99 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.93000000000000005 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -161.34 -51.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.765 . . . . 1.03 109.256 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.477 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.6 OUTLIER 32.15 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.131 0.491 . . . . 1.04 111.461 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.507 ' N ' ' O ' ' A' ' 110' ' ' THR . 7.6 mttt -124.73 64.92 1.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.77000000000000002 110.357 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.61 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.1 t90 -123.3 -67.94 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.897 . . . . 0.41999999999999998 110.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.516 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 72.8 p -99.38 54.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.44 110.151 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 17.5 mmtt -145.31 87.15 1.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.48999999999999999 110.289 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 116' ' ' MET . 2.1 tmm? -121.34 -4.45 9.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.29999999999999999 110.052 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.467 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.14999999999999999 110.076 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.433 HD21 ' CB ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -147.29 -167.1 2.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.13 110.31 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.531 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.6 OUTLIER -133.66 156.37 48.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.12 110.473 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.644 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 46.0 p90 -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.49 -0.884 . . . . 0.33000000000000002 110.94 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.468 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 1.1 mtt85 -124.85 151.39 45.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.54000000000000004 110.114 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.645 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.2 pp -114.02 97.93 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.947 . . . . 0.33000000000000002 111.14 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.467 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 7.3 m -147.34 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.27000000000000002 110.471 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.0 t30 -44.31 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.40999999999999998 109.379 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.566 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.0 t80 -179.85 -166.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.437 -0.79 . . . . 0.40000000000000002 109.736 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -148.95 48.2 0.57 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.982 -1.074 . . . . 0.45000000000000001 110.693 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.566 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.3 Cg_endo -74.04 -87.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.998 1.525 . . . . 0.35999999999999999 110.268 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.96 -0.89 57.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.25 109.65 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.539 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -119.55 158.83 25.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.816 . . . . 0.39000000000000001 109.718 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -112.31 177.03 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.47999999999999998 110.183 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 130' ' ' THR . 1.3 t-160 -43.18 -40.12 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.40000000000000002 109.71 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 23.3 t -61.49 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.46000000000000002 109.629 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.3 OUTLIER -62.63 -60.74 3.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 0.46999999999999997 109.375 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.498 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 4.9 t -45.72 -36.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.882 -1.155 . . . . 0.31 107.882 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.492 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -58.21 -40.81 82.59 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.053 -1.091 . . . . 0.47999999999999998 108.053 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.593 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.7 tttt -72.74 -54.56 8.6 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.76 -0.83 . . . . 0.64000000000000001 108.76 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.628 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.88 -63.22 1.02 Allowed 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.958 -1.088 . . . . 0.41999999999999998 110.101 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -61.7 -55.82 26.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.213 -0.93 . . . . 0.34000000000000002 110.849 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 3.3 tttt -64.96 -73.2 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.46999999999999997 110.331 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.37 -63.06 0.53 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.686 -0.634 . . . . 0.46999999999999997 110.562 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.51 -36.92 7.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.77 -1.206 . . . . 0.25 108.665 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -72.62 -33.05 66.4 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.361 -0.837 . . . . 0.34999999999999998 108.937 178.669 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.226 -0.921 . . . . 0.69999999999999996 108.784 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.447 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 40.8 t -72.13 -48.28 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.589 -0.694 . . . . 0.60999999999999999 109.294 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.584 ' CH2' HG13 ' A' ' 262' ' ' ILE . 32.0 t-105 -56.71 -40.18 75.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.788 . . . . 0.39000000000000001 109.047 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.2 m -73.12 -31.23 64.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.598 -0.89 . . . . 0.34999999999999998 108.598 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.447 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -57.74 -43.22 85.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.132 -0.692 . . . . 0.35999999999999999 109.132 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.7 m -76.16 -33.0 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.618 -0.833 . . . . 0.5 109.739 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.528 ' N ' HG22 ' A' ' 148' ' ' VAL . 4.6 t -145.1 120.57 5.86 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 0.51000000000000001 110.149 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.36 58.86 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.757 1.399 . . . . 0.31 110.658 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.571 HD22 ' CD1' ' A' ' 266' ' ' TYR . 8.8 mt -72.58 161.17 31.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.17999999999999999 110.027 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.467 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.0 OUTLIER -104.46 102.02 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.17000000000000001 110.255 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.558 ' CE2' ' HB3' ' A' ' 151' ' ' LEU . 37.3 m-85 -123.3 142.86 50.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.14000000000000001 110.2 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 119' ' ' THR . 3.3 m -142.0 141.35 32.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.184 -0.948 . . . . 0.14999999999999999 110.448 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.644 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -100.06 91.64 4.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.20000000000000001 109.985 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.448 HD21 ' HB3' ' A' ' 158' ' ' ASP . 0.1 OUTLIER -94.06 106.91 18.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.22 110.153 179.935 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 158' ' ' ASP . 51.1 p-80 -63.83 -29.62 70.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.32000000000000001 110.145 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.448 ' HB3' HD21 ' A' ' 156' ' ' LEU . 2.1 t0 -41.19 -30.58 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.589 -0.694 . . . . 0.33000000000000002 110.098 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.73 32.13 0.72 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.716 -1.354 . . . . 0.28000000000000003 109.716 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 119' ' ' THR . 39.9 mt -121.51 71.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.127 -1.219 . . . . 0.29999999999999999 109.513 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.498 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -138.55 156.19 47.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.888 -0.725 . . . . 0.20000000000000001 110.767 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.433 ' CB ' HD21 ' A' ' 118' ' ' LEU . 39.0 t0 -124.64 -31.08 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.439 -0.788 . . . . 0.10000000000000001 110.036 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.571 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -122.47 160.66 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.236 -0.915 . . . . 0.10000000000000001 109.912 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.468 ' HB3' ' HB2' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -165.36 140.96 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.373 -1.454 . . . . 0.11 111.6 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.554 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 3.9 tt -90.32 116.67 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 0.10000000000000001 109.538 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 3.7 p -156.1 159.88 39.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.921 -1.112 . . . . 0.10000000000000001 110.46 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.8 p90 -76.55 116.59 17.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.409 -0.807 . . . . 0.089999999999999997 109.735 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -64.16 119.69 16.83 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.434 -1.066 . . . . 0.20000000000000001 110.434 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.576 ' O ' ' C ' ' A' ' 170' ' ' LYS . 1.7 tp -117.09 97.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.639 -0.918 . . . . 0.55000000000000004 109.532 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.579 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.09 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 112.634 0.605 . . . . 0.84999999999999998 112.634 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -156.03 17.1 0.36 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.847 . . . . 0.70999999999999996 110.606 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.581 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 2.2 m170 -82.58 -90.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.41999999999999998 110.207 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -177.35 -36.73 0.06 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.42 -1.472 . . . . 0.33000000000000002 109.42 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -148.41 -65.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.33000000000000002 110.185 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.479 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 58.0 t80 -42.13 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.27000000000000002 110.403 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 174' ' ' ASP . 10.9 m-30 -47.9 104.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.34000000000000002 110.264 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.526 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 49.1 Cg_endo -79.72 -64.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.09 1.574 . . . . 0.46999999999999997 110.677 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.579 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -72.64 138.33 46.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.072 -1.017 . . . . 0.34999999999999998 111.07 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 202' ' ' ASP . 0.5 OUTLIER 178.79 78.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.071 -1.052 . . . . 0.20000000000000001 111.652 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.551 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 35.41 -153.66 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.86 -0.896 . . . . 0.25 110.86 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.466 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.6 Cg_endo -74.93 3.39 5.62 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.554 1.818 . . . . 0.44 110.361 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 184' ' ' LEU . 14.1 t -40.15 162.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.56999999999999995 110.256 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.544 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -59.13 76.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.498 -1.041 . . . . 0.48999999999999999 110.498 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.535 ' N ' ' O ' ' A' ' 182' ' ' SER . 9.9 tp 179.76 84.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.391 -1.064 . . . . 0.40999999999999998 110.047 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.576 HD11 ' CZ ' ' A' ' 214' ' ' TYR . 0.4 OUTLIER -100.92 -25.27 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.224 . . . . 0.29999999999999999 111.07 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.647 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.4 105.07 3.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.68 -1.262 . . . . 0.20000000000000001 111.928 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.579 ' CD2' ' O ' ' A' ' 187' ' ' HIS . 21.2 p-80 -110.65 122.55 48.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.16 109.437 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.525 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -116.29 131.3 56.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.23000000000000001 110.422 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.581 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.7 OUTLIER -73.48 169.33 18.76 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.38 110.675 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.8 Cg_endo -73.59 144.0 35.07 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.171 1.617 . . . . 0.40000000000000002 109.618 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.47 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.2 Cg_endo -70.71 81.12 1.09 Allowed 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.91 1.479 . . . . 0.32000000000000001 110.82 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.4 -107.28 2.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.466 -1.454 . . . . 0.32000000000000001 109.466 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -75.76 -162.76 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.927 1.488 . . . . 0.46999999999999997 110.731 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -57.85 -15.43 8.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.63 110.316 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.22 54.96 0.7 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.496 -0.753 . . . . 0.53000000000000003 110.251 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.4 170.09 21.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.409 -1.476 . . . . 0.25 109.409 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.495 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 41.76 27.44 0.35 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.62 -1.392 . . . . 0.10000000000000001 109.62 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.498 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 2.0 m-20 -76.75 92.12 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.239 . . . . 0.10000000000000001 110.087 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.532 ' HB3' ' CG ' ' A' ' 223' ' ' GLU . . . -74.69 98.63 3.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.089999999999999997 109.954 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.572 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 29.2 m170 -117.47 126.03 51.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.218 -0.926 . . . . 0.089999999999999997 110.688 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 203' ' ' ASP . 32.6 m-85 -93.41 141.97 27.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.10000000000000001 110.571 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.533 ' CB ' ' HG3' ' A' ' 205' ' ' GLU . 0.1 OUTLIER -49.0 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.183 -1.043 . . . . 0.14000000000000001 108.183 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.564 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 4.3 p30 -37.21 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.17999999999999999 111.604 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.551 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.7 t0 -75.56 -1.62 25.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.568 -1.333 . . . . 0.23999999999999999 110.994 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.533 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 21.4 mm-40 -94.15 -163.52 1.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.937 -1.102 . . . . 0.41999999999999998 110.379 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.424 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -125.94 150.84 47.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.46999999999999997 110.729 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.564 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -143.36 140.86 30.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 0.27000000000000002 109.295 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.501 ' O ' ' CD1' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.18 177.67 11.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.877 -1.139 . . . . 0.29999999999999999 110.95 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.47 ' OG ' ' O ' ' A' ' 209' ' ' SER . 2.0 t -131.56 45.95 2.72 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.584 0.707 . . . . 0.60999999999999999 109.6 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.1 t -112.38 -105.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.78000000000000003 110.164 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 210' ' ' SER . 25.2 p -157.48 17.85 0.27 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.91000000000000003 110.268 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 213' ' ' GLY . 4.2 mttp -125.91 -86.45 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.93000000000000005 110.193 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . -49.08 -178.3 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.317 . . . . 0.79000000000000004 109.806 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.576 ' CZ ' HD11 ' A' ' 185' ' ' LEU . 94.8 m-85 -57.08 115.15 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.68999999999999995 109.992 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.529 ' O ' ' N ' ' A' ' 218' ' ' LEU . 9.9 m-80 -82.67 116.03 21.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.008 . . . . 0.40000000000000002 109.044 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.628 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 1.2 mp -41.73 -33.38 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.436 -0.79 . . . . 0.17000000000000001 110.283 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.593 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 5.2 m-85 -53.44 -45.07 69.33 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 118.07 -1.452 . . . . 0.28000000000000003 107.431 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.583 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 20.9 tp -82.52 -71.0 0.51 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.523 -0.762 . . . . 0.46000000000000002 110.993 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.603 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -47.86 -56.61 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.39000000000000001 110.19 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -59.56 -46.92 87.51 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.968 -1.083 . . . . 0.17000000000000001 111.131 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.577 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -60.33 -23.6 64.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.164 -1.585 . . . . 0.10000000000000001 108.454 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.622 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 3.4 t-160 -80.43 -50.04 10.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.373 -0.603 . . . . 0.20999999999999999 109.373 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.532 ' CG ' ' HB3' ' A' ' 199' ' ' ALA . 2.7 tp10 -62.31 -33.32 74.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.065 -1.022 . . . . 0.28000000000000003 108.442 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.535 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 6.2 m-85 -64.78 -66.87 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.669 0.747 . . . . 0.17999999999999999 108.99 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.463 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.35 -28.15 0.54 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.762 -1.735 . . . . 0.20999999999999999 108.762 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.441 ' CE1' ' HB3' ' A' ' 240' ' ' MET . 3.3 m80 -81.42 -68.07 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -1.166 . . . . 0.17000000000000001 110.842 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.525 ' CA ' ' HB2' ' A' ' 188' ' ' ALA . 0.2 OUTLIER -40.36 -42.78 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.33000000000000002 111.88 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.534 ' CD1' ' OH ' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -101.16 -37.77 8.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.885 -1.134 . . . . 0.53000000000000003 111.364 -178.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.49 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -65.09 -81.86 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.624 -0.99 . . . . 0.40999999999999998 110.624 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.492 ' CD1' ' C ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -169.85 -147.83 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -1.18 . . . . 0.45000000000000001 110.658 -178.838 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -86.87 -44.48 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.356 -0.84 . . . . 0.62 110.532 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -179.99 161.88 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.45000000000000001 110.284 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 p -168.67 28.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.38 109.797 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.604 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -104.3 22.45 14.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -0.779 . . . . 0.47999999999999998 111.002 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.532 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -35.25 -50.37 1.24 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.559 -0.713 . . . . 0.38 110.685 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.532 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 47.5 Cg_endo -86.73 -49.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.433 1.228 . . . . 0.28000000000000003 111.14 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.06 101.33 0.14 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.137 -1.506 . . . . 0.23999999999999999 111.544 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.604 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -145.36 173.58 11.87 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.371 -1.076 . . . . 0.28000000000000003 109.7 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.598 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -80.85 38.31 0.45 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.826 -1.171 . . . . 0.40000000000000002 109.916 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.616 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 25.6 mtp -123.01 -17.61 6.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.45000000000000001 109.746 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -56.0 170.25 0.47 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.184 -0.948 . . . . 0.56999999999999995 110.97 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.522 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 46.3 Cg_endo -73.73 -10.9 23.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.626 1.329 . . . . 0.76000000000000001 110.006 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.586 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 36.5 mt -104.84 147.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.89000000000000001 109.787 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.583 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 41.8 p90 -131.25 -24.45 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.78000000000000003 111.115 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.535 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.2 OUTLIER 2.88 -68.97 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 113.534 0.938 . . . . 0.60999999999999999 113.534 -179.086 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.58 ' CZ ' ' O ' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -62.72 107.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.447 -1.408 . . . . 0.73999999999999999 109.5 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.447 ' N ' ' HB2' ' A' ' 250' ' ' SER . 42.7 p -54.1 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.81000000000000005 110.215 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.04 -9.76 54.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.317 -1.513 . . . . 0.56000000000000005 109.317 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -149.27 29.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -1.18 . . . . 0.37 110.526 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.447 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.6 OUTLIER -73.84 -31.52 63.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.996 -1.065 . . . . 0.44 110.091 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.8 -60.23 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.53000000000000003 109.913 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.58 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 179.42 -175.61 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.38 110.306 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.468 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 25.9 ptt? -68.83 52.5 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.19 110.416 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.646 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.2 -46.85 44.82 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 107.912 -1.144 . . . . 0.28000000000000003 107.912 177.514 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.646 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.3 Cg_endo -73.81 52.3 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.956 1.503 . . . . 0.48999999999999999 110.715 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.586 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 12.4 m-20 -57.22 -28.58 63.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.371 -0.831 . . . . 0.48999999999999999 110.436 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.546 ' HB2' ' CB ' ' A' ' 238' ' ' ALA . 2.0 m-20 -51.31 -45.44 62.23 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.015 -1.053 . . . . 0.31 109.235 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.55 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.02 -34.18 50.75 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.365 -0.976 . . . . 0.14000000000000001 108.365 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.586 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 98.6 t -58.6 -74.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.899 -0.72 . . . . 0.17000000000000001 110.533 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.637 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 14.1 pt20 -69.9 -37.05 75.87 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.267 -0.896 . . . . 0.26000000000000001 109.769 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.489 ' N ' ' HG3' ' A' ' 260' ' ' GLN . . . -41.53 -53.92 4.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.466 -1.454 . . . . 0.19 109.466 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.584 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -92.1 -23.58 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.963 -1.316 . . . . 0.22 110.97 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.637 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 7.1 tp60 -54.81 -26.12 32.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.001 -1.48 . . . . 0.39000000000000001 107.947 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.1 p -103.92 -41.68 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.244 0.545 . . . . 0.46999999999999997 111.127 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.465 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 4.0 mm? -73.95 -51.85 14.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.47999999999999998 111.477 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.571 ' CD1' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -76.18 -9.67 58.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.40999999999999998 110.533 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -60.38 -111.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.356 -1.498 . . . . 0.46000000000000002 109.356 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 88.98 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.819 1.431 . . . . 0.57999999999999996 110.226 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.29 168.53 50.67 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.605 -1.398 . . . . 0.64000000000000001 109.605 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.61 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 1.3 m-20 -96.61 -72.8 0.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.94999999999999996 110.247 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.516 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 2.3 tt0 58.24 20.36 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.2 110.259 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 270' ' ' ASP . 9.8 p-10 -177.66 142.63 0.48 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 1.2 110.077 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.04 -13.17 33.64 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 1.0600000000000001 110.453 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.994 -1.003 . . . . 0.78000000000000003 110.075 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.622 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.575 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.647 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.273 0.559 . . . . 0.40999999999999998 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -86.64 80.27 8.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.945 . . . . 0.26000000000000001 110.236 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 22.3 t -82.81 174.25 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.33000000000000002 110.12 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -56.17 134.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.289 -0.882 . . . . 0.65000000000000002 110.194 -179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.502 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 48.8 Cg_endo -74.61 -158.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.921 1.485 . . . . 0.83999999999999997 110.061 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 45.4 mtt180 69.73 75.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.93000000000000005 110.271 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.512 ' HA ' HD11 ' A' ' 230' ' ' LEU . 1.1 p -137.2 -64.87 0.55 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 1.03 109.444 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER 30.92 38.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.208 0.528 . . . . 1.04 111.356 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -135.96 61.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.77000000000000002 109.536 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.607 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 8.3 t90 -131.19 -50.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.41999999999999998 110.682 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 28.5 t -111.89 62.85 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.44 110.928 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.464 ' HG2' ' C ' ' A' ' 114' ' ' SER . 19.5 mmmt -149.09 42.05 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.074 -1.017 . . . . 0.48999999999999999 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.462 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 2.2 ttp -72.77 -19.58 61.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.137 -0.977 . . . . 0.29999999999999999 110.837 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.529 ' O ' ' CD2' ' A' ' 118' ' ' LEU . 5.7 p30 -138.48 113.23 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.14999999999999999 110.743 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.529 ' CD2' ' O ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -143.47 -179.68 6.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.13 110.261 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.525 ' CG2' ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -124.04 173.53 8.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.12 110.078 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 14.6 p90 -167.78 179.25 4.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.128 -0.982 . . . . 0.33000000000000002 111.008 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 22.9 tpt85 -126.03 147.66 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.54000000000000004 109.989 179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.625 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 pp -110.36 77.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.33000000000000002 110.789 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.479 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 8.3 m -125.54 42.17 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.27000000000000002 110.299 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.612 ' OD1' ' N ' ' A' ' 124' ' ' ASN . 0.0 OUTLIER -40.33 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.567 -0.853 . . . . 0.40999999999999998 109.212 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.667 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 2.9 t80 -178.9 169.33 1.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.044 -1.035 . . . . 0.40000000000000002 110.293 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -125.23 49.69 3.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.97 . . . . 0.45000000000000001 110.481 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.1 Cg_endo -73.97 -87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.121 1.59 . . . . 0.35999999999999999 110.317 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.08 2.1 50.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.25 109.805 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.517 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -117.88 159.15 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.39000000000000001 109.829 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -109.73 175.96 5.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.47999999999999998 110.103 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.469 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 71.6 t60 -43.39 -32.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.40000000000000002 109.738 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.45 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.3 t -68.42 -59.16 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.46000000000000002 109.752 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.517 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 32.8 mp0 -51.46 -59.87 3.76 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.309 -0.87 . . . . 0.46999999999999997 109.645 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 6.2 t -46.04 -37.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.261 -1.015 . . . . 0.31 108.261 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.56 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 12.1 tt0 -57.63 -39.1 76.2 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.347 -0.983 . . . . 0.47999999999999998 108.347 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -73.84 -52.66 12.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.948 0.88 . . . . 0.64000000000000001 108.819 178.67 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.669 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.48 -64.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.112 -0.993 . . . . 0.41999999999999998 110.508 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -63.17 -53.73 48.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.34000000000000002 111.327 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.65 -72.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.928 -1.107 . . . . 0.46999999999999997 110.371 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -39.49 -61.84 0.75 Allowed 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.697 -0.627 . . . . 0.46999999999999997 110.494 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -45.62 -37.99 6.17 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.795 -1.162 . . . . 0.25 108.291 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.37 -37.83 74.66 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.029 -0.73 . . . . 0.34999999999999998 109.029 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttpt -55.38 -40.66 71.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.69999999999999996 108.754 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 24.1 t -68.5 -44.84 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.69 -0.632 . . . . 0.60999999999999999 109.342 179.097 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.592 ' CH2' HG13 ' A' ' 262' ' ' ILE . 29.1 t-105 -56.3 -41.5 76.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.39000000000000001 109.161 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.5 OUTLIER -71.11 -34.42 71.06 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.288 -0.883 . . . . 0.34999999999999998 108.858 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -57.41 -41.64 80.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.602 -0.686 . . . . 0.35999999999999999 109.625 179.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.53 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 28.4 m -78.24 -29.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.5 110.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 146' ' ' SER . 13.4 t -152.27 141.91 14.59 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.94 -1.1 . . . . 0.51000000000000001 110.586 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.37 58.0 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.895 1.471 . . . . 0.31 110.313 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.495 HD22 ' HB3' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -77.01 138.41 39.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.17999999999999999 110.265 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.408 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.6 OUTLIER -100.16 120.52 40.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.17000000000000001 109.995 179.78 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.513 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.0 p90 -137.57 141.01 41.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.14000000000000001 110.389 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.525 ' O ' ' CG2' ' A' ' 119' ' ' THR . 2.6 m -139.58 134.5 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.14999999999999999 110.011 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.599 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 1.1 mtm180 -92.64 89.63 6.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.20000000000000001 109.731 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.23 107.65 18.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.22 110.52 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -66.61 -11.9 55.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.32000000000000001 109.79 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -54.53 -21.73 11.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.649 -0.657 . . . . 0.33000000000000002 109.515 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.56 15.78 4.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.28000000000000003 109.477 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.525 ' O ' ' HB ' ' A' ' 119' ' ' THR . 24.3 mm -106.22 78.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.119 -1.224 . . . . 0.29999999999999999 108.943 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 124.78 45.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.20000000000000001 111.018 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -94.08 -46.31 7.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.10000000000000001 109.393 179.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.533 ' CG2' ' HA3' ' A' ' 197' ' ' GLY . 12.2 pt -128.56 177.94 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 0.10000000000000001 109.302 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.465 ' HB3' ' O ' ' A' ' 163' ' ' ILE . 4.0 ptt? -177.28 154.62 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.598 -1.314 . . . . 0.11 111.242 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.54 ' CD1' ' HB2' ' A' ' 220' ' ' ALA . 3.0 tt -102.55 119.81 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.403 -0.811 . . . . 0.10000000000000001 109.547 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.479 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 5.1 p -160.57 148.23 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.10000000000000001 111.176 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.667 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 3.2 p90 -68.95 116.35 9.31 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.594 -0.691 . . . . 0.089999999999999997 109.523 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -74.42 113.38 4.06 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.367 -1.093 . . . . 0.20000000000000001 110.367 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -111.04 99.84 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -1.043 . . . . 0.55000000000000004 109.585 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.634 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.26 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.365 0.602 . . . . 0.84999999999999998 112.553 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.59 -3.51 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.70999999999999996 110.192 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -75.62 -80.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.41999999999999998 110.042 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 135.57 -39.57 1.65 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.587 -1.405 . . . . 0.33000000000000002 109.587 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -77.46 -88.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -1.158 . . . . 0.33000000000000002 110.33 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.466 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.1 OUTLIER -88.21 136.12 33.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.27000000000000002 110.274 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.94 108.46 35.26 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.34000000000000002 109.745 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.466 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 45.2 Cg_endo -77.51 -68.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.998 1.525 . . . . 0.46999999999999997 110.581 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.634 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 6.3 p90 -40.81 136.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.87 . . . . 0.34999999999999998 110.749 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.483 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 11.1 p30 179.21 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.20000000000000001 110.759 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.544 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 43.17 -158.06 0.1 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.421 -1.472 . . . . 0.25 109.421 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.6 Cg_endo -77.04 8.52 3.14 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.101 1.58 . . . . 0.44 110.304 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.478 ' O ' ' N ' ' A' ' 184' ' ' LEU . 58.3 m -44.67 172.18 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.258 -0.901 . . . . 0.56999999999999995 110.444 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.522 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.91 73.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 C-N-CA 120.393 -0.908 . . . . 0.48999999999999999 110.893 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.559 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 3.2 tt 179.82 87.39 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.014 -1.286 . . . . 0.40999999999999998 111.002 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.51 HD12 ' CE2' ' A' ' 214' ' ' TYR . 8.3 tt -103.72 -22.61 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.686 -1.205 . . . . 0.29999999999999999 110.88 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.659 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.21 100.0 2.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.72 -1.237 . . . . 0.20000000000000001 111.973 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.563 ' NE2' ' CB ' ' A' ' 200' ' ' HIS . 1.2 p80 -100.8 127.38 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.958 -1.089 . . . . 0.16 109.111 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.578 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -115.0 126.22 54.51 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.961 -1.087 . . . . 0.23000000000000001 110.651 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.471 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 2.4 m-85 -71.85 155.93 91.57 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.38 110.185 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.521 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.5 Cg_endo -72.3 141.65 35.96 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.945 1.497 . . . . 0.40000000000000002 109.93 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 64.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.32000000000000001 110.783 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.47 -103.36 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.244 -1.543 . . . . 0.32000000000000001 109.244 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.16 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.925 1.487 . . . . 0.46999999999999997 110.314 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -65.02 -9.34 21.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.63 110.373 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 59.37 0.61 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.34 -0.85 . . . . 0.53000000000000003 110.147 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -137.16 164.81 25.27 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.073 -1.611 . . . . 0.25 109.073 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 57.95 16.93 27.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.354 -1.498 . . . . 0.10000000000000001 109.354 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.455 ' OD1' ' HE2' ' A' ' 164' ' ' MET . 8.4 m-20 -81.94 88.71 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 0.10000000000000001 110.466 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.501 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -62.43 115.51 4.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.089999999999999997 109.894 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.563 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 15.0 m170 -123.44 127.79 48.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.089999999999999997 111.003 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 11.3 m-30 -96.76 132.41 42.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.10000000000000001 110.223 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.546 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.3 OUTLIER -49.98 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.97 -1.122 . . . . 0.14000000000000001 107.97 178.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.4 p30 -35.21 -28.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.17999999999999999 112.267 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.546 ' N ' ' O ' ' A' ' 202' ' ' ASP . 0.1 OUTLIER -78.61 3.31 16.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.427 -1.421 . . . . 0.23999999999999999 110.971 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.521 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 18.0 mm-40 -97.99 -168.97 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.934 -1.104 . . . . 0.41999999999999998 110.229 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.501 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 12.5 m -122.29 151.53 41.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.46999999999999997 110.383 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.501 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.2 m-90 -148.09 141.02 24.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.306 -0.871 . . . . 0.27000000000000002 109.67 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -159.0 179.63 8.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.999 -1.063 . . . . 0.29999999999999999 110.62 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.421 ' OG ' ' O ' ' A' ' 209' ' ' SER . 3.9 t -125.28 49.84 1.85 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.807 -0.757 . . . . 0.60999999999999999 109.551 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.515 ' OG ' ' N ' ' A' ' 211' ' ' SER . 15.9 t -125.84 -144.62 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.78000000000000003 109.962 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.515 ' N ' ' OG ' ' A' ' 210' ' ' SER . 56.6 p -101.95 -27.97 12.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.91000000000000003 110.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 213' ' ' GLY . 2.2 mppt? -93.01 -176.84 4.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.93000000000000005 110.364 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 48.58 -176.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.614 -1.394 . . . . 0.79000000000000004 109.614 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.51 ' CE2' HD12 ' A' ' 185' ' ' LEU . 66.1 m-85 -79.79 118.09 21.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -1.081 . . . . 0.68999999999999995 109.606 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.503 ' ND2' HG22 ' A' ' 247' ' ' THR . 7.8 p30 -83.13 124.77 30.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.933 -1.105 . . . . 0.40000000000000002 108.818 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.669 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -42.2 -36.92 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.17000000000000001 110.522 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.8 m-85 -50.98 -47.12 61.46 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.419 -1.312 . . . . 0.28000000000000003 107.793 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.547 ' CD1' ' HH2' ' A' ' 3' ' ' MSB . 20.3 tp -77.65 -70.7 0.46 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.683 -0.689 . . . . 0.46000000000000002 110.912 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.553 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -49.18 -63.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.035 -1.041 . . . . 0.39000000000000001 109.903 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -50.93 -52.28 43.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.17000000000000001 111.287 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.89 -35.06 66.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.183 -1.573 . . . . 0.10000000000000001 108.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.604 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 5.6 t60 -69.11 -49.48 56.72 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.212 0.529 . . . . 0.20999999999999999 109.738 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.501 ' CG ' ' HB1' ' A' ' 199' ' ' ALA . 2.5 tp10 -64.1 -27.48 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.28000000000000003 108.777 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.416 ' HE2' ' CD2' ' A' ' 142' ' ' PHE . 5.2 m-30 -70.2 -61.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.043 -0.725 . . . . 0.17999999999999999 109.043 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -48.62 -27.72 6.28 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.802 -1.719 . . . . 0.20999999999999999 108.802 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.528 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 1.8 m80 -81.41 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -1.203 . . . . 0.17000000000000001 111.601 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.578 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -58.32 -29.82 66.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.33000000000000002 111.971 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.488 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 7.0 tp -100.21 -39.72 7.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.53000000000000003 111.623 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.456 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -78.36 -79.07 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.211 -1.156 . . . . 0.40999999999999998 110.211 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.5 OUTLIER -170.83 -166.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -1.22 . . . . 0.45000000000000001 110.846 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.0 OUTLIER -55.12 -55.92 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.62 110.573 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.573 ' CD2' ' HB3' ' A' ' 240' ' ' MET . 0.7 OUTLIER -167.25 -179.6 4.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.145 -0.972 . . . . 0.45000000000000001 110.763 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 257' ' ' ASP . 9.9 t 179.5 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.015 -0.735 . . . . 0.38 109.015 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.576 ' HA ' ' HB2' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -128.6 22.03 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -0.811 . . . . 0.47999999999999998 111.247 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.547 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -40.96 -52.38 6.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.438 -0.905 . . . . 0.38 110.101 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.547 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -87.04 -49.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.614 1.323 . . . . 0.28000000000000003 110.589 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.56 99.21 0.12 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.435 -1.364 . . . . 0.23999999999999999 111.543 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.604 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.82 162.8 35.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -1.183 . . . . 0.28000000000000003 110.103 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.592 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -72.5 58.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.40000000000000002 108.823 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.602 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 1.4 mtt -142.74 -36.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.335 -0.853 . . . . 0.45000000000000001 110.432 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.584 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -46.01 174.98 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.235 -0.916 . . . . 0.56999999999999995 110.377 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 48.6 Cg_endo -78.43 22.57 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.476 1.25 . . . . 0.76000000000000001 111.127 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.575 ' O ' ' CE1' ' A' ' 241' ' ' PHE . 12.6 mm -127.76 140.79 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.89000000000000001 109.107 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.596 ' CB ' ' CH ' ' A' ' 3' ' ' MSB . 54.3 p90 -126.29 -31.27 2.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.145 . . . . 0.78000000000000003 110.633 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.541 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER 3.8 -78.52 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 113.152 0.797 . . . . 0.60999999999999999 113.152 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.568 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -43.82 114.79 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.7 -1.25 . . . . 0.73999999999999999 109.687 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.529 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 6.1 m -72.6 172.86 9.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.865 . . . . 0.81000000000000005 110.306 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -53.13 -22.35 13.44 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.351 -1.5 . . . . 0.56000000000000005 109.351 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 48.1 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -1.109 . . . . 0.37 110.193 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -61.03 1.87 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.44 110.465 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.676 ' CD2' ' CE2' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -133.38 -77.16 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.53000000000000003 110.649 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.676 ' CE2' ' CD2' ' A' ' 251' ' ' HIS . 23.1 m-85 -151.17 -178.03 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.38 110.948 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.468 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -66.7 58.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.672 -0.642 . . . . 0.19 110.018 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 2.6 mp -44.32 -47.08 24.92 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.066 -1.087 . . . . 0.28000000000000003 108.066 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.5 Cg_endo -72.49 46.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.894 1.47 . . . . 0.48999999999999999 111.231 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.492 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.5 m-20 -46.7 -32.74 3.77 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.576 -1.328 . . . . 0.48999999999999999 110.367 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.604 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.83 -54.62 40.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.948 -1.101 . . . . 0.31 109.241 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.546 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.88 -33.69 76.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.174 -1.01 . . . . 0.14000000000000001 108.873 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.525 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 74.2 t -67.41 -86.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.17000000000000001 110.566 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.2 tt0 -52.84 -42.18 64.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.008 -1.058 . . . . 0.26000000000000001 109.353 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.72 -70.91 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.368 -1.093 . . . . 0.19 110.368 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.592 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -72.82 -18.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.735 -1.45 . . . . 0.22 110.035 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.586 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 6.6 tt0 -64.37 -21.97 66.8 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.854 -1.138 . . . . 0.39000000000000001 108.355 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.3 p -103.7 -42.42 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.222 -0.591 . . . . 0.46999999999999997 111.502 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.474 ' HB3' ' HG3' ' A' ' 112' ' ' LYS . 7.6 mp -86.15 -46.18 10.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.47999999999999998 111.266 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.495 ' HB3' HD22 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -77.95 -14.24 59.6 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.306 -0.871 . . . . 0.40999999999999998 110.404 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.462 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.33 -94.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.889 -1.684 . . . . 0.46000000000000002 108.889 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.43 109.73 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.083 1.57 . . . . 0.57999999999999996 110.244 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.445 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -82.38 132.96 11.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.552 -1.419 . . . . 0.64000000000000001 109.552 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.607 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -78.59 -66.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.94999999999999996 110.283 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.533 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 27.5 tt0 58.03 21.66 8.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.962 . . . . 1.2 110.032 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -171.27 99.85 0.4 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 1.2 110.245 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.21 66.12 2.68 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.046 1.551 . . . . 1.0600000000000001 110.417 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.022 -0.989 . . . . 0.78000000000000003 110.232 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.604 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.621 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.659 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.188 0.518 . . . . 0.40999999999999998 110.319 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.45 ' C ' ' CG2' ' A' ' 106' ' ' VAL . 8.5 m-80 -141.09 131.07 24.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.26000000000000001 110.129 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.45 ' CG2' ' C ' ' A' ' 105' ' ' ASN . 11.6 t -149.28 -62.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.33000000000000002 110.648 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.37 99.09 39.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.65000000000000002 110.896 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.424 ' C ' ' HG3' ' A' ' 109' ' ' ARG . 47.7 Cg_endo -75.02 54.19 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.861 1.453 . . . . 0.83999999999999997 109.966 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.509 ' NE ' ' OD2' ' A' ' 231' ' ' ASP . 11.9 mtt180 -138.77 53.18 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.93000000000000005 110.28 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.507 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 4.8 p -119.97 -55.77 2.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 1.03 109.851 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.488 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.5 mm? 39.12 47.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 1.04 111.118 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.514 ' CG ' ' HB3' ' A' ' 265' ' ' LEU . 2.1 tptm -128.17 60.99 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.003 . . . . 0.77000000000000002 109.967 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.539 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 10.7 t90 -139.48 -65.55 0.47 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.41999999999999998 110.637 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.526 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 79.1 p -98.85 46.15 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.44 110.562 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 6.9 mmpt? -130.09 76.41 1.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.48999999999999999 110.248 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 8.5 tmm? -111.85 -3.4 14.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.29999999999999999 110.173 179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.448 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -159.11 125.78 4.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.14999999999999999 109.859 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.462 HD21 ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.4 -177.06 5.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.13 110.751 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.535 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -127.29 165.88 18.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.12 109.848 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.555 ' CB ' HG13 ' A' ' 163' ' ' ILE . 46.1 p90 -162.89 -176.77 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.025 -1.047 . . . . 0.33000000000000002 111.367 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -140.38 155.45 46.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.54000000000000004 110.23 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.594 HG13 ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -114.41 123.5 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.494 -0.754 . . . . 0.33000000000000002 111.134 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.54 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 1.2 m -165.86 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.27000000000000002 109.72 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.48 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 0.9 OUTLIER -39.68 -80.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.718 . . . . 0.40999999999999998 109.395 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.565 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 4.9 t80 -179.2 -159.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.432 -0.792 . . . . 0.40000000000000002 109.527 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.547 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -154.0 50.38 0.56 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.45000000000000001 110.656 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.547 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.65 -85.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.807 1.425 . . . . 0.35999999999999999 110.388 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.6 0.45 49.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.25 109.982 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.03 160.04 22.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.39000000000000001 110.168 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.7 m -106.33 168.86 8.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.47999999999999998 110.254 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -44.7 -32.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.40000000000000002 109.806 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.459 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -66.28 -49.36 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.46000000000000002 109.562 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 1.8 mp0 -60.79 -57.64 11.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.249 -0.907 . . . . 0.46999999999999997 109.17 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.435 ' C ' ' O ' ' A' ' 133' ' ' GLU . 5.6 t -46.22 -36.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.761 -1.2 . . . . 0.31 107.761 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.48 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -56.89 -42.38 79.74 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.03 -1.1 . . . . 0.47999999999999998 108.03 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.4 tttt -71.24 -49.98 37.63 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.65 -0.87 . . . . 0.64000000000000001 108.65 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.658 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.83 -57.39 4.36 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.96 -1.087 . . . . 0.41999999999999998 109.749 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.602 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -65.11 -56.29 13.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.34000000000000002 110.734 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.602 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.61 -73.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.984 . . . . 0.46999999999999997 110.157 -179.494 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -36.87 -60.99 0.58 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.823 -0.548 . . . . 0.46999999999999997 110.667 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.46 -40.95 19.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.618 -1.301 . . . . 0.25 108.709 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 138' ' ' PHE . 2.5 m-85 -69.38 -32.97 72.35 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.998 . . . . 0.34999999999999998 108.774 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 17.1 tttm -56.15 -41.66 75.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.977 -1.119 . . . . 0.69999999999999996 107.977 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.448 ' O ' HG23 ' A' ' 148' ' ' VAL . 10.9 t -67.11 -41.91 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.537 -0.912 . . . . 0.60999999999999999 108.537 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.593 ' CH2' HG13 ' A' ' 262' ' ' ILE . 25.5 t-105 -54.9 -38.67 67.89 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.819 -0.808 . . . . 0.39000000000000001 108.819 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.7 OUTLIER -75.95 -41.23 52.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.347 -0.846 . . . . 0.34999999999999998 108.74 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.43 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 3.0 m-20 -50.47 -33.3 20.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.968 -0.753 . . . . 0.35999999999999999 108.968 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.0 m -91.16 -38.52 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.532 -0.73 . . . . 0.5 110.108 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.513 ' N ' HG22 ' A' ' 148' ' ' VAL . 14.1 t -149.43 124.15 4.78 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.51000000000000001 110.136 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.21 59.27 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.859 1.452 . . . . 0.31 110.599 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.518 ' CD2' ' O ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -73.81 139.24 45.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.17999999999999999 110.154 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.448 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 7.4 t-20 -76.62 105.49 7.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.17000000000000001 109.912 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.503 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 7.8 p90 -117.34 143.67 45.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.14000000000000001 110.479 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.468 ' O ' ' HA ' ' A' ' 119' ' ' THR . 20.5 m -141.27 145.6 35.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.927 . . . . 0.14999999999999999 110.125 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.519 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -124.84 79.87 1.82 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.706 -0.621 . . . . 0.20000000000000001 110.152 -178.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -85.42 114.73 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.22 110.092 179.877 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -56.42 -18.0 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.32000000000000001 109.98 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -23.25 5.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.449 -0.782 . . . . 0.33000000000000002 109.632 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.42 7.94 5.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.534 -1.426 . . . . 0.28000000000000003 109.534 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.535 ' O ' ' HB ' ' A' ' 119' ' ' THR . 8.7 mt -87.91 91.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.126 -1.22 . . . . 0.29999999999999999 109.034 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.462 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -154.98 107.07 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.968 -0.693 . . . . 0.20000000000000001 110.336 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.462 ' CB ' HD21 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -76.51 -42.74 42.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.10000000000000001 109.808 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.555 HG13 ' CB ' ' A' ' 120' ' ' TYR . 1.1 pt -118.09 171.91 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.10000000000000001 109.546 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.461 ' O ' ' CB ' ' A' ' 199' ' ' ALA . 1.8 ptp -170.08 157.28 6.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.715 -1.241 . . . . 0.11 111.188 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.54 ' CD1' ' HB1' ' A' ' 220' ' ' ALA . 2.0 tt -104.9 120.78 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.10000000000000001 109.806 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.463 ' O ' ' HA ' ' A' ' 200' ' ' HIS . 11.5 p -162.45 156.4 21.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.786 -1.196 . . . . 0.10000000000000001 111.142 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.9 p90 -73.17 118.43 16.12 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.493 -0.755 . . . . 0.089999999999999997 109.272 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -76.9 131.66 11.54 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.46 -1.056 . . . . 0.20000000000000001 110.46 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.583 ' O ' ' C ' ' A' ' 170' ' ' LYS . 2.5 tp -126.34 93.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.614 -0.933 . . . . 0.55000000000000004 109.154 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 0.87 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.358 0.599 . . . . 0.84999999999999998 112.466 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -148.69 17.22 1.01 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.343 -0.848 . . . . 0.70999999999999996 109.861 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.401 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m170 -78.96 -68.84 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.39 -0.819 . . . . 0.41999999999999998 110.306 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.72 34.86 0.42 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.446 -1.461 . . . . 0.33000000000000002 109.446 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -149.06 -69.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -1.11 . . . . 0.33000000000000002 110.091 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -123.29 174.48 7.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.27000000000000002 110.167 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.4 m-30 -98.57 110.34 56.49 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.34000000000000002 110.237 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.487 ' CD ' ' HD2' ' A' ' 170' ' ' LYS . 41.9 Cg_endo -73.33 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.968 1.51 . . . . 0.46999999999999997 110.616 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.582 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.6 OUTLIER -49.58 142.05 8.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.34999999999999998 110.575 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.477 ' O ' ' HB2' ' A' ' 182' ' ' SER . 5.5 p30 179.64 80.3 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.202 -0.936 . . . . 0.20000000000000001 110.453 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.511 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.72 -155.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.398 . . . . 0.25 109.606 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.7 Cg_endo -77.34 8.65 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.077 1.567 . . . . 0.44 110.573 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.2 t -42.75 166.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.56999999999999995 110.318 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.544 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.45 73.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.712 -0.955 . . . . 0.48999999999999999 110.712 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.52 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 1.0 OUTLIER 179.86 87.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.193 -1.181 . . . . 0.40999999999999998 110.649 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.56 HD13 ' CD2' ' A' ' 214' ' ' TYR . 7.8 tt -103.85 -23.05 13.42 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.616 -1.234 . . . . 0.29999999999999999 110.969 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.631 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -151.94 106.2 3.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.524 -1.36 . . . . 0.20000000000000001 112.333 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.521 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.2 OUTLIER -101.84 133.02 47.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.16 109.229 178.427 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.58 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -122.09 118.72 29.38 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.134 -0.978 . . . . 0.23000000000000001 110.476 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.433 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-85 -67.86 167.48 16.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.38 110.372 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.483 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.4 Cg_endo -72.89 136.65 25.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.145 1.603 . . . . 0.40000000000000002 109.856 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.0 84.62 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.903 1.475 . . . . 0.32000000000000001 110.561 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.9 -102.22 0.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.958 -1.257 . . . . 0.32000000000000001 109.958 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.34 -163.6 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.46999999999999997 110.859 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.89 -7.28 26.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.404 -0.81 . . . . 0.63 110.152 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.46 48.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.383 -0.823 . . . . 0.53000000000000003 109.838 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -136.06 169.23 23.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.029 -1.629 . . . . 0.25 109.029 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.584 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 57.31 17.68 25.78 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.088 -1.605 . . . . 0.10000000000000001 109.088 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.86 91.31 4.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.429 -1.042 . . . . 0.10000000000000001 110.508 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.505 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -73.47 95.93 2.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.089999999999999997 109.866 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.521 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 28.7 m170 -111.93 134.45 53.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.089999999999999997 110.887 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.4 m-85 -104.51 137.6 42.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.154 -0.966 . . . . 0.10000000000000001 110.59 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.522 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.7 OUTLIER -47.03 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.14000000000000001 108.554 179.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.2 p30 -36.88 -27.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.516 -0.74 . . . . 0.17999999999999999 112.046 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.525 ' N ' ' OD1' ' A' ' 203' ' ' ASP . 1.0 OUTLIER -78.79 2.93 18.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.488 -1.383 . . . . 0.23999999999999999 110.848 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.479 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 11.6 mm-40 -95.91 -168.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.942 -1.099 . . . . 0.41999999999999998 110.237 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.8 m -123.72 140.21 53.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.46999999999999997 110.498 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.542 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.8 OUTLIER -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.27000000000000002 109.312 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.544 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.33 178.61 9.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.959 -1.088 . . . . 0.29999999999999999 110.792 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.407 ' OG ' ' CZ ' ' A' ' 217' ' ' PHE . 29.9 t -130.48 32.37 4.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.534 0.683 . . . . 0.60999999999999999 109.285 179.055 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -103.98 -90.87 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.78000000000000003 110.686 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -157.21 -33.97 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.462 -0.774 . . . . 0.91000000000000003 109.793 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 213' ' ' GLY . 3.5 pttt -87.91 -171.96 3.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.93000000000000005 109.932 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 45.42 -155.59 0.44 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.243 -1.543 . . . . 0.79000000000000004 109.243 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.56 ' CD2' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -94.13 126.24 39.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -1.193 . . . . 0.68999999999999995 109.931 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.494 ' HA ' ' O ' ' A' ' 208' ' ' THR . 42.6 m-80 -89.65 121.4 31.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.018 -1.051 . . . . 0.40000000000000002 108.879 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.658 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -41.59 -37.84 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.611 -0.836 . . . . 0.17000000000000001 110.375 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' CD1' ' N ' ' A' ' 217' ' ' PHE . 3.1 m-30 -51.67 -46.91 63.98 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.382 -1.327 . . . . 0.28000000000000003 107.585 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.562 ' CD1' ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.26 -73.4 0.28 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.781 -0.645 . . . . 0.46000000000000002 110.277 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.548 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.61 -65.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.39000000000000001 110.302 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -49.66 -48.87 49.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.366 -0.834 . . . . 0.17000000000000001 111.737 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.99 -41.71 92.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.185 -1.572 . . . . 0.10000000000000001 108.645 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.604 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.3 t60 -60.2 -51.26 70.33 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.377 0.608 . . . . 0.20999999999999999 109.792 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.505 ' CG ' ' HB1' ' A' ' 199' ' ' ALA . 2.0 tp10 -64.8 -29.16 70.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.092 -1.005 . . . . 0.28000000000000003 109.138 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 220' ' ' ALA . 13.8 m-30 -66.12 -64.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.447 -0.783 . . . . 0.17999999999999999 109.177 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -49.84 -26.7 8.52 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.045 -1.622 . . . . 0.20999999999999999 109.045 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -78.93 -58.7 3.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.081 -1.247 . . . . 0.17000000000000001 111.557 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.584 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.9 OUTLIER -69.22 -23.77 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.33000000000000002 111.78 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.523 ' CD2' ' OH ' ' A' ' 266' ' ' TYR . 0.8 OUTLIER -99.21 -43.82 6.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.028 -1.045 . . . . 0.53000000000000003 111.258 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -83.03 -70.86 1.33 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.184 -1.008 . . . . 0.40999999999999998 110.589 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.525 HD22 ' N ' ' A' ' 230' ' ' LEU . 0.4 OUTLIER -165.01 -162.11 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.241 . . . . 0.45000000000000001 110.86 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -75.01 -51.7 12.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.62 110.34 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.622 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.8 OUTLIER -162.48 172.79 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.45000000000000001 110.959 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.412 ' O ' ' OG ' ' A' ' 233' ' ' SER . 5.7 t 179.56 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.615 -0.678 . . . . 0.38 109.24 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.623 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -117.19 20.26 13.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.47999999999999998 111.005 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -30.55 -53.81 0.38 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.894 -0.503 . . . . 0.38 111.507 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.7 Cg_endo -89.49 -47.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.4 1.21 . . . . 0.28000000000000003 111.063 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.12 100.54 0.13 Allowed Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.498 -1.334 . . . . 0.23999999999999999 111.268 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -146.78 168.73 20.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.131 -1.217 . . . . 0.28000000000000003 110.518 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.604 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.7 OUTLIER -73.67 55.42 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.301 -0.875 . . . . 0.40000000000000002 109.011 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.581 ' HA ' ' CE1' ' A' ' 226' ' ' HIS . 1.9 mtt -140.87 -5.6 1.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.288 -0.882 . . . . 0.45000000000000001 111.356 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -79.71 168.82 23.4 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.932 -1.105 . . . . 0.56999999999999995 110.134 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.518 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -69.56 -4.27 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.848 1.447 . . . . 0.76000000000000001 110.665 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.605 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 50.2 mm -104.63 143.87 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.89000000000000001 109.808 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.562 ' HB2' ' CD1' ' A' ' 218' ' ' LEU . 42.8 p90 -131.39 -28.95 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.948 -1.095 . . . . 0.78000000000000003 110.913 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.53 ' C ' ' O ' ' A' ' 244' ' ' TYR . 98.8 m 2.79 -69.63 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.412 0.893 . . . . 0.60999999999999999 113.412 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -55.81 101.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.604 -1.31 . . . . 0.73999999999999999 109.511 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.494 ' N ' ' HB3' ' A' ' 250' ' ' SER . 0.2 OUTLIER -48.09 179.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.431 -0.793 . . . . 0.81000000000000005 110.263 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.71 -29.25 25.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.446 -1.461 . . . . 0.56000000000000005 109.446 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -143.1 31.24 1.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.37 110.084 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.494 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.4 OUTLIER -59.56 -23.03 62.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.44 110.186 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 6.8 t-80 -156.21 -67.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.882 . . . . 0.53000000000000003 110.004 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.1 m-85 -168.38 -178.36 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.38 110.164 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.479 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 5.6 ptt? -72.26 54.99 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.72 . . . . 0.19 110.225 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.69 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 7.6 tp -45.03 -46.07 28.53 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 107.975 -1.12 . . . . 0.28000000000000003 107.975 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -71.58 48.19 0.99 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.76 1.4 . . . . 0.48999999999999999 110.944 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.59 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.2 m-20 -52.63 -27.14 15.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.855 -1.153 . . . . 0.48999999999999999 110.575 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.608 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -57.15 -43.76 82.78 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.578 -1.249 . . . . 0.31 109.454 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -79.57 -32.95 42.1 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.184 -1.006 . . . . 0.14000000000000001 108.548 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.59 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 54.4 t -65.43 -75.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.816 0.817 . . . . 0.17000000000000001 110.019 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.533 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -63.57 -34.1 77.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.768 . . . . 0.26000000000000001 109.612 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -49.53 -67.24 1.85 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.124 -1.19 . . . . 0.19 110.124 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.593 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -70.35 -21.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.811 -1.405 . . . . 0.22 109.895 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.533 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 20.4 tp60 -67.31 -19.44 65.47 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.028 -1.045 . . . . 0.39000000000000001 108.625 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.1 m -103.41 -38.6 7.12 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.119 -0.633 . . . . 0.46999999999999997 111.709 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.514 ' HB3' ' CG ' ' A' ' 112' ' ' LYS . 8.5 mp -97.79 -42.51 7.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.179 -0.951 . . . . 0.47999999999999998 111.166 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -72.15 -21.48 61.45 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.37 -0.831 . . . . 0.40999999999999998 109.808 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -55.6 -97.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.293 -1.523 . . . . 0.46000000000000002 109.293 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.7 108.29 2.52 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.044 1.549 . . . . 0.57999999999999996 110.258 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.17 151.43 23.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.696 -1.362 . . . . 0.64000000000000001 109.696 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.539 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 6.8 t0 -95.05 -57.79 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.94999999999999996 110.203 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.526 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 14.5 tt0 43.85 38.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.2 110.192 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.87 144.17 11.91 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 1.2 110.036 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.25 91.91 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.033 1.544 . . . . 1.0600000000000001 110.32 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.08 -0.962 . . . . 0.78000000000000003 110.262 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.59 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.594 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.631 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 34.4 p90 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.287 0.565 . . . . 0.40999999999999998 110.204 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.85 85.18 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.26000000000000001 110.17 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.1 t -92.25 -40.31 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.33000000000000002 110.2 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.1 106.13 33.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.836 . . . . 0.65000000000000002 110.217 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.455 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.9 Cg_endo -72.86 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.927 1.488 . . . . 0.83999999999999997 110.287 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.484 ' O ' HG22 ' A' ' 110' ' ' THR . 47.5 mtt-85 64.99 75.24 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.93000000000000005 110.304 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.493 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -158.21 -58.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.463 -0.773 . . . . 1.03 109.71 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.534 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 5.9 mp 32.08 37.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.079 0.466 . . . . 1.04 111.454 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -121.51 42.6 3.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.77000000000000002 109.869 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.576 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 22.7 t90 -110.63 -65.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.853 . . . . 0.41999999999999998 110.106 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 31.9 t -102.36 60.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.44 110.267 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 0.0 OUTLIER -146.26 85.48 1.66 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.935 . . . . 0.48999999999999999 110.617 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.419 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 ttt -119.82 -18.33 8.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.29999999999999999 110.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 8.7 p30 -157.3 111.88 2.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.14999999999999999 109.984 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -133.08 -160.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.13 110.466 -179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.467 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -137.91 155.35 49.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.12 110.275 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.599 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 13.2 p90 -152.73 -167.6 2.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.247 -0.908 . . . . 0.33000000000000002 110.857 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.412 ' N ' ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.36 155.94 47.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.54000000000000004 110.662 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.561 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 5.6 pt -112.67 115.75 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.805 . . . . 0.33000000000000002 110.698 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 1.1 m -165.72 42.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.201 -0.937 . . . . 0.27000000000000002 110.301 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 125' ' ' TYR . 2.5 t-20 -42.28 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.40999999999999998 109.742 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.518 ' N ' ' OD1' ' A' ' 124' ' ' ASN . 4.8 t80 -179.32 -155.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -0.795 . . . . 0.40000000000000002 109.497 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.543 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -161.26 51.47 0.36 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.45000000000000001 110.583 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.543 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -78.14 -85.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.906 1.477 . . . . 0.35999999999999999 109.963 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.93 -2.09 56.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.25 109.638 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.535 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -121.06 160.75 22.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.39000000000000001 110.137 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.14 -175.05 2.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.875 . . . . 0.47999999999999998 110.211 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.43 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -48.46 -37.49 17.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.40000000000000002 109.978 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.469 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t -60.47 -50.08 75.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.46000000000000002 109.845 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.535 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 7.7 mp0 -64.88 -63.64 1.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.194 -0.941 . . . . 0.46999999999999997 109.92 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.452 ' C ' ' O ' ' A' ' 133' ' ' GLU . 16.3 t -42.96 -37.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.694 -0.854 . . . . 0.31 108.694 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.569 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 6.5 mt-10 -59.24 -43.23 92.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.387 -0.968 . . . . 0.47999999999999998 108.387 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.5 tttp -70.33 -47.34 61.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.416 -0.957 . . . . 0.64000000000000001 108.416 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.646 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.79 -60.71 2.07 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.31 -0.868 . . . . 0.41999999999999998 110.101 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -66.96 -52.31 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.34000000000000002 110.897 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 4.1 tttt -66.58 -73.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.84 -1.162 . . . . 0.46999999999999997 110.124 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.71 -60.8 0.79 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.754 -0.592 . . . . 0.46999999999999997 110.779 179.006 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.28 -38.93 13.42 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.54 -1.264 . . . . 0.25 108.341 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -70.08 -33.66 72.19 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.611 -0.836 . . . . 0.34999999999999998 108.976 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -56.31 -41.55 76.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.931 -1.137 . . . . 0.69999999999999996 107.931 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 12.6 t -66.05 -41.73 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.578 -0.897 . . . . 0.60999999999999999 108.578 178.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.585 ' CH2' HG13 ' A' ' 262' ' ' ILE . 27.9 t-105 -56.88 -39.21 73.94 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.818 -0.808 . . . . 0.39000000000000001 108.818 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 149' ' ' THR . 69.1 m -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.427 -0.796 . . . . 0.34999999999999998 108.854 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -54.89 -37.51 66.39 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.586 -0.696 . . . . 0.35999999999999999 109.359 179.076 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 26.8 m -84.82 -34.86 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.5 110.195 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.522 ' N ' HG22 ' A' ' 148' ' ' VAL . 14.4 t -152.12 131.63 6.87 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.51000000000000001 110.264 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.41 59.05 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.965 1.508 . . . . 0.31 110.808 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.625 ' CD2' ' CD1' ' A' ' 266' ' ' TYR . 3.6 mp -76.88 169.09 18.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.17999999999999999 110.014 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -114.64 116.42 28.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.17000000000000001 110.568 -179.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.532 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 8.4 p90 -126.33 125.78 42.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.14000000000000001 109.723 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.467 ' O ' ' HA ' ' A' ' 119' ' ' THR . 10.7 m -125.72 133.08 52.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.197 -0.94 . . . . 0.14999999999999999 110.62 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.599 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.31 81.71 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.20000000000000001 109.877 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.526 ' CG ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -60.43 129.79 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.22 110.49 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -91.79 40.61 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.44 -0.787 . . . . 0.32000000000000001 109.921 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.464 ' OD2' HD11 ' A' ' 160' ' ' ILE . 3.2 t0 -135.55 -38.95 0.73 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.33000000000000002 109.52 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 144.2 37.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.661 -1.376 . . . . 0.28000000000000003 109.661 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.526 HD13 ' CG ' ' A' ' 156' ' ' LEU . 3.1 mp -123.82 69.45 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.29999999999999999 109.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.467 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -144.47 156.29 44.12 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.032 -0.667 . . . . 0.20000000000000001 110.111 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -23.52 5.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.10000000000000001 110.337 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.546 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tt -125.49 168.51 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.178 -0.951 . . . . 0.10000000000000001 110.142 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.48 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 11.9 ptp -177.3 151.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.522 -1.361 . . . . 0.11 111.645 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.546 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 5.4 tt -97.98 112.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.593 -0.692 . . . . 0.10000000000000001 110.032 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.469 ' O ' ' HA ' ' A' ' 200' ' ' HIS . 4.4 p -153.76 149.71 27.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.901 -1.125 . . . . 0.10000000000000001 110.39 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 8.0 p90 -68.64 127.53 33.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.089999999999999997 109.758 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.67 120.99 6.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.235 -1.146 . . . . 0.20000000000000001 110.235 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.569 ' O ' ' CG2' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.33 102.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.445 -1.032 . . . . 0.55000000000000004 109.135 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.578 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 26.1 tptp 1.07 84.08 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.422 0.629 . . . . 0.84999999999999998 112.532 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.46 0.76 4.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.70999999999999996 109.942 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 10.8 m-70 -74.01 -81.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.878 . . . . 0.41999999999999998 110.331 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.97 8.3 7.41 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.194 -1.562 . . . . 0.33000000000000002 109.194 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.417 ' OD2' ' CE2' ' A' ' 175' ' ' PHE . 3.1 t0 -126.3 -70.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -1.103 . . . . 0.33000000000000002 110.198 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.467 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 98.3 m-85 -107.25 144.5 33.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.27000000000000002 110.093 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -63.65 111.07 4.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.34000000000000002 110.355 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 49.7 Cg_endo -78.74 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.976 1.514 . . . . 0.46999999999999997 110.444 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.596 ' CD2' ' OD2' ' A' ' 203' ' ' ASP . 0.4 OUTLIER -94.21 178.59 5.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.34999999999999998 110.232 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.3 p-10 -180.0 -53.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.923 . . . . 0.20000000000000001 110.804 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.565 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 146.39 -134.98 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.364 -1.494 . . . . 0.25 109.364 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.11 -1.6 10.78 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 124.053 1.554 . . . . 0.44 109.809 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.427 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -57.02 -177.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.428 -0.795 . . . . 0.56999999999999995 110.296 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.545 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -81.3 76.55 2.15 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.575 -1.01 . . . . 0.48999999999999999 110.575 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.543 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 5.5 tt 179.64 94.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.273 -1.133 . . . . 0.40999999999999998 110.789 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.579 HD11 ' CG ' ' A' ' 214' ' ' TYR . 8.6 tt -112.13 -18.45 12.57 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.554 -1.258 . . . . 0.29999999999999999 111.109 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.624 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.11 109.56 3.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.503 -1.373 . . . . 0.20000000000000001 111.832 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -121.35 135.59 55.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.16 109.971 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.539 ' CB ' ' HB3' ' A' ' 227' ' ' SER . . . -123.78 160.8 26.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.096 -1.003 . . . . 0.23000000000000001 110.454 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 1.1 m-30 -99.04 170.23 7.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.38 110.176 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.474 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.8 Cg_endo -71.74 128.3 14.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.562 . . . . 0.40000000000000002 109.745 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.469 ' HA ' ' HA3' ' A' ' 196' ' ' GLY . 42.9 Cg_endo -69.05 68.3 1.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.873 1.459 . . . . 0.32000000000000001 110.62 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.98 -83.67 1.2 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.267 -1.533 . . . . 0.32000000000000001 109.267 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 -159.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.559 . . . . 0.46999999999999997 110.042 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.12 0.52 27.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.63 110.34 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.74 40.84 2.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.319 -0.863 . . . . 0.53000000000000003 110.326 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -108.63 -179.3 21.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.961 -1.656 . . . . 0.25 108.961 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.481 ' O ' HG13 ' A' ' 163' ' ' ILE . . . 38.91 27.13 0.05 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.213 -1.155 . . . . 0.10000000000000001 110.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 196' ' ' GLY . 0.8 OUTLIER -77.59 88.23 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.331 . . . . 0.10000000000000001 109.25 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.489 ' HB3' ' HA ' ' A' ' 165' ' ' ILE . . . -71.72 90.24 1.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.089999999999999997 110.74 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.499 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 12.8 m170 -100.86 120.83 40.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.089999999999999997 109.909 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 203' ' ' ASP . 20.2 m-85 -89.6 135.24 33.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.156 -0.965 . . . . 0.10000000000000001 110.722 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.543 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 58.8 t0 -44.2 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.857 -0.794 . . . . 0.14000000000000001 108.857 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.9 p30 -41.76 -31.64 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.17999999999999999 111.49 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.565 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 17.1 t0 -71.15 -5.54 32.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.558 -1.338 . . . . 0.23999999999999999 110.329 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.472 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 16.6 mm-40 -93.73 -164.71 1.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.088 . . . . 0.41999999999999998 109.878 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.559 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 33.3 m -127.37 159.08 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.128 . . . . 0.46999999999999997 110.769 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.559 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.2 m-90 -150.12 142.8 24.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.27000000000000002 109.555 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -153.93 173.65 15.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.853 -1.154 . . . . 0.29999999999999999 110.795 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.447 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.8 t -128.21 29.79 5.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.781 0.8 . . . . 0.60999999999999999 108.945 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 -72.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.504 0.669 . . . . 0.78000000000000003 110.108 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.132 -0.692 . . . . 0.91000000000000003 109.132 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.43 133.17 33.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.548 -0.72 . . . . 0.93000000000000005 109.553 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.18 -171.54 38.81 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.109 -1.596 . . . . 0.79000000000000004 109.109 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.579 ' CG ' HD11 ' A' ' 185' ' ' LEU . 66.1 m-85 -75.66 113.54 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.68999999999999995 109.999 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' A' ' 208' ' ' THR . 34.5 m-80 -79.87 121.97 26.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.054 -1.028 . . . . 0.40000000000000002 108.627 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.646 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -40.56 -38.01 0.8 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.329 -0.857 . . . . 0.17000000000000001 110.504 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 3.3 m-85 -52.97 -48.33 67.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.529 -1.268 . . . . 0.28000000000000003 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.56 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 40.9 tp -72.06 -71.36 0.28 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.978 -0.556 . . . . 0.46000000000000002 110.185 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.533 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -51.32 -70.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.156 -0.965 . . . . 0.39000000000000001 110.144 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -42.22 -50.21 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.876 -1.14 . . . . 0.17000000000000001 111.565 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -60.86 -34.7 75.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.309 -1.494 . . . . 0.10000000000000001 108.924 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.592 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.7 t60 -69.33 -50.83 42.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.465 0.65 . . . . 0.20999999999999999 109.792 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.496 ' OE2' ' CB ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -60.9 -44.09 97.62 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.28000000000000003 109.181 178.839 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.512 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 7.4 m-85 -55.08 -62.02 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.17999999999999999 108.926 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.46 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.62 -32.03 1.9 Allowed Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.804 -1.718 . . . . 0.20999999999999999 108.804 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.578 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.41 -71.96 0.43 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -1.174 . . . . 0.17000000000000001 111.068 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.539 ' HB3' ' CB ' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.05 -44.19 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.33000000000000002 112.006 -178.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.473 ' HB3' ' OH ' ' A' ' 266' ' ' TYR . 0.8 OUTLIER -100.37 -37.41 8.87 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.784 -1.197 . . . . 0.53000000000000003 111.328 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -67.66 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.173 -1.171 . . . . 0.40999999999999998 110.173 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.578 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.8 OUTLIER -169.21 -172.62 1.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.45000000000000001 110.936 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 1.9 m-20 -53.05 -58.04 8.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.62 110.172 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.578 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -163.67 179.63 7.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.45000000000000001 111.017 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.515 ' N ' ' SD ' ' A' ' 240' ' ' MET . 1.8 t 179.53 54.35 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.083 -0.71 . . . . 0.38 109.083 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.31 23.89 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.47999999999999998 111.351 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -38.72 -47.01 3.35 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.36 -0.936 . . . . 0.38 109.346 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 43.0 Cg_endo -92.1 -47.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.029 1.542 . . . . 0.28000000000000003 110.968 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.514 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 176.83 100.9 0.14 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.725 -1.703 . . . . 0.23999999999999999 112.506 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -148.08 160.92 42.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.317 -1.108 . . . . 0.28000000000000003 109.998 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.592 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 1.0 OUTLIER -69.31 62.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.076 0.941 . . . . 0.40000000000000002 108.596 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.566 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.7 mtt -146.56 -33.98 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.59 -0.694 . . . . 0.45000000000000001 110.758 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -44.13 168.5 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.56999999999999995 110.325 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.4 Cg_endo -72.66 -12.51 26.77 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.879 1.463 . . . . 0.76000000000000001 109.817 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.568 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 5.9 tt -98.25 151.09 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.89000000000000001 109.695 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.56 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 32.6 p90 -131.89 -28.28 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.78000000000000003 111.038 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.532 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 2.45 -69.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 113.196 0.813 . . . . 0.60999999999999999 113.196 -179.009 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.588 ' CD2' ' O ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -67.96 104.25 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.547 -1.346 . . . . 0.73999999999999999 109.554 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.511 ' HA ' HD22 ' A' ' 218' ' ' LEU . 26.5 p -56.08 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.81000000000000005 110.352 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.4 -7.15 57.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.56000000000000005 109.495 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -149.21 27.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -1.16 . . . . 0.37 110.174 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.533 ' HB3' ' CD1' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -68.21 -13.93 62.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.44 110.339 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.0 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.53000000000000003 110.326 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -167.54 178.39 5.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.38 110.501 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.509 ' HE3' ' CE2' ' A' ' 252' ' ' PHE . 4.7 ptp -68.23 53.98 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.393 -0.817 . . . . 0.19 110.61 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.674 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -43.97 -48.34 22.22 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.131 -1.063 . . . . 0.28000000000000003 108.131 177.655 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.674 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -72.49 48.05 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 124.125 1.592 . . . . 0.48999999999999999 111.251 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.575 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.3 m-20 -52.77 -30.86 35.22 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.763 -1.211 . . . . 0.48999999999999999 109.761 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.55 ' HB2' ' CB ' ' A' ' 238' ' ' ALA . 3.1 m-20 -50.47 -45.59 56.34 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.589 -0.844 . . . . 0.31 109.57 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -80.18 -32.31 38.71 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.379 -0.971 . . . . 0.14000000000000001 108.379 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.575 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 83.6 t -60.35 -73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.17000000000000001 110.072 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.642 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 6.2 pt20 -72.52 -31.35 65.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.331 -0.855 . . . . 0.26000000000000001 110.094 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -47.73 -57.79 7.33 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.092 -1.603 . . . . 0.19 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.585 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -83.5 -21.71 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -1.228 . . . . 0.22 110.674 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.642 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 29.6 tt0 -64.47 -20.01 65.92 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.493 -1.379 . . . . 0.39000000000000001 108.348 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 2.8 p -103.68 -38.98 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.152 -0.619 . . . . 0.46999999999999997 111.354 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.457 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.9 mp -90.88 -44.57 9.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.103 -0.998 . . . . 0.47999999999999998 111.343 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.625 ' CD1' ' CD2' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -72.92 -10.91 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.40999999999999998 110.057 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.419 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -60.75 -92.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.461 . . . . 0.46000000000000002 109.446 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 117.03 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.57999999999999996 110.332 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.06 123.72 7.88 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.446 -1.462 . . . . 0.64000000000000001 109.446 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.576 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -69.22 -63.71 1.01 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.94999999999999996 109.93 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.517 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 tt0 50.15 28.96 3.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 1.2 110.149 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.62 125.66 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 1.2 110.07 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.66 81.45 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.843 1.443 . . . . 1.0600000000000001 110.511 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.999 -1.001 . . . . 0.78000000000000003 110.223 179.905 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.59 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.615 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.624 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.278 0.561 . . . . 0.40999999999999998 110.214 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -122.88 96.22 4.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.965 . . . . 0.26000000000000001 110.26 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 m -89.7 -179.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.33000000000000002 110.196 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -60.84 131.51 91.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.65000000000000002 110.194 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.53 61.68 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.824 1.434 . . . . 0.83999999999999997 110.565 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.477 ' O ' HG23 ' A' ' 110' ' ' THR . 23.6 mtp180 -142.0 63.26 1.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.223 -0.923 . . . . 0.93000000000000005 110.12 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.533 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -148.52 -64.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 1.03 109.944 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.2 OUTLIER 33.15 53.76 0.41 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.909 -0.494 . . . . 1.04 111.881 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.533 ' HE2' ' CB ' ' A' ' 110' ' ' THR . 17.4 pttt -140.75 78.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.77000000000000002 109.688 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.584 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 11.6 t90 -142.27 -71.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.41999999999999998 111.017 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.527 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 95.4 p -101.13 60.67 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.44 110.489 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.472 ' HG2' ' O ' ' A' ' 114' ' ' SER . 30.3 mttp -148.72 78.72 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.48999999999999999 110.183 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.46 ' HA ' HD12 ' A' ' 151' ' ' LEU . 12.6 ttt -105.71 -13.01 15.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 0.29999999999999999 109.956 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.475 ' OD1' ' HB3' ' A' ' 152' ' ' ASN . 6.4 t30 -151.86 124.64 8.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.14999999999999999 109.993 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.455 HD11 ' O ' ' A' ' 117' ' ' ASN . 3.2 tp -145.99 -170.2 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.13 110.258 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.524 ' CG2' ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -122.05 158.05 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.12 110.161 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.572 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 37.0 p90 -151.06 169.2 22.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.367 -0.833 . . . . 0.33000000000000002 110.704 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.452 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -120.87 147.1 45.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -0.816 . . . . 0.54000000000000004 109.776 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.56 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.7 pp -112.87 120.45 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.116 -0.99 . . . . 0.33000000000000002 110.997 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.535 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 1.0 OUTLIER -164.77 49.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.838 . . . . 0.27000000000000002 109.416 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 124' ' ' ASN . 1.4 m120 -39.67 -84.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.696 -0.627 . . . . 0.40999999999999998 109.843 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.585 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.8 t80 179.89 -168.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.40000000000000002 109.089 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.592 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -138.61 42.71 0.6 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.707 -1.246 . . . . 0.45000000000000001 111.705 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -76.96 -83.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.484 1.255 . . . . 0.35999999999999999 110.506 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.9 m-20 -107.83 -0.9 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.25 110.053 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.56 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -126.39 89.95 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.39000000000000001 109.778 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.465 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -48.21 -179.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.47999999999999998 110.939 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -48.49 -39.27 22.54 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.40000000000000002 110.032 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -53.68 -61.2 2.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.46000000000000002 109.615 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.56 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 31.6 mp0 -54.01 -54.49 38.38 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.565 -0.854 . . . . 0.46999999999999997 109.43 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.458 HG21 ' SD ' ' A' ' 129' ' ' MET . 53.2 t -45.76 -34.41 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 132' ' ' SER . 0.7 OUTLIER -61.38 -43.21 99.25 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.776 -1.194 . . . . 0.47999999999999998 107.776 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.577 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 1.4 tttp -70.34 -56.98 5.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.64000000000000001 108.337 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.672 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -43.75 -69.94 0.12 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.186 -0.946 . . . . 0.41999999999999998 110.189 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -52.81 -59.46 4.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.34000000000000002 110.945 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 5.1 tmtt? -65.56 -74.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.978 -1.076 . . . . 0.46999999999999997 110.893 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.8 OUTLIER -38.24 -62.39 0.58 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.679 -0.638 . . . . 0.46999999999999997 110.669 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -45.89 -38.15 7.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.798 -1.161 . . . . 0.25 108.386 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -70.42 -34.87 73.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.362 -0.836 . . . . 0.34999999999999998 108.892 178.301 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 10.6 ttmm -58.51 -42.4 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.69999999999999996 108.961 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 13.5 t -67.86 -46.72 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.535 -0.728 . . . . 0.60999999999999999 109.094 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.6 ' CH2' HG13 ' A' ' 262' ' ' ILE . 13.3 t-105 -53.55 -41.66 66.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.777 . . . . 0.39000000000000001 108.967 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.483 ' HA ' ' O ' ' A' ' 149' ' ' THR . 14.5 m -71.76 -37.15 70.54 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.412 -0.805 . . . . 0.34999999999999998 109.02 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.66 -41.61 66.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.595 -0.691 . . . . 0.35999999999999999 109.549 179.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.522 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 29.4 m -79.63 -30.81 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.5 110.071 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.483 ' O ' ' HA ' ' A' ' 146' ' ' SER . 3.6 t -144.22 127.33 8.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.51000000000000001 110.339 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 59.76 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.748 1.394 . . . . 0.31 110.745 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 266' ' ' TYR . 1.4 mm? -88.72 156.01 19.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.17999999999999999 110.158 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.475 ' HB3' ' OD1' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -103.38 146.35 28.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.17000000000000001 110.381 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.481 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 6.9 p90 -152.49 138.6 18.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.868 . . . . 0.14000000000000001 110.384 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 119' ' ' THR . 4.2 m -143.02 135.4 27.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.14999999999999999 110.261 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.572 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -93.61 89.03 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.978 -1.076 . . . . 0.20000000000000001 110.024 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.536 ' CB ' ' HB ' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -62.97 100.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.22 110.371 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.57 ' O ' ' CD2' ' A' ' 157' ' ' HIS . 53.6 p-80 -67.14 57.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.331 -0.856 . . . . 0.32000000000000001 110.357 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.454 ' N ' ' O ' ' A' ' 156' ' ' LEU . 10.9 t0 -154.31 -51.53 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.33000000000000002 109.904 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.41 35.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.037 -1.225 . . . . 0.28000000000000003 110.037 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.536 ' HB ' ' CB ' ' A' ' 156' ' ' LEU . 72.1 mt -128.83 65.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -1.18 . . . . 0.29999999999999999 109.289 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.488 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -126.01 150.16 48.29 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.2 -0.6 . . . . 0.20000000000000001 110.568 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.428 ' OD2' ' HG ' ' A' ' 118' ' ' LEU . 1.2 m-20 -113.27 -34.22 5.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.356 -0.84 . . . . 0.10000000000000001 109.883 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.534 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -126.03 170.38 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.10000000000000001 110.155 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.524 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 8.5 ptm -168.93 139.12 2.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.891 -1.131 . . . . 0.11 110.95 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.568 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 4.2 tt -96.88 115.44 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.401 -0.812 . . . . 0.10000000000000001 109.29 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.535 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 14.2 p -160.07 148.48 17.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.511 -1.368 . . . . 0.10000000000000001 111.065 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.601 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.0 p90 -64.55 114.75 4.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.089999999999999997 109.354 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.511 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -72.52 148.42 42.01 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.441 -1.464 . . . . 0.20000000000000001 109.441 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.582 ' O ' ' C ' ' A' ' 170' ' ' LYS . 10.3 pt -141.41 97.46 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.752 -0.852 . . . . 0.55000000000000004 109.853 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.64 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.07 78.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.277 0.561 . . . . 0.84999999999999998 112.127 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -121.1 -5.57 9.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.70999999999999996 110.266 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 172' ' ' HIS . 19.9 m-70 -82.19 -150.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.41999999999999998 110.011 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.97 30.31 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.704 -1.358 . . . . 0.33000000000000002 109.704 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 175' ' ' PHE . 2.9 p30 -127.51 -148.21 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -1.223 . . . . 0.33000000000000002 110.176 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -49.22 153.35 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.27000000000000002 110.09 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 9.2 m-30 -80.96 112.23 30.57 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.34000000000000002 110.314 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.48 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 45.9 Cg_endo -78.41 -67.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.901 1.474 . . . . 0.46999999999999997 110.631 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -51.74 149.79 4.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.34999999999999998 110.714 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.447 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.6 p30 -174.21 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.214 -0.994 . . . . 0.20000000000000001 111.482 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.561 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 120.43 -140.32 14.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.178 -1.569 . . . . 0.25 109.178 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.29 53.88 3.13 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 124.103 1.58 . . . . 0.44 109.628 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.415 ' CB ' ' OD1' ' A' ' 179' ' ' ASP . 0.2 OUTLIER -114.4 -177.41 3.12 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.526 -0.733 . . . . 0.56999999999999995 110.055 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.544 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -72.03 65.18 1.23 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.482 -1.047 . . . . 0.48999999999999999 110.482 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.545 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 2.6 tt 179.69 93.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -1.17 . . . . 0.40999999999999998 110.846 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.583 ' CD1' ' CZ ' ' A' ' 214' ' ' TYR . 4.1 tt -114.48 -13.3 12.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.606 -1.237 . . . . 0.29999999999999999 111.352 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.672 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -156.32 102.62 2.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.488 -1.382 . . . . 0.20000000000000001 111.671 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.54 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -117.26 122.77 44.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.16 109.51 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.587 ' CB ' ' CB ' ' A' ' 227' ' ' SER . . . -110.52 158.66 18.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.23000000000000001 110.207 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.468 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.9 m-30 -96.0 166.79 13.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.38 110.545 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 46.5 Cg_endo -72.86 136.38 25.13 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.091 1.574 . . . . 0.40000000000000002 109.742 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 58.98 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.93 1.489 . . . . 0.32000000000000001 110.611 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -99.18 -94.62 2.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.32000000000000001 109.464 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.8 -165.89 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.965 1.508 . . . . 0.46999999999999997 110.38 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -9.07 26.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.63 110.279 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 54.56 0.66 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.42 -0.8 . . . . 0.53000000000000003 110.226 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -124.08 174.76 16.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.049 -1.621 . . . . 0.25 109.049 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.542 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.14 24.66 0.59 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.716 -1.354 . . . . 0.10000000000000001 109.716 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.468 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 1.5 m-20 -79.8 87.35 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.068 -1.254 . . . . 0.10000000000000001 109.96 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.464 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -63.73 113.25 3.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.089999999999999997 110.502 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.458 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 11.4 m170 -121.24 119.07 31.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.325 -0.859 . . . . 0.089999999999999997 110.602 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.0 m-85 -90.5 141.78 28.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.228 -0.92 . . . . 0.10000000000000001 110.677 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.545 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 24.0 t0 -52.27 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.578 -0.701 . . . . 0.14000000000000001 109.476 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.531 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.7 p-10 -35.78 -37.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.17999999999999999 112.059 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.561 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 3.0 m-20 -65.62 -14.1 60.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.725 -1.234 . . . . 0.23999999999999999 111.175 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.536 ' OE1' ' CB ' ' A' ' 185' ' ' LEU . 0.5 OUTLIER -93.13 -156.99 0.51 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.716 -1.24 . . . . 0.41999999999999998 110.325 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.513 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 3.2 m -137.16 161.43 36.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.944 -1.098 . . . . 0.46999999999999997 111.062 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.513 ' CG ' ' C ' ' A' ' 206' ' ' THR . 1.1 m-90 -149.19 149.1 30.44 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.033 -0.728 . . . . 0.27000000000000002 109.033 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.76 -174.45 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.804 -1.185 . . . . 0.29999999999999999 110.708 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -123.36 30.2 6.38 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.893 -0.723 . . . . 0.60999999999999999 109.822 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -117.21 -172.49 2.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.41 -0.806 . . . . 0.78000000000000003 110.161 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.488 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.4 OUTLIER -80.88 0.84 33.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.91000000000000003 110.236 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -113.79 149.67 34.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.158 -0.964 . . . . 0.93000000000000005 110.184 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 68.46 -173.8 32.53 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.79000000000000004 109.402 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.583 ' CZ ' ' CD1' ' A' ' 185' ' ' LEU . 76.8 m-85 -77.16 114.26 15.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.68999999999999995 110.157 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.558 ' O ' ' N ' ' A' ' 218' ' ' LEU . 1.6 m120 -77.45 123.24 26.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.99 -1.069 . . . . 0.40000000000000002 108.653 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.672 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.6 OUTLIER -44.72 -35.18 2.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.787 -1.165 . . . . 0.17000000000000001 108.691 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.584 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 6.6 m-85 -55.74 -46.42 77.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.968 -1.493 . . . . 0.28000000000000003 106.968 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.558 ' N ' ' O ' ' A' ' 215' ' ' ASN . 21.8 tp -74.19 -74.8 0.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.901 -0.59 . . . . 0.46000000000000002 110.742 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.542 ' O ' ' HB3' ' A' ' 222' ' ' HIS . 1.2 p -48.19 -61.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.106 -0.996 . . . . 0.39000000000000001 110.852 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -53.6 -51.15 63.93 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.79 -1.194 . . . . 0.17000000000000001 111.336 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.247 -1.533 . . . . 0.10000000000000001 108.682 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.618 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 5.9 t60 -77.08 -51.69 10.61 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.223 0.535 . . . . 0.20999999999999999 109.647 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.482 ' O ' ' OG ' ' A' ' 227' ' ' SER . 3.1 tp10 -59.41 -44.08 92.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.987 -1.071 . . . . 0.28000000000000003 108.341 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.467 ' CZ ' HD11 ' A' ' 165' ' ' ILE . 7.5 m-30 -53.38 -61.96 1.96 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.734 . . . . 0.17999999999999999 109.102 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -32.72 2.16 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.925 -1.67 . . . . 0.20999999999999999 108.925 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.639 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -81.97 -77.99 0.21 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -1.178 . . . . 0.17000000000000001 111.229 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.587 ' CB ' ' CB ' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.73 -39.84 0.16 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.558 -0.714 . . . . 0.33000000000000002 111.937 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.469 ' O ' ' OH ' ' A' ' 266' ' ' TYR . 3.0 tp -96.41 -39.45 9.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.968 -1.082 . . . . 0.53000000000000003 110.667 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -74.73 -91.09 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.099 -1.201 . . . . 0.40999999999999998 110.099 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.647 ' CD1' ' N ' ' A' ' 230' ' ' LEU . 0.0 OUTLIER -175.93 170.44 2.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -1.118 . . . . 0.45000000000000001 111.17 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.531 ' N ' HD22 ' A' ' 230' ' ' LEU . 7.2 t70 -25.7 -70.82 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 120.992 0.425 . . . . 0.62 112.024 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.639 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -162.12 -179.83 7.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.01 -1.056 . . . . 0.45000000000000001 111.176 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.3 OUTLIER 179.46 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.467 0.651 . . . . 0.38 109.401 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.555 ' HA ' ' CB ' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -101.76 23.09 11.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.534 -0.729 . . . . 0.47999999999999998 111.472 -179.197 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.592 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -37.3 -66.71 0.27 Allowed Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.81 -0.756 . . . . 0.38 110.381 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.592 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 55.0 Cg_endo -76.87 -47.28 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.292 1.154 . . . . 0.28000000000000003 110.578 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.494 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.79 101.17 0.14 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.981 -1.58 . . . . 0.23999999999999999 111.936 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.582 ' O ' ' CE2' ' A' ' 241' ' ' PHE . . . -144.57 160.25 41.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -1.058 . . . . 0.28000000000000003 110.207 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.618 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -75.2 64.98 1.5 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.23 1.015 . . . . 0.40000000000000002 108.747 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.585 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 3.1 mtp -141.64 -37.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.805 . . . . 0.45000000000000001 110.011 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -47.99 170.25 0.11 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.56999999999999995 109.795 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.0 Cg_endo -70.69 -2.64 11.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.582 1.306 . . . . 0.76000000000000001 110.512 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.546 ' O ' ' CE1' ' A' ' 241' ' ' PHE . 4.3 mt -98.64 145.12 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.89000000000000001 110.054 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.598 ' CB ' ' CH ' ' A' ' 3' ' ' MSB . 46.9 p90 -134.65 -33.62 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.78000000000000003 110.486 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.522 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER 3.15 -68.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.646 0.98 . . . . 0.60999999999999999 113.646 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.555 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -54.0 107.79 0.3 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.355 -1.466 . . . . 0.73999999999999999 109.854 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.547 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 53.3 m -58.38 172.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.81000000000000005 110.363 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.455 ' N ' ' CG2' ' A' ' 247' ' ' THR . . . -43.15 -40.76 4.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.899 -1.28 . . . . 0.56000000000000005 109.899 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 46.74 1.64 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.254 . . . . 0.37 110.638 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.461 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 1.2 t -89.29 1.93 55.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.44 110.093 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.86 -69.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.53000000000000003 110.238 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.408 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.2 OUTLIER 179.75 178.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.38 110.47 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.501 ' O ' ' CG ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -69.04 56.16 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.768 . . . . 0.19 109.853 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.654 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.79 -46.12 50.44 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 108.0 -1.111 . . . . 0.28000000000000003 108.0 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.654 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -73.89 49.69 1.95 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.94 1.495 . . . . 0.48999999999999999 111.499 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.511 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.3 m-20 -48.82 -34.11 11.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.48999999999999999 110.689 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.567 ' CB ' ' HB1' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -54.69 -53.28 56.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.615 -1.234 . . . . 0.31 108.79 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.531 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.22 -36.43 84.13 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.498 -0.881 . . . . 0.14000000000000001 108.819 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.52 ' O ' HD12 ' A' ' 262' ' ' ILE . 78.3 t -64.73 -84.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.17000000000000001 110.753 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 11.0 tt0 -54.68 -43.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.045 . . . . 0.26000000000000001 109.395 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.0 -70.12 0.39 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.518 -1.033 . . . . 0.19 110.518 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.6 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -71.25 -24.93 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.594 -1.533 . . . . 0.22 110.005 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.522 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 5.4 tt0 -57.33 -23.36 48.25 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.998 -1.081 . . . . 0.39000000000000001 108.554 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 -43.49 5.48 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.155 -0.618 . . . . 0.46999999999999997 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.53 ' CD1' ' HD2' ' A' ' 112' ' ' LYS . 7.0 mt -73.92 -53.45 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.812 . . . . 0.47999999999999998 110.876 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.513 ' O ' ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -75.37 -8.48 56.8 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.251 -0.905 . . . . 0.40999999999999998 109.837 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.43 -106.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.097 -1.601 . . . . 0.46000000000000002 109.097 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.81 115.42 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.878 1.462 . . . . 0.57999999999999996 109.999 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.08 143.13 18.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.66 -1.376 . . . . 0.64000000000000001 109.66 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.584 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 -80.83 -60.92 2.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.94999999999999996 110.064 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.527 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 14.9 tt0 42.88 26.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 1.2 110.259 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 270' ' ' ASP . 5.3 t0 -167.21 105.2 0.62 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 1.2 110.4 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.22 56.6 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.984 1.518 . . . . 1.0600000000000001 110.435 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.993 -1.003 . . . . 0.78000000000000003 110.242 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.607 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.549 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.672 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.244 0.545 . . . . 0.40999999999999998 110.138 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -126.89 110.4 12.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.26000000000000001 110.436 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.0 m -103.23 169.8 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.33000000000000002 109.957 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.01 129.88 7.2 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.181 -0.949 . . . . 0.65000000000000002 109.939 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.497 ' C ' ' CG ' ' A' ' 109' ' ' ARG . 46.1 Cg_endo -73.46 66.4 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.914 1.481 . . . . 0.83999999999999997 110.375 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.521 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 79.7 mtt180 -155.23 71.21 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.93000000000000005 109.727 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.545 ' CA ' HD12 ' A' ' 230' ' ' LEU . 1.6 p -135.34 -67.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 1.03 109.41 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.484 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.64 48.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.783 -0.573 . . . . 1.04 111.363 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -138.72 78.83 1.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.997 . . . . 0.77000000000000002 109.61 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.593 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 6.4 t90 -151.15 -67.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.893 . . . . 0.41999999999999998 111.176 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.552 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 35.9 t -87.79 40.68 0.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.44 110.86 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.478 ' HD3' ' CD1' ' A' ' 118' ' ' LEU . 13.1 mmtt -143.31 83.69 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.48999999999999999 110.807 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.1 ttp -100.26 -21.03 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.974 . . . . 0.29999999999999999 109.391 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.435 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 1.7 p-10 -138.52 137.83 37.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.14999999999999999 109.455 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.535 HD21 ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -151.07 167.56 27.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 0.13 110.824 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.513 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -110.17 168.45 9.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.12 109.604 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.663 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 8.5 p90 -167.32 176.13 6.88 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.934 -1.107 . . . . 0.33000000000000002 111.486 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.472 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 6.2 tpt85 -123.38 152.73 41.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.698 -0.626 . . . . 0.54000000000000004 109.38 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.659 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -121.32 95.05 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.084 -1.01 . . . . 0.33000000000000002 111.16 -179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 3.5 m -141.53 50.33 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.134 -0.979 . . . . 0.27000000000000002 110.257 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.481 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 1.8 t-20 -43.33 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.40999999999999998 109.404 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.481 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 30.6 t80 179.89 175.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.40000000000000002 110.127 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -118.97 59.28 4.24 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.45000000000000001 109.964 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.439 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.8 Cg_endo -70.73 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.109 1.584 . . . . 0.35999999999999999 110.567 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.19 4.39 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.25 109.795 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.538 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -115.41 139.9 49.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.518 -0.739 . . . . 0.39000000000000001 109.83 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -78.53 167.52 21.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.47999999999999998 110.378 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 130' ' ' THR . 22.3 t-80 -43.28 -39.21 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.40000000000000002 109.751 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 8.4 t -59.32 -49.36 78.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.46000000000000002 109.709 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.538 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.5 OUTLIER -58.25 -57.62 12.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.33 -0.857 . . . . 0.46999999999999997 109.337 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 125' ' ' TYR . 4.6 t -46.42 -35.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.608 -1.256 . . . . 0.31 107.608 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.584 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -57.79 -42.37 84.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.013 -1.106 . . . . 0.47999999999999998 108.013 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.578 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 7.8 tttt -69.31 -49.66 53.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.197 0.999 . . . . 0.64000000000000001 108.397 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.609 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -48.12 -61.71 1.84 Allowed 'General case' 0 C--N 1.287 -2.138 0 O-C-N 121.245 -0.91 . . . . 0.41999999999999998 110.816 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.659 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.34 -52.25 35.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.234 -0.916 . . . . 0.34000000000000002 111.026 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.631 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.2 -71.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.46999999999999997 110.397 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -41.99 -57.55 2.39 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.527 -0.733 . . . . 0.46999999999999997 110.307 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.97 -38.51 17.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.296 -1.362 . . . . 0.25 108.345 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.663 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -71.57 -34.71 70.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.308 -0.87 . . . . 0.34999999999999998 108.994 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' CD ' ' C ' ' A' ' 143' ' ' LYS . 0.1 OUTLIER -60.63 -41.25 94.52 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.797 -0.816 . . . . 0.69999999999999996 108.797 179.044 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.99 -49.96 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.661 -0.866 . . . . 0.60999999999999999 108.661 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.612 ' CH2' HG13 ' A' ' 262' ' ' ILE . 29.4 t-105 -52.43 -36.24 53.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.682 -0.859 . . . . 0.39000000000000001 108.682 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.513 ' HA ' ' O ' ' A' ' 149' ' ' THR . 57.8 m -75.24 -35.39 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.475 -0.766 . . . . 0.34999999999999998 109.095 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.68 -40.15 78.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.429 -0.794 . . . . 0.35999999999999999 109.375 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.474 ' O ' ' HB2' ' A' ' 263' ' ' GLN . 20.0 m -80.37 -31.23 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.777 -0.769 . . . . 0.5 110.119 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 146' ' ' SER . 12.8 t -150.59 131.9 7.53 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.047 . . . . 0.51000000000000001 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.14 58.93 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.854 1.45 . . . . 0.31 110.545 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.526 ' CD2' ' HB3' ' A' ' 266' ' ' TYR . 2.1 mm? -77.2 134.89 38.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.17999999999999999 110.284 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.435 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 1.7 m-20 -80.94 130.13 34.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.17000000000000001 110.123 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.5 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 8.4 p90 -137.15 139.57 41.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.14000000000000001 110.268 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.471 ' HB ' HG21 ' A' ' 119' ' ' THR . 18.2 m -147.06 131.31 17.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.302 -0.874 . . . . 0.14999999999999999 110.554 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.59 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -98.65 118.23 34.91 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.695 -0.628 . . . . 0.20000000000000001 109.471 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.43 99.74 7.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.22 110.311 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 158' ' ' ASP . 11.1 p-80 -54.03 -28.77 40.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.32000000000000001 109.833 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.5 t0 -41.76 -57.21 2.41 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.475 0.655 . . . . 0.33000000000000002 109.719 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.72 37.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.616 -1.394 . . . . 0.28000000000000003 109.616 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.513 ' O ' ' HB ' ' A' ' 119' ' ' THR . 23.5 mm -128.26 67.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.146 -1.208 . . . . 0.29999999999999999 109.373 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.8 127.94 52.41 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.78 -0.575 . . . . 0.20000000000000001 110.356 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.535 ' CB ' HD21 ' A' ' 118' ' ' LEU . 29.5 m-20 -90.0 -45.16 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.10000000000000001 110.058 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.536 HG13 ' CB ' ' A' ' 120' ' ' TYR . 1.4 pp -127.02 172.84 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.10000000000000001 109.719 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.472 ' HB2' ' HB3' ' A' ' 121' ' ' ARG . 4.3 ptt? -174.39 163.51 3.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.11 111.563 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.559 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 4.0 tt -106.23 116.25 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.542 -0.724 . . . . 0.10000000000000001 109.683 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.531 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 4.8 p -157.12 141.08 16.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.598 -1.314 . . . . 0.10000000000000001 111.304 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.7 p90 -60.76 121.68 12.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.547 -0.72 . . . . 0.089999999999999997 109.913 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -90.86 126.86 8.58 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.094 -1.203 . . . . 0.20000000000000001 110.094 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.584 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.2 tt -122.88 97.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.936 . . . . 0.55000000000000004 109.457 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 7.0 tptt 0.28 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.291 0.567 . . . . 0.84999999999999998 112.401 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.66 15.18 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.70999999999999996 110.168 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.412 ' CE1' ' CE1' ' A' ' 200' ' ' HIS . 29.6 m-70 -85.08 -86.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.41999999999999998 110.302 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.48 41.72 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.422 -1.471 . . . . 0.33000000000000002 109.422 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.97 -89.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -1.112 . . . . 0.33000000000000002 110.355 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.469 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 3.5 m-85 -116.66 -171.26 1.98 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.27000000000000002 110.411 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.551 ' CD1' ' HE2' ' A' ' 170' ' ' LYS . 4.2 m-30 -90.45 109.83 36.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.34000000000000002 110.176 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.469 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 42.9 Cg_endo -75.56 -72.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.46999999999999997 110.536 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CG ' ' OD2' ' A' ' 203' ' ' ASP . 2.1 p90 -64.85 177.61 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.34999999999999998 109.936 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.8 p-10 179.13 -51.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.164 -0.96 . . . . 0.20000000000000001 111.022 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.576 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 138.29 -136.59 8.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.366 -1.494 . . . . 0.25 109.366 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -71.64 -5.41 16.99 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 O-C-N 124.15 1.606 . . . . 0.44 109.392 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.449 ' HB2' ' OD2' ' A' ' 179' ' ' ASP . 1.8 m -55.04 -176.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.397 -0.814 . . . . 0.56999999999999995 109.616 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.542 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -82.63 76.34 2.24 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.038 -1.077 . . . . 0.48999999999999999 110.672 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.532 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 6.6 tt 179.77 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -1.146 . . . . 0.40999999999999998 110.841 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.578 HD11 ' CE2' ' A' ' 214' ' ' TYR . 9.4 tt -109.43 -15.59 14.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.803 -1.186 . . . . 0.29999999999999999 111.248 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.638 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -154.28 109.16 3.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.437 -1.414 . . . . 0.20000000000000001 111.8 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.569 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 1.1 p80 -109.77 127.04 54.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.89 -1.131 . . . . 0.16 109.862 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.542 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -104.2 130.98 51.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.459 -0.775 . . . . 0.23000000000000001 110.359 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.439 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -78.53 163.49 61.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.085 -1.009 . . . . 0.38 110.42 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.471 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.2 Cg_endo -72.73 133.43 20.26 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 124.105 1.582 . . . . 0.40000000000000002 109.933 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.484 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.7 Cg_endo -70.55 70.07 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.874 1.46 . . . . 0.32000000000000001 110.399 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.36 -105.5 2.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.564 -1.414 . . . . 0.32000000000000001 109.564 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.74 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.916 1.482 . . . . 0.46999999999999997 110.223 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -63.17 -10.95 17.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.101 -1.0 . . . . 0.63 110.175 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.63 68.79 0.8 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.499 -0.75 . . . . 0.53000000000000003 110.032 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -151.53 165.33 30.47 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.901 -1.68 . . . . 0.25 108.901 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.541 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 58.28 16.18 26.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.066 -1.614 . . . . 0.10000000000000001 109.066 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -79.24 87.5 4.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -1.113 . . . . 0.10000000000000001 110.576 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.523 ' HB2' ' CG ' ' A' ' 223' ' ' GLU . . . -62.7 95.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.089999999999999997 109.59 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.569 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 19.6 m170 -97.08 141.05 30.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.089999999999999997 110.394 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.583 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 5.4 m-30 -108.0 136.84 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.10000000000000001 110.98 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 179' ' ' ASP . 59.5 t0 -50.86 86.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.786 -0.82 . . . . 0.14000000000000001 108.786 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.597 ' OD2' ' CG ' ' A' ' 178' ' ' PHE . 1.3 p30 -39.34 -32.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.17999999999999999 111.844 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.576 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -78.81 3.0 17.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.645 -1.285 . . . . 0.23999999999999999 110.715 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.499 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 9.1 mm-40 -96.63 -162.83 0.99 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.012 -1.055 . . . . 0.41999999999999998 110.126 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.92 147.5 48.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.023 -1.048 . . . . 0.46999999999999997 110.51 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.511 ' CZ2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -138.71 144.94 39.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.27000000000000002 109.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.501 ' CG2' ' C ' ' A' ' 207' ' ' TRP . 0.1 OUTLIER -160.27 177.58 10.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.93 -1.106 . . . . 0.29999999999999999 110.833 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -128.61 41.19 3.53 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.912 0.863 . . . . 0.60999999999999999 109.109 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 4.0 t -122.19 -164.79 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.502 -0.749 . . . . 0.78000000000000003 109.955 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -89.02 14.45 10.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.91000000000000003 109.889 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -130.28 163.16 27.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.93000000000000005 110.316 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 58.76 -175.26 2.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.79000000000000004 109.461 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.578 ' CE2' HD11 ' A' ' 185' ' ' LEU . 63.0 m-85 -74.62 117.76 16.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.68999999999999995 110.144 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.482 ' OD1' ' N ' ' A' ' 218' ' ' LEU . 9.3 p30 -87.75 118.66 27.41 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.192 -0.943 . . . . 0.40000000000000002 108.709 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.609 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 1.6 mp -41.83 -32.72 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.483 -0.76 . . . . 0.17000000000000001 110.649 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.1 m-85 -50.89 -47.64 60.6 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.297 -1.372 . . . . 0.28000000000000003 107.297 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.565 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 42.1 tp -82.49 -70.16 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.423 -0.808 . . . . 0.46000000000000002 110.976 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.599 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.43 -60.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.39000000000000001 109.753 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -54.8 -48.69 72.42 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.892 -1.13 . . . . 0.17000000000000001 110.916 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.22 -29.99 66.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.328 -1.483 . . . . 0.10000000000000001 108.846 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.608 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 5.4 t60 -74.75 -51.06 15.19 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.746 -0.661 . . . . 0.20999999999999999 109.523 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.523 ' CG ' ' HB2' ' A' ' 199' ' ' ALA . 2.9 tp10 -61.09 -32.9 72.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.28000000000000003 109.042 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 225' ' ' GLY . 13.6 m-30 -65.85 -64.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.42 -0.8 . . . . 0.17999999999999999 108.986 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -28.27 1.19 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.076 -1.61 . . . . 0.20999999999999999 109.076 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.63 -70.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -1.221 . . . . 0.17000000000000001 111.657 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.542 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 5.0 p -51.77 -31.17 25.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.33000000000000002 112.124 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.487 HD12 ' CG2' ' A' ' 163' ' ' ILE . 9.8 tp -99.96 -41.83 7.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.89 -1.131 . . . . 0.53000000000000003 111.157 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.568 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -74.89 -83.93 0.36 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.758 -0.937 . . . . 0.40999999999999998 110.758 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.552 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 2.0 pt? -161.13 -157.73 0.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.031 -1.276 . . . . 0.45000000000000001 110.785 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.52 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -70.74 -50.95 30.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.62 110.36 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.614 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -169.09 176.18 5.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 0.45000000000000001 110.59 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.71 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.443 -0.785 . . . . 0.38 109.316 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.587 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -138.98 22.22 2.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.47999999999999998 110.889 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -38.78 -48.47 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.464 -0.772 . . . . 0.38 110.433 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 45.6 Cg_endo -87.36 -48.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.846 1.445 . . . . 0.28000000000000003 111.372 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.506 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.28 100.43 0.13 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 118.962 -1.589 . . . . 0.23999999999999999 111.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.587 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -144.89 -161.62 1.33 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -1.143 . . . . 0.28000000000000003 109.808 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.593 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -105.66 49.84 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.341 -0.985 . . . . 0.40000000000000002 108.341 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.594 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 3.4 mtt -134.37 -21.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.374 -0.829 . . . . 0.45000000000000001 111.157 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.625 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -59.07 168.5 1.51 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.793 -1.192 . . . . 0.56999999999999995 111.035 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.532 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.7 Cg_endo -71.23 -8.65 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.684 1.36 . . . . 0.76000000000000001 109.93 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.567 ' O ' ' CE1' ' A' ' 241' ' ' PHE . 17.1 mm -101.06 139.08 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.452 -0.78 . . . . 0.89000000000000001 109.647 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.565 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 48.2 p90 -125.6 -25.56 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.78000000000000003 110.664 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.514 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.5 OUTLIER 2.45 -67.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 113.635 0.976 . . . . 0.60999999999999999 113.635 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.568 ' CD1' ' OG ' ' A' ' 250' ' ' SER . 0.1 OUTLIER -68.63 117.19 10.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.38 -1.45 . . . . 0.73999999999999999 109.289 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.496 ' HA ' HD21 ' A' ' 218' ' ' LEU . 49.3 p -47.13 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.81000000000000005 110.206 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.79 -21.16 3.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.432 -1.467 . . . . 0.56000000000000005 109.432 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.443 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 1.1 ptmm? -162.5 49.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.246 . . . . 0.37 110.665 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.568 ' OG ' ' CD1' ' A' ' 246' ' ' TYR . 1.4 m -43.77 -61.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.44 109.856 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.7 OUTLIER -147.37 4.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.53000000000000003 111.016 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.554 ' CE2' ' HG2' ' A' ' 253' ' ' MET . 92.7 t80 179.98 170.91 1.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.934 -1.104 . . . . 0.38 110.939 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.554 ' HG2' ' CE2' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -90.58 59.89 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.55 -0.719 . . . . 0.19 110.013 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.667 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.7 OUTLIER -44.41 -47.33 25.75 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.979 -1.119 . . . . 0.28000000000000003 107.979 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.2 Cg_endo -73.34 50.58 1.95 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.143 1.602 . . . . 0.48999999999999999 110.922 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.588 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.4 m-20 -55.54 -29.15 58.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.072 -1.017 . . . . 0.48999999999999999 110.633 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.533 ' HB2' ' HB3' ' A' ' 238' ' ' ALA . 35.3 m-20 -54.7 -48.95 71.83 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.111 -0.993 . . . . 0.31 109.234 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.536 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.98 -33.31 63.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.57 -0.9 . . . . 0.14000000000000001 108.57 178.764 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.588 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 72.8 t -62.23 -82.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.811 . . . . 0.17000000000000001 110.055 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.572 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 21.4 tm0? -59.84 -41.76 92.08 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.345 -0.847 . . . . 0.26000000000000001 109.665 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.69 -64.87 1.12 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.612 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -80.21 -21.66 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.744 -1.445 . . . . 0.22 110.278 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.572 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 6.3 tt0 -60.35 -22.67 63.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.788 -1.165 . . . . 0.39000000000000001 108.158 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 31.2 t -104.09 -41.21 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.268 -0.573 . . . . 0.46999999999999997 111.092 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.467 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 0.4 OUTLIER -79.75 -50.2 10.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.47999999999999998 111.527 -178.562 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.568 ' CE2' ' HA2' ' A' ' 229' ' ' GLY . 0.0 OUTLIER -78.7 -17.09 56.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.40999999999999998 110.059 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -52.88 -93.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.815 -1.714 . . . . 0.46000000000000002 108.815 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 128.49 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.017 1.535 . . . . 0.57999999999999996 110.067 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.418 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -101.02 147.7 17.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.583 -1.407 . . . . 0.64000000000000001 109.583 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.593 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -99.03 -68.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -1.134 . . . . 0.94999999999999996 110.054 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.552 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 3.2 tm-20 57.01 35.69 26.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 1.2 110.263 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.467 ' OD1' ' HB3' ' A' ' 270' ' ' ASP . 11.6 p-10 -133.73 75.12 68.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.408 -0.808 . . . . 1.2 110.274 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.23 56.81 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.975 1.513 . . . . 1.0600000000000001 110.364 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.006 -0.997 . . . . 0.78000000000000003 110.249 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.608 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.612 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.638 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.233 0.54 . . . . 0.40999999999999998 110.227 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -121.09 150.3 41.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.26000000000000001 110.308 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 53.0 t -84.13 -88.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.33000000000000002 110.227 -179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.3 m-85 -113.83 131.37 23.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.65000000000000002 110.178 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.29 54.69 2.85 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.0 1.526 . . . . 0.83999999999999997 110.305 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.465 ' O ' HD11 ' A' ' 230' ' ' LEU . 71.7 mtt-85 -145.13 52.13 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.93000000000000005 110.233 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.515 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 6.7 p -121.49 -53.33 2.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 1.03 109.967 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.516 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 45.06 23.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.187 -0.945 . . . . 1.04 111.285 179.282 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.497 ' HG2' ' CD2' ' A' ' 266' ' ' TYR . 28.9 mtpt -123.64 74.45 1.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.051 -1.031 . . . . 0.77000000000000002 109.598 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.566 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 5.9 t90 -145.44 -67.91 0.3 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.225 -0.922 . . . . 0.41999999999999998 110.907 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 271' ' ' GLU . 30.1 t -97.84 58.52 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.865 . . . . 0.44 110.835 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 114' ' ' SER . 9.5 mttm -160.03 61.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.94 . . . . 0.48999999999999999 110.43 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.473 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 7.3 tmm? -85.05 13.69 5.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.29999999999999999 110.355 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -171.82 126.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.14999999999999999 110.278 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.459 HD11 ' OD2' ' A' ' 162' ' ' ASP . 2.8 mt -151.3 -164.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.13 110.177 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.546 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -128.78 171.38 12.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.12 109.75 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 154' ' ' THR . 36.2 p90 -171.4 -172.97 1.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.09 . . . . 0.33000000000000002 111.168 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.449 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 2.3 mtm-85 -127.98 164.84 21.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.54000000000000004 110.196 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 138' ' ' PHE . 6.6 pt -128.19 70.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.33000000000000002 110.365 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.487 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 4.8 m -120.67 50.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.27000000000000002 110.793 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.464 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 6.8 t30 -44.13 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.40999999999999998 109.267 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.524 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 7.5 t80 -178.99 174.43 1.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.506 -0.746 . . . . 0.40000000000000002 109.836 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.508 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -128.74 53.78 12.23 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.45000000000000001 110.425 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.508 ' HD3' ' N ' ' A' ' 126' ' ' THR . 47.2 Cg_endo -77.14 -86.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.989 1.52 . . . . 0.35999999999999999 110.609 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.02 -1.38 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.25 110.064 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.528 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -112.19 150.52 30.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.39000000000000001 110.111 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -98.03 166.24 11.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.47999999999999998 110.069 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' THR . 17.2 t-80 -41.3 -32.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.395 -0.816 . . . . 0.40000000000000002 110.194 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.463 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -69.87 -46.32 65.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.46000000000000002 110.261 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.528 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.8 OUTLIER -67.67 -58.11 5.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.083 -1.01 . . . . 0.46999999999999997 109.528 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.524 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 13.8 t -45.07 -37.78 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.817 -1.179 . . . . 0.31 107.817 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.9 mt-10 -57.58 -45.95 84.6 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.887 -1.153 . . . . 0.47999999999999998 107.887 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 3.3 tttt -63.2 -48.94 76.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.798 0.809 . . . . 0.64000000000000001 109.011 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.67 -59.02 2.99 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.123 -0.986 . . . . 0.41999999999999998 110.155 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.624 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -66.71 -54.15 26.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.34000000000000002 110.568 -179.25 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -64.6 -74.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.099 -1.0 . . . . 0.46999999999999997 109.942 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.9 tmtt? -37.32 -62.7 0.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 O-C-N 122.07 -0.394 . . . . 0.46999999999999997 110.886 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.92 -36.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.686 -1.206 . . . . 0.25 108.585 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.83 -28.94 61.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.34999999999999998 109.111 178.628 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.93 -43.73 97.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.379 -0.971 . . . . 0.69999999999999996 108.379 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.7 t -70.29 -49.66 52.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.649 -0.871 . . . . 0.60999999999999999 108.649 178.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.603 ' CH2' HG13 ' A' ' 262' ' ' ILE . 51.3 t-105 -53.54 -31.52 46.74 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.755 -0.831 . . . . 0.39000000000000001 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 149' ' ' THR . 67.6 m -78.95 -34.25 44.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.235 -1.024 . . . . 0.34999999999999998 108.235 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -57.9 -37.37 73.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.793 -0.818 . . . . 0.35999999999999999 108.793 178.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.543 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.1 m -80.67 -35.14 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.767 -0.773 . . . . 0.5 109.751 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.507 ' N ' HG23 ' A' ' 148' ' ' VAL . 4.6 t -147.83 127.6 6.56 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.994 . . . . 0.51000000000000001 110.389 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 54.25 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.803 1.422 . . . . 0.31 110.601 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.527 ' CD1' ' O ' ' A' ' 266' ' ' TYR . 4.1 tp -73.85 147.79 42.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.17999999999999999 110.318 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.9 OUTLIER -88.22 117.62 27.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.93 . . . . 0.17000000000000001 110.204 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.478 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 6.0 p90 -125.12 119.75 29.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.14000000000000001 110.297 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.565 ' O ' ' CD1' ' A' ' 120' ' ' TYR . 23.0 m -120.45 170.75 9.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.14999999999999999 110.256 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.488 ' N ' ' CG2' ' A' ' 154' ' ' THR . 2.3 ptt180 -156.64 114.52 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.902 -0.719 . . . . 0.20000000000000001 110.481 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 110.67 14.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.22 109.995 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 158' ' ' ASP . 23.9 p-80 -51.86 -23.63 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.32000000000000001 109.954 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.523 ' OD2' ' CD1' ' A' ' 160' ' ' ILE . 1.1 t70 -44.24 -26.16 0.29 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.39 -0.819 . . . . 0.33000000000000002 109.666 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.72 28.9 1.01 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.543 -1.423 . . . . 0.28000000000000003 109.543 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.546 ' O ' ' HB ' ' A' ' 119' ' ' THR . 7.2 mt -115.3 81.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.2 -1.176 . . . . 0.29999999999999999 108.483 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.514 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -144.81 123.68 12.7 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.068 -0.653 . . . . 0.20000000000000001 110.828 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.459 ' OD2' HD11 ' A' ' 118' ' ' LEU . 39.4 t0 -92.29 -51.61 5.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.10000000000000001 109.697 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.505 HG12 ' HB3' ' A' ' 120' ' ' TYR . 1.1 pt -115.82 179.43 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.307 -0.87 . . . . 0.10000000000000001 109.05 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.479 ' HB3' ' O ' ' A' ' 163' ' ' ILE . 8.2 ptp -177.82 151.6 0.71 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 0.11 111.618 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.573 ' HB ' ' CE2' ' A' ' 224' ' ' PHE . 3.6 tt -93.98 117.6 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.10000000000000001 109.374 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.487 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 4.1 p -159.31 150.57 20.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.74 -1.225 . . . . 0.10000000000000001 110.587 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.584 ' CE2' ' HB ' ' A' ' 169' ' ' ILE . 6.7 p90 -72.94 117.74 15.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.499 -0.751 . . . . 0.089999999999999997 110.168 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.479 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -67.75 118.82 10.18 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.051 -1.22 . . . . 0.20000000000000001 110.051 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.584 ' HB ' ' CE2' ' A' ' 167' ' ' PHE . 19.7 tt -118.5 101.08 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.88 -0.776 . . . . 0.55000000000000004 109.422 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.9 OUTLIER 1.93 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.331 0.586 . . . . 0.84999999999999998 112.488 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.22 -0.04 3.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.70999999999999996 110.088 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 17.3 m-70 -91.36 -154.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.41999999999999998 110.191 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -159.08 31.61 0.45 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.467 . . . . 0.33000000000000002 109.434 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -131.47 -52.84 1.01 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -1.155 . . . . 0.33000000000000002 110.125 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -136.87 175.98 9.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.27000000000000002 110.231 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -95.09 110.15 48.49 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.34000000000000002 110.255 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.534 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.2 Cg_endo -73.38 -37.96 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.984 1.518 . . . . 0.46999999999999997 110.592 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 4.4 p90 -109.73 170.19 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.34999999999999998 110.734 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.484 ' OD1' ' N ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -179.77 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.20000000000000001 111.142 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.564 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 159.2 -141.66 7.73 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.561 -1.415 . . . . 0.25 109.561 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.65 -3.82 13.83 Favored 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.236 1.65 . . . . 0.44 109.875 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.86 177.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.463 -0.773 . . . . 0.56999999999999995 110.019 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.554 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -74.97 79.77 0.98 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.234 -1.146 . . . . 0.48999999999999999 110.234 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 15.1 tp 179.82 91.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -1.12 . . . . 0.40999999999999998 110.888 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.577 HD12 ' CD1' ' A' ' 214' ' ' TYR . 8.0 tt -113.83 -17.38 12.06 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.461 -1.296 . . . . 0.29999999999999999 111.293 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.683 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.14 104.55 2.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.555 -1.341 . . . . 0.20000000000000001 111.864 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 0.4 OUTLIER -109.41 121.0 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.16 109.77 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.533 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -110.83 136.01 50.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.23000000000000001 110.413 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.698 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.8 m-30 -85.57 159.36 55.72 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.38 110.216 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.506 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 43.8 Cg_endo -70.88 140.28 38.14 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.145 1.603 . . . . 0.40000000000000002 109.588 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.516 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 42.0 Cg_endo -68.75 82.0 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.015 1.534 . . . . 0.32000000000000001 110.836 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.61 -91.23 1.12 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.17 -1.572 . . . . 0.32000000000000001 109.17 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.28 -158.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.074 1.565 . . . . 0.46999999999999997 109.981 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -82.51 12.26 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 0.63 110.323 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.471 ' O ' ' HB2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -117.78 -3.34 11.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.249 -0.907 . . . . 0.53000000000000003 109.982 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.506 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -68.54 171.31 37.52 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.331 -1.508 . . . . 0.25 109.331 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.487 ' O ' ' HB ' ' A' ' 163' ' ' ILE . . . 48.22 21.76 2.0 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.775 -1.33 . . . . 0.10000000000000001 109.775 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.471 ' HB2' ' O ' ' A' ' 195' ' ' TYR . 0.4 OUTLIER -81.71 85.55 6.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.317 . . . . 0.10000000000000001 110.096 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.528 ' HB2' ' CG ' ' A' ' 223' ' ' GLU . . . -62.17 101.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.089999999999999997 110.033 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.572 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -112.53 120.88 43.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.837 . . . . 0.089999999999999997 110.461 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 203' ' ' ASP . 22.6 m-85 -90.67 144.37 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.10000000000000001 110.477 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.579 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 15.1 t0 -52.84 85.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.593 -0.892 . . . . 0.14000000000000001 108.593 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.552 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.8 p30 -38.19 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.17999999999999999 111.799 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.564 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -75.68 -0.65 21.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.792 -1.193 . . . . 0.23999999999999999 110.929 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 202' ' ' ASP . 0.0 OUTLIER -101.98 -156.14 0.55 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 0.41999999999999998 110.218 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 17.5 m -133.98 156.4 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 0.46999999999999997 110.768 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -151.65 150.64 30.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.27000000000000002 109.272 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -161.05 173.18 15.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.726 -1.234 . . . . 0.29999999999999999 111.038 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.0 OUTLIER -129.84 25.35 5.31 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.716 0.769 . . . . 0.60999999999999999 108.993 178.62 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.34 -67.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.463 0.649 . . . . 0.78000000000000003 110.525 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.75 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.488 -0.757 . . . . 0.91000000000000003 109.724 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.99 -178.99 4.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.369 -0.832 . . . . 0.93000000000000005 110.063 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.05 -174.7 0.17 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.539 -1.424 . . . . 0.79000000000000004 109.539 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.577 ' CD1' HD12 ' A' ' 185' ' ' LEU . 93.9 m-85 -67.36 120.13 13.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -1.109 . . . . 0.68999999999999995 109.814 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.507 ' O ' ' N ' ' A' ' 218' ' ' LEU . 40.6 m-80 -88.17 119.5 28.63 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.974 -1.079 . . . . 0.40000000000000002 108.8 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.656 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -41.84 -36.24 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -0.863 . . . . 0.17000000000000001 110.236 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.583 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 4.6 m-85 -51.58 -44.11 62.67 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.407 -1.317 . . . . 0.28000000000000003 107.746 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.551 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 12.3 tp -83.65 -71.29 0.51 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.894 -0.594 . . . . 0.46000000000000002 111.106 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.589 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.4 p -46.31 -56.11 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.986 -1.071 . . . . 0.39000000000000001 109.817 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -59.95 -48.92 79.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.101 -0.999 . . . . 0.17000000000000001 110.873 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.583 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -57.36 -24.92 58.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.234 -1.541 . . . . 0.10000000000000001 108.556 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.626 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 3.8 t-160 -79.64 -54.89 5.44 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.95 -0.568 . . . . 0.20999999999999999 109.872 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.528 ' CG ' ' HB2' ' A' ' 199' ' ' ALA . 3.3 tp10 -59.51 -50.94 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.979 -1.076 . . . . 0.28000000000000003 109.092 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.573 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 1.9 m-85 -52.82 -57.99 8.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.17999999999999999 109.163 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.02 -32.58 4.84 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.251 -1.539 . . . . 0.20999999999999999 109.251 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.64 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.0 -72.14 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.09 -1.241 . . . . 0.17000000000000001 111.001 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.533 ' CA ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -38.05 -42.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.33000000000000002 111.9 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.53 HD22 ' CE2' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -95.95 -38.49 10.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.878 -1.139 . . . . 0.53000000000000003 111.335 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.523 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -75.13 -87.09 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.653 -0.979 . . . . 0.40999999999999998 110.653 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.515 ' HB3' ' O ' ' A' ' 110' ' ' THR . 0.3 OUTLIER -158.69 -167.72 2.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -1.194 . . . . 0.45000000000000001 110.855 -178.766 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.503 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -64.41 -55.43 21.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.62 109.75 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.64 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -157.38 179.98 8.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.264 -0.898 . . . . 0.45000000000000001 110.62 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 14.2 t 179.24 50.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.38 109.381 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.616 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -131.06 21.56 4.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.47999999999999998 111.13 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.582 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -37.44 -52.86 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.38 110.708 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.582 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.2 Cg_endo -90.12 -46.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.52 1.274 . . . . 0.28000000000000003 110.873 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.01 96.11 0.1 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.295 -1.431 . . . . 0.23999999999999999 111.419 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.616 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -143.37 165.95 26.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.347 -1.09 . . . . 0.28000000000000003 110.133 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.582 ' CD2' ' HB2' ' A' ' 222' ' ' HIS . 7.0 tt -74.46 55.7 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.40000000000000002 109.736 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.586 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.6 mmm -133.7 -34.72 1.01 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.004 -1.06 . . . . 0.45000000000000001 110.32 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -42.99 168.51 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 0.56999999999999995 110.464 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.465 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.9 Cg_endo -72.89 -2.43 11.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.89 1.468 . . . . 0.76000000000000001 110.024 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.57 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 26.1 mm -106.89 149.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.89000000000000001 110.04 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.551 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 26.4 p90 -134.51 -28.3 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.78000000000000003 110.922 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.536 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 2.93 -69.52 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.495 0.924 . . . . 0.60999999999999999 113.495 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.595 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -55.17 104.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.309 -1.495 . . . . 0.73999999999999999 109.628 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.519 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 0.2 OUTLIER -52.52 -177.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.81000000000000005 110.201 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.58 -8.31 51.31 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.317 -1.513 . . . . 0.56000000000000005 109.317 179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 29.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.37 110.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.482 ' HB2' ' CB ' ' A' ' 247' ' ' THR . 0.9 OUTLIER -82.35 -10.62 59.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.056 -1.028 . . . . 0.44 109.746 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.555 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -156.92 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.53000000000000003 109.785 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER 179.22 -172.27 0.15 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.38 110.407 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.466 ' CE ' ' OD2' ' A' ' 256' ' ' ASP . 19.7 ptt? -66.31 53.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.19 110.825 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.681 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.6 OUTLIER -46.22 -47.39 45.06 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 107.933 -1.136 . . . . 0.28000000000000003 107.933 177.271 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.681 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -72.92 50.32 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 124.076 1.567 . . . . 0.48999999999999999 111.309 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.54 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.0 m-20 -48.51 -32.48 7.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.945 -1.097 . . . . 0.48999999999999999 110.6 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.613 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -53.89 -53.54 51.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.887 -1.125 . . . . 0.31 109.233 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.541 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -67.46 -32.86 73.99 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.021 -1.05 . . . . 0.14000000000000001 108.915 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.54 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 59.2 t -66.54 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.17000000000000001 110.398 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.523 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 8.7 tt0 -53.9 -41.97 68.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.26000000000000001 109.231 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.69 -71.66 0.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.603 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -71.54 -19.48 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.707 -1.466 . . . . 0.22 110.073 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.599 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 40.3 tt0 -59.6 -26.44 65.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.543 -1.28 . . . . 0.39000000000000001 107.543 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.7 t -104.59 -42.47 5.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.411 0.624 . . . . 0.46999999999999997 110.887 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.413 ' HB2' ' HA ' ' A' ' 262' ' ' ILE . 26.5 mt -69.15 -55.02 11.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.47999999999999998 111.223 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.53 ' CE2' HD22 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -81.33 -6.84 59.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.40999999999999998 110.032 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.473 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.29 -108.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.129 -1.588 . . . . 0.46000000000000002 109.129 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.74 76.84 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.733 1.386 . . . . 0.57999999999999996 110.325 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -48.19 161.04 0.51 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.64000000000000001 109.554 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.566 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -98.51 -68.46 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.94999999999999996 110.125 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.534 ' CG ' ' OG ' ' A' ' 114' ' ' SER . 3.7 tt0 57.89 21.11 7.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 1.2 110.225 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.44 137.72 10.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 1.2 110.551 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.13 56.07 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.025 1.54 . . . . 1.0600000000000001 110.415 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.41 ' O ' ' ND2' ' A' ' 274' ' ' ASN . 1.7 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.948 -1.025 . . . . 0.78000000000000003 110.281 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.626 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.576 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.683 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.238 0.542 . . . . 0.40999999999999998 110.178 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 105' ' ' ASN . 2.7 p-10 -168.45 119.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.26000000000000001 110.18 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 107' ' ' PHE . 32.7 m -97.63 -154.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.33000000000000002 110.099 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -43.83 111.43 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.65000000000000002 110.026 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.6 Cg_endo -71.85 -162.69 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.96 1.506 . . . . 0.83999999999999997 110.631 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 19.7 mtt180 69.55 76.63 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.93000000000000005 109.963 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -150.79 -72.21 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.491 -0.755 . . . . 1.03 109.505 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.3 tp 35.53 30.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.817 -0.552 . . . . 1.04 111.18 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -108.59 51.53 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.945 . . . . 0.77000000000000002 110.239 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.501 ' NE1' ' HB3' ' A' ' 270' ' ' ASP . 8.0 t90 -139.79 -56.47 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.41999999999999998 110.124 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.522 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 79.5 p -90.67 49.74 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.44 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 6.4 mmtt -148.48 87.71 1.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.48999999999999999 110.174 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.426 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 35.9 ttp -123.02 -8.81 8.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.162 -0.961 . . . . 0.29999999999999999 110.098 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 7.0 p-10 -159.77 126.73 4.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.14999999999999999 109.974 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.555 ' CD2' ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -152.98 -172.58 4.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.13 110.426 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.521 ' HB ' ' HA ' ' A' ' 161' ' ' ALA . 1.2 p -127.59 139.14 52.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.12 110.557 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.544 ' CB ' HG12 ' A' ' 163' ' ' ILE . 26.6 p90 -127.32 177.99 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.33000000000000002 111.398 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.503 ' HB3' ' CB ' ' A' ' 164' ' ' MET . 7.2 tpt180 -133.08 150.39 52.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.54000000000000004 109.508 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.585 HD11 ' CE2' ' A' ' 138' ' ' PHE . 3.4 pt -112.62 118.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.003 . . . . 0.33000000000000002 111.771 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 1.8 m -166.26 38.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.27000000000000002 110.079 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.541 ' OD1' ' CG2' ' A' ' 134' ' ' VAL . 0.8 OUTLIER -42.89 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.399 -0.92 . . . . 0.40999999999999998 109.116 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.538 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 4.7 t80 179.58 -171.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.885 . . . . 0.40000000000000002 109.991 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.541 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.8 53.02 3.47 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.798 -1.189 . . . . 0.45000000000000001 110.913 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.9 Cg_endo -80.38 -84.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.858 1.452 . . . . 0.35999999999999999 110.571 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.15 -3.96 57.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.25 109.95 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.507 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -123.0 160.38 26.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.303 -0.873 . . . . 0.39000000000000001 110.369 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.26 179.51 4.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.47999999999999998 109.759 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -47.02 -39.26 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.40000000000000002 110.208 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -59.96 -57.87 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.46000000000000002 110.037 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.524 ' O ' ' N ' ' A' ' 136' ' ' LYS . 4.4 mp0 -53.69 -54.61 35.52 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.219 -0.925 . . . . 0.46999999999999997 109.607 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.541 ' CG2' ' OD1' ' A' ' 124' ' ' ASN . 2.6 t -46.16 -36.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.939 -1.134 . . . . 0.31 107.939 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.571 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 5.1 tt0 -61.2 -40.28 93.35 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.242 -1.022 . . . . 0.47999999999999998 108.242 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.581 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -72.44 -52.0 17.8 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.3 -0.96 . . . . 0.64000000000000001 108.776 178.42 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.657 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -44.67 -62.63 1.13 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.081 -1.012 . . . . 0.41999999999999998 110.447 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -64.32 -52.98 55.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.439 -0.788 . . . . 0.34000000000000002 111.343 -178.903 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.645 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -68.78 -71.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.905 -1.122 . . . . 0.46999999999999997 110.328 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.54 -59.78 0.88 Allowed 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.933 -0.479 . . . . 0.46999999999999997 110.33 178.994 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.22 -41.38 27.22 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.594 -1.242 . . . . 0.25 107.984 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -68.29 -27.47 66.34 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.432 -0.793 . . . . 0.34999999999999998 109.11 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 2.6 tttt -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.465 -0.939 . . . . 0.69999999999999996 108.465 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.456 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 13.4 t -73.14 -46.86 49.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.905 -0.776 . . . . 0.60999999999999999 108.905 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.584 ' CH2' HG13 ' A' ' 262' ' ' ILE . 42.3 t-105 -58.52 -42.53 87.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.9 -0.778 . . . . 0.39000000000000001 108.9 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.3 m -70.86 -32.06 68.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.431 -0.952 . . . . 0.34999999999999998 108.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.456 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -55.65 -46.87 77.41 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.107 -0.701 . . . . 0.35999999999999999 109.107 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.559 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 28.1 m -72.34 -34.62 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.448 -0.901 . . . . 0.5 109.369 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.527 HG21 ' CD1' ' A' ' 151' ' ' LEU . 1.1 t -141.37 118.69 7.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.103 -0.998 . . . . 0.51000000000000001 109.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.49 62.58 3.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.68 1.358 . . . . 0.31 111.153 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.64 ' CD2' ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -76.48 174.2 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.003 -1.06 . . . . 0.17999999999999999 109.931 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.447 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 12.5 t-20 -107.81 126.23 52.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.228 -0.92 . . . . 0.17000000000000001 109.873 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -131.37 143.03 50.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 0.14000000000000001 110.925 -179.526 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.505 ' O ' ' HA ' ' A' ' 119' ' ' THR . 33.0 m -143.61 141.51 30.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.337 -0.852 . . . . 0.14999999999999999 110.38 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.443 ' NH1' ' OH ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -117.35 88.24 2.87 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.29 -0.882 . . . . 0.20000000000000001 109.935 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.54 ' CB ' ' HB ' ' A' ' 160' ' ' ILE . 0.1 OUTLIER -79.81 129.07 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.22 110.461 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -89.0 36.78 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.32000000000000001 109.965 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -34.63 2.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.511 -0.743 . . . . 0.33000000000000002 109.648 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 147.1 37.13 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.051 -1.22 . . . . 0.28000000000000003 110.051 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.54 ' HB ' ' CB ' ' A' ' 156' ' ' LEU . 1.9 mp -126.02 70.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.251 . . . . 0.29999999999999999 108.983 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.521 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -139.22 162.27 35.39 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 0.20000000000000001 110.702 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.555 ' CB ' ' CD2' ' A' ' 118' ' ' LEU . 7.0 t70 -134.18 -33.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.10000000000000001 110.458 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.557 ' CG2' ' HA3' ' A' ' 197' ' ' GLY . 0.2 OUTLIER -127.5 173.29 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.038 . . . . 0.10000000000000001 109.77 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.503 ' CB ' ' HB3' ' A' ' 121' ' ' ARG . 2.9 ptt? -176.98 159.12 1.65 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.605 -1.309 . . . . 0.11 111.754 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.56 ' HB ' ' CZ ' ' A' ' 224' ' ' PHE . 3.3 tt -103.0 116.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.10000000000000001 109.301 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.468 ' HA ' ' HA ' ' A' ' 124' ' ' ASN . 4.3 p -157.32 154.58 29.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.789 -1.195 . . . . 0.10000000000000001 111.035 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.3 p90 -75.03 122.13 23.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.089999999999999997 109.448 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -84.52 115.72 4.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.244 -1.142 . . . . 0.20000000000000001 110.244 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.577 ' O ' ' CG2' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -105.43 104.21 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -1.034 . . . . 0.55000000000000004 109.246 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.588 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.72 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.42 0.628 . . . . 0.84999999999999998 112.374 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -130.15 -2.13 4.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 0.70999999999999996 110.181 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 10.3 m-70 -84.83 178.95 7.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.41999999999999998 109.857 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.74 28.38 4.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.33000000000000002 109.683 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -121.77 -97.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.33000000000000002 110.14 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.404 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 97.3 m-85 -102.09 126.94 49.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.27000000000000002 110.022 179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -54.48 109.59 1.65 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.93 . . . . 0.34000000000000002 110.301 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.461 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 42.7 Cg_endo -74.16 -66.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.015 1.534 . . . . 0.46999999999999997 110.76 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -47.72 137.75 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.34999999999999998 110.406 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.493 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 7.6 p30 179.14 81.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.402 -0.919 . . . . 0.20000000000000001 110.584 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.485 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 38.2 -152.01 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.741 -1.343 . . . . 0.25 109.741 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -82.49 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.969 1.51 . . . . 0.44 110.584 179.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.4 t -58.39 176.13 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.56999999999999995 110.354 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.532 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.49 70.49 0.04 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.219 -1.153 . . . . 0.48999999999999999 110.219 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.544 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 7.4 tp 179.9 81.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.349 -1.089 . . . . 0.40999999999999998 110.175 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.558 HD12 ' CG ' ' A' ' 214' ' ' TYR . 6.4 tt -100.84 -24.34 14.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.355 -1.338 . . . . 0.29999999999999999 111.036 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.633 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -149.01 101.71 3.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.723 -1.235 . . . . 0.20000000000000001 112.254 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.518 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.1 OUTLIER -102.97 133.35 48.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.16 109.236 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.519 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -121.37 130.93 53.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 0.23000000000000001 110.595 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.403 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -79.14 165.15 50.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.38 110.341 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.53 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.9 Cg_endo -73.41 141.27 31.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.974 1.512 . . . . 0.40000000000000002 110.038 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.463 ' HD3' ' O ' ' A' ' 227' ' ' SER . 42.9 Cg_endo -70.08 83.25 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.911 1.48 . . . . 0.32000000000000001 110.626 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.72 -101.52 1.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.32000000000000001 109.589 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -162.49 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.942 1.496 . . . . 0.46999999999999997 110.539 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -62.0 -17.79 58.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.63 110.023 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.44 59.55 0.67 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.532 -0.73 . . . . 0.53000000000000003 110.377 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -131.22 168.16 22.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.828 -1.709 . . . . 0.25 108.828 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.557 ' HA3' ' CG2' ' A' ' 163' ' ' ILE . . . 42.78 26.61 0.46 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.67 -1.372 . . . . 0.10000000000000001 109.67 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLY . 7.3 m-20 -79.06 86.18 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.10000000000000001 109.914 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.531 ' HB2' ' CG ' ' A' ' 223' ' ' GLU . . . -62.6 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.074 -1.016 . . . . 0.089999999999999997 109.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.518 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 17.9 m170 -101.97 131.19 48.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.855 . . . . 0.089999999999999997 110.707 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 203' ' ' ASP . 42.4 m-85 -103.52 137.61 41.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.913 . . . . 0.10000000000000001 110.515 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -49.05 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.14000000000000001 108.956 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.548 ' OD2' ' CB ' ' A' ' 178' ' ' PHE . 2.6 p30 -35.95 -29.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.653 -0.654 . . . . 0.17999999999999999 111.772 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 202' ' ' ASP . 10.4 m-20 -79.12 2.27 21.4 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.607 -1.308 . . . . 0.23999999999999999 111.457 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.473 ' N ' ' O ' ' A' ' 202' ' ' ASP . 9.8 mm-40 -93.65 -166.45 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.773 -1.204 . . . . 0.41999999999999998 110.347 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.32 140.81 52.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.46999999999999997 110.468 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.462 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -140.6 130.39 24.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.275 -0.89 . . . . 0.27000000000000002 109.737 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.542 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -138.83 176.46 8.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.021 -1.05 . . . . 0.29999999999999999 110.583 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.462 ' OG ' ' O ' ' A' ' 209' ' ' SER . 2.1 t -130.5 35.94 3.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.873 -0.788 . . . . 0.60999999999999999 108.873 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.9 t -115.26 -111.62 0.35 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.702 -0.624 . . . . 0.78000000000000003 110.065 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.517 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 t -143.88 11.23 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.91000000000000003 109.952 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 123.52 29.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.93000000000000005 109.917 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.99 -171.7 31.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.175 -1.57 . . . . 0.79000000000000004 109.175 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.558 ' CG ' HD12 ' A' ' 185' ' ' LEU . 64.8 m-85 -69.47 122.11 18.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -1.192 . . . . 0.68999999999999995 109.687 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.507 ' HA ' ' O ' ' A' ' 208' ' ' THR . 1.1 p-10 -95.73 119.82 34.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.986 -1.072 . . . . 0.40000000000000002 108.965 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.657 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -38.45 -37.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.672 -0.643 . . . . 0.17000000000000001 111.093 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.581 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.6 m-30 -49.92 -48.39 51.73 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.439 -1.304 . . . . 0.28000000000000003 107.719 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.555 ' CD1' HD12 ' A' ' 239' ' ' LEU . 4.7 tp -79.79 -69.45 0.58 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.906 -0.588 . . . . 0.46000000000000002 110.53 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.575 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.99 -65.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.39000000000000001 109.786 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -48.53 -50.27 32.65 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.832 -1.167 . . . . 0.17000000000000001 111.564 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -63.52 -24.88 68.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.329 -1.482 . . . . 0.10000000000000001 109.052 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.614 ' CE1' ' CA ' ' A' ' 240' ' ' MET . 6.6 t60 -76.78 -54.5 6.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.281 -0.637 . . . . 0.20999999999999999 109.281 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.531 ' CG ' ' HB2' ' A' ' 199' ' ' ALA . 3.2 tp10 -58.76 -47.9 83.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.181 -0.949 . . . . 0.28000000000000003 108.538 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.56 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -54.79 -55.76 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.17999999999999999 109.049 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.53 -31.52 5.07 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.848 -1.701 . . . . 0.20999999999999999 108.848 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.564 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -82.07 -76.71 0.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.241 -1.152 . . . . 0.17000000000000001 110.865 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.542 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -35.22 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.832 -0.543 . . . . 0.33000000000000002 111.834 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.54 ' HG ' ' CG2' ' A' ' 163' ' ' ILE . 0.3 OUTLIER -99.82 -41.23 7.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 0.53000000000000003 110.731 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.458 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -72.19 -79.32 0.45 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.26 -1.136 . . . . 0.40999999999999998 110.26 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.513 ' HG ' ' N ' ' A' ' 231' ' ' ASP . 0.7 OUTLIER -173.54 -163.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.253 . . . . 0.45000000000000001 110.525 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.513 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -61.55 -54.62 40.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.62 110.288 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.564 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -167.77 177.14 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.45000000000000001 111.056 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.405 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 27.7 t 179.26 51.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.748 -0.834 . . . . 0.38 108.748 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.603 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -132.41 24.66 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.47999999999999998 111.41 -178.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.549 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.1 OUTLIER -37.13 -53.61 2.03 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.491 -0.756 . . . . 0.38 110.976 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.549 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -84.27 -49.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.715 1.376 . . . . 0.28000000000000003 111.202 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.57 101.56 0.15 Allowed Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.361 -1.399 . . . . 0.23999999999999999 111.357 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.603 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -146.73 163.27 36.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.341 -1.094 . . . . 0.28000000000000003 110.246 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.581 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -69.64 58.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.40000000000000002 109.026 179.16 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.614 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 2.8 mtp -144.17 -37.29 0.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.45000000000000001 110.045 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -48.56 171.39 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.865 -1.147 . . . . 0.56999999999999995 110.063 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.525 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.3 Cg_endo -74.25 3.91 4.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.578 1.304 . . . . 0.76000000000000001 110.553 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.8 mt -104.8 134.58 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.89000000000000001 110.182 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.556 ' CB ' ' CH ' ' A' ' 3' ' ' MSB . 49.8 p90 -127.87 -36.53 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.854 . . . . 0.78000000000000003 109.72 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 244' ' ' TYR . 53.7 m 1.41 -69.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 112.977 0.732 . . . . 0.60999999999999999 112.977 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.577 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -60.14 101.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.73999999999999999 109.33 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.52 ' N ' ' HB2' ' A' ' 250' ' ' SER . 38.7 p -46.79 175.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.81000000000000005 110.484 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.22 8.05 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.703 -1.359 . . . . 0.56000000000000005 109.703 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.48 28.48 1.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.156 . . . . 0.37 110.345 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.52 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.5 OUTLIER -58.52 -27.34 64.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.44 109.941 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 252' ' ' PHE . 6.9 t-160 -150.59 -55.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.53000000000000003 110.03 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER -176.94 -179.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.38 110.191 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.476 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 1.5 ptt? -68.77 54.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.418 -0.801 . . . . 0.19 110.371 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.667 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.6 mp -44.75 -47.72 28.56 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.974 -1.121 . . . . 0.28000000000000003 107.974 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.667 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.5 Cg_endo -72.89 50.13 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.962 1.506 . . . . 0.48999999999999999 110.94 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.543 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.7 m-20 -52.51 -29.77 26.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.037 -1.039 . . . . 0.48999999999999999 110.157 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.588 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.07 -51.55 63.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.118 -1.033 . . . . 0.31 109.487 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.558 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.32 -33.92 70.11 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.938 -1.105 . . . . 0.14000000000000001 108.553 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.543 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 72.2 t -62.51 -85.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.573 -0.851 . . . . 0.17000000000000001 110.22 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.548 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.4 tt0 -58.04 -43.52 86.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.26000000000000001 110.007 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.532 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.1 -63.87 1.66 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.556 -1.018 . . . . 0.19 110.556 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.593 ' CD1' ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -80.18 -19.19 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.755 -1.438 . . . . 0.22 109.994 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.593 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 0.7 OUTLIER -59.33 -24.65 63.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.849 -1.167 . . . . 0.39000000000000001 107.849 178.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.4 p -103.9 -40.85 6.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.273 -0.571 . . . . 0.46999999999999997 111.806 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.43 ' HB3' ' CG ' ' A' ' 112' ' ' LYS . 4.9 mp -83.96 -46.85 11.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.47999999999999998 111.789 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.64 ' CD1' ' CD2' ' A' ' 151' ' ' LEU . 0.1 OUTLIER -76.08 -21.42 56.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.061 -1.025 . . . . 0.40999999999999998 110.481 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -57.7 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.165 -1.574 . . . . 0.46000000000000002 109.165 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.426 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.0 Cg_endo -75.19 95.68 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.789 1.415 . . . . 0.57999999999999996 110.062 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.8 178.26 43.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.558 -1.417 . . . . 0.64000000000000001 109.558 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.501 ' HB3' ' NE1' ' A' ' 113' ' ' TRP . 27.9 t0 -115.4 -50.74 2.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -1.138 . . . . 0.94999999999999996 110.138 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.522 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 13.5 tt0 59.02 48.41 10.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 1.2 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.92 132.68 0.25 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 1.2 110.2 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.99 -1.84 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.899 1.473 . . . . 1.0600000000000001 110.326 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.969 -1.015 . . . . 0.78000000000000003 110.176 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.593 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.599 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.633 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 84.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.22 0.533 . . . . 0.40999999999999998 110.186 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -142.67 80.11 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.26000000000000001 110.106 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.4 t -110.75 -4.31 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.33000000000000002 110.319 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.23 75.08 79.76 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.65000000000000002 110.185 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.468 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.4 Cg_endo -71.4 -161.95 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.06 1.558 . . . . 0.83999999999999997 110.703 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 30.7 mtt-85 65.21 70.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.93000000000000005 110.515 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.521 ' CA ' HD12 ' A' ' 230' ' ' LEU . 3.1 p -148.82 -68.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.445 -0.784 . . . . 1.03 109.407 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.51 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.9 mp 49.2 18.36 0.24 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.386 -0.821 . . . . 1.04 111.541 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 265' ' ' LEU . 9.6 mttm -97.41 78.89 2.72 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.837 -1.164 . . . . 0.77000000000000002 109.643 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.536 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.3 t90 -165.38 -68.33 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.41999999999999998 111.36 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.525 ' O ' ' CD ' ' A' ' 115' ' ' LYS . 79.9 p -104.69 84.47 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.44 110.952 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 3.4 mptt -173.53 83.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.48999999999999999 110.312 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 116' ' ' MET . 7.7 tmm? -123.75 -8.88 7.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.29999999999999999 110.134 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.418 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 10.1 p30 -158.31 117.34 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.14999999999999999 109.941 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' CD2' ' OD2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -141.88 -178.83 5.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.13 110.611 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.497 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -119.93 170.36 9.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.85 . . . . 0.12 109.56 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.531 ' CZ ' ' HG3' ' A' ' 155' ' ' ARG . 41.0 p90 -165.22 -158.54 0.39 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.041 . . . . 0.33000000000000002 110.947 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -150.34 143.17 24.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 0.54000000000000004 110.138 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.623 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.7 pp -103.81 108.25 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.33000000000000002 110.866 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.5 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 15.6 m -158.76 43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.27000000000000002 110.352 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.504 ' N ' ' O ' ' A' ' 165' ' ' ILE . 16.1 t-20 -42.68 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.40999999999999998 109.328 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.558 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.0 t80 -179.17 -168.98 0.14 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.383 -0.823 . . . . 0.40000000000000002 109.537 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.579 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -143.34 45.71 0.62 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.832 -1.167 . . . . 0.45000000000000001 111.353 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.2 Cg_endo -75.49 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.783 1.412 . . . . 0.35999999999999999 110.041 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -5.84 51.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.858 . . . . 0.25 109.655 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.507 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 1.9 ptt? -118.49 146.87 44.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.39000000000000001 109.94 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -104.07 -179.35 3.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.47999999999999998 110.149 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t-80 -43.43 -35.33 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.40000000000000002 109.872 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -66.62 -59.99 3.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.46000000000000002 110.096 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.518 ' O ' ' N ' ' A' ' 136' ' ' LYS . 1.3 mp0 -50.72 -61.21 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.46999999999999997 109.409 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 125' ' ' TYR . 8.2 t -45.13 -37.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.28 -1.007 . . . . 0.31 108.28 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.558 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.87 -41.05 77.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.319 -0.993 . . . . 0.47999999999999998 108.319 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.577 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.2 tttp -75.09 -51.63 13.0 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.05 0.928 . . . . 0.64000000000000001 108.608 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.663 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -45.5 -63.47 0.95 Allowed 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.093 -1.005 . . . . 0.41999999999999998 110.418 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -61.26 -54.31 45.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.34000000000000002 111.289 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.658 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -69.62 -72.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.46999999999999997 110.485 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.1 tmtp? -37.91 -61.59 0.63 Allowed 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.899 -0.5 . . . . 0.46999999999999997 110.607 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.55 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.06 -40.32 14.78 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.69 -1.204 . . . . 0.25 108.257 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -68.28 -32.82 73.24 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.508 -0.877 . . . . 0.34999999999999998 108.947 178.418 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 140' ' ' LYS . 13.1 ttpp -59.53 -39.23 83.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.261 -1.014 . . . . 0.69999999999999996 108.261 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.86 -41.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.813 -0.81 . . . . 0.60999999999999999 108.813 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.587 ' CH2' HG13 ' A' ' 262' ' ' ILE . 20.6 t-105 -60.99 -39.74 90.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.047 -0.723 . . . . 0.39000000000000001 109.047 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.6 m -73.46 -34.51 65.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.412 -0.805 . . . . 0.34999999999999998 108.834 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -41.55 76.83 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.595 -0.691 . . . . 0.35999999999999999 109.291 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 35.2 m -78.35 -31.7 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.5 110.11 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.506 ' N ' HG21 ' A' ' 148' ' ' VAL . 5.7 t -148.12 135.21 10.38 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.51000000000000001 110.56 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.98 59.65 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.84 1.442 . . . . 0.31 110.377 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.604 ' CD2' ' CD1' ' A' ' 266' ' ' TYR . 1.1 mp -80.8 163.43 23.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.17999999999999999 110.5 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.418 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -107.4 110.18 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.17000000000000001 110.178 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.511 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 8.1 p90 -115.71 122.62 46.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.887 . . . . 0.14000000000000001 110.015 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.512 ' CG2' HD13 ' A' ' 156' ' ' LEU . 8.3 m -127.42 140.87 51.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.14999999999999999 110.373 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.531 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.5 82.09 1.87 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.421 -0.799 . . . . 0.20000000000000001 109.622 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.512 HD13 ' CG2' ' A' ' 154' ' ' THR . 1.3 mp -91.26 85.48 5.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.22 110.44 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' GLY . 36.6 p-80 -57.32 -19.72 24.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.32000000000000001 109.789 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.96 -26.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.481 -0.762 . . . . 0.33000000000000002 109.823 179.13 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.38 20.68 1.24 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.829 -1.308 . . . . 0.28000000000000003 109.829 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.476 ' O ' ' HB ' ' A' ' 119' ' ' THR . 12.1 mt -122.64 65.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.045 -1.268 . . . . 0.29999999999999999 109.259 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.467 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -118.96 141.45 48.65 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.198 -0.601 . . . . 0.20000000000000001 110.4 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD2' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -107.12 -47.55 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.10000000000000001 109.961 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.599 ' CD1' ' CD1' ' A' ' 228' ' ' LEU . 0.1 OUTLIER -116.34 173.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 0.10000000000000001 109.824 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.54 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 4.4 ptp -170.67 142.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.11 110.63 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 3.8 tt -92.89 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.10000000000000001 109.086 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.496 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 5.0 p -157.38 156.54 32.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.805 -1.184 . . . . 0.10000000000000001 111.262 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -74.23 118.48 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.692 -0.63 . . . . 0.089999999999999997 109.665 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -71.67 119.8 7.83 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.024 -1.231 . . . . 0.20000000000000001 110.024 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.581 ' O ' ' C ' ' A' ' 170' ' ' LYS . 6.9 tp -116.61 97.65 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -1.063 . . . . 0.55000000000000004 109.985 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.63 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 3.7 tmtt? 0.07 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.289 0.566 . . . . 0.84999999999999998 112.388 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -162.47 24.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.70999999999999996 110.351 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -97.11 -69.59 0.75 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.41999999999999998 110.132 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.43 -35.82 1.51 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.494 -1.442 . . . . 0.33000000000000002 109.494 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -75.29 -144.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -1.171 . . . . 0.33000000000000002 110.517 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.427 ' C ' ' CD1' ' A' ' 176' ' ' TYR . 58.3 m-85 -55.65 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.27000000000000002 110.509 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 5.4 m-30 -111.01 110.94 56.52 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.34000000000000002 110.306 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.88 -68.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.929 1.489 . . . . 0.46999999999999997 110.558 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -51.21 137.58 22.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.34999999999999998 110.417 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 178' ' ' PHE . 51.6 p-10 -178.44 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.20000000000000001 110.624 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.545 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 44.44 -158.73 0.15 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.782 -1.327 . . . . 0.25 109.782 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.8 Cg_endo -74.95 7.28 2.91 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.14 1.6 . . . . 0.44 110.725 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 184' ' ' LEU . 6.4 t -42.58 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.967 . . . . 0.56999999999999995 110.36 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.534 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.98 76.51 0.02 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.418 -1.073 . . . . 0.48999999999999999 110.418 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.548 ' HG ' ' CG1' ' A' ' 1' ' ' HAV . 3.3 tt 179.9 88.13 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.222 -1.163 . . . . 0.40999999999999998 110.389 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.567 HD13 ' CE2' ' A' ' 214' ' ' TYR . 4.8 tt -103.84 -23.22 13.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.29999999999999999 110.944 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.619 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -148.45 108.03 3.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.602 -1.311 . . . . 0.20000000000000001 112.126 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -105.7 118.76 37.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.16 109.529 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -107.8 141.02 40.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.23000000000000001 110.202 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 3.2 m-30 -91.04 161.51 35.12 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.38 110.32 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.5 Cg_endo -72.41 142.98 37.96 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.967 1.509 . . . . 0.40000000000000002 109.409 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.3 Cg_endo -69.64 74.41 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.849 1.447 . . . . 0.32000000000000001 110.693 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.84 -93.71 1.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.408 -1.477 . . . . 0.32000000000000001 109.408 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 -158.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.981 1.516 . . . . 0.46999999999999997 110.406 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -79.51 8.82 5.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.63 110.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.426 ' HA ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -114.67 6.98 15.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.324 -0.86 . . . . 0.53000000000000003 109.717 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -80.89 168.8 51.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.594 -1.402 . . . . 0.25 109.594 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.561 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 51.84 18.65 4.38 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.658 -1.377 . . . . 0.10000000000000001 109.658 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.426 ' OD2' ' HA ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -79.98 92.19 5.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -1.125 . . . . 0.10000000000000001 110.339 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.532 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -72.44 97.44 2.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.942 . . . . 0.089999999999999997 109.952 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.468 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 1.4 m170 -111.13 131.99 54.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.089999999999999997 110.328 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.626 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 59.5 m-85 -103.27 136.61 42.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.992 -1.067 . . . . 0.10000000000000001 110.678 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 204' ' ' ASP . 1.0 OUTLIER -46.52 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.719 -0.845 . . . . 0.14000000000000001 108.719 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.587 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.4 p30 -36.84 -27.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.17999999999999999 111.674 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.545 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -77.69 -0.24 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.675 -1.266 . . . . 0.23999999999999999 111.217 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.48 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 12.6 mm-40 -94.82 -164.17 1.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.41999999999999998 110.303 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 m -125.58 140.48 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.46999999999999997 110.582 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.587 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.1 m-90 -135.56 142.81 45.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -0.823 . . . . 0.27000000000000002 109.43 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.543 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.83 179.93 8.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.932 -1.105 . . . . 0.29999999999999999 110.565 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.408 ' OG ' ' CZ ' ' A' ' 217' ' ' PHE . 42.8 t -124.62 43.07 3.11 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.686 0.755 . . . . 0.60999999999999999 109.251 178.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.8 t -131.63 -165.9 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.697 -0.627 . . . . 0.78000000000000003 110.076 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.522 ' N ' ' OG ' ' A' ' 210' ' ' SER . 8.7 t -87.64 -0.51 56.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.91000000000000003 110.14 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 149.75 28.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.93000000000000005 109.969 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.23 -164.25 33.27 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.35 -1.5 . . . . 0.79000000000000004 109.35 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.567 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.8 m-85 -84.52 120.78 26.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -1.195 . . . . 0.68999999999999995 109.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.519 ' OD1' ' CB ' ' A' ' 218' ' ' LEU . 7.3 p30 -87.62 121.7 30.39 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.067 -1.021 . . . . 0.40000000000000002 108.852 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.663 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -39.89 -38.78 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.487 -0.758 . . . . 0.17000000000000001 110.867 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.577 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 4.0 m-85 -51.31 -48.87 62.22 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 118.435 -1.306 . . . . 0.28000000000000003 107.527 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.551 ' HG ' ' CH ' ' A' ' 3' ' ' MSB . 0.5 OUTLIER -73.87 -72.6 0.26 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.726 -0.67 . . . . 0.46000000000000002 110.151 178.678 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.626 ' CG2' ' CE1' ' A' ' 201' ' ' PHE . 0.7 OUTLIER -47.93 -69.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.39000000000000001 109.914 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -42.27 -54.79 3.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.17000000000000001 111.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -57.58 -30.72 65.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.499 -1.376 . . . . 0.10000000000000001 109.578 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.592 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.7 t60 -75.51 -43.78 47.24 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.353 0.597 . . . . 0.20999999999999999 109.686 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.532 ' CG ' ' HB1' ' A' ' 199' ' ' ALA . 22.8 tp10 -64.4 -35.97 82.63 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -0.884 . . . . 0.28000000000000003 108.894 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.51 ' CD2' ' O ' ' A' ' 220' ' ' ALA . 19.1 m-85 -66.93 -48.52 68.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.755 -0.831 . . . . 0.17999999999999999 108.755 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -52.47 -31.66 36.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.288 -1.925 . . . . 0.20999999999999999 108.288 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.662 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.7 OUTLIER -80.62 -78.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -1.056 . . . . 0.17000000000000001 110.674 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.561 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.9 OUTLIER -38.5 -45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.33000000000000002 111.268 -178.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.599 ' CD1' ' CD1' ' A' ' 163' ' ' ILE . 6.0 mt -83.37 -46.3 12.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.53000000000000003 110.878 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.51 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -71.31 -85.14 0.19 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.363 -1.095 . . . . 0.40999999999999998 110.363 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.521 HD12 ' CA ' ' A' ' 110' ' ' THR . 2.6 pt? -176.62 -158.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -1.2 . . . . 0.45000000000000001 110.563 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.51 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 7.4 t70 -49.88 -56.1 11.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.62 110.148 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.662 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -164.69 -175.68 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.45000000000000001 109.861 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.409 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER -179.78 58.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.38 109.809 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.583 ' CB ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -152.29 27.06 0.59 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.47999999999999998 111.196 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.546 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.7 OUTLIER -37.83 -48.89 2.89 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.38 110.674 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.546 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 41.1 Cg_endo -86.81 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.913 1.481 . . . . 0.28000000000000003 112.289 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.32 99.58 0.12 Allowed Glycine 0 N--CA 1.5 2.94 0 C-N-CA 118.638 -1.744 . . . . 0.23999999999999999 112.127 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.611 ' HB3' ' N ' ' A' ' 258' ' ' ASP . . . -150.03 169.49 21.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.031 -1.276 . . . . 0.28000000000000003 110.556 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.572 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -80.19 49.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.40000000000000002 108.79 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.592 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.9 OUTLIER -133.99 -22.45 1.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.005 -1.059 . . . . 0.45000000000000001 110.915 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -60.72 172.09 0.91 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.873 -1.142 . . . . 0.56999999999999995 110.204 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.567 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 40.6 Cg_endo -67.79 -2.73 9.1 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.413 1.217 . . . . 0.76000000000000001 110.935 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.569 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.6 mp -108.04 153.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.89000000000000001 109.649 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.578 ' CD1' ' N ' ' A' ' 244' ' ' TYR . 14.3 p90 -135.78 -22.93 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.78000000000000003 111.685 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.529 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 4.0 -70.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 113.44 0.904 . . . . 0.60999999999999999 113.44 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.562 ' CZ ' ' O ' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -72.27 117.34 13.8 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.454 -1.404 . . . . 0.73999999999999999 109.77 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.446 ' HA ' HD12 ' A' ' 218' ' ' LEU . 47.6 p -62.17 -161.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.81000000000000005 110.403 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.58 -32.61 79.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.56000000000000005 109.593 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.48 41.67 2.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -1.124 . . . . 0.37 110.517 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -63.52 -20.87 65.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.44 109.751 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 20.4 m-70 -167.9 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.786 . . . . 0.53000000000000003 109.911 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.9 m-85 -170.22 176.6 4.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.41 -0.806 . . . . 0.38 110.205 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.466 ' O ' ' OD1' ' A' ' 256' ' ' ASP . 0.0 OUTLIER -70.56 54.38 0.15 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.19 110.043 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.663 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.2 mm? -43.82 -47.56 20.83 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.176 -1.046 . . . . 0.28000000000000003 108.176 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.663 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.21 49.81 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.015 1.534 . . . . 0.48999999999999999 110.787 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.558 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 6.2 m-20 -54.19 -29.45 45.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.48999999999999999 110.236 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.522 ' OD2' ' N ' ' A' ' 237' ' ' GLY . 55.4 m-20 -57.2 -41.2 78.92 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.31 109.339 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.611 ' N ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -78.43 -33.2 48.7 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.986 -1.116 . . . . 0.14000000000000001 107.986 178.673 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.558 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 83.5 t -65.55 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.17000000000000001 109.906 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.535 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.4 tt0 -58.18 -42.37 85.9 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.29 -0.881 . . . . 0.26000000000000001 109.446 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.46 -70.33 0.5 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.178 -1.169 . . . . 0.19 110.178 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.598 ' CD1' ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -73.75 -18.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.963 -1.316 . . . . 0.22 110.392 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.598 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 44.9 tt0 -65.54 -20.3 66.28 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.9 -1.12 . . . . 0.39000000000000001 108.163 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 260' ' ' GLN . 0.8 OUTLIER -103.37 -40.69 6.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.779 -0.576 . . . . 0.46999999999999997 111.145 -179.811 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.508 ' CD1' ' HB3' ' A' ' 112' ' ' LYS . 4.3 mm? -86.71 -45.4 11.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.185 -0.947 . . . . 0.47999999999999998 111.179 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.604 ' CD1' ' CD2' ' A' ' 151' ' ' LEU . 0.2 OUTLIER -76.95 -13.68 59.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.40999999999999998 110.53 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -62.7 -107.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.953 -1.659 . . . . 0.46000000000000002 108.953 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.1 95.07 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.57999999999999996 110.079 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.87 171.04 37.08 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.825 -1.31 . . . . 0.64000000000000001 109.825 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.536 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -96.42 -70.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -1.103 . . . . 0.94999999999999996 110.13 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.432 ' O ' ' HG2' ' A' ' 271' ' ' GLU . 78.7 tt0 52.37 28.76 6.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 1.2 110.115 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 270' ' ' ASP . 2.0 p30 -168.21 131.98 1.37 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 1.2 110.201 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.84 -10.47 26.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.9 1.474 . . . . 1.0600000000000001 110.416 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.159 -0.963 . . . . 0.78000000000000003 110.215 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.571 ' O1 ' ' CD2' ' A' ' 226' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.619 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.272 0.558 . . . . 0.40999999999999998 110.193 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -147.58 74.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.26000000000000001 110.128 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.9 t -122.82 -37.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.33000000000000002 110.263 -179.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.541 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 1.6 m-85 -134.48 52.61 8.0 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.65000000000000002 110.487 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.541 ' HD3' ' N ' ' A' ' 107' ' ' PHE . 51.6 Cg_endo -79.24 12.06 2.43 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.919 1.484 . . . . 0.83999999999999997 110.693 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' O ' HD13 ' A' ' 230' ' ' LEU . 63.8 mtt180 -121.38 58.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 0.93000000000000005 110.202 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.5 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p -127.34 -39.81 1.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 1.03 109.59 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 3.2 mm? 40.75 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.545 -0.722 . . . . 1.04 111.373 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.507 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 1.8 mttt -123.44 65.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.856 -1.153 . . . . 0.77000000000000002 109.939 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.61 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 19.3 t90 -123.03 -71.67 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.41999999999999998 110.573 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 22.1 t -105.15 58.33 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.302 -0.874 . . . . 0.44 110.291 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.412 ' HG3' ' C ' ' A' ' 114' ' ' SER . 39.0 mttp -141.72 59.49 1.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.48999999999999999 110.489 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.48 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.6 OUTLIER -89.9 11.2 21.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.29999999999999999 109.793 179.55 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.489 ' ND2' ' HB3' ' A' ' 152' ' ' ASN . 0.9 OUTLIER -172.0 115.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.14999999999999999 109.512 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.477 ' CD2' ' O ' ' A' ' 117' ' ' ASN . 1.2 mm? -137.48 178.01 7.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.184 -0.947 . . . . 0.13 110.72 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.0 OUTLIER -120.34 174.11 6.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.12 109.902 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.501 ' HB2' HG13 ' A' ' 163' ' ' ILE . 31.3 p90 -178.94 178.74 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.33000000000000002 111.425 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.431 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 1.3 ttp180 -121.05 158.51 27.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.54000000000000004 109.654 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.564 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.6 pp -125.7 98.42 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.33000000000000002 110.881 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.529 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 3.4 m -145.57 53.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.27000000000000002 110.334 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 17.9 t30 -43.39 -84.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.40999999999999998 109.623 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.56 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 8.6 t80 -177.53 -175.07 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.40000000000000002 109.917 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.51 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -139.03 52.52 4.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.45000000000000001 110.716 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.56 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.2 Cg_endo -76.26 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.819 1.431 . . . . 0.35999999999999999 109.767 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.77 -4.62 54.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.25 109.588 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.541 ' HE1' ' CG2' ' A' ' 134' ' ' VAL . 1.8 ptm -119.76 170.71 8.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.469 -0.769 . . . . 0.39000000000000001 109.955 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.91 -172.46 2.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.47999999999999998 110.34 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.402 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.5 t60 -53.09 -36.4 60.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.40000000000000002 110.03 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.454 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 6.9 t -60.83 -48.68 80.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.46000000000000002 109.336 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.536 ' O ' ' N ' ' A' ' 136' ' ' LYS . 13.1 mp0 -62.79 -63.33 1.24 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.34 -0.85 . . . . 0.46999999999999997 109.527 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.541 ' CG2' ' HE1' ' A' ' 129' ' ' MET . 13.4 t -43.68 -38.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.611 -0.885 . . . . 0.31 108.611 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.566 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 3.0 mt-10 -56.68 -42.14 78.54 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.47999999999999998 108.246 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 2.4 tttm -73.8 -50.13 22.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.471 -0.936 . . . . 0.64000000000000001 108.471 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.665 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -46.05 -60.79 2.07 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.19 -0.944 . . . . 0.41999999999999998 110.225 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.649 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -64.74 -53.63 44.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.34000000000000002 111.018 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.82 -72.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.857 -1.152 . . . . 0.46999999999999997 110.347 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.2 tmtm? -38.65 -61.16 0.74 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.752 -0.593 . . . . 0.46999999999999997 110.655 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.59 -38.59 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.611 -1.235 . . . . 0.25 108.374 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -70.11 -32.76 70.94 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.335 -0.853 . . . . 0.34999999999999998 109.15 178.634 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' LYS . 4.6 tttp -59.82 -38.82 83.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.38 -0.971 . . . . 0.69999999999999996 108.38 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.422 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 16.1 t -71.91 -44.34 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 109.035 -0.728 . . . . 0.60999999999999999 109.035 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.6 ' CH2' HG13 ' A' ' 262' ' ' ILE . 13.6 t-105 -56.63 -44.93 81.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.39000000000000001 109.01 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.455 ' HA ' ' O ' ' A' ' 149' ' ' THR . 26.0 m -71.01 -35.05 71.88 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.32 -0.862 . . . . 0.34999999999999998 108.739 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.422 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -53.06 -42.43 65.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.576 -0.703 . . . . 0.35999999999999999 109.416 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.527 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 31.1 m -80.47 -32.59 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.779 -0.768 . . . . 0.5 110.198 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.487 ' N ' HG23 ' A' ' 148' ' ' VAL . 2.5 t -137.94 124.59 13.27 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.068 . . . . 0.51000000000000001 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -78.28 62.24 8.04 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.31 110.341 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.524 ' O ' ' CD1' ' A' ' 151' ' ' LEU . 0.3 OUTLIER -101.0 156.31 17.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.17999999999999999 110.127 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.489 ' HB3' ' ND2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -76.94 134.41 38.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.35 -0.844 . . . . 0.17000000000000001 111.341 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.536 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 7.7 p90 -135.19 121.99 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.14000000000000001 109.618 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.462 ' O ' ' HA ' ' A' ' 119' ' ' THR . 42.4 m -127.0 161.68 27.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.14999999999999999 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -142.18 68.95 1.32 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.655 -0.653 . . . . 0.20000000000000001 110.09 -178.94 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 93.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.22 110.038 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' ASP . 50.4 p-80 -48.51 -28.15 3.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.32000000000000001 110.083 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' HIS . 4.3 t70 -42.36 -70.27 0.11 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.576 -0.703 . . . . 0.33000000000000002 109.819 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 179.39 30.68 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.28000000000000003 109.586 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.565 ' O ' ' HB ' ' A' ' 119' ' ' THR . 20.9 mm -121.57 79.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.267 -1.137 . . . . 0.29999999999999999 108.339 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.482 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -136.14 112.02 9.53 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.097 -0.641 . . . . 0.20000000000000001 110.714 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -73.37 -54.36 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.10000000000000001 109.97 179.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.572 ' CG2' ' HG ' ' A' ' 228' ' ' LEU . 5.4 pt -111.84 175.9 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.10000000000000001 109.677 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.487 ' O ' ' HB1' ' A' ' 199' ' ' ALA . 23.2 ptm -170.35 136.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.844 -1.16 . . . . 0.11 111.122 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.533 ' CD1' ' HB3' ' A' ' 220' ' ' ALA . 1.6 tt -90.24 123.44 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.447 -0.783 . . . . 0.10000000000000001 109.852 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.529 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 23.0 p -168.37 143.05 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.831 -1.168 . . . . 0.10000000000000001 110.922 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.8 p90 -58.49 117.21 4.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.372 -0.83 . . . . 0.089999999999999997 109.507 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -83.79 115.3 4.03 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.901 -1.28 . . . . 0.20000000000000001 109.901 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.574 ' O ' ' C ' ' A' ' 170' ' ' LYS . 7.0 tt -106.63 100.26 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.957 . . . . 0.55000000000000004 109.781 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.574 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 0.91 87.47 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.33 0.586 . . . . 0.84999999999999998 112.397 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -130.06 -1.75 4.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.70999999999999996 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -77.18 -86.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.41999999999999998 110.035 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.28 58.8 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.339 -1.504 . . . . 0.33000000000000002 109.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -155.16 -80.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -1.105 . . . . 0.33000000000000002 110.377 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.489 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 83.9 m-85 -115.67 103.67 10.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.27000000000000002 110.335 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.427 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.3 m-30 -40.32 98.82 0.18 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.34000000000000002 110.156 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 48.9 Cg_endo -82.67 -59.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.099 1.579 . . . . 0.46999999999999997 110.775 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CB ' ' OD1' ' A' ' 203' ' ' ASP . 10.8 p90 -50.7 163.4 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.34999999999999998 110.209 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 180' ' ' GLY . 0.9 OUTLIER 179.48 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.941 -1.099 . . . . 0.20000000000000001 111.451 179.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.555 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 141.89 -123.55 2.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.157 -1.577 . . . . 0.25 109.157 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.4 2.62 7.91 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 O-C-N 123.919 1.484 . . . . 0.44 109.768 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 177.53 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.434 -0.791 . . . . 0.56999999999999995 110.228 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.532 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -77.03 76.33 1.63 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.594 -1.003 . . . . 0.48999999999999999 110.594 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 0.6 OUTLIER 179.77 98.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -1.127 . . . . 0.40999999999999998 110.288 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.549 HD12 ' CE2' ' A' ' 214' ' ' TYR . 1.4 tt -116.74 -17.6 10.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.746 -1.182 . . . . 0.29999999999999999 111.334 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.644 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -157.52 105.1 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.452 -1.405 . . . . 0.20000000000000001 111.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -102.76 121.35 42.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.16 110.086 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.466 ' HB3' ' HA ' ' A' ' 227' ' ' SER . . . -106.41 119.03 38.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.23000000000000001 110.075 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -69.7 170.25 10.18 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.257 -0.902 . . . . 0.38 110.401 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.511 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 46.2 Cg_endo -73.15 130.73 15.68 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.101 1.579 . . . . 0.40000000000000002 109.698 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.6 Cg_endo -69.88 74.8 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.956 1.503 . . . . 0.32000000000000001 110.572 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.01 -91.45 1.02 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.703 -1.359 . . . . 0.32000000000000001 109.703 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.0 -163.57 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.991 1.521 . . . . 0.46999999999999997 110.489 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -6.58 35.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.63 110.047 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . 0.438 ' C ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -111.55 49.7 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.423 -0.798 . . . . 0.53000000000000003 109.796 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.511 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -123.89 174.62 16.81 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.36 -1.496 . . . . 0.25 109.36 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.559 ' HA3' ' CG2' ' A' ' 163' ' ' ILE . . . 41.59 27.63 0.32 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.081 -1.208 . . . . 0.10000000000000001 110.081 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD2' ' C ' ' A' ' 195' ' ' TYR . 57.7 m-20 -79.53 90.07 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.057 -1.261 . . . . 0.10000000000000001 110.031 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.487 ' HB1' ' O ' ' A' ' 164' ' ' MET . . . -68.59 89.97 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.053 -1.029 . . . . 0.089999999999999997 109.81 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.521 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 3.1 m170 -102.92 128.31 49.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.089999999999999997 110.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.567 ' O ' ' N ' ' A' ' 203' ' ' ASP . 21.2 m-85 -96.73 132.13 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.10000000000000001 111.173 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.552 ' HB3' ' CG ' ' A' ' 205' ' ' GLU . 35.8 t0 -40.06 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.245 -0.65 . . . . 0.14000000000000001 109.245 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -36.43 -38.89 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.17999999999999999 112.161 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.555 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 14.0 t0 -73.68 -6.65 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.642 -1.286 . . . . 0.23999999999999999 111.225 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.552 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 14.7 mm-40 -84.79 -165.21 1.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.847 -1.158 . . . . 0.41999999999999998 110.176 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.55 148.26 52.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.46999999999999997 110.441 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.425 ' C ' HG22 ' A' ' 208' ' ' THR . 0.9 OUTLIER -142.24 140.36 32.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.267 -0.895 . . . . 0.27000000000000002 109.57 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -149.03 174.85 11.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.857 -1.152 . . . . 0.29999999999999999 110.748 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -129.06 24.79 5.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.794 0.807 . . . . 0.60999999999999999 109.206 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.3 t -94.6 -111.46 0.12 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.615 -0.678 . . . . 0.78000000000000003 110.03 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.531 ' N ' ' OG ' ' A' ' 210' ' ' SER . 4.4 p -141.28 8.39 2.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.134 . . . . 0.91000000000000003 110.008 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 -179.26 5.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.93000000000000005 109.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.76 -154.88 5.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.038 -1.625 . . . . 0.79000000000000004 109.038 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.549 ' CE2' HD12 ' A' ' 185' ' ' LEU . 79.0 m-85 -90.16 109.94 20.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.251 . . . . 0.68999999999999995 110.066 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.471 ' O ' ' N ' ' A' ' 218' ' ' LEU . 32.6 m-20 -79.15 120.92 24.36 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.097 -1.002 . . . . 0.40000000000000002 108.866 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.665 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -41.26 -36.53 0.79 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.556 -0.858 . . . . 0.17000000000000001 110.718 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.576 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 4.1 m-85 -53.05 -46.92 68.74 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.315 -1.354 . . . . 0.28000000000000003 107.589 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.581 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 5.8 tp -77.27 -71.86 0.38 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.4 -0.818 . . . . 0.46000000000000002 110.683 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.547 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.3 p -48.78 -61.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.39000000000000001 110.385 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -53.06 -48.56 67.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.061 -1.024 . . . . 0.17000000000000001 111.439 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.95 -29.11 66.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.201 -1.562 . . . . 0.10000000000000001 108.743 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.596 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 4.0 t60 -77.0 -44.12 32.19 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.31 0.576 . . . . 0.20999999999999999 109.747 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.481 ' OE1' ' CB ' ' A' ' 186' ' ' ALA . 17.8 tp10 -64.58 -45.61 86.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.02 . . . . 0.28000000000000003 108.667 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.528 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 18.4 m-30 -56.35 -60.51 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.17999999999999999 109.029 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.462 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.07 -34.15 1.99 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.971 -1.652 . . . . 0.20999999999999999 108.971 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.437 ' O ' ' C ' ' A' ' 227' ' ' SER . 0.2 OUTLIER -80.87 -70.16 0.55 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.106 -1.232 . . . . 0.17000000000000001 111.235 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.526 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.1 OUTLIER -36.66 -44.33 0.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.33000000000000002 112.017 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.572 ' HG ' ' CG2' ' A' ' 163' ' ' ILE . 1.0 OUTLIER -101.09 -37.49 8.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.661 -1.274 . . . . 0.53000000000000003 111.317 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -65.01 -85.08 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.316 -1.114 . . . . 0.40999999999999998 110.316 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -172.54 -173.28 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.245 . . . . 0.45000000000000001 110.473 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.519 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 42.0 t0 -51.35 -59.72 3.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.62 109.975 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.519 ' ND1' ' O ' ' A' ' 231' ' ' ASP . 1.6 m80 -163.82 -179.98 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.45000000000000001 110.256 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.492 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.1 OUTLIER 179.23 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.457 -0.777 . . . . 0.38 109.391 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.624 ' HB3' ' HB2' ' A' ' 240' ' ' MET . 0.0 OUTLIER -137.04 21.43 3.02 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.468 -0.893 . . . . 0.47999999999999998 111.197 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.538 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -35.58 -49.66 1.38 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 120.055 -0.658 . . . . 0.38 110.635 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.538 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -88.5 -48.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.701 1.369 . . . . 0.28000000000000003 111.132 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.1 101.73 0.15 Allowed Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.409 -1.377 . . . . 0.23999999999999999 111.401 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.584 ' HB3' ' CB ' ' A' ' 257' ' ' ASP . . . -147.47 163.16 37.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.372 -1.075 . . . . 0.28000000000000003 110.463 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.18 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.074 -1.016 . . . . 0.40000000000000002 108.818 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.624 ' HB2' ' HB3' ' A' ' 234' ' ' LYS . 50.6 mtt -135.9 -34.4 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.793 . . . . 0.45000000000000001 110.437 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -43.88 169.85 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.195 -0.941 . . . . 0.56999999999999995 110.359 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.2 Cg_endo -69.35 -8.02 22.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.786 1.413 . . . . 0.76000000000000001 110.198 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.544 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 16.0 mm -103.26 159.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.89000000000000001 109.845 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.589 ' CD1' ' N ' ' A' ' 244' ' ' TYR . 16.8 p90 -138.07 -24.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.78000000000000003 111.446 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.517 HG21 ' CG2' ' A' ' 243' ' ' ILE . 0.1 OUTLIER 3.19 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.824 1.046 . . . . 0.60999999999999999 113.824 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.55 ' CZ ' ' O ' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -71.82 115.64 11.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.438 -1.413 . . . . 0.73999999999999999 110.022 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.45 HG22 ' HB2' ' A' ' 218' ' ' LEU . 2.9 m -54.04 -174.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.81000000000000005 110.301 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.409 ' O ' ' OH ' ' A' ' 246' ' ' TYR . . . -50.83 -25.29 9.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.56000000000000005 109.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.632 ' N ' ' CD ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -167.46 36.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -1.135 . . . . 0.37 110.353 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.2 t -58.54 -16.19 14.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.44 110.147 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.413 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 11.2 t60 -145.55 -48.7 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.53000000000000003 110.086 179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.55 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.8 OUTLIER 179.99 172.75 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.38 110.122 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.487 ' HG3' ' O ' ' A' ' 253' ' ' MET . 4.8 ptp -72.85 52.38 0.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.122 -0.986 . . . . 0.19 110.055 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.642 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.1 OUTLIER -45.24 -47.39 33.45 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 108.014 -1.106 . . . . 0.28000000000000003 108.014 177.695 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.642 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -73.76 51.9 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.085 1.571 . . . . 0.48999999999999999 110.905 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.562 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.7 m-20 -52.17 -31.44 31.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.129 -0.982 . . . . 0.48999999999999999 110.151 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.584 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -51.89 -51.5 56.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.945 -1.102 . . . . 0.31 109.346 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.537 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -69.48 -35.6 75.74 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.074 -1.051 . . . . 0.14000000000000001 108.553 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.562 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 73.8 t -63.41 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.17000000000000001 110.273 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.546 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 33.0 tt0 -54.03 -43.87 70.5 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.246 -0.909 . . . . 0.26000000000000001 109.902 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.04 -69.04 0.55 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.345 -1.102 . . . . 0.19 110.345 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.6 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -76.37 -19.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.786 -1.42 . . . . 0.22 110.264 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.597 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 14.3 tt0 -61.54 -23.58 66.05 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.863 -1.135 . . . . 0.39000000000000001 107.94 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 p -103.87 -42.58 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.386 0.612 . . . . 0.46999999999999997 110.691 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.507 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 75.3 mt -73.95 -52.11 13.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.422 -0.799 . . . . 0.47999999999999998 111.319 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.53 ' OH ' ' CD2' ' A' ' 228' ' ' LEU . 0.1 OUTLIER -75.6 -11.82 60.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.40999999999999998 110.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.48 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.89 -102.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.059 -1.617 . . . . 0.46000000000000002 109.059 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.52 101.65 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.86 1.452 . . . . 0.57999999999999996 110.158 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -78.82 165.71 51.37 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.587 -1.405 . . . . 0.64000000000000001 109.587 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.61 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -95.41 -68.75 0.78 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -1.124 . . . . 0.94999999999999996 110.254 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.53 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 2.9 tm-20 49.42 30.86 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 1.2 110.143 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -100.15 108.43 52.21 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.908 . . . . 1.2 110.424 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.75 56.58 2.93 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.976 1.514 . . . . 1.0600000000000001 110.354 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.016 -0.992 . . . . 0.78000000000000003 110.234 -179.819 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.586 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.552 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.644 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . 0.552 ' CE2' HG12 ' A' ' 106' ' ' VAL . 19.9 t80 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.23 0.538 . . . . 0.40999999999999998 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . 0.455 ' OD1' ' O ' ' A' ' 105' ' ' ASN . 13.3 p30 -62.35 88.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.26000000000000001 110.241 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.552 HG12 ' CE2' ' A' ' 104' ' ' TYR . 22.1 m -62.25 -145.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.33000000000000002 110.124 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 106' ' ' VAL . 8.3 m-85 -43.26 113.5 1.42 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.65000000000000002 110.218 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.494 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 47.3 Cg_endo -73.01 -158.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.886 1.466 . . . . 0.83999999999999997 110.757 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.496 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 2.1 mtp180 64.96 71.44 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.528 -0.732 . . . . 0.93000000000000005 110.241 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.538 ' CA ' HD12 ' A' ' 230' ' ' LEU . 1.5 p -138.32 -63.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 1.03 109.484 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.462 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.4 OUTLIER 39.09 30.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.643 -0.66 . . . . 1.04 111.428 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.472 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -114.35 68.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.043 -1.036 . . . . 0.77000000000000002 109.433 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.556 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 20.8 t90 -147.52 -66.85 0.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.41999999999999998 111.063 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.539 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 24.0 p -97.1 51.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.44 110.952 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 114' ' ' SER . 4.5 mmmt -148.48 85.77 1.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.48999999999999999 109.91 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.46 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 tmm? -120.86 -15.72 8.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.025 -1.047 . . . . 0.29999999999999999 110.473 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.453 ' O ' HD21 ' A' ' 118' ' ' LEU . 7.3 p-10 -153.46 114.28 4.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.14999999999999999 110.211 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.453 HD21 ' O ' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -141.0 -151.87 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.304 -0.873 . . . . 0.13 110.201 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.552 ' CB ' ' O ' ' A' ' 160' ' ' ILE . 0.7 OUTLIER -136.32 155.35 50.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.12 110.142 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.585 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 29.0 p90 -148.92 163.33 37.77 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.496 -0.882 . . . . 0.33000000000000002 111.055 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 151.38 35.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.48 -0.763 . . . . 0.54000000000000004 109.881 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.642 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.1 pp -116.91 111.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.33000000000000002 111.163 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.522 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 2.8 m -161.82 49.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.27000000000000002 110.261 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.479 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.8 t30 -42.95 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.40999999999999998 109.451 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.484 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 24.6 t80 -179.03 -176.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.40000000000000002 110.042 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.428 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -129.09 57.95 33.73 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.982 . . . . 0.45000000000000001 109.834 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.448 ' HD3' ' HB3' ' A' ' 125' ' ' TYR . 47.8 Cg_endo -75.1 -88.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.275 1.671 . . . . 0.35999999999999999 110.688 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.37 -8.27 21.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.25 110.163 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.567 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.04 174.95 5.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.39000000000000001 110.204 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 132' ' ' SER . 3.0 m -115.17 167.03 11.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.47999999999999998 109.302 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 130' ' ' THR . 7.9 t-160 -43.38 -26.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.40000000000000002 109.61 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.2 OUTLIER -68.8 -45.57 70.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.831 . . . . 0.46000000000000002 110.116 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.567 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.1 OUTLIER -70.71 -50.54 35.21 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.938 -1.101 . . . . 0.46999999999999997 109.248 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.484 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 9.5 t -47.18 -36.61 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.242 -1.392 . . . . 0.31 107.242 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.565 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 1.4 tt0 -58.96 -45.88 89.42 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.474 -1.306 . . . . 0.47999999999999998 107.474 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.31 -50.36 71.98 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.068 0.937 . . . . 0.64000000000000001 108.704 178.164 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.649 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -46.33 -62.93 1.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.149 -0.969 . . . . 0.41999999999999998 110.718 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.642 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.73 -52.53 56.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.34000000000000002 110.7 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -65.91 -74.82 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.901 -1.124 . . . . 0.46999999999999997 110.175 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -38.48 -61.6 0.68 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.807 -0.558 . . . . 0.46999999999999997 110.66 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.96 -38.56 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.665 -1.272 . . . . 0.25 108.359 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -71.65 -28.92 64.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -0.869 . . . . 0.34999999999999998 109.156 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.02 -42.2 98.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.69999999999999996 108.416 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.451 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 4.4 t -72.31 -51.36 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.817 -0.809 . . . . 0.60999999999999999 108.817 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.595 ' CH2' HG13 ' A' ' 262' ' ' ILE . 47.8 t-105 -50.85 -34.47 28.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.523 -0.917 . . . . 0.39000000000000001 108.523 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -76.28 -36.02 58.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.45 -0.944 . . . . 0.34999999999999998 108.45 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.31 -43.23 70.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.981 -0.748 . . . . 0.35999999999999999 108.981 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 31.4 m -74.85 -35.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.703 -0.799 . . . . 0.5 109.552 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.507 ' N ' HG23 ' A' ' 148' ' ' VAL . 13.0 t -148.06 121.77 4.81 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 0.51000000000000001 110.305 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.79 60.74 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.819 1.431 . . . . 0.31 110.335 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.587 HD23 ' CG ' ' A' ' 266' ' ' TYR . 1.1 mp -73.9 173.86 9.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.17999999999999999 110.815 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -110.25 121.83 46.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.17000000000000001 109.95 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.575 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 9.0 p90 -138.8 131.23 28.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.14000000000000001 110.266 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.524 ' O ' ' CG2' ' A' ' 119' ' ' THR . 7.8 m -136.84 130.58 32.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.14999999999999999 110.22 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.585 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -94.12 69.83 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.20000000000000001 109.945 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 110.64 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.22 110.11 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 158' ' ' ASP . 4.6 m-70 -67.74 -24.53 65.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.32000000000000001 110.01 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.461 ' OD2' HD11 ' A' ' 160' ' ' ILE . 4.5 t0 -42.44 -27.71 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.33000000000000002 109.646 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.86 26.52 1.25 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.614 -1.395 . . . . 0.28000000000000003 109.614 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.552 ' O ' ' CB ' ' A' ' 119' ' ' THR . 8.0 mt -116.65 74.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.203 -1.175 . . . . 0.29999999999999999 109.432 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.485 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -135.57 152.94 51.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.664 -0.648 . . . . 0.20000000000000001 110.491 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.98 -35.27 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.10000000000000001 110.185 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.541 HG13 ' N ' ' A' ' 164' ' ' MET . 0.7 OUTLIER -115.21 163.21 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.291 -0.881 . . . . 0.10000000000000001 109.335 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.541 ' N ' HG13 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -174.63 142.57 0.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.375 -1.453 . . . . 0.11 111.71 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.534 ' CD1' ' HB3' ' A' ' 220' ' ' ALA . 6.7 tt -94.74 118.42 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.469 -0.769 . . . . 0.10000000000000001 109.777 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.499 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 9.7 p -160.94 153.4 20.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.808 -1.183 . . . . 0.10000000000000001 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.0 p90 -68.81 120.46 14.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.089999999999999997 109.727 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -81.95 129.92 9.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.529 -1.028 . . . . 0.20000000000000001 110.529 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.583 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -125.06 99.99 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.709 -0.877 . . . . 0.55000000000000004 108.94 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 1.43 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.42 0.629 . . . . 0.84999999999999998 112.475 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -163.3 24.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.70999999999999996 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 14.4 m-70 -93.29 -57.96 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.41999999999999998 110.253 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 110.86 55.34 0.51 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.65 -1.38 . . . . 0.33000000000000002 109.65 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.434 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 8.0 p-10 -176.71 -37.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -1.079 . . . . 0.33000000000000002 110.202 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.465 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.6 OUTLIER -156.05 149.07 24.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.27000000000000002 110.106 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -77.34 112.24 22.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.34000000000000002 110.138 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.1 Cg_endo -74.15 -55.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.954 1.502 . . . . 0.46999999999999997 110.625 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.596 ' CG ' ' OD2' ' A' ' 203' ' ' ASP . 3.3 p90 -79.64 162.44 25.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.038 . . . . 0.34999999999999998 110.528 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -169.51 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.019 . . . . 0.20000000000000001 110.989 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.601 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 160.48 -149.11 18.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.25 109.49 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.83 -2.05 10.85 Favored 'Trans proline' 0 C--N 1.297 -2.174 0 O-C-N 124.228 1.646 . . . . 0.44 109.765 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.519 ' CB ' ' OD1' ' A' ' 179' ' ' ASP . 20.2 t -49.88 175.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.56999999999999995 110.184 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.554 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -68.61 76.53 0.28 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.781 -0.928 . . . . 0.48999999999999999 110.781 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.554 ' CD2' ' O ' ' A' ' 177' ' ' PRO . 1.0 OUTLIER 179.35 85.94 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.199 -1.177 . . . . 0.40999999999999998 110.575 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.596 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.6 tt -105.79 -21.4 13.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.612 -1.305 . . . . 0.29999999999999999 111.664 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.63 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -146.63 109.7 4.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.526 -1.359 . . . . 0.20000000000000001 111.985 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -112.61 115.26 28.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.16 109.538 178.872 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.529 ' CB ' ' HB3' ' A' ' 227' ' ' SER . . . -111.1 145.72 38.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.23000000000000001 110.116 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 2.2 m-30 -95.72 165.78 15.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.233 -0.917 . . . . 0.38 110.757 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -71.04 150.58 60.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.069 1.562 . . . . 0.40000000000000002 109.163 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.499 ' HD3' ' O ' ' A' ' 227' ' ' SER . 45.4 Cg_endo -72.89 76.27 2.53 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.681 1.359 . . . . 0.32000000000000001 110.5 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.07 -108.29 2.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.498 -1.441 . . . . 0.32000000000000001 109.498 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.89 -158.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.935 1.492 . . . . 0.46999999999999997 110.26 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -3.42 13.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.161 -0.962 . . . . 0.63 110.554 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.36 27.51 8.66 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.53000000000000003 110.227 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -105.35 166.72 14.51 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.136 -1.586 . . . . 0.25 109.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.539 ' O ' ' CD1' ' A' ' 163' ' ' ILE . . . 51.43 21.04 5.85 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.937 -1.665 . . . . 0.10000000000000001 108.937 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.42 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.9 OUTLIER -77.44 88.83 3.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -1.143 . . . . 0.10000000000000001 110.267 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.516 ' HB2' ' CG ' ' A' ' 223' ' ' GLU . . . -72.96 84.98 1.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.089999999999999997 109.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 52.9 m170 -97.82 127.06 43.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.089999999999999997 110.628 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.3 m-85 -97.89 141.03 31.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.995 . . . . 0.10000000000000001 109.818 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.53 ' O ' ' N ' ' A' ' 205' ' ' GLU . 0.2 OUTLIER -51.76 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.373 -0.973 . . . . 0.14000000000000001 108.373 178.773 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.596 ' OD2' ' CG ' ' A' ' 178' ' ' PHE . 1.7 p30 -34.86 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.17999999999999999 112.204 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.601 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 18.5 t0 -80.18 10.12 4.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.683 -1.261 . . . . 0.23999999999999999 110.744 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.53 ' N ' ' O ' ' A' ' 202' ' ' ASP . 21.8 mm-40 -101.41 -162.15 0.91 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.41999999999999998 109.961 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.0 m -128.41 141.85 51.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.036 -1.04 . . . . 0.46999999999999997 110.381 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.538 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -142.41 139.03 31.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.968 . . . . 0.27000000000000002 109.9 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -144.29 172.91 12.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.975 -1.078 . . . . 0.29999999999999999 110.545 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -128.2 27.5 5.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.951 0.882 . . . . 0.60999999999999999 108.996 178.786 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.6 t -99.66 -99.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.69 -0.632 . . . . 0.78000000000000003 110.15 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.53 ' N ' ' OG ' ' A' ' 210' ' ' SER . 13.2 t -153.0 15.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.033 -1.042 . . . . 0.91000000000000003 110.328 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 213' ' ' GLY . 0.0 OUTLIER -133.27 -172.12 2.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.93000000000000005 109.93 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 42.69 -147.95 0.62 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.179 -1.569 . . . . 0.79000000000000004 109.179 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.596 ' CE1' HD13 ' A' ' 185' ' ' LEU . 90.8 m-85 -93.24 103.1 15.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.106 -1.232 . . . . 0.68999999999999995 109.738 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.493 ' O ' ' N ' ' A' ' 218' ' ' LEU . 58.1 m-80 -71.65 120.27 17.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.094 -1.004 . . . . 0.40000000000000002 108.933 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.649 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -42.03 -34.7 0.75 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.564 -0.854 . . . . 0.17000000000000001 110.051 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.582 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 7.2 m-85 -54.37 -46.09 72.93 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.572 -1.27 . . . . 0.28000000000000003 107.572 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.558 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 10.2 tp -78.08 -71.15 0.44 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.775 -0.648 . . . . 0.46000000000000002 110.694 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.556 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.17 -62.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 0.39000000000000001 110.141 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.573 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -53.08 -53.63 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.067 . . . . 0.17000000000000001 111.391 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -56.44 -25.94 52.06 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.404 -1.435 . . . . 0.10000000000000001 108.965 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.577 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 6.3 t60 -78.82 -46.79 17.95 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.767 -0.583 . . . . 0.20999999999999999 109.748 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.516 ' CG ' ' HB2' ' A' ' 199' ' ' ALA . 3.7 tp10 -63.99 -38.3 90.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.28000000000000003 109.244 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 6.8 m-30 -64.33 -63.08 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.816 . . . . 0.17999999999999999 109.084 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.44 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -44.72 -31.68 2.7 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.86 -1.696 . . . . 0.20999999999999999 108.86 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.643 ' CE1' ' CG ' ' A' ' 240' ' ' MET . 0.0 OUTLIER -77.36 -74.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -1.139 . . . . 0.17000000000000001 110.639 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.529 ' HB3' ' CB ' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -39.35 -54.83 1.83 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.484 -0.76 . . . . 0.33000000000000002 111.492 -179.029 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.471 ' N ' ' OG ' ' A' ' 227' ' ' SER . 0.2 OUTLIER -78.79 -46.04 19.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.53000000000000003 110.785 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -60.3 -78.77 0.13 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.717 -1.353 . . . . 0.40999999999999998 109.717 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.538 HD12 ' CA ' ' A' ' 110' ' ' THR . 0.5 OUTLIER -177.76 -162.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.45000000000000001 110.08 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.5 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -55.8 -55.3 34.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.62 109.789 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.628 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -162.09 -179.96 7.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.45000000000000001 109.385 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 67.3 p -178.97 48.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.38 110.569 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.614 ' HA ' ' HB2' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -135.39 27.29 3.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.242 -0.911 . . . . 0.47999999999999998 110.559 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -39.83 -50.76 5.6 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.595 -0.842 . . . . 0.38 109.622 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 43.4 Cg_endo -90.53 -46.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.747 1.393 . . . . 0.28000000000000003 110.462 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.542 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.57 96.31 0.1 Allowed Glycine 0 N--CA 1.498 2.795 0 C-N-CA 119.065 -1.541 . . . . 0.23999999999999999 112.304 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.614 ' HB2' ' HA ' ' A' ' 234' ' ' LYS . . . -145.25 160.33 41.64 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.263 -1.14 . . . . 0.28000000000000003 109.57 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.574 ' CD2' ' HB2' ' A' ' 222' ' ' HIS . 1.5 tt -68.18 57.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.40000000000000002 109.237 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.643 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -141.72 -6.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.45000000000000001 111.547 -178.762 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -78.21 165.23 51.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.556 -1.34 . . . . 0.56999999999999995 110.987 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.502 ' HA ' ' HB2' ' A' ' 2' ' ' 3MP . 41.1 Cg_endo -68.11 -18.34 45.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.78 1.41 . . . . 0.76000000000000001 110.053 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.1 mm -90.21 136.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.934 -0.765 . . . . 0.89000000000000001 108.934 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.558 ' HB2' ' CD2' ' A' ' 218' ' ' LEU . 38.5 p90 -126.96 -30.64 2.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.942 -1.099 . . . . 0.78000000000000003 110.405 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.548 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 2.49 -70.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 113.203 0.816 . . . . 0.60999999999999999 113.203 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.591 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -53.41 105.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.556 -1.34 . . . . 0.73999999999999999 109.321 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.505 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 22.5 p -57.16 166.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.849 . . . . 0.81000000000000005 109.998 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -53.7 -19.8 10.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.092 -1.603 . . . . 0.56000000000000005 109.092 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.95 31.87 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.37 110.631 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.474 ' HB3' ' N ' ' A' ' 247' ' ' THR . 1.9 t -83.76 -22.67 31.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.05 -1.031 . . . . 0.44 109.927 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -152.41 -69.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.53000000000000003 109.873 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.456 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.64 -176.01 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.38 110.47 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.476 ' N ' ' SD ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -66.1 55.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.593 -0.692 . . . . 0.19 110.702 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.691 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -45.83 -46.88 40.44 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.017 -1.105 . . . . 0.28000000000000003 108.017 177.576 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.691 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.3 Cg_endo -71.82 48.91 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.954 1.502 . . . . 0.48999999999999999 110.966 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.551 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.8 m-20 -47.39 -32.42 4.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.887 -1.133 . . . . 0.48999999999999999 110.453 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.547 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 1.4 m-20 -50.49 -50.81 51.68 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.138 -0.976 . . . . 0.31 109.51 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.556 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -73.35 -33.01 64.87 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.169 -1.012 . . . . 0.14000000000000001 108.468 179.021 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.551 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 84.8 t -60.56 -81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.252 -0.979 . . . . 0.17000000000000001 110.153 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.565 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.3 OUTLIER -62.05 -42.85 99.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.238 -0.914 . . . . 0.26000000000000001 109.786 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.521 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.65 -64.92 1.1 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.396 -1.082 . . . . 0.19 110.396 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.595 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -77.49 -19.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.816 -1.402 . . . . 0.22 110.441 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.594 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 17.3 tt0 -64.37 -21.87 66.77 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.838 -1.145 . . . . 0.39000000000000001 108.317 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.0 t -104.22 -41.52 5.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.157 -0.617 . . . . 0.46999999999999997 111.487 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.472 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 9.2 mt -87.5 -45.86 10.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.227 -0.921 . . . . 0.47999999999999998 111.669 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.587 ' CG ' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.85 -8.78 57.36 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.206 -0.934 . . . . 0.40999999999999998 110.156 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.46 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -73.73 -107.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.032 -1.627 . . . . 0.46000000000000002 109.032 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 269' ' ' GLY . 46.3 Cg_endo -73.01 74.99 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.784 1.413 . . . . 0.57999999999999996 110.112 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 268' ' ' PRO . . . -61.81 -137.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.64000000000000001 109.723 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.556 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -149.45 -63.72 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.94999999999999996 110.139 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.539 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 3.4 tt0 64.36 13.54 8.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.2 110.303 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.43 ' HB3' ' OD1' ' A' ' 274' ' ' ASN . 1.2 m-20 -179.49 126.02 0.24 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 1.2 110.03 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.68 73.01 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.877 1.462 . . . . 1.0600000000000001 110.375 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.43 ' OD1' ' HB3' ' A' ' 272' ' ' ASP . 22.9 m120 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.78000000000000003 110.162 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.577 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.62 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.63 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.291 0.567 . . . . 0.40999999999999998 110.223 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.54 87.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.26000000000000001 110.089 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.438 ' C ' ' HD3' ' A' ' 108' ' ' PRO . 12.9 t -115.05 2.91 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.33000000000000002 110.385 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.474 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 m-85 -129.24 59.86 47.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.65000000000000002 110.053 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.48 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 53.4 Cg_endo -81.92 31.81 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.83999999999999997 111.036 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER -143.54 74.85 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.93000000000000005 109.898 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.519 ' O ' ' N ' ' A' ' 112' ' ' LYS . 1.7 p -142.63 -56.81 0.43 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.342 -0.849 . . . . 1.03 109.692 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.7 OUTLIER 37.24 28.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.706 -0.621 . . . . 1.04 111.107 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -100.22 91.05 4.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.121 -0.987 . . . . 0.77000000000000002 110.015 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.578 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 21.7 t90 -164.08 -71.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.41999999999999998 110.284 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.523 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 88.4 p -91.71 69.52 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.44 110.268 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 27.1 mttp -165.65 86.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.48999999999999999 110.465 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.415 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 5.8 ttp -123.23 -12.79 7.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.29999999999999999 110.149 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 20.3 p-10 -155.3 124.21 6.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.14999999999999999 109.84 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.493 ' CD2' ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.98 -177.82 6.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.13 110.424 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.484 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -121.44 147.14 46.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.12 109.766 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.59 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 9.6 p90 -145.01 160.71 40.94 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.254 -0.978 . . . . 0.33000000000000002 111.015 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -103.68 160.69 14.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.472 -0.768 . . . . 0.54000000000000004 110.032 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.648 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 7.6 pt -122.32 62.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.33000000000000002 110.727 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.505 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 12.1 m -110.39 48.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.995 -1.066 . . . . 0.27000000000000002 110.727 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.511 ' ND2' ' HG ' ' A' ' 216' ' ' LEU . 41.6 t-20 -43.18 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.40999999999999998 109.297 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.586 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 5.6 t80 -178.81 -175.1 0.39 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.346 -0.846 . . . . 0.40000000000000002 109.47 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.55 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -136.36 48.29 2.44 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.45000000000000001 110.805 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.586 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.8 Cg_endo -76.14 -85.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.814 1.429 . . . . 0.35999999999999999 110.343 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 1.5 m-20 -95.53 2.85 54.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.25 109.638 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.533 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -124.3 156.5 36.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 0.39000000000000001 109.75 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -110.41 176.48 5.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.47999999999999998 109.95 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.444 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -43.37 -34.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.40000000000000002 109.931 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.447 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -68.87 -50.01 53.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.46000000000000002 109.646 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' O ' ' N ' ' A' ' 136' ' ' LYS . 5.2 mp0 -58.44 -62.09 2.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.364 -0.835 . . . . 0.46999999999999997 109.41 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.525 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 9.5 t -45.16 -39.7 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.139 -1.06 . . . . 0.31 108.139 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.498 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -54.11 -40.48 67.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.057 -1.09 . . . . 0.47999999999999998 108.057 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.57 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 17.0 tttt -74.54 -52.24 12.41 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.867 0.842 . . . . 0.64000000000000001 108.846 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.661 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -46.31 -60.81 2.1 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.962 -1.086 . . . . 0.41999999999999998 110.561 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.654 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -64.54 -54.17 36.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.34000000000000002 111.004 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.654 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 7.9 tttm -68.09 -72.76 0.16 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.94 -1.1 . . . . 0.46999999999999997 110.28 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.4 OUTLIER -38.48 -61.24 0.72 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.731 -0.605 . . . . 0.46999999999999997 110.709 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.43 -38.27 13.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.641 -1.287 . . . . 0.25 108.344 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.53 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -72.53 -28.58 62.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.31 -0.869 . . . . 0.34999999999999998 109.068 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 140' ' ' LYS . 58.7 tttt -63.4 -39.75 95.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.43 -0.952 . . . . 0.69999999999999996 108.43 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.469 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 11.3 t -75.76 -51.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.086 -0.709 . . . . 0.60999999999999999 109.086 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.605 ' CH2' HG13 ' A' ' 262' ' ' ILE . 45.2 t-105 -52.19 -34.18 44.16 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.441 -0.948 . . . . 0.39000000000000001 108.441 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 149' ' ' THR . 41.5 m -77.38 -38.41 50.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.395 -0.965 . . . . 0.34999999999999998 108.395 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.469 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.43 -43.88 62.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.862 -0.792 . . . . 0.35999999999999999 108.862 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.552 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 32.3 m -74.05 -38.52 49.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.477 -0.764 . . . . 0.5 109.55 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.524 ' N ' HG22 ' A' ' 148' ' ' VAL . 7.2 t -142.78 119.53 6.89 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.51000000000000001 110.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.41 58.57 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.663 1.349 . . . . 0.31 110.793 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.553 HD13 ' CD1' ' A' ' 266' ' ' TYR . 59.4 mt -70.48 167.12 19.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.17999999999999999 110.043 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -105.89 103.08 12.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.892 . . . . 0.17000000000000001 110.22 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.428 ' CD1' ' O ' ' A' ' 153' ' ' PHE . 8.6 p90 -116.08 144.68 43.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.14000000000000001 110.312 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.534 HG21 ' CD2' ' A' ' 156' ' ' LEU . 27.7 m -147.9 130.55 15.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.14999999999999999 110.439 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.59 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -99.62 84.4 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.20000000000000001 109.904 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.534 ' CD2' HG21 ' A' ' 154' ' ' THR . 0.5 OUTLIER -77.11 104.35 7.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.22 110.224 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' ASP . 55.8 p-80 -56.06 -27.96 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.96 . . . . 0.32000000000000001 109.948 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.454 ' OD1' HD11 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -42.12 -41.91 2.79 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.56 -0.712 . . . . 0.33000000000000002 109.941 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.73 33.22 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.733 -1.347 . . . . 0.28000000000000003 109.733 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.478 ' O ' ' HB ' ' A' ' 119' ' ' THR . 6.5 mt -121.13 71.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.064 -1.257 . . . . 0.29999999999999999 109.542 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -125.3 137.6 54.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.029 -0.668 . . . . 0.20000000000000001 110.411 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.493 ' CB ' ' CD2' ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.52 -34.9 8.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.10000000000000001 109.653 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.546 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -122.72 173.11 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.10000000000000001 109.052 179.347 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.537 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 3.5 ptp -177.05 144.63 0.44 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.495 -1.378 . . . . 0.11 111.656 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.544 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 1.5 tt -93.31 120.87 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.10000000000000001 109.272 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.505 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 4.3 p -163.62 142.56 8.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.735 -1.228 . . . . 0.10000000000000001 110.702 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.62 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.8 p90 -67.03 112.3 4.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.324 -0.86 . . . . 0.089999999999999997 109.618 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -60.63 143.28 48.12 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.281 -1.527 . . . . 0.20000000000000001 109.281 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.586 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.7 tt -138.15 96.91 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.972 . . . . 0.55000000000000004 109.905 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.586 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 1.06 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.382 0.611 . . . . 0.84999999999999998 112.363 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 11.83 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.70999999999999996 110.108 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.404 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m-70 -80.25 -87.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.41999999999999998 110.031 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.58 -35.2 1.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.485 -1.446 . . . . 0.33000000000000002 109.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 -87.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.33000000000000002 110.26 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -111.01 -170.01 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.27000000000000002 110.569 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -101.95 110.62 62.72 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.34000000000000002 110.349 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.445 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.1 Cg_endo -76.92 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.829 1.437 . . . . 0.46999999999999997 110.668 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.571 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -50.38 140.68 13.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.34999999999999998 110.606 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.465 ' O ' ' O ' ' A' ' 180' ' ' GLY . 6.0 p30 -178.74 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.932 -1.107 . . . . 0.20000000000000001 111.703 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 36.97 -157.54 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.562 -1.015 . . . . 0.25 110.562 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.462 ' HA ' ' OE1' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -78.62 43.74 1.5 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.183 1.623 . . . . 0.44 110.535 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 184' ' ' LEU . 0.5 OUTLIER -83.33 179.32 7.72 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.285 -0.885 . . . . 0.56999999999999995 109.816 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.2 68.6 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.566 -1.013 . . . . 0.48999999999999999 110.566 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.554 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 0.8 OUTLIER 179.64 84.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.132 -1.217 . . . . 0.40999999999999998 110.954 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.582 HD12 ' CZ ' ' A' ' 214' ' ' TYR . 0.5 OUTLIER -100.18 -24.17 14.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.964 -1.094 . . . . 0.29999999999999999 110.741 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.659 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.36 99.55 2.51 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.79 -1.194 . . . . 0.20000000000000001 111.788 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.539 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -100.97 124.47 46.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.051 -1.031 . . . . 0.16 109.987 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.521 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -106.08 124.49 49.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.974 . . . . 0.23000000000000001 110.333 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.4 OUTLIER -68.5 162.83 59.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.38 110.443 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.4 Cg_endo -72.26 138.58 30.63 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.40000000000000002 109.772 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.56 72.88 2.34 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.92 1.484 . . . . 0.32000000000000001 110.575 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.59 -105.95 2.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.32000000000000001 109.443 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.65 -159.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.943 1.497 . . . . 0.46999999999999997 110.396 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -63.61 -11.8 28.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.63 110.279 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.27 63.58 0.66 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.45 -0.781 . . . . 0.53000000000000003 109.997 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.19 173.89 22.46 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.097 -1.601 . . . . 0.25 109.097 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.537 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.28 25.5 0.76 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.481 -1.448 . . . . 0.10000000000000001 109.481 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 12.5 m-20 -79.04 87.44 4.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -1.209 . . . . 0.10000000000000001 110.666 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.541 ' HB3' ' CG ' ' A' ' 223' ' ' GLU . . . -62.8 98.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.089999999999999997 109.539 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.529 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 8.5 m170 -110.57 119.86 40.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.089999999999999997 111.266 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 203' ' ' ASP . 13.7 m-30 -90.62 131.93 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.10000000000000001 109.556 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.497 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -49.33 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.079 . . . . 0.14000000000000001 108.717 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -34.55 -32.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.566 -0.709 . . . . 0.17999999999999999 111.738 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.532 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 1.8 m-20 -64.1 -16.75 62.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.638 -1.289 . . . . 0.23999999999999999 110.631 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.464 ' HG2' ' HB3' ' A' ' 202' ' ' ASP . 11.4 mm-40 -86.77 -176.02 5.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.002 . . . . 0.41999999999999998 110.49 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.528 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 83.8 m -122.11 154.74 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.46999999999999997 110.006 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.528 ' CG ' ' C ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -149.49 147.28 28.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 0.27000000000000002 109.756 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.533 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.32 177.55 11.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.02 -1.05 . . . . 0.29999999999999999 110.595 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 209' ' ' SER . 0.1 OUTLIER -129.06 20.28 5.88 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.729 0.776 . . . . 0.60999999999999999 109.553 178.985 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -89.38 -69.81 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.566 0.698 . . . . 0.78000000000000003 110.078 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.415 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER 179.41 -30.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.58 -0.7 . . . . 0.91000000000000003 109.543 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 177.61 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.548 -0.72 . . . . 0.93000000000000005 109.98 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 50.11 -161.4 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.79000000000000004 109.432 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.582 ' CZ ' HD12 ' A' ' 185' ' ' LEU . 80.1 m-85 -81.69 126.2 31.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.68999999999999995 109.473 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.486 ' HA ' ' O ' ' A' ' 208' ' ' THR . 16.8 m-80 -89.2 118.6 29.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.026 -1.046 . . . . 0.40000000000000002 108.658 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.661 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -41.37 -36.98 0.92 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.672 -0.811 . . . . 0.17000000000000001 110.334 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.57 ' CZ ' ' HG2' ' A' ' 136' ' ' LYS . 3.0 m-85 -51.24 -49.34 61.31 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.574 -1.25 . . . . 0.28000000000000003 107.833 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.545 ' CD1' ' HH1' ' A' ' 3' ' ' MSB . 12.7 tp -75.09 -70.42 0.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.791 -0.64 . . . . 0.46000000000000002 110.54 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -49.96 -68.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.39000000000000001 110.03 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -44.46 -52.96 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.978 -1.076 . . . . 0.17000000000000001 111.23 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.99 -47.71 77.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.275 -1.516 . . . . 0.10000000000000001 108.722 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.602 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 5.6 t60 -54.25 -52.18 62.17 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.419 0.628 . . . . 0.20999999999999999 109.942 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.541 ' CG ' ' HB3' ' A' ' 199' ' ' ALA . 3.4 tp10 -59.81 -43.7 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.207 -0.933 . . . . 0.28000000000000003 108.87 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 224' ' ' PHE . 11.6 m-30 -55.0 -62.35 1.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.17999999999999999 109.091 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.449 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.59 -32.97 1.4 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.786 -1.725 . . . . 0.20999999999999999 108.786 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -79.83 -76.46 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.195 -1.179 . . . . 0.17000000000000001 111.052 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.537 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.1 OUTLIER -34.55 -42.57 0.15 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.83 -0.544 . . . . 0.33000000000000002 112.336 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.522 ' CD2' ' OH ' ' A' ' 266' ' ' TYR . 3.1 tp -101.17 -38.74 7.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.839 -1.163 . . . . 0.53000000000000003 111.309 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.449 ' HA3' ' O ' ' A' ' 225' ' ' GLY . . . -68.29 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.762 -0.935 . . . . 0.40999999999999998 110.762 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.509 ' CD2' ' HD2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -160.45 -155.34 0.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.131 -1.217 . . . . 0.45000000000000001 111.098 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 37.3 m-20 -74.4 -48.34 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.62 110.712 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.624 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -174.82 157.82 2.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -1.0 . . . . 0.45000000000000001 111.098 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 24.1 p -162.71 47.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.033 -0.728 . . . . 0.38 109.033 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.64 ' HA ' ' HB2' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -127.06 23.09 6.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.449 -0.782 . . . . 0.47999999999999998 111.001 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.534 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -43.86 -60.24 2.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.38 109.494 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.534 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.0 Cg_endo -75.97 -50.76 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.735 1.387 . . . . 0.28000000000000003 110.681 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.06 95.03 0.1 OUTLIER Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.337 -1.411 . . . . 0.23999999999999999 111.404 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.64 ' HB2' ' HA ' ' A' ' 234' ' ' LYS . . . -145.77 164.93 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.426 -1.044 . . . . 0.28000000000000003 110.022 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.576 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 1.1 tp -72.14 57.33 0.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -0.916 . . . . 0.40000000000000002 109.131 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.572 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 4.3 mmm -146.86 14.46 1.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.102 -0.998 . . . . 0.45000000000000001 110.576 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -106.14 166.67 10.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.56999999999999995 110.704 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.469 ' HA ' ' HB2' ' A' ' 2' ' ' 3MP . 45.3 Cg_endo -70.24 -7.53 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.008 1.53 . . . . 0.76000000000000001 109.981 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.596 ' O ' ' CE1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -101.41 112.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.137 -0.69 . . . . 0.89000000000000001 109.137 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.554 ' CD1' ' N ' ' A' ' 245' ' ' THR . 52.1 p90 -116.6 -31.58 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.04 . . . . 0.78000000000000003 110.731 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.593 ' CG2' ' CD1' ' A' ' 243' ' ' ILE . 0.5 OUTLIER 1.89 -68.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.235 0.828 . . . . 0.60999999999999999 113.235 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.585 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -48.6 106.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.51 -1.369 . . . . 0.73999999999999999 109.524 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 70.0 p -53.8 171.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.81000000000000005 110.164 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.3 -15.23 29.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.27 -1.532 . . . . 0.56000000000000005 109.27 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.7 20.09 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.37 110.441 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.447 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -64.74 -17.88 64.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.44 109.795 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -168.36 -64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.53000000000000003 110.187 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.425 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.1 OUTLIER 179.95 -172.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.38 110.605 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.484 ' HG3' ' OD1' ' A' ' 256' ' ' ASP . 0.0 OUTLIER -66.32 56.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.716 -0.615 . . . . 0.19 110.541 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.673 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.9 OUTLIER -44.01 -47.6 22.43 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.0 -1.111 . . . . 0.28000000000000003 108.0 177.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.673 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.65 50.67 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 124.101 1.579 . . . . 0.48999999999999999 111.176 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.599 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 31.3 m-20 -53.54 -28.52 32.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.48999999999999999 110.786 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.572 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 1.7 m-20 -54.25 -47.76 71.91 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.035 -1.041 . . . . 0.31 109.436 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.553 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -76.21 -31.82 58.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.277 -0.969 . . . . 0.14000000000000001 108.442 178.507 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.599 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 70.8 t -61.83 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.658 -0.817 . . . . 0.17000000000000001 109.98 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.55 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -61.41 -40.96 96.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.247 -0.908 . . . . 0.26000000000000001 109.525 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.53 -66.71 0.92 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.355 -1.098 . . . . 0.19 110.355 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.605 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -76.14 -20.17 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.912 -1.346 . . . . 0.22 110.613 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.55 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 13.4 tp60 -61.37 -23.86 66.07 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.648 -1.221 . . . . 0.39000000000000001 107.969 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -103.12 -36.34 8.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.936 -0.705 . . . . 0.46999999999999997 111.672 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 265' ' ' LEU . 4.3 mm? -90.76 -46.52 8.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.973 -1.079 . . . . 0.47999999999999998 111.923 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.574 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -71.23 -18.09 62.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.964 -1.085 . . . . 0.40999999999999998 109.904 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.415 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.95 -88.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.999 -1.64 . . . . 0.46000000000000002 108.999 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.9 114.24 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.072 1.564 . . . . 0.57999999999999996 110.001 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.92 154.97 17.27 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.842 -1.303 . . . . 0.64000000000000001 109.842 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -105.04 -75.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -1.13 . . . . 0.94999999999999996 109.986 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.523 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 35.2 tt0 60.3 12.94 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.2 110.53 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.466 ' HB3' ' O ' ' A' ' 271' ' ' GLU . 1.7 p30 179.55 137.68 0.28 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 1.2 110.363 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.56 61.69 4.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.987 1.519 . . . . 1.0600000000000001 110.331 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.948 -1.025 . . . . 0.78000000000000003 110.204 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.602 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.633 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.659 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.26 0.553 . . . . 0.40999999999999998 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.14 89.13 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.26000000000000001 110.283 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.457 HG21 ' N ' ' A' ' 107' ' ' PHE . 17.3 m -68.59 -144.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.33000000000000002 110.15 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . 0.457 ' N ' HG21 ' A' ' 106' ' ' VAL . 14.1 m-30 -81.36 113.97 45.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.65000000000000002 110.137 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.482 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 44.8 Cg_endo -71.99 -170.69 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.83999999999999997 110.265 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 1.1 mtt85 59.97 82.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.93000000000000005 110.096 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.559 ' O ' ' CG ' ' A' ' 112' ' ' LYS . 1.1 p -149.48 -60.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.552 -0.718 . . . . 1.03 109.204 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER 48.11 32.66 3.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 1.04 111.469 178.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 110' ' ' THR . 1.2 mtpt -117.75 92.88 3.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.77000000000000002 109.883 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.59 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 9.9 t90 -160.91 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.009 -1.057 . . . . 0.41999999999999998 111.307 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.533 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 87.6 p -102.23 69.23 1.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -0.998 . . . . 0.44 110.865 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 114' ' ' SER . 7.3 mttm -161.59 50.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.48999999999999999 110.352 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.486 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 3.9 ttt -74.91 -5.16 42.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.247 -0.908 . . . . 0.29999999999999999 110.427 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.447 ' CB ' ' HB3' ' A' ' 152' ' ' ASN . 29.7 p30 -156.78 149.13 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.14999999999999999 110.502 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.478 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 9.3 tp -171.15 177.64 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.13 109.857 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.533 ' CG2' ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -110.36 158.84 18.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.008 . . . . 0.12 110.458 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.584 ' CE1' ' HG3' ' A' ' 155' ' ' ARG . 21.4 p90 -154.45 167.85 28.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.422 -0.799 . . . . 0.33000000000000002 110.329 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.464 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -130.06 144.21 51.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -0.818 . . . . 0.54000000000000004 110.102 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.591 HG22 ' CD1' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -105.18 123.85 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.346 -0.846 . . . . 0.33000000000000002 110.704 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 2.0 m -165.41 44.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.802 . . . . 0.27000000000000002 109.818 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.3 t-20 -40.11 -80.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.40999999999999998 109.539 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 7.8 t80 -179.11 178.46 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.314 -0.866 . . . . 0.40000000000000002 109.951 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.553 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -131.9 55.71 19.71 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.45000000000000001 110.576 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.553 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.6 Cg_endo -82.86 -81.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.789 1.415 . . . . 0.35999999999999999 110.517 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.77 -4.03 25.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.25 110.048 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.535 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 1.0 OUTLIER -113.76 160.98 18.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.39000000000000001 110.211 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.3 m -106.89 167.74 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.47999999999999998 109.839 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.472 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 2.0 t60 -44.29 -29.98 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.40000000000000002 109.845 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -66.71 -51.5 55.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.46000000000000002 109.654 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.535 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 10.3 mt-10 -62.16 -58.0 9.42 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.249 -0.907 . . . . 0.46999999999999997 109.18 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 125' ' ' TYR . 5.7 t -46.37 -34.76 2.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.935 -1.135 . . . . 0.31 107.935 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.484 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -59.0 -42.4 90.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.938 -1.134 . . . . 0.47999999999999998 107.938 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.583 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 47.1 tttt -68.97 -45.49 70.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.219 -1.03 . . . . 0.64000000000000001 108.219 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.666 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -49.17 -59.71 3.43 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.321 -0.862 . . . . 0.41999999999999998 109.739 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -65.39 -55.79 16.17 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.542 -0.724 . . . . 0.34000000000000002 110.509 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -64.27 -73.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.46999999999999997 110.603 -179.153 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -39.64 -60.27 1.0 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.633 -0.667 . . . . 0.46999999999999997 110.73 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.11 -36.86 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.521 -1.362 . . . . 0.25 108.339 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -72.33 -31.41 65.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.9 -0.778 . . . . 0.34999999999999998 108.9 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -61.29 -42.32 98.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.69999999999999996 108.655 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.432 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.3 t -73.22 -48.55 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.566 -0.709 . . . . 0.60999999999999999 109.208 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.59 ' CH2' HG13 ' A' ' 262' ' ' ILE . 43.1 t-105 -54.72 -39.38 68.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.39000000000000001 109.215 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 149' ' ' THR . 75.5 m -74.9 -35.18 62.25 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.508 -0.923 . . . . 0.34999999999999998 108.508 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.432 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.524 0.678 . . . . 0.35999999999999999 109.375 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.535 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.2 m -82.29 -32.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.419 -0.801 . . . . 0.5 110.256 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.513 ' N ' HG22 ' A' ' 148' ' ' VAL . 5.0 t -146.29 136.65 12.17 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.51000000000000001 110.557 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.93 58.44 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.972 1.512 . . . . 0.31 110.542 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.579 HD23 ' CG ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -75.63 129.54 37.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.17999999999999999 110.431 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.492 ' N ' HD12 ' A' ' 151' ' ' LEU . 64.6 t-20 -87.25 123.59 32.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.17000000000000001 109.841 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.58 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 7.5 p90 -133.11 152.97 51.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.14000000000000001 110.467 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.533 ' O ' ' CG2' ' A' ' 119' ' ' THR . 22.5 m -152.49 125.81 8.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.14999999999999999 110.319 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.584 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -92.04 105.43 17.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.20000000000000001 109.755 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.472 HD21 HG23 ' A' ' 154' ' ' THR . 0.3 OUTLIER -101.76 96.97 7.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.22 110.395 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.3 p-80 -52.5 -28.34 20.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.32000000000000001 109.954 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.3 t0 -41.42 -60.7 1.22 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.587 -0.696 . . . . 0.33000000000000002 109.752 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.99 35.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.963 -1.255 . . . . 0.28000000000000003 109.963 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 160' ' ' ILE . 50.4 mt -126.09 68.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -1.205 . . . . 0.29999999999999999 109.398 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.41 55.26 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.641 -0.662 . . . . 0.20000000000000001 110.758 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.431 ' HB3' HD22 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -96.9 -51.07 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.10000000000000001 109.798 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.574 HD11 ' CD1' ' A' ' 224' ' ' PHE . 18.5 tt -116.53 160.84 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.346 -0.846 . . . . 0.10000000000000001 109.644 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.515 ' O ' ' CB ' ' A' ' 199' ' ' ALA . 15.6 ptp -160.81 139.73 10.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.56 -1.338 . . . . 0.11 111.439 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.555 HD13 ' CE2' ' A' ' 201' ' ' PHE . 0.3 OUTLIER -93.6 113.97 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.10000000000000001 109.292 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.507 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 63.6 p -162.23 166.4 25.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.777 -1.202 . . . . 0.10000000000000001 111.36 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.616 ' CG ' ' CD1' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -79.99 136.56 36.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.55 -0.719 . . . . 0.089999999999999997 109.979 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.481 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.72 128.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.793 -1.323 . . . . 0.20000000000000001 109.793 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.56 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.1 tt -118.29 100.87 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -1.037 . . . . 0.55000000000000004 109.737 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.582 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 3.0 tmtt? -9.71 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.284 0.564 . . . . 0.84999999999999998 112.352 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 9.3 tt0 -146.16 11.85 1.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.70999999999999996 110.278 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -74.78 -75.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.41999999999999998 110.107 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . 0.444 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 120.12 52.45 0.26 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.795 -1.322 . . . . 0.33000000000000002 109.795 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . 0.444 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 6.5 p-10 -177.1 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -1.151 . . . . 0.33000000000000002 110.083 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.452 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.2 OUTLIER -132.03 154.72 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.27000000000000002 110.083 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.571 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 3.0 m-30 -106.48 88.98 3.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.941 . . . . 0.34000000000000002 110.168 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.463 ' O ' HD22 ' A' ' 184' ' ' LEU . 44.3 Cg_endo -72.6 -58.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.46999999999999997 109.968 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.582 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -49.12 131.49 19.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.34999999999999998 110.362 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.473 ' HB3' ' O ' ' A' ' 178' ' ' PHE . 14.8 p30 179.33 82.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.134 -0.979 . . . . 0.20000000000000001 110.804 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.475 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 35.71 -154.13 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.094 -1.202 . . . . 0.25 110.094 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -78.96 43.74 1.54 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.965 1.508 . . . . 0.44 110.2 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.1 t -80.78 176.67 9.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.103 -0.998 . . . . 0.56999999999999995 110.076 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.554 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.35 67.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.664 -0.974 . . . . 0.48999999999999999 110.664 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.528 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 0.3 OUTLIER 179.57 88.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.178 -1.189 . . . . 0.40999999999999998 110.709 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.553 HD11 ' CE2' ' A' ' 214' ' ' TYR . 4.9 tt -105.9 -19.11 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.759 -1.176 . . . . 0.29999999999999999 110.919 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.653 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.25 111.11 4.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.20000000000000001 112.074 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -114.64 125.83 54.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.84 . . . . 0.16 109.414 178.696 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.528 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -123.04 116.89 24.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.106 . . . . 0.23000000000000001 110.512 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -58.57 167.68 1.68 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.38 110.146 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.465 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -72.19 145.87 44.85 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.027 1.541 . . . . 0.40000000000000002 109.489 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.3 Cg_endo -72.48 86.43 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.831 1.438 . . . . 0.32000000000000001 110.35 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.49 -98.55 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.591 -1.404 . . . . 0.32000000000000001 109.591 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.61 -166.39 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.46999999999999997 110.573 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -69.67 -6.58 32.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.63 110.343 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 26.46 10.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.33 -0.856 . . . . 0.53000000000000003 109.891 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -106.34 176.94 22.02 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.082 -1.607 . . . . 0.25 109.082 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.514 ' O ' HG13 ' A' ' 163' ' ' ILE . . . 45.3 25.33 1.16 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.226 -1.55 . . . . 0.10000000000000001 109.226 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 196' ' ' GLY . 10.7 m-20 -78.79 87.49 4.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.10000000000000001 110.026 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 164' ' ' MET . . . -69.72 97.99 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.089999999999999997 109.895 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.481 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 41.4 m170 -115.27 129.47 56.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -0.876 . . . . 0.089999999999999997 110.602 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.9 m-85 -96.79 139.25 33.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.085 -1.009 . . . . 0.10000000000000001 110.365 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -47.78 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.14000000000000001 108.544 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.7 p-10 -35.48 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.013 -0.675 . . . . 0.17999999999999999 111.985 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 0.8 OUTLIER -76.66 -3.21 36.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.771 -1.205 . . . . 0.23999999999999999 111.271 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.474 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 14.5 mm-40 -91.22 -164.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.031 -1.043 . . . . 0.41999999999999998 110.171 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.446 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 16.0 m -127.88 150.95 49.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.46999999999999997 110.223 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.508 ' C ' ' CG2' ' A' ' 208' ' ' THR . 1.2 m-90 -145.9 146.25 31.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.27000000000000002 109.56 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.526 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -162.17 175.4 11.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.867 -1.145 . . . . 0.29999999999999999 111.104 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.9 t -126.58 45.24 2.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.855 0.836 . . . . 0.60999999999999999 109.037 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.497 ' OG ' ' N ' ' A' ' 211' ' ' SER . 11.0 t -127.38 -157.99 0.84 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.676 . . . . 0.78000000000000003 110.035 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.497 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 p -97.62 27.92 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.91000000000000003 110.349 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -145.09 150.13 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.93000000000000005 110.013 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.1 -176.2 12.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.174 -1.57 . . . . 0.79000000000000004 109.174 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.553 ' CE2' HD11 ' A' ' 185' ' ' LEU . 86.7 m-85 -65.33 139.6 58.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 0.68999999999999995 109.565 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.519 ' ND2' ' CB ' ' A' ' 218' ' ' LEU . 0.6 OUTLIER -108.32 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.061 -1.024 . . . . 0.40000000000000002 108.678 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.666 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -39.08 -38.76 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.044 -0.662 . . . . 0.17000000000000001 110.801 -178.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.583 ' CZ ' ' HG2' ' A' ' 136' ' ' LYS . 2.0 m-85 -50.62 -46.66 58.25 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.302 -1.359 . . . . 0.28000000000000003 107.592 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.548 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 13.4 tp -80.72 -72.86 0.4 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.707 -0.678 . . . . 0.46000000000000002 110.908 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.56 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -46.1 -57.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.39000000000000001 110.395 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -59.36 -49.56 77.33 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.336 -0.852 . . . . 0.17000000000000001 111.385 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.23 -27.07 65.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.338 -1.476 . . . . 0.10000000000000001 108.998 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.605 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 4.0 t60 -76.53 -56.17 4.87 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.305 0.574 . . . . 0.20999999999999999 109.768 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.481 ' CD ' ' CE1' ' A' ' 201' ' ' PHE . 34.7 tt0 -58.43 -39.28 79.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.126 -0.983 . . . . 0.28000000000000003 109.015 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.574 ' CD1' HD11 ' A' ' 163' ' ' ILE . 0.4 OUTLIER -60.47 -62.39 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.17999999999999999 109.005 178.648 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.83 -29.71 0.86 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.701 -1.76 . . . . 0.20999999999999999 108.701 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.43 -66.05 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -1.122 . . . . 0.17000000000000001 110.884 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.528 ' CA ' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -40.78 -42.91 1.89 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.443 -0.786 . . . . 0.33000000000000002 111.691 -178.945 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.513 ' HB2' ' CD1' ' A' ' 163' ' ' ILE . 0.9 OUTLIER -100.27 -37.87 8.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.772 -1.205 . . . . 0.53000000000000003 110.942 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.469 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -67.91 -85.74 0.1 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.255 -1.138 . . . . 0.40999999999999998 110.255 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.561 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.7 OUTLIER -170.23 -163.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.066 -1.255 . . . . 0.45000000000000001 111.05 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.444 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -59.03 -55.78 30.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.765 . . . . 0.62 110.329 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.481 ' HA ' ' CE1' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -161.72 -179.69 7.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.937 . . . . 0.45000000000000001 110.802 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 1.2 t 179.35 56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.714 -0.616 . . . . 0.38 109.474 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.569 ' HA ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -139.25 26.36 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.47999999999999998 110.862 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.509 ' C ' ' O ' ' A' ' 234' ' ' LYS . 0.5 OUTLIER -34.03 -52.6 0.89 Allowed Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 120.005 -0.678 . . . . 0.38 110.273 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.505 ' CG ' ' CG ' ' A' ' 257' ' ' ASP . 50.2 Cg_endo -75.25 -56.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.634 1.334 . . . . 0.28000000000000003 110.12 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.62 37.22 0.05 OUTLIER Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.328 -1.415 . . . . 0.23999999999999999 111.655 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.573 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . . . -69.9 171.97 8.49 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.389 -1.653 . . . . 0.28000000000000003 111.009 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.575 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.21 58.79 1.29 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.938 0.875 . . . . 0.40000000000000002 109.148 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.571 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.6 mmt -138.07 -33.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.45000000000000001 110.519 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.642 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -52.62 169.93 0.26 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.56999999999999995 110.344 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.519 ' HB3' ' CD2' ' A' ' 2' ' ' 3MP . 44.7 Cg_endo -72.17 -1.42 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.592 1.312 . . . . 0.76000000000000001 110.369 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 4.1 mt -111.97 141.96 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.89000000000000001 109.965 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.558 ' O ' ' C ' ' A' ' 245' ' ' THR . 22.4 p90 -130.15 -19.66 3.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.151 -0.968 . . . . 0.78000000000000003 111.201 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.558 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER 4.46 -76.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 113.006 0.743 . . . . 0.60999999999999999 113.006 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.583 ' CE2' ' HD3' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -45.49 121.09 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.498 -1.376 . . . . 0.73999999999999999 109.612 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 0.6 OUTLIER -71.14 157.96 37.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.828 . . . . 0.81000000000000005 110.228 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.87 -22.09 4.16 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.528 -1.429 . . . . 0.56000000000000005 109.528 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -131.07 31.56 4.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -1.154 . . . . 0.37 110.744 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 1.6 t -76.28 -69.5 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.806 -1.184 . . . . 0.44 110.114 179.795 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . 0.537 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 2.4 t60 -116.73 -60.09 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.53000000000000003 110.338 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.2 OUTLIER 179.85 -169.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.977 . . . . 0.38 110.898 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.462 ' C ' ' HD2' ' A' ' 255' ' ' PRO . 26.0 ptp -64.92 55.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.998 -0.439 . . . . 0.19 110.658 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.698 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -45.38 -46.96 35.16 Favored Pre-proline 0 N--CA 1.484 1.238 0 N-CA-C 107.897 -1.149 . . . . 0.28000000000000003 107.897 177.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.698 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.3 Cg_endo -71.42 48.72 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.901 1.474 . . . . 0.48999999999999999 111.194 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.531 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 7.7 m-20 -49.29 -32.54 11.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.887 -1.133 . . . . 0.48999999999999999 110.325 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.548 ' O ' ' HA3' ' A' ' 261' ' ' GLY . 0.5 OUTLIER -55.96 -50.69 70.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.966 -1.093 . . . . 0.31 108.974 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.557 ' CB ' ' HB1' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -68.54 -35.13 77.0 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.257 -0.977 . . . . 0.14000000000000001 108.672 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.531 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 53.6 t -66.49 -86.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.17000000000000001 110.543 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.51 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 10.0 tt0 -53.77 -39.62 65.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 0.26000000000000001 109.631 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -45.9 -70.83 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.354 -1.098 . . . . 0.19 110.354 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.59 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -69.96 -20.65 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.22 109.89 -179.538 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.524 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 3.4 tp-100 -58.87 -25.99 63.83 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.722 -1.191 . . . . 0.39000000000000001 107.821 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 25.5 t -103.07 -43.05 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.308 0.575 . . . . 0.46999999999999997 110.857 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.489 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 1.6 mt -72.52 -53.06 13.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.47999999999999998 111.054 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.579 ' CG ' HD23 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -80.13 -8.1 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.40999999999999998 110.291 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.486 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.0 -100.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.103 -1.599 . . . . 0.46000000000000002 109.103 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.33 132.74 13.98 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.967 1.509 . . . . 0.57999999999999996 110.088 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -98.37 140.88 15.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.737 -1.345 . . . . 0.64000000000000001 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.59 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -89.81 -64.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -1.15 . . . . 0.94999999999999996 109.903 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.533 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 5.1 tm-20 45.35 24.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 1.2 110.146 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -152.25 84.98 4.69 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 1.2 110.235 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 274' ' ' ASN . 44.5 Cg_endo -72.98 -1.21 10.15 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.048 1.552 . . . . 1.0600000000000001 110.515 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 273' ' ' PRO . 2.9 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.013 -0.994 . . . . 0.78000000000000003 110.239 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.605 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.554 ' HE1' ' CA ' ' A' ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.653 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.345 0.593 . . . . 0.40999999999999998 110.263 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -145.95 138.7 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.299 -0.876 . . . . 0.26000000000000001 110.169 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.8 m -133.87 155.38 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.33000000000000002 110.193 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -52.29 152.07 6.5 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.65000000000000002 110.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.57 -85.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.143 1.602 . . . . 0.83999999999999997 110.807 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.476 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 18.8 mtp180 48.26 65.37 1.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.93000000000000005 109.825 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.496 ' HA ' HD11 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -141.93 -58.05 0.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.507 -0.746 . . . . 1.03 109.439 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.434 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.6 mt 40.05 31.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 1.04 111.017 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.484 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -119.97 76.68 1.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.77000000000000002 109.74 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.578 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 23.5 t90 -140.92 -71.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.41999999999999998 110.54 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.511 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 4.6 t -103.48 54.0 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.44 110.326 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.471 ' CD ' HD11 ' A' ' 118' ' ' LEU . 59.6 mmtt -136.54 46.65 2.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.48999999999999999 110.311 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.446 ' HE1' ' HB2' ' A' ' 152' ' ' ASN . 1.1 ttp -82.47 -15.34 52.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.296 -0.878 . . . . 0.29999999999999999 109.989 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.453 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 17.3 p30 -140.17 115.52 9.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.831 . . . . 0.14999999999999999 110.077 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -138.76 176.2 8.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.13 110.108 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.541 ' HB ' ' O ' ' A' ' 160' ' ' ILE . 0.9 OUTLIER -123.64 162.04 23.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.12 109.992 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.584 ' HA ' ' O ' ' A' ' 163' ' ' ILE . 16.0 p90 -164.66 167.7 18.85 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.199 -1.0 . . . . 0.33000000000000002 111.285 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -120.45 151.83 38.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.416 -0.803 . . . . 0.54000000000000004 109.875 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.632 ' CG2' ' CD1' ' A' ' 138' ' ' PHE . 1.5 pp -109.47 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.862 . . . . 0.33000000000000002 110.989 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.531 ' CG2' ' HB3' ' A' ' 166' ' ' SER . 2.8 m -143.63 43.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.27000000000000002 110.396 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.482 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 4.0 t30 -42.04 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.40999999999999998 109.303 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.519 ' O ' ' CG2' ' A' ' 134' ' ' VAL . 2.9 t80 -179.69 -167.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.40000000000000002 109.68 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.526 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.7 OUTLIER -150.97 50.07 0.66 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.45000000000000001 110.533 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.526 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -75.76 -84.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.838 1.441 . . . . 0.35999999999999999 110.508 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.71 -0.25 51.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.25 109.998 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.54 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -115.99 163.57 15.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.39000000000000001 110.007 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.17 168.68 9.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.47999999999999998 110.049 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -43.6 -32.83 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.40000000000000002 110.04 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -64.4 -46.32 83.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.46000000000000002 109.512 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 12.5 mt-10 -67.23 -57.5 6.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.138 -0.976 . . . . 0.46999999999999997 109.66 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 125' ' ' TYR . 17.5 t -45.33 -32.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.95 -1.13 . . . . 0.31 107.95 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.493 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.7 mt-10 -63.55 -44.54 93.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.078 -1.082 . . . . 0.47999999999999998 108.078 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.2 ttmt -68.56 -49.07 62.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.24 -0.984 . . . . 0.64000000000000001 108.651 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.66 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -46.39 -59.75 2.76 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.212 -0.93 . . . . 0.41999999999999998 110.245 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.632 ' CD1' ' CG2' ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.68 -53.78 30.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.34000000000000002 110.825 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.63 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.18 -73.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.46999999999999997 110.335 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtt? -38.63 -60.63 0.8 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.865 -0.522 . . . . 0.46999999999999997 110.603 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.565 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.38 -38.71 13.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.676 -1.265 . . . . 0.25 108.528 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -71.68 -29.68 64.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.368 -0.832 . . . . 0.34999999999999998 109.079 178.797 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 140' ' ' LYS . 6.1 ttmm -61.24 -44.91 96.5 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.19 -1.041 . . . . 0.69999999999999996 108.19 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.468 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 6.5 t -63.61 -43.35 98.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.7 -0.852 . . . . 0.60999999999999999 108.7 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.515 ' O ' ' CG2' ' A' ' 148' ' ' VAL . 46.2 t-105 -56.35 -44.4 80.05 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.79 -0.819 . . . . 0.39000000000000001 108.79 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.499 ' HA ' ' O ' ' A' ' 149' ' ' THR . 9.6 m -64.66 -32.12 73.65 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.34999999999999998 108.886 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.468 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -62.72 -36.57 83.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.521 -0.737 . . . . 0.35999999999999999 109.334 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.519 ' O ' ' HB2' ' A' ' 263' ' ' GLN . 35.3 m -89.17 -11.56 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -0.85 . . . . 0.5 110.534 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.512 HG21 ' CG1' ' A' ' 262' ' ' ILE . 14.9 t -175.92 132.67 0.42 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.927 -1.108 . . . . 0.51000000000000001 110.247 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.04 60.1 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.866 1.456 . . . . 0.31 110.804 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.535 ' CD2' ' HB3' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -72.32 129.63 38.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.17999999999999999 109.879 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.453 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -87.19 124.73 33.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.17000000000000001 110.191 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.528 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -136.27 155.85 49.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.14000000000000001 110.508 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.472 ' O ' HG22 ' A' ' 119' ' ' THR . 34.5 m -152.81 132.11 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.14999999999999999 110.222 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.471 ' HA ' ' O ' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -101.55 91.21 4.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.978 . . . . 0.20000000000000001 110.123 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.5 94.32 7.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.22 110.286 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 158' ' ' ASP . 14.3 p-80 -52.71 -25.85 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.32000000000000001 109.867 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' HIS . 1.5 t70 -41.53 -62.79 0.81 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.468 0.652 . . . . 0.33000000000000002 109.679 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.58 34.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.888 -1.285 . . . . 0.28000000000000003 109.888 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.541 ' O ' ' HB ' ' A' ' 119' ' ' THR . 22.6 mm -126.5 69.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.065 -1.256 . . . . 0.29999999999999999 109.108 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -127.91 136.9 51.99 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.001 -0.68 . . . . 0.20000000000000001 110.572 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.33 -35.81 3.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.10000000000000001 110.269 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.596 ' CG2' ' CD1' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -126.82 163.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.294 -0.879 . . . . 0.10000000000000001 109.511 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.526 ' N ' HD13 ' A' ' 163' ' ' ILE . 6.5 ptm -172.77 156.19 3.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.208 -1.558 . . . . 0.11 111.727 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.57 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 4.5 tt -98.43 114.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.654 -0.654 . . . . 0.10000000000000001 109.447 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.531 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 80.9 p -155.85 151.61 27.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 0.10000000000000001 110.92 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -72.45 119.15 16.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.522 -0.736 . . . . 0.089999999999999997 109.826 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.468 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -77.87 129.31 9.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.219 -1.152 . . . . 0.20000000000000001 110.219 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.5 tt -126.18 98.55 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.614 -0.933 . . . . 0.55000000000000004 109.634 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.589 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 1.2 tmtt? 1.15 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.589 0.588 . . . . 0.84999999999999998 112.589 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 20.21 0.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.70999999999999996 110.282 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -93.31 -88.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.41999999999999998 110.268 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.29 -20.96 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.325 -1.51 . . . . 0.33000000000000002 109.325 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.68 -66.91 0.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -1.062 . . . . 0.33000000000000002 110.339 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.465 ' C ' ' CD1' ' A' ' 175' ' ' PHE . 23.4 p90 -148.24 163.51 36.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.27000000000000002 110.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.0 m-30 -69.24 114.95 27.37 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.34000000000000002 110.186 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.495 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 44.1 Cg_endo -77.07 -72.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.857 1.451 . . . . 0.46999999999999997 110.784 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -54.2 146.87 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.34999999999999998 110.422 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.503 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 44.4 p-10 -178.08 76.82 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.20000000000000001 110.459 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.514 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 53.18 -169.39 0.88 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.121 -1.591 . . . . 0.25 109.121 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.444 ' O ' ' O ' ' A' ' 182' ' ' SER . 49.3 Cg_endo -78.28 10.05 2.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.042 1.548 . . . . 0.44 110.478 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 184' ' ' LEU . 28.5 t -47.59 177.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.56999999999999995 110.915 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.528 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.02 76.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.479 -1.048 . . . . 0.48999999999999999 110.479 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.515 HD12 ' CG1' ' A' ' 1' ' ' HAV . 5.0 tp 179.47 87.68 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.369 -1.077 . . . . 0.40999999999999998 109.767 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.535 HD12 ' CG ' ' A' ' 214' ' ' TYR . 6.4 tt -109.84 -23.47 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.901 -1.124 . . . . 0.29999999999999999 111.42 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.602 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.5 101.84 2.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.517 -1.365 . . . . 0.20000000000000001 111.935 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 2.2 p80 -100.76 120.84 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.054 . . . . 0.16 110.016 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.511 ' N ' ' OE2' ' A' ' 223' ' ' GLU . . . -102.64 132.45 48.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.23000000000000001 110.179 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.443 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-30 -78.91 168.92 23.19 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.38 110.421 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.477 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 48.0 Cg_endo -73.68 125.47 10.05 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.994 1.523 . . . . 0.40000000000000002 109.553 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.25 68.22 1.41 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.897 1.472 . . . . 0.32000000000000001 110.6 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.36 -86.23 1.4 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.366 -1.494 . . . . 0.32000000000000001 109.366 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 -164.46 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.072 1.564 . . . . 0.46999999999999997 110.367 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . 0.434 ' ND2' ' N ' ' A' ' 194' ' ' ASN . 3.4 m120 -74.22 -0.89 18.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.63 110.386 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.89 48.67 1.19 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.53000000000000003 110.162 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -124.32 177.37 16.79 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.313 -1.515 . . . . 0.25 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.519 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 46.79 22.74 1.22 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.902 -1.279 . . . . 0.10000000000000001 109.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.88 86.58 6.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -1.211 . . . . 0.10000000000000001 109.745 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.473 ' HB1' ' O ' ' A' ' 164' ' ' MET . . . -61.58 97.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.143 -0.973 . . . . 0.089999999999999997 110.057 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.529 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 14.1 m170 -107.34 126.73 52.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.089999999999999997 110.341 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.5 m-85 -99.0 132.58 44.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.173 -0.954 . . . . 0.10000000000000001 110.529 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.529 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.6 OUTLIER -46.74 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.834 -0.802 . . . . 0.14000000000000001 108.834 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.52 -27.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.17999999999999999 111.638 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.529 ' N ' ' O ' ' A' ' 202' ' ' ASP . 19.6 m-20 -77.17 3.15 13.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.622 -1.299 . . . . 0.23999999999999999 110.731 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.471 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 17.2 mm-40 -98.41 -167.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.934 -1.104 . . . . 0.41999999999999998 110.41 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . 0.532 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -124.94 151.72 45.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.46999999999999997 110.177 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.1 m-90 -148.95 144.52 26.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.27000000000000002 109.911 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.524 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.57 170.17 21.42 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.958 -1.089 . . . . 0.29999999999999999 110.638 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.1 t -129.58 26.98 5.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.822 -0.807 . . . . 0.60999999999999999 108.822 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -95.26 -94.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.715 -0.615 . . . . 0.78000000000000003 110.296 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.483 ' N ' ' OG ' ' A' ' 210' ' ' SER . 18.0 p -156.78 20.96 0.33 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.91000000000000003 109.8 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 213' ' ' GLY . 5.4 mttm -141.94 -177.16 5.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.439 -0.788 . . . . 0.93000000000000005 110.134 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 43.68 -166.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.385 -1.486 . . . . 0.79000000000000004 109.385 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.535 ' CG ' HD12 ' A' ' 185' ' ' LEU . 73.7 m-85 -73.75 120.54 19.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.68999999999999995 109.793 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.481 ' HA ' ' O ' ' A' ' 208' ' ' THR . 57.2 m-80 -84.52 120.05 25.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.963 -1.086 . . . . 0.40000000000000002 108.856 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.66 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.5 OUTLIER -41.33 -37.2 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.17000000000000001 110.439 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.58 ' CD1' ' N ' ' A' ' 217' ' ' PHE . 3.1 m-30 -51.33 -47.79 62.59 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 118.619 -1.232 . . . . 0.28000000000000003 107.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.545 ' HG ' ' CH ' ' A' ' 3' ' ' MSB . 7.3 tp -77.0 -70.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.9 -0.591 . . . . 0.46000000000000002 110.605 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.563 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -48.89 -66.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.944 -1.097 . . . . 0.39000000000000001 109.808 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -46.57 -48.55 19.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.111 -0.993 . . . . 0.17000000000000001 111.077 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.59 -45.43 89.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.323 -1.485 . . . . 0.10000000000000001 108.764 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.639 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 2.7 t-160 -58.08 -54.52 45.99 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.415 0.626 . . . . 0.20999999999999999 109.811 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 188' ' ' ALA . 24.6 tp10 -58.5 -57.12 14.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.28000000000000003 109.156 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 3.3 m-85 -43.73 -57.89 2.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.17999999999999999 109.016 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.474 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -46.96 -35.04 7.76 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.421 -1.472 . . . . 0.20999999999999999 109.421 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.588 ' CE1' ' HB3' ' A' ' 240' ' ' MET . 0.1 OUTLIER -81.8 -67.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.095 -1.238 . . . . 0.17000000000000001 111.08 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.519 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.1 OUTLIER -38.08 -42.95 0.7 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.46 -0.775 . . . . 0.33000000000000002 111.726 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.596 ' CD1' ' CG2' ' A' ' 163' ' ' ILE . 2.1 tp -99.95 -36.72 9.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.815 -1.178 . . . . 0.53000000000000003 110.753 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.58 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -64.99 -79.71 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.3 -1.12 . . . . 0.40999999999999998 110.3 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.496 HD11 ' HA ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -177.37 -152.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.45000000000000001 110.896 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -50.67 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.62 110.199 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.56 ' CD2' ' HB3' ' A' ' 240' ' ' MET . 0.2 OUTLIER -175.19 169.15 3.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.45000000000000001 110.017 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.9 p -169.31 53.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.38 109.229 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.596 ' HA ' ' HB3' ' A' ' 238' ' ' ALA . 0.2 OUTLIER -139.33 25.14 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.47999999999999998 111.525 -178.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.529 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -39.39 -51.06 4.8 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.38 110.428 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.529 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 53.2 Cg_endo -81.03 -52.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.571 1.301 . . . . 0.28000000000000003 110.687 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 176.75 101.72 0.15 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.2 -1.476 . . . . 0.23999999999999999 111.508 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.596 ' HB3' ' HA ' ' A' ' 234' ' ' LYS . . . -139.4 177.4 7.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.261 -1.141 . . . . 0.28000000000000003 109.65 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.595 ' N ' ' CB ' ' A' ' 255' ' ' PRO . 2.0 tp -67.8 -3.98 11.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.065 -1.022 . . . . 0.40000000000000002 109.86 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.588 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 6.4 mmt -94.91 -6.81 41.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.45000000000000001 111.709 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -53.8 169.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.768 -1.208 . . . . 0.56999999999999995 110.681 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.532 ' O ' ' CG1' ' A' ' 243' ' ' ILE . 49.5 Cg_endo -80.22 43.0 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.662 1.349 . . . . 0.76000000000000001 110.055 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 242' ' ' PRO . 9.0 mt -161.01 144.38 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.797 -0.816 . . . . 0.89000000000000001 108.797 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.559 ' CB ' ' CH ' ' A' ' 3' ' ' MSB . 53.7 p90 -124.97 -34.15 2.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.965 -1.084 . . . . 0.78000000000000003 110.057 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.558 ' C ' ' O ' ' A' ' 244' ' ' TYR . 15.7 m 2.9 -70.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.831 0.678 . . . . 0.60999999999999999 112.831 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.55 ' CE2' ' HD3' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -61.34 106.96 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.632 -1.292 . . . . 0.73999999999999999 108.977 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.458 ' HA ' HD22 ' A' ' 218' ' ' LEU . 0.2 OUTLIER -47.03 174.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.81000000000000005 110.263 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.31 -16.5 27.87 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.037 -1.625 . . . . 0.56000000000000005 109.037 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.428 ' HD2' ' O ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -146.89 31.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.37 110.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.453 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -56.56 -19.22 14.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.44 110.144 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -170.97 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.53000000000000003 110.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.491 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -177.92 177.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.38 111.019 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.482 ' N ' ' SD ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -71.32 56.68 0.24 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.64 -0.663 . . . . 0.19 110.903 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.69 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.0 OUTLIER -43.82 -47.07 20.79 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.019 -1.104 . . . . 0.28000000000000003 108.019 177.182 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.5 Cg_endo -71.29 50.89 1.3 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.983 1.518 . . . . 0.48999999999999999 111.085 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.556 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 15.1 m-20 -54.56 -28.77 48.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.021 -1.05 . . . . 0.48999999999999999 111.192 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.535 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -54.38 -46.3 73.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.726 -1.234 . . . . 0.31 109.396 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.563 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.07 -32.02 56.5 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.297 -1.001 . . . . 0.14000000000000001 108.297 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.556 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 66.7 t -61.25 -76.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.661 -0.816 . . . . 0.17000000000000001 110.269 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.568 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.3 tt0 -65.78 -42.26 90.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.101 -0.999 . . . . 0.26000000000000001 109.434 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.5 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.38 -63.44 1.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.129 -1.189 . . . . 0.19 110.129 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.563 ' CD1' ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -77.75 -20.49 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.762 -1.434 . . . . 0.22 110.395 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.568 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 0.0 OUTLIER -59.72 -25.98 65.25 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.795 -1.19 . . . . 0.39000000000000001 108.028 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.0 m -104.38 -33.54 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.145 -0.622 . . . . 0.46999999999999997 111.764 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.484 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 2.2 mm? -90.08 -44.99 9.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.075 -1.015 . . . . 0.47999999999999998 111.563 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.58 ' CE2' ' HA2' ' A' ' 229' ' ' GLY . 0.1 OUTLIER -85.09 -11.28 55.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.40999999999999998 110.647 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -58.3 -110.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.516 . . . . 0.46000000000000002 109.311 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.66 93.78 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.809 1.426 . . . . 0.57999999999999996 110.353 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 113' ' ' TRP . . . -79.18 156.08 41.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.44 -1.464 . . . . 0.64000000000000001 109.44 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.578 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 38.0 t0 -76.34 -66.08 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -1.151 . . . . 0.94999999999999996 110.396 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.511 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 6.9 tt0 56.12 27.39 11.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 1.2 110.229 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -153.32 161.68 28.5 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.275 -0.891 . . . . 1.2 110.051 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 274' ' ' ASN . 44.7 Cg_endo -72.68 66.49 3.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.97 1.511 . . . . 1.0600000000000001 110.332 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 273' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.025 -0.988 . . . . 0.78000000000000003 110.221 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.639 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.56 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.604 ' CE1' ' ND1' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.239 0.543 . . . . 0.40999999999999998 110.177 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.25 99.83 6.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.26000000000000001 110.213 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.1 -37.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.33000000000000002 110.222 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -121.41 87.89 45.49 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.65000000000000002 110.324 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.489 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.7 Cg_endo -73.1 -159.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.003 1.528 . . . . 0.83999999999999997 110.296 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.489 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 0.0 OUTLIER 67.73 82.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.93000000000000005 110.201 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.5 ' HA ' HD13 ' A' ' 230' ' ' LEU . 1.6 p -143.36 -60.07 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 1.03 109.568 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 0.3 OUTLIER 38.21 42.53 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.577 . . . . 1.04 111.126 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.43 ' HD3' HD21 ' A' ' 265' ' ' LEU . 1.2 ptpt -134.3 66.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.77000000000000002 109.303 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.594 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 12.3 t90 -140.37 -65.15 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.41999999999999998 110.822 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 36.1 t -103.69 56.41 0.74 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.44 111.09 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.468 ' HD3' ' O ' ' A' ' 114' ' ' SER . 30.4 mmtt -150.9 45.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.028 -1.045 . . . . 0.48999999999999999 110.476 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.505 ' HB2' ' CA ' ' A' ' 269' ' ' GLY . 2.0 ttp -81.66 -1.9 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.29999999999999999 110.458 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.461 ' O ' HD13 ' A' ' 118' ' ' LEU . 1.4 p30 -148.51 119.53 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.14999999999999999 110.012 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.47 ' CD2' HD11 ' A' ' 228' ' ' LEU . 1.5 tp -152.13 174.3 13.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.13 110.493 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.493 ' CB ' ' HA ' ' A' ' 161' ' ' ALA . 0.6 OUTLIER -118.2 159.46 23.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.12 110.256 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.542 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 20.1 p90 -154.35 170.22 21.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.616 -0.834 . . . . 0.33000000000000002 110.591 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 147.39 49.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.54000000000000004 110.12 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.546 HG21 ' CD1' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -107.09 125.05 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.33000000000000002 110.929 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.542 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 1.3 m -167.19 43.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.27000000000000002 109.768 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.514 ' OD1' ' CE ' ' A' ' 129' ' ' MET . 1.0 OUTLIER -40.07 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.40999999999999998 109.429 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.547 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 19.9 t80 -178.46 -178.62 0.62 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 0.40000000000000002 109.641 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -119.7 48.2 1.12 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.917 -1.114 . . . . 0.45000000000000001 110.664 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -71.28 -87.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.11 1.584 . . . . 0.35999999999999999 110.52 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -108.41 -15.09 14.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 0.25 109.909 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.583 ' CB ' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -111.24 104.95 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.39000000000000001 109.548 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -51.46 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.47999999999999998 110.593 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.58 -39.35 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.40000000000000002 110.209 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -55.45 -57.82 10.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.46000000000000002 109.668 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.583 ' CB ' ' CB ' ' A' ' 129' ' ' MET . 2.2 mp0 -55.72 -56.75 16.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.46999999999999997 109.256 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.444 ' C ' ' O ' ' A' ' 133' ' ' GLU 0.253 5.1 t -44.47 -35.46 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.016 -1.105 . . . . 0.31 108.016 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 132' ' ' SER . 5.0 tt0 -59.47 -44.43 93.02 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.888 -1.153 . . . . 0.47999999999999998 107.888 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.569 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.8 tttp -68.22 -44.0 76.71 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.581 -0.896 . . . . 0.64000000000000001 108.581 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.642 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -47.96 -58.53 4.3 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.205 -0.934 . . . . 0.41999999999999998 109.893 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -69.92 -51.76 30.28 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.704 -0.798 . . . . 0.34000000000000002 110.701 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.623 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 10.8 tttt -64.22 -73.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 0.46999999999999997 109.993 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -39.14 -60.84 0.83 Allowed 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.837 -0.539 . . . . 0.46999999999999997 110.693 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.88 -37.4 8.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.665 -1.214 . . . . 0.25 108.519 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -73.23 -34.27 65.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.781 . . . . 0.34999999999999998 109.217 178.827 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -56.36 -40.68 74.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.269 -1.011 . . . . 0.69999999999999996 108.269 178.957 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.421 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 4.1 t -69.25 -44.58 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.893 -0.78 . . . . 0.60999999999999999 108.893 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.592 ' CH2' HG13 ' A' ' 262' ' ' ILE . 27.4 t-105 -54.71 -42.66 71.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.464 -0.773 . . . . 0.39000000000000001 109.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 149' ' ' THR . 20.0 m -70.37 -33.41 71.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.81 . . . . 0.34999999999999998 108.929 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . 0.421 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -58.1 -36.48 72.94 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.612 -0.68 . . . . 0.35999999999999999 109.457 179.267 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 34.7 m -86.9 -29.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.5 110.634 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.491 ' O ' ' HA ' ' A' ' 146' ' ' SER . 5.2 t -153.04 135.93 9.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.869 -1.144 . . . . 0.51000000000000001 110.526 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.88 58.1 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.986 1.519 . . . . 0.31 110.644 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.49 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -80.15 136.52 36.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 0.17999999999999999 110.076 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.458 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 9.3 t30 -88.08 126.11 34.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.17000000000000001 110.391 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.79 139.52 45.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.14000000000000001 110.207 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.469 ' O ' HG22 ' A' ' 119' ' ' THR . 11.5 m -141.47 137.57 32.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.14999999999999999 110.369 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.53 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.6 130.77 47.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 0.20000000000000001 109.677 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.477 HD21 ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -128.43 105.7 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.22 110.193 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.507 ' CD2' ' N ' ' A' ' 158' ' ' ASP . 4.7 p-80 -54.54 -33.8 60.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.32000000000000001 110.075 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.515 ' OD2' ' CG1' ' A' ' 160' ' ' ILE . 1.3 t70 -42.25 -42.38 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.589 -0.694 . . . . 0.33000000000000002 109.869 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.57 33.77 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.442 -1.463 . . . . 0.28000000000000003 109.442 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.515 ' CG1' ' OD2' ' A' ' 158' ' ' ASP . 6.7 mt -116.15 75.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.286 -1.126 . . . . 0.29999999999999999 109.631 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.493 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -143.6 147.78 34.89 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.528 -0.732 . . . . 0.20000000000000001 110.403 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 -18.22 14.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.10000000000000001 110.285 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 1.2 tt -136.07 166.93 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.153 -0.967 . . . . 0.10000000000000001 110.077 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.465 ' O ' ' HB2' ' A' ' 199' ' ' ALA . 6.9 ptp -171.38 146.38 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.288 . . . . 0.11 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.53 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 2.4 tt -98.72 119.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.423 -0.798 . . . . 0.10000000000000001 110.082 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.44 ' HB3' ' CG2' ' A' ' 123' ' ' VAL . 14.9 p -161.8 158.58 25.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.965 -1.084 . . . . 0.10000000000000001 110.82 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 18.6 p90 -76.41 122.46 24.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.089999999999999997 110.061 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.462 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -78.19 134.8 14.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.023 -1.231 . . . . 0.20000000000000001 110.023 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.585 ' O ' ' C ' ' A' ' 170' ' ' LYS . 1.3 tt -130.17 98.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.977 . . . . 0.55000000000000004 109.702 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.588 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.4 OUTLIER 1.09 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 121.359 0.6 . . . . 0.84999999999999998 112.266 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -141.52 7.0 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.70999999999999996 110.215 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.411 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 12.8 m-70 -77.98 -51.61 10.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.41999999999999998 110.002 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 94.65 39.38 4.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.433 -1.467 . . . . 0.33000000000000002 109.433 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.24 -51.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -1.095 . . . . 0.33000000000000002 110.036 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.86 159.28 16.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.27000000000000002 110.135 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 14.5 m-30 -113.0 85.27 7.75 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.34000000000000002 110.097 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.474 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 46.3 Cg_endo -73.69 -57.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.993 1.523 . . . . 0.46999999999999997 110.386 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.588 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -57.96 135.37 56.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.34999999999999998 110.698 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.483 ' N ' ' OD2' ' A' ' 204' ' ' ASP . 3.2 p30 179.97 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.206 -0.997 . . . . 0.20000000000000001 111.602 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.2 -161.33 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.247 -1.141 . . . . 0.25 110.247 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.443 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.6 Cg_endo -80.11 44.01 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.086 1.572 . . . . 0.44 110.157 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.7 m -81.08 177.66 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.095 -1.003 . . . . 0.56999999999999995 110.231 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.504 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.74 71.32 0.03 OUTLIER Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.892 -1.283 . . . . 0.48999999999999999 109.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.555 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 0.7 OUTLIER 179.58 95.31 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.303 -1.116 . . . . 0.40999999999999998 110.202 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.485 ' HB3' ' OB2' ' A' ' 3' ' ' MSB . 6.7 tt -114.0 -18.41 11.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.708 -1.245 . . . . 0.29999999999999999 111.375 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.628 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -151.0 105.76 3.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.493 -1.379 . . . . 0.20000000000000001 112.001 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.5 OUTLIER -115.08 119.81 37.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.16 109.485 178.797 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.519 ' CB ' ' OE2' ' A' ' 223' ' ' GLU . . . -109.68 142.03 41.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.981 -1.075 . . . . 0.23000000000000001 110.691 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.464 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -72.56 168.94 19.34 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.38 110.327 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.436 ' HD2' ' CD2' ' A' ' 189' ' ' PHE . 46.6 Cg_endo -74.69 137.87 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.40000000000000002 109.502 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.3 Cg_endo -70.8 82.1 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.85 1.447 . . . . 0.32000000000000001 110.569 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 -99.72 1.29 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.396 -1.482 . . . . 0.32000000000000001 109.396 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.94 -162.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 0.46999999999999997 110.241 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -65.58 -11.82 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.63 109.991 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.42 60.89 0.64 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.557 -0.714 . . . . 0.53000000000000003 110.058 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -134.33 177.07 19.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.559 -1.816 . . . . 0.25 108.559 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.485 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.83 25.88 0.25 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.808 -1.317 . . . . 0.10000000000000001 109.808 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 196' ' ' GLY . 72.7 m-20 -79.71 91.77 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.962 -1.316 . . . . 0.10000000000000001 109.898 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.475 ' HB1' ' HA ' ' A' ' 165' ' ' ILE . . . -67.38 111.69 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.089999999999999997 110.421 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.578 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 31.2 m170 -121.6 126.43 49.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 0.089999999999999997 110.2 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 203' ' ' ASP . 23.2 m-85 -98.1 137.63 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.939 -1.1 . . . . 0.10000000000000001 110.674 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 205' ' ' GLU . 1.1 m-20 -49.19 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.14000000000000001 108.889 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.541 ' OD2' ' CB ' ' A' ' 178' ' ' PHE . 1.4 p30 -35.94 -30.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.772 . . . . 0.17999999999999999 111.663 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 9.4 m-20 -79.06 2.07 21.92 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.59 -1.319 . . . . 0.23999999999999999 111.245 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 29.4 mm-40 -95.95 -162.51 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.982 -1.074 . . . . 0.41999999999999998 110.155 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.8 m -125.81 148.53 49.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.112 -0.992 . . . . 0.46999999999999997 110.529 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.518 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.5 m-90 -142.27 142.85 32.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.267 -0.896 . . . . 0.27000000000000002 109.785 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.531 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -155.37 174.3 15.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.954 -1.091 . . . . 0.29999999999999999 110.722 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.437 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.1 t -129.27 21.97 5.66 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.649 -0.871 . . . . 0.60999999999999999 108.649 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.4 OUTLIER -99.2 -81.47 0.45 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.712 0.767 . . . . 0.78000000000000003 110.376 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.7 p -171.77 -35.32 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.958 -0.756 . . . . 0.91000000000000003 108.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . 0.458 ' O ' ' HG3' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -80.06 139.81 36.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.469 -0.769 . . . . 0.93000000000000005 109.538 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.04 -154.96 32.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.935 -1.666 . . . . 0.79000000000000004 108.935 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.491 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 60.0 m-85 -93.77 117.25 29.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.243 . . . . 0.68999999999999995 109.555 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 208' ' ' THR . 46.9 m-80 -81.4 122.4 27.44 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.946 -1.096 . . . . 0.40000000000000002 109.028 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.642 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.3 OUTLIER -42.28 -37.42 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.17000000000000001 109.937 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.582 ' CD1' ' N ' ' A' ' 217' ' ' PHE . 2.3 m-30 -51.98 -48.74 64.23 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.423 -1.325 . . . . 0.28000000000000003 107.423 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.534 ' CD2' ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -73.34 -73.57 0.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.819 -0.628 . . . . 0.46000000000000002 109.906 178.464 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.538 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.6 OUTLIER -47.77 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.39000000000000001 110.043 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -41.61 -51.28 4.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.735 -1.228 . . . . 0.17000000000000001 111.484 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.91 -33.51 71.96 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.249 -1.532 . . . . 0.10000000000000001 109.045 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.616 ' CE1' ' CA ' ' A' ' 240' ' ' MET . 5.3 t60 -71.63 -58.6 3.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.311 0.577 . . . . 0.20999999999999999 109.564 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.519 ' OE2' ' CB ' ' A' ' 188' ' ' ALA . 0.7 OUTLIER -55.87 -25.04 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.62 -0.882 . . . . 0.28000000000000003 108.62 178.525 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.7 m-30 -72.11 -67.65 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.6 0.714 . . . . 0.17999999999999999 109.261 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.443 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.98 -27.25 0.99 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.646 -1.782 . . . . 0.20999999999999999 108.646 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.598 ' CE1' ' HG2' ' A' ' 240' ' ' MET . 0.0 OUTLIER -80.98 -58.41 3.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -1.085 . . . . 0.17000000000000001 110.348 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.495 ' HB3' ' CB ' ' A' ' 188' ' ' ALA . 0.4 OUTLIER -47.74 -45.39 28.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.668 -0.645 . . . . 0.33000000000000002 111.794 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.47 HD11 ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -100.54 -38.15 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.02 . . . . 0.53000000000000003 111.044 -178.75 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -63.96 -77.2 0.24 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.043 -1.223 . . . . 0.40999999999999998 110.043 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.504 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 1.7 pt? -177.14 -162.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.187 . . . . 0.45000000000000001 110.488 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.495 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.2 OUTLIER -62.5 -54.6 37.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.62 109.904 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.556 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 2.2 m80 -163.71 178.26 8.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.45000000000000001 110.379 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 2.5 t 179.59 60.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.38 109.122 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.57 ' HA ' ' HB1' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -144.61 22.13 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.589 -0.844 . . . . 0.47999999999999998 111.174 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.53 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -37.12 -49.13 2.19 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.759 -0.776 . . . . 0.38 110.775 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.53 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 47.1 Cg_endo -89.41 -46.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.738 1.389 . . . . 0.28000000000000003 111.586 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.66 98.88 0.12 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 118.971 -1.585 . . . . 0.23999999999999999 111.91 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.583 ' O ' ' CZ ' ' A' ' 241' ' ' PHE . . . -149.22 165.5 31.69 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.39 -1.065 . . . . 0.28000000000000003 110.012 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.579 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -79.32 55.63 1.93 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.40000000000000002 108.837 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.616 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 14.0 mtt -137.96 -24.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.81 . . . . 0.45000000000000001 110.998 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -60.05 171.35 0.93 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.7 -1.25 . . . . 0.56999999999999995 109.962 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.8 Cg_endo -69.48 -4.69 14.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.377 1.198 . . . . 0.76000000000000001 110.128 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 10.2 mm -100.43 148.47 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.89000000000000001 109.689 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.599 ' CB ' ' CH ' ' A' ' 3' ' ' MSB . 35.0 p90 -133.35 -27.46 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.095 -1.003 . . . . 0.78000000000000003 111.174 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.523 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.1 OUTLIER 3.27 -69.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.642 0.978 . . . . 0.60999999999999999 113.642 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.524 ' N ' ' O ' ' A' ' 244' ' ' TYR . 0.0 OUTLIER -66.32 129.82 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.348 -1.47 . . . . 0.73999999999999999 109.676 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -161.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.81000000000000005 110.202 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . 0.474 ' O ' ' CG ' ' A' ' 249' ' ' LYS . . . -86.93 10.89 66.39 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.427 -1.469 . . . . 0.56000000000000005 109.427 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -177.59 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.37 110.37 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -32.88 73.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 0.44 110.167 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.79 -88.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.53000000000000003 110.174 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -164.18 92.59 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 0.38 110.387 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.521 ' CG ' ' O ' ' A' ' 252' ' ' PHE . 3.1 ptt? 36.09 47.77 0.48 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.544 -0.722 . . . . 0.19 111.596 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.67 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.9 tp -47.65 -44.69 56.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.862 -1.135 . . . . 0.28000000000000003 107.958 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.67 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -73.1 49.62 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.646 1.34 . . . . 0.48999999999999999 111.055 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.542 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.6 m-20 -47.48 -32.41 5.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.754 -1.216 . . . . 0.48999999999999999 110.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.547 ' CB ' ' HB1' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -55.57 -49.81 71.72 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.131 -0.981 . . . . 0.31 109.821 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.535 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.66 -32.08 63.8 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.448 -0.901 . . . . 0.14000000000000001 108.615 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.542 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 71.1 t -66.72 -82.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.17000000000000001 110.061 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.527 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.0 tt0 -55.92 -40.9 73.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.306 -0.871 . . . . 0.26000000000000001 109.247 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.29 -70.65 0.45 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.113 -1.195 . . . . 0.19 110.113 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.592 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.0 OUTLIER -74.24 -21.01 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.952 -1.322 . . . . 0.22 110.342 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.558 ' N ' ' CD1' ' A' ' 262' ' ' ILE . 47.7 tt0 -64.05 -20.36 65.88 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.904 -1.118 . . . . 0.39000000000000001 108.422 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 18.8 t -103.42 -42.45 5.7 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.249 -0.58 . . . . 0.46999999999999997 111.347 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.43 HD21 ' HD3' ' A' ' 112' ' ' LYS . 4.2 mp -87.32 -45.64 10.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.141 -0.974 . . . . 0.47999999999999998 111.202 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.49 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -79.08 -5.11 53.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.40999999999999998 109.948 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.5 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.65 -72.28 0.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.608 -1.397 . . . . 0.46000000000000002 109.608 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -86.9 142.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.987 1.52 . . . . 0.57999999999999996 110.761 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.505 ' CA ' ' HB2' ' A' ' 116' ' ' MET . . . -105.46 121.76 6.95 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.498 -1.441 . . . . 0.64000000000000001 109.498 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.594 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -86.63 -69.62 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -1.231 . . . . 0.94999999999999996 110.149 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.522 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 0.5 OUTLIER 54.38 30.97 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 1.2 110.087 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -101.61 113.36 65.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 1.2 109.829 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 75.16 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.966 1.508 . . . . 1.0600000000000001 110.576 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.986 -1.007 . . . . 0.78000000000000003 110.179 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.558 ' HB ' ' CG ' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.558 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.628 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.40999999999999998 110.263 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.24 73.74 1.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.26000000000000001 110.126 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 11.9 t -96.95 176.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.33000000000000002 110.3 -179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -45.29 107.71 0.68 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.65000000000000002 110.304 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' PRO . . . . . 0.474 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 47.1 Cg_endo -73.83 114.49 4.05 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.994 1.523 . . . . 0.83999999999999997 110.558 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 10.8 mtp180 -142.62 -48.49 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -0.816 . . . . 0.93000000000000005 109.852 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' THR . . . . . 0.575 ' CA ' ' HB2' ' A' ' 230' ' ' LEU . 1.0 OUTLIER -28.9 -57.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.482 0.658 . . . . 1.03 111.488 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.544 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 0.7 OUTLIER 40.73 48.49 2.65 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.268 -0.895 . . . . 1.04 111.471 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.513 ' HE2' ' CG2' ' A' ' 110' ' ' THR . 4.1 pttt -146.82 79.07 1.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.77000000000000002 109.113 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TRP . . . . . 0.593 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 7.6 t90 -143.89 -70.1 0.31 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.41999999999999998 111.398 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 93.6 p -96.95 63.0 1.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.44 111.015 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 114' ' ' SER . 14.2 mttm -159.59 53.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.48999999999999999 110.082 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' MET . . . . . 0.451 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -60.79 -19.89 60.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.29999999999999999 110.408 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -138.34 156.2 47.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.14999999999999999 110.446 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -166.09 -174.61 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.13 110.127 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' THR . . . . . 0.497 ' HB ' ' HA ' ' A' ' 161' ' ' ALA . 0.2 OUTLIER -128.47 149.26 50.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.181 -0.949 . . . . 0.12 110.11 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' TYR . . . . . 0.588 ' CE1' ' HB2' ' A' ' 153' ' ' PHE . 23.1 p90 -149.87 165.12 33.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -0.922 . . . . 0.33000000000000002 111.18 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.467 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.2 OUTLIER -118.08 150.91 38.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.54000000000000004 109.89 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ILE . . . . . 0.577 HG21 ' CE1' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -115.65 124.76 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.886 . . . . 0.33000000000000002 110.543 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' VAL . . . . . 0.534 ' CG1' ' O ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -168.76 43.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.27000000000000002 109.932 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASN . . . . . 0.485 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.3 t-20 -40.79 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.40999999999999998 109.501 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TYR . . . . . 0.575 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.7 t80 -179.35 -164.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.40000000000000002 109.553 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' THR . . . . . 0.577 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 1.8 m -148.12 46.78 0.48 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.913 -1.117 . . . . 0.45000000000000001 110.864 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -74.03 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.896 1.472 . . . . 0.35999999999999999 110.109 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.26 -4.46 58.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.955 . . . . 0.25 109.689 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' MET . . . . . 0.508 ' CE ' HG23 ' A' ' 134' ' ' VAL . 1.2 ptm -122.85 171.87 8.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.39000000000000001 110.107 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' THR . . . . . 0.463 ' HA ' HG21 ' A' ' 126' ' ' THR . 0.2 OUTLIER -119.66 171.63 8.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.47999999999999998 109.768 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -45.74 -28.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.036 -1.04 . . . . 0.40000000000000002 109.715 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -67.31 -58.28 5.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.46000000000000002 109.464 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.4 mp0 -55.82 -55.32 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.24 -0.913 . . . . 0.46999999999999997 108.775 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' VAL . . . . . 0.508 HG23 ' CE ' ' A' ' 129' ' ' MET . 4.9 t -46.19 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.826 -1.176 . . . . 0.31 107.826 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' GLU . . . . . 0.554 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 8.1 tt0 -59.37 -42.48 91.73 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.782 -1.192 . . . . 0.47999999999999998 107.782 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.572 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 23.4 tttt -70.65 -47.59 59.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.185 0.993 . . . . 0.64000000000000001 108.456 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.677 ' CB ' ' CB ' ' A' ' 216' ' ' LEU . . . -49.26 -62.22 1.66 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.566 -0.709 . . . . 0.41999999999999998 110.217 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.636 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -66.89 -52.51 42.45 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.41 -0.806 . . . . 0.34000000000000002 110.842 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' LYS . . . . . 0.636 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 1.0 OUTLIER -64.52 -72.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.976 -1.077 . . . . 0.46999999999999997 110.555 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' LYS . . . . . 0.553 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -41.5 -58.68 1.83 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.581 -0.699 . . . . 0.46999999999999997 110.383 179.254 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.81 -35.4 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.564 -1.254 . . . . 0.25 108.351 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.63 -39.35 64.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.443 -0.786 . . . . 0.34999999999999998 109.117 178.823 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -56.03 -38.82 71.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.08 -1.012 . . . . 0.69999999999999996 108.455 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.9 t -68.92 -45.28 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.112 -0.699 . . . . 0.60999999999999999 109.112 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' TRP . . . . . 0.589 ' CH2' HG13 ' A' ' 262' ' ' ILE . 50.4 t-105 -57.11 -35.31 69.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.39000000000000001 108.895 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.7 m -75.73 -39.64 56.94 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.327 -0.858 . . . . 0.34999999999999998 108.788 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -40.74 72.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.35999999999999999 109.51 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' VAL . . . . . 0.528 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.6 m -75.78 -33.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.5 109.781 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . 0.536 ' CB ' ' HA ' ' A' ' 263' ' ' GLN . 9.9 t -147.2 147.33 28.44 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.168 -0.958 . . . . 0.51000000000000001 110.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.67 58.69 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.948 1.499 . . . . 0.31 110.222 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . 0.455 HD13 ' N ' ' A' ' 152' ' ' ASN . 1.4 tm? -84.0 139.46 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.17999999999999999 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ASN . . . . . 0.455 ' N ' HD13 ' A' ' 151' ' ' LEU . 1.2 m-20 -104.26 139.2 39.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.17000000000000001 110.118 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' PHE . . . . . 0.588 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 2.1 p90 -151.24 155.95 39.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.14000000000000001 110.593 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . 0.484 ' CG2' HD11 ' A' ' 156' ' ' LEU . 7.3 m -152.9 131.05 11.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.406 -0.809 . . . . 0.14999999999999999 109.943 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ARG . . . . . 0.555 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 5.2 mtm180 -96.62 82.47 3.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.20000000000000001 110.595 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.484 HD11 ' CG2' ' A' ' 154' ' ' THR . 1.6 mp -74.98 83.34 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.155 -0.965 . . . . 0.22 109.71 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.7 p-80 -42.82 -26.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.32000000000000001 110.16 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -41.14 -37.87 0.97 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.616 -0.677 . . . . 0.33000000000000002 109.768 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.38 33.71 0.3 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.879 -1.288 . . . . 0.28000000000000003 109.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ILE . . . . . 0.515 ' CD1' ' OD1' ' A' ' 158' ' ' ASP . 2.7 mp -127.83 65.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -1.223 . . . . 0.29999999999999999 109.507 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ALA . . . . . 0.497 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -122.36 144.38 49.06 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.232 -0.587 . . . . 0.20000000000000001 110.364 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' ASP . . . . . 0.435 ' HB2' HD22 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -107.6 -36.54 6.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.885 . . . . 0.10000000000000001 110.205 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ILE . . . . . 0.567 ' O ' ' HA ' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -127.57 156.87 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.132 -0.98 . . . . 0.10000000000000001 110.001 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' MET . . . . . 0.501 ' N ' HG13 ' A' ' 163' ' ' ILE . 13.7 ptm -163.94 160.45 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.42 -1.425 . . . . 0.11 111.564 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . 0.567 ' CD1' ' HB3' ' A' ' 220' ' ' ALA . 0.8 OUTLIER -106.75 119.41 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.46 -0.775 . . . . 0.10000000000000001 109.985 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' SER . . . . . 0.464 ' O ' ' HA ' ' A' ' 200' ' ' HIS . 11.6 p -158.68 146.01 17.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.10000000000000001 110.389 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' PHE . . . . . 0.599 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 10.4 p90 -66.34 114.24 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.089999999999999997 109.667 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -73.49 119.81 6.74 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.225 -1.15 . . . . 0.20000000000000001 110.225 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ILE . . . . . 0.587 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.0 OUTLIER -110.05 103.25 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.48 -1.012 . . . . 0.55000000000000004 109.311 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . 0.601 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 2.0 tmtt? 1.26 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.32 0.581 . . . . 0.84999999999999998 112.317 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.475 ' CG ' ' O ' ' A' ' 171' ' ' GLU . 1.9 tm-20 -137.17 5.21 2.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.70999999999999996 110.218 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -87.14 -87.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.978 . . . . 0.41999999999999998 110.284 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 134.13 -34.86 2.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.165 -1.574 . . . . 0.33000000000000002 109.165 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.53 -31.25 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 0.33000000000000002 110.153 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' PHE . . . . . 0.434 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 2.4 t80 -172.52 116.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.27000000000000002 110.183 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.3 m-30 -47.14 105.72 0.51 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34000000000000002 110.192 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.2 Cg_endo -74.18 -61.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.902 1.475 . . . . 0.46999999999999997 110.422 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -55.23 144.49 24.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.34999999999999998 110.64 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ASP . . . . . 0.49 ' O ' ' OD1' ' A' ' 179' ' ' ASP . 2.7 p30 179.12 80.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.396 -0.815 . . . . 0.20000000000000001 110.093 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.82 -154.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.335 -1.506 . . . . 0.25 109.335 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 182' ' ' SER . 53.3 Cg_endo -79.63 11.29 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.994 1.523 . . . . 0.44 110.393 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' SER . . . . . 0.477 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 0.8 OUTLIER -45.28 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.56999999999999995 110.669 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' GLY . . . . . 0.572 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -64.71 72.34 0.07 OUTLIER Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.795 -0.922 . . . . 0.48999999999999999 110.795 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' LEU . . . . . 0.539 ' HA ' ' CG1' ' A' ' 1' ' ' HAV . 4.4 tt 179.52 92.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.191 -1.182 . . . . 0.40999999999999998 110.322 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' LEU . . . . . 0.5 ' HB3' ' OB2' ' A' ' 3' ' ' MSB . 4.1 tt -110.15 -23.84 11.05 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.561 -1.256 . . . . 0.29999999999999999 111.471 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' ALA . . . . . 0.622 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.9 103.3 3.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.521 -1.362 . . . . 0.20000000000000001 112.065 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' HIS . . . . . 0.529 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 1.5 p80 -103.0 141.12 36.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.103 . . . . 0.16 109.683 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ALA . . . . . 0.532 ' HB2' ' CA ' ' A' ' 227' ' ' SER . . . -123.78 128.04 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.23000000000000001 110.478 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' PHE . . . . . 0.451 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -75.25 169.78 18.78 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.38 110.337 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.496 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.8 Cg_endo -75.08 134.51 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.119 1.589 . . . . 0.40000000000000002 109.792 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' PRO . . . . . 0.544 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 43.9 Cg_endo -70.62 73.53 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.962 1.506 . . . . 0.32000000000000001 110.431 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.87 -98.09 2.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.632 -1.387 . . . . 0.32000000000000001 109.632 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.04 -161.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.988 1.52 . . . . 0.46999999999999997 110.045 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -67.75 -9.41 43.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 0.63 110.237 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.53 55.86 0.64 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.387 -0.821 . . . . 0.53000000000000003 110.23 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.07 174.87 19.41 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.185 -1.566 . . . . 0.25 109.185 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' GLY . . . . . 0.56 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 43.55 24.63 0.43 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.971 -1.252 . . . . 0.10000000000000001 109.971 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.451 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.1 OUTLIER -78.18 92.02 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -1.22 . . . . 0.10000000000000001 110.604 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' ALA . . . . . 0.466 ' HB3' ' HG2' ' A' ' 223' ' ' GLU . . . -73.36 99.47 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.089999999999999997 109.779 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' HIS . . . . . 0.529 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.9 m170 -112.58 138.59 49.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.089999999999999997 110.388 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 203' ' ' ASP . 25.8 m-85 -105.74 137.52 43.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.10000000000000001 110.526 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ASP . . . . . 0.535 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.5 OUTLIER -49.47 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.092 -1.077 . . . . 0.14000000000000001 108.092 178.529 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.5 p30 -36.07 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.1 -0.64 . . . . 0.17999999999999999 111.967 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 202' ' ' ASP . 32.0 m-20 -80.58 6.36 12.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.739 -1.225 . . . . 0.23999999999999999 111.006 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' GLU . . . . . 0.523 ' N ' ' O ' ' A' ' 202' ' ' ASP . 16.8 mm-40 -97.91 -167.07 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.922 -1.111 . . . . 0.41999999999999998 110.226 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.0 143.86 50.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.46999999999999997 110.446 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' TRP . . . . . 0.475 ' HB3' HD13 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -143.17 131.38 21.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.93 . . . . 0.27000000000000002 109.409 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' THR . . . . . 0.528 ' O ' ' CD2' ' A' ' 216' ' ' LEU . 0.1 OUTLIER -145.08 170.5 16.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.832 -1.167 . . . . 0.29999999999999999 111.114 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' SER . . . . . 0.532 ' OG ' ' CZ ' ' A' ' 217' ' ' PHE . 17.4 t -130.92 26.71 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.81 0.814 . . . . 0.60999999999999999 108.956 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -89.09 -93.53 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.752 -0.592 . . . . 0.78000000000000003 110.272 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -155.41 18.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.91000000000000003 110.156 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.64 -176.3 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.93000000000000005 110.221 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.8 -172.24 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.256 -1.537 . . . . 0.79000000000000004 109.256 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 244' ' ' TYR . 75.6 m-85 -68.22 101.68 1.22 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -1.222 . . . . 0.68999999999999995 109.734 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' ASN . . . . . 0.474 ' HA ' ' O ' ' A' ' 208' ' ' THR . 64.8 m-80 -76.1 117.77 18.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.047 -1.033 . . . . 0.40000000000000002 108.857 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' LEU . . . . . 0.677 ' CB ' ' CB ' ' A' ' 137' ' ' ALA . 0.4 OUTLIER -40.17 -36.73 0.54 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.716 . . . . 0.17000000000000001 110.528 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' PHE . . . . . 0.572 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.3 m-85 -49.45 -49.79 43.75 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.335 -1.346 . . . . 0.28000000000000003 107.736 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' LEU . . . . . 0.539 ' HG ' ' CH ' ' A' ' 3' ' ' MSB . 47.5 tp -76.83 -68.64 0.58 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.7 -0.682 . . . . 0.46000000000000002 110.778 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' VAL . . . . . 0.578 ' CG1' ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -50.89 -66.69 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.39000000000000001 109.718 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 216' ' ' LEU . . . -44.25 -49.69 9.18 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.727 -1.233 . . . . 0.17000000000000001 110.653 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -64.73 -23.1 67.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.535 -1.353 . . . . 0.10000000000000001 109.194 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.591 ' HA ' ' CD2' ' A' ' 239' ' ' LEU . 6.0 t60 -79.97 -55.7 4.78 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.186 0.517 . . . . 0.20999999999999999 109.778 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' GLU . . . . . 0.54 ' CD ' ' CE1' ' A' ' 201' ' ' PHE . 29.1 tt0 -58.75 -43.65 90.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.127 -0.983 . . . . 0.28000000000000003 108.71 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.559 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 2.7 m-85 -58.42 -60.36 3.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.86 . . . . 0.17999999999999999 109.46 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -31.33 1.94 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.18 -1.568 . . . . 0.20999999999999999 109.18 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' HIS . . . . . 0.529 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 1.4 m80 -78.58 -74.77 0.26 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.107 -1.231 . . . . 0.17000000000000001 110.679 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' SER . . . . . 0.56 ' CB ' ' HA2' ' A' ' 197' ' ' GLY . 0.0 OUTLIER -41.18 -36.67 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.385 0.513 . . . . 0.33000000000000002 112.385 -178.531 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' LEU . . . . . 0.506 ' CD2' ' CE2' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -101.39 -35.06 9.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.81 -1.181 . . . . 0.53000000000000003 112.172 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' GLY . . . . . 0.42 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -85.36 -87.52 0.94 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.97 -1.081 . . . . 0.40999999999999998 111.442 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' LEU . . . . . 0.594 HD23 ' N ' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -154.27 156.01 36.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -1.127 . . . . 0.45000000000000001 110.483 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.551 ' N ' HD23 ' A' ' 230' ' ' LEU . 1.3 m-20 -37.08 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.349 -0.844 . . . . 0.62 110.98 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' HIS . . . . . 0.594 ' N ' HD23 ' A' ' 230' ' ' LEU . 6.3 m80 -143.12 161.39 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.247 -0.908 . . . . 0.45000000000000001 110.588 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' SER . . . . . 0.468 ' O ' ' HB3' ' A' ' 238' ' ' ALA . 1.0 OUTLIER -165.67 35.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.38 109.937 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' LYS . . . . . 0.558 ' HA ' ' CB ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -103.23 20.48 17.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.47999999999999998 110.624 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' ASP . . . . . 0.589 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -41.36 -60.15 1.95 Allowed Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.291 -0.964 . . . . 0.38 109.299 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' PRO . . . . . 0.589 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 54.7 Cg_endo -81.07 -50.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.666 1.351 . . . . 0.28000000000000003 109.742 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.37 93.49 0.09 OUTLIER Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.788 -1.196 . . . . 0.23999999999999999 111.36 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' ALA . . . . . 0.559 ' HB3' ' CB ' ' A' ' 257' ' ' ASP . . . -137.48 162.76 32.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.929 -1.336 . . . . 0.28000000000000003 110.12 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' LEU . . . . . 0.591 ' CD2' ' HA ' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -73.22 57.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.195 -0.941 . . . . 0.40000000000000002 109.275 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' MET . . . . . 0.578 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.0 OUTLIER -140.37 -31.04 0.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.45000000000000001 110.687 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' PHE . . . . . 0.546 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -42.0 167.22 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.56999999999999995 110.553 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.23 -5.6 17.19 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.965 1.508 . . . . 0.76000000000000001 109.605 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' ILE . . . . . 0.532 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 19.4 mt -102.78 145.67 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.89000000000000001 109.812 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 246' ' ' TYR . 45.8 p90 -128.65 -31.73 2.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.78000000000000003 110.419 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' THR . . . . . 0.531 ' C ' ' O ' ' A' ' 244' ' ' TYR . 0.4 OUTLIER 2.17 -67.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.571 0.952 . . . . 0.60999999999999999 113.571 -179.338 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' TYR . . . . . 0.557 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -59.4 101.99 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.478 -1.389 . . . . 0.73999999999999999 109.415 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' THR . . . . . 0.526 ' N ' ' HB2' ' A' ' 250' ' ' SER . 1.4 m -47.98 178.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.763 . . . . 0.81000000000000005 110.475 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -52.1 -20.36 6.56 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.938 -1.265 . . . . 0.56000000000000005 109.938 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.26 31.35 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.083 -1.245 . . . . 0.37 110.639 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' SER . . . . . 0.526 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.2 OUTLIER -49.65 -47.35 49.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 0.44 109.876 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -47.65 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.53000000000000003 110.022 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER 179.46 -178.19 0.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.38 110.494 -179.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' MET . . . . . 0.474 ' HG3' ' OD2' ' A' ' 256' ' ' ASP . 0.0 OUTLIER -68.32 55.52 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.19 110.595 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.692 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.8 tp -43.99 -47.61 22.29 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.061 -1.088 . . . . 0.28000000000000003 108.061 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' PRO . . . . . 0.692 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -71.1 48.52 0.89 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.054 1.555 . . . . 0.48999999999999999 111.279 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ASP . . . . . 0.564 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.4 m-20 -52.64 -28.78 22.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.882 -1.136 . . . . 0.48999999999999999 111.191 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' ASP . . . . . 0.559 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.58 -52.67 62.97 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.875 -1.13 . . . . 0.31 109.523 -178.874 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ASP . . . . . 0.544 ' O ' ' CD1' ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.22 -32.29 68.62 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.203 -0.999 . . . . 0.14000000000000001 108.947 179.083 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' VAL . . . . . 0.564 ' HB ' ' HA ' ' A' ' 256' ' ' ASP . 61.1 t -64.02 -82.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.807 -0.757 . . . . 0.17000000000000001 110.054 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' GLN . . . . . 0.556 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.8 tt0 -55.59 -42.43 74.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 0.26000000000000001 108.951 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' GLY . . . . . 0.501 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -38.95 -72.4 0.21 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' ILE . . . . . 0.589 HG13 ' CH2' ' A' ' 145' ' ' TRP . 0.1 OUTLIER -72.33 -22.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.34 . . . . 0.22 110.082 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLN . . . . . 0.556 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 0.8 OUTLIER -57.25 -24.84 57.4 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.843 -1.143 . . . . 0.39000000000000001 108.424 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.0 -37.44 7.37 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.146 -0.622 . . . . 0.46999999999999997 111.507 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' LEU . . . . . 0.44 ' N ' ' CD2' ' A' ' 265' ' ' LEU . 4.5 mm? -83.15 -47.98 11.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.47999999999999998 111.951 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -82.74 -9.94 59.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.40999999999999998 110.691 -179.136 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -54.62 -97.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.009 -1.636 . . . . 0.46000000000000002 109.009 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.05 116.75 4.67 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.097 1.577 . . . . 0.57999999999999996 110.246 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLY . . . . . 0.451 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -67.33 134.92 31.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.749 -1.34 . . . . 0.64000000000000001 109.749 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' ASP . . . . . 0.593 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -89.44 -63.84 1.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.94999999999999996 110.037 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' GLU . . . . . 0.504 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 0.3 OUTLIER 43.09 31.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.392 -0.817 . . . . 1.2 110.25 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.75 79.07 47.36 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 1.2 110.297 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 59.53 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.04 1.547 . . . . 1.0600000000000001 110.466 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.918 -1.039 . . . . 0.78000000000000003 110.188 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' HAV . . . . . 0.589 ' O1 ' ' CD2' ' A' ' 222' ' ' HIS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' 3MP . . . . . 0.619 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MSB . . . . . 0.622 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.965 ' N ' HD13 ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.469 0.652 . . . . 1.03 109.727 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.507 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 6.3 tp 39.41 30.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 1.04 111.178 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.74 ' HB3' HD12 ' A' ' 265' ' ' LEU . 0.3 OUTLIER -118.4 88.75 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.023 . . . . 0.77 109.776 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.611 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 13.4 t90 -153.52 -65.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.42 111.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 17.8 t -105.02 59.97 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.44 111.207 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 114' ' ' SER . 10.9 mmtm -154.57 53.45 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.035 -1.041 . . . . 0.49 110.379 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.482 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 59.2 ttp -72.97 -15.67 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.3 110.393 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 15.3 p-10 -142.78 140.42 31.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.15 110.416 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 118' ' ' LEU . 12.8 tp -158.23 166.39 32.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.379 -0.826 . . . . 0.13 109.841 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -107.57 162.94 13.5 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -0.983 . . . . 0.12 110.081 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.613 ' HB3' HG23 ' A' ' 163' ' ' ILE . 36.5 p90 -157.63 164.02 37.65 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.376 -0.93 . . . . 0.33 110.887 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.24 146.46 45.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.422 -0.799 . . . . 0.54 110.301 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.766 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.2 pt -106.31 117.46 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.33 110.574 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.9 m -162.82 42.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.27 110.04 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 11.3 t-20 -40.63 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.79 -0.764 . . . . 0.41 109.311 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 7.8 t80 -178.92 178.46 0.76 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.409 -0.807 . . . . 0.4 109.78 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -130.56 51.08 6.9 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.45 110.126 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -75.85 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.125 1.592 . . . . 0.36 110.639 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -99.58 -2.09 36.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.25 109.938 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.577 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -110.47 168.76 9.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -0.8 . . . . 0.39 109.879 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.48 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -116.97 169.08 9.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.48 110.25 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -43.28 -32.96 0.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.4 109.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.9 m -67.98 -47.93 67.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.46 109.84 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 9.5 mp0 -63.07 -58.83 5.95 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.137 -0.977 . . . . 0.47 109.745 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 125' ' ' TYR . 10.9 t -45.68 -36.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.042 -1.096 . . . . 0.31 108.042 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.4 tt0 -57.84 -42.06 83.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.096 -1.076 . . . . 0.48 108.096 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 5.9 tttt -72.53 -51.1 21.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.448 -0.901 . . . . 0.64 108.732 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.865 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -44.92 -60.08 2.24 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.137 -0.977 . . . . 0.42 110.223 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.745 ' CE2' HD12 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -67.47 -52.82 34.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.34 110.974 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.07 -71.67 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.931 -1.105 . . . . 0.47 110.159 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtp? -39.49 -61.29 0.82 Allowed 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.809 -0.557 . . . . 0.47 110.508 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.41 -37.16 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.693 -1.254 . . . . 0.25 108.305 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.2 -36.67 74.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.743 -0.836 . . . . 0.35 108.743 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttmm -58.03 -41.39 83.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.228 -0.92 . . . . 0.7 108.923 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.79 -48.42 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.592 -0.692 . . . . 0.61 109.4 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.615 ' CH2' HG13 ' A' ' 262' ' ' ILE . 57.0 t-105 -55.01 -38.05 67.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.39 109.157 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -73.5 -34.0 65.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.305 -0.872 . . . . 0.35 108.936 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -44.18 89.45 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.36 109.251 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 145' ' ' TRP . 26.9 m -72.93 -32.2 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.634 -0.826 . . . . 0.5 109.753 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 146' ' ' SER . 15.3 t -152.0 134.18 8.54 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.51 110.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.29 59.83 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.951 1.501 . . . . 0.31 110.158 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -76.72 136.04 39.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.18 110.414 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -82.35 120.45 25.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.17 109.92 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.561 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.5 p90 -131.6 133.99 45.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 0.14 110.521 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.857 ' O ' HG22 ' A' ' 119' ' ' THR . 6.3 m -140.02 128.9 23.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.364 -0.835 . . . . 0.15 110.11 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.698 HH12 HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -96.67 81.85 3.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.2 109.972 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.627 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -82.26 89.1 6.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.094 -1.004 . . . . 0.22 110.109 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 158' ' ' ASP . 15.0 p80 -48.45 -24.43 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.32 109.963 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.0 t70 -42.29 -27.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.497 -0.752 . . . . 0.33 109.811 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 124.55 26.33 1.46 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.72 -1.352 . . . . 0.28 109.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.627 HD12 ' CD2' ' A' ' 156' ' ' LEU . 51.7 mt -119.85 70.93 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -1.215 . . . . 0.3 109.725 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.483 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -124.35 143.48 50.56 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.15 -0.62 . . . . 0.2 110.598 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.441 ' CG ' HD21 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -108.1 -43.78 4.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.1 109.965 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 227' ' ' SER . 1.0 OUTLIER -119.86 156.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.259 -0.901 . . . . 0.1 109.84 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.941 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.1 ptt? -156.85 153.01 27.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.515 -1.365 . . . . 0.11 111.602 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 165' ' ' ILE . 4.1 tt -101.24 116.69 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.1 109.316 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.998 ' HB3' HG23 ' A' ' 123' ' ' VAL . 12.9 p -162.64 148.64 12.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.578 -1.326 . . . . 0.1 111.364 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.571 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.3 p90 -67.79 117.15 9.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -0.823 . . . . 0.09 109.411 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -75.38 142.76 29.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.91 -0.876 . . . . 0.2 110.91 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -134.54 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.754 -0.851 . . . . 0.55 109.124 178.959 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 11.7 tmtt? 1.08 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.375 0.607 . . . . 0.85 112.428 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 171' ' ' GLU . 14.3 tt0 -146.16 23.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.326 -0.859 . . . . 0.71 110.11 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.8 m80 -96.89 -67.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.42 110.267 -179.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 124.6 5.96 6.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.649 -1.38 . . . . 0.33 109.649 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -121.51 -82.62 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -1.226 . . . . 0.33 110.217 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.476 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 65.3 m-85 -102.48 154.6 18.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.27 110.016 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.2 m-30 -96.56 105.74 24.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.34 110.039 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 43.7 Cg_endo -73.17 -66.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.929 1.489 . . . . 0.47 110.823 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -49.47 135.39 18.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.35 110.634 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 182' ' ' SER . 7.6 p30 179.56 83.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.241 -0.912 . . . . 0.2 110.398 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.496 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.47 -156.59 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.688 -1.365 . . . . 0.25 109.688 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.6 Cg_endo -76.45 6.35 4.07 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.123 1.591 . . . . 0.44 110.308 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 1.5 t -41.06 165.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.57 110.738 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.62 76.18 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.536 -1.025 . . . . 0.49 110.536 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.848 HD22 ' OD1' ' A' ' 202' ' ' ASP . 3.3 tt 179.78 89.28 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.358 -1.084 . . . . 0.41 110.058 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.596 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 1.3 tt -106.2 -21.66 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.787 -1.196 . . . . 0.3 111.533 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.595 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -152.59 108.86 3.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.473 -1.392 . . . . 0.2 112.247 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.1 OUTLIER -106.48 125.74 51.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 0.16 109.73 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.826 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -115.54 150.62 36.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.16 -0.963 . . . . 0.23 110.613 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -107.53 165.33 12.99 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.937 . . . . 0.38 110.471 179.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 43.4 Cg_endo -71.18 137.81 32.11 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.012 1.532 . . . . 0.4 109.901 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 41.2 Cg_endo -67.53 74.5 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.041 1.548 . . . . 0.32 110.807 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.62 -92.66 1.97 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.913 -1.675 . . . . 0.32 108.913 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.37 -159.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.001 1.527 . . . . 0.47 110.17 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.32 2.63 12.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.63 110.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 15.71 19.66 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.287 -0.883 . . . . 0.53 110.094 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -86.55 167.0 38.42 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.438 -1.465 . . . . 0.25 109.438 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 45.93 24.23 1.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.354 -1.499 . . . . 0.1 109.354 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.76 93.83 3.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.208 . . . . 0.1 110.192 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -75.74 105.13 6.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.09 109.925 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 166' ' ' SER . 10.3 m170 -119.24 122.18 41.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.09 110.237 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 203' ' ' ASP . 29.7 m-85 -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.1 110.455 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.848 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -48.78 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.282 -0.886 . . . . 0.14 108.789 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -36.33 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.901 -0.72 . . . . 0.18 111.694 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 202' ' ' ASP . 66.2 m-20 -77.62 2.08 17.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.812 -1.18 . . . . 0.24 111.075 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 202' ' ' ASP . 28.6 mm-40 -97.32 -170.78 2.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.997 -1.065 . . . . 0.42 110.548 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.414 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 96.5 m -121.37 146.52 46.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.47 110.367 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.6 ' C ' HG22 ' A' ' 208' ' ' THR . 0.9 OUTLIER -145.05 145.42 31.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.887 . . . . 0.27 109.663 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.999 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -163.7 -177.97 5.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.877 -1.139 . . . . 0.3 111.159 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.478 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.2 t -125.54 30.26 5.8 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.72 0.772 . . . . 0.61 108.999 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.611 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 1.3 t -126.93 -175.69 3.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.569 -0.707 . . . . 0.78 110.375 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.475 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -82.38 61.32 5.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.91 110.135 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.451 ' HG2' ' OG ' ' A' ' 210' ' ' SER . 3.5 pttt -170.0 106.26 0.34 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.957 . . . . 0.93 110.157 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 96.16 -162.47 22.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.363 -1.495 . . . . 0.79 109.363 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.596 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 83.7 m-85 -81.56 127.33 32.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -1.18 . . . . 0.69 109.986 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 210' ' ' SER . 13.1 m120 -89.25 119.25 29.57 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.095 -1.003 . . . . 0.4 108.939 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 208' ' ' THR . 0.6 OUTLIER -41.39 -36.59 0.86 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.515 -0.874 . . . . 0.17 110.214 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 5.0 m-85 -52.55 -47.04 67.01 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.468 -1.308 . . . . 0.28 107.468 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 244' ' ' TYR . 11.5 tp -78.5 -72.1 0.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.617 -0.72 . . . . 0.46 110.835 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.822 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -46.8 -61.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.936 -1.103 . . . . 0.39 110.23 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.924 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -54.35 -52.86 60.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.17 111.207 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -54.79 -29.48 54.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.352 -1.467 . . . . 0.1 109.043 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.683 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 11.8 t-80 -77.17 -52.21 9.65 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.423 0.63 . . . . 0.21 109.895 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.73 ' OE2' ' HB2' ' A' ' 188' ' ' ALA . 19.0 tp10 -58.38 -53.87 53.39 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.28 109.01 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.645 ' HA ' HD11 ' A' ' 163' ' ' ILE . 2.4 m-85 -53.99 -46.61 71.77 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.304 -0.872 . . . . 0.18 108.84 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -49.83 -31.85 17.3 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.315 -1.914 . . . . 0.21 108.315 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.743 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -86.54 -68.38 0.75 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.385 -1.068 . . . . 0.17 110.402 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.866 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -38.74 -39.64 0.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.574 -0.704 . . . . 0.33 111.108 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 163' ' ' ILE . 4.6 tp -98.19 -34.18 10.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.086 -1.009 . . . . 0.53 110.356 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -75.58 -88.85 0.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.107 -1.197 . . . . 0.41 110.107 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -177.68 -170.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -1.088 . . . . 0.45 110.878 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.521 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -39.23 -64.91 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.556 -0.715 . . . . 0.62 110.823 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.743 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 1.3 m80 -166.92 -177.44 3.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.45 110.096 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 232' ' ' HIS . 24.1 p 179.92 60.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.768 . . . . 0.38 109.406 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 1.099 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -148.12 26.4 0.98 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.48 111.415 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.528 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.6 OUTLIER -34.34 -51.09 0.97 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.38 111.173 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 46.8 Cg_endo -83.94 -49.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.72 1.379 . . . . 0.28 111.644 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.34 103.16 0.17 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.193 -1.479 . . . . 0.24 111.424 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 1.099 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -149.84 167.84 25.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.287 -1.125 . . . . 0.28 110.532 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.596 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -73.3 58.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.326 -0.99 . . . . 0.4 108.326 178.586 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.683 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 24.7 mmm -140.42 -34.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.45 110.813 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.613 ' CG ' HG22 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -58.11 170.54 0.71 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.047 -1.033 . . . . 0.57 110.243 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.1 Cg_endo -68.72 -7.55 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.544 1.286 . . . . 0.76 110.046 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.613 HG22 ' CG ' ' A' ' 241' ' ' PHE . 1.2 tp -98.66 142.48 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 0.89 109.57 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 1.013 ' HB2' HD21 ' A' ' 218' ' ' LEU . 16.1 p90 -131.93 -21.29 2.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.246 -0.908 . . . . 0.78 111.257 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 4.25 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 112.999 0.74 . . . . 0.61 112.999 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.701 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -66.36 115.9 6.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.571 -1.331 . . . . 0.74 109.619 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 250' ' ' SER . 0.2 OUTLIER -61.46 174.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.81 110.358 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -46.74 -34.28 6.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.822 -1.311 . . . . 0.56 109.822 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -148.73 51.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.044 -1.268 . . . . 0.37 110.572 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 247' ' ' THR . 83.6 p -102.07 13.19 35.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.44 109.875 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 1.7 t60 -173.65 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.53 109.959 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.549 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 2.5 t80 179.9 177.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.38 110.193 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.851 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -75.33 48.94 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.891 . . . . 0.19 110.451 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.702 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -44.46 -47.89 26.11 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.17 -1.048 . . . . 0.28 108.17 177.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.7 Cg_endo -72.52 51.04 1.75 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.054 1.555 . . . . 0.49 110.662 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.619 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.4 m-20 -53.4 -30.23 38.93 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.118 -0.989 . . . . 0.49 109.399 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 1.091 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -50.59 -42.64 56.04 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.228 -0.92 . . . . 0.31 109.897 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.995 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.78 -33.46 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.248 -1.019 . . . . 0.14 108.248 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 253' ' ' MET . 97.0 t -62.26 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.544 -0.862 . . . . 0.17 109.727 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.9 tm0? -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.295 -0.878 . . . . 0.26 109.597 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.12 -65.29 1.29 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.19 109.919 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.995 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -78.35 -20.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.22 110.615 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.928 ' N ' HD13 ' A' ' 262' ' ' ILE . 1.7 tm0? -66.25 -21.15 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.839 -1.144 . . . . 0.39 108.513 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t -104.11 -42.54 5.51 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.383 0.611 . . . . 0.47 110.897 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -79.18 -48.42 14.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.48 111.254 -178.753 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.485 ' OH ' ' HG ' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -84.55 -7.46 59.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.41 110.542 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -50.73 -98.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.001 -1.64 . . . . 0.46 109.001 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.65 133.89 13.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.839 1.442 . . . . 0.58 110.037 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -94.7 161.06 23.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.484 -1.446 . . . . 0.64 109.484 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.611 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.148 -1.207 . . . . 0.95 110.134 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.525 ' CA ' HD13 ' A' ' 230' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.337 -0.616 . . . . 1.03 109.337 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 36.3 40.08 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.694 -0.629 . . . . 1.04 111.545 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.631 ' HD3' HD22 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -126.85 81.94 2.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.77 109.496 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 15.6 t90 -151.64 -70.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.134 -0.979 . . . . 0.42 111.16 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 13.2 p -102.4 77.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.44 111.098 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -169.31 51.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.49 110.326 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.499 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 5.6 ttt -85.37 -13.38 49.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.3 110.42 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.493 ' O ' HD12 ' A' ' 118' ' ' LEU . 6.5 p-10 -143.96 109.62 5.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.208 -0.933 . . . . 0.15 110.043 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.706 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -138.24 -168.4 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.13 110.658 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.89 HG22 ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -130.59 176.95 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.12 110.321 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CZ ' ' HG3' ' A' ' 155' ' ' ARG . 36.7 p90 -174.43 -169.24 0.43 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.27 -0.894 . . . . 0.33 110.918 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -127.87 156.46 42.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.54 110.037 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 138' ' ' PHE . 2.7 pt -122.77 95.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.33 110.436 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.992 HG23 ' HB3' ' A' ' 166' ' ' SER . 4.2 m -149.9 56.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.982 . . . . 0.27 110.812 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 1.0 OUTLIER -44.34 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.41 109.306 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 167' ' ' PHE . 11.9 t80 -178.69 -173.95 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.4 109.69 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.531 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 2.6 m -136.35 53.89 8.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.45 110.774 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -78.26 -86.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.981 1.517 . . . . 0.36 109.922 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.47 0.04 41.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.895 . . . . 0.25 109.699 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.901 ' SD ' HD21 ' A' ' 216' ' ' LEU . 2.6 ptm -121.77 147.99 45.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 0.39 109.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -92.78 169.36 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.48 110.118 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' THR . 11.2 t-160 -43.51 -33.64 1.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.4 109.622 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 2.5 m -57.98 -54.6 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.46 109.23 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.6 OUTLIER -58.1 -54.35 47.99 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.542 -0.863 . . . . 0.47 108.913 179.04 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.537 ' CG2' ' CE ' ' A' ' 129' ' ' MET . 10.5 t -45.25 -34.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.169 -1.049 . . . . 0.31 108.169 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -63.44 -41.58 98.67 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.435 -0.95 . . . . 0.48 108.435 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 2.6 ttmt -70.5 -49.54 47.33 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.922 0.868 . . . . 0.64 108.999 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.802 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -44.77 -59.6 2.44 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 121.149 -0.969 . . . . 0.42 110.206 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.669 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.54 -53.59 33.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.34 110.775 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.12 -72.69 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.994 -1.067 . . . . 0.47 110.167 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.629 ' NZ ' HG23 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -38.47 -61.89 0.65 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.85 -0.531 . . . . 0.47 110.427 178.74 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.23 -38.86 12.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.678 -1.264 . . . . 0.25 108.413 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.3 OUTLIER -69.43 -31.92 70.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.35 109.063 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -61.29 -43.85 98.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.208 -0.933 . . . . 0.7 108.699 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.629 HG23 ' NZ ' ' A' ' 140' ' ' LYS . 7.5 t -69.58 -46.56 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.915 -0.772 . . . . 0.61 108.915 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.605 ' CH2' HG13 ' A' ' 262' ' ' ILE . 53.9 t-105 -54.72 -37.1 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.485 -0.76 . . . . 0.39 109.012 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 149' ' ' THR . 56.5 m -74.93 -33.17 61.93 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.915 . . . . 0.35 108.711 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.9 OUTLIER -57.85 -43.12 85.68 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.094 -0.706 . . . . 0.36 109.094 179.026 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 145' ' ' TRP . 29.5 m -74.64 -33.98 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.438 -0.789 . . . . 0.5 109.903 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.535 HG21 HD12 ' A' ' 151' ' ' LEU . 13.1 t -148.3 129.46 7.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -0.982 . . . . 0.51 110.216 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.43 59.17 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.968 1.51 . . . . 0.31 110.582 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.825 HD11 ' HB3' ' A' ' 266' ' ' TYR . 11.6 mt -80.25 171.31 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.18 110.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -122.79 136.64 54.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.17 110.463 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.422 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.8 p90 -154.91 145.02 21.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.14 110.316 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.89 ' O ' HG22 ' A' ' 119' ' ' THR . 2.8 m -143.99 142.95 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.15 110.14 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.624 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -93.74 86.51 5.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.2 110.12 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -92.62 85.14 5.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.22 110.419 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 159' ' ' GLY . 45.5 p-80 -56.88 -19.12 15.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.32 109.873 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.884 ' HB3' HD12 ' A' ' 156' ' ' LEU . 2.4 t0 -43.4 -26.14 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.494 -0.754 . . . . 0.33 109.776 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.75 21.87 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.95 -1.26 . . . . 0.28 109.95 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.51 ' O ' ' CB ' ' A' ' 119' ' ' THR . 14.8 mt -125.63 64.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.035 -1.273 . . . . 0.3 109.274 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -115.86 137.0 52.51 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.254 -0.579 . . . . 0.2 110.594 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.706 ' CB ' HD23 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -101.34 -51.79 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.1 110.034 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.719 HG22 ' HA3' ' A' ' 197' ' ' GLY . 3.1 pt -120.01 -177.33 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.1 109.229 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.802 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.1 ptp -174.88 139.54 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.5 -1.375 . . . . 0.11 111.836 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -90.35 118.71 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.1 109.443 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.992 ' HB3' HG23 ' A' ' 123' ' ' VAL . 29.5 p -169.83 162.45 9.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.722 -1.236 . . . . 0.1 111.291 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.594 ' O ' ' CD1' ' A' ' 167' ' ' PHE . 0.1 OUTLIER -75.19 150.46 38.67 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.471 -0.768 . . . . 0.09 109.24 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -111.9 131.59 10.32 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.754 -1.212 . . . . 0.2 110.986 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.594 ' O ' ' C ' ' A' ' 170' ' ' LYS . 12.4 pt -125.74 101.31 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.629 -0.924 . . . . 0.55 109.358 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.594 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 2.08 78.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.462 0.649 . . . . 0.85 112.202 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -4.48 10.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.71 110.135 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 9.1 m-70 -83.94 -153.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.923 . . . . 0.42 110.186 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.4 36.64 1.7 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.244 -1.542 . . . . 0.33 109.244 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' PHE . 15.0 p-10 -140.87 -146.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -1.093 . . . . 0.33 110.205 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 174' ' ' ASP . 28.5 m-85 -45.84 169.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.27 110.046 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -86.31 127.12 62.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.34 110.43 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.506 ' CG ' ' HA ' ' A' ' 170' ' ' LYS . 44.6 Cg_endo -79.01 -79.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.885 1.466 . . . . 0.47 110.497 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.2 p90 -58.91 149.83 25.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.35 110.307 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 182' ' ' SER . 1.6 p30 178.89 78.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.2 110.491 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.547 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 42.63 -160.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.522 -1.431 . . . . 0.25 109.522 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 52.0 Cg_endo -78.23 9.34 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.019 1.537 . . . . 0.44 110.483 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.489 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 40.5 m -46.9 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.57 110.575 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.87 74.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 111.149 -0.78 . . . . 0.49 111.149 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 1.022 HD22 ' OD1' ' A' ' 202' ' ' ASP . 4.0 tt 179.56 90.45 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.22 -1.164 . . . . 0.41 110.379 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.62 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.3 tt -109.18 -21.48 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.3 111.179 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.536 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -150.1 105.56 3.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.665 -1.272 . . . . 0.2 111.775 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -107.08 122.54 46.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.16 109.632 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.956 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -114.64 134.07 55.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.23 110.399 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.477 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.1 m-30 -79.63 174.78 5.56 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.38 110.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.523 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.6 Cg_endo -72.77 130.72 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.089 1.573 . . . . 0.4 109.458 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.4 Cg_endo -71.22 77.28 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.95 1.5 . . . . 0.32 110.457 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.13 -90.01 0.51 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.686 -1.245 . . . . 0.32 110.217 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.5 -179.98 4.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.47 111.014 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -58.92 -14.83 10.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.815 . . . . 0.63 110.133 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.97 53.3 0.7 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.538 0.685 . . . . 0.53 109.937 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -133.97 -178.52 15.67 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.392 -1.483 . . . . 0.25 109.392 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.719 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 43.56 26.14 0.64 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.67 -1.372 . . . . 0.1 109.67 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 196' ' ' GLY . 3.7 m-20 -79.28 87.95 4.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.1 110.22 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.66 97.1 1.67 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.09 110.027 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 166' ' ' SER . 2.5 m-70 -112.97 134.19 54.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.09 110.69 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.7 m-85 -101.1 135.92 41.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.905 . . . . 0.1 110.296 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 1.022 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -46.58 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.265 -1.013 . . . . 0.14 108.265 178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.09 -26.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.827 -0.749 . . . . 0.18 111.826 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.547 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.0 OUTLIER -78.06 3.59 14.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.499 -1.376 . . . . 0.24 110.749 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.62 ' OE1' HD12 ' A' ' 185' ' ' LEU . 21.6 mm-40 -100.27 -174.55 2.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.008 -1.058 . . . . 0.42 110.107 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 144.27 47.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.47 110.439 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.536 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -141.4 134.11 28.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.27 109.488 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.987 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -142.34 171.12 14.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.062 . . . . 0.3 110.508 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.607 ' HB2' HD23 ' A' ' 216' ' ' LEU . 1.2 t -129.24 25.95 5.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.573 -0.899 . . . . 0.61 108.573 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -69.3 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.78 110.357 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.583 -0.698 . . . . 0.91 109.518 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -95.8 157.86 15.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.449 -0.782 . . . . 0.93 110.022 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.25 -174.55 37.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.101 -1.6 . . . . 0.79 109.101 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.544 ' CE2' HD13 ' A' ' 185' ' ' LEU . 83.9 m-85 -67.31 114.96 6.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -1.228 . . . . 0.69 109.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.617 ' O ' HG12 ' A' ' 219' ' ' VAL . 45.5 m-80 -84.37 120.33 26.14 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.985 -1.072 . . . . 0.4 109.001 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.987 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -41.18 -36.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.17 110.397 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.59 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 3.9 m-85 -52.4 -47.64 66.13 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.279 -1.378 . . . . 0.28 107.279 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.16 -73.04 0.29 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.812 -0.631 . . . . 0.46 110.422 178.581 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.2 -62.78 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.136 -0.978 . . . . 0.39 110.566 -179.491 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -51.81 -50.69 60.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.026 -1.047 . . . . 0.17 111.263 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.9 -37.52 76.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.342 -1.474 . . . . 0.1 108.829 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.603 ' CA ' HD21 ' A' ' 239' ' ' LEU . 27.1 t-80 -63.68 -59.29 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.197 0.522 . . . . 0.21 109.606 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.672 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.0 tp10 -54.3 -39.44 66.97 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.252 -1.018 . . . . 0.28 108.252 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.2 m-30 -56.33 -61.32 2.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.435 -0.79 . . . . 0.18 109.057 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -45.07 -30.39 2.55 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.669 -1.772 . . . . 0.21 108.669 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 1.6 m80 -81.36 -78.27 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -1.156 . . . . 0.17 111.115 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.956 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -37.9 -37.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.584 -0.697 . . . . 0.33 112.47 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.582 ' HB2' HD13 ' A' ' 163' ' ' ILE . 11.5 tp -100.6 -36.72 9.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.717 -1.239 . . . . 0.53 111.278 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -75.82 -86.88 0.31 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.171 -1.172 . . . . 0.41 110.171 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.631 HD22 ' HD3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -172.57 -170.18 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -1.154 . . . . 0.45 110.661 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.509 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.2 t0 -43.08 -60.79 1.51 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.62 110.77 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.517 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -166.97 -175.56 3.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.45 110.359 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.449 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER 179.59 61.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.488 -0.758 . . . . 0.38 109.698 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 1.076 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.79 23.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.48 111.26 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.531 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -34.51 -47.43 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.647 . . . . 0.38 110.926 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 41.2 Cg_endo -90.78 -45.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.82 1.432 . . . . 0.28 111.987 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.31 102.02 0.15 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 118.829 -1.653 . . . . 0.24 111.991 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 1.076 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -150.46 166.47 30.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.334 -1.098 . . . . 0.28 110.257 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.603 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.3 53.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.972 . . . . 0.4 109.21 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.579 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 5.2 mtt -137.3 -30.63 0.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.45 110.372 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -47.49 171.27 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 0.57 110.6 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -70.29 -2.83 11.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.511 1.269 . . . . 0.76 110.454 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 6.4 tt -110.66 153.93 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.89 109.919 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.807 ' HB2' HD21 ' A' ' 218' ' ' LEU . 32.5 p90 -128.35 -20.61 3.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.78 110.935 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.6 OUTLIER 2.75 -67.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.717 1.006 . . . . 0.61 113.717 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -72.56 119.57 16.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.339 -1.476 . . . . 0.74 109.833 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 250' ' ' SER . 21.6 p -63.12 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.81 . . . . 0.81 110.424 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.84 -20.64 57.57 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.722 -1.351 . . . . 0.56 109.722 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -158.07 40.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -1.226 . . . . 0.37 110.507 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 247' ' ' THR . 4.6 m -63.79 -13.0 40.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.44 109.781 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.2 OUTLIER -171.13 -48.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.53 110.329 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.596 ' CD2' ' HG2' ' A' ' 253' ' ' MET . 4.7 t80 -179.1 178.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.38 110.777 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 253' ' ' MET . . . . . 1.01 ' HB2' HG21 ' A' ' 259' ' ' VAL . 6.8 ptp -68.14 55.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.424 -0.797 . . . . 0.19 110.263 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.668 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -44.11 -47.97 23.25 Favored Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 108.021 -1.103 . . . . 0.28 108.021 177.605 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.9 Cg_endo -74.31 50.53 2.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.129 1.594 . . . . 0.49 110.698 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.6 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.1 m-20 -50.87 -32.27 19.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.069 -1.019 . . . . 0.49 110.008 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.977 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 51.8 m-20 -54.17 -46.47 72.35 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.24 -0.984 . . . . 0.31 109.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.993 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -72.96 -36.32 67.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.491 -0.929 . . . . 0.14 108.491 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 1.01 HG21 ' HB2' ' A' ' 253' ' ' MET . 74.1 t -63.88 -82.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.17 110.266 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.3 tp60 -56.62 -43.09 79.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.276 -0.89 . . . . 0.26 109.495 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.76 -69.86 0.45 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.496 -1.042 . . . . 0.19 110.496 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.86 -22.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.777 -1.425 . . . . 0.22 110.032 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.941 ' N ' HD13 ' A' ' 262' ' ' ILE . 40.9 tt0 -59.98 -23.17 63.4 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.98 -1.088 . . . . 0.39 108.208 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.1 t -103.6 -43.0 5.49 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.406 0.622 . . . . 0.47 110.913 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.522 ' CB ' ' HG2' ' A' ' 112' ' ' LYS . 54.7 mt -75.31 -52.49 10.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.48 111.187 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.825 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -82.61 -1.36 50.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.41 109.959 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.31 -108.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.226 -1.55 . . . . 0.46 109.226 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.499 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.6 Cg_endo -75.91 84.29 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.702 1.369 . . . . 0.58 110.223 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.69 174.48 1.06 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.64 109.48 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.623 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.95 110.117 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.171 0.51 . . . . 1.03 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 39.49 27.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 1.04 110.88 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.607 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -114.94 72.76 0.8 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.0 . . . . 0.77 109.781 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.63 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.0 t90 -143.85 -65.09 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.42 110.474 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.428 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 13.4 t -103.06 60.31 0.78 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.44 110.537 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 3.8 mmtp -146.01 85.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.146 -0.971 . . . . 0.49 110.302 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.418 ' O ' ' HB2' ' A' ' 152' ' ' ASN . 34.1 ttp -112.99 -20.78 11.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.3 110.28 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.546 ' O ' ' ND2' ' A' ' 117' ' ' ASN . 0.4 OUTLIER -144.97 129.48 17.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.169 -0.957 . . . . 0.15 110.106 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.557 HD22 ' CB ' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -152.32 -175.73 5.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.13 110.662 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 154' ' ' THR . 1.0 OUTLIER -126.39 155.44 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 0.12 109.992 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.631 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 46.1 p90 -148.61 159.46 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.33 110.776 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -116.9 151.33 36.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.51 -0.744 . . . . 0.54 109.873 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.734 HG21 ' CD1' ' A' ' 138' ' ' PHE . 2.0 pp -113.51 115.19 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.33 110.983 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.917 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.6 m -160.56 41.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.313 -0.867 . . . . 0.27 110.19 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 2.3 t-20 -40.78 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.41 109.491 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.722 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.7 t80 -179.39 -163.45 0.05 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.43 -0.794 . . . . 0.4 109.57 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -152.84 47.87 0.41 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.063 -1.023 . . . . 0.45 110.436 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -73.73 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.956 1.503 . . . . 0.36 110.311 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.95 -5.21 56.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.25 109.755 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.602 ' SD ' HD21 ' A' ' 216' ' ' LEU . 0.6 OUTLIER -115.96 172.07 7.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.39 110.068 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -123.7 177.67 5.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.48 109.993 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 4.7 t60 -45.53 -36.92 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.4 110.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 5.7 t -63.59 -50.58 68.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.46 109.595 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 129' ' ' MET . 51.9 mp0 -59.87 -62.74 1.65 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.255 -0.903 . . . . 0.47 109.378 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 125' ' ' TYR . 13.1 t -44.02 -37.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.478 -0.934 . . . . 0.31 108.478 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.559 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.77 -42.04 78.69 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.319 -0.993 . . . . 0.48 108.319 178.448 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.591 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 42.2 tttt -74.69 -47.52 31.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.005 0.907 . . . . 0.64 108.577 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.851 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -47.64 -60.71 2.36 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.333 -0.854 . . . . 0.42 110.001 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.734 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.25 -51.36 46.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.34 111.095 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.54 -72.1 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.963 -1.086 . . . . 0.47 110.277 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -40.95 -59.33 1.47 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.693 -0.629 . . . . 0.47 110.437 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.86 -37.16 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.691 -1.256 . . . . 0.25 108.012 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -69.85 -40.74 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.499 -0.751 . . . . 0.35 109.02 178.559 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -52.67 -37.47 58.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.06 -1.025 . . . . 0.7 108.565 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 89.0 t -72.75 -45.17 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.351 0.596 . . . . 0.61 109.572 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.713 ' HH2' HG21 ' A' ' 262' ' ' ILE . 26.1 t-105 -58.72 -44.37 90.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.39 109.333 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 149' ' ' THR . 58.8 m -69.11 -33.4 73.43 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.137 -0.977 . . . . 0.35 108.745 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -56.12 -44.92 79.61 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.36 109.302 179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 145' ' ' TRP . 27.2 m -76.24 -30.83 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.5 109.778 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 149' ' ' THR . 12.7 t -151.8 114.7 2.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.51 109.944 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.91 59.96 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.826 1.435 . . . . 0.31 110.52 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 266' ' ' TYR . 65.7 mt -76.27 165.91 24.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.18 110.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.42 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -91.58 128.05 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.17 110.147 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 5.8 p90 -147.41 125.34 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.14 110.234 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 119' ' ' THR . 6.0 m -128.59 139.85 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.15 110.439 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.631 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -106.5 87.11 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.2 109.931 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.566 HD22 HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -95.38 89.52 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.22 110.05 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 158' ' ' ASP . 10.0 p80 -49.12 -23.78 1.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.32 109.916 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.0 t0 -42.76 -32.77 0.64 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.625 -0.672 . . . . 0.33 109.644 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.56 32.79 0.37 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.81 -1.316 . . . . 0.28 109.81 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.566 HD12 HD22 ' A' ' 156' ' ' LEU . 17.7 mt -126.79 67.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.236 . . . . 0.3 109.271 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -125.76 149.63 48.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.657 -0.652 . . . . 0.2 110.906 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.557 ' CB ' HD22 ' A' ' 118' ' ' LEU . 3.7 t70 -113.19 -38.05 4.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.1 109.623 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.973 HG22 ' HA3' ' A' ' 197' ' ' GLY . 6.6 pt -125.17 172.81 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.1 109.382 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.496 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 1.2 ptp -171.88 141.51 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.808 -1.183 . . . . 0.11 111.222 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.8 tt -93.87 117.23 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.389 -0.819 . . . . 0.1 109.563 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.917 ' HB3' HG23 ' A' ' 123' ' ' VAL . 69.4 p -158.53 159.59 35.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.893 -1.129 . . . . 0.1 110.489 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.559 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 9.1 p90 -76.63 126.41 30.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.383 -0.823 . . . . 0.09 109.709 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -88.23 117.04 4.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.148 -1.181 . . . . 0.2 110.148 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -110.25 103.01 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.67 -0.9 . . . . 0.55 109.264 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.587 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.82 81.12 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.329 0.585 . . . . 0.85 112.523 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.24 -6.26 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.71 110.048 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.464 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 13.1 m-70 -80.75 -86.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.42 110.418 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.47 4.11 6.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.526 -1.43 . . . . 0.33 109.526 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -113.28 -64.73 1.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.33 110.132 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.435 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 18.7 m-85 -112.79 118.14 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.27 110.245 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -45.78 104.29 0.39 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.34 110.36 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.521 ' O ' HD22 ' A' ' 184' ' ' LEU . 44.4 Cg_endo -74.5 -59.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.925 1.487 . . . . 0.47 110.374 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -89.2 161.04 16.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.35 109.919 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 0.9 OUTLIER -173.65 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.2 111.206 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.581 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 130.9 -137.23 9.32 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.929 -1.668 . . . . 0.25 108.929 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 182' ' ' SER . 54.0 Cg_endo -72.13 -3.37 13.15 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 O-C-N 124.076 1.566 . . . . 0.44 109.664 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -50.21 -179.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.358 -0.839 . . . . 0.57 110.158 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -82.88 73.58 2.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.278 -1.129 . . . . 0.49 110.278 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 184' ' ' LEU . 4.4 tt -179.96 93.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.221 -1.164 . . . . 0.41 110.788 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.605 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 3.2 tt -109.55 -15.58 14.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.823 -1.151 . . . . 0.3 110.719 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.731 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -153.15 102.81 2.66 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.774 -1.203 . . . . 0.2 111.591 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 4.2 p-80 -112.15 119.2 37.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.16 109.789 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -110.11 151.41 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.23 110.488 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.1 m-30 -90.64 165.53 22.41 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.38 110.686 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.7 Cg_endo -73.56 143.03 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.021 1.537 . . . . 0.4 109.804 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -70.5 72.74 1.78 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.896 1.471 . . . . 0.32 110.572 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.3 -101.5 2.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.433 -1.467 . . . . 0.32 109.433 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.15 -160.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.902 1.475 . . . . 0.47 110.28 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -6.97 26.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.993 . . . . 0.63 110.112 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.11 52.08 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.473 -0.767 . . . . 0.53 109.772 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -127.68 172.27 18.93 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.409 -1.477 . . . . 0.25 109.409 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.973 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 45.69 24.63 1.25 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.33 -1.508 . . . . 0.1 109.33 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -81.47 92.83 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -1.142 . . . . 0.1 110.233 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.654 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -69.37 98.55 1.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.09 110.294 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.52 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 19.2 m170 -102.98 138.14 40.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.09 110.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.649 ' CE1' HG22 ' A' ' 219' ' ' VAL . 17.5 m-85 -107.15 133.16 52.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.1 111.284 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 42.9 t0 -45.55 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.936 -0.764 . . . . 0.14 108.936 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 201' ' ' PHE . 0.8 OUTLIER -40.86 -34.16 0.37 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.014 -1.053 . . . . 0.18 111.525 -177.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.581 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 48.8 t0 -73.75 0.54 12.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.772 -1.205 . . . . 0.24 110.46 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 10.5 mm-40 -97.42 -161.72 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.123 . . . . 0.42 109.903 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.539 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 69.6 m -133.24 153.67 51.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.916 -1.115 . . . . 0.47 110.835 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.67 ' C ' HG22 ' A' ' 208' ' ' THR . 0.8 OUTLIER -148.3 166.47 27.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.308 -0.87 . . . . 0.27 109.796 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.999 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.3 OUTLIER -178.81 175.07 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.069 -1.019 . . . . 0.3 110.871 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.46 ' N ' ' OG1' ' A' ' 208' ' ' THR . 0.0 OUTLIER -139.01 25.75 2.49 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.565 -0.854 . . . . 0.61 109.817 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.2 t -90.66 -88.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 0.78 110.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 210' ' ' SER . 35.7 p -158.88 18.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.91 110.0 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 213' ' ' GLY . 6.9 ptpt -145.69 -174.11 4.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.93 110.133 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 44.34 -168.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.79 109.625 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.605 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 97.7 m-85 -70.33 121.56 17.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.69 110.195 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.631 ' O ' HG12 ' A' ' 219' ' ' VAL . 47.7 m-80 -87.31 116.89 25.71 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.159 -0.963 . . . . 0.4 109.086 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.17 -35.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.625 -0.83 . . . . 0.17 110.332 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.608 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 2.2 m-85 -52.37 -45.87 65.95 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.405 -1.331 . . . . 0.28 107.405 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.979 HD21 ' HB2' ' A' ' 244' ' ' TYR . 9.7 tp -81.42 -73.16 0.39 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.435 -0.802 . . . . 0.46 110.993 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.816 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.6 p -45.5 -56.14 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.39 110.325 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.934 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -60.5 -48.5 81.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.087 -1.008 . . . . 0.17 111.114 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -56.7 -24.59 50.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.177 -1.577 . . . . 0.1 108.406 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.683 ' CA ' HD21 ' A' ' 239' ' ' LEU . 17.1 t-80 -83.33 -49.87 8.93 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.749 -0.659 . . . . 0.21 110.325 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.731 ' CD ' ' HB1' ' A' ' 186' ' ' ALA . 3.0 tp10 -61.69 -44.54 96.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.933 -1.104 . . . . 0.28 108.782 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER -60.23 -62.16 2.07 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.472 -0.768 . . . . 0.18 109.026 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.85 -28.86 0.73 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.918 -1.673 . . . . 0.21 108.918 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.535 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 1.0 OUTLIER -80.91 -68.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -1.134 . . . . 0.17 111.084 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.997 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -46.93 -38.41 10.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.51 -0.744 . . . . 0.33 112.288 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER -100.13 -37.45 8.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.53 110.977 -178.6 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.666 ' N ' HD23 ' A' ' 228' ' ' LEU . . . -74.39 -87.42 0.23 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.963 -1.255 . . . . 0.41 109.963 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 230' ' ' LEU . 0.7 OUTLIER -161.96 -176.23 5.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.45 110.789 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 2.6 m-20 -55.17 -58.84 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.374 -0.829 . . . . 0.62 110.19 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.535 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 3.6 m80 -161.6 176.15 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.45 110.639 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 2.4 p 179.73 50.69 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.79 -0.818 . . . . 0.38 108.79 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -125.09 20.21 8.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.537 -0.727 . . . . 0.48 110.584 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.579 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -43.12 -53.53 10.54 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 119.443 -0.903 . . . . 0.38 109.831 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 50.5 Cg_endo -86.05 -47.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.595 1.313 . . . . 0.28 110.573 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 178.23 94.55 0.09 OUTLIER Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.233 -1.46 . . . . 0.24 111.589 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.833 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -144.42 162.16 37.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.211 -1.17 . . . . 0.28 110.358 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.683 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -77.61 57.73 1.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.4 108.72 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.637 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 21.6 mmm -133.14 -35.71 1.03 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.45 110.354 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -43.99 169.86 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.152 -0.968 . . . . 0.57 110.366 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.5 Cg_endo -71.85 -8.09 22.35 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.763 1.402 . . . . 0.76 109.842 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 245' ' ' THR . 16.1 mt -98.83 146.76 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.89 109.699 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.979 ' HB2' HD21 ' A' ' 218' ' ' LEU . 36.8 p90 -128.92 -25.97 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.03 -1.044 . . . . 0.78 110.976 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.743 HG22 HG22 ' A' ' 243' ' ' ILE . 0.2 OUTLIER 2.73 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.602 0.964 . . . . 0.61 113.602 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.732 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -70.23 107.56 3.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.381 -1.45 . . . . 0.74 109.686 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.774 ' HA ' HD13 ' A' ' 218' ' ' LEU . 2.2 t -65.32 -151.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 0.81 110.252 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 247' ' ' THR . . . -84.31 -5.0 87.63 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.404 -1.478 . . . . 0.56 109.404 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.754 ' H ' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -147.04 30.13 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -1.155 . . . . 0.37 110.38 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 246' ' ' TYR . 0.3 OUTLIER -74.16 -28.8 61.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.44 110.406 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 1.9 m-70 -164.82 -61.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.53 110.425 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 2.8 m-85 -174.38 -174.4 0.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.967 . . . . 0.38 110.516 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.842 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -68.07 53.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.51 -0.744 . . . . 0.19 110.559 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.695 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.1 -47.57 43.52 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 107.963 -1.125 . . . . 0.28 107.963 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.9 Cg_endo -73.59 51.0 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.137 1.598 . . . . 0.49 110.979 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.1 m-20 -50.65 -32.42 19.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.018 -1.051 . . . . 0.49 110.494 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.833 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -53.82 -54.13 42.75 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.885 -1.126 . . . . 0.31 109.136 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.017 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -66.01 -35.48 80.69 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.074 -1.05 . . . . 0.14 108.784 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 253' ' ' MET . 55.2 t -63.93 -86.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.17 110.581 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -55.0 -43.73 73.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.099 -1.001 . . . . 0.26 109.569 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.83 -70.2 0.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.641 -0.984 . . . . 0.19 110.641 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.017 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.66 -21.13 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.727 -1.455 . . . . 0.22 110.296 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.995 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.6 OUTLIER -64.86 -20.47 66.43 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.985 -1.072 . . . . 0.39 108.659 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 29.1 t -103.72 -41.88 5.8 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.203 -0.599 . . . . 0.47 111.164 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -84.3 -47.09 11.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.353 -0.842 . . . . 0.48 111.145 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -69.64 -20.52 63.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.41 110.223 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -53.51 -102.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.276 -1.53 . . . . 0.46 109.276 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.33 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.867 1.457 . . . . 0.58 110.333 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -83.22 155.79 33.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.64 109.388 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.63 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.206 -1.173 . . . . 0.95 110.414 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.59 ' N ' HD13 ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.525 0.679 . . . . 1.03 109.259 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.01 55.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.682 -0.636 . . . . 1.04 111.67 178.969 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -140.94 77.03 1.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.193 -0.942 . . . . 0.77 109.403 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.573 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 10.1 t90 -149.72 -69.22 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.42 111.411 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.6 t -100.48 77.17 1.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.44 111.101 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -170.21 49.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.279 -0.888 . . . . 0.49 110.185 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.2 OUTLIER -75.46 -29.15 59.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.3 110.141 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 25.0 p-10 -129.74 123.46 31.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.15 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' A' ' 162' ' ' ASP . 3.8 mt -141.32 -178.62 5.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.13 110.364 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -122.6 150.75 42.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.12 109.829 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.733 ' HB3' HG23 ' A' ' 163' ' ' ILE . 40.3 p90 -145.11 -164.31 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.33 110.692 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.1 154.2 40.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.54 110.888 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.936 HD13 ' HB3' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.48 110.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.33 110.223 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.4 m -159.91 41.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.27 110.147 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 3.4 t-20 -41.36 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.696 -0.802 . . . . 0.41 108.993 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 6.3 t80 -179.91 -176.14 0.33 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.514 -0.741 . . . . 0.4 109.593 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -132.52 49.77 4.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.013 -1.054 . . . . 0.45 110.611 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.4 Cg_endo -76.78 -85.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.854 1.45 . . . . 0.36 110.253 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.31 -0.5 38.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.25 109.622 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.821 ' SD ' HD21 ' A' ' 216' ' ' LEU . 3.6 ptm -123.12 133.93 54.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.39 109.976 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 131' ' ' HIS . 1.4 m -86.33 178.52 7.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.48 110.354 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.483 ' H ' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -45.74 -33.76 3.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.845 . . . . 0.4 110.068 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.5 t -63.16 -58.3 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.46 109.791 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.55 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 6.3 mp0 -54.46 -57.72 10.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.268 -0.895 . . . . 0.47 109.566 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.792 HG23 ' HE2' ' A' ' 129' ' ' MET . 4.0 t -45.34 -37.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.111 -1.07 . . . . 0.31 108.111 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 9.6 tt0 -59.03 -39.97 83.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.486 -0.931 . . . . 0.48 108.486 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 12.9 tttt -73.07 -50.37 23.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.64 108.776 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.806 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.64 -60.61 2.1 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.163 -0.961 . . . . 0.42 110.537 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.936 ' HB3' HD13 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.44 -50.97 48.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.34 111.216 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.625 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.91 -71.17 0.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.957 -1.089 . . . . 0.47 110.147 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -40.18 -58.78 1.4 Allowed 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.651 -0.656 . . . . 0.47 110.114 178.731 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.75 -38.81 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.707 -1.246 . . . . 0.25 108.365 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -71.0 -34.73 71.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.846 . . . . 0.35 108.985 178.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -56.4 -45.45 80.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.7 108.394 178.77 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.403 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 22.9 t -64.68 -44.67 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.987 -0.746 . . . . 0.61 108.987 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.64 ' HH2' HG21 ' A' ' 262' ' ' ILE . 26.3 t-105 -55.02 -36.69 65.74 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.718 -0.845 . . . . 0.39 108.718 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -74.12 -38.42 63.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.742 -0.836 . . . . 0.35 108.742 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -53.1 -37.48 61.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.533 -0.729 . . . . 0.36 109.045 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 145' ' ' TRP . 34.8 m -85.45 -35.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.5 110.116 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.702 ' CG2' HD23 ' A' ' 151' ' ' LEU . 15.3 t -153.93 127.25 4.24 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.038 -1.039 . . . . 0.51 110.15 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.67 59.88 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.871 1.459 . . . . 0.31 110.813 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 266' ' ' TYR . 1.9 mm? -72.53 145.88 47.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.18 110.086 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -91.88 133.68 35.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.17 110.32 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.9 p90 -149.11 147.91 29.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.14 110.237 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.931 ' O ' HG22 ' A' ' 119' ' ' THR . 6.5 m -152.72 133.03 13.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.15 110.29 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 32.1 mtm180 -91.86 119.32 31.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.013 -1.054 . . . . 0.2 110.16 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.405 HD12 HG21 ' A' ' 119' ' ' THR . 0.3 OUTLIER -117.56 108.67 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.22 110.3 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -72.17 -4.11 27.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.32 110.091 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -30.08 69.79 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.409 -0.807 . . . . 0.33 109.581 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.81 30.65 0.63 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.734 -1.346 . . . . 0.28 109.734 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.726 ' O ' HG22 ' A' ' 160' ' ' ILE . 57.7 mt -126.68 66.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.073 -1.251 . . . . 0.3 109.308 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -121.9 152.1 39.99 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.358 0.599 . . . . 0.2 110.612 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' CB ' HD22 ' A' ' 118' ' ' LEU . 5.4 t70 -120.5 -40.04 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.1 109.818 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.919 HG21 HD13 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -128.57 171.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.36 -0.838 . . . . 0.1 110.105 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.745 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 2.3 ptp -177.14 153.99 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.539 -1.351 . . . . 0.11 111.379 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.6 tt -99.3 118.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.1 109.408 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.988 ' HB3' HG23 ' A' ' 123' ' ' VAL . 15.1 p -162.85 144.64 10.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.752 -1.218 . . . . 0.1 111.237 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.652 ' CE2' ' CG2' ' A' ' 169' ' ' ILE . 0.9 OUTLIER -66.42 122.83 18.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.09 110.006 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -80.87 127.94 8.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.972 -1.251 . . . . 0.2 109.972 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.652 ' CG2' ' CE2' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -116.07 102.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.535 -0.98 . . . . 0.55 109.659 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.639 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.78 81.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.439 0.638 . . . . 0.85 112.257 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 169' ' ' ILE . 1.7 mm-40 -125.95 -4.86 6.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.71 110.267 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.524 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 8.8 m-70 -87.41 -140.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.42 109.995 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -169.89 -36.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.399 -1.48 . . . . 0.33 109.399 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -61.36 -61.23 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -1.104 . . . . 0.33 110.194 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.8 116.02 17.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.27 110.16 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -55.41 114.43 7.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 0.34 110.071 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.518 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 42.9 Cg_endo -73.14 -79.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.907 1.477 . . . . 0.47 110.898 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -46.59 142.95 2.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 0.35 110.778 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' A' ' 184' ' ' LEU . 4.4 p30 179.5 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.2 110.751 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.573 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 46.76 -167.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.38 -1.488 . . . . 0.25 109.38 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.2 Cg_endo -75.81 5.01 4.66 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.197 1.63 . . . . 0.44 110.304 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -44.57 173.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -0.797 . . . . 0.57 110.898 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.64 76.71 0.02 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.895 -0.882 . . . . 0.49 110.895 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.957 HD23 ' OD1' ' A' ' 202' ' ' ASP . 0.4 OUTLIER 179.46 88.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.174 -1.192 . . . . 0.41 110.373 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.557 HD12 ' OE1' ' A' ' 205' ' ' GLU . 4.6 tt -108.76 -21.13 12.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.832 -1.168 . . . . 0.3 111.612 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.552 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -149.97 101.09 3.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.48 -1.388 . . . . 0.2 111.907 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.7 OUTLIER -101.76 123.78 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.473 -0.767 . . . . 0.16 109.431 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.93 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -108.88 137.32 46.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.23 110.65 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -80.0 173.1 8.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.38 110.369 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 48.4 Cg_endo -73.75 133.34 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.975 1.513 . . . . 0.4 109.786 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.552 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -69.79 81.17 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.866 1.456 . . . . 0.32 110.604 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.55 -106.63 1.78 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.292 -1.523 . . . . 0.32 109.292 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.95 -159.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.882 1.464 . . . . 0.47 110.337 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -63.07 -11.27 18.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.941 . . . . 0.63 110.383 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.76 56.02 0.68 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.428 -0.795 . . . . 0.53 110.147 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.3 174.59 22.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.212 -1.555 . . . . 0.25 109.212 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 42.09 25.75 0.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.946 -1.261 . . . . 0.1 109.946 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.3 OUTLIER -79.38 86.16 5.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.32 . . . . 0.1 110.005 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.94 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.09 110.002 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.541 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.4 m170 -98.79 134.01 42.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.09 110.669 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.598 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 13.3 m-30 -102.74 131.07 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -0.903 . . . . 0.1 109.877 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.957 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -46.3 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.544 -0.91 . . . . 0.14 108.544 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.0 p30 -37.68 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.18 111.53 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.573 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -77.7 3.95 12.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.762 -1.211 . . . . 0.24 110.829 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.557 ' OE1' HD12 ' A' ' 185' ' ' LEU . 15.6 mm-40 -100.68 -167.39 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.036 . . . . 0.42 110.315 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.507 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 3.2 m -124.64 150.28 46.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -0.929 . . . . 0.47 110.385 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.55 ' HB3' HD11 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -147.42 142.74 27.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.902 . . . . 0.27 109.636 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.958 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -157.81 174.21 15.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.822 -1.174 . . . . 0.3 110.984 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.476 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.5 t -130.66 41.0 3.44 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.639 0.733 . . . . 0.61 109.384 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.9 t -109.87 -99.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.78 110.267 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.494 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -149.59 13.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.068 -1.02 . . . . 0.91 110.247 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.99 155.55 44.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.93 109.858 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.81 -175.24 53.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.081 -1.608 . . . . 0.79 109.081 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 185' ' ' LEU . 67.7 m-85 -71.26 106.53 3.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 0.69 109.931 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.517 ' O ' HG12 ' A' ' 219' ' ' VAL . 61.6 m-20 -75.04 119.28 18.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.154 -0.966 . . . . 0.4 108.528 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.958 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -39.71 -37.01 0.47 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.82 -0.752 . . . . 0.17 110.271 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.571 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.3 m-30 -52.16 -48.82 64.73 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.653 -1.24 . . . . 0.28 107.653 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' A' ' 244' ' ' TYR . 6.8 tp -74.56 -69.81 0.44 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.856 -0.611 . . . . 0.46 110.45 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.5 OUTLIER -50.12 -70.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.077 -1.014 . . . . 0.39 109.75 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -41.73 -52.55 3.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.07 . . . . 0.17 111.248 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.47 -37.3 77.84 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.417 -1.427 . . . . 0.1 108.977 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.836 ' HB2' HD11 ' A' ' 239' ' ' LEU . 5.6 t60 -64.91 -53.39 47.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.421 0.629 . . . . 0.21 109.551 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.552 ' OE1' ' HB1' ' A' ' 186' ' ' ALA . 25.0 tp10 -57.99 -46.14 85.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.28 109.301 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.531 ' CZ ' ' HB1' ' A' ' 220' ' ' ALA . 12.3 m-30 -52.57 -63.44 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.18 109.279 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -34.46 2.73 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.913 -1.675 . . . . 0.21 108.913 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.86 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -76.03 -79.02 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -1.132 . . . . 0.17 110.839 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.93 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.4 -53.93 0.65 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.666 -0.646 . . . . 0.33 111.916 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -80.59 -44.83 18.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.998 -1.064 . . . . 0.53 110.725 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -63.58 -82.78 0.08 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.775 -1.33 . . . . 0.41 109.775 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 110' ' ' THR . 0.5 OUTLIER -177.5 -170.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -1.076 . . . . 0.45 110.299 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 230' ' ' LEU . 1.8 m-20 -42.22 -61.62 1.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.62 110.51 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.86 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -159.51 -175.9 5.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.289 -0.882 . . . . 0.45 109.989 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.0 61.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.295 -0.878 . . . . 0.38 109.56 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.907 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.68 24.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.279 -0.968 . . . . 0.48 111.502 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -35.93 -51.9 1.58 Allowed Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.987 -0.685 . . . . 0.38 111.106 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 51.1 Cg_endo -85.58 -49.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.643 1.338 . . . . 0.28 111.291 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.19 101.25 0.14 Allowed Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.214 -1.47 . . . . 0.24 111.581 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.907 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -143.22 -174.21 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -1.124 . . . . 0.28 110.238 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.836 HD11 ' HB2' ' A' ' 222' ' ' HIS . 3.1 tp -88.86 27.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.371 1.081 . . . . 0.4 108.87 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.663 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -119.44 -6.46 10.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.872 -1.142 . . . . 0.45 110.655 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -60.53 170.31 1.42 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 121.15 -0.969 . . . . 0.57 111.558 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.1 Cg_endo -76.09 6.08 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.516 1.272 . . . . 0.76 110.597 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.732 HG22 HG22 ' A' ' 245' ' ' THR . 16.1 mt -126.89 164.88 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.337 -0.852 . . . . 0.89 109.506 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.652 ' HB2' HD21 ' A' ' 218' ' ' LEU . 33.3 p90 -139.72 -29.2 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.78 111.249 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.2 OUTLIER 3.18 -67.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 114.14 1.163 . . . . 0.61 114.14 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -59.87 101.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.279 -1.513 . . . . 0.74 109.816 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.505 ' N ' ' HB2' ' A' ' 250' ' ' SER . 80.6 p -50.44 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.81 110.146 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -56.79 -26.14 53.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.463 -1.455 . . . . 0.56 109.463 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.31 29.33 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.16 . . . . 0.37 110.014 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.521 ' O ' ' ND1' ' A' ' 251' ' ' HIS . 0.5 OUTLIER -62.8 -10.98 14.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.44 109.982 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 250' ' ' SER . 0.1 OUTLIER -174.42 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.53 110.204 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.3 OUTLIER 179.67 -173.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.38 110.285 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.916 ' HB2' HG21 ' A' ' 259' ' ' VAL . 14.2 ptt? -66.55 53.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.605 -0.684 . . . . 0.19 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.695 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -47.84 -46.3 62.52 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.28 107.833 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.9 Cg_endo -74.54 52.52 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.958 1.504 . . . . 0.49 110.806 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.639 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 9.9 m-20 -55.78 -31.51 62.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.159 -0.963 . . . . 0.49 110.572 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.851 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -51.35 -45.91 62.52 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.655 -1.218 . . . . 0.31 108.551 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.933 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.72 -39.47 64.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.453 -0.943 . . . . 0.14 108.453 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.916 HG21 ' HB2' ' A' ' 253' ' ' MET . 97.3 t -56.24 -76.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.17 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.71 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 7.1 pt20 -71.05 -34.76 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.32 -0.862 . . . . 0.26 110.567 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -44.37 -58.34 4.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.308 -1.517 . . . . 0.19 109.308 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.933 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -82.87 -23.12 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.023 -1.28 . . . . 0.22 110.89 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.722 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -62.63 -20.0 64.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.462 . . . . 0.39 108.195 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -103.18 -36.92 7.93 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.181 -0.608 . . . . 0.47 111.125 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 48.5 mt -88.32 -46.89 8.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.139 -0.976 . . . . 0.48 111.216 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.749 ' HB3' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -81.33 -4.76 56.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.41 110.299 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.8 -112.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.231 -1.548 . . . . 0.46 109.231 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.55 86.2 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.789 1.415 . . . . 0.58 110.296 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.27 170.12 1.8 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.64 109.575 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.573 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.95 110.166 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.256 -0.646 . . . . 1.03 109.256 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.6 OUTLIER 32.15 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.131 0.491 . . . . 1.04 111.461 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.883 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 7.6 mttt -124.73 64.92 1.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.77 110.357 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.628 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.1 t90 -123.3 -67.94 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.897 . . . . 0.42 110.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.421 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 72.8 p -99.38 54.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.44 110.151 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 17.5 mmtt -145.31 87.15 1.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.49 110.289 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 116' ' ' MET . 2.1 tmm? -121.34 -4.45 9.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.3 110.052 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.15 110.076 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.429 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -147.29 -167.1 2.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.13 110.31 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -133.66 156.37 48.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.12 110.473 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.804 ' CB ' HG23 ' A' ' 163' ' ' ILE . 46.0 p90 -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.49 -0.884 . . . . 0.33 110.94 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 1.1 mtt85 -124.85 151.39 45.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.54 110.114 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.723 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.2 pp -114.02 97.93 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.947 . . . . 0.33 111.14 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' A' ' 166' ' ' SER . 7.3 m -147.34 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.27 110.471 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 16.0 t-20 -44.31 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.41 109.379 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.553 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.0 t80 -179.85 -166.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.437 -0.79 . . . . 0.4 109.736 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -148.95 48.2 0.57 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.982 -1.074 . . . . 0.45 110.693 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.3 Cg_endo -74.04 -87.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.998 1.525 . . . . 0.36 110.268 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.96 -0.89 57.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.25 109.65 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.783 ' SD ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -119.55 158.83 25.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.816 . . . . 0.39 109.718 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -112.31 177.03 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.48 110.183 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 130' ' ' THR . 1.3 t-160 -43.18 -40.12 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.4 109.71 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 23.3 t -61.49 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.46 109.629 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.3 OUTLIER -62.63 -60.74 3.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 0.47 109.375 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.9 t -45.72 -36.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.882 -1.155 . . . . 0.31 107.882 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -58.21 -40.81 82.59 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.053 -1.091 . . . . 0.48 108.053 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.603 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.7 tttt -72.74 -54.56 8.6 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.76 -0.83 . . . . 0.64 108.76 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.862 ' HB1' HD22 ' A' ' 216' ' ' LEU . . . -45.88 -63.22 1.02 Allowed 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.958 -1.088 . . . . 0.42 110.101 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -61.7 -55.82 26.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.213 -0.93 . . . . 0.34 110.849 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 3.3 tttt -64.96 -73.2 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.47 110.331 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.37 -63.06 0.53 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.686 -0.634 . . . . 0.47 110.562 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -46.51 -36.92 7.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.77 -1.206 . . . . 0.25 108.665 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -72.62 -33.05 66.4 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.361 -0.837 . . . . 0.35 108.937 178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.226 -0.921 . . . . 0.7 108.784 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 40.8 t -72.13 -48.28 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.589 -0.694 . . . . 0.61 109.294 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.827 ' HH2' HG21 ' A' ' 262' ' ' ILE . 32.0 t-105 -56.71 -40.18 75.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.788 . . . . 0.39 109.047 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.2 m -73.12 -31.23 64.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.598 -0.89 . . . . 0.35 108.598 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -57.74 -43.22 85.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.132 -0.692 . . . . 0.36 109.132 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.802 HG23 HG22 ' A' ' 149' ' ' THR . 27.7 m -76.16 -33.0 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.618 -0.833 . . . . 0.5 109.739 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.802 HG22 HG23 ' A' ' 148' ' ' VAL . 4.6 t -145.1 120.57 5.86 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 0.51 110.149 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.36 58.86 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.757 1.399 . . . . 0.31 110.658 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 266' ' ' TYR . 8.8 mt -72.58 161.17 31.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.18 110.027 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.0 OUTLIER -104.46 102.02 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.17 110.255 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 151' ' ' LEU . 37.3 m-85 -123.3 142.86 50.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.14 110.2 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.678 ' O ' HG22 ' A' ' 119' ' ' THR . 3.3 m -142.0 141.35 32.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.184 -0.948 . . . . 0.15 110.448 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.644 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -100.06 91.64 4.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.2 109.985 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.06 106.91 18.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.22 110.153 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 158' ' ' ASP . 51.1 p-80 -63.83 -29.62 70.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.32 110.145 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' HIS . 2.1 t0 -41.19 -30.58 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.589 -0.694 . . . . 0.33 110.098 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.73 32.13 0.72 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.716 -1.354 . . . . 0.28 109.716 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 119' ' ' THR . 39.9 mt -121.51 71.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.127 -1.219 . . . . 0.3 109.513 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -138.55 156.19 47.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.888 -0.725 . . . . 0.2 110.767 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.429 ' CB ' HD23 ' A' ' 118' ' ' LEU . 39.0 t0 -124.64 -31.08 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.439 -0.788 . . . . 0.1 110.036 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.804 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -122.47 160.66 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.236 -0.915 . . . . 0.1 109.912 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.727 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -165.36 140.96 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.373 -1.454 . . . . 0.11 111.6 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.9 tt -90.32 116.67 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 0.1 109.538 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.889 ' HB3' HG23 ' A' ' 123' ' ' VAL . 3.7 p -156.1 159.88 39.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.921 -1.112 . . . . 0.1 110.46 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.8 p90 -76.55 116.59 17.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.409 -0.807 . . . . 0.09 109.735 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -64.16 119.69 16.83 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.434 -1.066 . . . . 0.2 110.434 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 169' ' ' ILE . 1.7 tp -117.09 97.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.639 -0.918 . . . . 0.55 109.532 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.603 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.09 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 112.634 0.605 . . . . 0.85 112.634 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -156.03 17.1 0.36 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.847 . . . . 0.71 110.606 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -82.58 -90.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.42 110.207 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -177.35 -36.73 0.06 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.42 -1.472 . . . . 0.33 109.42 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -148.41 -65.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.33 110.185 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.46 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 58.0 t80 -42.13 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.27 110.403 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 174' ' ' ASP . 10.9 m-30 -47.9 104.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.34 110.264 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.819 ' O ' HD23 ' A' ' 184' ' ' LEU . 49.1 Cg_endo -79.72 -64.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.09 1.574 . . . . 0.47 110.677 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.603 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -72.64 138.33 46.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.072 -1.017 . . . . 0.35 111.07 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 202' ' ' ASP . 0.5 OUTLIER 178.79 78.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.071 -1.052 . . . . 0.2 111.652 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.569 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 35.41 -153.66 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.86 -0.896 . . . . 0.25 110.86 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -74.93 3.39 5.62 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.554 1.818 . . . . 0.44 110.361 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 184' ' ' LEU . 14.1 t -40.15 162.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.57 110.256 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -59.13 76.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.498 -1.041 . . . . 0.49 110.498 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.874 HD23 ' OD1' ' A' ' 202' ' ' ASP . 9.9 tp 179.76 84.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.391 -1.064 . . . . 0.41 110.047 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.606 HD12 ' OE1' ' A' ' 205' ' ' GLU . 0.4 OUTLIER -100.92 -25.27 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.224 . . . . 0.3 111.07 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 223' ' ' GLU . . . -150.4 105.07 3.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.68 -1.262 . . . . 0.2 111.928 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 21.2 p-80 -110.65 122.55 48.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.16 109.437 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -116.29 131.3 56.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.23 110.422 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.513 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.7 OUTLIER -73.48 169.33 18.76 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.38 110.675 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.8 Cg_endo -73.59 144.0 35.07 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.171 1.617 . . . . 0.4 109.618 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.2 Cg_endo -70.71 81.12 1.09 Allowed 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.91 1.479 . . . . 0.32 110.82 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.4 -107.28 2.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.466 -1.454 . . . . 0.32 109.466 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -75.76 -162.76 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.927 1.488 . . . . 0.47 110.731 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -57.85 -15.43 8.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.63 110.316 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.22 54.96 0.7 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.496 -0.753 . . . . 0.53 110.251 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.4 170.09 21.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.409 -1.476 . . . . 0.25 109.409 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.76 27.44 0.35 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.62 -1.392 . . . . 0.1 109.62 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 2.0 m-20 -76.75 92.12 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.239 . . . . 0.1 110.087 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.878 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -74.69 98.63 3.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.09 109.954 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 7.2 m-70 -117.47 126.03 51.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.218 -0.926 . . . . 0.09 110.688 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 203' ' ' ASP . 32.6 m-85 -93.41 141.97 27.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.1 110.571 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.874 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -49.0 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.183 -1.043 . . . . 0.14 108.183 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.613 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 4.3 p30 -37.21 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.18 111.604 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.569 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.7 t0 -75.56 -1.62 25.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.568 -1.333 . . . . 0.24 110.994 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.606 ' OE1' HD12 ' A' ' 185' ' ' LEU . 21.4 mm-40 -94.15 -163.52 1.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.937 -1.102 . . . . 0.42 110.379 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.424 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -125.94 150.84 47.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.47 110.729 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.613 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -143.36 140.86 30.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 0.27 109.295 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.985 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.18 177.67 11.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.877 -1.139 . . . . 0.3 110.95 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 209' ' ' SER . 2.0 t -131.56 45.95 2.72 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.584 0.707 . . . . 0.61 109.6 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.1 t -112.38 -105.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.78 110.164 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 210' ' ' SER . 25.2 p -157.48 17.85 0.27 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.91 110.268 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 213' ' ' GLY . 4.2 mttp -125.91 -86.45 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.93 110.193 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . -49.08 -178.3 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.317 . . . . 0.79 109.806 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.441 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 94.8 m-85 -57.08 115.15 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.69 109.992 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.565 ' O ' HG12 ' A' ' 219' ' ' VAL . 7.4 m120 -82.67 116.03 21.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.008 . . . . 0.4 109.044 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.985 HD12 ' O ' ' A' ' 208' ' ' THR . 1.2 mp -41.73 -33.38 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.436 -0.79 . . . . 0.17 110.283 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.61 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 5.2 m-85 -53.44 -45.07 69.33 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 118.07 -1.452 . . . . 0.28 107.431 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 244' ' ' TYR . 20.9 tp -82.52 -71.0 0.51 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.523 -0.762 . . . . 0.46 110.993 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.849 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -47.86 -56.61 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.39 110.19 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.977 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.56 -46.92 87.51 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.968 -1.083 . . . . 0.17 111.131 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -60.33 -23.6 64.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.164 -1.585 . . . . 0.1 108.454 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.661 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 3.4 t-160 -80.43 -50.04 10.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.373 -0.603 . . . . 0.21 109.373 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.878 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.7 tp10 -62.31 -33.32 74.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.065 -1.022 . . . . 0.28 108.442 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.554 ' CE1' HD11 ' A' ' 163' ' ' ILE . 6.2 m-85 -64.78 -66.87 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.669 0.747 . . . . 0.18 108.99 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.453 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.35 -28.15 0.54 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.762 -1.735 . . . . 0.21 108.762 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 224' ' ' PHE . 3.3 m80 -81.42 -68.07 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -1.166 . . . . 0.17 110.842 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.912 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.2 OUTLIER -40.36 -42.78 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.33 111.88 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.798 HD12 ' OH ' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -101.16 -37.77 8.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.885 -1.134 . . . . 0.53 111.364 -178.734 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -65.09 -81.86 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.624 -0.99 . . . . 0.41 110.624 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -169.85 -147.83 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -1.18 . . . . 0.45 110.658 -178.838 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -86.87 -44.48 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.356 -0.84 . . . . 0.62 110.532 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -179.99 161.88 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.45 110.284 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 p -168.67 28.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.38 109.797 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.922 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -104.3 22.45 14.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -0.779 . . . . 0.48 111.002 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.543 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -35.25 -50.37 1.24 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.559 -0.713 . . . . 0.38 110.685 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 47.5 Cg_endo -86.73 -49.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.433 1.228 . . . . 0.28 111.14 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.06 101.33 0.14 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.137 -1.506 . . . . 0.24 111.544 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.922 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -145.36 173.58 11.87 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.371 -1.076 . . . . 0.28 109.7 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.607 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -80.85 38.31 0.45 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.826 -1.171 . . . . 0.4 109.916 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.661 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 25.6 mtp -123.01 -17.61 6.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.45 109.746 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -56.0 170.25 0.47 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.184 -0.948 . . . . 0.57 110.97 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 46.3 Cg_endo -73.73 -10.9 23.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.626 1.329 . . . . 0.76 110.006 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.656 HG22 HG22 ' A' ' 245' ' ' THR . 36.5 mt -104.84 147.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.89 109.787 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 1.037 ' HB2' HD21 ' A' ' 218' ' ' LEU . 41.8 p90 -131.25 -24.45 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.78 111.115 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.738 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.2 OUTLIER 2.88 -68.97 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 113.534 0.938 . . . . 0.61 113.534 -179.086 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.738 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -62.72 107.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.447 -1.408 . . . . 0.74 109.5 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.488 HG22 ' OD1' ' A' ' 215' ' ' ASN . 42.7 p -54.1 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.81 110.215 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.04 -9.76 54.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.317 -1.513 . . . . 0.56 109.317 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -149.27 29.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -1.18 . . . . 0.37 110.526 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.446 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.6 OUTLIER -73.84 -31.52 63.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.996 -1.065 . . . . 0.44 110.091 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.8 -60.23 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.53 109.913 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.58 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 179.42 -175.61 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.38 110.306 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.861 ' HB2' HG21 ' A' ' 259' ' ' VAL . 25.9 ptt? -68.83 52.5 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.19 110.416 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.683 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.2 -46.85 44.82 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 107.912 -1.144 . . . . 0.28 107.912 177.514 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.3 Cg_endo -73.81 52.3 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.956 1.503 . . . . 0.49 110.715 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.662 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 12.4 m-20 -57.22 -28.58 63.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.371 -0.831 . . . . 0.49 110.436 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.911 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 2.0 m-20 -51.31 -45.44 62.23 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.015 -1.053 . . . . 0.31 109.235 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.844 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.02 -34.18 50.75 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.365 -0.976 . . . . 0.14 108.365 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.861 HG21 ' HB2' ' A' ' 253' ' ' MET . 98.6 t -58.6 -74.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.899 -0.72 . . . . 0.17 110.533 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 14.1 pt20 -69.9 -37.05 75.87 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.267 -0.896 . . . . 0.26 109.769 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.508 ' N ' ' HG3' ' A' ' 260' ' ' GLN . . . -41.53 -53.92 4.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.466 -1.454 . . . . 0.19 109.466 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.883 HG22 ' NZ ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -92.1 -23.58 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.963 -1.316 . . . . 0.22 110.97 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.735 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 7.1 tp60 -54.81 -26.12 32.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.001 -1.48 . . . . 0.39 107.947 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.1 p -103.92 -41.68 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.244 0.545 . . . . 0.47 111.127 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 4.0 mm? -73.95 -51.85 14.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.48 111.477 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.798 ' OH ' HD12 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -76.18 -9.67 58.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.41 110.533 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -60.38 -111.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.356 -1.498 . . . . 0.46 109.356 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 88.98 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.819 1.431 . . . . 0.58 110.226 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.29 168.53 50.67 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.605 -1.398 . . . . 0.64 109.605 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.628 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 1.3 m-20 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.95 110.247 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 111' ' ' LEU . 1.1 p . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.444 -0.576 . . . . 1.03 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER 30.92 38.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.208 0.528 . . . . 1.04 111.356 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.529 ' HE2' HD22 ' A' ' 265' ' ' LEU . 0.8 OUTLIER -135.96 61.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.77 109.536 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.624 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 8.3 t90 -131.19 -50.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.42 110.682 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.458 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 28.5 t -111.89 62.85 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.44 110.928 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HG2' ' C ' ' A' ' 114' ' ' SER . 19.5 mmmt -149.09 42.05 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.074 -1.017 . . . . 0.49 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 2.2 ttp -72.77 -19.58 61.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.137 -0.977 . . . . 0.3 110.837 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 1.052 ' O ' HD22 ' A' ' 118' ' ' LEU . 5.7 p30 -138.48 113.23 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.15 110.743 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.052 HD22 ' O ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -143.47 -179.68 6.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.13 110.261 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -124.04 173.53 8.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.12 110.078 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 14.6 p90 -167.78 179.25 4.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.128 -0.982 . . . . 0.33 111.008 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 22.9 tpt85 -126.03 147.66 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.54 109.989 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.712 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.1 pp -110.36 77.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.33 110.789 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.971 HG23 ' HB3' ' A' ' 166' ' ' SER . 8.3 m -125.54 42.17 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.27 110.299 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.734 ' ND2' HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -40.33 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.567 -0.853 . . . . 0.41 109.212 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.667 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 2.9 t80 -178.9 169.33 1.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.044 -1.035 . . . . 0.4 110.293 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -125.23 49.69 3.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.97 . . . . 0.45 110.481 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.1 Cg_endo -73.97 -87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.121 1.59 . . . . 0.36 110.317 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.08 2.1 50.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.25 109.805 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.991 ' HE2' HD21 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -117.88 159.15 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.39 109.829 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -109.73 175.96 5.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.48 110.103 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 71.6 t60 -43.39 -32.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.4 109.738 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 1.3 t -68.42 -59.16 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.46 109.752 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 32.8 mp0 -51.46 -59.87 3.76 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.309 -0.87 . . . . 0.47 109.645 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 ' ND2' ' A' ' 124' ' ' ASN . 6.2 t -46.04 -37.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.261 -1.015 . . . . 0.31 108.261 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.596 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 12.1 tt0 -57.63 -39.1 76.2 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.347 -0.983 . . . . 0.48 108.347 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -73.84 -52.66 12.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.948 0.88 . . . . 0.64 108.819 178.67 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.827 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.48 -64.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.112 -0.993 . . . . 0.42 110.508 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.712 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -63.17 -53.73 48.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.34 111.327 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.65 -72.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.928 -1.107 . . . . 0.47 110.371 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -39.49 -61.84 0.75 Allowed 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.697 -0.627 . . . . 0.47 110.494 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -45.62 -37.99 6.17 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.795 -1.162 . . . . 0.25 108.291 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.37 -37.83 74.66 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.029 -0.73 . . . . 0.35 109.029 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttpt -55.38 -40.66 71.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.7 108.754 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.413 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 24.1 t -68.5 -44.84 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.69 -0.632 . . . . 0.61 109.342 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.66 ' HH2' HG21 ' A' ' 262' ' ' ILE . 29.1 t-105 -56.3 -41.5 76.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.39 109.161 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.5 OUTLIER -71.11 -34.42 71.06 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.288 -0.883 . . . . 0.35 108.858 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 1.1 m-20 -57.41 -41.64 80.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.602 -0.686 . . . . 0.36 109.625 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 145' ' ' TRP . 28.4 m -78.24 -29.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.5 110.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.541 HG21 HG12 ' A' ' 262' ' ' ILE . 13.4 t -152.27 141.91 14.59 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.94 -1.1 . . . . 0.51 110.586 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.37 58.0 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.895 1.471 . . . . 0.31 110.313 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.619 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -77.01 138.41 39.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.18 110.265 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.16 120.52 40.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.17 109.995 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.51 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.0 p90 -137.57 141.01 41.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.14 110.389 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.912 ' O ' HG22 ' A' ' 119' ' ' THR . 2.6 m -139.58 134.5 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.15 110.011 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.599 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 1.1 mtm180 -92.64 89.63 6.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.2 109.731 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.23 107.65 18.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.22 110.52 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -66.61 -11.9 55.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.32 109.79 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -54.53 -21.73 11.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.649 -0.657 . . . . 0.33 109.515 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.56 15.78 4.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.28 109.477 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.53 ' O ' ' HB ' ' A' ' 119' ' ' THR . 24.3 mm -106.22 78.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.119 -1.224 . . . . 0.3 108.943 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 124.78 45.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.2 111.018 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.684 ' HB2' HD12 ' A' ' 118' ' ' LEU . 14.8 t70 -94.08 -46.31 7.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.1 109.393 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.004 HD13 HD22 ' A' ' 228' ' ' LEU . 12.2 pt -128.56 177.94 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 0.1 109.302 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.78 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 4.0 ptt? -177.28 154.62 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.598 -1.314 . . . . 0.11 111.242 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 124' ' ' ASN . 3.0 tt -102.55 119.81 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.403 -0.811 . . . . 0.1 109.547 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.971 ' HB3' HG23 ' A' ' 123' ' ' VAL . 5.1 p -160.57 148.23 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.1 111.176 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.667 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 3.2 p90 -68.95 116.35 9.31 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.594 -0.691 . . . . 0.09 109.523 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -74.42 113.38 4.06 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.367 -1.093 . . . . 0.2 110.367 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -111.04 99.84 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -1.043 . . . . 0.55 109.585 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.634 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.26 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.365 0.602 . . . . 0.85 112.553 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.59 -3.51 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.71 110.192 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -75.62 -80.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.42 110.042 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 135.57 -39.57 1.65 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.587 -1.405 . . . . 0.33 109.587 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -77.46 -88.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -1.158 . . . . 0.33 110.33 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.1 OUTLIER -88.21 136.12 33.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.27 110.274 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.94 108.46 35.26 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.34 109.745 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 45.2 Cg_endo -77.51 -68.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.998 1.525 . . . . 0.47 110.581 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.634 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 6.3 p90 -40.81 136.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.87 . . . . 0.35 110.749 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.498 ' OD1' ' OD2' ' A' ' 202' ' ' ASP . 11.1 p30 179.21 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.2 110.759 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.55 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 43.17 -158.06 0.1 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.421 -1.472 . . . . 0.25 109.421 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.6 Cg_endo -77.04 8.52 3.14 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.101 1.58 . . . . 0.44 110.304 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.497 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 58.3 m -44.67 172.18 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.258 -0.901 . . . . 0.57 110.444 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.91 73.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 C-N-CA 120.393 -0.908 . . . . 0.49 110.893 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.821 HD22 ' OD1' ' A' ' 202' ' ' ASP . 3.2 tt 179.82 87.39 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.014 -1.286 . . . . 0.41 111.002 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 214' ' ' TYR . 8.3 tt -103.72 -22.61 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.686 -1.205 . . . . 0.3 110.88 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 223' ' ' GLU . . . -150.21 100.0 2.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.72 -1.237 . . . . 0.2 111.973 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.563 ' NE2' ' CB ' ' A' ' 200' ' ' HIS . 1.2 p80 -100.8 127.38 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.958 -1.089 . . . . 0.16 109.111 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.94 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -115.0 126.22 54.51 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.961 -1.087 . . . . 0.23 110.651 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.471 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 2.4 m-85 -71.85 155.93 91.57 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.38 110.185 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.521 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.5 Cg_endo -72.3 141.65 35.96 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.945 1.497 . . . . 0.4 109.93 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 64.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.32 110.783 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.47 -103.36 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.244 -1.543 . . . . 0.32 109.244 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.16 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.925 1.487 . . . . 0.47 110.314 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -65.02 -9.34 21.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.63 110.373 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 59.37 0.61 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.34 -0.85 . . . . 0.53 110.147 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -137.16 164.81 25.27 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.073 -1.611 . . . . 0.25 109.073 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.975 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 57.95 16.93 27.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.354 -1.498 . . . . 0.1 109.354 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.664 ' OD1' ' HE2' ' A' ' 164' ' ' MET . 8.4 m-20 -81.94 88.71 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 0.1 110.466 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.43 115.51 4.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.09 109.894 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.563 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 15.0 m170 -123.44 127.79 48.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.09 111.003 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 11.3 m-30 -96.76 132.41 42.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.1 110.223 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.821 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -49.98 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.97 -1.122 . . . . 0.14 107.97 178.558 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.4 p30 -35.21 -28.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.18 112.267 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.55 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -78.61 3.31 16.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.427 -1.421 . . . . 0.24 110.971 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.549 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 18.0 mm-40 -97.99 -168.97 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.934 -1.104 . . . . 0.42 110.229 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.501 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 12.5 m -122.29 151.53 41.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.47 110.383 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.536 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.2 m-90 -148.09 141.02 24.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.306 -0.871 . . . . 0.27 109.67 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.024 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -159.0 179.63 8.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.999 -1.063 . . . . 0.3 110.62 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.9 t -125.28 49.84 1.85 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.807 -0.757 . . . . 0.61 109.551 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 15.9 t -125.84 -144.62 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.78 109.962 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 56.6 p -101.95 -27.97 12.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.91 110.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 213' ' ' GLY . 2.2 mppt? -93.01 -176.84 4.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.93 110.364 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 48.58 -176.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.614 -1.394 . . . . 0.79 109.614 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.509 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.1 m-85 -79.79 118.09 21.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -1.081 . . . . 0.69 109.606 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.669 ' ND2' HG23 ' A' ' 247' ' ' THR . 7.8 p30 -83.13 124.77 30.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.933 -1.105 . . . . 0.4 108.818 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.024 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -42.2 -36.92 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.17 110.522 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.8 m-85 -50.98 -47.12 61.46 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.419 -1.312 . . . . 0.28 107.793 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.671 HD21 ' HB2' ' A' ' 244' ' ' TYR . 20.3 tp -77.65 -70.7 0.46 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.683 -0.689 . . . . 0.46 110.912 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -49.18 -63.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.035 -1.041 . . . . 0.39 109.903 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -50.93 -52.28 43.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.17 111.287 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.89 -35.06 66.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.183 -1.573 . . . . 0.1 108.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.649 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.6 t60 -69.11 -49.48 56.72 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.212 0.529 . . . . 0.21 109.738 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.668 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.5 tp10 -64.1 -27.48 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.28 108.777 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.418 ' HE2' ' CD2' ' A' ' 142' ' ' PHE . 5.2 m-30 -70.2 -61.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.043 -0.725 . . . . 0.18 109.043 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -48.62 -27.72 6.28 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.802 -1.719 . . . . 0.21 108.802 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 1.8 m80 -81.41 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -1.203 . . . . 0.17 111.601 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.94 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -58.32 -29.82 66.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.33 111.971 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 1.004 HD22 HD13 ' A' ' 163' ' ' ILE . 7.0 tp -100.21 -39.72 7.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.53 111.623 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -78.36 -79.07 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.211 -1.156 . . . . 0.41 110.211 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.5 OUTLIER -170.83 -166.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -1.22 . . . . 0.45 110.846 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.0 OUTLIER -55.12 -55.92 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.62 110.573 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.596 ' CD2' ' HB3' ' A' ' 240' ' ' MET . 0.7 OUTLIER -167.25 -179.6 4.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.145 -0.972 . . . . 0.45 110.763 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 257' ' ' ASP . 9.9 t 179.5 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.015 -0.735 . . . . 0.38 109.015 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.686 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -128.6 22.03 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -0.811 . . . . 0.48 111.247 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -40.96 -52.38 6.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.438 -0.905 . . . . 0.38 110.101 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -87.04 -49.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.614 1.323 . . . . 0.28 110.589 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.56 99.21 0.12 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.435 -1.364 . . . . 0.24 111.543 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.865 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.82 162.8 35.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -1.183 . . . . 0.28 110.103 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.598 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -72.5 58.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.4 108.823 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.649 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 1.4 mtt -142.74 -36.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.335 -0.853 . . . . 0.45 110.432 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.596 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . 0.1 OUTLIER -46.01 174.98 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.235 -0.916 . . . . 0.57 110.377 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 48.6 Cg_endo -78.43 22.57 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.476 1.25 . . . . 0.76 111.127 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.714 HG22 HG22 ' A' ' 245' ' ' THR . 12.6 mm -127.76 140.79 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.89 109.107 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.671 ' HB2' HD21 ' A' ' 218' ' ' LEU . 54.3 p90 -126.29 -31.27 2.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.145 . . . . 0.78 110.633 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 243' ' ' ILE . 0.0 OUTLIER 3.8 -78.52 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 113.152 0.797 . . . . 0.61 113.152 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.677 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -43.82 114.79 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.7 -1.25 . . . . 0.74 109.687 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.669 HG23 ' ND2' ' A' ' 215' ' ' ASN . 6.1 m -72.6 172.86 9.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.865 . . . . 0.81 110.306 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.425 ' H ' HG22 ' A' ' 247' ' ' THR . . . -53.13 -22.35 13.44 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.351 -1.5 . . . . 0.56 109.351 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 48.1 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -1.109 . . . . 0.37 110.193 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -61.03 1.87 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.44 110.465 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.539 ' C ' ' CG ' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -133.38 -77.16 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.53 110.649 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.539 ' CG ' ' C ' ' A' ' 251' ' ' HIS . 23.1 m-85 -151.17 -178.03 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.38 110.948 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.965 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.7 58.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.672 -0.642 . . . . 0.19 110.018 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.73 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 2.6 mp -44.32 -47.08 24.92 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.066 -1.087 . . . . 0.28 108.066 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.5 Cg_endo -72.49 46.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.894 1.47 . . . . 0.49 111.231 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.5 m-20 -46.7 -32.74 3.77 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.576 -1.328 . . . . 0.49 110.367 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.865 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.83 -54.62 40.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.948 -1.101 . . . . 0.31 109.241 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.088 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.88 -33.69 76.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.174 -1.01 . . . . 0.14 108.873 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.965 HG21 ' HB2' ' A' ' 253' ' ' MET . 74.2 t -67.41 -86.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.17 110.566 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.2 tt0 -52.84 -42.18 64.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.008 -1.058 . . . . 0.26 109.353 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.72 -70.91 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.368 -1.093 . . . . 0.19 110.368 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.088 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.82 -18.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.735 -1.45 . . . . 0.22 110.035 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 1.083 ' N ' HD13 ' A' ' 262' ' ' ILE . 6.6 tt0 -64.37 -21.97 66.8 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.854 -1.138 . . . . 0.39 108.355 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.3 p -103.7 -42.42 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.222 -0.591 . . . . 0.47 111.502 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.529 HD22 ' HE2' ' A' ' 112' ' ' LYS . 7.6 mp -86.15 -46.18 10.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.48 111.266 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.619 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -77.95 -14.24 59.6 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.306 -0.871 . . . . 0.41 110.404 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.33 -94.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.889 -1.684 . . . . 0.46 108.889 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.43 109.73 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.083 1.57 . . . . 0.58 110.244 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -82.38 132.96 11.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.552 -1.419 . . . . 0.64 109.552 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.624 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.95 110.283 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.685 ' HA ' HD12 ' A' ' 230' ' ' LEU . 4.8 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.351 0.596 . . . . 1.03 109.851 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.5 mm? 39.12 47.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 1.04 111.118 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.594 ' HB3' HD23 ' A' ' 265' ' ' LEU . 2.1 tptm -128.17 60.99 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.003 . . . . 0.77 109.967 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.557 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 10.7 t90 -139.48 -65.55 0.47 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.42 110.637 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.456 ' O ' ' HE3' ' A' ' 115' ' ' LYS . 79.1 p -98.85 46.15 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.44 110.562 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 6.9 mmpt? -130.09 76.41 1.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.49 110.248 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.403 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 8.5 tmm? -111.85 -3.4 14.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.3 110.173 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -159.11 125.78 4.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.15 109.859 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.472 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.4 -177.06 5.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.13 110.751 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.832 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -127.29 165.88 18.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.12 109.848 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.576 ' CB ' HG13 ' A' ' 163' ' ' ILE . 46.1 p90 -162.89 -176.77 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.025 -1.047 . . . . 0.33 111.367 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -140.38 155.45 46.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.54 110.23 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.898 ' O ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -114.41 123.5 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.494 -0.754 . . . . 0.33 111.134 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.888 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.2 m -165.86 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.27 109.72 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 0.9 OUTLIER -39.68 -80.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.718 . . . . 0.41 109.395 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.689 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.9 t80 -179.2 -159.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.432 -0.792 . . . . 0.4 109.527 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -154.0 50.38 0.56 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.45 110.656 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.65 -85.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.807 1.425 . . . . 0.36 110.388 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.6 0.45 49.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.25 109.982 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.572 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.03 160.04 22.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.39 110.168 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.7 m -106.33 168.86 8.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.48 110.254 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -44.7 -32.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.4 109.806 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -66.28 -49.36 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.46 109.562 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 1.8 mp0 -60.79 -57.64 11.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.249 -0.907 . . . . 0.47 109.17 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 125' ' ' TYR . 5.6 t -46.22 -36.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.761 -1.2 . . . . 0.31 107.761 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -56.89 -42.38 79.74 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.03 -1.1 . . . . 0.48 108.03 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.4 tttt -71.24 -49.98 37.63 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.65 -0.87 . . . . 0.64 108.65 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.827 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.83 -57.39 4.36 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.96 -1.087 . . . . 0.42 109.749 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CD2' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.11 -56.29 13.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.34 110.734 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.602 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.61 -73.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.984 . . . . 0.47 110.157 -179.494 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -36.87 -60.99 0.58 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.823 -0.548 . . . . 0.47 110.667 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.46 -40.95 19.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.618 -1.301 . . . . 0.25 108.709 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 138' ' ' PHE . 2.5 m-85 -69.38 -32.97 72.35 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.998 . . . . 0.35 108.774 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 17.1 tttm -56.15 -41.66 75.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.977 -1.119 . . . . 0.7 107.977 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.9 t -67.11 -41.91 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.537 -0.912 . . . . 0.61 108.537 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.594 ' CH2' HG13 ' A' ' 262' ' ' ILE . 25.5 t-105 -54.9 -38.67 67.89 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.819 -0.808 . . . . 0.39 108.819 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.7 OUTLIER -75.95 -41.23 52.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.347 -0.846 . . . . 0.35 108.74 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 3.0 m-20 -50.47 -33.3 20.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.968 -0.753 . . . . 0.36 108.968 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.0 m -91.16 -38.52 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.532 -0.73 . . . . 0.5 110.108 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 149' ' ' THR . 14.1 t -149.43 124.15 4.78 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.51 110.136 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.21 59.27 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.859 1.452 . . . . 0.31 110.599 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.856 HD21 ' O ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -73.81 139.24 45.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.18 110.154 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 7.4 t-20 -76.62 105.49 7.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.17 109.912 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 7.8 p90 -117.34 143.67 45.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.14 110.479 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 119' ' ' THR . 20.5 m -141.27 145.6 35.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.927 . . . . 0.15 110.125 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.519 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -124.84 79.87 1.82 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.706 -0.621 . . . . 0.2 110.152 -178.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -85.42 114.73 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.22 110.092 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -56.42 -18.0 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.32 109.98 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -23.25 5.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.449 -0.782 . . . . 0.33 109.632 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.42 7.94 5.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.534 -1.426 . . . . 0.28 109.534 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.832 HG22 HG21 ' A' ' 119' ' ' THR . 8.7 mt -87.91 91.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.126 -1.22 . . . . 0.3 109.034 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -154.98 107.07 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.968 -0.693 . . . . 0.2 110.336 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' CB ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -76.51 -42.74 42.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.1 109.808 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.02 HG21 HD12 ' A' ' 228' ' ' LEU . 1.1 pt -118.09 171.91 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.1 109.546 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.873 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 1.8 ptp -170.08 157.28 6.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.715 -1.241 . . . . 0.11 111.188 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.0 tt -104.9 120.78 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.1 109.806 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.888 ' HB3' HG23 ' A' ' 123' ' ' VAL . 11.5 p -162.45 156.4 21.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.786 -1.196 . . . . 0.1 111.142 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.9 p90 -73.17 118.43 16.12 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.493 -0.755 . . . . 0.09 109.272 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -76.9 131.66 11.54 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.46 -1.056 . . . . 0.2 110.46 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.583 ' O ' ' C ' ' A' ' 170' ' ' LYS . 2.5 tp -126.34 93.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.614 -0.933 . . . . 0.55 109.154 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.601 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 0.87 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.358 0.599 . . . . 0.85 112.466 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -148.69 17.22 1.01 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.343 -0.848 . . . . 0.71 109.861 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -78.96 -68.84 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.39 -0.819 . . . . 0.42 110.306 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.72 34.86 0.42 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.446 -1.461 . . . . 0.33 109.446 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -149.06 -69.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -1.11 . . . . 0.33 110.091 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -123.29 174.48 7.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.27 110.167 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.4 m-30 -98.57 110.34 56.49 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.34 110.237 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.514 ' HD2' ' HD2' ' A' ' 170' ' ' LYS . 41.9 Cg_endo -73.33 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.968 1.51 . . . . 0.47 110.616 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.6 OUTLIER -49.58 142.05 8.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.35 110.575 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 182' ' ' SER . 5.5 p30 179.64 80.3 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.202 -0.936 . . . . 0.2 110.453 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.72 -155.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.398 . . . . 0.25 109.606 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.7 Cg_endo -77.34 8.65 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.077 1.567 . . . . 0.44 110.573 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.2 t -42.75 166.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.57 110.318 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.45 73.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.712 -0.955 . . . . 0.49 110.712 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.909 HD23 ' OD1' ' A' ' 202' ' ' ASP . 1.0 OUTLIER 179.86 87.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.193 -1.181 . . . . 0.41 110.649 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.799 HD12 ' OE1' ' A' ' 205' ' ' GLU . 7.8 tt -103.85 -23.05 13.42 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.616 -1.234 . . . . 0.3 110.969 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.548 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -151.94 106.2 3.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.524 -1.36 . . . . 0.2 112.333 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.541 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.2 OUTLIER -101.84 133.02 47.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.16 109.229 178.427 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -122.09 118.72 29.38 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.134 -0.978 . . . . 0.23 110.476 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.464 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-85 -67.86 167.48 16.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.38 110.372 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.508 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.4 Cg_endo -72.89 136.65 25.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.145 1.603 . . . . 0.4 109.856 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.0 84.62 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.903 1.475 . . . . 0.32 110.561 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.9 -102.22 0.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.958 -1.257 . . . . 0.32 109.958 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.34 -163.6 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.47 110.859 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.89 -7.28 26.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.404 -0.81 . . . . 0.63 110.152 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.46 48.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.383 -0.823 . . . . 0.53 109.838 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -136.06 169.23 23.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.029 -1.629 . . . . 0.25 109.029 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.963 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 57.31 17.68 25.78 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.088 -1.605 . . . . 0.1 109.088 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.86 91.31 4.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.429 -1.042 . . . . 0.1 110.508 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.873 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -73.47 95.93 2.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.09 109.866 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.541 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 3.0 m-70 -111.93 134.45 53.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.09 110.887 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.4 m-85 -104.51 137.6 42.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.154 -0.966 . . . . 0.1 110.59 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.909 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -47.03 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.14 108.554 179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.599 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 3.2 p30 -36.88 -27.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.516 -0.74 . . . . 0.18 112.046 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.537 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.0 OUTLIER -78.79 2.93 18.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.488 -1.383 . . . . 0.24 110.848 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.799 ' OE1' HD12 ' A' ' 185' ' ' LEU . 11.6 mm-40 -95.91 -168.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.942 -1.099 . . . . 0.42 110.237 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.8 m -123.72 140.21 53.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.47 110.498 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.599 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.8 OUTLIER -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.27 109.312 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.008 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.33 178.61 9.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.959 -1.088 . . . . 0.3 110.792 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 29.9 t -130.48 32.37 4.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.534 0.683 . . . . 0.61 109.285 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -103.98 -90.87 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.78 110.686 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -157.21 -33.97 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.462 -0.774 . . . . 0.91 109.793 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 213' ' ' GLY . 3.5 pttt -87.91 -171.96 3.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.93 109.932 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 45.42 -155.59 0.44 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.243 -1.543 . . . . 0.79 109.243 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.595 ' CE2' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -94.13 126.24 39.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -1.193 . . . . 0.69 109.931 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.616 ' O ' HG12 ' A' ' 219' ' ' VAL . 42.6 m-80 -89.65 121.4 31.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.018 -1.051 . . . . 0.4 108.879 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.008 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.59 -37.84 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.611 -0.836 . . . . 0.17 110.375 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 3.1 m-30 -51.67 -46.91 63.98 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.382 -1.327 . . . . 0.28 107.585 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.26 -73.4 0.28 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.781 -0.645 . . . . 0.46 110.277 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.88 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.61 -65.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.39 110.302 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -49.66 -48.87 49.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.366 -0.834 . . . . 0.17 111.737 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.99 -41.71 92.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.185 -1.572 . . . . 0.1 108.645 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.576 ' NE2' ' HA ' ' A' ' 240' ' ' MET . 5.3 t60 -60.2 -51.26 70.33 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.377 0.608 . . . . 0.21 109.792 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.67 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.0 tp10 -64.8 -29.16 70.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.092 -1.005 . . . . 0.28 109.138 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 220' ' ' ALA . 13.8 m-30 -66.12 -64.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.447 -0.783 . . . . 0.18 109.177 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -49.84 -26.7 8.52 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.045 -1.622 . . . . 0.21 109.045 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -78.93 -58.7 3.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.081 -1.247 . . . . 0.17 111.557 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.913 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -69.22 -23.77 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.33 111.78 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -99.21 -43.82 6.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.028 -1.045 . . . . 0.53 111.258 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -83.03 -70.86 1.33 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.184 -1.008 . . . . 0.41 110.589 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -165.01 -162.11 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.241 . . . . 0.45 110.86 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -75.01 -51.7 12.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.62 110.34 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.622 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.8 OUTLIER -162.48 172.79 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.45 110.959 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.455 ' HB2' HD11 ' A' ' 230' ' ' LEU . 5.7 t 179.56 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.615 -0.678 . . . . 0.38 109.24 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.673 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -117.19 20.26 13.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.48 111.005 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.577 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -30.55 -53.81 0.38 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.894 -0.503 . . . . 0.38 111.507 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.7 Cg_endo -89.49 -47.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.4 1.21 . . . . 0.28 111.063 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.12 100.54 0.13 Allowed Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.498 -1.334 . . . . 0.24 111.268 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.935 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -146.78 168.73 20.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.131 -1.217 . . . . 0.28 110.518 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.558 HD21 ' N ' ' A' ' 222' ' ' HIS . 0.7 OUTLIER -73.67 55.42 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.301 -0.875 . . . . 0.4 109.011 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.576 ' HA ' ' NE2' ' A' ' 222' ' ' HIS . 1.9 mtt -140.87 -5.6 1.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.288 -0.882 . . . . 0.45 111.356 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -79.71 168.82 23.4 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.932 -1.105 . . . . 0.57 110.134 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -69.56 -4.27 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.848 1.447 . . . . 0.76 110.665 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.605 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 50.2 mm -104.63 143.87 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.89 109.808 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.834 ' HB2' HD21 ' A' ' 218' ' ' LEU . 42.8 p90 -131.39 -28.95 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.948 -1.095 . . . . 0.78 110.913 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.53 ' C ' ' O ' ' A' ' 244' ' ' TYR . 98.8 m 2.79 -69.63 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.412 0.893 . . . . 0.61 113.412 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -55.81 101.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.604 -1.31 . . . . 0.74 109.511 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.51 ' N ' ' HB3' ' A' ' 250' ' ' SER . 0.2 OUTLIER -48.09 179.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.431 -0.793 . . . . 0.81 110.263 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.71 -29.25 25.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.446 -1.461 . . . . 0.56 109.446 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -143.1 31.24 1.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.37 110.084 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.51 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.4 OUTLIER -59.56 -23.03 62.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.44 110.186 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 6.8 t-80 -156.21 -67.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.882 . . . . 0.53 110.004 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.1 m-85 -168.38 -178.36 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.38 110.164 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.974 ' HB2' HG21 ' A' ' 259' ' ' VAL . 5.6 ptt? -72.26 54.99 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.72 . . . . 0.19 110.225 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.726 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 7.6 tp -45.03 -46.07 28.53 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 107.975 -1.12 . . . . 0.28 107.975 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -71.58 48.19 0.99 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.76 1.4 . . . . 0.49 110.944 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.673 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.2 m-20 -52.63 -27.14 15.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.855 -1.153 . . . . 0.49 110.575 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.935 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -57.15 -43.76 82.78 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.578 -1.249 . . . . 0.31 109.454 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -79.57 -32.95 42.1 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.184 -1.006 . . . . 0.14 108.548 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.974 HG21 ' HB2' ' A' ' 253' ' ' MET . 54.4 t -65.43 -75.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.816 0.817 . . . . 0.17 110.019 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.628 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -63.57 -34.1 77.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.768 . . . . 0.26 109.612 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -49.53 -67.24 1.85 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.124 -1.19 . . . . 0.19 110.124 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -70.35 -21.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.811 -1.405 . . . . 0.22 109.895 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.674 ' N ' HD13 ' A' ' 262' ' ' ILE . 20.4 tp60 -67.31 -19.44 65.47 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.028 -1.045 . . . . 0.39 108.625 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.1 m -103.41 -38.6 7.12 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.119 -0.633 . . . . 0.47 111.709 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 112' ' ' LYS . 8.5 mp -97.79 -42.51 7.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.179 -0.951 . . . . 0.48 111.166 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.856 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -72.15 -21.48 61.45 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.37 -0.831 . . . . 0.41 109.808 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -55.6 -97.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.293 -1.523 . . . . 0.46 109.293 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.7 108.29 2.52 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.044 1.549 . . . . 0.58 110.258 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.17 151.43 23.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.696 -1.362 . . . . 0.64 109.696 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.557 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 6.8 t0 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.95 110.203 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.109 0.481 . . . . 1.03 109.71 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.534 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 5.9 mp 32.08 37.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.079 0.466 . . . . 1.04 111.454 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -121.51 42.6 3.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.77 109.869 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 22.7 t90 -110.63 -65.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.853 . . . . 0.42 110.106 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 31.9 t -102.36 60.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.44 110.267 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.579 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 0.0 OUTLIER -146.26 85.48 1.66 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.935 . . . . 0.49 110.617 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 ttt -119.82 -18.33 8.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.3 110.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 8.7 p30 -157.3 111.88 2.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.15 109.984 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.447 HD13 HD21 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -133.08 -160.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.13 110.466 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -137.91 155.35 49.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.12 110.275 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.856 ' HB3' HG23 ' A' ' 163' ' ' ILE . 13.2 p90 -152.73 -167.6 2.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.247 -0.908 . . . . 0.33 110.857 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.412 ' N ' ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.36 155.94 47.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.54 110.662 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.852 ' O ' HG13 ' A' ' 123' ' ' VAL . 5.6 pt -112.67 115.75 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.805 . . . . 0.33 110.698 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 122' ' ' ILE . 1.1 m -165.72 42.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.201 -0.937 . . . . 0.27 110.301 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 125' ' ' TYR . 2.5 t-20 -42.28 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.41 109.742 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.729 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.8 t80 -179.32 -155.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -0.795 . . . . 0.4 109.497 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.558 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -161.26 51.47 0.36 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.45 110.583 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -78.14 -85.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.906 1.477 . . . . 0.36 109.963 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.93 -2.09 56.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.25 109.638 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.914 ' SD ' HD21 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -121.06 160.75 22.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.39 110.137 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.14 -175.05 2.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.875 . . . . 0.48 110.211 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -48.46 -37.49 17.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.4 109.978 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t -60.47 -50.08 75.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.46 109.845 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 7.7 mp0 -64.88 -63.64 1.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.194 -0.941 . . . . 0.47 109.92 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 125' ' ' TYR . 16.3 t -42.96 -37.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.694 -0.854 . . . . 0.31 108.694 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 6.5 mt-10 -59.24 -43.23 92.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.387 -0.968 . . . . 0.48 108.387 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.563 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.5 tttp -70.33 -47.34 61.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.416 -0.957 . . . . 0.64 108.416 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.819 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -45.79 -60.71 2.07 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.31 -0.868 . . . . 0.42 110.101 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.709 ' CE2' HD12 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -66.96 -52.31 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.34 110.897 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 4.1 tttt -66.58 -73.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.84 -1.162 . . . . 0.47 110.124 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.71 -60.8 0.79 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.754 -0.592 . . . . 0.47 110.779 179.006 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.28 -38.93 13.42 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.54 -1.264 . . . . 0.25 108.341 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -70.08 -33.66 72.19 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.611 -0.836 . . . . 0.35 108.976 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -56.31 -41.55 76.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.931 -1.137 . . . . 0.7 107.931 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 12.6 t -66.05 -41.73 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.578 -0.897 . . . . 0.61 108.578 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.589 ' CH2' HG13 ' A' ' 262' ' ' ILE . 27.9 t-105 -56.88 -39.21 73.94 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.818 -0.808 . . . . 0.39 108.818 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 149' ' ' THR . 69.1 m -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.427 -0.796 . . . . 0.35 108.854 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -54.89 -37.51 66.39 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.586 -0.696 . . . . 0.36 109.359 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 145' ' ' TRP . 26.8 m -84.82 -34.86 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.5 110.195 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.577 ' OG1' HD13 ' A' ' 151' ' ' LEU . 14.4 t -152.12 131.63 6.87 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.51 110.264 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.41 59.05 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.965 1.508 . . . . 0.31 110.808 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.009 HD21 ' CG ' ' A' ' 266' ' ' TYR . 3.6 mp -76.88 169.09 18.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.18 110.014 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -114.64 116.42 28.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.17 110.568 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.4 p90 -126.33 125.78 42.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.14 109.723 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 119' ' ' THR . 10.7 m -125.72 133.08 52.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.197 -0.94 . . . . 0.15 110.62 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.625 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.31 81.71 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.2 109.877 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.617 ' HG ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -60.43 129.79 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.22 110.49 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -91.79 40.61 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.44 -0.787 . . . . 0.32 109.921 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.607 ' OD2' HD11 ' A' ' 160' ' ' ILE . 3.2 t0 -135.55 -38.95 0.73 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.33 109.52 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 144.2 37.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.661 -1.376 . . . . 0.28 109.661 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.617 HD13 ' HG ' ' A' ' 156' ' ' LEU . 3.1 mp -123.82 69.45 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.3 109.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -144.47 156.29 44.12 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.032 -0.667 . . . . 0.2 110.111 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.5 OUTLIER -121.39 -23.52 5.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.1 110.337 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.856 HG23 ' HB3' ' A' ' 120' ' ' TYR . 1.2 tt -125.49 168.51 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.178 -0.951 . . . . 0.1 110.142 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.851 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 11.9 ptp -177.3 151.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.522 -1.361 . . . . 0.11 111.645 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 165' ' ' ILE . 5.4 tt -97.98 112.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.593 -0.692 . . . . 0.1 110.032 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.76 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.4 p -153.76 149.71 27.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.901 -1.125 . . . . 0.1 110.39 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 8.0 p90 -68.64 127.53 33.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.09 109.758 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.67 120.99 6.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.235 -1.146 . . . . 0.2 110.235 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.743 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.33 102.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.445 -1.032 . . . . 0.55 109.135 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 26.1 tptp 1.07 84.08 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.422 0.629 . . . . 0.85 112.532 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.46 0.76 4.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.71 109.942 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 10.5 m80 -74.01 -81.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.878 . . . . 0.42 110.331 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.97 8.3 7.41 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.194 -1.562 . . . . 0.33 109.194 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.417 ' OD2' ' CE2' ' A' ' 175' ' ' PHE . 3.1 t0 -126.3 -70.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -1.103 . . . . 0.33 110.198 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.461 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 98.3 m-85 -107.25 144.5 33.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.27 110.093 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -63.65 111.07 4.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.34 110.355 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.544 ' O ' HD22 ' A' ' 184' ' ' LEU . 49.7 Cg_endo -78.74 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.976 1.514 . . . . 0.47 110.444 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -94.21 178.59 5.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.35 110.232 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.3 p-10 -180.0 -53.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.923 . . . . 0.2 110.804 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.574 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 146.39 -134.98 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.364 -1.494 . . . . 0.25 109.364 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.11 -1.6 10.78 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 124.053 1.554 . . . . 0.44 109.809 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.443 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -57.02 -177.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.428 -0.795 . . . . 0.57 110.296 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -81.3 76.55 2.15 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.575 -1.01 . . . . 0.49 110.575 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 5.5 tt 179.64 94.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.273 -1.133 . . . . 0.41 110.789 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.668 HD13 ' CE2' ' A' ' 214' ' ' TYR . 8.6 tt -112.13 -18.45 12.57 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.554 -1.258 . . . . 0.3 111.109 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.524 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -152.11 109.56 3.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.503 -1.373 . . . . 0.2 111.832 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.502 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 0.6 OUTLIER -121.35 135.59 55.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.16 109.971 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.83 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -123.78 160.8 26.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.096 -1.003 . . . . 0.23 110.454 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.475 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.1 m-30 -99.04 170.23 7.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.38 110.176 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.506 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.8 Cg_endo -71.74 128.3 14.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.562 . . . . 0.4 109.745 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.485 ' HA ' ' HA3' ' A' ' 196' ' ' GLY . 42.9 Cg_endo -69.05 68.3 1.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.873 1.459 . . . . 0.32 110.62 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.98 -83.67 1.2 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.267 -1.533 . . . . 0.32 109.267 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 -159.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.559 . . . . 0.47 110.042 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.12 0.52 27.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.63 110.34 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.74 40.84 2.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.319 -0.863 . . . . 0.53 110.326 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -108.63 -179.3 21.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.961 -1.656 . . . . 0.25 108.961 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 163' ' ' ILE . . . 38.91 27.13 0.05 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.213 -1.155 . . . . 0.1 110.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 196' ' ' GLY . 0.8 OUTLIER -77.59 88.23 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.331 . . . . 0.1 109.25 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.851 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.72 90.24 1.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.09 110.74 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.504 ' HA ' ' O ' ' A' ' 166' ' ' SER . 12.8 m170 -100.86 120.83 40.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.09 109.909 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 203' ' ' ASP . 20.2 m-85 -89.6 135.24 33.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.156 -0.965 . . . . 0.1 110.722 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 58.8 t0 -44.2 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.857 -0.794 . . . . 0.14 108.857 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.9 p30 -41.76 -31.64 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.18 111.49 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.574 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 17.1 t0 -71.15 -5.54 32.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.558 -1.338 . . . . 0.24 110.329 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 16.6 mm-40 -93.73 -164.71 1.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.088 . . . . 0.42 109.878 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.559 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 33.3 m -127.37 159.08 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.128 . . . . 0.47 110.769 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.592 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.2 m-90 -150.12 142.8 24.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.27 109.555 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.993 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -153.93 173.65 15.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.853 -1.154 . . . . 0.3 110.795 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.8 t -128.21 29.79 5.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.781 0.8 . . . . 0.61 108.945 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 -72.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.504 0.669 . . . . 0.78 110.108 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.132 -0.692 . . . . 0.91 109.132 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.43 133.17 33.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.548 -0.72 . . . . 0.93 109.553 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.18 -171.54 38.81 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.109 -1.596 . . . . 0.79 109.109 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.668 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.1 m-85 -75.66 113.54 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.69 109.999 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.567 ' O ' HG12 ' A' ' 219' ' ' VAL . 34.5 m-80 -79.87 121.97 26.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.054 -1.028 . . . . 0.4 108.627 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.993 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -40.56 -38.01 0.8 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.329 -0.857 . . . . 0.17 110.504 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 3.3 m-85 -52.97 -48.33 67.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.529 -1.268 . . . . 0.28 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' A' ' 244' ' ' TYR . 40.9 tp -72.06 -71.36 0.28 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.978 -0.556 . . . . 0.46 110.185 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.869 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -51.32 -70.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.156 -0.965 . . . . 0.39 110.144 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -42.22 -50.21 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.876 -1.14 . . . . 0.17 111.565 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -60.86 -34.7 75.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.309 -1.494 . . . . 0.1 108.924 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.769 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 17.4 t-80 -69.33 -50.83 42.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.465 0.65 . . . . 0.21 109.792 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.807 ' OE2' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -60.9 -44.09 97.62 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.28 109.181 178.839 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.519 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 7.4 m-85 -55.08 -62.02 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.18 108.926 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.448 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.62 -32.03 1.9 Allowed Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.804 -1.718 . . . . 0.21 108.804 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.578 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.41 -71.96 0.43 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -1.174 . . . . 0.17 111.068 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.83 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.05 -44.19 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.33 112.006 -178.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.695 HD22 ' OH ' ' A' ' 266' ' ' TYR . 0.8 OUTLIER -100.37 -37.41 8.87 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.784 -1.197 . . . . 0.53 111.328 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -67.66 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.173 -1.171 . . . . 0.41 110.173 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 230' ' ' LEU . 0.8 OUTLIER -169.21 -172.62 1.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.45 110.936 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 1.9 m-20 -53.05 -58.04 8.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.62 110.172 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.578 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -163.67 179.63 7.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.45 111.017 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.515 ' N ' ' SD ' ' A' ' 240' ' ' MET . 1.8 t 179.53 54.35 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.083 -0.71 . . . . 0.38 109.083 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.31 23.89 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.48 111.351 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -38.72 -47.01 3.35 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.36 -0.936 . . . . 0.38 109.346 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 43.0 Cg_endo -92.1 -47.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.029 1.542 . . . . 0.28 110.968 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.83 100.9 0.14 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.725 -1.703 . . . . 0.24 112.506 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.961 ' HB2' ' HB2' ' A' ' 257' ' ' ASP . . . -148.08 160.92 42.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.317 -1.108 . . . . 0.28 109.998 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.569 HD21 ' C ' ' A' ' 221' ' ' ALA . 1.0 OUTLIER -69.31 62.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.076 0.941 . . . . 0.4 108.596 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.769 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.7 mtt -146.56 -33.98 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.59 -0.694 . . . . 0.45 110.758 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -44.13 168.5 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.57 110.325 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.4 Cg_endo -72.66 -12.51 26.77 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.879 1.463 . . . . 0.76 109.817 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.659 HG12 HG22 ' A' ' 245' ' ' THR . 5.9 tt -98.25 151.09 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.89 109.695 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.779 ' HB2' HD21 ' A' ' 218' ' ' LEU . 32.6 p90 -131.89 -28.28 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.78 111.038 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.748 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.45 -69.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 113.196 0.813 . . . . 0.61 113.196 -179.009 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.748 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -67.96 104.25 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.547 -1.346 . . . . 0.74 109.554 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.647 ' HA ' HD22 ' A' ' 218' ' ' LEU . 26.5 p -56.08 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.81 110.352 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.4 -7.15 57.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.56 109.495 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -149.21 27.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -1.16 . . . . 0.37 110.174 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -68.21 -13.93 62.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.44 110.339 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.0 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.53 110.326 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -167.54 178.39 5.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.38 110.501 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.938 ' HB2' HG21 ' A' ' 259' ' ' VAL . 4.7 ptp -68.23 53.98 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.393 -0.817 . . . . 0.19 110.61 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.708 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -43.97 -48.34 22.22 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.131 -1.063 . . . . 0.28 108.131 177.655 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.708 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -72.49 48.05 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 124.125 1.592 . . . . 0.49 111.251 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.632 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.3 m-20 -52.77 -30.86 35.22 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.763 -1.211 . . . . 0.49 109.761 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.961 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 3.1 m-20 -50.47 -45.59 56.34 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.589 -0.844 . . . . 0.31 109.57 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.955 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -80.18 -32.31 38.71 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.379 -0.971 . . . . 0.14 108.379 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.938 HG21 ' HB2' ' A' ' 253' ' ' MET . 83.6 t -60.35 -73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.17 110.072 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.719 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 6.2 pt20 -72.52 -31.35 65.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.331 -0.855 . . . . 0.26 110.094 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -47.73 -57.79 7.33 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.092 -1.603 . . . . 0.19 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -83.5 -21.71 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -1.228 . . . . 0.22 110.674 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.79 ' N ' HD13 ' A' ' 262' ' ' ILE . 29.6 tt0 -64.47 -20.01 65.92 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.493 -1.379 . . . . 0.39 108.348 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 264' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 260' ' ' GLN . 2.8 p -103.68 -38.98 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.152 -0.619 . . . . 0.47 111.354 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.9 mp -90.88 -44.57 9.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.103 -0.998 . . . . 0.48 111.343 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 1.009 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -72.92 -10.91 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.41 110.057 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -60.75 -92.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.461 . . . . 0.46 109.446 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 117.03 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.58 110.332 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.06 123.72 7.88 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.446 -1.462 . . . . 0.64 109.446 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.579 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.95 109.93 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.539 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.403 0.62 . . . . 1.03 109.944 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.2 OUTLIER 33.15 53.76 0.41 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.909 -0.494 . . . . 1.04 111.881 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.779 ' HD2' HD13 ' A' ' 265' ' ' LEU . 17.4 pttt -140.75 78.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.77 109.688 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.584 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 11.6 t90 -142.27 -71.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.42 111.017 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 95.4 p -101.13 60.67 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.44 110.489 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 114' ' ' SER . 30.3 mttp -148.72 78.72 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.49 110.183 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.582 ' O ' HD13 ' A' ' 151' ' ' LEU . 12.6 ttt -105.71 -13.01 15.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 0.3 109.956 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.483 ' OD1' ' HB3' ' A' ' 152' ' ' ASN . 6.4 t30 -151.86 124.64 8.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.15 109.993 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 118' ' ' LEU . 3.2 tp -145.99 -170.2 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.13 110.258 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -122.05 158.05 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.12 110.161 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.756 ' CB ' HG23 ' A' ' 163' ' ' ILE . 37.0 p90 -151.06 169.2 22.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.367 -0.833 . . . . 0.33 110.704 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -120.87 147.1 45.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -0.816 . . . . 0.54 109.776 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.7 pp -112.87 120.45 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.116 -0.99 . . . . 0.33 110.997 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.919 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.0 OUTLIER -164.77 49.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.838 . . . . 0.27 109.416 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.706 ' ND2' HD13 ' A' ' 165' ' ' ILE . 1.4 m120 -39.67 -84.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.696 -0.627 . . . . 0.41 109.843 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.571 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.8 t80 179.89 -168.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.4 109.089 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.608 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -138.61 42.71 0.6 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.707 -1.246 . . . . 0.45 111.705 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -76.96 -83.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.484 1.255 . . . . 0.36 110.506 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.9 m-20 -107.83 -0.9 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.25 110.053 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.586 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -126.39 89.95 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.39 109.778 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.465 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -48.21 -179.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.48 110.939 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -48.49 -39.27 22.54 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.4 110.032 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -53.68 -61.2 2.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.46 109.615 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.586 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 31.6 mp0 -54.01 -54.49 38.38 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.565 -0.854 . . . . 0.47 109.43 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' ' 124' ' ' ASN . 53.2 t -45.76 -34.41 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 132' ' ' SER . 0.7 OUTLIER -61.38 -43.21 99.25 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.776 -1.194 . . . . 0.48 107.776 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 1.4 tttp -70.34 -56.98 5.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.64 108.337 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.861 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -43.75 -69.94 0.12 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.186 -0.946 . . . . 0.42 110.189 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.724 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -52.81 -59.46 4.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.34 110.945 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 5.1 tmtt? -65.56 -74.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.978 -1.076 . . . . 0.47 110.893 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.8 OUTLIER -38.24 -62.39 0.58 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.679 -0.638 . . . . 0.47 110.669 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -45.89 -38.15 7.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.798 -1.161 . . . . 0.25 108.386 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -70.42 -34.87 73.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.362 -0.836 . . . . 0.35 108.892 178.301 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 10.6 ttmm -58.51 -42.4 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.7 108.961 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 13.5 t -67.86 -46.72 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.535 -0.728 . . . . 0.61 109.094 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.627 ' HH2' HG21 ' A' ' 262' ' ' ILE . 13.3 t-105 -53.55 -41.66 66.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.777 . . . . 0.39 108.967 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 149' ' ' THR . 14.5 m -71.76 -37.15 70.54 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.412 -0.805 . . . . 0.35 109.02 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -53.66 -41.61 66.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.595 -0.691 . . . . 0.36 109.549 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.805 HG23 HG22 ' A' ' 149' ' ' THR . 29.4 m -79.63 -30.81 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.5 110.071 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.815 ' OG1' HD23 ' A' ' 151' ' ' LEU . 3.6 t -144.22 127.33 8.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.51 110.339 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 59.76 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.748 1.394 . . . . 0.31 110.745 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.008 HD21 ' O ' ' A' ' 266' ' ' TYR . 1.4 mm? -88.72 156.01 19.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.18 110.158 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.483 ' HB3' ' OD1' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -103.38 146.35 28.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.17 110.381 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.9 p90 -152.49 138.6 18.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.868 . . . . 0.14 110.384 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.906 ' O ' HG22 ' A' ' 119' ' ' THR . 4.2 m -143.02 135.4 27.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.15 110.261 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.587 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -93.61 89.03 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.978 -1.076 . . . . 0.2 110.024 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -62.97 100.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.22 110.371 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 157' ' ' HIS . 53.6 p-80 -67.14 57.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.331 -0.856 . . . . 0.32 110.357 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 156' ' ' LEU . 10.9 t0 -154.31 -51.53 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.33 109.904 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.41 35.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.037 -1.225 . . . . 0.28 110.037 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.547 ' HB ' ' CB ' ' A' ' 156' ' ' LEU . 72.1 mt -128.83 65.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -1.18 . . . . 0.3 109.289 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -126.01 150.16 48.29 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.2 -0.6 . . . . 0.2 110.568 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' GLY . 1.2 m-20 -113.27 -34.22 5.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.356 -0.84 . . . . 0.1 109.883 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.756 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -126.03 170.38 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.1 110.155 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.729 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.5 ptm -168.93 139.12 2.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.891 -1.131 . . . . 0.11 110.95 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.706 HD13 ' ND2' ' A' ' 124' ' ' ASN . 4.2 tt -96.88 115.44 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.401 -0.812 . . . . 0.1 109.29 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.919 ' HB3' HG23 ' A' ' 123' ' ' VAL . 14.2 p -160.07 148.48 17.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.511 -1.368 . . . . 0.1 111.065 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.622 ' CE2' HG21 ' A' ' 169' ' ' ILE . 2.0 p90 -64.55 114.75 4.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.09 109.354 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.511 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -72.52 148.42 42.01 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.441 -1.464 . . . . 0.2 109.441 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.622 HG21 ' CE2' ' A' ' 167' ' ' PHE . 10.3 pt -141.41 97.46 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.752 -0.852 . . . . 0.55 109.853 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.64 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.07 78.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.277 0.561 . . . . 0.85 112.127 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -121.1 -5.57 9.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.71 110.266 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 172' ' ' HIS . 19.9 m-70 -82.19 -150.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.42 110.011 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.97 30.31 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.704 -1.358 . . . . 0.33 109.704 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 175' ' ' PHE . 2.9 p30 -127.51 -148.21 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -1.223 . . . . 0.33 110.176 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -49.22 153.35 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.27 110.09 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 9.2 m-30 -80.96 112.23 30.57 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.34 110.314 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.877 ' O ' HD22 ' A' ' 184' ' ' LEU . 45.9 Cg_endo -78.41 -67.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.901 1.474 . . . . 0.47 110.631 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -51.74 149.79 4.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.35 110.714 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.6 p30 -174.21 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.214 -0.994 . . . . 0.2 111.482 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.588 ' N ' ' HB2' ' A' ' 204' ' ' ASP . . . 120.43 -140.32 14.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.178 -1.569 . . . . 0.25 109.178 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.29 53.88 3.13 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 124.103 1.58 . . . . 0.44 109.628 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 0.2 OUTLIER -114.4 -177.41 3.12 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.526 -0.733 . . . . 0.57 110.055 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -72.03 65.18 1.23 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.482 -1.047 . . . . 0.49 110.482 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.877 HD22 ' O ' ' A' ' 177' ' ' PRO . 2.6 tt 179.69 93.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -1.17 . . . . 0.41 110.846 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.853 HD12 ' CD ' ' A' ' 205' ' ' GLU . 4.1 tt -114.48 -13.3 12.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.606 -1.237 . . . . 0.3 111.352 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.32 102.62 2.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.488 -1.382 . . . . 0.2 111.671 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.54 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 2.1 p-80 -117.26 122.77 44.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.16 109.51 178.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 1.041 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -110.52 158.66 18.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.23 110.207 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.9 m-30 -96.0 166.79 13.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.38 110.545 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 46.5 Cg_endo -72.86 136.38 25.13 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.091 1.574 . . . . 0.4 109.742 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 58.98 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.93 1.489 . . . . 0.32 110.611 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -99.18 -94.62 2.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.32 109.464 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.8 -165.89 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.965 1.508 . . . . 0.47 110.38 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -9.07 26.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.63 110.279 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 54.56 0.66 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.42 -0.8 . . . . 0.53 110.226 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -124.08 174.76 16.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.049 -1.621 . . . . 0.25 109.049 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.555 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.14 24.66 0.59 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.716 -1.354 . . . . 0.1 109.716 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 164' ' ' MET . 1.5 m-20 -79.8 87.35 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.068 -1.254 . . . . 0.1 109.96 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -63.73 113.25 3.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.09 110.502 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.415 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 11.4 m170 -121.24 119.07 31.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.325 -0.859 . . . . 0.09 110.602 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.0 m-85 -90.5 141.78 28.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.228 -0.92 . . . . 0.1 110.677 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 24.0 t0 -52.27 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.578 -0.701 . . . . 0.14 109.476 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.561 ' OD1' ' HB2' ' A' ' 178' ' ' PHE . 1.7 p-10 -35.78 -37.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.18 112.059 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.588 ' HB2' ' N ' ' A' ' 180' ' ' GLY . 3.0 m-20 -65.62 -14.1 60.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.725 -1.234 . . . . 0.24 111.175 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.853 ' CD ' HD12 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -93.13 -156.99 0.51 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.716 -1.24 . . . . 0.42 110.325 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.513 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 3.2 m -137.16 161.43 36.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.944 -1.098 . . . . 0.47 111.062 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.514 ' NE1' ' HB3' ' A' ' 201' ' ' PHE . 1.1 m-90 -149.19 149.1 30.44 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.033 -0.728 . . . . 0.27 109.033 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.008 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.76 -174.45 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.804 -1.185 . . . . 0.3 110.708 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -123.36 30.2 6.38 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.893 -0.723 . . . . 0.61 109.822 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -117.21 -172.49 2.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.41 -0.806 . . . . 0.78 110.161 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.488 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.4 OUTLIER -80.88 0.84 33.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.91 110.236 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -113.79 149.67 34.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.158 -0.964 . . . . 0.93 110.184 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 68.46 -173.8 32.53 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.79 109.402 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.834 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -77.16 114.26 15.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.69 110.157 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.622 ' O ' HG12 ' A' ' 219' ' ' VAL . 1.6 m120 -77.45 123.24 26.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.99 -1.069 . . . . 0.4 108.653 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.008 HD22 ' O ' ' A' ' 208' ' ' THR . 0.6 OUTLIER -44.72 -35.18 2.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.787 -1.165 . . . . 0.17 108.691 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.584 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 6.6 m-85 -55.74 -46.42 77.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.968 -1.493 . . . . 0.28 106.968 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 244' ' ' TYR . 21.8 tp -74.19 -74.8 0.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.901 -0.59 . . . . 0.46 110.742 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.732 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -48.19 -61.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.106 -0.996 . . . . 0.39 110.852 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.952 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.6 -51.15 63.93 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.79 -1.194 . . . . 0.17 111.336 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.247 -1.533 . . . . 0.1 108.682 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.628 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.9 t60 -77.08 -51.69 10.61 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.223 0.535 . . . . 0.21 109.647 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.586 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.1 tp10 -59.41 -44.08 92.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.987 -1.071 . . . . 0.28 108.341 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.48 ' CZ ' HD12 ' A' ' 165' ' ' ILE . 7.5 m-30 -53.38 -61.96 1.96 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.734 . . . . 0.18 109.102 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -32.72 2.16 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.925 -1.67 . . . . 0.21 108.925 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.639 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -81.97 -77.99 0.21 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -1.178 . . . . 0.17 111.229 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' SER . . . . . 1.041 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.73 -39.84 0.16 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.558 -0.714 . . . . 0.33 111.937 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.477 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 3.0 tp -96.41 -39.45 9.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.968 -1.082 . . . . 0.53 110.667 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -74.73 -91.09 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.099 -1.201 . . . . 0.41 110.099 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.773 HD22 ' C ' ' A' ' 230' ' ' LEU . 0.0 OUTLIER -175.93 170.44 2.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -1.118 . . . . 0.45 111.17 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.572 ' N ' HD22 ' A' ' 230' ' ' LEU . 7.2 t70 -25.7 -70.82 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 120.992 0.425 . . . . 0.62 112.024 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.728 ' O ' HD21 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -162.12 -179.83 7.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.01 -1.056 . . . . 0.45 111.176 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.3 OUTLIER 179.46 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.467 0.651 . . . . 0.38 109.401 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.686 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -101.76 23.09 11.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.534 -0.729 . . . . 0.48 111.472 -179.197 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.613 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -37.3 -66.71 0.27 Allowed Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.81 -0.756 . . . . 0.38 110.381 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 55.0 Cg_endo -76.87 -47.28 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.292 1.154 . . . . 0.28 110.578 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.79 101.17 0.14 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.981 -1.58 . . . . 0.24 111.936 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 257' ' ' ASP . . . -144.57 160.25 41.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -1.058 . . . . 0.28 110.207 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.628 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -75.2 64.98 1.5 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.23 1.015 . . . . 0.4 108.747 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.614 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.1 mtp -141.64 -37.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.805 . . . . 0.45 110.011 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -47.99 170.25 0.11 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.57 109.795 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.0 Cg_endo -70.69 -2.64 11.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.582 1.306 . . . . 0.76 110.512 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.548 HG22 HG22 ' A' ' 245' ' ' THR . 4.3 mt -98.64 145.12 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.89 110.054 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.644 ' HB2' HD21 ' A' ' 218' ' ' LEU . 46.9 p90 -134.65 -33.62 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.78 110.486 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 3.15 -68.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.646 0.98 . . . . 0.61 113.646 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.692 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -54.0 107.79 0.3 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.355 -1.466 . . . . 0.74 109.854 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.613 HG23 ' OD1' ' A' ' 215' ' ' ASN . 53.3 m -58.38 172.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.81 110.363 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 247' ' ' THR . . . -43.15 -40.76 4.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.899 -1.28 . . . . 0.56 109.899 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 46.74 1.64 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.254 . . . . 0.37 110.638 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 1.2 t -89.29 1.93 55.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.44 110.093 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.86 -69.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.53 110.238 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.2 OUTLIER 179.75 178.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.38 110.47 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.909 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -69.04 56.16 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.768 . . . . 0.19 109.853 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.69 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.79 -46.12 50.44 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 108.0 -1.111 . . . . 0.28 108.0 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -73.89 49.69 1.95 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.94 1.495 . . . . 0.49 111.499 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.581 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.3 m-20 -48.82 -34.11 11.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.49 110.689 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -54.69 -53.28 56.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.615 -1.234 . . . . 0.31 108.79 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.947 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.22 -36.43 84.13 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.498 -0.881 . . . . 0.14 108.819 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 253' ' ' MET . 78.3 t -64.73 -84.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.17 110.753 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 11.0 tt0 -54.68 -43.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.045 . . . . 0.26 109.395 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.0 -70.12 0.39 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.518 -1.033 . . . . 0.19 110.518 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.947 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -71.25 -24.93 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.594 -1.533 . . . . 0.22 110.005 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.814 ' N ' HD13 ' A' ' 262' ' ' ILE . 5.4 tt0 -57.33 -23.36 48.25 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.998 -1.081 . . . . 0.39 108.554 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 -43.49 5.48 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.155 -0.618 . . . . 0.47 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.779 HD13 ' HD2' ' A' ' 112' ' ' LYS . 7.0 mt -73.92 -53.45 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.812 . . . . 0.48 110.876 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 1.008 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -75.37 -8.48 56.8 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.251 -0.905 . . . . 0.41 109.837 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.43 -106.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.097 -1.601 . . . . 0.46 109.097 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.81 115.42 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.878 1.462 . . . . 0.58 109.999 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.08 143.13 18.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.66 -1.376 . . . . 0.64 109.66 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.584 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.95 110.064 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.374 0.607 . . . . 1.03 109.41 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.512 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.64 48.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.783 -0.573 . . . . 1.04 111.363 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -138.72 78.83 1.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.997 . . . . 0.77 109.61 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.606 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 6.4 t90 -151.15 -67.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.893 . . . . 0.42 111.176 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 35.9 t -87.79 40.68 0.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.44 110.86 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.823 ' HD3' HD11 ' A' ' 118' ' ' LEU . 13.1 mmtt -143.31 83.69 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.49 110.807 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.1 ttp -100.26 -21.03 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.974 . . . . 0.3 109.391 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.411 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 1.7 p-10 -138.52 137.83 37.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.15 109.455 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -151.07 167.56 27.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 0.13 110.824 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -110.17 168.45 9.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.12 109.604 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.663 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 8.5 p90 -167.32 176.13 6.88 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.934 -1.107 . . . . 0.33 111.486 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 6.2 tpt85 -123.38 152.73 41.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.698 -0.626 . . . . 0.54 109.38 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.815 HG21 ' CD1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -121.32 95.05 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.084 -1.01 . . . . 0.33 111.16 -179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.989 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.5 m -141.53 50.33 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.134 -0.979 . . . . 0.27 110.257 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.707 ' OD1' HD21 ' A' ' 216' ' ' LEU . 1.8 t-20 -43.33 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.41 109.404 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 30.6 t80 179.89 175.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.4 110.127 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -118.97 59.28 4.24 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.45 109.964 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 125' ' ' TYR . 44.8 Cg_endo -70.73 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.109 1.584 . . . . 0.36 110.567 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.19 4.39 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.25 109.795 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.605 ' SD ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -115.41 139.9 49.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.518 -0.739 . . . . 0.39 109.83 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -78.53 167.52 21.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.48 110.378 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 130' ' ' THR . 22.3 t-80 -43.28 -39.21 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.4 109.751 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 8.4 t -59.32 -49.36 78.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.46 109.709 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.566 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.5 OUTLIER -58.25 -57.62 12.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.33 -0.857 . . . . 0.47 109.337 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.6 t -46.42 -35.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.608 -1.256 . . . . 0.31 107.608 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.611 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -57.79 -42.37 84.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.013 -1.106 . . . . 0.48 108.013 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 7.8 tttt -69.31 -49.66 53.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.197 0.999 . . . . 0.64 108.397 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.85 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -48.12 -61.71 1.84 Allowed 'General case' 0 C--N 1.287 -2.138 0 O-C-N 121.245 -0.91 . . . . 0.42 110.816 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.815 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.34 -52.25 35.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.234 -0.916 . . . . 0.34 111.026 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.631 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.2 -71.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.47 110.397 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -41.99 -57.55 2.39 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.527 -0.733 . . . . 0.47 110.307 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.97 -38.51 17.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.296 -1.362 . . . . 0.25 108.345 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.663 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -71.57 -34.71 70.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.308 -0.87 . . . . 0.35 108.994 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.421 ' CD ' ' C ' ' A' ' 143' ' ' LYS . 0.1 OUTLIER -60.63 -41.25 94.52 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.797 -0.816 . . . . 0.7 108.797 179.044 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.99 -49.96 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.661 -0.866 . . . . 0.61 108.661 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.68 ' HH2' HG21 ' A' ' 262' ' ' ILE . 29.4 t-105 -52.43 -36.24 53.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.682 -0.859 . . . . 0.39 108.682 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 149' ' ' THR . 57.8 m -75.24 -35.39 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.475 -0.766 . . . . 0.35 109.095 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.68 -40.15 78.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.429 -0.794 . . . . 0.36 109.375 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.48 HG23 HG22 ' A' ' 149' ' ' THR . 20.0 m -80.37 -31.23 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.777 -0.769 . . . . 0.5 110.119 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.696 ' CG2' HD23 ' A' ' 151' ' ' LEU . 12.8 t -150.59 131.9 7.53 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.047 . . . . 0.51 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.14 58.93 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.854 1.45 . . . . 0.31 110.545 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.935 HD21 ' HB3' ' A' ' 266' ' ' TYR . 2.1 mm? -77.2 134.89 38.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.18 110.284 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.411 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 1.7 m-20 -80.94 130.13 34.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.17 110.123 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.4 p90 -137.15 139.57 41.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.14 110.268 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.708 ' O ' HG22 ' A' ' 119' ' ' THR . 18.2 m -147.06 131.31 17.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.302 -0.874 . . . . 0.15 110.554 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.608 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -98.65 118.23 34.91 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.695 -0.628 . . . . 0.2 109.471 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.43 99.74 7.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.22 110.311 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 158' ' ' ASP . 11.1 p-80 -54.03 -28.77 40.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.32 109.833 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.5 t0 -41.76 -57.21 2.41 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.475 0.655 . . . . 0.33 109.719 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.72 37.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.616 -1.394 . . . . 0.28 109.616 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 160' ' ' ILE . 23.5 mm -128.26 67.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.146 -1.208 . . . . 0.3 109.373 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.8 127.94 52.41 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.78 -0.575 . . . . 0.2 110.356 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.819 ' OD2' HD23 ' A' ' 118' ' ' LEU . 29.5 m-20 -90.0 -45.16 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.1 110.058 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.0 HG22 ' HA3' ' A' ' 197' ' ' GLY . 1.4 pp -127.02 172.84 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.1 109.719 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.759 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 4.3 ptt? -174.39 163.51 3.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.11 111.563 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 165' ' ' ILE . 4.0 tt -106.23 116.25 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.542 -0.724 . . . . 0.1 109.683 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.989 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.8 p -157.12 141.08 16.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.598 -1.314 . . . . 0.1 111.304 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.7 p90 -60.76 121.68 12.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.547 -0.72 . . . . 0.09 109.913 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -90.86 126.86 8.58 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.094 -1.203 . . . . 0.2 110.094 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.2 tt -122.88 97.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.936 . . . . 0.55 109.457 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 7.0 tptt 0.28 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.291 0.567 . . . . 0.85 112.401 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.66 15.18 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.71 110.168 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.412 ' CE1' ' CE1' ' A' ' 200' ' ' HIS . 29.6 m-70 -85.08 -86.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.42 110.302 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.48 41.72 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.422 -1.471 . . . . 0.33 109.422 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.97 -89.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -1.112 . . . . 0.33 110.355 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.48 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 3.5 m-85 -116.66 -171.26 1.98 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.27 110.411 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.573 ' CD1' ' HE2' ' A' ' 170' ' ' LYS . 4.2 m-30 -90.45 109.83 36.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.34 110.176 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.494 ' O ' HD22 ' A' ' 184' ' ' LEU . 42.9 Cg_endo -75.56 -72.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.47 110.536 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CG ' ' OD2' ' A' ' 203' ' ' ASP . 2.1 p90 -64.85 177.61 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.35 109.936 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.8 p-10 179.13 -51.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.164 -0.96 . . . . 0.2 111.022 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 138.29 -136.59 8.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.366 -1.494 . . . . 0.25 109.366 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 180' ' ' GLY . 55.2 Cg_endo -71.64 -5.41 16.99 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 O-C-N 124.15 1.606 . . . . 0.44 109.392 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.474 ' HB2' ' OD2' ' A' ' 179' ' ' ASP . 1.8 m -55.04 -176.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.397 -0.814 . . . . 0.57 109.616 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -82.63 76.34 2.24 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.038 -1.077 . . . . 0.49 110.672 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 184' ' ' LEU . 6.6 tt 179.77 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -1.146 . . . . 0.41 110.841 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 214' ' ' TYR . 9.4 tt -109.43 -15.59 14.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.803 -1.186 . . . . 0.3 111.248 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.55 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -154.28 109.16 3.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.437 -1.414 . . . . 0.2 111.8 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 1.1 p80 -109.77 127.04 54.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.89 -1.131 . . . . 0.16 109.862 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.826 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -104.2 130.98 51.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.459 -0.775 . . . . 0.23 110.359 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -78.53 163.49 61.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.085 -1.009 . . . . 0.38 110.42 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.504 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.2 Cg_endo -72.73 133.43 20.26 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 124.105 1.582 . . . . 0.4 109.933 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.7 Cg_endo -70.55 70.07 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.874 1.46 . . . . 0.32 110.399 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.36 -105.5 2.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.564 -1.414 . . . . 0.32 109.564 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.74 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.916 1.482 . . . . 0.47 110.223 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -63.17 -10.95 17.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.101 -1.0 . . . . 0.63 110.175 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.63 68.79 0.8 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.499 -0.75 . . . . 0.53 110.032 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -151.53 165.33 30.47 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.901 -1.68 . . . . 0.25 108.901 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 1.0 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 58.28 16.18 26.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.066 -1.614 . . . . 0.1 109.066 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -79.24 87.5 4.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -1.113 . . . . 0.1 110.576 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.7 95.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.09 109.59 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.582 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 19.6 m170 -97.08 141.05 30.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.09 110.394 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 5.4 m-30 -108.0 136.84 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.1 110.98 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 59.5 t0 -50.86 86.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.786 -0.82 . . . . 0.14 108.786 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.597 ' OD2' ' CG ' ' A' ' 178' ' ' PHE . 1.3 p30 -39.34 -32.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.18 111.844 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.587 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -78.81 3.0 17.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.645 -1.285 . . . . 0.24 110.715 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 9.1 mm-40 -96.63 -162.83 0.99 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.012 -1.055 . . . . 0.42 110.126 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.92 147.5 48.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.023 -1.048 . . . . 0.47 110.51 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.569 ' CZ2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -138.71 144.94 39.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.27 109.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.27 177.58 10.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.93 -1.106 . . . . 0.3 110.833 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.2 t -128.61 41.19 3.53 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.912 0.863 . . . . 0.61 109.109 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 4.0 t -122.19 -164.79 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.502 -0.749 . . . . 0.78 109.955 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -89.02 14.45 10.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.91 109.889 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -130.28 163.16 27.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.93 110.316 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 58.76 -175.26 2.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.79 109.461 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.621 ' CE2' HD13 ' A' ' 185' ' ' LEU . 63.0 m-85 -74.62 117.76 16.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.69 110.144 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.615 ' O ' HG12 ' A' ' 219' ' ' VAL . 9.3 p30 -87.75 118.66 27.41 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.192 -0.943 . . . . 0.4 108.709 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.956 ' O ' ' HB3' ' A' ' 220' ' ' ALA . 1.6 mp -41.83 -32.72 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.483 -0.76 . . . . 0.17 110.649 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 2.1 m-85 -50.89 -47.64 60.6 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.297 -1.372 . . . . 0.28 107.297 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 244' ' ' TYR . 42.1 tp -82.49 -70.16 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.423 -0.808 . . . . 0.46 110.976 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.948 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.43 -60.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.39 109.753 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.956 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -54.8 -48.69 72.42 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.892 -1.13 . . . . 0.17 110.916 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -58.22 -29.99 66.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.328 -1.483 . . . . 0.1 108.846 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.653 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.4 t60 -74.75 -51.06 15.19 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.746 -0.661 . . . . 0.21 109.523 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.624 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.9 tp10 -61.09 -32.9 72.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.28 109.042 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 225' ' ' GLY . 13.6 m-30 -65.85 -64.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.42 -0.8 . . . . 0.18 108.986 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -28.27 1.19 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.076 -1.61 . . . . 0.21 109.076 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.63 -70.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -1.221 . . . . 0.17 111.657 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.826 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 5.0 p -51.77 -31.17 25.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.33 112.124 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 118' ' ' LEU . 9.8 tp -99.96 -41.83 7.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.89 -1.131 . . . . 0.53 111.157 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.581 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -74.89 -83.93 0.36 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.758 -0.937 . . . . 0.41 110.758 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.712 ' H ' HD23 ' A' ' 230' ' ' LEU . 2.0 pt? -161.13 -157.73 0.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.031 -1.276 . . . . 0.45 110.785 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.522 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -70.74 -50.95 30.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.62 110.36 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.624 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -169.09 176.18 5.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 0.45 110.59 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.71 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.443 -0.785 . . . . 0.38 109.316 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.961 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -138.98 22.22 2.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.48 110.889 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -38.78 -48.47 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.464 -0.772 . . . . 0.38 110.433 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 45.6 Cg_endo -87.36 -48.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.846 1.445 . . . . 0.28 111.372 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.506 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.28 100.43 0.13 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 118.962 -1.589 . . . . 0.24 111.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.961 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -144.89 -161.62 1.33 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -1.143 . . . . 0.28 109.808 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.619 HD11 HD12 ' A' ' 218' ' ' LEU . 0.3 OUTLIER -105.66 49.84 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.341 -0.985 . . . . 0.4 108.341 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.653 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.4 mtt -134.37 -21.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.374 -0.829 . . . . 0.45 111.157 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.625 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -59.07 168.5 1.51 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.793 -1.192 . . . . 0.57 111.035 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.7 Cg_endo -71.23 -8.65 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.684 1.36 . . . . 0.76 109.93 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.672 HG22 HG22 ' A' ' 245' ' ' THR . 17.1 mm -101.06 139.08 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.452 -0.78 . . . . 0.89 109.647 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.72 ' HB2' HD21 ' A' ' 218' ' ' LEU . 48.2 p90 -125.6 -25.56 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.78 110.664 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.743 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER 2.45 -67.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 113.635 0.976 . . . . 0.61 113.635 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.743 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -68.63 117.19 10.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.38 -1.45 . . . . 0.74 109.289 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 250' ' ' SER . 49.3 p -47.13 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.81 110.206 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.79 -21.16 3.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.432 -1.467 . . . . 0.56 109.432 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.434 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 1.1 ptmm? -162.5 49.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.246 . . . . 0.37 110.665 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.488 ' OG ' ' CD1' ' A' ' 246' ' ' TYR . 1.4 m -43.77 -61.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.44 109.856 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.7 OUTLIER -147.37 4.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.53 111.016 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 253' ' ' MET . 92.7 t80 179.98 170.91 1.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.934 -1.104 . . . . 0.38 110.939 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.934 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -90.58 59.89 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.55 -0.719 . . . . 0.19 110.013 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.702 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.7 OUTLIER -44.41 -47.33 25.75 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.979 -1.119 . . . . 0.28 107.979 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.2 Cg_endo -73.34 50.58 1.95 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.143 1.602 . . . . 0.49 110.922 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.656 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.4 m-20 -55.54 -29.15 58.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.072 -1.017 . . . . 0.49 110.633 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.889 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 35.3 m-20 -54.7 -48.95 71.83 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.111 -0.993 . . . . 0.31 109.234 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.949 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.98 -33.31 63.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.57 -0.9 . . . . 0.14 108.57 178.764 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 253' ' ' MET . 72.8 t -62.23 -82.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.811 . . . . 0.17 110.055 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.652 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 21.4 tm0? -59.84 -41.76 92.08 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.345 -0.847 . . . . 0.26 109.665 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.68 ' O ' HD12 ' A' ' 265' ' ' LEU . . . -40.69 -64.87 1.12 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.949 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -80.21 -21.66 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.744 -1.445 . . . . 0.22 110.278 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.867 ' N ' HD13 ' A' ' 262' ' ' ILE . 45.7 tt0 -60.35 -22.67 63.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.788 -1.165 . . . . 0.39 108.158 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 31.2 t -104.09 -41.21 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.268 -0.573 . . . . 0.47 111.092 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 261' ' ' GLY . 0.4 OUTLIER -79.75 -50.2 10.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.48 111.527 -178.562 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.935 ' HB3' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -78.7 -17.09 56.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.41 110.059 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -52.88 -93.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.815 -1.714 . . . . 0.46 108.815 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 128.49 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.017 1.535 . . . . 0.58 110.067 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -101.02 147.7 17.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.583 -1.407 . . . . 0.64 109.583 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.606 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.273 -1.134 . . . . 0.95 110.054 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 6.7 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 1.03 109.967 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.613 HD22 ' HD2' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 45.06 23.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.187 -0.945 . . . . 1.04 111.285 179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 266' ' ' TYR . 28.9 mtpt -123.64 74.45 1.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.051 -1.031 . . . . 0.77 109.598 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.577 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 5.9 t90 -145.44 -67.91 0.3 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.225 -0.922 . . . . 0.42 110.907 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.1 t -97.84 58.52 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.865 . . . . 0.44 110.835 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 114' ' ' SER . 9.5 mttm -160.03 61.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.94 . . . . 0.49 110.43 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 7.3 tmm? -85.05 13.69 5.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.3 110.355 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -171.82 126.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.15 110.278 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.772 HD13 ' OD2' ' A' ' 162' ' ' ASP . 2.8 mt -151.3 -164.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.13 110.177 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' THR . . . . . 1.071 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -128.78 171.38 12.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.12 109.75 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 154' ' ' THR . 36.2 p90 -171.4 -172.97 1.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.09 . . . . 0.33 111.168 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 2.3 mtm-85 -127.98 164.84 21.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.54 110.196 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 138' ' ' PHE . 6.6 pt -128.19 70.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.33 110.365 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.949 HG23 ' HB3' ' A' ' 166' ' ' SER . 4.8 m -120.67 50.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.27 110.793 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.534 ' C ' HD21 ' A' ' 124' ' ' ASN . 0.5 OUTLIER -44.13 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.41 109.267 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.66 ' O ' HG21 ' A' ' 134' ' ' VAL . 7.5 t80 -178.99 174.43 1.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.506 -0.746 . . . . 0.4 109.836 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -128.74 53.78 12.23 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.45 110.425 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 126' ' ' THR . 47.2 Cg_endo -77.14 -86.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.989 1.52 . . . . 0.36 110.609 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.02 -1.38 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.25 110.064 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.644 ' HE3' HD21 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -112.19 150.52 30.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.39 110.111 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -98.03 166.24 11.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.48 110.069 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' THR . 17.2 t-80 -41.3 -32.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.395 -0.816 . . . . 0.4 110.194 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -69.87 -46.32 65.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.46 110.261 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.8 OUTLIER -67.67 -58.11 5.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.083 -1.01 . . . . 0.47 109.528 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.66 HG21 ' O ' ' A' ' 125' ' ' TYR . 13.8 t -45.07 -37.78 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.817 -1.179 . . . . 0.31 107.817 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.9 mt-10 -57.58 -45.95 84.6 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.887 -1.153 . . . . 0.48 107.887 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 3.3 tttt -63.2 -48.94 76.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.798 0.809 . . . . 0.64 109.011 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.821 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.67 -59.02 2.99 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.123 -0.986 . . . . 0.42 110.155 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.624 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -66.71 -54.15 26.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.34 110.568 -179.25 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -64.6 -74.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.099 -1.0 . . . . 0.47 109.942 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.9 tmtt? -37.32 -62.7 0.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 O-C-N 122.07 -0.394 . . . . 0.47 110.886 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.92 -36.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.686 -1.206 . . . . 0.25 108.585 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.83 -28.94 61.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.35 109.111 178.628 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.93 -43.73 97.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.379 -0.971 . . . . 0.7 108.379 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 5.7 t -70.29 -49.66 52.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.649 -0.871 . . . . 0.61 108.649 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.618 ' CH2' HG13 ' A' ' 262' ' ' ILE . 51.3 t-105 -53.54 -31.52 46.74 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.755 -0.831 . . . . 0.39 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 149' ' ' THR . 67.6 m -78.95 -34.25 44.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.235 -1.024 . . . . 0.35 108.235 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.7 OUTLIER -57.9 -37.37 73.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.793 -0.818 . . . . 0.36 108.793 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.84 HG23 HG22 ' A' ' 149' ' ' THR . 27.1 m -80.67 -35.14 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.767 -0.773 . . . . 0.5 109.751 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.84 HG22 HG23 ' A' ' 148' ' ' VAL . 4.6 t -147.83 127.6 6.56 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.994 . . . . 0.51 110.389 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 54.25 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.803 1.422 . . . . 0.31 110.601 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.575 HD21 ' CG ' ' A' ' 266' ' ' TYR . 4.1 tp -73.85 147.79 42.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.18 110.318 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.9 OUTLIER -88.22 117.62 27.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.93 . . . . 0.17 110.204 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.0 p90 -125.12 119.75 29.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.14 110.297 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 155' ' ' ARG . 23.0 m -120.45 170.75 9.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.15 110.256 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 154' ' ' THR . 2.3 ptt180 -156.64 114.52 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.902 -0.719 . . . . 0.2 110.481 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 110.67 14.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.22 109.995 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 158' ' ' ASP . 23.9 p-80 -51.86 -23.63 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.32 109.954 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.523 ' OD2' ' CD1' ' A' ' 160' ' ' ILE . 1.1 t70 -44.24 -26.16 0.29 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.39 -0.819 . . . . 0.33 109.666 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.72 28.9 1.01 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.543 -1.423 . . . . 0.28 109.543 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 1.071 HG22 HG21 ' A' ' 119' ' ' THR . 7.2 mt -115.3 81.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.2 -1.176 . . . . 0.3 108.483 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -144.81 123.68 12.7 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.068 -0.653 . . . . 0.2 110.828 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.772 ' OD2' HD13 ' A' ' 118' ' ' LEU . 39.4 t0 -92.29 -51.61 5.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.1 109.697 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.628 HG22 ' HA3' ' A' ' 197' ' ' GLY . 1.1 pt -115.82 179.43 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.307 -0.87 . . . . 0.1 109.05 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.811 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.2 ptp -177.82 151.6 0.71 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 0.11 111.618 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.568 ' HB ' ' CE2' ' A' ' 224' ' ' PHE . 3.6 tt -93.98 117.6 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.1 109.374 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.949 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.1 p -159.31 150.57 20.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.74 -1.225 . . . . 0.1 110.587 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 169' ' ' ILE . 6.7 p90 -72.94 117.74 15.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.499 -0.751 . . . . 0.09 110.168 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -67.75 118.82 10.18 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.051 -1.22 . . . . 0.2 110.051 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 169' ' ' ILE . 19.7 tt -118.5 101.08 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.88 -0.776 . . . . 0.55 109.422 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.9 OUTLIER 1.93 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.331 0.586 . . . . 0.85 112.488 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.22 -0.04 3.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.71 110.088 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 17.3 m-70 -91.36 -154.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.42 110.191 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -159.08 31.61 0.45 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.467 . . . . 0.33 109.434 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -131.47 -52.84 1.01 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -1.155 . . . . 0.33 110.125 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -136.87 175.98 9.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.27 110.231 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -95.09 110.15 48.49 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.34 110.255 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.534 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.2 Cg_endo -73.38 -37.96 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.984 1.518 . . . . 0.47 110.592 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 4.4 p90 -109.73 170.19 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.35 110.734 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.509 ' OD2' HD23 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -179.77 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.2 111.142 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.588 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 159.2 -141.66 7.73 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.561 -1.415 . . . . 0.25 109.561 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.65 -3.82 13.83 Favored 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.236 1.65 . . . . 0.44 109.875 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.86 177.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.463 -0.773 . . . . 0.57 110.019 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -74.97 79.77 0.98 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.234 -1.146 . . . . 0.49 110.234 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.601 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 15.1 tp 179.82 91.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -1.12 . . . . 0.41 110.888 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.705 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.0 tt -113.83 -17.38 12.06 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.461 -1.296 . . . . 0.3 111.293 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -152.14 104.55 2.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.555 -1.341 . . . . 0.2 111.864 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 0.4 OUTLIER -109.41 121.0 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.16 109.77 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -110.83 136.01 50.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.23 110.413 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.698 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.8 m-30 -85.57 159.36 55.72 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.38 110.216 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.52 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 43.8 Cg_endo -70.88 140.28 38.14 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.145 1.603 . . . . 0.4 109.588 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.613 ' HD2' HD22 ' A' ' 111' ' ' LEU . 42.0 Cg_endo -68.75 82.0 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.015 1.534 . . . . 0.32 110.836 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.61 -91.23 1.12 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.17 -1.572 . . . . 0.32 109.17 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.28 -158.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.074 1.565 . . . . 0.47 109.981 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -82.51 12.26 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 0.63 110.323 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -117.78 -3.34 11.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.249 -0.907 . . . . 0.53 109.982 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -68.54 171.31 37.52 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.331 -1.508 . . . . 0.25 109.331 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.628 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 48.22 21.76 2.0 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.775 -1.33 . . . . 0.1 109.775 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 195' ' ' TYR . 0.4 OUTLIER -81.71 85.55 6.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.317 . . . . 0.1 110.096 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.811 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.17 101.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.09 110.033 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.572 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -112.53 120.88 43.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.837 . . . . 0.09 110.461 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 203' ' ' ASP . 22.6 m-85 -90.67 144.37 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.1 110.477 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 15.1 t0 -52.84 85.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.593 -0.892 . . . . 0.14 108.593 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.567 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.8 p30 -38.19 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.18 111.799 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.588 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -75.68 -0.65 21.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.792 -1.193 . . . . 0.24 110.929 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.65 ' HG2' HD12 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -101.98 -156.14 0.55 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 0.42 110.218 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 17.5 m -133.98 156.4 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 0.47 110.768 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -151.65 150.64 30.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.27 109.272 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.003 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -161.05 173.18 15.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.726 -1.234 . . . . 0.3 111.038 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.0 OUTLIER -129.84 25.35 5.31 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.716 0.769 . . . . 0.61 108.993 178.62 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.34 -67.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.463 0.649 . . . . 0.78 110.525 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.75 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.488 -0.757 . . . . 0.91 109.724 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.99 -178.99 4.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.369 -0.832 . . . . 0.93 110.063 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.05 -174.7 0.17 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.539 -1.424 . . . . 0.79 109.539 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.705 ' CE1' HD13 ' A' ' 185' ' ' LEU . 93.9 m-85 -67.36 120.13 13.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -1.109 . . . . 0.69 109.814 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.611 ' O ' HG12 ' A' ' 219' ' ' VAL . 40.6 m-80 -88.17 119.5 28.63 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.974 -1.079 . . . . 0.4 108.8 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.003 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.84 -36.24 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -0.863 . . . . 0.17 110.236 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.612 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 4.6 m-85 -51.58 -44.11 62.67 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.407 -1.317 . . . . 0.28 107.746 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 244' ' ' TYR . 12.3 tp -83.65 -71.29 0.51 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.894 -0.594 . . . . 0.46 111.106 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.837 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.4 p -46.31 -56.11 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.986 -1.071 . . . . 0.39 109.817 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.95 -48.92 79.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.101 -0.999 . . . . 0.17 110.873 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -57.36 -24.92 58.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.234 -1.541 . . . . 0.1 108.556 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.843 ' HB2' HD21 ' A' ' 239' ' ' LEU . 6.5 t-80 -79.64 -54.89 5.44 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.95 -0.568 . . . . 0.21 109.872 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.612 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.3 tp10 -59.51 -50.94 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.979 -1.076 . . . . 0.28 109.092 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.568 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 1.9 m-85 -52.82 -57.99 8.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.18 109.163 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.02 -32.58 4.84 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.251 -1.539 . . . . 0.21 109.251 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.438 ' NE2' ' ND1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.0 -72.14 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.09 -1.241 . . . . 0.17 111.001 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.933 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -38.05 -42.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.33 111.9 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.604 ' HB2' HD13 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -95.95 -38.49 10.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.878 -1.139 . . . . 0.53 111.335 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.538 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -75.13 -87.09 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.653 -0.979 . . . . 0.41 110.653 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.811 HD11 ' O ' ' A' ' 232' ' ' HIS . 0.3 OUTLIER -158.69 -167.72 2.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -1.194 . . . . 0.45 110.855 -178.766 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.514 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -64.41 -55.43 21.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.62 109.75 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.811 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -157.38 179.98 8.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.264 -0.898 . . . . 0.45 110.62 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 14.2 t 179.24 50.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.38 109.381 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.739 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -131.06 21.56 4.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.48 111.13 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.586 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -37.44 -52.86 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.38 110.708 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.2 Cg_endo -90.12 -46.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.52 1.274 . . . . 0.28 110.873 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.01 96.11 0.1 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.295 -1.431 . . . . 0.24 111.419 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.856 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.37 165.95 26.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.347 -1.09 . . . . 0.28 110.133 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.901 ' O ' HD23 ' A' ' 239' ' ' LEU . 7.0 tt -74.46 55.7 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.4 109.736 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.77 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.6 mmm -133.7 -34.72 1.01 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.004 -1.06 . . . . 0.45 110.32 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -42.99 168.51 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 0.57 110.464 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.9 Cg_endo -72.89 -2.43 11.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.89 1.468 . . . . 0.76 110.024 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 245' ' ' THR . 26.1 mm -106.89 149.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.89 110.04 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 218' ' ' LEU . 26.4 p90 -134.51 -28.3 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.78 110.922 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.93 -69.52 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.495 0.924 . . . . 0.61 113.495 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -55.17 104.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.309 -1.495 . . . . 0.74 109.628 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.545 HG23 ' ND2' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -52.52 -177.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.81 110.201 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 247' ' ' THR . . . -67.58 -8.31 51.31 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.317 -1.513 . . . . 0.56 109.317 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 29.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.37 110.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 247' ' ' THR . 0.9 OUTLIER -82.35 -10.62 59.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.056 -1.028 . . . . 0.44 109.746 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.555 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -156.92 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.53 109.785 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER 179.22 -172.27 0.15 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.38 110.407 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.886 ' HB2' HG21 ' A' ' 259' ' ' VAL . 19.7 ptt? -66.31 53.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.19 110.825 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.715 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.6 OUTLIER -46.22 -47.39 45.06 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 107.933 -1.136 . . . . 0.28 107.933 177.271 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.715 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -72.92 50.32 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 124.076 1.567 . . . . 0.49 111.309 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.0 m-20 -48.51 -32.48 7.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.945 -1.097 . . . . 0.49 110.6 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.856 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -53.89 -53.54 51.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.887 -1.125 . . . . 0.31 109.233 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.074 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -67.46 -32.86 73.99 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.021 -1.05 . . . . 0.14 108.915 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.886 HG21 ' HB2' ' A' ' 253' ' ' MET . 59.2 t -66.54 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.17 110.398 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.605 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 8.7 tt0 -53.9 -41.97 68.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.26 109.231 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.69 -71.66 0.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.091 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -71.54 -19.48 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.707 -1.466 . . . . 0.22 110.073 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 1.091 ' N ' HD13 ' A' ' 262' ' ' ILE . 40.3 tt0 -59.6 -26.44 65.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.543 -1.28 . . . . 0.39 107.543 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.7 t -104.59 -42.47 5.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.411 0.624 . . . . 0.47 110.887 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 262' ' ' ILE . 26.5 mt -69.15 -55.02 11.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.48 111.223 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.575 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -81.33 -6.84 59.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.41 110.032 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.29 -108.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.129 -1.588 . . . . 0.46 109.129 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.74 76.84 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.733 1.386 . . . . 0.58 110.325 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -48.19 161.04 0.51 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.64 109.554 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.577 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.95 110.125 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.591 ' CA ' HD12 ' A' ' 230' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.287 0.565 . . . . 1.03 109.505 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.3 tp 35.53 30.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.817 -0.552 . . . . 1.04 111.18 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -108.59 51.53 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.945 . . . . 0.77 110.239 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.525 ' NE1' ' HB3' ' A' ' 270' ' ' ASP . 8.0 t90 -139.79 -56.47 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.42 110.124 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 79.5 p -90.67 49.74 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.44 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 6.4 mmtt -148.48 87.71 1.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.49 110.174 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 35.9 ttp -123.02 -8.81 8.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.162 -0.961 . . . . 0.3 110.098 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 7.0 p-10 -159.77 126.73 4.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.15 109.974 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -152.98 -172.58 4.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.13 110.426 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.804 HG21 HG22 ' A' ' 160' ' ' ILE . 1.2 p -127.59 139.14 52.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.12 110.557 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.557 ' CB ' HG12 ' A' ' 163' ' ' ILE . 26.6 p90 -127.32 177.99 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.33 111.398 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.511 ' HB3' ' CB ' ' A' ' 164' ' ' MET . 7.2 tpt180 -133.08 150.39 52.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.54 109.508 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.846 ' O ' HG13 ' A' ' 123' ' ' VAL . 3.4 pt -112.62 118.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.003 . . . . 0.33 111.771 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.852 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.8 m -166.26 38.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.27 110.079 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.757 ' OD1' HG22 ' A' ' 134' ' ' VAL . 0.8 OUTLIER -42.89 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.399 -0.92 . . . . 0.41 109.116 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.542 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.7 t80 179.58 -171.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.885 . . . . 0.4 109.991 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.8 53.02 3.47 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.798 -1.189 . . . . 0.45 110.913 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.9 Cg_endo -80.38 -84.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.858 1.452 . . . . 0.36 110.571 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.15 -3.96 57.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.25 109.95 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.533 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -123.0 160.38 26.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.303 -0.873 . . . . 0.39 110.369 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.26 179.51 4.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.48 109.759 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -47.02 -39.26 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.4 110.208 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -59.96 -57.87 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.46 110.037 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.533 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 4.4 mp0 -53.69 -54.61 35.52 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.219 -0.925 . . . . 0.47 109.607 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.757 HG22 ' OD1' ' A' ' 124' ' ' ASN . 2.6 t -46.16 -36.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.939 -1.134 . . . . 0.31 107.939 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.61 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 5.1 tt0 -61.2 -40.28 93.35 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.242 -1.022 . . . . 0.48 108.242 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.584 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -72.44 -52.0 17.8 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.3 -0.96 . . . . 0.64 108.776 178.42 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.825 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -44.67 -62.63 1.13 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.081 -1.012 . . . . 0.42 110.447 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.32 -52.98 55.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.439 -0.788 . . . . 0.34 111.343 -178.903 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.645 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -68.78 -71.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.905 -1.122 . . . . 0.47 110.328 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.54 -59.78 0.88 Allowed 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.933 -0.479 . . . . 0.47 110.33 178.994 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.22 -41.38 27.22 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.594 -1.242 . . . . 0.25 107.984 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -68.29 -27.47 66.34 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.432 -0.793 . . . . 0.35 109.11 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 2.6 tttt -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.465 -0.939 . . . . 0.7 108.465 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 13.4 t -73.14 -46.86 49.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.905 -0.776 . . . . 0.61 108.905 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.745 ' HH2' HG21 ' A' ' 262' ' ' ILE . 42.3 t-105 -58.52 -42.53 87.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.9 -0.778 . . . . 0.39 108.9 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.3 m -70.86 -32.06 68.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.431 -0.952 . . . . 0.35 108.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -55.65 -46.87 77.41 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.107 -0.701 . . . . 0.36 109.107 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.971 HG23 HG22 ' A' ' 149' ' ' THR . 28.1 m -72.34 -34.62 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.448 -0.901 . . . . 0.5 109.369 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . 1.015 HG23 HD11 ' A' ' 151' ' ' LEU . 1.1 t -141.37 118.69 7.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.103 -0.998 . . . . 0.51 109.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.49 62.58 3.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.68 1.358 . . . . 0.31 111.153 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 149' ' ' THR . 0.2 OUTLIER -76.48 174.2 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.003 -1.06 . . . . 0.18 109.931 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 12.5 t-20 -107.81 126.23 52.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.228 -0.92 . . . . 0.17 109.873 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' HE2' ' HG ' ' A' ' 146' ' ' SER . 9.3 p90 -131.37 143.03 50.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 0.14 110.925 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.669 ' HB ' HG22 ' A' ' 119' ' ' THR . 33.0 m -143.61 141.51 30.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.337 -0.852 . . . . 0.15 110.38 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.456 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -117.35 88.24 2.87 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.29 -0.882 . . . . 0.2 109.935 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -79.81 129.07 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.22 110.461 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -89.0 36.78 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.32 109.965 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -34.63 2.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.511 -0.743 . . . . 0.33 109.648 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 147.1 37.13 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.051 -1.22 . . . . 0.28 110.051 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.926 HD13 HD22 ' A' ' 156' ' ' LEU . 1.9 mp -126.02 70.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.251 . . . . 0.3 108.983 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -139.22 162.27 35.39 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 0.2 110.702 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.665 ' HB3' HD22 ' A' ' 118' ' ' LEU . 7.0 t70 -134.18 -33.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.1 110.458 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.054 HG21 ' HG ' ' A' ' 228' ' ' LEU . 0.2 OUTLIER -127.5 173.29 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.038 . . . . 0.1 109.77 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.824 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 2.9 ptt? -176.98 159.12 1.65 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.605 -1.309 . . . . 0.11 111.754 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.3 tt -103.0 116.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.1 109.301 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.852 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.3 p -157.32 154.58 29.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.789 -1.195 . . . . 0.1 111.035 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.3 p90 -75.03 122.13 23.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.09 109.448 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -84.52 115.72 4.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.244 -1.142 . . . . 0.2 110.244 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -105.43 104.21 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -1.034 . . . . 0.55 109.246 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.72 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.42 0.628 . . . . 0.85 112.374 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -130.15 -2.13 4.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 0.71 110.181 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -84.83 178.95 7.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.42 109.857 179.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.74 28.38 4.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.33 109.683 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -121.77 -97.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.33 110.14 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -102.09 126.94 49.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.27 110.022 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -54.48 109.59 1.65 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.93 . . . . 0.34 110.301 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.625 ' O ' HD23 ' A' ' 184' ' ' LEU . 42.7 Cg_endo -74.16 -66.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.015 1.534 . . . . 0.47 110.76 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -47.72 137.75 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.35 110.406 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 179' ' ' ASP . 7.6 p30 179.14 81.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.402 -0.919 . . . . 0.2 110.584 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.51 ' H ' ' CB ' ' A' ' 204' ' ' ASP . . . 38.2 -152.01 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.741 -1.343 . . . . 0.25 109.741 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.409 ' HA ' ' CD ' ' A' ' 205' ' ' GLU . 54.6 Cg_endo -82.49 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.969 1.51 . . . . 0.44 110.584 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.4 t -58.39 176.13 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.57 110.354 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.49 70.49 0.04 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.219 -1.153 . . . . 0.49 110.219 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 177' ' ' PRO . 7.4 tp 179.9 81.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.349 -1.089 . . . . 0.41 110.175 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.882 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.4 tt -100.84 -24.34 14.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.355 -1.338 . . . . 0.3 111.036 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.454 ' O ' ' OE1' ' A' ' 223' ' ' GLU . . . -149.01 101.71 3.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.723 -1.235 . . . . 0.2 112.254 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.542 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.1 OUTLIER -102.97 133.35 48.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.16 109.236 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.957 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -121.37 130.93 53.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 0.23 110.595 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -79.14 165.15 50.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.38 110.341 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.53 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.9 Cg_endo -73.41 141.27 31.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.974 1.512 . . . . 0.4 110.038 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' SER . 42.9 Cg_endo -70.08 83.25 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.911 1.48 . . . . 0.32 110.626 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.72 -101.52 1.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.32 109.589 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -162.49 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.942 1.496 . . . . 0.47 110.539 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -62.0 -17.79 58.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.63 110.023 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.44 59.55 0.67 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.532 -0.73 . . . . 0.53 110.377 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -131.22 168.16 22.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.828 -1.709 . . . . 0.25 108.828 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 1.002 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 42.78 26.61 0.46 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.67 -1.372 . . . . 0.1 109.67 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 196' ' ' GLY . 7.3 m-20 -79.06 86.18 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.1 109.914 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.6 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.074 -1.016 . . . . 0.09 109.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.542 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 17.9 m170 -101.97 131.19 48.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.855 . . . . 0.09 110.707 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 203' ' ' ASP . 42.4 m-85 -103.52 137.61 41.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.913 . . . . 0.1 110.515 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -49.05 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.14 108.956 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.548 ' OD2' ' CB ' ' A' ' 178' ' ' PHE . 2.6 p30 -35.95 -29.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.653 -0.654 . . . . 0.18 111.772 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 202' ' ' ASP . 10.4 m-20 -79.12 2.27 21.4 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.607 -1.308 . . . . 0.24 111.457 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.882 ' OE1' HD12 ' A' ' 185' ' ' LEU . 9.8 mm-40 -93.65 -166.45 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.773 -1.204 . . . . 0.42 110.347 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.32 140.81 52.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.47 110.468 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.516 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -140.6 130.39 24.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.275 -0.89 . . . . 0.27 109.737 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.021 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -138.83 176.46 8.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.021 -1.05 . . . . 0.3 110.583 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.49 ' HB2' HD23 ' A' ' 216' ' ' LEU . 2.1 t -130.5 35.94 3.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.873 -0.788 . . . . 0.61 108.873 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.9 t -115.26 -111.62 0.35 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.702 -0.624 . . . . 0.78 110.065 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.517 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 t -143.88 11.23 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.91 109.952 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 123.52 29.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.93 109.917 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.99 -171.7 31.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.175 -1.57 . . . . 0.79 109.175 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.607 ' CE1' HD13 ' A' ' 185' ' ' LEU . 64.8 m-85 -69.47 122.11 18.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -1.192 . . . . 0.69 109.687 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 219' ' ' VAL . 1.1 p-10 -95.73 119.82 34.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.986 -1.072 . . . . 0.4 108.965 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.021 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -38.45 -37.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.672 -0.643 . . . . 0.17 111.093 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.6 m-30 -49.92 -48.39 51.73 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.439 -1.304 . . . . 0.28 107.719 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 239' ' ' LEU . 4.7 tp -79.79 -69.45 0.58 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.906 -0.588 . . . . 0.46 110.53 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.969 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.99 -65.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.39 109.786 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -48.53 -50.27 32.65 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.832 -1.167 . . . . 0.17 111.564 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -63.52 -24.88 68.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.329 -1.482 . . . . 0.1 109.052 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.618 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.6 t60 -76.78 -54.5 6.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.281 -0.637 . . . . 0.21 109.281 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.613 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.2 tp10 -58.76 -47.9 83.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.181 -0.949 . . . . 0.28 108.538 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -54.79 -55.76 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.18 109.049 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.53 -31.52 5.07 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.848 -1.701 . . . . 0.21 108.848 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.573 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -82.07 -76.71 0.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.241 -1.152 . . . . 0.17 110.865 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.957 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.22 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.832 -0.543 . . . . 0.33 111.834 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 1.054 ' HG ' HG21 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -99.82 -41.23 7.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 0.53 110.731 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -72.19 -79.32 0.45 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.26 -1.136 . . . . 0.41 110.26 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.591 HD12 ' CA ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -173.54 -163.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.253 . . . . 0.45 110.525 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.517 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -61.55 -54.62 40.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.62 110.288 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.573 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -167.77 177.14 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.45 111.056 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 27.7 t 179.26 51.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.748 -0.834 . . . . 0.38 108.748 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.83 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -132.41 24.66 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.48 111.41 -178.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.554 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.1 OUTLIER -37.13 -53.61 2.03 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.491 -0.756 . . . . 0.38 110.976 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -84.27 -49.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.715 1.376 . . . . 0.28 111.202 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.57 101.56 0.15 Allowed Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.361 -1.399 . . . . 0.24 111.357 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.907 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -146.73 163.27 36.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.341 -1.094 . . . . 0.28 110.246 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -69.64 58.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.4 109.026 179.16 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.618 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.8 mtp -144.17 -37.29 0.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.45 110.045 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -48.56 171.39 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.865 -1.147 . . . . 0.57 110.063 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.3 Cg_endo -74.25 3.91 4.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.578 1.304 . . . . 0.76 110.553 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.8 mt -104.8 134.58 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.89 110.182 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.554 ' O ' ' C ' ' A' ' 245' ' ' THR . 49.8 p90 -127.87 -36.53 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.854 . . . . 0.78 109.72 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 244' ' ' TYR . 53.7 m 1.41 -69.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 112.977 0.732 . . . . 0.61 112.977 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.577 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -60.14 101.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.74 109.33 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.519 ' N ' ' HB2' ' A' ' 250' ' ' SER . 38.7 p -46.79 175.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.81 110.484 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.22 8.05 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.703 -1.359 . . . . 0.56 109.703 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.48 28.48 1.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.156 . . . . 0.37 110.345 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.519 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.5 OUTLIER -58.52 -27.34 64.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.44 109.941 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 252' ' ' PHE . 6.9 t-160 -150.59 -55.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.53 110.03 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER -176.94 -179.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.38 110.191 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.882 ' HB2' HG21 ' A' ' 259' ' ' VAL . 1.5 ptt? -68.77 54.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.418 -0.801 . . . . 0.19 110.371 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.6 mp -44.75 -47.72 28.56 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.974 -1.121 . . . . 0.28 107.974 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.5 Cg_endo -72.89 50.13 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.962 1.506 . . . . 0.49 110.94 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.609 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.7 m-20 -52.51 -29.77 26.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.037 -1.039 . . . . 0.49 110.157 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.907 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.07 -51.55 63.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.118 -1.033 . . . . 0.31 109.487 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.066 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.32 -33.92 70.11 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.938 -1.105 . . . . 0.14 108.553 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 253' ' ' MET . 72.2 t -62.51 -85.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.573 -0.851 . . . . 0.17 110.22 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.4 tt0 -58.04 -43.52 86.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.26 110.007 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.1 -63.87 1.66 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.556 -1.018 . . . . 0.19 110.556 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.1 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -80.18 -19.19 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.755 -1.438 . . . . 0.22 109.994 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 1.1 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.7 OUTLIER -59.33 -24.65 63.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.849 -1.167 . . . . 0.39 107.849 178.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.4 p -103.9 -40.85 6.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.273 -0.571 . . . . 0.47 111.806 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 112' ' ' LYS . 4.9 mp -83.96 -46.85 11.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.48 111.789 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.936 ' OH ' HD22 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -76.08 -21.42 56.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.061 -1.025 . . . . 0.41 110.481 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -57.7 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.165 -1.574 . . . . 0.46 109.165 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.0 Cg_endo -75.19 95.68 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.789 1.415 . . . . 0.58 110.062 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.8 178.26 43.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.558 -1.417 . . . . 0.64 109.558 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.525 ' HB3' ' NE1' ' A' ' 113' ' ' TRP . 27.9 t0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.266 -1.138 . . . . 0.95 110.138 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 3.1 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.6 0.714 . . . . 1.03 109.407 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.9 mp 49.2 18.36 0.24 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.386 -0.821 . . . . 1.04 111.541 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.75 ' HB3' HD12 ' A' ' 265' ' ' LEU . 9.6 mttm -97.41 78.89 2.72 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.837 -1.164 . . . . 0.77 109.643 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.56 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.3 t90 -165.38 -68.33 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.42 111.36 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.525 ' O ' ' CD ' ' A' ' 115' ' ' LYS . 79.9 p -104.69 84.47 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.44 110.952 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 266' ' ' TYR . 3.4 mptt -173.53 83.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.49 110.312 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 116' ' ' MET . 7.7 tmm? -123.75 -8.88 7.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.3 110.134 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 10.1 p30 -158.31 117.34 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.15 109.941 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.515 ' CD2' ' OD2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -141.88 -178.83 5.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.13 110.611 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -119.93 170.36 9.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.85 . . . . 0.12 109.56 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.55 ' HB3' HG23 ' A' ' 163' ' ' ILE . 41.0 p90 -165.22 -158.54 0.39 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.041 . . . . 0.33 110.947 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -150.34 143.17 24.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 0.54 110.138 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.636 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.7 pp -103.81 108.25 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.33 110.866 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.939 HG23 ' HB3' ' A' ' 166' ' ' SER . 15.6 m -158.76 43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.27 110.352 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 16.1 t-20 -42.68 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.41 109.328 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.563 ' O ' HG21 ' A' ' 134' ' ' VAL . 3.0 t80 -179.17 -168.98 0.14 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.383 -0.823 . . . . 0.4 109.537 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.579 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -143.34 45.71 0.62 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.832 -1.167 . . . . 0.45 111.353 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.2 Cg_endo -75.49 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.783 1.412 . . . . 0.36 110.041 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -5.84 51.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.858 . . . . 0.25 109.655 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.713 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.9 ptt? -118.49 146.87 44.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.39 109.94 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -104.07 -179.35 3.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.48 110.149 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t-80 -43.43 -35.33 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.4 109.872 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -66.62 -59.99 3.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.46 110.096 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.531 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 1.3 mp0 -50.72 -61.21 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.47 109.409 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 125' ' ' TYR . 8.2 t -45.13 -37.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.28 -1.007 . . . . 0.31 108.28 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.6 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.87 -41.05 77.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.319 -0.993 . . . . 0.48 108.319 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.576 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.2 tttp -75.09 -51.63 13.0 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.05 0.928 . . . . 0.64 108.608 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.82 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.5 -63.47 0.95 Allowed 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.093 -1.005 . . . . 0.42 110.418 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -61.26 -54.31 45.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.34 111.289 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.658 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -69.62 -72.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.47 110.485 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.1 tmtp? -37.91 -61.59 0.63 Allowed 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.899 -0.5 . . . . 0.47 110.607 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -47.06 -40.32 14.78 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.69 -1.204 . . . . 0.25 108.257 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -68.28 -32.82 73.24 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.508 -0.877 . . . . 0.35 108.947 178.418 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 140' ' ' LYS . 13.1 ttpp -59.53 -39.23 83.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.261 -1.014 . . . . 0.7 108.261 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.86 -41.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.813 -0.81 . . . . 0.61 108.813 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.639 ' O ' HG22 ' A' ' 148' ' ' VAL . 20.6 t-105 -60.99 -39.74 90.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.047 -0.723 . . . . 0.39 109.047 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.6 m -73.46 -34.51 65.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.412 -0.805 . . . . 0.35 108.834 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -41.55 76.83 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.595 -0.691 . . . . 0.36 109.291 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.791 HG23 HG22 ' A' ' 149' ' ' THR . 35.2 m -78.35 -31.7 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.5 110.11 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.791 HG22 HG23 ' A' ' 148' ' ' VAL . 5.7 t -148.12 135.21 10.38 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.51 110.56 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.98 59.65 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.84 1.442 . . . . 0.31 110.377 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 1.015 HD21 ' CD1' ' A' ' 266' ' ' TYR . 1.1 mp -80.8 163.43 23.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.18 110.5 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -107.4 110.18 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.17 110.178 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.511 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.1 p90 -115.71 122.62 46.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.887 . . . . 0.14 110.015 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.945 ' CG2' HD13 ' A' ' 156' ' ' LEU . 8.3 m -127.42 140.87 51.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.15 110.373 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.5 82.09 1.87 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.421 -0.799 . . . . 0.2 109.622 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.945 HD13 ' CG2' ' A' ' 154' ' ' THR . 1.3 mp -91.26 85.48 5.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.22 110.44 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' GLY . 36.6 p-80 -57.32 -19.72 24.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.32 109.789 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.96 -26.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.481 -0.762 . . . . 0.33 109.823 179.13 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.38 20.68 1.24 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.829 -1.308 . . . . 0.28 109.829 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 160' ' ' ILE . 12.1 mt -122.64 65.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.045 -1.268 . . . . 0.3 109.259 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -118.96 141.45 48.65 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.198 -0.601 . . . . 0.2 110.4 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD2' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -107.12 -47.55 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.1 109.961 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.001 ' CD1' HD11 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -116.34 173.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 0.1 109.824 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.54 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 4.4 ptp -170.67 142.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.11 110.63 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.8 tt -92.89 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.1 109.086 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.939 ' HB3' HG23 ' A' ' 123' ' ' VAL . 5.0 p -157.38 156.54 32.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.805 -1.184 . . . . 0.1 111.262 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -74.23 118.48 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.692 -0.63 . . . . 0.09 109.665 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -71.67 119.8 7.83 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.024 -1.231 . . . . 0.2 110.024 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 169' ' ' ILE . 6.9 tp -116.61 97.65 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -1.063 . . . . 0.55 109.985 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.63 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 3.7 tmtt? 0.07 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.289 0.566 . . . . 0.85 112.388 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -162.47 24.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.71 110.351 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -97.11 -69.59 0.75 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.42 110.132 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.43 -35.82 1.51 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.494 -1.442 . . . . 0.33 109.494 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -75.29 -144.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -1.171 . . . . 0.33 110.517 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.427 ' C ' ' CD1' ' A' ' 176' ' ' TYR . 58.3 m-85 -55.65 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.27 110.509 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 5.4 m-30 -111.01 110.94 56.52 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.34 110.306 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.88 -68.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.929 1.489 . . . . 0.47 110.558 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -51.21 137.58 22.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.35 110.417 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 178' ' ' PHE . 51.6 p-10 -178.44 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.2 110.624 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.57 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 44.44 -158.73 0.15 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.782 -1.327 . . . . 0.25 109.782 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.8 Cg_endo -74.95 7.28 2.91 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.14 1.6 . . . . 0.44 110.725 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 184' ' ' LEU . 6.4 t -42.58 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.967 . . . . 0.57 110.36 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.98 76.51 0.02 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.418 -1.073 . . . . 0.49 110.418 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.955 HD22 ' OD1' ' A' ' 202' ' ' ASP . 3.3 tt 179.9 88.13 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.222 -1.163 . . . . 0.41 110.389 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.585 HD13 ' CE2' ' A' ' 214' ' ' TYR . 4.8 tt -103.84 -23.22 13.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.3 110.944 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.764 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -148.45 108.03 3.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.602 -1.311 . . . . 0.2 112.126 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -105.7 118.76 37.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.16 109.529 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.863 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -107.8 141.02 40.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.23 110.202 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 3.2 m-30 -91.04 161.51 35.12 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.38 110.32 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.5 Cg_endo -72.41 142.98 37.96 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.967 1.509 . . . . 0.4 109.409 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.3 Cg_endo -69.64 74.41 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.849 1.447 . . . . 0.32 110.693 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.84 -93.71 1.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.408 -1.477 . . . . 0.32 109.408 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 -158.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.981 1.516 . . . . 0.47 110.406 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -79.51 8.82 5.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.63 110.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.493 ' HA ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -114.67 6.98 15.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.324 -0.86 . . . . 0.53 109.717 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -80.89 168.8 51.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.594 -1.402 . . . . 0.25 109.594 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.568 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 51.84 18.65 4.38 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.658 -1.377 . . . . 0.1 109.658 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -79.98 92.19 5.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -1.125 . . . . 0.1 110.339 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -72.44 97.44 2.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.942 . . . . 0.09 109.952 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.468 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 1.4 m170 -111.13 131.99 54.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.09 110.328 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.626 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 59.5 m-85 -103.27 136.61 42.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.992 -1.067 . . . . 0.1 110.678 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.955 ' OD1' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -46.52 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.719 -0.845 . . . . 0.14 108.719 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.642 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.4 p30 -36.84 -27.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.18 111.674 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.57 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -77.69 -0.24 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.675 -1.266 . . . . 0.24 111.217 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 12.6 mm-40 -94.82 -164.17 1.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.42 110.303 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 m -125.58 140.48 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.47 110.582 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.642 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.1 m-90 -135.56 142.81 45.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -0.823 . . . . 0.27 109.43 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.035 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.83 179.93 8.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.932 -1.105 . . . . 0.3 110.565 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.8 t -124.62 43.07 3.11 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.686 0.755 . . . . 0.61 109.251 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.8 t -131.63 -165.9 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.697 -0.627 . . . . 0.78 110.076 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.522 ' N ' ' OG ' ' A' ' 210' ' ' SER . 8.7 t -87.64 -0.51 56.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.91 110.14 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 149.75 28.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.93 109.969 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.23 -164.25 33.27 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.35 -1.5 . . . . 0.79 109.35 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.585 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.8 m-85 -84.52 120.78 26.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -1.195 . . . . 0.69 109.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.92 ' ND2' HG22 ' A' ' 247' ' ' THR . 7.3 p30 -87.62 121.7 30.39 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.067 -1.021 . . . . 0.4 108.852 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.035 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -39.89 -38.78 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.487 -0.758 . . . . 0.17 110.867 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 4.0 m-85 -51.31 -48.87 62.22 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 118.435 -1.306 . . . . 0.28 107.527 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.874 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.5 OUTLIER -73.87 -72.6 0.26 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.726 -0.67 . . . . 0.46 110.151 178.678 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.916 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.93 -69.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.39 109.914 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -42.27 -54.79 3.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.17 111.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -57.58 -30.72 65.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.499 -1.376 . . . . 0.1 109.578 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.644 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.7 t60 -75.51 -43.78 47.24 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.353 0.597 . . . . 0.21 109.686 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.764 ' OE1' ' HB1' ' A' ' 186' ' ' ALA . 22.8 tp10 -64.4 -35.97 82.63 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -0.884 . . . . 0.28 108.894 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 220' ' ' ALA . 19.1 m-85 -66.93 -48.52 68.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.755 -0.831 . . . . 0.18 108.755 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -52.47 -31.66 36.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.288 -1.925 . . . . 0.21 108.288 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.662 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.7 OUTLIER -80.62 -78.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -1.056 . . . . 0.17 110.674 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.863 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -38.5 -45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.33 111.268 -178.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 1.001 HD11 ' CD1' ' A' ' 163' ' ' ILE . 6.0 mt -83.37 -46.3 12.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.53 110.878 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -71.31 -85.14 0.19 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.363 -1.095 . . . . 0.41 110.363 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 230' ' ' LEU . 2.6 pt? -176.62 -158.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -1.2 . . . . 0.45 110.563 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.52 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 7.4 t70 -49.88 -56.1 11.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.62 110.148 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.662 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -164.69 -175.68 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.45 109.861 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.42 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER -179.78 58.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.38 109.809 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 1.084 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -152.29 27.06 0.59 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.48 111.196 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.545 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.7 OUTLIER -37.83 -48.89 2.89 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.38 110.674 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 41.1 Cg_endo -86.81 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.913 1.481 . . . . 0.28 112.289 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.32 99.58 0.12 Allowed Glycine 0 N--CA 1.5 2.94 0 C-N-CA 118.638 -1.744 . . . . 0.24 112.127 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 1.084 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -150.03 169.49 21.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.031 -1.276 . . . . 0.28 110.556 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.613 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -80.19 49.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.4 108.79 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.644 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.9 OUTLIER -133.99 -22.45 1.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.005 -1.059 . . . . 0.45 110.915 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -60.72 172.09 0.91 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.873 -1.142 . . . . 0.57 110.204 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 40.6 Cg_endo -67.79 -2.73 9.1 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.413 1.217 . . . . 0.76 110.935 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.569 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.6 mp -108.04 153.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.89 109.649 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.874 ' HB2' HD21 ' A' ' 218' ' ' LEU . 14.3 p90 -135.78 -22.93 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.78 111.685 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.756 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 4.0 -70.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 113.44 0.904 . . . . 0.61 113.44 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.756 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -72.27 117.34 13.8 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.454 -1.404 . . . . 0.74 109.77 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.92 HG22 ' ND2' ' A' ' 215' ' ' ASN . 47.6 p -62.17 -161.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.81 110.403 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.58 -32.61 79.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.56 109.593 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.48 41.67 2.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -1.124 . . . . 0.37 110.517 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -63.52 -20.87 65.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.44 109.751 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 20.4 m-70 -167.9 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.786 . . . . 0.53 109.911 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.9 m-85 -170.22 176.6 4.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.41 -0.806 . . . . 0.38 110.205 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.943 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -70.56 54.38 0.15 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.19 110.043 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.2 mm? -43.82 -47.56 20.83 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.176 -1.046 . . . . 0.28 108.176 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.21 49.81 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.015 1.534 . . . . 0.49 110.787 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.615 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 6.2 m-20 -54.19 -29.45 45.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.49 110.236 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.913 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 55.4 m-20 -57.2 -41.2 78.92 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.31 109.339 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.056 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.43 -33.2 48.7 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.986 -1.116 . . . . 0.14 107.986 178.673 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.943 HG21 ' HB2' ' A' ' 253' ' ' MET . 83.5 t -65.55 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.17 109.906 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.622 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.4 tt0 -58.18 -42.37 85.9 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.29 -0.881 . . . . 0.26 109.446 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.46 -70.33 0.5 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.178 -1.169 . . . . 0.19 110.178 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.089 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -73.75 -18.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.963 -1.316 . . . . 0.22 110.392 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 1.089 ' N ' HD13 ' A' ' 262' ' ' ILE . 44.9 tt0 -65.54 -20.3 66.28 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.9 -1.12 . . . . 0.39 108.163 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.37 -40.69 6.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.779 -0.576 . . . . 0.47 111.145 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 112' ' ' LYS . 4.3 mm? -86.71 -45.4 11.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.185 -0.947 . . . . 0.48 111.179 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 1.015 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -76.95 -13.68 59.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.41 110.53 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -62.7 -107.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.953 -1.659 . . . . 0.46 108.953 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.1 95.07 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.58 110.079 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.87 171.04 37.08 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.825 -1.31 . . . . 0.64 109.825 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.325 -1.103 . . . . 0.95 110.13 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.529 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.643 0.735 . . . . 1.03 109.59 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 3.2 mm? 40.75 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.545 -0.722 . . . . 1.04 111.373 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 1.8 mttt -123.44 65.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.856 -1.153 . . . . 0.77 109.939 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.632 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 19.3 t90 -123.03 -71.67 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.42 110.573 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.421 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 22.1 t -105.15 58.33 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.302 -0.874 . . . . 0.44 110.291 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HG3' ' C ' ' A' ' 114' ' ' SER . 39.0 mttp -141.72 59.49 1.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.49 110.489 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.48 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.6 OUTLIER -89.9 11.2 21.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.3 109.793 179.55 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.991 ' O ' HD22 ' A' ' 118' ' ' LEU . 8.5 t30 -172.0 115.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.15 109.512 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.991 HD22 ' O ' ' A' ' 117' ' ' ASN . 1.2 mm? -137.48 178.01 7.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.184 -0.947 . . . . 0.13 110.72 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.636 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -120.34 174.11 6.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.12 109.902 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.556 ' HB3' HG12 ' A' ' 163' ' ' ILE . 31.3 p90 -178.94 178.74 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.33 111.425 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.469 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 1.3 ttp180 -121.05 158.51 27.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.54 109.654 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.726 HD13 ' CD2' ' A' ' 138' ' ' PHE . 1.6 pp -125.7 98.42 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.33 110.881 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.995 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.4 m -145.57 53.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.27 110.334 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 8.2 t-20 -43.39 -84.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.41 109.623 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 8.6 t80 -177.53 -175.07 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.4 109.917 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 130' ' ' THR . 0.0 OUTLIER -139.03 52.52 4.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.45 110.716 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.543 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.2 Cg_endo -76.26 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.819 1.431 . . . . 0.36 109.767 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.77 -4.62 54.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.25 109.588 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.957 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.8 ptm -119.76 170.71 8.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.469 -0.769 . . . . 0.39 109.955 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.547 ' HA ' HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -121.91 -172.46 2.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.48 110.34 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.458 ' H ' HG22 ' A' ' 130' ' ' THR . 1.5 t60 -53.09 -36.4 60.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.4 110.03 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 6.9 t -60.83 -48.68 80.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.46 109.336 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 13.1 mp0 -62.79 -63.33 1.24 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.34 -0.85 . . . . 0.47 109.527 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.684 HG23 ' HE2' ' A' ' 129' ' ' MET . 13.4 t -43.68 -38.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.611 -0.885 . . . . 0.31 108.611 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.611 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 3.0 mt-10 -56.68 -42.14 78.54 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.48 108.246 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 2.4 tttm -73.8 -50.13 22.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.471 -0.936 . . . . 0.64 108.471 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.84 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.05 -60.79 2.07 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.19 -0.944 . . . . 0.42 110.225 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.726 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.74 -53.63 44.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.34 111.018 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.82 -72.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.857 -1.152 . . . . 0.47 110.347 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.2 tmtm? -38.65 -61.16 0.74 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.752 -0.593 . . . . 0.47 110.655 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -47.59 -38.59 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.611 -1.235 . . . . 0.25 108.374 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -70.11 -32.76 70.94 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.335 -0.853 . . . . 0.35 109.15 178.634 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' LYS . 4.6 tttp -59.82 -38.82 83.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.38 -0.971 . . . . 0.7 108.38 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 16.1 t -71.91 -44.34 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 109.035 -0.728 . . . . 0.61 109.035 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.628 ' O ' HG22 ' A' ' 149' ' ' THR . 13.6 t-105 -56.63 -44.93 81.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.39 109.01 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 149' ' ' THR . 26.0 m -71.01 -35.05 71.88 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.32 -0.862 . . . . 0.35 108.739 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -53.06 -42.43 65.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.576 -0.703 . . . . 0.36 109.416 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.761 HG23 HG22 ' A' ' 149' ' ' THR . 31.1 m -80.47 -32.59 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.779 -0.768 . . . . 0.5 110.198 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.761 HG22 HG23 ' A' ' 148' ' ' VAL . 2.5 t -137.94 124.59 13.27 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.068 . . . . 0.51 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -78.28 62.24 8.04 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.31 110.341 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.851 ' O ' HD12 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -101.0 156.31 17.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.18 110.127 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -76.94 134.41 38.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.35 -0.844 . . . . 0.17 111.341 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 7.7 p90 -135.19 121.99 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.14 109.618 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.55 ' HB ' HG23 ' A' ' 119' ' ' THR . 42.4 m -127.0 161.68 27.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.15 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -142.18 68.95 1.32 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.655 -0.653 . . . . 0.2 110.09 -178.94 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 93.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.22 110.038 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' ASP . 50.4 p-80 -48.51 -28.15 3.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.32 110.083 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' HIS . 4.3 t70 -42.36 -70.27 0.11 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.576 -0.703 . . . . 0.33 109.819 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 179.39 30.68 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.28 109.586 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 119' ' ' THR . 20.9 mm -121.57 79.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.267 -1.137 . . . . 0.3 108.339 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.502 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -136.14 112.02 9.53 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.097 -0.641 . . . . 0.2 110.714 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 118' ' ' LEU . 33.5 t70 -73.37 -54.36 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.1 109.97 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.942 HG22 ' HA3' ' A' ' 197' ' ' GLY . 5.4 pt -111.84 175.9 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.1 109.677 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 23.2 ptm -170.35 136.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.844 -1.16 . . . . 0.11 111.122 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 122' ' ' ILE . 1.6 tt -90.24 123.44 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.447 -0.783 . . . . 0.1 109.852 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.995 ' HB3' HG23 ' A' ' 123' ' ' VAL . 23.0 p -168.37 143.05 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.831 -1.168 . . . . 0.1 110.922 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.8 p90 -58.49 117.21 4.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.372 -0.83 . . . . 0.09 109.507 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -83.79 115.3 4.03 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.901 -1.28 . . . . 0.2 109.901 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 169' ' ' ILE . 7.0 tt -106.63 100.26 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.957 . . . . 0.55 109.781 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.574 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 0.91 87.47 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.33 0.586 . . . . 0.85 112.397 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -130.06 -1.75 4.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.71 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -77.18 -86.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.42 110.035 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.28 58.8 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.339 -1.504 . . . . 0.33 109.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -155.16 -80.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -1.105 . . . . 0.33 110.377 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 83.9 m-85 -115.67 103.67 10.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.27 110.335 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.427 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.3 m-30 -40.32 98.82 0.18 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.34 110.156 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.868 ' O ' HD22 ' A' ' 184' ' ' LEU . 48.9 Cg_endo -82.67 -59.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.099 1.579 . . . . 0.47 110.775 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CB ' ' OD1' ' A' ' 203' ' ' ASP . 10.8 p90 -50.7 163.4 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.35 110.209 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 180' ' ' GLY . 0.9 OUTLIER 179.48 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.941 -1.099 . . . . 0.2 111.451 179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 141.89 -123.55 2.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.157 -1.577 . . . . 0.25 109.157 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.4 2.62 7.91 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 O-C-N 123.919 1.484 . . . . 0.44 109.768 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 177.53 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.434 -0.791 . . . . 0.57 110.228 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -77.03 76.33 1.63 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.594 -1.003 . . . . 0.49 110.594 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.868 HD22 ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 179.77 98.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -1.127 . . . . 0.41 110.288 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.702 HD12 ' CD ' ' A' ' 205' ' ' GLU . 1.4 tt -116.74 -17.6 10.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.746 -1.182 . . . . 0.3 111.334 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.725 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -157.52 105.1 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.452 -1.405 . . . . 0.2 111.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -102.76 121.35 42.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.16 110.086 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.833 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -106.41 119.03 38.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.23 110.075 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -69.7 170.25 10.18 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.257 -0.902 . . . . 0.38 110.401 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.2 Cg_endo -73.15 130.73 15.68 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.101 1.579 . . . . 0.4 109.698 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.6 Cg_endo -69.88 74.8 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.956 1.503 . . . . 0.32 110.572 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.01 -91.45 1.02 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.703 -1.359 . . . . 0.32 109.703 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.0 -163.57 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.991 1.521 . . . . 0.47 110.489 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -6.58 35.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.63 110.047 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 195' ' ' TYR . . . . . 0.438 ' C ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -111.55 49.7 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.423 -0.798 . . . . 0.53 109.796 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -123.89 174.62 16.81 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.36 -1.496 . . . . 0.25 109.36 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.942 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 41.59 27.63 0.32 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.081 -1.208 . . . . 0.1 110.081 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD2' ' C ' ' A' ' 195' ' ' TYR . 57.7 m-20 -79.53 90.07 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.057 -1.261 . . . . 0.1 110.031 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -68.59 89.97 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.053 -1.029 . . . . 0.09 109.81 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.544 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 3.1 m170 -102.92 128.31 49.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.09 110.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.567 ' O ' ' N ' ' A' ' 203' ' ' ASP . 21.2 m-85 -96.73 132.13 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.1 111.173 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.573 ' HB3' ' CG ' ' A' ' 205' ' ' GLU . 35.8 t0 -40.06 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.245 -0.65 . . . . 0.14 109.245 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -36.43 -38.89 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.18 112.161 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.553 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 14.0 t0 -73.68 -6.65 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.642 -1.286 . . . . 0.24 111.225 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.702 ' CD ' HD12 ' A' ' 185' ' ' LEU . 14.7 mm-40 -84.79 -165.21 1.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.847 -1.158 . . . . 0.42 110.176 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.55 148.26 52.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.47 110.441 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.437 ' NE1' ' HB3' ' A' ' 201' ' ' PHE . 0.9 OUTLIER -142.24 140.36 32.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.267 -0.895 . . . . 0.27 109.57 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.016 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -149.03 174.85 11.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.857 -1.152 . . . . 0.3 110.748 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -129.06 24.79 5.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.794 0.807 . . . . 0.61 109.206 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.3 t -94.6 -111.46 0.12 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.615 -0.678 . . . . 0.78 110.03 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.531 ' N ' ' OG ' ' A' ' 210' ' ' SER . 4.4 p -141.28 8.39 2.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.134 . . . . 0.91 110.008 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 -179.26 5.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.93 109.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.76 -154.88 5.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.038 -1.625 . . . . 0.79 109.038 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 185' ' ' LEU . 79.0 m-85 -90.16 109.94 20.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.251 . . . . 0.69 110.066 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.61 ' O ' HG12 ' A' ' 219' ' ' VAL . 32.6 m-20 -79.15 120.92 24.36 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.097 -1.002 . . . . 0.4 108.866 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.016 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.26 -36.53 0.79 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.556 -0.858 . . . . 0.17 110.718 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.576 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 4.1 m-85 -53.05 -46.92 68.74 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.315 -1.354 . . . . 0.28 107.589 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 1.031 HD21 ' HB2' ' A' ' 244' ' ' TYR . 5.8 tp -77.27 -71.86 0.38 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.4 -0.818 . . . . 0.46 110.683 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.3 p -48.78 -61.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.39 110.385 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.92 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.06 -48.56 67.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.061 -1.024 . . . . 0.17 111.439 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.95 -29.11 66.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.201 -1.562 . . . . 0.1 108.743 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.661 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 8.0 t-80 -77.0 -44.12 32.19 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.31 0.576 . . . . 0.21 109.747 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.803 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 17.8 tp10 -64.58 -45.61 86.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.02 . . . . 0.28 108.667 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.531 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 18.4 m-30 -56.35 -60.51 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.18 109.029 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.451 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.07 -34.15 1.99 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.971 -1.652 . . . . 0.21 108.971 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.672 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -80.87 -70.16 0.55 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.106 -1.232 . . . . 0.17 111.235 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.833 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.66 -44.33 0.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.33 112.017 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.868 ' HG ' HG21 ' A' ' 163' ' ' ILE . 1.0 OUTLIER -101.09 -37.49 8.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.661 -1.274 . . . . 0.53 111.317 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -65.01 -85.08 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.316 -1.114 . . . . 0.41 110.316 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -172.54 -173.28 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.245 . . . . 0.45 110.473 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.519 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 42.0 t0 -51.35 -59.72 3.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.62 109.975 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.672 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 1.6 m80 -163.82 -179.98 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.45 110.256 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.492 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.1 OUTLIER 179.23 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.457 -0.777 . . . . 0.38 109.391 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.899 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.04 21.43 3.02 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.468 -0.893 . . . . 0.48 111.197 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.535 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -35.58 -49.66 1.38 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 120.055 -0.658 . . . . 0.38 110.635 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -88.5 -48.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.701 1.369 . . . . 0.28 111.132 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.1 101.73 0.15 Allowed Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.409 -1.377 . . . . 0.24 111.401 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.899 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -147.47 163.16 37.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.372 -1.075 . . . . 0.28 110.463 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.66 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.18 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.074 -1.016 . . . . 0.4 108.818 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.661 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 50.6 mtt -135.9 -34.4 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.793 . . . . 0.45 110.437 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -43.88 169.85 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.195 -0.941 . . . . 0.57 110.359 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.2 Cg_endo -69.35 -8.02 22.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.786 1.413 . . . . 0.76 110.198 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.702 HG22 HG22 ' A' ' 245' ' ' THR . 16.0 mm -103.26 159.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.89 109.845 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 1.031 ' HB2' HD21 ' A' ' 218' ' ' LEU . 16.8 p90 -138.07 -24.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.78 111.446 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.731 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 3.19 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.824 1.046 . . . . 0.61 113.824 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.731 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -71.82 115.64 11.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.438 -1.413 . . . . 0.74 110.022 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.746 ' HA ' HD13 ' A' ' 218' ' ' LEU . 2.9 m -54.04 -174.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.81 110.301 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.696 ' H ' HG22 ' A' ' 247' ' ' THR . . . -50.83 -25.29 9.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.56 109.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.632 ' CD ' ' N ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -167.46 36.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -1.135 . . . . 0.37 110.353 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.2 t -58.54 -16.19 14.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.44 110.147 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -145.55 -48.7 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.53 110.086 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.55 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.8 OUTLIER 179.99 172.75 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.38 110.122 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.894 ' HB2' HG21 ' A' ' 259' ' ' VAL . 4.8 ptp -72.85 52.38 0.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.122 -0.986 . . . . 0.19 110.055 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.677 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.1 OUTLIER -45.24 -47.39 33.45 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 108.014 -1.106 . . . . 0.28 108.014 177.695 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -73.76 51.9 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.085 1.571 . . . . 0.49 110.905 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.63 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.7 m-20 -52.17 -31.44 31.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.129 -0.982 . . . . 0.49 110.151 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.892 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -51.89 -51.5 56.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.945 -1.102 . . . . 0.31 109.346 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.036 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -69.48 -35.6 75.74 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.074 -1.051 . . . . 0.14 108.553 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 253' ' ' MET . 73.8 t -63.41 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.17 110.273 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 33.0 tt0 -54.03 -43.87 70.5 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.246 -0.909 . . . . 0.26 109.902 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.04 -69.04 0.55 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.345 -1.102 . . . . 0.19 110.345 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.085 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -76.37 -19.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.786 -1.42 . . . . 0.22 110.264 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 1.085 ' N ' HD13 ' A' ' 262' ' ' ILE . 14.3 tt0 -61.54 -23.58 66.05 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.863 -1.135 . . . . 0.39 107.94 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 p -103.87 -42.58 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.386 0.612 . . . . 0.47 110.691 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 75.3 mt -73.95 -52.11 13.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.422 -0.799 . . . . 0.48 111.319 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.779 ' OH ' HD22 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -75.6 -11.82 60.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.41 110.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.48 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.89 -102.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.059 -1.617 . . . . 0.46 109.059 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.52 101.65 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.86 1.452 . . . . 0.58 110.158 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -78.82 165.71 51.37 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.587 -1.405 . . . . 0.64 109.587 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.632 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.29 -1.124 . . . . 0.95 110.254 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' LEU . 1.5 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.513 0.673 . . . . 1.03 109.484 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.4 OUTLIER 39.09 30.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.643 -0.66 . . . . 1.04 111.428 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -114.35 68.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.043 -1.036 . . . . 0.77 109.433 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.578 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 20.8 t90 -147.52 -66.85 0.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.42 111.063 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 24.0 p -97.1 51.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.44 110.952 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 114' ' ' SER . 4.5 mmmt -148.48 85.77 1.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.49 109.91 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 tmm? -120.86 -15.72 8.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.025 -1.047 . . . . 0.3 110.473 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.594 ' O ' HD22 ' A' ' 118' ' ' LEU . 7.3 p-10 -153.46 114.28 4.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.15 110.211 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -141.0 -151.87 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.304 -0.873 . . . . 0.13 110.201 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.881 HG22 ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -136.32 155.35 50.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.12 110.142 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.878 ' HB3' HG23 ' A' ' 163' ' ' ILE . 29.0 p90 -148.92 163.33 37.77 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.496 -0.882 . . . . 0.33 111.055 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 151.38 35.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.48 -0.763 . . . . 0.54 109.881 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.856 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.1 pp -116.91 111.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.33 111.163 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.936 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.8 m -161.82 49.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.27 110.261 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.8 t30 -42.95 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.41 109.451 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.58 ' O ' HG21 ' A' ' 134' ' ' VAL . 24.6 t80 -179.03 -176.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.4 110.042 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.434 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -129.09 57.95 33.73 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.982 . . . . 0.45 109.834 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 125' ' ' TYR . 47.8 Cg_endo -75.1 -88.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.275 1.671 . . . . 0.36 110.688 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.37 -8.27 21.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.25 110.163 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.568 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.04 174.95 5.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.39 110.204 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 132' ' ' SER . 3.0 m -115.17 167.03 11.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.48 109.302 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 130' ' ' THR . 7.9 t-160 -43.38 -26.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.4 109.61 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.2 OUTLIER -68.8 -45.57 70.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.831 . . . . 0.46 110.116 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.568 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.1 OUTLIER -70.71 -50.54 35.21 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.938 -1.101 . . . . 0.47 109.248 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 125' ' ' TYR . 9.5 t -47.18 -36.61 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.242 -1.392 . . . . 0.31 107.242 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.595 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 1.4 tt0 -58.96 -45.88 89.42 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.474 -1.306 . . . . 0.48 107.474 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.31 -50.36 71.98 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.068 0.937 . . . . 0.64 108.704 178.164 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.793 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -46.33 -62.93 1.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.149 -0.969 . . . . 0.42 110.718 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.856 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.73 -52.53 56.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.34 110.7 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -65.91 -74.82 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.901 -1.124 . . . . 0.47 110.175 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -38.48 -61.6 0.68 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.807 -0.558 . . . . 0.47 110.66 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -46.96 -38.56 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.665 -1.272 . . . . 0.25 108.359 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -71.65 -28.92 64.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -0.869 . . . . 0.35 109.156 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.02 -42.2 98.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.7 108.416 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 4.4 t -72.31 -51.36 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.817 -0.809 . . . . 0.61 108.817 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.638 ' HH2' HG21 ' A' ' 262' ' ' ILE . 47.8 t-105 -50.85 -34.47 28.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.523 -0.917 . . . . 0.39 108.523 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -76.28 -36.02 58.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.45 -0.944 . . . . 0.35 108.45 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.31 -43.23 70.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.981 -0.748 . . . . 0.36 108.981 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 31.4 m -74.85 -35.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.703 -0.799 . . . . 0.5 109.552 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 149' ' ' THR . 13.0 t -148.06 121.77 4.81 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 0.51 110.305 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.79 60.74 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.819 1.431 . . . . 0.31 110.335 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.976 HD11 ' O ' ' A' ' 266' ' ' TYR . 1.1 mp -73.9 173.86 9.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.18 110.815 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -110.25 121.83 46.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.17 109.95 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 9.0 p90 -138.8 131.23 28.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.14 110.266 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.881 ' O ' HG22 ' A' ' 119' ' ' THR . 7.8 m -136.84 130.58 32.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.15 110.22 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.603 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -94.12 69.83 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.2 109.945 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 110.64 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.22 110.11 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 158' ' ' ASP . 4.6 m-70 -67.74 -24.53 65.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.32 110.01 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 158' ' ' ASP . 4.5 t0 -42.44 -27.71 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.33 109.646 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.86 26.52 1.25 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.614 -1.395 . . . . 0.28 109.614 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 160' ' ' ILE . 8.0 mt -116.65 74.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.203 -1.175 . . . . 0.3 109.432 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -135.57 152.94 51.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.664 -0.648 . . . . 0.2 110.491 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.3 OUTLIER -128.98 -35.27 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.1 110.185 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.075 HD12 ' O ' ' A' ' 197' ' ' GLY . 0.7 OUTLIER -115.21 163.21 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.291 -0.881 . . . . 0.1 109.335 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.793 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -174.63 142.57 0.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.375 -1.453 . . . . 0.11 111.71 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 165' ' ' ILE . 6.7 tt -94.74 118.42 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.469 -0.769 . . . . 0.1 109.777 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.936 ' HB3' HG23 ' A' ' 123' ' ' VAL . 9.7 p -160.94 153.4 20.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.808 -1.183 . . . . 0.1 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.0 p90 -68.81 120.46 14.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.09 109.727 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -81.95 129.92 9.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.529 -1.028 . . . . 0.2 110.529 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -125.06 99.99 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.709 -0.877 . . . . 0.55 108.94 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.43 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.42 0.629 . . . . 0.85 112.475 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -163.3 24.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.71 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.401 ' CD2' ' CZ ' ' A' ' 189' ' ' PHE . 10.1 m80 -93.29 -57.96 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.42 110.253 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 110.86 55.34 0.51 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.65 -1.38 . . . . 0.33 109.65 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 8.0 p-10 -176.71 -37.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -1.079 . . . . 0.33 110.202 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.6 OUTLIER -156.05 149.07 24.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.27 110.106 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -77.34 112.24 22.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.34 110.138 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.1 Cg_endo -74.15 -55.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.954 1.502 . . . . 0.47 110.625 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.3 p90 -79.64 162.44 25.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.038 . . . . 0.35 110.528 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -169.51 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.019 . . . . 0.2 110.989 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.611 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 160.48 -149.11 18.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.25 109.49 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.83 -2.05 10.85 Favored 'Trans proline' 0 C--N 1.297 -2.174 0 O-C-N 124.228 1.646 . . . . 0.44 109.765 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.519 ' CB ' ' OD1' ' A' ' 179' ' ' ASP . 20.2 t -49.88 175.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.57 110.184 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -68.61 76.53 0.28 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.781 -0.928 . . . . 0.49 110.781 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.891 HD23 ' OD1' ' A' ' 202' ' ' ASP . 1.0 OUTLIER 179.35 85.94 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.199 -1.177 . . . . 0.41 110.575 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.644 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.6 tt -105.79 -21.4 13.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.612 -1.305 . . . . 0.3 111.664 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -146.63 109.7 4.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.526 -1.359 . . . . 0.2 111.985 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -112.61 115.26 28.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.16 109.538 178.872 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.922 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -111.1 145.72 38.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.23 110.116 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.436 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 2.2 m-30 -95.72 165.78 15.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.233 -0.917 . . . . 0.38 110.757 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -71.04 150.58 60.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.069 1.562 . . . . 0.4 109.163 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 227' ' ' SER . 45.4 Cg_endo -72.89 76.27 2.53 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.681 1.359 . . . . 0.32 110.5 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.07 -108.29 2.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.498 -1.441 . . . . 0.32 109.498 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.89 -158.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.935 1.492 . . . . 0.47 110.26 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -3.42 13.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.161 -0.962 . . . . 0.63 110.554 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.36 27.51 8.66 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.53 110.227 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -105.35 166.72 14.51 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.136 -1.586 . . . . 0.25 109.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 1.075 ' O ' HD12 ' A' ' 163' ' ' ILE . . . 51.43 21.04 5.85 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.937 -1.665 . . . . 0.1 108.937 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.9 OUTLIER -77.44 88.83 3.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -1.143 . . . . 0.1 110.267 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -72.96 84.98 1.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.09 109.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.495 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 52.9 m170 -97.82 127.06 43.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.09 110.628 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.3 m-85 -97.89 141.03 31.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.995 . . . . 0.1 109.818 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.891 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -51.76 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.373 -0.973 . . . . 0.14 108.373 178.773 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.596 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 1.7 p30 -34.86 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.18 112.204 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.611 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 18.5 t0 -80.18 10.12 4.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.683 -1.261 . . . . 0.24 110.744 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.559 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 21.8 mm-40 -101.41 -162.15 0.91 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.42 109.961 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.0 m -128.41 141.85 51.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.036 -1.04 . . . . 0.47 110.381 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -142.41 139.03 31.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.968 . . . . 0.27 109.9 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.04 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -144.29 172.91 12.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.975 -1.078 . . . . 0.3 110.545 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -128.2 27.5 5.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.951 0.882 . . . . 0.61 108.996 178.786 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.6 t -99.66 -99.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.69 -0.632 . . . . 0.78 110.15 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.53 ' N ' ' OG ' ' A' ' 210' ' ' SER . 13.2 t -153.0 15.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.033 -1.042 . . . . 0.91 110.328 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 213' ' ' GLY . 0.0 OUTLIER -133.27 -172.12 2.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.93 109.93 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 42.69 -147.95 0.62 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.179 -1.569 . . . . 0.79 109.179 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.644 ' CE1' HD13 ' A' ' 185' ' ' LEU . 90.8 m-85 -93.24 103.1 15.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.106 -1.232 . . . . 0.69 109.738 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.593 ' O ' HG12 ' A' ' 219' ' ' VAL . 58.1 m-80 -71.65 120.27 17.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.094 -1.004 . . . . 0.4 108.933 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.04 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -42.03 -34.7 0.75 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.564 -0.854 . . . . 0.17 110.051 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.582 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 7.2 m-85 -54.37 -46.09 72.93 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.572 -1.27 . . . . 0.28 107.572 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 244' ' ' TYR . 10.2 tp -78.08 -71.15 0.44 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.775 -0.648 . . . . 0.46 110.694 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.836 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.17 -62.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 0.39 110.141 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.08 -53.63 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.067 . . . . 0.17 111.391 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -56.44 -25.94 52.06 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.404 -1.435 . . . . 0.1 108.965 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.794 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 27.2 t-80 -78.82 -46.79 17.95 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.767 -0.583 . . . . 0.21 109.748 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.628 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.7 tp10 -63.99 -38.3 90.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.28 109.244 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 6.8 m-30 -64.33 -63.08 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.816 . . . . 0.18 109.084 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -44.72 -31.68 2.7 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.86 -1.696 . . . . 0.21 108.86 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.869 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -77.36 -74.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -1.139 . . . . 0.17 110.639 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.922 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -39.35 -54.83 1.83 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.484 -0.76 . . . . 0.33 111.492 -179.029 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.552 HD23 ' OH ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -78.79 -46.04 19.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.53 110.785 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -60.3 -78.77 0.13 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.717 -1.353 . . . . 0.41 109.717 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.603 HD21 ' O ' ' A' ' 232' ' ' HIS . 0.5 OUTLIER -177.76 -162.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.45 110.08 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.507 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -55.8 -55.3 34.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.62 109.789 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.869 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -162.09 -179.96 7.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.45 109.385 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 67.3 p -178.97 48.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.38 110.569 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -135.39 27.29 3.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.242 -0.911 . . . . 0.48 110.559 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -39.83 -50.76 5.6 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.595 -0.842 . . . . 0.38 109.622 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 43.4 Cg_endo -90.53 -46.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.747 1.393 . . . . 0.28 110.462 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.57 96.31 0.1 Allowed Glycine 0 N--CA 1.498 2.795 0 C-N-CA 119.065 -1.541 . . . . 0.24 112.304 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.914 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -145.25 160.33 41.64 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.263 -1.14 . . . . 0.28 109.57 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.726 HD23 ' CD2' ' A' ' 222' ' ' HIS . 1.5 tt -68.18 57.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.4 109.237 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.794 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.1 OUTLIER -141.72 -6.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.45 111.547 -178.762 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -78.21 165.23 51.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.556 -1.34 . . . . 0.57 110.987 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 41.1 Cg_endo -68.11 -18.34 45.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.78 1.41 . . . . 0.76 110.053 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.1 mm -90.21 136.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.934 -0.765 . . . . 0.89 108.934 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.7 ' HB2' HD21 ' A' ' 218' ' ' LEU . 38.5 p90 -126.96 -30.64 2.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.942 -1.099 . . . . 0.78 110.405 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.758 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.49 -70.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 113.203 0.816 . . . . 0.61 113.203 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.758 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -53.41 105.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.556 -1.34 . . . . 0.74 109.321 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.505 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 22.5 p -57.16 166.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.849 . . . . 0.81 109.998 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -53.7 -19.8 10.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.092 -1.603 . . . . 0.56 109.092 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.95 31.87 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.37 110.631 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.492 ' HB3' ' N ' ' A' ' 247' ' ' THR . 1.9 t -83.76 -22.67 31.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.05 -1.031 . . . . 0.44 109.927 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -152.41 -69.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.53 109.873 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.64 -176.01 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.38 110.47 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.964 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.1 55.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.593 -0.692 . . . . 0.19 110.702 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.724 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -45.83 -46.88 40.44 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.017 -1.105 . . . . 0.28 108.017 177.576 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.724 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.3 Cg_endo -71.82 48.91 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.954 1.502 . . . . 0.49 110.966 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.616 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.8 m-20 -47.39 -32.42 4.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.887 -1.133 . . . . 0.49 110.453 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.914 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 1.4 m-20 -50.49 -50.81 51.68 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.138 -0.976 . . . . 0.31 109.51 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.06 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -73.35 -33.01 64.87 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.169 -1.012 . . . . 0.14 108.468 179.021 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 253' ' ' MET . 84.8 t -60.56 -81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.252 -0.979 . . . . 0.17 110.153 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.65 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.3 OUTLIER -62.05 -42.85 99.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.238 -0.914 . . . . 0.26 109.786 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.65 -64.92 1.1 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.396 -1.082 . . . . 0.19 110.396 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.065 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -77.49 -19.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.816 -1.402 . . . . 0.22 110.441 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 1.065 ' N ' HD13 ' A' ' 262' ' ' ILE . 17.3 tt0 -64.37 -21.87 66.77 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.838 -1.145 . . . . 0.39 108.317 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.0 t -104.22 -41.52 5.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.157 -0.617 . . . . 0.47 111.487 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 9.2 mt -87.5 -45.86 10.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.227 -0.921 . . . . 0.48 111.669 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.976 ' O ' HD11 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.85 -8.78 57.36 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.206 -0.934 . . . . 0.41 110.156 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -73.73 -107.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.032 -1.627 . . . . 0.46 109.032 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 268' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 269' ' ' GLY . 46.3 Cg_endo -73.01 74.99 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.784 1.413 . . . . 0.58 110.112 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 268' ' ' PRO . . . -61.81 -137.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.64 109.723 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.95 110.139 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.526 ' O ' HD22 ' A' ' 230' ' ' LEU . 1.7 p . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.325 0.583 . . . . 1.03 109.692 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.7 OUTLIER 37.24 28.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.706 -0.621 . . . . 1.04 111.107 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HD3' HD22 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -100.22 91.05 4.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.121 -0.987 . . . . 0.77 110.015 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.602 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 21.7 t90 -164.08 -71.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.42 110.284 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.493 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 88.4 p -91.71 69.52 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.44 110.268 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 27.1 mttp -165.65 86.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.49 110.465 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 5.8 ttp -123.23 -12.79 7.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.3 110.149 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 20.3 p-10 -155.3 124.21 6.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.15 109.84 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.98 -177.82 6.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.13 110.424 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -121.44 147.14 46.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.12 109.766 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.818 ' CB ' HG23 ' A' ' 163' ' ' ILE . 9.6 p90 -145.01 160.71 40.94 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.254 -0.978 . . . . 0.33 111.015 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.423 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -103.68 160.69 14.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.472 -0.768 . . . . 0.54 110.032 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.689 HG21 ' CD1' ' A' ' 138' ' ' PHE . 7.6 pt -122.32 62.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.33 110.727 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 1.021 HG23 ' HB3' ' A' ' 166' ' ' SER . 12.1 m -110.39 48.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.995 -1.066 . . . . 0.27 110.727 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 0.6 OUTLIER -43.18 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.41 109.297 179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.623 ' O ' HG21 ' A' ' 134' ' ' VAL . 5.6 t80 -178.81 -175.1 0.39 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.346 -0.846 . . . . 0.4 109.47 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.571 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -136.36 48.29 2.44 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.45 110.805 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.14 -85.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.814 1.429 . . . . 0.36 110.343 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 1.5 m-20 -95.53 2.85 54.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.25 109.638 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.558 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -124.3 156.5 36.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 0.39 109.75 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -110.41 176.48 5.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.48 109.95 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -43.37 -34.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.4 109.931 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -68.87 -50.01 53.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.46 109.646 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.558 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 5.2 mp0 -58.44 -62.09 2.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.364 -0.835 . . . . 0.47 109.41 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.623 HG21 ' O ' ' A' ' 125' ' ' TYR . 9.5 t -45.16 -39.7 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.139 -1.06 . . . . 0.31 108.139 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -54.11 -40.48 67.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.057 -1.09 . . . . 0.48 108.057 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 17.0 tttt -74.54 -52.24 12.41 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.867 0.842 . . . . 0.64 108.846 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.82 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.31 -60.81 2.1 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.962 -1.086 . . . . 0.42 110.561 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.689 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.54 -54.17 36.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.34 111.004 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.654 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 7.9 tttm -68.09 -72.76 0.16 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.94 -1.1 . . . . 0.47 110.28 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.4 OUTLIER -38.48 -61.24 0.72 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.731 -0.605 . . . . 0.47 110.709 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.43 -38.27 13.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.641 -1.287 . . . . 0.25 108.344 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.53 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -72.53 -28.58 62.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.31 -0.869 . . . . 0.35 109.068 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 140' ' ' LYS . 58.7 tttt -63.4 -39.75 95.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.43 -0.952 . . . . 0.7 108.43 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 11.3 t -75.76 -51.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.086 -0.709 . . . . 0.61 109.086 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HH2' HG21 ' A' ' 262' ' ' ILE . 45.2 t-105 -52.19 -34.18 44.16 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.441 -0.948 . . . . 0.39 108.441 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 149' ' ' THR . 41.5 m -77.38 -38.41 50.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.395 -0.965 . . . . 0.35 108.395 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.43 -43.88 62.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.862 -0.792 . . . . 0.36 108.862 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.699 HG23 HG22 ' A' ' 149' ' ' THR . 32.3 m -74.05 -38.52 49.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.477 -0.764 . . . . 0.5 109.55 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.699 HG22 HG23 ' A' ' 148' ' ' VAL . 7.2 t -142.78 119.53 6.89 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.51 110.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.41 58.57 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.663 1.349 . . . . 0.31 110.793 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.515 HD11 ' CG ' ' A' ' 266' ' ' TYR . 59.4 mt -70.48 167.12 19.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.18 110.043 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 3.1 t30 -105.89 103.08 12.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.892 . . . . 0.17 110.22 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.428 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.6 p90 -116.08 144.68 43.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.14 110.312 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.761 ' O ' HG22 ' A' ' 119' ' ' THR . 27.7 m -147.9 130.55 15.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.15 110.439 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.612 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -99.62 84.4 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.2 109.904 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 154' ' ' THR . 0.5 OUTLIER -77.11 104.35 7.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.22 110.224 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' ASP . 55.8 p-80 -56.06 -27.96 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.96 . . . . 0.32 109.948 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.12 -41.91 2.79 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.56 -0.712 . . . . 0.33 109.941 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.73 33.22 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.733 -1.347 . . . . 0.28 109.733 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 119' ' ' THR . 6.5 mt -121.13 71.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.064 -1.257 . . . . 0.3 109.542 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -125.3 137.6 54.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.029 -0.668 . . . . 0.2 110.411 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.516 ' HB3' HD22 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.52 -34.9 8.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.1 109.653 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.818 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -122.72 173.11 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.1 109.052 179.347 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.772 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.5 ptp -177.05 144.63 0.44 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.495 -1.378 . . . . 0.11 111.656 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 122' ' ' ILE . 1.5 tt -93.31 120.87 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.1 109.272 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 166' ' ' SER . . . . . 1.021 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.3 p -163.62 142.56 8.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.735 -1.228 . . . . 0.1 110.702 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.62 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.8 p90 -67.03 112.3 4.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.324 -0.86 . . . . 0.09 109.618 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -60.63 143.28 48.12 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.281 -1.527 . . . . 0.2 109.281 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.734 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.7 tt -138.15 96.91 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.972 . . . . 0.55 109.905 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.591 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.06 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.382 0.611 . . . . 0.85 112.363 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 11.83 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.71 110.108 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 7.4 m80 -80.25 -87.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.42 110.031 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.58 -35.2 1.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.485 -1.446 . . . . 0.33 109.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 -87.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.33 110.26 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -111.01 -170.01 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.27 110.569 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -101.95 110.62 62.72 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.34 110.349 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.445 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.1 Cg_endo -76.92 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.829 1.437 . . . . 0.47 110.668 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -50.38 140.68 13.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.35 110.606 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 182' ' ' SER . 6.0 p30 -178.74 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.932 -1.107 . . . . 0.2 111.703 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 36.97 -157.54 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.562 -1.015 . . . . 0.25 110.562 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.452 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -78.62 43.74 1.5 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.183 1.623 . . . . 0.44 110.535 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 184' ' ' LEU . 0.5 OUTLIER -83.33 179.32 7.72 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.285 -0.885 . . . . 0.57 109.816 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.2 68.6 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.566 -1.013 . . . . 0.49 110.566 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 182' ' ' SER . 0.8 OUTLIER 179.64 84.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.132 -1.217 . . . . 0.41 110.954 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.552 HD12 ' CD ' ' A' ' 205' ' ' GLU . 0.5 OUTLIER -100.18 -24.17 14.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.964 -1.094 . . . . 0.3 110.741 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -152.36 99.55 2.51 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.79 -1.194 . . . . 0.2 111.788 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.539 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -100.97 124.47 46.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.051 -1.031 . . . . 0.16 109.987 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.828 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -106.08 124.49 49.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.974 . . . . 0.23 110.333 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.4 OUTLIER -68.5 162.83 59.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.38 110.443 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.4 Cg_endo -72.26 138.58 30.63 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.4 109.772 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.56 72.88 2.34 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.92 1.484 . . . . 0.32 110.575 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.59 -105.95 2.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.32 109.443 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.65 -159.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.943 1.497 . . . . 0.47 110.396 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -63.61 -11.8 28.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.63 110.279 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.27 63.58 0.66 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.45 -0.781 . . . . 0.53 109.997 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.19 173.89 22.46 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.097 -1.601 . . . . 0.25 109.097 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.28 25.5 0.76 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.481 -1.448 . . . . 0.1 109.481 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 12.5 m-20 -79.04 87.44 4.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -1.209 . . . . 0.1 110.666 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.8 98.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.09 109.539 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.538 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 8.5 m170 -110.57 119.86 40.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.09 111.266 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 203' ' ' ASP . 13.7 m-30 -90.62 131.93 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.1 109.556 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.519 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 0.4 OUTLIER -49.33 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.079 . . . . 0.14 108.717 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -34.55 -32.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.566 -0.709 . . . . 0.18 111.738 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.532 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 1.8 m-20 -64.1 -16.75 62.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.638 -1.289 . . . . 0.24 110.631 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.552 ' CD ' HD12 ' A' ' 185' ' ' LEU . 11.4 mm-40 -86.77 -176.02 5.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.002 . . . . 0.42 110.49 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.528 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 83.8 m -122.11 154.74 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.47 110.006 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.553 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -149.49 147.28 28.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 0.27 109.756 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.013 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.32 177.55 11.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.02 -1.05 . . . . 0.3 110.595 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.1 OUTLIER -129.06 20.28 5.88 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.729 0.776 . . . . 0.61 109.553 178.985 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -89.38 -69.81 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.566 0.698 . . . . 0.78 110.078 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.415 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER 179.41 -30.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.58 -0.7 . . . . 0.91 109.543 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 177.61 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.548 -0.72 . . . . 0.93 109.98 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 50.11 -161.4 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.79 109.432 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.465 ' CE2' ' CE2' ' A' ' 244' ' ' TYR . 80.1 m-85 -81.69 126.2 31.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.69 109.473 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.62 ' O ' HG12 ' A' ' 219' ' ' VAL . 16.8 m-80 -89.2 118.6 29.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.026 -1.046 . . . . 0.4 108.658 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.013 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.37 -36.98 0.92 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.672 -0.811 . . . . 0.17 110.334 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 3.0 m-85 -51.24 -49.34 61.31 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.574 -1.25 . . . . 0.28 107.833 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 244' ' ' TYR . 12.7 tp -75.09 -70.42 0.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.791 -0.64 . . . . 0.46 110.54 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -49.96 -68.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.39 110.03 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -44.46 -52.96 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.978 -1.076 . . . . 0.17 111.23 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.99 -47.71 77.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.275 -1.516 . . . . 0.1 108.722 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.673 ' N ' HD21 ' A' ' 239' ' ' LEU . 5.6 t60 -54.25 -52.18 62.17 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.419 0.628 . . . . 0.21 109.942 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.642 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.4 tp10 -59.81 -43.7 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.207 -0.933 . . . . 0.28 108.87 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 224' ' ' PHE . 11.6 m-30 -55.0 -62.35 1.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.18 109.091 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.59 -32.97 1.4 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.786 -1.725 . . . . 0.21 108.786 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -79.83 -76.46 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.195 -1.179 . . . . 0.17 111.052 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.828 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -34.55 -42.57 0.15 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.83 -0.544 . . . . 0.33 112.336 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 163' ' ' ILE . 3.1 tp -101.17 -38.74 7.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.839 -1.163 . . . . 0.53 111.309 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 225' ' ' GLY . . . -68.29 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.762 -0.935 . . . . 0.41 110.762 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.625 HD12 ' H ' ' A' ' 232' ' ' HIS . 0.5 OUTLIER -160.45 -155.34 0.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.131 -1.217 . . . . 0.45 111.098 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 37.3 m-20 -74.4 -48.34 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.62 110.712 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.625 ' H ' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -174.82 157.82 2.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -1.0 . . . . 0.45 111.098 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 24.1 p -162.71 47.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.033 -0.728 . . . . 0.38 109.033 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.714 ' CA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -127.06 23.09 6.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.449 -0.782 . . . . 0.48 111.001 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.553 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -43.86 -60.24 2.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.38 109.494 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.0 Cg_endo -75.97 -50.76 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.735 1.387 . . . . 0.28 110.681 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.06 95.03 0.1 OUTLIER Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.337 -1.411 . . . . 0.24 111.404 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.928 ' HB2' ' HB2' ' A' ' 257' ' ' ASP . . . -145.77 164.93 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.426 -1.044 . . . . 0.28 110.022 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.673 HD21 ' N ' ' A' ' 222' ' ' HIS . 1.1 tp -72.14 57.33 0.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -0.916 . . . . 0.4 109.131 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.601 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 4.3 mmm -146.86 14.46 1.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.102 -0.998 . . . . 0.45 110.576 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -106.14 166.67 10.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.57 110.704 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.3 Cg_endo -70.24 -7.53 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.008 1.53 . . . . 0.76 109.981 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.727 HD11 ' CG2' ' A' ' 245' ' ' THR . 0.0 OUTLIER -101.41 112.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.137 -0.69 . . . . 0.89 109.137 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.68 ' HB2' HD21 ' A' ' 218' ' ' LEU . 52.1 p90 -116.6 -31.58 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.04 . . . . 0.78 110.731 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.762 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER 1.89 -68.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.235 0.828 . . . . 0.61 113.235 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.762 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -48.6 106.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.51 -1.369 . . . . 0.74 109.524 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 70.0 p -53.8 171.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.81 110.164 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.3 -15.23 29.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.27 -1.532 . . . . 0.56 109.27 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.7 20.09 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.37 110.441 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.467 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -64.74 -17.88 64.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.44 109.795 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -168.36 -64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.53 110.187 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.1 OUTLIER 179.95 -172.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.38 110.605 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 253' ' ' MET . . . . . 1.011 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.32 56.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.716 -0.615 . . . . 0.19 110.541 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.704 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.9 OUTLIER -44.01 -47.6 22.43 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.0 -1.111 . . . . 0.28 108.0 177.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.65 50.67 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 124.101 1.579 . . . . 0.49 111.176 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.666 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 31.3 m-20 -53.54 -28.52 32.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.49 110.786 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.928 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 1.7 m-20 -54.25 -47.76 71.91 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.035 -1.041 . . . . 0.31 109.436 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.037 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -76.21 -31.82 58.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.277 -0.969 . . . . 0.14 108.442 178.507 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 1.011 HG21 ' HB2' ' A' ' 253' ' ' MET . 70.8 t -61.83 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.658 -0.817 . . . . 0.17 109.98 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.7 tp60 -61.41 -40.96 96.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.247 -0.908 . . . . 0.26 109.525 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.53 -66.71 0.92 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.355 -1.098 . . . . 0.19 110.355 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.037 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -76.14 -20.17 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.912 -1.346 . . . . 0.22 110.613 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 262' ' ' ILE . 13.4 tp60 -61.37 -23.86 66.07 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.648 -1.221 . . . . 0.39 107.969 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -103.12 -36.34 8.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.936 -0.705 . . . . 0.47 111.672 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 265' ' ' LEU . 4.3 mm? -90.76 -46.52 8.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.973 -1.079 . . . . 0.48 111.923 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.644 ' OH ' HD23 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -71.23 -18.09 62.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.964 -1.085 . . . . 0.41 109.904 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.95 -88.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.999 -1.64 . . . . 0.46 108.999 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.9 114.24 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.072 1.564 . . . . 0.58 110.001 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.92 154.97 17.27 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.842 -1.303 . . . . 0.64 109.842 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.602 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.279 -1.13 . . . . 0.95 109.986 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.698 ' HA ' HD12 ' A' ' 230' ' ' LEU . 1.1 p . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.505 0.669 . . . . 1.03 109.204 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 48.11 32.66 3.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 1.04 111.469 178.963 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 110' ' ' THR . 1.2 mtpt -117.75 92.88 3.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.77 109.883 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.614 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 9.9 t90 -160.91 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.009 -1.057 . . . . 0.42 111.307 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.483 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 87.6 p -102.23 69.23 1.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -0.998 . . . . 0.44 110.865 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 114' ' ' SER . 7.3 mttm -161.59 50.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.49 110.352 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 3.9 ttt -74.91 -5.16 42.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.247 -0.908 . . . . 0.3 110.427 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.453 ' CB ' ' HB3' ' A' ' 152' ' ' ASN . 29.7 p30 -156.78 149.13 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.15 110.502 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.728 HD23 HD11 ' A' ' 228' ' ' LEU . 9.3 tp -171.15 177.64 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.13 109.857 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.91 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -110.36 158.84 18.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.008 . . . . 0.12 110.458 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.752 ' HB2' HG23 ' A' ' 163' ' ' ILE . 21.4 p90 -154.45 167.85 28.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.422 -0.799 . . . . 0.33 110.329 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -130.06 144.21 51.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -0.818 . . . . 0.54 110.102 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.839 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -105.18 123.85 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.346 -0.846 . . . . 0.33 110.704 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.995 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.0 m -165.41 44.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.802 . . . . 0.27 109.818 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.3 t-20 -40.11 -80.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.41 109.539 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 7.8 t80 -179.11 178.46 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.314 -0.866 . . . . 0.4 109.951 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -131.9 55.71 19.71 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.45 110.576 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.6 Cg_endo -82.86 -81.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.789 1.415 . . . . 0.36 110.517 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.77 -4.03 25.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.25 110.048 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.552 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 1.0 OUTLIER -113.76 160.98 18.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.39 110.211 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.3 m -106.89 167.74 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.48 109.839 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 2.0 t60 -44.29 -29.98 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.4 109.845 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -66.71 -51.5 55.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.46 109.654 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.552 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 10.3 mt-10 -62.16 -58.0 9.42 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.249 -0.907 . . . . 0.47 109.18 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 125' ' ' TYR . 5.7 t -46.37 -34.76 2.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.935 -1.135 . . . . 0.31 107.935 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -59.0 -42.4 90.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.938 -1.134 . . . . 0.48 107.938 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 47.1 tttt -68.97 -45.49 70.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.219 -1.03 . . . . 0.64 108.219 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.822 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -49.17 -59.71 3.43 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.321 -0.862 . . . . 0.42 109.739 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.717 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.39 -55.79 16.17 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.542 -0.724 . . . . 0.34 110.509 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -64.27 -73.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.47 110.603 -179.153 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -39.64 -60.27 1.0 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.633 -0.667 . . . . 0.47 110.73 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.11 -36.86 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.521 -1.362 . . . . 0.25 108.339 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -72.33 -31.41 65.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.9 -0.778 . . . . 0.35 108.9 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -61.29 -42.32 98.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.7 108.655 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.3 t -73.22 -48.55 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.566 -0.709 . . . . 0.61 109.208 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.596 ' CH2' HG13 ' A' ' 262' ' ' ILE . 43.1 t-105 -54.72 -39.38 68.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.39 109.215 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 149' ' ' THR . 75.5 m -74.9 -35.18 62.25 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.508 -0.923 . . . . 0.35 108.508 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.524 0.678 . . . . 0.36 109.375 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.783 HG23 HG22 ' A' ' 149' ' ' THR . 27.2 m -82.29 -32.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.419 -0.801 . . . . 0.5 110.256 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.783 HG22 HG23 ' A' ' 148' ' ' VAL . 5.0 t -146.29 136.65 12.17 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.51 110.557 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.93 58.44 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.972 1.512 . . . . 0.31 110.542 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.796 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -75.63 129.54 37.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.18 110.431 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 117' ' ' ASN . 64.6 t-20 -87.25 123.59 32.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.17 109.841 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.591 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 7.5 p90 -133.11 152.97 51.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.14 110.467 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.91 ' O ' HG22 ' A' ' 119' ' ' THR . 22.5 m -152.49 125.81 8.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.15 110.319 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.602 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -92.04 105.43 17.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.2 109.755 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -101.76 96.97 7.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.22 110.395 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.3 p-80 -52.5 -28.34 20.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.32 109.954 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.691 ' HB3' HD12 ' A' ' 156' ' ' LEU . 3.3 t0 -41.42 -60.7 1.22 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.587 -0.696 . . . . 0.33 109.752 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.99 35.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.963 -1.255 . . . . 0.28 109.963 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.769 ' O ' HG22 ' A' ' 160' ' ' ILE . 50.4 mt -126.09 68.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -1.205 . . . . 0.3 109.398 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.41 55.26 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.641 -0.662 . . . . 0.2 110.758 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.539 ' CG ' HD21 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -96.9 -51.07 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.1 109.798 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.752 HG23 ' HB2' ' A' ' 120' ' ' TYR . 18.5 tt -116.53 160.84 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.346 -0.846 . . . . 0.1 109.644 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.946 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 15.6 ptp -160.81 139.73 10.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.56 -1.338 . . . . 0.11 111.439 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -93.6 113.97 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.1 109.292 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.995 ' HB3' HG23 ' A' ' 123' ' ' VAL . 63.6 p -162.23 166.4 25.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.777 -1.202 . . . . 0.1 111.36 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.616 ' CG ' ' CD1' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -79.99 136.56 36.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.55 -0.719 . . . . 0.09 109.979 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.512 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.72 128.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.793 -1.323 . . . . 0.2 109.793 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.1 tt -118.29 100.87 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -1.037 . . . . 0.55 109.737 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 3.0 tmtt? -9.71 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.284 0.564 . . . . 0.85 112.352 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 9.3 tt0 -146.16 11.85 1.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.71 110.278 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -74.78 -75.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.42 110.107 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 120.12 52.45 0.26 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.795 -1.322 . . . . 0.33 109.795 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 6.5 p-10 -177.1 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -1.151 . . . . 0.33 110.083 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.483 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.2 OUTLIER -132.03 154.72 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.27 110.083 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.58 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 3.0 m-30 -106.48 88.98 3.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.941 . . . . 0.34 110.168 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 44.3 Cg_endo -72.6 -58.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.47 109.968 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -49.12 131.49 19.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.35 110.362 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 182' ' ' SER . 14.8 p30 179.33 82.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.134 -0.979 . . . . 0.2 110.804 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.497 ' H ' ' CB ' ' A' ' 204' ' ' ASP . . . 35.71 -154.13 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.094 -1.202 . . . . 0.25 110.094 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -78.96 43.74 1.54 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.965 1.508 . . . . 0.44 110.2 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.1 t -80.78 176.67 9.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.103 -0.998 . . . . 0.57 110.076 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.35 67.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.664 -0.974 . . . . 0.49 110.664 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 182' ' ' SER . 0.3 OUTLIER 179.57 88.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.178 -1.189 . . . . 0.41 110.709 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.591 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 4.9 tt -105.9 -19.11 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.759 -1.176 . . . . 0.3 110.919 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.424 ' HB1' ' OE2' ' A' ' 223' ' ' GLU . . . -150.25 111.11 4.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.2 112.074 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -114.64 125.83 54.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.84 . . . . 0.16 109.414 178.696 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -123.04 116.89 24.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.106 . . . . 0.23 110.512 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -58.57 167.68 1.68 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.38 110.146 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.491 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -72.19 145.87 44.85 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.027 1.541 . . . . 0.4 109.489 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.3 Cg_endo -72.48 86.43 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.831 1.438 . . . . 0.32 110.35 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.49 -98.55 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.591 -1.404 . . . . 0.32 109.591 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.61 -166.39 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.47 110.573 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -69.67 -6.58 32.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.63 110.343 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 26.46 10.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.33 -0.856 . . . . 0.53 109.891 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -106.34 176.94 22.02 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.082 -1.607 . . . . 0.25 109.082 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.533 ' O ' HG13 ' A' ' 163' ' ' ILE . . . 45.3 25.33 1.16 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.226 -1.55 . . . . 0.1 109.226 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 196' ' ' GLY . 10.7 m-20 -78.79 87.49 4.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.1 110.026 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.946 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -69.72 97.99 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.09 109.895 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.512 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 41.4 m170 -115.27 129.47 56.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -0.876 . . . . 0.09 110.602 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.9 m-85 -96.79 139.25 33.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.085 -1.009 . . . . 0.1 110.365 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -47.78 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.14 108.544 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.7 p-10 -35.48 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.013 -0.675 . . . . 0.18 111.985 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 0.8 OUTLIER -76.66 -3.21 36.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.771 -1.205 . . . . 0.24 111.271 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 14.5 mm-40 -91.22 -164.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.031 -1.043 . . . . 0.42 110.171 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.446 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 16.0 m -127.88 150.95 49.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.47 110.223 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.56 ' C ' HG22 ' A' ' 208' ' ' THR . 1.2 m-90 -145.9 146.25 31.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.27 109.56 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.986 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -162.17 175.4 11.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.867 -1.145 . . . . 0.3 111.104 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.9 t -126.58 45.24 2.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.855 0.836 . . . . 0.61 109.037 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 211' ' ' SER . 11.0 t -127.38 -157.99 0.84 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.676 . . . . 0.78 110.035 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 p -97.62 27.92 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.91 110.349 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -145.09 150.13 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.93 110.013 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.1 -176.2 12.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.174 -1.57 . . . . 0.79 109.174 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.591 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 86.7 m-85 -65.33 139.6 58.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 0.69 109.565 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.619 ' O ' HG12 ' A' ' 219' ' ' VAL . 0.6 OUTLIER -108.32 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.061 -1.024 . . . . 0.4 108.678 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.986 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -39.08 -38.76 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.044 -0.662 . . . . 0.17 110.801 -178.874 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 136' ' ' LYS . 2.0 m-85 -50.62 -46.66 58.25 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.302 -1.359 . . . . 0.28 107.592 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.914 HD21 ' HB2' ' A' ' 244' ' ' TYR . 13.4 tp -80.72 -72.86 0.4 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.707 -0.678 . . . . 0.46 110.908 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -46.1 -57.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.39 110.395 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.36 -49.56 77.33 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.336 -0.852 . . . . 0.17 111.385 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.23 -27.07 65.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.338 -1.476 . . . . 0.1 108.998 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.758 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 8.1 t-80 -76.53 -56.17 4.87 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.305 0.574 . . . . 0.21 109.768 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.643 ' OE1' ' HB1' ' A' ' 199' ' ' ALA . 34.7 tt0 -58.43 -39.28 79.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.126 -0.983 . . . . 0.28 109.015 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 220' ' ' ALA . 0.4 OUTLIER -60.47 -62.39 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.18 109.005 178.648 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.83 -29.71 0.86 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.701 -1.76 . . . . 0.21 108.701 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.48 ' CE1' ' HA ' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.43 -66.05 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -1.122 . . . . 0.17 110.884 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.959 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -40.78 -42.91 1.89 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.443 -0.786 . . . . 0.33 111.691 -178.945 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.75 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -100.27 -37.87 8.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.772 -1.205 . . . . 0.53 110.942 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -67.91 -85.74 0.1 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.255 -1.138 . . . . 0.41 110.255 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -170.23 -163.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.066 -1.255 . . . . 0.45 111.05 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.451 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -59.03 -55.78 30.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.765 . . . . 0.62 110.329 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -161.72 -179.69 7.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.937 . . . . 0.45 110.802 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 1.2 t 179.35 56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.714 -0.616 . . . . 0.38 109.474 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.672 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -139.25 26.36 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.48 110.862 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.519 ' N ' ' HD2' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -34.03 -52.6 0.89 Allowed Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 120.005 -0.678 . . . . 0.38 110.273 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 235' ' ' ASP . 50.2 Cg_endo -75.25 -56.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.634 1.334 . . . . 0.28 110.12 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.62 37.22 0.05 OUTLIER Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.328 -1.415 . . . . 0.24 111.655 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.672 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -69.9 171.97 8.49 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.389 -1.653 . . . . 0.28 111.009 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.632 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.21 58.79 1.29 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.938 0.875 . . . . 0.4 109.148 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.758 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.6 mmt -138.07 -33.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.45 110.519 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.642 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -52.62 169.93 0.26 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.57 110.344 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 44.7 Cg_endo -72.17 -1.42 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.592 1.312 . . . . 0.76 110.369 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 4.1 mt -111.97 141.96 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.89 109.965 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.914 ' HB2' HD21 ' A' ' 218' ' ' LEU . 22.4 p90 -130.15 -19.66 3.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.151 -0.968 . . . . 0.78 111.201 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 4.46 -76.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 113.006 0.743 . . . . 0.61 113.006 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.694 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -45.49 121.09 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.498 -1.376 . . . . 0.74 109.612 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 0.6 OUTLIER -71.14 157.96 37.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.828 . . . . 0.81 110.228 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.87 -22.09 4.16 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.528 -1.429 . . . . 0.56 109.528 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -131.07 31.56 4.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -1.154 . . . . 0.37 110.744 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.407 ' HB2' ' H ' ' A' ' 247' ' ' THR . 1.6 t -76.28 -69.5 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.806 -1.184 . . . . 0.44 110.114 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' HIS . . . . . 0.537 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 2.4 t60 -116.73 -60.09 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.53 110.338 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.2 OUTLIER 179.85 -169.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.977 . . . . 0.38 110.898 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.927 ' HB2' HG21 ' A' ' 259' ' ' VAL . 26.0 ptp -64.92 55.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.998 -0.439 . . . . 0.19 110.658 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.727 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -45.38 -46.96 35.16 Favored Pre-proline 0 N--CA 1.484 1.238 0 N-CA-C 107.897 -1.149 . . . . 0.28 107.897 177.317 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.3 Cg_endo -71.42 48.72 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.901 1.474 . . . . 0.49 111.194 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.588 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 7.7 m-20 -49.29 -32.54 11.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.887 -1.133 . . . . 0.49 110.325 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.626 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.96 -50.69 70.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.966 -1.093 . . . . 0.31 108.974 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.023 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -68.54 -35.13 77.0 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.257 -0.977 . . . . 0.14 108.672 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.927 HG21 ' HB2' ' A' ' 253' ' ' MET . 53.6 t -66.49 -86.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.17 110.543 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.587 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 10.0 tt0 -53.77 -39.62 65.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 0.26 109.631 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 265' ' ' LEU . . . -45.9 -70.83 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.354 -1.098 . . . . 0.19 110.354 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.023 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -69.96 -20.65 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.22 109.89 -179.538 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.968 ' N ' HD13 ' A' ' 262' ' ' ILE . 11.0 tp60 -58.87 -25.99 63.83 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.722 -1.191 . . . . 0.39 107.821 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 25.5 t -103.07 -43.05 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.308 0.575 . . . . 0.47 110.857 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 261' ' ' GLY . 1.6 mt -72.52 -53.06 13.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.48 111.054 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.796 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -80.13 -8.1 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.41 110.291 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.0 -100.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.103 -1.599 . . . . 0.46 109.103 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.33 132.74 13.98 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.967 1.509 . . . . 0.58 110.088 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -98.37 140.88 15.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.737 -1.345 . . . . 0.64 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.614 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.244 -1.15 . . . . 0.95 109.903 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.528 ' HA ' HD13 ' A' ' 230' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.52 0.676 . . . . 1.03 109.439 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.6 mt 40.05 31.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 1.04 111.017 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.798 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -119.97 76.68 1.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.77 109.74 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.578 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 23.5 t90 -140.92 -71.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.42 110.54 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 t -103.48 54.0 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.44 110.326 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.743 ' HD3' HD11 ' A' ' 118' ' ' LEU . 59.6 mmtt -136.54 46.65 2.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.49 110.311 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.573 ' O ' ' HE3' ' A' ' 116' ' ' MET . 1.1 ttp -82.47 -15.34 52.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.296 -0.878 . . . . 0.3 109.989 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 17.3 p30 -140.17 115.52 9.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.831 . . . . 0.15 110.077 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 1.0 HD22 HD11 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -138.76 176.2 8.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.13 110.108 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 154' ' ' THR . 0.9 OUTLIER -123.64 162.04 23.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.12 109.992 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.784 ' HB2' HD13 ' A' ' 163' ' ' ILE . 16.0 p90 -164.66 167.7 18.85 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.199 -1.0 . . . . 0.33 111.285 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -120.45 151.83 38.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.416 -0.803 . . . . 0.54 109.875 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.801 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.5 pp -109.47 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.862 . . . . 0.33 110.989 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.952 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.8 m -143.63 43.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.27 110.396 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 4.0 t30 -42.04 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.41 109.303 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.691 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.9 t80 -179.69 -167.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.4 109.68 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.7 OUTLIER -150.97 50.07 0.66 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.45 110.533 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -75.76 -84.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.838 1.441 . . . . 0.36 110.508 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.71 -0.25 51.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.25 109.998 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -115.99 163.57 15.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.39 110.007 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.17 168.68 9.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.48 110.049 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -43.6 -32.83 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.4 110.04 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -64.4 -46.32 83.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.46 109.512 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 12.5 mt-10 -67.23 -57.5 6.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.138 -0.976 . . . . 0.47 109.66 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 125' ' ' TYR . 17.5 t -45.33 -32.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.95 -1.13 . . . . 0.31 107.95 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.7 mt-10 -63.55 -44.54 93.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.078 -1.082 . . . . 0.48 108.078 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.2 ttmt -68.56 -49.07 62.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.24 -0.984 . . . . 0.64 108.651 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.831 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.39 -59.75 2.76 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.212 -0.93 . . . . 0.42 110.245 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.68 -53.78 30.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.34 110.825 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.63 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.18 -73.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.47 110.335 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtt? -38.63 -60.63 0.8 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.865 -0.522 . . . . 0.47 110.603 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.38 -38.71 13.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.676 -1.265 . . . . 0.25 108.528 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -71.68 -29.68 64.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.368 -0.832 . . . . 0.35 109.079 178.797 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 140' ' ' LYS . 6.1 ttmm -61.24 -44.91 96.5 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.19 -1.041 . . . . 0.7 108.19 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 6.5 t -63.61 -43.35 98.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.7 -0.852 . . . . 0.61 108.7 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.628 ' O ' HG22 ' A' ' 148' ' ' VAL . 46.2 t-105 -56.35 -44.4 80.05 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.79 -0.819 . . . . 0.39 108.79 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 149' ' ' THR . 9.6 m -64.66 -32.12 73.65 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.35 108.886 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -62.72 -36.57 83.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.521 -0.737 . . . . 0.36 109.334 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 145' ' ' TRP . 35.3 m -89.17 -11.56 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -0.85 . . . . 0.5 110.534 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 146' ' ' SER . 14.9 t -175.92 132.67 0.42 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.927 -1.108 . . . . 0.51 110.247 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.04 60.1 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.866 1.456 . . . . 0.31 110.804 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 ' CG ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -72.32 129.63 38.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.18 109.879 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.19 124.73 33.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.17 110.191 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.535 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -136.27 155.85 49.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.14 110.508 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.567 ' O ' HG22 ' A' ' 119' ' ' THR . 34.5 m -152.81 132.11 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.15 110.222 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.57 ' HD3' HG23 ' A' ' 122' ' ' ILE . 0.8 OUTLIER -101.55 91.21 4.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.978 . . . . 0.2 110.123 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.5 94.32 7.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.22 110.286 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 158' ' ' ASP . 14.3 p-80 -52.71 -25.85 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.32 109.867 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' HIS . 1.5 t70 -41.53 -62.79 0.81 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.468 0.652 . . . . 0.33 109.679 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.58 34.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.888 -1.285 . . . . 0.28 109.888 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 119' ' ' THR . 22.6 mm -126.5 69.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.065 -1.256 . . . . 0.3 109.108 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -127.91 136.9 51.99 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.001 -0.68 . . . . 0.2 110.572 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -118.33 -35.81 3.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.1 110.269 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 1.047 HG21 HD13 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -126.82 163.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.294 -0.879 . . . . 0.1 109.511 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.806 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 6.5 ptm -172.77 156.19 3.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.208 -1.558 . . . . 0.11 111.727 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 122' ' ' ILE . 4.5 tt -98.43 114.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.654 -0.654 . . . . 0.1 109.447 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.952 ' HB3' HG23 ' A' ' 123' ' ' VAL . 80.9 p -155.85 151.61 27.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 0.1 110.92 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -72.45 119.15 16.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.522 -0.736 . . . . 0.09 109.826 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -77.87 129.31 9.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.219 -1.152 . . . . 0.2 110.219 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.5 tt -126.18 98.55 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.614 -0.933 . . . . 0.55 109.634 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.596 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 1.2 tmtt? 1.15 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.589 0.588 . . . . 0.85 112.589 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 20.21 0.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.71 110.282 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -93.31 -88.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.42 110.268 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.29 -20.96 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.325 -1.51 . . . . 0.33 109.325 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.68 -66.91 0.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -1.062 . . . . 0.33 110.339 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 175' ' ' PHE . 23.4 p90 -148.24 163.51 36.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.27 110.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.0 m-30 -69.24 114.95 27.37 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.34 110.186 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.5 ' O ' HD23 ' A' ' 184' ' ' LEU . 44.1 Cg_endo -77.07 -72.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.857 1.451 . . . . 0.47 110.784 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -54.2 146.87 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.35 110.422 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 179' ' ' ASP . 44.4 p-10 -178.08 76.82 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.2 110.459 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 53.18 -169.39 0.88 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.121 -1.591 . . . . 0.25 109.121 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.513 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.3 Cg_endo -78.28 10.05 2.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.042 1.548 . . . . 0.44 110.478 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 184' ' ' LEU . 28.5 t -47.59 177.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.57 110.915 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.02 76.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.479 -1.048 . . . . 0.49 110.479 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.651 HD23 ' OD1' ' A' ' 202' ' ' ASP . 5.0 tp 179.47 87.68 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.369 -1.077 . . . . 0.41 109.767 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.859 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.4 tt -109.84 -23.47 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.901 -1.124 . . . . 0.3 111.42 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 201' ' ' PHE . . . -152.5 101.84 2.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.517 -1.365 . . . . 0.2 111.935 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 2.2 p80 -100.76 120.84 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.054 . . . . 0.16 110.016 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.78 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -102.64 132.45 48.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.23 110.179 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.468 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-30 -78.91 168.92 23.19 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.38 110.421 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 48.0 Cg_endo -73.68 125.47 10.05 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.994 1.523 . . . . 0.4 109.553 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.25 68.22 1.41 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.897 1.472 . . . . 0.32 110.6 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.36 -86.23 1.4 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.366 -1.494 . . . . 0.32 109.366 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 -164.46 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.072 1.564 . . . . 0.47 110.367 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -74.22 -0.89 18.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.63 110.386 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.89 48.67 1.19 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.53 110.162 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -124.32 177.37 16.79 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.313 -1.515 . . . . 0.25 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 46.79 22.74 1.22 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.902 -1.279 . . . . 0.1 109.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.88 86.58 6.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -1.211 . . . . 0.1 109.745 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -61.58 97.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.143 -0.973 . . . . 0.09 110.057 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 14.1 m170 -107.34 126.73 52.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.09 110.341 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.5 m-85 -99.0 132.58 44.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.173 -0.954 . . . . 0.1 110.529 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.651 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -46.74 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.834 -0.802 . . . . 0.14 108.834 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.52 -27.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.18 111.638 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.537 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 19.6 m-20 -77.17 3.15 13.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.622 -1.299 . . . . 0.24 110.731 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.859 ' OE1' HD12 ' A' ' 185' ' ' LEU . 17.2 mm-40 -98.41 -167.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.934 -1.104 . . . . 0.42 110.41 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . 0.532 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -124.94 151.72 45.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.47 110.177 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.1 m-90 -148.95 144.52 26.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.27 109.911 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.986 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.57 170.17 21.42 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.958 -1.089 . . . . 0.3 110.638 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.464 ' HB2' HD23 ' A' ' 216' ' ' LEU . 1.1 t -129.58 26.98 5.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.822 -0.807 . . . . 0.61 108.822 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -95.26 -94.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.715 -0.615 . . . . 0.78 110.296 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.483 ' N ' ' OG ' ' A' ' 210' ' ' SER . 18.0 p -156.78 20.96 0.33 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.91 109.8 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 213' ' ' GLY . 5.4 mttm -141.94 -177.16 5.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.439 -0.788 . . . . 0.93 110.134 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 43.68 -166.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.385 -1.486 . . . . 0.79 109.385 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.476 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 73.7 m-85 -73.75 120.54 19.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.69 109.793 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.589 ' O ' HG12 ' A' ' 219' ' ' VAL . 57.2 m-80 -84.52 120.05 25.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.963 -1.086 . . . . 0.4 108.856 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.986 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.33 -37.2 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.17 110.439 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 3.1 m-30 -51.33 -47.79 62.59 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 118.619 -1.232 . . . . 0.28 107.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 244' ' ' TYR . 7.3 tp -77.0 -70.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.9 -0.591 . . . . 0.46 110.605 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -48.89 -66.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.944 -1.097 . . . . 0.39 109.808 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -46.57 -48.55 19.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.111 -0.993 . . . . 0.17 111.077 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -58.59 -45.43 89.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.323 -1.485 . . . . 0.1 108.764 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.851 ' HB2' HD11 ' A' ' 239' ' ' LEU . 2.7 t-160 -58.08 -54.52 45.99 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.415 0.626 . . . . 0.21 109.811 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 188' ' ' ALA . 24.6 tp10 -58.5 -57.12 14.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.28 109.156 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.835 ' CE1' HD11 ' A' ' 163' ' ' ILE . 3.3 m-85 -43.73 -57.89 2.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.18 109.016 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.496 ' HA3' ' HE1' ' A' ' 240' ' ' MET . . . -46.96 -35.04 7.76 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.421 -1.472 . . . . 0.21 109.421 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.774 ' NE2' ' CE1' ' A' ' 232' ' ' HIS . 0.1 OUTLIER -81.8 -67.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.095 -1.238 . . . . 0.17 111.08 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.78 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -38.08 -42.95 0.7 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.46 -0.775 . . . . 0.33 111.726 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 163' ' ' ILE . 2.1 tp -99.95 -36.72 9.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.815 -1.178 . . . . 0.53 110.753 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.59 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -64.99 -79.71 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.3 -1.12 . . . . 0.41 110.3 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.609 HD11 ' O ' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -177.37 -152.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.45 110.896 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.48 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -68.87 -50.67 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.62 110.199 179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.774 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 0.9 OUTLIER -175.19 169.15 3.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.45 110.017 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.9 p -169.31 53.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.38 109.229 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.99 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.2 OUTLIER -139.33 25.14 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.48 111.525 -178.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.545 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -39.39 -51.06 4.8 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.38 110.428 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 53.2 Cg_endo -81.03 -52.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.571 1.301 . . . . 0.28 110.687 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 176.75 101.72 0.15 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.2 -1.476 . . . . 0.24 111.508 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.99 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -139.4 177.4 7.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.261 -1.141 . . . . 0.28 109.65 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 222' ' ' HIS . 2.0 tp -67.8 -3.98 11.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.065 -1.022 . . . . 0.4 109.86 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.652 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 6.4 mmt -94.91 -6.81 41.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.45 111.709 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -53.8 169.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.768 -1.208 . . . . 0.57 110.681 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.532 ' O ' ' CG1' ' A' ' 243' ' ' ILE . 49.5 Cg_endo -80.22 43.0 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.662 1.349 . . . . 0.76 110.055 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 242' ' ' PRO . 9.0 mt -161.01 144.38 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.797 -0.816 . . . . 0.89 108.797 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.559 ' HB2' HD21 ' A' ' 218' ' ' LEU . 53.7 p90 -124.97 -34.15 2.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.965 -1.084 . . . . 0.78 110.057 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.558 ' C ' ' O ' ' A' ' 244' ' ' TYR . 15.7 m 2.9 -70.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.831 0.678 . . . . 0.61 112.831 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.581 ' CE2' ' HD3' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -61.34 106.96 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.632 -1.292 . . . . 0.74 108.977 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.455 ' N ' ' HB2' ' A' ' 250' ' ' SER . 0.2 OUTLIER -47.03 174.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.81 110.263 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.31 -16.5 27.87 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.037 -1.625 . . . . 0.56 109.037 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -146.89 31.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.37 110.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.455 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -56.56 -19.22 14.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.44 110.144 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -170.97 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.53 110.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.491 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -177.92 177.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.38 111.019 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -71.32 56.68 0.24 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.64 -0.663 . . . . 0.19 110.903 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.729 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.0 OUTLIER -43.82 -47.07 20.79 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.019 -1.104 . . . . 0.28 108.019 177.182 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.5 Cg_endo -71.29 50.89 1.3 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.983 1.518 . . . . 0.49 111.085 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.629 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 15.1 m-20 -54.56 -28.77 48.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.021 -1.05 . . . . 0.49 111.192 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.94 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -54.38 -46.3 73.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.726 -1.234 . . . . 0.31 109.396 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.025 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.07 -32.02 56.5 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.297 -1.001 . . . . 0.14 108.297 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.991 HG21 ' HB2' ' A' ' 253' ' ' MET . 66.7 t -61.25 -76.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.661 -0.816 . . . . 0.17 110.269 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.632 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.3 tt0 -65.78 -42.26 90.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.101 -0.999 . . . . 0.26 109.434 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.38 -63.44 1.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.129 -1.189 . . . . 0.19 110.129 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.025 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -77.75 -20.49 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.762 -1.434 . . . . 0.22 110.395 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.844 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -59.72 -25.98 65.25 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.795 -1.19 . . . . 0.39 108.028 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.0 m -104.38 -33.54 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.145 -0.622 . . . . 0.47 111.764 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 112' ' ' LYS . 2.2 mm? -90.08 -44.99 9.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.075 -1.015 . . . . 0.48 111.563 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.885 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -85.09 -11.28 55.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.41 110.647 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.3 -110.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.516 . . . . 0.46 109.311 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.66 93.78 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.809 1.426 . . . . 0.58 110.353 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 113' ' ' TRP . . . -79.18 156.08 41.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.44 -1.464 . . . . 0.64 109.44 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.578 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 38.0 t0 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.244 -1.151 . . . . 0.95 110.396 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.379 0.609 . . . . 1.03 109.568 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 0.3 OUTLIER 38.21 42.53 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.577 . . . . 1.04 111.126 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.867 ' CD ' HD23 ' A' ' 265' ' ' LEU . 1.2 ptpt -134.3 66.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.77 109.303 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.616 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 12.3 t90 -140.37 -65.15 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.42 110.822 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 36.1 t -103.69 56.41 0.74 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.44 111.09 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 114' ' ' SER . 30.4 mmtt -150.9 45.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.028 -1.045 . . . . 0.49 110.476 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.556 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 2.0 ttp -81.66 -1.9 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.3 110.458 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.566 ' O ' HD12 ' A' ' 118' ' ' LEU . 2.4 p-10 -148.51 119.53 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.15 110.012 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.862 HD22 HD11 ' A' ' 228' ' ' LEU . 1.5 tp -152.13 174.3 13.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.13 110.493 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -118.2 159.46 23.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.12 110.256 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.864 ' HB3' HG23 ' A' ' 163' ' ' ILE . 20.1 p90 -154.35 170.22 21.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.616 -0.834 . . . . 0.33 110.591 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 147.39 49.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.54 110.12 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.863 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -107.09 125.05 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.33 110.929 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.907 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.3 m -167.19 43.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.27 109.768 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.514 ' OD1' ' CE ' ' A' ' 129' ' ' MET . 1.0 OUTLIER -40.07 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.41 109.429 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.538 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 19.9 t80 -178.46 -178.62 0.62 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 0.4 109.641 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -119.7 48.2 1.12 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.917 -1.114 . . . . 0.45 110.664 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -71.28 -87.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.11 1.584 . . . . 0.36 110.52 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -108.41 -15.09 14.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 0.25 109.909 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.583 ' CB ' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -111.24 104.95 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.39 109.548 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -51.46 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.48 110.593 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.58 -39.35 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.4 110.209 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -55.45 -57.82 10.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.46 109.668 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.583 ' CB ' ' CB ' ' A' ' 129' ' ' MET . 2.2 mp0 -55.72 -56.75 16.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.47 109.256 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 125' ' ' TYR 0.253 5.1 t -44.47 -35.46 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.016 -1.105 . . . . 0.31 108.016 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 132' ' ' SER . 5.0 tt0 -59.47 -44.43 93.02 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.888 -1.153 . . . . 0.48 107.888 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.8 tttp -68.22 -44.0 76.71 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.581 -0.896 . . . . 0.64 108.581 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -47.96 -58.53 4.3 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.205 -0.934 . . . . 0.42 109.893 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -69.92 -51.76 30.28 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.704 -0.798 . . . . 0.34 110.701 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.623 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 10.8 tttt -64.22 -73.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 0.47 109.993 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -39.14 -60.84 0.83 Allowed 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.837 -0.539 . . . . 0.47 110.693 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.88 -37.4 8.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.665 -1.214 . . . . 0.25 108.519 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -73.23 -34.27 65.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.781 . . . . 0.35 109.217 178.827 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -56.36 -40.68 74.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.269 -1.011 . . . . 0.7 108.269 178.957 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 4.1 t -69.25 -44.58 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.893 -0.78 . . . . 0.61 108.893 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.652 ' O ' HG22 ' A' ' 148' ' ' VAL . 27.4 t-105 -54.71 -42.66 71.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.464 -0.773 . . . . 0.39 109.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 149' ' ' THR . 20.0 m -70.37 -33.41 71.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.81 . . . . 0.35 108.929 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -58.1 -36.48 72.94 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.612 -0.68 . . . . 0.36 109.457 179.267 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.827 HG23 HG22 ' A' ' 149' ' ' THR . 34.7 m -86.9 -29.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.5 110.634 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.827 HG22 HG23 ' A' ' 148' ' ' VAL . 5.2 t -153.04 135.93 9.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.869 -1.144 . . . . 0.51 110.526 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.88 58.1 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.986 1.519 . . . . 0.31 110.644 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -80.15 136.52 36.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 0.18 110.076 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 9.3 t30 -88.08 126.11 34.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.17 110.391 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.79 139.52 45.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.14 110.207 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.642 ' O ' HG22 ' A' ' 119' ' ' THR . 11.5 m -141.47 137.57 32.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.15 110.369 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.549 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.6 130.77 47.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 0.2 109.677 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.803 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -128.43 105.7 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.22 110.193 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 158' ' ' ASP . 11.2 p80 -54.54 -33.8 60.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.32 110.075 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.602 ' OD2' HD11 ' A' ' 160' ' ' ILE . 1.3 t70 -42.25 -42.38 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.589 -0.694 . . . . 0.33 109.869 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.57 33.77 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.442 -1.463 . . . . 0.28 109.442 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.803 HD12 ' CD2' ' A' ' 156' ' ' LEU . 6.7 mt -116.15 75.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.286 -1.126 . . . . 0.3 109.631 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 120' ' ' TYR . . . -143.6 147.78 34.89 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.528 -0.732 . . . . 0.2 110.403 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.2 OUTLIER -105.67 -18.22 14.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.1 110.285 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.864 HG23 ' HB3' ' A' ' 120' ' ' TYR . 1.2 tt -136.07 166.93 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.153 -0.967 . . . . 0.1 110.077 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.746 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 6.9 ptp -171.38 146.38 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.288 . . . . 0.11 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.4 tt -98.72 119.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.423 -0.798 . . . . 0.1 110.082 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.907 ' HB3' HG23 ' A' ' 123' ' ' VAL . 14.9 p -161.8 158.58 25.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.965 -1.084 . . . . 0.1 110.82 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 18.6 p90 -76.41 122.46 24.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.09 110.061 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.462 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -78.19 134.8 14.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.023 -1.231 . . . . 0.2 110.023 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 169' ' ' ILE . 1.3 tt -130.17 98.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.977 . . . . 0.55 109.702 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.4 OUTLIER 1.09 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 121.359 0.6 . . . . 0.85 112.266 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -141.52 7.0 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.71 110.215 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 6.9 m80 -77.98 -51.61 10.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.42 110.002 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 94.65 39.38 4.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.433 -1.467 . . . . 0.33 109.433 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.24 -51.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -1.095 . . . . 0.33 110.036 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.86 159.28 16.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.27 110.135 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 14.5 m-30 -113.0 85.27 7.75 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.34 110.097 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.474 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 46.3 Cg_endo -73.69 -57.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.993 1.523 . . . . 0.47 110.386 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.61 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -57.96 135.37 56.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.35 110.698 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.483 ' N ' ' OD2' ' A' ' 204' ' ' ASP . 3.2 p30 179.97 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.206 -0.997 . . . . 0.2 111.602 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.2 -161.33 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.247 -1.141 . . . . 0.25 110.247 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.511 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.6 Cg_endo -80.11 44.01 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.086 1.572 . . . . 0.44 110.157 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.7 m -81.08 177.66 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.095 -1.003 . . . . 0.57 110.231 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.74 71.32 0.03 OUTLIER Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.892 -1.283 . . . . 0.49 109.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.731 HD23 ' OD1' ' A' ' 202' ' ' ASP . 0.7 OUTLIER 179.58 95.31 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.303 -1.116 . . . . 0.41 110.202 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.467 HD13 ' CE2' ' A' ' 214' ' ' TYR . 6.7 tt -114.0 -18.41 11.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.708 -1.245 . . . . 0.3 111.375 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' ALA . . . . . 0.934 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -151.0 105.76 3.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.493 -1.379 . . . . 0.2 112.001 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 2.2 p-80 -115.08 119.81 37.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.16 109.485 178.797 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.877 ' HB2' ' CD ' ' A' ' 223' ' ' GLU . . . -109.68 142.03 41.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.981 -1.075 . . . . 0.23 110.691 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.463 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -72.56 168.94 19.34 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.38 110.327 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 189' ' ' PHE . 46.6 Cg_endo -74.69 137.87 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.4 109.502 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.473 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.3 Cg_endo -70.8 82.1 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.85 1.447 . . . . 0.32 110.569 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 -99.72 1.29 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.396 -1.482 . . . . 0.32 109.396 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.94 -162.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 0.47 110.241 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -65.58 -11.82 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.63 109.991 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.42 60.89 0.64 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.557 -0.714 . . . . 0.53 110.058 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 162' ' ' ASP . . . -134.33 177.07 19.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.559 -1.816 . . . . 0.25 108.559 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.83 25.88 0.25 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.808 -1.317 . . . . 0.1 109.808 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 196' ' ' GLY . 72.7 m-20 -79.71 91.77 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.962 -1.316 . . . . 0.1 109.898 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -67.38 111.69 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.09 110.421 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.501 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 31.2 m170 -121.6 126.43 49.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 0.09 110.2 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 203' ' ' ASP . 23.2 m-85 -98.1 137.63 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.939 -1.1 . . . . 0.1 110.674 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.731 ' OD1' HD23 ' A' ' 184' ' ' LEU . 1.1 m-20 -49.19 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.14 108.889 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.576 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 1.4 p30 -35.94 -30.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.772 . . . . 0.18 111.663 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 9.4 m-20 -79.06 2.07 21.92 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.59 -1.319 . . . . 0.24 111.245 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 29.4 mm-40 -95.95 -162.51 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.982 -1.074 . . . . 0.42 110.155 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.8 m -125.81 148.53 49.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.112 -0.992 . . . . 0.47 110.529 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.576 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.5 m-90 -142.27 142.85 32.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.267 -0.896 . . . . 0.27 109.785 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 208' ' ' THR . . . . . 1.028 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -155.37 174.3 15.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.954 -1.091 . . . . 0.3 110.722 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.1 t -129.27 21.97 5.66 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.649 -0.871 . . . . 0.61 108.649 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.4 OUTLIER -99.2 -81.47 0.45 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.712 0.767 . . . . 0.78 110.376 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.7 p -171.77 -35.32 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.958 -0.756 . . . . 0.91 108.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -80.06 139.81 36.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.469 -0.769 . . . . 0.93 109.538 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.04 -154.96 32.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.935 -1.666 . . . . 0.79 108.935 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.491 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 60.0 m-85 -93.77 117.25 29.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.243 . . . . 0.69 109.555 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.62 ' O ' HG12 ' A' ' 219' ' ' VAL . 46.9 m-80 -81.4 122.4 27.44 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.946 -1.096 . . . . 0.4 109.028 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 1.028 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -42.28 -37.42 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.17 109.937 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 2.3 m-30 -51.98 -48.74 64.23 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.423 -1.325 . . . . 0.28 107.423 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -73.34 -73.57 0.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.819 -0.628 . . . . 0.46 109.906 178.464 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.6 OUTLIER -47.77 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.39 110.043 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -41.61 -51.28 4.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.735 -1.228 . . . . 0.17 111.484 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.91 -33.51 71.96 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.249 -1.532 . . . . 0.1 109.045 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.638 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.3 t60 -71.63 -58.6 3.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.311 0.577 . . . . 0.21 109.564 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.934 ' CG ' ' HB1' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -55.87 -25.04 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.62 -0.882 . . . . 0.28 108.62 178.525 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.7 m-30 -72.11 -67.65 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.6 0.714 . . . . 0.18 109.261 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.43 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.98 -27.25 0.99 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.646 -1.782 . . . . 0.21 108.646 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.836 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -80.98 -58.41 3.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -1.085 . . . . 0.17 110.348 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.772 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.4 OUTLIER -47.74 -45.39 28.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.668 -0.645 . . . . 0.33 111.794 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.862 HD11 HD22 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -100.54 -38.15 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.02 . . . . 0.53 111.044 -178.75 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -63.96 -77.2 0.24 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.043 -1.223 . . . . 0.41 110.043 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 0.63 HD11 ' O ' ' A' ' 232' ' ' HIS . 1.7 pt? -177.14 -162.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.187 . . . . 0.45 110.488 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.5 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.2 OUTLIER -62.5 -54.6 37.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.62 109.904 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.836 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 2.2 m80 -163.71 178.26 8.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.45 110.379 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 2.5 t 179.59 60.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.38 109.122 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.881 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -144.61 22.13 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.589 -0.844 . . . . 0.48 111.174 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.525 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -37.12 -49.13 2.19 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.759 -0.776 . . . . 0.38 110.775 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 47.1 Cg_endo -89.41 -46.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.738 1.389 . . . . 0.28 111.586 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.66 98.88 0.12 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 118.971 -1.585 . . . . 0.24 111.91 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.881 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -149.22 165.5 31.69 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.39 -1.065 . . . . 0.28 110.012 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.617 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -79.32 55.63 1.93 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.4 108.837 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.638 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 14.0 mtt -137.96 -24.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.81 . . . . 0.45 110.998 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -60.05 171.35 0.93 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.7 -1.25 . . . . 0.57 109.962 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.8 Cg_endo -69.48 -4.69 14.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.377 1.198 . . . . 0.76 110.128 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 10.2 mm -100.43 148.47 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.89 109.689 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.817 ' HB2' HD21 ' A' ' 218' ' ' LEU . 35.0 p90 -133.35 -27.46 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.095 -1.003 . . . . 0.78 111.174 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.729 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 3.27 -69.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.642 0.978 . . . . 0.61 113.642 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.729 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -66.32 129.82 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.348 -1.47 . . . . 0.74 109.676 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -161.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.81 110.202 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.474 ' O ' ' CG ' ' A' ' 249' ' ' LYS . . . -86.93 10.89 66.39 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.427 -1.469 . . . . 0.56 109.427 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 249' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -177.59 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.37 110.37 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -32.88 73.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 0.44 110.167 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.79 -88.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.53 110.174 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -164.18 92.59 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 0.38 110.387 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.762 ' HB2' HG21 ' A' ' 259' ' ' VAL . 3.1 ptt? 36.09 47.77 0.48 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.544 -0.722 . . . . 0.19 111.596 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.704 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.9 tp -47.65 -44.69 56.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.862 -1.135 . . . . 0.28 107.958 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -73.1 49.62 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.646 1.34 . . . . 0.49 111.055 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.604 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.6 m-20 -47.48 -32.41 5.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.754 -1.216 . . . . 0.49 110.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.875 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -55.57 -49.81 71.72 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.131 -0.981 . . . . 0.31 109.821 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 1.011 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.66 -32.08 63.8 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.448 -0.901 . . . . 0.14 108.615 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 253' ' ' MET . 71.1 t -66.72 -82.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.17 110.061 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.0 tt0 -55.92 -40.9 73.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.306 -0.871 . . . . 0.26 109.247 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.29 -70.65 0.45 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.113 -1.195 . . . . 0.19 110.113 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 1.011 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -74.24 -21.01 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.952 -1.322 . . . . 0.22 110.342 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 1.006 ' N ' HD13 ' A' ' 262' ' ' ILE . 47.7 tt0 -64.05 -20.36 65.88 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.904 -1.118 . . . . 0.39 108.422 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 18.8 t -103.42 -42.45 5.7 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.249 -0.58 . . . . 0.47 111.347 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.867 HD23 ' CD ' ' A' ' 112' ' ' LYS . 4.2 mp -87.32 -45.64 10.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.141 -0.974 . . . . 0.48 111.202 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.655 ' OH ' HD12 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -79.08 -5.11 53.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.41 109.948 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.65 -72.28 0.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.608 -1.397 . . . . 0.46 109.608 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -86.9 142.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.987 1.52 . . . . 0.58 110.761 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.556 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -105.46 121.76 6.95 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.498 -1.441 . . . . 0.64 109.498 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.616 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.107 -1.231 . . . . 0.95 110.149 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' THR . . . . . 0.679 HG22 ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 121.482 0.658 . . . . 1.03 111.488 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' CG ' ' A' ' 191' ' ' PRO . 0.7 OUTLIER 40.73 48.49 2.65 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.268 -0.895 . . . . 1.04 111.471 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.679 ' HE2' HG22 ' A' ' 110' ' ' THR . 4.1 pttt -146.82 79.07 1.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.77 109.113 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TRP . . . . . 0.616 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 7.6 t90 -143.89 -70.1 0.31 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.42 111.398 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 93.6 p -96.95 63.0 1.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.44 111.015 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 114' ' ' SER . 14.2 mttm -159.59 53.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.49 110.082 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' MET . . . . . 0.464 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -60.79 -19.89 60.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.3 110.408 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -138.34 156.2 47.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.15 110.446 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -166.09 -174.61 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.13 110.127 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' THR . . . . . 0.88 HG22 ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -128.47 149.26 50.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.181 -0.949 . . . . 0.12 110.11 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' TYR . . . . . 0.663 ' HB3' HG23 ' A' ' 163' ' ' ILE . 23.1 p90 -149.87 165.12 33.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -0.922 . . . . 0.33 111.18 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.2 OUTLIER -118.08 150.91 38.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.54 109.89 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ILE . . . . . 0.897 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -115.65 124.76 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.886 . . . . 0.33 110.543 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 123' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -168.76 43.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.27 109.932 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.3 t-20 -40.79 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.41 109.501 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TYR . . . . . 0.685 ' O ' HG21 ' A' ' 134' ' ' VAL . 3.7 t80 -179.35 -164.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.4 109.553 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 130' ' ' THR . 1.8 m -148.12 46.78 0.48 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.913 -1.117 . . . . 0.45 110.864 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -74.03 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.896 1.472 . . . . 0.36 110.109 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.26 -4.46 58.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.955 . . . . 0.25 109.689 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' MET . . . . . 0.781 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.2 ptm -122.85 171.87 8.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.39 110.107 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' THR . . . . . 0.592 ' HA ' HG23 ' A' ' 126' ' ' THR . 0.2 OUTLIER -119.66 171.63 8.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.48 109.768 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -45.74 -28.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.036 -1.04 . . . . 0.4 109.715 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -67.31 -58.28 5.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.46 109.464 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.4 mp0 -55.82 -55.32 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.24 -0.913 . . . . 0.47 108.775 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.9 t -46.19 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.826 -1.176 . . . . 0.31 107.826 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' GLU . . . . . 0.579 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 8.1 tt0 -59.37 -42.48 91.73 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.782 -1.192 . . . . 0.48 107.782 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.575 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 23.4 tttt -70.65 -47.59 59.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.185 0.993 . . . . 0.64 108.456 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.872 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -49.26 -62.22 1.66 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.566 -0.709 . . . . 0.42 110.217 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.636 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -66.89 -52.51 42.45 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.41 -0.806 . . . . 0.34 110.842 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 139' ' ' LYS . . . . . 0.636 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 1.0 OUTLIER -64.52 -72.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.976 -1.077 . . . . 0.47 110.555 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 140' ' ' LYS . . . . . 0.557 ' HD3' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -41.5 -58.68 1.83 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.581 -0.699 . . . . 0.47 110.383 179.254 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.81 -35.4 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.564 -1.254 . . . . 0.25 108.351 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.63 -39.35 64.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.443 -0.786 . . . . 0.35 109.117 178.823 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -56.03 -38.82 71.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.08 -1.012 . . . . 0.7 108.455 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.9 t -68.92 -45.28 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.112 -0.699 . . . . 0.61 109.112 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' TRP . . . . . 0.866 ' HH2' HG21 ' A' ' 262' ' ' ILE . 50.4 t-105 -57.11 -35.31 69.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.39 108.895 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.7 m -75.73 -39.64 56.94 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.327 -0.858 . . . . 0.35 108.788 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -40.74 72.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.36 109.51 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 149' ' ' THR . 27.6 m -75.78 -33.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.5 109.781 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 145' ' ' TRP . 9.9 t -147.2 147.33 28.44 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.168 -0.958 . . . . 0.51 110.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.67 58.69 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.948 1.499 . . . . 0.31 110.222 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 152' ' ' ASN . 1.4 tm? -84.0 139.46 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.18 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ASN . . . . . 0.946 ' N ' HD13 ' A' ' 151' ' ' LEU . 1.2 m-20 -104.26 139.2 39.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.17 110.118 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' PHE . . . . . 0.59 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 2.1 p90 -151.24 155.95 39.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.14 110.593 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' THR . . . . . 0.88 ' O ' HG22 ' A' ' 119' ' ' THR . 7.3 m -152.9 131.05 11.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.406 -0.809 . . . . 0.15 109.943 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ARG . . . . . 0.572 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 5.2 mtm180 -96.62 82.47 3.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.2 110.595 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.673 HD23 HD13 ' A' ' 160' ' ' ILE . 1.6 mp -74.98 83.34 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.155 -0.965 . . . . 0.22 109.71 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.7 p-80 -42.82 -26.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.32 110.16 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -41.14 -37.87 0.97 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.616 -0.677 . . . . 0.33 109.768 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.38 33.71 0.3 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.879 -1.288 . . . . 0.28 109.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ILE . . . . . 0.673 HD13 HD23 ' A' ' 156' ' ' LEU . 2.7 mp -127.83 65.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -1.223 . . . . 0.3 109.507 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ALA . . . . . 0.503 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -122.36 144.38 49.06 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.232 -0.587 . . . . 0.2 110.364 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.7 OUTLIER -107.6 -36.54 6.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.885 . . . . 0.1 110.205 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 227' ' ' SER . 0.4 OUTLIER -127.57 156.87 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.132 -0.98 . . . . 0.1 110.001 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' MET . . . . . 0.818 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 13.7 ptm -163.94 160.45 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.42 -1.425 . . . . 0.11 111.564 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . 0.671 ' O ' HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -106.75 119.41 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.46 -0.775 . . . . 0.1 109.985 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' SER . . . . . 0.872 ' HB3' HG23 ' A' ' 123' ' ' VAL . 11.6 p -158.68 146.01 17.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.1 110.389 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' PHE . . . . . 0.599 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 10.4 p90 -66.34 114.24 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.09 109.667 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -73.49 119.81 6.74 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.225 -1.15 . . . . 0.2 110.225 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -110.05 103.25 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.48 -1.012 . . . . 0.55 109.311 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 2.0 tmtt? 1.26 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.32 0.581 . . . . 0.85 112.317 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 1.9 tm-20 -137.17 5.21 2.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.71 110.218 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -87.14 -87.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.978 . . . . 0.42 110.284 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 134.13 -34.86 2.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.165 -1.574 . . . . 0.33 109.165 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.53 -31.25 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 0.33 110.153 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' PHE . . . . . 0.419 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 2.4 t80 -172.52 116.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.27 110.183 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.3 m-30 -47.14 105.72 0.51 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34 110.192 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.2 Cg_endo -74.18 -61.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.902 1.475 . . . . 0.47 110.422 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -55.23 144.49 24.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.35 110.64 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 182' ' ' SER . 2.7 p30 179.12 80.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.396 -0.815 . . . . 0.2 110.093 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.82 -154.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.335 -1.506 . . . . 0.25 109.335 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 182' ' ' SER . 53.3 Cg_endo -79.63 11.29 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.994 1.523 . . . . 0.44 110.393 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 0.8 OUTLIER -45.28 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.57 110.669 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 183' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -64.71 72.34 0.07 OUTLIER Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.795 -0.922 . . . . 0.49 110.795 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' LEU . . . . . 0.862 HD22 ' OD1' ' A' ' 202' ' ' ASP . 4.4 tt 179.52 92.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.191 -1.182 . . . . 0.41 110.322 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 205' ' ' GLU . 4.1 tt -110.15 -23.84 11.05 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.561 -1.256 . . . . 0.3 111.471 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -150.9 103.3 3.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.521 -1.362 . . . . 0.2 112.065 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 1.5 p80 -103.0 141.12 36.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.103 . . . . 0.16 109.683 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' ALA . . . . . 0.943 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -123.78 128.04 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.23 110.478 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -75.25 169.78 18.78 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.38 110.337 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 190' ' ' PRO . . . . . 0.496 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.8 Cg_endo -75.08 134.51 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.119 1.589 . . . . 0.4 109.792 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 191' ' ' PRO . . . . . 0.705 ' CG ' HD23 ' A' ' 111' ' ' LEU . 43.9 Cg_endo -70.62 73.53 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.962 1.506 . . . . 0.32 110.431 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.87 -98.09 2.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.632 -1.387 . . . . 0.32 109.632 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.04 -161.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.988 1.52 . . . . 0.47 110.045 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -67.75 -9.41 43.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 0.63 110.237 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.53 55.86 0.64 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.387 -0.821 . . . . 0.53 110.23 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.07 174.87 19.41 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.185 -1.566 . . . . 0.25 109.185 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 43.55 24.63 0.43 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.971 -1.252 . . . . 0.1 109.971 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.1 OUTLIER -78.18 92.02 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -1.22 . . . . 0.1 110.604 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 199' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -73.36 99.47 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.09 109.779 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' HIS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 1.9 m-70 -112.58 138.59 49.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.09 110.388 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 203' ' ' ASP . 25.8 m-85 -105.74 137.52 43.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.1 110.526 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ASP . . . . . 0.862 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -49.47 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.092 -1.077 . . . . 0.14 108.092 178.529 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.5 p30 -36.07 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.1 -0.64 . . . . 0.18 111.967 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 202' ' ' ASP . 32.0 m-20 -80.58 6.36 12.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.739 -1.225 . . . . 0.24 111.006 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 205' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 185' ' ' LEU . 16.8 mm-40 -97.91 -167.07 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.922 -1.111 . . . . 0.42 110.226 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.0 143.86 50.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.47 110.446 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' TRP . . . . . 0.524 ' HB3' HD11 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -143.17 131.38 21.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.93 . . . . 0.27 109.409 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 208' ' ' THR . . . . . 0.974 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -145.08 170.5 16.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.832 -1.167 . . . . 0.3 111.114 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 209' ' ' SER . . . . . 0.631 ' HB2' HD23 ' A' ' 216' ' ' LEU . 17.4 t -130.92 26.71 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.81 0.814 . . . . 0.61 108.956 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -89.09 -93.53 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.752 -0.592 . . . . 0.78 110.272 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 211' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -155.41 18.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.91 110.156 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.64 -176.3 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.93 110.221 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.8 -172.24 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.256 -1.537 . . . . 0.79 109.256 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 244' ' ' TYR . 75.6 m-85 -68.22 101.68 1.22 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -1.222 . . . . 0.69 109.734 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' ASN . . . . . 0.585 ' O ' HG12 ' A' ' 219' ' ' VAL . 29.7 m120 -76.1 117.77 18.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.047 -1.033 . . . . 0.4 108.857 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' LEU . . . . . 0.974 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -40.17 -36.73 0.54 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.716 . . . . 0.17 110.528 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 217' ' ' PHE . . . . . 0.575 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.3 m-85 -49.45 -49.79 43.75 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.335 -1.346 . . . . 0.28 107.736 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' LEU . . . . . 0.55 HD12 HD11 ' A' ' 239' ' ' LEU . 47.5 tp -76.83 -68.64 0.58 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.7 -0.682 . . . . 0.46 110.778 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' VAL . . . . . 0.95 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -50.89 -66.69 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.39 109.718 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -44.25 -49.69 9.18 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.727 -1.233 . . . . 0.17 110.653 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -64.73 -23.1 67.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.535 -1.353 . . . . 0.1 109.194 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.706 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 19.1 t-80 -79.97 -55.7 4.78 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.186 0.517 . . . . 0.21 109.778 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' GLU . . . . . 0.773 ' OE1' ' HB1' ' A' ' 199' ' ' ALA . 29.1 tt0 -58.75 -43.65 90.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.127 -0.983 . . . . 0.28 108.71 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 2.7 m-85 -58.42 -60.36 3.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.86 . . . . 0.18 109.46 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -31.33 1.94 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.18 -1.568 . . . . 0.21 109.18 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 226' ' ' HIS . . . . . 0.53 ' NE2' ' CE1' ' A' ' 222' ' ' HIS . 1.4 m80 -78.58 -74.77 0.26 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.107 -1.231 . . . . 0.17 110.679 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' SER . . . . . 0.972 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -41.18 -36.67 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.385 0.513 . . . . 0.33 112.385 -178.531 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 228' ' ' LEU . . . . . 0.682 ' HB2' HD13 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -101.39 -35.06 9.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.81 -1.181 . . . . 0.53 112.172 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 229' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -85.36 -87.52 0.94 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.97 -1.081 . . . . 0.41 111.442 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 230' ' ' LEU . . . . . 1.064 ' O ' HD13 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -154.27 156.01 36.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -1.127 . . . . 0.45 110.483 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.897 ' N ' HD22 ' A' ' 230' ' ' LEU . 1.3 m-20 -37.08 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.349 -0.844 . . . . 0.62 110.98 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 232' ' ' HIS . . . . . 0.747 ' O ' HD21 ' A' ' 230' ' ' LEU . 8.9 m-70 -143.12 161.39 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.247 -0.908 . . . . 0.45 110.588 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' HD11 ' A' ' 230' ' ' LEU . 1.0 OUTLIER -165.67 35.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.38 109.937 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 234' ' ' LYS . . . . . 0.61 ' CA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -103.23 20.48 17.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.48 110.624 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 235' ' ' ASP . . . . . 0.611 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -41.36 -60.15 1.95 Allowed Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.291 -0.964 . . . . 0.38 109.299 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 236' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 54.7 Cg_endo -81.07 -50.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.666 1.351 . . . . 0.28 109.742 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.37 93.49 0.09 OUTLIER Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.788 -1.196 . . . . 0.24 111.36 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' ALA . . . . . 0.878 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -137.48 162.76 32.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.929 -1.336 . . . . 0.28 110.12 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' LEU . . . . . 0.586 ' N ' ' HB2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -73.22 57.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.195 -0.941 . . . . 0.4 109.275 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 240' ' ' MET . . . . . 0.706 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.0 OUTLIER -140.37 -31.04 0.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.45 110.687 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 241' ' ' PHE . . . . . 0.552 ' HB3' ' HG3' ' A' ' 234' ' ' LYS . 0.1 OUTLIER -42.0 167.22 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.57 110.553 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.23 -5.6 17.19 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.965 1.508 . . . . 0.76 109.605 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' ILE . . . . . 0.753 HG22 HG22 ' A' ' 245' ' ' THR . 19.4 mt -102.78 145.67 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.89 109.812 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 244' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 246' ' ' TYR . 45.8 p90 -128.65 -31.73 2.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.78 110.419 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 245' ' ' THR . . . . . 0.753 HG22 HG22 ' A' ' 243' ' ' ILE . 0.4 OUTLIER 2.17 -67.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.571 0.952 . . . . 0.61 113.571 -179.338 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 246' ' ' TYR . . . . . 0.745 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -59.4 101.99 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.478 -1.389 . . . . 0.74 109.415 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.526 ' N ' ' HB2' ' A' ' 250' ' ' SER . 1.4 m -47.98 178.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.763 . . . . 0.81 110.475 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 247' ' ' THR . . . -52.1 -20.36 6.56 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.938 -1.265 . . . . 0.56 109.938 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.26 31.35 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.083 -1.245 . . . . 0.37 110.639 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 250' ' ' SER . . . . . 0.526 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.2 OUTLIER -49.65 -47.35 49.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 0.44 109.876 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -47.65 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.53 110.022 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.46 -178.19 0.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.38 110.494 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 253' ' ' MET . . . . . 0.881 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -68.32 55.52 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.19 110.595 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.727 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.8 tp -43.99 -47.61 22.29 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.061 -1.088 . . . . 0.28 108.061 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -71.1 48.52 0.89 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.054 1.555 . . . . 0.49 111.279 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ASP . . . . . 0.644 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.4 m-20 -52.64 -28.78 22.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.882 -1.136 . . . . 0.49 111.191 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 257' ' ' ASP . . . . . 0.878 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.58 -52.67 62.97 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.875 -1.13 . . . . 0.31 109.523 -178.874 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ASP . . . . . 0.94 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.22 -32.29 68.62 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.203 -0.999 . . . . 0.14 108.947 179.083 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 259' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 253' ' ' MET . 61.1 t -64.02 -82.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.807 -0.757 . . . . 0.17 110.054 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' GLN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.8 tt0 -55.59 -42.43 74.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 0.26 108.951 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -38.95 -72.4 0.21 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 262' ' ' ILE . . . . . 0.94 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -72.33 -22.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.34 . . . . 0.22 110.082 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLN . . . . . 0.829 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.8 OUTLIER -57.25 -24.84 57.4 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.843 -1.143 . . . . 0.39 108.424 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.0 -37.44 7.37 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.146 -0.622 . . . . 0.47 111.507 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' LEU . . . . . 0.488 ' N ' HD22 ' A' ' 265' ' ' LEU . 4.5 mm? -83.15 -47.98 11.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.48 111.951 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 266' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -82.74 -9.94 59.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.41 110.691 -179.136 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 267' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -54.62 -97.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.009 -1.636 . . . . 0.46 109.009 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.05 116.75 4.67 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.097 1.577 . . . . 0.58 110.246 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -67.33 134.92 31.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.749 -1.34 . . . . 0.64 109.749 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 270' ' ' ASP . . . . . 0.616 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.95 110.037 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.206 0.527 . . . . 0.41 110.18 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 106' ' ' VAL . 13.8 p30 -150.31 136.2 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.26 110.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.61 HG12 ' N ' ' A' ' 107' ' ' PHE . 54.9 t -156.5 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 0.33 110.0 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.61 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.7 m-85 -92.37 114.22 61.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.65 109.949 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 44.9 Cg_endo -72.18 67.45 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.877 1.461 . . . . 0.84 110.672 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.811 ' C ' HD13 ' A' ' 230' ' ' LEU . 1.2 mtt180 -148.64 95.14 2.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.93 110.153 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.965 ' N ' HD13 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -171.63 -60.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.45 -0.781 . . . . 1.03 109.727 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.507 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 6.3 tp 39.41 30.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 1.04 111.178 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.74 ' HB3' HD12 ' A' ' 265' ' ' LEU . 0.3 OUTLIER -118.4 88.75 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.023 . . . . 0.77 109.776 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.611 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 13.4 t90 -153.52 -65.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.42 111.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.518 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 17.8 t -105.02 59.97 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.44 111.207 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 114' ' ' SER . 10.9 mmtm -154.57 53.45 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.035 -1.041 . . . . 0.49 110.379 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.482 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 59.2 ttp -72.97 -15.67 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.3 110.393 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 15.3 p-10 -142.78 140.42 31.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.15 110.416 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 118' ' ' LEU . 12.8 tp -158.23 166.39 32.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.379 -0.826 . . . . 0.13 109.841 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -107.57 162.94 13.5 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -0.983 . . . . 0.12 110.081 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.613 ' HB3' HG23 ' A' ' 163' ' ' ILE . 36.5 p90 -157.63 164.02 37.65 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.376 -0.93 . . . . 0.33 110.887 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.24 146.46 45.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.422 -0.799 . . . . 0.54 110.301 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.766 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.2 pt -106.31 117.46 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.33 110.574 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.9 m -162.82 42.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.27 110.04 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 11.3 t-20 -40.63 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.79 -0.764 . . . . 0.41 109.311 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 7.8 t80 -178.92 178.46 0.76 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.409 -0.807 . . . . 0.4 109.78 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -130.56 51.08 6.9 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.45 110.126 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -75.85 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.125 1.592 . . . . 0.36 110.639 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -99.58 -2.09 36.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.25 109.938 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.577 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -110.47 168.76 9.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -0.8 . . . . 0.39 109.879 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.48 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -116.97 169.08 9.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.48 110.25 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -43.28 -32.96 0.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.4 109.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.9 m -67.98 -47.93 67.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.46 109.84 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 9.5 mp0 -63.07 -58.83 5.95 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.137 -0.977 . . . . 0.47 109.745 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 125' ' ' TYR . 10.9 t -45.68 -36.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.042 -1.096 . . . . 0.31 108.042 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.4 tt0 -57.84 -42.06 83.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.096 -1.076 . . . . 0.48 108.096 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 5.9 tttt -72.53 -51.1 21.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.448 -0.901 . . . . 0.64 108.732 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.865 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -44.92 -60.08 2.24 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.137 -0.977 . . . . 0.42 110.223 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.745 ' CE2' HD12 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -67.47 -52.82 34.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.34 110.974 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.07 -71.67 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.931 -1.105 . . . . 0.47 110.159 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtp? -39.49 -61.29 0.82 Allowed 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.809 -0.557 . . . . 0.47 110.508 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.41 -37.16 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.693 -1.254 . . . . 0.25 108.305 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.2 -36.67 74.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.743 -0.836 . . . . 0.35 108.743 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttmm -58.03 -41.39 83.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.228 -0.92 . . . . 0.7 108.923 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.79 -48.42 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.592 -0.692 . . . . 0.61 109.4 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.615 ' CH2' HG13 ' A' ' 262' ' ' ILE . 57.0 t-105 -55.01 -38.05 67.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.39 109.157 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -73.5 -34.0 65.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.305 -0.872 . . . . 0.35 108.936 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -44.18 89.45 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.36 109.251 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 145' ' ' TRP . 26.9 m -72.93 -32.2 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.634 -0.826 . . . . 0.5 109.753 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 146' ' ' SER . 15.3 t -152.0 134.18 8.54 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.51 110.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.29 59.83 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.951 1.501 . . . . 0.31 110.158 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -76.72 136.04 39.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.18 110.414 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -82.35 120.45 25.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.17 109.92 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.561 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.5 p90 -131.6 133.99 45.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 0.14 110.521 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.857 ' O ' HG22 ' A' ' 119' ' ' THR . 6.3 m -140.02 128.9 23.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.364 -0.835 . . . . 0.15 110.11 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.698 HH12 HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -96.67 81.85 3.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.2 109.972 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.627 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -82.26 89.1 6.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.094 -1.004 . . . . 0.22 110.109 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.439 ' O ' ' C ' ' A' ' 158' ' ' ASP . 15.0 p80 -48.45 -24.43 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.32 109.963 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.439 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.0 t70 -42.29 -27.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.497 -0.752 . . . . 0.33 109.811 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 124.55 26.33 1.46 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.72 -1.352 . . . . 0.28 109.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.627 HD12 ' CD2' ' A' ' 156' ' ' LEU . 51.7 mt -119.85 70.93 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -1.215 . . . . 0.3 109.725 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.483 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -124.35 143.48 50.56 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.15 -0.62 . . . . 0.2 110.598 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.441 ' CG ' HD21 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -108.1 -43.78 4.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.1 109.965 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 227' ' ' SER . 1.0 OUTLIER -119.86 156.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.259 -0.901 . . . . 0.1 109.84 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.941 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.1 ptt? -156.85 153.01 27.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.515 -1.365 . . . . 0.11 111.602 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 165' ' ' ILE . 4.1 tt -101.24 116.69 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.1 109.316 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.998 ' HB3' HG23 ' A' ' 123' ' ' VAL . 12.9 p -162.64 148.64 12.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.578 -1.326 . . . . 0.1 111.364 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.571 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.3 p90 -67.79 117.15 9.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -0.823 . . . . 0.09 109.411 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -75.38 142.76 29.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.91 -0.876 . . . . 0.2 110.91 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -134.54 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.754 -0.851 . . . . 0.55 109.124 178.959 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 11.7 tmtt? 1.08 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.375 0.607 . . . . 0.85 112.428 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 171' ' ' GLU . 14.3 tt0 -146.16 23.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.326 -0.859 . . . . 0.71 110.11 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.433 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 12.1 m170 -96.89 -67.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.42 110.267 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 124.6 5.96 6.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.649 -1.38 . . . . 0.33 109.649 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -121.51 -82.62 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -1.226 . . . . 0.33 110.217 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.476 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 65.3 m-85 -102.48 154.6 18.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.27 110.016 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.2 m-30 -96.56 105.74 24.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.34 110.039 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 43.7 Cg_endo -73.17 -66.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.929 1.489 . . . . 0.47 110.823 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -49.47 135.39 18.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.35 110.634 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 182' ' ' SER . 7.6 p30 179.56 83.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.241 -0.912 . . . . 0.2 110.398 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.496 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.47 -156.59 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.688 -1.365 . . . . 0.25 109.688 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.6 Cg_endo -76.45 6.35 4.07 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.123 1.591 . . . . 0.44 110.308 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 1.5 t -41.06 165.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.57 110.738 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.545 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.62 76.18 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.536 -1.025 . . . . 0.49 110.536 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.984 ' HA ' HG13 ' A' ' 1' ' ' HAV . 3.3 tt 179.78 89.28 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.358 -1.084 . . . . 0.41 110.058 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.596 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 1.3 tt -106.2 -21.66 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.787 -1.196 . . . . 0.3 111.533 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.619 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.59 108.86 3.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.473 -1.392 . . . . 0.2 112.247 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.1 OUTLIER -106.48 125.74 51.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 0.16 109.73 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.826 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -115.54 150.62 36.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.16 -0.963 . . . . 0.23 110.613 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.433 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.6 m-30 -107.53 165.33 12.99 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.937 . . . . 0.38 110.471 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 43.4 Cg_endo -71.18 137.81 32.11 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.012 1.532 . . . . 0.4 109.901 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 41.2 Cg_endo -67.53 74.5 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.041 1.548 . . . . 0.32 110.807 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.62 -92.66 1.97 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.913 -1.675 . . . . 0.32 108.913 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.37 -159.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.001 1.527 . . . . 0.47 110.17 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.32 2.63 12.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.63 110.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 15.71 19.66 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.287 -0.883 . . . . 0.53 110.094 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -86.55 167.0 38.42 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.438 -1.465 . . . . 0.25 109.438 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 45.93 24.23 1.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.354 -1.499 . . . . 0.1 109.354 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.76 93.83 3.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.208 . . . . 0.1 110.192 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -75.74 105.13 6.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.09 109.925 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 166' ' ' SER . 10.3 m170 -119.24 122.18 41.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.09 110.237 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 203' ' ' ASP . 29.7 m-85 -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.1 110.455 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.848 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -48.78 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.282 -0.886 . . . . 0.14 108.789 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -36.33 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.901 -0.72 . . . . 0.18 111.694 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 202' ' ' ASP . 66.2 m-20 -77.62 2.08 17.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.812 -1.18 . . . . 0.24 111.075 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 202' ' ' ASP . 28.6 mm-40 -97.32 -170.78 2.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.997 -1.065 . . . . 0.42 110.548 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.414 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 96.5 m -121.37 146.52 46.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.47 110.367 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.6 ' C ' HG22 ' A' ' 208' ' ' THR . 0.9 OUTLIER -145.05 145.42 31.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.887 . . . . 0.27 109.663 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.999 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -163.7 -177.97 5.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.877 -1.139 . . . . 0.3 111.159 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.478 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.2 t -125.54 30.26 5.8 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.72 0.772 . . . . 0.61 108.999 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.611 ' O ' ' ND2' ' A' ' 215' ' ' ASN . 1.3 t -126.93 -175.69 3.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.569 -0.707 . . . . 0.78 110.375 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.475 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -82.38 61.32 5.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.91 110.135 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.451 ' HG2' ' OG ' ' A' ' 210' ' ' SER . 3.5 pttt -170.0 106.26 0.34 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.957 . . . . 0.93 110.157 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 96.16 -162.47 22.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.363 -1.495 . . . . 0.79 109.363 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.596 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 83.7 m-85 -81.56 127.33 32.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -1.18 . . . . 0.69 109.986 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.611 ' ND2' ' O ' ' A' ' 210' ' ' SER . 13.1 m120 -89.25 119.25 29.57 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.095 -1.003 . . . . 0.4 108.939 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 208' ' ' THR . 0.6 OUTLIER -41.39 -36.59 0.86 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.515 -0.874 . . . . 0.17 110.214 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 5.0 m-85 -52.55 -47.04 67.01 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.468 -1.308 . . . . 0.28 107.468 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 244' ' ' TYR . 11.5 tp -78.5 -72.1 0.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.617 -0.72 . . . . 0.46 110.835 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.822 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -46.8 -61.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.936 -1.103 . . . . 0.39 110.23 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.924 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -54.35 -52.86 60.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.17 111.207 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -54.79 -29.48 54.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.352 -1.467 . . . . 0.1 109.043 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.596 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.0 t60 -77.17 -52.21 9.65 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.423 0.63 . . . . 0.21 109.895 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.73 ' OE2' ' HB2' ' A' ' 188' ' ' ALA . 19.0 tp10 -58.38 -53.87 53.39 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.28 109.01 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.645 ' HA ' HD11 ' A' ' 163' ' ' ILE . 2.4 m-85 -53.99 -46.61 71.77 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.304 -0.872 . . . . 0.18 108.84 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -49.83 -31.85 17.3 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.315 -1.914 . . . . 0.21 108.315 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.532 ' NE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -86.54 -68.38 0.75 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.385 -1.068 . . . . 0.17 110.402 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.866 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -38.74 -39.64 0.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.574 -0.704 . . . . 0.33 111.108 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 163' ' ' ILE . 4.6 tp -98.19 -34.18 10.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.086 -1.009 . . . . 0.53 110.356 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -75.58 -88.85 0.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.107 -1.197 . . . . 0.41 110.107 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -177.68 -170.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -1.088 . . . . 0.45 110.878 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.521 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -39.23 -64.91 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.556 -0.715 . . . . 0.62 110.823 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.532 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 1.3 m80 -166.92 -177.44 3.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.45 110.096 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 232' ' ' HIS . 24.1 p 179.92 60.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.768 . . . . 0.38 109.406 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 1.099 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -148.12 26.4 0.98 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.48 111.415 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.528 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.6 OUTLIER -34.34 -51.09 0.97 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.38 111.173 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 46.8 Cg_endo -83.94 -49.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.72 1.379 . . . . 0.28 111.644 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.34 103.16 0.17 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.193 -1.479 . . . . 0.24 111.424 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 1.099 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -149.84 167.84 25.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.287 -1.125 . . . . 0.28 110.532 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.596 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -73.3 58.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.326 -0.99 . . . . 0.4 108.326 178.586 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.59 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 24.7 mmm -140.42 -34.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.45 110.813 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.613 ' CG ' HG22 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -58.11 170.54 0.71 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.047 -1.033 . . . . 0.57 110.243 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.1 Cg_endo -68.72 -7.55 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.544 1.286 . . . . 0.76 110.046 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.613 HG22 ' CG ' ' A' ' 241' ' ' PHE . 1.2 tp -98.66 142.48 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 0.89 109.57 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 1.013 ' HB2' HD21 ' A' ' 218' ' ' LEU . 16.1 p90 -131.93 -21.29 2.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.246 -0.908 . . . . 0.78 111.257 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 4.25 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 112.999 0.74 . . . . 0.61 112.999 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.701 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -66.36 115.9 6.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.571 -1.331 . . . . 0.74 109.619 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 250' ' ' SER . 0.2 OUTLIER -61.46 174.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.81 110.358 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -46.74 -34.28 6.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.822 -1.311 . . . . 0.56 109.822 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -148.73 51.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.044 -1.268 . . . . 0.37 110.572 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 247' ' ' THR . 83.6 p -102.07 13.19 35.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.44 109.875 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 1.7 t60 -173.65 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.53 109.959 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.549 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 2.5 t80 179.9 177.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.38 110.193 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.851 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -75.33 48.94 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.891 . . . . 0.19 110.451 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.702 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -44.46 -47.89 26.11 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.17 -1.048 . . . . 0.28 108.17 177.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.7 Cg_endo -72.52 51.04 1.75 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.054 1.555 . . . . 0.49 110.662 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.619 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.4 m-20 -53.4 -30.23 38.93 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.118 -0.989 . . . . 0.49 109.399 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 1.091 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -50.59 -42.64 56.04 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.228 -0.92 . . . . 0.31 109.897 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.995 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.78 -33.46 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.248 -1.019 . . . . 0.14 108.248 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 253' ' ' MET . 97.0 t -62.26 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.544 -0.862 . . . . 0.17 109.727 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.9 tm0? -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.295 -0.878 . . . . 0.26 109.597 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.12 -65.29 1.29 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.19 109.919 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.995 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -78.35 -20.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.22 110.615 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.928 ' N ' HD13 ' A' ' 262' ' ' ILE . 1.7 tm0? -66.25 -21.15 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.839 -1.144 . . . . 0.39 108.513 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t -104.11 -42.54 5.51 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.383 0.611 . . . . 0.47 110.897 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -79.18 -48.42 14.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.48 111.254 -178.753 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.485 ' OH ' ' HG ' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -84.55 -7.46 59.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.41 110.542 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -50.73 -98.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.001 -1.64 . . . . 0.46 109.001 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.65 133.89 13.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.839 1.442 . . . . 0.58 110.037 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -94.7 161.06 23.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.484 -1.446 . . . . 0.64 109.484 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.611 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -112.15 -62.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -1.207 . . . . 0.95 110.134 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.518 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 81.4 tt0 46.46 29.32 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 1.2 110.177 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.79 114.21 11.01 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 1.2 110.18 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.89 75.3 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.937 1.493 . . . . 1.06 110.333 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.997 -1.001 . . . . 0.78 110.211 -179.986 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.984 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.566 ' HB1' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.619 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.2 t80 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.338 0.59 . . . . 0.41 110.216 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -133.73 120.81 21.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.26 110.046 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 107' ' ' PHE . 79.0 t -135.34 -89.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.943 . . . . 0.33 110.468 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.518 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.5 m-30 -101.77 101.0 16.01 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.65 110.234 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 48.7 Cg_endo -75.32 -158.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.974 1.512 . . . . 0.84 110.557 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER 70.94 82.65 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 0.93 110.677 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.525 ' CA ' HD13 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -149.15 -64.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.556 -0.715 . . . . 1.03 109.337 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 36.3 40.08 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.694 -0.629 . . . . 1.04 111.545 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.631 ' HD3' HD22 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -126.85 81.94 2.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.77 109.496 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 15.6 t90 -151.64 -70.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.134 -0.979 . . . . 0.42 111.16 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.539 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 13.2 p -102.4 77.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.44 111.098 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -169.31 51.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.49 110.326 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.499 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 5.6 ttt -85.37 -13.38 49.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.3 110.42 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.493 ' O ' HD12 ' A' ' 118' ' ' LEU . 6.5 p-10 -143.96 109.62 5.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.208 -0.933 . . . . 0.15 110.043 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.706 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -138.24 -168.4 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.13 110.658 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.89 HG22 ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -130.59 176.95 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.12 110.321 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CZ ' ' HG3' ' A' ' 155' ' ' ARG . 36.7 p90 -174.43 -169.24 0.43 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.27 -0.894 . . . . 0.33 110.918 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -127.87 156.46 42.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.54 110.037 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 138' ' ' PHE . 2.7 pt -122.77 95.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.33 110.436 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.992 HG23 ' HB3' ' A' ' 166' ' ' SER . 4.2 m -149.9 56.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.982 . . . . 0.27 110.812 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 1.0 OUTLIER -44.34 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.41 109.306 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 167' ' ' PHE . 11.9 t80 -178.69 -173.95 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.4 109.69 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.531 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 2.6 m -136.35 53.89 8.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.45 110.774 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -78.26 -86.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.981 1.517 . . . . 0.36 109.922 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.47 0.04 41.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.895 . . . . 0.25 109.699 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.901 ' SD ' HD21 ' A' ' 216' ' ' LEU . 2.6 ptm -121.77 147.99 45.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 0.39 109.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -92.78 169.36 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.48 110.118 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' THR . 11.2 t-160 -43.51 -33.64 1.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.4 109.622 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 2.5 m -57.98 -54.6 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.46 109.23 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.6 OUTLIER -58.1 -54.35 47.99 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.542 -0.863 . . . . 0.47 108.913 179.04 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.537 ' CG2' ' CE ' ' A' ' 129' ' ' MET . 10.5 t -45.25 -34.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.169 -1.049 . . . . 0.31 108.169 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -63.44 -41.58 98.67 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.435 -0.95 . . . . 0.48 108.435 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 2.6 ttmt -70.5 -49.54 47.33 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.922 0.868 . . . . 0.64 108.999 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.802 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -44.77 -59.6 2.44 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 121.149 -0.969 . . . . 0.42 110.206 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.669 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.54 -53.59 33.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.34 110.775 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.12 -72.69 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.994 -1.067 . . . . 0.47 110.167 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.629 ' NZ ' HG23 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -38.47 -61.89 0.65 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.85 -0.531 . . . . 0.47 110.427 178.74 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.23 -38.86 12.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.678 -1.264 . . . . 0.25 108.413 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.3 OUTLIER -69.43 -31.92 70.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.35 109.063 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -61.29 -43.85 98.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.208 -0.933 . . . . 0.7 108.699 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.629 HG23 ' NZ ' ' A' ' 140' ' ' LYS . 7.5 t -69.58 -46.56 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.915 -0.772 . . . . 0.61 108.915 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.605 ' CH2' HG13 ' A' ' 262' ' ' ILE . 53.9 t-105 -54.72 -37.1 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.485 -0.76 . . . . 0.39 109.012 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 149' ' ' THR . 56.5 m -74.93 -33.17 61.93 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.915 . . . . 0.35 108.711 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.9 OUTLIER -57.85 -43.12 85.68 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.094 -0.706 . . . . 0.36 109.094 179.026 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 145' ' ' TRP . 29.5 m -74.64 -33.98 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.438 -0.789 . . . . 0.5 109.903 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.535 HG21 HD12 ' A' ' 151' ' ' LEU . 13.1 t -148.3 129.46 7.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -0.982 . . . . 0.51 110.216 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.43 59.17 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.968 1.51 . . . . 0.31 110.582 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.825 HD11 ' HB3' ' A' ' 266' ' ' TYR . 11.6 mt -80.25 171.31 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.18 110.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -122.79 136.64 54.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.17 110.463 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.422 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.8 p90 -154.91 145.02 21.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.14 110.316 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.89 ' O ' HG22 ' A' ' 119' ' ' THR . 2.8 m -143.99 142.95 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.15 110.14 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.624 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -93.74 86.51 5.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.2 110.12 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -92.62 85.14 5.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.22 110.419 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 159' ' ' GLY . 45.5 p-80 -56.88 -19.12 15.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.32 109.873 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.884 ' HB3' HD12 ' A' ' 156' ' ' LEU . 2.4 t0 -43.4 -26.14 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.494 -0.754 . . . . 0.33 109.776 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.75 21.87 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.95 -1.26 . . . . 0.28 109.95 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.51 ' O ' ' CB ' ' A' ' 119' ' ' THR . 14.8 mt -125.63 64.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.035 -1.273 . . . . 0.3 109.274 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -115.86 137.0 52.51 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.254 -0.579 . . . . 0.2 110.594 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.706 ' CB ' HD23 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -101.34 -51.79 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.1 110.034 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.719 HG22 ' HA3' ' A' ' 197' ' ' GLY . 3.1 pt -120.01 -177.33 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.1 109.229 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.802 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.1 ptp -174.88 139.54 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.5 -1.375 . . . . 0.11 111.836 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -90.35 118.71 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.1 109.443 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.992 ' HB3' HG23 ' A' ' 123' ' ' VAL . 29.5 p -169.83 162.45 9.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.722 -1.236 . . . . 0.1 111.291 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.594 ' O ' ' CD1' ' A' ' 167' ' ' PHE . 0.1 OUTLIER -75.19 150.46 38.67 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.471 -0.768 . . . . 0.09 109.24 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -111.9 131.59 10.32 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.754 -1.212 . . . . 0.2 110.986 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.594 ' O ' ' C ' ' A' ' 170' ' ' LYS . 12.4 pt -125.74 101.31 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.629 -0.924 . . . . 0.55 109.358 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.594 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 2.08 78.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.462 0.649 . . . . 0.85 112.202 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -4.48 10.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.71 110.135 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 9.1 m-70 -83.94 -153.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.923 . . . . 0.42 110.186 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.4 36.64 1.7 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.244 -1.542 . . . . 0.33 109.244 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' PHE . 15.0 p-10 -140.87 -146.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -1.093 . . . . 0.33 110.205 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 174' ' ' ASP . 28.5 m-85 -45.84 169.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.27 110.046 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -86.31 127.12 62.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.34 110.43 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.506 ' CG ' ' HA ' ' A' ' 170' ' ' LYS . 44.6 Cg_endo -79.01 -79.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.885 1.466 . . . . 0.47 110.497 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.2 p90 -58.91 149.83 25.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.35 110.307 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 182' ' ' SER . 1.6 p30 178.89 78.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.2 110.491 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.547 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 42.63 -160.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.522 -1.431 . . . . 0.25 109.522 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 52.0 Cg_endo -78.23 9.34 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.019 1.537 . . . . 0.44 110.483 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.489 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 40.5 m -46.9 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.57 110.575 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.561 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.87 74.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 111.149 -0.78 . . . . 0.49 111.149 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.022 HD22 ' OD1' ' A' ' 202' ' ' ASP . 4.0 tt 179.56 90.45 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.22 -1.164 . . . . 0.41 110.379 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.62 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.3 tt -109.18 -21.48 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.3 111.179 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.655 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.1 105.56 3.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.665 -1.272 . . . . 0.2 111.775 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -107.08 122.54 46.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.16 109.632 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.956 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -114.64 134.07 55.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.23 110.399 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.477 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.1 m-30 -79.63 174.78 5.56 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.38 110.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.523 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.6 Cg_endo -72.77 130.72 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.089 1.573 . . . . 0.4 109.458 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.4 Cg_endo -71.22 77.28 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.95 1.5 . . . . 0.32 110.457 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.13 -90.01 0.51 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.686 -1.245 . . . . 0.32 110.217 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.5 -179.98 4.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.47 111.014 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -58.92 -14.83 10.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.815 . . . . 0.63 110.133 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.97 53.3 0.7 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.538 0.685 . . . . 0.53 109.937 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -133.97 -178.52 15.67 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.392 -1.483 . . . . 0.25 109.392 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.719 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 43.56 26.14 0.64 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.67 -1.372 . . . . 0.1 109.67 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 196' ' ' GLY . 3.7 m-20 -79.28 87.95 4.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.1 110.22 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.66 97.1 1.67 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.09 110.027 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 166' ' ' SER . 52.3 m170 -112.97 134.19 54.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.09 110.69 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.7 m-85 -101.1 135.92 41.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.905 . . . . 0.1 110.296 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 1.022 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -46.58 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.265 -1.013 . . . . 0.14 108.265 178.762 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.09 -26.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.827 -0.749 . . . . 0.18 111.826 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.547 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.0 OUTLIER -78.06 3.59 14.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.499 -1.376 . . . . 0.24 110.749 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.62 ' OE1' HD12 ' A' ' 185' ' ' LEU . 21.6 mm-40 -100.27 -174.55 2.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.008 -1.058 . . . . 0.42 110.107 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 144.27 47.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.47 110.439 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.536 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -141.4 134.11 28.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.27 109.488 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.987 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -142.34 171.12 14.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.062 . . . . 0.3 110.508 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.607 ' HB2' HD23 ' A' ' 216' ' ' LEU . 1.2 t -129.24 25.95 5.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.573 -0.899 . . . . 0.61 108.573 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -69.3 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.78 110.357 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.583 -0.698 . . . . 0.91 109.518 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -95.8 157.86 15.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.449 -0.782 . . . . 0.93 110.022 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.25 -174.55 37.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.101 -1.6 . . . . 0.79 109.101 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.544 ' CE2' HD13 ' A' ' 185' ' ' LEU . 83.9 m-85 -67.31 114.96 6.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -1.228 . . . . 0.69 109.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.617 ' O ' HG12 ' A' ' 219' ' ' VAL . 45.5 m-80 -84.37 120.33 26.14 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.985 -1.072 . . . . 0.4 109.001 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.987 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -41.18 -36.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.17 110.397 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.59 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 3.9 m-85 -52.4 -47.64 66.13 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.279 -1.378 . . . . 0.28 107.279 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.16 -73.04 0.29 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.812 -0.631 . . . . 0.46 110.422 178.581 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.2 -62.78 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.136 -0.978 . . . . 0.39 110.566 -179.491 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -51.81 -50.69 60.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.026 -1.047 . . . . 0.17 111.263 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.9 -37.52 76.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.342 -1.474 . . . . 0.1 108.829 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.622 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.6 t60 -63.68 -59.29 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.197 0.522 . . . . 0.21 109.606 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.672 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.0 tp10 -54.3 -39.44 66.97 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.252 -1.018 . . . . 0.28 108.252 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.2 m-30 -56.33 -61.32 2.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.435 -0.79 . . . . 0.18 109.057 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -45.07 -30.39 2.55 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.669 -1.772 . . . . 0.21 108.669 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 1.6 m80 -81.36 -78.27 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -1.156 . . . . 0.17 111.115 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.956 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -37.9 -37.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.584 -0.697 . . . . 0.33 112.47 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.582 ' HB2' HD13 ' A' ' 163' ' ' ILE . 11.5 tp -100.6 -36.72 9.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.717 -1.239 . . . . 0.53 111.278 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -75.82 -86.88 0.31 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.171 -1.172 . . . . 0.41 110.171 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.631 HD22 ' HD3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -172.57 -170.18 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -1.154 . . . . 0.45 110.661 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.509 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.2 t0 -43.08 -60.79 1.51 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.62 110.77 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.517 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -166.97 -175.56 3.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.45 110.359 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.449 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER 179.59 61.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.488 -0.758 . . . . 0.38 109.698 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 1.076 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.79 23.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.48 111.26 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.531 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -34.51 -47.43 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.647 . . . . 0.38 110.926 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 41.2 Cg_endo -90.78 -45.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.82 1.432 . . . . 0.28 111.987 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.31 102.02 0.15 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 118.829 -1.653 . . . . 0.24 111.991 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 1.076 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -150.46 166.47 30.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.334 -1.098 . . . . 0.28 110.257 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.603 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.3 53.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.972 . . . . 0.4 109.21 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.622 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 5.2 mtt -137.3 -30.63 0.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.45 110.372 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -47.49 171.27 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 0.57 110.6 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -70.29 -2.83 11.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.511 1.269 . . . . 0.76 110.454 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 6.4 tt -110.66 153.93 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.89 109.919 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.807 ' HB2' HD21 ' A' ' 218' ' ' LEU . 32.5 p90 -128.35 -20.61 3.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.78 110.935 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.6 OUTLIER 2.75 -67.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.717 1.006 . . . . 0.61 113.717 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -72.56 119.57 16.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.339 -1.476 . . . . 0.74 109.833 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 250' ' ' SER . 21.6 p -63.12 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.81 . . . . 0.81 110.424 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.84 -20.64 57.57 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.722 -1.351 . . . . 0.56 109.722 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -158.07 40.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -1.226 . . . . 0.37 110.507 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 247' ' ' THR . 4.6 m -63.79 -13.0 40.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.44 109.781 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.2 OUTLIER -171.13 -48.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.53 110.329 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.596 ' CD2' ' HG2' ' A' ' 253' ' ' MET . 4.7 t80 -179.1 178.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.38 110.777 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 253' ' ' MET . . . . . 1.01 ' HB2' HG21 ' A' ' 259' ' ' VAL . 6.8 ptp -68.14 55.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.424 -0.797 . . . . 0.19 110.263 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.668 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -44.11 -47.97 23.25 Favored Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 108.021 -1.103 . . . . 0.28 108.021 177.605 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.9 Cg_endo -74.31 50.53 2.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.129 1.594 . . . . 0.49 110.698 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.6 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.1 m-20 -50.87 -32.27 19.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.069 -1.019 . . . . 0.49 110.008 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.977 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 51.8 m-20 -54.17 -46.47 72.35 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.24 -0.984 . . . . 0.31 109.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.993 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -72.96 -36.32 67.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.491 -0.929 . . . . 0.14 108.491 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 1.01 HG21 ' HB2' ' A' ' 253' ' ' MET . 74.1 t -63.88 -82.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.17 110.266 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.3 tp60 -56.62 -43.09 79.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.276 -0.89 . . . . 0.26 109.495 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.76 -69.86 0.45 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.496 -1.042 . . . . 0.19 110.496 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.86 -22.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.777 -1.425 . . . . 0.22 110.032 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.941 ' N ' HD13 ' A' ' 262' ' ' ILE . 40.9 tt0 -59.98 -23.17 63.4 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.98 -1.088 . . . . 0.39 108.208 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.1 t -103.6 -43.0 5.49 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.406 0.622 . . . . 0.47 110.913 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.522 ' CB ' ' HG2' ' A' ' 112' ' ' LYS . 54.7 mt -75.31 -52.49 10.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.48 111.187 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.825 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -82.61 -1.36 50.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.41 109.959 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.31 -108.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.226 -1.55 . . . . 0.46 109.226 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.499 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.6 Cg_endo -75.91 84.29 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.702 1.369 . . . . 0.58 110.223 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.69 174.48 1.06 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.64 109.48 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.623 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -115.6 -69.01 0.88 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.95 110.117 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 28.7 tt0 41.93 37.96 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.401 -0.812 . . . . 1.2 110.259 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.455 ' OD1' ' OD2' ' A' ' 270' ' ' ASP . 8.3 p-10 -131.35 94.44 26.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 1.2 110.546 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -74.35 56.03 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.918 1.483 . . . . 1.06 110.252 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.997 -1.002 . . . . 0.78 110.16 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.991 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.599 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.655 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.231 0.539 . . . . 0.41 110.242 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 105' ' ' ASN . 18.7 p30 -145.14 140.85 28.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.26 110.183 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.81 -37.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.33 110.253 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -130.71 146.38 61.69 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.65 110.264 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.2 Cg_endo -73.44 -160.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.84 110.418 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 56.7 mtt180 58.72 66.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.336 -0.852 . . . . 0.93 110.309 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.7 OUTLIER -141.91 -61.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 1.03 110.189 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 39.49 27.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 1.04 110.88 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.607 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -114.94 72.76 0.8 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.0 . . . . 0.77 109.781 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.63 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.0 t90 -143.85 -65.09 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.42 110.474 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 271' ' ' GLU . 13.4 t -103.06 60.31 0.78 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.44 110.537 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 3.8 mmtp -146.01 85.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.146 -0.971 . . . . 0.49 110.302 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.418 ' O ' ' HB2' ' A' ' 152' ' ' ASN . 34.1 ttp -112.99 -20.78 11.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.3 110.28 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.546 ' O ' ' ND2' ' A' ' 117' ' ' ASN . 0.4 OUTLIER -144.97 129.48 17.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.169 -0.957 . . . . 0.15 110.106 179.951 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.557 HD22 ' CB ' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -152.32 -175.73 5.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.13 110.662 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 154' ' ' THR . 1.0 OUTLIER -126.39 155.44 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 0.12 109.992 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.631 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 46.1 p90 -148.61 159.46 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.33 110.776 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -116.9 151.33 36.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.51 -0.744 . . . . 0.54 109.873 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.734 HG21 ' CD1' ' A' ' 138' ' ' PHE . 2.0 pp -113.51 115.19 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.33 110.983 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.917 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.6 m -160.56 41.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.313 -0.867 . . . . 0.27 110.19 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 2.3 t-20 -40.78 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.41 109.491 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.722 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.7 t80 -179.39 -163.45 0.05 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.43 -0.794 . . . . 0.4 109.57 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -152.84 47.87 0.41 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.063 -1.023 . . . . 0.45 110.436 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -73.73 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.956 1.503 . . . . 0.36 110.311 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.95 -5.21 56.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.25 109.755 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.602 ' SD ' HD21 ' A' ' 216' ' ' LEU . 0.6 OUTLIER -115.96 172.07 7.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.39 110.068 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -123.7 177.67 5.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.48 109.993 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 4.7 t60 -45.53 -36.92 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.4 110.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 5.7 t -63.59 -50.58 68.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.46 109.595 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 129' ' ' MET . 51.9 mp0 -59.87 -62.74 1.65 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.255 -0.903 . . . . 0.47 109.378 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 125' ' ' TYR . 13.1 t -44.02 -37.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.478 -0.934 . . . . 0.31 108.478 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.559 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.77 -42.04 78.69 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.319 -0.993 . . . . 0.48 108.319 178.448 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.591 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 42.2 tttt -74.69 -47.52 31.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.005 0.907 . . . . 0.64 108.577 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.851 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -47.64 -60.71 2.36 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.333 -0.854 . . . . 0.42 110.001 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.734 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.25 -51.36 46.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.34 111.095 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.54 -72.1 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.963 -1.086 . . . . 0.47 110.277 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -40.95 -59.33 1.47 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.693 -0.629 . . . . 0.47 110.437 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.86 -37.16 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.691 -1.256 . . . . 0.25 108.012 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -69.85 -40.74 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.499 -0.751 . . . . 0.35 109.02 178.559 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -52.67 -37.47 58.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.06 -1.025 . . . . 0.7 108.565 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 89.0 t -72.75 -45.17 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.351 0.596 . . . . 0.61 109.572 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.713 ' HH2' HG21 ' A' ' 262' ' ' ILE . 26.1 t-105 -58.72 -44.37 90.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.39 109.333 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 149' ' ' THR . 58.8 m -69.11 -33.4 73.43 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.137 -0.977 . . . . 0.35 108.745 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -56.12 -44.92 79.61 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.36 109.302 179.17 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 145' ' ' TRP . 27.2 m -76.24 -30.83 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.5 109.778 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 149' ' ' THR . 12.7 t -151.8 114.7 2.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.51 109.944 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.91 59.96 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.826 1.435 . . . . 0.31 110.52 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 266' ' ' TYR . 65.7 mt -76.27 165.91 24.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.18 110.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.42 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -91.58 128.05 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.17 110.147 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 5.8 p90 -147.41 125.34 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.14 110.234 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 119' ' ' THR . 6.0 m -128.59 139.85 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.15 110.439 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.631 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -106.5 87.11 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.2 109.931 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.566 HD22 HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -95.38 89.52 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.22 110.05 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 158' ' ' ASP . 10.0 p80 -49.12 -23.78 1.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.32 109.916 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.0 t0 -42.76 -32.77 0.64 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.625 -0.672 . . . . 0.33 109.644 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.56 32.79 0.37 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.81 -1.316 . . . . 0.28 109.81 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.566 HD12 HD22 ' A' ' 156' ' ' LEU . 17.7 mt -126.79 67.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.236 . . . . 0.3 109.271 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -125.76 149.63 48.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.657 -0.652 . . . . 0.2 110.906 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.557 ' CB ' HD22 ' A' ' 118' ' ' LEU . 3.7 t70 -113.19 -38.05 4.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.1 109.623 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.973 HG22 ' HA3' ' A' ' 197' ' ' GLY . 6.6 pt -125.17 172.81 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.1 109.382 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.496 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 1.2 ptp -171.88 141.51 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.808 -1.183 . . . . 0.11 111.222 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.8 tt -93.87 117.23 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.389 -0.819 . . . . 0.1 109.563 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.917 ' HB3' HG23 ' A' ' 123' ' ' VAL . 69.4 p -158.53 159.59 35.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.893 -1.129 . . . . 0.1 110.489 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.559 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 9.1 p90 -76.63 126.41 30.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.383 -0.823 . . . . 0.09 109.709 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -88.23 117.04 4.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.148 -1.181 . . . . 0.2 110.148 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -110.25 103.01 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.67 -0.9 . . . . 0.55 109.264 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.587 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.82 81.12 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.329 0.585 . . . . 0.85 112.523 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.24 -6.26 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.71 110.048 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.464 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 13.1 m-70 -80.75 -86.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.42 110.418 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.47 4.11 6.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.526 -1.43 . . . . 0.33 109.526 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -113.28 -64.73 1.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.33 110.132 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.435 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 18.7 m-85 -112.79 118.14 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.27 110.245 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -45.78 104.29 0.39 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.34 110.36 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.521 ' O ' HD22 ' A' ' 184' ' ' LEU . 44.4 Cg_endo -74.5 -59.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.925 1.487 . . . . 0.47 110.374 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -89.2 161.04 16.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.35 109.919 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 0.9 OUTLIER -173.65 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.2 111.206 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.581 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 130.9 -137.23 9.32 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.929 -1.668 . . . . 0.25 108.929 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 182' ' ' SER . 54.0 Cg_endo -72.13 -3.37 13.15 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 O-C-N 124.076 1.566 . . . . 0.44 109.664 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -50.21 -179.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.358 -0.839 . . . . 0.57 110.158 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.544 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -82.88 73.58 2.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.278 -1.129 . . . . 0.49 110.278 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.012 ' HA ' HG13 ' A' ' 1' ' ' HAV . 4.4 tt -179.96 93.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.221 -1.164 . . . . 0.41 110.788 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.605 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 3.2 tt -109.55 -15.58 14.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.823 -1.151 . . . . 0.3 110.719 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.731 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -153.15 102.81 2.66 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.774 -1.203 . . . . 0.2 111.591 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -112.15 119.2 37.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.16 109.789 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -110.11 151.41 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.23 110.488 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.1 m-30 -90.64 165.53 22.41 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.38 110.686 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.7 Cg_endo -73.56 143.03 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.021 1.537 . . . . 0.4 109.804 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -70.5 72.74 1.78 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.896 1.471 . . . . 0.32 110.572 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.3 -101.5 2.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.433 -1.467 . . . . 0.32 109.433 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.15 -160.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.902 1.475 . . . . 0.47 110.28 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -6.97 26.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.993 . . . . 0.63 110.112 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.11 52.08 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.473 -0.767 . . . . 0.53 109.772 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -127.68 172.27 18.93 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.409 -1.477 . . . . 0.25 109.409 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.973 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 45.69 24.63 1.25 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.33 -1.508 . . . . 0.1 109.33 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -81.47 92.83 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -1.142 . . . . 0.1 110.233 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.654 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -69.37 98.55 1.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.09 110.294 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.43 ' O ' ' OE2' ' A' ' 223' ' ' GLU . 19.2 m170 -102.98 138.14 40.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.09 110.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.649 ' CE1' HG22 ' A' ' 219' ' ' VAL . 17.5 m-85 -107.15 133.16 52.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.1 111.284 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 42.9 t0 -45.55 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.936 -0.764 . . . . 0.14 108.936 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 201' ' ' PHE . 0.8 OUTLIER -40.86 -34.16 0.37 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.014 -1.053 . . . . 0.18 111.525 -177.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.581 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 48.8 t0 -73.75 0.54 12.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.772 -1.205 . . . . 0.24 110.46 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 10.5 mm-40 -97.42 -161.72 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.123 . . . . 0.42 109.903 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.539 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 69.6 m -133.24 153.67 51.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.916 -1.115 . . . . 0.47 110.835 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.67 ' C ' HG22 ' A' ' 208' ' ' THR . 0.8 OUTLIER -148.3 166.47 27.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.308 -0.87 . . . . 0.27 109.796 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.999 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.3 OUTLIER -178.81 175.07 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.069 -1.019 . . . . 0.3 110.871 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.46 ' N ' ' OG1' ' A' ' 208' ' ' THR . 0.0 OUTLIER -139.01 25.75 2.49 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.565 -0.854 . . . . 0.61 109.817 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.2 t -90.66 -88.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 0.78 110.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 210' ' ' SER . 35.7 p -158.88 18.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.91 110.0 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 213' ' ' GLY . 6.9 ptpt -145.69 -174.11 4.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.93 110.133 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 44.34 -168.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.79 109.625 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.605 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 97.7 m-85 -70.33 121.56 17.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.69 110.195 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.631 ' O ' HG12 ' A' ' 219' ' ' VAL . 47.7 m-80 -87.31 116.89 25.71 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.159 -0.963 . . . . 0.4 109.086 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.17 -35.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.625 -0.83 . . . . 0.17 110.332 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.608 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 2.2 m-85 -52.37 -45.87 65.95 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.405 -1.331 . . . . 0.28 107.405 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.979 HD21 ' HB2' ' A' ' 244' ' ' TYR . 9.7 tp -81.42 -73.16 0.39 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.435 -0.802 . . . . 0.46 110.993 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.816 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.6 p -45.5 -56.14 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.39 110.325 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.934 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -60.5 -48.5 81.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.087 -1.008 . . . . 0.17 111.114 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -56.7 -24.59 50.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.177 -1.577 . . . . 0.1 108.406 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.683 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.3 t60 -83.33 -49.87 8.93 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.749 -0.659 . . . . 0.21 110.325 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.731 ' CD ' ' HB1' ' A' ' 186' ' ' ALA . 3.0 tp10 -61.69 -44.54 96.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.933 -1.104 . . . . 0.28 108.782 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER -60.23 -62.16 2.07 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.472 -0.768 . . . . 0.18 109.026 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.85 -28.86 0.73 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.918 -1.673 . . . . 0.21 108.918 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.512 ' CE1' ' HE3' ' A' ' 240' ' ' MET . 1.0 OUTLIER -80.91 -68.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -1.134 . . . . 0.17 111.084 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.997 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -46.93 -38.41 10.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.51 -0.744 . . . . 0.33 112.288 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER -100.13 -37.45 8.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.53 110.977 -178.6 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.666 ' N ' HD23 ' A' ' 228' ' ' LEU . . . -74.39 -87.42 0.23 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.963 -1.255 . . . . 0.41 109.963 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 230' ' ' LEU . 0.7 OUTLIER -161.96 -176.23 5.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.45 110.789 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 2.6 m-20 -55.17 -58.84 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.374 -0.829 . . . . 0.62 110.19 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 231' ' ' ASP . 3.6 m80 -161.6 176.15 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.45 110.639 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 2.4 p 179.73 50.69 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.79 -0.818 . . . . 0.38 108.79 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -125.09 20.21 8.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.537 -0.727 . . . . 0.48 110.584 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.579 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -43.12 -53.53 10.54 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 119.443 -0.903 . . . . 0.38 109.831 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 50.5 Cg_endo -86.05 -47.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.595 1.313 . . . . 0.28 110.573 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 178.23 94.55 0.09 OUTLIER Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.233 -1.46 . . . . 0.24 111.589 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.833 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -144.42 162.16 37.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.211 -1.17 . . . . 0.28 110.358 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.683 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -77.61 57.73 1.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.4 108.72 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.581 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 21.6 mmm -133.14 -35.71 1.03 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.45 110.354 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -43.99 169.86 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.152 -0.968 . . . . 0.57 110.366 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.5 Cg_endo -71.85 -8.09 22.35 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.763 1.402 . . . . 0.76 109.842 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 245' ' ' THR . 16.1 mt -98.83 146.76 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.89 109.699 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.979 ' HB2' HD21 ' A' ' 218' ' ' LEU . 36.8 p90 -128.92 -25.97 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.03 -1.044 . . . . 0.78 110.976 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.743 HG22 HG22 ' A' ' 243' ' ' ILE . 0.2 OUTLIER 2.73 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.602 0.964 . . . . 0.61 113.602 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.732 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -70.23 107.56 3.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.381 -1.45 . . . . 0.74 109.686 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.774 ' HA ' HD13 ' A' ' 218' ' ' LEU . 2.2 t -65.32 -151.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 0.81 110.252 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 247' ' ' THR . . . -84.31 -5.0 87.63 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.404 -1.478 . . . . 0.56 109.404 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.754 ' H ' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -147.04 30.13 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -1.155 . . . . 0.37 110.38 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 246' ' ' TYR . 0.3 OUTLIER -74.16 -28.8 61.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.44 110.406 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 1.9 m-70 -164.82 -61.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.53 110.425 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 2.8 m-85 -174.38 -174.4 0.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.967 . . . . 0.38 110.516 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.842 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -68.07 53.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.51 -0.744 . . . . 0.19 110.559 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.695 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.1 -47.57 43.52 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 107.963 -1.125 . . . . 0.28 107.963 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.9 Cg_endo -73.59 51.0 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.137 1.598 . . . . 0.49 110.979 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.1 m-20 -50.65 -32.42 19.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.018 -1.051 . . . . 0.49 110.494 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.833 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -53.82 -54.13 42.75 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.885 -1.126 . . . . 0.31 109.136 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.017 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -66.01 -35.48 80.69 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.074 -1.05 . . . . 0.14 108.784 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 253' ' ' MET . 55.2 t -63.93 -86.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.17 110.581 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -55.0 -43.73 73.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.099 -1.001 . . . . 0.26 109.569 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.83 -70.2 0.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.641 -0.984 . . . . 0.19 110.641 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.017 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.66 -21.13 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.727 -1.455 . . . . 0.22 110.296 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.995 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.6 OUTLIER -64.86 -20.47 66.43 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.985 -1.072 . . . . 0.39 108.659 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 29.1 t -103.72 -41.88 5.8 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.203 -0.599 . . . . 0.47 111.164 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -84.3 -47.09 11.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.353 -0.842 . . . . 0.48 111.145 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -69.64 -20.52 63.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.41 110.223 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -53.51 -102.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.276 -1.53 . . . . 0.46 109.276 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.33 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.867 1.457 . . . . 0.58 110.333 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -83.22 155.79 33.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.64 109.388 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.63 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.4 OUTLIER -93.09 -61.64 1.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -1.173 . . . . 0.95 110.414 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.461 ' HB2' ' OG ' ' A' ' 114' ' ' SER . 5.2 tp10 50.27 35.49 10.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 1.2 110.004 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.0 133.41 10.25 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 1.2 110.226 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.28 85.72 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.925 1.487 . . . . 1.06 110.476 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.021 -0.99 . . . . 0.78 110.254 -179.904 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.012 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.577 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.73 ' HH2' ' CB ' ' A' ' 244' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 36.1 p90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.284 0.564 . . . . 0.41 110.253 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -166.31 75.61 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.26 110.148 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.61 -24.54 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.33 110.565 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.11 64.99 13.7 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.99 . . . . 0.65 110.696 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.1 Cg_endo -71.39 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.03 1.542 . . . . 0.84 109.984 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.8 ' C ' HD13 ' A' ' 230' ' ' LEU . 21.3 mtt180 70.63 82.64 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.93 110.46 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.59 ' N ' HD13 ' A' ' 230' ' ' LEU . 1.6 p -147.8 -65.83 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.711 . . . . 1.03 109.259 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.01 55.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.682 -0.636 . . . . 1.04 111.67 178.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -140.94 77.03 1.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.193 -0.942 . . . . 0.77 109.403 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.573 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 10.1 t90 -149.72 -69.22 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.42 111.411 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.6 t -100.48 77.17 1.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.44 111.101 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -170.21 49.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.279 -0.888 . . . . 0.49 110.185 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.2 OUTLIER -75.46 -29.15 59.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.3 110.141 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 25.0 p-10 -129.74 123.46 31.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.15 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' A' ' 162' ' ' ASP . 3.8 mt -141.32 -178.62 5.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.13 110.364 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -122.6 150.75 42.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.12 109.829 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.733 ' HB3' HG23 ' A' ' 163' ' ' ILE . 40.3 p90 -145.11 -164.31 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.33 110.692 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.1 154.2 40.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.54 110.888 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.936 HD13 ' HB3' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.48 110.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.33 110.223 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.4 m -159.91 41.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.27 110.147 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 3.4 t-20 -41.36 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.696 -0.802 . . . . 0.41 108.993 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 6.3 t80 -179.91 -176.14 0.33 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.514 -0.741 . . . . 0.4 109.593 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -132.52 49.77 4.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.013 -1.054 . . . . 0.45 110.611 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.4 Cg_endo -76.78 -85.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.854 1.45 . . . . 0.36 110.253 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.31 -0.5 38.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.25 109.622 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.821 ' SD ' HD21 ' A' ' 216' ' ' LEU . 3.6 ptm -123.12 133.93 54.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.39 109.976 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 131' ' ' HIS . 1.4 m -86.33 178.52 7.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.48 110.354 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.483 ' H ' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -45.74 -33.76 3.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.845 . . . . 0.4 110.068 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.5 t -63.16 -58.3 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.46 109.791 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.55 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 6.3 mp0 -54.46 -57.72 10.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.268 -0.895 . . . . 0.47 109.566 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.792 HG23 ' HE2' ' A' ' 129' ' ' MET . 4.0 t -45.34 -37.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.111 -1.07 . . . . 0.31 108.111 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 9.6 tt0 -59.03 -39.97 83.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.486 -0.931 . . . . 0.48 108.486 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 12.9 tttt -73.07 -50.37 23.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.64 108.776 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.806 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.64 -60.61 2.1 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.163 -0.961 . . . . 0.42 110.537 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.936 ' HB3' HD13 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.44 -50.97 48.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.34 111.216 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.625 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.91 -71.17 0.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.957 -1.089 . . . . 0.47 110.147 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -40.18 -58.78 1.4 Allowed 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.651 -0.656 . . . . 0.47 110.114 178.731 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.75 -38.81 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.707 -1.246 . . . . 0.25 108.365 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -71.0 -34.73 71.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.846 . . . . 0.35 108.985 178.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -56.4 -45.45 80.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.7 108.394 178.77 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.403 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 22.9 t -64.68 -44.67 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.987 -0.746 . . . . 0.61 108.987 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.64 ' HH2' HG21 ' A' ' 262' ' ' ILE . 26.3 t-105 -55.02 -36.69 65.74 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.718 -0.845 . . . . 0.39 108.718 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -74.12 -38.42 63.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.742 -0.836 . . . . 0.35 108.742 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -53.1 -37.48 61.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.533 -0.729 . . . . 0.36 109.045 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 145' ' ' TRP . 34.8 m -85.45 -35.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.5 110.116 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.702 ' CG2' HD23 ' A' ' 151' ' ' LEU . 15.3 t -153.93 127.25 4.24 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.038 -1.039 . . . . 0.51 110.15 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.67 59.88 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.871 1.459 . . . . 0.31 110.813 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 266' ' ' TYR . 1.9 mm? -72.53 145.88 47.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.18 110.086 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -91.88 133.68 35.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.17 110.32 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.9 p90 -149.11 147.91 29.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.14 110.237 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.931 ' O ' HG22 ' A' ' 119' ' ' THR . 6.5 m -152.72 133.03 13.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.15 110.29 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 32.1 mtm180 -91.86 119.32 31.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.013 -1.054 . . . . 0.2 110.16 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.405 HD12 HG21 ' A' ' 119' ' ' THR . 0.3 OUTLIER -117.56 108.67 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.22 110.3 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -72.17 -4.11 27.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.32 110.091 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -30.08 69.79 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.409 -0.807 . . . . 0.33 109.581 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.81 30.65 0.63 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.734 -1.346 . . . . 0.28 109.734 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.726 ' O ' HG22 ' A' ' 160' ' ' ILE . 57.7 mt -126.68 66.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.073 -1.251 . . . . 0.3 109.308 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -121.9 152.1 39.99 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.358 0.599 . . . . 0.2 110.612 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' CB ' HD22 ' A' ' 118' ' ' LEU . 5.4 t70 -120.5 -40.04 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.1 109.818 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.919 HG21 HD13 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -128.57 171.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.36 -0.838 . . . . 0.1 110.105 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.745 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 2.3 ptp -177.14 153.99 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.539 -1.351 . . . . 0.11 111.379 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.6 tt -99.3 118.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.1 109.408 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.988 ' HB3' HG23 ' A' ' 123' ' ' VAL . 15.1 p -162.85 144.64 10.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.752 -1.218 . . . . 0.1 111.237 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.652 ' CE2' ' CG2' ' A' ' 169' ' ' ILE . 0.9 OUTLIER -66.42 122.83 18.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.09 110.006 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -80.87 127.94 8.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.972 -1.251 . . . . 0.2 109.972 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.652 ' CG2' ' CE2' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -116.07 102.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.535 -0.98 . . . . 0.55 109.659 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.639 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.78 81.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.439 0.638 . . . . 0.85 112.257 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 169' ' ' ILE . 1.7 mm-40 -125.95 -4.86 6.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.71 110.267 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.524 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 8.8 m-70 -87.41 -140.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.42 109.995 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -169.89 -36.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.399 -1.48 . . . . 0.33 109.399 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -61.36 -61.23 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -1.104 . . . . 0.33 110.194 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.8 116.02 17.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.27 110.16 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -55.41 114.43 7.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 0.34 110.071 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.518 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 42.9 Cg_endo -73.14 -79.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.907 1.477 . . . . 0.47 110.898 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -46.59 142.95 2.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 0.35 110.778 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' A' ' 184' ' ' LEU . 4.4 p30 179.5 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.2 110.751 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.573 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 46.76 -167.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.38 -1.488 . . . . 0.25 109.38 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.2 Cg_endo -75.81 5.01 4.66 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.197 1.63 . . . . 0.44 110.304 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -44.57 173.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -0.797 . . . . 0.57 110.898 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.564 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.64 76.71 0.02 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.895 -0.882 . . . . 0.49 110.895 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.046 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.4 OUTLIER 179.46 88.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.174 -1.192 . . . . 0.41 110.373 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.557 HD12 ' OE1' ' A' ' 205' ' ' GLU . 4.6 tt -108.76 -21.13 12.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.832 -1.168 . . . . 0.3 111.612 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.631 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -149.97 101.09 3.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.48 -1.388 . . . . 0.2 111.907 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.7 OUTLIER -101.76 123.78 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.473 -0.767 . . . . 0.16 109.431 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.93 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -108.88 137.32 46.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.23 110.65 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -80.0 173.1 8.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.38 110.369 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 48.4 Cg_endo -73.75 133.34 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.975 1.513 . . . . 0.4 109.786 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.552 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -69.79 81.17 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.866 1.456 . . . . 0.32 110.604 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.55 -106.63 1.78 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.292 -1.523 . . . . 0.32 109.292 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.95 -159.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.882 1.464 . . . . 0.47 110.337 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -63.07 -11.27 18.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.941 . . . . 0.63 110.383 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.76 56.02 0.68 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.428 -0.795 . . . . 0.53 110.147 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.3 174.59 22.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.212 -1.555 . . . . 0.25 109.212 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 42.09 25.75 0.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.946 -1.261 . . . . 0.1 109.946 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.3 OUTLIER -79.38 86.16 5.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.32 . . . . 0.1 110.005 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.94 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.09 110.002 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.541 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.4 m170 -98.79 134.01 42.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.09 110.669 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.598 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 13.3 m-30 -102.74 131.07 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -0.903 . . . . 0.1 109.877 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.957 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -46.3 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.544 -0.91 . . . . 0.14 108.544 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.0 p30 -37.68 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.18 111.53 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.573 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -77.7 3.95 12.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.762 -1.211 . . . . 0.24 110.829 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.557 ' OE1' HD12 ' A' ' 185' ' ' LEU . 15.6 mm-40 -100.68 -167.39 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.036 . . . . 0.42 110.315 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.507 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 3.2 m -124.64 150.28 46.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -0.929 . . . . 0.47 110.385 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.55 ' HB3' HD11 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -147.42 142.74 27.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.902 . . . . 0.27 109.636 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.958 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -157.81 174.21 15.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.822 -1.174 . . . . 0.3 110.984 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.476 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.5 t -130.66 41.0 3.44 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.639 0.733 . . . . 0.61 109.384 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.9 t -109.87 -99.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.78 110.267 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.494 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -149.59 13.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.068 -1.02 . . . . 0.91 110.247 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.99 155.55 44.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.93 109.858 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.81 -175.24 53.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.081 -1.608 . . . . 0.79 109.081 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 185' ' ' LEU . 67.7 m-85 -71.26 106.53 3.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 0.69 109.931 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.517 ' O ' HG12 ' A' ' 219' ' ' VAL . 61.6 m-20 -75.04 119.28 18.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.154 -0.966 . . . . 0.4 108.528 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.958 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -39.71 -37.01 0.47 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.82 -0.752 . . . . 0.17 110.271 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.571 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.3 m-30 -52.16 -48.82 64.73 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.653 -1.24 . . . . 0.28 107.653 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.953 HD11 ' HH1' ' A' ' 3' ' ' MSB . 6.8 tp -74.56 -69.81 0.44 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.856 -0.611 . . . . 0.46 110.45 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.5 OUTLIER -50.12 -70.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.077 -1.014 . . . . 0.39 109.75 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -41.73 -52.55 3.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.07 . . . . 0.17 111.248 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.47 -37.3 77.84 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.417 -1.427 . . . . 0.1 108.977 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.836 ' HB2' HD11 ' A' ' 239' ' ' LEU . 5.6 t60 -64.91 -53.39 47.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.421 0.629 . . . . 0.21 109.551 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.552 ' OE1' ' HB1' ' A' ' 186' ' ' ALA . 25.0 tp10 -57.99 -46.14 85.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.28 109.301 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.531 ' CZ ' ' HB1' ' A' ' 220' ' ' ALA . 12.3 m-30 -52.57 -63.44 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.18 109.279 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -34.46 2.73 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.913 -1.675 . . . . 0.21 108.913 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.711 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -76.03 -79.02 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -1.132 . . . . 0.17 110.839 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.93 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.4 -53.93 0.65 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.666 -0.646 . . . . 0.33 111.916 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -80.59 -44.83 18.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.998 -1.064 . . . . 0.53 110.725 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -63.58 -82.78 0.08 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.775 -1.33 . . . . 0.41 109.775 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -177.5 -170.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -1.076 . . . . 0.45 110.299 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 230' ' ' LEU . 1.8 m-20 -42.22 -61.62 1.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.62 110.51 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.711 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -159.51 -175.9 5.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.289 -0.882 . . . . 0.45 109.989 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.0 61.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.295 -0.878 . . . . 0.38 109.56 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.907 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.68 24.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.279 -0.968 . . . . 0.48 111.502 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -35.93 -51.9 1.58 Allowed Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.987 -0.685 . . . . 0.38 111.106 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 51.1 Cg_endo -85.58 -49.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.643 1.338 . . . . 0.28 111.291 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.19 101.25 0.14 Allowed Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.214 -1.47 . . . . 0.24 111.581 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.907 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -143.22 -174.21 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -1.124 . . . . 0.28 110.238 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.836 HD11 ' HB2' ' A' ' 222' ' ' HIS . 3.1 tp -88.86 27.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.371 1.081 . . . . 0.4 108.87 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.663 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -119.44 -6.46 10.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.872 -1.142 . . . . 0.45 110.655 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -60.53 170.31 1.42 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 121.15 -0.969 . . . . 0.57 111.558 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.1 Cg_endo -76.09 6.08 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.516 1.272 . . . . 0.76 110.597 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.732 HG22 HG22 ' A' ' 245' ' ' THR . 16.1 mt -126.89 164.88 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.337 -0.852 . . . . 0.89 109.506 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.666 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 33.3 p90 -139.72 -29.2 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.78 111.249 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.2 OUTLIER 3.18 -67.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 114.14 1.163 . . . . 0.61 114.14 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -59.87 101.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.279 -1.513 . . . . 0.74 109.816 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.505 ' N ' ' HB2' ' A' ' 250' ' ' SER . 80.6 p -50.44 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.81 110.146 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -56.79 -26.14 53.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.463 -1.455 . . . . 0.56 109.463 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.31 29.33 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.16 . . . . 0.37 110.014 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.521 ' O ' ' ND1' ' A' ' 251' ' ' HIS . 0.5 OUTLIER -62.8 -10.98 14.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.44 109.982 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 250' ' ' SER . 0.1 OUTLIER -174.42 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.53 110.204 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.3 OUTLIER 179.67 -173.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.38 110.285 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.916 ' HB2' HG21 ' A' ' 259' ' ' VAL . 14.2 ptt? -66.55 53.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.605 -0.684 . . . . 0.19 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.695 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -47.84 -46.3 62.52 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.28 107.833 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.9 Cg_endo -74.54 52.52 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.958 1.504 . . . . 0.49 110.806 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.639 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 9.9 m-20 -55.78 -31.51 62.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.159 -0.963 . . . . 0.49 110.572 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.851 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -51.35 -45.91 62.52 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.655 -1.218 . . . . 0.31 108.551 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.933 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.72 -39.47 64.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.453 -0.943 . . . . 0.14 108.453 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.916 HG21 ' HB2' ' A' ' 253' ' ' MET . 97.3 t -56.24 -76.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.17 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.71 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 7.1 pt20 -71.05 -34.76 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.32 -0.862 . . . . 0.26 110.567 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -44.37 -58.34 4.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.308 -1.517 . . . . 0.19 109.308 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.933 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -82.87 -23.12 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.023 -1.28 . . . . 0.22 110.89 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.722 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -62.63 -20.0 64.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.462 . . . . 0.39 108.195 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -103.18 -36.92 7.93 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.181 -0.608 . . . . 0.47 111.125 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 48.5 mt -88.32 -46.89 8.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.139 -0.976 . . . . 0.48 111.216 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.749 ' HB3' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -81.33 -4.76 56.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.41 110.299 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.8 -112.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.231 -1.548 . . . . 0.46 109.231 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.55 86.2 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.789 1.415 . . . . 0.58 110.296 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.27 170.12 1.8 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.64 109.575 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.573 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 -108.82 -61.35 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.95 110.166 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 1.9 tm-20 54.07 30.64 12.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 1.2 110.259 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.7 102.04 0.34 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 1.2 110.465 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 274' ' ' ASN . 46.2 Cg_endo -73.72 -7.3 19.96 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.035 1.545 . . . . 1.06 110.335 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 273' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.969 -1.015 . . . . 0.78 110.35 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.046 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.576 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.953 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.258 0.551 . . . . 0.41 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -93.62 108.82 20.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 0.26 110.162 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.576 HG12 ' CD2' ' A' ' 107' ' ' PHE . 15.9 t -79.15 -118.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.33 109.918 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.576 ' CD2' HG12 ' A' ' 106' ' ' VAL . 77.6 m-85 -108.52 122.19 41.07 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 120.774 -1.204 . . . . 0.65 110.313 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.9 56.72 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.896 1.472 . . . . 0.84 110.465 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.529 ' O ' HG23 ' A' ' 110' ' ' THR . 49.0 mtt-85 -141.14 85.78 1.99 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.93 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -161.34 -51.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.765 . . . . 1.03 109.256 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.6 OUTLIER 32.15 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.131 0.491 . . . . 1.04 111.461 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.883 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 7.6 mttt -124.73 64.92 1.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.77 110.357 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.628 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.1 t90 -123.3 -67.94 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.897 . . . . 0.42 110.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.468 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 72.8 p -99.38 54.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.44 110.151 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 17.5 mmtt -145.31 87.15 1.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.49 110.289 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 116' ' ' MET . 2.1 tmm? -121.34 -4.45 9.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.3 110.052 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.15 110.076 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.429 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -147.29 -167.1 2.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.13 110.31 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -133.66 156.37 48.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.12 110.473 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.804 ' CB ' HG23 ' A' ' 163' ' ' ILE . 46.0 p90 -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.49 -0.884 . . . . 0.33 110.94 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 1.1 mtt85 -124.85 151.39 45.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.54 110.114 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.723 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.2 pp -114.02 97.93 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.947 . . . . 0.33 111.14 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' A' ' 166' ' ' SER . 7.3 m -147.34 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.27 110.471 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 16.0 t-20 -44.31 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.41 109.379 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.553 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.0 t80 -179.85 -166.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.437 -0.79 . . . . 0.4 109.736 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -148.95 48.2 0.57 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.982 -1.074 . . . . 0.45 110.693 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.3 Cg_endo -74.04 -87.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.998 1.525 . . . . 0.36 110.268 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.96 -0.89 57.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.25 109.65 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.783 ' SD ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -119.55 158.83 25.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.816 . . . . 0.39 109.718 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -112.31 177.03 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.48 110.183 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 130' ' ' THR . 1.3 t-160 -43.18 -40.12 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.4 109.71 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 23.3 t -61.49 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.46 109.629 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.3 OUTLIER -62.63 -60.74 3.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 0.47 109.375 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.9 t -45.72 -36.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.882 -1.155 . . . . 0.31 107.882 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -58.21 -40.81 82.59 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.053 -1.091 . . . . 0.48 108.053 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.603 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.7 tttt -72.74 -54.56 8.6 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.76 -0.83 . . . . 0.64 108.76 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.862 ' HB1' HD22 ' A' ' 216' ' ' LEU . . . -45.88 -63.22 1.02 Allowed 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.958 -1.088 . . . . 0.42 110.101 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -61.7 -55.82 26.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.213 -0.93 . . . . 0.34 110.849 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 3.3 tttt -64.96 -73.2 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.47 110.331 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.37 -63.06 0.53 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.686 -0.634 . . . . 0.47 110.562 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -46.51 -36.92 7.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.77 -1.206 . . . . 0.25 108.665 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -72.62 -33.05 66.4 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.361 -0.837 . . . . 0.35 108.937 178.669 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.226 -0.921 . . . . 0.7 108.784 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 40.8 t -72.13 -48.28 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.589 -0.694 . . . . 0.61 109.294 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.827 ' HH2' HG21 ' A' ' 262' ' ' ILE . 32.0 t-105 -56.71 -40.18 75.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.788 . . . . 0.39 109.047 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.2 m -73.12 -31.23 64.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.598 -0.89 . . . . 0.35 108.598 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -57.74 -43.22 85.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.132 -0.692 . . . . 0.36 109.132 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.802 HG23 HG22 ' A' ' 149' ' ' THR . 27.7 m -76.16 -33.0 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.618 -0.833 . . . . 0.5 109.739 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.802 HG22 HG23 ' A' ' 148' ' ' VAL . 4.6 t -145.1 120.57 5.86 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 0.51 110.149 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.36 58.86 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.757 1.399 . . . . 0.31 110.658 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 266' ' ' TYR . 8.8 mt -72.58 161.17 31.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.18 110.027 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.0 OUTLIER -104.46 102.02 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.17 110.255 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 151' ' ' LEU . 37.3 m-85 -123.3 142.86 50.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.14 110.2 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.678 ' O ' HG22 ' A' ' 119' ' ' THR . 3.3 m -142.0 141.35 32.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.184 -0.948 . . . . 0.15 110.448 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.644 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -100.06 91.64 4.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.2 109.985 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.06 106.91 18.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.22 110.153 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 158' ' ' ASP . 51.1 p-80 -63.83 -29.62 70.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.32 110.145 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' HIS . 2.1 t0 -41.19 -30.58 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.589 -0.694 . . . . 0.33 110.098 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.73 32.13 0.72 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.716 -1.354 . . . . 0.28 109.716 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 119' ' ' THR . 39.9 mt -121.51 71.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.127 -1.219 . . . . 0.3 109.513 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -138.55 156.19 47.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.888 -0.725 . . . . 0.2 110.767 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.429 ' CB ' HD23 ' A' ' 118' ' ' LEU . 39.0 t0 -124.64 -31.08 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.439 -0.788 . . . . 0.1 110.036 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.804 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -122.47 160.66 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.236 -0.915 . . . . 0.1 109.912 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.727 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -165.36 140.96 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.373 -1.454 . . . . 0.11 111.6 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.9 tt -90.32 116.67 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 0.1 109.538 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.889 ' HB3' HG23 ' A' ' 123' ' ' VAL . 3.7 p -156.1 159.88 39.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.921 -1.112 . . . . 0.1 110.46 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.8 p90 -76.55 116.59 17.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.409 -0.807 . . . . 0.09 109.735 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -64.16 119.69 16.83 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.434 -1.066 . . . . 0.2 110.434 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 169' ' ' ILE . 1.7 tp -117.09 97.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.639 -0.918 . . . . 0.55 109.532 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.603 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.09 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 112.634 0.605 . . . . 0.85 112.634 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -156.03 17.1 0.36 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.847 . . . . 0.71 110.606 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.581 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 2.2 m170 -82.58 -90.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.42 110.207 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -177.35 -36.73 0.06 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.42 -1.472 . . . . 0.33 109.42 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -148.41 -65.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.33 110.185 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.46 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 58.0 t80 -42.13 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.27 110.403 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 174' ' ' ASP . 10.9 m-30 -47.9 104.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.34 110.264 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.819 ' O ' HD23 ' A' ' 184' ' ' LEU . 49.1 Cg_endo -79.72 -64.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.09 1.574 . . . . 0.47 110.677 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.603 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -72.64 138.33 46.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.072 -1.017 . . . . 0.35 111.07 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 202' ' ' ASP . 0.5 OUTLIER 178.79 78.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.071 -1.052 . . . . 0.2 111.652 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.569 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 35.41 -153.66 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.86 -0.896 . . . . 0.25 110.86 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -74.93 3.39 5.62 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.554 1.818 . . . . 0.44 110.361 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 184' ' ' LEU . 14.1 t -40.15 162.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.57 110.256 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.554 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -59.13 76.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.498 -1.041 . . . . 0.49 110.498 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.977 ' HA ' HG13 ' A' ' 1' ' ' HAV . 9.9 tp 179.76 84.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.391 -1.064 . . . . 0.41 110.047 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.606 HD12 ' OE1' ' A' ' 205' ' ' GLU . 0.4 OUTLIER -100.92 -25.27 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.224 . . . . 0.3 111.07 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.647 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.4 105.07 3.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.68 -1.262 . . . . 0.2 111.928 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 21.2 p-80 -110.65 122.55 48.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.16 109.437 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -116.29 131.3 56.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.23 110.422 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.581 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.7 OUTLIER -73.48 169.33 18.76 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.38 110.675 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.8 Cg_endo -73.59 144.0 35.07 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.171 1.617 . . . . 0.4 109.618 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.2 Cg_endo -70.71 81.12 1.09 Allowed 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.91 1.479 . . . . 0.32 110.82 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.4 -107.28 2.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.466 -1.454 . . . . 0.32 109.466 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -75.76 -162.76 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.927 1.488 . . . . 0.47 110.731 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -57.85 -15.43 8.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.63 110.316 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.22 54.96 0.7 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.496 -0.753 . . . . 0.53 110.251 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.4 170.09 21.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.409 -1.476 . . . . 0.25 109.409 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.76 27.44 0.35 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.62 -1.392 . . . . 0.1 109.62 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 2.0 m-20 -76.75 92.12 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.239 . . . . 0.1 110.087 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.878 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -74.69 98.63 3.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.09 109.954 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 29.2 m170 -117.47 126.03 51.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.218 -0.926 . . . . 0.09 110.688 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 203' ' ' ASP . 32.6 m-85 -93.41 141.97 27.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.1 110.571 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.874 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -49.0 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.183 -1.043 . . . . 0.14 108.183 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.613 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 4.3 p30 -37.21 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.18 111.604 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.569 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.7 t0 -75.56 -1.62 25.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.568 -1.333 . . . . 0.24 110.994 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.606 ' OE1' HD12 ' A' ' 185' ' ' LEU . 21.4 mm-40 -94.15 -163.52 1.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.937 -1.102 . . . . 0.42 110.379 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.424 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -125.94 150.84 47.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.47 110.729 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.613 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -143.36 140.86 30.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 0.27 109.295 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.985 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.18 177.67 11.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.877 -1.139 . . . . 0.3 110.95 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 209' ' ' SER . 2.0 t -131.56 45.95 2.72 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.584 0.707 . . . . 0.61 109.6 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.1 t -112.38 -105.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.78 110.164 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 210' ' ' SER . 25.2 p -157.48 17.85 0.27 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.91 110.268 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 213' ' ' GLY . 4.2 mttp -125.91 -86.45 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.93 110.193 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . -49.08 -178.3 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.317 . . . . 0.79 109.806 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.441 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 94.8 m-85 -57.08 115.15 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.69 109.992 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.565 ' O ' HG12 ' A' ' 219' ' ' VAL . 7.4 m120 -82.67 116.03 21.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.008 . . . . 0.4 109.044 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.985 HD12 ' O ' ' A' ' 208' ' ' THR . 1.2 mp -41.73 -33.38 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.436 -0.79 . . . . 0.17 110.283 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.61 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 5.2 m-85 -53.44 -45.07 69.33 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 118.07 -1.452 . . . . 0.28 107.431 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 244' ' ' TYR . 20.9 tp -82.52 -71.0 0.51 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.523 -0.762 . . . . 0.46 110.993 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.849 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -47.86 -56.61 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.39 110.19 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.977 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.56 -46.92 87.51 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.968 -1.083 . . . . 0.17 111.131 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -60.33 -23.6 64.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.164 -1.585 . . . . 0.1 108.454 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.661 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 3.4 t-160 -80.43 -50.04 10.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.373 -0.603 . . . . 0.21 109.373 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.878 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.7 tp10 -62.31 -33.32 74.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.065 -1.022 . . . . 0.28 108.442 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.554 ' CE1' HD11 ' A' ' 163' ' ' ILE . 6.2 m-85 -64.78 -66.87 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.669 0.747 . . . . 0.18 108.99 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.453 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.35 -28.15 0.54 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.762 -1.735 . . . . 0.21 108.762 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.431 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 3.3 m80 -81.42 -68.07 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -1.166 . . . . 0.17 110.842 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.912 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.2 OUTLIER -40.36 -42.78 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.33 111.88 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.798 HD12 ' OH ' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -101.16 -37.77 8.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.885 -1.134 . . . . 0.53 111.364 -178.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -65.09 -81.86 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.624 -0.99 . . . . 0.41 110.624 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.508 HD13 ' C ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -169.85 -147.83 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -1.18 . . . . 0.45 110.658 -178.838 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -86.87 -44.48 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.356 -0.84 . . . . 0.62 110.532 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -179.99 161.88 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.45 110.284 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 p -168.67 28.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.38 109.797 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.922 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -104.3 22.45 14.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -0.779 . . . . 0.48 111.002 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.543 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -35.25 -50.37 1.24 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.559 -0.713 . . . . 0.38 110.685 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 47.5 Cg_endo -86.73 -49.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.433 1.228 . . . . 0.28 111.14 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.06 101.33 0.14 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.137 -1.506 . . . . 0.24 111.544 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.922 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -145.36 173.58 11.87 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.371 -1.076 . . . . 0.28 109.7 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.607 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -80.85 38.31 0.45 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.826 -1.171 . . . . 0.4 109.916 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.661 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 25.6 mtp -123.01 -17.61 6.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.45 109.746 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -56.0 170.25 0.47 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.184 -0.948 . . . . 0.57 110.97 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 46.3 Cg_endo -73.73 -10.9 23.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.626 1.329 . . . . 0.76 110.006 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.656 HG22 HG22 ' A' ' 245' ' ' THR . 36.5 mt -104.84 147.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.89 109.787 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 1.037 ' HB2' HD21 ' A' ' 218' ' ' LEU . 41.8 p90 -131.25 -24.45 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.78 111.115 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.738 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.2 OUTLIER 2.88 -68.97 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 113.534 0.938 . . . . 0.61 113.534 -179.086 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.738 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -62.72 107.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.447 -1.408 . . . . 0.74 109.5 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.488 HG22 ' OD1' ' A' ' 215' ' ' ASN . 42.7 p -54.1 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.81 110.215 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.04 -9.76 54.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.317 -1.513 . . . . 0.56 109.317 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -149.27 29.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -1.18 . . . . 0.37 110.526 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.446 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.6 OUTLIER -73.84 -31.52 63.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.996 -1.065 . . . . 0.44 110.091 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.8 -60.23 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.53 109.913 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.58 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 179.42 -175.61 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.38 110.306 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.861 ' HB2' HG21 ' A' ' 259' ' ' VAL . 25.9 ptt? -68.83 52.5 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.19 110.416 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.683 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.2 -46.85 44.82 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 107.912 -1.144 . . . . 0.28 107.912 177.514 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.3 Cg_endo -73.81 52.3 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.956 1.503 . . . . 0.49 110.715 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.662 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 12.4 m-20 -57.22 -28.58 63.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.371 -0.831 . . . . 0.49 110.436 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.911 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 2.0 m-20 -51.31 -45.44 62.23 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.015 -1.053 . . . . 0.31 109.235 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.844 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.02 -34.18 50.75 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.365 -0.976 . . . . 0.14 108.365 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.861 HG21 ' HB2' ' A' ' 253' ' ' MET . 98.6 t -58.6 -74.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.899 -0.72 . . . . 0.17 110.533 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 14.1 pt20 -69.9 -37.05 75.87 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.267 -0.896 . . . . 0.26 109.769 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.508 ' N ' ' HG3' ' A' ' 260' ' ' GLN . . . -41.53 -53.92 4.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.466 -1.454 . . . . 0.19 109.466 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.883 HG22 ' NZ ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -92.1 -23.58 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.963 -1.316 . . . . 0.22 110.97 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.735 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 7.1 tp60 -54.81 -26.12 32.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.001 -1.48 . . . . 0.39 107.947 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.1 p -103.92 -41.68 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.244 0.545 . . . . 0.47 111.127 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 4.0 mm? -73.95 -51.85 14.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.48 111.477 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.798 ' OH ' HD12 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -76.18 -9.67 58.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.41 110.533 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -60.38 -111.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.356 -1.498 . . . . 0.46 109.356 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 88.98 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.819 1.431 . . . . 0.58 110.226 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.29 168.53 50.67 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.605 -1.398 . . . . 0.64 109.605 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.628 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 1.3 m-20 -96.61 -72.8 0.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.95 110.247 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.468 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 2.3 tt0 58.24 20.36 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.2 110.259 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 270' ' ' ASP . 9.8 p-10 -177.66 142.63 0.48 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 1.2 110.077 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.04 -13.17 33.64 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 1.06 110.453 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.994 -1.003 . . . . 0.78 110.075 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.977 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.591 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.824 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.273 0.559 . . . . 0.41 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -86.64 80.27 8.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.945 . . . . 0.26 110.236 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 107' ' ' PHE . 22.3 t -82.81 174.25 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.33 110.12 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -56.17 134.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.289 -0.882 . . . . 0.65 110.194 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 48.8 Cg_endo -74.61 -158.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.921 1.485 . . . . 0.84 110.061 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.819 ' O ' HD12 ' A' ' 230' ' ' LEU . 45.4 mtt180 69.73 75.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.93 110.271 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 111' ' ' LEU . 1.1 p -137.2 -64.87 0.55 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 1.03 109.444 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER 30.92 38.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.208 0.528 . . . . 1.04 111.356 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.529 ' HE2' HD22 ' A' ' 265' ' ' LEU . 0.8 OUTLIER -135.96 61.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.77 109.536 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.624 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 8.3 t90 -131.19 -50.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.42 110.682 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 28.5 t -111.89 62.85 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.44 110.928 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HG2' ' C ' ' A' ' 114' ' ' SER . 19.5 mmmt -149.09 42.05 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.074 -1.017 . . . . 0.49 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 2.2 ttp -72.77 -19.58 61.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.137 -0.977 . . . . 0.3 110.837 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 1.052 ' O ' HD22 ' A' ' 118' ' ' LEU . 5.7 p30 -138.48 113.23 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.15 110.743 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.052 HD22 ' O ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -143.47 -179.68 6.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.13 110.261 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -124.04 173.53 8.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.12 110.078 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 14.6 p90 -167.78 179.25 4.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.128 -0.982 . . . . 0.33 111.008 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 22.9 tpt85 -126.03 147.66 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.54 109.989 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.712 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.1 pp -110.36 77.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.33 110.789 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.971 HG23 ' HB3' ' A' ' 166' ' ' SER . 8.3 m -125.54 42.17 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.27 110.299 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.734 ' ND2' HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -40.33 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.567 -0.853 . . . . 0.41 109.212 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.667 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 2.9 t80 -178.9 169.33 1.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.044 -1.035 . . . . 0.4 110.293 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -125.23 49.69 3.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.97 . . . . 0.45 110.481 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.1 Cg_endo -73.97 -87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.121 1.59 . . . . 0.36 110.317 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.08 2.1 50.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.25 109.805 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.991 ' HE2' HD21 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -117.88 159.15 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.39 109.829 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -109.73 175.96 5.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.48 110.103 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 71.6 t60 -43.39 -32.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.4 109.738 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 1.3 t -68.42 -59.16 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.46 109.752 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 32.8 mp0 -51.46 -59.87 3.76 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.309 -0.87 . . . . 0.47 109.645 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 ' ND2' ' A' ' 124' ' ' ASN . 6.2 t -46.04 -37.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.261 -1.015 . . . . 0.31 108.261 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.596 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 12.1 tt0 -57.63 -39.1 76.2 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.347 -0.983 . . . . 0.48 108.347 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -73.84 -52.66 12.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.948 0.88 . . . . 0.64 108.819 178.67 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.827 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.48 -64.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.112 -0.993 . . . . 0.42 110.508 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.712 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -63.17 -53.73 48.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.34 111.327 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.65 -72.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.928 -1.107 . . . . 0.47 110.371 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -39.49 -61.84 0.75 Allowed 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.697 -0.627 . . . . 0.47 110.494 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -45.62 -37.99 6.17 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.795 -1.162 . . . . 0.25 108.291 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.37 -37.83 74.66 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.029 -0.73 . . . . 0.35 109.029 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttpt -55.38 -40.66 71.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.7 108.754 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.413 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 24.1 t -68.5 -44.84 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.69 -0.632 . . . . 0.61 109.342 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.66 ' HH2' HG21 ' A' ' 262' ' ' ILE . 29.1 t-105 -56.3 -41.5 76.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.39 109.161 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.5 OUTLIER -71.11 -34.42 71.06 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.288 -0.883 . . . . 0.35 108.858 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 1.1 m-20 -57.41 -41.64 80.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.602 -0.686 . . . . 0.36 109.625 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 145' ' ' TRP . 28.4 m -78.24 -29.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.5 110.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.541 HG21 HG12 ' A' ' 262' ' ' ILE . 13.4 t -152.27 141.91 14.59 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.94 -1.1 . . . . 0.51 110.586 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.37 58.0 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.895 1.471 . . . . 0.31 110.313 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.619 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -77.01 138.41 39.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.18 110.265 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.16 120.52 40.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.17 109.995 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.51 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.0 p90 -137.57 141.01 41.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.14 110.389 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.912 ' O ' HG22 ' A' ' 119' ' ' THR . 2.6 m -139.58 134.5 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.15 110.011 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.599 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 1.1 mtm180 -92.64 89.63 6.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.2 109.731 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.23 107.65 18.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.22 110.52 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -66.61 -11.9 55.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.32 109.79 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -54.53 -21.73 11.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.649 -0.657 . . . . 0.33 109.515 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.56 15.78 4.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.28 109.477 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.53 ' O ' ' HB ' ' A' ' 119' ' ' THR . 24.3 mm -106.22 78.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.119 -1.224 . . . . 0.3 108.943 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 124.78 45.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.2 111.018 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.684 ' HB2' HD12 ' A' ' 118' ' ' LEU . 14.8 t70 -94.08 -46.31 7.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.1 109.393 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.004 HD13 HD22 ' A' ' 228' ' ' LEU . 12.2 pt -128.56 177.94 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 0.1 109.302 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.78 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 4.0 ptt? -177.28 154.62 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.598 -1.314 . . . . 0.11 111.242 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 124' ' ' ASN . 3.0 tt -102.55 119.81 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.403 -0.811 . . . . 0.1 109.547 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.971 ' HB3' HG23 ' A' ' 123' ' ' VAL . 5.1 p -160.57 148.23 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.1 111.176 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.667 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 3.2 p90 -68.95 116.35 9.31 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.594 -0.691 . . . . 0.09 109.523 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -74.42 113.38 4.06 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.367 -1.093 . . . . 0.2 110.367 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -111.04 99.84 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -1.043 . . . . 0.55 109.585 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.634 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.26 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.365 0.602 . . . . 0.85 112.553 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.59 -3.51 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.71 110.192 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -75.62 -80.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.42 110.042 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 135.57 -39.57 1.65 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.587 -1.405 . . . . 0.33 109.587 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -77.46 -88.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -1.158 . . . . 0.33 110.33 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.1 OUTLIER -88.21 136.12 33.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.27 110.274 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.94 108.46 35.26 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.34 109.745 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 45.2 Cg_endo -77.51 -68.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.998 1.525 . . . . 0.47 110.581 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.634 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 6.3 p90 -40.81 136.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.87 . . . . 0.35 110.749 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.497 ' OD1' ' HB2' ' A' ' 182' ' ' SER . 11.1 p30 179.21 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.2 110.759 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.55 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 43.17 -158.06 0.1 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.421 -1.472 . . . . 0.25 109.421 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.6 Cg_endo -77.04 8.52 3.14 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.101 1.58 . . . . 0.44 110.304 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.497 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 58.3 m -44.67 172.18 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.258 -0.901 . . . . 0.57 110.444 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.91 73.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 C-N-CA 120.393 -0.908 . . . . 0.49 110.893 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.051 ' HA ' HG13 ' A' ' 1' ' ' HAV . 3.2 tt 179.82 87.39 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.014 -1.286 . . . . 0.41 111.002 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 214' ' ' TYR . 8.3 tt -103.72 -22.61 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.686 -1.205 . . . . 0.3 110.88 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.659 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.21 100.0 2.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.72 -1.237 . . . . 0.2 111.973 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.563 ' NE2' ' CB ' ' A' ' 200' ' ' HIS . 1.2 p80 -100.8 127.38 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.958 -1.089 . . . . 0.16 109.111 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.94 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -115.0 126.22 54.51 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.961 -1.087 . . . . 0.23 110.651 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.471 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 2.4 m-85 -71.85 155.93 91.57 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.38 110.185 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.521 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.5 Cg_endo -72.3 141.65 35.96 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.945 1.497 . . . . 0.4 109.93 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 64.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.32 110.783 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.47 -103.36 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.244 -1.543 . . . . 0.32 109.244 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.16 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.925 1.487 . . . . 0.47 110.314 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -65.02 -9.34 21.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.63 110.373 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 59.37 0.61 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.34 -0.85 . . . . 0.53 110.147 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -137.16 164.81 25.27 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.073 -1.611 . . . . 0.25 109.073 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.975 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 57.95 16.93 27.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.354 -1.498 . . . . 0.1 109.354 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.664 ' OD1' ' HE2' ' A' ' 164' ' ' MET . 8.4 m-20 -81.94 88.71 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 0.1 110.466 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.43 115.51 4.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.09 109.894 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.563 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 15.0 m170 -123.44 127.79 48.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.09 111.003 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 11.3 m-30 -96.76 132.41 42.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.1 110.223 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.821 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -49.98 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.97 -1.122 . . . . 0.14 107.97 178.558 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.4 p30 -35.21 -28.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.18 112.267 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.55 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -78.61 3.31 16.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.427 -1.421 . . . . 0.24 110.971 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.549 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 18.0 mm-40 -97.99 -168.97 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.934 -1.104 . . . . 0.42 110.229 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.501 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 12.5 m -122.29 151.53 41.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.47 110.383 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.536 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.2 m-90 -148.09 141.02 24.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.306 -0.871 . . . . 0.27 109.67 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.024 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -159.0 179.63 8.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.999 -1.063 . . . . 0.3 110.62 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.9 t -125.28 49.84 1.85 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.807 -0.757 . . . . 0.61 109.551 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 15.9 t -125.84 -144.62 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.78 109.962 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 56.6 p -101.95 -27.97 12.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.91 110.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 213' ' ' GLY . 2.2 mppt? -93.01 -176.84 4.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.93 110.364 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 48.58 -176.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.614 -1.394 . . . . 0.79 109.614 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.509 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.1 m-85 -79.79 118.09 21.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -1.081 . . . . 0.69 109.606 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.669 ' ND2' HG23 ' A' ' 247' ' ' THR . 7.8 p30 -83.13 124.77 30.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.933 -1.105 . . . . 0.4 108.818 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.024 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -42.2 -36.92 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.17 110.522 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.8 m-85 -50.98 -47.12 61.46 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.419 -1.312 . . . . 0.28 107.793 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.684 HD11 ' HH1' ' A' ' 3' ' ' MSB . 20.3 tp -77.65 -70.7 0.46 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.683 -0.689 . . . . 0.46 110.912 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -49.18 -63.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.035 -1.041 . . . . 0.39 109.903 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -50.93 -52.28 43.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.17 111.287 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.89 -35.06 66.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.183 -1.573 . . . . 0.1 108.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.649 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.6 t60 -69.11 -49.48 56.72 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.212 0.529 . . . . 0.21 109.738 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.668 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.5 tp10 -64.1 -27.48 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.28 108.777 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.418 ' HE2' ' CD2' ' A' ' 142' ' ' PHE . 5.2 m-30 -70.2 -61.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.043 -0.725 . . . . 0.18 109.043 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -48.62 -27.72 6.28 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.802 -1.719 . . . . 0.21 108.802 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.528 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 1.8 m80 -81.41 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -1.203 . . . . 0.17 111.601 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.94 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -58.32 -29.82 66.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.33 111.971 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 1.004 HD22 HD13 ' A' ' 163' ' ' ILE . 7.0 tp -100.21 -39.72 7.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.53 111.623 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -78.36 -79.07 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.211 -1.156 . . . . 0.41 110.211 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -170.83 -166.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -1.22 . . . . 0.45 110.846 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.0 OUTLIER -55.12 -55.92 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.62 110.573 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.596 ' CD2' ' HB3' ' A' ' 240' ' ' MET . 0.7 OUTLIER -167.25 -179.6 4.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.145 -0.972 . . . . 0.45 110.763 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 257' ' ' ASP . 9.9 t 179.5 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.015 -0.735 . . . . 0.38 109.015 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.686 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -128.6 22.03 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -0.811 . . . . 0.48 111.247 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -40.96 -52.38 6.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.438 -0.905 . . . . 0.38 110.101 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -87.04 -49.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.614 1.323 . . . . 0.28 110.589 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.56 99.21 0.12 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.435 -1.364 . . . . 0.24 111.543 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.865 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.82 162.8 35.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -1.183 . . . . 0.28 110.103 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.598 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -72.5 58.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.4 108.823 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.649 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 1.4 mtt -142.74 -36.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.335 -0.853 . . . . 0.45 110.432 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.596 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . 0.1 OUTLIER -46.01 174.98 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.235 -0.916 . . . . 0.57 110.377 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 48.6 Cg_endo -78.43 22.57 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.476 1.25 . . . . 0.76 111.127 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.714 HG22 HG22 ' A' ' 245' ' ' THR . 12.6 mm -127.76 140.79 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.89 109.107 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.671 ' HB2' HD21 ' A' ' 218' ' ' LEU . 54.3 p90 -126.29 -31.27 2.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.145 . . . . 0.78 110.633 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 243' ' ' ILE . 0.0 OUTLIER 3.8 -78.52 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 113.152 0.797 . . . . 0.61 113.152 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.677 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -43.82 114.79 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.7 -1.25 . . . . 0.74 109.687 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.669 HG23 ' ND2' ' A' ' 215' ' ' ASN . 6.1 m -72.6 172.86 9.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.865 . . . . 0.81 110.306 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.425 ' H ' HG22 ' A' ' 247' ' ' THR . . . -53.13 -22.35 13.44 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.351 -1.5 . . . . 0.56 109.351 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 48.1 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -1.109 . . . . 0.37 110.193 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -61.03 1.87 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.44 110.465 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.539 ' C ' ' CG ' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -133.38 -77.16 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.53 110.649 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.539 ' CG ' ' C ' ' A' ' 251' ' ' HIS . 23.1 m-85 -151.17 -178.03 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.38 110.948 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.965 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.7 58.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.672 -0.642 . . . . 0.19 110.018 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.73 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 2.6 mp -44.32 -47.08 24.92 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.066 -1.087 . . . . 0.28 108.066 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.5 Cg_endo -72.49 46.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.894 1.47 . . . . 0.49 111.231 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.5 m-20 -46.7 -32.74 3.77 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.576 -1.328 . . . . 0.49 110.367 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.865 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.83 -54.62 40.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.948 -1.101 . . . . 0.31 109.241 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.088 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.88 -33.69 76.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.174 -1.01 . . . . 0.14 108.873 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.965 HG21 ' HB2' ' A' ' 253' ' ' MET . 74.2 t -67.41 -86.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.17 110.566 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.2 tt0 -52.84 -42.18 64.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.008 -1.058 . . . . 0.26 109.353 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.72 -70.91 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.368 -1.093 . . . . 0.19 110.368 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.088 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.82 -18.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.735 -1.45 . . . . 0.22 110.035 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 1.083 ' N ' HD13 ' A' ' 262' ' ' ILE . 6.6 tt0 -64.37 -21.97 66.8 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.854 -1.138 . . . . 0.39 108.355 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.3 p -103.7 -42.42 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.222 -0.591 . . . . 0.47 111.502 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.529 HD22 ' HE2' ' A' ' 112' ' ' LYS . 7.6 mp -86.15 -46.18 10.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.48 111.266 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.619 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -77.95 -14.24 59.6 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.306 -0.871 . . . . 0.41 110.404 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.33 -94.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.889 -1.684 . . . . 0.46 108.889 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.43 109.73 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.083 1.57 . . . . 0.58 110.244 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -82.38 132.96 11.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.552 -1.419 . . . . 0.64 109.552 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.624 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -78.59 -66.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.95 110.283 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.533 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 27.5 tt0 58.03 21.66 8.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.962 . . . . 1.2 110.032 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 273' ' ' PRO . 0.6 OUTLIER -171.27 99.85 0.4 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 1.2 110.245 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 273' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 272' ' ' ASP . 45.0 Cg_endo -71.21 66.12 2.68 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.046 1.551 . . . . 1.06 110.417 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.022 -0.989 . . . . 0.78 110.232 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.051 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.63 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.684 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.188 0.518 . . . . 0.41 110.319 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.475 ' C ' HG23 ' A' ' 106' ' ' VAL . 8.5 m-80 -141.09 131.07 24.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.26 110.129 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.475 HG23 ' C ' ' A' ' 105' ' ' ASN . 11.6 t -149.28 -62.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.33 110.648 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.37 99.09 39.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.65 110.896 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.431 ' C ' ' HG3' ' A' ' 109' ' ' ARG . 47.7 Cg_endo -75.02 54.19 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.861 1.453 . . . . 0.84 109.966 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.679 ' O ' HD12 ' A' ' 230' ' ' LEU . 11.9 mtt180 -138.77 53.18 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.93 110.28 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.685 ' HA ' HD12 ' A' ' 230' ' ' LEU . 4.8 p -119.97 -55.77 2.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 1.03 109.851 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.5 mm? 39.12 47.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 1.04 111.118 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.594 ' HB3' HD23 ' A' ' 265' ' ' LEU . 2.1 tptm -128.17 60.99 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.003 . . . . 0.77 109.967 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.557 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 10.7 t90 -139.48 -65.55 0.47 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.42 110.637 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.467 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 79.1 p -98.85 46.15 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.44 110.562 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 6.9 mmpt? -130.09 76.41 1.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.49 110.248 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.403 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 8.5 tmm? -111.85 -3.4 14.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.3 110.173 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -159.11 125.78 4.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.15 109.859 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.472 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.4 -177.06 5.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.13 110.751 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.832 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -127.29 165.88 18.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.12 109.848 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.576 ' CB ' HG13 ' A' ' 163' ' ' ILE . 46.1 p90 -162.89 -176.77 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.025 -1.047 . . . . 0.33 111.367 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -140.38 155.45 46.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.54 110.23 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.898 ' O ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -114.41 123.5 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.494 -0.754 . . . . 0.33 111.134 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.888 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.2 m -165.86 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.27 109.72 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 0.9 OUTLIER -39.68 -80.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.718 . . . . 0.41 109.395 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.689 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.9 t80 -179.2 -159.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.432 -0.792 . . . . 0.4 109.527 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -154.0 50.38 0.56 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.45 110.656 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.65 -85.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.807 1.425 . . . . 0.36 110.388 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.6 0.45 49.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.25 109.982 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.572 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.03 160.04 22.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.39 110.168 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.7 m -106.33 168.86 8.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.48 110.254 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -44.7 -32.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.4 109.806 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -66.28 -49.36 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.46 109.562 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 1.8 mp0 -60.79 -57.64 11.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.249 -0.907 . . . . 0.47 109.17 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 125' ' ' TYR . 5.6 t -46.22 -36.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.761 -1.2 . . . . 0.31 107.761 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -56.89 -42.38 79.74 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.03 -1.1 . . . . 0.48 108.03 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.4 tttt -71.24 -49.98 37.63 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.65 -0.87 . . . . 0.64 108.65 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.827 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.83 -57.39 4.36 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.96 -1.087 . . . . 0.42 109.749 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CD2' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.11 -56.29 13.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.34 110.734 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.602 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.61 -73.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.984 . . . . 0.47 110.157 -179.494 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -36.87 -60.99 0.58 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.823 -0.548 . . . . 0.47 110.667 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.46 -40.95 19.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.618 -1.301 . . . . 0.25 108.709 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 138' ' ' PHE . 2.5 m-85 -69.38 -32.97 72.35 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.998 . . . . 0.35 108.774 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 17.1 tttm -56.15 -41.66 75.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.977 -1.119 . . . . 0.7 107.977 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.9 t -67.11 -41.91 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.537 -0.912 . . . . 0.61 108.537 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.594 ' CH2' HG13 ' A' ' 262' ' ' ILE . 25.5 t-105 -54.9 -38.67 67.89 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.819 -0.808 . . . . 0.39 108.819 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.7 OUTLIER -75.95 -41.23 52.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.347 -0.846 . . . . 0.35 108.74 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 3.0 m-20 -50.47 -33.3 20.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.968 -0.753 . . . . 0.36 108.968 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.0 m -91.16 -38.52 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.532 -0.73 . . . . 0.5 110.108 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 149' ' ' THR . 14.1 t -149.43 124.15 4.78 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.51 110.136 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.21 59.27 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.859 1.452 . . . . 0.31 110.599 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.856 HD21 ' O ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -73.81 139.24 45.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.18 110.154 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 7.4 t-20 -76.62 105.49 7.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.17 109.912 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 7.8 p90 -117.34 143.67 45.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.14 110.479 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 119' ' ' THR . 20.5 m -141.27 145.6 35.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.927 . . . . 0.15 110.125 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.519 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -124.84 79.87 1.82 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.706 -0.621 . . . . 0.2 110.152 -178.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -85.42 114.73 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.22 110.092 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -56.42 -18.0 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.32 109.98 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -23.25 5.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.449 -0.782 . . . . 0.33 109.632 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.42 7.94 5.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.534 -1.426 . . . . 0.28 109.534 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.832 HG22 HG21 ' A' ' 119' ' ' THR . 8.7 mt -87.91 91.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.126 -1.22 . . . . 0.3 109.034 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -154.98 107.07 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.968 -0.693 . . . . 0.2 110.336 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' CB ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -76.51 -42.74 42.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.1 109.808 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.02 HG21 HD12 ' A' ' 228' ' ' LEU . 1.1 pt -118.09 171.91 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.1 109.546 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.873 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 1.8 ptp -170.08 157.28 6.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.715 -1.241 . . . . 0.11 111.188 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.0 tt -104.9 120.78 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.1 109.806 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.888 ' HB3' HG23 ' A' ' 123' ' ' VAL . 11.5 p -162.45 156.4 21.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.786 -1.196 . . . . 0.1 111.142 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.9 p90 -73.17 118.43 16.12 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.493 -0.755 . . . . 0.09 109.272 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -76.9 131.66 11.54 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.46 -1.056 . . . . 0.2 110.46 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.583 ' O ' ' C ' ' A' ' 170' ' ' LYS . 2.5 tp -126.34 93.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.614 -0.933 . . . . 0.55 109.154 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.601 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 0.87 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.358 0.599 . . . . 0.85 112.466 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -148.69 17.22 1.01 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.343 -0.848 . . . . 0.71 109.861 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.403 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m170 -78.96 -68.84 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.39 -0.819 . . . . 0.42 110.306 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.72 34.86 0.42 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.446 -1.461 . . . . 0.33 109.446 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -149.06 -69.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -1.11 . . . . 0.33 110.091 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -123.29 174.48 7.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.27 110.167 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.4 m-30 -98.57 110.34 56.49 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.34 110.237 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.514 ' HD2' ' HD2' ' A' ' 170' ' ' LYS . 41.9 Cg_endo -73.33 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.968 1.51 . . . . 0.47 110.616 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.6 OUTLIER -49.58 142.05 8.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.35 110.575 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 182' ' ' SER . 5.5 p30 179.64 80.3 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.202 -0.936 . . . . 0.2 110.453 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.72 -155.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.398 . . . . 0.25 109.606 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.7 Cg_endo -77.34 8.65 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.077 1.567 . . . . 0.44 110.573 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.2 t -42.75 166.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.57 110.318 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.555 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.45 73.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.712 -0.955 . . . . 0.49 110.712 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.002 ' HA ' HG13 ' A' ' 1' ' ' HAV . 1.0 OUTLIER 179.86 87.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.193 -1.181 . . . . 0.41 110.649 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.799 HD12 ' OE1' ' A' ' 205' ' ' GLU . 7.8 tt -103.85 -23.05 13.42 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.616 -1.234 . . . . 0.3 110.969 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.631 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -151.94 106.2 3.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.524 -1.36 . . . . 0.2 112.333 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.541 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.2 OUTLIER -101.84 133.02 47.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.16 109.229 178.427 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -122.09 118.72 29.38 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.134 -0.978 . . . . 0.23 110.476 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.464 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-85 -67.86 167.48 16.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.38 110.372 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.508 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.4 Cg_endo -72.89 136.65 25.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.145 1.603 . . . . 0.4 109.856 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.0 84.62 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.903 1.475 . . . . 0.32 110.561 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.9 -102.22 0.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.958 -1.257 . . . . 0.32 109.958 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.34 -163.6 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.47 110.859 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.89 -7.28 26.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.404 -0.81 . . . . 0.63 110.152 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.46 48.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.383 -0.823 . . . . 0.53 109.838 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -136.06 169.23 23.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.029 -1.629 . . . . 0.25 109.029 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.963 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 57.31 17.68 25.78 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.088 -1.605 . . . . 0.1 109.088 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.86 91.31 4.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.429 -1.042 . . . . 0.1 110.508 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.873 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -73.47 95.93 2.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.09 109.866 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.541 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 28.7 m170 -111.93 134.45 53.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.09 110.887 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.4 m-85 -104.51 137.6 42.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.154 -0.966 . . . . 0.1 110.59 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.909 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -47.03 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.14 108.554 179.009 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.599 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 3.2 p30 -36.88 -27.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.516 -0.74 . . . . 0.18 112.046 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.537 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.0 OUTLIER -78.79 2.93 18.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.488 -1.383 . . . . 0.24 110.848 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.799 ' OE1' HD12 ' A' ' 185' ' ' LEU . 11.6 mm-40 -95.91 -168.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.942 -1.099 . . . . 0.42 110.237 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.8 m -123.72 140.21 53.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.47 110.498 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.599 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.8 OUTLIER -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.27 109.312 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.008 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.33 178.61 9.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.959 -1.088 . . . . 0.3 110.792 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 29.9 t -130.48 32.37 4.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.534 0.683 . . . . 0.61 109.285 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -103.98 -90.87 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.78 110.686 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -157.21 -33.97 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.462 -0.774 . . . . 0.91 109.793 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 213' ' ' GLY . 3.5 pttt -87.91 -171.96 3.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.93 109.932 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 45.42 -155.59 0.44 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.243 -1.543 . . . . 0.79 109.243 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.595 ' CE2' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -94.13 126.24 39.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -1.193 . . . . 0.69 109.931 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.616 ' O ' HG12 ' A' ' 219' ' ' VAL . 42.6 m-80 -89.65 121.4 31.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.018 -1.051 . . . . 0.4 108.879 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.008 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.59 -37.84 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.611 -0.836 . . . . 0.17 110.375 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 3.1 m-30 -51.67 -46.91 63.98 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.382 -1.327 . . . . 0.28 107.585 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.26 -73.4 0.28 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.781 -0.645 . . . . 0.46 110.277 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.88 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.61 -65.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.39 110.302 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -49.66 -48.87 49.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.366 -0.834 . . . . 0.17 111.737 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.99 -41.71 92.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.185 -1.572 . . . . 0.1 108.645 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.59 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 5.3 t60 -60.2 -51.26 70.33 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.377 0.608 . . . . 0.21 109.792 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.67 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.0 tp10 -64.8 -29.16 70.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.092 -1.005 . . . . 0.28 109.138 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 220' ' ' ALA . 13.8 m-30 -66.12 -64.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.447 -0.783 . . . . 0.18 109.177 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -49.84 -26.7 8.52 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.045 -1.622 . . . . 0.21 109.045 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -78.93 -58.7 3.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.081 -1.247 . . . . 0.17 111.557 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.913 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -69.22 -23.77 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.33 111.78 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -99.21 -43.82 6.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.028 -1.045 . . . . 0.53 111.258 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -83.03 -70.86 1.33 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.184 -1.008 . . . . 0.41 110.589 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -165.01 -162.11 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.241 . . . . 0.45 110.86 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -75.01 -51.7 12.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.62 110.34 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.622 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.8 OUTLIER -162.48 172.79 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.45 110.959 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.455 ' HB2' HD11 ' A' ' 230' ' ' LEU . 5.7 t 179.56 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.615 -0.678 . . . . 0.38 109.24 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.673 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -117.19 20.26 13.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.48 111.005 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.577 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -30.55 -53.81 0.38 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.894 -0.503 . . . . 0.38 111.507 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.7 Cg_endo -89.49 -47.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.4 1.21 . . . . 0.28 111.063 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.12 100.54 0.13 Allowed Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.498 -1.334 . . . . 0.24 111.268 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.935 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -146.78 168.73 20.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.131 -1.217 . . . . 0.28 110.518 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.558 HD21 ' N ' ' A' ' 222' ' ' HIS . 0.7 OUTLIER -73.67 55.42 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.301 -0.875 . . . . 0.4 109.011 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.576 ' HA ' ' NE2' ' A' ' 222' ' ' HIS . 1.9 mtt -140.87 -5.6 1.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.288 -0.882 . . . . 0.45 111.356 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -79.71 168.82 23.4 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.932 -1.105 . . . . 0.57 110.134 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -69.56 -4.27 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.848 1.447 . . . . 0.76 110.665 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.605 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 50.2 mm -104.63 143.87 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.89 109.808 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.834 ' HB2' HD21 ' A' ' 218' ' ' LEU . 42.8 p90 -131.39 -28.95 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.948 -1.095 . . . . 0.78 110.913 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.53 ' C ' ' O ' ' A' ' 244' ' ' TYR . 98.8 m 2.79 -69.63 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.412 0.893 . . . . 0.61 113.412 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -55.81 101.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.604 -1.31 . . . . 0.74 109.511 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.51 ' N ' ' HB3' ' A' ' 250' ' ' SER . 0.2 OUTLIER -48.09 179.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.431 -0.793 . . . . 0.81 110.263 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.71 -29.25 25.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.446 -1.461 . . . . 0.56 109.446 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -143.1 31.24 1.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.37 110.084 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.51 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.4 OUTLIER -59.56 -23.03 62.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.44 110.186 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 6.8 t-80 -156.21 -67.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.882 . . . . 0.53 110.004 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.1 m-85 -168.38 -178.36 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.38 110.164 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.974 ' HB2' HG21 ' A' ' 259' ' ' VAL . 5.6 ptt? -72.26 54.99 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.72 . . . . 0.19 110.225 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.726 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 7.6 tp -45.03 -46.07 28.53 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 107.975 -1.12 . . . . 0.28 107.975 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -71.58 48.19 0.99 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.76 1.4 . . . . 0.49 110.944 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.673 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.2 m-20 -52.63 -27.14 15.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.855 -1.153 . . . . 0.49 110.575 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.935 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -57.15 -43.76 82.78 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.578 -1.249 . . . . 0.31 109.454 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -79.57 -32.95 42.1 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.184 -1.006 . . . . 0.14 108.548 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.974 HG21 ' HB2' ' A' ' 253' ' ' MET . 54.4 t -65.43 -75.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.816 0.817 . . . . 0.17 110.019 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.628 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -63.57 -34.1 77.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.768 . . . . 0.26 109.612 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -49.53 -67.24 1.85 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.124 -1.19 . . . . 0.19 110.124 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -70.35 -21.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.811 -1.405 . . . . 0.22 109.895 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.674 ' N ' HD13 ' A' ' 262' ' ' ILE . 20.4 tp60 -67.31 -19.44 65.47 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.028 -1.045 . . . . 0.39 108.625 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.1 m -103.41 -38.6 7.12 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.119 -0.633 . . . . 0.47 111.709 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 112' ' ' LYS . 8.5 mp -97.79 -42.51 7.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.179 -0.951 . . . . 0.48 111.166 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.856 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -72.15 -21.48 61.45 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.37 -0.831 . . . . 0.41 109.808 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -55.6 -97.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.293 -1.523 . . . . 0.46 109.293 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.7 108.29 2.52 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.044 1.549 . . . . 0.58 110.258 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.17 151.43 23.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.696 -1.362 . . . . 0.64 109.696 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.557 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 6.8 t0 -95.05 -57.79 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.95 110.203 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 14.5 tt0 43.85 38.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.2 110.192 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.87 144.17 11.91 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 1.2 110.036 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.25 91.91 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.033 1.544 . . . . 1.06 110.32 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.08 -0.962 . . . . 0.78 110.262 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.002 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.631 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 34.4 p90 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.287 0.565 . . . . 0.41 110.204 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.85 85.18 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.26 110.17 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.1 t -92.25 -40.31 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.33 110.2 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.1 106.13 33.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.836 . . . . 0.65 110.217 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.9 Cg_endo -72.86 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.927 1.488 . . . . 0.84 110.287 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' O ' HD12 ' A' ' 230' ' ' LEU . 47.5 mtt-85 64.99 75.24 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.93 110.304 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -158.21 -58.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.463 -0.773 . . . . 1.03 109.71 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.534 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 5.9 mp 32.08 37.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.079 0.466 . . . . 1.04 111.454 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -121.51 42.6 3.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.77 109.869 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 22.7 t90 -110.63 -65.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.853 . . . . 0.42 110.106 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 31.9 t -102.36 60.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.44 110.267 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 0.0 OUTLIER -146.26 85.48 1.66 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.935 . . . . 0.49 110.617 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 ttt -119.82 -18.33 8.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.3 110.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 8.7 p30 -157.3 111.88 2.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.15 109.984 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.447 HD13 HD21 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -133.08 -160.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.13 110.466 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -137.91 155.35 49.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.12 110.275 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.856 ' HB3' HG23 ' A' ' 163' ' ' ILE . 13.2 p90 -152.73 -167.6 2.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.247 -0.908 . . . . 0.33 110.857 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.412 ' N ' ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.36 155.94 47.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.54 110.662 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.852 ' O ' HG13 ' A' ' 123' ' ' VAL . 5.6 pt -112.67 115.75 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.805 . . . . 0.33 110.698 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 122' ' ' ILE . 1.1 m -165.72 42.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.201 -0.937 . . . . 0.27 110.301 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 125' ' ' TYR . 2.5 t-20 -42.28 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.41 109.742 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.729 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.8 t80 -179.32 -155.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -0.795 . . . . 0.4 109.497 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.558 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -161.26 51.47 0.36 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.45 110.583 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -78.14 -85.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.906 1.477 . . . . 0.36 109.963 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.93 -2.09 56.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.25 109.638 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.914 ' SD ' HD21 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -121.06 160.75 22.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.39 110.137 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.14 -175.05 2.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.875 . . . . 0.48 110.211 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -48.46 -37.49 17.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.4 109.978 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t -60.47 -50.08 75.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.46 109.845 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 7.7 mp0 -64.88 -63.64 1.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.194 -0.941 . . . . 0.47 109.92 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 125' ' ' TYR . 16.3 t -42.96 -37.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.694 -0.854 . . . . 0.31 108.694 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 6.5 mt-10 -59.24 -43.23 92.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.387 -0.968 . . . . 0.48 108.387 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.563 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.5 tttp -70.33 -47.34 61.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.416 -0.957 . . . . 0.64 108.416 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.819 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -45.79 -60.71 2.07 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.31 -0.868 . . . . 0.42 110.101 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.709 ' CE2' HD12 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -66.96 -52.31 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.34 110.897 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 4.1 tttt -66.58 -73.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.84 -1.162 . . . . 0.47 110.124 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.71 -60.8 0.79 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.754 -0.592 . . . . 0.47 110.779 179.006 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.28 -38.93 13.42 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.54 -1.264 . . . . 0.25 108.341 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -70.08 -33.66 72.19 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.611 -0.836 . . . . 0.35 108.976 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -56.31 -41.55 76.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.931 -1.137 . . . . 0.7 107.931 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 12.6 t -66.05 -41.73 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.578 -0.897 . . . . 0.61 108.578 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.589 ' CH2' HG13 ' A' ' 262' ' ' ILE . 27.9 t-105 -56.88 -39.21 73.94 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.818 -0.808 . . . . 0.39 108.818 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 149' ' ' THR . 69.1 m -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.427 -0.796 . . . . 0.35 108.854 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -54.89 -37.51 66.39 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.586 -0.696 . . . . 0.36 109.359 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 145' ' ' TRP . 26.8 m -84.82 -34.86 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.5 110.195 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.577 ' OG1' HD13 ' A' ' 151' ' ' LEU . 14.4 t -152.12 131.63 6.87 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.51 110.264 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.41 59.05 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.965 1.508 . . . . 0.31 110.808 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.009 HD21 ' CG ' ' A' ' 266' ' ' TYR . 3.6 mp -76.88 169.09 18.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.18 110.014 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -114.64 116.42 28.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.17 110.568 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.4 p90 -126.33 125.78 42.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.14 109.723 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 119' ' ' THR . 10.7 m -125.72 133.08 52.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.197 -0.94 . . . . 0.15 110.62 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.625 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.31 81.71 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.2 109.877 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.617 ' HG ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -60.43 129.79 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.22 110.49 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -91.79 40.61 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.44 -0.787 . . . . 0.32 109.921 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.607 ' OD2' HD11 ' A' ' 160' ' ' ILE . 3.2 t0 -135.55 -38.95 0.73 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.33 109.52 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 144.2 37.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.661 -1.376 . . . . 0.28 109.661 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.617 HD13 ' HG ' ' A' ' 156' ' ' LEU . 3.1 mp -123.82 69.45 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.3 109.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -144.47 156.29 44.12 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.032 -0.667 . . . . 0.2 110.111 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -23.52 5.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.1 110.337 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.856 HG23 ' HB3' ' A' ' 120' ' ' TYR . 1.2 tt -125.49 168.51 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.178 -0.951 . . . . 0.1 110.142 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.851 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 11.9 ptp -177.3 151.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.522 -1.361 . . . . 0.11 111.645 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 165' ' ' ILE . 5.4 tt -97.98 112.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.593 -0.692 . . . . 0.1 110.032 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.76 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.4 p -153.76 149.71 27.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.901 -1.125 . . . . 0.1 110.39 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 8.0 p90 -68.64 127.53 33.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.09 109.758 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.67 120.99 6.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.235 -1.146 . . . . 0.2 110.235 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.743 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.33 102.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.445 -1.032 . . . . 0.55 109.135 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 26.1 tptp 1.07 84.08 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.422 0.629 . . . . 0.85 112.532 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.46 0.76 4.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.71 109.942 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 10.8 m-70 -74.01 -81.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.878 . . . . 0.42 110.331 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.97 8.3 7.41 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.194 -1.562 . . . . 0.33 109.194 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.417 ' OD2' ' CE2' ' A' ' 175' ' ' PHE . 3.1 t0 -126.3 -70.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -1.103 . . . . 0.33 110.198 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.461 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 98.3 m-85 -107.25 144.5 33.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.27 110.093 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -63.65 111.07 4.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.34 110.355 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.544 ' O ' HD22 ' A' ' 184' ' ' LEU . 49.7 Cg_endo -78.74 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.976 1.514 . . . . 0.47 110.444 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -94.21 178.59 5.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.35 110.232 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.3 p-10 -180.0 -53.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.923 . . . . 0.2 110.804 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.574 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 146.39 -134.98 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.364 -1.494 . . . . 0.25 109.364 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.11 -1.6 10.78 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 124.053 1.554 . . . . 0.44 109.809 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.443 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -57.02 -177.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.428 -0.795 . . . . 0.57 110.296 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.555 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -81.3 76.55 2.15 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.575 -1.01 . . . . 0.49 110.575 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.943 ' HA ' HG13 ' A' ' 1' ' ' HAV . 5.5 tt 179.64 94.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.273 -1.133 . . . . 0.41 110.789 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.668 HD13 ' CE2' ' A' ' 214' ' ' TYR . 8.6 tt -112.13 -18.45 12.57 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.554 -1.258 . . . . 0.3 111.109 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.624 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.11 109.56 3.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.503 -1.373 . . . . 0.2 111.832 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -121.35 135.59 55.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.16 109.971 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.83 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -123.78 160.8 26.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.096 -1.003 . . . . 0.23 110.454 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 1.1 m-30 -99.04 170.23 7.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.38 110.176 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.506 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.8 Cg_endo -71.74 128.3 14.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.562 . . . . 0.4 109.745 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.485 ' HA ' ' HA3' ' A' ' 196' ' ' GLY . 42.9 Cg_endo -69.05 68.3 1.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.873 1.459 . . . . 0.32 110.62 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.98 -83.67 1.2 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.267 -1.533 . . . . 0.32 109.267 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 -159.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.559 . . . . 0.47 110.042 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.12 0.52 27.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.63 110.34 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.74 40.84 2.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.319 -0.863 . . . . 0.53 110.326 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -108.63 -179.3 21.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.961 -1.656 . . . . 0.25 108.961 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 163' ' ' ILE . . . 38.91 27.13 0.05 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.213 -1.155 . . . . 0.1 110.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 196' ' ' GLY . 0.8 OUTLIER -77.59 88.23 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.331 . . . . 0.1 109.25 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.851 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.72 90.24 1.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.09 110.74 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 12.8 m170 -100.86 120.83 40.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.09 109.909 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 203' ' ' ASP . 20.2 m-85 -89.6 135.24 33.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.156 -0.965 . . . . 0.1 110.722 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 58.8 t0 -44.2 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.857 -0.794 . . . . 0.14 108.857 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.9 p30 -41.76 -31.64 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.18 111.49 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.574 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 17.1 t0 -71.15 -5.54 32.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.558 -1.338 . . . . 0.24 110.329 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 16.6 mm-40 -93.73 -164.71 1.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.088 . . . . 0.42 109.878 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.559 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 33.3 m -127.37 159.08 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.128 . . . . 0.47 110.769 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.592 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.2 m-90 -150.12 142.8 24.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.27 109.555 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.993 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -153.93 173.65 15.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.853 -1.154 . . . . 0.3 110.795 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.8 t -128.21 29.79 5.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.781 0.8 . . . . 0.61 108.945 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 -72.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.504 0.669 . . . . 0.78 110.108 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.132 -0.692 . . . . 0.91 109.132 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.43 133.17 33.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.548 -0.72 . . . . 0.93 109.553 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.18 -171.54 38.81 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.109 -1.596 . . . . 0.79 109.109 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.668 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.1 m-85 -75.66 113.54 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.69 109.999 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.567 ' O ' HG12 ' A' ' 219' ' ' VAL . 34.5 m-80 -79.87 121.97 26.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.054 -1.028 . . . . 0.4 108.627 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.993 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -40.56 -38.01 0.8 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.329 -0.857 . . . . 0.17 110.504 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 3.3 m-85 -52.97 -48.33 67.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.529 -1.268 . . . . 0.28 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' A' ' 244' ' ' TYR . 40.9 tp -72.06 -71.36 0.28 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.978 -0.556 . . . . 0.46 110.185 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.869 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -51.32 -70.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.156 -0.965 . . . . 0.39 110.144 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -42.22 -50.21 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.876 -1.14 . . . . 0.17 111.565 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -60.86 -34.7 75.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.309 -1.494 . . . . 0.1 108.924 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.7 t60 -69.33 -50.83 42.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.465 0.65 . . . . 0.21 109.792 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.807 ' OE2' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -60.9 -44.09 97.62 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.28 109.181 178.839 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.519 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 7.4 m-85 -55.08 -62.02 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.18 108.926 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.448 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.62 -32.03 1.9 Allowed Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.804 -1.718 . . . . 0.21 108.804 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.578 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.41 -71.96 0.43 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -1.174 . . . . 0.17 111.068 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.83 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.05 -44.19 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.33 112.006 -178.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.695 HD22 ' OH ' ' A' ' 266' ' ' TYR . 0.8 OUTLIER -100.37 -37.41 8.87 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.784 -1.197 . . . . 0.53 111.328 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -67.66 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.173 -1.171 . . . . 0.41 110.173 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 230' ' ' LEU . 0.8 OUTLIER -169.21 -172.62 1.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.45 110.936 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 1.9 m-20 -53.05 -58.04 8.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.62 110.172 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.578 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -163.67 179.63 7.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.45 111.017 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.515 ' N ' ' SD ' ' A' ' 240' ' ' MET . 1.8 t 179.53 54.35 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.083 -0.71 . . . . 0.38 109.083 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.31 23.89 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.48 111.351 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -38.72 -47.01 3.35 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.36 -0.936 . . . . 0.38 109.346 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 43.0 Cg_endo -92.1 -47.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.029 1.542 . . . . 0.28 110.968 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.83 100.9 0.14 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.725 -1.703 . . . . 0.24 112.506 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.961 ' HB2' ' HB2' ' A' ' 257' ' ' ASP . . . -148.08 160.92 42.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.317 -1.108 . . . . 0.28 109.998 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.569 HD21 ' C ' ' A' ' 221' ' ' ALA . 1.0 OUTLIER -69.31 62.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.076 0.941 . . . . 0.4 108.596 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.613 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.7 mtt -146.56 -33.98 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.59 -0.694 . . . . 0.45 110.758 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -44.13 168.5 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.57 110.325 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 2' ' ' 3MP . 45.4 Cg_endo -72.66 -12.51 26.77 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.879 1.463 . . . . 0.76 109.817 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.659 HG12 HG22 ' A' ' 245' ' ' THR . 5.9 tt -98.25 151.09 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.89 109.695 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.779 ' HB2' HD21 ' A' ' 218' ' ' LEU . 32.6 p90 -131.89 -28.28 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.78 111.038 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.748 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.45 -69.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 113.196 0.813 . . . . 0.61 113.196 -179.009 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.748 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -67.96 104.25 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.547 -1.346 . . . . 0.74 109.554 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.647 ' HA ' HD22 ' A' ' 218' ' ' LEU . 26.5 p -56.08 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.81 110.352 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.4 -7.15 57.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.56 109.495 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -149.21 27.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -1.16 . . . . 0.37 110.174 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -68.21 -13.93 62.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.44 110.339 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.0 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.53 110.326 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -167.54 178.39 5.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.38 110.501 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.938 ' HB2' HG21 ' A' ' 259' ' ' VAL . 4.7 ptp -68.23 53.98 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.393 -0.817 . . . . 0.19 110.61 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.708 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -43.97 -48.34 22.22 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.131 -1.063 . . . . 0.28 108.131 177.655 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.708 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -72.49 48.05 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 124.125 1.592 . . . . 0.49 111.251 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.632 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.3 m-20 -52.77 -30.86 35.22 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.763 -1.211 . . . . 0.49 109.761 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.961 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 3.1 m-20 -50.47 -45.59 56.34 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.589 -0.844 . . . . 0.31 109.57 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.955 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -80.18 -32.31 38.71 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.379 -0.971 . . . . 0.14 108.379 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.938 HG21 ' HB2' ' A' ' 253' ' ' MET . 83.6 t -60.35 -73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.17 110.072 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.719 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 6.2 pt20 -72.52 -31.35 65.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.331 -0.855 . . . . 0.26 110.094 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -47.73 -57.79 7.33 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.092 -1.603 . . . . 0.19 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -83.5 -21.71 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -1.228 . . . . 0.22 110.674 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.79 ' N ' HD13 ' A' ' 262' ' ' ILE . 29.6 tt0 -64.47 -20.01 65.92 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.493 -1.379 . . . . 0.39 108.348 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 264' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 260' ' ' GLN . 2.8 p -103.68 -38.98 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.152 -0.619 . . . . 0.47 111.354 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.9 mp -90.88 -44.57 9.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.103 -0.998 . . . . 0.48 111.343 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 1.009 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -72.92 -10.91 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.41 110.057 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -60.75 -92.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.461 . . . . 0.46 109.446 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 117.03 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.58 110.332 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.06 123.72 7.88 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.446 -1.462 . . . . 0.64 109.446 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.579 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -69.22 -63.71 1.01 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.95 109.93 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.517 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 tt0 50.15 28.96 3.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 1.2 110.149 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.62 125.66 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 1.2 110.07 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.66 81.45 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.843 1.443 . . . . 1.06 110.511 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.999 -1.001 . . . . 0.78 110.223 179.905 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.943 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.626 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.626 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.278 0.561 . . . . 0.41 110.214 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -122.88 96.22 4.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.965 . . . . 0.26 110.26 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 m -89.7 -179.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.33 110.196 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -60.84 131.51 91.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.65 110.194 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.53 61.68 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.824 1.434 . . . . 0.84 110.565 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.755 ' C ' HD23 ' A' ' 230' ' ' LEU . 23.6 mtp180 -142.0 63.26 1.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.223 -0.923 . . . . 0.93 110.12 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.539 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -148.52 -64.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 1.03 109.944 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.2 OUTLIER 33.15 53.76 0.41 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.909 -0.494 . . . . 1.04 111.881 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.779 ' HD2' HD13 ' A' ' 265' ' ' LEU . 17.4 pttt -140.75 78.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.77 109.688 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.584 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 11.6 t90 -142.27 -71.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.42 111.017 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.548 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 95.4 p -101.13 60.67 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.44 110.489 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 114' ' ' SER . 30.3 mttp -148.72 78.72 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.49 110.183 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.582 ' O ' HD13 ' A' ' 151' ' ' LEU . 12.6 ttt -105.71 -13.01 15.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 0.3 109.956 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.483 ' OD1' ' HB3' ' A' ' 152' ' ' ASN . 6.4 t30 -151.86 124.64 8.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.15 109.993 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 118' ' ' LEU . 3.2 tp -145.99 -170.2 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.13 110.258 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -122.05 158.05 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.12 110.161 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.756 ' CB ' HG23 ' A' ' 163' ' ' ILE . 37.0 p90 -151.06 169.2 22.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.367 -0.833 . . . . 0.33 110.704 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -120.87 147.1 45.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -0.816 . . . . 0.54 109.776 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.7 pp -112.87 120.45 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.116 -0.99 . . . . 0.33 110.997 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.919 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.0 OUTLIER -164.77 49.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.838 . . . . 0.27 109.416 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.706 ' ND2' HD13 ' A' ' 165' ' ' ILE . 1.4 m120 -39.67 -84.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.696 -0.627 . . . . 0.41 109.843 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.571 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.8 t80 179.89 -168.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.4 109.089 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.608 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -138.61 42.71 0.6 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.707 -1.246 . . . . 0.45 111.705 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -76.96 -83.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.484 1.255 . . . . 0.36 110.506 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.9 m-20 -107.83 -0.9 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.25 110.053 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.586 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -126.39 89.95 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.39 109.778 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.465 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -48.21 -179.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.48 110.939 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -48.49 -39.27 22.54 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.4 110.032 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -53.68 -61.2 2.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.46 109.615 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.586 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 31.6 mp0 -54.01 -54.49 38.38 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.565 -0.854 . . . . 0.47 109.43 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' ' 124' ' ' ASN . 53.2 t -45.76 -34.41 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 132' ' ' SER . 0.7 OUTLIER -61.38 -43.21 99.25 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.776 -1.194 . . . . 0.48 107.776 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 1.4 tttp -70.34 -56.98 5.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.64 108.337 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.861 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -43.75 -69.94 0.12 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.186 -0.946 . . . . 0.42 110.189 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.724 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -52.81 -59.46 4.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.34 110.945 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 5.1 tmtt? -65.56 -74.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.978 -1.076 . . . . 0.47 110.893 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.8 OUTLIER -38.24 -62.39 0.58 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.679 -0.638 . . . . 0.47 110.669 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -45.89 -38.15 7.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.798 -1.161 . . . . 0.25 108.386 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -70.42 -34.87 73.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.362 -0.836 . . . . 0.35 108.892 178.301 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 10.6 ttmm -58.51 -42.4 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.7 108.961 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 13.5 t -67.86 -46.72 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.535 -0.728 . . . . 0.61 109.094 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.627 ' HH2' HG21 ' A' ' 262' ' ' ILE . 13.3 t-105 -53.55 -41.66 66.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.777 . . . . 0.39 108.967 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 149' ' ' THR . 14.5 m -71.76 -37.15 70.54 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.412 -0.805 . . . . 0.35 109.02 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -53.66 -41.61 66.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.595 -0.691 . . . . 0.36 109.549 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.805 HG23 HG22 ' A' ' 149' ' ' THR . 29.4 m -79.63 -30.81 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.5 110.071 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.815 ' OG1' HD23 ' A' ' 151' ' ' LEU . 3.6 t -144.22 127.33 8.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.51 110.339 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 59.76 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.748 1.394 . . . . 0.31 110.745 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.008 HD21 ' O ' ' A' ' 266' ' ' TYR . 1.4 mm? -88.72 156.01 19.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.18 110.158 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.483 ' HB3' ' OD1' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -103.38 146.35 28.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.17 110.381 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.9 p90 -152.49 138.6 18.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.868 . . . . 0.14 110.384 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.906 ' O ' HG22 ' A' ' 119' ' ' THR . 4.2 m -143.02 135.4 27.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.15 110.261 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.587 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -93.61 89.03 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.978 -1.076 . . . . 0.2 110.024 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -62.97 100.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.22 110.371 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 157' ' ' HIS . 53.6 p-80 -67.14 57.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.331 -0.856 . . . . 0.32 110.357 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 156' ' ' LEU . 10.9 t0 -154.31 -51.53 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.33 109.904 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.41 35.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.037 -1.225 . . . . 0.28 110.037 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.547 ' HB ' ' CB ' ' A' ' 156' ' ' LEU . 72.1 mt -128.83 65.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -1.18 . . . . 0.3 109.289 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -126.01 150.16 48.29 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.2 -0.6 . . . . 0.2 110.568 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.434 ' OD2' ' HG ' ' A' ' 118' ' ' LEU . 1.2 m-20 -113.27 -34.22 5.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.356 -0.84 . . . . 0.1 109.883 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.756 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -126.03 170.38 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.1 110.155 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.729 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.5 ptm -168.93 139.12 2.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.891 -1.131 . . . . 0.11 110.95 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.706 HD13 ' ND2' ' A' ' 124' ' ' ASN . 4.2 tt -96.88 115.44 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.401 -0.812 . . . . 0.1 109.29 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.919 ' HB3' HG23 ' A' ' 123' ' ' VAL . 14.2 p -160.07 148.48 17.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.511 -1.368 . . . . 0.1 111.065 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.622 ' CE2' HG21 ' A' ' 169' ' ' ILE . 2.0 p90 -64.55 114.75 4.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.09 109.354 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.511 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -72.52 148.42 42.01 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.441 -1.464 . . . . 0.2 109.441 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.622 HG21 ' CE2' ' A' ' 167' ' ' PHE . 10.3 pt -141.41 97.46 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.752 -0.852 . . . . 0.55 109.853 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.64 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.07 78.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.277 0.561 . . . . 0.85 112.127 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -121.1 -5.57 9.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.71 110.266 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 172' ' ' HIS . 19.9 m-70 -82.19 -150.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.42 110.011 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.97 30.31 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.704 -1.358 . . . . 0.33 109.704 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 175' ' ' PHE . 2.9 p30 -127.51 -148.21 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -1.223 . . . . 0.33 110.176 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -49.22 153.35 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.27 110.09 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 9.2 m-30 -80.96 112.23 30.57 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.34 110.314 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.877 ' O ' HD22 ' A' ' 184' ' ' LEU . 45.9 Cg_endo -78.41 -67.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.901 1.474 . . . . 0.47 110.631 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -51.74 149.79 4.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.35 110.714 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.6 p30 -174.21 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.214 -0.994 . . . . 0.2 111.482 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.588 ' N ' ' HB2' ' A' ' 204' ' ' ASP . . . 120.43 -140.32 14.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.178 -1.569 . . . . 0.25 109.178 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.29 53.88 3.13 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 124.103 1.58 . . . . 0.44 109.628 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 0.2 OUTLIER -114.4 -177.41 3.12 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.526 -0.733 . . . . 0.57 110.055 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.554 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -72.03 65.18 1.23 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.482 -1.047 . . . . 0.49 110.482 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.982 ' HA ' HG13 ' A' ' 1' ' ' HAV . 2.6 tt 179.69 93.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -1.17 . . . . 0.41 110.846 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.853 HD12 ' CD ' ' A' ' 205' ' ' GLU . 4.1 tt -114.48 -13.3 12.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.606 -1.237 . . . . 0.3 111.352 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.672 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -156.32 102.62 2.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.488 -1.382 . . . . 0.2 111.671 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.54 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -117.26 122.77 44.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.16 109.51 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 1.041 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -110.52 158.66 18.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.23 110.207 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.9 m-30 -96.0 166.79 13.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.38 110.545 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 46.5 Cg_endo -72.86 136.38 25.13 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.091 1.574 . . . . 0.4 109.742 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 58.98 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.93 1.489 . . . . 0.32 110.611 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -99.18 -94.62 2.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.32 109.464 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.8 -165.89 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.965 1.508 . . . . 0.47 110.38 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -9.07 26.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.63 110.279 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 54.56 0.66 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.42 -0.8 . . . . 0.53 110.226 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -124.08 174.76 16.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.049 -1.621 . . . . 0.25 109.049 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.555 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.14 24.66 0.59 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.716 -1.354 . . . . 0.1 109.716 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 164' ' ' MET . 1.5 m-20 -79.8 87.35 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.068 -1.254 . . . . 0.1 109.96 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -63.73 113.25 3.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.09 110.502 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 11.4 m170 -121.24 119.07 31.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.325 -0.859 . . . . 0.09 110.602 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.0 m-85 -90.5 141.78 28.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.228 -0.92 . . . . 0.1 110.677 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 24.0 t0 -52.27 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.578 -0.701 . . . . 0.14 109.476 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.561 ' OD1' ' HB2' ' A' ' 178' ' ' PHE . 1.7 p-10 -35.78 -37.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.18 112.059 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.588 ' HB2' ' N ' ' A' ' 180' ' ' GLY . 3.0 m-20 -65.62 -14.1 60.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.725 -1.234 . . . . 0.24 111.175 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.853 ' CD ' HD12 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -93.13 -156.99 0.51 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.716 -1.24 . . . . 0.42 110.325 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.513 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 3.2 m -137.16 161.43 36.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.944 -1.098 . . . . 0.47 111.062 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.514 ' NE1' ' HB3' ' A' ' 201' ' ' PHE . 1.1 m-90 -149.19 149.1 30.44 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.033 -0.728 . . . . 0.27 109.033 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.008 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.76 -174.45 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.804 -1.185 . . . . 0.3 110.708 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -123.36 30.2 6.38 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.893 -0.723 . . . . 0.61 109.822 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -117.21 -172.49 2.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.41 -0.806 . . . . 0.78 110.161 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.488 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.4 OUTLIER -80.88 0.84 33.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.91 110.236 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -113.79 149.67 34.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.158 -0.964 . . . . 0.93 110.184 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 68.46 -173.8 32.53 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.79 109.402 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.834 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -77.16 114.26 15.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.69 110.157 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.622 ' O ' HG12 ' A' ' 219' ' ' VAL . 1.6 m120 -77.45 123.24 26.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.99 -1.069 . . . . 0.4 108.653 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.008 HD22 ' O ' ' A' ' 208' ' ' THR . 0.6 OUTLIER -44.72 -35.18 2.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.787 -1.165 . . . . 0.17 108.691 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.584 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 6.6 m-85 -55.74 -46.42 77.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.968 -1.493 . . . . 0.28 106.968 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 244' ' ' TYR . 21.8 tp -74.19 -74.8 0.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.901 -0.59 . . . . 0.46 110.742 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.732 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -48.19 -61.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.106 -0.996 . . . . 0.39 110.852 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.952 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.6 -51.15 63.93 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.79 -1.194 . . . . 0.17 111.336 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.247 -1.533 . . . . 0.1 108.682 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.628 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.9 t60 -77.08 -51.69 10.61 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.223 0.535 . . . . 0.21 109.647 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.586 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.1 tp10 -59.41 -44.08 92.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.987 -1.071 . . . . 0.28 108.341 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.48 ' CZ ' HD12 ' A' ' 165' ' ' ILE . 7.5 m-30 -53.38 -61.96 1.96 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.734 . . . . 0.18 109.102 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -32.72 2.16 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.925 -1.67 . . . . 0.21 108.925 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.639 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -81.97 -77.99 0.21 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -1.178 . . . . 0.17 111.229 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' SER . . . . . 1.041 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.73 -39.84 0.16 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.558 -0.714 . . . . 0.33 111.937 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.477 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 3.0 tp -96.41 -39.45 9.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.968 -1.082 . . . . 0.53 110.667 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -74.73 -91.09 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.099 -1.201 . . . . 0.41 110.099 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.773 HD22 ' C ' ' A' ' 230' ' ' LEU . 0.0 OUTLIER -175.93 170.44 2.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -1.118 . . . . 0.45 111.17 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.572 ' N ' HD22 ' A' ' 230' ' ' LEU . 7.2 t70 -25.7 -70.82 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 120.992 0.425 . . . . 0.62 112.024 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.728 ' O ' HD21 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -162.12 -179.83 7.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.01 -1.056 . . . . 0.45 111.176 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.3 OUTLIER 179.46 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.467 0.651 . . . . 0.38 109.401 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.686 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -101.76 23.09 11.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.534 -0.729 . . . . 0.48 111.472 -179.197 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.613 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -37.3 -66.71 0.27 Allowed Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.81 -0.756 . . . . 0.38 110.381 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 55.0 Cg_endo -76.87 -47.28 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.292 1.154 . . . . 0.28 110.578 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.79 101.17 0.14 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.981 -1.58 . . . . 0.24 111.936 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 257' ' ' ASP . . . -144.57 160.25 41.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -1.058 . . . . 0.28 110.207 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.628 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -75.2 64.98 1.5 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.23 1.015 . . . . 0.4 108.747 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.614 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.1 mtp -141.64 -37.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.805 . . . . 0.45 110.011 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -47.99 170.25 0.11 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.57 109.795 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.0 Cg_endo -70.69 -2.64 11.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.582 1.306 . . . . 0.76 110.512 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.548 HG22 HG22 ' A' ' 245' ' ' THR . 4.3 mt -98.64 145.12 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.89 110.054 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.702 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 46.9 p90 -134.65 -33.62 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.78 110.486 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 3.15 -68.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.646 0.98 . . . . 0.61 113.646 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.692 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -54.0 107.79 0.3 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.355 -1.466 . . . . 0.74 109.854 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.613 HG23 ' OD1' ' A' ' 215' ' ' ASN . 53.3 m -58.38 172.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.81 110.363 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 247' ' ' THR . . . -43.15 -40.76 4.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.899 -1.28 . . . . 0.56 109.899 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 46.74 1.64 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.254 . . . . 0.37 110.638 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 1.2 t -89.29 1.93 55.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.44 110.093 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.86 -69.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.53 110.238 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.2 OUTLIER 179.75 178.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.38 110.47 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.909 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -69.04 56.16 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.768 . . . . 0.19 109.853 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.69 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.79 -46.12 50.44 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 108.0 -1.111 . . . . 0.28 108.0 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -73.89 49.69 1.95 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.94 1.495 . . . . 0.49 111.499 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.581 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.3 m-20 -48.82 -34.11 11.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.49 110.689 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -54.69 -53.28 56.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.615 -1.234 . . . . 0.31 108.79 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.947 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.22 -36.43 84.13 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.498 -0.881 . . . . 0.14 108.819 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 253' ' ' MET . 78.3 t -64.73 -84.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.17 110.753 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 11.0 tt0 -54.68 -43.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.045 . . . . 0.26 109.395 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.0 -70.12 0.39 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.518 -1.033 . . . . 0.19 110.518 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.947 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -71.25 -24.93 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.594 -1.533 . . . . 0.22 110.005 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.814 ' N ' HD13 ' A' ' 262' ' ' ILE . 5.4 tt0 -57.33 -23.36 48.25 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.998 -1.081 . . . . 0.39 108.554 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 -43.49 5.48 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.155 -0.618 . . . . 0.47 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.779 HD13 ' HD2' ' A' ' 112' ' ' LYS . 7.0 mt -73.92 -53.45 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.812 . . . . 0.48 110.876 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 1.008 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -75.37 -8.48 56.8 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.251 -0.905 . . . . 0.41 109.837 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.43 -106.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.097 -1.601 . . . . 0.46 109.097 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.81 115.42 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.878 1.462 . . . . 0.58 109.999 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.08 143.13 18.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.66 -1.376 . . . . 0.64 109.66 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.584 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 -80.83 -60.92 2.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.95 110.064 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 14.9 tt0 42.88 26.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 1.2 110.259 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 270' ' ' ASP . 5.3 t0 -167.21 105.2 0.62 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 1.2 110.4 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.22 56.6 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.984 1.518 . . . . 1.06 110.435 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.993 -1.003 . . . . 0.78 110.242 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.982 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.559 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.702 ' HH2' ' CB ' ' A' ' 244' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.244 0.545 . . . . 0.41 110.138 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -126.89 110.4 12.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.26 110.436 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.0 m -103.23 169.8 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.33 109.957 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.01 129.88 7.2 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.181 -0.949 . . . . 0.65 109.939 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 46.1 Cg_endo -73.46 66.4 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.914 1.481 . . . . 0.84 110.375 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.868 ' O ' HD12 ' A' ' 230' ' ' LEU . 79.7 mtt180 -155.23 71.21 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.93 109.727 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 1.6 p -135.34 -67.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 1.03 109.41 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.512 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.64 48.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.783 -0.573 . . . . 1.04 111.363 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -138.72 78.83 1.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.997 . . . . 0.77 109.61 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.606 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 6.4 t90 -151.15 -67.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.893 . . . . 0.42 111.176 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.552 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 35.9 t -87.79 40.68 0.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.44 110.86 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.823 ' HD3' HD11 ' A' ' 118' ' ' LEU . 13.1 mmtt -143.31 83.69 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.49 110.807 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.1 ttp -100.26 -21.03 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.974 . . . . 0.3 109.391 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.411 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 1.7 p-10 -138.52 137.83 37.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.15 109.455 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -151.07 167.56 27.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 0.13 110.824 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -110.17 168.45 9.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.12 109.604 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.663 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 8.5 p90 -167.32 176.13 6.88 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.934 -1.107 . . . . 0.33 111.486 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 6.2 tpt85 -123.38 152.73 41.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.698 -0.626 . . . . 0.54 109.38 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.815 HG21 ' CD1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -121.32 95.05 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.084 -1.01 . . . . 0.33 111.16 -179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.989 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.5 m -141.53 50.33 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.134 -0.979 . . . . 0.27 110.257 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.707 ' OD1' HD21 ' A' ' 216' ' ' LEU . 1.8 t-20 -43.33 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.41 109.404 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 30.6 t80 179.89 175.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.4 110.127 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -118.97 59.28 4.24 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.45 109.964 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 125' ' ' TYR . 44.8 Cg_endo -70.73 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.109 1.584 . . . . 0.36 110.567 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.19 4.39 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.25 109.795 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.605 ' SD ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -115.41 139.9 49.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.518 -0.739 . . . . 0.39 109.83 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -78.53 167.52 21.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.48 110.378 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 130' ' ' THR . 22.3 t-80 -43.28 -39.21 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.4 109.751 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 8.4 t -59.32 -49.36 78.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.46 109.709 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.566 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.5 OUTLIER -58.25 -57.62 12.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.33 -0.857 . . . . 0.47 109.337 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.6 t -46.42 -35.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.608 -1.256 . . . . 0.31 107.608 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.611 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -57.79 -42.37 84.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.013 -1.106 . . . . 0.48 108.013 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 7.8 tttt -69.31 -49.66 53.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.197 0.999 . . . . 0.64 108.397 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.85 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -48.12 -61.71 1.84 Allowed 'General case' 0 C--N 1.287 -2.138 0 O-C-N 121.245 -0.91 . . . . 0.42 110.816 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.815 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.34 -52.25 35.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.234 -0.916 . . . . 0.34 111.026 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.631 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.2 -71.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.47 110.397 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -41.99 -57.55 2.39 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.527 -0.733 . . . . 0.47 110.307 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.97 -38.51 17.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.296 -1.362 . . . . 0.25 108.345 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.663 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -71.57 -34.71 70.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.308 -0.87 . . . . 0.35 108.994 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' CD ' ' C ' ' A' ' 143' ' ' LYS . 0.1 OUTLIER -60.63 -41.25 94.52 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.797 -0.816 . . . . 0.7 108.797 179.044 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.99 -49.96 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.661 -0.866 . . . . 0.61 108.661 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.68 ' HH2' HG21 ' A' ' 262' ' ' ILE . 29.4 t-105 -52.43 -36.24 53.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.682 -0.859 . . . . 0.39 108.682 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 149' ' ' THR . 57.8 m -75.24 -35.39 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.475 -0.766 . . . . 0.35 109.095 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.68 -40.15 78.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.429 -0.794 . . . . 0.36 109.375 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.48 HG23 HG22 ' A' ' 149' ' ' THR . 20.0 m -80.37 -31.23 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.777 -0.769 . . . . 0.5 110.119 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.696 ' CG2' HD23 ' A' ' 151' ' ' LEU . 12.8 t -150.59 131.9 7.53 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.047 . . . . 0.51 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.14 58.93 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.854 1.45 . . . . 0.31 110.545 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.935 HD21 ' HB3' ' A' ' 266' ' ' TYR . 2.1 mm? -77.2 134.89 38.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.18 110.284 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.411 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 1.7 m-20 -80.94 130.13 34.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.17 110.123 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.4 p90 -137.15 139.57 41.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.14 110.268 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.708 ' O ' HG22 ' A' ' 119' ' ' THR . 18.2 m -147.06 131.31 17.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.302 -0.874 . . . . 0.15 110.554 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.608 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -98.65 118.23 34.91 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.695 -0.628 . . . . 0.2 109.471 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.43 99.74 7.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.22 110.311 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 158' ' ' ASP . 11.1 p-80 -54.03 -28.77 40.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.32 109.833 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.5 t0 -41.76 -57.21 2.41 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.475 0.655 . . . . 0.33 109.719 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.72 37.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.616 -1.394 . . . . 0.28 109.616 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 160' ' ' ILE . 23.5 mm -128.26 67.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.146 -1.208 . . . . 0.3 109.373 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.8 127.94 52.41 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.78 -0.575 . . . . 0.2 110.356 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.819 ' OD2' HD23 ' A' ' 118' ' ' LEU . 29.5 m-20 -90.0 -45.16 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.1 110.058 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.0 HG22 ' HA3' ' A' ' 197' ' ' GLY . 1.4 pp -127.02 172.84 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.1 109.719 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.759 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 4.3 ptt? -174.39 163.51 3.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.11 111.563 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 165' ' ' ILE . 4.0 tt -106.23 116.25 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.542 -0.724 . . . . 0.1 109.683 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.989 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.8 p -157.12 141.08 16.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.598 -1.314 . . . . 0.1 111.304 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.7 p90 -60.76 121.68 12.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.547 -0.72 . . . . 0.09 109.913 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -90.86 126.86 8.58 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.094 -1.203 . . . . 0.2 110.094 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.2 tt -122.88 97.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.936 . . . . 0.55 109.457 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 7.0 tptt 0.28 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.291 0.567 . . . . 0.85 112.401 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.66 15.18 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.71 110.168 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.412 ' CE1' ' CE1' ' A' ' 200' ' ' HIS . 29.6 m-70 -85.08 -86.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.42 110.302 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.48 41.72 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.422 -1.471 . . . . 0.33 109.422 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.97 -89.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -1.112 . . . . 0.33 110.355 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.48 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 3.5 m-85 -116.66 -171.26 1.98 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.27 110.411 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.573 ' CD1' ' HE2' ' A' ' 170' ' ' LYS . 4.2 m-30 -90.45 109.83 36.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.34 110.176 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.494 ' O ' HD22 ' A' ' 184' ' ' LEU . 42.9 Cg_endo -75.56 -72.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.47 110.536 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CG ' ' OD2' ' A' ' 203' ' ' ASP . 2.1 p90 -64.85 177.61 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.35 109.936 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.8 p-10 179.13 -51.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.164 -0.96 . . . . 0.2 111.022 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 138.29 -136.59 8.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.366 -1.494 . . . . 0.25 109.366 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 180' ' ' GLY . 55.2 Cg_endo -71.64 -5.41 16.99 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 O-C-N 124.15 1.606 . . . . 0.44 109.392 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.474 ' HB2' ' OD2' ' A' ' 179' ' ' ASP . 1.8 m -55.04 -176.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.397 -0.814 . . . . 0.57 109.616 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.551 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -82.63 76.34 2.24 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.038 -1.077 . . . . 0.49 110.672 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.034 ' HA ' HG13 ' A' ' 1' ' ' HAV . 6.6 tt 179.77 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -1.146 . . . . 0.41 110.841 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 214' ' ' TYR . 9.4 tt -109.43 -15.59 14.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.803 -1.186 . . . . 0.3 111.248 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.638 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -154.28 109.16 3.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.437 -1.414 . . . . 0.2 111.8 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 1.1 p80 -109.77 127.04 54.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.89 -1.131 . . . . 0.16 109.862 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.826 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -104.2 130.98 51.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.459 -0.775 . . . . 0.23 110.359 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -78.53 163.49 61.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.085 -1.009 . . . . 0.38 110.42 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.504 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.2 Cg_endo -72.73 133.43 20.26 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 124.105 1.582 . . . . 0.4 109.933 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.7 Cg_endo -70.55 70.07 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.874 1.46 . . . . 0.32 110.399 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.36 -105.5 2.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.564 -1.414 . . . . 0.32 109.564 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.74 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.916 1.482 . . . . 0.47 110.223 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -63.17 -10.95 17.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.101 -1.0 . . . . 0.63 110.175 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.63 68.79 0.8 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.499 -0.75 . . . . 0.53 110.032 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -151.53 165.33 30.47 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.901 -1.68 . . . . 0.25 108.901 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 1.0 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 58.28 16.18 26.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.066 -1.614 . . . . 0.1 109.066 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -79.24 87.5 4.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -1.113 . . . . 0.1 110.576 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.7 95.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.09 109.59 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.582 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 19.6 m170 -97.08 141.05 30.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.09 110.394 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 5.4 m-30 -108.0 136.84 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.1 110.98 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 59.5 t0 -50.86 86.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.786 -0.82 . . . . 0.14 108.786 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.597 ' OD2' ' CG ' ' A' ' 178' ' ' PHE . 1.3 p30 -39.34 -32.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.18 111.844 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.587 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -78.81 3.0 17.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.645 -1.285 . . . . 0.24 110.715 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 9.1 mm-40 -96.63 -162.83 0.99 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.012 -1.055 . . . . 0.42 110.126 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.92 147.5 48.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.023 -1.048 . . . . 0.47 110.51 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.569 ' CZ2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -138.71 144.94 39.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.27 109.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.27 177.58 10.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.93 -1.106 . . . . 0.3 110.833 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.2 t -128.61 41.19 3.53 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.912 0.863 . . . . 0.61 109.109 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 4.0 t -122.19 -164.79 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.502 -0.749 . . . . 0.78 109.955 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -89.02 14.45 10.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.91 109.889 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -130.28 163.16 27.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.93 110.316 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 58.76 -175.26 2.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.79 109.461 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.621 ' CE2' HD13 ' A' ' 185' ' ' LEU . 63.0 m-85 -74.62 117.76 16.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.69 110.144 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.615 ' O ' HG12 ' A' ' 219' ' ' VAL . 9.3 p30 -87.75 118.66 27.41 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.192 -0.943 . . . . 0.4 108.709 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.956 ' O ' ' HB3' ' A' ' 220' ' ' ALA . 1.6 mp -41.83 -32.72 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.483 -0.76 . . . . 0.17 110.649 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 2.1 m-85 -50.89 -47.64 60.6 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.297 -1.372 . . . . 0.28 107.297 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 244' ' ' TYR . 42.1 tp -82.49 -70.16 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.423 -0.808 . . . . 0.46 110.976 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.948 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.43 -60.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.39 109.753 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.956 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -54.8 -48.69 72.42 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.892 -1.13 . . . . 0.17 110.916 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -58.22 -29.99 66.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.328 -1.483 . . . . 0.1 108.846 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.653 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.4 t60 -74.75 -51.06 15.19 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.746 -0.661 . . . . 0.21 109.523 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.624 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.9 tp10 -61.09 -32.9 72.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.28 109.042 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 225' ' ' GLY . 13.6 m-30 -65.85 -64.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.42 -0.8 . . . . 0.18 108.986 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -28.27 1.19 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.076 -1.61 . . . . 0.21 109.076 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.63 -70.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -1.221 . . . . 0.17 111.657 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.826 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 5.0 p -51.77 -31.17 25.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.33 112.124 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 118' ' ' LEU . 9.8 tp -99.96 -41.83 7.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.89 -1.131 . . . . 0.53 111.157 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.581 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -74.89 -83.93 0.36 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.758 -0.937 . . . . 0.41 110.758 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 109' ' ' ARG . 2.0 pt? -161.13 -157.73 0.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.031 -1.276 . . . . 0.45 110.785 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.522 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -70.74 -50.95 30.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.62 110.36 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.614 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -169.09 176.18 5.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 0.45 110.59 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.71 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.443 -0.785 . . . . 0.38 109.316 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.961 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -138.98 22.22 2.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.48 110.889 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -38.78 -48.47 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.464 -0.772 . . . . 0.38 110.433 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 45.6 Cg_endo -87.36 -48.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.846 1.445 . . . . 0.28 111.372 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.506 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.28 100.43 0.13 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 118.962 -1.589 . . . . 0.24 111.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.961 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -144.89 -161.62 1.33 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -1.143 . . . . 0.28 109.808 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.619 HD11 HD12 ' A' ' 218' ' ' LEU . 0.3 OUTLIER -105.66 49.84 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.341 -0.985 . . . . 0.4 108.341 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.653 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.4 mtt -134.37 -21.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.374 -0.829 . . . . 0.45 111.157 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.625 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -59.07 168.5 1.51 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.793 -1.192 . . . . 0.57 111.035 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.7 Cg_endo -71.23 -8.65 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.684 1.36 . . . . 0.76 109.93 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.672 HG22 HG22 ' A' ' 245' ' ' THR . 17.1 mm -101.06 139.08 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.452 -0.78 . . . . 0.89 109.647 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.72 ' HB2' HD21 ' A' ' 218' ' ' LEU . 48.2 p90 -125.6 -25.56 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.78 110.664 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.743 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER 2.45 -67.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 113.635 0.976 . . . . 0.61 113.635 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.743 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -68.63 117.19 10.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.38 -1.45 . . . . 0.74 109.289 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 250' ' ' SER . 49.3 p -47.13 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.81 110.206 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.79 -21.16 3.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.432 -1.467 . . . . 0.56 109.432 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.434 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 1.1 ptmm? -162.5 49.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.246 . . . . 0.37 110.665 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.488 ' OG ' ' CD1' ' A' ' 246' ' ' TYR . 1.4 m -43.77 -61.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.44 109.856 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.7 OUTLIER -147.37 4.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.53 111.016 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 253' ' ' MET . 92.7 t80 179.98 170.91 1.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.934 -1.104 . . . . 0.38 110.939 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.934 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -90.58 59.89 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.55 -0.719 . . . . 0.19 110.013 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.702 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.7 OUTLIER -44.41 -47.33 25.75 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.979 -1.119 . . . . 0.28 107.979 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.2 Cg_endo -73.34 50.58 1.95 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.143 1.602 . . . . 0.49 110.922 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.656 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.4 m-20 -55.54 -29.15 58.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.072 -1.017 . . . . 0.49 110.633 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.889 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 35.3 m-20 -54.7 -48.95 71.83 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.111 -0.993 . . . . 0.31 109.234 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.949 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.98 -33.31 63.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.57 -0.9 . . . . 0.14 108.57 178.764 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 253' ' ' MET . 72.8 t -62.23 -82.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.811 . . . . 0.17 110.055 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.652 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 21.4 tm0? -59.84 -41.76 92.08 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.345 -0.847 . . . . 0.26 109.665 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.68 ' O ' HD12 ' A' ' 265' ' ' LEU . . . -40.69 -64.87 1.12 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.949 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -80.21 -21.66 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.744 -1.445 . . . . 0.22 110.278 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.867 ' N ' HD13 ' A' ' 262' ' ' ILE . 45.7 tt0 -60.35 -22.67 63.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.788 -1.165 . . . . 0.39 108.158 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 31.2 t -104.09 -41.21 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.268 -0.573 . . . . 0.47 111.092 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 261' ' ' GLY . 0.4 OUTLIER -79.75 -50.2 10.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.48 111.527 -178.562 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.935 ' HB3' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -78.7 -17.09 56.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.41 110.059 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -52.88 -93.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.815 -1.714 . . . . 0.46 108.815 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 128.49 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.017 1.535 . . . . 0.58 110.067 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -101.02 147.7 17.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.583 -1.407 . . . . 0.64 109.583 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.606 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -99.03 -68.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -1.134 . . . . 0.95 110.054 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.552 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 3.2 tm-20 57.01 35.69 26.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 1.2 110.263 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.45 ' OD1' ' HB3' ' A' ' 270' ' ' ASP . 11.6 p-10 -133.73 75.12 68.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.408 -0.808 . . . . 1.2 110.274 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.23 56.81 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.975 1.513 . . . . 1.06 110.364 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.006 -0.997 . . . . 0.78 110.249 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.034 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.626 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.638 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.233 0.54 . . . . 0.41 110.227 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -121.09 150.3 41.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.26 110.308 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 107' ' ' PHE . 53.0 t -84.13 -88.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.33 110.227 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.572 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.3 m-85 -113.83 131.37 23.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.65 110.178 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.29 54.69 2.85 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.0 1.526 . . . . 0.84 110.305 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.71 ' O ' HD12 ' A' ' 230' ' ' LEU . 71.7 mtt-85 -145.13 52.13 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.93 110.233 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 6.7 p -121.49 -53.33 2.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 1.03 109.967 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD22 ' HD2' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 45.06 23.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.187 -0.945 . . . . 1.04 111.285 179.282 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 266' ' ' TYR . 28.9 mtpt -123.64 74.45 1.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.051 -1.031 . . . . 0.77 109.598 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.577 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 5.9 t90 -145.44 -67.91 0.3 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.225 -0.922 . . . . 0.42 110.907 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 271' ' ' GLU . 30.1 t -97.84 58.52 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.865 . . . . 0.44 110.835 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 114' ' ' SER . 9.5 mttm -160.03 61.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.94 . . . . 0.49 110.43 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 7.3 tmm? -85.05 13.69 5.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.3 110.355 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -171.82 126.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.15 110.278 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.772 HD13 ' OD2' ' A' ' 162' ' ' ASP . 2.8 mt -151.3 -164.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.13 110.177 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' THR . . . . . 1.071 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -128.78 171.38 12.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.12 109.75 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 154' ' ' THR . 36.2 p90 -171.4 -172.97 1.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.09 . . . . 0.33 111.168 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 2.3 mtm-85 -127.98 164.84 21.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.54 110.196 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 138' ' ' PHE . 6.6 pt -128.19 70.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.33 110.365 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.949 HG23 ' HB3' ' A' ' 166' ' ' SER . 4.8 m -120.67 50.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.27 110.793 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.534 ' C ' HD21 ' A' ' 124' ' ' ASN . 0.5 OUTLIER -44.13 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.41 109.267 179.562 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.66 ' O ' HG21 ' A' ' 134' ' ' VAL . 7.5 t80 -178.99 174.43 1.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.506 -0.746 . . . . 0.4 109.836 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -128.74 53.78 12.23 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.45 110.425 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 126' ' ' THR . 47.2 Cg_endo -77.14 -86.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.989 1.52 . . . . 0.36 110.609 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.02 -1.38 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.25 110.064 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.644 ' HE3' HD21 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -112.19 150.52 30.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.39 110.111 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -98.03 166.24 11.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.48 110.069 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' THR . 17.2 t-80 -41.3 -32.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.395 -0.816 . . . . 0.4 110.194 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -69.87 -46.32 65.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.46 110.261 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.8 OUTLIER -67.67 -58.11 5.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.083 -1.01 . . . . 0.47 109.528 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.66 HG21 ' O ' ' A' ' 125' ' ' TYR . 13.8 t -45.07 -37.78 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.817 -1.179 . . . . 0.31 107.817 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.9 mt-10 -57.58 -45.95 84.6 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.887 -1.153 . . . . 0.48 107.887 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 3.3 tttt -63.2 -48.94 76.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.798 0.809 . . . . 0.64 109.011 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.821 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.67 -59.02 2.99 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.123 -0.986 . . . . 0.42 110.155 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.624 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -66.71 -54.15 26.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.34 110.568 -179.25 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -64.6 -74.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.099 -1.0 . . . . 0.47 109.942 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.9 tmtt? -37.32 -62.7 0.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 O-C-N 122.07 -0.394 . . . . 0.47 110.886 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.92 -36.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.686 -1.206 . . . . 0.25 108.585 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.83 -28.94 61.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.35 109.111 178.628 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.93 -43.73 97.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.379 -0.971 . . . . 0.7 108.379 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 5.7 t -70.29 -49.66 52.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.649 -0.871 . . . . 0.61 108.649 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' CH2' HG13 ' A' ' 262' ' ' ILE . 51.3 t-105 -53.54 -31.52 46.74 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.755 -0.831 . . . . 0.39 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 149' ' ' THR . 67.6 m -78.95 -34.25 44.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.235 -1.024 . . . . 0.35 108.235 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.7 OUTLIER -57.9 -37.37 73.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.793 -0.818 . . . . 0.36 108.793 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.84 HG23 HG22 ' A' ' 149' ' ' THR . 27.1 m -80.67 -35.14 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.767 -0.773 . . . . 0.5 109.751 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.84 HG22 HG23 ' A' ' 148' ' ' VAL . 4.6 t -147.83 127.6 6.56 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.994 . . . . 0.51 110.389 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 54.25 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.803 1.422 . . . . 0.31 110.601 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.575 HD21 ' CG ' ' A' ' 266' ' ' TYR . 4.1 tp -73.85 147.79 42.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.18 110.318 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.9 OUTLIER -88.22 117.62 27.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.93 . . . . 0.17 110.204 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.0 p90 -125.12 119.75 29.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.14 110.297 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 155' ' ' ARG . 23.0 m -120.45 170.75 9.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.15 110.256 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 154' ' ' THR . 2.3 ptt180 -156.64 114.52 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.902 -0.719 . . . . 0.2 110.481 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 110.67 14.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.22 109.995 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 158' ' ' ASP . 23.9 p-80 -51.86 -23.63 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.32 109.954 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.523 ' OD2' ' CD1' ' A' ' 160' ' ' ILE . 1.1 t70 -44.24 -26.16 0.29 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.39 -0.819 . . . . 0.33 109.666 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.72 28.9 1.01 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.543 -1.423 . . . . 0.28 109.543 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 1.071 HG22 HG21 ' A' ' 119' ' ' THR . 7.2 mt -115.3 81.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.2 -1.176 . . . . 0.3 108.483 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -144.81 123.68 12.7 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.068 -0.653 . . . . 0.2 110.828 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.772 ' OD2' HD13 ' A' ' 118' ' ' LEU . 39.4 t0 -92.29 -51.61 5.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.1 109.697 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.628 HG22 ' HA3' ' A' ' 197' ' ' GLY . 1.1 pt -115.82 179.43 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.307 -0.87 . . . . 0.1 109.05 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.811 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.2 ptp -177.82 151.6 0.71 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 0.11 111.618 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.568 ' HB ' ' CE2' ' A' ' 224' ' ' PHE . 3.6 tt -93.98 117.6 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.1 109.374 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.949 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.1 p -159.31 150.57 20.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.74 -1.225 . . . . 0.1 110.587 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 169' ' ' ILE . 6.7 p90 -72.94 117.74 15.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.499 -0.751 . . . . 0.09 110.168 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -67.75 118.82 10.18 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.051 -1.22 . . . . 0.2 110.051 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 169' ' ' ILE . 19.7 tt -118.5 101.08 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.88 -0.776 . . . . 0.55 109.422 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.9 OUTLIER 1.93 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.331 0.586 . . . . 0.85 112.488 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.22 -0.04 3.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.71 110.088 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 17.3 m-70 -91.36 -154.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.42 110.191 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -159.08 31.61 0.45 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.467 . . . . 0.33 109.434 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -131.47 -52.84 1.01 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -1.155 . . . . 0.33 110.125 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -136.87 175.98 9.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.27 110.231 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -95.09 110.15 48.49 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.34 110.255 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.534 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.2 Cg_endo -73.38 -37.96 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.984 1.518 . . . . 0.47 110.592 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 4.4 p90 -109.73 170.19 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.35 110.734 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.509 ' OD2' HD23 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -179.77 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.2 111.142 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.588 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 159.2 -141.66 7.73 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.561 -1.415 . . . . 0.25 109.561 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.65 -3.82 13.83 Favored 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.236 1.65 . . . . 0.44 109.875 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.86 177.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.463 -0.773 . . . . 0.57 110.019 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.564 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -74.97 79.77 0.98 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.234 -1.146 . . . . 0.49 110.234 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.009 HD12 ' CG1' ' A' ' 1' ' ' HAV . 15.1 tp 179.82 91.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -1.12 . . . . 0.41 110.888 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.705 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.0 tt -113.83 -17.38 12.06 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.461 -1.296 . . . . 0.3 111.293 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.683 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.14 104.55 2.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.555 -1.341 . . . . 0.2 111.864 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 0.4 OUTLIER -109.41 121.0 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.16 109.77 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -110.83 136.01 50.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.23 110.413 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.698 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.8 m-30 -85.57 159.36 55.72 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.38 110.216 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.52 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 43.8 Cg_endo -70.88 140.28 38.14 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.145 1.603 . . . . 0.4 109.588 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.613 ' HD2' HD22 ' A' ' 111' ' ' LEU . 42.0 Cg_endo -68.75 82.0 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.015 1.534 . . . . 0.32 110.836 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.61 -91.23 1.12 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.17 -1.572 . . . . 0.32 109.17 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.28 -158.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.074 1.565 . . . . 0.47 109.981 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -82.51 12.26 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 0.63 110.323 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -117.78 -3.34 11.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.249 -0.907 . . . . 0.53 109.982 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -68.54 171.31 37.52 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.331 -1.508 . . . . 0.25 109.331 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.628 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 48.22 21.76 2.0 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.775 -1.33 . . . . 0.1 109.775 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 195' ' ' TYR . 0.4 OUTLIER -81.71 85.55 6.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.317 . . . . 0.1 110.096 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.811 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.17 101.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.09 110.033 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.572 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -112.53 120.88 43.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.837 . . . . 0.09 110.461 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 203' ' ' ASP . 22.6 m-85 -90.67 144.37 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.1 110.477 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 15.1 t0 -52.84 85.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.593 -0.892 . . . . 0.14 108.593 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.567 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.8 p30 -38.19 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.18 111.799 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.588 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -75.68 -0.65 21.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.792 -1.193 . . . . 0.24 110.929 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.65 ' HG2' HD12 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -101.98 -156.14 0.55 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 0.42 110.218 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 17.5 m -133.98 156.4 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 0.47 110.768 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -151.65 150.64 30.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.27 109.272 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.003 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -161.05 173.18 15.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.726 -1.234 . . . . 0.3 111.038 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.0 OUTLIER -129.84 25.35 5.31 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.716 0.769 . . . . 0.61 108.993 178.62 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.34 -67.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.463 0.649 . . . . 0.78 110.525 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.75 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.488 -0.757 . . . . 0.91 109.724 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.99 -178.99 4.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.369 -0.832 . . . . 0.93 110.063 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.05 -174.7 0.17 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.539 -1.424 . . . . 0.79 109.539 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.705 ' CE1' HD13 ' A' ' 185' ' ' LEU . 93.9 m-85 -67.36 120.13 13.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -1.109 . . . . 0.69 109.814 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.611 ' O ' HG12 ' A' ' 219' ' ' VAL . 40.6 m-80 -88.17 119.5 28.63 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.974 -1.079 . . . . 0.4 108.8 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.003 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.84 -36.24 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -0.863 . . . . 0.17 110.236 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.612 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 4.6 m-85 -51.58 -44.11 62.67 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.407 -1.317 . . . . 0.28 107.746 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.995 HD11 ' HH1' ' A' ' 3' ' ' MSB . 12.3 tp -83.65 -71.29 0.51 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.894 -0.594 . . . . 0.46 111.106 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.837 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.4 p -46.31 -56.11 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.986 -1.071 . . . . 0.39 109.817 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.95 -48.92 79.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.101 -0.999 . . . . 0.17 110.873 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -57.36 -24.92 58.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.234 -1.541 . . . . 0.1 108.556 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.843 ' HB2' HD21 ' A' ' 239' ' ' LEU . 3.8 t-160 -79.64 -54.89 5.44 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.95 -0.568 . . . . 0.21 109.872 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.612 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.3 tp10 -59.51 -50.94 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.979 -1.076 . . . . 0.28 109.092 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.568 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 1.9 m-85 -52.82 -57.99 8.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.18 109.163 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.02 -32.58 4.84 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.251 -1.539 . . . . 0.21 109.251 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.438 ' NE2' ' ND1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.0 -72.14 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.09 -1.241 . . . . 0.17 111.001 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.933 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -38.05 -42.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.33 111.9 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.604 ' HB2' HD13 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -95.95 -38.49 10.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.878 -1.139 . . . . 0.53 111.335 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.538 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -75.13 -87.09 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.653 -0.979 . . . . 0.41 110.653 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.811 HD11 ' O ' ' A' ' 232' ' ' HIS . 0.3 OUTLIER -158.69 -167.72 2.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -1.194 . . . . 0.45 110.855 -178.766 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.514 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -64.41 -55.43 21.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.62 109.75 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.811 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -157.38 179.98 8.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.264 -0.898 . . . . 0.45 110.62 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 14.2 t 179.24 50.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.38 109.381 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.739 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -131.06 21.56 4.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.48 111.13 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.586 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -37.44 -52.86 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.38 110.708 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.2 Cg_endo -90.12 -46.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.52 1.274 . . . . 0.28 110.873 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.01 96.11 0.1 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.295 -1.431 . . . . 0.24 111.419 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.856 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.37 165.95 26.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.347 -1.09 . . . . 0.28 110.133 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.901 ' O ' HD23 ' A' ' 239' ' ' LEU . 7.0 tt -74.46 55.7 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.4 109.736 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.631 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.6 mmm -133.7 -34.72 1.01 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.004 -1.06 . . . . 0.45 110.32 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -42.99 168.51 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 0.57 110.464 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.9 Cg_endo -72.89 -2.43 11.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.89 1.468 . . . . 0.76 110.024 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 245' ' ' THR . 26.1 mm -106.89 149.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.89 110.04 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 218' ' ' LEU . 26.4 p90 -134.51 -28.3 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.78 110.922 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.93 -69.52 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.495 0.924 . . . . 0.61 113.495 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -55.17 104.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.309 -1.495 . . . . 0.74 109.628 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.545 HG23 ' ND2' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -52.52 -177.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.81 110.201 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 247' ' ' THR . . . -67.58 -8.31 51.31 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.317 -1.513 . . . . 0.56 109.317 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 29.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.37 110.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 247' ' ' THR . 0.9 OUTLIER -82.35 -10.62 59.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.056 -1.028 . . . . 0.44 109.746 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.555 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -156.92 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.53 109.785 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER 179.22 -172.27 0.15 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.38 110.407 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.886 ' HB2' HG21 ' A' ' 259' ' ' VAL . 19.7 ptt? -66.31 53.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.19 110.825 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.715 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.6 OUTLIER -46.22 -47.39 45.06 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 107.933 -1.136 . . . . 0.28 107.933 177.271 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.715 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -72.92 50.32 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 124.076 1.567 . . . . 0.49 111.309 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.0 m-20 -48.51 -32.48 7.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.945 -1.097 . . . . 0.49 110.6 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.856 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -53.89 -53.54 51.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.887 -1.125 . . . . 0.31 109.233 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.074 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -67.46 -32.86 73.99 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.021 -1.05 . . . . 0.14 108.915 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.886 HG21 ' HB2' ' A' ' 253' ' ' MET . 59.2 t -66.54 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.17 110.398 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.605 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 8.7 tt0 -53.9 -41.97 68.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.26 109.231 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.69 -71.66 0.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.091 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -71.54 -19.48 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.707 -1.466 . . . . 0.22 110.073 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 1.091 ' N ' HD13 ' A' ' 262' ' ' ILE . 40.3 tt0 -59.6 -26.44 65.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.543 -1.28 . . . . 0.39 107.543 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.7 t -104.59 -42.47 5.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.411 0.624 . . . . 0.47 110.887 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 262' ' ' ILE . 26.5 mt -69.15 -55.02 11.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.48 111.223 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.575 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -81.33 -6.84 59.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.41 110.032 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.29 -108.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.129 -1.588 . . . . 0.46 109.129 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.74 76.84 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.733 1.386 . . . . 0.58 110.325 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -48.19 161.04 0.51 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.64 109.554 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.577 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -98.51 -68.46 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.95 110.125 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.534 ' CG ' ' OG ' ' A' ' 114' ' ' SER . 3.7 tt0 57.89 21.11 7.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 1.2 110.225 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.44 137.72 10.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 1.2 110.551 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.13 56.07 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.025 1.54 . . . . 1.06 110.415 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.41 ' O ' ' ND2' ' A' ' 274' ' ' ASN . 1.7 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.948 -1.025 . . . . 0.78 110.281 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.009 ' CG1' HD12 ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.599 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.995 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.238 0.542 . . . . 0.41 110.178 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 9.1 p30 -168.45 119.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.26 110.18 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 107' ' ' PHE . 32.7 m -97.63 -154.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.33 110.099 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -43.83 111.43 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.65 110.026 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.6 Cg_endo -71.85 -162.69 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.96 1.506 . . . . 0.84 110.631 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.619 ' C ' HD12 ' A' ' 230' ' ' LEU . 19.7 mtt180 69.55 76.63 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.93 109.963 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.591 ' CA ' HD12 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -150.79 -72.21 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.491 -0.755 . . . . 1.03 109.505 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.3 tp 35.53 30.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.817 -0.552 . . . . 1.04 111.18 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -108.59 51.53 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.945 . . . . 0.77 110.239 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.525 ' NE1' ' HB3' ' A' ' 270' ' ' ASP . 8.0 t90 -139.79 -56.47 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.42 110.124 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.483 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 79.5 p -90.67 49.74 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.44 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 6.4 mmtt -148.48 87.71 1.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.49 110.174 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 35.9 ttp -123.02 -8.81 8.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.162 -0.961 . . . . 0.3 110.098 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 7.0 p-10 -159.77 126.73 4.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.15 109.974 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -152.98 -172.58 4.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.13 110.426 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.804 HG21 HG22 ' A' ' 160' ' ' ILE . 1.2 p -127.59 139.14 52.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.12 110.557 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.557 ' CB ' HG12 ' A' ' 163' ' ' ILE . 26.6 p90 -127.32 177.99 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.33 111.398 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.511 ' HB3' ' CB ' ' A' ' 164' ' ' MET . 7.2 tpt180 -133.08 150.39 52.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.54 109.508 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.846 ' O ' HG13 ' A' ' 123' ' ' VAL . 3.4 pt -112.62 118.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.003 . . . . 0.33 111.771 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.852 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.8 m -166.26 38.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.27 110.079 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.757 ' OD1' HG22 ' A' ' 134' ' ' VAL . 0.8 OUTLIER -42.89 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.399 -0.92 . . . . 0.41 109.116 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.542 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.7 t80 179.58 -171.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.885 . . . . 0.4 109.991 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.8 53.02 3.47 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.798 -1.189 . . . . 0.45 110.913 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.9 Cg_endo -80.38 -84.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.858 1.452 . . . . 0.36 110.571 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.15 -3.96 57.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.25 109.95 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.533 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -123.0 160.38 26.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.303 -0.873 . . . . 0.39 110.369 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.26 179.51 4.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.48 109.759 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -47.02 -39.26 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.4 110.208 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -59.96 -57.87 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.46 110.037 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.533 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 4.4 mp0 -53.69 -54.61 35.52 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.219 -0.925 . . . . 0.47 109.607 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.757 HG22 ' OD1' ' A' ' 124' ' ' ASN . 2.6 t -46.16 -36.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.939 -1.134 . . . . 0.31 107.939 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.61 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 5.1 tt0 -61.2 -40.28 93.35 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.242 -1.022 . . . . 0.48 108.242 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.584 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -72.44 -52.0 17.8 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.3 -0.96 . . . . 0.64 108.776 178.42 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.825 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -44.67 -62.63 1.13 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.081 -1.012 . . . . 0.42 110.447 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.32 -52.98 55.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.439 -0.788 . . . . 0.34 111.343 -178.903 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.645 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -68.78 -71.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.905 -1.122 . . . . 0.47 110.328 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.54 -59.78 0.88 Allowed 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.933 -0.479 . . . . 0.47 110.33 178.994 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.22 -41.38 27.22 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.594 -1.242 . . . . 0.25 107.984 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -68.29 -27.47 66.34 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.432 -0.793 . . . . 0.35 109.11 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 2.6 tttt -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.465 -0.939 . . . . 0.7 108.465 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 13.4 t -73.14 -46.86 49.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.905 -0.776 . . . . 0.61 108.905 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.745 ' HH2' HG21 ' A' ' 262' ' ' ILE . 42.3 t-105 -58.52 -42.53 87.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.9 -0.778 . . . . 0.39 108.9 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.3 m -70.86 -32.06 68.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.431 -0.952 . . . . 0.35 108.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -55.65 -46.87 77.41 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.107 -0.701 . . . . 0.36 109.107 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.971 HG23 HG22 ' A' ' 149' ' ' THR . 28.1 m -72.34 -34.62 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.448 -0.901 . . . . 0.5 109.369 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . 1.015 HG23 HD11 ' A' ' 151' ' ' LEU . 1.1 t -141.37 118.69 7.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.103 -0.998 . . . . 0.51 109.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.49 62.58 3.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.68 1.358 . . . . 0.31 111.153 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 149' ' ' THR . 0.2 OUTLIER -76.48 174.2 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.003 -1.06 . . . . 0.18 109.931 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 12.5 t-20 -107.81 126.23 52.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.228 -0.92 . . . . 0.17 109.873 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' HE2' ' HG ' ' A' ' 146' ' ' SER . 9.3 p90 -131.37 143.03 50.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 0.14 110.925 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.669 ' HB ' HG22 ' A' ' 119' ' ' THR . 33.0 m -143.61 141.51 30.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.337 -0.852 . . . . 0.15 110.38 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.456 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -117.35 88.24 2.87 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.29 -0.882 . . . . 0.2 109.935 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -79.81 129.07 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.22 110.461 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -89.0 36.78 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.32 109.965 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -34.63 2.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.511 -0.743 . . . . 0.33 109.648 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 147.1 37.13 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.051 -1.22 . . . . 0.28 110.051 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.926 HD13 HD22 ' A' ' 156' ' ' LEU . 1.9 mp -126.02 70.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.251 . . . . 0.3 108.983 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -139.22 162.27 35.39 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 0.2 110.702 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.665 ' HB3' HD22 ' A' ' 118' ' ' LEU . 7.0 t70 -134.18 -33.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.1 110.458 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.054 HG21 ' HG ' ' A' ' 228' ' ' LEU . 0.2 OUTLIER -127.5 173.29 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.038 . . . . 0.1 109.77 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.824 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 2.9 ptt? -176.98 159.12 1.65 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.605 -1.309 . . . . 0.11 111.754 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.3 tt -103.0 116.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.1 109.301 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.852 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.3 p -157.32 154.58 29.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.789 -1.195 . . . . 0.1 111.035 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.3 p90 -75.03 122.13 23.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.09 109.448 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -84.52 115.72 4.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.244 -1.142 . . . . 0.2 110.244 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -105.43 104.21 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -1.034 . . . . 0.55 109.246 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.72 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.42 0.628 . . . . 0.85 112.374 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -130.15 -2.13 4.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 0.71 110.181 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 10.3 m-70 -84.83 178.95 7.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.42 109.857 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.74 28.38 4.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.33 109.683 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -121.77 -97.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.33 110.14 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -102.09 126.94 49.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.27 110.022 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -54.48 109.59 1.65 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.93 . . . . 0.34 110.301 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.625 ' O ' HD23 ' A' ' 184' ' ' LEU . 42.7 Cg_endo -74.16 -66.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.015 1.534 . . . . 0.47 110.76 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -47.72 137.75 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.35 110.406 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 179' ' ' ASP . 7.6 p30 179.14 81.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.402 -0.919 . . . . 0.2 110.584 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.51 ' H ' ' CB ' ' A' ' 204' ' ' ASP . . . 38.2 -152.01 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.741 -1.343 . . . . 0.25 109.741 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.409 ' HA ' ' CD ' ' A' ' 205' ' ' GLU . 54.6 Cg_endo -82.49 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.969 1.51 . . . . 0.44 110.584 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.4 t -58.39 176.13 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.57 110.354 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.541 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.49 70.49 0.04 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.219 -1.153 . . . . 0.49 110.219 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.998 ' HA ' HG13 ' A' ' 1' ' ' HAV . 7.4 tp 179.9 81.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.349 -1.089 . . . . 0.41 110.175 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.882 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.4 tt -100.84 -24.34 14.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.355 -1.338 . . . . 0.3 111.036 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.633 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -149.01 101.71 3.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.723 -1.235 . . . . 0.2 112.254 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.542 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.1 OUTLIER -102.97 133.35 48.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.16 109.236 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.957 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -121.37 130.93 53.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 0.23 110.595 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -79.14 165.15 50.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.38 110.341 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.53 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.9 Cg_endo -73.41 141.27 31.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.974 1.512 . . . . 0.4 110.038 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' SER . 42.9 Cg_endo -70.08 83.25 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.911 1.48 . . . . 0.32 110.626 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.72 -101.52 1.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.32 109.589 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -162.49 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.942 1.496 . . . . 0.47 110.539 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -62.0 -17.79 58.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.63 110.023 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.44 59.55 0.67 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.532 -0.73 . . . . 0.53 110.377 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -131.22 168.16 22.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.828 -1.709 . . . . 0.25 108.828 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 1.002 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 42.78 26.61 0.46 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.67 -1.372 . . . . 0.1 109.67 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLY . 7.3 m-20 -79.06 86.18 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.1 109.914 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.6 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.074 -1.016 . . . . 0.09 109.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.542 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 17.9 m170 -101.97 131.19 48.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.855 . . . . 0.09 110.707 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 203' ' ' ASP . 42.4 m-85 -103.52 137.61 41.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.913 . . . . 0.1 110.515 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -49.05 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.14 108.956 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.548 ' OD2' ' CB ' ' A' ' 178' ' ' PHE . 2.6 p30 -35.95 -29.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.653 -0.654 . . . . 0.18 111.772 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 202' ' ' ASP . 10.4 m-20 -79.12 2.27 21.4 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.607 -1.308 . . . . 0.24 111.457 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.882 ' OE1' HD12 ' A' ' 185' ' ' LEU . 9.8 mm-40 -93.65 -166.45 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.773 -1.204 . . . . 0.42 110.347 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.32 140.81 52.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.47 110.468 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.516 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -140.6 130.39 24.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.275 -0.89 . . . . 0.27 109.737 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.021 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -138.83 176.46 8.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.021 -1.05 . . . . 0.3 110.583 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.49 ' HB2' HD23 ' A' ' 216' ' ' LEU . 2.1 t -130.5 35.94 3.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.873 -0.788 . . . . 0.61 108.873 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.9 t -115.26 -111.62 0.35 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.702 -0.624 . . . . 0.78 110.065 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.517 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 t -143.88 11.23 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.91 109.952 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 123.52 29.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.93 109.917 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.99 -171.7 31.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.175 -1.57 . . . . 0.79 109.175 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.607 ' CE1' HD13 ' A' ' 185' ' ' LEU . 64.8 m-85 -69.47 122.11 18.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -1.192 . . . . 0.69 109.687 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 219' ' ' VAL . 1.1 p-10 -95.73 119.82 34.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.986 -1.072 . . . . 0.4 108.965 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.021 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -38.45 -37.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.672 -0.643 . . . . 0.17 111.093 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.6 m-30 -49.92 -48.39 51.73 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.439 -1.304 . . . . 0.28 107.719 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.021 HD11 ' HH1' ' A' ' 3' ' ' MSB . 4.7 tp -79.79 -69.45 0.58 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.906 -0.588 . . . . 0.46 110.53 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.969 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.99 -65.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.39 109.786 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -48.53 -50.27 32.65 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.832 -1.167 . . . . 0.17 111.564 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -63.52 -24.88 68.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.329 -1.482 . . . . 0.1 109.052 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.618 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.6 t60 -76.78 -54.5 6.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.281 -0.637 . . . . 0.21 109.281 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.613 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.2 tp10 -58.76 -47.9 83.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.181 -0.949 . . . . 0.28 108.538 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -54.79 -55.76 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.18 109.049 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.53 -31.52 5.07 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.848 -1.701 . . . . 0.21 108.848 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.564 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -82.07 -76.71 0.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.241 -1.152 . . . . 0.17 110.865 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.957 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.22 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.832 -0.543 . . . . 0.33 111.834 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 1.054 ' HG ' HG21 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -99.82 -41.23 7.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 0.53 110.731 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -72.19 -79.32 0.45 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.26 -1.136 . . . . 0.41 110.26 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.619 HD12 ' C ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -173.54 -163.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.253 . . . . 0.45 110.525 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.517 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -61.55 -54.62 40.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.62 110.288 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.564 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -167.77 177.14 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.45 111.056 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 27.7 t 179.26 51.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.748 -0.834 . . . . 0.38 108.748 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.83 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -132.41 24.66 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.48 111.41 -178.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.554 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.1 OUTLIER -37.13 -53.61 2.03 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.491 -0.756 . . . . 0.38 110.976 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -84.27 -49.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.715 1.376 . . . . 0.28 111.202 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.57 101.56 0.15 Allowed Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.361 -1.399 . . . . 0.24 111.357 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.907 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -146.73 163.27 36.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.341 -1.094 . . . . 0.28 110.246 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -69.64 58.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.4 109.026 179.16 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.618 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.8 mtp -144.17 -37.29 0.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.45 110.045 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -48.56 171.39 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.865 -1.147 . . . . 0.57 110.063 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.3 Cg_endo -74.25 3.91 4.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.578 1.304 . . . . 0.76 110.553 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.8 mt -104.8 134.58 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.89 110.182 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.726 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 49.8 p90 -127.87 -36.53 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.854 . . . . 0.78 109.72 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 244' ' ' TYR . 53.7 m 1.41 -69.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 112.977 0.732 . . . . 0.61 112.977 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.577 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -60.14 101.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.74 109.33 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.519 ' N ' ' HB2' ' A' ' 250' ' ' SER . 38.7 p -46.79 175.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.81 110.484 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.22 8.05 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.703 -1.359 . . . . 0.56 109.703 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.48 28.48 1.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.156 . . . . 0.37 110.345 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.519 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.5 OUTLIER -58.52 -27.34 64.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.44 109.941 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 252' ' ' PHE . 6.9 t-160 -150.59 -55.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.53 110.03 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER -176.94 -179.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.38 110.191 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.882 ' HB2' HG21 ' A' ' 259' ' ' VAL . 1.5 ptt? -68.77 54.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.418 -0.801 . . . . 0.19 110.371 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.6 mp -44.75 -47.72 28.56 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.974 -1.121 . . . . 0.28 107.974 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.5 Cg_endo -72.89 50.13 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.962 1.506 . . . . 0.49 110.94 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.609 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.7 m-20 -52.51 -29.77 26.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.037 -1.039 . . . . 0.49 110.157 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.907 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.07 -51.55 63.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.118 -1.033 . . . . 0.31 109.487 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.066 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.32 -33.92 70.11 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.938 -1.105 . . . . 0.14 108.553 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 253' ' ' MET . 72.2 t -62.51 -85.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.573 -0.851 . . . . 0.17 110.22 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.4 tt0 -58.04 -43.52 86.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.26 110.007 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.1 -63.87 1.66 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.556 -1.018 . . . . 0.19 110.556 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.1 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -80.18 -19.19 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.755 -1.438 . . . . 0.22 109.994 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 1.1 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.7 OUTLIER -59.33 -24.65 63.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.849 -1.167 . . . . 0.39 107.849 178.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.4 p -103.9 -40.85 6.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.273 -0.571 . . . . 0.47 111.806 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 112' ' ' LYS . 4.9 mp -83.96 -46.85 11.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.48 111.789 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.936 ' OH ' HD22 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -76.08 -21.42 56.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.061 -1.025 . . . . 0.41 110.481 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -57.7 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.165 -1.574 . . . . 0.46 109.165 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.0 Cg_endo -75.19 95.68 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.789 1.415 . . . . 0.58 110.062 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.8 178.26 43.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.558 -1.417 . . . . 0.64 109.558 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.525 ' HB3' ' NE1' ' A' ' 113' ' ' TRP . 27.9 t0 -115.4 -50.74 2.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -1.138 . . . . 0.95 110.138 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.483 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 13.5 tt0 59.02 48.41 10.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 1.2 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.92 132.68 0.25 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 1.2 110.2 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.99 -1.84 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.899 1.473 . . . . 1.06 110.326 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.969 -1.015 . . . . 0.78 110.176 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.998 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.617 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 1.021 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 84.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.22 0.533 . . . . 0.41 110.186 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -142.67 80.11 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.26 110.106 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.4 t -110.75 -4.31 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.33 110.319 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.23 75.08 79.76 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.65 110.185 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.4 Cg_endo -71.4 -161.95 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.06 1.558 . . . . 0.84 110.703 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.616 ' C ' HD12 ' A' ' 230' ' ' LEU . 30.7 mtt-85 65.21 70.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.93 110.515 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 3.1 p -148.82 -68.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.445 -0.784 . . . . 1.03 109.407 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.9 mp 49.2 18.36 0.24 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.386 -0.821 . . . . 1.04 111.541 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.75 ' HB3' HD12 ' A' ' 265' ' ' LEU . 9.6 mttm -97.41 78.89 2.72 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.837 -1.164 . . . . 0.77 109.643 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.56 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.3 t90 -165.38 -68.33 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.42 111.36 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.525 ' O ' ' CD ' ' A' ' 115' ' ' LYS . 79.9 p -104.69 84.47 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.44 110.952 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 266' ' ' TYR . 3.4 mptt -173.53 83.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.49 110.312 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 116' ' ' MET . 7.7 tmm? -123.75 -8.88 7.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.3 110.134 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 10.1 p30 -158.31 117.34 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.15 109.941 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' CD2' ' OD2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -141.88 -178.83 5.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.13 110.611 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -119.93 170.36 9.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.85 . . . . 0.12 109.56 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.55 ' HB3' HG23 ' A' ' 163' ' ' ILE . 41.0 p90 -165.22 -158.54 0.39 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.041 . . . . 0.33 110.947 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -150.34 143.17 24.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 0.54 110.138 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.636 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.7 pp -103.81 108.25 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.33 110.866 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.939 HG23 ' HB3' ' A' ' 166' ' ' SER . 15.6 m -158.76 43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.27 110.352 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 16.1 t-20 -42.68 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.41 109.328 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.563 ' O ' HG21 ' A' ' 134' ' ' VAL . 3.0 t80 -179.17 -168.98 0.14 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.383 -0.823 . . . . 0.4 109.537 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.579 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -143.34 45.71 0.62 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.832 -1.167 . . . . 0.45 111.353 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.2 Cg_endo -75.49 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.783 1.412 . . . . 0.36 110.041 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -5.84 51.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.858 . . . . 0.25 109.655 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.713 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.9 ptt? -118.49 146.87 44.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.39 109.94 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -104.07 -179.35 3.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.48 110.149 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t-80 -43.43 -35.33 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.4 109.872 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -66.62 -59.99 3.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.46 110.096 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.531 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 1.3 mp0 -50.72 -61.21 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.47 109.409 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 125' ' ' TYR . 8.2 t -45.13 -37.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.28 -1.007 . . . . 0.31 108.28 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.6 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.87 -41.05 77.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.319 -0.993 . . . . 0.48 108.319 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.576 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.2 tttp -75.09 -51.63 13.0 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.05 0.928 . . . . 0.64 108.608 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.82 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.5 -63.47 0.95 Allowed 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.093 -1.005 . . . . 0.42 110.418 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -61.26 -54.31 45.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.34 111.289 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.658 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -69.62 -72.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.47 110.485 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.1 tmtp? -37.91 -61.59 0.63 Allowed 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.899 -0.5 . . . . 0.47 110.607 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -47.06 -40.32 14.78 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.69 -1.204 . . . . 0.25 108.257 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -68.28 -32.82 73.24 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.508 -0.877 . . . . 0.35 108.947 178.418 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 140' ' ' LYS . 13.1 ttpp -59.53 -39.23 83.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.261 -1.014 . . . . 0.7 108.261 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.86 -41.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.813 -0.81 . . . . 0.61 108.813 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.639 ' O ' HG22 ' A' ' 148' ' ' VAL . 20.6 t-105 -60.99 -39.74 90.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.047 -0.723 . . . . 0.39 109.047 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.6 m -73.46 -34.51 65.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.412 -0.805 . . . . 0.35 108.834 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -41.55 76.83 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.595 -0.691 . . . . 0.36 109.291 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.791 HG23 HG22 ' A' ' 149' ' ' THR . 35.2 m -78.35 -31.7 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.5 110.11 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.791 HG22 HG23 ' A' ' 148' ' ' VAL . 5.7 t -148.12 135.21 10.38 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.51 110.56 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.98 59.65 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.84 1.442 . . . . 0.31 110.377 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 1.015 HD21 ' CD1' ' A' ' 266' ' ' TYR . 1.1 mp -80.8 163.43 23.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.18 110.5 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -107.4 110.18 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.17 110.178 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.511 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.1 p90 -115.71 122.62 46.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.887 . . . . 0.14 110.015 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.945 ' CG2' HD13 ' A' ' 156' ' ' LEU . 8.3 m -127.42 140.87 51.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.15 110.373 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.5 82.09 1.87 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.421 -0.799 . . . . 0.2 109.622 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.945 HD13 ' CG2' ' A' ' 154' ' ' THR . 1.3 mp -91.26 85.48 5.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.22 110.44 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' GLY . 36.6 p-80 -57.32 -19.72 24.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.32 109.789 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.96 -26.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.481 -0.762 . . . . 0.33 109.823 179.13 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.38 20.68 1.24 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.829 -1.308 . . . . 0.28 109.829 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 160' ' ' ILE . 12.1 mt -122.64 65.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.045 -1.268 . . . . 0.3 109.259 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -118.96 141.45 48.65 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.198 -0.601 . . . . 0.2 110.4 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD2' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -107.12 -47.55 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.1 109.961 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.001 ' CD1' HD11 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -116.34 173.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 0.1 109.824 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.54 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 4.4 ptp -170.67 142.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.11 110.63 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.8 tt -92.89 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.1 109.086 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.939 ' HB3' HG23 ' A' ' 123' ' ' VAL . 5.0 p -157.38 156.54 32.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.805 -1.184 . . . . 0.1 111.262 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -74.23 118.48 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.692 -0.63 . . . . 0.09 109.665 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -71.67 119.8 7.83 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.024 -1.231 . . . . 0.2 110.024 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 169' ' ' ILE . 6.9 tp -116.61 97.65 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -1.063 . . . . 0.55 109.985 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.63 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 3.7 tmtt? 0.07 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.289 0.566 . . . . 0.85 112.388 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -162.47 24.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.71 110.351 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -97.11 -69.59 0.75 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.42 110.132 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.43 -35.82 1.51 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.494 -1.442 . . . . 0.33 109.494 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -75.29 -144.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -1.171 . . . . 0.33 110.517 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.427 ' C ' ' CD1' ' A' ' 176' ' ' TYR . 58.3 m-85 -55.65 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.27 110.509 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 5.4 m-30 -111.01 110.94 56.52 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.34 110.306 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.88 -68.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.929 1.489 . . . . 0.47 110.558 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -51.21 137.58 22.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.35 110.417 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 178' ' ' PHE . 51.6 p-10 -178.44 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.2 110.624 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.57 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 44.44 -158.73 0.15 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.782 -1.327 . . . . 0.25 109.782 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.8 Cg_endo -74.95 7.28 2.91 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.14 1.6 . . . . 0.44 110.725 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 184' ' ' LEU . 6.4 t -42.58 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.967 . . . . 0.57 110.36 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.541 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.98 76.51 0.02 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.418 -1.073 . . . . 0.49 110.418 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.04 ' HA ' HG13 ' A' ' 1' ' ' HAV . 3.3 tt 179.9 88.13 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.222 -1.163 . . . . 0.41 110.389 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.585 HD13 ' CE2' ' A' ' 214' ' ' TYR . 4.8 tt -103.84 -23.22 13.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.3 110.944 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.764 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -148.45 108.03 3.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.602 -1.311 . . . . 0.2 112.126 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -105.7 118.76 37.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.16 109.529 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.863 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -107.8 141.02 40.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.23 110.202 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 3.2 m-30 -91.04 161.51 35.12 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.38 110.32 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.5 Cg_endo -72.41 142.98 37.96 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.967 1.509 . . . . 0.4 109.409 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.3 Cg_endo -69.64 74.41 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.849 1.447 . . . . 0.32 110.693 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.84 -93.71 1.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.408 -1.477 . . . . 0.32 109.408 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 -158.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.981 1.516 . . . . 0.47 110.406 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -79.51 8.82 5.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.63 110.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.493 ' HA ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -114.67 6.98 15.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.324 -0.86 . . . . 0.53 109.717 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -80.89 168.8 51.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.594 -1.402 . . . . 0.25 109.594 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.568 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 51.84 18.65 4.38 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.658 -1.377 . . . . 0.1 109.658 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -79.98 92.19 5.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -1.125 . . . . 0.1 110.339 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -72.44 97.44 2.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.942 . . . . 0.09 109.952 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.468 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 1.4 m170 -111.13 131.99 54.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.09 110.328 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.626 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 59.5 m-85 -103.27 136.61 42.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.992 -1.067 . . . . 0.1 110.678 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.955 ' OD1' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -46.52 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.719 -0.845 . . . . 0.14 108.719 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.642 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.4 p30 -36.84 -27.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.18 111.674 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.57 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -77.69 -0.24 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.675 -1.266 . . . . 0.24 111.217 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 12.6 mm-40 -94.82 -164.17 1.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.42 110.303 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 m -125.58 140.48 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.47 110.582 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.642 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.1 m-90 -135.56 142.81 45.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -0.823 . . . . 0.27 109.43 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.035 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.83 179.93 8.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.932 -1.105 . . . . 0.3 110.565 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.8 t -124.62 43.07 3.11 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.686 0.755 . . . . 0.61 109.251 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.8 t -131.63 -165.9 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.697 -0.627 . . . . 0.78 110.076 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.522 ' N ' ' OG ' ' A' ' 210' ' ' SER . 8.7 t -87.64 -0.51 56.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.91 110.14 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 149.75 28.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.93 109.969 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.23 -164.25 33.27 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.35 -1.5 . . . . 0.79 109.35 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.585 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.8 m-85 -84.52 120.78 26.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -1.195 . . . . 0.69 109.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.92 ' ND2' HG22 ' A' ' 247' ' ' THR . 7.3 p30 -87.62 121.7 30.39 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.067 -1.021 . . . . 0.4 108.852 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.035 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -39.89 -38.78 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.487 -0.758 . . . . 0.17 110.867 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 4.0 m-85 -51.31 -48.87 62.22 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 118.435 -1.306 . . . . 0.28 107.527 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.874 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.5 OUTLIER -73.87 -72.6 0.26 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.726 -0.67 . . . . 0.46 110.151 178.678 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.916 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.93 -69.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.39 109.914 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -42.27 -54.79 3.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.17 111.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -57.58 -30.72 65.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.499 -1.376 . . . . 0.1 109.578 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.644 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.7 t60 -75.51 -43.78 47.24 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.353 0.597 . . . . 0.21 109.686 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.764 ' OE1' ' HB1' ' A' ' 186' ' ' ALA . 22.8 tp10 -64.4 -35.97 82.63 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -0.884 . . . . 0.28 108.894 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 220' ' ' ALA . 19.1 m-85 -66.93 -48.52 68.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.755 -0.831 . . . . 0.18 108.755 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -52.47 -31.66 36.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.288 -1.925 . . . . 0.21 108.288 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.662 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.7 OUTLIER -80.62 -78.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -1.056 . . . . 0.17 110.674 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.863 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -38.5 -45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.33 111.268 -178.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 1.001 HD11 ' CD1' ' A' ' 163' ' ' ILE . 6.0 mt -83.37 -46.3 12.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.53 110.878 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -71.31 -85.14 0.19 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.363 -1.095 . . . . 0.41 110.363 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 230' ' ' LEU . 2.6 pt? -176.62 -158.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -1.2 . . . . 0.45 110.563 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.52 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 7.4 t70 -49.88 -56.1 11.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.62 110.148 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.662 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -164.69 -175.68 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.45 109.861 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.42 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER -179.78 58.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.38 109.809 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 1.084 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -152.29 27.06 0.59 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.48 111.196 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.545 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.7 OUTLIER -37.83 -48.89 2.89 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.38 110.674 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 41.1 Cg_endo -86.81 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.913 1.481 . . . . 0.28 112.289 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.32 99.58 0.12 Allowed Glycine 0 N--CA 1.5 2.94 0 C-N-CA 118.638 -1.744 . . . . 0.24 112.127 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 1.084 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -150.03 169.49 21.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.031 -1.276 . . . . 0.28 110.556 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.613 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -80.19 49.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.4 108.79 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.644 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.9 OUTLIER -133.99 -22.45 1.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.005 -1.059 . . . . 0.45 110.915 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -60.72 172.09 0.91 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.873 -1.142 . . . . 0.57 110.204 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 40.6 Cg_endo -67.79 -2.73 9.1 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.413 1.217 . . . . 0.76 110.935 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.569 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.6 mp -108.04 153.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.89 109.649 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.874 ' HB2' HD21 ' A' ' 218' ' ' LEU . 14.3 p90 -135.78 -22.93 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.78 111.685 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.756 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 4.0 -70.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 113.44 0.904 . . . . 0.61 113.44 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.756 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -72.27 117.34 13.8 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.454 -1.404 . . . . 0.74 109.77 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.92 HG22 ' ND2' ' A' ' 215' ' ' ASN . 47.6 p -62.17 -161.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.81 110.403 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.58 -32.61 79.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.56 109.593 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.48 41.67 2.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -1.124 . . . . 0.37 110.517 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -63.52 -20.87 65.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.44 109.751 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 20.4 m-70 -167.9 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.786 . . . . 0.53 109.911 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.9 m-85 -170.22 176.6 4.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.41 -0.806 . . . . 0.38 110.205 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.943 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -70.56 54.38 0.15 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.19 110.043 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.2 mm? -43.82 -47.56 20.83 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.176 -1.046 . . . . 0.28 108.176 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.21 49.81 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.015 1.534 . . . . 0.49 110.787 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.615 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 6.2 m-20 -54.19 -29.45 45.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.49 110.236 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.913 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 55.4 m-20 -57.2 -41.2 78.92 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.31 109.339 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.056 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.43 -33.2 48.7 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.986 -1.116 . . . . 0.14 107.986 178.673 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.943 HG21 ' HB2' ' A' ' 253' ' ' MET . 83.5 t -65.55 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.17 109.906 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.622 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.4 tt0 -58.18 -42.37 85.9 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.29 -0.881 . . . . 0.26 109.446 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.46 -70.33 0.5 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.178 -1.169 . . . . 0.19 110.178 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.089 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -73.75 -18.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.963 -1.316 . . . . 0.22 110.392 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 1.089 ' N ' HD13 ' A' ' 262' ' ' ILE . 44.9 tt0 -65.54 -20.3 66.28 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.9 -1.12 . . . . 0.39 108.163 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.37 -40.69 6.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.779 -0.576 . . . . 0.47 111.145 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 112' ' ' LYS . 4.3 mm? -86.71 -45.4 11.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.185 -0.947 . . . . 0.48 111.179 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 1.015 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -76.95 -13.68 59.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.41 110.53 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -62.7 -107.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.953 -1.659 . . . . 0.46 108.953 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.1 95.07 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.58 110.079 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.87 171.04 37.08 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.825 -1.31 . . . . 0.64 109.825 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -96.42 -70.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -1.103 . . . . 0.95 110.13 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 271' ' ' GLU . 78.7 tt0 52.37 28.76 6.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 1.2 110.115 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 270' ' ' ASP . 2.0 p30 -168.21 131.98 1.37 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 1.2 110.201 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.84 -10.47 26.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.9 1.474 . . . . 1.06 110.416 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.159 -0.963 . . . . 0.78 110.215 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.04 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.619 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.619 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.272 0.558 . . . . 0.41 110.193 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 13.0 p-10 -147.58 74.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.26 110.128 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG12 ' HD1' ' A' ' 107' ' ' PHE . 36.9 t -122.82 -37.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.33 110.263 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.729 ' HD1' HG12 ' A' ' 106' ' ' VAL . 1.6 m-85 -134.48 52.61 8.0 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.65 110.487 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 107' ' ' PHE . 51.6 Cg_endo -79.24 12.06 2.43 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.919 1.484 . . . . 0.84 110.693 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.672 ' O ' HD12 ' A' ' 230' ' ' LEU . 63.8 mtt180 -121.38 58.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 0.93 110.202 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.529 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p -127.34 -39.81 1.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 1.03 109.59 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 3.2 mm? 40.75 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.545 -0.722 . . . . 1.04 111.373 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 1.8 mttt -123.44 65.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.856 -1.153 . . . . 0.77 109.939 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.632 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 19.3 t90 -123.03 -71.67 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.42 110.573 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 22.1 t -105.15 58.33 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.302 -0.874 . . . . 0.44 110.291 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HG3' ' C ' ' A' ' 114' ' ' SER . 39.0 mttp -141.72 59.49 1.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.49 110.489 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.48 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.6 OUTLIER -89.9 11.2 21.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.3 109.793 179.55 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.991 ' O ' HD22 ' A' ' 118' ' ' LEU . 8.5 t30 -172.0 115.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.15 109.512 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.991 HD22 ' O ' ' A' ' 117' ' ' ASN . 1.2 mm? -137.48 178.01 7.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.184 -0.947 . . . . 0.13 110.72 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.636 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -120.34 174.11 6.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.12 109.902 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.556 ' HB3' HG12 ' A' ' 163' ' ' ILE . 31.3 p90 -178.94 178.74 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.33 111.425 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.469 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 1.3 ttp180 -121.05 158.51 27.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.54 109.654 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.726 HD13 ' CD2' ' A' ' 138' ' ' PHE . 1.6 pp -125.7 98.42 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.33 110.881 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.995 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.4 m -145.57 53.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.27 110.334 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 8.2 t-20 -43.39 -84.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.41 109.623 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 8.6 t80 -177.53 -175.07 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.4 109.917 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 130' ' ' THR . 0.0 OUTLIER -139.03 52.52 4.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.45 110.716 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.543 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.2 Cg_endo -76.26 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.819 1.431 . . . . 0.36 109.767 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.77 -4.62 54.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.25 109.588 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.957 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.8 ptm -119.76 170.71 8.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.469 -0.769 . . . . 0.39 109.955 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.547 ' HA ' HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -121.91 -172.46 2.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.48 110.34 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.458 ' H ' HG22 ' A' ' 130' ' ' THR . 1.5 t60 -53.09 -36.4 60.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.4 110.03 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 6.9 t -60.83 -48.68 80.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.46 109.336 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 13.1 mp0 -62.79 -63.33 1.24 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.34 -0.85 . . . . 0.47 109.527 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.684 HG23 ' HE2' ' A' ' 129' ' ' MET . 13.4 t -43.68 -38.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.611 -0.885 . . . . 0.31 108.611 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.611 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 3.0 mt-10 -56.68 -42.14 78.54 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.48 108.246 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 2.4 tttm -73.8 -50.13 22.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.471 -0.936 . . . . 0.64 108.471 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.84 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.05 -60.79 2.07 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.19 -0.944 . . . . 0.42 110.225 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.726 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.74 -53.63 44.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.34 111.018 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.82 -72.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.857 -1.152 . . . . 0.47 110.347 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.2 tmtm? -38.65 -61.16 0.74 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.752 -0.593 . . . . 0.47 110.655 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -47.59 -38.59 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.611 -1.235 . . . . 0.25 108.374 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -70.11 -32.76 70.94 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.335 -0.853 . . . . 0.35 109.15 178.634 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' LYS . 4.6 tttp -59.82 -38.82 83.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.38 -0.971 . . . . 0.7 108.38 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 16.1 t -71.91 -44.34 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 109.035 -0.728 . . . . 0.61 109.035 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.628 ' O ' HG22 ' A' ' 149' ' ' THR . 13.6 t-105 -56.63 -44.93 81.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.39 109.01 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 149' ' ' THR . 26.0 m -71.01 -35.05 71.88 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.32 -0.862 . . . . 0.35 108.739 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -53.06 -42.43 65.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.576 -0.703 . . . . 0.36 109.416 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.761 HG23 HG22 ' A' ' 149' ' ' THR . 31.1 m -80.47 -32.59 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.779 -0.768 . . . . 0.5 110.198 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.761 HG22 HG23 ' A' ' 148' ' ' VAL . 2.5 t -137.94 124.59 13.27 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.068 . . . . 0.51 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -78.28 62.24 8.04 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.31 110.341 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.851 ' O ' HD12 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -101.0 156.31 17.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.18 110.127 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.481 ' HB2' ' HB2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -76.94 134.41 38.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.35 -0.844 . . . . 0.17 111.341 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 7.7 p90 -135.19 121.99 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.14 109.618 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.55 ' HB ' HG23 ' A' ' 119' ' ' THR . 42.4 m -127.0 161.68 27.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.15 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -142.18 68.95 1.32 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.655 -0.653 . . . . 0.2 110.09 -178.94 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 93.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.22 110.038 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' ASP . 50.4 p-80 -48.51 -28.15 3.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.32 110.083 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' HIS . 4.3 t70 -42.36 -70.27 0.11 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.576 -0.703 . . . . 0.33 109.819 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 179.39 30.68 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.28 109.586 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 119' ' ' THR . 20.9 mm -121.57 79.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.267 -1.137 . . . . 0.3 108.339 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.502 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -136.14 112.02 9.53 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.097 -0.641 . . . . 0.2 110.714 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 118' ' ' LEU . 33.5 t70 -73.37 -54.36 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.1 109.97 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.942 HG22 ' HA3' ' A' ' 197' ' ' GLY . 5.4 pt -111.84 175.9 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.1 109.677 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 23.2 ptm -170.35 136.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.844 -1.16 . . . . 0.11 111.122 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 122' ' ' ILE . 1.6 tt -90.24 123.44 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.447 -0.783 . . . . 0.1 109.852 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.995 ' HB3' HG23 ' A' ' 123' ' ' VAL . 23.0 p -168.37 143.05 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.831 -1.168 . . . . 0.1 110.922 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.8 p90 -58.49 117.21 4.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.372 -0.83 . . . . 0.09 109.507 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -83.79 115.3 4.03 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.901 -1.28 . . . . 0.2 109.901 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 169' ' ' ILE . 7.0 tt -106.63 100.26 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.957 . . . . 0.55 109.781 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.574 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 0.91 87.47 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.33 0.586 . . . . 0.85 112.397 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -130.06 -1.75 4.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.71 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -77.18 -86.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.42 110.035 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.28 58.8 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.339 -1.504 . . . . 0.33 109.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -155.16 -80.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -1.105 . . . . 0.33 110.377 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 83.9 m-85 -115.67 103.67 10.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.27 110.335 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.427 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.3 m-30 -40.32 98.82 0.18 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.34 110.156 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.868 ' O ' HD22 ' A' ' 184' ' ' LEU . 48.9 Cg_endo -82.67 -59.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.099 1.579 . . . . 0.47 110.775 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CB ' ' OD1' ' A' ' 203' ' ' ASP . 10.8 p90 -50.7 163.4 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.35 110.209 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 180' ' ' GLY . 0.9 OUTLIER 179.48 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.941 -1.099 . . . . 0.2 111.451 179.206 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 141.89 -123.55 2.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.157 -1.577 . . . . 0.25 109.157 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.4 2.62 7.91 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 O-C-N 123.919 1.484 . . . . 0.44 109.768 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 177.53 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.434 -0.791 . . . . 0.57 110.228 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.541 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -77.03 76.33 1.63 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.594 -1.003 . . . . 0.49 110.594 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.876 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.6 OUTLIER 179.77 98.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -1.127 . . . . 0.41 110.288 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.702 HD12 ' CD ' ' A' ' 205' ' ' GLU . 1.4 tt -116.74 -17.6 10.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.746 -1.182 . . . . 0.3 111.334 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.725 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -157.52 105.1 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.452 -1.405 . . . . 0.2 111.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -102.76 121.35 42.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.16 110.086 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.833 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -106.41 119.03 38.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.23 110.075 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -69.7 170.25 10.18 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.257 -0.902 . . . . 0.38 110.401 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.2 Cg_endo -73.15 130.73 15.68 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.101 1.579 . . . . 0.4 109.698 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.6 Cg_endo -69.88 74.8 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.956 1.503 . . . . 0.32 110.572 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.01 -91.45 1.02 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.703 -1.359 . . . . 0.32 109.703 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.0 -163.57 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.991 1.521 . . . . 0.47 110.489 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -6.58 35.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.63 110.047 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 195' ' ' TYR . . . . . 0.438 ' C ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -111.55 49.7 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.423 -0.798 . . . . 0.53 109.796 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -123.89 174.62 16.81 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.36 -1.496 . . . . 0.25 109.36 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.942 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 41.59 27.63 0.32 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.081 -1.208 . . . . 0.1 110.081 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD2' ' C ' ' A' ' 195' ' ' TYR . 57.7 m-20 -79.53 90.07 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.057 -1.261 . . . . 0.1 110.031 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -68.59 89.97 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.053 -1.029 . . . . 0.09 109.81 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.544 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 3.1 m170 -102.92 128.31 49.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.09 110.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.567 ' O ' ' N ' ' A' ' 203' ' ' ASP . 21.2 m-85 -96.73 132.13 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.1 111.173 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.573 ' HB3' ' CG ' ' A' ' 205' ' ' GLU . 35.8 t0 -40.06 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.245 -0.65 . . . . 0.14 109.245 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -36.43 -38.89 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.18 112.161 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.553 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 14.0 t0 -73.68 -6.65 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.642 -1.286 . . . . 0.24 111.225 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.702 ' CD ' HD12 ' A' ' 185' ' ' LEU . 14.7 mm-40 -84.79 -165.21 1.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.847 -1.158 . . . . 0.42 110.176 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.55 148.26 52.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.47 110.441 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.437 ' NE1' ' HB3' ' A' ' 201' ' ' PHE . 0.9 OUTLIER -142.24 140.36 32.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.267 -0.895 . . . . 0.27 109.57 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.016 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -149.03 174.85 11.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.857 -1.152 . . . . 0.3 110.748 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -129.06 24.79 5.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.794 0.807 . . . . 0.61 109.206 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.3 t -94.6 -111.46 0.12 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.615 -0.678 . . . . 0.78 110.03 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.531 ' N ' ' OG ' ' A' ' 210' ' ' SER . 4.4 p -141.28 8.39 2.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.134 . . . . 0.91 110.008 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 -179.26 5.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.93 109.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.76 -154.88 5.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.038 -1.625 . . . . 0.79 109.038 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 185' ' ' LEU . 79.0 m-85 -90.16 109.94 20.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.251 . . . . 0.69 110.066 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.61 ' O ' HG12 ' A' ' 219' ' ' VAL . 32.6 m-20 -79.15 120.92 24.36 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.097 -1.002 . . . . 0.4 108.866 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.016 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.26 -36.53 0.79 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.556 -0.858 . . . . 0.17 110.718 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.576 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 4.1 m-85 -53.05 -46.92 68.74 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.315 -1.354 . . . . 0.28 107.589 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 1.031 HD21 ' HB2' ' A' ' 244' ' ' TYR . 5.8 tp -77.27 -71.86 0.38 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.4 -0.818 . . . . 0.46 110.683 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.3 p -48.78 -61.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.39 110.385 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.92 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.06 -48.56 67.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.061 -1.024 . . . . 0.17 111.439 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.95 -29.11 66.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.201 -1.562 . . . . 0.1 108.743 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.66 ' CA ' HD21 ' A' ' 239' ' ' LEU . 4.0 t60 -77.0 -44.12 32.19 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.31 0.576 . . . . 0.21 109.747 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.803 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 17.8 tp10 -64.58 -45.61 86.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.02 . . . . 0.28 108.667 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.531 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 18.4 m-30 -56.35 -60.51 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.18 109.029 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.451 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.07 -34.15 1.99 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.971 -1.652 . . . . 0.21 108.971 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.62 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -80.87 -70.16 0.55 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.106 -1.232 . . . . 0.17 111.235 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.833 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.66 -44.33 0.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.33 112.017 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.868 ' HG ' HG21 ' A' ' 163' ' ' ILE . 1.0 OUTLIER -101.09 -37.49 8.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.661 -1.274 . . . . 0.53 111.317 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -65.01 -85.08 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.316 -1.114 . . . . 0.41 110.316 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -172.54 -173.28 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.245 . . . . 0.45 110.473 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.519 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 42.0 t0 -51.35 -59.72 3.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.62 109.975 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.62 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 1.6 m80 -163.82 -179.98 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.45 110.256 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.492 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.1 OUTLIER 179.23 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.457 -0.777 . . . . 0.38 109.391 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.899 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.04 21.43 3.02 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.468 -0.893 . . . . 0.48 111.197 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.535 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -35.58 -49.66 1.38 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 120.055 -0.658 . . . . 0.38 110.635 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -88.5 -48.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.701 1.369 . . . . 0.28 111.132 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.1 101.73 0.15 Allowed Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.409 -1.377 . . . . 0.24 111.401 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.899 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -147.47 163.16 37.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.372 -1.075 . . . . 0.28 110.463 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.66 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.18 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.074 -1.016 . . . . 0.4 108.818 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.657 ' HB2' ' HB3' ' A' ' 234' ' ' LYS . 50.6 mtt -135.9 -34.4 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.793 . . . . 0.45 110.437 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -43.88 169.85 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.195 -0.941 . . . . 0.57 110.359 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.2 Cg_endo -69.35 -8.02 22.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.786 1.413 . . . . 0.76 110.198 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.702 HG22 HG22 ' A' ' 245' ' ' THR . 16.0 mm -103.26 159.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.89 109.845 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 1.031 ' HB2' HD21 ' A' ' 218' ' ' LEU . 16.8 p90 -138.07 -24.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.78 111.446 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.731 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 3.19 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.824 1.046 . . . . 0.61 113.824 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.731 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -71.82 115.64 11.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.438 -1.413 . . . . 0.74 110.022 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.746 ' HA ' HD13 ' A' ' 218' ' ' LEU . 2.9 m -54.04 -174.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.81 110.301 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.696 ' H ' HG22 ' A' ' 247' ' ' THR . . . -50.83 -25.29 9.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.56 109.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.632 ' CD ' ' N ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -167.46 36.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -1.135 . . . . 0.37 110.353 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.2 t -58.54 -16.19 14.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.44 110.147 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -145.55 -48.7 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.53 110.086 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.55 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.8 OUTLIER 179.99 172.75 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.38 110.122 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.894 ' HB2' HG21 ' A' ' 259' ' ' VAL . 4.8 ptp -72.85 52.38 0.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.122 -0.986 . . . . 0.19 110.055 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.677 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.1 OUTLIER -45.24 -47.39 33.45 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 108.014 -1.106 . . . . 0.28 108.014 177.695 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -73.76 51.9 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.085 1.571 . . . . 0.49 110.905 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.63 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.7 m-20 -52.17 -31.44 31.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.129 -0.982 . . . . 0.49 110.151 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.892 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -51.89 -51.5 56.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.945 -1.102 . . . . 0.31 109.346 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.036 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -69.48 -35.6 75.74 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.074 -1.051 . . . . 0.14 108.553 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 253' ' ' MET . 73.8 t -63.41 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.17 110.273 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 33.0 tt0 -54.03 -43.87 70.5 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.246 -0.909 . . . . 0.26 109.902 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.04 -69.04 0.55 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.345 -1.102 . . . . 0.19 110.345 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.085 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -76.37 -19.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.786 -1.42 . . . . 0.22 110.264 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 1.085 ' N ' HD13 ' A' ' 262' ' ' ILE . 14.3 tt0 -61.54 -23.58 66.05 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.863 -1.135 . . . . 0.39 107.94 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 p -103.87 -42.58 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.386 0.612 . . . . 0.47 110.691 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 75.3 mt -73.95 -52.11 13.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.422 -0.799 . . . . 0.48 111.319 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.779 ' OH ' HD22 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -75.6 -11.82 60.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.41 110.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.48 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.89 -102.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.059 -1.617 . . . . 0.46 109.059 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.52 101.65 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.86 1.452 . . . . 0.58 110.158 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -78.82 165.71 51.37 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.587 -1.405 . . . . 0.64 109.587 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.632 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -95.41 -68.75 0.78 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -1.124 . . . . 0.95 110.254 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.53 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 2.9 tm-20 49.42 30.86 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 1.2 110.143 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -100.15 108.43 52.21 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.908 . . . . 1.2 110.424 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.75 56.58 2.93 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.976 1.514 . . . . 1.06 110.354 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.016 -0.992 . . . . 0.78 110.234 -179.819 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.876 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.569 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.644 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' TYR . . . . . 0.664 ' CE2' HG12 ' A' ' 106' ' ' VAL . 19.9 t80 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.23 0.538 . . . . 0.41 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 105' ' ' ASN . 13.3 p30 -62.35 88.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.26 110.241 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.664 HG12 ' CE2' ' A' ' 104' ' ' TYR . 22.1 m -62.25 -145.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.33 110.124 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 106' ' ' VAL . 8.3 m-85 -43.26 113.5 1.42 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.65 110.218 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 47.3 Cg_endo -73.01 -158.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.886 1.466 . . . . 0.84 110.757 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.891 ' O ' HD12 ' A' ' 230' ' ' LEU . 2.1 mtp180 64.96 71.44 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.528 -0.732 . . . . 0.93 110.241 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' LEU . 1.5 p -138.32 -63.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 1.03 109.484 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.4 OUTLIER 39.09 30.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.643 -0.66 . . . . 1.04 111.428 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -114.35 68.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.043 -1.036 . . . . 0.77 109.433 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.578 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 20.8 t90 -147.52 -66.85 0.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.42 111.063 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 24.0 p -97.1 51.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.44 110.952 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 114' ' ' SER . 4.5 mmmt -148.48 85.77 1.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.49 109.91 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 tmm? -120.86 -15.72 8.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.025 -1.047 . . . . 0.3 110.473 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.594 ' O ' HD22 ' A' ' 118' ' ' LEU . 7.3 p-10 -153.46 114.28 4.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.15 110.211 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -141.0 -151.87 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.304 -0.873 . . . . 0.13 110.201 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.881 HG22 ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -136.32 155.35 50.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.12 110.142 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.878 ' HB3' HG23 ' A' ' 163' ' ' ILE . 29.0 p90 -148.92 163.33 37.77 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.496 -0.882 . . . . 0.33 111.055 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 151.38 35.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.48 -0.763 . . . . 0.54 109.881 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.856 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.1 pp -116.91 111.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.33 111.163 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.936 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.8 m -161.82 49.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.27 110.261 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.8 t30 -42.95 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.41 109.451 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.58 ' O ' HG21 ' A' ' 134' ' ' VAL . 24.6 t80 -179.03 -176.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.4 110.042 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.434 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -129.09 57.95 33.73 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.982 . . . . 0.45 109.834 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 125' ' ' TYR . 47.8 Cg_endo -75.1 -88.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.275 1.671 . . . . 0.36 110.688 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.37 -8.27 21.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.25 110.163 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.568 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.04 174.95 5.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.39 110.204 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 132' ' ' SER . 3.0 m -115.17 167.03 11.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.48 109.302 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 130' ' ' THR . 7.9 t-160 -43.38 -26.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.4 109.61 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.2 OUTLIER -68.8 -45.57 70.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.831 . . . . 0.46 110.116 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.568 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.1 OUTLIER -70.71 -50.54 35.21 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.938 -1.101 . . . . 0.47 109.248 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 125' ' ' TYR . 9.5 t -47.18 -36.61 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.242 -1.392 . . . . 0.31 107.242 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.595 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 1.4 tt0 -58.96 -45.88 89.42 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.474 -1.306 . . . . 0.48 107.474 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.31 -50.36 71.98 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.068 0.937 . . . . 0.64 108.704 178.164 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.793 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -46.33 -62.93 1.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.149 -0.969 . . . . 0.42 110.718 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.856 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.73 -52.53 56.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.34 110.7 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -65.91 -74.82 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.901 -1.124 . . . . 0.47 110.175 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -38.48 -61.6 0.68 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.807 -0.558 . . . . 0.47 110.66 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -46.96 -38.56 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.665 -1.272 . . . . 0.25 108.359 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -71.65 -28.92 64.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -0.869 . . . . 0.35 109.156 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.02 -42.2 98.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.7 108.416 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 4.4 t -72.31 -51.36 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.817 -0.809 . . . . 0.61 108.817 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.638 ' HH2' HG21 ' A' ' 262' ' ' ILE . 47.8 t-105 -50.85 -34.47 28.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.523 -0.917 . . . . 0.39 108.523 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -76.28 -36.02 58.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.45 -0.944 . . . . 0.35 108.45 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.31 -43.23 70.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.981 -0.748 . . . . 0.36 108.981 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 31.4 m -74.85 -35.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.703 -0.799 . . . . 0.5 109.552 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 149' ' ' THR . 13.0 t -148.06 121.77 4.81 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 0.51 110.305 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.79 60.74 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.819 1.431 . . . . 0.31 110.335 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.976 HD11 ' O ' ' A' ' 266' ' ' TYR . 1.1 mp -73.9 173.86 9.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.18 110.815 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -110.25 121.83 46.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.17 109.95 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 9.0 p90 -138.8 131.23 28.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.14 110.266 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.881 ' O ' HG22 ' A' ' 119' ' ' THR . 7.8 m -136.84 130.58 32.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.15 110.22 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.603 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -94.12 69.83 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.2 109.945 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 110.64 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.22 110.11 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 158' ' ' ASP . 4.6 m-70 -67.74 -24.53 65.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.32 110.01 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 158' ' ' ASP . 4.5 t0 -42.44 -27.71 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.33 109.646 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.86 26.52 1.25 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.614 -1.395 . . . . 0.28 109.614 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 160' ' ' ILE . 8.0 mt -116.65 74.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.203 -1.175 . . . . 0.3 109.432 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -135.57 152.94 51.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.664 -0.648 . . . . 0.2 110.491 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.98 -35.27 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.1 110.185 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.075 HD12 ' O ' ' A' ' 197' ' ' GLY . 0.7 OUTLIER -115.21 163.21 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.291 -0.881 . . . . 0.1 109.335 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.793 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -174.63 142.57 0.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.375 -1.453 . . . . 0.11 111.71 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 165' ' ' ILE . 6.7 tt -94.74 118.42 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.469 -0.769 . . . . 0.1 109.777 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.936 ' HB3' HG23 ' A' ' 123' ' ' VAL . 9.7 p -160.94 153.4 20.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.808 -1.183 . . . . 0.1 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.0 p90 -68.81 120.46 14.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.09 109.727 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -81.95 129.92 9.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.529 -1.028 . . . . 0.2 110.529 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -125.06 99.99 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.709 -0.877 . . . . 0.55 108.94 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.43 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.42 0.629 . . . . 0.85 112.475 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -163.3 24.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.71 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 14.4 m-70 -93.29 -57.96 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.42 110.253 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 110.86 55.34 0.51 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.65 -1.38 . . . . 0.33 109.65 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 8.0 p-10 -176.71 -37.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -1.079 . . . . 0.33 110.202 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.6 OUTLIER -156.05 149.07 24.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.27 110.106 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -77.34 112.24 22.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.34 110.138 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.1 Cg_endo -74.15 -55.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.954 1.502 . . . . 0.47 110.625 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.3 p90 -79.64 162.44 25.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.038 . . . . 0.35 110.528 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -169.51 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.019 . . . . 0.2 110.989 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.611 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 160.48 -149.11 18.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.25 109.49 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.83 -2.05 10.85 Favored 'Trans proline' 0 C--N 1.297 -2.174 0 O-C-N 124.228 1.646 . . . . 0.44 109.765 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.519 ' CB ' ' OD1' ' A' ' 179' ' ' ASP . 20.2 t -49.88 175.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.57 110.184 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.563 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -68.61 76.53 0.28 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.781 -0.928 . . . . 0.49 110.781 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.997 ' HA ' HG13 ' A' ' 1' ' ' HAV . 1.0 OUTLIER 179.35 85.94 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.199 -1.177 . . . . 0.41 110.575 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.644 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.6 tt -105.79 -21.4 13.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.612 -1.305 . . . . 0.3 111.664 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.63 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -146.63 109.7 4.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.526 -1.359 . . . . 0.2 111.985 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -112.61 115.26 28.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.16 109.538 178.872 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.922 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -111.1 145.72 38.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.23 110.116 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 2.2 m-30 -95.72 165.78 15.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.233 -0.917 . . . . 0.38 110.757 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -71.04 150.58 60.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.069 1.562 . . . . 0.4 109.163 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 227' ' ' SER . 45.4 Cg_endo -72.89 76.27 2.53 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.681 1.359 . . . . 0.32 110.5 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.07 -108.29 2.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.498 -1.441 . . . . 0.32 109.498 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.89 -158.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.935 1.492 . . . . 0.47 110.26 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -3.42 13.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.161 -0.962 . . . . 0.63 110.554 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.36 27.51 8.66 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.53 110.227 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -105.35 166.72 14.51 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.136 -1.586 . . . . 0.25 109.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 1.075 ' O ' HD12 ' A' ' 163' ' ' ILE . . . 51.43 21.04 5.85 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.937 -1.665 . . . . 0.1 108.937 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.9 OUTLIER -77.44 88.83 3.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -1.143 . . . . 0.1 110.267 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -72.96 84.98 1.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.09 109.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.495 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 52.9 m170 -97.82 127.06 43.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.09 110.628 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.3 m-85 -97.89 141.03 31.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.995 . . . . 0.1 109.818 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.891 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -51.76 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.373 -0.973 . . . . 0.14 108.373 178.773 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.596 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 1.7 p30 -34.86 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.18 112.204 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.611 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 18.5 t0 -80.18 10.12 4.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.683 -1.261 . . . . 0.24 110.744 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.559 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 21.8 mm-40 -101.41 -162.15 0.91 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.42 109.961 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.0 m -128.41 141.85 51.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.036 -1.04 . . . . 0.47 110.381 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -142.41 139.03 31.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.968 . . . . 0.27 109.9 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.04 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -144.29 172.91 12.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.975 -1.078 . . . . 0.3 110.545 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -128.2 27.5 5.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.951 0.882 . . . . 0.61 108.996 178.786 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.6 t -99.66 -99.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.69 -0.632 . . . . 0.78 110.15 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.53 ' N ' ' OG ' ' A' ' 210' ' ' SER . 13.2 t -153.0 15.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.033 -1.042 . . . . 0.91 110.328 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 213' ' ' GLY . 0.0 OUTLIER -133.27 -172.12 2.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.93 109.93 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 42.69 -147.95 0.62 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.179 -1.569 . . . . 0.79 109.179 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.644 ' CE1' HD13 ' A' ' 185' ' ' LEU . 90.8 m-85 -93.24 103.1 15.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.106 -1.232 . . . . 0.69 109.738 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.593 ' O ' HG12 ' A' ' 219' ' ' VAL . 58.1 m-80 -71.65 120.27 17.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.094 -1.004 . . . . 0.4 108.933 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.04 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -42.03 -34.7 0.75 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.564 -0.854 . . . . 0.17 110.051 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.582 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 7.2 m-85 -54.37 -46.09 72.93 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.572 -1.27 . . . . 0.28 107.572 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.904 HD11 ' HH1' ' A' ' 3' ' ' MSB . 10.2 tp -78.08 -71.15 0.44 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.775 -0.648 . . . . 0.46 110.694 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.836 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.17 -62.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 0.39 110.141 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.08 -53.63 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.067 . . . . 0.17 111.391 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -56.44 -25.94 52.06 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.404 -1.435 . . . . 0.1 108.965 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.642 ' HA ' HD22 ' A' ' 239' ' ' LEU . 6.3 t60 -78.82 -46.79 17.95 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.767 -0.583 . . . . 0.21 109.748 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.628 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.7 tp10 -63.99 -38.3 90.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.28 109.244 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 6.8 m-30 -64.33 -63.08 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.816 . . . . 0.18 109.084 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -44.72 -31.68 2.7 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.86 -1.696 . . . . 0.21 108.86 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.73 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -77.36 -74.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -1.139 . . . . 0.17 110.639 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.922 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -39.35 -54.83 1.83 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.484 -0.76 . . . . 0.33 111.492 -179.029 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.552 HD23 ' OH ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -78.79 -46.04 19.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.53 110.785 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -60.3 -78.77 0.13 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.717 -1.353 . . . . 0.41 109.717 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -177.76 -162.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.45 110.08 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.507 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -55.8 -55.3 34.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.62 109.789 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.73 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -162.09 -179.96 7.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.45 109.385 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 67.3 p -178.97 48.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.38 110.569 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -135.39 27.29 3.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.242 -0.911 . . . . 0.48 110.559 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -39.83 -50.76 5.6 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.595 -0.842 . . . . 0.38 109.622 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 43.4 Cg_endo -90.53 -46.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.747 1.393 . . . . 0.28 110.462 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.57 96.31 0.1 Allowed Glycine 0 N--CA 1.498 2.795 0 C-N-CA 119.065 -1.541 . . . . 0.24 112.304 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.914 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -145.25 160.33 41.64 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.263 -1.14 . . . . 0.28 109.57 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 222' ' ' HIS . 1.5 tt -68.18 57.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.4 109.237 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.643 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -141.72 -6.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.45 111.547 -178.762 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -78.21 165.23 51.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.556 -1.34 . . . . 0.57 110.987 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.569 ' HA ' ' HB2' ' A' ' 2' ' ' 3MP . 41.1 Cg_endo -68.11 -18.34 45.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.78 1.41 . . . . 0.76 110.053 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.1 mm -90.21 136.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.934 -0.765 . . . . 0.89 108.934 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.7 ' HB2' HD21 ' A' ' 218' ' ' LEU . 38.5 p90 -126.96 -30.64 2.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.942 -1.099 . . . . 0.78 110.405 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.758 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.49 -70.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 113.203 0.816 . . . . 0.61 113.203 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.758 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -53.41 105.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.556 -1.34 . . . . 0.74 109.321 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.505 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 22.5 p -57.16 166.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.849 . . . . 0.81 109.998 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -53.7 -19.8 10.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.092 -1.603 . . . . 0.56 109.092 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.95 31.87 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.37 110.631 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.492 ' HB3' ' N ' ' A' ' 247' ' ' THR . 1.9 t -83.76 -22.67 31.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.05 -1.031 . . . . 0.44 109.927 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -152.41 -69.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.53 109.873 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.64 -176.01 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.38 110.47 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.964 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.1 55.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.593 -0.692 . . . . 0.19 110.702 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.724 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -45.83 -46.88 40.44 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.017 -1.105 . . . . 0.28 108.017 177.576 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.724 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.3 Cg_endo -71.82 48.91 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.954 1.502 . . . . 0.49 110.966 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.616 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.8 m-20 -47.39 -32.42 4.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.887 -1.133 . . . . 0.49 110.453 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.914 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 1.4 m-20 -50.49 -50.81 51.68 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.138 -0.976 . . . . 0.31 109.51 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.06 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -73.35 -33.01 64.87 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.169 -1.012 . . . . 0.14 108.468 179.021 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 253' ' ' MET . 84.8 t -60.56 -81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.252 -0.979 . . . . 0.17 110.153 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.65 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.3 OUTLIER -62.05 -42.85 99.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.238 -0.914 . . . . 0.26 109.786 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.65 -64.92 1.1 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.396 -1.082 . . . . 0.19 110.396 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.065 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -77.49 -19.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.816 -1.402 . . . . 0.22 110.441 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 1.065 ' N ' HD13 ' A' ' 262' ' ' ILE . 17.3 tt0 -64.37 -21.87 66.77 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.838 -1.145 . . . . 0.39 108.317 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.0 t -104.22 -41.52 5.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.157 -0.617 . . . . 0.47 111.487 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 9.2 mt -87.5 -45.86 10.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.227 -0.921 . . . . 0.48 111.669 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.976 ' O ' HD11 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.85 -8.78 57.36 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.206 -0.934 . . . . 0.41 110.156 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -73.73 -107.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.032 -1.627 . . . . 0.46 109.032 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 268' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 269' ' ' GLY . 46.3 Cg_endo -73.01 74.99 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.784 1.413 . . . . 0.58 110.112 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 268' ' ' PRO . . . -61.81 -137.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.64 109.723 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -149.45 -63.72 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.95 110.139 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.503 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 3.4 tt0 64.36 13.54 8.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.2 110.303 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.451 ' HB3' ' OD1' ' A' ' 274' ' ' ASN . 1.2 m-20 -179.49 126.02 0.24 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 1.2 110.03 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.68 73.01 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.877 1.462 . . . . 1.06 110.375 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 272' ' ' ASP . 22.9 m120 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.78 110.162 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.997 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.62 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.904 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.291 0.567 . . . . 0.41 110.223 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.54 87.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.26 110.089 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.461 ' C ' ' HD3' ' A' ' 108' ' ' PRO . 12.9 t -115.05 2.91 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.33 110.385 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 m-85 -129.24 59.86 47.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.65 110.053 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 107' ' ' PHE . 53.4 Cg_endo -81.92 31.81 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.84 111.036 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.617 ' O ' HD13 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -143.54 74.85 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.93 109.898 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.526 ' O ' HD22 ' A' ' 230' ' ' LEU . 1.7 p -142.63 -56.81 0.43 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.342 -0.849 . . . . 1.03 109.692 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.7 OUTLIER 37.24 28.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.706 -0.621 . . . . 1.04 111.107 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HD3' HD22 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -100.22 91.05 4.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.121 -0.987 . . . . 0.77 110.015 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.602 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 21.7 t90 -164.08 -71.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.42 110.284 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.543 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 88.4 p -91.71 69.52 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.44 110.268 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 27.1 mttp -165.65 86.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.49 110.465 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 5.8 ttp -123.23 -12.79 7.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.3 110.149 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 20.3 p-10 -155.3 124.21 6.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.15 109.84 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.98 -177.82 6.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.13 110.424 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -121.44 147.14 46.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.12 109.766 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.818 ' CB ' HG23 ' A' ' 163' ' ' ILE . 9.6 p90 -145.01 160.71 40.94 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.254 -0.978 . . . . 0.33 111.015 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.423 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -103.68 160.69 14.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.472 -0.768 . . . . 0.54 110.032 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.689 HG21 ' CD1' ' A' ' 138' ' ' PHE . 7.6 pt -122.32 62.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.33 110.727 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 1.021 HG23 ' HB3' ' A' ' 166' ' ' SER . 12.1 m -110.39 48.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.995 -1.066 . . . . 0.27 110.727 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.49 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 0.6 OUTLIER -43.18 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.41 109.297 179.515 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.623 ' O ' HG21 ' A' ' 134' ' ' VAL . 5.6 t80 -178.81 -175.1 0.39 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.346 -0.846 . . . . 0.4 109.47 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.571 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -136.36 48.29 2.44 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.45 110.805 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.14 -85.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.814 1.429 . . . . 0.36 110.343 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 1.5 m-20 -95.53 2.85 54.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.25 109.638 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.558 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -124.3 156.5 36.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 0.39 109.75 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -110.41 176.48 5.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.48 109.95 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -43.37 -34.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.4 109.931 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -68.87 -50.01 53.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.46 109.646 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.558 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 5.2 mp0 -58.44 -62.09 2.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.364 -0.835 . . . . 0.47 109.41 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.623 HG21 ' O ' ' A' ' 125' ' ' TYR . 9.5 t -45.16 -39.7 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.139 -1.06 . . . . 0.31 108.139 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -54.11 -40.48 67.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.057 -1.09 . . . . 0.48 108.057 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 17.0 tttt -74.54 -52.24 12.41 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.867 0.842 . . . . 0.64 108.846 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.82 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.31 -60.81 2.1 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.962 -1.086 . . . . 0.42 110.561 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.689 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.54 -54.17 36.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.34 111.004 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.654 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 7.9 tttm -68.09 -72.76 0.16 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.94 -1.1 . . . . 0.47 110.28 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.4 OUTLIER -38.48 -61.24 0.72 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.731 -0.605 . . . . 0.47 110.709 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.43 -38.27 13.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.641 -1.287 . . . . 0.25 108.344 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.53 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -72.53 -28.58 62.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.31 -0.869 . . . . 0.35 109.068 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 140' ' ' LYS . 58.7 tttt -63.4 -39.75 95.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.43 -0.952 . . . . 0.7 108.43 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 11.3 t -75.76 -51.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.086 -0.709 . . . . 0.61 109.086 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HH2' HG21 ' A' ' 262' ' ' ILE . 45.2 t-105 -52.19 -34.18 44.16 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.441 -0.948 . . . . 0.39 108.441 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 149' ' ' THR . 41.5 m -77.38 -38.41 50.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.395 -0.965 . . . . 0.35 108.395 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.43 -43.88 62.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.862 -0.792 . . . . 0.36 108.862 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.699 HG23 HG22 ' A' ' 149' ' ' THR . 32.3 m -74.05 -38.52 49.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.477 -0.764 . . . . 0.5 109.55 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.699 HG22 HG23 ' A' ' 148' ' ' VAL . 7.2 t -142.78 119.53 6.89 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.51 110.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.41 58.57 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.663 1.349 . . . . 0.31 110.793 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.515 HD11 ' CG ' ' A' ' 266' ' ' TYR . 59.4 mt -70.48 167.12 19.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.18 110.043 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 3.1 t30 -105.89 103.08 12.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.892 . . . . 0.17 110.22 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.428 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.6 p90 -116.08 144.68 43.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.14 110.312 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.761 ' O ' HG22 ' A' ' 119' ' ' THR . 27.7 m -147.9 130.55 15.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.15 110.439 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.612 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -99.62 84.4 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.2 109.904 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 154' ' ' THR . 0.5 OUTLIER -77.11 104.35 7.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.22 110.224 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' ASP . 55.8 p-80 -56.06 -27.96 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.96 . . . . 0.32 109.948 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.12 -41.91 2.79 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.56 -0.712 . . . . 0.33 109.941 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.73 33.22 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.733 -1.347 . . . . 0.28 109.733 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 119' ' ' THR . 6.5 mt -121.13 71.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.064 -1.257 . . . . 0.3 109.542 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -125.3 137.6 54.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.029 -0.668 . . . . 0.2 110.411 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.516 ' HB3' HD22 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.52 -34.9 8.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.1 109.653 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.818 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -122.72 173.11 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.1 109.052 179.347 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.772 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.5 ptp -177.05 144.63 0.44 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.495 -1.378 . . . . 0.11 111.656 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 122' ' ' ILE . 1.5 tt -93.31 120.87 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.1 109.272 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 166' ' ' SER . . . . . 1.021 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.3 p -163.62 142.56 8.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.735 -1.228 . . . . 0.1 110.702 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.62 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.8 p90 -67.03 112.3 4.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.324 -0.86 . . . . 0.09 109.618 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -60.63 143.28 48.12 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.281 -1.527 . . . . 0.2 109.281 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.734 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.7 tt -138.15 96.91 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.972 . . . . 0.55 109.905 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.591 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.06 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.382 0.611 . . . . 0.85 112.363 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 11.83 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.71 110.108 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.406 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m-70 -80.25 -87.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.42 110.031 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.58 -35.2 1.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.485 -1.446 . . . . 0.33 109.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 -87.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.33 110.26 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -111.01 -170.01 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.27 110.569 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -101.95 110.62 62.72 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.34 110.349 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.445 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.1 Cg_endo -76.92 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.829 1.437 . . . . 0.47 110.668 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -50.38 140.68 13.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.35 110.606 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 182' ' ' SER . 6.0 p30 -178.74 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.932 -1.107 . . . . 0.2 111.703 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 36.97 -157.54 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.562 -1.015 . . . . 0.25 110.562 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.452 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -78.62 43.74 1.5 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.183 1.623 . . . . 0.44 110.535 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 184' ' ' LEU . 0.5 OUTLIER -83.33 179.32 7.72 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.285 -0.885 . . . . 0.57 109.816 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.499 ' HA2' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.2 68.6 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.566 -1.013 . . . . 0.49 110.566 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.978 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.8 OUTLIER 179.64 84.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.132 -1.217 . . . . 0.41 110.954 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.552 HD12 ' CD ' ' A' ' 205' ' ' GLU . 0.5 OUTLIER -100.18 -24.17 14.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.964 -1.094 . . . . 0.3 110.741 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.659 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.36 99.55 2.51 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.79 -1.194 . . . . 0.2 111.788 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.539 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -100.97 124.47 46.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.051 -1.031 . . . . 0.16 109.987 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.828 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -106.08 124.49 49.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.974 . . . . 0.23 110.333 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.4 OUTLIER -68.5 162.83 59.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.38 110.443 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.4 Cg_endo -72.26 138.58 30.63 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.4 109.772 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.56 72.88 2.34 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.92 1.484 . . . . 0.32 110.575 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.59 -105.95 2.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.32 109.443 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.65 -159.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.943 1.497 . . . . 0.47 110.396 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -63.61 -11.8 28.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.63 110.279 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.27 63.58 0.66 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.45 -0.781 . . . . 0.53 109.997 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.19 173.89 22.46 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.097 -1.601 . . . . 0.25 109.097 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.28 25.5 0.76 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.481 -1.448 . . . . 0.1 109.481 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 12.5 m-20 -79.04 87.44 4.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -1.209 . . . . 0.1 110.666 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.8 98.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.09 109.539 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.538 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 8.5 m170 -110.57 119.86 40.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.09 111.266 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 203' ' ' ASP . 13.7 m-30 -90.62 131.93 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.1 109.556 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.519 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 0.4 OUTLIER -49.33 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.079 . . . . 0.14 108.717 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -34.55 -32.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.566 -0.709 . . . . 0.18 111.738 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.532 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 1.8 m-20 -64.1 -16.75 62.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.638 -1.289 . . . . 0.24 110.631 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.552 ' CD ' HD12 ' A' ' 185' ' ' LEU . 11.4 mm-40 -86.77 -176.02 5.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.002 . . . . 0.42 110.49 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.528 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 83.8 m -122.11 154.74 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.47 110.006 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.553 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -149.49 147.28 28.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 0.27 109.756 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.013 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.32 177.55 11.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.02 -1.05 . . . . 0.3 110.595 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.1 OUTLIER -129.06 20.28 5.88 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.729 0.776 . . . . 0.61 109.553 178.985 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -89.38 -69.81 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.566 0.698 . . . . 0.78 110.078 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.415 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER 179.41 -30.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.58 -0.7 . . . . 0.91 109.543 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 177.61 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.548 -0.72 . . . . 0.93 109.98 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 50.11 -161.4 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.79 109.432 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.465 ' CE2' ' CE2' ' A' ' 244' ' ' TYR . 80.1 m-85 -81.69 126.2 31.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.69 109.473 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.62 ' O ' HG12 ' A' ' 219' ' ' VAL . 16.8 m-80 -89.2 118.6 29.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.026 -1.046 . . . . 0.4 108.658 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.013 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.37 -36.98 0.92 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.672 -0.811 . . . . 0.17 110.334 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 3.0 m-85 -51.24 -49.34 61.31 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.574 -1.25 . . . . 0.28 107.833 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 244' ' ' TYR . 12.7 tp -75.09 -70.42 0.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.791 -0.64 . . . . 0.46 110.54 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -49.96 -68.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.39 110.03 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -44.46 -52.96 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.978 -1.076 . . . . 0.17 111.23 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.99 -47.71 77.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.275 -1.516 . . . . 0.1 108.722 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.673 ' N ' HD21 ' A' ' 239' ' ' LEU . 5.6 t60 -54.25 -52.18 62.17 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.419 0.628 . . . . 0.21 109.942 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.642 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.4 tp10 -59.81 -43.7 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.207 -0.933 . . . . 0.28 108.87 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 224' ' ' PHE . 11.6 m-30 -55.0 -62.35 1.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.18 109.091 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.59 -32.97 1.4 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.786 -1.725 . . . . 0.21 108.786 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -79.83 -76.46 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.195 -1.179 . . . . 0.17 111.052 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.828 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -34.55 -42.57 0.15 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.83 -0.544 . . . . 0.33 112.336 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 163' ' ' ILE . 3.1 tp -101.17 -38.74 7.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.839 -1.163 . . . . 0.53 111.309 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 225' ' ' GLY . . . -68.29 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.762 -0.935 . . . . 0.41 110.762 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.625 HD12 ' H ' ' A' ' 232' ' ' HIS . 0.5 OUTLIER -160.45 -155.34 0.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.131 -1.217 . . . . 0.45 111.098 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.468 ' HB2' ' CG ' ' A' ' 109' ' ' ARG . 37.3 m-20 -74.4 -48.34 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.62 110.712 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.625 ' H ' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -174.82 157.82 2.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -1.0 . . . . 0.45 111.098 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 24.1 p -162.71 47.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.033 -0.728 . . . . 0.38 109.033 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.714 ' CA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -127.06 23.09 6.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.449 -0.782 . . . . 0.48 111.001 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.553 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -43.86 -60.24 2.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.38 109.494 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.0 Cg_endo -75.97 -50.76 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.735 1.387 . . . . 0.28 110.681 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.06 95.03 0.1 OUTLIER Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.337 -1.411 . . . . 0.24 111.404 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.928 ' HB2' ' HB2' ' A' ' 257' ' ' ASP . . . -145.77 164.93 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.426 -1.044 . . . . 0.28 110.022 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.673 HD21 ' N ' ' A' ' 222' ' ' HIS . 1.1 tp -72.14 57.33 0.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -0.916 . . . . 0.4 109.131 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.601 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 4.3 mmm -146.86 14.46 1.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.102 -0.998 . . . . 0.45 110.576 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -106.14 166.67 10.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.57 110.704 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.52 ' HA ' ' HD2' ' A' ' 3' ' ' MSB . 45.3 Cg_endo -70.24 -7.53 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.008 1.53 . . . . 0.76 109.981 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.727 HD11 ' CG2' ' A' ' 245' ' ' THR . 0.0 OUTLIER -101.41 112.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.137 -0.69 . . . . 0.89 109.137 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.68 ' HB2' HD21 ' A' ' 218' ' ' LEU . 52.1 p90 -116.6 -31.58 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.04 . . . . 0.78 110.731 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.762 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER 1.89 -68.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.235 0.828 . . . . 0.61 113.235 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.762 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -48.6 106.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.51 -1.369 . . . . 0.74 109.524 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 70.0 p -53.8 171.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.81 110.164 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.3 -15.23 29.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.27 -1.532 . . . . 0.56 109.27 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.7 20.09 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.37 110.441 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.467 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -64.74 -17.88 64.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.44 109.795 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -168.36 -64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.53 110.187 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.1 OUTLIER 179.95 -172.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.38 110.605 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 253' ' ' MET . . . . . 1.011 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.32 56.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.716 -0.615 . . . . 0.19 110.541 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.704 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.9 OUTLIER -44.01 -47.6 22.43 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.0 -1.111 . . . . 0.28 108.0 177.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.65 50.67 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 124.101 1.579 . . . . 0.49 111.176 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.666 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 31.3 m-20 -53.54 -28.52 32.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.49 110.786 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.928 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 1.7 m-20 -54.25 -47.76 71.91 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.035 -1.041 . . . . 0.31 109.436 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.037 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -76.21 -31.82 58.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.277 -0.969 . . . . 0.14 108.442 178.507 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 1.011 HG21 ' HB2' ' A' ' 253' ' ' MET . 70.8 t -61.83 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.658 -0.817 . . . . 0.17 109.98 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.7 tp60 -61.41 -40.96 96.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.247 -0.908 . . . . 0.26 109.525 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.53 -66.71 0.92 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.355 -1.098 . . . . 0.19 110.355 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.037 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -76.14 -20.17 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.912 -1.346 . . . . 0.22 110.613 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 262' ' ' ILE . 13.4 tp60 -61.37 -23.86 66.07 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.648 -1.221 . . . . 0.39 107.969 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -103.12 -36.34 8.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.936 -0.705 . . . . 0.47 111.672 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 265' ' ' LEU . 4.3 mm? -90.76 -46.52 8.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.973 -1.079 . . . . 0.48 111.923 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.644 ' OH ' HD23 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -71.23 -18.09 62.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.964 -1.085 . . . . 0.41 109.904 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.95 -88.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.999 -1.64 . . . . 0.46 108.999 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.9 114.24 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.072 1.564 . . . . 0.58 110.001 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.92 154.97 17.27 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.842 -1.303 . . . . 0.64 109.842 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.602 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -105.04 -75.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -1.13 . . . . 0.95 109.986 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.543 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 35.2 tt0 60.3 12.94 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.2 110.53 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 270' ' ' ASP . 1.7 p30 179.55 137.68 0.28 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 1.2 110.363 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.56 61.69 4.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.987 1.519 . . . . 1.06 110.331 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.948 -1.025 . . . . 0.78 110.204 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.978 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.657 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.659 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.26 0.553 . . . . 0.41 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.14 89.13 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.26 110.283 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 107' ' ' PHE . 17.3 m -68.59 -144.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.33 110.15 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.467 ' N ' HG23 ' A' ' 106' ' ' VAL . 14.1 m-30 -81.36 113.97 45.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.65 110.137 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 44.8 Cg_endo -71.99 -170.69 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.84 110.265 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 1.1 mtt85 59.97 82.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.93 110.096 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.698 ' HA ' HD12 ' A' ' 230' ' ' LEU . 1.1 p -149.48 -60.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.552 -0.718 . . . . 1.03 109.204 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 48.11 32.66 3.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 1.04 111.469 178.963 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 110' ' ' THR . 1.2 mtpt -117.75 92.88 3.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.77 109.883 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.614 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 9.9 t90 -160.91 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.009 -1.057 . . . . 0.42 111.307 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.556 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 87.6 p -102.23 69.23 1.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -0.998 . . . . 0.44 110.865 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 114' ' ' SER . 7.3 mttm -161.59 50.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.49 110.352 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 3.9 ttt -74.91 -5.16 42.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.247 -0.908 . . . . 0.3 110.427 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.453 ' CB ' ' HB3' ' A' ' 152' ' ' ASN . 29.7 p30 -156.78 149.13 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.15 110.502 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.728 HD23 HD11 ' A' ' 228' ' ' LEU . 9.3 tp -171.15 177.64 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.13 109.857 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.91 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -110.36 158.84 18.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.008 . . . . 0.12 110.458 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.752 ' HB2' HG23 ' A' ' 163' ' ' ILE . 21.4 p90 -154.45 167.85 28.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.422 -0.799 . . . . 0.33 110.329 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -130.06 144.21 51.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -0.818 . . . . 0.54 110.102 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.839 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -105.18 123.85 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.346 -0.846 . . . . 0.33 110.704 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.995 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.0 m -165.41 44.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.802 . . . . 0.27 109.818 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.3 t-20 -40.11 -80.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.41 109.539 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 7.8 t80 -179.11 178.46 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.314 -0.866 . . . . 0.4 109.951 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -131.9 55.71 19.71 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.45 110.576 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.6 Cg_endo -82.86 -81.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.789 1.415 . . . . 0.36 110.517 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.77 -4.03 25.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.25 110.048 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.552 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 1.0 OUTLIER -113.76 160.98 18.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.39 110.211 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.3 m -106.89 167.74 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.48 109.839 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 2.0 t60 -44.29 -29.98 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.4 109.845 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -66.71 -51.5 55.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.46 109.654 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.552 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 10.3 mt-10 -62.16 -58.0 9.42 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.249 -0.907 . . . . 0.47 109.18 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 125' ' ' TYR . 5.7 t -46.37 -34.76 2.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.935 -1.135 . . . . 0.31 107.935 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -59.0 -42.4 90.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.938 -1.134 . . . . 0.48 107.938 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 47.1 tttt -68.97 -45.49 70.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.219 -1.03 . . . . 0.64 108.219 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.822 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -49.17 -59.71 3.43 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.321 -0.862 . . . . 0.42 109.739 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.717 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.39 -55.79 16.17 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.542 -0.724 . . . . 0.34 110.509 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -64.27 -73.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.47 110.603 -179.153 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -39.64 -60.27 1.0 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.633 -0.667 . . . . 0.47 110.73 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.11 -36.86 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.521 -1.362 . . . . 0.25 108.339 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -72.33 -31.41 65.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.9 -0.778 . . . . 0.35 108.9 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -61.29 -42.32 98.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.7 108.655 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.3 t -73.22 -48.55 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.566 -0.709 . . . . 0.61 109.208 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.596 ' CH2' HG13 ' A' ' 262' ' ' ILE . 43.1 t-105 -54.72 -39.38 68.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.39 109.215 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 149' ' ' THR . 75.5 m -74.9 -35.18 62.25 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.508 -0.923 . . . . 0.35 108.508 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.524 0.678 . . . . 0.36 109.375 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.783 HG23 HG22 ' A' ' 149' ' ' THR . 27.2 m -82.29 -32.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.419 -0.801 . . . . 0.5 110.256 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.783 HG22 HG23 ' A' ' 148' ' ' VAL . 5.0 t -146.29 136.65 12.17 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.51 110.557 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.93 58.44 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.972 1.512 . . . . 0.31 110.542 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.796 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -75.63 129.54 37.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.18 110.431 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 117' ' ' ASN . 64.6 t-20 -87.25 123.59 32.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.17 109.841 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.591 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 7.5 p90 -133.11 152.97 51.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.14 110.467 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.91 ' O ' HG22 ' A' ' 119' ' ' THR . 22.5 m -152.49 125.81 8.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.15 110.319 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.602 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -92.04 105.43 17.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.2 109.755 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -101.76 96.97 7.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.22 110.395 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.3 p-80 -52.5 -28.34 20.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.32 109.954 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.691 ' HB3' HD12 ' A' ' 156' ' ' LEU . 3.3 t0 -41.42 -60.7 1.22 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.587 -0.696 . . . . 0.33 109.752 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.99 35.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.963 -1.255 . . . . 0.28 109.963 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.769 ' O ' HG22 ' A' ' 160' ' ' ILE . 50.4 mt -126.09 68.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -1.205 . . . . 0.3 109.398 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.41 55.26 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.641 -0.662 . . . . 0.2 110.758 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.539 ' CG ' HD21 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -96.9 -51.07 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.1 109.798 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.752 HG23 ' HB2' ' A' ' 120' ' ' TYR . 18.5 tt -116.53 160.84 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.346 -0.846 . . . . 0.1 109.644 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.946 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 15.6 ptp -160.81 139.73 10.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.56 -1.338 . . . . 0.11 111.439 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -93.6 113.97 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.1 109.292 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.995 ' HB3' HG23 ' A' ' 123' ' ' VAL . 63.6 p -162.23 166.4 25.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.777 -1.202 . . . . 0.1 111.36 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.616 ' CG ' ' CD1' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -79.99 136.56 36.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.55 -0.719 . . . . 0.09 109.979 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.512 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.72 128.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.793 -1.323 . . . . 0.2 109.793 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.1 tt -118.29 100.87 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -1.037 . . . . 0.55 109.737 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 3.0 tmtt? -9.71 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.284 0.564 . . . . 0.85 112.352 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 9.3 tt0 -146.16 11.85 1.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.71 110.278 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -74.78 -75.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.42 110.107 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 120.12 52.45 0.26 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.795 -1.322 . . . . 0.33 109.795 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 6.5 p-10 -177.1 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -1.151 . . . . 0.33 110.083 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.483 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.2 OUTLIER -132.03 154.72 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.27 110.083 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.58 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 3.0 m-30 -106.48 88.98 3.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.941 . . . . 0.34 110.168 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 44.3 Cg_endo -72.6 -58.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.47 109.968 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -49.12 131.49 19.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.35 110.362 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 182' ' ' SER . 14.8 p30 179.33 82.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.134 -0.979 . . . . 0.2 110.804 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.497 ' H ' ' CB ' ' A' ' 204' ' ' ASP . . . 35.71 -154.13 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.094 -1.202 . . . . 0.25 110.094 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -78.96 43.74 1.54 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.965 1.508 . . . . 0.44 110.2 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.1 t -80.78 176.67 9.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.103 -0.998 . . . . 0.57 110.076 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.566 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.35 67.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.664 -0.974 . . . . 0.49 110.664 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.025 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.3 OUTLIER 179.57 88.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.178 -1.189 . . . . 0.41 110.709 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.591 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 4.9 tt -105.9 -19.11 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.759 -1.176 . . . . 0.3 110.919 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.653 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.25 111.11 4.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.2 112.074 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -114.64 125.83 54.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.84 . . . . 0.16 109.414 178.696 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -123.04 116.89 24.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.106 . . . . 0.23 110.512 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -58.57 167.68 1.68 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.38 110.146 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.491 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -72.19 145.87 44.85 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.027 1.541 . . . . 0.4 109.489 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.3 Cg_endo -72.48 86.43 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.831 1.438 . . . . 0.32 110.35 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.49 -98.55 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.591 -1.404 . . . . 0.32 109.591 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.61 -166.39 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.47 110.573 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -69.67 -6.58 32.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.63 110.343 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 26.46 10.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.33 -0.856 . . . . 0.53 109.891 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -106.34 176.94 22.02 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.082 -1.607 . . . . 0.25 109.082 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.533 ' O ' HG13 ' A' ' 163' ' ' ILE . . . 45.3 25.33 1.16 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.226 -1.55 . . . . 0.1 109.226 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 196' ' ' GLY . 10.7 m-20 -78.79 87.49 4.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.1 110.026 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.946 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -69.72 97.99 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.09 109.895 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.512 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 41.4 m170 -115.27 129.47 56.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -0.876 . . . . 0.09 110.602 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.9 m-85 -96.79 139.25 33.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.085 -1.009 . . . . 0.1 110.365 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -47.78 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.14 108.544 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.7 p-10 -35.48 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.013 -0.675 . . . . 0.18 111.985 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 0.8 OUTLIER -76.66 -3.21 36.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.771 -1.205 . . . . 0.24 111.271 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 14.5 mm-40 -91.22 -164.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.031 -1.043 . . . . 0.42 110.171 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.446 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 16.0 m -127.88 150.95 49.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.47 110.223 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.56 ' C ' HG22 ' A' ' 208' ' ' THR . 1.2 m-90 -145.9 146.25 31.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.27 109.56 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.986 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -162.17 175.4 11.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.867 -1.145 . . . . 0.3 111.104 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.9 t -126.58 45.24 2.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.855 0.836 . . . . 0.61 109.037 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 211' ' ' SER . 11.0 t -127.38 -157.99 0.84 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.676 . . . . 0.78 110.035 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 p -97.62 27.92 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.91 110.349 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -145.09 150.13 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.93 110.013 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.1 -176.2 12.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.174 -1.57 . . . . 0.79 109.174 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.591 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 86.7 m-85 -65.33 139.6 58.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 0.69 109.565 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.619 ' O ' HG12 ' A' ' 219' ' ' VAL . 0.6 OUTLIER -108.32 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.061 -1.024 . . . . 0.4 108.678 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.986 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -39.08 -38.76 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.044 -0.662 . . . . 0.17 110.801 -178.874 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 136' ' ' LYS . 2.0 m-85 -50.62 -46.66 58.25 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.302 -1.359 . . . . 0.28 107.592 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.914 HD21 ' HB2' ' A' ' 244' ' ' TYR . 13.4 tp -80.72 -72.86 0.4 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.707 -0.678 . . . . 0.46 110.908 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -46.1 -57.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.39 110.395 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.36 -49.56 77.33 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.336 -0.852 . . . . 0.17 111.385 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.23 -27.07 65.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.338 -1.476 . . . . 0.1 108.998 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.632 ' CA ' HD21 ' A' ' 239' ' ' LEU . 4.0 t60 -76.53 -56.17 4.87 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.305 0.574 . . . . 0.21 109.768 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.643 ' OE1' ' HB1' ' A' ' 199' ' ' ALA . 34.7 tt0 -58.43 -39.28 79.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.126 -0.983 . . . . 0.28 109.015 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 220' ' ' ALA . 0.4 OUTLIER -60.47 -62.39 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.18 109.005 178.648 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.83 -29.71 0.86 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.701 -1.76 . . . . 0.21 108.701 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.48 ' CE1' ' HA ' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.43 -66.05 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -1.122 . . . . 0.17 110.884 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.959 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -40.78 -42.91 1.89 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.443 -0.786 . . . . 0.33 111.691 -178.945 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.75 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -100.27 -37.87 8.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.772 -1.205 . . . . 0.53 110.942 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -67.91 -85.74 0.1 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.255 -1.138 . . . . 0.41 110.255 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -170.23 -163.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.066 -1.255 . . . . 0.45 111.05 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.451 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -59.03 -55.78 30.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.765 . . . . 0.62 110.329 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -161.72 -179.69 7.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.937 . . . . 0.45 110.802 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 1.2 t 179.35 56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.714 -0.616 . . . . 0.38 109.474 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.672 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -139.25 26.36 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.48 110.862 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.519 ' N ' ' HD2' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -34.03 -52.6 0.89 Allowed Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 120.005 -0.678 . . . . 0.38 110.273 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 235' ' ' ASP . 50.2 Cg_endo -75.25 -56.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.634 1.334 . . . . 0.28 110.12 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.62 37.22 0.05 OUTLIER Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.328 -1.415 . . . . 0.24 111.655 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.672 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -69.9 171.97 8.49 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.389 -1.653 . . . . 0.28 111.009 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.632 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.21 58.79 1.29 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.938 0.875 . . . . 0.4 109.148 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.622 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.6 mmt -138.07 -33.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.45 110.519 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.642 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -52.62 169.93 0.26 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.57 110.344 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 44.7 Cg_endo -72.17 -1.42 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.592 1.312 . . . . 0.76 110.369 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 4.1 mt -111.97 141.96 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.89 109.965 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.914 ' HB2' HD21 ' A' ' 218' ' ' LEU . 22.4 p90 -130.15 -19.66 3.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.151 -0.968 . . . . 0.78 111.201 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 4.46 -76.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 113.006 0.743 . . . . 0.61 113.006 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.694 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -45.49 121.09 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.498 -1.376 . . . . 0.74 109.612 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 0.6 OUTLIER -71.14 157.96 37.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.828 . . . . 0.81 110.228 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.87 -22.09 4.16 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.528 -1.429 . . . . 0.56 109.528 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -131.07 31.56 4.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -1.154 . . . . 0.37 110.744 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.407 ' HB2' ' H ' ' A' ' 247' ' ' THR . 1.6 t -76.28 -69.5 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.806 -1.184 . . . . 0.44 110.114 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' HIS . . . . . 0.537 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 2.4 t60 -116.73 -60.09 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.53 110.338 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.2 OUTLIER 179.85 -169.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.977 . . . . 0.38 110.898 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.927 ' HB2' HG21 ' A' ' 259' ' ' VAL . 26.0 ptp -64.92 55.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.998 -0.439 . . . . 0.19 110.658 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.727 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -45.38 -46.96 35.16 Favored Pre-proline 0 N--CA 1.484 1.238 0 N-CA-C 107.897 -1.149 . . . . 0.28 107.897 177.317 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.3 Cg_endo -71.42 48.72 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.901 1.474 . . . . 0.49 111.194 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.588 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 7.7 m-20 -49.29 -32.54 11.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.887 -1.133 . . . . 0.49 110.325 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.626 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.96 -50.69 70.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.966 -1.093 . . . . 0.31 108.974 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.023 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -68.54 -35.13 77.0 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.257 -0.977 . . . . 0.14 108.672 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.927 HG21 ' HB2' ' A' ' 253' ' ' MET . 53.6 t -66.49 -86.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.17 110.543 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.587 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 10.0 tt0 -53.77 -39.62 65.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 0.26 109.631 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 265' ' ' LEU . . . -45.9 -70.83 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.354 -1.098 . . . . 0.19 110.354 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.023 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -69.96 -20.65 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.22 109.89 -179.538 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.968 ' N ' HD13 ' A' ' 262' ' ' ILE . 11.0 tp60 -58.87 -25.99 63.83 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.722 -1.191 . . . . 0.39 107.821 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 25.5 t -103.07 -43.05 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.308 0.575 . . . . 0.47 110.857 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 261' ' ' GLY . 1.6 mt -72.52 -53.06 13.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.48 111.054 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.796 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -80.13 -8.1 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.41 110.291 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.0 -100.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.103 -1.599 . . . . 0.46 109.103 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.33 132.74 13.98 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.967 1.509 . . . . 0.58 110.088 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -98.37 140.88 15.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.737 -1.345 . . . . 0.64 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.614 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -89.81 -64.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -1.15 . . . . 0.95 109.903 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.556 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 5.1 tm-20 45.35 24.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 1.2 110.146 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -152.25 84.98 4.69 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 1.2 110.235 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 274' ' ' ASN . 44.5 Cg_endo -72.98 -1.21 10.15 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.048 1.552 . . . . 1.06 110.515 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 273' ' ' PRO . 2.9 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.013 -0.994 . . . . 0.78 110.239 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.025 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.566 ' HE1' ' CA ' ' A' ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.858 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.345 0.593 . . . . 0.41 110.263 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -145.95 138.7 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.299 -0.876 . . . . 0.26 110.169 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.8 m -133.87 155.38 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.33 110.193 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -52.29 152.07 6.5 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.65 110.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.57 -85.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.143 1.602 . . . . 0.84 110.807 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.476 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 18.8 mtp180 48.26 65.37 1.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.93 109.825 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.528 ' HA ' HD13 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -141.93 -58.05 0.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.507 -0.746 . . . . 1.03 109.439 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.6 mt 40.05 31.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 1.04 111.017 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.798 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -119.97 76.68 1.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.77 109.74 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.578 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 23.5 t90 -140.92 -71.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.42 110.54 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.465 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 4.6 t -103.48 54.0 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.44 110.326 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.743 ' HD3' HD11 ' A' ' 118' ' ' LEU . 59.6 mmtt -136.54 46.65 2.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.49 110.311 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.573 ' O ' ' HE3' ' A' ' 116' ' ' MET . 1.1 ttp -82.47 -15.34 52.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.296 -0.878 . . . . 0.3 109.989 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 17.3 p30 -140.17 115.52 9.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.831 . . . . 0.15 110.077 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 1.0 HD22 HD11 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -138.76 176.2 8.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.13 110.108 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 154' ' ' THR . 0.9 OUTLIER -123.64 162.04 23.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.12 109.992 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.784 ' HB2' HD13 ' A' ' 163' ' ' ILE . 16.0 p90 -164.66 167.7 18.85 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.199 -1.0 . . . . 0.33 111.285 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -120.45 151.83 38.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.416 -0.803 . . . . 0.54 109.875 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.801 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.5 pp -109.47 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.862 . . . . 0.33 110.989 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.952 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.8 m -143.63 43.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.27 110.396 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 4.0 t30 -42.04 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.41 109.303 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.691 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.9 t80 -179.69 -167.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.4 109.68 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.7 OUTLIER -150.97 50.07 0.66 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.45 110.533 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -75.76 -84.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.838 1.441 . . . . 0.36 110.508 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.71 -0.25 51.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.25 109.998 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -115.99 163.57 15.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.39 110.007 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.17 168.68 9.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.48 110.049 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -43.6 -32.83 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.4 110.04 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -64.4 -46.32 83.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.46 109.512 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 12.5 mt-10 -67.23 -57.5 6.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.138 -0.976 . . . . 0.47 109.66 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 125' ' ' TYR . 17.5 t -45.33 -32.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.95 -1.13 . . . . 0.31 107.95 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.7 mt-10 -63.55 -44.54 93.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.078 -1.082 . . . . 0.48 108.078 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.2 ttmt -68.56 -49.07 62.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.24 -0.984 . . . . 0.64 108.651 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.831 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.39 -59.75 2.76 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.212 -0.93 . . . . 0.42 110.245 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.68 -53.78 30.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.34 110.825 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.63 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.18 -73.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.47 110.335 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtt? -38.63 -60.63 0.8 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.865 -0.522 . . . . 0.47 110.603 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.38 -38.71 13.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.676 -1.265 . . . . 0.25 108.528 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -71.68 -29.68 64.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.368 -0.832 . . . . 0.35 109.079 178.797 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 140' ' ' LYS . 6.1 ttmm -61.24 -44.91 96.5 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.19 -1.041 . . . . 0.7 108.19 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 6.5 t -63.61 -43.35 98.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.7 -0.852 . . . . 0.61 108.7 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.628 ' O ' HG22 ' A' ' 148' ' ' VAL . 46.2 t-105 -56.35 -44.4 80.05 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.79 -0.819 . . . . 0.39 108.79 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 149' ' ' THR . 9.6 m -64.66 -32.12 73.65 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.35 108.886 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -62.72 -36.57 83.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.521 -0.737 . . . . 0.36 109.334 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 145' ' ' TRP . 35.3 m -89.17 -11.56 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -0.85 . . . . 0.5 110.534 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 146' ' ' SER . 14.9 t -175.92 132.67 0.42 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.927 -1.108 . . . . 0.51 110.247 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.04 60.1 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.866 1.456 . . . . 0.31 110.804 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 ' CG ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -72.32 129.63 38.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.18 109.879 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.19 124.73 33.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.17 110.191 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.535 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -136.27 155.85 49.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.14 110.508 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.567 ' O ' HG22 ' A' ' 119' ' ' THR . 34.5 m -152.81 132.11 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.15 110.222 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.57 ' HD3' HG23 ' A' ' 122' ' ' ILE . 0.8 OUTLIER -101.55 91.21 4.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.978 . . . . 0.2 110.123 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.5 94.32 7.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.22 110.286 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 158' ' ' ASP . 14.3 p-80 -52.71 -25.85 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.32 109.867 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' HIS . 1.5 t70 -41.53 -62.79 0.81 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.468 0.652 . . . . 0.33 109.679 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.58 34.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.888 -1.285 . . . . 0.28 109.888 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 119' ' ' THR . 22.6 mm -126.5 69.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.065 -1.256 . . . . 0.3 109.108 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -127.91 136.9 51.99 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.001 -0.68 . . . . 0.2 110.572 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.33 -35.81 3.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.1 110.269 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 1.047 HG21 HD13 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -126.82 163.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.294 -0.879 . . . . 0.1 109.511 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.806 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 6.5 ptm -172.77 156.19 3.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.208 -1.558 . . . . 0.11 111.727 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 122' ' ' ILE . 4.5 tt -98.43 114.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.654 -0.654 . . . . 0.1 109.447 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.952 ' HB3' HG23 ' A' ' 123' ' ' VAL . 80.9 p -155.85 151.61 27.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 0.1 110.92 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -72.45 119.15 16.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.522 -0.736 . . . . 0.09 109.826 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -77.87 129.31 9.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.219 -1.152 . . . . 0.2 110.219 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.5 tt -126.18 98.55 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.614 -0.933 . . . . 0.55 109.634 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.596 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 1.2 tmtt? 1.15 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.589 0.588 . . . . 0.85 112.589 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 20.21 0.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.71 110.282 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -93.31 -88.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.42 110.268 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.29 -20.96 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.325 -1.51 . . . . 0.33 109.325 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.68 -66.91 0.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -1.062 . . . . 0.33 110.339 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 175' ' ' PHE . 23.4 p90 -148.24 163.51 36.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.27 110.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.0 m-30 -69.24 114.95 27.37 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.34 110.186 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.5 ' O ' HD23 ' A' ' 184' ' ' LEU . 44.1 Cg_endo -77.07 -72.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.857 1.451 . . . . 0.47 110.784 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -54.2 146.87 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.35 110.422 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 179' ' ' ASP . 44.4 p-10 -178.08 76.82 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.2 110.459 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 53.18 -169.39 0.88 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.121 -1.591 . . . . 0.25 109.121 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.513 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.3 Cg_endo -78.28 10.05 2.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.042 1.548 . . . . 0.44 110.478 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 184' ' ' LEU . 28.5 t -47.59 177.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.57 110.915 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.538 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.02 76.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.479 -1.048 . . . . 0.49 110.479 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.889 ' HA ' HG13 ' A' ' 1' ' ' HAV . 5.0 tp 179.47 87.68 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.369 -1.077 . . . . 0.41 109.767 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.859 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.4 tt -109.84 -23.47 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.901 -1.124 . . . . 0.3 111.42 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.602 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.5 101.84 2.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.517 -1.365 . . . . 0.2 111.935 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 2.2 p80 -100.76 120.84 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.054 . . . . 0.16 110.016 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.78 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -102.64 132.45 48.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.23 110.179 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.468 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-30 -78.91 168.92 23.19 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.38 110.421 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 48.0 Cg_endo -73.68 125.47 10.05 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.994 1.523 . . . . 0.4 109.553 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.25 68.22 1.41 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.897 1.472 . . . . 0.32 110.6 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.36 -86.23 1.4 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.366 -1.494 . . . . 0.32 109.366 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 -164.46 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.072 1.564 . . . . 0.47 110.367 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.6 m-20 -74.22 -0.89 18.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.63 110.386 -179.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.89 48.67 1.19 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.53 110.162 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -124.32 177.37 16.79 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.313 -1.515 . . . . 0.25 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 46.79 22.74 1.22 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.902 -1.279 . . . . 0.1 109.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.88 86.58 6.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -1.211 . . . . 0.1 109.745 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -61.58 97.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.143 -0.973 . . . . 0.09 110.057 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 14.1 m170 -107.34 126.73 52.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.09 110.341 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.5 m-85 -99.0 132.58 44.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.173 -0.954 . . . . 0.1 110.529 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.651 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -46.74 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.834 -0.802 . . . . 0.14 108.834 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.52 -27.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.18 111.638 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.537 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 19.6 m-20 -77.17 3.15 13.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.622 -1.299 . . . . 0.24 110.731 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.859 ' OE1' HD12 ' A' ' 185' ' ' LEU . 17.2 mm-40 -98.41 -167.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.934 -1.104 . . . . 0.42 110.41 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . 0.532 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -124.94 151.72 45.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.47 110.177 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.1 m-90 -148.95 144.52 26.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.27 109.911 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.986 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.57 170.17 21.42 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.958 -1.089 . . . . 0.3 110.638 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.464 ' HB2' HD23 ' A' ' 216' ' ' LEU . 1.1 t -129.58 26.98 5.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.822 -0.807 . . . . 0.61 108.822 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -95.26 -94.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.715 -0.615 . . . . 0.78 110.296 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.483 ' N ' ' OG ' ' A' ' 210' ' ' SER . 18.0 p -156.78 20.96 0.33 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.91 109.8 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 213' ' ' GLY . 5.4 mttm -141.94 -177.16 5.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.439 -0.788 . . . . 0.93 110.134 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 43.68 -166.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.385 -1.486 . . . . 0.79 109.385 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.476 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 73.7 m-85 -73.75 120.54 19.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.69 109.793 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.589 ' O ' HG12 ' A' ' 219' ' ' VAL . 57.2 m-80 -84.52 120.05 25.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.963 -1.086 . . . . 0.4 108.856 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.986 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.33 -37.2 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.17 110.439 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 3.1 m-30 -51.33 -47.79 62.59 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 118.619 -1.232 . . . . 0.28 107.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.946 HD11 ' HH1' ' A' ' 3' ' ' MSB . 7.3 tp -77.0 -70.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.9 -0.591 . . . . 0.46 110.605 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -48.89 -66.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.944 -1.097 . . . . 0.39 109.808 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -46.57 -48.55 19.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.111 -0.993 . . . . 0.17 111.077 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -58.59 -45.43 89.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.323 -1.485 . . . . 0.1 108.764 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.851 ' HB2' HD11 ' A' ' 239' ' ' LEU . 2.7 t-160 -58.08 -54.52 45.99 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.415 0.626 . . . . 0.21 109.811 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 188' ' ' ALA . 24.6 tp10 -58.5 -57.12 14.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.28 109.156 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.835 ' CE1' HD11 ' A' ' 163' ' ' ILE . 3.3 m-85 -43.73 -57.89 2.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.18 109.016 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.799 ' HA3' ' HE1' ' A' ' 240' ' ' MET . . . -46.96 -35.04 7.76 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.421 -1.472 . . . . 0.21 109.421 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.755 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.1 OUTLIER -81.8 -67.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.095 -1.238 . . . . 0.17 111.08 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.78 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -38.08 -42.95 0.7 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.46 -0.775 . . . . 0.33 111.726 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 163' ' ' ILE . 2.1 tp -99.95 -36.72 9.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.815 -1.178 . . . . 0.53 110.753 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.59 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -64.99 -79.71 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.3 -1.12 . . . . 0.41 110.3 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.609 HD11 ' O ' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -177.37 -152.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.45 110.896 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -50.67 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.62 110.199 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.755 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.2 OUTLIER -175.19 169.15 3.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.45 110.017 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.9 p -169.31 53.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.38 109.229 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.99 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.2 OUTLIER -139.33 25.14 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.48 111.525 -178.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.545 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -39.39 -51.06 4.8 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.38 110.428 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 53.2 Cg_endo -81.03 -52.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.571 1.301 . . . . 0.28 110.687 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 176.75 101.72 0.15 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.2 -1.476 . . . . 0.24 111.508 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.99 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -139.4 177.4 7.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.261 -1.141 . . . . 0.28 109.65 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 222' ' ' HIS . 2.0 tp -67.8 -3.98 11.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.065 -1.022 . . . . 0.4 109.86 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.799 ' HE1' ' HA3' ' A' ' 225' ' ' GLY . 6.4 mmt -94.91 -6.81 41.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.45 111.709 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -53.8 169.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.768 -1.208 . . . . 0.57 110.681 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.532 ' O ' ' CG1' ' A' ' 243' ' ' ILE . 49.5 Cg_endo -80.22 43.0 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.662 1.349 . . . . 0.76 110.055 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 242' ' ' PRO . 9.0 mt -161.01 144.38 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.797 -0.816 . . . . 0.89 108.797 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.607 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 53.7 p90 -124.97 -34.15 2.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.965 -1.084 . . . . 0.78 110.057 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.558 ' C ' ' O ' ' A' ' 244' ' ' TYR . 15.7 m 2.9 -70.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.831 0.678 . . . . 0.61 112.831 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.581 ' CE2' ' HD3' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -61.34 106.96 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.632 -1.292 . . . . 0.74 108.977 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.455 ' N ' ' HB2' ' A' ' 250' ' ' SER . 0.2 OUTLIER -47.03 174.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.81 110.263 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.31 -16.5 27.87 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.037 -1.625 . . . . 0.56 109.037 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -146.89 31.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.37 110.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.455 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -56.56 -19.22 14.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.44 110.144 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -170.97 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.53 110.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.491 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -177.92 177.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.38 111.019 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -71.32 56.68 0.24 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.64 -0.663 . . . . 0.19 110.903 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.729 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.0 OUTLIER -43.82 -47.07 20.79 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.019 -1.104 . . . . 0.28 108.019 177.182 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.5 Cg_endo -71.29 50.89 1.3 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.983 1.518 . . . . 0.49 111.085 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.629 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 15.1 m-20 -54.56 -28.77 48.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.021 -1.05 . . . . 0.49 111.192 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.94 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -54.38 -46.3 73.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.726 -1.234 . . . . 0.31 109.396 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.025 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.07 -32.02 56.5 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.297 -1.001 . . . . 0.14 108.297 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.991 HG21 ' HB2' ' A' ' 253' ' ' MET . 66.7 t -61.25 -76.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.661 -0.816 . . . . 0.17 110.269 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.632 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.3 tt0 -65.78 -42.26 90.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.101 -0.999 . . . . 0.26 109.434 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.38 -63.44 1.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.129 -1.189 . . . . 0.19 110.129 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.025 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -77.75 -20.49 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.762 -1.434 . . . . 0.22 110.395 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.844 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -59.72 -25.98 65.25 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.795 -1.19 . . . . 0.39 108.028 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.0 m -104.38 -33.54 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.145 -0.622 . . . . 0.47 111.764 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 112' ' ' LYS . 2.2 mm? -90.08 -44.99 9.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.075 -1.015 . . . . 0.48 111.563 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.885 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -85.09 -11.28 55.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.41 110.647 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.3 -110.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.516 . . . . 0.46 109.311 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.66 93.78 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.809 1.426 . . . . 0.58 110.353 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 113' ' ' TRP . . . -79.18 156.08 41.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.44 -1.464 . . . . 0.64 109.44 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.578 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 38.0 t0 -76.34 -66.08 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -1.151 . . . . 0.95 110.396 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.465 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 6.9 tt0 56.12 27.39 11.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 1.2 110.229 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -153.32 161.68 28.5 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.275 -0.891 . . . . 1.2 110.051 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 274' ' ' ASN . 44.7 Cg_endo -72.68 66.49 3.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.97 1.511 . . . . 1.06 110.332 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 273' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.025 -0.988 . . . . 0.78 110.221 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.889 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.568 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.946 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.239 0.543 . . . . 0.41 110.177 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.25 99.83 6.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.26 110.213 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.1 -37.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.33 110.222 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -121.41 87.89 45.49 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.65 110.324 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.7 Cg_endo -73.1 -159.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.003 1.528 . . . . 0.84 110.296 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.774 ' O ' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER 67.73 82.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.93 110.201 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p -143.36 -60.07 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 1.03 109.568 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 0.3 OUTLIER 38.21 42.53 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.577 . . . . 1.04 111.126 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.867 ' CD ' HD23 ' A' ' 265' ' ' LEU . 1.2 ptpt -134.3 66.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.77 109.303 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.616 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 12.3 t90 -140.37 -65.15 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.42 110.822 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 36.1 t -103.69 56.41 0.74 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.44 111.09 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 114' ' ' SER . 30.4 mmtt -150.9 45.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.028 -1.045 . . . . 0.49 110.476 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.556 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 2.0 ttp -81.66 -1.9 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.3 110.458 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.566 ' O ' HD12 ' A' ' 118' ' ' LEU . 2.4 p-10 -148.51 119.53 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.15 110.012 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.862 HD22 HD11 ' A' ' 228' ' ' LEU . 1.5 tp -152.13 174.3 13.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.13 110.493 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -118.2 159.46 23.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.12 110.256 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.864 ' HB3' HG23 ' A' ' 163' ' ' ILE . 20.1 p90 -154.35 170.22 21.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.616 -0.834 . . . . 0.33 110.591 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 147.39 49.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.54 110.12 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.863 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -107.09 125.05 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.33 110.929 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.907 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.3 m -167.19 43.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.27 109.768 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.514 ' OD1' ' CE ' ' A' ' 129' ' ' MET . 1.0 OUTLIER -40.07 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.41 109.429 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.538 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 19.9 t80 -178.46 -178.62 0.62 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 0.4 109.641 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -119.7 48.2 1.12 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.917 -1.114 . . . . 0.45 110.664 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -71.28 -87.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.11 1.584 . . . . 0.36 110.52 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -108.41 -15.09 14.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 0.25 109.909 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.583 ' CB ' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -111.24 104.95 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.39 109.548 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -51.46 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.48 110.593 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.58 -39.35 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.4 110.209 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -55.45 -57.82 10.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.46 109.668 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.583 ' CB ' ' CB ' ' A' ' 129' ' ' MET . 2.2 mp0 -55.72 -56.75 16.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.47 109.256 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 125' ' ' TYR 0.253 5.1 t -44.47 -35.46 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.016 -1.105 . . . . 0.31 108.016 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 132' ' ' SER . 5.0 tt0 -59.47 -44.43 93.02 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.888 -1.153 . . . . 0.48 107.888 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.8 tttp -68.22 -44.0 76.71 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.581 -0.896 . . . . 0.64 108.581 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -47.96 -58.53 4.3 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.205 -0.934 . . . . 0.42 109.893 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -69.92 -51.76 30.28 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.704 -0.798 . . . . 0.34 110.701 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.623 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 10.8 tttt -64.22 -73.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 0.47 109.993 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -39.14 -60.84 0.83 Allowed 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.837 -0.539 . . . . 0.47 110.693 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.88 -37.4 8.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.665 -1.214 . . . . 0.25 108.519 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -73.23 -34.27 65.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.781 . . . . 0.35 109.217 178.827 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -56.36 -40.68 74.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.269 -1.011 . . . . 0.7 108.269 178.957 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 4.1 t -69.25 -44.58 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.893 -0.78 . . . . 0.61 108.893 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.652 ' O ' HG22 ' A' ' 148' ' ' VAL . 27.4 t-105 -54.71 -42.66 71.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.464 -0.773 . . . . 0.39 109.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 149' ' ' THR . 20.0 m -70.37 -33.41 71.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.81 . . . . 0.35 108.929 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -58.1 -36.48 72.94 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.612 -0.68 . . . . 0.36 109.457 179.267 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.827 HG23 HG22 ' A' ' 149' ' ' THR . 34.7 m -86.9 -29.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.5 110.634 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.827 HG22 HG23 ' A' ' 148' ' ' VAL . 5.2 t -153.04 135.93 9.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.869 -1.144 . . . . 0.51 110.526 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.88 58.1 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.986 1.519 . . . . 0.31 110.644 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -80.15 136.52 36.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 0.18 110.076 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 9.3 t30 -88.08 126.11 34.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.17 110.391 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.79 139.52 45.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.14 110.207 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.642 ' O ' HG22 ' A' ' 119' ' ' THR . 11.5 m -141.47 137.57 32.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.15 110.369 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.549 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.6 130.77 47.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 0.2 109.677 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.803 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -128.43 105.7 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.22 110.193 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.426 ' O ' ' C ' ' A' ' 158' ' ' ASP . 11.2 p80 -54.54 -33.8 60.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.32 110.075 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.602 ' OD2' HD11 ' A' ' 160' ' ' ILE . 1.3 t70 -42.25 -42.38 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.589 -0.694 . . . . 0.33 109.869 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.57 33.77 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.442 -1.463 . . . . 0.28 109.442 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.803 HD12 ' CD2' ' A' ' 156' ' ' LEU . 6.7 mt -116.15 75.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.286 -1.126 . . . . 0.3 109.631 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 120' ' ' TYR . . . -143.6 147.78 34.89 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.528 -0.732 . . . . 0.2 110.403 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 -18.22 14.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.1 110.285 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.864 HG23 ' HB3' ' A' ' 120' ' ' TYR . 1.2 tt -136.07 166.93 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.153 -0.967 . . . . 0.1 110.077 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.746 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 6.9 ptp -171.38 146.38 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.288 . . . . 0.11 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.4 tt -98.72 119.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.423 -0.798 . . . . 0.1 110.082 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.907 ' HB3' HG23 ' A' ' 123' ' ' VAL . 14.9 p -161.8 158.58 25.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.965 -1.084 . . . . 0.1 110.82 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 18.6 p90 -76.41 122.46 24.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.09 110.061 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.462 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -78.19 134.8 14.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.023 -1.231 . . . . 0.2 110.023 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 169' ' ' ILE . 1.3 tt -130.17 98.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.977 . . . . 0.55 109.702 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.4 OUTLIER 1.09 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 121.359 0.6 . . . . 0.85 112.266 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -141.52 7.0 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.71 110.215 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.411 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 12.8 m-70 -77.98 -51.61 10.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.42 110.002 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 94.65 39.38 4.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.433 -1.467 . . . . 0.33 109.433 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.24 -51.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -1.095 . . . . 0.33 110.036 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.86 159.28 16.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.27 110.135 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 14.5 m-30 -113.0 85.27 7.75 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.34 110.097 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.474 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 46.3 Cg_endo -73.69 -57.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.993 1.523 . . . . 0.47 110.386 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.61 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -57.96 135.37 56.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.35 110.698 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.483 ' N ' ' OD2' ' A' ' 204' ' ' ASP . 3.2 p30 179.97 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.206 -0.997 . . . . 0.2 111.602 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.2 -161.33 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.247 -1.141 . . . . 0.25 110.247 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.511 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.6 Cg_endo -80.11 44.01 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.086 1.572 . . . . 0.44 110.157 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.7 m -81.08 177.66 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.095 -1.003 . . . . 0.57 110.231 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.513 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.74 71.32 0.03 OUTLIER Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.892 -1.283 . . . . 0.49 109.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 0.992 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.7 OUTLIER 179.58 95.31 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.303 -1.116 . . . . 0.41 110.202 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.484 ' HB3' ' OB2' ' A' ' 3' ' ' MSB . 6.7 tt -114.0 -18.41 11.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.708 -1.245 . . . . 0.3 111.375 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.934 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -151.0 105.76 3.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.493 -1.379 . . . . 0.2 112.001 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.604 ' CD2' ' HB2' ' A' ' 200' ' ' HIS . 0.5 OUTLIER -115.08 119.81 37.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.16 109.485 178.797 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.877 ' HB2' ' CD ' ' A' ' 223' ' ' GLU . . . -109.68 142.03 41.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.981 -1.075 . . . . 0.23 110.691 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.463 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -72.56 168.94 19.34 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.38 110.327 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 189' ' ' PHE . 46.6 Cg_endo -74.69 137.87 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.4 109.502 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.473 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.3 Cg_endo -70.8 82.1 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.85 1.447 . . . . 0.32 110.569 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 -99.72 1.29 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.396 -1.482 . . . . 0.32 109.396 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.94 -162.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 0.47 110.241 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -65.58 -11.82 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.63 109.991 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.42 60.89 0.64 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.557 -0.714 . . . . 0.53 110.058 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -134.33 177.07 19.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.559 -1.816 . . . . 0.25 108.559 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.83 25.88 0.25 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.808 -1.317 . . . . 0.1 109.808 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 196' ' ' GLY . 72.7 m-20 -79.71 91.77 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.962 -1.316 . . . . 0.1 109.898 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -67.38 111.69 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.09 110.421 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 31.2 m170 -121.6 126.43 49.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 0.09 110.2 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 203' ' ' ASP . 23.2 m-85 -98.1 137.63 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.939 -1.1 . . . . 0.1 110.674 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.731 ' OD1' HD23 ' A' ' 184' ' ' LEU . 1.1 m-20 -49.19 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.14 108.889 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.576 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 1.4 p30 -35.94 -30.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.772 . . . . 0.18 111.663 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 9.4 m-20 -79.06 2.07 21.92 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.59 -1.319 . . . . 0.24 111.245 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 29.4 mm-40 -95.95 -162.51 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.982 -1.074 . . . . 0.42 110.155 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.8 m -125.81 148.53 49.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.112 -0.992 . . . . 0.47 110.529 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.576 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.5 m-90 -142.27 142.85 32.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.267 -0.896 . . . . 0.27 109.785 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 208' ' ' THR . . . . . 1.028 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -155.37 174.3 15.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.954 -1.091 . . . . 0.3 110.722 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.1 t -129.27 21.97 5.66 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.649 -0.871 . . . . 0.61 108.649 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.4 OUTLIER -99.2 -81.47 0.45 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.712 0.767 . . . . 0.78 110.376 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.7 p -171.77 -35.32 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.958 -0.756 . . . . 0.91 108.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -80.06 139.81 36.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.469 -0.769 . . . . 0.93 109.538 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.04 -154.96 32.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.935 -1.666 . . . . 0.79 108.935 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.491 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 60.0 m-85 -93.77 117.25 29.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.243 . . . . 0.69 109.555 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.62 ' O ' HG12 ' A' ' 219' ' ' VAL . 46.9 m-80 -81.4 122.4 27.44 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.946 -1.096 . . . . 0.4 109.028 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 1.028 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -42.28 -37.42 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.17 109.937 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 2.3 m-30 -51.98 -48.74 64.23 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.423 -1.325 . . . . 0.28 107.423 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -73.34 -73.57 0.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.819 -0.628 . . . . 0.46 109.906 178.464 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.6 OUTLIER -47.77 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.39 110.043 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -41.61 -51.28 4.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.735 -1.228 . . . . 0.17 111.484 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.91 -33.51 71.96 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.249 -1.532 . . . . 0.1 109.045 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.638 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.3 t60 -71.63 -58.6 3.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.311 0.577 . . . . 0.21 109.564 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.934 ' CG ' ' HB1' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -55.87 -25.04 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.62 -0.882 . . . . 0.28 108.62 178.525 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.7 m-30 -72.11 -67.65 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.6 0.714 . . . . 0.18 109.261 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.43 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.98 -27.25 0.99 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.646 -1.782 . . . . 0.21 108.646 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.584 ' CE1' ' HG2' ' A' ' 240' ' ' MET . 0.0 OUTLIER -80.98 -58.41 3.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -1.085 . . . . 0.17 110.348 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.772 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.4 OUTLIER -47.74 -45.39 28.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.668 -0.645 . . . . 0.33 111.794 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.862 HD11 HD22 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -100.54 -38.15 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.02 . . . . 0.53 111.044 -178.75 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -63.96 -77.2 0.24 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.043 -1.223 . . . . 0.41 110.043 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 0.774 HD12 ' O ' ' A' ' 109' ' ' ARG . 1.7 pt? -177.14 -162.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.187 . . . . 0.45 110.488 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.5 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.2 OUTLIER -62.5 -54.6 37.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.62 109.904 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.63 ' O ' HD11 ' A' ' 230' ' ' LEU . 2.2 m80 -163.71 178.26 8.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.45 110.379 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 2.5 t 179.59 60.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.38 109.122 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.881 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -144.61 22.13 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.589 -0.844 . . . . 0.48 111.174 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.525 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -37.12 -49.13 2.19 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.759 -0.776 . . . . 0.38 110.775 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 47.1 Cg_endo -89.41 -46.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.738 1.389 . . . . 0.28 111.586 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.66 98.88 0.12 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 118.971 -1.585 . . . . 0.24 111.91 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.881 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -149.22 165.5 31.69 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.39 -1.065 . . . . 0.28 110.012 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.617 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -79.32 55.63 1.93 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.4 108.837 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.638 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 14.0 mtt -137.96 -24.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.81 . . . . 0.45 110.998 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -60.05 171.35 0.93 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.7 -1.25 . . . . 0.57 109.962 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.8 Cg_endo -69.48 -4.69 14.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.377 1.198 . . . . 0.76 110.128 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 10.2 mm -100.43 148.47 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.89 109.689 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.84 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 35.0 p90 -133.35 -27.46 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.095 -1.003 . . . . 0.78 111.174 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.729 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 3.27 -69.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.642 0.978 . . . . 0.61 113.642 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.729 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -66.32 129.82 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.348 -1.47 . . . . 0.74 109.676 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -161.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.81 110.202 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.474 ' O ' ' CG ' ' A' ' 249' ' ' LYS . . . -86.93 10.89 66.39 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.427 -1.469 . . . . 0.56 109.427 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -177.59 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.37 110.37 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -32.88 73.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 0.44 110.167 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.79 -88.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.53 110.174 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -164.18 92.59 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 0.38 110.387 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.762 ' HB2' HG21 ' A' ' 259' ' ' VAL . 3.1 ptt? 36.09 47.77 0.48 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.544 -0.722 . . . . 0.19 111.596 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.704 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.9 tp -47.65 -44.69 56.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.862 -1.135 . . . . 0.28 107.958 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -73.1 49.62 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.646 1.34 . . . . 0.49 111.055 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.604 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.6 m-20 -47.48 -32.41 5.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.754 -1.216 . . . . 0.49 110.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.875 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -55.57 -49.81 71.72 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.131 -0.981 . . . . 0.31 109.821 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 1.011 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.66 -32.08 63.8 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.448 -0.901 . . . . 0.14 108.615 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 253' ' ' MET . 71.1 t -66.72 -82.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.17 110.061 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.0 tt0 -55.92 -40.9 73.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.306 -0.871 . . . . 0.26 109.247 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.29 -70.65 0.45 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.113 -1.195 . . . . 0.19 110.113 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 1.011 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -74.24 -21.01 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.952 -1.322 . . . . 0.22 110.342 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 1.006 ' N ' HD13 ' A' ' 262' ' ' ILE . 47.7 tt0 -64.05 -20.36 65.88 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.904 -1.118 . . . . 0.39 108.422 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 18.8 t -103.42 -42.45 5.7 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.249 -0.58 . . . . 0.47 111.347 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.867 HD23 ' CD ' ' A' ' 112' ' ' LYS . 4.2 mp -87.32 -45.64 10.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.141 -0.974 . . . . 0.48 111.202 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.655 ' OH ' HD12 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -79.08 -5.11 53.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.41 109.948 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.65 -72.28 0.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.608 -1.397 . . . . 0.46 109.608 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -86.9 142.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.987 1.52 . . . . 0.58 110.761 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.556 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -105.46 121.76 6.95 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.498 -1.441 . . . . 0.64 109.498 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.616 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -86.63 -69.62 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -1.231 . . . . 0.95 110.149 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.522 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 0.5 OUTLIER 54.38 30.97 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 1.2 110.087 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -101.61 113.36 65.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 1.2 109.829 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 75.16 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.966 1.508 . . . . 1.06 110.576 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.986 -1.007 . . . . 0.78 110.179 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 0.992 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.569 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.84 ' HH2' ' CB ' ' A' ' 244' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.41 110.263 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.24 73.74 1.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.26 110.126 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 107' ' ' PHE . 11.9 t -96.95 176.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.33 110.3 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . 0.541 ' H ' HG12 ' A' ' 106' ' ' VAL . 50.1 m-85 -45.29 107.71 0.68 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.65 110.304 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 47.1 Cg_endo -73.83 114.49 4.05 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.994 1.523 . . . . 0.84 110.558 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 10.8 mtp180 -142.62 -48.49 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -0.816 . . . . 0.93 109.852 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' THR . . . . . 0.679 HG22 ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -28.9 -57.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.482 0.658 . . . . 1.03 111.488 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' CG ' ' A' ' 191' ' ' PRO . 0.7 OUTLIER 40.73 48.49 2.65 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.268 -0.895 . . . . 1.04 111.471 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.679 ' HE2' HG22 ' A' ' 110' ' ' THR . 4.1 pttt -146.82 79.07 1.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.77 109.113 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TRP . . . . . 0.616 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 7.6 t90 -143.89 -70.1 0.31 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.42 111.398 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 93.6 p -96.95 63.0 1.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.44 111.015 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 114' ' ' SER . 14.2 mttm -159.59 53.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.49 110.082 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' MET . . . . . 0.464 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -60.79 -19.89 60.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.3 110.408 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -138.34 156.2 47.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.15 110.446 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -166.09 -174.61 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.13 110.127 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' THR . . . . . 0.88 HG22 ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -128.47 149.26 50.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.181 -0.949 . . . . 0.12 110.11 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' TYR . . . . . 0.663 ' HB3' HG23 ' A' ' 163' ' ' ILE . 23.1 p90 -149.87 165.12 33.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -0.922 . . . . 0.33 111.18 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.2 OUTLIER -118.08 150.91 38.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.54 109.89 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ILE . . . . . 0.897 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -115.65 124.76 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.886 . . . . 0.33 110.543 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 123' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -168.76 43.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.27 109.932 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.3 t-20 -40.79 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.41 109.501 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TYR . . . . . 0.685 ' O ' HG21 ' A' ' 134' ' ' VAL . 3.7 t80 -179.35 -164.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.4 109.553 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 130' ' ' THR . 1.8 m -148.12 46.78 0.48 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.913 -1.117 . . . . 0.45 110.864 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -74.03 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.896 1.472 . . . . 0.36 110.109 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.26 -4.46 58.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.955 . . . . 0.25 109.689 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' MET . . . . . 0.781 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.2 ptm -122.85 171.87 8.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.39 110.107 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' THR . . . . . 0.592 ' HA ' HG23 ' A' ' 126' ' ' THR . 0.2 OUTLIER -119.66 171.63 8.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.48 109.768 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -45.74 -28.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.036 -1.04 . . . . 0.4 109.715 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -67.31 -58.28 5.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.46 109.464 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.4 mp0 -55.82 -55.32 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.24 -0.913 . . . . 0.47 108.775 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.9 t -46.19 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.826 -1.176 . . . . 0.31 107.826 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' GLU . . . . . 0.579 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 8.1 tt0 -59.37 -42.48 91.73 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.782 -1.192 . . . . 0.48 107.782 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.575 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 23.4 tttt -70.65 -47.59 59.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.185 0.993 . . . . 0.64 108.456 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.872 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -49.26 -62.22 1.66 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.566 -0.709 . . . . 0.42 110.217 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.636 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -66.89 -52.51 42.45 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.41 -0.806 . . . . 0.34 110.842 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 139' ' ' LYS . . . . . 0.636 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 1.0 OUTLIER -64.52 -72.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.976 -1.077 . . . . 0.47 110.555 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 140' ' ' LYS . . . . . 0.557 ' HD3' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -41.5 -58.68 1.83 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.581 -0.699 . . . . 0.47 110.383 179.254 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.81 -35.4 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.564 -1.254 . . . . 0.25 108.351 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.63 -39.35 64.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.443 -0.786 . . . . 0.35 109.117 178.823 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -56.03 -38.82 71.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.08 -1.012 . . . . 0.7 108.455 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.9 t -68.92 -45.28 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.112 -0.699 . . . . 0.61 109.112 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' TRP . . . . . 0.866 ' HH2' HG21 ' A' ' 262' ' ' ILE . 50.4 t-105 -57.11 -35.31 69.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.39 108.895 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.7 m -75.73 -39.64 56.94 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.327 -0.858 . . . . 0.35 108.788 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -40.74 72.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.36 109.51 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 149' ' ' THR . 27.6 m -75.78 -33.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.5 109.781 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 145' ' ' TRP . 9.9 t -147.2 147.33 28.44 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.168 -0.958 . . . . 0.51 110.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.67 58.69 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.948 1.499 . . . . 0.31 110.222 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 152' ' ' ASN . 1.4 tm? -84.0 139.46 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.18 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ASN . . . . . 0.946 ' N ' HD13 ' A' ' 151' ' ' LEU . 1.2 m-20 -104.26 139.2 39.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.17 110.118 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' PHE . . . . . 0.59 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 2.1 p90 -151.24 155.95 39.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.14 110.593 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.88 ' O ' HG22 ' A' ' 119' ' ' THR . 7.3 m -152.9 131.05 11.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.406 -0.809 . . . . 0.15 109.943 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ARG . . . . . 0.572 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 5.2 mtm180 -96.62 82.47 3.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.2 110.595 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.673 HD23 HD13 ' A' ' 160' ' ' ILE . 1.6 mp -74.98 83.34 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.155 -0.965 . . . . 0.22 109.71 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.7 p-80 -42.82 -26.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.32 110.16 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -41.14 -37.87 0.97 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.616 -0.677 . . . . 0.33 109.768 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.38 33.71 0.3 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.879 -1.288 . . . . 0.28 109.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ILE . . . . . 0.673 HD13 HD23 ' A' ' 156' ' ' LEU . 2.7 mp -127.83 65.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -1.223 . . . . 0.3 109.507 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ALA . . . . . 0.503 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -122.36 144.38 49.06 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.232 -0.587 . . . . 0.2 110.364 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 162' ' ' ASP . . . . . 0.426 ' HB2' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -107.6 -36.54 6.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.885 . . . . 0.1 110.205 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 227' ' ' SER . 0.4 OUTLIER -127.57 156.87 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.132 -0.98 . . . . 0.1 110.001 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' MET . . . . . 0.818 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 13.7 ptm -163.94 160.45 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.42 -1.425 . . . . 0.11 111.564 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . 0.671 ' O ' HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -106.75 119.41 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.46 -0.775 . . . . 0.1 109.985 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' SER . . . . . 0.872 ' HB3' HG23 ' A' ' 123' ' ' VAL . 11.6 p -158.68 146.01 17.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.1 110.389 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' PHE . . . . . 0.599 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 10.4 p90 -66.34 114.24 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.09 109.667 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -73.49 119.81 6.74 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.225 -1.15 . . . . 0.2 110.225 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -110.05 103.25 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.48 -1.012 . . . . 0.55 109.311 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 2.0 tmtt? 1.26 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.32 0.581 . . . . 0.85 112.317 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 1.9 tm-20 -137.17 5.21 2.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.71 110.218 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -87.14 -87.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.978 . . . . 0.42 110.284 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 134.13 -34.86 2.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.165 -1.574 . . . . 0.33 109.165 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.53 -31.25 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 0.33 110.153 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' PHE . . . . . 0.419 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 2.4 t80 -172.52 116.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.27 110.183 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.3 m-30 -47.14 105.72 0.51 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34 110.192 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.2 Cg_endo -74.18 -61.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.902 1.475 . . . . 0.47 110.422 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -55.23 144.49 24.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.35 110.64 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 182' ' ' SER . 2.7 p30 179.12 80.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.396 -0.815 . . . . 0.2 110.093 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.82 -154.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.335 -1.506 . . . . 0.25 109.335 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 182' ' ' SER . 53.3 Cg_endo -79.63 11.29 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.994 1.523 . . . . 0.44 110.393 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 0.8 OUTLIER -45.28 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.57 110.669 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 183' ' ' GLY . . . . . 0.582 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -64.71 72.34 0.07 OUTLIER Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.795 -0.922 . . . . 0.49 110.795 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' LEU . . . . . 1.051 ' HA ' HG13 ' A' ' 1' ' ' HAV . 4.4 tt 179.52 92.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.191 -1.182 . . . . 0.41 110.322 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 205' ' ' GLU . 4.1 tt -110.15 -23.84 11.05 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.561 -1.256 . . . . 0.3 111.471 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' ALA . . . . . 0.622 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.9 103.3 3.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.521 -1.362 . . . . 0.2 112.065 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 1.5 p80 -103.0 141.12 36.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.103 . . . . 0.16 109.683 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ALA . . . . . 0.943 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -123.78 128.04 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.23 110.478 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -75.25 169.78 18.78 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.38 110.337 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.496 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.8 Cg_endo -75.08 134.51 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.119 1.589 . . . . 0.4 109.792 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 191' ' ' PRO . . . . . 0.705 ' CG ' HD23 ' A' ' 111' ' ' LEU . 43.9 Cg_endo -70.62 73.53 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.962 1.506 . . . . 0.32 110.431 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.87 -98.09 2.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.632 -1.387 . . . . 0.32 109.632 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.04 -161.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.988 1.52 . . . . 0.47 110.045 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -67.75 -9.41 43.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 0.63 110.237 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.53 55.86 0.64 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.387 -0.821 . . . . 0.53 110.23 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.07 174.87 19.41 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.185 -1.566 . . . . 0.25 109.185 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 43.55 24.63 0.43 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.971 -1.252 . . . . 0.1 109.971 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.1 OUTLIER -78.18 92.02 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -1.22 . . . . 0.1 110.604 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 199' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -73.36 99.47 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.09 109.779 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' HIS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.9 m170 -112.58 138.59 49.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.09 110.388 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 203' ' ' ASP . 25.8 m-85 -105.74 137.52 43.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.1 110.526 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ASP . . . . . 0.862 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -49.47 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.092 -1.077 . . . . 0.14 108.092 178.529 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.5 p30 -36.07 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.1 -0.64 . . . . 0.18 111.967 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 202' ' ' ASP . 32.0 m-20 -80.58 6.36 12.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.739 -1.225 . . . . 0.24 111.006 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 205' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 185' ' ' LEU . 16.8 mm-40 -97.91 -167.07 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.922 -1.111 . . . . 0.42 110.226 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.0 143.86 50.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.47 110.446 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' TRP . . . . . 0.524 ' HB3' HD11 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -143.17 131.38 21.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.93 . . . . 0.27 109.409 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 208' ' ' THR . . . . . 0.974 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -145.08 170.5 16.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.832 -1.167 . . . . 0.3 111.114 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 209' ' ' SER . . . . . 0.631 ' HB2' HD23 ' A' ' 216' ' ' LEU . 17.4 t -130.92 26.71 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.81 0.814 . . . . 0.61 108.956 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -89.09 -93.53 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.752 -0.592 . . . . 0.78 110.272 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 211' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -155.41 18.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.91 110.156 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.64 -176.3 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.93 110.221 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.8 -172.24 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.256 -1.537 . . . . 0.79 109.256 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 244' ' ' TYR . 75.6 m-85 -68.22 101.68 1.22 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -1.222 . . . . 0.69 109.734 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' ASN . . . . . 0.585 ' O ' HG12 ' A' ' 219' ' ' VAL . 29.7 m120 -76.1 117.77 18.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.047 -1.033 . . . . 0.4 108.857 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' LEU . . . . . 0.974 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -40.17 -36.73 0.54 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.716 . . . . 0.17 110.528 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 217' ' ' PHE . . . . . 0.575 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.3 m-85 -49.45 -49.79 43.75 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.335 -1.346 . . . . 0.28 107.736 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' LEU . . . . . 0.55 ' HG ' ' CH ' ' A' ' 3' ' ' MSB . 47.5 tp -76.83 -68.64 0.58 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.7 -0.682 . . . . 0.46 110.778 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' VAL . . . . . 0.95 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -50.89 -66.69 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.39 109.718 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -44.25 -49.69 9.18 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.727 -1.233 . . . . 0.17 110.653 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -64.73 -23.1 67.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.535 -1.353 . . . . 0.1 109.194 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.621 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.0 t60 -79.97 -55.7 4.78 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.186 0.517 . . . . 0.21 109.778 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' GLU . . . . . 0.773 ' OE1' ' HB1' ' A' ' 199' ' ' ALA . 29.1 tt0 -58.75 -43.65 90.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.127 -0.983 . . . . 0.28 108.71 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 2.7 m-85 -58.42 -60.36 3.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.86 . . . . 0.18 109.46 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -31.33 1.94 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.18 -1.568 . . . . 0.21 109.18 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' HIS . . . . . 0.529 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 1.4 m80 -78.58 -74.77 0.26 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.107 -1.231 . . . . 0.17 110.679 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' SER . . . . . 0.972 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -41.18 -36.67 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.385 0.513 . . . . 0.33 112.385 -178.531 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 228' ' ' LEU . . . . . 0.682 ' HB2' HD13 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -101.39 -35.06 9.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.81 -1.181 . . . . 0.53 112.172 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -85.36 -87.52 0.94 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.97 -1.081 . . . . 0.41 111.442 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' LEU . . . . . 1.064 ' O ' HD13 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -154.27 156.01 36.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -1.127 . . . . 0.45 110.483 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.897 ' N ' HD22 ' A' ' 230' ' ' LEU . 1.3 m-20 -37.08 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.349 -0.844 . . . . 0.62 110.98 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 232' ' ' HIS . . . . . 0.747 ' O ' HD21 ' A' ' 230' ' ' LEU . 6.3 m80 -143.12 161.39 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.247 -0.908 . . . . 0.45 110.588 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' HD11 ' A' ' 230' ' ' LEU . 1.0 OUTLIER -165.67 35.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.38 109.937 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 234' ' ' LYS . . . . . 0.61 ' CA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -103.23 20.48 17.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.48 110.624 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 235' ' ' ASP . . . . . 0.611 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -41.36 -60.15 1.95 Allowed Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.291 -0.964 . . . . 0.38 109.299 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 236' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 54.7 Cg_endo -81.07 -50.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.666 1.351 . . . . 0.28 109.742 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.37 93.49 0.09 OUTLIER Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.788 -1.196 . . . . 0.24 111.36 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' ALA . . . . . 0.878 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -137.48 162.76 32.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.929 -1.336 . . . . 0.28 110.12 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' LEU . . . . . 0.586 ' N ' ' HB2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -73.22 57.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.195 -0.941 . . . . 0.4 109.275 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 240' ' ' MET . . . . . 0.621 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.0 OUTLIER -140.37 -31.04 0.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.45 110.687 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 241' ' ' PHE . . . . . 0.552 ' HB3' ' HG3' ' A' ' 234' ' ' LYS . 0.1 OUTLIER -42.0 167.22 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.57 110.553 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 242' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 2' ' ' 3MP . 46.5 Cg_endo -74.23 -5.6 17.19 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.965 1.508 . . . . 0.76 109.605 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' ILE . . . . . 0.753 HG22 HG22 ' A' ' 245' ' ' THR . 19.4 mt -102.78 145.67 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.89 109.812 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 244' ' ' TYR . . . . . 0.596 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 45.8 p90 -128.65 -31.73 2.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.78 110.419 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 245' ' ' THR . . . . . 0.753 HG22 HG22 ' A' ' 243' ' ' ILE . 0.4 OUTLIER 2.17 -67.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.571 0.952 . . . . 0.61 113.571 -179.338 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 246' ' ' TYR . . . . . 0.745 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -59.4 101.99 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.478 -1.389 . . . . 0.74 109.415 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.526 ' N ' ' HB2' ' A' ' 250' ' ' SER . 1.4 m -47.98 178.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.763 . . . . 0.81 110.475 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 247' ' ' THR . . . -52.1 -20.36 6.56 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.938 -1.265 . . . . 0.56 109.938 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.26 31.35 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.083 -1.245 . . . . 0.37 110.639 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 250' ' ' SER . . . . . 0.526 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.2 OUTLIER -49.65 -47.35 49.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 0.44 109.876 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -47.65 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.53 110.022 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.46 -178.19 0.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.38 110.494 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 253' ' ' MET . . . . . 0.881 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -68.32 55.52 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.19 110.595 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.727 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.8 tp -43.99 -47.61 22.29 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.061 -1.088 . . . . 0.28 108.061 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -71.1 48.52 0.89 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.054 1.555 . . . . 0.49 111.279 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ASP . . . . . 0.644 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.4 m-20 -52.64 -28.78 22.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.882 -1.136 . . . . 0.49 111.191 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 257' ' ' ASP . . . . . 0.878 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.58 -52.67 62.97 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.875 -1.13 . . . . 0.31 109.523 -178.874 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ASP . . . . . 0.94 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.22 -32.29 68.62 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.203 -0.999 . . . . 0.14 108.947 179.083 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 259' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 253' ' ' MET . 61.1 t -64.02 -82.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.807 -0.757 . . . . 0.17 110.054 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' GLN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.8 tt0 -55.59 -42.43 74.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 0.26 108.951 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -38.95 -72.4 0.21 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' ILE . . . . . 0.94 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -72.33 -22.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.34 . . . . 0.22 110.082 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLN . . . . . 0.829 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.8 OUTLIER -57.25 -24.84 57.4 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.843 -1.143 . . . . 0.39 108.424 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.0 -37.44 7.37 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.146 -0.622 . . . . 0.47 111.507 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' LEU . . . . . 0.488 ' N ' HD22 ' A' ' 265' ' ' LEU . 4.5 mm? -83.15 -47.98 11.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.48 111.951 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 266' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -82.74 -9.94 59.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.41 110.691 -179.136 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 267' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -54.62 -97.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.009 -1.636 . . . . 0.46 109.009 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.05 116.75 4.67 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.097 1.577 . . . . 0.58 110.246 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -67.33 134.92 31.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.749 -1.34 . . . . 0.64 109.749 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 270' ' ' ASP . . . . . 0.616 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -89.44 -63.84 1.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.95 110.037 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 271' ' ' GLU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 0.3 OUTLIER 43.09 31.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.392 -0.817 . . . . 1.2 110.25 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.75 79.07 47.36 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 1.2 110.297 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 59.53 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.04 1.547 . . . . 1.06 110.466 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.918 -1.039 . . . . 0.78 110.188 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' HAV . . . . . 1.051 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' 3MP . . . . . 0.638 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MSB . . . . . 0.638 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.965 ' N ' HD13 ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.588 0 CA-C-O 121.469 0.652 . . . . 1.03 109.727 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.507 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 6.3 tp 39.41 30.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 1.04 111.178 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.74 ' HB3' HD12 ' A' ' 265' ' ' LEU . 0.3 OUTLIER -118.4 88.75 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.023 . . . . 0.77 109.776 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.611 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 13.4 t90 -153.52 -65.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.42 111.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.47 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 17.8 t -105.02 59.97 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.44 111.207 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 114' ' ' SER . 10.9 mmtm -154.57 53.45 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.035 -1.041 . . . . 0.49 110.379 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.482 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 59.2 ttp -72.97 -15.67 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.3 110.393 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 15.3 p-10 -142.78 140.42 31.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.15 110.416 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 118' ' ' LEU . 12.8 tp -158.23 166.39 32.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.379 -0.826 . . . . 0.13 109.841 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -107.57 162.94 13.5 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -0.983 . . . . 0.12 110.081 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.613 ' HB3' HG23 ' A' ' 163' ' ' ILE . 36.5 p90 -157.63 164.02 37.65 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.376 -0.93 . . . . 0.33 110.887 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.24 146.46 45.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.422 -0.799 . . . . 0.54 110.301 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.766 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.2 pt -106.31 117.46 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.33 110.574 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.9 m -162.82 42.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.27 110.04 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 11.3 t-20 -40.63 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.79 -0.764 . . . . 0.41 109.311 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 7.8 t80 -178.92 178.46 0.76 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.409 -0.807 . . . . 0.4 109.78 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -130.56 51.08 6.9 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.45 110.126 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -75.85 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.125 1.592 . . . . 0.36 110.639 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -99.58 -2.09 36.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.25 109.938 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.577 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -110.47 168.76 9.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -0.8 . . . . 0.39 109.879 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.48 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -116.97 169.08 9.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.48 110.25 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -43.28 -32.96 0.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.4 109.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.9 m -67.98 -47.93 67.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.46 109.84 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 9.5 mp0 -63.07 -58.83 5.95 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.137 -0.977 . . . . 0.47 109.745 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 125' ' ' TYR . 10.9 t -45.68 -36.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.042 -1.096 . . . . 0.31 108.042 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.4 tt0 -57.84 -42.06 83.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.096 -1.076 . . . . 0.48 108.096 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 5.9 tttt -72.53 -51.1 21.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.448 -0.901 . . . . 0.64 108.732 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.865 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -44.92 -60.08 2.24 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.137 -0.977 . . . . 0.42 110.223 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.745 ' CE2' HD12 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -67.47 -52.82 34.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.34 110.974 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.07 -71.67 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.931 -1.105 . . . . 0.47 110.159 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtp? -39.49 -61.29 0.82 Allowed 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.809 -0.557 . . . . 0.47 110.508 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.41 -37.16 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.693 -1.254 . . . . 0.25 108.305 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.2 -36.67 74.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.743 -0.836 . . . . 0.35 108.743 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttmm -58.03 -41.39 83.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.228 -0.92 . . . . 0.7 108.923 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.79 -48.42 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.592 -0.692 . . . . 0.61 109.4 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.615 ' CH2' HG13 ' A' ' 262' ' ' ILE . 57.0 t-105 -55.01 -38.05 67.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.39 109.157 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -73.5 -34.0 65.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.305 -0.872 . . . . 0.35 108.936 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -44.18 89.45 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.36 109.251 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 145' ' ' TRP . 26.9 m -72.93 -32.2 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.634 -0.826 . . . . 0.5 109.753 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 146' ' ' SER . 15.3 t -152.0 134.18 8.54 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.51 110.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.29 59.83 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.951 1.501 . . . . 0.31 110.158 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -76.72 136.04 39.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.18 110.414 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -82.35 120.45 25.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.17 109.92 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.561 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.5 p90 -131.6 133.99 45.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 0.14 110.521 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.857 ' O ' HG22 ' A' ' 119' ' ' THR . 6.3 m -140.02 128.9 23.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.364 -0.835 . . . . 0.15 110.11 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.698 HH12 HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -96.67 81.85 3.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.2 109.972 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.627 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -82.26 89.1 6.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.094 -1.004 . . . . 0.22 110.109 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.465 ' CD2' ' N ' ' A' ' 158' ' ' ASP . 5.1 p-80 -48.45 -24.43 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.32 109.963 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.465 ' N ' ' CD2' ' A' ' 157' ' ' HIS . 3.0 t70 -42.29 -27.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.497 -0.752 . . . . 0.33 109.811 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 124.55 26.33 1.46 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.72 -1.352 . . . . 0.28 109.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.627 HD12 ' CD2' ' A' ' 156' ' ' LEU . 51.7 mt -119.85 70.93 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -1.215 . . . . 0.3 109.725 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.483 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -124.35 143.48 50.56 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.15 -0.62 . . . . 0.2 110.598 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.441 ' CG ' HD21 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -108.1 -43.78 4.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.1 109.965 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 227' ' ' SER . 1.0 OUTLIER -119.86 156.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.259 -0.901 . . . . 0.1 109.84 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.941 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.1 ptt? -156.85 153.01 27.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.515 -1.365 . . . . 0.11 111.602 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 165' ' ' ILE . 4.1 tt -101.24 116.69 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.1 109.316 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.998 ' HB3' HG23 ' A' ' 123' ' ' VAL . 12.9 p -162.64 148.64 12.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.578 -1.326 . . . . 0.1 111.364 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.571 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.3 p90 -67.79 117.15 9.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -0.823 . . . . 0.09 109.411 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -75.38 142.76 29.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.91 -0.876 . . . . 0.2 110.91 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -134.54 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.754 -0.851 . . . . 0.55 109.124 178.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 11.7 tmtt? 1.08 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.375 0.607 . . . . 0.85 112.428 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 171' ' ' GLU . 14.3 tt0 -146.16 23.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.326 -0.859 . . . . 0.71 110.11 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.433 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 12.1 m170 -96.89 -67.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.42 110.267 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 124.6 5.96 6.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.649 -1.38 . . . . 0.33 109.649 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -121.51 -82.62 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -1.226 . . . . 0.33 110.217 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.476 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 65.3 m-85 -102.48 154.6 18.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.27 110.016 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.2 m-30 -96.56 105.74 24.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.34 110.039 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 43.7 Cg_endo -73.17 -66.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.929 1.489 . . . . 0.47 110.823 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -49.47 135.39 18.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.35 110.634 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 182' ' ' SER . 7.6 p30 179.56 83.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.241 -0.912 . . . . 0.2 110.398 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.496 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.47 -156.59 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.688 -1.365 . . . . 0.25 109.688 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.6 Cg_endo -76.45 6.35 4.07 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.123 1.591 . . . . 0.44 110.308 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 1.5 t -41.06 165.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.57 110.738 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.493 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.62 76.18 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.536 -1.025 . . . . 0.49 110.536 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.848 HD22 ' OD1' ' A' ' 202' ' ' ASP . 3.3 tt 179.78 89.28 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.358 -1.084 . . . . 0.41 110.058 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.596 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 1.3 tt -106.2 -21.66 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.787 -1.196 . . . . 0.3 111.533 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.595 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -152.59 108.86 3.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.473 -1.392 . . . . 0.2 112.247 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.1 OUTLIER -106.48 125.74 51.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 0.16 109.73 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.826 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -115.54 150.62 36.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.16 -0.963 . . . . 0.23 110.613 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.433 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.6 m-30 -107.53 165.33 12.99 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.937 . . . . 0.38 110.471 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 43.4 Cg_endo -71.18 137.81 32.11 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.012 1.532 . . . . 0.4 109.901 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 41.2 Cg_endo -67.53 74.5 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.041 1.548 . . . . 0.32 110.807 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.62 -92.66 1.97 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.913 -1.675 . . . . 0.32 108.913 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.37 -159.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.001 1.527 . . . . 0.47 110.17 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.32 2.63 12.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.63 110.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 15.71 19.66 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.287 -0.883 . . . . 0.53 110.094 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -86.55 167.0 38.42 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.438 -1.465 . . . . 0.25 109.438 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 45.93 24.23 1.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.354 -1.499 . . . . 0.1 109.354 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.76 93.83 3.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.208 . . . . 0.1 110.192 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -75.74 105.13 6.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.09 109.925 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 166' ' ' SER . 10.3 m170 -119.24 122.18 41.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.09 110.237 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 203' ' ' ASP . 29.7 m-85 -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.1 110.455 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.848 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -48.78 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.282 -0.886 . . . . 0.14 108.789 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -36.33 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.901 -0.72 . . . . 0.18 111.694 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 202' ' ' ASP . 66.2 m-20 -77.62 2.08 17.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.812 -1.18 . . . . 0.24 111.075 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 202' ' ' ASP . 28.6 mm-40 -97.32 -170.78 2.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.997 -1.065 . . . . 0.42 110.548 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.414 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 96.5 m -121.37 146.52 46.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.47 110.367 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.6 ' C ' HG22 ' A' ' 208' ' ' THR . 0.9 OUTLIER -145.05 145.42 31.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.887 . . . . 0.27 109.663 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.999 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -163.7 -177.97 5.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.877 -1.139 . . . . 0.3 111.159 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.478 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.2 t -125.54 30.26 5.8 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.72 0.772 . . . . 0.61 108.999 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -126.93 -175.69 3.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.569 -0.707 . . . . 0.78 110.375 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.475 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -82.38 61.32 5.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.91 110.135 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.451 ' HG2' ' OG ' ' A' ' 210' ' ' SER . 3.5 pttt -170.0 106.26 0.34 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.957 . . . . 0.93 110.157 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 96.16 -162.47 22.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.363 -1.495 . . . . 0.79 109.363 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.596 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 83.7 m-85 -81.56 127.33 32.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -1.18 . . . . 0.69 109.986 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.599 ' O ' HG12 ' A' ' 219' ' ' VAL . 16.5 m-80 -89.25 119.25 29.57 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.095 -1.003 . . . . 0.4 108.939 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 208' ' ' THR . 0.6 OUTLIER -41.39 -36.59 0.86 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.515 -0.874 . . . . 0.17 110.214 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 5.0 m-85 -52.55 -47.04 67.01 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.468 -1.308 . . . . 0.28 107.468 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 244' ' ' TYR . 11.5 tp -78.5 -72.1 0.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.617 -0.72 . . . . 0.46 110.835 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.822 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -46.8 -61.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.936 -1.103 . . . . 0.39 110.23 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.924 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -54.35 -52.86 60.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.17 111.207 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -54.79 -29.48 54.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.352 -1.467 . . . . 0.1 109.043 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.596 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.0 t60 -77.17 -52.21 9.65 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.423 0.63 . . . . 0.21 109.895 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.73 ' OE2' ' HB2' ' A' ' 188' ' ' ALA . 19.0 tp10 -58.38 -53.87 53.39 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.28 109.01 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.645 ' HA ' HD11 ' A' ' 163' ' ' ILE . 2.4 m-85 -53.99 -46.61 71.77 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.304 -0.872 . . . . 0.18 108.84 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -49.83 -31.85 17.3 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.315 -1.914 . . . . 0.21 108.315 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.743 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -86.54 -68.38 0.75 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.385 -1.068 . . . . 0.17 110.402 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.866 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -38.74 -39.64 0.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.574 -0.704 . . . . 0.33 111.108 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 163' ' ' ILE . 4.6 tp -98.19 -34.18 10.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.086 -1.009 . . . . 0.53 110.356 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -75.58 -88.85 0.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.107 -1.197 . . . . 0.41 110.107 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -177.68 -170.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -1.088 . . . . 0.45 110.878 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.521 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -39.23 -64.91 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.556 -0.715 . . . . 0.62 110.823 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.743 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 1.3 m80 -166.92 -177.44 3.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.45 110.096 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 232' ' ' HIS . 24.1 p 179.92 60.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.768 . . . . 0.38 109.406 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 1.099 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -148.12 26.4 0.98 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.48 111.415 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.528 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.6 OUTLIER -34.34 -51.09 0.97 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.38 111.173 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 46.8 Cg_endo -83.94 -49.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.72 1.379 . . . . 0.28 111.644 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.34 103.16 0.17 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.193 -1.479 . . . . 0.24 111.424 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 1.099 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -149.84 167.84 25.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.287 -1.125 . . . . 0.28 110.532 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.596 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -73.3 58.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.326 -0.99 . . . . 0.4 108.326 178.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.59 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 24.7 mmm -140.42 -34.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.45 110.813 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.613 ' CG ' HG22 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -58.11 170.54 0.71 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.047 -1.033 . . . . 0.57 110.243 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.1 Cg_endo -68.72 -7.55 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.544 1.286 . . . . 0.76 110.046 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.613 HG22 ' CG ' ' A' ' 241' ' ' PHE . 1.2 tp -98.66 142.48 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 0.89 109.57 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 1.013 ' HB2' HD21 ' A' ' 218' ' ' LEU . 16.1 p90 -131.93 -21.29 2.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.246 -0.908 . . . . 0.78 111.257 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 4.25 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 112.999 0.74 . . . . 0.61 112.999 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.701 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -66.36 115.9 6.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.571 -1.331 . . . . 0.74 109.619 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 250' ' ' SER . 0.2 OUTLIER -61.46 174.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.81 110.358 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -46.74 -34.28 6.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.822 -1.311 . . . . 0.56 109.822 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -148.73 51.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.044 -1.268 . . . . 0.37 110.572 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 247' ' ' THR . 83.6 p -102.07 13.19 35.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.44 109.875 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 1.7 t60 -173.65 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.53 109.959 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.549 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 2.5 t80 179.9 177.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.38 110.193 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.851 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -75.33 48.94 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.891 . . . . 0.19 110.451 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.702 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -44.46 -47.89 26.11 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.17 -1.048 . . . . 0.28 108.17 177.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.7 Cg_endo -72.52 51.04 1.75 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.054 1.555 . . . . 0.49 110.662 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.619 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.4 m-20 -53.4 -30.23 38.93 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.118 -0.989 . . . . 0.49 109.399 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 1.091 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -50.59 -42.64 56.04 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.228 -0.92 . . . . 0.31 109.897 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.995 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.78 -33.46 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.248 -1.019 . . . . 0.14 108.248 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 253' ' ' MET . 97.0 t -62.26 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.544 -0.862 . . . . 0.17 109.727 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.9 tm0? -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.295 -0.878 . . . . 0.26 109.597 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.12 -65.29 1.29 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.19 109.919 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.995 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -78.35 -20.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.22 110.615 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.928 ' N ' HD13 ' A' ' 262' ' ' ILE . 1.7 tm0? -66.25 -21.15 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.839 -1.144 . . . . 0.39 108.513 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t -104.11 -42.54 5.51 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.383 0.611 . . . . 0.47 110.897 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -79.18 -48.42 14.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.48 111.254 -178.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.485 ' OH ' ' HG ' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -84.55 -7.46 59.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.41 110.542 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -50.73 -98.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.001 -1.64 . . . . 0.46 109.001 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.65 133.89 13.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.839 1.442 . . . . 0.58 110.037 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -94.7 161.06 23.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.484 -1.446 . . . . 0.64 109.484 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.611 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.489 1.501 0 O-C-N 121.148 -1.207 . . . . 0.95 110.134 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.525 ' CA ' HD13 ' A' ' 230' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.491 1.589 0 N-CA-C 109.337 -0.616 . . . . 1.03 109.337 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 36.3 40.08 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.694 -0.629 . . . . 1.04 111.545 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.631 ' HD3' HD22 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -126.85 81.94 2.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.77 109.496 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 15.6 t90 -151.64 -70.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.134 -0.979 . . . . 0.42 111.16 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.529 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 13.2 p -102.4 77.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.44 111.098 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -169.31 51.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.49 110.326 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.499 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 5.6 ttt -85.37 -13.38 49.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.3 110.42 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.493 ' O ' HD12 ' A' ' 118' ' ' LEU . 6.5 p-10 -143.96 109.62 5.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.208 -0.933 . . . . 0.15 110.043 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.706 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -138.24 -168.4 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.13 110.658 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.89 HG22 ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -130.59 176.95 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.12 110.321 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CZ ' ' HG3' ' A' ' 155' ' ' ARG . 36.7 p90 -174.43 -169.24 0.43 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.27 -0.894 . . . . 0.33 110.918 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -127.87 156.46 42.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.54 110.037 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 138' ' ' PHE . 2.7 pt -122.77 95.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.33 110.436 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.992 HG23 ' HB3' ' A' ' 166' ' ' SER . 4.2 m -149.9 56.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.982 . . . . 0.27 110.812 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 1.0 OUTLIER -44.34 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.41 109.306 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 167' ' ' PHE . 11.9 t80 -178.69 -173.95 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.4 109.69 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.531 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 2.6 m -136.35 53.89 8.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.45 110.774 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -78.26 -86.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.981 1.517 . . . . 0.36 109.922 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.47 0.04 41.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.895 . . . . 0.25 109.699 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.901 ' SD ' HD21 ' A' ' 216' ' ' LEU . 2.6 ptm -121.77 147.99 45.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 0.39 109.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -92.78 169.36 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.48 110.118 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' THR . 11.2 t-160 -43.51 -33.64 1.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.4 109.622 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 2.5 m -57.98 -54.6 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.46 109.23 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.6 OUTLIER -58.1 -54.35 47.99 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.542 -0.863 . . . . 0.47 108.913 179.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.537 ' CG2' ' CE ' ' A' ' 129' ' ' MET . 10.5 t -45.25 -34.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.169 -1.049 . . . . 0.31 108.169 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -63.44 -41.58 98.67 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.435 -0.95 . . . . 0.48 108.435 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 2.6 ttmt -70.5 -49.54 47.33 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.922 0.868 . . . . 0.64 108.999 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.802 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -44.77 -59.6 2.44 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 121.149 -0.969 . . . . 0.42 110.206 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.669 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.54 -53.59 33.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.34 110.775 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.12 -72.69 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.994 -1.067 . . . . 0.47 110.167 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.629 ' NZ ' HG23 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -38.47 -61.89 0.65 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.85 -0.531 . . . . 0.47 110.427 178.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.23 -38.86 12.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.678 -1.264 . . . . 0.25 108.413 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.3 OUTLIER -69.43 -31.92 70.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.35 109.063 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -61.29 -43.85 98.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.208 -0.933 . . . . 0.7 108.699 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.629 HG23 ' NZ ' ' A' ' 140' ' ' LYS . 7.5 t -69.58 -46.56 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.915 -0.772 . . . . 0.61 108.915 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.605 ' CH2' HG13 ' A' ' 262' ' ' ILE . 53.9 t-105 -54.72 -37.1 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.485 -0.76 . . . . 0.39 109.012 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 149' ' ' THR . 56.5 m -74.93 -33.17 61.93 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.915 . . . . 0.35 108.711 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.9 OUTLIER -57.85 -43.12 85.68 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.094 -0.706 . . . . 0.36 109.094 179.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 145' ' ' TRP . 29.5 m -74.64 -33.98 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.438 -0.789 . . . . 0.5 109.903 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.535 HG21 HD12 ' A' ' 151' ' ' LEU . 13.1 t -148.3 129.46 7.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -0.982 . . . . 0.51 110.216 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.43 59.17 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.968 1.51 . . . . 0.31 110.582 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.825 HD11 ' HB3' ' A' ' 266' ' ' TYR . 11.6 mt -80.25 171.31 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.18 110.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -122.79 136.64 54.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.17 110.463 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.422 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.8 p90 -154.91 145.02 21.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.14 110.316 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.89 ' O ' HG22 ' A' ' 119' ' ' THR . 2.8 m -143.99 142.95 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.15 110.14 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.624 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -93.74 86.51 5.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.2 110.12 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -92.62 85.14 5.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.22 110.419 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 159' ' ' GLY . 45.5 p-80 -56.88 -19.12 15.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.32 109.873 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.884 ' HB3' HD12 ' A' ' 156' ' ' LEU . 2.4 t0 -43.4 -26.14 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.494 -0.754 . . . . 0.33 109.776 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.75 21.87 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.95 -1.26 . . . . 0.28 109.95 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.51 ' O ' ' CB ' ' A' ' 119' ' ' THR . 14.8 mt -125.63 64.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.035 -1.273 . . . . 0.3 109.274 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -115.86 137.0 52.51 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.254 -0.579 . . . . 0.2 110.594 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.706 ' CB ' HD23 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -101.34 -51.79 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.1 110.034 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.719 HG22 ' HA3' ' A' ' 197' ' ' GLY . 3.1 pt -120.01 -177.33 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.1 109.229 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.802 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.1 ptp -174.88 139.54 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.5 -1.375 . . . . 0.11 111.836 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -90.35 118.71 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.1 109.443 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.992 ' HB3' HG23 ' A' ' 123' ' ' VAL . 29.5 p -169.83 162.45 9.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.722 -1.236 . . . . 0.1 111.291 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.594 ' O ' ' CD1' ' A' ' 167' ' ' PHE . 0.1 OUTLIER -75.19 150.46 38.67 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.471 -0.768 . . . . 0.09 109.24 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -111.9 131.59 10.32 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.754 -1.212 . . . . 0.2 110.986 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.594 ' O ' ' C ' ' A' ' 170' ' ' LYS . 12.4 pt -125.74 101.31 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.629 -0.924 . . . . 0.55 109.358 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.594 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 2.08 78.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.462 0.649 . . . . 0.85 112.202 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -4.48 10.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.71 110.135 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 9.1 m-70 -83.94 -153.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.923 . . . . 0.42 110.186 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.4 36.64 1.7 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.244 -1.542 . . . . 0.33 109.244 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' PHE . 15.0 p-10 -140.87 -146.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -1.093 . . . . 0.33 110.205 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 174' ' ' ASP . 28.5 m-85 -45.84 169.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.27 110.046 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -86.31 127.12 62.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.34 110.43 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.506 ' CG ' ' HA ' ' A' ' 170' ' ' LYS . 44.6 Cg_endo -79.01 -79.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.885 1.466 . . . . 0.47 110.497 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.2 p90 -58.91 149.83 25.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.35 110.307 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 182' ' ' SER . 1.6 p30 178.89 78.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.2 110.491 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.547 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 42.63 -160.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.522 -1.431 . . . . 0.25 109.522 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 52.0 Cg_endo -78.23 9.34 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.019 1.537 . . . . 0.44 110.483 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.489 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 40.5 m -46.9 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.57 110.575 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.518 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.87 74.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 111.149 -0.78 . . . . 0.49 111.149 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 1.022 HD22 ' OD1' ' A' ' 202' ' ' ASP . 4.0 tt 179.56 90.45 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.22 -1.164 . . . . 0.41 110.379 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.62 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.3 tt -109.18 -21.48 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.3 111.179 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.536 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -150.1 105.56 3.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.665 -1.272 . . . . 0.2 111.775 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -107.08 122.54 46.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.16 109.632 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.956 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -114.64 134.07 55.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.23 110.399 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.477 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.1 m-30 -79.63 174.78 5.56 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.38 110.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.523 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.6 Cg_endo -72.77 130.72 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.089 1.573 . . . . 0.4 109.458 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.4 Cg_endo -71.22 77.28 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.95 1.5 . . . . 0.32 110.457 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.13 -90.01 0.51 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.686 -1.245 . . . . 0.32 110.217 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.5 -179.98 4.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.47 111.014 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -58.92 -14.83 10.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.815 . . . . 0.63 110.133 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.97 53.3 0.7 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.538 0.685 . . . . 0.53 109.937 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -133.97 -178.52 15.67 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.392 -1.483 . . . . 0.25 109.392 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.719 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 43.56 26.14 0.64 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.67 -1.372 . . . . 0.1 109.67 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 196' ' ' GLY . 3.7 m-20 -79.28 87.95 4.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.1 110.22 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.66 97.1 1.67 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.09 110.027 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 166' ' ' SER . 52.3 m170 -112.97 134.19 54.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.09 110.69 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.7 m-85 -101.1 135.92 41.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.905 . . . . 0.1 110.296 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 1.022 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -46.58 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.265 -1.013 . . . . 0.14 108.265 178.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.09 -26.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.827 -0.749 . . . . 0.18 111.826 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.547 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.0 OUTLIER -78.06 3.59 14.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.499 -1.376 . . . . 0.24 110.749 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.62 ' OE1' HD12 ' A' ' 185' ' ' LEU . 21.6 mm-40 -100.27 -174.55 2.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.008 -1.058 . . . . 0.42 110.107 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 144.27 47.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.47 110.439 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.536 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -141.4 134.11 28.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.27 109.488 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.987 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -142.34 171.12 14.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.062 . . . . 0.3 110.508 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.607 ' HB2' HD23 ' A' ' 216' ' ' LEU . 1.2 t -129.24 25.95 5.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.573 -0.899 . . . . 0.61 108.573 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -69.3 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.78 110.357 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.583 -0.698 . . . . 0.91 109.518 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -95.8 157.86 15.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.449 -0.782 . . . . 0.93 110.022 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.25 -174.55 37.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.101 -1.6 . . . . 0.79 109.101 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.544 ' CE2' HD13 ' A' ' 185' ' ' LEU . 83.9 m-85 -67.31 114.96 6.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -1.228 . . . . 0.69 109.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.617 ' O ' HG12 ' A' ' 219' ' ' VAL . 45.5 m-80 -84.37 120.33 26.14 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.985 -1.072 . . . . 0.4 109.001 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.987 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -41.18 -36.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.17 110.397 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.59 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 3.9 m-85 -52.4 -47.64 66.13 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.279 -1.378 . . . . 0.28 107.279 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.16 -73.04 0.29 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.812 -0.631 . . . . 0.46 110.422 178.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.2 -62.78 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.136 -0.978 . . . . 0.39 110.566 -179.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -51.81 -50.69 60.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.026 -1.047 . . . . 0.17 111.263 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.9 -37.52 76.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.342 -1.474 . . . . 0.1 108.829 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.622 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.6 t60 -63.68 -59.29 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.197 0.522 . . . . 0.21 109.606 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.672 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.0 tp10 -54.3 -39.44 66.97 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.252 -1.018 . . . . 0.28 108.252 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.2 m-30 -56.33 -61.32 2.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.435 -0.79 . . . . 0.18 109.057 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -45.07 -30.39 2.55 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.669 -1.772 . . . . 0.21 108.669 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 1.6 m80 -81.36 -78.27 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -1.156 . . . . 0.17 111.115 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.956 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -37.9 -37.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.584 -0.697 . . . . 0.33 112.47 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.582 ' HB2' HD13 ' A' ' 163' ' ' ILE . 11.5 tp -100.6 -36.72 9.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.717 -1.239 . . . . 0.53 111.278 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -75.82 -86.88 0.31 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.171 -1.172 . . . . 0.41 110.171 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.631 HD22 ' HD3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -172.57 -170.18 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -1.154 . . . . 0.45 110.661 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.509 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.2 t0 -43.08 -60.79 1.51 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.62 110.77 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.517 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -166.97 -175.56 3.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.45 110.359 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.449 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER 179.59 61.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.488 -0.758 . . . . 0.38 109.698 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 1.076 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.79 23.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.48 111.26 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.531 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -34.51 -47.43 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.647 . . . . 0.38 110.926 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 41.2 Cg_endo -90.78 -45.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.82 1.432 . . . . 0.28 111.987 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.31 102.02 0.15 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 118.829 -1.653 . . . . 0.24 111.991 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 1.076 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -150.46 166.47 30.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.334 -1.098 . . . . 0.28 110.257 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.603 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.3 53.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.972 . . . . 0.4 109.21 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.622 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 5.2 mtt -137.3 -30.63 0.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.45 110.372 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -47.49 171.27 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 0.57 110.6 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -70.29 -2.83 11.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.511 1.269 . . . . 0.76 110.454 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 6.4 tt -110.66 153.93 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.89 109.919 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.807 ' HB2' HD21 ' A' ' 218' ' ' LEU . 32.5 p90 -128.35 -20.61 3.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.78 110.935 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.6 OUTLIER 2.75 -67.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.717 1.006 . . . . 0.61 113.717 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -72.56 119.57 16.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.339 -1.476 . . . . 0.74 109.833 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 250' ' ' SER . 21.6 p -63.12 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.81 . . . . 0.81 110.424 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.84 -20.64 57.57 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.722 -1.351 . . . . 0.56 109.722 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -158.07 40.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -1.226 . . . . 0.37 110.507 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 247' ' ' THR . 4.6 m -63.79 -13.0 40.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.44 109.781 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.2 OUTLIER -171.13 -48.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.53 110.329 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.596 ' CD2' ' HG2' ' A' ' 253' ' ' MET . 4.7 t80 -179.1 178.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.38 110.777 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 1.01 ' HB2' HG21 ' A' ' 259' ' ' VAL . 6.8 ptp -68.14 55.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.424 -0.797 . . . . 0.19 110.263 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.668 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -44.11 -47.97 23.25 Favored Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 108.021 -1.103 . . . . 0.28 108.021 177.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.9 Cg_endo -74.31 50.53 2.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.129 1.594 . . . . 0.49 110.698 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.6 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.1 m-20 -50.87 -32.27 19.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.069 -1.019 . . . . 0.49 110.008 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.977 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 51.8 m-20 -54.17 -46.47 72.35 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.24 -0.984 . . . . 0.31 109.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.993 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -72.96 -36.32 67.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.491 -0.929 . . . . 0.14 108.491 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 1.01 HG21 ' HB2' ' A' ' 253' ' ' MET . 74.1 t -63.88 -82.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.17 110.266 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.3 tp60 -56.62 -43.09 79.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.276 -0.89 . . . . 0.26 109.495 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.76 -69.86 0.45 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.496 -1.042 . . . . 0.19 110.496 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.86 -22.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.777 -1.425 . . . . 0.22 110.032 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.941 ' N ' HD13 ' A' ' 262' ' ' ILE . 6.0 tt0 -59.98 -23.17 63.4 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.98 -1.088 . . . . 0.39 108.208 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.1 t -103.6 -43.0 5.49 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.406 0.622 . . . . 0.47 110.913 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.522 ' CB ' ' HG2' ' A' ' 112' ' ' LYS . 54.7 mt -75.31 -52.49 10.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.48 111.187 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.825 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -82.61 -1.36 50.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.41 109.959 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.31 -108.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.226 -1.55 . . . . 0.46 109.226 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.499 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.6 Cg_endo -75.91 84.29 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.702 1.369 . . . . 0.58 110.223 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.69 174.48 1.06 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.64 109.48 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.623 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.95 110.117 179.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.171 0.51 . . . . 1.03 110.189 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 39.49 27.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 1.04 110.88 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.607 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -114.94 72.76 0.8 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.0 . . . . 0.77 109.781 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.63 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.0 t90 -143.85 -65.09 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.42 110.474 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.428 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 13.4 t -103.06 60.31 0.78 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.44 110.537 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 3.8 mmtp -146.01 85.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.146 -0.971 . . . . 0.49 110.302 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.418 ' O ' ' HB2' ' A' ' 152' ' ' ASN . 34.1 ttp -112.99 -20.78 11.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.3 110.28 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 11.3 p30 -144.97 129.48 17.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.169 -0.957 . . . . 0.15 110.106 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.557 HD22 ' CB ' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -152.32 -175.73 5.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.13 110.662 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 154' ' ' THR . 1.0 OUTLIER -126.39 155.44 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 0.12 109.992 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.631 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 46.1 p90 -148.61 159.46 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.33 110.776 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -116.9 151.33 36.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.51 -0.744 . . . . 0.54 109.873 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.734 HG21 ' CD1' ' A' ' 138' ' ' PHE . 2.0 pp -113.51 115.19 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.33 110.983 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.917 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.6 m -160.56 41.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.313 -0.867 . . . . 0.27 110.19 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 2.3 t-20 -40.78 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.41 109.491 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.722 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.7 t80 -179.39 -163.45 0.05 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.43 -0.794 . . . . 0.4 109.57 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -152.84 47.87 0.41 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.063 -1.023 . . . . 0.45 110.436 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -73.73 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.956 1.503 . . . . 0.36 110.311 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.95 -5.21 56.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.25 109.755 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.602 ' SD ' HD21 ' A' ' 216' ' ' LEU . 0.6 OUTLIER -115.96 172.07 7.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.39 110.068 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -123.7 177.67 5.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.48 109.993 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 4.7 t60 -45.53 -36.92 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.4 110.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 5.7 t -63.59 -50.58 68.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.46 109.595 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 129' ' ' MET . 51.9 mp0 -59.87 -62.74 1.65 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.255 -0.903 . . . . 0.47 109.378 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 125' ' ' TYR . 13.1 t -44.02 -37.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.478 -0.934 . . . . 0.31 108.478 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.559 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.77 -42.04 78.69 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.319 -0.993 . . . . 0.48 108.319 178.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.591 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 42.2 tttt -74.69 -47.52 31.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.005 0.907 . . . . 0.64 108.577 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.851 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -47.64 -60.71 2.36 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.333 -0.854 . . . . 0.42 110.001 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.734 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.25 -51.36 46.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.34 111.095 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.54 -72.1 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.963 -1.086 . . . . 0.47 110.277 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -40.95 -59.33 1.47 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.693 -0.629 . . . . 0.47 110.437 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.86 -37.16 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.691 -1.256 . . . . 0.25 108.012 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -69.85 -40.74 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.499 -0.751 . . . . 0.35 109.02 178.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -52.67 -37.47 58.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.06 -1.025 . . . . 0.7 108.565 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 89.0 t -72.75 -45.17 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.351 0.596 . . . . 0.61 109.572 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.713 ' HH2' HG21 ' A' ' 262' ' ' ILE . 26.1 t-105 -58.72 -44.37 90.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.39 109.333 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 149' ' ' THR . 58.8 m -69.11 -33.4 73.43 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.137 -0.977 . . . . 0.35 108.745 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -56.12 -44.92 79.61 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.36 109.302 179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 145' ' ' TRP . 27.2 m -76.24 -30.83 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.5 109.778 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 149' ' ' THR . 12.7 t -151.8 114.7 2.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.51 109.944 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.91 59.96 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.826 1.435 . . . . 0.31 110.52 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 266' ' ' TYR . 65.7 mt -76.27 165.91 24.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.18 110.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.42 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -91.58 128.05 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.17 110.147 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 5.8 p90 -147.41 125.34 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.14 110.234 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 119' ' ' THR . 6.0 m -128.59 139.85 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.15 110.439 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.631 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -106.5 87.11 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.2 109.931 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.566 HD22 HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -95.38 89.52 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.22 110.05 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 158' ' ' ASP . 3.4 p-80 -49.12 -23.78 1.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.32 109.916 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.0 t0 -42.76 -32.77 0.64 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.625 -0.672 . . . . 0.33 109.644 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.56 32.79 0.37 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.81 -1.316 . . . . 0.28 109.81 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.566 HD12 HD22 ' A' ' 156' ' ' LEU . 17.7 mt -126.79 67.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.236 . . . . 0.3 109.271 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -125.76 149.63 48.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.657 -0.652 . . . . 0.2 110.906 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.557 ' CB ' HD22 ' A' ' 118' ' ' LEU . 3.7 t70 -113.19 -38.05 4.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.1 109.623 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.973 HG22 ' HA3' ' A' ' 197' ' ' GLY . 6.6 pt -125.17 172.81 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.1 109.382 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.496 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 1.2 ptp -171.88 141.51 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.808 -1.183 . . . . 0.11 111.222 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.8 tt -93.87 117.23 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.389 -0.819 . . . . 0.1 109.563 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.917 ' HB3' HG23 ' A' ' 123' ' ' VAL . 69.4 p -158.53 159.59 35.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.893 -1.129 . . . . 0.1 110.489 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.559 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 9.1 p90 -76.63 126.41 30.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.383 -0.823 . . . . 0.09 109.709 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -88.23 117.04 4.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.148 -1.181 . . . . 0.2 110.148 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -110.25 103.01 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.67 -0.9 . . . . 0.55 109.264 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.587 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.82 81.12 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.329 0.585 . . . . 0.85 112.523 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.24 -6.26 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.71 110.048 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.464 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 13.1 m-70 -80.75 -86.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.42 110.418 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.47 4.11 6.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.526 -1.43 . . . . 0.33 109.526 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -113.28 -64.73 1.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.33 110.132 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.435 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 18.7 m-85 -112.79 118.14 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.27 110.245 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -45.78 104.29 0.39 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.34 110.36 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.521 ' O ' HD22 ' A' ' 184' ' ' LEU . 44.4 Cg_endo -74.5 -59.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.925 1.487 . . . . 0.47 110.374 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -89.2 161.04 16.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.35 109.919 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 0.9 OUTLIER -173.65 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.2 111.206 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.581 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 130.9 -137.23 9.32 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.929 -1.668 . . . . 0.25 108.929 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 182' ' ' SER . 54.0 Cg_endo -72.13 -3.37 13.15 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 O-C-N 124.076 1.566 . . . . 0.44 109.664 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -50.21 -179.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.358 -0.839 . . . . 0.57 110.158 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -82.88 73.58 2.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.278 -1.129 . . . . 0.49 110.278 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.62 ' C ' HD23 ' A' ' 184' ' ' LEU . 4.4 tt -179.96 93.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.221 -1.164 . . . . 0.41 110.788 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.605 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 3.2 tt -109.55 -15.58 14.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.823 -1.151 . . . . 0.3 110.719 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.731 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -153.15 102.81 2.66 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.774 -1.203 . . . . 0.2 111.591 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -112.15 119.2 37.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.16 109.789 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -110.11 151.41 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.23 110.488 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.1 m-30 -90.64 165.53 22.41 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.38 110.686 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.7 Cg_endo -73.56 143.03 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.021 1.537 . . . . 0.4 109.804 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -70.5 72.74 1.78 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.896 1.471 . . . . 0.32 110.572 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.3 -101.5 2.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.433 -1.467 . . . . 0.32 109.433 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.15 -160.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.902 1.475 . . . . 0.47 110.28 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -6.97 26.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.993 . . . . 0.63 110.112 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.11 52.08 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.473 -0.767 . . . . 0.53 109.772 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -127.68 172.27 18.93 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.409 -1.477 . . . . 0.25 109.409 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.973 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 45.69 24.63 1.25 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.33 -1.508 . . . . 0.1 109.33 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -81.47 92.83 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -1.142 . . . . 0.1 110.233 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.654 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -69.37 98.55 1.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.09 110.294 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.43 ' O ' ' OE2' ' A' ' 223' ' ' GLU . 19.2 m170 -102.98 138.14 40.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.09 110.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.649 ' CE1' HG22 ' A' ' 219' ' ' VAL . 17.5 m-85 -107.15 133.16 52.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.1 111.284 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 42.9 t0 -45.55 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.936 -0.764 . . . . 0.14 108.936 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 201' ' ' PHE . 0.8 OUTLIER -40.86 -34.16 0.37 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.014 -1.053 . . . . 0.18 111.525 -177.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.581 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 48.8 t0 -73.75 0.54 12.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.772 -1.205 . . . . 0.24 110.46 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 10.5 mm-40 -97.42 -161.72 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.123 . . . . 0.42 109.903 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.539 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 69.6 m -133.24 153.67 51.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.916 -1.115 . . . . 0.47 110.835 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.67 ' C ' HG22 ' A' ' 208' ' ' THR . 0.8 OUTLIER -148.3 166.47 27.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.308 -0.87 . . . . 0.27 109.796 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.999 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.3 OUTLIER -178.81 175.07 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.069 -1.019 . . . . 0.3 110.871 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.46 ' N ' ' OG1' ' A' ' 208' ' ' THR . 0.0 OUTLIER -139.01 25.75 2.49 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.565 -0.854 . . . . 0.61 109.817 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.2 t -90.66 -88.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 0.78 110.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 210' ' ' SER . 35.7 p -158.88 18.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.91 110.0 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 213' ' ' GLY . 6.9 ptpt -145.69 -174.11 4.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.93 110.133 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 44.34 -168.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.79 109.625 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.605 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 97.7 m-85 -70.33 121.56 17.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.69 110.195 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.631 ' O ' HG12 ' A' ' 219' ' ' VAL . 47.7 m-80 -87.31 116.89 25.71 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.159 -0.963 . . . . 0.4 109.086 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.17 -35.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.625 -0.83 . . . . 0.17 110.332 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.608 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 2.2 m-85 -52.37 -45.87 65.95 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.405 -1.331 . . . . 0.28 107.405 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.979 HD21 ' HB2' ' A' ' 244' ' ' TYR . 9.7 tp -81.42 -73.16 0.39 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.435 -0.802 . . . . 0.46 110.993 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.816 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.6 p -45.5 -56.14 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.39 110.325 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.934 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -60.5 -48.5 81.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.087 -1.008 . . . . 0.17 111.114 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -56.7 -24.59 50.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.177 -1.577 . . . . 0.1 108.406 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.683 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.3 t60 -83.33 -49.87 8.93 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.749 -0.659 . . . . 0.21 110.325 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.731 ' CD ' ' HB1' ' A' ' 186' ' ' ALA . 3.0 tp10 -61.69 -44.54 96.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.933 -1.104 . . . . 0.28 108.782 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER -60.23 -62.16 2.07 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.472 -0.768 . . . . 0.18 109.026 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.85 -28.86 0.73 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.918 -1.673 . . . . 0.21 108.918 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.535 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 1.0 OUTLIER -80.91 -68.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -1.134 . . . . 0.17 111.084 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.997 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -46.93 -38.41 10.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.51 -0.744 . . . . 0.33 112.288 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER -100.13 -37.45 8.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.53 110.977 -178.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.666 ' N ' HD23 ' A' ' 228' ' ' LEU . . . -74.39 -87.42 0.23 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.963 -1.255 . . . . 0.41 109.963 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 230' ' ' LEU . 0.7 OUTLIER -161.96 -176.23 5.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.45 110.789 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 2.6 m-20 -55.17 -58.84 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.374 -0.829 . . . . 0.62 110.19 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.535 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 3.6 m80 -161.6 176.15 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.45 110.639 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 2.4 p 179.73 50.69 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.79 -0.818 . . . . 0.38 108.79 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -125.09 20.21 8.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.537 -0.727 . . . . 0.48 110.584 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.579 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -43.12 -53.53 10.54 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 119.443 -0.903 . . . . 0.38 109.831 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 50.5 Cg_endo -86.05 -47.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.595 1.313 . . . . 0.28 110.573 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 178.23 94.55 0.09 OUTLIER Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.233 -1.46 . . . . 0.24 111.589 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.833 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -144.42 162.16 37.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.211 -1.17 . . . . 0.28 110.358 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.683 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -77.61 57.73 1.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.4 108.72 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.581 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 21.6 mmm -133.14 -35.71 1.03 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.45 110.354 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -43.99 169.86 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.152 -0.968 . . . . 0.57 110.366 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.5 Cg_endo -71.85 -8.09 22.35 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.763 1.402 . . . . 0.76 109.842 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 245' ' ' THR . 16.1 mt -98.83 146.76 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.89 109.699 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.979 ' HB2' HD21 ' A' ' 218' ' ' LEU . 36.8 p90 -128.92 -25.97 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.03 -1.044 . . . . 0.78 110.976 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.743 HG22 HG22 ' A' ' 243' ' ' ILE . 0.2 OUTLIER 2.73 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.602 0.964 . . . . 0.61 113.602 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.732 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -70.23 107.56 3.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.381 -1.45 . . . . 0.74 109.686 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.774 ' HA ' HD13 ' A' ' 218' ' ' LEU . 2.2 t -65.32 -151.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 0.81 110.252 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 247' ' ' THR . . . -84.31 -5.0 87.63 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.404 -1.478 . . . . 0.56 109.404 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.754 ' H ' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -147.04 30.13 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -1.155 . . . . 0.37 110.38 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 246' ' ' TYR . 0.3 OUTLIER -74.16 -28.8 61.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.44 110.406 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 1.9 m-70 -164.82 -61.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.53 110.425 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 2.8 m-85 -174.38 -174.4 0.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.967 . . . . 0.38 110.516 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.842 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -68.07 53.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.51 -0.744 . . . . 0.19 110.559 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.695 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.1 -47.57 43.52 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 107.963 -1.125 . . . . 0.28 107.963 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.9 Cg_endo -73.59 51.0 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.137 1.598 . . . . 0.49 110.979 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.1 m-20 -50.65 -32.42 19.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.018 -1.051 . . . . 0.49 110.494 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.833 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -53.82 -54.13 42.75 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.885 -1.126 . . . . 0.31 109.136 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.017 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -66.01 -35.48 80.69 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.074 -1.05 . . . . 0.14 108.784 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 253' ' ' MET . 55.2 t -63.93 -86.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.17 110.581 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -55.0 -43.73 73.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.099 -1.001 . . . . 0.26 109.569 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.83 -70.2 0.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.641 -0.984 . . . . 0.19 110.641 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.017 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.66 -21.13 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.727 -1.455 . . . . 0.22 110.296 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.995 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.6 OUTLIER -64.86 -20.47 66.43 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.985 -1.072 . . . . 0.39 108.659 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 29.1 t -103.72 -41.88 5.8 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.203 -0.599 . . . . 0.47 111.164 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -84.3 -47.09 11.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.353 -0.842 . . . . 0.48 111.145 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -69.64 -20.52 63.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.41 110.223 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -53.51 -102.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.276 -1.53 . . . . 0.46 109.276 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.33 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.867 1.457 . . . . 0.58 110.333 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -83.22 155.79 33.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.64 109.388 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.63 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 O-C-N 121.206 -1.173 . . . . 0.95 110.414 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.59 ' N ' HD13 ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.49 1.567 0 CA-C-O 121.525 0.679 . . . . 1.03 109.259 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.01 55.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.682 -0.636 . . . . 1.04 111.67 178.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -140.94 77.03 1.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.193 -0.942 . . . . 0.77 109.403 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.573 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 10.1 t90 -149.72 -69.22 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.42 111.411 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.6 t -100.48 77.17 1.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.44 111.101 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -170.21 49.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.279 -0.888 . . . . 0.49 110.185 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.2 OUTLIER -75.46 -29.15 59.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.3 110.141 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 25.0 p-10 -129.74 123.46 31.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.15 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' A' ' 162' ' ' ASP . 3.8 mt -141.32 -178.62 5.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.13 110.364 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -122.6 150.75 42.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.12 109.829 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.733 ' HB3' HG23 ' A' ' 163' ' ' ILE . 40.3 p90 -145.11 -164.31 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.33 110.692 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.1 154.2 40.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.54 110.888 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.936 HD13 ' HB3' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.48 110.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.33 110.223 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.4 m -159.91 41.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.27 110.147 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 3.4 t-20 -41.36 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.696 -0.802 . . . . 0.41 108.993 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 6.3 t80 -179.91 -176.14 0.33 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.514 -0.741 . . . . 0.4 109.593 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -132.52 49.77 4.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.013 -1.054 . . . . 0.45 110.611 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.4 Cg_endo -76.78 -85.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.854 1.45 . . . . 0.36 110.253 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.31 -0.5 38.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.25 109.622 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.821 ' SD ' HD21 ' A' ' 216' ' ' LEU . 3.6 ptm -123.12 133.93 54.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.39 109.976 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 131' ' ' HIS . 1.4 m -86.33 178.52 7.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.48 110.354 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.483 ' H ' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -45.74 -33.76 3.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.845 . . . . 0.4 110.068 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.5 t -63.16 -58.3 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.46 109.791 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.55 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 6.3 mp0 -54.46 -57.72 10.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.268 -0.895 . . . . 0.47 109.566 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.792 HG23 ' HE2' ' A' ' 129' ' ' MET . 4.0 t -45.34 -37.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.111 -1.07 . . . . 0.31 108.111 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 9.6 tt0 -59.03 -39.97 83.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.486 -0.931 . . . . 0.48 108.486 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 12.9 tttt -73.07 -50.37 23.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.64 108.776 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.806 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.64 -60.61 2.1 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.163 -0.961 . . . . 0.42 110.537 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.936 ' HB3' HD13 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.44 -50.97 48.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.34 111.216 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.625 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.91 -71.17 0.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.957 -1.089 . . . . 0.47 110.147 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -40.18 -58.78 1.4 Allowed 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.651 -0.656 . . . . 0.47 110.114 178.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.75 -38.81 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.707 -1.246 . . . . 0.25 108.365 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -71.0 -34.73 71.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.846 . . . . 0.35 108.985 178.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -56.4 -45.45 80.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.7 108.394 178.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.403 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 22.9 t -64.68 -44.67 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.987 -0.746 . . . . 0.61 108.987 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.64 ' HH2' HG21 ' A' ' 262' ' ' ILE . 26.3 t-105 -55.02 -36.69 65.74 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.718 -0.845 . . . . 0.39 108.718 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -74.12 -38.42 63.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.742 -0.836 . . . . 0.35 108.742 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -53.1 -37.48 61.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.533 -0.729 . . . . 0.36 109.045 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 145' ' ' TRP . 34.8 m -85.45 -35.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.5 110.116 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.702 ' CG2' HD23 ' A' ' 151' ' ' LEU . 15.3 t -153.93 127.25 4.24 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.038 -1.039 . . . . 0.51 110.15 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.67 59.88 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.871 1.459 . . . . 0.31 110.813 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 266' ' ' TYR . 1.9 mm? -72.53 145.88 47.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.18 110.086 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -91.88 133.68 35.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.17 110.32 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.9 p90 -149.11 147.91 29.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.14 110.237 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.931 ' O ' HG22 ' A' ' 119' ' ' THR . 6.5 m -152.72 133.03 13.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.15 110.29 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 32.1 mtm180 -91.86 119.32 31.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.013 -1.054 . . . . 0.2 110.16 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.405 HD12 HG21 ' A' ' 119' ' ' THR . 0.3 OUTLIER -117.56 108.67 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.22 110.3 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -72.17 -4.11 27.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.32 110.091 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -30.08 69.79 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.409 -0.807 . . . . 0.33 109.581 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.81 30.65 0.63 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.734 -1.346 . . . . 0.28 109.734 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.726 ' O ' HG22 ' A' ' 160' ' ' ILE . 57.7 mt -126.68 66.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.073 -1.251 . . . . 0.3 109.308 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -121.9 152.1 39.99 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.358 0.599 . . . . 0.2 110.612 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.512 ' CB ' HD22 ' A' ' 118' ' ' LEU . 5.4 t70 -120.5 -40.04 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.1 109.818 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.919 HG21 HD13 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -128.57 171.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.36 -0.838 . . . . 0.1 110.105 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.745 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 2.3 ptp -177.14 153.99 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.539 -1.351 . . . . 0.11 111.379 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.6 tt -99.3 118.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.1 109.408 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.988 ' HB3' HG23 ' A' ' 123' ' ' VAL . 15.1 p -162.85 144.64 10.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.752 -1.218 . . . . 0.1 111.237 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.652 ' CE2' ' CG2' ' A' ' 169' ' ' ILE . 0.9 OUTLIER -66.42 122.83 18.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.09 110.006 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -80.87 127.94 8.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.972 -1.251 . . . . 0.2 109.972 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.652 ' CG2' ' CE2' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -116.07 102.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.535 -0.98 . . . . 0.55 109.659 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.639 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.78 81.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.439 0.638 . . . . 0.85 112.257 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 169' ' ' ILE . 1.7 mm-40 -125.95 -4.86 6.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.71 110.267 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.524 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 8.8 m-70 -87.41 -140.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.42 109.995 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -169.89 -36.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.399 -1.48 . . . . 0.33 109.399 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -61.36 -61.23 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -1.104 . . . . 0.33 110.194 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.8 116.02 17.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.27 110.16 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -55.41 114.43 7.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 0.34 110.071 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.518 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 42.9 Cg_endo -73.14 -79.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.907 1.477 . . . . 0.47 110.898 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -46.59 142.95 2.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 0.35 110.778 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' A' ' 184' ' ' LEU . 4.4 p30 179.5 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.2 110.751 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.573 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 46.76 -167.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.38 -1.488 . . . . 0.25 109.38 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.2 Cg_endo -75.81 5.01 4.66 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.197 1.63 . . . . 0.44 110.304 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -44.57 173.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -0.797 . . . . 0.57 110.898 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.64 76.71 0.02 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.895 -0.882 . . . . 0.49 110.895 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.957 HD23 ' OD1' ' A' ' 202' ' ' ASP . 0.4 OUTLIER 179.46 88.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.174 -1.192 . . . . 0.41 110.373 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.557 HD12 ' OE1' ' A' ' 205' ' ' GLU . 4.6 tt -108.76 -21.13 12.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.832 -1.168 . . . . 0.3 111.612 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.552 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -149.97 101.09 3.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.48 -1.388 . . . . 0.2 111.907 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.7 OUTLIER -101.76 123.78 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.473 -0.767 . . . . 0.16 109.431 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.93 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -108.88 137.32 46.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.23 110.65 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -80.0 173.1 8.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.38 110.369 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 48.4 Cg_endo -73.75 133.34 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.975 1.513 . . . . 0.4 109.786 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.552 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -69.79 81.17 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.866 1.456 . . . . 0.32 110.604 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.55 -106.63 1.78 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.292 -1.523 . . . . 0.32 109.292 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.95 -159.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.882 1.464 . . . . 0.47 110.337 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -63.07 -11.27 18.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.941 . . . . 0.63 110.383 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.76 56.02 0.68 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.428 -0.795 . . . . 0.53 110.147 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.3 174.59 22.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.212 -1.555 . . . . 0.25 109.212 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 42.09 25.75 0.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.946 -1.261 . . . . 0.1 109.946 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.3 OUTLIER -79.38 86.16 5.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.32 . . . . 0.1 110.005 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.94 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.09 110.002 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.541 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.4 m170 -98.79 134.01 42.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.09 110.669 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.598 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 13.3 m-30 -102.74 131.07 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -0.903 . . . . 0.1 109.877 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.957 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -46.3 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.544 -0.91 . . . . 0.14 108.544 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.0 p30 -37.68 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.18 111.53 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.573 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -77.7 3.95 12.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.762 -1.211 . . . . 0.24 110.829 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.557 ' OE1' HD12 ' A' ' 185' ' ' LEU . 15.6 mm-40 -100.68 -167.39 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.036 . . . . 0.42 110.315 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.507 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 3.2 m -124.64 150.28 46.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -0.929 . . . . 0.47 110.385 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.55 ' HB3' HD11 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -147.42 142.74 27.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.902 . . . . 0.27 109.636 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.958 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -157.81 174.21 15.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.822 -1.174 . . . . 0.3 110.984 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.476 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.5 t -130.66 41.0 3.44 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.639 0.733 . . . . 0.61 109.384 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.9 t -109.87 -99.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.78 110.267 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.494 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -149.59 13.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.068 -1.02 . . . . 0.91 110.247 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.99 155.55 44.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.93 109.858 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.81 -175.24 53.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.081 -1.608 . . . . 0.79 109.081 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 185' ' ' LEU . 67.7 m-85 -71.26 106.53 3.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 0.69 109.931 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.517 ' O ' HG12 ' A' ' 219' ' ' VAL . 61.6 m-20 -75.04 119.28 18.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.154 -0.966 . . . . 0.4 108.528 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.958 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -39.71 -37.01 0.47 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.82 -0.752 . . . . 0.17 110.271 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.571 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.3 m-30 -52.16 -48.82 64.73 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.653 -1.24 . . . . 0.28 107.653 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.652 HD21 ' HB2' ' A' ' 244' ' ' TYR . 6.8 tp -74.56 -69.81 0.44 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.856 -0.611 . . . . 0.46 110.45 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.5 OUTLIER -50.12 -70.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.077 -1.014 . . . . 0.39 109.75 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -41.73 -52.55 3.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.07 . . . . 0.17 111.248 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.47 -37.3 77.84 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.417 -1.427 . . . . 0.1 108.977 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.836 ' HB2' HD11 ' A' ' 239' ' ' LEU . 5.6 t60 -64.91 -53.39 47.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.421 0.629 . . . . 0.21 109.551 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.552 ' OE1' ' HB1' ' A' ' 186' ' ' ALA . 25.0 tp10 -57.99 -46.14 85.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.28 109.301 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.531 ' CZ ' ' HB1' ' A' ' 220' ' ' ALA . 12.3 m-30 -52.57 -63.44 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.18 109.279 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -34.46 2.73 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.913 -1.675 . . . . 0.21 108.913 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.86 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -76.03 -79.02 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -1.132 . . . . 0.17 110.839 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.93 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.4 -53.93 0.65 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.666 -0.646 . . . . 0.33 111.916 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -80.59 -44.83 18.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.998 -1.064 . . . . 0.53 110.725 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -63.58 -82.78 0.08 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.775 -1.33 . . . . 0.41 109.775 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.59 HD13 ' N ' ' A' ' 110' ' ' THR . 0.5 OUTLIER -177.5 -170.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -1.076 . . . . 0.45 110.299 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 230' ' ' LEU . 1.8 m-20 -42.22 -61.62 1.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.62 110.51 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.86 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -159.51 -175.9 5.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.289 -0.882 . . . . 0.45 109.989 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.0 61.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.295 -0.878 . . . . 0.38 109.56 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.907 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.68 24.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.279 -0.968 . . . . 0.48 111.502 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -35.93 -51.9 1.58 Allowed Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.987 -0.685 . . . . 0.38 111.106 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 51.1 Cg_endo -85.58 -49.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.643 1.338 . . . . 0.28 111.291 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.19 101.25 0.14 Allowed Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.214 -1.47 . . . . 0.24 111.581 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.907 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -143.22 -174.21 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -1.124 . . . . 0.28 110.238 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.836 HD11 ' HB2' ' A' ' 222' ' ' HIS . 3.1 tp -88.86 27.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.371 1.081 . . . . 0.4 108.87 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.663 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -119.44 -6.46 10.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.872 -1.142 . . . . 0.45 110.655 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -60.53 170.31 1.42 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 121.15 -0.969 . . . . 0.57 111.558 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.1 Cg_endo -76.09 6.08 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.516 1.272 . . . . 0.76 110.597 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.732 HG22 HG22 ' A' ' 245' ' ' THR . 16.1 mt -126.89 164.88 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.337 -0.852 . . . . 0.89 109.506 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.652 ' HB2' HD21 ' A' ' 218' ' ' LEU . 33.3 p90 -139.72 -29.2 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.78 111.249 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.2 OUTLIER 3.18 -67.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 114.14 1.163 . . . . 0.61 114.14 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -59.87 101.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.279 -1.513 . . . . 0.74 109.816 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.505 ' N ' ' HB2' ' A' ' 250' ' ' SER . 80.6 p -50.44 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.81 110.146 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -56.79 -26.14 53.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.463 -1.455 . . . . 0.56 109.463 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.31 29.33 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.16 . . . . 0.37 110.014 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.521 ' O ' ' ND1' ' A' ' 251' ' ' HIS . 0.5 OUTLIER -62.8 -10.98 14.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.44 109.982 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 250' ' ' SER . 0.1 OUTLIER -174.42 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.53 110.204 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.3 OUTLIER 179.67 -173.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.38 110.285 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.916 ' HB2' HG21 ' A' ' 259' ' ' VAL . 14.2 ptt? -66.55 53.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.605 -0.684 . . . . 0.19 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.695 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -47.84 -46.3 62.52 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.28 107.833 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.9 Cg_endo -74.54 52.52 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.958 1.504 . . . . 0.49 110.806 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.639 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 9.9 m-20 -55.78 -31.51 62.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.159 -0.963 . . . . 0.49 110.572 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.851 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -51.35 -45.91 62.52 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.655 -1.218 . . . . 0.31 108.551 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.933 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.72 -39.47 64.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.453 -0.943 . . . . 0.14 108.453 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.916 HG21 ' HB2' ' A' ' 253' ' ' MET . 97.3 t -56.24 -76.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.17 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.71 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 7.1 pt20 -71.05 -34.76 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.32 -0.862 . . . . 0.26 110.567 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -44.37 -58.34 4.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.308 -1.517 . . . . 0.19 109.308 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.933 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -82.87 -23.12 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.023 -1.28 . . . . 0.22 110.89 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.722 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -62.63 -20.0 64.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.462 . . . . 0.39 108.195 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -103.18 -36.92 7.93 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.181 -0.608 . . . . 0.47 111.125 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 48.5 mt -88.32 -46.89 8.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.139 -0.976 . . . . 0.48 111.216 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.749 ' HB3' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -81.33 -4.76 56.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.41 110.299 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.8 -112.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.231 -1.548 . . . . 0.46 109.231 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.55 86.2 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.789 1.415 . . . . 0.58 110.296 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.27 170.12 1.8 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.64 109.575 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.573 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 . . . . . 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.95 110.166 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.507 ' O ' ' N ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.256 -0.646 . . . . 1.03 109.256 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.6 OUTLIER 32.15 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.131 0.491 . . . . 1.04 111.461 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.883 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 7.6 mttt -124.73 64.92 1.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.77 110.357 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.628 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.1 t90 -123.3 -67.94 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.897 . . . . 0.42 110.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.421 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 72.8 p -99.38 54.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.44 110.151 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.443 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 17.5 mmtt -145.31 87.15 1.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.49 110.289 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 116' ' ' MET . 2.1 tmm? -121.34 -4.45 9.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.3 110.052 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.15 110.076 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.429 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -147.29 -167.1 2.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.13 110.31 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -133.66 156.37 48.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.12 110.473 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.804 ' CB ' HG23 ' A' ' 163' ' ' ILE . 46.0 p90 -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.49 -0.884 . . . . 0.33 110.94 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 1.1 mtt85 -124.85 151.39 45.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.54 110.114 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.723 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.2 pp -114.02 97.93 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.947 . . . . 0.33 111.14 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' A' ' 166' ' ' SER . 7.3 m -147.34 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.27 110.471 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.0 t30 -44.31 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.41 109.379 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.553 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.0 t80 -179.85 -166.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.437 -0.79 . . . . 0.4 109.736 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -148.95 48.2 0.57 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.982 -1.074 . . . . 0.45 110.693 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.3 Cg_endo -74.04 -87.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.998 1.525 . . . . 0.36 110.268 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.96 -0.89 57.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.25 109.65 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.783 ' SD ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -119.55 158.83 25.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.816 . . . . 0.39 109.718 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -112.31 177.03 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.48 110.183 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 130' ' ' THR . 1.3 t-160 -43.18 -40.12 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.4 109.71 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 23.3 t -61.49 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.46 109.629 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.3 OUTLIER -62.63 -60.74 3.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 0.47 109.375 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.9 t -45.72 -36.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.882 -1.155 . . . . 0.31 107.882 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -58.21 -40.81 82.59 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.053 -1.091 . . . . 0.48 108.053 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.603 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.7 tttt -72.74 -54.56 8.6 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.76 -0.83 . . . . 0.64 108.76 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.862 ' HB1' HD22 ' A' ' 216' ' ' LEU . . . -45.88 -63.22 1.02 Allowed 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.958 -1.088 . . . . 0.42 110.101 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -61.7 -55.82 26.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.213 -0.93 . . . . 0.34 110.849 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 3.3 tttt -64.96 -73.2 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.47 110.331 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.37 -63.06 0.53 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.686 -0.634 . . . . 0.47 110.562 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -46.51 -36.92 7.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.77 -1.206 . . . . 0.25 108.665 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -72.62 -33.05 66.4 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.361 -0.837 . . . . 0.35 108.937 178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.226 -0.921 . . . . 0.7 108.784 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 40.8 t -72.13 -48.28 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.589 -0.694 . . . . 0.61 109.294 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.827 ' HH2' HG21 ' A' ' 262' ' ' ILE . 32.0 t-105 -56.71 -40.18 75.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.788 . . . . 0.39 109.047 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.2 m -73.12 -31.23 64.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.598 -0.89 . . . . 0.35 108.598 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -57.74 -43.22 85.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.132 -0.692 . . . . 0.36 109.132 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.802 HG23 HG22 ' A' ' 149' ' ' THR . 27.7 m -76.16 -33.0 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.618 -0.833 . . . . 0.5 109.739 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.802 HG22 HG23 ' A' ' 148' ' ' VAL . 4.6 t -145.1 120.57 5.86 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 0.51 110.149 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.36 58.86 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.757 1.399 . . . . 0.31 110.658 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 266' ' ' TYR . 8.8 mt -72.58 161.17 31.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.18 110.027 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.0 OUTLIER -104.46 102.02 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.17 110.255 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 151' ' ' LEU . 37.3 m-85 -123.3 142.86 50.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.14 110.2 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.678 ' O ' HG22 ' A' ' 119' ' ' THR . 3.3 m -142.0 141.35 32.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.184 -0.948 . . . . 0.15 110.448 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.644 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -100.06 91.64 4.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.2 109.985 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.06 106.91 18.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.22 110.153 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 158' ' ' ASP . 51.1 p-80 -63.83 -29.62 70.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.32 110.145 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' HIS . 2.1 t0 -41.19 -30.58 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.589 -0.694 . . . . 0.33 110.098 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.73 32.13 0.72 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.716 -1.354 . . . . 0.28 109.716 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 119' ' ' THR . 39.9 mt -121.51 71.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.127 -1.219 . . . . 0.3 109.513 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -138.55 156.19 47.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.888 -0.725 . . . . 0.2 110.767 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.429 ' CB ' HD23 ' A' ' 118' ' ' LEU . 39.0 t0 -124.64 -31.08 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.439 -0.788 . . . . 0.1 110.036 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.804 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -122.47 160.66 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.236 -0.915 . . . . 0.1 109.912 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.727 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -165.36 140.96 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.373 -1.454 . . . . 0.11 111.6 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.9 tt -90.32 116.67 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 0.1 109.538 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.889 ' HB3' HG23 ' A' ' 123' ' ' VAL . 3.7 p -156.1 159.88 39.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.921 -1.112 . . . . 0.1 110.46 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.8 p90 -76.55 116.59 17.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.409 -0.807 . . . . 0.09 109.735 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -64.16 119.69 16.83 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.434 -1.066 . . . . 0.2 110.434 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 169' ' ' ILE . 1.7 tp -117.09 97.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.639 -0.918 . . . . 0.55 109.532 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.603 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.09 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 112.634 0.605 . . . . 0.85 112.634 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -156.03 17.1 0.36 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.847 . . . . 0.71 110.606 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.581 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 2.2 m170 -82.58 -90.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.42 110.207 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -177.35 -36.73 0.06 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.42 -1.472 . . . . 0.33 109.42 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -148.41 -65.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.33 110.185 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.46 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 58.0 t80 -42.13 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.27 110.403 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 174' ' ' ASP . 10.9 m-30 -47.9 104.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.34 110.264 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.819 ' O ' HD23 ' A' ' 184' ' ' LEU . 49.1 Cg_endo -79.72 -64.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.09 1.574 . . . . 0.47 110.677 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.603 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -72.64 138.33 46.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.072 -1.017 . . . . 0.35 111.07 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 202' ' ' ASP . 0.5 OUTLIER 178.79 78.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.071 -1.052 . . . . 0.2 111.652 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.569 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 35.41 -153.66 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.86 -0.896 . . . . 0.25 110.86 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -74.93 3.39 5.62 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.554 1.818 . . . . 0.44 110.361 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 184' ' ' LEU . 14.1 t -40.15 162.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.57 110.256 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -59.13 76.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.498 -1.041 . . . . 0.49 110.498 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.874 HD23 ' OD1' ' A' ' 202' ' ' ASP . 9.9 tp 179.76 84.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.391 -1.064 . . . . 0.41 110.047 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.606 HD12 ' OE1' ' A' ' 205' ' ' GLU . 0.4 OUTLIER -100.92 -25.27 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.224 . . . . 0.3 111.07 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.415 ' HB1' ' HB2' ' A' ' 223' ' ' GLU . . . -150.4 105.07 3.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.68 -1.262 . . . . 0.2 111.928 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 21.2 p-80 -110.65 122.55 48.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.16 109.437 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -116.29 131.3 56.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.23 110.422 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.581 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.7 OUTLIER -73.48 169.33 18.76 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.38 110.675 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.8 Cg_endo -73.59 144.0 35.07 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.171 1.617 . . . . 0.4 109.618 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.2 Cg_endo -70.71 81.12 1.09 Allowed 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.91 1.479 . . . . 0.32 110.82 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.4 -107.28 2.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.466 -1.454 . . . . 0.32 109.466 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -75.76 -162.76 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.927 1.488 . . . . 0.47 110.731 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -57.85 -15.43 8.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.63 110.316 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.22 54.96 0.7 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.496 -0.753 . . . . 0.53 110.251 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.4 170.09 21.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.409 -1.476 . . . . 0.25 109.409 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.76 27.44 0.35 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.62 -1.392 . . . . 0.1 109.62 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 2.0 m-20 -76.75 92.12 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.239 . . . . 0.1 110.087 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.878 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -74.69 98.63 3.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.09 109.954 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 29.2 m170 -117.47 126.03 51.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.218 -0.926 . . . . 0.09 110.688 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 203' ' ' ASP . 32.6 m-85 -93.41 141.97 27.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.1 110.571 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.874 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -49.0 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.183 -1.043 . . . . 0.14 108.183 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.613 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 4.3 p30 -37.21 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.18 111.604 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.569 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.7 t0 -75.56 -1.62 25.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.568 -1.333 . . . . 0.24 110.994 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.606 ' OE1' HD12 ' A' ' 185' ' ' LEU . 21.4 mm-40 -94.15 -163.52 1.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.937 -1.102 . . . . 0.42 110.379 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.424 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -125.94 150.84 47.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.47 110.729 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.613 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -143.36 140.86 30.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 0.27 109.295 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.985 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.18 177.67 11.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.877 -1.139 . . . . 0.3 110.95 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 209' ' ' SER . 2.0 t -131.56 45.95 2.72 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.584 0.707 . . . . 0.61 109.6 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.1 t -112.38 -105.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.78 110.164 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 210' ' ' SER . 25.2 p -157.48 17.85 0.27 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.91 110.268 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 213' ' ' GLY . 4.2 mttp -125.91 -86.45 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.93 110.193 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . -49.08 -178.3 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.317 . . . . 0.79 109.806 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.441 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 94.8 m-85 -57.08 115.15 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.69 109.992 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.637 ' ND2' HG22 ' A' ' 247' ' ' THR . 9.9 m-80 -82.67 116.03 21.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.008 . . . . 0.4 109.044 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.985 HD12 ' O ' ' A' ' 208' ' ' THR . 1.2 mp -41.73 -33.38 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.436 -0.79 . . . . 0.17 110.283 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.61 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 5.2 m-85 -53.44 -45.07 69.33 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 118.07 -1.452 . . . . 0.28 107.431 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 244' ' ' TYR . 20.9 tp -82.52 -71.0 0.51 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.523 -0.762 . . . . 0.46 110.993 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.849 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -47.86 -56.61 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.39 110.19 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.977 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.56 -46.92 87.51 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.968 -1.083 . . . . 0.17 111.131 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -60.33 -23.6 64.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.164 -1.585 . . . . 0.1 108.454 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.661 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 3.4 t-160 -80.43 -50.04 10.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.373 -0.603 . . . . 0.21 109.373 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.878 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.7 tp10 -62.31 -33.32 74.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.065 -1.022 . . . . 0.28 108.442 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.554 ' CE1' HD11 ' A' ' 163' ' ' ILE . 6.2 m-85 -64.78 -66.87 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.669 0.747 . . . . 0.18 108.99 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.453 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.35 -28.15 0.54 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.762 -1.735 . . . . 0.21 108.762 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.428 ' N ' ' O ' ' A' ' 224' ' ' PHE . 3.3 m80 -81.42 -68.07 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -1.166 . . . . 0.17 110.842 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.912 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.2 OUTLIER -40.36 -42.78 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.33 111.88 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.798 HD12 ' OH ' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -101.16 -37.77 8.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.885 -1.134 . . . . 0.53 111.364 -178.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -65.09 -81.86 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.624 -0.99 . . . . 0.41 110.624 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 110' ' ' THR . 0.8 OUTLIER -169.85 -147.83 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -1.18 . . . . 0.45 110.658 -178.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -86.87 -44.48 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.356 -0.84 . . . . 0.62 110.532 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -179.99 161.88 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.45 110.284 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 p -168.67 28.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.38 109.797 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.922 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -104.3 22.45 14.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -0.779 . . . . 0.48 111.002 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.543 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -35.25 -50.37 1.24 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.559 -0.713 . . . . 0.38 110.685 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 47.5 Cg_endo -86.73 -49.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.433 1.228 . . . . 0.28 111.14 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.06 101.33 0.14 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.137 -1.506 . . . . 0.24 111.544 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.922 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -145.36 173.58 11.87 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.371 -1.076 . . . . 0.28 109.7 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.607 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -80.85 38.31 0.45 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.826 -1.171 . . . . 0.4 109.916 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.661 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 25.6 mtp -123.01 -17.61 6.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.45 109.746 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.645 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -56.0 170.25 0.47 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.184 -0.948 . . . . 0.57 110.97 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 46.3 Cg_endo -73.73 -10.9 23.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.626 1.329 . . . . 0.76 110.006 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.656 HG22 HG22 ' A' ' 245' ' ' THR . 36.5 mt -104.84 147.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.89 109.787 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 1.037 ' HB2' HD21 ' A' ' 218' ' ' LEU . 41.8 p90 -131.25 -24.45 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.78 111.115 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.738 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.2 OUTLIER 2.88 -68.97 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 113.534 0.938 . . . . 0.61 113.534 -179.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.738 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -62.72 107.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.447 -1.408 . . . . 0.74 109.5 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.637 HG22 ' ND2' ' A' ' 215' ' ' ASN . 42.7 p -54.1 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.81 110.215 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.04 -9.76 54.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.317 -1.513 . . . . 0.56 109.317 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -149.27 29.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -1.18 . . . . 0.37 110.526 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.446 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.6 OUTLIER -73.84 -31.52 63.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.996 -1.065 . . . . 0.44 110.091 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.8 -60.23 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.53 109.913 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.58 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 179.42 -175.61 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.38 110.306 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.861 ' HB2' HG21 ' A' ' 259' ' ' VAL . 25.9 ptt? -68.83 52.5 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.19 110.416 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.683 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.2 -46.85 44.82 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 107.912 -1.144 . . . . 0.28 107.912 177.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.3 Cg_endo -73.81 52.3 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.956 1.503 . . . . 0.49 110.715 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.662 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 12.4 m-20 -57.22 -28.58 63.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.371 -0.831 . . . . 0.49 110.436 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.911 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 2.0 m-20 -51.31 -45.44 62.23 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.015 -1.053 . . . . 0.31 109.235 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.844 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.02 -34.18 50.75 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.365 -0.976 . . . . 0.14 108.365 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.861 HG21 ' HB2' ' A' ' 253' ' ' MET . 98.6 t -58.6 -74.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.899 -0.72 . . . . 0.17 110.533 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 14.1 pt20 -69.9 -37.05 75.87 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.267 -0.896 . . . . 0.26 109.769 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.508 ' N ' ' HG3' ' A' ' 260' ' ' GLN . . . -41.53 -53.92 4.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.466 -1.454 . . . . 0.19 109.466 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.883 HG22 ' NZ ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -92.1 -23.58 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.963 -1.316 . . . . 0.22 110.97 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.735 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 7.1 tp60 -54.81 -26.12 32.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.001 -1.48 . . . . 0.39 107.947 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.1 p -103.92 -41.68 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.244 0.545 . . . . 0.47 111.127 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 4.0 mm? -73.95 -51.85 14.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.48 111.477 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.798 ' OH ' HD12 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -76.18 -9.67 58.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.41 110.533 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -60.38 -111.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.356 -1.498 . . . . 0.46 109.356 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 88.98 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.819 1.431 . . . . 0.58 110.226 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.29 168.53 50.67 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.605 -1.398 . . . . 0.64 109.605 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.628 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 1.3 m-20 . . . . . 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.95 110.247 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 111' ' ' LEU . 1.1 p . . . . . 0 N--CA 1.488 1.444 0 N-CA-C 109.444 -0.576 . . . . 1.03 109.444 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER 30.92 38.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.208 0.528 . . . . 1.04 111.356 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.529 ' HE2' HD22 ' A' ' 265' ' ' LEU . 0.8 OUTLIER -135.96 61.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.77 109.536 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.624 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 8.3 t90 -131.19 -50.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.42 110.682 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.458 ' C ' ' HG2' ' A' ' 115' ' ' LYS . 28.5 t -111.89 62.85 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.44 110.928 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HG2' ' C ' ' A' ' 114' ' ' SER . 19.5 mmmt -149.09 42.05 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.074 -1.017 . . . . 0.49 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 2.2 ttp -72.77 -19.58 61.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.137 -0.977 . . . . 0.3 110.837 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 1.052 ' O ' HD22 ' A' ' 118' ' ' LEU . 5.7 p30 -138.48 113.23 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.15 110.743 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.052 HD22 ' O ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -143.47 -179.68 6.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.13 110.261 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -124.04 173.53 8.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.12 110.078 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 14.6 p90 -167.78 179.25 4.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.128 -0.982 . . . . 0.33 111.008 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 22.9 tpt85 -126.03 147.66 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.54 109.989 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.712 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.1 pp -110.36 77.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.33 110.789 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.971 HG23 ' HB3' ' A' ' 166' ' ' SER . 8.3 m -125.54 42.17 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.27 110.299 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.734 ' ND2' HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -40.33 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.567 -0.853 . . . . 0.41 109.212 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.667 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 2.9 t80 -178.9 169.33 1.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.044 -1.035 . . . . 0.4 110.293 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -125.23 49.69 3.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.97 . . . . 0.45 110.481 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.1 Cg_endo -73.97 -87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.121 1.59 . . . . 0.36 110.317 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.08 2.1 50.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.25 109.805 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.991 ' HE2' HD21 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -117.88 159.15 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.39 109.829 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -109.73 175.96 5.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.48 110.103 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 71.6 t60 -43.39 -32.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.4 109.738 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 1.3 t -68.42 -59.16 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.46 109.752 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 32.8 mp0 -51.46 -59.87 3.76 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.309 -0.87 . . . . 0.47 109.645 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 ' ND2' ' A' ' 124' ' ' ASN . 6.2 t -46.04 -37.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.261 -1.015 . . . . 0.31 108.261 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.596 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 12.1 tt0 -57.63 -39.1 76.2 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.347 -0.983 . . . . 0.48 108.347 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -73.84 -52.66 12.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.948 0.88 . . . . 0.64 108.819 178.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.827 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.48 -64.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.112 -0.993 . . . . 0.42 110.508 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.712 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -63.17 -53.73 48.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.34 111.327 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.65 -72.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.928 -1.107 . . . . 0.47 110.371 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -39.49 -61.84 0.75 Allowed 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.697 -0.627 . . . . 0.47 110.494 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -45.62 -37.99 6.17 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.795 -1.162 . . . . 0.25 108.291 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.37 -37.83 74.66 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.029 -0.73 . . . . 0.35 109.029 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttpt -55.38 -40.66 71.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.7 108.754 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.413 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 24.1 t -68.5 -44.84 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.69 -0.632 . . . . 0.61 109.342 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.66 ' HH2' HG21 ' A' ' 262' ' ' ILE . 29.1 t-105 -56.3 -41.5 76.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.39 109.161 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.5 OUTLIER -71.11 -34.42 71.06 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.288 -0.883 . . . . 0.35 108.858 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 1.1 m-20 -57.41 -41.64 80.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.602 -0.686 . . . . 0.36 109.625 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 145' ' ' TRP . 28.4 m -78.24 -29.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.5 110.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.541 HG21 HG12 ' A' ' 262' ' ' ILE . 13.4 t -152.27 141.91 14.59 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.94 -1.1 . . . . 0.51 110.586 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.37 58.0 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.895 1.471 . . . . 0.31 110.313 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.619 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -77.01 138.41 39.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.18 110.265 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.16 120.52 40.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.17 109.995 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.51 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.0 p90 -137.57 141.01 41.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.14 110.389 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.912 ' O ' HG22 ' A' ' 119' ' ' THR . 2.6 m -139.58 134.5 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.15 110.011 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.599 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 1.1 mtm180 -92.64 89.63 6.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.2 109.731 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.23 107.65 18.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.22 110.52 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -66.61 -11.9 55.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.32 109.79 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -54.53 -21.73 11.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.649 -0.657 . . . . 0.33 109.515 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.56 15.78 4.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.28 109.477 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.53 ' O ' ' HB ' ' A' ' 119' ' ' THR . 24.3 mm -106.22 78.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.119 -1.224 . . . . 0.3 108.943 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 124.78 45.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.2 111.018 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.684 ' HB2' HD12 ' A' ' 118' ' ' LEU . 14.8 t70 -94.08 -46.31 7.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.1 109.393 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.004 HD13 HD22 ' A' ' 228' ' ' LEU . 12.2 pt -128.56 177.94 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 0.1 109.302 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.78 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 4.0 ptt? -177.28 154.62 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.598 -1.314 . . . . 0.11 111.242 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 124' ' ' ASN . 3.0 tt -102.55 119.81 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.403 -0.811 . . . . 0.1 109.547 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.971 ' HB3' HG23 ' A' ' 123' ' ' VAL . 5.1 p -160.57 148.23 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.1 111.176 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.667 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 3.2 p90 -68.95 116.35 9.31 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.594 -0.691 . . . . 0.09 109.523 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -74.42 113.38 4.06 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.367 -1.093 . . . . 0.2 110.367 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -111.04 99.84 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -1.043 . . . . 0.55 109.585 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.634 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.26 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.365 0.602 . . . . 0.85 112.553 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.59 -3.51 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.71 110.192 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -75.62 -80.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.42 110.042 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 135.57 -39.57 1.65 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.587 -1.405 . . . . 0.33 109.587 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -77.46 -88.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -1.158 . . . . 0.33 110.33 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.1 OUTLIER -88.21 136.12 33.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.27 110.274 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.94 108.46 35.26 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.34 109.745 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 45.2 Cg_endo -77.51 -68.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.998 1.525 . . . . 0.47 110.581 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.634 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 6.3 p90 -40.81 136.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.87 . . . . 0.35 110.749 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.498 ' OD1' ' OD2' ' A' ' 202' ' ' ASP . 11.1 p30 179.21 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.2 110.759 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.55 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 43.17 -158.06 0.1 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.421 -1.472 . . . . 0.25 109.421 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.6 Cg_endo -77.04 8.52 3.14 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.101 1.58 . . . . 0.44 110.304 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.497 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 58.3 m -44.67 172.18 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.258 -0.901 . . . . 0.57 110.444 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.91 73.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 C-N-CA 120.393 -0.908 . . . . 0.49 110.893 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.821 HD22 ' OD1' ' A' ' 202' ' ' ASP . 3.2 tt 179.82 87.39 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.014 -1.286 . . . . 0.41 111.002 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 214' ' ' TYR . 8.3 tt -103.72 -22.61 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.686 -1.205 . . . . 0.3 110.88 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.443 ' O ' ' OE1' ' A' ' 223' ' ' GLU . . . -150.21 100.0 2.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.72 -1.237 . . . . 0.2 111.973 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.563 ' NE2' ' CB ' ' A' ' 200' ' ' HIS . 1.2 p80 -100.8 127.38 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.958 -1.089 . . . . 0.16 109.111 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.94 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -115.0 126.22 54.51 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.961 -1.087 . . . . 0.23 110.651 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.471 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 2.4 m-85 -71.85 155.93 91.57 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.38 110.185 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.521 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.5 Cg_endo -72.3 141.65 35.96 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.945 1.497 . . . . 0.4 109.93 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 64.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.32 110.783 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.47 -103.36 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.244 -1.543 . . . . 0.32 109.244 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.16 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.925 1.487 . . . . 0.47 110.314 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -65.02 -9.34 21.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.63 110.373 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 59.37 0.61 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.34 -0.85 . . . . 0.53 110.147 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -137.16 164.81 25.27 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.073 -1.611 . . . . 0.25 109.073 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.975 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 57.95 16.93 27.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.354 -1.498 . . . . 0.1 109.354 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.664 ' OD1' ' HE2' ' A' ' 164' ' ' MET . 8.4 m-20 -81.94 88.71 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 0.1 110.466 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.43 115.51 4.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.09 109.894 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.563 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 15.0 m170 -123.44 127.79 48.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.09 111.003 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 11.3 m-30 -96.76 132.41 42.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.1 110.223 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.821 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -49.98 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.97 -1.122 . . . . 0.14 107.97 178.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.4 p30 -35.21 -28.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.18 112.267 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.55 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -78.61 3.31 16.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.427 -1.421 . . . . 0.24 110.971 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.549 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 18.0 mm-40 -97.99 -168.97 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.934 -1.104 . . . . 0.42 110.229 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.501 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 12.5 m -122.29 151.53 41.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.47 110.383 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.536 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.2 m-90 -148.09 141.02 24.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.306 -0.871 . . . . 0.27 109.67 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.024 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -159.0 179.63 8.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.999 -1.063 . . . . 0.3 110.62 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.9 t -125.28 49.84 1.85 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.807 -0.757 . . . . 0.61 109.551 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 15.9 t -125.84 -144.62 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.78 109.962 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 56.6 p -101.95 -27.97 12.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.91 110.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 213' ' ' GLY . 2.2 mppt? -93.01 -176.84 4.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.93 110.364 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 48.58 -176.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.614 -1.394 . . . . 0.79 109.614 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.509 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.1 m-85 -79.79 118.09 21.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -1.081 . . . . 0.69 109.606 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.669 ' ND2' HG23 ' A' ' 247' ' ' THR . 7.8 p30 -83.13 124.77 30.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.933 -1.105 . . . . 0.4 108.818 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.024 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -42.2 -36.92 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.17 110.522 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.8 m-85 -50.98 -47.12 61.46 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.419 -1.312 . . . . 0.28 107.793 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.671 HD21 ' HB2' ' A' ' 244' ' ' TYR . 20.3 tp -77.65 -70.7 0.46 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.683 -0.689 . . . . 0.46 110.912 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -49.18 -63.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.035 -1.041 . . . . 0.39 109.903 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -50.93 -52.28 43.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.17 111.287 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.89 -35.06 66.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.183 -1.573 . . . . 0.1 108.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.649 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.6 t60 -69.11 -49.48 56.72 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.212 0.529 . . . . 0.21 109.738 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.668 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.5 tp10 -64.1 -27.48 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.28 108.777 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.418 ' HE2' ' CD2' ' A' ' 142' ' ' PHE . 5.2 m-30 -70.2 -61.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.043 -0.725 . . . . 0.18 109.043 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -48.62 -27.72 6.28 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.802 -1.719 . . . . 0.21 108.802 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.44 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 1.8 m80 -81.41 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -1.203 . . . . 0.17 111.601 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.94 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -58.32 -29.82 66.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.33 111.971 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 1.004 HD22 HD13 ' A' ' 163' ' ' ILE . 7.0 tp -100.21 -39.72 7.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.53 111.623 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -78.36 -79.07 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.211 -1.156 . . . . 0.41 110.211 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.587 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.5 OUTLIER -170.83 -166.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -1.22 . . . . 0.45 110.846 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.0 OUTLIER -55.12 -55.92 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.62 110.573 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.596 ' CD2' ' HB3' ' A' ' 240' ' ' MET . 0.7 OUTLIER -167.25 -179.6 4.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.145 -0.972 . . . . 0.45 110.763 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 257' ' ' ASP . 9.9 t 179.5 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.015 -0.735 . . . . 0.38 109.015 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.686 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -128.6 22.03 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -0.811 . . . . 0.48 111.247 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -40.96 -52.38 6.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.438 -0.905 . . . . 0.38 110.101 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -87.04 -49.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.614 1.323 . . . . 0.28 110.589 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.56 99.21 0.12 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.435 -1.364 . . . . 0.24 111.543 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.865 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.82 162.8 35.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -1.183 . . . . 0.28 110.103 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.598 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -72.5 58.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.4 108.823 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.649 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 1.4 mtt -142.74 -36.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.335 -0.853 . . . . 0.45 110.432 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.596 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . 0.1 OUTLIER -46.01 174.98 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.235 -0.916 . . . . 0.57 110.377 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 48.6 Cg_endo -78.43 22.57 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.476 1.25 . . . . 0.76 111.127 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.714 HG22 HG22 ' A' ' 245' ' ' THR . 12.6 mm -127.76 140.79 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.89 109.107 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.671 ' HB2' HD21 ' A' ' 218' ' ' LEU . 54.3 p90 -126.29 -31.27 2.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.145 . . . . 0.78 110.633 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 243' ' ' ILE . 0.0 OUTLIER 3.8 -78.52 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 113.152 0.797 . . . . 0.61 113.152 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.677 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -43.82 114.79 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.7 -1.25 . . . . 0.74 109.687 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.669 HG23 ' ND2' ' A' ' 215' ' ' ASN . 6.1 m -72.6 172.86 9.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.865 . . . . 0.81 110.306 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.425 ' H ' HG22 ' A' ' 247' ' ' THR . . . -53.13 -22.35 13.44 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.351 -1.5 . . . . 0.56 109.351 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 48.1 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -1.109 . . . . 0.37 110.193 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -61.03 1.87 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.44 110.465 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.676 ' CD2' ' CE2' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -133.38 -77.16 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.53 110.649 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.676 ' CE2' ' CD2' ' A' ' 251' ' ' HIS . 23.1 m-85 -151.17 -178.03 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.38 110.948 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.965 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.7 58.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.672 -0.642 . . . . 0.19 110.018 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.73 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 2.6 mp -44.32 -47.08 24.92 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.066 -1.087 . . . . 0.28 108.066 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.5 Cg_endo -72.49 46.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.894 1.47 . . . . 0.49 111.231 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.5 m-20 -46.7 -32.74 3.77 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.576 -1.328 . . . . 0.49 110.367 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.865 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.83 -54.62 40.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.948 -1.101 . . . . 0.31 109.241 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.088 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.88 -33.69 76.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.174 -1.01 . . . . 0.14 108.873 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.965 HG21 ' HB2' ' A' ' 253' ' ' MET . 74.2 t -67.41 -86.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.17 110.566 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.2 tt0 -52.84 -42.18 64.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.008 -1.058 . . . . 0.26 109.353 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.72 -70.91 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.368 -1.093 . . . . 0.19 110.368 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.088 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.82 -18.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.735 -1.45 . . . . 0.22 110.035 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 1.083 ' N ' HD13 ' A' ' 262' ' ' ILE . 6.6 tt0 -64.37 -21.97 66.8 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.854 -1.138 . . . . 0.39 108.355 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.3 p -103.7 -42.42 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.222 -0.591 . . . . 0.47 111.502 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.529 HD22 ' HE2' ' A' ' 112' ' ' LYS . 7.6 mp -86.15 -46.18 10.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.48 111.266 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.619 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -77.95 -14.24 59.6 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.306 -0.871 . . . . 0.41 110.404 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.33 -94.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.889 -1.684 . . . . 0.46 108.889 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.43 109.73 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.083 1.57 . . . . 0.58 110.244 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -82.38 132.96 11.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.552 -1.419 . . . . 0.64 109.552 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.624 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.95 110.283 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.685 ' HA ' HD12 ' A' ' 230' ' ' LEU . 4.8 p . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.351 0.596 . . . . 1.03 109.851 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.5 mm? 39.12 47.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 1.04 111.118 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.594 ' HB3' HD23 ' A' ' 265' ' ' LEU . 2.1 tptm -128.17 60.99 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.003 . . . . 0.77 109.967 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.557 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 10.7 t90 -139.48 -65.55 0.47 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.42 110.637 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.456 ' O ' ' HE3' ' A' ' 115' ' ' LYS . 79.1 p -98.85 46.15 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.44 110.562 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 6.9 mmpt? -130.09 76.41 1.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.49 110.248 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.403 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 8.5 tmm? -111.85 -3.4 14.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.3 110.173 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -159.11 125.78 4.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.15 109.859 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.472 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.4 -177.06 5.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.13 110.751 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.832 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -127.29 165.88 18.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.12 109.848 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.576 ' CB ' HG13 ' A' ' 163' ' ' ILE . 46.1 p90 -162.89 -176.77 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.025 -1.047 . . . . 0.33 111.367 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -140.38 155.45 46.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.54 110.23 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.898 ' O ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -114.41 123.5 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.494 -0.754 . . . . 0.33 111.134 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.888 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.2 m -165.86 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.27 109.72 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 0.9 OUTLIER -39.68 -80.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.718 . . . . 0.41 109.395 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.689 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.9 t80 -179.2 -159.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.432 -0.792 . . . . 0.4 109.527 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -154.0 50.38 0.56 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.45 110.656 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.65 -85.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.807 1.425 . . . . 0.36 110.388 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.6 0.45 49.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.25 109.982 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.572 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.03 160.04 22.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.39 110.168 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.7 m -106.33 168.86 8.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.48 110.254 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -44.7 -32.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.4 109.806 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -66.28 -49.36 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.46 109.562 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 1.8 mp0 -60.79 -57.64 11.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.249 -0.907 . . . . 0.47 109.17 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 125' ' ' TYR . 5.6 t -46.22 -36.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.761 -1.2 . . . . 0.31 107.761 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -56.89 -42.38 79.74 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.03 -1.1 . . . . 0.48 108.03 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.4 tttt -71.24 -49.98 37.63 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.65 -0.87 . . . . 0.64 108.65 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.827 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.83 -57.39 4.36 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.96 -1.087 . . . . 0.42 109.749 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CD2' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.11 -56.29 13.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.34 110.734 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.602 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.61 -73.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.984 . . . . 0.47 110.157 -179.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -36.87 -60.99 0.58 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.823 -0.548 . . . . 0.47 110.667 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.46 -40.95 19.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.618 -1.301 . . . . 0.25 108.709 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 138' ' ' PHE . 2.5 m-85 -69.38 -32.97 72.35 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.998 . . . . 0.35 108.774 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 17.1 tttm -56.15 -41.66 75.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.977 -1.119 . . . . 0.7 107.977 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.9 t -67.11 -41.91 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.537 -0.912 . . . . 0.61 108.537 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.594 ' CH2' HG13 ' A' ' 262' ' ' ILE . 25.5 t-105 -54.9 -38.67 67.89 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.819 -0.808 . . . . 0.39 108.819 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.7 OUTLIER -75.95 -41.23 52.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.347 -0.846 . . . . 0.35 108.74 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 3.0 m-20 -50.47 -33.3 20.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.968 -0.753 . . . . 0.36 108.968 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.0 m -91.16 -38.52 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.532 -0.73 . . . . 0.5 110.108 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 149' ' ' THR . 14.1 t -149.43 124.15 4.78 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.51 110.136 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.21 59.27 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.859 1.452 . . . . 0.31 110.599 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.856 HD21 ' O ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -73.81 139.24 45.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.18 110.154 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 7.4 t-20 -76.62 105.49 7.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.17 109.912 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 7.8 p90 -117.34 143.67 45.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.14 110.479 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 119' ' ' THR . 20.5 m -141.27 145.6 35.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.927 . . . . 0.15 110.125 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.519 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -124.84 79.87 1.82 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.706 -0.621 . . . . 0.2 110.152 -178.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -85.42 114.73 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.22 110.092 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -56.42 -18.0 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.32 109.98 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -23.25 5.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.449 -0.782 . . . . 0.33 109.632 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.42 7.94 5.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.534 -1.426 . . . . 0.28 109.534 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.832 HG22 HG21 ' A' ' 119' ' ' THR . 8.7 mt -87.91 91.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.126 -1.22 . . . . 0.3 109.034 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -154.98 107.07 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.968 -0.693 . . . . 0.2 110.336 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.472 ' CB ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -76.51 -42.74 42.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.1 109.808 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.02 HG21 HD12 ' A' ' 228' ' ' LEU . 1.1 pt -118.09 171.91 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.1 109.546 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.873 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 1.8 ptp -170.08 157.28 6.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.715 -1.241 . . . . 0.11 111.188 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.0 tt -104.9 120.78 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.1 109.806 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.888 ' HB3' HG23 ' A' ' 123' ' ' VAL . 11.5 p -162.45 156.4 21.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.786 -1.196 . . . . 0.1 111.142 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.9 p90 -73.17 118.43 16.12 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.493 -0.755 . . . . 0.09 109.272 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -76.9 131.66 11.54 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.46 -1.056 . . . . 0.2 110.46 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.583 ' O ' ' C ' ' A' ' 170' ' ' LYS . 2.5 tp -126.34 93.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.614 -0.933 . . . . 0.55 109.154 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.601 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 0.87 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.358 0.599 . . . . 0.85 112.466 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -148.69 17.22 1.01 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.343 -0.848 . . . . 0.71 109.861 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.403 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m170 -78.96 -68.84 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.39 -0.819 . . . . 0.42 110.306 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.72 34.86 0.42 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.446 -1.461 . . . . 0.33 109.446 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -149.06 -69.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -1.11 . . . . 0.33 110.091 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -123.29 174.48 7.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.27 110.167 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.4 m-30 -98.57 110.34 56.49 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.34 110.237 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.514 ' HD2' ' HD2' ' A' ' 170' ' ' LYS . 41.9 Cg_endo -73.33 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.968 1.51 . . . . 0.47 110.616 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.6 OUTLIER -49.58 142.05 8.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.35 110.575 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 182' ' ' SER . 5.5 p30 179.64 80.3 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.202 -0.936 . . . . 0.2 110.453 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.72 -155.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.398 . . . . 0.25 109.606 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.7 Cg_endo -77.34 8.65 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.077 1.567 . . . . 0.44 110.573 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.2 t -42.75 166.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.57 110.318 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.45 73.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.712 -0.955 . . . . 0.49 110.712 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.909 HD23 ' OD1' ' A' ' 202' ' ' ASP . 1.0 OUTLIER 179.86 87.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.193 -1.181 . . . . 0.41 110.649 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.799 HD12 ' OE1' ' A' ' 205' ' ' GLU . 7.8 tt -103.85 -23.05 13.42 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.616 -1.234 . . . . 0.3 110.969 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.548 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -151.94 106.2 3.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.524 -1.36 . . . . 0.2 112.333 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.541 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.2 OUTLIER -101.84 133.02 47.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.16 109.229 178.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -122.09 118.72 29.38 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.134 -0.978 . . . . 0.23 110.476 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.464 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-85 -67.86 167.48 16.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.38 110.372 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.508 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.4 Cg_endo -72.89 136.65 25.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.145 1.603 . . . . 0.4 109.856 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.0 84.62 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.903 1.475 . . . . 0.32 110.561 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.9 -102.22 0.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.958 -1.257 . . . . 0.32 109.958 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.34 -163.6 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.47 110.859 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.89 -7.28 26.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.404 -0.81 . . . . 0.63 110.152 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.46 48.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.383 -0.823 . . . . 0.53 109.838 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -136.06 169.23 23.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.029 -1.629 . . . . 0.25 109.029 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.963 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 57.31 17.68 25.78 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.088 -1.605 . . . . 0.1 109.088 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.86 91.31 4.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.429 -1.042 . . . . 0.1 110.508 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.873 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -73.47 95.93 2.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.09 109.866 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.541 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 28.7 m170 -111.93 134.45 53.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.09 110.887 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.4 m-85 -104.51 137.6 42.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.154 -0.966 . . . . 0.1 110.59 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.909 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -47.03 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.14 108.554 179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.599 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 3.2 p30 -36.88 -27.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.516 -0.74 . . . . 0.18 112.046 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.537 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.0 OUTLIER -78.79 2.93 18.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.488 -1.383 . . . . 0.24 110.848 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.799 ' OE1' HD12 ' A' ' 185' ' ' LEU . 11.6 mm-40 -95.91 -168.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.942 -1.099 . . . . 0.42 110.237 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.8 m -123.72 140.21 53.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.47 110.498 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.599 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.8 OUTLIER -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.27 109.312 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.008 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.33 178.61 9.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.959 -1.088 . . . . 0.3 110.792 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 29.9 t -130.48 32.37 4.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.534 0.683 . . . . 0.61 109.285 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -103.98 -90.87 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.78 110.686 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -157.21 -33.97 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.462 -0.774 . . . . 0.91 109.793 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 213' ' ' GLY . 3.5 pttt -87.91 -171.96 3.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.93 109.932 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 45.42 -155.59 0.44 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.243 -1.543 . . . . 0.79 109.243 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.595 ' CE2' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -94.13 126.24 39.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -1.193 . . . . 0.69 109.931 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.616 ' O ' HG12 ' A' ' 219' ' ' VAL . 42.6 m-80 -89.65 121.4 31.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.018 -1.051 . . . . 0.4 108.879 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.008 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.59 -37.84 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.611 -0.836 . . . . 0.17 110.375 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 3.1 m-30 -51.67 -46.91 63.98 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.382 -1.327 . . . . 0.28 107.585 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.26 -73.4 0.28 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.781 -0.645 . . . . 0.46 110.277 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.88 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.61 -65.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.39 110.302 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -49.66 -48.87 49.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.366 -0.834 . . . . 0.17 111.737 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.99 -41.71 92.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.185 -1.572 . . . . 0.1 108.645 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.576 ' NE2' ' HA ' ' A' ' 240' ' ' MET . 5.3 t60 -60.2 -51.26 70.33 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.377 0.608 . . . . 0.21 109.792 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.67 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.0 tp10 -64.8 -29.16 70.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.092 -1.005 . . . . 0.28 109.138 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 220' ' ' ALA . 13.8 m-30 -66.12 -64.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.447 -0.783 . . . . 0.18 109.177 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -49.84 -26.7 8.52 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.045 -1.622 . . . . 0.21 109.045 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -78.93 -58.7 3.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.081 -1.247 . . . . 0.17 111.557 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.913 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -69.22 -23.77 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.33 111.78 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -99.21 -43.82 6.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.028 -1.045 . . . . 0.53 111.258 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -83.03 -70.86 1.33 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.184 -1.008 . . . . 0.41 110.589 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -165.01 -162.11 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.241 . . . . 0.45 110.86 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -75.01 -51.7 12.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.62 110.34 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.622 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.8 OUTLIER -162.48 172.79 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.45 110.959 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.455 ' HB2' HD11 ' A' ' 230' ' ' LEU . 5.7 t 179.56 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.615 -0.678 . . . . 0.38 109.24 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.673 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -117.19 20.26 13.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.48 111.005 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.577 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -30.55 -53.81 0.38 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.894 -0.503 . . . . 0.38 111.507 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.7 Cg_endo -89.49 -47.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.4 1.21 . . . . 0.28 111.063 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.12 100.54 0.13 Allowed Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.498 -1.334 . . . . 0.24 111.268 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.935 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -146.78 168.73 20.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.131 -1.217 . . . . 0.28 110.518 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.558 HD21 ' N ' ' A' ' 222' ' ' HIS . 0.7 OUTLIER -73.67 55.42 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.301 -0.875 . . . . 0.4 109.011 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.576 ' HA ' ' NE2' ' A' ' 222' ' ' HIS . 1.9 mtt -140.87 -5.6 1.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.288 -0.882 . . . . 0.45 111.356 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -79.71 168.82 23.4 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.932 -1.105 . . . . 0.57 110.134 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -69.56 -4.27 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.848 1.447 . . . . 0.76 110.665 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.605 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 50.2 mm -104.63 143.87 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.89 109.808 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.834 ' HB2' HD21 ' A' ' 218' ' ' LEU . 42.8 p90 -131.39 -28.95 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.948 -1.095 . . . . 0.78 110.913 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.53 ' C ' ' O ' ' A' ' 244' ' ' TYR . 98.8 m 2.79 -69.63 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.412 0.893 . . . . 0.61 113.412 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -55.81 101.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.604 -1.31 . . . . 0.74 109.511 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.51 ' N ' ' HB3' ' A' ' 250' ' ' SER . 0.2 OUTLIER -48.09 179.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.431 -0.793 . . . . 0.81 110.263 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.71 -29.25 25.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.446 -1.461 . . . . 0.56 109.446 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -143.1 31.24 1.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.37 110.084 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.51 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.4 OUTLIER -59.56 -23.03 62.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.44 110.186 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 6.8 t-80 -156.21 -67.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.882 . . . . 0.53 110.004 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.1 m-85 -168.38 -178.36 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.38 110.164 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.974 ' HB2' HG21 ' A' ' 259' ' ' VAL . 5.6 ptt? -72.26 54.99 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.72 . . . . 0.19 110.225 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.726 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 7.6 tp -45.03 -46.07 28.53 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 107.975 -1.12 . . . . 0.28 107.975 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -71.58 48.19 0.99 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.76 1.4 . . . . 0.49 110.944 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.673 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.2 m-20 -52.63 -27.14 15.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.855 -1.153 . . . . 0.49 110.575 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.935 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -57.15 -43.76 82.78 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.578 -1.249 . . . . 0.31 109.454 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -79.57 -32.95 42.1 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.184 -1.006 . . . . 0.14 108.548 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.974 HG21 ' HB2' ' A' ' 253' ' ' MET . 54.4 t -65.43 -75.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.816 0.817 . . . . 0.17 110.019 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.628 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -63.57 -34.1 77.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.768 . . . . 0.26 109.612 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -49.53 -67.24 1.85 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.124 -1.19 . . . . 0.19 110.124 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -70.35 -21.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.811 -1.405 . . . . 0.22 109.895 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.674 ' N ' HD13 ' A' ' 262' ' ' ILE . 20.4 tp60 -67.31 -19.44 65.47 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.028 -1.045 . . . . 0.39 108.625 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.1 m -103.41 -38.6 7.12 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.119 -0.633 . . . . 0.47 111.709 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 112' ' ' LYS . 8.5 mp -97.79 -42.51 7.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.179 -0.951 . . . . 0.48 111.166 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.856 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -72.15 -21.48 61.45 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.37 -0.831 . . . . 0.41 109.808 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -55.6 -97.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.293 -1.523 . . . . 0.46 109.293 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.7 108.29 2.52 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.044 1.549 . . . . 0.58 110.258 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.17 151.43 23.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.696 -1.362 . . . . 0.64 109.696 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.557 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 6.8 t0 . . . . . 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.95 110.203 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.109 0.481 . . . . 1.03 109.71 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.534 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 5.9 mp 32.08 37.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.079 0.466 . . . . 1.04 111.454 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -121.51 42.6 3.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.77 109.869 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 22.7 t90 -110.63 -65.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.853 . . . . 0.42 110.106 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.472 ' O ' ' HG3' ' A' ' 115' ' ' LYS . 31.9 t -102.36 60.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.44 110.267 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.579 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 0.0 OUTLIER -146.26 85.48 1.66 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.935 . . . . 0.49 110.617 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 ttt -119.82 -18.33 8.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.3 110.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 8.7 p30 -157.3 111.88 2.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.15 109.984 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.447 HD13 HD21 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -133.08 -160.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.13 110.466 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -137.91 155.35 49.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.12 110.275 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.856 ' HB3' HG23 ' A' ' 163' ' ' ILE . 13.2 p90 -152.73 -167.6 2.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.247 -0.908 . . . . 0.33 110.857 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.412 ' N ' ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.36 155.94 47.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.54 110.662 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.852 ' O ' HG13 ' A' ' 123' ' ' VAL . 5.6 pt -112.67 115.75 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.805 . . . . 0.33 110.698 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 122' ' ' ILE . 1.1 m -165.72 42.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.201 -0.937 . . . . 0.27 110.301 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 125' ' ' TYR . 2.5 t-20 -42.28 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.41 109.742 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.729 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.8 t80 -179.32 -155.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -0.795 . . . . 0.4 109.497 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.558 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -161.26 51.47 0.36 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.45 110.583 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -78.14 -85.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.906 1.477 . . . . 0.36 109.963 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.93 -2.09 56.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.25 109.638 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.914 ' SD ' HD21 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -121.06 160.75 22.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.39 110.137 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.14 -175.05 2.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.875 . . . . 0.48 110.211 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -48.46 -37.49 17.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.4 109.978 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t -60.47 -50.08 75.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.46 109.845 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 7.7 mp0 -64.88 -63.64 1.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.194 -0.941 . . . . 0.47 109.92 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 125' ' ' TYR . 16.3 t -42.96 -37.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.694 -0.854 . . . . 0.31 108.694 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 6.5 mt-10 -59.24 -43.23 92.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.387 -0.968 . . . . 0.48 108.387 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.563 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.5 tttp -70.33 -47.34 61.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.416 -0.957 . . . . 0.64 108.416 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.819 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -45.79 -60.71 2.07 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.31 -0.868 . . . . 0.42 110.101 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.709 ' CE2' HD12 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -66.96 -52.31 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.34 110.897 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 4.1 tttt -66.58 -73.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.84 -1.162 . . . . 0.47 110.124 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.71 -60.8 0.79 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.754 -0.592 . . . . 0.47 110.779 179.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.28 -38.93 13.42 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.54 -1.264 . . . . 0.25 108.341 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -70.08 -33.66 72.19 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.611 -0.836 . . . . 0.35 108.976 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -56.31 -41.55 76.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.931 -1.137 . . . . 0.7 107.931 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 12.6 t -66.05 -41.73 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.578 -0.897 . . . . 0.61 108.578 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.589 ' CH2' HG13 ' A' ' 262' ' ' ILE . 27.9 t-105 -56.88 -39.21 73.94 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.818 -0.808 . . . . 0.39 108.818 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 149' ' ' THR . 69.1 m -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.427 -0.796 . . . . 0.35 108.854 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -54.89 -37.51 66.39 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.586 -0.696 . . . . 0.36 109.359 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 145' ' ' TRP . 26.8 m -84.82 -34.86 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.5 110.195 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.577 ' OG1' HD13 ' A' ' 151' ' ' LEU . 14.4 t -152.12 131.63 6.87 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.51 110.264 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.41 59.05 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.965 1.508 . . . . 0.31 110.808 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.009 HD21 ' CG ' ' A' ' 266' ' ' TYR . 3.6 mp -76.88 169.09 18.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.18 110.014 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -114.64 116.42 28.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.17 110.568 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.4 p90 -126.33 125.78 42.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.14 109.723 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 119' ' ' THR . 10.7 m -125.72 133.08 52.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.197 -0.94 . . . . 0.15 110.62 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.625 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.31 81.71 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.2 109.877 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.617 ' HG ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -60.43 129.79 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.22 110.49 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -91.79 40.61 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.44 -0.787 . . . . 0.32 109.921 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.607 ' OD2' HD11 ' A' ' 160' ' ' ILE . 3.2 t0 -135.55 -38.95 0.73 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.33 109.52 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 144.2 37.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.661 -1.376 . . . . 0.28 109.661 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.617 HD13 ' HG ' ' A' ' 156' ' ' LEU . 3.1 mp -123.82 69.45 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.3 109.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -144.47 156.29 44.12 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.032 -0.667 . . . . 0.2 110.111 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.486 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.5 OUTLIER -121.39 -23.52 5.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.1 110.337 -179.884 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.856 HG23 ' HB3' ' A' ' 120' ' ' TYR . 1.2 tt -125.49 168.51 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.178 -0.951 . . . . 0.1 110.142 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.851 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 11.9 ptp -177.3 151.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.522 -1.361 . . . . 0.11 111.645 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 165' ' ' ILE . 5.4 tt -97.98 112.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.593 -0.692 . . . . 0.1 110.032 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.76 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.4 p -153.76 149.71 27.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.901 -1.125 . . . . 0.1 110.39 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 8.0 p90 -68.64 127.53 33.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.09 109.758 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.67 120.99 6.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.235 -1.146 . . . . 0.2 110.235 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.743 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.33 102.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.445 -1.032 . . . . 0.55 109.135 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 26.1 tptp 1.07 84.08 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.422 0.629 . . . . 0.85 112.532 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.46 0.76 4.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.71 109.942 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 10.8 m-70 -74.01 -81.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.878 . . . . 0.42 110.331 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.97 8.3 7.41 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.194 -1.562 . . . . 0.33 109.194 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.417 ' OD2' ' CE2' ' A' ' 175' ' ' PHE . 3.1 t0 -126.3 -70.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -1.103 . . . . 0.33 110.198 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.461 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 98.3 m-85 -107.25 144.5 33.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.27 110.093 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -63.65 111.07 4.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.34 110.355 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.544 ' O ' HD22 ' A' ' 184' ' ' LEU . 49.7 Cg_endo -78.74 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.976 1.514 . . . . 0.47 110.444 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -94.21 178.59 5.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.35 110.232 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.3 p-10 -180.0 -53.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.923 . . . . 0.2 110.804 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.574 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 146.39 -134.98 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.364 -1.494 . . . . 0.25 109.364 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.11 -1.6 10.78 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 124.053 1.554 . . . . 0.44 109.809 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.443 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -57.02 -177.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.428 -0.795 . . . . 0.57 110.296 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -81.3 76.55 2.15 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.575 -1.01 . . . . 0.49 110.575 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.561 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 5.5 tt 179.64 94.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.273 -1.133 . . . . 0.41 110.789 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.668 HD13 ' CE2' ' A' ' 214' ' ' TYR . 8.6 tt -112.13 -18.45 12.57 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.554 -1.258 . . . . 0.3 111.109 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.524 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -152.11 109.56 3.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.503 -1.373 . . . . 0.2 111.832 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -121.35 135.59 55.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.16 109.971 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.83 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -123.78 160.8 26.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.096 -1.003 . . . . 0.23 110.454 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 1.1 m-30 -99.04 170.23 7.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.38 110.176 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.506 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.8 Cg_endo -71.74 128.3 14.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.562 . . . . 0.4 109.745 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.485 ' HA ' ' HA3' ' A' ' 196' ' ' GLY . 42.9 Cg_endo -69.05 68.3 1.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.873 1.459 . . . . 0.32 110.62 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.98 -83.67 1.2 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.267 -1.533 . . . . 0.32 109.267 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 -159.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.559 . . . . 0.47 110.042 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.12 0.52 27.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.63 110.34 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.74 40.84 2.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.319 -0.863 . . . . 0.53 110.326 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -108.63 -179.3 21.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.961 -1.656 . . . . 0.25 108.961 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 163' ' ' ILE . . . 38.91 27.13 0.05 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.213 -1.155 . . . . 0.1 110.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 196' ' ' GLY . 0.8 OUTLIER -77.59 88.23 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.331 . . . . 0.1 109.25 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.851 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.72 90.24 1.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.09 110.74 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 12.8 m170 -100.86 120.83 40.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.09 109.909 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 203' ' ' ASP . 20.2 m-85 -89.6 135.24 33.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.156 -0.965 . . . . 0.1 110.722 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 58.8 t0 -44.2 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.857 -0.794 . . . . 0.14 108.857 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.9 p30 -41.76 -31.64 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.18 111.49 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.574 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 17.1 t0 -71.15 -5.54 32.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.558 -1.338 . . . . 0.24 110.329 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 16.6 mm-40 -93.73 -164.71 1.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.088 . . . . 0.42 109.878 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.559 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 33.3 m -127.37 159.08 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.128 . . . . 0.47 110.769 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.592 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.2 m-90 -150.12 142.8 24.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.27 109.555 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.993 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -153.93 173.65 15.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.853 -1.154 . . . . 0.3 110.795 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.8 t -128.21 29.79 5.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.781 0.8 . . . . 0.61 108.945 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 -72.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.504 0.669 . . . . 0.78 110.108 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.132 -0.692 . . . . 0.91 109.132 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.43 133.17 33.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.548 -0.72 . . . . 0.93 109.553 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.18 -171.54 38.81 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.109 -1.596 . . . . 0.79 109.109 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.668 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.1 m-85 -75.66 113.54 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.69 109.999 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.567 ' O ' HG12 ' A' ' 219' ' ' VAL . 34.5 m-80 -79.87 121.97 26.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.054 -1.028 . . . . 0.4 108.627 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.993 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -40.56 -38.01 0.8 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.329 -0.857 . . . . 0.17 110.504 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 3.3 m-85 -52.97 -48.33 67.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.529 -1.268 . . . . 0.28 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' A' ' 244' ' ' TYR . 40.9 tp -72.06 -71.36 0.28 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.978 -0.556 . . . . 0.46 110.185 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.869 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -51.32 -70.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.156 -0.965 . . . . 0.39 110.144 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -42.22 -50.21 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.876 -1.14 . . . . 0.17 111.565 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -60.86 -34.7 75.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.309 -1.494 . . . . 0.1 108.924 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.7 t60 -69.33 -50.83 42.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.465 0.65 . . . . 0.21 109.792 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.807 ' OE2' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -60.9 -44.09 97.62 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.28 109.181 178.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.519 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 7.4 m-85 -55.08 -62.02 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.18 108.926 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.448 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.62 -32.03 1.9 Allowed Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.804 -1.718 . . . . 0.21 108.804 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.578 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.41 -71.96 0.43 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -1.174 . . . . 0.17 111.068 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.83 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.05 -44.19 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.33 112.006 -178.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.695 HD22 ' OH ' ' A' ' 266' ' ' TYR . 0.8 OUTLIER -100.37 -37.41 8.87 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.784 -1.197 . . . . 0.53 111.328 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -67.66 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.173 -1.171 . . . . 0.41 110.173 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 230' ' ' LEU . 0.8 OUTLIER -169.21 -172.62 1.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.45 110.936 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 1.9 m-20 -53.05 -58.04 8.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.62 110.172 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.578 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -163.67 179.63 7.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.45 111.017 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.515 ' N ' ' SD ' ' A' ' 240' ' ' MET . 1.8 t 179.53 54.35 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.083 -0.71 . . . . 0.38 109.083 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.31 23.89 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.48 111.351 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -38.72 -47.01 3.35 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.36 -0.936 . . . . 0.38 109.346 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 43.0 Cg_endo -92.1 -47.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.029 1.542 . . . . 0.28 110.968 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.83 100.9 0.14 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.725 -1.703 . . . . 0.24 112.506 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.961 ' HB2' ' HB2' ' A' ' 257' ' ' ASP . . . -148.08 160.92 42.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.317 -1.108 . . . . 0.28 109.998 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.569 HD21 ' C ' ' A' ' 221' ' ' ALA . 1.0 OUTLIER -69.31 62.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.076 0.941 . . . . 0.4 108.596 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.613 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.7 mtt -146.56 -33.98 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.59 -0.694 . . . . 0.45 110.758 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -44.13 168.5 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.57 110.325 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.455 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.4 Cg_endo -72.66 -12.51 26.77 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.879 1.463 . . . . 0.76 109.817 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.659 HG12 HG22 ' A' ' 245' ' ' THR . 5.9 tt -98.25 151.09 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.89 109.695 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.779 ' HB2' HD21 ' A' ' 218' ' ' LEU . 32.6 p90 -131.89 -28.28 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.78 111.038 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.748 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.45 -69.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 113.196 0.813 . . . . 0.61 113.196 -179.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.748 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -67.96 104.25 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.547 -1.346 . . . . 0.74 109.554 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.647 ' HA ' HD22 ' A' ' 218' ' ' LEU . 26.5 p -56.08 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.81 110.352 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.4 -7.15 57.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.56 109.495 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -149.21 27.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -1.16 . . . . 0.37 110.174 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -68.21 -13.93 62.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.44 110.339 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.0 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.53 110.326 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -167.54 178.39 5.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.38 110.501 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.938 ' HB2' HG21 ' A' ' 259' ' ' VAL . 4.7 ptp -68.23 53.98 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.393 -0.817 . . . . 0.19 110.61 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.708 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -43.97 -48.34 22.22 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.131 -1.063 . . . . 0.28 108.131 177.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.708 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -72.49 48.05 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 124.125 1.592 . . . . 0.49 111.251 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.632 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.3 m-20 -52.77 -30.86 35.22 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.763 -1.211 . . . . 0.49 109.761 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.961 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 3.1 m-20 -50.47 -45.59 56.34 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.589 -0.844 . . . . 0.31 109.57 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.955 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -80.18 -32.31 38.71 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.379 -0.971 . . . . 0.14 108.379 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.938 HG21 ' HB2' ' A' ' 253' ' ' MET . 83.6 t -60.35 -73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.17 110.072 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.719 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 6.2 pt20 -72.52 -31.35 65.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.331 -0.855 . . . . 0.26 110.094 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -47.73 -57.79 7.33 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.092 -1.603 . . . . 0.19 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -83.5 -21.71 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -1.228 . . . . 0.22 110.674 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.79 ' N ' HD13 ' A' ' 262' ' ' ILE . 29.6 tt0 -64.47 -20.01 65.92 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.493 -1.379 . . . . 0.39 108.348 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 260' ' ' GLN . 2.8 p -103.68 -38.98 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.152 -0.619 . . . . 0.47 111.354 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.9 mp -90.88 -44.57 9.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.103 -0.998 . . . . 0.48 111.343 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 1.009 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -72.92 -10.91 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.41 110.057 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -60.75 -92.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.461 . . . . 0.46 109.446 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 117.03 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.58 110.332 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.06 123.72 7.88 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.446 -1.462 . . . . 0.64 109.446 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.579 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.95 109.93 179.943 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.539 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.403 0.62 . . . . 1.03 109.944 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.2 OUTLIER 33.15 53.76 0.41 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.909 -0.494 . . . . 1.04 111.881 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.779 ' HD2' HD13 ' A' ' 265' ' ' LEU . 17.4 pttt -140.75 78.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.77 109.688 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.584 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 11.6 t90 -142.27 -71.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.42 111.017 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.489 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 95.4 p -101.13 60.67 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.44 110.489 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 114' ' ' SER . 30.3 mttp -148.72 78.72 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.49 110.183 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.582 ' O ' HD13 ' A' ' 151' ' ' LEU . 12.6 ttt -105.71 -13.01 15.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 0.3 109.956 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.483 ' OD1' ' HB3' ' A' ' 152' ' ' ASN . 6.4 t30 -151.86 124.64 8.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.15 109.993 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 118' ' ' LEU . 3.2 tp -145.99 -170.2 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.13 110.258 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -122.05 158.05 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.12 110.161 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.756 ' CB ' HG23 ' A' ' 163' ' ' ILE . 37.0 p90 -151.06 169.2 22.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.367 -0.833 . . . . 0.33 110.704 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -120.87 147.1 45.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -0.816 . . . . 0.54 109.776 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.7 pp -112.87 120.45 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.116 -0.99 . . . . 0.33 110.997 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.919 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.0 OUTLIER -164.77 49.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.838 . . . . 0.27 109.416 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.706 ' ND2' HD13 ' A' ' 165' ' ' ILE . 1.4 m120 -39.67 -84.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.696 -0.627 . . . . 0.41 109.843 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.571 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.8 t80 179.89 -168.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.4 109.089 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.608 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -138.61 42.71 0.6 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.707 -1.246 . . . . 0.45 111.705 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -76.96 -83.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.484 1.255 . . . . 0.36 110.506 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.9 m-20 -107.83 -0.9 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.25 110.053 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.586 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -126.39 89.95 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.39 109.778 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.465 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -48.21 -179.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.48 110.939 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -48.49 -39.27 22.54 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.4 110.032 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -53.68 -61.2 2.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.46 109.615 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.586 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 31.6 mp0 -54.01 -54.49 38.38 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.565 -0.854 . . . . 0.47 109.43 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' ' 124' ' ' ASN . 53.2 t -45.76 -34.41 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 132' ' ' SER . 0.7 OUTLIER -61.38 -43.21 99.25 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.776 -1.194 . . . . 0.48 107.776 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 1.4 tttp -70.34 -56.98 5.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.64 108.337 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.861 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -43.75 -69.94 0.12 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.186 -0.946 . . . . 0.42 110.189 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.724 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -52.81 -59.46 4.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.34 110.945 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 5.1 tmtt? -65.56 -74.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.978 -1.076 . . . . 0.47 110.893 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.8 OUTLIER -38.24 -62.39 0.58 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.679 -0.638 . . . . 0.47 110.669 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -45.89 -38.15 7.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.798 -1.161 . . . . 0.25 108.386 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -70.42 -34.87 73.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.362 -0.836 . . . . 0.35 108.892 178.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 10.6 ttmm -58.51 -42.4 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.7 108.961 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 13.5 t -67.86 -46.72 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.535 -0.728 . . . . 0.61 109.094 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.627 ' HH2' HG21 ' A' ' 262' ' ' ILE . 13.3 t-105 -53.55 -41.66 66.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.777 . . . . 0.39 108.967 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 149' ' ' THR . 14.5 m -71.76 -37.15 70.54 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.412 -0.805 . . . . 0.35 109.02 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -53.66 -41.61 66.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.595 -0.691 . . . . 0.36 109.549 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.805 HG23 HG22 ' A' ' 149' ' ' THR . 29.4 m -79.63 -30.81 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.5 110.071 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.815 ' OG1' HD23 ' A' ' 151' ' ' LEU . 3.6 t -144.22 127.33 8.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.51 110.339 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 59.76 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.748 1.394 . . . . 0.31 110.745 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.008 HD21 ' O ' ' A' ' 266' ' ' TYR . 1.4 mm? -88.72 156.01 19.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.18 110.158 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.483 ' HB3' ' OD1' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -103.38 146.35 28.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.17 110.381 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.9 p90 -152.49 138.6 18.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.868 . . . . 0.14 110.384 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.906 ' O ' HG22 ' A' ' 119' ' ' THR . 4.2 m -143.02 135.4 27.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.15 110.261 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.587 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -93.61 89.03 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.978 -1.076 . . . . 0.2 110.024 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -62.97 100.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.22 110.371 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 157' ' ' HIS . 53.6 p-80 -67.14 57.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.331 -0.856 . . . . 0.32 110.357 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 156' ' ' LEU . 10.9 t0 -154.31 -51.53 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.33 109.904 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.41 35.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.037 -1.225 . . . . 0.28 110.037 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.547 ' HB ' ' CB ' ' A' ' 156' ' ' LEU . 72.1 mt -128.83 65.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -1.18 . . . . 0.3 109.289 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -126.01 150.16 48.29 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.2 -0.6 . . . . 0.2 110.568 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.462 ' O ' ' O ' ' A' ' 196' ' ' GLY . 1.2 m-20 -113.27 -34.22 5.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.356 -0.84 . . . . 0.1 109.883 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.756 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -126.03 170.38 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.1 110.155 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.729 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.5 ptm -168.93 139.12 2.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.891 -1.131 . . . . 0.11 110.95 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.706 HD13 ' ND2' ' A' ' 124' ' ' ASN . 4.2 tt -96.88 115.44 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.401 -0.812 . . . . 0.1 109.29 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.919 ' HB3' HG23 ' A' ' 123' ' ' VAL . 14.2 p -160.07 148.48 17.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.511 -1.368 . . . . 0.1 111.065 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.622 ' CE2' HG21 ' A' ' 169' ' ' ILE . 2.0 p90 -64.55 114.75 4.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.09 109.354 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.511 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -72.52 148.42 42.01 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.441 -1.464 . . . . 0.2 109.441 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.622 HG21 ' CE2' ' A' ' 167' ' ' PHE . 10.3 pt -141.41 97.46 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.752 -0.852 . . . . 0.55 109.853 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.64 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.07 78.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.277 0.561 . . . . 0.85 112.127 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -121.1 -5.57 9.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.71 110.266 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 172' ' ' HIS . 19.9 m-70 -82.19 -150.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.42 110.011 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.97 30.31 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.704 -1.358 . . . . 0.33 109.704 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 175' ' ' PHE . 2.9 p30 -127.51 -148.21 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -1.223 . . . . 0.33 110.176 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -49.22 153.35 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.27 110.09 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 9.2 m-30 -80.96 112.23 30.57 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.34 110.314 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.877 ' O ' HD22 ' A' ' 184' ' ' LEU . 45.9 Cg_endo -78.41 -67.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.901 1.474 . . . . 0.47 110.631 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -51.74 149.79 4.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.35 110.714 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.6 p30 -174.21 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.214 -0.994 . . . . 0.2 111.482 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.588 ' N ' ' HB2' ' A' ' 204' ' ' ASP . . . 120.43 -140.32 14.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.178 -1.569 . . . . 0.25 109.178 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.29 53.88 3.13 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 124.103 1.58 . . . . 0.44 109.628 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 0.2 OUTLIER -114.4 -177.41 3.12 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.526 -0.733 . . . . 0.57 110.055 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -72.03 65.18 1.23 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.482 -1.047 . . . . 0.49 110.482 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.877 HD22 ' O ' ' A' ' 177' ' ' PRO . 2.6 tt 179.69 93.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -1.17 . . . . 0.41 110.846 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.853 HD12 ' CD ' ' A' ' 205' ' ' GLU . 4.1 tt -114.48 -13.3 12.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.606 -1.237 . . . . 0.3 111.352 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -156.32 102.62 2.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.488 -1.382 . . . . 0.2 111.671 -179.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.54 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -117.26 122.77 44.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.16 109.51 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 1.041 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -110.52 158.66 18.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.23 110.207 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.9 m-30 -96.0 166.79 13.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.38 110.545 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 46.5 Cg_endo -72.86 136.38 25.13 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.091 1.574 . . . . 0.4 109.742 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 58.98 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.93 1.489 . . . . 0.32 110.611 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -99.18 -94.62 2.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.32 109.464 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.8 -165.89 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.965 1.508 . . . . 0.47 110.38 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -9.07 26.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.63 110.279 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 54.56 0.66 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.42 -0.8 . . . . 0.53 110.226 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -124.08 174.76 16.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.049 -1.621 . . . . 0.25 109.049 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.555 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.14 24.66 0.59 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.716 -1.354 . . . . 0.1 109.716 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 164' ' ' MET . 1.5 m-20 -79.8 87.35 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.068 -1.254 . . . . 0.1 109.96 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -63.73 113.25 3.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.09 110.502 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 11.4 m170 -121.24 119.07 31.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.325 -0.859 . . . . 0.09 110.602 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.0 m-85 -90.5 141.78 28.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.228 -0.92 . . . . 0.1 110.677 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 24.0 t0 -52.27 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.578 -0.701 . . . . 0.14 109.476 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.561 ' OD1' ' HB2' ' A' ' 178' ' ' PHE . 1.7 p-10 -35.78 -37.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.18 112.059 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.588 ' HB2' ' N ' ' A' ' 180' ' ' GLY . 3.0 m-20 -65.62 -14.1 60.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.725 -1.234 . . . . 0.24 111.175 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.853 ' CD ' HD12 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -93.13 -156.99 0.51 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.716 -1.24 . . . . 0.42 110.325 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.513 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 3.2 m -137.16 161.43 36.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.944 -1.098 . . . . 0.47 111.062 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.514 ' NE1' ' HB3' ' A' ' 201' ' ' PHE . 1.1 m-90 -149.19 149.1 30.44 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.033 -0.728 . . . . 0.27 109.033 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.008 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.76 -174.45 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.804 -1.185 . . . . 0.3 110.708 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -123.36 30.2 6.38 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.893 -0.723 . . . . 0.61 109.822 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -117.21 -172.49 2.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.41 -0.806 . . . . 0.78 110.161 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.488 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.4 OUTLIER -80.88 0.84 33.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.91 110.236 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -113.79 149.67 34.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.158 -0.964 . . . . 0.93 110.184 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 68.46 -173.8 32.53 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.79 109.402 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.834 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -77.16 114.26 15.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.69 110.157 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.622 ' O ' HG12 ' A' ' 219' ' ' VAL . 1.6 m120 -77.45 123.24 26.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.99 -1.069 . . . . 0.4 108.653 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.008 HD22 ' O ' ' A' ' 208' ' ' THR . 0.6 OUTLIER -44.72 -35.18 2.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.787 -1.165 . . . . 0.17 108.691 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.584 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 6.6 m-85 -55.74 -46.42 77.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.968 -1.493 . . . . 0.28 106.968 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 244' ' ' TYR . 21.8 tp -74.19 -74.8 0.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.901 -0.59 . . . . 0.46 110.742 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.732 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -48.19 -61.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.106 -0.996 . . . . 0.39 110.852 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.952 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.6 -51.15 63.93 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.79 -1.194 . . . . 0.17 111.336 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.247 -1.533 . . . . 0.1 108.682 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.628 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.9 t60 -77.08 -51.69 10.61 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.223 0.535 . . . . 0.21 109.647 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.586 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.1 tp10 -59.41 -44.08 92.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.987 -1.071 . . . . 0.28 108.341 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.48 ' CZ ' HD12 ' A' ' 165' ' ' ILE . 7.5 m-30 -53.38 -61.96 1.96 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.734 . . . . 0.18 109.102 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -32.72 2.16 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.925 -1.67 . . . . 0.21 108.925 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.639 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -81.97 -77.99 0.21 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -1.178 . . . . 0.17 111.229 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 1.041 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.73 -39.84 0.16 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.558 -0.714 . . . . 0.33 111.937 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.477 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 3.0 tp -96.41 -39.45 9.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.968 -1.082 . . . . 0.53 110.667 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -74.73 -91.09 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.099 -1.201 . . . . 0.41 110.099 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.773 HD22 ' C ' ' A' ' 230' ' ' LEU . 0.0 OUTLIER -175.93 170.44 2.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -1.118 . . . . 0.45 111.17 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.572 ' N ' HD22 ' A' ' 230' ' ' LEU . 7.2 t70 -25.7 -70.82 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 120.992 0.425 . . . . 0.62 112.024 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.728 ' O ' HD21 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -162.12 -179.83 7.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.01 -1.056 . . . . 0.45 111.176 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.3 OUTLIER 179.46 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.467 0.651 . . . . 0.38 109.401 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.686 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -101.76 23.09 11.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.534 -0.729 . . . . 0.48 111.472 -179.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.613 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -37.3 -66.71 0.27 Allowed Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.81 -0.756 . . . . 0.38 110.381 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 55.0 Cg_endo -76.87 -47.28 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.292 1.154 . . . . 0.28 110.578 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.79 101.17 0.14 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.981 -1.58 . . . . 0.24 111.936 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 257' ' ' ASP . . . -144.57 160.25 41.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -1.058 . . . . 0.28 110.207 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.628 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -75.2 64.98 1.5 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.23 1.015 . . . . 0.4 108.747 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.614 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.1 mtp -141.64 -37.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.805 . . . . 0.45 110.011 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -47.99 170.25 0.11 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.57 109.795 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.0 Cg_endo -70.69 -2.64 11.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.582 1.306 . . . . 0.76 110.512 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.548 HG22 HG22 ' A' ' 245' ' ' THR . 4.3 mt -98.64 145.12 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.89 110.054 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.644 ' HB2' HD21 ' A' ' 218' ' ' LEU . 46.9 p90 -134.65 -33.62 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.78 110.486 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 3.15 -68.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.646 0.98 . . . . 0.61 113.646 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.692 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -54.0 107.79 0.3 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.355 -1.466 . . . . 0.74 109.854 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.613 HG23 ' OD1' ' A' ' 215' ' ' ASN . 53.3 m -58.38 172.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.81 110.363 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 247' ' ' THR . . . -43.15 -40.76 4.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.899 -1.28 . . . . 0.56 109.899 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 46.74 1.64 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.254 . . . . 0.37 110.638 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 1.2 t -89.29 1.93 55.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.44 110.093 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.86 -69.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.53 110.238 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.2 OUTLIER 179.75 178.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.38 110.47 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.909 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -69.04 56.16 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.768 . . . . 0.19 109.853 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.69 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.79 -46.12 50.44 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 108.0 -1.111 . . . . 0.28 108.0 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -73.89 49.69 1.95 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.94 1.495 . . . . 0.49 111.499 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.581 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.3 m-20 -48.82 -34.11 11.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.49 110.689 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -54.69 -53.28 56.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.615 -1.234 . . . . 0.31 108.79 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.947 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.22 -36.43 84.13 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.498 -0.881 . . . . 0.14 108.819 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 253' ' ' MET . 78.3 t -64.73 -84.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.17 110.753 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 11.0 tt0 -54.68 -43.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.045 . . . . 0.26 109.395 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.0 -70.12 0.39 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.518 -1.033 . . . . 0.19 110.518 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.947 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -71.25 -24.93 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.594 -1.533 . . . . 0.22 110.005 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.814 ' N ' HD13 ' A' ' 262' ' ' ILE . 5.4 tt0 -57.33 -23.36 48.25 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.998 -1.081 . . . . 0.39 108.554 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 -43.49 5.48 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.155 -0.618 . . . . 0.47 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.779 HD13 ' HD2' ' A' ' 112' ' ' LYS . 7.0 mt -73.92 -53.45 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.812 . . . . 0.48 110.876 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 1.008 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -75.37 -8.48 56.8 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.251 -0.905 . . . . 0.41 109.837 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.43 -106.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.097 -1.601 . . . . 0.46 109.097 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.81 115.42 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.878 1.462 . . . . 0.58 109.999 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.08 143.13 18.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.66 -1.376 . . . . 0.64 109.66 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.584 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 . . . . . 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.95 110.064 179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 1.6 p . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.374 0.607 . . . . 1.03 109.41 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.512 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.64 48.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.783 -0.573 . . . . 1.04 111.363 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -138.72 78.83 1.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.997 . . . . 0.77 109.61 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.606 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 6.4 t90 -151.15 -67.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.893 . . . . 0.42 111.176 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.461 ' O ' ' HG2' ' A' ' 115' ' ' LYS . 35.9 t -87.79 40.68 0.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.44 110.86 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.823 ' HD3' HD11 ' A' ' 118' ' ' LEU . 13.1 mmtt -143.31 83.69 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.49 110.807 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.1 ttp -100.26 -21.03 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.974 . . . . 0.3 109.391 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.411 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 1.7 p-10 -138.52 137.83 37.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.15 109.455 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -151.07 167.56 27.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 0.13 110.824 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -110.17 168.45 9.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.12 109.604 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.663 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 8.5 p90 -167.32 176.13 6.88 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.934 -1.107 . . . . 0.33 111.486 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 6.2 tpt85 -123.38 152.73 41.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.698 -0.626 . . . . 0.54 109.38 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.815 HG21 ' CD1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -121.32 95.05 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.084 -1.01 . . . . 0.33 111.16 -179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.989 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.5 m -141.53 50.33 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.134 -0.979 . . . . 0.27 110.257 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.707 ' OD1' HD21 ' A' ' 216' ' ' LEU . 1.8 t-20 -43.33 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.41 109.404 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 30.6 t80 179.89 175.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.4 110.127 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -118.97 59.28 4.24 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.45 109.964 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 125' ' ' TYR . 44.8 Cg_endo -70.73 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.109 1.584 . . . . 0.36 110.567 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.19 4.39 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.25 109.795 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.605 ' SD ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -115.41 139.9 49.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.518 -0.739 . . . . 0.39 109.83 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -78.53 167.52 21.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.48 110.378 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 130' ' ' THR . 22.3 t-80 -43.28 -39.21 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.4 109.751 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 8.4 t -59.32 -49.36 78.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.46 109.709 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.566 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.5 OUTLIER -58.25 -57.62 12.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.33 -0.857 . . . . 0.47 109.337 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.6 t -46.42 -35.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.608 -1.256 . . . . 0.31 107.608 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.611 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -57.79 -42.37 84.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.013 -1.106 . . . . 0.48 108.013 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 7.8 tttt -69.31 -49.66 53.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.197 0.999 . . . . 0.64 108.397 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.85 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -48.12 -61.71 1.84 Allowed 'General case' 0 C--N 1.287 -2.138 0 O-C-N 121.245 -0.91 . . . . 0.42 110.816 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.815 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.34 -52.25 35.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.234 -0.916 . . . . 0.34 111.026 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.631 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.2 -71.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.47 110.397 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -41.99 -57.55 2.39 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.527 -0.733 . . . . 0.47 110.307 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.97 -38.51 17.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.296 -1.362 . . . . 0.25 108.345 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.663 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -71.57 -34.71 70.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.308 -0.87 . . . . 0.35 108.994 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.421 ' CD ' ' C ' ' A' ' 143' ' ' LYS . 0.1 OUTLIER -60.63 -41.25 94.52 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.797 -0.816 . . . . 0.7 108.797 179.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.99 -49.96 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.661 -0.866 . . . . 0.61 108.661 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.68 ' HH2' HG21 ' A' ' 262' ' ' ILE . 29.4 t-105 -52.43 -36.24 53.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.682 -0.859 . . . . 0.39 108.682 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 149' ' ' THR . 57.8 m -75.24 -35.39 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.475 -0.766 . . . . 0.35 109.095 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.68 -40.15 78.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.429 -0.794 . . . . 0.36 109.375 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.48 HG23 HG22 ' A' ' 149' ' ' THR . 20.0 m -80.37 -31.23 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.777 -0.769 . . . . 0.5 110.119 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.696 ' CG2' HD23 ' A' ' 151' ' ' LEU . 12.8 t -150.59 131.9 7.53 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.047 . . . . 0.51 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.14 58.93 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.854 1.45 . . . . 0.31 110.545 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.935 HD21 ' HB3' ' A' ' 266' ' ' TYR . 2.1 mm? -77.2 134.89 38.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.18 110.284 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.411 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 1.7 m-20 -80.94 130.13 34.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.17 110.123 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.4 p90 -137.15 139.57 41.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.14 110.268 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.708 ' O ' HG22 ' A' ' 119' ' ' THR . 18.2 m -147.06 131.31 17.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.302 -0.874 . . . . 0.15 110.554 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.608 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -98.65 118.23 34.91 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.695 -0.628 . . . . 0.2 109.471 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.43 99.74 7.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.22 110.311 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 158' ' ' ASP . 11.1 p-80 -54.03 -28.77 40.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.32 109.833 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.5 t0 -41.76 -57.21 2.41 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.475 0.655 . . . . 0.33 109.719 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.72 37.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.616 -1.394 . . . . 0.28 109.616 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 160' ' ' ILE . 23.5 mm -128.26 67.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.146 -1.208 . . . . 0.3 109.373 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.8 127.94 52.41 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.78 -0.575 . . . . 0.2 110.356 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.819 ' OD2' HD23 ' A' ' 118' ' ' LEU . 29.5 m-20 -90.0 -45.16 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.1 110.058 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.0 HG22 ' HA3' ' A' ' 197' ' ' GLY . 1.4 pp -127.02 172.84 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.1 109.719 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.759 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 4.3 ptt? -174.39 163.51 3.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.11 111.563 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 165' ' ' ILE . 4.0 tt -106.23 116.25 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.542 -0.724 . . . . 0.1 109.683 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.989 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.8 p -157.12 141.08 16.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.598 -1.314 . . . . 0.1 111.304 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.7 p90 -60.76 121.68 12.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.547 -0.72 . . . . 0.09 109.913 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -90.86 126.86 8.58 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.094 -1.203 . . . . 0.2 110.094 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.2 tt -122.88 97.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.936 . . . . 0.55 109.457 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 7.0 tptt 0.28 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.291 0.567 . . . . 0.85 112.401 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.66 15.18 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.71 110.168 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.412 ' CE1' ' CE1' ' A' ' 200' ' ' HIS . 29.6 m-70 -85.08 -86.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.42 110.302 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.48 41.72 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.422 -1.471 . . . . 0.33 109.422 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.97 -89.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -1.112 . . . . 0.33 110.355 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.48 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 3.5 m-85 -116.66 -171.26 1.98 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.27 110.411 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.573 ' CD1' ' HE2' ' A' ' 170' ' ' LYS . 4.2 m-30 -90.45 109.83 36.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.34 110.176 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.494 ' O ' HD22 ' A' ' 184' ' ' LEU . 42.9 Cg_endo -75.56 -72.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.47 110.536 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CG ' ' OD2' ' A' ' 203' ' ' ASP . 2.1 p90 -64.85 177.61 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.35 109.936 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.8 p-10 179.13 -51.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.164 -0.96 . . . . 0.2 111.022 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 138.29 -136.59 8.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.366 -1.494 . . . . 0.25 109.366 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 180' ' ' GLY . 55.2 Cg_endo -71.64 -5.41 16.99 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 O-C-N 124.15 1.606 . . . . 0.44 109.392 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.474 ' HB2' ' OD2' ' A' ' 179' ' ' ASP . 1.8 m -55.04 -176.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.397 -0.814 . . . . 0.57 109.616 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -82.63 76.34 2.24 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.038 -1.077 . . . . 0.49 110.672 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.55 ' C ' HD23 ' A' ' 184' ' ' LEU . 6.6 tt 179.77 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -1.146 . . . . 0.41 110.841 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 214' ' ' TYR . 9.4 tt -109.43 -15.59 14.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.803 -1.186 . . . . 0.3 111.248 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.55 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -154.28 109.16 3.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.437 -1.414 . . . . 0.2 111.8 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 1.1 p80 -109.77 127.04 54.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.89 -1.131 . . . . 0.16 109.862 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.826 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -104.2 130.98 51.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.459 -0.775 . . . . 0.23 110.359 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -78.53 163.49 61.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.085 -1.009 . . . . 0.38 110.42 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.504 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.2 Cg_endo -72.73 133.43 20.26 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 124.105 1.582 . . . . 0.4 109.933 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.7 Cg_endo -70.55 70.07 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.874 1.46 . . . . 0.32 110.399 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.36 -105.5 2.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.564 -1.414 . . . . 0.32 109.564 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.74 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.916 1.482 . . . . 0.47 110.223 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -63.17 -10.95 17.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.101 -1.0 . . . . 0.63 110.175 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.63 68.79 0.8 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.499 -0.75 . . . . 0.53 110.032 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -151.53 165.33 30.47 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.901 -1.68 . . . . 0.25 108.901 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 1.0 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 58.28 16.18 26.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.066 -1.614 . . . . 0.1 109.066 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -79.24 87.5 4.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -1.113 . . . . 0.1 110.576 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.7 95.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.09 109.59 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.582 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 19.6 m170 -97.08 141.05 30.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.09 110.394 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 5.4 m-30 -108.0 136.84 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.1 110.98 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 59.5 t0 -50.86 86.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.786 -0.82 . . . . 0.14 108.786 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.597 ' OD2' ' CG ' ' A' ' 178' ' ' PHE . 1.3 p30 -39.34 -32.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.18 111.844 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.587 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -78.81 3.0 17.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.645 -1.285 . . . . 0.24 110.715 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 9.1 mm-40 -96.63 -162.83 0.99 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.012 -1.055 . . . . 0.42 110.126 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.92 147.5 48.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.023 -1.048 . . . . 0.47 110.51 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.569 ' CZ2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -138.71 144.94 39.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.27 109.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.27 177.58 10.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.93 -1.106 . . . . 0.3 110.833 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.2 t -128.61 41.19 3.53 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.912 0.863 . . . . 0.61 109.109 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 4.0 t -122.19 -164.79 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.502 -0.749 . . . . 0.78 109.955 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -89.02 14.45 10.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.91 109.889 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -130.28 163.16 27.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.93 110.316 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 58.76 -175.26 2.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.79 109.461 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.621 ' CE2' HD13 ' A' ' 185' ' ' LEU . 63.0 m-85 -74.62 117.76 16.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.69 110.144 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.615 ' O ' HG12 ' A' ' 219' ' ' VAL . 9.3 p30 -87.75 118.66 27.41 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.192 -0.943 . . . . 0.4 108.709 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.956 ' O ' ' HB3' ' A' ' 220' ' ' ALA . 1.6 mp -41.83 -32.72 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.483 -0.76 . . . . 0.17 110.649 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 2.1 m-85 -50.89 -47.64 60.6 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.297 -1.372 . . . . 0.28 107.297 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 244' ' ' TYR . 42.1 tp -82.49 -70.16 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.423 -0.808 . . . . 0.46 110.976 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.948 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.43 -60.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.39 109.753 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.956 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -54.8 -48.69 72.42 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.892 -1.13 . . . . 0.17 110.916 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -58.22 -29.99 66.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.328 -1.483 . . . . 0.1 108.846 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.653 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.4 t60 -74.75 -51.06 15.19 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.746 -0.661 . . . . 0.21 109.523 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.624 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.9 tp10 -61.09 -32.9 72.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.28 109.042 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 225' ' ' GLY . 13.6 m-30 -65.85 -64.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.42 -0.8 . . . . 0.18 108.986 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -28.27 1.19 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.076 -1.61 . . . . 0.21 109.076 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.63 -70.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -1.221 . . . . 0.17 111.657 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.826 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 5.0 p -51.77 -31.17 25.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.33 112.124 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 118' ' ' LEU . 9.8 tp -99.96 -41.83 7.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.89 -1.131 . . . . 0.53 111.157 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.581 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -74.89 -83.93 0.36 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.758 -0.937 . . . . 0.41 110.758 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.712 ' H ' HD23 ' A' ' 230' ' ' LEU . 2.0 pt? -161.13 -157.73 0.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.031 -1.276 . . . . 0.45 110.785 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.522 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -70.74 -50.95 30.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.62 110.36 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.624 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -169.09 176.18 5.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 0.45 110.59 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.71 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.443 -0.785 . . . . 0.38 109.316 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.961 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -138.98 22.22 2.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.48 110.889 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -38.78 -48.47 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.464 -0.772 . . . . 0.38 110.433 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 45.6 Cg_endo -87.36 -48.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.846 1.445 . . . . 0.28 111.372 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.506 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.28 100.43 0.13 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 118.962 -1.589 . . . . 0.24 111.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.961 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -144.89 -161.62 1.33 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -1.143 . . . . 0.28 109.808 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.619 HD11 HD12 ' A' ' 218' ' ' LEU . 0.3 OUTLIER -105.66 49.84 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.341 -0.985 . . . . 0.4 108.341 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.653 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.4 mtt -134.37 -21.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.374 -0.829 . . . . 0.45 111.157 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.625 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -59.07 168.5 1.51 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.793 -1.192 . . . . 0.57 111.035 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.7 Cg_endo -71.23 -8.65 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.684 1.36 . . . . 0.76 109.93 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.672 HG22 HG22 ' A' ' 245' ' ' THR . 17.1 mm -101.06 139.08 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.452 -0.78 . . . . 0.89 109.647 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.72 ' HB2' HD21 ' A' ' 218' ' ' LEU . 48.2 p90 -125.6 -25.56 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.78 110.664 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.743 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER 2.45 -67.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 113.635 0.976 . . . . 0.61 113.635 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.743 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -68.63 117.19 10.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.38 -1.45 . . . . 0.74 109.289 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 250' ' ' SER . 49.3 p -47.13 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.81 110.206 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.79 -21.16 3.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.432 -1.467 . . . . 0.56 109.432 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.434 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 1.1 ptmm? -162.5 49.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.246 . . . . 0.37 110.665 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.488 ' OG ' ' CD1' ' A' ' 246' ' ' TYR . 1.4 m -43.77 -61.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.44 109.856 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.7 OUTLIER -147.37 4.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.53 111.016 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 253' ' ' MET . 92.7 t80 179.98 170.91 1.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.934 -1.104 . . . . 0.38 110.939 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.934 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -90.58 59.89 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.55 -0.719 . . . . 0.19 110.013 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.702 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.7 OUTLIER -44.41 -47.33 25.75 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.979 -1.119 . . . . 0.28 107.979 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.2 Cg_endo -73.34 50.58 1.95 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.143 1.602 . . . . 0.49 110.922 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.656 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.4 m-20 -55.54 -29.15 58.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.072 -1.017 . . . . 0.49 110.633 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.889 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 35.3 m-20 -54.7 -48.95 71.83 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.111 -0.993 . . . . 0.31 109.234 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.949 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.98 -33.31 63.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.57 -0.9 . . . . 0.14 108.57 178.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 253' ' ' MET . 72.8 t -62.23 -82.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.811 . . . . 0.17 110.055 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.652 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 21.4 tm0? -59.84 -41.76 92.08 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.345 -0.847 . . . . 0.26 109.665 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.68 ' O ' HD12 ' A' ' 265' ' ' LEU . . . -40.69 -64.87 1.12 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.949 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -80.21 -21.66 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.744 -1.445 . . . . 0.22 110.278 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.867 ' N ' HD13 ' A' ' 262' ' ' ILE . 6.3 tt0 -60.35 -22.67 63.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.788 -1.165 . . . . 0.39 108.158 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 31.2 t -104.09 -41.21 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.268 -0.573 . . . . 0.47 111.092 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 261' ' ' GLY . 0.4 OUTLIER -79.75 -50.2 10.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.48 111.527 -178.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.935 ' HB3' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -78.7 -17.09 56.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.41 110.059 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -52.88 -93.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.815 -1.714 . . . . 0.46 108.815 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 128.49 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.017 1.535 . . . . 0.58 110.067 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -101.02 147.7 17.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.583 -1.407 . . . . 0.64 109.583 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.606 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.273 -1.134 . . . . 0.95 110.054 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 6.7 p . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 121.578 0.704 . . . . 1.03 109.967 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.613 HD22 ' HD2' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 45.06 23.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.187 -0.945 . . . . 1.04 111.285 179.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 266' ' ' TYR . 28.9 mtpt -123.64 74.45 1.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.051 -1.031 . . . . 0.77 109.598 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.577 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 5.9 t90 -145.44 -67.91 0.3 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.225 -0.922 . . . . 0.42 110.907 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.516 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.1 t -97.84 58.52 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.865 . . . . 0.44 110.835 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 114' ' ' SER . 9.5 mttm -160.03 61.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.94 . . . . 0.49 110.43 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 7.3 tmm? -85.05 13.69 5.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.3 110.355 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -171.82 126.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.15 110.278 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.772 HD13 ' OD2' ' A' ' 162' ' ' ASP . 2.8 mt -151.3 -164.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.13 110.177 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 1.071 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -128.78 171.38 12.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.12 109.75 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 154' ' ' THR . 36.2 p90 -171.4 -172.97 1.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.09 . . . . 0.33 111.168 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 2.3 mtm-85 -127.98 164.84 21.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.54 110.196 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 138' ' ' PHE . 6.6 pt -128.19 70.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.33 110.365 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.949 HG23 ' HB3' ' A' ' 166' ' ' SER . 4.8 m -120.67 50.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.27 110.793 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.497 ' N ' HG23 ' A' ' 165' ' ' ILE . 6.8 t30 -44.13 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.41 109.267 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.66 ' O ' HG21 ' A' ' 134' ' ' VAL . 7.5 t80 -178.99 174.43 1.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.506 -0.746 . . . . 0.4 109.836 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -128.74 53.78 12.23 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.45 110.425 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 126' ' ' THR . 47.2 Cg_endo -77.14 -86.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.989 1.52 . . . . 0.36 110.609 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.02 -1.38 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.25 110.064 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.723 ' HE3' HD21 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -112.19 150.52 30.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.39 110.111 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -98.03 166.24 11.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.48 110.069 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' THR . 17.2 t-80 -41.3 -32.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.395 -0.816 . . . . 0.4 110.194 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -69.87 -46.32 65.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.46 110.261 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.8 OUTLIER -67.67 -58.11 5.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.083 -1.01 . . . . 0.47 109.528 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.66 HG21 ' O ' ' A' ' 125' ' ' TYR . 13.8 t -45.07 -37.78 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.817 -1.179 . . . . 0.31 107.817 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.9 mt-10 -57.58 -45.95 84.6 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.887 -1.153 . . . . 0.48 107.887 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 3.3 tttt -63.2 -48.94 76.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.798 0.809 . . . . 0.64 109.011 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.821 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.67 -59.02 2.99 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.123 -0.986 . . . . 0.42 110.155 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.624 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -66.71 -54.15 26.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.34 110.568 -179.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -64.6 -74.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.099 -1.0 . . . . 0.47 109.942 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.9 tmtt? -37.32 -62.7 0.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 O-C-N 122.07 -0.394 . . . . 0.47 110.886 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.92 -36.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.686 -1.206 . . . . 0.25 108.585 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.83 -28.94 61.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.35 109.111 178.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.93 -43.73 97.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.379 -0.971 . . . . 0.7 108.379 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 5.7 t -70.29 -49.66 52.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.649 -0.871 . . . . 0.61 108.649 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.618 ' CH2' HG13 ' A' ' 262' ' ' ILE . 51.3 t-105 -53.54 -31.52 46.74 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.755 -0.831 . . . . 0.39 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 149' ' ' THR . 67.6 m -78.95 -34.25 44.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.235 -1.024 . . . . 0.35 108.235 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.7 OUTLIER -57.9 -37.37 73.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.793 -0.818 . . . . 0.36 108.793 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.84 HG23 HG22 ' A' ' 149' ' ' THR . 27.1 m -80.67 -35.14 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.767 -0.773 . . . . 0.5 109.751 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.84 HG22 HG23 ' A' ' 148' ' ' VAL . 4.6 t -147.83 127.6 6.56 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.994 . . . . 0.51 110.389 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 54.25 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.803 1.422 . . . . 0.31 110.601 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.575 HD21 ' CG ' ' A' ' 266' ' ' TYR . 4.1 tp -73.85 147.79 42.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.18 110.318 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.9 OUTLIER -88.22 117.62 27.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.93 . . . . 0.17 110.204 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.0 p90 -125.12 119.75 29.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.14 110.297 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 155' ' ' ARG . 23.0 m -120.45 170.75 9.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.15 110.256 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 154' ' ' THR . 2.3 ptt180 -156.64 114.52 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.902 -0.719 . . . . 0.2 110.481 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 110.67 14.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.22 109.995 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 158' ' ' ASP . 23.9 p-80 -51.86 -23.63 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.32 109.954 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.523 ' OD2' ' CD1' ' A' ' 160' ' ' ILE . 1.1 t70 -44.24 -26.16 0.29 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.39 -0.819 . . . . 0.33 109.666 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.72 28.9 1.01 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.543 -1.423 . . . . 0.28 109.543 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 1.071 HG22 HG21 ' A' ' 119' ' ' THR . 7.2 mt -115.3 81.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.2 -1.176 . . . . 0.3 108.483 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -144.81 123.68 12.7 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.068 -0.653 . . . . 0.2 110.828 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.772 ' OD2' HD13 ' A' ' 118' ' ' LEU . 39.4 t0 -92.29 -51.61 5.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.1 109.697 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.628 HG22 ' HA3' ' A' ' 197' ' ' GLY . 1.1 pt -115.82 179.43 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.307 -0.87 . . . . 0.1 109.05 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.811 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.2 ptp -177.82 151.6 0.71 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 0.11 111.618 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.568 ' HB ' ' CE2' ' A' ' 224' ' ' PHE . 3.6 tt -93.98 117.6 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.1 109.374 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.949 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.1 p -159.31 150.57 20.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.74 -1.225 . . . . 0.1 110.587 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 169' ' ' ILE . 6.7 p90 -72.94 117.74 15.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.499 -0.751 . . . . 0.09 110.168 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -67.75 118.82 10.18 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.051 -1.22 . . . . 0.2 110.051 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 169' ' ' ILE . 19.7 tt -118.5 101.08 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.88 -0.776 . . . . 0.55 109.422 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.9 OUTLIER 1.93 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.331 0.586 . . . . 0.85 112.488 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.22 -0.04 3.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.71 110.088 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 17.3 m-70 -91.36 -154.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.42 110.191 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -159.08 31.61 0.45 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.467 . . . . 0.33 109.434 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -131.47 -52.84 1.01 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -1.155 . . . . 0.33 110.125 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -136.87 175.98 9.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.27 110.231 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -95.09 110.15 48.49 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.34 110.255 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.534 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.2 Cg_endo -73.38 -37.96 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.984 1.518 . . . . 0.47 110.592 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 4.4 p90 -109.73 170.19 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.35 110.734 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.509 ' OD2' HD23 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -179.77 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.2 111.142 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.588 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 159.2 -141.66 7.73 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.561 -1.415 . . . . 0.25 109.561 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.65 -3.82 13.83 Favored 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.236 1.65 . . . . 0.44 109.875 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.86 177.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.463 -0.773 . . . . 0.57 110.019 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -74.97 79.77 0.98 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.234 -1.146 . . . . 0.49 110.234 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.601 ' O ' ' HB2' ' A' ' 202' ' ' ASP . 15.1 tp 179.82 91.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -1.12 . . . . 0.41 110.888 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.705 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.0 tt -113.83 -17.38 12.06 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.461 -1.296 . . . . 0.3 111.293 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -152.14 104.55 2.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.555 -1.341 . . . . 0.2 111.864 -179.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 0.4 OUTLIER -109.41 121.0 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.16 109.77 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -110.83 136.01 50.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.23 110.413 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.698 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.8 m-30 -85.57 159.36 55.72 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.38 110.216 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.52 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 43.8 Cg_endo -70.88 140.28 38.14 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.145 1.603 . . . . 0.4 109.588 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.613 ' HD2' HD22 ' A' ' 111' ' ' LEU . 42.0 Cg_endo -68.75 82.0 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.015 1.534 . . . . 0.32 110.836 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.61 -91.23 1.12 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.17 -1.572 . . . . 0.32 109.17 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.28 -158.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.074 1.565 . . . . 0.47 109.981 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -82.51 12.26 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 0.63 110.323 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -117.78 -3.34 11.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.249 -0.907 . . . . 0.53 109.982 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -68.54 171.31 37.52 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.331 -1.508 . . . . 0.25 109.331 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.628 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 48.22 21.76 2.0 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.775 -1.33 . . . . 0.1 109.775 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 195' ' ' TYR . 0.4 OUTLIER -81.71 85.55 6.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.317 . . . . 0.1 110.096 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.811 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.17 101.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.09 110.033 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.572 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -112.53 120.88 43.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.837 . . . . 0.09 110.461 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 203' ' ' ASP . 22.6 m-85 -90.67 144.37 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.1 110.477 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 15.1 t0 -52.84 85.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.593 -0.892 . . . . 0.14 108.593 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.567 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.8 p30 -38.19 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.18 111.799 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.588 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -75.68 -0.65 21.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.792 -1.193 . . . . 0.24 110.929 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.65 ' HG2' HD12 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -101.98 -156.14 0.55 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 0.42 110.218 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 17.5 m -133.98 156.4 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 0.47 110.768 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -151.65 150.64 30.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.27 109.272 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.003 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -161.05 173.18 15.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.726 -1.234 . . . . 0.3 111.038 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.0 OUTLIER -129.84 25.35 5.31 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.716 0.769 . . . . 0.61 108.993 178.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.34 -67.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.463 0.649 . . . . 0.78 110.525 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.75 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.488 -0.757 . . . . 0.91 109.724 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.99 -178.99 4.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.369 -0.832 . . . . 0.93 110.063 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.05 -174.7 0.17 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.539 -1.424 . . . . 0.79 109.539 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.705 ' CE1' HD13 ' A' ' 185' ' ' LEU . 93.9 m-85 -67.36 120.13 13.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -1.109 . . . . 0.69 109.814 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.611 ' O ' HG12 ' A' ' 219' ' ' VAL . 40.6 m-80 -88.17 119.5 28.63 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.974 -1.079 . . . . 0.4 108.8 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.003 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.84 -36.24 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -0.863 . . . . 0.17 110.236 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.612 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 4.6 m-85 -51.58 -44.11 62.67 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.407 -1.317 . . . . 0.28 107.746 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.716 HD21 ' HB2' ' A' ' 244' ' ' TYR . 12.3 tp -83.65 -71.29 0.51 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.894 -0.594 . . . . 0.46 111.106 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.837 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.4 p -46.31 -56.11 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.986 -1.071 . . . . 0.39 109.817 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.95 -48.92 79.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.101 -0.999 . . . . 0.17 110.873 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -57.36 -24.92 58.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.234 -1.541 . . . . 0.1 108.556 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.843 ' HB2' HD21 ' A' ' 239' ' ' LEU . 3.8 t-160 -79.64 -54.89 5.44 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.95 -0.568 . . . . 0.21 109.872 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.612 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.3 tp10 -59.51 -50.94 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.979 -1.076 . . . . 0.28 109.092 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.568 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 1.9 m-85 -52.82 -57.99 8.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.18 109.163 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.02 -32.58 4.84 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.251 -1.539 . . . . 0.21 109.251 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.774 ' HE2' ' CD2' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.0 -72.14 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.09 -1.241 . . . . 0.17 111.001 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.933 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -38.05 -42.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.33 111.9 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.604 ' HB2' HD13 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -95.95 -38.49 10.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.878 -1.139 . . . . 0.53 111.335 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.538 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -75.13 -87.09 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.653 -0.979 . . . . 0.41 110.653 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.811 HD11 ' O ' ' A' ' 232' ' ' HIS . 0.3 OUTLIER -158.69 -167.72 2.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -1.194 . . . . 0.45 110.855 -178.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.514 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -64.41 -55.43 21.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.62 109.75 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.811 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -157.38 179.98 8.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.264 -0.898 . . . . 0.45 110.62 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 14.2 t 179.24 50.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.38 109.381 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.739 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -131.06 21.56 4.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.48 111.13 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.586 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -37.44 -52.86 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.38 110.708 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.2 Cg_endo -90.12 -46.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.52 1.274 . . . . 0.28 110.873 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.01 96.11 0.1 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.295 -1.431 . . . . 0.24 111.419 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.856 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.37 165.95 26.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.347 -1.09 . . . . 0.28 110.133 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.901 ' O ' HD23 ' A' ' 239' ' ' LEU . 7.0 tt -74.46 55.7 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.4 109.736 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.631 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.6 mmm -133.7 -34.72 1.01 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.004 -1.06 . . . . 0.45 110.32 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -42.99 168.51 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 0.57 110.464 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.9 Cg_endo -72.89 -2.43 11.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.89 1.468 . . . . 0.76 110.024 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 245' ' ' THR . 26.1 mm -106.89 149.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.89 110.04 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 218' ' ' LEU . 26.4 p90 -134.51 -28.3 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.78 110.922 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.93 -69.52 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.495 0.924 . . . . 0.61 113.495 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -55.17 104.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.309 -1.495 . . . . 0.74 109.628 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.545 HG23 ' ND2' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -52.52 -177.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.81 110.201 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 247' ' ' THR . . . -67.58 -8.31 51.31 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.317 -1.513 . . . . 0.56 109.317 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 29.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.37 110.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 247' ' ' THR . 0.9 OUTLIER -82.35 -10.62 59.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.056 -1.028 . . . . 0.44 109.746 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.555 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -156.92 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.53 109.785 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER 179.22 -172.27 0.15 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.38 110.407 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.886 ' HB2' HG21 ' A' ' 259' ' ' VAL . 19.7 ptt? -66.31 53.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.19 110.825 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.715 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.6 OUTLIER -46.22 -47.39 45.06 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 107.933 -1.136 . . . . 0.28 107.933 177.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.715 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -72.92 50.32 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 124.076 1.567 . . . . 0.49 111.309 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.0 m-20 -48.51 -32.48 7.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.945 -1.097 . . . . 0.49 110.6 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.856 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -53.89 -53.54 51.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.887 -1.125 . . . . 0.31 109.233 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.074 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -67.46 -32.86 73.99 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.021 -1.05 . . . . 0.14 108.915 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.886 HG21 ' HB2' ' A' ' 253' ' ' MET . 59.2 t -66.54 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.17 110.398 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.605 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 8.7 tt0 -53.9 -41.97 68.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.26 109.231 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.69 -71.66 0.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.091 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -71.54 -19.48 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.707 -1.466 . . . . 0.22 110.073 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 1.091 ' N ' HD13 ' A' ' 262' ' ' ILE . 40.3 tt0 -59.6 -26.44 65.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.543 -1.28 . . . . 0.39 107.543 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.7 t -104.59 -42.47 5.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.411 0.624 . . . . 0.47 110.887 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 262' ' ' ILE . 26.5 mt -69.15 -55.02 11.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.48 111.223 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.575 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -81.33 -6.84 59.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.41 110.032 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.29 -108.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.129 -1.588 . . . . 0.46 109.129 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.74 76.84 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.733 1.386 . . . . 0.58 110.325 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -48.19 161.04 0.51 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.64 109.554 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.577 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.95 110.125 179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.591 ' CA ' HD12 ' A' ' 230' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.488 1.449 0 CA-C-O 121.287 0.565 . . . . 1.03 109.505 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.3 tp 35.53 30.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.817 -0.552 . . . . 1.04 111.18 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -108.59 51.53 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.945 . . . . 0.77 110.239 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.525 ' NE1' ' HB3' ' A' ' 270' ' ' ASP . 8.0 t90 -139.79 -56.47 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.42 110.124 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.473 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 79.5 p -90.67 49.74 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.44 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 6.4 mmtt -148.48 87.71 1.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.49 110.174 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 35.9 ttp -123.02 -8.81 8.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.162 -0.961 . . . . 0.3 110.098 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 7.0 p-10 -159.77 126.73 4.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.15 109.974 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -152.98 -172.58 4.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.13 110.426 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.804 HG21 HG22 ' A' ' 160' ' ' ILE . 1.2 p -127.59 139.14 52.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.12 110.557 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.557 ' CB ' HG12 ' A' ' 163' ' ' ILE . 26.6 p90 -127.32 177.99 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.33 111.398 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.511 ' HB3' ' CB ' ' A' ' 164' ' ' MET . 7.2 tpt180 -133.08 150.39 52.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.54 109.508 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.846 ' O ' HG13 ' A' ' 123' ' ' VAL . 3.4 pt -112.62 118.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.003 . . . . 0.33 111.771 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.852 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.8 m -166.26 38.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.27 110.079 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.757 ' OD1' HG22 ' A' ' 134' ' ' VAL . 0.8 OUTLIER -42.89 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.399 -0.92 . . . . 0.41 109.116 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.542 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.7 t80 179.58 -171.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.885 . . . . 0.4 109.991 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.8 53.02 3.47 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.798 -1.189 . . . . 0.45 110.913 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.9 Cg_endo -80.38 -84.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.858 1.452 . . . . 0.36 110.571 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.15 -3.96 57.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.25 109.95 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.533 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -123.0 160.38 26.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.303 -0.873 . . . . 0.39 110.369 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.26 179.51 4.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.48 109.759 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -47.02 -39.26 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.4 110.208 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -59.96 -57.87 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.46 110.037 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.533 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 4.4 mp0 -53.69 -54.61 35.52 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.219 -0.925 . . . . 0.47 109.607 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.757 HG22 ' OD1' ' A' ' 124' ' ' ASN . 2.6 t -46.16 -36.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.939 -1.134 . . . . 0.31 107.939 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.61 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 5.1 tt0 -61.2 -40.28 93.35 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.242 -1.022 . . . . 0.48 108.242 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.584 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -72.44 -52.0 17.8 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.3 -0.96 . . . . 0.64 108.776 178.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.825 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -44.67 -62.63 1.13 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.081 -1.012 . . . . 0.42 110.447 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.32 -52.98 55.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.439 -0.788 . . . . 0.34 111.343 -178.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.645 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -68.78 -71.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.905 -1.122 . . . . 0.47 110.328 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.54 -59.78 0.88 Allowed 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.933 -0.479 . . . . 0.47 110.33 178.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.22 -41.38 27.22 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.594 -1.242 . . . . 0.25 107.984 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -68.29 -27.47 66.34 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.432 -0.793 . . . . 0.35 109.11 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 2.6 tttt -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.465 -0.939 . . . . 0.7 108.465 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 13.4 t -73.14 -46.86 49.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.905 -0.776 . . . . 0.61 108.905 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.745 ' HH2' HG21 ' A' ' 262' ' ' ILE . 42.3 t-105 -58.52 -42.53 87.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.9 -0.778 . . . . 0.39 108.9 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.3 m -70.86 -32.06 68.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.431 -0.952 . . . . 0.35 108.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -55.65 -46.87 77.41 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.107 -0.701 . . . . 0.36 109.107 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.971 HG23 HG22 ' A' ' 149' ' ' THR . 28.1 m -72.34 -34.62 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.448 -0.901 . . . . 0.5 109.369 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 1.015 HG23 HD11 ' A' ' 151' ' ' LEU . 1.1 t -141.37 118.69 7.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.103 -0.998 . . . . 0.51 109.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.49 62.58 3.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.68 1.358 . . . . 0.31 111.153 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 149' ' ' THR . 0.2 OUTLIER -76.48 174.2 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.003 -1.06 . . . . 0.18 109.931 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 12.5 t-20 -107.81 126.23 52.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.228 -0.92 . . . . 0.17 109.873 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.544 ' HE2' ' HG ' ' A' ' 146' ' ' SER . 9.3 p90 -131.37 143.03 50.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 0.14 110.925 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.669 ' HB ' HG22 ' A' ' 119' ' ' THR . 33.0 m -143.61 141.51 30.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.337 -0.852 . . . . 0.15 110.38 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.456 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -117.35 88.24 2.87 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.29 -0.882 . . . . 0.2 109.935 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -79.81 129.07 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.22 110.461 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -89.0 36.78 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.32 109.965 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -34.63 2.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.511 -0.743 . . . . 0.33 109.648 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 147.1 37.13 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.051 -1.22 . . . . 0.28 110.051 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.926 HD13 HD22 ' A' ' 156' ' ' LEU . 1.9 mp -126.02 70.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.251 . . . . 0.3 108.983 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -139.22 162.27 35.39 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 0.2 110.702 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.665 ' HB3' HD22 ' A' ' 118' ' ' LEU . 7.0 t70 -134.18 -33.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.1 110.458 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.054 HG21 ' HG ' ' A' ' 228' ' ' LEU . 0.2 OUTLIER -127.5 173.29 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.038 . . . . 0.1 109.77 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.824 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 2.9 ptt? -176.98 159.12 1.65 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.605 -1.309 . . . . 0.11 111.754 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.3 tt -103.0 116.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.1 109.301 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.852 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.3 p -157.32 154.58 29.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.789 -1.195 . . . . 0.1 111.035 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.3 p90 -75.03 122.13 23.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.09 109.448 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -84.52 115.72 4.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.244 -1.142 . . . . 0.2 110.244 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -105.43 104.21 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -1.034 . . . . 0.55 109.246 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.72 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.42 0.628 . . . . 0.85 112.374 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -130.15 -2.13 4.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 0.71 110.181 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 10.3 m-70 -84.83 178.95 7.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.42 109.857 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.74 28.38 4.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.33 109.683 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -121.77 -97.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.33 110.14 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -102.09 126.94 49.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.27 110.022 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -54.48 109.59 1.65 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.93 . . . . 0.34 110.301 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.625 ' O ' HD23 ' A' ' 184' ' ' LEU . 42.7 Cg_endo -74.16 -66.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.015 1.534 . . . . 0.47 110.76 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -47.72 137.75 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.35 110.406 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 179' ' ' ASP . 7.6 p30 179.14 81.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.402 -0.919 . . . . 0.2 110.584 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.51 ' H ' ' CB ' ' A' ' 204' ' ' ASP . . . 38.2 -152.01 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.741 -1.343 . . . . 0.25 109.741 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.409 ' HA ' ' CD ' ' A' ' 205' ' ' GLU . 54.6 Cg_endo -82.49 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.969 1.51 . . . . 0.44 110.584 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.4 t -58.39 176.13 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.57 110.354 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.49 70.49 0.04 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.219 -1.153 . . . . 0.49 110.219 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.625 HD23 ' O ' ' A' ' 177' ' ' PRO . 7.4 tp 179.9 81.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.349 -1.089 . . . . 0.41 110.175 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.882 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.4 tt -100.84 -24.34 14.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.355 -1.338 . . . . 0.3 111.036 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.454 ' O ' ' OE1' ' A' ' 223' ' ' GLU . . . -149.01 101.71 3.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.723 -1.235 . . . . 0.2 112.254 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.542 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.1 OUTLIER -102.97 133.35 48.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.16 109.236 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.957 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -121.37 130.93 53.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 0.23 110.595 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -79.14 165.15 50.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.38 110.341 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.53 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.9 Cg_endo -73.41 141.27 31.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.974 1.512 . . . . 0.4 110.038 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' SER . 42.9 Cg_endo -70.08 83.25 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.911 1.48 . . . . 0.32 110.626 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.72 -101.52 1.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.32 109.589 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -162.49 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.942 1.496 . . . . 0.47 110.539 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -62.0 -17.79 58.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.63 110.023 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.44 59.55 0.67 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.532 -0.73 . . . . 0.53 110.377 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -131.22 168.16 22.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.828 -1.709 . . . . 0.25 108.828 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 1.002 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 42.78 26.61 0.46 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.67 -1.372 . . . . 0.1 109.67 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.461 ' OD1' ' O ' ' A' ' 196' ' ' GLY . 7.3 m-20 -79.06 86.18 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.1 109.914 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.6 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.074 -1.016 . . . . 0.09 109.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.542 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 17.9 m170 -101.97 131.19 48.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.855 . . . . 0.09 110.707 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 203' ' ' ASP . 42.4 m-85 -103.52 137.61 41.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.913 . . . . 0.1 110.515 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -49.05 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.14 108.956 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.548 ' OD2' ' CB ' ' A' ' 178' ' ' PHE . 2.6 p30 -35.95 -29.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.653 -0.654 . . . . 0.18 111.772 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 202' ' ' ASP . 10.4 m-20 -79.12 2.27 21.4 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.607 -1.308 . . . . 0.24 111.457 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.882 ' OE1' HD12 ' A' ' 185' ' ' LEU . 9.8 mm-40 -93.65 -166.45 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.773 -1.204 . . . . 0.42 110.347 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.32 140.81 52.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.47 110.468 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.516 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -140.6 130.39 24.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.275 -0.89 . . . . 0.27 109.737 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.021 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -138.83 176.46 8.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.021 -1.05 . . . . 0.3 110.583 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.49 ' HB2' HD23 ' A' ' 216' ' ' LEU . 2.1 t -130.5 35.94 3.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.873 -0.788 . . . . 0.61 108.873 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.9 t -115.26 -111.62 0.35 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.702 -0.624 . . . . 0.78 110.065 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.517 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 t -143.88 11.23 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.91 109.952 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 123.52 29.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.93 109.917 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.99 -171.7 31.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.175 -1.57 . . . . 0.79 109.175 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.607 ' CE1' HD13 ' A' ' 185' ' ' LEU . 64.8 m-85 -69.47 122.11 18.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -1.192 . . . . 0.69 109.687 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 219' ' ' VAL . 1.1 p-10 -95.73 119.82 34.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.986 -1.072 . . . . 0.4 108.965 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.021 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -38.45 -37.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.672 -0.643 . . . . 0.17 111.093 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.6 m-30 -49.92 -48.39 51.73 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.439 -1.304 . . . . 0.28 107.719 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.639 HD12 HD11 ' A' ' 239' ' ' LEU . 4.7 tp -79.79 -69.45 0.58 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.906 -0.588 . . . . 0.46 110.53 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.969 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.99 -65.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.39 109.786 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -48.53 -50.27 32.65 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.832 -1.167 . . . . 0.17 111.564 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -63.52 -24.88 68.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.329 -1.482 . . . . 0.1 109.052 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.618 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.6 t60 -76.78 -54.5 6.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.281 -0.637 . . . . 0.21 109.281 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.613 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.2 tp10 -58.76 -47.9 83.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.181 -0.949 . . . . 0.28 108.538 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -54.79 -55.76 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.18 109.049 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.53 -31.52 5.07 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.848 -1.701 . . . . 0.21 108.848 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.573 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -82.07 -76.71 0.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.241 -1.152 . . . . 0.17 110.865 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.957 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.22 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.832 -0.543 . . . . 0.33 111.834 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 1.054 ' HG ' HG21 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -99.82 -41.23 7.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 0.53 110.731 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -72.19 -79.32 0.45 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.26 -1.136 . . . . 0.41 110.26 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.591 HD12 ' CA ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -173.54 -163.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.253 . . . . 0.45 110.525 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.517 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -61.55 -54.62 40.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.62 110.288 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.573 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -167.77 177.14 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.45 111.056 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 27.7 t 179.26 51.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.748 -0.834 . . . . 0.38 108.748 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.83 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -132.41 24.66 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.48 111.41 -178.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.554 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.1 OUTLIER -37.13 -53.61 2.03 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.491 -0.756 . . . . 0.38 110.976 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -84.27 -49.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.715 1.376 . . . . 0.28 111.202 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.57 101.56 0.15 Allowed Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.361 -1.399 . . . . 0.24 111.357 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.907 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -146.73 163.27 36.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.341 -1.094 . . . . 0.28 110.246 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -69.64 58.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.4 109.026 179.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.618 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.8 mtp -144.17 -37.29 0.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.45 110.045 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -48.56 171.39 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.865 -1.147 . . . . 0.57 110.063 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.3 Cg_endo -74.25 3.91 4.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.578 1.304 . . . . 0.76 110.553 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.8 mt -104.8 134.58 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.89 110.182 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.554 ' O ' ' C ' ' A' ' 245' ' ' THR . 49.8 p90 -127.87 -36.53 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.854 . . . . 0.78 109.72 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 244' ' ' TYR . 53.7 m 1.41 -69.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 112.977 0.732 . . . . 0.61 112.977 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.577 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -60.14 101.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.74 109.33 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.519 ' N ' ' HB2' ' A' ' 250' ' ' SER . 38.7 p -46.79 175.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.81 110.484 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.22 8.05 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.703 -1.359 . . . . 0.56 109.703 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.48 28.48 1.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.156 . . . . 0.37 110.345 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.519 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.5 OUTLIER -58.52 -27.34 64.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.44 109.941 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 252' ' ' PHE . 6.9 t-160 -150.59 -55.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.53 110.03 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER -176.94 -179.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.38 110.191 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.882 ' HB2' HG21 ' A' ' 259' ' ' VAL . 1.5 ptt? -68.77 54.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.418 -0.801 . . . . 0.19 110.371 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.6 mp -44.75 -47.72 28.56 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.974 -1.121 . . . . 0.28 107.974 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.5 Cg_endo -72.89 50.13 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.962 1.506 . . . . 0.49 110.94 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.609 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.7 m-20 -52.51 -29.77 26.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.037 -1.039 . . . . 0.49 110.157 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.907 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.07 -51.55 63.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.118 -1.033 . . . . 0.31 109.487 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.066 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.32 -33.92 70.11 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.938 -1.105 . . . . 0.14 108.553 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 253' ' ' MET . 72.2 t -62.51 -85.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.573 -0.851 . . . . 0.17 110.22 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.4 tt0 -58.04 -43.52 86.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.26 110.007 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.1 -63.87 1.66 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.556 -1.018 . . . . 0.19 110.556 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.1 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -80.18 -19.19 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.755 -1.438 . . . . 0.22 109.994 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 1.1 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.7 OUTLIER -59.33 -24.65 63.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.849 -1.167 . . . . 0.39 107.849 178.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.4 p -103.9 -40.85 6.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.273 -0.571 . . . . 0.47 111.806 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 112' ' ' LYS . 4.9 mp -83.96 -46.85 11.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.48 111.789 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.936 ' OH ' HD22 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -76.08 -21.42 56.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.061 -1.025 . . . . 0.41 110.481 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -57.7 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.165 -1.574 . . . . 0.46 109.165 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.0 Cg_endo -75.19 95.68 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.789 1.415 . . . . 0.58 110.062 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.8 178.26 43.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.558 -1.417 . . . . 0.64 109.558 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.525 ' HB3' ' NE1' ' A' ' 113' ' ' TRP . 27.9 t0 . . . . . 0 N--CA 1.491 1.594 0 O-C-N 121.266 -1.138 . . . . 0.95 110.138 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 3.1 p . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.6 0.714 . . . . 1.03 109.407 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.9 mp 49.2 18.36 0.24 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.386 -0.821 . . . . 1.04 111.541 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.75 ' HB3' HD12 ' A' ' 265' ' ' LEU . 9.6 mttm -97.41 78.89 2.72 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.837 -1.164 . . . . 0.77 109.643 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.56 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.3 t90 -165.38 -68.33 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.42 111.36 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.525 ' O ' ' CD ' ' A' ' 115' ' ' LYS . 79.9 p -104.69 84.47 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.44 110.952 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 266' ' ' TYR . 3.4 mptt -173.53 83.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.49 110.312 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 116' ' ' MET . 7.7 tmm? -123.75 -8.88 7.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.3 110.134 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 10.1 p30 -158.31 117.34 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.15 109.941 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.515 ' CD2' ' OD2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -141.88 -178.83 5.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.13 110.611 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -119.93 170.36 9.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.85 . . . . 0.12 109.56 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.55 ' HB3' HG23 ' A' ' 163' ' ' ILE . 41.0 p90 -165.22 -158.54 0.39 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.041 . . . . 0.33 110.947 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -150.34 143.17 24.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 0.54 110.138 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.636 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.7 pp -103.81 108.25 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.33 110.866 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.939 HG23 ' HB3' ' A' ' 166' ' ' SER . 15.6 m -158.76 43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.27 110.352 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 16.1 t-20 -42.68 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.41 109.328 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.563 ' O ' HG21 ' A' ' 134' ' ' VAL . 3.0 t80 -179.17 -168.98 0.14 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.383 -0.823 . . . . 0.4 109.537 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.579 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -143.34 45.71 0.62 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.832 -1.167 . . . . 0.45 111.353 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.2 Cg_endo -75.49 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.783 1.412 . . . . 0.36 110.041 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -5.84 51.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.858 . . . . 0.25 109.655 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.713 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.9 ptt? -118.49 146.87 44.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.39 109.94 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -104.07 -179.35 3.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.48 110.149 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t-80 -43.43 -35.33 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.4 109.872 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -66.62 -59.99 3.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.46 110.096 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.531 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 1.3 mp0 -50.72 -61.21 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.47 109.409 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 125' ' ' TYR . 8.2 t -45.13 -37.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.28 -1.007 . . . . 0.31 108.28 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.6 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.87 -41.05 77.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.319 -0.993 . . . . 0.48 108.319 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.576 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.2 tttp -75.09 -51.63 13.0 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.05 0.928 . . . . 0.64 108.608 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.82 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.5 -63.47 0.95 Allowed 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.093 -1.005 . . . . 0.42 110.418 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -61.26 -54.31 45.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.34 111.289 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.658 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -69.62 -72.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.47 110.485 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.1 tmtp? -37.91 -61.59 0.63 Allowed 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.899 -0.5 . . . . 0.47 110.607 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -47.06 -40.32 14.78 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.69 -1.204 . . . . 0.25 108.257 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -68.28 -32.82 73.24 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.508 -0.877 . . . . 0.35 108.947 178.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 140' ' ' LYS . 13.1 ttpp -59.53 -39.23 83.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.261 -1.014 . . . . 0.7 108.261 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.86 -41.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.813 -0.81 . . . . 0.61 108.813 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.639 ' O ' HG22 ' A' ' 148' ' ' VAL . 20.6 t-105 -60.99 -39.74 90.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.047 -0.723 . . . . 0.39 109.047 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.6 m -73.46 -34.51 65.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.412 -0.805 . . . . 0.35 108.834 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -41.55 76.83 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.595 -0.691 . . . . 0.36 109.291 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.791 HG23 HG22 ' A' ' 149' ' ' THR . 35.2 m -78.35 -31.7 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.5 110.11 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.791 HG22 HG23 ' A' ' 148' ' ' VAL . 5.7 t -148.12 135.21 10.38 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.51 110.56 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.98 59.65 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.84 1.442 . . . . 0.31 110.377 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 1.015 HD21 ' CD1' ' A' ' 266' ' ' TYR . 1.1 mp -80.8 163.43 23.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.18 110.5 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -107.4 110.18 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.17 110.178 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.511 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.1 p90 -115.71 122.62 46.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.887 . . . . 0.14 110.015 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.945 ' CG2' HD13 ' A' ' 156' ' ' LEU . 8.3 m -127.42 140.87 51.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.15 110.373 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.5 82.09 1.87 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.421 -0.799 . . . . 0.2 109.622 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.945 HD13 ' CG2' ' A' ' 154' ' ' THR . 1.3 mp -91.26 85.48 5.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.22 110.44 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' GLY . 36.6 p-80 -57.32 -19.72 24.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.32 109.789 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.96 -26.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.481 -0.762 . . . . 0.33 109.823 179.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.38 20.68 1.24 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.829 -1.308 . . . . 0.28 109.829 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 160' ' ' ILE . 12.1 mt -122.64 65.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.045 -1.268 . . . . 0.3 109.259 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.475 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -118.96 141.45 48.65 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.198 -0.601 . . . . 0.2 110.4 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD2' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -107.12 -47.55 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.1 109.961 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.001 ' CD1' HD11 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -116.34 173.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 0.1 109.824 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.54 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 4.4 ptp -170.67 142.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.11 110.63 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.8 tt -92.89 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.1 109.086 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.939 ' HB3' HG23 ' A' ' 123' ' ' VAL . 5.0 p -157.38 156.54 32.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.805 -1.184 . . . . 0.1 111.262 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -74.23 118.48 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.692 -0.63 . . . . 0.09 109.665 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -71.67 119.8 7.83 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.024 -1.231 . . . . 0.2 110.024 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 169' ' ' ILE . 6.9 tp -116.61 97.65 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -1.063 . . . . 0.55 109.985 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.63 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 3.7 tmtt? 0.07 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.289 0.566 . . . . 0.85 112.388 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -162.47 24.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.71 110.351 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -97.11 -69.59 0.75 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.42 110.132 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.43 -35.82 1.51 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.494 -1.442 . . . . 0.33 109.494 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -75.29 -144.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -1.171 . . . . 0.33 110.517 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.427 ' C ' ' CD1' ' A' ' 176' ' ' TYR . 58.3 m-85 -55.65 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.27 110.509 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 5.4 m-30 -111.01 110.94 56.52 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.34 110.306 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.88 -68.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.929 1.489 . . . . 0.47 110.558 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -51.21 137.58 22.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.35 110.417 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 178' ' ' PHE . 51.6 p-10 -178.44 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.2 110.624 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.57 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 44.44 -158.73 0.15 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.782 -1.327 . . . . 0.25 109.782 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.8 Cg_endo -74.95 7.28 2.91 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.14 1.6 . . . . 0.44 110.725 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 184' ' ' LEU . 6.4 t -42.58 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.967 . . . . 0.57 110.36 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -61.98 76.51 0.02 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.418 -1.073 . . . . 0.49 110.418 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.955 HD22 ' OD1' ' A' ' 202' ' ' ASP . 3.3 tt 179.9 88.13 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.222 -1.163 . . . . 0.41 110.389 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.585 HD13 ' CE2' ' A' ' 214' ' ' TYR . 4.8 tt -103.84 -23.22 13.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.3 110.944 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.764 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -148.45 108.03 3.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.602 -1.311 . . . . 0.2 112.126 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -105.7 118.76 37.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.16 109.529 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.863 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -107.8 141.02 40.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.23 110.202 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 3.2 m-30 -91.04 161.51 35.12 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.38 110.32 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.5 Cg_endo -72.41 142.98 37.96 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.967 1.509 . . . . 0.4 109.409 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.3 Cg_endo -69.64 74.41 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.849 1.447 . . . . 0.32 110.693 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.84 -93.71 1.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.408 -1.477 . . . . 0.32 109.408 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 -158.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.981 1.516 . . . . 0.47 110.406 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -79.51 8.82 5.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.63 110.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.493 ' HA ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -114.67 6.98 15.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.324 -0.86 . . . . 0.53 109.717 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -80.89 168.8 51.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.594 -1.402 . . . . 0.25 109.594 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.568 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 51.84 18.65 4.38 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.658 -1.377 . . . . 0.1 109.658 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -79.98 92.19 5.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -1.125 . . . . 0.1 110.339 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -72.44 97.44 2.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.942 . . . . 0.09 109.952 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.468 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 1.4 m170 -111.13 131.99 54.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.09 110.328 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.626 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 59.5 m-85 -103.27 136.61 42.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.992 -1.067 . . . . 0.1 110.678 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.955 ' OD1' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -46.52 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.719 -0.845 . . . . 0.14 108.719 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.642 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.4 p30 -36.84 -27.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.18 111.674 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.57 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -77.69 -0.24 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.675 -1.266 . . . . 0.24 111.217 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 12.6 mm-40 -94.82 -164.17 1.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.42 110.303 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 m -125.58 140.48 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.47 110.582 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.642 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.1 m-90 -135.56 142.81 45.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -0.823 . . . . 0.27 109.43 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.035 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.83 179.93 8.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.932 -1.105 . . . . 0.3 110.565 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.8 t -124.62 43.07 3.11 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.686 0.755 . . . . 0.61 109.251 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.8 t -131.63 -165.9 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.697 -0.627 . . . . 0.78 110.076 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.522 ' N ' ' OG ' ' A' ' 210' ' ' SER . 8.7 t -87.64 -0.51 56.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.91 110.14 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 149.75 28.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.93 109.969 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.23 -164.25 33.27 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.35 -1.5 . . . . 0.79 109.35 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.585 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.8 m-85 -84.52 120.78 26.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -1.195 . . . . 0.69 109.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.92 ' ND2' HG22 ' A' ' 247' ' ' THR . 7.3 p30 -87.62 121.7 30.39 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.067 -1.021 . . . . 0.4 108.852 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.035 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -39.89 -38.78 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.487 -0.758 . . . . 0.17 110.867 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 4.0 m-85 -51.31 -48.87 62.22 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 118.435 -1.306 . . . . 0.28 107.527 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.874 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.5 OUTLIER -73.87 -72.6 0.26 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.726 -0.67 . . . . 0.46 110.151 178.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.916 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.93 -69.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.39 109.914 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -42.27 -54.79 3.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.17 111.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -57.58 -30.72 65.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.499 -1.376 . . . . 0.1 109.578 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.644 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.7 t60 -75.51 -43.78 47.24 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.353 0.597 . . . . 0.21 109.686 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.764 ' OE1' ' HB1' ' A' ' 186' ' ' ALA . 22.8 tp10 -64.4 -35.97 82.63 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -0.884 . . . . 0.28 108.894 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 220' ' ' ALA . 19.1 m-85 -66.93 -48.52 68.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.755 -0.831 . . . . 0.18 108.755 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -52.47 -31.66 36.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.288 -1.925 . . . . 0.21 108.288 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.662 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.7 OUTLIER -80.62 -78.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -1.056 . . . . 0.17 110.674 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.863 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -38.5 -45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.33 111.268 -178.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 1.001 HD11 ' CD1' ' A' ' 163' ' ' ILE . 6.0 mt -83.37 -46.3 12.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.53 110.878 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -71.31 -85.14 0.19 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.363 -1.095 . . . . 0.41 110.363 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 230' ' ' LEU . 2.6 pt? -176.62 -158.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -1.2 . . . . 0.45 110.563 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.52 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 7.4 t70 -49.88 -56.1 11.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.62 110.148 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.662 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -164.69 -175.68 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.45 109.861 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.42 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER -179.78 58.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.38 109.809 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 1.084 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -152.29 27.06 0.59 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.48 111.196 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.545 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.7 OUTLIER -37.83 -48.89 2.89 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.38 110.674 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 41.1 Cg_endo -86.81 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.913 1.481 . . . . 0.28 112.289 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.32 99.58 0.12 Allowed Glycine 0 N--CA 1.5 2.94 0 C-N-CA 118.638 -1.744 . . . . 0.24 112.127 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 1.084 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -150.03 169.49 21.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.031 -1.276 . . . . 0.28 110.556 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.613 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -80.19 49.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.4 108.79 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.644 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.9 OUTLIER -133.99 -22.45 1.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.005 -1.059 . . . . 0.45 110.915 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -60.72 172.09 0.91 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.873 -1.142 . . . . 0.57 110.204 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 40.6 Cg_endo -67.79 -2.73 9.1 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.413 1.217 . . . . 0.76 110.935 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.569 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.6 mp -108.04 153.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.89 109.649 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.874 ' HB2' HD21 ' A' ' 218' ' ' LEU . 14.3 p90 -135.78 -22.93 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.78 111.685 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.756 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 4.0 -70.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 113.44 0.904 . . . . 0.61 113.44 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.756 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -72.27 117.34 13.8 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.454 -1.404 . . . . 0.74 109.77 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.92 HG22 ' ND2' ' A' ' 215' ' ' ASN . 47.6 p -62.17 -161.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.81 110.403 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.58 -32.61 79.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.56 109.593 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.48 41.67 2.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -1.124 . . . . 0.37 110.517 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -63.52 -20.87 65.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.44 109.751 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 20.4 m-70 -167.9 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.786 . . . . 0.53 109.911 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.9 m-85 -170.22 176.6 4.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.41 -0.806 . . . . 0.38 110.205 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.943 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -70.56 54.38 0.15 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.19 110.043 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.2 mm? -43.82 -47.56 20.83 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.176 -1.046 . . . . 0.28 108.176 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.21 49.81 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.015 1.534 . . . . 0.49 110.787 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.615 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 6.2 m-20 -54.19 -29.45 45.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.49 110.236 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.913 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 55.4 m-20 -57.2 -41.2 78.92 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.31 109.339 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.056 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.43 -33.2 48.7 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.986 -1.116 . . . . 0.14 107.986 178.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.943 HG21 ' HB2' ' A' ' 253' ' ' MET . 83.5 t -65.55 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.17 109.906 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.622 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.4 tt0 -58.18 -42.37 85.9 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.29 -0.881 . . . . 0.26 109.446 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.46 -70.33 0.5 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.178 -1.169 . . . . 0.19 110.178 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.089 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -73.75 -18.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.963 -1.316 . . . . 0.22 110.392 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 1.089 ' N ' HD13 ' A' ' 262' ' ' ILE . 44.9 tt0 -65.54 -20.3 66.28 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.9 -1.12 . . . . 0.39 108.163 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.37 -40.69 6.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.779 -0.576 . . . . 0.47 111.145 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 112' ' ' LYS . 4.3 mm? -86.71 -45.4 11.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.185 -0.947 . . . . 0.48 111.179 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 1.015 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -76.95 -13.68 59.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.41 110.53 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -62.7 -107.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.953 -1.659 . . . . 0.46 108.953 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.1 95.07 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.58 110.079 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.87 171.04 37.08 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.825 -1.31 . . . . 0.64 109.825 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.9 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 O-C-N 121.325 -1.103 . . . . 0.95 110.13 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.529 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.489 1.511 0 CA-C-O 121.643 0.735 . . . . 1.03 109.59 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 3.2 mm? 40.75 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.545 -0.722 . . . . 1.04 111.373 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 1.8 mttt -123.44 65.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.856 -1.153 . . . . 0.77 109.939 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.632 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 19.3 t90 -123.03 -71.67 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.42 110.573 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.421 ' C ' ' HG3' ' A' ' 115' ' ' LYS . 22.1 t -105.15 58.33 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.302 -0.874 . . . . 0.44 110.291 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HG3' ' C ' ' A' ' 114' ' ' SER . 39.0 mttp -141.72 59.49 1.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.49 110.489 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.48 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.6 OUTLIER -89.9 11.2 21.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.3 109.793 179.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.991 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -172.0 115.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.15 109.512 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.991 HD22 ' O ' ' A' ' 117' ' ' ASN . 1.2 mm? -137.48 178.01 7.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.184 -0.947 . . . . 0.13 110.72 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.636 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -120.34 174.11 6.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.12 109.902 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.556 ' HB3' HG12 ' A' ' 163' ' ' ILE . 31.3 p90 -178.94 178.74 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.33 111.425 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.469 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 1.3 ttp180 -121.05 158.51 27.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.54 109.654 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.726 HD13 ' CD2' ' A' ' 138' ' ' PHE . 1.6 pp -125.7 98.42 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.33 110.881 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.995 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.4 m -145.57 53.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.27 110.334 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 17.9 t30 -43.39 -84.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.41 109.623 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 8.6 t80 -177.53 -175.07 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.4 109.917 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 130' ' ' THR . 0.0 OUTLIER -139.03 52.52 4.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.45 110.716 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.543 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.2 Cg_endo -76.26 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.819 1.431 . . . . 0.36 109.767 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.77 -4.62 54.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.25 109.588 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.957 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.8 ptm -119.76 170.71 8.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.469 -0.769 . . . . 0.39 109.955 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.547 ' HA ' HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -121.91 -172.46 2.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.48 110.34 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.458 ' H ' HG22 ' A' ' 130' ' ' THR . 1.5 t60 -53.09 -36.4 60.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.4 110.03 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 6.9 t -60.83 -48.68 80.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.46 109.336 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 13.1 mp0 -62.79 -63.33 1.24 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.34 -0.85 . . . . 0.47 109.527 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.614 HG23 ' HE2' ' A' ' 129' ' ' MET . 13.4 t -43.68 -38.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.611 -0.885 . . . . 0.31 108.611 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.611 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 3.0 mt-10 -56.68 -42.14 78.54 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.48 108.246 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 2.4 tttm -73.8 -50.13 22.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.471 -0.936 . . . . 0.64 108.471 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.84 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.05 -60.79 2.07 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.19 -0.944 . . . . 0.42 110.225 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.726 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.74 -53.63 44.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.34 111.018 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.82 -72.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.857 -1.152 . . . . 0.47 110.347 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.2 tmtm? -38.65 -61.16 0.74 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.752 -0.593 . . . . 0.47 110.655 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -47.59 -38.59 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.611 -1.235 . . . . 0.25 108.374 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -70.11 -32.76 70.94 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.335 -0.853 . . . . 0.35 109.15 178.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' LYS . 4.6 tttp -59.82 -38.82 83.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.38 -0.971 . . . . 0.7 108.38 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 16.1 t -71.91 -44.34 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 109.035 -0.728 . . . . 0.61 109.035 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.628 ' O ' HG22 ' A' ' 149' ' ' THR . 13.6 t-105 -56.63 -44.93 81.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.39 109.01 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 149' ' ' THR . 26.0 m -71.01 -35.05 71.88 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.32 -0.862 . . . . 0.35 108.739 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -53.06 -42.43 65.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.576 -0.703 . . . . 0.36 109.416 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.761 HG23 HG22 ' A' ' 149' ' ' THR . 31.1 m -80.47 -32.59 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.779 -0.768 . . . . 0.5 110.198 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.761 HG22 HG23 ' A' ' 148' ' ' VAL . 2.5 t -137.94 124.59 13.27 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.068 . . . . 0.51 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -78.28 62.24 8.04 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.31 110.341 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.851 ' O ' HD12 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -101.0 156.31 17.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.18 110.127 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.5 ' HB3' ' ND2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -76.94 134.41 38.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.35 -0.844 . . . . 0.17 111.341 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 7.7 p90 -135.19 121.99 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.14 109.618 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.55 ' HB ' HG23 ' A' ' 119' ' ' THR . 42.4 m -127.0 161.68 27.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.15 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -142.18 68.95 1.32 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.655 -0.653 . . . . 0.2 110.09 -178.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 93.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.22 110.038 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' ASP . 50.4 p-80 -48.51 -28.15 3.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.32 110.083 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' HIS . 4.3 t70 -42.36 -70.27 0.11 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.576 -0.703 . . . . 0.33 109.819 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 179.39 30.68 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.28 109.586 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 119' ' ' THR . 20.9 mm -121.57 79.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.267 -1.137 . . . . 0.3 108.339 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.502 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -136.14 112.02 9.53 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.097 -0.641 . . . . 0.2 110.714 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 118' ' ' LEU . 33.5 t70 -73.37 -54.36 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.1 109.97 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.942 HG22 ' HA3' ' A' ' 197' ' ' GLY . 5.4 pt -111.84 175.9 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.1 109.677 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 23.2 ptm -170.35 136.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.844 -1.16 . . . . 0.11 111.122 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 122' ' ' ILE . 1.6 tt -90.24 123.44 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.447 -0.783 . . . . 0.1 109.852 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.995 ' HB3' HG23 ' A' ' 123' ' ' VAL . 23.0 p -168.37 143.05 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.831 -1.168 . . . . 0.1 110.922 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.8 p90 -58.49 117.21 4.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.372 -0.83 . . . . 0.09 109.507 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -83.79 115.3 4.03 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.901 -1.28 . . . . 0.2 109.901 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 169' ' ' ILE . 7.0 tt -106.63 100.26 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.957 . . . . 0.55 109.781 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.574 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 0.91 87.47 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.33 0.586 . . . . 0.85 112.397 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -130.06 -1.75 4.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.71 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -77.18 -86.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.42 110.035 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.28 58.8 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.339 -1.504 . . . . 0.33 109.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -155.16 -80.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -1.105 . . . . 0.33 110.377 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 83.9 m-85 -115.67 103.67 10.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.27 110.335 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.427 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.3 m-30 -40.32 98.82 0.18 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.34 110.156 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.868 ' O ' HD22 ' A' ' 184' ' ' LEU . 48.9 Cg_endo -82.67 -59.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.099 1.579 . . . . 0.47 110.775 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CB ' ' OD1' ' A' ' 203' ' ' ASP . 10.8 p90 -50.7 163.4 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.35 110.209 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 180' ' ' GLY . 0.9 OUTLIER 179.48 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.941 -1.099 . . . . 0.2 111.451 179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 141.89 -123.55 2.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.157 -1.577 . . . . 0.25 109.157 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.4 2.62 7.91 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 O-C-N 123.919 1.484 . . . . 0.44 109.768 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 177.53 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.434 -0.791 . . . . 0.57 110.228 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.488 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -77.03 76.33 1.63 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.594 -1.003 . . . . 0.49 110.594 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.868 HD22 ' O ' ' A' ' 177' ' ' PRO . 0.6 OUTLIER 179.77 98.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -1.127 . . . . 0.41 110.288 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.702 HD12 ' CD ' ' A' ' 205' ' ' GLU . 1.4 tt -116.74 -17.6 10.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.746 -1.182 . . . . 0.3 111.334 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.725 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -157.52 105.1 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.452 -1.405 . . . . 0.2 111.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -102.76 121.35 42.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.16 110.086 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.833 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -106.41 119.03 38.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.23 110.075 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -69.7 170.25 10.18 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.257 -0.902 . . . . 0.38 110.401 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.2 Cg_endo -73.15 130.73 15.68 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.101 1.579 . . . . 0.4 109.698 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.6 Cg_endo -69.88 74.8 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.956 1.503 . . . . 0.32 110.572 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.01 -91.45 1.02 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.703 -1.359 . . . . 0.32 109.703 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.0 -163.57 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.991 1.521 . . . . 0.47 110.489 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -6.58 35.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.63 110.047 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . 0.438 ' C ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -111.55 49.7 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.423 -0.798 . . . . 0.53 109.796 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -123.89 174.62 16.81 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.36 -1.496 . . . . 0.25 109.36 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.942 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 41.59 27.63 0.32 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.081 -1.208 . . . . 0.1 110.081 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD2' ' C ' ' A' ' 195' ' ' TYR . 57.7 m-20 -79.53 90.07 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.057 -1.261 . . . . 0.1 110.031 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -68.59 89.97 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.053 -1.029 . . . . 0.09 109.81 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.544 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 3.1 m170 -102.92 128.31 49.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.09 110.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.567 ' O ' ' N ' ' A' ' 203' ' ' ASP . 21.2 m-85 -96.73 132.13 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.1 111.173 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.573 ' HB3' ' CG ' ' A' ' 205' ' ' GLU . 35.8 t0 -40.06 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.245 -0.65 . . . . 0.14 109.245 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -36.43 -38.89 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.18 112.161 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.553 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 14.0 t0 -73.68 -6.65 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.642 -1.286 . . . . 0.24 111.225 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.702 ' CD ' HD12 ' A' ' 185' ' ' LEU . 14.7 mm-40 -84.79 -165.21 1.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.847 -1.158 . . . . 0.42 110.176 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.55 148.26 52.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.47 110.441 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.437 ' NE1' ' HB3' ' A' ' 201' ' ' PHE . 0.9 OUTLIER -142.24 140.36 32.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.267 -0.895 . . . . 0.27 109.57 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.016 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -149.03 174.85 11.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.857 -1.152 . . . . 0.3 110.748 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -129.06 24.79 5.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.794 0.807 . . . . 0.61 109.206 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.3 t -94.6 -111.46 0.12 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.615 -0.678 . . . . 0.78 110.03 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.531 ' N ' ' OG ' ' A' ' 210' ' ' SER . 4.4 p -141.28 8.39 2.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.134 . . . . 0.91 110.008 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 -179.26 5.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.93 109.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.76 -154.88 5.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.038 -1.625 . . . . 0.79 109.038 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 185' ' ' LEU . 79.0 m-85 -90.16 109.94 20.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.251 . . . . 0.69 110.066 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.61 ' O ' HG12 ' A' ' 219' ' ' VAL . 32.6 m-20 -79.15 120.92 24.36 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.097 -1.002 . . . . 0.4 108.866 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.016 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.26 -36.53 0.79 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.556 -0.858 . . . . 0.17 110.718 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.576 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 4.1 m-85 -53.05 -46.92 68.74 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.315 -1.354 . . . . 0.28 107.589 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 1.031 HD21 ' HB2' ' A' ' 244' ' ' TYR . 5.8 tp -77.27 -71.86 0.38 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.4 -0.818 . . . . 0.46 110.683 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.3 p -48.78 -61.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.39 110.385 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.92 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.06 -48.56 67.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.061 -1.024 . . . . 0.17 111.439 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.95 -29.11 66.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.201 -1.562 . . . . 0.1 108.743 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.66 ' CA ' HD21 ' A' ' 239' ' ' LEU . 4.0 t60 -77.0 -44.12 32.19 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.31 0.576 . . . . 0.21 109.747 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.803 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 17.8 tp10 -64.58 -45.61 86.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.02 . . . . 0.28 108.667 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.531 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 18.4 m-30 -56.35 -60.51 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.18 109.029 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.451 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.07 -34.15 1.99 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.971 -1.652 . . . . 0.21 108.971 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.672 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -80.87 -70.16 0.55 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.106 -1.232 . . . . 0.17 111.235 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.833 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.66 -44.33 0.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.33 112.017 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.868 ' HG ' HG21 ' A' ' 163' ' ' ILE . 1.0 OUTLIER -101.09 -37.49 8.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.661 -1.274 . . . . 0.53 111.317 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -65.01 -85.08 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.316 -1.114 . . . . 0.41 110.316 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -172.54 -173.28 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.245 . . . . 0.45 110.473 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.519 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 42.0 t0 -51.35 -59.72 3.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.62 109.975 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.672 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 1.6 m80 -163.82 -179.98 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.45 110.256 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.492 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.1 OUTLIER 179.23 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.457 -0.777 . . . . 0.38 109.391 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.899 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.04 21.43 3.02 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.468 -0.893 . . . . 0.48 111.197 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.535 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -35.58 -49.66 1.38 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 120.055 -0.658 . . . . 0.38 110.635 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -88.5 -48.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.701 1.369 . . . . 0.28 111.132 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.1 101.73 0.15 Allowed Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.409 -1.377 . . . . 0.24 111.401 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.899 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -147.47 163.16 37.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.372 -1.075 . . . . 0.28 110.463 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.66 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.18 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.074 -1.016 . . . . 0.4 108.818 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.657 ' HB2' ' HB3' ' A' ' 234' ' ' LYS . 50.6 mtt -135.9 -34.4 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.793 . . . . 0.45 110.437 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -43.88 169.85 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.195 -0.941 . . . . 0.57 110.359 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.2 Cg_endo -69.35 -8.02 22.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.786 1.413 . . . . 0.76 110.198 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.702 HG22 HG22 ' A' ' 245' ' ' THR . 16.0 mm -103.26 159.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.89 109.845 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 1.031 ' HB2' HD21 ' A' ' 218' ' ' LEU . 16.8 p90 -138.07 -24.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.78 111.446 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.731 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 3.19 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.824 1.046 . . . . 0.61 113.824 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.731 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -71.82 115.64 11.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.438 -1.413 . . . . 0.74 110.022 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.746 ' HA ' HD13 ' A' ' 218' ' ' LEU . 2.9 m -54.04 -174.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.81 110.301 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.696 ' H ' HG22 ' A' ' 247' ' ' THR . . . -50.83 -25.29 9.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.56 109.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.632 ' CD ' ' N ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -167.46 36.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -1.135 . . . . 0.37 110.353 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.2 t -58.54 -16.19 14.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.44 110.147 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -145.55 -48.7 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.53 110.086 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.55 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.8 OUTLIER 179.99 172.75 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.38 110.122 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.894 ' HB2' HG21 ' A' ' 259' ' ' VAL . 4.8 ptp -72.85 52.38 0.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.122 -0.986 . . . . 0.19 110.055 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.677 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.1 OUTLIER -45.24 -47.39 33.45 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 108.014 -1.106 . . . . 0.28 108.014 177.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -73.76 51.9 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.085 1.571 . . . . 0.49 110.905 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.63 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.7 m-20 -52.17 -31.44 31.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.129 -0.982 . . . . 0.49 110.151 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.892 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -51.89 -51.5 56.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.945 -1.102 . . . . 0.31 109.346 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.036 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -69.48 -35.6 75.74 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.074 -1.051 . . . . 0.14 108.553 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 253' ' ' MET . 73.8 t -63.41 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.17 110.273 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 33.0 tt0 -54.03 -43.87 70.5 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.246 -0.909 . . . . 0.26 109.902 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.04 -69.04 0.55 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.345 -1.102 . . . . 0.19 110.345 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.085 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -76.37 -19.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.786 -1.42 . . . . 0.22 110.264 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 1.085 ' N ' HD13 ' A' ' 262' ' ' ILE . 14.3 tt0 -61.54 -23.58 66.05 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.863 -1.135 . . . . 0.39 107.94 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 p -103.87 -42.58 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.386 0.612 . . . . 0.47 110.691 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 75.3 mt -73.95 -52.11 13.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.422 -0.799 . . . . 0.48 111.319 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.779 ' OH ' HD22 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -75.6 -11.82 60.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.41 110.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.48 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.89 -102.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.059 -1.617 . . . . 0.46 109.059 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.52 101.65 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.86 1.452 . . . . 0.58 110.158 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -78.82 165.71 51.37 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.587 -1.405 . . . . 0.64 109.587 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.632 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.29 -1.124 . . . . 0.95 110.254 179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' LEU . 1.5 p . . . . . 0 N--CA 1.49 1.573 0 CA-C-O 121.513 0.673 . . . . 1.03 109.484 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.4 OUTLIER 39.09 30.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.643 -0.66 . . . . 1.04 111.428 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -114.35 68.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.043 -1.036 . . . . 0.77 109.433 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.578 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 20.8 t90 -147.52 -66.85 0.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.42 111.063 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.481 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 24.0 p -97.1 51.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.44 110.952 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 114' ' ' SER . 4.5 mmmt -148.48 85.77 1.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.49 109.91 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 tmm? -120.86 -15.72 8.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.025 -1.047 . . . . 0.3 110.473 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.594 ' O ' HD22 ' A' ' 118' ' ' LEU . 7.3 p-10 -153.46 114.28 4.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.15 110.211 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -141.0 -151.87 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.304 -0.873 . . . . 0.13 110.201 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.881 HG22 ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -136.32 155.35 50.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.12 110.142 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.878 ' HB3' HG23 ' A' ' 163' ' ' ILE . 29.0 p90 -148.92 163.33 37.77 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.496 -0.882 . . . . 0.33 111.055 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 151.38 35.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.48 -0.763 . . . . 0.54 109.881 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.856 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.1 pp -116.91 111.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.33 111.163 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.936 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.8 m -161.82 49.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.27 110.261 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.8 t30 -42.95 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.41 109.451 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.58 ' O ' HG21 ' A' ' 134' ' ' VAL . 24.6 t80 -179.03 -176.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.4 110.042 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.434 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -129.09 57.95 33.73 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.982 . . . . 0.45 109.834 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 125' ' ' TYR . 47.8 Cg_endo -75.1 -88.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.275 1.671 . . . . 0.36 110.688 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.37 -8.27 21.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.25 110.163 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.568 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.04 174.95 5.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.39 110.204 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 132' ' ' SER . 3.0 m -115.17 167.03 11.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.48 109.302 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 130' ' ' THR . 7.9 t-160 -43.38 -26.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.4 109.61 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.2 OUTLIER -68.8 -45.57 70.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.831 . . . . 0.46 110.116 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.568 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.1 OUTLIER -70.71 -50.54 35.21 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.938 -1.101 . . . . 0.47 109.248 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 125' ' ' TYR . 9.5 t -47.18 -36.61 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.242 -1.392 . . . . 0.31 107.242 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.595 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 1.4 tt0 -58.96 -45.88 89.42 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.474 -1.306 . . . . 0.48 107.474 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.31 -50.36 71.98 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.068 0.937 . . . . 0.64 108.704 178.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.793 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -46.33 -62.93 1.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.149 -0.969 . . . . 0.42 110.718 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.856 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.73 -52.53 56.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.34 110.7 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -65.91 -74.82 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.901 -1.124 . . . . 0.47 110.175 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -38.48 -61.6 0.68 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.807 -0.558 . . . . 0.47 110.66 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -46.96 -38.56 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.665 -1.272 . . . . 0.25 108.359 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -71.65 -28.92 64.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -0.869 . . . . 0.35 109.156 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.02 -42.2 98.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.7 108.416 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 4.4 t -72.31 -51.36 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.817 -0.809 . . . . 0.61 108.817 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.638 ' HH2' HG21 ' A' ' 262' ' ' ILE . 47.8 t-105 -50.85 -34.47 28.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.523 -0.917 . . . . 0.39 108.523 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -76.28 -36.02 58.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.45 -0.944 . . . . 0.35 108.45 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.31 -43.23 70.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.981 -0.748 . . . . 0.36 108.981 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 31.4 m -74.85 -35.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.703 -0.799 . . . . 0.5 109.552 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 149' ' ' THR . 13.0 t -148.06 121.77 4.81 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 0.51 110.305 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.79 60.74 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.819 1.431 . . . . 0.31 110.335 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.976 HD11 ' O ' ' A' ' 266' ' ' TYR . 1.1 mp -73.9 173.86 9.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.18 110.815 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -110.25 121.83 46.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.17 109.95 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 9.0 p90 -138.8 131.23 28.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.14 110.266 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.881 ' O ' HG22 ' A' ' 119' ' ' THR . 7.8 m -136.84 130.58 32.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.15 110.22 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.603 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -94.12 69.83 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.2 109.945 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 110.64 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.22 110.11 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 158' ' ' ASP . 4.6 m-70 -67.74 -24.53 65.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.32 110.01 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 158' ' ' ASP . 4.5 t0 -42.44 -27.71 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.33 109.646 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.86 26.52 1.25 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.614 -1.395 . . . . 0.28 109.614 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 160' ' ' ILE . 8.0 mt -116.65 74.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.203 -1.175 . . . . 0.3 109.432 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -135.57 152.94 51.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.664 -0.648 . . . . 0.2 110.491 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.463 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.3 OUTLIER -128.98 -35.27 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.1 110.185 -179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.075 HD12 ' O ' ' A' ' 197' ' ' GLY . 0.7 OUTLIER -115.21 163.21 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.291 -0.881 . . . . 0.1 109.335 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.793 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -174.63 142.57 0.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.375 -1.453 . . . . 0.11 111.71 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 165' ' ' ILE . 6.7 tt -94.74 118.42 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.469 -0.769 . . . . 0.1 109.777 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.936 ' HB3' HG23 ' A' ' 123' ' ' VAL . 9.7 p -160.94 153.4 20.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.808 -1.183 . . . . 0.1 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.0 p90 -68.81 120.46 14.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.09 109.727 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -81.95 129.92 9.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.529 -1.028 . . . . 0.2 110.529 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -125.06 99.99 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.709 -0.877 . . . . 0.55 108.94 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.43 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.42 0.629 . . . . 0.85 112.475 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -163.3 24.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.71 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 14.4 m-70 -93.29 -57.96 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.42 110.253 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 110.86 55.34 0.51 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.65 -1.38 . . . . 0.33 109.65 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 8.0 p-10 -176.71 -37.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -1.079 . . . . 0.33 110.202 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.6 OUTLIER -156.05 149.07 24.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.27 110.106 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -77.34 112.24 22.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.34 110.138 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.1 Cg_endo -74.15 -55.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.954 1.502 . . . . 0.47 110.625 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.3 p90 -79.64 162.44 25.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.038 . . . . 0.35 110.528 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -169.51 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.019 . . . . 0.2 110.989 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.611 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 160.48 -149.11 18.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.25 109.49 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.83 -2.05 10.85 Favored 'Trans proline' 0 C--N 1.297 -2.174 0 O-C-N 124.228 1.646 . . . . 0.44 109.765 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.519 ' CB ' ' OD1' ' A' ' 179' ' ' ASP . 20.2 t -49.88 175.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.57 110.184 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.507 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -68.61 76.53 0.28 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.781 -0.928 . . . . 0.49 110.781 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.891 HD23 ' OD1' ' A' ' 202' ' ' ASP . 1.0 OUTLIER 179.35 85.94 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.199 -1.177 . . . . 0.41 110.575 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.644 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.6 tt -105.79 -21.4 13.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.612 -1.305 . . . . 0.3 111.664 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -146.63 109.7 4.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.526 -1.359 . . . . 0.2 111.985 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -112.61 115.26 28.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.16 109.538 178.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.922 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -111.1 145.72 38.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.23 110.116 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 2.2 m-30 -95.72 165.78 15.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.233 -0.917 . . . . 0.38 110.757 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -71.04 150.58 60.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.069 1.562 . . . . 0.4 109.163 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 227' ' ' SER . 45.4 Cg_endo -72.89 76.27 2.53 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.681 1.359 . . . . 0.32 110.5 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.07 -108.29 2.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.498 -1.441 . . . . 0.32 109.498 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.89 -158.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.935 1.492 . . . . 0.47 110.26 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -3.42 13.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.161 -0.962 . . . . 0.63 110.554 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.36 27.51 8.66 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.53 110.227 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -105.35 166.72 14.51 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.136 -1.586 . . . . 0.25 109.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 1.075 ' O ' HD12 ' A' ' 163' ' ' ILE . . . 51.43 21.04 5.85 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.937 -1.665 . . . . 0.1 108.937 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.9 OUTLIER -77.44 88.83 3.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -1.143 . . . . 0.1 110.267 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -72.96 84.98 1.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.09 109.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.495 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 52.9 m170 -97.82 127.06 43.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.09 110.628 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.3 m-85 -97.89 141.03 31.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.995 . . . . 0.1 109.818 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.891 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -51.76 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.373 -0.973 . . . . 0.14 108.373 178.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.596 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 1.7 p30 -34.86 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.18 112.204 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.611 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 18.5 t0 -80.18 10.12 4.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.683 -1.261 . . . . 0.24 110.744 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.559 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 21.8 mm-40 -101.41 -162.15 0.91 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.42 109.961 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.0 m -128.41 141.85 51.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.036 -1.04 . . . . 0.47 110.381 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -142.41 139.03 31.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.968 . . . . 0.27 109.9 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.04 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -144.29 172.91 12.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.975 -1.078 . . . . 0.3 110.545 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -128.2 27.5 5.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.951 0.882 . . . . 0.61 108.996 178.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.6 t -99.66 -99.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.69 -0.632 . . . . 0.78 110.15 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.53 ' N ' ' OG ' ' A' ' 210' ' ' SER . 13.2 t -153.0 15.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.033 -1.042 . . . . 0.91 110.328 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 213' ' ' GLY . 0.0 OUTLIER -133.27 -172.12 2.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.93 109.93 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 42.69 -147.95 0.62 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.179 -1.569 . . . . 0.79 109.179 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.644 ' CE1' HD13 ' A' ' 185' ' ' LEU . 90.8 m-85 -93.24 103.1 15.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.106 -1.232 . . . . 0.69 109.738 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.593 ' O ' HG12 ' A' ' 219' ' ' VAL . 58.1 m-80 -71.65 120.27 17.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.094 -1.004 . . . . 0.4 108.933 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.04 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -42.03 -34.7 0.75 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.564 -0.854 . . . . 0.17 110.051 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.582 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 7.2 m-85 -54.37 -46.09 72.93 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.572 -1.27 . . . . 0.28 107.572 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 244' ' ' TYR . 10.2 tp -78.08 -71.15 0.44 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.775 -0.648 . . . . 0.46 110.694 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.836 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.17 -62.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 0.39 110.141 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.08 -53.63 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.067 . . . . 0.17 111.391 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -56.44 -25.94 52.06 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.404 -1.435 . . . . 0.1 108.965 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.642 ' HA ' HD22 ' A' ' 239' ' ' LEU . 6.3 t60 -78.82 -46.79 17.95 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.767 -0.583 . . . . 0.21 109.748 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.628 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.7 tp10 -63.99 -38.3 90.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.28 109.244 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 6.8 m-30 -64.33 -63.08 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.816 . . . . 0.18 109.084 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -44.72 -31.68 2.7 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.86 -1.696 . . . . 0.21 108.86 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.869 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -77.36 -74.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -1.139 . . . . 0.17 110.639 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.922 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -39.35 -54.83 1.83 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.484 -0.76 . . . . 0.33 111.492 -179.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.552 HD23 ' OH ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -78.79 -46.04 19.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.53 110.785 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -60.3 -78.77 0.13 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.717 -1.353 . . . . 0.41 109.717 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.603 HD21 ' O ' ' A' ' 232' ' ' HIS . 0.5 OUTLIER -177.76 -162.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.45 110.08 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.507 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -55.8 -55.3 34.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.62 109.789 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.869 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -162.09 -179.96 7.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.45 109.385 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 67.3 p -178.97 48.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.38 110.569 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -135.39 27.29 3.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.242 -0.911 . . . . 0.48 110.559 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -39.83 -50.76 5.6 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.595 -0.842 . . . . 0.38 109.622 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 43.4 Cg_endo -90.53 -46.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.747 1.393 . . . . 0.28 110.462 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.57 96.31 0.1 Allowed Glycine 0 N--CA 1.498 2.795 0 C-N-CA 119.065 -1.541 . . . . 0.24 112.304 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.914 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -145.25 160.33 41.64 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.263 -1.14 . . . . 0.28 109.57 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 222' ' ' HIS . 1.5 tt -68.18 57.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.4 109.237 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.643 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -141.72 -6.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.45 111.547 -178.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -78.21 165.23 51.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.556 -1.34 . . . . 0.57 110.987 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 41.1 Cg_endo -68.11 -18.34 45.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.78 1.41 . . . . 0.76 110.053 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.1 mm -90.21 136.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.934 -0.765 . . . . 0.89 108.934 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.7 ' HB2' HD21 ' A' ' 218' ' ' LEU . 38.5 p90 -126.96 -30.64 2.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.942 -1.099 . . . . 0.78 110.405 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.758 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.49 -70.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 113.203 0.816 . . . . 0.61 113.203 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.758 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -53.41 105.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.556 -1.34 . . . . 0.74 109.321 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.505 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 22.5 p -57.16 166.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.849 . . . . 0.81 109.998 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -53.7 -19.8 10.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.092 -1.603 . . . . 0.56 109.092 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.95 31.87 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.37 110.631 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.492 ' HB3' ' N ' ' A' ' 247' ' ' THR . 1.9 t -83.76 -22.67 31.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.05 -1.031 . . . . 0.44 109.927 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -152.41 -69.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.53 109.873 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.64 -176.01 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.38 110.47 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.964 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.1 55.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.593 -0.692 . . . . 0.19 110.702 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.724 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -45.83 -46.88 40.44 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.017 -1.105 . . . . 0.28 108.017 177.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.724 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.3 Cg_endo -71.82 48.91 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.954 1.502 . . . . 0.49 110.966 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.616 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.8 m-20 -47.39 -32.42 4.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.887 -1.133 . . . . 0.49 110.453 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.914 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 1.4 m-20 -50.49 -50.81 51.68 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.138 -0.976 . . . . 0.31 109.51 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.06 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -73.35 -33.01 64.87 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.169 -1.012 . . . . 0.14 108.468 179.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 253' ' ' MET . 84.8 t -60.56 -81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.252 -0.979 . . . . 0.17 110.153 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.65 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.3 OUTLIER -62.05 -42.85 99.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.238 -0.914 . . . . 0.26 109.786 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.65 -64.92 1.1 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.396 -1.082 . . . . 0.19 110.396 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.065 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -77.49 -19.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.816 -1.402 . . . . 0.22 110.441 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 1.065 ' N ' HD13 ' A' ' 262' ' ' ILE . 17.3 tt0 -64.37 -21.87 66.77 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.838 -1.145 . . . . 0.39 108.317 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.0 t -104.22 -41.52 5.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.157 -0.617 . . . . 0.47 111.487 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 9.2 mt -87.5 -45.86 10.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.227 -0.921 . . . . 0.48 111.669 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.976 ' O ' HD11 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.85 -8.78 57.36 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.206 -0.934 . . . . 0.41 110.156 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -73.73 -107.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.032 -1.627 . . . . 0.46 109.032 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 269' ' ' GLY . 46.3 Cg_endo -73.01 74.99 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.784 1.413 . . . . 0.58 110.112 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 268' ' ' PRO . . . -61.81 -137.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.64 109.723 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.95 110.139 -179.946 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.526 ' O ' HD22 ' A' ' 230' ' ' LEU . 1.7 p . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 121.325 0.583 . . . . 1.03 109.692 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.7 OUTLIER 37.24 28.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.706 -0.621 . . . . 1.04 111.107 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HD3' HD22 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -100.22 91.05 4.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.121 -0.987 . . . . 0.77 110.015 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.602 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 21.7 t90 -164.08 -71.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.42 110.284 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.493 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 88.4 p -91.71 69.52 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.44 110.268 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 27.1 mttp -165.65 86.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.49 110.465 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 5.8 ttp -123.23 -12.79 7.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.3 110.149 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 20.3 p-10 -155.3 124.21 6.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.15 109.84 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.98 -177.82 6.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.13 110.424 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -121.44 147.14 46.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.12 109.766 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.818 ' CB ' HG23 ' A' ' 163' ' ' ILE . 9.6 p90 -145.01 160.71 40.94 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.254 -0.978 . . . . 0.33 111.015 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.423 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -103.68 160.69 14.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.472 -0.768 . . . . 0.54 110.032 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.689 HG21 ' CD1' ' A' ' 138' ' ' PHE . 7.6 pt -122.32 62.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.33 110.727 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 1.021 HG23 ' HB3' ' A' ' 166' ' ' SER . 12.1 m -110.39 48.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.995 -1.066 . . . . 0.27 110.727 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.52 ' ND2' ' HG ' ' A' ' 216' ' ' LEU . 41.6 t-20 -43.18 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.41 109.297 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.623 ' O ' HG21 ' A' ' 134' ' ' VAL . 5.6 t80 -178.81 -175.1 0.39 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.346 -0.846 . . . . 0.4 109.47 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.571 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -136.36 48.29 2.44 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.45 110.805 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.14 -85.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.814 1.429 . . . . 0.36 110.343 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 1.5 m-20 -95.53 2.85 54.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.25 109.638 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.558 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -124.3 156.5 36.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 0.39 109.75 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -110.41 176.48 5.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.48 109.95 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -43.37 -34.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.4 109.931 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -68.87 -50.01 53.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.46 109.646 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.558 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 5.2 mp0 -58.44 -62.09 2.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.364 -0.835 . . . . 0.47 109.41 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.623 HG21 ' O ' ' A' ' 125' ' ' TYR . 9.5 t -45.16 -39.7 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.139 -1.06 . . . . 0.31 108.139 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -54.11 -40.48 67.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.057 -1.09 . . . . 0.48 108.057 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 17.0 tttt -74.54 -52.24 12.41 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.867 0.842 . . . . 0.64 108.846 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.82 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.31 -60.81 2.1 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.962 -1.086 . . . . 0.42 110.561 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.689 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.54 -54.17 36.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.34 111.004 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.654 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 7.9 tttm -68.09 -72.76 0.16 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.94 -1.1 . . . . 0.47 110.28 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.4 OUTLIER -38.48 -61.24 0.72 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.731 -0.605 . . . . 0.47 110.709 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.43 -38.27 13.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.641 -1.287 . . . . 0.25 108.344 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.53 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -72.53 -28.58 62.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.31 -0.869 . . . . 0.35 109.068 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 140' ' ' LYS . 58.7 tttt -63.4 -39.75 95.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.43 -0.952 . . . . 0.7 108.43 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 11.3 t -75.76 -51.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.086 -0.709 . . . . 0.61 109.086 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HH2' HG21 ' A' ' 262' ' ' ILE . 45.2 t-105 -52.19 -34.18 44.16 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.441 -0.948 . . . . 0.39 108.441 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 149' ' ' THR . 41.5 m -77.38 -38.41 50.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.395 -0.965 . . . . 0.35 108.395 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.43 -43.88 62.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.862 -0.792 . . . . 0.36 108.862 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.699 HG23 HG22 ' A' ' 149' ' ' THR . 32.3 m -74.05 -38.52 49.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.477 -0.764 . . . . 0.5 109.55 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.699 HG22 HG23 ' A' ' 148' ' ' VAL . 7.2 t -142.78 119.53 6.89 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.51 110.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.41 58.57 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.663 1.349 . . . . 0.31 110.793 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.515 HD11 ' CG ' ' A' ' 266' ' ' TYR . 59.4 mt -70.48 167.12 19.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.18 110.043 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 3.1 t30 -105.89 103.08 12.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.892 . . . . 0.17 110.22 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.428 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.6 p90 -116.08 144.68 43.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.14 110.312 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.761 ' O ' HG22 ' A' ' 119' ' ' THR . 27.7 m -147.9 130.55 15.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.15 110.439 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.612 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -99.62 84.4 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.2 109.904 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 154' ' ' THR . 0.5 OUTLIER -77.11 104.35 7.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.22 110.224 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' ASP . 55.8 p-80 -56.06 -27.96 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.96 . . . . 0.32 109.948 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.12 -41.91 2.79 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.56 -0.712 . . . . 0.33 109.941 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.73 33.22 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.733 -1.347 . . . . 0.28 109.733 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 119' ' ' THR . 6.5 mt -121.13 71.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.064 -1.257 . . . . 0.3 109.542 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -125.3 137.6 54.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.029 -0.668 . . . . 0.2 110.411 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.516 ' HB3' HD22 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.52 -34.9 8.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.1 109.653 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.818 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -122.72 173.11 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.1 109.052 179.347 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.772 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.5 ptp -177.05 144.63 0.44 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.495 -1.378 . . . . 0.11 111.656 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 122' ' ' ILE . 1.5 tt -93.31 120.87 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.1 109.272 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 1.021 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.3 p -163.62 142.56 8.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.735 -1.228 . . . . 0.1 110.702 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.62 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.8 p90 -67.03 112.3 4.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.324 -0.86 . . . . 0.09 109.618 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -60.63 143.28 48.12 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.281 -1.527 . . . . 0.2 109.281 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.734 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.7 tt -138.15 96.91 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.972 . . . . 0.55 109.905 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.591 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.06 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.382 0.611 . . . . 0.85 112.363 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 11.83 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.71 110.108 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.406 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m-70 -80.25 -87.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.42 110.031 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.58 -35.2 1.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.485 -1.446 . . . . 0.33 109.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 -87.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.33 110.26 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -111.01 -170.01 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.27 110.569 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -101.95 110.62 62.72 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.34 110.349 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.445 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.1 Cg_endo -76.92 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.829 1.437 . . . . 0.47 110.668 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -50.38 140.68 13.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.35 110.606 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 182' ' ' SER . 6.0 p30 -178.74 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.932 -1.107 . . . . 0.2 111.703 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 36.97 -157.54 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.562 -1.015 . . . . 0.25 110.562 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.452 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -78.62 43.74 1.5 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.183 1.623 . . . . 0.44 110.535 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 184' ' ' LEU . 0.5 OUTLIER -83.33 179.32 7.72 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.285 -0.885 . . . . 0.57 109.816 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.2 68.6 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.566 -1.013 . . . . 0.49 110.566 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.528 ' N ' ' O ' ' A' ' 182' ' ' SER . 0.8 OUTLIER 179.64 84.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.132 -1.217 . . . . 0.41 110.954 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.552 HD12 ' CD ' ' A' ' 205' ' ' GLU . 0.5 OUTLIER -100.18 -24.17 14.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.964 -1.094 . . . . 0.3 110.741 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -152.36 99.55 2.51 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.79 -1.194 . . . . 0.2 111.788 -179.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.539 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -100.97 124.47 46.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.051 -1.031 . . . . 0.16 109.987 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.828 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -106.08 124.49 49.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.974 . . . . 0.23 110.333 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.4 OUTLIER -68.5 162.83 59.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.38 110.443 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.4 Cg_endo -72.26 138.58 30.63 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.4 109.772 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.56 72.88 2.34 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.92 1.484 . . . . 0.32 110.575 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.59 -105.95 2.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.32 109.443 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.65 -159.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.943 1.497 . . . . 0.47 110.396 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -63.61 -11.8 28.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.63 110.279 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.27 63.58 0.66 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.45 -0.781 . . . . 0.53 109.997 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.19 173.89 22.46 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.097 -1.601 . . . . 0.25 109.097 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.28 25.5 0.76 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.481 -1.448 . . . . 0.1 109.481 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 12.5 m-20 -79.04 87.44 4.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -1.209 . . . . 0.1 110.666 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.8 98.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.09 109.539 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.538 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 8.5 m170 -110.57 119.86 40.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.09 111.266 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 203' ' ' ASP . 13.7 m-30 -90.62 131.93 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.1 109.556 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.519 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 0.4 OUTLIER -49.33 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.079 . . . . 0.14 108.717 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -34.55 -32.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.566 -0.709 . . . . 0.18 111.738 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.532 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 1.8 m-20 -64.1 -16.75 62.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.638 -1.289 . . . . 0.24 110.631 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.552 ' CD ' HD12 ' A' ' 185' ' ' LEU . 11.4 mm-40 -86.77 -176.02 5.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.002 . . . . 0.42 110.49 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.528 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 83.8 m -122.11 154.74 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.47 110.006 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.553 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -149.49 147.28 28.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 0.27 109.756 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.013 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.32 177.55 11.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.02 -1.05 . . . . 0.3 110.595 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.1 OUTLIER -129.06 20.28 5.88 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.729 0.776 . . . . 0.61 109.553 178.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -89.38 -69.81 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.566 0.698 . . . . 0.78 110.078 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.415 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER 179.41 -30.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.58 -0.7 . . . . 0.91 109.543 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 177.61 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.548 -0.72 . . . . 0.93 109.98 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 50.11 -161.4 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.79 109.432 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.465 ' CE2' ' CE2' ' A' ' 244' ' ' TYR . 80.1 m-85 -81.69 126.2 31.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.69 109.473 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.62 ' O ' HG12 ' A' ' 219' ' ' VAL . 16.8 m-80 -89.2 118.6 29.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.026 -1.046 . . . . 0.4 108.658 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.013 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.37 -36.98 0.92 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.672 -0.811 . . . . 0.17 110.334 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 3.0 m-85 -51.24 -49.34 61.31 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.574 -1.25 . . . . 0.28 107.833 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 244' ' ' TYR . 12.7 tp -75.09 -70.42 0.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.791 -0.64 . . . . 0.46 110.54 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -49.96 -68.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.39 110.03 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -44.46 -52.96 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.978 -1.076 . . . . 0.17 111.23 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.99 -47.71 77.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.275 -1.516 . . . . 0.1 108.722 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.673 ' N ' HD21 ' A' ' 239' ' ' LEU . 5.6 t60 -54.25 -52.18 62.17 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.419 0.628 . . . . 0.21 109.942 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.642 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.4 tp10 -59.81 -43.7 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.207 -0.933 . . . . 0.28 108.87 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 224' ' ' PHE . 11.6 m-30 -55.0 -62.35 1.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.18 109.091 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.59 -32.97 1.4 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.786 -1.725 . . . . 0.21 108.786 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -79.83 -76.46 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.195 -1.179 . . . . 0.17 111.052 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.828 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -34.55 -42.57 0.15 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.83 -0.544 . . . . 0.33 112.336 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 163' ' ' ILE . 3.1 tp -101.17 -38.74 7.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.839 -1.163 . . . . 0.53 111.309 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 225' ' ' GLY . . . -68.29 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.762 -0.935 . . . . 0.41 110.762 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.625 HD12 ' H ' ' A' ' 232' ' ' HIS . 0.5 OUTLIER -160.45 -155.34 0.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.131 -1.217 . . . . 0.45 111.098 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.446 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 37.3 m-20 -74.4 -48.34 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.62 110.712 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.625 ' H ' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -174.82 157.82 2.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -1.0 . . . . 0.45 111.098 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 24.1 p -162.71 47.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.033 -0.728 . . . . 0.38 109.033 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.714 ' CA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -127.06 23.09 6.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.449 -0.782 . . . . 0.48 111.001 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.553 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -43.86 -60.24 2.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.38 109.494 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.0 Cg_endo -75.97 -50.76 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.735 1.387 . . . . 0.28 110.681 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.06 95.03 0.1 OUTLIER Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.337 -1.411 . . . . 0.24 111.404 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.928 ' HB2' ' HB2' ' A' ' 257' ' ' ASP . . . -145.77 164.93 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.426 -1.044 . . . . 0.28 110.022 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.673 HD21 ' N ' ' A' ' 222' ' ' HIS . 1.1 tp -72.14 57.33 0.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -0.916 . . . . 0.4 109.131 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.601 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 4.3 mmm -146.86 14.46 1.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.102 -0.998 . . . . 0.45 110.576 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -106.14 166.67 10.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.57 110.704 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.474 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.3 Cg_endo -70.24 -7.53 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.008 1.53 . . . . 0.76 109.981 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.727 HD11 ' CG2' ' A' ' 245' ' ' THR . 0.0 OUTLIER -101.41 112.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.137 -0.69 . . . . 0.89 109.137 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.68 ' HB2' HD21 ' A' ' 218' ' ' LEU . 52.1 p90 -116.6 -31.58 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.04 . . . . 0.78 110.731 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.762 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER 1.89 -68.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.235 0.828 . . . . 0.61 113.235 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.762 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -48.6 106.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.51 -1.369 . . . . 0.74 109.524 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 70.0 p -53.8 171.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.81 110.164 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.3 -15.23 29.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.27 -1.532 . . . . 0.56 109.27 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.7 20.09 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.37 110.441 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.467 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -64.74 -17.88 64.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.44 109.795 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -168.36 -64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.53 110.187 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.1 OUTLIER 179.95 -172.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.38 110.605 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 1.011 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.32 56.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.716 -0.615 . . . . 0.19 110.541 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.704 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.9 OUTLIER -44.01 -47.6 22.43 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.0 -1.111 . . . . 0.28 108.0 177.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.65 50.67 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 124.101 1.579 . . . . 0.49 111.176 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.666 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 31.3 m-20 -53.54 -28.52 32.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.49 110.786 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.928 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 1.7 m-20 -54.25 -47.76 71.91 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.035 -1.041 . . . . 0.31 109.436 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.037 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -76.21 -31.82 58.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.277 -0.969 . . . . 0.14 108.442 178.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 1.011 HG21 ' HB2' ' A' ' 253' ' ' MET . 70.8 t -61.83 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.658 -0.817 . . . . 0.17 109.98 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -61.41 -40.96 96.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.247 -0.908 . . . . 0.26 109.525 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.53 -66.71 0.92 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.355 -1.098 . . . . 0.19 110.355 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.037 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -76.14 -20.17 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.912 -1.346 . . . . 0.22 110.613 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 262' ' ' ILE . 13.4 tp60 -61.37 -23.86 66.07 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.648 -1.221 . . . . 0.39 107.969 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -103.12 -36.34 8.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.936 -0.705 . . . . 0.47 111.672 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 265' ' ' LEU . 4.3 mm? -90.76 -46.52 8.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.973 -1.079 . . . . 0.48 111.923 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.644 ' OH ' HD23 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -71.23 -18.09 62.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.964 -1.085 . . . . 0.41 109.904 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.95 -88.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.999 -1.64 . . . . 0.46 108.999 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.9 114.24 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.072 1.564 . . . . 0.58 110.001 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.92 154.97 17.27 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.842 -1.303 . . . . 0.64 109.842 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.602 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.662 0 O-C-N 121.279 -1.13 . . . . 0.95 109.986 179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.698 ' HA ' HD12 ' A' ' 230' ' ' LEU . 1.1 p . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.505 0.669 . . . . 1.03 109.204 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 48.11 32.66 3.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 1.04 111.469 178.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 110' ' ' THR . 1.2 mtpt -117.75 92.88 3.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.77 109.883 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.614 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 9.9 t90 -160.91 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.009 -1.057 . . . . 0.42 111.307 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.483 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 87.6 p -102.23 69.23 1.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -0.998 . . . . 0.44 110.865 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 114' ' ' SER . 7.3 mttm -161.59 50.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.49 110.352 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 3.9 ttt -74.91 -5.16 42.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.247 -0.908 . . . . 0.3 110.427 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.453 ' CB ' ' HB3' ' A' ' 152' ' ' ASN . 29.7 p30 -156.78 149.13 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.15 110.502 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.728 HD23 HD11 ' A' ' 228' ' ' LEU . 9.3 tp -171.15 177.64 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.13 109.857 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.91 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -110.36 158.84 18.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.008 . . . . 0.12 110.458 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.752 ' HB2' HG23 ' A' ' 163' ' ' ILE . 21.4 p90 -154.45 167.85 28.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.422 -0.799 . . . . 0.33 110.329 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -130.06 144.21 51.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -0.818 . . . . 0.54 110.102 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.839 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -105.18 123.85 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.346 -0.846 . . . . 0.33 110.704 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.995 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.0 m -165.41 44.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.802 . . . . 0.27 109.818 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.3 t-20 -40.11 -80.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.41 109.539 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 7.8 t80 -179.11 178.46 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.314 -0.866 . . . . 0.4 109.951 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -131.9 55.71 19.71 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.45 110.576 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.6 Cg_endo -82.86 -81.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.789 1.415 . . . . 0.36 110.517 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.77 -4.03 25.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.25 110.048 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.552 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 1.0 OUTLIER -113.76 160.98 18.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.39 110.211 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.3 m -106.89 167.74 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.48 109.839 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 2.0 t60 -44.29 -29.98 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.4 109.845 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -66.71 -51.5 55.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.46 109.654 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.552 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 10.3 mt-10 -62.16 -58.0 9.42 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.249 -0.907 . . . . 0.47 109.18 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 125' ' ' TYR . 5.7 t -46.37 -34.76 2.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.935 -1.135 . . . . 0.31 107.935 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -59.0 -42.4 90.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.938 -1.134 . . . . 0.48 107.938 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 47.1 tttt -68.97 -45.49 70.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.219 -1.03 . . . . 0.64 108.219 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.822 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -49.17 -59.71 3.43 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.321 -0.862 . . . . 0.42 109.739 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.717 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.39 -55.79 16.17 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.542 -0.724 . . . . 0.34 110.509 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -64.27 -73.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.47 110.603 -179.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -39.64 -60.27 1.0 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.633 -0.667 . . . . 0.47 110.73 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.11 -36.86 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.521 -1.362 . . . . 0.25 108.339 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -72.33 -31.41 65.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.9 -0.778 . . . . 0.35 108.9 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -61.29 -42.32 98.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.7 108.655 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.3 t -73.22 -48.55 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.566 -0.709 . . . . 0.61 109.208 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.596 ' CH2' HG13 ' A' ' 262' ' ' ILE . 43.1 t-105 -54.72 -39.38 68.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.39 109.215 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 149' ' ' THR . 75.5 m -74.9 -35.18 62.25 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.508 -0.923 . . . . 0.35 108.508 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.524 0.678 . . . . 0.36 109.375 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.783 HG23 HG22 ' A' ' 149' ' ' THR . 27.2 m -82.29 -32.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.419 -0.801 . . . . 0.5 110.256 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.783 HG22 HG23 ' A' ' 148' ' ' VAL . 5.0 t -146.29 136.65 12.17 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.51 110.557 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.93 58.44 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.972 1.512 . . . . 0.31 110.542 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.796 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -75.63 129.54 37.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.18 110.431 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 117' ' ' ASN . 64.6 t-20 -87.25 123.59 32.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.17 109.841 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.591 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 7.5 p90 -133.11 152.97 51.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.14 110.467 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.91 ' O ' HG22 ' A' ' 119' ' ' THR . 22.5 m -152.49 125.81 8.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.15 110.319 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.602 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -92.04 105.43 17.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.2 109.755 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -101.76 96.97 7.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.22 110.395 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.3 p-80 -52.5 -28.34 20.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.32 109.954 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.691 ' HB3' HD12 ' A' ' 156' ' ' LEU . 3.3 t0 -41.42 -60.7 1.22 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.587 -0.696 . . . . 0.33 109.752 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.99 35.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.963 -1.255 . . . . 0.28 109.963 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.769 ' O ' HG22 ' A' ' 160' ' ' ILE . 50.4 mt -126.09 68.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -1.205 . . . . 0.3 109.398 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.41 55.26 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.641 -0.662 . . . . 0.2 110.758 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.539 ' CG ' HD21 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -96.9 -51.07 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.1 109.798 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.752 HG23 ' HB2' ' A' ' 120' ' ' TYR . 18.5 tt -116.53 160.84 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.346 -0.846 . . . . 0.1 109.644 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.946 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 15.6 ptp -160.81 139.73 10.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.56 -1.338 . . . . 0.11 111.439 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -93.6 113.97 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.1 109.292 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.995 ' HB3' HG23 ' A' ' 123' ' ' VAL . 63.6 p -162.23 166.4 25.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.777 -1.202 . . . . 0.1 111.36 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.616 ' CG ' ' CD1' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -79.99 136.56 36.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.55 -0.719 . . . . 0.09 109.979 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.512 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.72 128.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.793 -1.323 . . . . 0.2 109.793 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.1 tt -118.29 100.87 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -1.037 . . . . 0.55 109.737 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 3.0 tmtt? -9.71 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.284 0.564 . . . . 0.85 112.352 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 9.3 tt0 -146.16 11.85 1.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.71 110.278 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -74.78 -75.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.42 110.107 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 120.12 52.45 0.26 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.795 -1.322 . . . . 0.33 109.795 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 6.5 p-10 -177.1 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -1.151 . . . . 0.33 110.083 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.483 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.2 OUTLIER -132.03 154.72 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.27 110.083 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.58 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 3.0 m-30 -106.48 88.98 3.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.941 . . . . 0.34 110.168 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 44.3 Cg_endo -72.6 -58.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.47 109.968 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -49.12 131.49 19.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.35 110.362 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 182' ' ' SER . 14.8 p30 179.33 82.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.134 -0.979 . . . . 0.2 110.804 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.497 ' H ' ' CB ' ' A' ' 204' ' ' ASP . . . 35.71 -154.13 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.094 -1.202 . . . . 0.25 110.094 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -78.96 43.74 1.54 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.965 1.508 . . . . 0.44 110.2 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.1 t -80.78 176.67 9.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.103 -0.998 . . . . 0.57 110.076 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.509 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -63.35 67.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.664 -0.974 . . . . 0.49 110.664 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.52 ' N ' ' O ' ' A' ' 182' ' ' SER . 0.3 OUTLIER 179.57 88.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.178 -1.189 . . . . 0.41 110.709 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.591 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 4.9 tt -105.9 -19.11 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.759 -1.176 . . . . 0.3 110.919 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.424 ' HB1' ' OE2' ' A' ' 223' ' ' GLU . . . -150.25 111.11 4.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.2 112.074 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -114.64 125.83 54.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.84 . . . . 0.16 109.414 178.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -123.04 116.89 24.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.106 . . . . 0.23 110.512 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -58.57 167.68 1.68 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.38 110.146 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.491 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -72.19 145.87 44.85 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.027 1.541 . . . . 0.4 109.489 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.3 Cg_endo -72.48 86.43 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.831 1.438 . . . . 0.32 110.35 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.49 -98.55 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.591 -1.404 . . . . 0.32 109.591 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.61 -166.39 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.47 110.573 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -69.67 -6.58 32.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.63 110.343 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 26.46 10.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.33 -0.856 . . . . 0.53 109.891 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -106.34 176.94 22.02 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.082 -1.607 . . . . 0.25 109.082 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.533 ' O ' HG13 ' A' ' 163' ' ' ILE . . . 45.3 25.33 1.16 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.226 -1.55 . . . . 0.1 109.226 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 196' ' ' GLY . 10.7 m-20 -78.79 87.49 4.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.1 110.026 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.946 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -69.72 97.99 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.09 109.895 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.512 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 41.4 m170 -115.27 129.47 56.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -0.876 . . . . 0.09 110.602 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.9 m-85 -96.79 139.25 33.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.085 -1.009 . . . . 0.1 110.365 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -47.78 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.14 108.544 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.7 p-10 -35.48 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.013 -0.675 . . . . 0.18 111.985 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 0.8 OUTLIER -76.66 -3.21 36.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.771 -1.205 . . . . 0.24 111.271 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 14.5 mm-40 -91.22 -164.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.031 -1.043 . . . . 0.42 110.171 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.446 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 16.0 m -127.88 150.95 49.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.47 110.223 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.56 ' C ' HG22 ' A' ' 208' ' ' THR . 1.2 m-90 -145.9 146.25 31.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.27 109.56 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.986 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -162.17 175.4 11.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.867 -1.145 . . . . 0.3 111.104 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.9 t -126.58 45.24 2.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.855 0.836 . . . . 0.61 109.037 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 211' ' ' SER . 11.0 t -127.38 -157.99 0.84 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.676 . . . . 0.78 110.035 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 p -97.62 27.92 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.91 110.349 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -145.09 150.13 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.93 110.013 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.1 -176.2 12.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.174 -1.57 . . . . 0.79 109.174 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.591 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 86.7 m-85 -65.33 139.6 58.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 0.69 109.565 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.619 ' O ' HG12 ' A' ' 219' ' ' VAL . 0.6 OUTLIER -108.32 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.061 -1.024 . . . . 0.4 108.678 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.986 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -39.08 -38.76 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.044 -0.662 . . . . 0.17 110.801 -178.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 136' ' ' LYS . 2.0 m-85 -50.62 -46.66 58.25 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.302 -1.359 . . . . 0.28 107.592 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.914 HD21 ' HB2' ' A' ' 244' ' ' TYR . 13.4 tp -80.72 -72.86 0.4 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.707 -0.678 . . . . 0.46 110.908 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -46.1 -57.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.39 110.395 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.36 -49.56 77.33 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.336 -0.852 . . . . 0.17 111.385 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.23 -27.07 65.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.338 -1.476 . . . . 0.1 108.998 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.632 ' CA ' HD21 ' A' ' 239' ' ' LEU . 4.0 t60 -76.53 -56.17 4.87 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.305 0.574 . . . . 0.21 109.768 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.643 ' OE1' ' HB1' ' A' ' 199' ' ' ALA . 34.7 tt0 -58.43 -39.28 79.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.126 -0.983 . . . . 0.28 109.015 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 220' ' ' ALA . 0.4 OUTLIER -60.47 -62.39 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.18 109.005 178.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.83 -29.71 0.86 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.701 -1.76 . . . . 0.21 108.701 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.48 ' CE1' ' HA ' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.43 -66.05 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -1.122 . . . . 0.17 110.884 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.959 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -40.78 -42.91 1.89 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.443 -0.786 . . . . 0.33 111.691 -178.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.75 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -100.27 -37.87 8.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.772 -1.205 . . . . 0.53 110.942 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -67.91 -85.74 0.1 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.255 -1.138 . . . . 0.41 110.255 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -170.23 -163.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.066 -1.255 . . . . 0.45 111.05 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.451 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -59.03 -55.78 30.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.765 . . . . 0.62 110.329 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -161.72 -179.69 7.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.937 . . . . 0.45 110.802 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 1.2 t 179.35 56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.714 -0.616 . . . . 0.38 109.474 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.672 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -139.25 26.36 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.48 110.862 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.519 ' N ' ' HD2' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -34.03 -52.6 0.89 Allowed Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 120.005 -0.678 . . . . 0.38 110.273 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 235' ' ' ASP . 50.2 Cg_endo -75.25 -56.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.634 1.334 . . . . 0.28 110.12 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.62 37.22 0.05 OUTLIER Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.328 -1.415 . . . . 0.24 111.655 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.672 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -69.9 171.97 8.49 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.389 -1.653 . . . . 0.28 111.009 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.632 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.21 58.79 1.29 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.938 0.875 . . . . 0.4 109.148 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.622 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.6 mmt -138.07 -33.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.45 110.519 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.642 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -52.62 169.93 0.26 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.57 110.344 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 44.7 Cg_endo -72.17 -1.42 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.592 1.312 . . . . 0.76 110.369 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 4.1 mt -111.97 141.96 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.89 109.965 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.914 ' HB2' HD21 ' A' ' 218' ' ' LEU . 22.4 p90 -130.15 -19.66 3.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.151 -0.968 . . . . 0.78 111.201 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 4.46 -76.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 113.006 0.743 . . . . 0.61 113.006 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.694 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -45.49 121.09 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.498 -1.376 . . . . 0.74 109.612 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 0.6 OUTLIER -71.14 157.96 37.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.828 . . . . 0.81 110.228 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.87 -22.09 4.16 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.528 -1.429 . . . . 0.56 109.528 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -131.07 31.56 4.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -1.154 . . . . 0.37 110.744 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.407 ' HB2' ' H ' ' A' ' 247' ' ' THR . 1.6 t -76.28 -69.5 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.806 -1.184 . . . . 0.44 110.114 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . 0.537 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 2.4 t60 -116.73 -60.09 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.53 110.338 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.2 OUTLIER 179.85 -169.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.977 . . . . 0.38 110.898 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.927 ' HB2' HG21 ' A' ' 259' ' ' VAL . 26.0 ptp -64.92 55.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.998 -0.439 . . . . 0.19 110.658 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.727 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -45.38 -46.96 35.16 Favored Pre-proline 0 N--CA 1.484 1.238 0 N-CA-C 107.897 -1.149 . . . . 0.28 107.897 177.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.3 Cg_endo -71.42 48.72 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.901 1.474 . . . . 0.49 111.194 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.588 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 7.7 m-20 -49.29 -32.54 11.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.887 -1.133 . . . . 0.49 110.325 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.626 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.96 -50.69 70.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.966 -1.093 . . . . 0.31 108.974 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.023 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -68.54 -35.13 77.0 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.257 -0.977 . . . . 0.14 108.672 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.927 HG21 ' HB2' ' A' ' 253' ' ' MET . 53.6 t -66.49 -86.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.17 110.543 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.587 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 10.0 tt0 -53.77 -39.62 65.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 0.26 109.631 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 265' ' ' LEU . . . -45.9 -70.83 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.354 -1.098 . . . . 0.19 110.354 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.023 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -69.96 -20.65 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.22 109.89 -179.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.968 ' N ' HD13 ' A' ' 262' ' ' ILE . 3.4 tp-100 -58.87 -25.99 63.83 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.722 -1.191 . . . . 0.39 107.821 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 25.5 t -103.07 -43.05 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.308 0.575 . . . . 0.47 110.857 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 261' ' ' GLY . 1.6 mt -72.52 -53.06 13.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.48 111.054 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.796 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -80.13 -8.1 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.41 110.291 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.0 -100.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.103 -1.599 . . . . 0.46 109.103 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.33 132.74 13.98 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.967 1.509 . . . . 0.58 110.088 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -98.37 140.88 15.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.737 -1.345 . . . . 0.64 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.614 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 O-C-N 121.244 -1.15 . . . . 0.95 109.903 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.528 ' HA ' HD13 ' A' ' 230' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 121.52 0.676 . . . . 1.03 109.439 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.6 mt 40.05 31.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 1.04 111.017 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.798 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -119.97 76.68 1.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.77 109.74 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.578 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 23.5 t90 -140.92 -71.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.42 110.54 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . . . . . . . . . 4.6 t -103.48 54.0 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.44 110.326 -179.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.743 ' HD3' HD11 ' A' ' 118' ' ' LEU . 59.6 mmtt -136.54 46.65 2.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.49 110.311 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.573 ' O ' ' HE3' ' A' ' 116' ' ' MET . 1.1 ttp -82.47 -15.34 52.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.296 -0.878 . . . . 0.3 109.989 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 17.3 p30 -140.17 115.52 9.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.831 . . . . 0.15 110.077 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 1.0 HD22 HD11 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -138.76 176.2 8.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.13 110.108 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 154' ' ' THR . 0.9 OUTLIER -123.64 162.04 23.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.12 109.992 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.784 ' HB2' HD13 ' A' ' 163' ' ' ILE . 16.0 p90 -164.66 167.7 18.85 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.199 -1.0 . . . . 0.33 111.285 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -120.45 151.83 38.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.416 -0.803 . . . . 0.54 109.875 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.801 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.5 pp -109.47 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.862 . . . . 0.33 110.989 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.952 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.8 m -143.63 43.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.27 110.396 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 4.0 t30 -42.04 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.41 109.303 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.691 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.9 t80 -179.69 -167.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.4 109.68 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.7 OUTLIER -150.97 50.07 0.66 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.45 110.533 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -75.76 -84.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.838 1.441 . . . . 0.36 110.508 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.71 -0.25 51.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.25 109.998 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -115.99 163.57 15.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.39 110.007 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.17 168.68 9.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.48 110.049 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -43.6 -32.83 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.4 110.04 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -64.4 -46.32 83.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.46 109.512 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 12.5 mt-10 -67.23 -57.5 6.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.138 -0.976 . . . . 0.47 109.66 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 125' ' ' TYR . 17.5 t -45.33 -32.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.95 -1.13 . . . . 0.31 107.95 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.7 mt-10 -63.55 -44.54 93.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.078 -1.082 . . . . 0.48 108.078 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.2 ttmt -68.56 -49.07 62.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.24 -0.984 . . . . 0.64 108.651 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.831 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.39 -59.75 2.76 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.212 -0.93 . . . . 0.42 110.245 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.68 -53.78 30.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.34 110.825 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.63 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.18 -73.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.47 110.335 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtt? -38.63 -60.63 0.8 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.865 -0.522 . . . . 0.47 110.603 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.38 -38.71 13.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.676 -1.265 . . . . 0.25 108.528 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -71.68 -29.68 64.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.368 -0.832 . . . . 0.35 109.079 178.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 140' ' ' LYS . 6.1 ttmm -61.24 -44.91 96.5 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.19 -1.041 . . . . 0.7 108.19 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 6.5 t -63.61 -43.35 98.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.7 -0.852 . . . . 0.61 108.7 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.628 ' O ' HG22 ' A' ' 148' ' ' VAL . 46.2 t-105 -56.35 -44.4 80.05 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.79 -0.819 . . . . 0.39 108.79 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 149' ' ' THR . 9.6 m -64.66 -32.12 73.65 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.35 108.886 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -62.72 -36.57 83.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.521 -0.737 . . . . 0.36 109.334 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 145' ' ' TRP . 35.3 m -89.17 -11.56 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -0.85 . . . . 0.5 110.534 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 146' ' ' SER . 14.9 t -175.92 132.67 0.42 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.927 -1.108 . . . . 0.51 110.247 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.04 60.1 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.866 1.456 . . . . 0.31 110.804 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 ' CG ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -72.32 129.63 38.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.18 109.879 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.19 124.73 33.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.17 110.191 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.535 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -136.27 155.85 49.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.14 110.508 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.567 ' O ' HG22 ' A' ' 119' ' ' THR . 34.5 m -152.81 132.11 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.15 110.222 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.57 ' HD3' HG23 ' A' ' 122' ' ' ILE . 0.8 OUTLIER -101.55 91.21 4.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.978 . . . . 0.2 110.123 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.5 94.32 7.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.22 110.286 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 158' ' ' ASP . 14.3 p-80 -52.71 -25.85 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.32 109.867 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' HIS . 1.5 t70 -41.53 -62.79 0.81 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.468 0.652 . . . . 0.33 109.679 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.58 34.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.888 -1.285 . . . . 0.28 109.888 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 119' ' ' THR . 22.6 mm -126.5 69.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.065 -1.256 . . . . 0.3 109.108 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -127.91 136.9 51.99 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.001 -0.68 . . . . 0.2 110.572 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.474 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -118.33 -35.81 3.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.1 110.269 179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 1.047 HG21 HD13 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -126.82 163.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.294 -0.879 . . . . 0.1 109.511 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.806 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 6.5 ptm -172.77 156.19 3.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.208 -1.558 . . . . 0.11 111.727 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 122' ' ' ILE . 4.5 tt -98.43 114.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.654 -0.654 . . . . 0.1 109.447 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.952 ' HB3' HG23 ' A' ' 123' ' ' VAL . 80.9 p -155.85 151.61 27.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 0.1 110.92 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -72.45 119.15 16.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.522 -0.736 . . . . 0.09 109.826 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -77.87 129.31 9.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.219 -1.152 . . . . 0.2 110.219 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.5 tt -126.18 98.55 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.614 -0.933 . . . . 0.55 109.634 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.596 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 1.2 tmtt? 1.15 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.589 0.588 . . . . 0.85 112.589 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 20.21 0.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.71 110.282 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -93.31 -88.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.42 110.268 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.29 -20.96 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.325 -1.51 . . . . 0.33 109.325 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.68 -66.91 0.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -1.062 . . . . 0.33 110.339 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 175' ' ' PHE . 23.4 p90 -148.24 163.51 36.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.27 110.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.0 m-30 -69.24 114.95 27.37 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.34 110.186 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.5 ' O ' HD23 ' A' ' 184' ' ' LEU . 44.1 Cg_endo -77.07 -72.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.857 1.451 . . . . 0.47 110.784 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -54.2 146.87 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.35 110.422 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 179' ' ' ASP . 44.4 p-10 -178.08 76.82 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.2 110.459 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 53.18 -169.39 0.88 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.121 -1.591 . . . . 0.25 109.121 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.513 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.3 Cg_endo -78.28 10.05 2.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.042 1.548 . . . . 0.44 110.478 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 184' ' ' LEU . 28.5 t -47.59 177.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.57 110.915 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.498 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.02 76.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.479 -1.048 . . . . 0.49 110.479 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.651 HD23 ' OD1' ' A' ' 202' ' ' ASP . 5.0 tp 179.47 87.68 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.369 -1.077 . . . . 0.41 109.767 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.859 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.4 tt -109.84 -23.47 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.901 -1.124 . . . . 0.3 111.42 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 201' ' ' PHE . . . -152.5 101.84 2.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.517 -1.365 . . . . 0.2 111.935 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 2.2 p80 -100.76 120.84 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.054 . . . . 0.16 110.016 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.78 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -102.64 132.45 48.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.23 110.179 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.468 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-30 -78.91 168.92 23.19 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.38 110.421 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 48.0 Cg_endo -73.68 125.47 10.05 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.994 1.523 . . . . 0.4 109.553 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.25 68.22 1.41 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.897 1.472 . . . . 0.32 110.6 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.36 -86.23 1.4 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.366 -1.494 . . . . 0.32 109.366 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 -164.46 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.072 1.564 . . . . 0.47 110.367 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 194' ' ' ASN . 3.4 m120 -74.22 -0.89 18.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.63 110.386 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.89 48.67 1.19 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.53 110.162 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -124.32 177.37 16.79 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.313 -1.515 . . . . 0.25 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 46.79 22.74 1.22 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.902 -1.279 . . . . 0.1 109.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.88 86.58 6.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -1.211 . . . . 0.1 109.745 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -61.58 97.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.143 -0.973 . . . . 0.09 110.057 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 14.1 m170 -107.34 126.73 52.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.09 110.341 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.5 m-85 -99.0 132.58 44.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.173 -0.954 . . . . 0.1 110.529 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.651 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -46.74 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.834 -0.802 . . . . 0.14 108.834 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.52 -27.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.18 111.638 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.537 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 19.6 m-20 -77.17 3.15 13.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.622 -1.299 . . . . 0.24 110.731 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.859 ' OE1' HD12 ' A' ' 185' ' ' LEU . 17.2 mm-40 -98.41 -167.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.934 -1.104 . . . . 0.42 110.41 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . 0.532 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -124.94 151.72 45.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.47 110.177 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.1 m-90 -148.95 144.52 26.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.27 109.911 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.986 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.57 170.17 21.42 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.958 -1.089 . . . . 0.3 110.638 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.464 ' HB2' HD23 ' A' ' 216' ' ' LEU . 1.1 t -129.58 26.98 5.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.822 -0.807 . . . . 0.61 108.822 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -95.26 -94.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.715 -0.615 . . . . 0.78 110.296 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.483 ' N ' ' OG ' ' A' ' 210' ' ' SER . 18.0 p -156.78 20.96 0.33 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.91 109.8 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 213' ' ' GLY . 5.4 mttm -141.94 -177.16 5.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.439 -0.788 . . . . 0.93 110.134 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 43.68 -166.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.385 -1.486 . . . . 0.79 109.385 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.476 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 73.7 m-85 -73.75 120.54 19.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.69 109.793 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.589 ' O ' HG12 ' A' ' 219' ' ' VAL . 57.2 m-80 -84.52 120.05 25.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.963 -1.086 . . . . 0.4 108.856 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.986 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.33 -37.2 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.17 110.439 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 3.1 m-30 -51.33 -47.79 62.59 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 118.619 -1.232 . . . . 0.28 107.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.559 HD21 ' HB2' ' A' ' 244' ' ' TYR . 7.3 tp -77.0 -70.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.9 -0.591 . . . . 0.46 110.605 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -48.89 -66.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.944 -1.097 . . . . 0.39 109.808 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -46.57 -48.55 19.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.111 -0.993 . . . . 0.17 111.077 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -58.59 -45.43 89.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.323 -1.485 . . . . 0.1 108.764 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.851 ' HB2' HD11 ' A' ' 239' ' ' LEU . 2.7 t-160 -58.08 -54.52 45.99 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.415 0.626 . . . . 0.21 109.811 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 188' ' ' ALA . 24.6 tp10 -58.5 -57.12 14.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.28 109.156 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.835 ' CE1' HD11 ' A' ' 163' ' ' ILE . 3.3 m-85 -43.73 -57.89 2.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.18 109.016 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.799 ' HA3' ' HE1' ' A' ' 240' ' ' MET . . . -46.96 -35.04 7.76 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.421 -1.472 . . . . 0.21 109.421 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.888 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.1 OUTLIER -81.8 -67.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.095 -1.238 . . . . 0.17 111.08 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.78 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -38.08 -42.95 0.7 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.46 -0.775 . . . . 0.33 111.726 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 163' ' ' ILE . 2.1 tp -99.95 -36.72 9.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.815 -1.178 . . . . 0.53 110.753 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.59 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -64.99 -79.71 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.3 -1.12 . . . . 0.41 110.3 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.609 HD11 ' O ' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -177.37 -152.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.45 110.896 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -50.67 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.62 110.199 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.888 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.2 OUTLIER -175.19 169.15 3.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.45 110.017 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.9 p -169.31 53.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.38 109.229 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.99 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.2 OUTLIER -139.33 25.14 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.48 111.525 -178.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.545 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -39.39 -51.06 4.8 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.38 110.428 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 53.2 Cg_endo -81.03 -52.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.571 1.301 . . . . 0.28 110.687 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 176.75 101.72 0.15 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.2 -1.476 . . . . 0.24 111.508 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.99 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -139.4 177.4 7.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.261 -1.141 . . . . 0.28 109.65 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 222' ' ' HIS . 2.0 tp -67.8 -3.98 11.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.065 -1.022 . . . . 0.4 109.86 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.799 ' HE1' ' HA3' ' A' ' 225' ' ' GLY . 6.4 mmt -94.91 -6.81 41.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.45 111.709 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -53.8 169.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.768 -1.208 . . . . 0.57 110.681 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.532 ' O ' ' CG1' ' A' ' 243' ' ' ILE . 49.5 Cg_endo -80.22 43.0 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.662 1.349 . . . . 0.76 110.055 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 242' ' ' PRO . 9.0 mt -161.01 144.38 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.797 -0.816 . . . . 0.89 108.797 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.559 ' HB2' HD21 ' A' ' 218' ' ' LEU . 53.7 p90 -124.97 -34.15 2.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.965 -1.084 . . . . 0.78 110.057 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.558 ' C ' ' O ' ' A' ' 244' ' ' TYR . 15.7 m 2.9 -70.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.831 0.678 . . . . 0.61 112.831 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.581 ' CE2' ' HD3' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -61.34 106.96 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.632 -1.292 . . . . 0.74 108.977 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.455 ' N ' ' HB2' ' A' ' 250' ' ' SER . 0.2 OUTLIER -47.03 174.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.81 110.263 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.31 -16.5 27.87 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.037 -1.625 . . . . 0.56 109.037 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -146.89 31.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.37 110.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.455 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -56.56 -19.22 14.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.44 110.144 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -170.97 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.53 110.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.491 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -177.92 177.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.38 111.019 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -71.32 56.68 0.24 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.64 -0.663 . . . . 0.19 110.903 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.729 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.0 OUTLIER -43.82 -47.07 20.79 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.019 -1.104 . . . . 0.28 108.019 177.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.5 Cg_endo -71.29 50.89 1.3 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.983 1.518 . . . . 0.49 111.085 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.629 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 15.1 m-20 -54.56 -28.77 48.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.021 -1.05 . . . . 0.49 111.192 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.94 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -54.38 -46.3 73.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.726 -1.234 . . . . 0.31 109.396 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.025 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.07 -32.02 56.5 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.297 -1.001 . . . . 0.14 108.297 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.991 HG21 ' HB2' ' A' ' 253' ' ' MET . 66.7 t -61.25 -76.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.661 -0.816 . . . . 0.17 110.269 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.632 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.3 tt0 -65.78 -42.26 90.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.101 -0.999 . . . . 0.26 109.434 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.38 -63.44 1.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.129 -1.189 . . . . 0.19 110.129 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.025 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -77.75 -20.49 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.762 -1.434 . . . . 0.22 110.395 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.844 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -59.72 -25.98 65.25 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.795 -1.19 . . . . 0.39 108.028 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.0 m -104.38 -33.54 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.145 -0.622 . . . . 0.47 111.764 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 112' ' ' LYS . 2.2 mm? -90.08 -44.99 9.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.075 -1.015 . . . . 0.48 111.563 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.885 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -85.09 -11.28 55.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.41 110.647 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.3 -110.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.516 . . . . 0.46 109.311 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.66 93.78 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.809 1.426 . . . . 0.58 110.353 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 113' ' ' TRP . . . -79.18 156.08 41.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.44 -1.464 . . . . 0.64 109.44 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.578 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 38.0 t0 . . . . . 0 N--CA 1.491 1.618 0 O-C-N 121.244 -1.151 . . . . 0.95 110.396 -179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.379 0.609 . . . . 1.03 109.568 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 0.3 OUTLIER 38.21 42.53 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.577 . . . . 1.04 111.126 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.867 ' CD ' HD23 ' A' ' 265' ' ' LEU . 1.2 ptpt -134.3 66.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.77 109.303 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.616 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 12.3 t90 -140.37 -65.15 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.42 110.822 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.453 ' O ' ' HD3' ' A' ' 115' ' ' LYS . 36.1 t -103.69 56.41 0.74 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.44 111.09 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 114' ' ' SER . 30.4 mmtt -150.9 45.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.028 -1.045 . . . . 0.49 110.476 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.556 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 2.0 ttp -81.66 -1.9 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.3 110.458 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.566 ' O ' HD12 ' A' ' 118' ' ' LEU . 1.4 p30 -148.51 119.53 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.15 110.012 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.862 HD22 HD11 ' A' ' 228' ' ' LEU . 1.5 tp -152.13 174.3 13.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.13 110.493 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -118.2 159.46 23.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.12 110.256 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.864 ' HB3' HG23 ' A' ' 163' ' ' ILE . 20.1 p90 -154.35 170.22 21.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.616 -0.834 . . . . 0.33 110.591 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 147.39 49.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.54 110.12 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.863 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -107.09 125.05 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.33 110.929 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.907 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.3 m -167.19 43.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.27 109.768 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.514 ' OD1' ' CE ' ' A' ' 129' ' ' MET . 1.0 OUTLIER -40.07 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.41 109.429 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.538 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 19.9 t80 -178.46 -178.62 0.62 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 0.4 109.641 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -119.7 48.2 1.12 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.917 -1.114 . . . . 0.45 110.664 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -71.28 -87.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.11 1.584 . . . . 0.36 110.52 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -108.41 -15.09 14.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 0.25 109.909 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.583 ' CB ' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -111.24 104.95 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.39 109.548 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -51.46 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.48 110.593 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.58 -39.35 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.4 110.209 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -55.45 -57.82 10.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.46 109.668 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.583 ' CB ' ' CB ' ' A' ' 129' ' ' MET . 2.2 mp0 -55.72 -56.75 16.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.47 109.256 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 125' ' ' TYR 0.253 5.1 t -44.47 -35.46 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.016 -1.105 . . . . 0.31 108.016 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 132' ' ' SER . 5.0 tt0 -59.47 -44.43 93.02 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.888 -1.153 . . . . 0.48 107.888 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.8 tttp -68.22 -44.0 76.71 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.581 -0.896 . . . . 0.64 108.581 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -47.96 -58.53 4.3 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.205 -0.934 . . . . 0.42 109.893 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -69.92 -51.76 30.28 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.704 -0.798 . . . . 0.34 110.701 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.623 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 10.8 tttt -64.22 -73.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 0.47 109.993 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -39.14 -60.84 0.83 Allowed 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.837 -0.539 . . . . 0.47 110.693 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.88 -37.4 8.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.665 -1.214 . . . . 0.25 108.519 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -73.23 -34.27 65.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.781 . . . . 0.35 109.217 178.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -56.36 -40.68 74.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.269 -1.011 . . . . 0.7 108.269 178.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 4.1 t -69.25 -44.58 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.893 -0.78 . . . . 0.61 108.893 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.652 ' O ' HG22 ' A' ' 148' ' ' VAL . 27.4 t-105 -54.71 -42.66 71.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.464 -0.773 . . . . 0.39 109.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 149' ' ' THR . 20.0 m -70.37 -33.41 71.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.81 . . . . 0.35 108.929 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -58.1 -36.48 72.94 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.612 -0.68 . . . . 0.36 109.457 179.267 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.827 HG23 HG22 ' A' ' 149' ' ' THR . 34.7 m -86.9 -29.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.5 110.634 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.827 HG22 HG23 ' A' ' 148' ' ' VAL . 5.2 t -153.04 135.93 9.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.869 -1.144 . . . . 0.51 110.526 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.88 58.1 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.986 1.519 . . . . 0.31 110.644 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -80.15 136.52 36.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 0.18 110.076 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 9.3 t30 -88.08 126.11 34.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.17 110.391 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.79 139.52 45.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.14 110.207 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.642 ' O ' HG22 ' A' ' 119' ' ' THR . 11.5 m -141.47 137.57 32.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.15 110.369 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.549 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.6 130.77 47.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 0.2 109.677 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.803 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -128.43 105.7 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.22 110.193 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.507 ' CD2' ' N ' ' A' ' 158' ' ' ASP . 4.7 p-80 -54.54 -33.8 60.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.32 110.075 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.602 ' OD2' HD11 ' A' ' 160' ' ' ILE . 1.3 t70 -42.25 -42.38 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.589 -0.694 . . . . 0.33 109.869 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.57 33.77 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.442 -1.463 . . . . 0.28 109.442 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.803 HD12 ' CD2' ' A' ' 156' ' ' LEU . 6.7 mt -116.15 75.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.286 -1.126 . . . . 0.3 109.631 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 120' ' ' TYR . . . -143.6 147.78 34.89 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.528 -0.732 . . . . 0.2 110.403 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.476 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.2 OUTLIER -105.67 -18.22 14.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.1 110.285 -179.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.864 HG23 ' HB3' ' A' ' 120' ' ' TYR . 1.2 tt -136.07 166.93 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.153 -0.967 . . . . 0.1 110.077 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.746 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 6.9 ptp -171.38 146.38 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.288 . . . . 0.11 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.4 tt -98.72 119.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.423 -0.798 . . . . 0.1 110.082 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.907 ' HB3' HG23 ' A' ' 123' ' ' VAL . 14.9 p -161.8 158.58 25.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.965 -1.084 . . . . 0.1 110.82 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 18.6 p90 -76.41 122.46 24.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.09 110.061 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.462 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -78.19 134.8 14.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.023 -1.231 . . . . 0.2 110.023 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 169' ' ' ILE . 1.3 tt -130.17 98.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.977 . . . . 0.55 109.702 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.4 OUTLIER 1.09 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 121.359 0.6 . . . . 0.85 112.266 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -141.52 7.0 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.71 110.215 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.411 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 12.8 m-70 -77.98 -51.61 10.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.42 110.002 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 94.65 39.38 4.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.433 -1.467 . . . . 0.33 109.433 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.24 -51.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -1.095 . . . . 0.33 110.036 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.86 159.28 16.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.27 110.135 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 14.5 m-30 -113.0 85.27 7.75 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.34 110.097 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.474 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 46.3 Cg_endo -73.69 -57.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.993 1.523 . . . . 0.47 110.386 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.61 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -57.96 135.37 56.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.35 110.698 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.483 ' N ' ' OD2' ' A' ' 204' ' ' ASP . 3.2 p30 179.97 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.206 -0.997 . . . . 0.2 111.602 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.2 -161.33 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.247 -1.141 . . . . 0.25 110.247 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.511 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.6 Cg_endo -80.11 44.01 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.086 1.572 . . . . 0.44 110.157 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.7 m -81.08 177.66 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.095 -1.003 . . . . 0.57 110.231 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.74 71.32 0.03 OUTLIER Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.892 -1.283 . . . . 0.49 109.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.731 HD23 ' OD1' ' A' ' 202' ' ' ASP . 0.7 OUTLIER 179.58 95.31 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.303 -1.116 . . . . 0.41 110.202 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.467 HD13 ' CE2' ' A' ' 214' ' ' TYR . 6.7 tt -114.0 -18.41 11.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.708 -1.245 . . . . 0.3 111.375 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . 0.934 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -151.0 105.76 3.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.493 -1.379 . . . . 0.2 112.001 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.604 ' CD2' ' HB2' ' A' ' 200' ' ' HIS . 0.5 OUTLIER -115.08 119.81 37.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.16 109.485 178.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.877 ' HB2' ' CD ' ' A' ' 223' ' ' GLU . . . -109.68 142.03 41.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.981 -1.075 . . . . 0.23 110.691 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.463 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -72.56 168.94 19.34 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.38 110.327 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 189' ' ' PHE . 46.6 Cg_endo -74.69 137.87 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.4 109.502 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.473 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.3 Cg_endo -70.8 82.1 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.85 1.447 . . . . 0.32 110.569 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 -99.72 1.29 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.396 -1.482 . . . . 0.32 109.396 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.94 -162.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 0.47 110.241 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -65.58 -11.82 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.63 109.991 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.42 60.89 0.64 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.557 -0.714 . . . . 0.53 110.058 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.476 ' O ' ' O ' ' A' ' 162' ' ' ASP . . . -134.33 177.07 19.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.559 -1.816 . . . . 0.25 108.559 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.83 25.88 0.25 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.808 -1.317 . . . . 0.1 109.808 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 196' ' ' GLY . 72.7 m-20 -79.71 91.77 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.962 -1.316 . . . . 0.1 109.898 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -67.38 111.69 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.09 110.421 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 31.2 m170 -121.6 126.43 49.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 0.09 110.2 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 203' ' ' ASP . 23.2 m-85 -98.1 137.63 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.939 -1.1 . . . . 0.1 110.674 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.731 ' OD1' HD23 ' A' ' 184' ' ' LEU . 1.1 m-20 -49.19 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.14 108.889 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.576 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 1.4 p30 -35.94 -30.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.772 . . . . 0.18 111.663 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 9.4 m-20 -79.06 2.07 21.92 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.59 -1.319 . . . . 0.24 111.245 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 29.4 mm-40 -95.95 -162.51 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.982 -1.074 . . . . 0.42 110.155 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.8 m -125.81 148.53 49.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.112 -0.992 . . . . 0.47 110.529 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.576 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.5 m-90 -142.27 142.85 32.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.267 -0.896 . . . . 0.27 109.785 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 1.028 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -155.37 174.3 15.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.954 -1.091 . . . . 0.3 110.722 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.1 t -129.27 21.97 5.66 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.649 -0.871 . . . . 0.61 108.649 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.4 OUTLIER -99.2 -81.47 0.45 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.712 0.767 . . . . 0.78 110.376 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.7 p -171.77 -35.32 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.958 -0.756 . . . . 0.91 108.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -80.06 139.81 36.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.469 -0.769 . . . . 0.93 109.538 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.04 -154.96 32.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.935 -1.666 . . . . 0.79 108.935 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.491 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 60.0 m-85 -93.77 117.25 29.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.243 . . . . 0.69 109.555 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.62 ' O ' HG12 ' A' ' 219' ' ' VAL . 46.9 m-80 -81.4 122.4 27.44 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.946 -1.096 . . . . 0.4 109.028 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 1.028 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -42.28 -37.42 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.17 109.937 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 2.3 m-30 -51.98 -48.74 64.23 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.423 -1.325 . . . . 0.28 107.423 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -73.34 -73.57 0.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.819 -0.628 . . . . 0.46 109.906 178.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.6 OUTLIER -47.77 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.39 110.043 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -41.61 -51.28 4.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.735 -1.228 . . . . 0.17 111.484 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.91 -33.51 71.96 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.249 -1.532 . . . . 0.1 109.045 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.638 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.3 t60 -71.63 -58.6 3.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.311 0.577 . . . . 0.21 109.564 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.934 ' CG ' ' HB1' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -55.87 -25.04 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.62 -0.882 . . . . 0.28 108.62 178.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.7 m-30 -72.11 -67.65 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.6 0.714 . . . . 0.18 109.261 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.43 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.98 -27.25 0.99 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.646 -1.782 . . . . 0.21 108.646 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.836 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -80.98 -58.41 3.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -1.085 . . . . 0.17 110.348 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.772 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.4 OUTLIER -47.74 -45.39 28.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.668 -0.645 . . . . 0.33 111.794 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.862 HD11 HD22 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -100.54 -38.15 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.02 . . . . 0.53 111.044 -178.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -63.96 -77.2 0.24 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.043 -1.223 . . . . 0.41 110.043 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 0.63 HD11 ' O ' ' A' ' 232' ' ' HIS . 1.7 pt? -177.14 -162.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.187 . . . . 0.45 110.488 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.5 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.2 OUTLIER -62.5 -54.6 37.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.62 109.904 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.836 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 2.2 m80 -163.71 178.26 8.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.45 110.379 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 2.5 t 179.59 60.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.38 109.122 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.881 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -144.61 22.13 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.589 -0.844 . . . . 0.48 111.174 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.525 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -37.12 -49.13 2.19 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.759 -0.776 . . . . 0.38 110.775 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 47.1 Cg_endo -89.41 -46.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.738 1.389 . . . . 0.28 111.586 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.66 98.88 0.12 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 118.971 -1.585 . . . . 0.24 111.91 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.881 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -149.22 165.5 31.69 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.39 -1.065 . . . . 0.28 110.012 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.617 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -79.32 55.63 1.93 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.4 108.837 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.638 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 14.0 mtt -137.96 -24.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.81 . . . . 0.45 110.998 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -60.05 171.35 0.93 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.7 -1.25 . . . . 0.57 109.962 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.8 Cg_endo -69.48 -4.69 14.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.377 1.198 . . . . 0.76 110.128 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 10.2 mm -100.43 148.47 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.89 109.689 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.817 ' HB2' HD21 ' A' ' 218' ' ' LEU . 35.0 p90 -133.35 -27.46 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.095 -1.003 . . . . 0.78 111.174 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.729 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 3.27 -69.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.642 0.978 . . . . 0.61 113.642 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.729 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -66.32 129.82 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.348 -1.47 . . . . 0.74 109.676 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -161.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.81 110.202 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.474 ' O ' ' CG ' ' A' ' 249' ' ' LYS . . . -86.93 10.89 66.39 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.427 -1.469 . . . . 0.56 109.427 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -177.59 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.37 110.37 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -32.88 73.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 0.44 110.167 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.79 -88.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.53 110.174 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -164.18 92.59 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 0.38 110.387 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.762 ' HB2' HG21 ' A' ' 259' ' ' VAL . 3.1 ptt? 36.09 47.77 0.48 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.544 -0.722 . . . . 0.19 111.596 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.704 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.9 tp -47.65 -44.69 56.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.862 -1.135 . . . . 0.28 107.958 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -73.1 49.62 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.646 1.34 . . . . 0.49 111.055 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.604 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.6 m-20 -47.48 -32.41 5.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.754 -1.216 . . . . 0.49 110.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.875 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -55.57 -49.81 71.72 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.131 -0.981 . . . . 0.31 109.821 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 1.011 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.66 -32.08 63.8 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.448 -0.901 . . . . 0.14 108.615 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 253' ' ' MET . 71.1 t -66.72 -82.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.17 110.061 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.0 tt0 -55.92 -40.9 73.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.306 -0.871 . . . . 0.26 109.247 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.29 -70.65 0.45 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.113 -1.195 . . . . 0.19 110.113 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 1.011 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -74.24 -21.01 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.952 -1.322 . . . . 0.22 110.342 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 1.006 ' N ' HD13 ' A' ' 262' ' ' ILE . 47.7 tt0 -64.05 -20.36 65.88 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.904 -1.118 . . . . 0.39 108.422 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 18.8 t -103.42 -42.45 5.7 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.249 -0.58 . . . . 0.47 111.347 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.867 HD23 ' CD ' ' A' ' 112' ' ' LYS . 4.2 mp -87.32 -45.64 10.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.141 -0.974 . . . . 0.48 111.202 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.655 ' OH ' HD12 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -79.08 -5.11 53.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.41 109.948 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.65 -72.28 0.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.608 -1.397 . . . . 0.46 109.608 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -86.9 142.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.987 1.52 . . . . 0.58 110.761 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.556 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -105.46 121.76 6.95 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.498 -1.441 . . . . 0.64 109.498 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.616 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER . . . . . 0 N--CA 1.489 1.504 0 O-C-N 121.107 -1.231 . . . . 0.95 110.149 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' THR . . . . . 0.679 HG22 ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 CA-C-O 121.482 0.658 . . . . 1.03 111.488 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' CG ' ' A' ' 191' ' ' PRO . 0.7 OUTLIER 40.73 48.49 2.65 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.268 -0.895 . . . . 1.04 111.471 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.679 ' HE2' HG22 ' A' ' 110' ' ' THR . 4.1 pttt -146.82 79.07 1.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.77 109.113 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TRP . . . . . 0.616 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 7.6 t90 -143.89 -70.1 0.31 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.42 111.398 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 93.6 p -96.95 63.0 1.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.44 111.015 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 114' ' ' SER . 14.2 mttm -159.59 53.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.49 110.082 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' MET . . . . . 0.464 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -60.79 -19.89 60.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.3 110.408 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -138.34 156.2 47.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.15 110.446 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -166.09 -174.61 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.13 110.127 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' THR . . . . . 0.88 HG22 ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -128.47 149.26 50.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.181 -0.949 . . . . 0.12 110.11 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' TYR . . . . . 0.663 ' HB3' HG23 ' A' ' 163' ' ' ILE . 23.1 p90 -149.87 165.12 33.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -0.922 . . . . 0.33 111.18 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.2 OUTLIER -118.08 150.91 38.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.54 109.89 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ILE . . . . . 0.897 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -115.65 124.76 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.886 . . . . 0.33 110.543 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -168.76 43.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.27 109.932 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.3 t-20 -40.79 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.41 109.501 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TYR . . . . . 0.685 ' O ' HG21 ' A' ' 134' ' ' VAL . 3.7 t80 -179.35 -164.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.4 109.553 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 130' ' ' THR . 1.8 m -148.12 46.78 0.48 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.913 -1.117 . . . . 0.45 110.864 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -74.03 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.896 1.472 . . . . 0.36 110.109 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.26 -4.46 58.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.955 . . . . 0.25 109.689 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' MET . . . . . 0.781 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.2 ptm -122.85 171.87 8.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.39 110.107 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' THR . . . . . 0.592 ' HA ' HG23 ' A' ' 126' ' ' THR . 0.2 OUTLIER -119.66 171.63 8.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.48 109.768 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -45.74 -28.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.036 -1.04 . . . . 0.4 109.715 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -67.31 -58.28 5.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.46 109.464 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.4 mp0 -55.82 -55.32 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.24 -0.913 . . . . 0.47 108.775 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.9 t -46.19 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.826 -1.176 . . . . 0.31 107.826 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' GLU . . . . . 0.579 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 8.1 tt0 -59.37 -42.48 91.73 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.782 -1.192 . . . . 0.48 107.782 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.575 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 23.4 tttt -70.65 -47.59 59.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.185 0.993 . . . . 0.64 108.456 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.872 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -49.26 -62.22 1.66 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.566 -0.709 . . . . 0.42 110.217 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.636 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -66.89 -52.51 42.45 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.41 -0.806 . . . . 0.34 110.842 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' LYS . . . . . 0.636 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 1.0 OUTLIER -64.52 -72.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.976 -1.077 . . . . 0.47 110.555 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' LYS . . . . . 0.557 ' HD3' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -41.5 -58.68 1.83 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.581 -0.699 . . . . 0.47 110.383 179.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.81 -35.4 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.564 -1.254 . . . . 0.25 108.351 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.63 -39.35 64.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.443 -0.786 . . . . 0.35 109.117 178.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -56.03 -38.82 71.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.08 -1.012 . . . . 0.7 108.455 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.9 t -68.92 -45.28 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.112 -0.699 . . . . 0.61 109.112 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' TRP . . . . . 0.866 ' HH2' HG21 ' A' ' 262' ' ' ILE . 50.4 t-105 -57.11 -35.31 69.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.39 108.895 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.7 m -75.73 -39.64 56.94 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.327 -0.858 . . . . 0.35 108.788 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -40.74 72.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.36 109.51 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 149' ' ' THR . 27.6 m -75.78 -33.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.5 109.781 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 145' ' ' TRP . 9.9 t -147.2 147.33 28.44 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.168 -0.958 . . . . 0.51 110.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.67 58.69 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.948 1.499 . . . . 0.31 110.222 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 152' ' ' ASN . 1.4 tm? -84.0 139.46 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.18 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ASN . . . . . 0.946 ' N ' HD13 ' A' ' 151' ' ' LEU . 1.2 m-20 -104.26 139.2 39.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.17 110.118 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' PHE . . . . . 0.59 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 2.1 p90 -151.24 155.95 39.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.14 110.593 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' THR . . . . . 0.88 ' O ' HG22 ' A' ' 119' ' ' THR . 7.3 m -152.9 131.05 11.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.406 -0.809 . . . . 0.15 109.943 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ARG . . . . . 0.572 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 5.2 mtm180 -96.62 82.47 3.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.2 110.595 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.673 HD23 HD13 ' A' ' 160' ' ' ILE . 1.6 mp -74.98 83.34 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.155 -0.965 . . . . 0.22 109.71 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.7 p-80 -42.82 -26.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.32 110.16 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -41.14 -37.87 0.97 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.616 -0.677 . . . . 0.33 109.768 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.38 33.71 0.3 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.879 -1.288 . . . . 0.28 109.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ILE . . . . . 0.673 HD13 HD23 ' A' ' 156' ' ' LEU . 2.7 mp -127.83 65.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -1.223 . . . . 0.3 109.507 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ALA . . . . . 0.503 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -122.36 144.38 49.06 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.232 -0.587 . . . . 0.2 110.364 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' ASP . . . . . 0.457 ' O ' ' O ' ' A' ' 196' ' ' GLY . 0.7 OUTLIER -107.6 -36.54 6.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.885 . . . . 0.1 110.205 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 227' ' ' SER . 0.4 OUTLIER -127.57 156.87 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.132 -0.98 . . . . 0.1 110.001 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' MET . . . . . 0.818 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 13.7 ptm -163.94 160.45 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.42 -1.425 . . . . 0.11 111.564 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . 0.671 ' O ' HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -106.75 119.41 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.46 -0.775 . . . . 0.1 109.985 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' SER . . . . . 0.872 ' HB3' HG23 ' A' ' 123' ' ' VAL . 11.6 p -158.68 146.01 17.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.1 110.389 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' PHE . . . . . 0.599 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 10.4 p90 -66.34 114.24 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.09 109.667 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -73.49 119.81 6.74 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.225 -1.15 . . . . 0.2 110.225 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -110.05 103.25 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.48 -1.012 . . . . 0.55 109.311 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 2.0 tmtt? 1.26 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.32 0.581 . . . . 0.85 112.317 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 1.9 tm-20 -137.17 5.21 2.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.71 110.218 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -87.14 -87.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.978 . . . . 0.42 110.284 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 134.13 -34.86 2.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.165 -1.574 . . . . 0.33 109.165 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.53 -31.25 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 0.33 110.153 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' PHE . . . . . 0.419 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 2.4 t80 -172.52 116.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.27 110.183 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.3 m-30 -47.14 105.72 0.51 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34 110.192 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.2 Cg_endo -74.18 -61.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.902 1.475 . . . . 0.47 110.422 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -55.23 144.49 24.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.35 110.64 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 182' ' ' SER . 2.7 p30 179.12 80.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.396 -0.815 . . . . 0.2 110.093 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.82 -154.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.335 -1.506 . . . . 0.25 109.335 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 182' ' ' SER . 53.3 Cg_endo -79.63 11.29 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.994 1.523 . . . . 0.44 110.393 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 0.8 OUTLIER -45.28 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.57 110.669 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -64.71 72.34 0.07 OUTLIER Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.795 -0.922 . . . . 0.49 110.795 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' LEU . . . . . 0.862 HD22 ' OD1' ' A' ' 202' ' ' ASP . 4.4 tt 179.52 92.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.191 -1.182 . . . . 0.41 110.322 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 205' ' ' GLU . 4.1 tt -110.15 -23.84 11.05 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.561 -1.256 . . . . 0.3 111.471 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' ALA . . . . . . . . . . . . . . . -150.9 103.3 3.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.521 -1.362 . . . . 0.2 112.065 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 1.5 p80 -103.0 141.12 36.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.103 . . . . 0.16 109.683 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' ALA . . . . . 0.943 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -123.78 128.04 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.23 110.478 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -75.25 169.78 18.78 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.38 110.337 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' PRO . . . . . 0.496 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.8 Cg_endo -75.08 134.51 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.119 1.589 . . . . 0.4 109.792 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' PRO . . . . . 0.705 ' CG ' HD23 ' A' ' 111' ' ' LEU . 43.9 Cg_endo -70.62 73.53 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.962 1.506 . . . . 0.32 110.431 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.87 -98.09 2.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.632 -1.387 . . . . 0.32 109.632 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.04 -161.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.988 1.52 . . . . 0.47 110.045 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -67.75 -9.41 43.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 0.63 110.237 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.53 55.86 0.64 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.387 -0.821 . . . . 0.53 110.23 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.07 174.87 19.41 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.185 -1.566 . . . . 0.25 109.185 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 43.55 24.63 0.43 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.971 -1.252 . . . . 0.1 109.971 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.1 OUTLIER -78.18 92.02 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -1.22 . . . . 0.1 110.604 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -73.36 99.47 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.09 109.779 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' HIS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.9 m170 -112.58 138.59 49.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.09 110.388 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 203' ' ' ASP . 25.8 m-85 -105.74 137.52 43.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.1 110.526 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ASP . . . . . 0.862 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -49.47 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.092 -1.077 . . . . 0.14 108.092 178.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.5 p30 -36.07 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.1 -0.64 . . . . 0.18 111.967 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 202' ' ' ASP . 32.0 m-20 -80.58 6.36 12.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.739 -1.225 . . . . 0.24 111.006 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 185' ' ' LEU . 16.8 mm-40 -97.91 -167.07 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.922 -1.111 . . . . 0.42 110.226 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.0 143.86 50.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.47 110.446 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' TRP . . . . . 0.524 ' HB3' HD11 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -143.17 131.38 21.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.93 . . . . 0.27 109.409 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' THR . . . . . 0.974 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -145.08 170.5 16.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.832 -1.167 . . . . 0.3 111.114 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' SER . . . . . 0.631 ' HB2' HD23 ' A' ' 216' ' ' LEU . 17.4 t -130.92 26.71 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.81 0.814 . . . . 0.61 108.956 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -89.09 -93.53 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.752 -0.592 . . . . 0.78 110.272 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -155.41 18.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.91 110.156 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.64 -176.3 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.93 110.221 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.8 -172.24 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.256 -1.537 . . . . 0.79 109.256 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 244' ' ' TYR . 75.6 m-85 -68.22 101.68 1.22 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -1.222 . . . . 0.69 109.734 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' ASN . . . . . 0.596 ' ND2' HG23 ' A' ' 247' ' ' THR . 64.8 m-80 -76.1 117.77 18.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.047 -1.033 . . . . 0.4 108.857 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' LEU . . . . . 0.974 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -40.17 -36.73 0.54 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.716 . . . . 0.17 110.528 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' PHE . . . . . 0.575 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.3 m-85 -49.45 -49.79 43.75 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.335 -1.346 . . . . 0.28 107.736 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' LEU . . . . . 0.55 HD12 HD11 ' A' ' 239' ' ' LEU . 47.5 tp -76.83 -68.64 0.58 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.7 -0.682 . . . . 0.46 110.778 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' VAL . . . . . 0.95 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -50.89 -66.69 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.39 109.718 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -44.25 -49.69 9.18 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.727 -1.233 . . . . 0.17 110.653 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -64.73 -23.1 67.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.535 -1.353 . . . . 0.1 109.194 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.621 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.0 t60 -79.97 -55.7 4.78 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.186 0.517 . . . . 0.21 109.778 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' GLU . . . . . 0.773 ' OE1' ' HB1' ' A' ' 199' ' ' ALA . 29.1 tt0 -58.75 -43.65 90.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.127 -0.983 . . . . 0.28 108.71 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 2.7 m-85 -58.42 -60.36 3.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.86 . . . . 0.18 109.46 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -31.33 1.94 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.18 -1.568 . . . . 0.21 109.18 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' HIS . . . . . 0.517 ' CE1' ' CG ' ' A' ' 240' ' ' MET . 1.4 m80 -78.58 -74.77 0.26 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.107 -1.231 . . . . 0.17 110.679 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' SER . . . . . 0.972 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -41.18 -36.67 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.385 0.513 . . . . 0.33 112.385 -178.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' LEU . . . . . 0.682 ' HB2' HD13 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -101.39 -35.06 9.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.81 -1.181 . . . . 0.53 112.172 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -85.36 -87.52 0.94 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.97 -1.081 . . . . 0.41 111.442 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' LEU . . . . . 1.064 ' O ' HD13 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -154.27 156.01 36.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -1.127 . . . . 0.45 110.483 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.897 ' N ' HD22 ' A' ' 230' ' ' LEU . 1.3 m-20 -37.08 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.349 -0.844 . . . . 0.62 110.98 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' HIS . . . . . 0.747 ' O ' HD21 ' A' ' 230' ' ' LEU . 6.3 m80 -143.12 161.39 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.247 -0.908 . . . . 0.45 110.588 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' HD11 ' A' ' 230' ' ' LEU . 1.0 OUTLIER -165.67 35.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.38 109.937 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' LYS . . . . . 0.61 ' CA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -103.23 20.48 17.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.48 110.624 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' ASP . . . . . 0.611 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -41.36 -60.15 1.95 Allowed Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.291 -0.964 . . . . 0.38 109.299 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 54.7 Cg_endo -81.07 -50.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.666 1.351 . . . . 0.28 109.742 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.37 93.49 0.09 OUTLIER Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.788 -1.196 . . . . 0.24 111.36 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' ALA . . . . . 0.878 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -137.48 162.76 32.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.929 -1.336 . . . . 0.28 110.12 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' LEU . . . . . 0.586 ' N ' ' HB2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -73.22 57.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.195 -0.941 . . . . 0.4 109.275 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' MET . . . . . 0.621 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.0 OUTLIER -140.37 -31.04 0.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.45 110.687 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' PHE . . . . . 0.552 ' HB3' ' HG3' ' A' ' 234' ' ' LYS . 0.1 OUTLIER -42.0 167.22 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.57 110.553 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.23 -5.6 17.19 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.965 1.508 . . . . 0.76 109.605 179.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' ILE . . . . . 0.753 HG22 HG22 ' A' ' 245' ' ' THR . 19.4 mt -102.78 145.67 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.89 109.812 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' TYR . . . . . 0.552 ' O ' ' N ' ' A' ' 246' ' ' TYR . 45.8 p90 -128.65 -31.73 2.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.78 110.419 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' THR . . . . . 0.753 HG22 HG22 ' A' ' 243' ' ' ILE . 0.4 OUTLIER 2.17 -67.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.571 0.952 . . . . 0.61 113.571 -179.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' TYR . . . . . 0.745 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -59.4 101.99 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.478 -1.389 . . . . 0.74 109.415 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.596 HG23 ' ND2' ' A' ' 215' ' ' ASN . 1.4 m -47.98 178.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.763 . . . . 0.81 110.475 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 247' ' ' THR . . . -52.1 -20.36 6.56 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.938 -1.265 . . . . 0.56 109.938 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.26 31.35 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.083 -1.245 . . . . 0.37 110.639 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' SER . . . . . 0.526 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.2 OUTLIER -49.65 -47.35 49.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 0.44 109.876 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -47.65 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.53 110.022 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.46 -178.19 0.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.38 110.494 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' MET . . . . . 0.881 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -68.32 55.52 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.19 110.595 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.727 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.8 tp -43.99 -47.61 22.29 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.061 -1.088 . . . . 0.28 108.061 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -71.1 48.52 0.89 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.054 1.555 . . . . 0.49 111.279 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ASP . . . . . 0.644 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.4 m-20 -52.64 -28.78 22.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.882 -1.136 . . . . 0.49 111.191 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' ASP . . . . . 0.878 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.58 -52.67 62.97 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.875 -1.13 . . . . 0.31 109.523 -178.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ASP . . . . . 0.94 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.22 -32.29 68.62 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.203 -0.999 . . . . 0.14 108.947 179.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 253' ' ' MET . 61.1 t -64.02 -82.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.807 -0.757 . . . . 0.17 110.054 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' GLN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.8 tt0 -55.59 -42.43 74.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 0.26 108.951 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -38.95 -72.4 0.21 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' ILE . . . . . 0.94 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -72.33 -22.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.34 . . . . 0.22 110.082 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLN . . . . . 0.829 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.8 OUTLIER -57.25 -24.84 57.4 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.843 -1.143 . . . . 0.39 108.424 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.0 -37.44 7.37 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.146 -0.622 . . . . 0.47 111.507 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' LEU . . . . . 0.488 ' N ' HD22 ' A' ' 265' ' ' LEU . 4.5 mm? -83.15 -47.98 11.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.48 111.951 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -82.74 -9.94 59.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.41 110.691 -179.136 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -54.62 -97.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.009 -1.636 . . . . 0.46 109.009 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.05 116.75 4.67 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.097 1.577 . . . . 0.58 110.246 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -67.33 134.92 31.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.749 -1.34 . . . . 0.64 109.749 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 270' ' ' ASP . . . . . 0.616 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.95 110.037 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 N--CA 1.491 1.6 0 CA-C-O 121.206 0.527 . . . . 0.41 110.18 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.591 ' O ' HG23 ' A' ' 106' ' ' VAL . 13.8 p30 -150.31 136.2 18.45 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.323 -0.861 . . . . 0.26 110.324 -179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.61 HG12 ' N ' ' A' ' 107' ' ' PHE . 54.9 t -156.5 -90.84 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.339 -0.851 . . . . 0.33 110.0 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.61 ' N ' HG12 ' A' ' 106' ' ' VAL . 1.7 m-85 -92.37 114.22 61.64 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.288 -0.883 . . . . 0.65 109.949 179.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.479 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 44.9 Cg_endo -72.18 67.45 3.4 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.877 1.461 . . . . 0.84 110.672 -179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.811 ' C ' HD13 ' A' ' 230' ' ' LEU . 1.2 mtt180 -148.64 95.14 2.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.193 -0.942 . . . . 0.93 110.153 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.965 ' N ' HD13 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -171.63 -60.65 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.45 -0.781 . . . . 1.03 109.727 179.872 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.507 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 6.3 tp 39.41 30.5 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.396 -0.815 . . . . 1.04 111.178 179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.74 ' HB3' HD12 ' A' ' 265' ' ' LEU . 0.3 OUTLIER -118.4 88.75 2.98 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.064 -1.023 . . . . 0.77 109.776 179.625 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.611 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 13.4 t90 -153.52 -65.58 0.15 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.169 -0.957 . . . . 0.42 111.069 -179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.518 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 17.8 t -105.02 59.97 0.68 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.165 -0.96 . . . . 0.44 111.207 -179.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.47 ' HG2' ' O ' ' A' ' 114' ' ' SER . 10.9 mmtm -154.57 53.45 0.66 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.035 -1.041 . . . . 0.49 110.379 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.482 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 59.2 ttp -72.97 -15.67 61.54 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.227 -0.92 . . . . 0.3 110.393 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.434 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 15.3 p-10 -142.78 140.42 31.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.23 -0.919 . . . . 0.15 110.416 179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' HA ' HD12 ' A' ' 118' ' ' LEU . 12.8 tp -158.23 166.39 32.51 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.379 -0.826 . . . . 0.13 109.841 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.857 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -107.57 162.94 13.5 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.126 -0.983 . . . . 0.12 110.081 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.613 ' HB3' HG23 ' A' ' 163' ' ' ILE . 36.5 p90 -157.63 164.02 37.65 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 119.376 -0.93 . . . . 0.33 110.887 179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -119.24 146.46 45.2 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.422 -0.799 . . . . 0.54 110.301 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.766 ' O ' HG13 ' A' ' 123' ' ' VAL . 4.2 pt -106.31 117.46 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.455 -0.778 . . . . 0.33 110.574 -179.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.998 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.9 m -162.82 42.17 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.155 -0.966 . . . . 0.27 110.04 179.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.535 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 11.3 t-20 -40.63 -81.67 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.79 -0.764 . . . . 0.41 109.311 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 7.8 t80 -178.92 178.46 0.76 Allowed 'General case' 0 C--N 1.3 -1.576 0 O-C-N 121.409 -0.807 . . . . 0.4 109.78 178.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.559 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -130.56 51.08 6.9 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.193 -0.942 . . . . 0.45 110.126 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.559 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -75.85 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 124.125 1.592 . . . . 0.36 110.639 179.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -99.58 -2.09 36.58 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.39 -0.819 . . . . 0.25 109.938 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.577 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -110.47 168.76 9.21 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.419 -0.8 . . . . 0.39 109.879 -179.982 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.48 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -116.97 169.08 9.68 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.207 -0.933 . . . . 0.48 110.25 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 2.3 t-80 -43.28 -32.96 0.87 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.298 -0.876 . . . . 0.4 109.803 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 57.9 m -67.98 -47.93 67.21 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.287 -0.883 . . . . 0.46 109.84 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.577 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 9.5 mp0 -63.07 -58.83 5.95 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.137 -0.977 . . . . 0.47 109.745 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 125' ' ' TYR . 10.9 t -45.68 -36.93 2.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.042 -1.096 . . . . 0.31 108.042 178.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.4 tt0 -57.84 -42.06 83.63 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 108.096 -1.076 . . . . 0.48 108.096 178.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.534 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 5.9 tttt -72.53 -51.1 21.36 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 119.448 -0.901 . . . . 0.64 108.732 178.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.865 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -44.92 -60.08 2.24 Favored 'General case' 0 C--N 1.291 -1.978 0 O-C-N 121.137 -0.977 . . . . 0.42 110.223 179.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.745 ' CE2' HD12 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -67.47 -52.82 34.8 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.366 -0.834 . . . . 0.34 110.974 -179.261 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.07 -71.67 0.19 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.931 -1.105 . . . . 0.47 110.159 -179.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.534 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtp? -39.49 -61.29 0.82 Allowed 'General case' 0 C--N 1.29 -2.008 0 O-C-N 121.809 -0.557 . . . . 0.47 110.508 178.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.41 -37.16 10.93 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.693 -1.254 . . . . 0.25 108.305 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.581 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.2 -36.67 74.77 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.743 -0.836 . . . . 0.35 108.743 178.536 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.447 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttmm -58.03 -41.39 83.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.228 -0.92 . . . . 0.7 108.923 179.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 54.5 t -69.79 -48.42 64.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.592 -0.692 . . . . 0.61 109.4 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.615 ' CH2' HG13 ' A' ' 262' ' ' ILE . 57.0 t-105 -55.01 -38.05 67.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.39 -0.819 . . . . 0.39 109.157 179.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -73.5 -34.0 65.07 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.305 -0.872 . . . . 0.35 108.936 178.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -58.52 -44.18 89.45 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.531 -0.731 . . . . 0.36 109.251 179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.592 HG22 ' O ' ' A' ' 145' ' ' TRP . 26.9 m -72.93 -32.2 38.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 C-N-CA 119.634 -0.826 . . . . 0.5 109.753 179.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 146' ' ' SER . 15.3 t -152.0 134.18 8.54 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.121 -0.987 . . . . 0.51 110.399 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.3 Cg_endo -71.29 59.83 2.48 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.951 1.501 . . . . 0.31 110.158 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.529 ' O ' ' CD2' ' A' ' 153' ' ' PHE . 0.2 OUTLIER -76.72 136.04 39.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.18 110.414 -179.849 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.437 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.7 OUTLIER -82.35 120.45 25.43 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.17 109.92 179.723 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.561 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.5 p90 -131.6 133.99 45.56 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.238 -0.914 . . . . 0.14 110.521 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.857 ' O ' HG22 ' A' ' 119' ' ' THR . 6.3 m -140.02 128.9 23.34 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.364 -0.835 . . . . 0.15 110.11 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.698 HH12 HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -96.67 81.85 3.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.316 -0.865 . . . . 0.2 109.972 -179.752 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.627 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -82.26 89.1 6.51 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.094 -1.004 . . . . 0.22 110.109 -179.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.465 ' CD2' ' N ' ' A' ' 158' ' ' ASP . 5.1 p-80 -48.45 -24.43 1.27 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.228 -0.92 . . . . 0.32 109.963 -179.842 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.465 ' N ' ' CD2' ' A' ' 157' ' ' HIS . 3.0 t70 -42.29 -27.96 0.17 Allowed 'General case' 0 C--N 1.301 -1.526 0 O-C-N 121.497 -0.752 . . . . 0.33 109.811 179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 124.55 26.33 1.46 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.72 -1.352 . . . . 0.28 109.72 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.627 HD12 ' CD2' ' A' ' 156' ' ' LEU . 51.7 mt -119.85 70.93 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.134 -1.215 . . . . 0.3 109.725 179.664 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.483 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -124.35 143.48 50.56 Favored 'General case' 0 C--N 1.3 -1.553 0 C-N-CA 120.15 -0.62 . . . . 0.2 110.598 -179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.441 ' CG ' HD21 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -108.1 -43.78 4.32 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.385 -0.822 . . . . 0.1 109.965 179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.866 HD12 ' HB2' ' A' ' 227' ' ' SER . 1.0 OUTLIER -119.86 156.56 22.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 121.259 -0.901 . . . . 0.1 109.84 179.851 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.941 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.1 ptt? -156.85 153.01 27.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.515 -1.365 . . . . 0.11 111.602 -179.409 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 165' ' ' ILE . 4.1 tt -101.24 116.69 45.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.756 0 O-C-N 121.5 -0.75 . . . . 0.1 109.316 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.998 ' HB3' HG23 ' A' ' 123' ' ' VAL . 12.9 p -162.64 148.64 12.56 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.578 -1.326 . . . . 0.1 111.364 -179.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.571 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.3 p90 -67.79 117.15 9.3 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.383 -0.823 . . . . 0.09 109.411 179.392 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -75.38 142.76 29.63 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 110.91 -0.876 . . . . 0.2 110.91 -178.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.821 HD13 ' N ' ' A' ' 169' ' ' ILE . 0.1 OUTLIER -134.54 98.88 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.456 0 O-C-N 121.754 -0.851 . . . . 0.55 109.124 178.959 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.583 ' C ' ' O ' ' A' ' 169' ' ' ILE . 11.7 tmtt? 1.08 93.79 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 121.375 0.607 . . . . 0.85 112.428 -179.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.454 ' O ' ' HG2' ' A' ' 171' ' ' GLU . 14.3 tt0 -146.16 23.53 1.33 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.326 -0.859 . . . . 0.71 110.11 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.433 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 12.1 m170 -96.89 -67.15 0.86 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.255 -0.903 . . . . 0.42 110.267 -179.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 124.6 5.96 6.86 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.649 -1.38 . . . . 0.33 109.649 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 68.3 m-20 -121.51 -82.62 0.65 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.116 -1.226 . . . . 0.33 110.217 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.476 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 65.3 m-85 -102.48 154.6 18.94 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.217 -0.927 . . . . 0.27 110.016 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.589 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.2 m-30 -96.56 105.74 24.94 Favored Pre-proline 0 N--CA 1.492 1.636 0 O-C-N 121.178 -0.951 . . . . 0.34 110.039 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 43.7 Cg_endo -73.17 -66.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.929 1.489 . . . . 0.47 110.823 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.566 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -49.47 135.39 18.03 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.167 -0.958 . . . . 0.35 110.634 -179.774 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.493 ' O ' ' HB2' ' A' ' 182' ' ' SER . 7.6 p30 179.56 83.0 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.241 -0.912 . . . . 0.2 110.398 179.287 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.496 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.47 -156.59 0.06 OUTLIER Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.688 -1.365 . . . . 0.25 109.688 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.474 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.6 Cg_endo -76.45 6.35 4.07 Favored 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 124.123 1.591 . . . . 0.44 110.308 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.493 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 1.5 t -41.06 165.57 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.322 -0.861 . . . . 0.57 110.738 -179.895 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.545 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.62 76.18 0.03 OUTLIER Glycine 0 N--CA 1.489 2.212 0 N-CA-C 110.536 -1.025 . . . . 0.49 110.536 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.984 ' HA ' HG13 ' A' ' 1' ' ' HAV . 3.3 tt 179.78 89.28 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 O-C-N 121.358 -1.084 . . . . 0.41 110.058 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.596 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 1.3 tt -106.2 -21.66 13.05 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.787 -1.196 . . . . 0.3 111.533 -179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.619 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.59 108.86 3.39 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 120.473 -1.392 . . . . 0.2 112.247 -179.549 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.514 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.1 OUTLIER -106.48 125.74 51.38 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.343 -0.848 . . . . 0.16 109.73 179.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.826 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -115.54 150.62 36.29 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.16 -0.963 . . . . 0.23 110.613 -179.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.433 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.6 m-30 -107.53 165.33 12.99 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.2 -0.937 . . . . 0.38 110.471 179.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.533 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 43.4 Cg_endo -71.18 137.81 32.11 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 124.012 1.532 . . . . 0.4 109.901 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 41.2 Cg_endo -67.53 74.5 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.041 1.548 . . . . 0.32 110.807 -179.271 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.62 -92.66 1.97 Allowed Glycine 0 N--CA 1.49 2.283 0 N-CA-C 108.913 -1.675 . . . . 0.32 108.913 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.37 -159.99 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 124.001 1.527 . . . . 0.47 110.17 179.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -76.32 2.63 12.86 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.143 -0.973 . . . . 0.63 110.489 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.9 15.71 19.66 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.287 -0.883 . . . . 0.53 110.094 -179.794 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.533 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -86.55 167.0 38.42 Favored Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.438 -1.465 . . . . 0.25 109.438 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 45.93 24.23 1.29 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 109.354 -1.499 . . . . 0.1 109.354 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -76.76 93.83 3.75 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.147 -1.208 . . . . 0.1 110.192 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -75.74 105.13 6.6 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.121 -0.987 . . . . 0.09 109.925 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.508 ' HA ' ' O ' ' A' ' 166' ' ' SER . 10.3 m170 -119.24 122.18 41.36 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.322 -0.861 . . . . 0.09 110.237 -179.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.545 ' O ' ' N ' ' A' ' 203' ' ' ASP . 29.7 m-85 -92.77 138.73 31.23 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.281 -0.887 . . . . 0.1 110.455 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.848 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.9 OUTLIER -48.78 92.78 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.331 0 O-C-N 121.282 -0.886 . . . . 0.14 108.789 178.993 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -36.33 -27.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 C-N-CA 119.901 -0.72 . . . . 0.18 111.694 -178.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.543 ' N ' ' O ' ' A' ' 202' ' ' ASP . 66.2 m-20 -77.62 2.08 17.72 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.812 -1.18 . . . . 0.24 111.075 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.517 ' N ' ' O ' ' A' ' 202' ' ' ASP . 28.6 mm-40 -97.32 -170.78 2.07 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.997 -1.065 . . . . 0.42 110.548 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.414 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 96.5 m -121.37 146.52 46.79 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.265 -0.897 . . . . 0.47 110.367 -179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.6 ' C ' HG22 ' A' ' 208' ' ' THR . 0.9 OUTLIER -145.05 145.42 31.46 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.28 -0.887 . . . . 0.27 109.663 179.932 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.999 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -163.7 -177.97 5.48 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 120.877 -1.139 . . . . 0.3 111.159 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.478 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.2 t -125.54 30.26 5.8 Favored 'General case' 0 C--N 1.299 -1.596 0 CA-C-O 121.72 0.772 . . . . 0.61 108.999 178.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.475 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -126.93 -175.69 3.49 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.569 -0.707 . . . . 0.78 110.375 -179.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.475 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -82.38 61.32 5.5 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.299 -0.876 . . . . 0.91 110.135 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.451 ' HG2' ' OG ' ' A' ' 210' ' ' SER . 3.5 pttt -170.0 106.26 0.34 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.168 -0.957 . . . . 0.93 110.157 -179.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 96.16 -162.47 22.81 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.363 -1.495 . . . . 0.79 109.363 -179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.596 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 83.7 m-85 -81.56 127.33 32.74 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.194 -1.18 . . . . 0.69 109.986 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.599 ' O ' HG12 ' A' ' 219' ' ' VAL . 16.5 m-80 -89.25 119.25 29.57 Favored 'General case' 0 C--N 1.304 -1.403 0 O-C-N 121.095 -1.003 . . . . 0.4 108.939 179.248 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 208' ' ' THR . 0.6 OUTLIER -41.39 -36.59 0.86 Allowed 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 119.515 -0.874 . . . . 0.17 110.214 -179.527 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 5.0 m-85 -52.55 -47.04 67.01 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 107.468 -1.308 . . . . 0.28 107.468 179.203 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.013 HD21 ' HB2' ' A' ' 244' ' ' TYR . 11.5 tp -78.5 -72.1 0.39 Allowed 'General case' 0 C--N 1.296 -1.729 0 CA-C-N 115.617 -0.72 . . . . 0.46 110.835 179.204 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.822 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -46.8 -61.1 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 120.936 -1.103 . . . . 0.39 110.23 -179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.924 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -54.35 -52.86 60.25 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.116 -0.99 . . . . 0.17 111.207 -179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -54.79 -29.48 54.49 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.352 -1.467 . . . . 0.1 109.043 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.596 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.0 t60 -77.17 -52.21 9.65 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.423 0.63 . . . . 0.21 109.895 179.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.73 ' OE2' ' HB2' ' A' ' 188' ' ' ALA . 19.0 tp10 -58.38 -53.87 53.39 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.314 -0.866 . . . . 0.28 109.01 179.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.645 ' HA ' HD11 ' A' ' 163' ' ' ILE . 2.4 m-85 -53.99 -46.61 71.77 Favored 'General case' 0 C--N 1.304 -1.384 0 O-C-N 121.304 -0.872 . . . . 0.18 108.84 178.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.4 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -49.83 -31.85 17.3 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 108.315 -1.914 . . . . 0.21 108.315 178.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.532 ' NE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -86.54 -68.38 0.75 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.385 -1.068 . . . . 0.17 110.402 179.397 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.866 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -38.74 -39.64 0.53 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.574 -0.704 . . . . 0.33 111.108 -179.484 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.575 ' HB2' HD13 ' A' ' 163' ' ' ILE . 4.6 tp -98.19 -34.18 10.83 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.086 -1.009 . . . . 0.53 110.356 -179.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -75.58 -88.85 0.24 Allowed Glycine 0 N--CA 1.491 2.333 0 N-CA-C 110.107 -1.197 . . . . 0.41 110.107 -179.636 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.965 HD13 ' N ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -177.68 -170.49 0.26 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.351 -1.088 . . . . 0.45 110.878 -179.386 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.521 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -39.23 -64.91 0.42 Allowed 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.556 -0.715 . . . . 0.62 110.823 -179.531 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.532 ' CE1' ' NE2' ' A' ' 226' ' ' HIS . 1.3 m80 -166.92 -177.44 3.81 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.362 -0.836 . . . . 0.45 110.096 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.488 ' HB3' ' O ' ' A' ' 232' ' ' HIS . 24.1 p 179.92 60.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.472 -0.768 . . . . 0.38 109.406 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 1.099 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -148.12 26.4 0.98 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.205 -0.934 . . . . 0.48 111.415 -179.234 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.528 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.6 OUTLIER -34.34 -51.09 0.97 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.57 -0.706 . . . . 0.38 111.173 -179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.528 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 46.8 Cg_endo -83.94 -49.53 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.72 1.379 . . . . 0.28 111.644 -179.922 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.34 103.16 0.17 Allowed Glycine 0 N--CA 1.497 2.748 0 C-N-CA 119.193 -1.479 . . . . 0.24 111.424 -179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 1.099 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -149.84 167.84 25.44 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.287 -1.125 . . . . 0.28 110.532 178.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.596 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.4 OUTLIER -73.3 58.38 0.54 Allowed 'General case' 0 N--CA 1.491 1.606 0 N-CA-C 108.326 -0.99 . . . . 0.4 108.326 178.586 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.59 ' CA ' ' CE1' ' A' ' 222' ' ' HIS . 24.7 mmm -140.42 -34.0 0.54 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.386 -0.821 . . . . 0.45 110.813 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.613 ' CG ' HG22 ' A' ' 243' ' ' ILE . 0.0 OUTLIER -58.11 170.54 0.71 Allowed Pre-proline 0 N--CA 1.495 1.794 0 O-C-N 121.047 -1.033 . . . . 0.57 110.243 -179.779 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.55 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.1 Cg_endo -68.72 -7.55 20.83 Favored 'Trans proline' 0 C--N 1.309 -1.503 0 O-C-N 123.544 1.286 . . . . 0.76 110.046 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.613 HG22 ' CG ' ' A' ' 241' ' ' PHE . 1.2 tp -98.66 142.48 14.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.316 -0.865 . . . . 0.89 109.57 179.539 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 1.013 ' HB2' HD21 ' A' ' 218' ' ' LEU . 16.1 p90 -131.93 -21.29 2.43 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.246 -0.908 . . . . 0.78 111.257 -179.05 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.701 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 4.25 -72.54 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.391 0 N-CA-C 112.999 0.74 . . . . 0.61 112.999 -178.999 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.701 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -66.36 115.9 6.8 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 120.571 -1.331 . . . . 0.74 109.619 -179.776 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.509 ' N ' ' OG ' ' A' ' 250' ' ' SER . 0.2 OUTLIER -61.46 174.8 0.68 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.266 -0.896 . . . . 0.81 110.358 -179.884 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -46.74 -34.28 6.91 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.822 -1.311 . . . . 0.56 109.822 -179.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 4.0 tttt -148.73 51.63 0.99 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.044 -1.268 . . . . 0.37 110.572 -179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.509 ' OG ' ' N ' ' A' ' 247' ' ' THR . 83.6 p -102.07 13.19 35.43 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.178 -0.951 . . . . 0.44 109.875 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.424 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 1.7 t60 -173.65 -64.2 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.372 -0.83 . . . . 0.53 109.959 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.549 ' O ' ' CE1' ' A' ' 246' ' ' TYR . 2.5 t80 179.9 177.02 0.67 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.263 -0.898 . . . . 0.38 110.193 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.851 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -75.33 48.94 0.45 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.275 -0.891 . . . . 0.19 110.451 179.742 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.702 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -44.46 -47.89 26.11 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.17 -1.048 . . . . 0.28 108.17 177.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.7 Cg_endo -72.52 51.04 1.75 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.054 1.555 . . . . 0.49 110.662 177.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.619 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.4 m-20 -53.4 -30.23 38.93 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.118 -0.989 . . . . 0.49 109.399 179.434 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 1.091 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -50.59 -42.64 56.04 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.228 -0.92 . . . . 0.31 109.897 -179.163 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.995 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -81.78 -33.46 30.88 Favored 'General case' 0 C--N 1.296 -1.748 0 N-CA-C 108.248 -1.019 . . . . 0.14 108.248 179.325 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.851 HG21 ' HB2' ' A' ' 253' ' ' MET . 97.0 t -62.26 -76.09 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 C-N-CA 119.544 -0.862 . . . . 0.17 109.727 179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.673 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.9 tm0? -63.89 -39.99 95.47 Favored 'General case' 0 C--N 1.302 -1.5 0 O-C-N 121.295 -0.878 . . . . 0.26 109.597 179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.12 -65.29 1.29 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.919 -1.272 . . . . 0.19 109.919 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.995 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -78.35 -20.32 13.36 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 120.995 -1.297 . . . . 0.22 110.615 -179.347 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.928 ' N ' HD13 ' A' ' 262' ' ' ILE . 1.7 tm0? -66.25 -21.15 66.28 Favored 'General case' 0 C--N 1.297 -1.689 0 C-N-CA 118.839 -1.144 . . . . 0.39 108.513 179.352 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.5 t -104.11 -42.54 5.51 Favored 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.383 0.611 . . . . 0.47 110.897 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.74 HD12 ' HB3' ' A' ' 112' ' ' LYS . 0.9 OUTLIER -79.18 -48.42 14.26 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.504 -0.747 . . . . 0.48 111.254 -178.753 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.485 ' OH ' ' HG ' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -84.55 -7.46 59.25 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.059 -1.025 . . . . 0.41 110.542 -179.417 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.482 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -50.73 -98.53 0.01 OUTLIER Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.001 -1.64 . . . . 0.46 109.001 179.645 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.9 Cg_endo -77.65 133.89 13.22 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 O-C-N 123.839 1.442 . . . . 0.58 110.037 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -94.7 161.06 23.65 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.484 -1.446 . . . . 0.64 109.484 179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.611 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -112.15 -62.3 1.59 Allowed 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.148 -1.207 . . . . 0.95 110.134 179.882 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.518 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 81.4 tt0 46.46 29.32 0.87 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.219 -0.926 . . . . 1.2 110.177 179.797 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -135.79 114.21 11.01 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 1.2 110.18 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -71.89 75.3 2.2 Favored 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.937 1.493 . . . . 1.06 110.333 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.997 -1.001 . . . . 0.78 110.211 -179.986 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.984 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.566 ' HB1' ' O ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.619 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 20.2 t80 . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.338 0.59 . . . . 0.41 110.216 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.9 p30 -133.73 120.81 21.04 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.269 -0.894 . . . . 0.26 110.046 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.518 HG12 ' N ' ' A' ' 107' ' ' PHE . 79.0 t -135.34 -89.43 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.192 -0.943 . . . . 0.33 110.468 -179.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.518 ' N ' HG12 ' A' ' 106' ' ' VAL . 8.5 m-30 -101.77 101.0 16.01 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.237 -0.915 . . . . 0.65 110.234 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.503 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 48.7 Cg_endo -75.32 -158.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.974 1.512 . . . . 0.84 110.557 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 0.3 OUTLIER 70.94 82.65 0.15 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.524 -0.735 . . . . 0.93 110.677 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.525 ' CA ' HD13 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -149.15 -64.72 0.23 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.556 -0.715 . . . . 1.03 109.337 179.626 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.49 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 36.3 40.08 0.1 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.694 -0.629 . . . . 1.04 111.545 179.023 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.631 ' HD3' HD22 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -126.85 81.94 2.05 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.074 -1.016 . . . . 0.77 109.496 179.327 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.623 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 15.6 t90 -151.64 -70.32 0.17 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.134 -0.979 . . . . 0.42 111.16 -179.231 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.539 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 13.2 p -102.4 77.74 1.67 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.194 -0.941 . . . . 0.44 111.098 -178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.529 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.0 OUTLIER -169.31 51.19 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.256 -0.902 . . . . 0.49 110.326 179.44 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.499 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 5.6 ttt -85.37 -13.38 49.63 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.147 -0.971 . . . . 0.3 110.42 179.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.493 ' O ' HD12 ' A' ' 118' ' ' LEU . 6.5 p-10 -143.96 109.62 5.21 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.208 -0.933 . . . . 0.15 110.043 179.823 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.706 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.3 OUTLIER -138.24 -168.4 2.36 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -0.936 . . . . 0.13 110.658 -179.678 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.89 HG22 ' O ' ' A' ' 154' ' ' THR . 0.0 OUTLIER -130.59 176.95 7.75 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.303 -0.873 . . . . 0.12 110.321 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.624 ' CZ ' ' HG3' ' A' ' 155' ' ' ARG . 36.7 p90 -174.43 -169.24 0.43 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.27 -0.894 . . . . 0.33 110.918 -179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.46 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.0 OUTLIER -127.87 156.46 42.53 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.41 -0.806 . . . . 0.54 110.037 179.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.669 HG21 ' CD1' ' A' ' 138' ' ' PHE . 2.7 pt -122.77 95.06 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.27 -0.894 . . . . 0.33 110.436 -179.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.992 HG23 ' HB3' ' A' ' 166' ' ' SER . 4.2 m -149.9 56.86 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.128 -0.982 . . . . 0.27 110.812 179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.561 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 1.0 OUTLIER -44.34 -82.29 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.117 -0.989 . . . . 0.41 109.306 179.303 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.572 ' CE1' ' CD2' ' A' ' 167' ' ' PHE . 11.9 t80 -178.69 -173.95 0.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.527 -0.733 . . . . 0.4 109.69 179.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.531 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 2.6 m -136.35 53.89 8.49 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.921 -1.112 . . . . 0.45 110.774 -179.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.531 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.7 Cg_endo -78.26 -86.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.981 1.517 . . . . 0.36 109.922 179.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -99.47 0.04 41.7 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.269 -0.895 . . . . 0.25 109.699 179.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.901 ' SD ' HD21 ' A' ' 216' ' ' LEU . 2.6 ptm -121.77 147.99 45.23 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.378 -0.826 . . . . 0.39 109.99 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.407 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.0 OUTLIER -92.78 169.36 10.53 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.26 -0.9 . . . . 0.48 110.118 179.795 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.407 ' C ' ' O ' ' A' ' 130' ' ' THR . 11.2 t-160 -43.51 -33.64 1.17 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.39 -0.819 . . . . 0.4 109.622 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.404 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 2.5 m -57.98 -54.6 45.12 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.317 -0.864 . . . . 0.46 109.23 179.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.6 OUTLIER -58.1 -54.35 47.99 Favored 'General case' 0 C--N 1.307 -1.257 0 C-N-CA 119.542 -0.863 . . . . 0.47 108.913 179.04 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.537 ' CG2' ' CE ' ' A' ' 129' ' ' MET . 10.5 t -45.25 -34.97 1.46 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.596 0 N-CA-C 108.169 -1.049 . . . . 0.31 108.169 178.275 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.502 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -63.44 -41.58 98.67 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 108.435 -0.95 . . . . 0.48 108.435 178.407 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 2.6 ttmt -70.5 -49.54 47.33 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.922 0.868 . . . . 0.64 108.999 178.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.802 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -44.77 -59.6 2.44 Favored 'General case' 0 C--N 1.29 -2.01 0 O-C-N 121.149 -0.969 . . . . 0.42 110.206 179.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.669 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.54 -53.59 33.13 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.315 -0.866 . . . . 0.34 110.775 -179.282 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.628 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.12 -72.69 0.15 Allowed 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.994 -1.067 . . . . 0.47 110.167 -179.582 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.629 ' NZ ' HG23 ' A' ' 144' ' ' VAL . 0.2 OUTLIER -38.47 -61.89 0.65 Allowed 'General case' 0 C--N 1.292 -1.922 0 O-C-N 121.85 -0.531 . . . . 0.47 110.427 178.74 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.573 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.23 -38.86 12.97 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.678 -1.264 . . . . 0.25 108.413 178.654 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.3 OUTLIER -69.43 -31.92 70.56 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.407 -0.808 . . . . 0.35 109.063 178.655 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -61.29 -43.85 98.2 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.208 -0.933 . . . . 0.7 108.699 179.164 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.629 HG23 ' NZ ' ' A' ' 140' ' ' LYS . 7.5 t -69.58 -46.56 75.23 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 N-CA-C 108.915 -0.772 . . . . 0.61 108.915 178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.605 ' CH2' HG13 ' A' ' 262' ' ' ILE . 53.9 t-105 -54.72 -37.1 65.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.485 -0.76 . . . . 0.39 109.012 178.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 149' ' ' THR . 56.5 m -74.93 -33.17 61.93 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.237 -0.915 . . . . 0.35 108.711 178.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.424 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.9 OUTLIER -57.85 -43.12 85.68 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 109.094 -0.706 . . . . 0.36 109.094 179.026 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.536 HG22 ' O ' ' A' ' 145' ' ' TRP . 29.5 m -74.64 -33.98 33.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.438 -0.789 . . . . 0.5 109.903 179.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.535 HG21 HD12 ' A' ' 151' ' ' LEU . 13.1 t -148.3 129.46 7.13 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.128 -0.982 . . . . 0.51 110.216 179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.43 59.17 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.968 1.51 . . . . 0.31 110.582 -179.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.825 HD11 ' HB3' ' A' ' 266' ' ' TYR . 11.6 mt -80.25 171.31 15.24 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.187 -0.946 . . . . 0.18 110.161 179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.436 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -122.79 136.64 54.93 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.206 -0.934 . . . . 0.17 110.463 -179.704 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.422 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.8 p90 -154.91 145.02 21.81 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.14 110.316 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.89 ' O ' HG22 ' A' ' 119' ' ' THR . 2.8 m -143.99 142.95 30.99 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.269 -0.895 . . . . 0.15 110.14 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.624 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -93.74 86.51 5.15 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.152 -0.968 . . . . 0.2 110.12 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.884 HD12 ' HB3' ' A' ' 158' ' ' ASP . 0.2 OUTLIER -92.62 85.14 5.18 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.252 -0.905 . . . . 0.22 110.419 -179.927 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.427 ' O ' ' N ' ' A' ' 159' ' ' GLY . 45.5 p-80 -56.88 -19.12 15.91 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.269 -0.894 . . . . 0.32 109.873 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.884 ' HB3' HD12 ' A' ' 156' ' ' LEU . 2.4 t0 -43.4 -26.14 0.18 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.494 -0.754 . . . . 0.33 109.776 179.029 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.427 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.75 21.87 1.08 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.95 -1.26 . . . . 0.28 109.95 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.51 ' O ' ' CB ' ' A' ' 119' ' ' THR . 14.8 mt -125.63 64.76 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 O-C-N 121.035 -1.273 . . . . 0.3 109.274 179.49 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.49 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -115.86 137.0 52.51 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.254 -0.579 . . . . 0.2 110.594 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.706 ' CB ' HD23 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -101.34 -51.79 3.4 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.33 -0.856 . . . . 0.1 110.034 179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.719 HG22 ' HA3' ' A' ' 197' ' ' GLY . 3.1 pt -120.01 -177.33 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.274 -0.891 . . . . 0.1 109.229 179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.802 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 9.1 ptp -174.88 139.54 0.51 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.5 -1.375 . . . . 0.11 111.836 -179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.549 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -90.35 118.71 36.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.697 -0.627 . . . . 0.1 109.443 179.279 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.992 ' HB3' HG23 ' A' ' 123' ' ' VAL . 29.5 p -169.83 162.45 9.46 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.722 -1.236 . . . . 0.1 111.291 -179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.594 ' O ' ' CD1' ' A' ' 167' ' ' PHE . 0.1 OUTLIER -75.19 150.46 38.67 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.471 -0.768 . . . . 0.09 109.24 179.38 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -111.9 131.59 10.32 Favored Glycine 0 N--CA 1.491 2.332 0 C-N-CA 119.754 -1.212 . . . . 0.2 110.986 -178.358 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.594 ' O ' ' C ' ' A' ' 170' ' ' LYS . 12.4 pt -125.74 101.31 8.1 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.629 -0.924 . . . . 0.55 109.358 178.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.594 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.3 OUTLIER 2.08 78.31 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.382 0 CA-C-O 121.462 0.649 . . . . 0.85 112.202 -179.225 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -119.05 -4.48 10.58 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.474 -0.766 . . . . 0.71 110.135 -179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.497 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 9.1 m-70 -83.94 -153.81 0.15 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.222 -0.923 . . . . 0.42 110.186 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -141.4 36.64 1.7 Allowed Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.244 -1.542 . . . . 0.33 109.244 179.802 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 175' ' ' PHE . 15.0 p-10 -140.87 -146.37 0.19 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.342 -1.093 . . . . 0.33 110.205 -179.816 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.428 ' O ' ' O ' ' A' ' 174' ' ' ASP . 28.5 m-85 -45.84 169.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 0.27 110.046 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 17.6 m-30 -86.31 127.12 62.48 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.147 -0.971 . . . . 0.34 110.43 -179.701 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.506 ' CG ' ' HA ' ' A' ' 170' ' ' LYS . 44.6 Cg_endo -79.01 -79.69 0.0 OUTLIER 'Trans proline' 0 C--N 1.308 -1.554 0 O-C-N 123.885 1.466 . . . . 0.47 110.497 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.576 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.2 p90 -58.91 149.83 25.96 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.166 -0.959 . . . . 0.35 110.307 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.489 ' OD1' ' HB2' ' A' ' 182' ' ' SER . 1.6 p30 178.89 78.98 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.209 -0.932 . . . . 0.2 110.491 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.547 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 42.63 -160.87 0.04 OUTLIER Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.522 -1.431 . . . . 0.25 109.522 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.493 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 52.0 Cg_endo -78.23 9.34 3.14 Favored 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.019 1.537 . . . . 0.44 110.483 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.489 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 40.5 m -46.9 175.41 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.141 -0.975 . . . . 0.57 110.575 -179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.561 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.87 74.27 0.05 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 111.149 -0.78 . . . . 0.49 111.149 -179.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.022 HD22 ' OD1' ' A' ' 202' ' ' ASP . 4.0 tt 179.56 90.45 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.59 0 O-C-N 121.22 -1.164 . . . . 0.41 110.379 179.464 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.62 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.3 tt -109.18 -21.48 12.55 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.759 -1.213 . . . . 0.3 111.179 179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.655 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.1 105.56 3.39 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 120.665 -1.272 . . . . 0.2 111.775 -179.51 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.569 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -107.08 122.54 46.67 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.114 -0.991 . . . . 0.16 109.632 178.926 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.956 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -114.64 134.07 55.35 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.202 -0.936 . . . . 0.23 110.399 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.477 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.1 m-30 -79.63 174.78 5.56 Favored Pre-proline 0 N--CA 1.494 1.762 0 O-C-N 121.305 -0.872 . . . . 0.38 110.462 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.523 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.6 Cg_endo -72.77 130.72 16.13 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.089 1.573 . . . . 0.4 109.458 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.4 Cg_endo -71.22 77.28 1.63 Allowed 'Trans proline' 0 C--N 1.303 -1.861 0 O-C-N 123.95 1.5 . . . . 0.32 110.457 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.13 -90.01 0.51 Allowed Glycine 0 N--CA 1.491 2.329 0 C-N-CA 119.686 -1.245 . . . . 0.32 110.217 -179.697 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -71.5 -179.98 4.14 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.954 1.502 . . . . 0.47 111.014 -179.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -58.92 -14.83 10.2 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.395 -0.815 . . . . 0.63 110.133 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.97 53.3 0.7 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.538 0.685 . . . . 0.53 109.937 -179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.523 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -133.97 -178.52 15.67 Favored Glycine 0 N--CA 1.486 2.029 0 N-CA-C 109.392 -1.483 . . . . 0.25 109.392 -179.769 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.719 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 43.56 26.14 0.64 Allowed Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.67 -1.372 . . . . 0.1 109.67 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.412 ' N ' ' O ' ' A' ' 196' ' ' GLY . 3.7 m-20 -79.28 87.95 4.95 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.202 -1.175 . . . . 0.1 110.22 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.802 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.66 97.1 1.67 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.253 -0.904 . . . . 0.09 110.027 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.538 ' HA ' ' O ' ' A' ' 166' ' ' SER . 52.3 m170 -112.97 134.19 54.59 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.313 -0.867 . . . . 0.09 110.69 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.564 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.7 m-85 -101.1 135.92 41.79 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.253 -0.905 . . . . 0.1 110.296 179.495 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 1.022 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -46.58 93.8 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.265 -1.013 . . . . 0.14 108.265 178.762 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.564 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.09 -26.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.827 -0.749 . . . . 0.18 111.826 -177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.547 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.0 OUTLIER -78.06 3.59 14.51 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.499 -1.376 . . . . 0.24 110.749 179.858 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.62 ' OE1' HD12 ' A' ' 185' ' ' LEU . 21.6 mm-40 -100.27 -174.55 2.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.008 -1.058 . . . . 0.42 110.107 179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.23 144.27 47.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.23 -0.919 . . . . 0.47 110.439 -179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.536 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -141.4 134.11 28.65 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.308 -0.87 . . . . 0.27 109.488 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.987 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -142.34 171.12 14.48 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.0 -1.062 . . . . 0.3 110.508 179.999 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.607 ' HB2' HD23 ' A' ' 216' ' ' LEU . 1.2 t -129.24 25.95 5.46 Favored 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 108.573 -0.899 . . . . 0.61 108.573 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -95.45 -69.3 0.76 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.607 0.718 . . . . 0.78 110.357 -179.594 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -30.56 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.536 0 O-C-N 121.583 -0.698 . . . . 0.91 109.518 -179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 9.0 mtmt -95.8 157.86 15.71 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.449 -0.782 . . . . 0.93 110.022 179.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 70.25 -174.55 37.58 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.101 -1.6 . . . . 0.79 109.101 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.544 ' CE2' HD13 ' A' ' 185' ' ' LEU . 83.9 m-85 -67.31 114.96 6.44 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.112 -1.228 . . . . 0.69 109.902 179.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.617 ' O ' HG12 ' A' ' 219' ' ' VAL . 45.5 m-80 -84.37 120.33 26.14 Favored 'General case' 0 C--N 1.305 -1.367 0 O-C-N 120.985 -1.072 . . . . 0.4 109.001 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.987 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -41.18 -36.37 0.73 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.335 -0.853 . . . . 0.17 110.397 -179.444 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.59 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 3.9 m-85 -52.4 -47.64 66.13 Favored 'General case' 0 C--N 1.286 -2.195 0 N-CA-C 107.279 -1.378 . . . . 0.28 107.279 179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.807 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.16 -73.04 0.29 Allowed 'General case' 0 C--N 1.297 -1.679 0 CA-C-N 115.812 -0.631 . . . . 0.46 110.422 178.581 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.2 -62.78 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.136 -0.978 . . . . 0.39 110.566 -179.491 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.908 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -51.81 -50.69 60.3 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.026 -1.047 . . . . 0.17 111.263 -179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.567 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.9 -37.52 76.8 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.342 -1.474 . . . . 0.1 108.829 179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.622 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.6 t60 -63.68 -59.29 4.78 Favored 'General case' 0 C--N 1.299 -1.624 0 CA-C-O 121.197 0.522 . . . . 0.21 109.606 179.138 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.672 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.0 tp10 -54.3 -39.44 66.97 Favored 'General case' 0 C--N 1.306 -1.319 0 N-CA-C 108.252 -1.018 . . . . 0.28 108.252 178.488 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.545 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.2 m-30 -56.33 -61.32 2.48 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.435 -0.79 . . . . 0.18 109.057 178.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -45.07 -30.39 2.55 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.669 -1.772 . . . . 0.21 108.669 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.473 ' HB2' ' O ' ' A' ' 223' ' ' GLU . 1.6 m80 -81.36 -78.27 0.19 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.236 -1.156 . . . . 0.17 111.115 179.665 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.956 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -37.9 -37.67 0.26 Allowed 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.584 -0.697 . . . . 0.33 112.47 -178.629 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.582 ' HB2' HD13 ' A' ' 163' ' ' ILE . 11.5 tp -100.6 -36.72 9.06 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 120.717 -1.239 . . . . 0.53 111.278 -178.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.49 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -75.82 -86.88 0.31 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 110.171 -1.172 . . . . 0.41 110.171 -179.503 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.631 HD22 ' HD3' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -172.57 -170.18 0.67 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.238 -1.154 . . . . 0.45 110.661 -179.467 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.509 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.2 t0 -43.08 -60.79 1.51 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.345 -0.847 . . . . 0.62 110.77 -179.65 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.517 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.8 OUTLIER -166.97 -175.56 3.08 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.241 -0.912 . . . . 0.45 110.359 -179.783 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.449 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER 179.59 61.33 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.488 -0.758 . . . . 0.38 109.698 179.747 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 1.076 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.79 23.99 0.87 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.167 -0.958 . . . . 0.48 111.26 -179.226 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.531 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -34.51 -47.43 0.85 Allowed Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 121.664 -0.647 . . . . 0.38 110.926 -179.687 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 41.2 Cg_endo -90.78 -45.75 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.833 0 O-C-N 123.82 1.432 . . . . 0.28 111.987 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.31 102.02 0.15 Allowed Glycine 0 N--CA 1.499 2.873 0 C-N-CA 118.829 -1.653 . . . . 0.24 111.991 -179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 1.076 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -150.46 166.47 30.04 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.334 -1.098 . . . . 0.28 110.257 178.589 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.603 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.3 53.62 0.84 Allowed 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.144 -0.972 . . . . 0.4 109.21 178.812 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.622 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 5.2 mtt -137.3 -30.63 0.84 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.246 -0.909 . . . . 0.45 110.372 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.615 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -47.49 171.27 0.08 OUTLIER Pre-proline 0 N--CA 1.495 1.796 0 O-C-N 121.151 -0.968 . . . . 0.57 110.6 -179.879 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.535 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -70.29 -2.83 11.19 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.511 1.269 . . . . 0.76 110.454 179.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.58 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 6.4 tt -110.66 153.93 12.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.222 -0.924 . . . . 0.89 109.919 179.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.807 ' HB2' HD21 ' A' ' 218' ' ' LEU . 32.5 p90 -128.35 -20.61 3.66 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.014 -1.054 . . . . 0.78 110.935 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.6 OUTLIER 2.75 -67.42 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 N-CA-C 113.717 1.006 . . . . 0.61 113.717 -179.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -72.56 119.57 16.97 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.339 -1.476 . . . . 0.74 109.833 -179.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.494 ' N ' ' OG ' ' A' ' 250' ' ' SER . 21.6 p -63.12 -143.17 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.403 -0.81 . . . . 0.81 110.424 -179.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -84.84 -20.64 57.57 Favored Glycine 0 N--CA 1.49 2.257 0 N-CA-C 109.722 -1.351 . . . . 0.56 109.722 -179.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.6 pttt -158.07 40.91 0.27 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.116 -1.226 . . . . 0.37 110.507 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 247' ' ' THR . 4.6 m -63.79 -13.0 40.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.146 -0.971 . . . . 0.44 109.781 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.439 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.2 OUTLIER -171.13 -48.42 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.329 -0.857 . . . . 0.53 110.329 179.821 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.596 ' CD2' ' HG2' ' A' ' 253' ' ' MET . 4.7 t80 -179.1 178.02 0.76 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.106 -0.996 . . . . 0.38 110.777 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 1.01 ' HB2' HG21 ' A' ' 259' ' ' VAL . 6.8 ptp -68.14 55.76 0.07 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.424 -0.797 . . . . 0.19 110.263 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.668 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -44.11 -47.97 23.25 Favored Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 108.021 -1.103 . . . . 0.28 108.021 177.605 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.668 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 37.9 Cg_endo -74.31 50.53 2.3 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 O-C-N 124.129 1.594 . . . . 0.49 110.698 177.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.6 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.1 m-20 -50.87 -32.27 19.89 Favored 'General case' 0 N--CA 1.487 1.393 0 O-C-N 121.069 -1.019 . . . . 0.49 110.008 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.977 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 51.8 m-20 -54.17 -46.47 72.35 Favored 'General case' 0 C--N 1.305 -1.338 0 C-N-CA 119.24 -0.984 . . . . 0.31 109.035 -179.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.993 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -72.96 -36.32 67.1 Favored 'General case' 0 C--N 1.294 -1.845 0 N-CA-C 108.491 -0.929 . . . . 0.14 108.491 178.947 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 1.01 HG21 ' HB2' ' A' ' 253' ' ' MET . 74.1 t -63.88 -82.65 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.567 -0.708 . . . . 0.17 110.266 179.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.3 tp60 -56.62 -43.09 79.85 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 121.276 -0.89 . . . . 0.26 109.495 179.739 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.76 -69.86 0.45 Allowed Glycine 0 N--CA 1.492 2.424 0 N-CA-C 110.496 -1.042 . . . . 0.19 110.496 -179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.993 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.86 -22.34 19.88 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.865 0 O-C-N 120.777 -1.425 . . . . 0.22 110.032 -179.325 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.941 ' N ' HD13 ' A' ' 262' ' ' ILE . 6.0 tt0 -59.98 -23.17 63.4 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.98 -1.088 . . . . 0.39 108.208 179.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.1 t -103.6 -43.0 5.49 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.406 0.622 . . . . 0.47 110.913 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.522 ' CB ' ' HG2' ' A' ' 112' ' ' LYS . 54.7 mt -75.31 -52.49 10.7 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.374 -0.829 . . . . 0.48 111.187 -178.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.825 ' HB3' HD11 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -82.61 -1.36 50.66 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.105 -0.997 . . . . 0.41 109.959 -179.763 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.483 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.31 -108.92 0.01 OUTLIER Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.226 -1.55 . . . . 0.46 109.226 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.499 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.6 Cg_endo -75.91 84.29 1.81 Allowed 'Trans proline' 0 C--N 1.306 -1.69 0 O-C-N 123.702 1.369 . . . . 0.58 110.223 179.761 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.69 174.48 1.06 Allowed Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.48 -1.448 . . . . 0.64 109.48 -179.774 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.623 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.1 OUTLIER -115.6 -69.01 0.88 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.224 -1.163 . . . . 0.95 110.117 179.956 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.539 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 28.7 tt0 41.93 37.96 0.93 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.401 -0.812 . . . . 1.2 110.259 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.455 ' OD1' ' OD2' ' A' ' 270' ' ' ASP . 8.3 p-10 -131.35 94.44 26.81 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.264 -0.898 . . . . 1.2 110.546 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -74.35 56.03 3.75 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.918 1.483 . . . . 1.06 110.252 179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 117.997 -1.002 . . . . 0.78 110.16 -179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.991 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.599 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.655 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 3.4 t80 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.231 0.539 . . . . 0.41 110.242 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.425 ' O ' ' OD1' ' A' ' 105' ' ' ASN . 18.7 p30 -145.14 140.85 28.27 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.261 -0.899 . . . . 0.26 110.183 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 7.0 m -136.81 -37.41 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.187 -0.946 . . . . 0.33 110.253 179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -130.71 146.38 61.69 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.368 -0.833 . . . . 0.65 110.264 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.444 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 46.2 Cg_endo -73.44 -160.26 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 123.996 1.524 . . . . 0.84 110.418 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.444 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 56.7 mtt180 58.72 66.99 0.98 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.336 -0.852 . . . . 0.93 110.309 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.514 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.7 OUTLIER -141.91 -61.43 0.46 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.285 -0.885 . . . . 1.03 110.189 179.991 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CD2' ' HD2' ' A' ' 191' ' ' PRO . 1.0 OUTLIER 39.49 27.54 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.407 -0.808 . . . . 1.04 110.88 179.857 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.607 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -114.94 72.76 0.8 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.099 -1.0 . . . . 0.77 109.781 179.833 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.63 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.0 t90 -143.85 -65.09 0.37 Allowed 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.276 -0.89 . . . . 0.42 110.474 -179.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.461 ' OG ' ' HB2' ' A' ' 271' ' ' GLU . 13.4 t -103.06 60.31 0.78 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.331 -0.855 . . . . 0.44 110.537 -179.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.576 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 3.8 mmtp -146.01 85.69 1.69 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.146 -0.971 . . . . 0.49 110.302 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.418 ' O ' ' HB2' ' A' ' 152' ' ' ASN . 34.1 ttp -112.99 -20.78 11.41 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.205 -0.935 . . . . 0.3 110.28 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.461 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 11.3 p30 -144.97 129.48 17.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.169 -0.957 . . . . 0.15 110.106 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.557 HD22 ' CB ' ' A' ' 162' ' ' ASP . 0.4 OUTLIER -152.32 -175.73 5.39 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.167 -0.958 . . . . 0.13 110.662 -179.529 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.526 HG22 ' O ' ' A' ' 154' ' ' THR . 1.0 OUTLIER -126.39 155.44 42.12 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.349 -0.844 . . . . 0.12 109.992 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.631 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 46.1 p90 -148.61 159.46 44.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.158 -0.964 . . . . 0.33 110.776 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.513 ' HG3' ' N ' ' A' ' 122' ' ' ILE . 0.0 OUTLIER -116.9 151.33 36.85 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.51 -0.744 . . . . 0.54 109.873 179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.734 HG21 ' CD1' ' A' ' 138' ' ' PHE . 2.0 pp -113.51 115.19 49.02 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.255 -0.903 . . . . 0.33 110.983 -179.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.917 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.6 m -160.56 41.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.683 0 O-C-N 121.313 -0.867 . . . . 0.27 110.19 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.512 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 2.3 t-20 -40.78 -78.51 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.362 -0.836 . . . . 0.41 109.491 179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.722 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.7 t80 -179.39 -163.45 0.05 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.43 -0.794 . . . . 0.4 109.57 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.57 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -152.84 47.87 0.41 Allowed Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 121.063 -1.023 . . . . 0.45 110.436 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.57 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -73.73 -86.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.956 1.503 . . . . 0.36 110.311 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -89.95 -5.21 56.96 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.232 -0.918 . . . . 0.25 109.755 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.602 ' SD ' HD21 ' A' ' 216' ' ' LEU . 0.6 OUTLIER -115.96 172.07 7.38 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.407 -0.808 . . . . 0.39 110.068 179.743 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.442 ' HA ' HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -123.7 177.67 5.59 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.3 -0.875 . . . . 0.48 109.993 179.699 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.451 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 4.7 t60 -45.53 -36.92 4.91 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.28 -0.887 . . . . 0.4 110.052 179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 5.7 t -63.59 -50.58 68.85 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.188 -0.945 . . . . 0.46 109.595 179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.59 ' HB2' ' HB2' ' A' ' 129' ' ' MET . 51.9 mp0 -59.87 -62.74 1.65 Allowed 'General case' 0 C--N 1.304 -1.399 0 O-C-N 121.255 -0.903 . . . . 0.47 109.378 179.423 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.722 HG21 ' O ' ' A' ' 125' ' ' TYR . 13.1 t -44.02 -37.69 1.27 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 N-CA-C 108.478 -0.934 . . . . 0.31 108.478 178.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.559 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.77 -42.04 78.69 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 108.319 -0.993 . . . . 0.48 108.319 178.448 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.591 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 42.2 tttt -74.69 -47.52 31.15 Favored 'General case' 0 N--CA 1.49 1.56 0 CA-C-O 122.005 0.907 . . . . 0.64 108.577 178.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.851 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -47.64 -60.71 2.36 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.333 -0.854 . . . . 0.42 110.001 179.607 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.734 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.25 -51.36 46.06 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.345 -0.847 . . . . 0.34 111.095 -179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.54 -72.1 0.17 Allowed 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.963 -1.086 . . . . 0.47 110.277 -179.45 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.538 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.5 OUTLIER -40.95 -59.33 1.47 Allowed 'General case' 0 C--N 1.29 -2.017 0 O-C-N 121.693 -0.629 . . . . 0.47 110.437 179.095 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.559 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.86 -37.16 13.35 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.691 -1.256 . . . . 0.25 108.012 178.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.525 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -69.85 -40.74 75.62 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.499 -0.751 . . . . 0.35 109.02 178.559 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 25.0 tttt -52.67 -37.47 58.78 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.06 -1.025 . . . . 0.7 108.565 178.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.43 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 89.0 t -72.75 -45.17 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 CA-C-O 121.351 0.596 . . . . 0.61 109.572 179.214 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.713 ' HH2' HG21 ' A' ' 262' ' ' ILE . 26.1 t-105 -58.72 -44.37 90.39 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.362 -0.836 . . . . 0.39 109.333 179.399 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.497 ' HA ' ' O ' ' A' ' 149' ' ' THR . 58.8 m -69.11 -33.4 73.43 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.137 -0.977 . . . . 0.35 108.745 178.765 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -56.12 -44.92 79.61 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.535 -0.728 . . . . 0.36 109.302 179.17 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.629 HG22 ' O ' ' A' ' 145' ' ' TRP . 27.2 m -76.24 -30.83 20.43 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.5 109.778 179.485 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.691 HG23 ' O ' ' A' ' 149' ' ' THR . 12.7 t -151.8 114.7 2.99 Favored Pre-proline 0 N--CA 1.493 1.722 0 O-C-N 121.242 -0.911 . . . . 0.51 109.944 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.91 59.96 2.93 Favored 'Trans proline' 0 C--N 1.307 -1.658 0 O-C-N 123.826 1.435 . . . . 0.31 110.52 -179.769 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.517 ' CD2' ' O ' ' A' ' 266' ' ' TYR . 65.7 mt -76.27 165.91 24.19 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.262 -0.899 . . . . 0.18 110.504 -179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.42 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -91.58 128.05 37.26 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.359 -0.838 . . . . 0.17 110.147 179.929 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.517 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 5.8 p90 -147.41 125.34 11.99 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.251 -0.906 . . . . 0.14 110.234 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.526 ' O ' HG22 ' A' ' 119' ' ' THR . 6.0 m -128.59 139.85 52.07 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.255 -0.903 . . . . 0.15 110.439 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.631 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -106.5 87.11 2.46 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.4 -0.812 . . . . 0.2 109.931 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.566 HD22 HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -95.38 89.52 5.47 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.14 -0.975 . . . . 0.22 110.05 179.892 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.407 ' O ' ' C ' ' A' ' 158' ' ' ASP . 3.4 p-80 -49.12 -23.78 1.39 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.191 -0.943 . . . . 0.32 109.916 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.407 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.0 t0 -42.76 -32.77 0.64 Allowed 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.625 -0.672 . . . . 0.33 109.644 179.094 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 133.56 32.79 0.37 Allowed Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.81 -1.316 . . . . 0.28 109.81 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.566 HD12 HD22 ' A' ' 156' ' ' LEU . 17.7 mt -126.79 67.14 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.495 0 O-C-N 121.098 -1.236 . . . . 0.3 109.271 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.474 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -125.76 149.63 48.4 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 121.657 -0.652 . . . . 0.2 110.906 -179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.557 ' CB ' HD22 ' A' ' 118' ' ' LEU . 3.7 t70 -113.19 -38.05 4.56 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.413 -0.804 . . . . 0.1 109.623 179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.973 HG22 ' HA3' ' A' ' 197' ' ' GLY . 6.6 pt -125.17 172.81 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.414 -0.804 . . . . 0.1 109.382 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.496 ' HB3' ' HB3' ' A' ' 121' ' ' ARG . 1.2 ptp -171.88 141.51 1.39 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.808 -1.183 . . . . 0.11 111.222 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.619 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.8 tt -93.87 117.23 36.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.389 -0.819 . . . . 0.1 109.563 179.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.917 ' HB3' HG23 ' A' ' 123' ' ' VAL . 69.4 p -158.53 159.59 35.73 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.893 -1.129 . . . . 0.1 110.489 -179.619 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.559 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 9.1 p90 -76.63 126.41 30.93 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.383 -0.823 . . . . 0.09 109.709 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.475 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -88.23 117.04 4.71 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.148 -1.181 . . . . 0.2 110.148 -179.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.607 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.8 OUTLIER -110.25 103.01 14.81 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.67 -0.9 . . . . 0.55 109.264 179.009 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.587 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.82 81.12 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.328 0 CA-C-O 121.329 0.585 . . . . 0.85 112.523 -179.335 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.24 -6.26 7.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.367 -0.833 . . . . 0.71 110.048 179.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.464 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 13.1 m-70 -80.75 -86.23 0.09 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.315 -0.866 . . . . 0.42 110.418 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 126.47 4.11 6.43 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.526 -1.43 . . . . 0.33 109.526 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -113.28 -64.73 1.27 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.266 -1.138 . . . . 0.33 110.132 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.435 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 18.7 m-85 -112.79 118.14 34.14 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.298 -0.876 . . . . 0.27 110.245 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 22.1 m-85 -45.78 104.29 0.39 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.193 -0.942 . . . . 0.34 110.36 179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.521 ' O ' HD22 ' A' ' 184' ' ' LEU . 44.4 Cg_endo -74.5 -59.72 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.925 1.487 . . . . 0.47 110.374 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.587 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -89.2 161.04 16.66 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.147 -0.97 . . . . 0.35 109.919 179.882 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.512 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 0.9 OUTLIER -173.65 -37.66 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.503 0 O-C-N 120.973 -1.08 . . . . 0.2 111.206 179.273 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.581 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 130.9 -137.23 9.32 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 108.929 -1.668 . . . . 0.25 108.929 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.426 ' O ' ' O ' ' A' ' 182' ' ' SER . 54.0 Cg_endo -72.13 -3.37 13.15 Favored 'Trans proline' 0 C--N 1.295 -2.253 0 O-C-N 124.076 1.566 . . . . 0.44 109.664 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.455 ' HB3' ' OD1' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -50.21 -179.2 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.358 -0.839 . . . . 0.57 110.158 179.443 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.544 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -82.88 73.58 2.66 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 110.278 -1.129 . . . . 0.49 110.278 -179.511 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.012 ' HA ' HG13 ' A' ' 1' ' ' HAV . 4.4 tt -179.96 93.15 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.221 -1.164 . . . . 0.41 110.788 179.804 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.605 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 3.2 tt -109.55 -15.58 14.16 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 118.823 -1.151 . . . . 0.3 110.719 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.731 ' HB1' ' CD ' ' A' ' 223' ' ' GLU . . . -153.15 102.81 2.66 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.774 -1.203 . . . . 0.2 111.591 -179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -112.15 119.2 37.59 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -0.941 . . . . 0.16 109.789 179.02 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.997 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -110.11 151.41 27.28 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.143 -0.973 . . . . 0.23 110.488 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.444 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.1 m-30 -90.64 165.53 22.41 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.274 -0.891 . . . . 0.38 110.686 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.7 Cg_endo -73.56 143.03 33.65 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.021 1.537 . . . . 0.4 109.804 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -70.5 72.74 1.78 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.896 1.471 . . . . 0.32 110.572 -179.506 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.3 -101.5 2.61 Favored Glycine 0 N--CA 1.491 2.355 0 N-CA-C 109.433 -1.467 . . . . 0.32 109.433 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -74.15 -160.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.902 1.475 . . . . 0.47 110.28 179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.24 -6.97 26.55 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.11 -0.993 . . . . 0.63 110.112 179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.11 52.08 0.72 Allowed 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.473 -0.767 . . . . 0.53 109.772 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.517 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -127.68 172.27 18.93 Favored Glycine 0 N--CA 1.487 2.061 0 N-CA-C 109.409 -1.477 . . . . 0.25 109.409 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.973 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 45.69 24.63 1.25 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.33 -1.508 . . . . 0.1 109.33 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.444 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.2 OUTLIER -81.47 92.83 6.53 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.258 -1.142 . . . . 0.1 110.233 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.654 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -69.37 98.55 1.09 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.09 110.294 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.43 ' O ' ' OE2' ' A' ' 223' ' ' GLU . 19.2 m170 -102.98 138.14 40.25 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.29 -0.881 . . . . 0.09 110.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.649 ' CE1' HG22 ' A' ' 219' ' ' VAL . 17.5 m-85 -107.15 133.16 52.15 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.201 -0.937 . . . . 0.1 111.284 -179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.548 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 42.9 t0 -45.55 88.73 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 108.936 -0.764 . . . . 0.14 108.936 178.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.581 ' N ' ' O ' ' A' ' 201' ' ' PHE . 0.8 OUTLIER -40.86 -34.16 0.37 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.014 -1.053 . . . . 0.18 111.525 -177.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.581 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 48.8 t0 -73.75 0.54 12.72 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 120.772 -1.205 . . . . 0.24 110.46 -179.837 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.535 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 10.5 mm-40 -97.42 -161.72 0.9 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.904 -1.123 . . . . 0.42 109.903 179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.539 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 69.6 m -133.24 153.67 51.34 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 120.916 -1.115 . . . . 0.47 110.835 -179.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.67 ' C ' HG22 ' A' ' 208' ' ' THR . 0.8 OUTLIER -148.3 166.47 27.91 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.308 -0.87 . . . . 0.27 109.796 179.798 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.999 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.3 OUTLIER -178.81 175.07 1.08 Allowed 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.069 -1.019 . . . . 0.3 110.871 179.252 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.46 ' N ' ' OG1' ' A' ' 208' ' ' THR . 0.0 OUTLIER -139.01 25.75 2.49 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 119.565 -0.854 . . . . 0.61 109.817 178.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.453 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.2 t -90.66 -88.19 0.18 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.487 -0.758 . . . . 0.78 110.138 179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.453 ' N ' ' OG ' ' A' ' 210' ' ' SER . 35.7 p -158.88 18.62 0.2 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.352 -0.843 . . . . 0.91 110.0 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.462 ' O ' ' O ' ' A' ' 213' ' ' GLY . 6.9 ptpt -145.69 -174.11 4.32 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.29 -0.882 . . . . 0.93 110.133 -179.743 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.462 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 44.34 -168.93 0.02 OUTLIER Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.625 -1.39 . . . . 0.79 109.625 179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.605 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 97.7 m-85 -70.33 121.56 17.9 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.272 -1.134 . . . . 0.69 110.195 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.631 ' O ' HG12 ' A' ' 219' ' ' VAL . 47.7 m-80 -87.31 116.89 25.71 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 121.159 -0.963 . . . . 0.4 109.086 179.427 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.999 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.17 -35.85 0.65 Allowed 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 119.625 -0.83 . . . . 0.17 110.332 -179.452 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.608 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 2.2 m-85 -52.37 -45.87 65.95 Favored 'General case' 0 C--N 1.283 -2.291 0 N-CA-C 107.405 -1.331 . . . . 0.28 107.405 179.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.979 HD21 ' HB2' ' A' ' 244' ' ' TYR . 9.7 tp -81.42 -73.16 0.39 Allowed 'General case' 0 C--N 1.294 -1.841 0 CA-C-N 115.435 -0.802 . . . . 0.46 110.993 179.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.816 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.6 p -45.5 -56.14 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.097 -1.002 . . . . 0.39 110.325 -179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.934 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -60.5 -48.5 81.48 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.087 -1.008 . . . . 0.17 111.114 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.608 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -56.7 -24.59 50.32 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.177 -1.577 . . . . 0.1 108.406 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.683 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.3 t60 -83.33 -49.87 8.93 Favored 'General case' 0 C--N 1.3 -1.576 0 CA-C-N 115.749 -0.659 . . . . 0.21 110.325 179.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.731 ' CD ' ' HB1' ' A' ' 186' ' ' ALA . 3.0 tp10 -61.69 -44.54 96.75 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.933 -1.104 . . . . 0.28 108.782 178.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.582 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 0.7 OUTLIER -60.23 -62.16 2.07 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 121.472 -0.768 . . . . 0.18 109.026 178.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.443 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.85 -28.86 0.73 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.918 -1.673 . . . . 0.21 108.918 179.21 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.512 ' CE1' ' HE3' ' A' ' 240' ' ' MET . 1.0 OUTLIER -80.91 -68.14 0.71 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.272 -1.134 . . . . 0.17 111.084 179.748 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.997 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -46.93 -38.41 10.5 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.51 -0.744 . . . . 0.33 112.288 -178.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.666 HD23 ' N ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER -100.13 -37.45 8.95 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 120.81 -1.181 . . . . 0.53 110.977 -178.6 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.666 ' N ' HD23 ' A' ' 228' ' ' LEU . . . -74.39 -87.42 0.23 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.963 -1.255 . . . . 0.41 109.963 -179.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.599 ' H ' HD23 ' A' ' 230' ' ' LEU . 0.7 OUTLIER -161.96 -176.23 5.09 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.204 -1.174 . . . . 0.45 110.789 -179.432 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 2.6 m-20 -55.17 -58.84 6.04 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.374 -0.829 . . . . 0.62 110.19 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.515 ' ND1' ' O ' ' A' ' 231' ' ' ASP . 3.6 m80 -161.6 176.15 11.31 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.152 -0.967 . . . . 0.45 110.639 179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.492 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 2.4 p 179.73 50.69 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 108.79 -0.818 . . . . 0.38 108.79 179.714 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.677 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -125.09 20.21 8.25 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.537 -0.727 . . . . 0.48 110.584 -179.315 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.579 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -43.12 -53.53 10.54 Favored Pre-proline 0 C--N 1.302 -1.474 0 C-N-CA 119.443 -0.903 . . . . 0.38 109.831 179.704 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.579 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 50.5 Cg_endo -86.05 -47.8 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.6 0 O-C-N 123.595 1.313 . . . . 0.28 110.573 179.31 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.542 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 178.23 94.55 0.09 OUTLIER Glycine 0 N--CA 1.497 2.756 0 C-N-CA 119.233 -1.46 . . . . 0.24 111.589 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.833 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -144.42 162.16 37.19 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.211 -1.17 . . . . 0.28 110.358 178.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.683 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -77.61 57.73 1.65 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.182 -0.949 . . . . 0.4 108.72 179.551 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.581 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 21.6 mmm -133.14 -35.71 1.03 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.333 -0.854 . . . . 0.45 110.354 -179.421 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -43.99 169.86 0.05 OUTLIER Pre-proline 0 N--CA 1.497 1.881 0 O-C-N 121.152 -0.968 . . . . 0.57 110.366 179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.499 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.5 Cg_endo -71.85 -8.09 22.35 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.763 1.402 . . . . 0.76 109.842 179.319 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.743 HG22 HG22 ' A' ' 245' ' ' THR . 16.1 mt -98.83 146.76 7.76 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.475 -0.765 . . . . 0.89 109.699 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.979 ' HB2' HD21 ' A' ' 218' ' ' LEU . 36.8 p90 -128.92 -25.97 2.72 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.03 -1.044 . . . . 0.78 110.976 -179.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.743 HG22 HG22 ' A' ' 243' ' ' ILE . 0.2 OUTLIER 2.73 -67.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 N-CA-C 113.602 0.964 . . . . 0.61 113.602 -179.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.732 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -70.23 107.56 3.77 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 120.381 -1.45 . . . . 0.74 109.686 -179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.774 ' HA ' HD13 ' A' ' 218' ' ' LEU . 2.2 t -65.32 -151.86 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.325 -0.86 . . . . 0.81 110.252 -179.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.508 ' N ' ' OG1' ' A' ' 247' ' ' THR . . . -84.31 -5.0 87.63 Favored Glycine 0 N--CA 1.489 2.178 0 N-CA-C 109.404 -1.478 . . . . 0.56 109.404 179.817 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.754 ' H ' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -147.04 30.13 0.96 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.237 -1.155 . . . . 0.37 110.38 -179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.423 ' CB ' ' HA ' ' A' ' 246' ' ' TYR . 0.3 OUTLIER -74.16 -28.8 61.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.135 -0.978 . . . . 0.44 110.406 179.992 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 1.9 m-70 -164.82 -61.09 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.152 -0.967 . . . . 0.53 110.425 179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.587 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 2.8 m-85 -174.38 -174.4 0.86 Allowed 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.154 -0.967 . . . . 0.38 110.516 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.842 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -68.07 53.15 0.07 Allowed 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.51 -0.744 . . . . 0.19 110.559 179.668 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.695 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.1 -47.57 43.52 Favored Pre-proline 0 N--CA 1.483 1.212 0 N-CA-C 107.963 -1.125 . . . . 0.28 107.963 177.492 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.9 Cg_endo -73.59 51.0 2.14 Favored 'Trans proline' 0 C--N 1.312 -1.366 0 O-C-N 124.137 1.598 . . . . 0.49 110.979 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.592 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.1 m-20 -50.65 -32.42 19.07 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.018 -1.051 . . . . 0.49 110.494 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.833 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -53.82 -54.13 42.75 Favored 'General case' 0 N--CA 1.486 1.36 0 C-N-CA 118.885 -1.126 . . . . 0.31 109.136 -179.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.017 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -66.01 -35.48 80.69 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.074 -1.05 . . . . 0.14 108.784 178.901 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.842 HG21 ' HB2' ' A' ' 253' ' ' MET . 55.2 t -63.93 -86.46 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.364 -0.835 . . . . 0.17 110.581 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.613 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -55.0 -43.73 73.87 Favored 'General case' 0 C--N 1.301 -1.506 0 O-C-N 121.099 -1.001 . . . . 0.26 109.569 179.912 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.83 -70.2 0.37 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 110.641 -0.984 . . . . 0.19 110.641 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.017 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.66 -21.13 19.61 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.727 -1.455 . . . . 0.22 110.296 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.995 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.6 OUTLIER -64.86 -20.47 66.43 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.985 -1.072 . . . . 0.39 108.659 179.213 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 29.1 t -103.72 -41.88 5.8 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 120.203 -0.599 . . . . 0.47 111.164 -179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.492 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 0.5 OUTLIER -84.3 -47.09 11.11 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.353 -0.842 . . . . 0.48 111.145 -178.66 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.576 ' CD1' ' O ' ' A' ' 115' ' ' LYS . 0.1 OUTLIER -69.64 -20.52 63.6 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.158 -0.964 . . . . 0.41 110.223 -179.479 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -53.51 -102.15 0.01 OUTLIER Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.276 -1.53 . . . . 0.46 109.276 179.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -74.33 105.27 2.01 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.867 1.457 . . . . 0.58 110.333 179.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -83.22 155.79 33.16 Favored Glycine 0 N--CA 1.49 2.283 0 N-CA-C 109.388 -1.485 . . . . 0.64 109.388 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.63 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.4 OUTLIER -93.09 -61.64 1.54 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.206 -1.173 . . . . 0.95 110.414 -179.906 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.461 ' HB2' ' OG ' ' A' ' 114' ' ' SER . 5.2 tp10 50.27 35.49 10.68 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.187 -0.946 . . . . 1.2 110.004 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -146.0 133.41 10.25 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.852 . . . . 1.2 110.226 179.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.28 85.72 1.22 Allowed 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 123.925 1.487 . . . . 1.06 110.476 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 12.5 m120 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.021 -0.99 . . . . 0.78 110.254 -179.904 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.012 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.577 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.73 ' HH2' ' CB ' ' A' ' 244' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 36.1 p90 . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 121.284 0.564 . . . . 0.41 110.253 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.8 m-20 -166.31 75.61 0.19 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.293 -0.88 . . . . 0.26 110.148 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 42.1 t -126.61 -24.54 1.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.173 -0.954 . . . . 0.33 110.565 -179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.2 m-85 -121.11 64.99 13.7 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.117 -0.99 . . . . 0.65 110.696 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.527 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.1 Cg_endo -71.39 -153.57 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.03 1.542 . . . . 0.84 109.984 179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.8 ' C ' HD13 ' A' ' 230' ' ' LEU . 21.3 mtt180 70.63 82.64 0.15 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.39 -0.819 . . . . 0.93 110.46 -179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.59 ' N ' HD13 ' A' ' 230' ' ' LEU . 1.6 p -147.8 -65.83 0.26 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.563 -0.711 . . . . 1.03 109.259 179.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.552 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.01 55.57 0.99 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.682 -0.636 . . . . 1.04 111.67 178.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.49 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.2 OUTLIER -140.94 77.03 1.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.193 -0.942 . . . . 0.77 109.403 179.395 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.573 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 10.1 t90 -149.72 -69.22 0.2 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.203 -0.936 . . . . 0.42 111.411 -179.079 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.532 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 30.6 t -100.48 77.17 1.9 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.237 -0.914 . . . . 0.44 111.101 -178.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.532 ' CG ' ' O ' ' A' ' 114' ' ' SER . 0.1 OUTLIER -170.21 49.79 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.279 -0.888 . . . . 0.49 110.185 179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.465 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.2 OUTLIER -75.46 -29.15 59.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.3 110.141 179.889 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.509 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 25.0 p-10 -129.74 123.46 31.1 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.293 -0.88 . . . . 0.15 109.994 179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.512 HD22 ' CB ' ' A' ' 162' ' ' ASP . 3.8 mt -141.32 -178.62 5.69 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.13 110.364 -179.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.931 HG22 ' O ' ' A' ' 154' ' ' THR . 0.1 OUTLIER -122.6 150.75 42.22 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.329 -0.857 . . . . 0.12 109.829 179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.733 ' HB3' HG23 ' A' ' 163' ' ' ILE . 40.3 p90 -145.11 -164.31 1.91 Allowed 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.199 -0.938 . . . . 0.33 110.692 -179.867 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -147.1 154.2 40.85 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.058 -1.026 . . . . 0.54 110.888 -179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.936 HD13 ' HB3' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -113.48 110.66 32.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.513 -0.742 . . . . 0.33 110.223 179.784 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.988 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.4 m -159.91 41.01 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.188 -0.945 . . . . 0.27 110.147 178.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.491 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 3.4 t-20 -41.36 -79.23 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 119.696 -0.802 . . . . 0.41 108.993 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.486 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 6.3 t80 -179.91 -176.14 0.33 Allowed 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.514 -0.741 . . . . 0.4 109.593 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -132.52 49.77 4.91 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.013 -1.054 . . . . 0.45 110.611 179.7 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 126' ' ' THR . 46.4 Cg_endo -76.78 -85.96 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.609 0 O-C-N 123.854 1.45 . . . . 0.36 110.253 179.541 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -100.31 -0.5 38.29 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.254 -0.904 . . . . 0.25 109.622 179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.821 ' SD ' HD21 ' A' ' 216' ' ' LEU . 3.6 ptm -123.12 133.93 54.25 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.388 -0.82 . . . . 0.39 109.976 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.483 HG22 ' H ' ' A' ' 131' ' ' HIS . 1.4 m -86.33 178.52 7.12 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.22 -0.925 . . . . 0.48 110.354 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.483 ' H ' HG22 ' A' ' 130' ' ' THR . 0.2 OUTLIER -45.74 -33.76 3.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.349 -0.845 . . . . 0.4 110.068 179.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.464 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 1.5 t -63.16 -58.3 7.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.27 -0.894 . . . . 0.46 109.791 179.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.55 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 6.3 mp0 -54.46 -57.72 10.25 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.268 -0.895 . . . . 0.47 109.566 179.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.792 HG23 ' HE2' ' A' ' 129' ' ' MET . 4.0 t -45.34 -37.27 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 108.111 -1.07 . . . . 0.31 108.111 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 9.6 tt0 -59.03 -39.97 83.58 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.486 -0.931 . . . . 0.48 108.486 178.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.557 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 12.9 tttt -73.07 -50.37 23.29 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 122.019 0.914 . . . . 0.64 108.776 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.806 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.64 -60.61 2.1 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 121.163 -0.961 . . . . 0.42 110.537 179.832 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.936 ' HB3' HD13 ' A' ' 122' ' ' ILE . 0.3 OUTLIER -68.44 -50.97 48.77 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.138 -0.976 . . . . 0.34 111.216 -178.981 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.625 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -66.91 -71.17 0.21 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.957 -1.089 . . . . 0.47 110.147 -179.657 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -40.18 -58.78 1.4 Allowed 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.651 -0.656 . . . . 0.47 110.114 178.731 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.546 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.75 -38.81 16.23 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.707 -1.246 . . . . 0.25 108.365 178.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.5 OUTLIER -71.0 -34.73 71.64 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.347 -0.846 . . . . 0.35 108.985 178.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.416 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.5 OUTLIER -56.4 -45.45 80.61 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.151 -0.968 . . . . 0.7 108.394 178.77 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.403 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 22.9 t -64.68 -44.67 96.59 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.987 -0.746 . . . . 0.61 108.987 178.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.64 ' HH2' HG21 ' A' ' 262' ' ' ILE . 26.3 t-105 -55.02 -36.69 65.74 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 108.718 -0.845 . . . . 0.39 108.718 178.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.0 OUTLIER -74.12 -38.42 63.8 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 108.742 -0.836 . . . . 0.35 108.742 178.618 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.403 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -53.1 -37.48 61.76 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.533 -0.729 . . . . 0.36 109.045 178.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 145' ' ' TRP . 34.8 m -85.45 -35.67 9.95 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.462 -0.774 . . . . 0.5 110.116 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.702 ' CG2' HD23 ' A' ' 151' ' ' LEU . 15.3 t -153.93 127.25 4.24 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 121.038 -1.039 . . . . 0.51 110.15 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -70.67 59.88 2.12 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.871 1.459 . . . . 0.31 110.813 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 266' ' ' TYR . 1.9 mm? -72.53 145.88 47.17 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.281 -0.887 . . . . 0.18 110.086 179.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.417 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -91.88 133.68 35.45 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.204 -0.935 . . . . 0.17 110.32 -179.855 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.501 ' HA ' ' O ' ' A' ' 118' ' ' LEU . 3.9 p90 -149.11 147.91 29.04 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.292 -0.88 . . . . 0.14 110.237 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.931 ' O ' HG22 ' A' ' 119' ' ' THR . 6.5 m -152.72 133.03 13.61 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.273 -0.892 . . . . 0.15 110.29 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.637 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 32.1 mtm180 -91.86 119.32 31.54 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.013 -1.054 . . . . 0.2 110.16 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.405 HD12 HG21 ' A' ' 119' ' ' THR . 0.3 OUTLIER -117.56 108.67 15.77 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -0.899 . . . . 0.22 110.3 -179.794 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 52.2 p-80 -72.17 -4.11 27.32 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.181 -0.949 . . . . 0.32 110.091 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -67.36 -30.08 69.79 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.409 -0.807 . . . . 0.33 109.581 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.81 30.65 0.63 Allowed Glycine 0 N--CA 1.489 2.174 0 N-CA-C 109.734 -1.346 . . . . 0.28 109.734 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.726 ' O ' HG22 ' A' ' 160' ' ' ILE . 57.7 mt -126.68 66.47 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 O-C-N 121.073 -1.251 . . . . 0.3 109.308 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.469 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -121.9 152.1 39.99 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.358 0.599 . . . . 0.2 110.612 -179.279 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.512 ' CB ' HD22 ' A' ' 118' ' ' LEU . 5.4 t70 -120.5 -40.04 2.71 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.317 -0.865 . . . . 0.1 109.818 179.757 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.919 HG21 HD13 ' A' ' 228' ' ' LEU . 0.6 OUTLIER -128.57 171.55 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.883 0 O-C-N 121.36 -0.838 . . . . 0.1 110.105 179.96 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.745 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 2.3 ptp -177.14 153.99 1.02 Allowed 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.539 -1.351 . . . . 0.11 111.379 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.631 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.6 tt -99.3 118.72 46.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.584 -0.698 . . . . 0.1 109.408 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.988 ' HB3' HG23 ' A' ' 123' ' ' VAL . 15.1 p -162.85 144.64 10.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 120.752 -1.218 . . . . 0.1 111.237 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.652 ' CE2' ' CG2' ' A' ' 169' ' ' ILE . 0.9 OUTLIER -66.42 122.83 18.41 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.49 -0.756 . . . . 0.09 110.006 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -80.87 127.94 8.18 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.972 -1.251 . . . . 0.2 109.972 -179.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.652 ' CG2' ' CE2' ' A' ' 167' ' ' PHE . 0.0 OUTLIER -116.07 102.66 14.0 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.535 -0.98 . . . . 0.55 109.659 179.238 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.639 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.78 81.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 121.439 0.638 . . . . 0.85 112.257 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.418 ' CG ' ' O ' ' A' ' 169' ' ' ILE . 1.7 mm-40 -125.95 -4.86 6.88 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.382 -0.824 . . . . 0.71 110.267 -179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.524 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 8.8 m-70 -87.41 -140.7 0.11 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.42 109.995 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -169.89 -36.26 0.03 OUTLIER Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.399 -1.48 . . . . 0.33 109.399 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.452 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.8 OUTLIER -61.36 -61.23 2.69 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.324 -1.104 . . . . 0.33 110.194 179.851 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -130.8 116.02 17.4 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.35 -0.844 . . . . 0.27 110.16 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 10.1 m-30 -55.41 114.43 7.24 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.144 -0.973 . . . . 0.34 110.071 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.518 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 42.9 Cg_endo -73.14 -79.06 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.907 1.477 . . . . 0.47 110.898 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.639 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -46.59 142.95 2.9 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.015 -1.053 . . . . 0.35 110.778 -179.695 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.59 ' OD2' HD22 ' A' ' 184' ' ' LEU . 4.4 p30 179.5 79.27 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.2 -0.938 . . . . 0.2 110.751 178.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.573 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 46.76 -167.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.38 -1.488 . . . . 0.25 109.38 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.491 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.2 Cg_endo -75.81 5.01 4.66 Favored 'Trans proline' 0 C--N 1.303 -1.867 0 O-C-N 124.197 1.63 . . . . 0.44 110.304 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.491 ' O ' ' O ' ' A' ' 181' ' ' PRO . 0.3 OUTLIER -44.57 173.84 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.425 -0.797 . . . . 0.57 110.898 -179.659 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.564 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.64 76.71 0.02 OUTLIER Glycine 0 N--CA 1.489 2.167 0 N-CA-C 110.895 -0.882 . . . . 0.49 110.895 -179.338 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.046 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.4 OUTLIER 179.46 88.77 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.658 0 O-C-N 121.174 -1.192 . . . . 0.41 110.373 179.41 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.557 HD12 ' OE1' ' A' ' 205' ' ' GLU . 4.6 tt -108.76 -21.13 12.82 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 120.832 -1.168 . . . . 0.3 111.612 -179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.631 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -149.97 101.09 3.0 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.48 -1.388 . . . . 0.2 111.907 -179.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.545 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.7 OUTLIER -101.76 123.78 46.29 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.473 -0.767 . . . . 0.16 109.431 178.597 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.93 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -108.88 137.32 46.99 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.001 -1.062 . . . . 0.23 110.65 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.471 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.5 OUTLIER -80.0 173.1 8.26 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.321 -0.862 . . . . 0.38 110.369 179.881 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.514 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 48.4 Cg_endo -73.75 133.34 18.45 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 123.975 1.513 . . . . 0.4 109.786 179.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.552 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.8 Cg_endo -69.79 81.17 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 123.866 1.456 . . . . 0.32 110.604 -179.65 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.55 -106.63 1.78 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.292 -1.523 . . . . 0.32 109.292 179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.95 -159.6 0.09 OUTLIER 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.882 1.464 . . . . 0.47 110.337 179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 11.1 p30 -63.07 -11.27 18.54 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.195 -0.941 . . . . 0.63 110.383 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.76 56.02 0.68 Allowed 'General case' 0 C--N 1.299 -1.599 0 O-C-N 121.428 -0.795 . . . . 0.53 110.147 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.514 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.3 174.59 22.13 Favored Glycine 0 N--CA 1.488 2.13 0 N-CA-C 109.212 -1.555 . . . . 0.25 109.212 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.552 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 42.09 25.75 0.27 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.946 -1.261 . . . . 0.1 109.946 -179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.471 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.3 OUTLIER -79.38 86.16 5.12 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.957 -1.32 . . . . 0.1 110.005 179.982 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.745 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.94 91.84 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.187 -0.946 . . . . 0.09 110.002 -179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.541 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.4 m170 -98.79 134.01 42.28 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.34 -0.85 . . . . 0.09 110.669 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.598 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 13.3 m-30 -102.74 131.07 49.83 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.255 -0.903 . . . . 0.1 109.877 179.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.957 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -46.3 91.3 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 N-CA-C 108.544 -0.91 . . . . 0.14 108.544 178.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.59 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.0 p30 -37.68 -27.26 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.337 -0.852 . . . . 0.18 111.53 -177.86 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.573 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.5 OUTLIER -77.7 3.95 12.75 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 120.762 -1.211 . . . . 0.24 110.829 179.848 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.557 ' OE1' HD12 ' A' ' 185' ' ' LEU . 15.6 mm-40 -100.68 -167.39 1.43 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.042 -1.036 . . . . 0.42 110.315 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.507 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 3.2 m -124.64 150.28 46.22 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.214 -0.929 . . . . 0.47 110.385 -179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.55 ' HB3' HD11 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -147.42 142.74 27.35 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.256 -0.902 . . . . 0.27 109.636 -179.987 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.958 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -157.81 174.21 15.63 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.822 -1.174 . . . . 0.3 110.984 179.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.476 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.5 t -130.66 41.0 3.44 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-O 121.639 0.733 . . . . 0.61 109.384 178.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.494 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.9 t -109.87 -99.72 0.39 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.444 -0.785 . . . . 0.78 110.267 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.494 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -149.59 13.37 0.83 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.068 -1.02 . . . . 0.91 110.247 -179.974 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.99 155.55 44.07 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.251 -0.906 . . . . 0.93 109.858 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.81 -175.24 53.77 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.081 -1.608 . . . . 0.79 109.081 -179.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.551 ' CE1' HD13 ' A' ' 185' ' ' LEU . 67.7 m-85 -71.26 106.53 3.86 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.176 -1.191 . . . . 0.69 109.931 179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.517 ' O ' HG12 ' A' ' 219' ' ' VAL . 61.6 m-20 -75.04 119.28 18.99 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.154 -0.966 . . . . 0.4 108.528 179.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.958 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -39.71 -37.01 0.47 Allowed 'General case' 0 C--N 1.304 -1.397 0 C-N-CA 119.82 -0.752 . . . . 0.17 110.271 -179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.571 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.3 m-30 -52.16 -48.82 64.73 Favored 'General case' 0 C--N 1.288 -2.068 0 N-CA-C 107.653 -1.24 . . . . 0.28 107.653 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.953 HD11 ' HH1' ' A' ' 3' ' ' MSB . 6.8 tp -74.56 -69.81 0.44 Allowed 'General case' 0 C--N 1.295 -1.792 0 CA-C-N 115.856 -0.611 . . . . 0.46 110.45 178.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.5 OUTLIER -50.12 -70.96 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.077 -1.014 . . . . 0.39 109.75 179.912 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -41.73 -52.55 3.87 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.989 -1.07 . . . . 0.17 111.248 179.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.571 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.47 -37.3 77.84 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.417 -1.427 . . . . 0.1 108.977 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.836 ' HB2' HD11 ' A' ' 239' ' ' LEU . 5.6 t60 -64.91 -53.39 47.22 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.421 0.629 . . . . 0.21 109.551 179.09 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.552 ' OE1' ' HB1' ' A' ' 186' ' ' ALA . 25.0 tp10 -57.99 -46.14 85.68 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.381 -0.824 . . . . 0.28 109.301 179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.531 ' CZ ' ' HB1' ' A' ' 220' ' ' ALA . 12.3 m-30 -52.57 -63.44 1.14 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.226 -0.921 . . . . 0.18 109.279 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.435 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -34.46 2.73 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 108.913 -1.675 . . . . 0.21 108.913 179.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.711 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -76.03 -79.02 0.11 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.276 -1.132 . . . . 0.17 110.839 179.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.93 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.4 -53.93 0.65 Allowed 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.666 -0.646 . . . . 0.33 111.916 -179.173 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.919 HD13 HG21 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -80.59 -44.83 18.33 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 120.998 -1.064 . . . . 0.53 110.725 -179.0 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.472 ' O ' ' HB3' ' A' ' 230' ' ' LEU . . . -63.58 -82.78 0.08 OUTLIER Glycine 0 N--CA 1.488 2.166 0 N-CA-C 109.775 -1.33 . . . . 0.41 109.775 -179.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.8 HD13 ' C ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -177.5 -170.59 0.28 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.371 -1.076 . . . . 0.45 110.299 -179.738 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.412 ' C ' ' O ' ' A' ' 230' ' ' LEU . 1.8 m-20 -42.22 -61.62 1.13 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -0.956 . . . . 0.62 110.51 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.711 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -159.51 -175.9 5.46 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.289 -0.882 . . . . 0.45 109.989 179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.0 61.52 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.543 0 O-C-N 121.295 -0.878 . . . . 0.38 109.56 179.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.907 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -149.68 24.12 0.88 Allowed 'General case' 0 N--CA 1.49 1.56 0 C-N-CA 119.279 -0.968 . . . . 0.48 111.502 -178.937 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -35.93 -51.9 1.58 Allowed Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.987 -0.685 . . . . 0.38 111.106 -179.51 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 51.1 Cg_endo -85.58 -49.67 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 123.643 1.338 . . . . 0.28 111.291 179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.19 101.25 0.14 Allowed Glycine 0 N--CA 1.497 2.709 0 C-N-CA 119.214 -1.47 . . . . 0.24 111.581 -179.599 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.907 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -143.22 -174.21 4.14 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.29 -1.124 . . . . 0.28 110.238 178.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.836 HD11 ' HB2' ' A' ' 222' ' ' HIS . 3.1 tp -88.86 27.28 1.36 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-O 122.371 1.081 . . . . 0.4 108.87 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.663 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -119.44 -6.46 10.27 Favored 'General case' 0 N--CA 1.486 1.362 0 O-C-N 120.872 -1.142 . . . . 0.45 110.655 -179.785 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.62 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -60.53 170.31 1.42 Allowed Pre-proline 0 N--CA 1.501 2.124 0 O-C-N 121.15 -0.969 . . . . 0.57 111.558 -179.16 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.566 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.1 Cg_endo -76.09 6.08 4.09 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.516 1.272 . . . . 0.76 110.597 179.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.732 HG22 HG22 ' A' ' 245' ' ' THR . 16.1 mt -126.89 164.88 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.337 -0.852 . . . . 0.89 109.506 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.666 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 33.3 p90 -139.72 -29.2 0.74 Allowed 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.914 -1.116 . . . . 0.78 111.249 -178.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.2 OUTLIER 3.18 -67.38 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.433 0 N-CA-C 114.14 1.163 . . . . 0.61 114.14 -179.263 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -59.87 101.18 0.11 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.279 -1.513 . . . . 0.74 109.816 -179.22 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.505 ' N ' ' HB2' ' A' ' 250' ' ' SER . 80.6 p -50.44 -178.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.43 -0.794 . . . . 0.81 110.146 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -56.79 -26.14 53.46 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.463 -1.455 . . . . 0.56 109.463 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.31 29.33 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.227 -1.16 . . . . 0.37 110.014 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.521 ' O ' ' ND1' ' A' ' 251' ' ' HIS . 0.5 OUTLIER -62.8 -10.98 14.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.178 -0.951 . . . . 0.44 109.982 179.958 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.521 ' ND1' ' O ' ' A' ' 250' ' ' SER . 0.1 OUTLIER -174.42 -61.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.272 -0.892 . . . . 0.53 110.204 179.966 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.497 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.3 OUTLIER 179.67 -173.31 0.2 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.27 -0.894 . . . . 0.38 110.285 -179.806 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.916 ' HB2' HG21 ' A' ' 259' ' ' VAL . 14.2 ptt? -66.55 53.15 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.605 -0.684 . . . . 0.19 110.689 179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.695 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -47.84 -46.3 62.52 Favored Pre-proline 0 C--N 1.309 -1.195 0 N-CA-C 107.833 -1.173 . . . . 0.28 107.833 177.232 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.695 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.9 Cg_endo -74.54 52.52 2.88 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.958 1.504 . . . . 0.49 110.806 178.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.639 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 9.9 m-20 -55.78 -31.51 62.67 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.159 -0.963 . . . . 0.49 110.572 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.851 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -51.35 -45.91 62.52 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 118.655 -1.218 . . . . 0.31 108.551 -179.576 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.933 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.72 -39.47 64.29 Favored 'General case' 0 C--N 1.292 -1.896 0 N-CA-C 108.453 -0.943 . . . . 0.14 108.453 178.681 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.916 HG21 ' HB2' ' A' ' 253' ' ' MET . 97.3 t -56.24 -76.78 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 O-C-N 121.544 -0.723 . . . . 0.17 110.998 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.71 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 7.1 pt20 -71.05 -34.76 71.54 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.32 -0.862 . . . . 0.26 110.567 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -44.37 -58.34 4.61 Favored Glycine 0 N--CA 1.488 2.137 0 N-CA-C 109.308 -1.517 . . . . 0.19 109.308 179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.933 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -82.87 -23.12 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.023 -1.28 . . . . 0.22 110.89 -179.56 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.722 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -62.63 -20.0 64.34 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.362 -1.462 . . . . 0.39 108.195 179.221 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.8 t -103.18 -36.92 7.93 Favored 'General case' 0 N--CA 1.49 1.547 0 C-N-CA 120.181 -0.608 . . . . 0.47 111.125 -179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.49 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 48.5 mt -88.32 -46.89 8.82 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.139 -0.976 . . . . 0.48 111.216 -178.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.749 ' HB3' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -81.33 -4.76 56.63 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.235 -0.915 . . . . 0.41 110.299 -179.644 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.465 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.8 -112.28 0.01 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.231 -1.548 . . . . 0.46 109.231 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.55 86.2 1.21 Allowed 'Trans proline' 0 C--N 1.308 -1.603 0 O-C-N 123.789 1.415 . . . . 0.58 110.296 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -55.27 170.12 1.8 Allowed Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.575 -1.41 . . . . 0.64 109.575 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.573 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 -108.82 -61.35 1.62 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.357 -1.084 . . . . 0.95 110.166 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.423 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 1.9 tm-20 54.07 30.64 12.28 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.268 -0.895 . . . . 1.2 110.259 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -172.7 102.04 0.34 Allowed Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.225 -0.922 . . . . 1.2 110.465 -179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . 0.422 ' O ' ' C ' ' A' ' 274' ' ' ASN . 46.2 Cg_endo -73.72 -7.3 19.96 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.035 1.545 . . . . 1.06 110.335 179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.422 ' C ' ' O ' ' A' ' 273' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 117.969 -1.015 . . . . 0.78 110.35 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.046 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.576 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.953 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.556 0 CA-C-O 121.258 0.551 . . . . 0.41 110.179 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 19.1 t30 -93.62 108.82 20.49 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 0.26 110.162 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.576 HG12 ' CD2' ' A' ' 107' ' ' PHE . 15.9 t -79.15 -118.85 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.315 -0.866 . . . . 0.33 109.918 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.576 ' CD2' HG12 ' A' ' 106' ' ' VAL . 77.6 m-85 -108.52 122.19 41.07 Favored Pre-proline 0 N--CA 1.488 1.446 0 O-C-N 120.774 -1.204 . . . . 0.65 110.313 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -73.9 56.72 3.66 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 O-C-N 123.896 1.472 . . . . 0.84 110.465 179.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.529 ' O ' HG23 ' A' ' 110' ' ' THR . 49.0 mtt-85 -141.14 85.78 1.99 Allowed 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.055 -1.028 . . . . 0.93 110.222 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -161.34 -51.36 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.477 -0.765 . . . . 1.03 109.256 179.772 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.481 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.6 OUTLIER 32.15 35.58 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.131 0.491 . . . . 1.04 111.461 179.012 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.883 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 7.6 mttt -124.73 64.92 1.1 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.066 -1.021 . . . . 0.77 110.357 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.628 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.1 t90 -123.3 -67.94 0.91 Allowed 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.264 -0.897 . . . . 0.42 110.043 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.468 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 72.8 p -99.38 54.51 0.96 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.322 -0.861 . . . . 0.44 110.151 179.905 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.443 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 17.5 mmtt -145.31 87.15 1.79 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.198 -0.939 . . . . 0.49 110.289 -179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.428 ' SD ' ' O ' ' A' ' 116' ' ' MET . 2.1 tmm? -121.34 -4.45 9.41 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.254 -0.904 . . . . 0.3 110.052 179.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.516 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -154.35 116.99 4.37 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.211 -0.931 . . . . 0.15 110.076 179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.429 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.0 OUTLIER -147.29 -167.1 2.69 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.246 -0.909 . . . . 0.13 110.31 -179.934 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.678 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -133.66 156.37 48.02 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.243 -0.911 . . . . 0.12 110.473 -179.987 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.804 ' CB ' HG23 ' A' ' 163' ' ' ILE . 46.0 p90 -148.11 175.99 10.57 Favored 'General case' 0 C--N 1.305 -1.346 0 C-N-CA 119.49 -0.884 . . . . 0.33 110.94 -179.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.509 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 1.1 mtt85 -124.85 151.39 45.34 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.288 -0.882 . . . . 0.54 110.114 -179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.723 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.2 pp -114.02 97.93 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.184 -0.947 . . . . 0.33 111.14 -179.693 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.889 HG23 ' HB3' ' A' ' 166' ' ' SER . 7.3 m -147.34 44.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.108 -0.995 . . . . 0.27 110.471 179.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.536 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.0 t30 -44.31 -75.17 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.069 -1.02 . . . . 0.41 109.379 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.553 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.0 t80 -179.85 -166.78 0.08 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.437 -0.79 . . . . 0.4 109.736 179.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -148.95 48.2 0.57 Allowed Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 120.982 -1.074 . . . . 0.45 110.693 179.769 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.562 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.3 Cg_endo -74.04 -87.05 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.998 1.525 . . . . 0.36 110.268 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 89.4 m-20 -91.96 -0.89 57.49 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.253 -0.904 . . . . 0.25 109.65 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.783 ' SD ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -119.55 158.83 25.52 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.395 -0.816 . . . . 0.39 109.718 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.404 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -112.31 177.03 4.78 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.161 -0.962 . . . . 0.48 110.183 -179.886 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.404 ' C ' ' O ' ' A' ' 130' ' ' THR . 1.3 t-160 -43.18 -40.12 3.18 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.4 109.71 179.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.458 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 23.3 t -61.49 -44.76 96.5 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.318 -0.864 . . . . 0.46 109.629 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.3 OUTLIER -62.63 -60.74 3.09 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.411 -0.806 . . . . 0.47 109.375 179.701 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.529 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.9 t -45.72 -36.45 2.17 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.882 -1.155 . . . . 0.31 107.882 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.516 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -58.21 -40.81 82.59 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 108.053 -1.091 . . . . 0.48 108.053 178.19 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.603 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.7 tttt -72.74 -54.56 8.6 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.76 -0.83 . . . . 0.64 108.76 178.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.862 ' HB1' HD22 ' A' ' 216' ' ' LEU . . . -45.88 -63.22 1.02 Allowed 'General case' 0 C--N 1.289 -2.029 0 O-C-N 120.958 -1.088 . . . . 0.42 110.101 179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.723 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -61.7 -55.82 26.23 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.213 -0.93 . . . . 0.34 110.849 -179.384 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 3.3 tttt -64.96 -73.2 0.13 Allowed 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.884 -1.135 . . . . 0.47 110.331 -179.243 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.37 -63.06 0.53 Allowed 'General case' 0 C--N 1.293 -1.86 0 O-C-N 121.686 -0.634 . . . . 0.47 110.562 178.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.61 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -46.51 -36.92 7.2 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.77 -1.206 . . . . 0.25 108.665 178.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -72.62 -33.05 66.4 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.361 -0.837 . . . . 0.35 108.937 178.669 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.481 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -61.29 -41.01 96.25 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 121.226 -0.921 . . . . 0.7 108.784 179.062 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.464 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 40.8 t -72.13 -48.28 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.589 -0.694 . . . . 0.61 109.294 179.207 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.827 ' HH2' HG21 ' A' ' 262' ' ' ILE . 32.0 t-105 -56.71 -40.18 75.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.44 -0.788 . . . . 0.39 109.047 179.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 149' ' ' THR . 3.2 m -73.12 -31.23 64.18 Favored 'General case' 0 C--N 1.305 -1.366 0 N-CA-C 108.598 -0.89 . . . . 0.35 108.598 178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -57.74 -43.22 85.19 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 109.132 -0.692 . . . . 0.36 109.132 179.029 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.802 HG23 HG22 ' A' ' 149' ' ' THR . 27.7 m -76.16 -33.0 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 C-N-CA 119.618 -0.833 . . . . 0.5 109.739 179.385 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.802 HG22 HG23 ' A' ' 148' ' ' VAL . 4.6 t -145.1 120.57 5.86 Favored Pre-proline 0 N--CA 1.493 1.703 0 O-C-N 121.216 -0.927 . . . . 0.51 110.149 179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.36 58.86 2.43 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.757 1.399 . . . . 0.31 110.658 -179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.647 HD21 ' CD1' ' A' ' 266' ' ' TYR . 8.8 mt -72.58 161.17 31.13 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.266 -0.896 . . . . 0.18 110.027 179.754 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.516 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 1.0 OUTLIER -104.46 102.02 11.68 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.229 -0.919 . . . . 0.17 110.255 179.95 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.581 ' CE2' ' HB3' ' A' ' 151' ' ' LEU . 37.3 m-85 -123.3 142.86 50.5 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.287 -0.883 . . . . 0.14 110.2 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.678 ' O ' HG22 ' A' ' 119' ' ' THR . 3.3 m -142.0 141.35 32.86 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.184 -0.948 . . . . 0.15 110.448 -179.955 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.644 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -100.06 91.64 4.88 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.182 -0.949 . . . . 0.2 109.985 179.876 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -94.06 106.91 18.87 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.215 -0.928 . . . . 0.22 110.153 179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.435 ' O ' ' C ' ' A' ' 158' ' ' ASP . 51.1 p-80 -63.83 -29.62 70.79 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.285 -0.884 . . . . 0.32 110.145 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.435 ' C ' ' O ' ' A' ' 157' ' ' HIS . 2.1 t0 -41.19 -30.58 0.16 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.589 -0.694 . . . . 0.33 110.098 179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.73 32.13 0.72 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.716 -1.354 . . . . 0.28 109.716 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.531 ' O ' ' CB ' ' A' ' 119' ' ' THR . 39.9 mt -121.51 71.47 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 O-C-N 121.127 -1.219 . . . . 0.3 109.513 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -138.55 156.19 47.71 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 119.888 -0.725 . . . . 0.2 110.767 -179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.429 ' CB ' HD23 ' A' ' 118' ' ' LEU . 39.0 t0 -124.64 -31.08 3.25 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.439 -0.788 . . . . 0.1 110.036 179.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.804 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -122.47 160.66 24.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 121.236 -0.915 . . . . 0.1 109.912 179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.727 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -165.36 140.96 5.23 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.373 -1.454 . . . . 0.11 111.6 -179.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.635 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.9 tt -90.32 116.67 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.508 -0.745 . . . . 0.1 109.538 179.234 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.889 ' HB3' HG23 ' A' ' 123' ' ' VAL . 3.7 p -156.1 159.88 39.45 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 120.921 -1.112 . . . . 0.1 110.46 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.584 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 5.8 p90 -76.55 116.59 17.37 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.409 -0.807 . . . . 0.09 109.735 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.48 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -64.16 119.69 16.83 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 110.434 -1.066 . . . . 0.2 110.434 -179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.584 ' O ' HG23 ' A' ' 169' ' ' ILE . 1.7 tp -117.09 97.9 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.639 -0.918 . . . . 0.55 109.532 179.277 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.603 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.09 92.73 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 112.634 0.605 . . . . 0.85 112.634 -179.589 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.495 ' HB2' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER -156.03 17.1 0.36 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.344 -0.847 . . . . 0.71 110.606 179.883 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.581 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 2.2 m170 -82.58 -90.21 0.08 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.097 -1.002 . . . . 0.42 110.207 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -177.35 -36.73 0.06 OUTLIER Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.42 -1.472 . . . . 0.33 109.42 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 176' ' ' TYR . 0.7 OUTLIER -148.41 -65.59 0.24 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.301 -1.117 . . . . 0.33 110.185 179.905 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.46 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 58.0 t80 -42.13 92.98 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.424 -0.798 . . . . 0.27 110.403 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 174' ' ' ASP . 10.9 m-30 -47.9 104.44 0.41 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.315 -0.866 . . . . 0.34 110.264 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.819 ' O ' HD23 ' A' ' 184' ' ' LEU . 49.1 Cg_endo -79.72 -64.52 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 O-C-N 124.09 1.574 . . . . 0.47 110.677 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.603 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -72.64 138.33 46.64 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.072 -1.017 . . . . 0.35 111.07 -179.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.532 ' N ' ' OD2' ' A' ' 202' ' ' ASP . 0.5 OUTLIER 178.79 78.23 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 119.071 -1.052 . . . . 0.2 111.652 178.861 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.569 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 35.41 -153.66 0.01 OUTLIER Glycine 0 N--CA 1.495 2.585 0 N-CA-C 110.86 -0.896 . . . . 0.25 110.86 178.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.477 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -74.93 3.39 5.62 Favored 'Trans proline' 0 C--N 1.303 -1.863 0 O-C-N 124.554 1.818 . . . . 0.44 110.361 -179.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.535 ' O ' ' N ' ' A' ' 184' ' ' LEU . 14.1 t -40.15 162.04 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.536 -0.728 . . . . 0.57 110.256 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.554 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -59.13 76.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.498 -1.041 . . . . 0.49 110.498 -179.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.977 ' HA ' HG13 ' A' ' 1' ' ' HAV . 9.9 tp 179.76 84.92 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.391 -1.064 . . . . 0.41 110.047 179.829 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.606 HD12 ' OE1' ' A' ' 205' ' ' GLU . 0.4 OUTLIER -100.92 -25.27 14.14 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.742 -1.224 . . . . 0.3 111.07 -179.898 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.647 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.4 105.07 3.29 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.68 -1.262 . . . . 0.2 111.928 -179.237 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.598 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 21.2 p-80 -110.65 122.55 48.06 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.175 -0.953 . . . . 0.16 109.437 178.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.912 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -116.29 131.3 56.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.196 -0.94 . . . . 0.23 110.422 -179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.581 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.7 OUTLIER -73.48 169.33 18.76 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.377 -0.827 . . . . 0.38 110.675 -179.801 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.529 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.8 Cg_endo -73.59 144.0 35.07 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.171 1.617 . . . . 0.4 109.618 179.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.2 Cg_endo -70.71 81.12 1.09 Allowed 'Trans proline' 0 C--N 1.301 -1.942 0 O-C-N 123.91 1.479 . . . . 0.32 110.82 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.4 -107.28 2.03 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.466 -1.454 . . . . 0.32 109.466 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -75.76 -162.76 0.17 Allowed 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.927 1.488 . . . . 0.47 110.731 -179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.7 p30 -57.85 -15.43 8.43 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.278 -0.889 . . . . 0.63 110.316 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -105.22 54.96 0.7 Allowed 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.496 -0.753 . . . . 0.53 110.251 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.529 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.4 170.09 21.06 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 109.409 -1.476 . . . . 0.25 109.409 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.538 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.76 27.44 0.35 Allowed Glycine 0 N--CA 1.488 2.159 0 N-CA-C 109.62 -1.392 . . . . 0.1 109.62 -179.825 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.513 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 2.0 m-20 -76.75 92.12 3.54 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.093 -1.239 . . . . 0.1 110.087 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.878 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -74.69 98.63 3.48 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.324 -0.86 . . . . 0.09 109.954 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.598 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 29.2 m170 -117.47 126.03 51.93 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.218 -0.926 . . . . 0.09 110.688 -179.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.563 ' O ' ' N ' ' A' ' 203' ' ' ASP . 32.6 m-85 -93.41 141.97 27.85 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.116 -0.99 . . . . 0.1 110.571 179.727 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.874 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.1 OUTLIER -49.0 92.43 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 108.183 -1.043 . . . . 0.14 108.183 178.398 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.613 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 4.3 p30 -37.21 -27.96 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.242 -0.911 . . . . 0.18 111.604 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.569 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.7 t0 -75.56 -1.62 25.28 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 120.568 -1.333 . . . . 0.24 110.994 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.606 ' OE1' HD12 ' A' ' 185' ' ' LEU . 21.4 mm-40 -94.15 -163.52 1.06 Allowed 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.937 -1.102 . . . . 0.42 110.379 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.424 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 0.2 OUTLIER -125.94 150.84 47.69 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.213 -0.929 . . . . 0.47 110.729 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.613 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -143.36 140.86 30.7 Favored 'General case' 0 N--CA 1.497 1.885 0 O-C-N 121.401 -0.812 . . . . 0.27 109.295 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.985 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.18 177.67 11.04 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.877 -1.139 . . . . 0.3 110.95 -179.809 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.47 ' O ' ' OG ' ' A' ' 209' ' ' SER . 2.0 t -131.56 45.95 2.72 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.584 0.707 . . . . 0.61 109.6 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.1 t -112.38 -105.62 0.38 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.464 -0.773 . . . . 0.78 110.164 -179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 210' ' ' SER . 25.2 p -157.48 17.85 0.27 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.97 -1.081 . . . . 0.91 110.268 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.475 ' O ' ' O ' ' A' ' 213' ' ' GLY . 4.2 mttp -125.91 -86.45 0.61 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.306 -0.871 . . . . 0.93 110.193 -179.879 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.475 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . -49.08 -178.3 0.01 OUTLIER Glycine 0 N--CA 1.483 1.818 0 N-CA-C 109.806 -1.317 . . . . 0.79 109.806 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.441 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 94.8 m-85 -57.08 115.15 2.47 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.265 -1.138 . . . . 0.69 109.992 179.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.637 ' ND2' HG22 ' A' ' 247' ' ' THR . 9.9 m-80 -82.67 116.03 21.87 Favored 'General case' 0 C--N 1.302 -1.492 0 O-C-N 121.088 -1.008 . . . . 0.4 109.044 179.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.985 HD12 ' O ' ' A' ' 208' ' ' THR . 1.2 mp -41.73 -33.38 0.49 Allowed 'General case' 0 C--N 1.301 -1.533 0 O-C-N 121.436 -0.79 . . . . 0.17 110.283 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.61 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 5.2 m-85 -53.44 -45.07 69.33 Favored 'General case' 0 C--N 1.282 -2.331 0 C-N-CA 118.07 -1.452 . . . . 0.28 107.431 178.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.037 HD21 ' HB2' ' A' ' 244' ' ' TYR . 20.9 tp -82.52 -71.0 0.51 Allowed 'General case' 0 C--N 1.296 -1.75 0 CA-C-N 115.523 -0.762 . . . . 0.46 110.993 179.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.849 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -47.86 -56.61 1.74 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 O-C-N 120.909 -1.119 . . . . 0.39 110.19 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.977 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.56 -46.92 87.51 Favored 'General case' 0 C--N 1.296 -1.745 0 O-C-N 120.968 -1.083 . . . . 0.17 111.131 179.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -60.33 -23.6 64.35 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 120.164 -1.585 . . . . 0.1 108.454 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.661 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 3.4 t-160 -80.43 -50.04 10.63 Favored 'General case' 0 C--N 1.3 -1.584 0 N-CA-C 109.373 -0.603 . . . . 0.21 109.373 179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.878 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.7 tp10 -62.31 -33.32 74.44 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.065 -1.022 . . . . 0.28 108.442 178.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.554 ' CE1' HD11 ' A' ' 163' ' ' ILE . 6.2 m-85 -64.78 -66.87 0.49 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.669 0.747 . . . . 0.18 108.99 178.682 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.453 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.35 -28.15 0.54 Allowed Glycine 0 N--CA 1.486 2.013 0 N-CA-C 108.762 -1.735 . . . . 0.21 108.762 179.519 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.431 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 3.3 m80 -81.42 -68.07 0.72 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.217 -1.166 . . . . 0.17 110.842 179.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.912 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.2 OUTLIER -40.36 -42.78 1.63 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.505 -0.747 . . . . 0.33 111.88 -178.893 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.798 HD12 ' OH ' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -101.16 -37.77 8.42 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 120.885 -1.134 . . . . 0.53 111.364 -178.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.498 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -65.09 -81.86 0.12 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 110.624 -0.99 . . . . 0.41 110.624 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.508 HD13 ' C ' ' A' ' 109' ' ' ARG . 0.8 OUTLIER -169.85 -147.83 0.06 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.195 -1.18 . . . . 0.45 110.658 -178.838 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -86.87 -44.48 11.65 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.356 -0.84 . . . . 0.62 110.532 -179.862 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.594 ' CG ' ' O ' ' A' ' 231' ' ' ASP . 0.9 OUTLIER -179.99 161.88 0.97 Allowed 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.323 -0.861 . . . . 0.45 110.284 -179.937 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 5.5 p -168.67 28.91 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.265 -0.897 . . . . 0.38 109.797 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.922 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -104.3 22.45 14.8 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.453 -0.779 . . . . 0.48 111.002 -179.315 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.543 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -35.25 -50.37 1.24 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.559 -0.713 . . . . 0.38 110.685 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.543 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 47.5 Cg_endo -86.73 -49.14 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 123.433 1.228 . . . . 0.28 111.14 179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.06 101.33 0.14 Allowed Glycine 0 N--CA 1.498 2.81 0 C-N-CA 119.137 -1.506 . . . . 0.24 111.544 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.922 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -145.36 173.58 11.87 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.371 -1.076 . . . . 0.28 109.7 178.317 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.607 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.5 OUTLIER -80.85 38.31 0.45 Allowed 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.826 -1.171 . . . . 0.4 109.916 179.577 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.661 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 25.6 mtp -123.01 -17.61 6.67 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.994 -1.066 . . . . 0.45 109.746 179.339 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.645 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -56.0 170.25 0.47 Allowed Pre-proline 0 N--CA 1.496 1.868 0 O-C-N 121.184 -0.948 . . . . 0.57 110.97 -179.649 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.544 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 46.3 Cg_endo -73.73 -10.9 23.77 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 O-C-N 123.626 1.329 . . . . 0.76 110.006 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.656 HG22 HG22 ' A' ' 245' ' ' THR . 36.5 mt -104.84 147.25 11.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.379 -0.826 . . . . 0.89 109.787 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 1.037 ' HB2' HD21 ' A' ' 218' ' ' LEU . 41.8 p90 -131.25 -24.45 2.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.78 111.115 -178.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.738 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.2 OUTLIER 2.88 -68.97 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.446 0 N-CA-C 113.534 0.938 . . . . 0.61 113.534 -179.086 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.738 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -62.72 107.02 0.88 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.447 -1.408 . . . . 0.74 109.5 -179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.637 HG22 ' ND2' ' A' ' 215' ' ' ASN . 42.7 p -54.1 -176.3 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.337 -0.852 . . . . 0.81 110.215 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.04 -9.76 54.66 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.317 -1.513 . . . . 0.56 109.317 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.0 mttt -149.27 29.85 0.78 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.194 -1.18 . . . . 0.37 110.526 179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.446 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.6 OUTLIER -73.84 -31.52 63.23 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.996 -1.065 . . . . 0.44 110.091 179.896 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -146.8 -60.23 0.29 Allowed 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.343 -0.848 . . . . 0.53 109.913 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.58 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 179.42 -175.61 0.26 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.3 -0.875 . . . . 0.38 110.306 179.976 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.861 ' HB2' HG21 ' A' ' 259' ' ' VAL . 25.9 ptt? -68.83 52.5 0.08 Allowed 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.308 -0.87 . . . . 0.19 110.416 179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.683 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.2 -46.85 44.82 Favored Pre-proline 0 N--CA 1.484 1.245 0 N-CA-C 107.912 -1.144 . . . . 0.28 107.912 177.514 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.683 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.3 Cg_endo -73.81 52.3 2.52 Favored 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 123.956 1.503 . . . . 0.49 110.715 177.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.662 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 12.4 m-20 -57.22 -28.58 63.01 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.371 -0.831 . . . . 0.49 110.436 179.848 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.911 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 2.0 m-20 -51.31 -45.44 62.23 Favored 'General case' 0 C--N 1.307 -1.258 0 O-C-N 121.015 -1.053 . . . . 0.31 109.235 -179.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.844 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.02 -34.18 50.75 Favored 'General case' 0 C--N 1.297 -1.674 0 N-CA-C 108.365 -0.976 . . . . 0.14 108.365 178.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.861 HG21 ' HB2' ' A' ' 253' ' ' MET . 98.6 t -58.6 -74.41 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 C-N-CA 119.899 -0.72 . . . . 0.17 110.533 179.581 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.735 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 14.1 pt20 -69.9 -37.05 75.87 Favored 'General case' 0 C--N 1.304 -1.39 0 O-C-N 121.267 -0.896 . . . . 0.26 109.769 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.508 ' N ' ' HG3' ' A' ' 260' ' ' GLN . . . -41.53 -53.92 4.17 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.466 -1.454 . . . . 0.19 109.466 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.883 HG22 ' NZ ' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -92.1 -23.58 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 120.963 -1.316 . . . . 0.22 110.97 -179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.735 ' HB3' ' HA ' ' A' ' 260' ' ' GLN . 7.1 tp60 -54.81 -26.12 32.82 Favored 'General case' 0 C--N 1.304 -1.374 0 C-N-CA 118.001 -1.48 . . . . 0.39 107.947 179.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 4.1 p -103.92 -41.68 5.8 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-O 121.244 0.545 . . . . 0.47 111.127 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.503 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . 4.0 mm? -73.95 -51.85 14.72 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.233 -0.917 . . . . 0.48 111.477 -178.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.798 ' OH ' HD12 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -76.18 -9.67 58.81 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.144 -0.972 . . . . 0.41 110.533 -179.487 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.409 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -60.38 -111.42 0.01 OUTLIER Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.356 -1.498 . . . . 0.46 109.356 179.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.72 88.98 0.87 Allowed 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.819 1.431 . . . . 0.58 110.226 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -71.29 168.53 50.67 Favored Glycine 0 N--CA 1.49 2.255 0 N-CA-C 109.605 -1.398 . . . . 0.64 109.605 -179.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.628 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 1.3 m-20 -96.61 -72.8 0.62 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.323 -1.104 . . . . 0.95 110.247 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.468 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 2.3 tt0 58.24 20.36 7.08 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 1.2 110.259 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 270' ' ' ASP . 9.8 p-10 -177.66 142.63 0.48 Allowed Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.269 -0.894 . . . . 1.2 110.077 179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -70.04 -13.17 33.64 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.026 1.54 . . . . 1.06 110.453 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.575 0 CA-C-O 117.994 -1.003 . . . . 0.78 110.075 179.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.977 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.591 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.824 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 121.273 0.559 . . . . 0.41 110.197 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 -86.64 80.27 8.63 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.189 -0.945 . . . . 0.26 110.236 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.531 HG12 ' N ' ' A' ' 107' ' ' PHE . 22.3 t -82.81 174.25 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.308 -0.87 . . . . 0.33 110.12 179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.531 ' N ' HG12 ' A' ' 106' ' ' VAL . 0.4 OUTLIER -56.17 134.22 74.98 Favored Pre-proline 0 N--CA 1.491 1.625 0 O-C-N 121.289 -0.882 . . . . 0.65 110.194 -179.917 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.492 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 48.8 Cg_endo -74.61 -158.11 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.698 0 O-C-N 123.921 1.485 . . . . 0.84 110.061 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.819 ' O ' HD12 ' A' ' 230' ' ' LEU . 45.4 mtt180 69.73 75.55 0.22 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.268 -0.895 . . . . 0.93 110.271 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.488 ' O ' ' C ' ' A' ' 111' ' ' LEU . 1.1 p -137.2 -64.87 0.55 Allowed 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.423 -0.798 . . . . 1.03 109.444 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.488 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER 30.92 38.48 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.834 0 CA-C-O 121.208 0.528 . . . . 1.04 111.356 179.223 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.529 ' HE2' HD22 ' A' ' 265' ' ' LEU . 0.8 OUTLIER -135.96 61.27 1.65 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.228 -0.92 . . . . 0.77 109.536 179.913 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.624 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 8.3 t90 -131.19 -50.78 1.02 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.467 -0.771 . . . . 0.42 110.682 -179.334 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.533 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 28.5 t -111.89 62.85 0.62 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.298 -0.876 . . . . 0.44 110.928 -179.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.458 ' HG2' ' C ' ' A' ' 114' ' ' SER . 19.5 mmmt -149.09 42.05 0.92 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.074 -1.017 . . . . 0.49 110.334 179.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.484 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 2.2 ttp -72.77 -19.58 61.33 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.137 -0.977 . . . . 0.3 110.837 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 1.052 ' O ' HD22 ' A' ' 118' ' ' LEU . 5.7 p30 -138.48 113.23 9.05 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.094 -1.004 . . . . 0.15 110.743 -179.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.052 HD22 ' O ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -143.47 -179.68 6.57 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.287 -0.883 . . . . 0.13 110.261 179.796 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.912 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -124.04 173.53 8.2 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.271 -0.893 . . . . 0.12 110.078 179.837 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.599 ' CZ ' ' CG ' ' A' ' 155' ' ' ARG . 14.6 p90 -167.78 179.25 4.85 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.128 -0.982 . . . . 0.33 111.008 179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.424 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 22.9 tpt85 -126.03 147.66 49.5 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.382 -0.824 . . . . 0.54 109.989 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.712 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.1 pp -110.36 77.82 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.266 -0.896 . . . . 0.33 110.789 -179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.971 HG23 ' HB3' ' A' ' 166' ' ' SER . 8.3 m -125.54 42.17 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.018 -1.051 . . . . 0.27 110.299 179.531 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.734 ' ND2' HG13 ' A' ' 134' ' ' VAL . 0.0 OUTLIER -40.33 -80.61 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.567 -0.853 . . . . 0.41 109.212 -179.459 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.667 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 2.9 t80 -178.9 169.33 1.6 Allowed 'General case' 0 C--N 1.3 -1.562 0 O-C-N 121.044 -1.035 . . . . 0.4 110.293 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.564 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -125.23 49.69 3.6 Favored Pre-proline 0 N--CA 1.494 1.726 0 O-C-N 121.149 -0.97 . . . . 0.45 110.481 -179.97 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.564 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.1 Cg_endo -73.97 -87.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.121 1.59 . . . . 0.36 110.317 179.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -97.08 2.1 50.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.284 -0.885 . . . . 0.25 109.805 179.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.991 ' HE2' HD21 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -117.88 159.15 23.57 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.414 -0.804 . . . . 0.39 109.829 179.844 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.411 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -109.73 175.96 5.25 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.224 -0.923 . . . . 0.48 110.103 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.475 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 71.6 t60 -43.39 -32.41 0.84 Allowed 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.261 -0.9 . . . . 0.4 109.738 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.458 ' O ' ' HB3' ' A' ' 135' ' ' GLU . 1.3 t -68.42 -59.16 3.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.468 -0.77 . . . . 0.46 109.752 179.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 32.8 mp0 -51.46 -59.87 3.76 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.309 -0.87 . . . . 0.47 109.645 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.734 HG13 ' ND2' ' A' ' 124' ' ' ASN . 6.2 t -46.04 -37.91 2.88 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.641 0 N-CA-C 108.261 -1.015 . . . . 0.31 108.261 178.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.596 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 12.1 tt0 -57.63 -39.1 76.2 Favored 'General case' 0 N--CA 1.485 1.322 0 N-CA-C 108.347 -0.983 . . . . 0.48 108.347 178.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.1 OUTLIER -73.84 -52.66 12.31 Favored 'General case' 0 N--CA 1.487 1.383 0 CA-C-O 121.948 0.88 . . . . 0.64 108.819 178.67 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.827 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.48 -64.19 0.78 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.112 -0.993 . . . . 0.42 110.508 179.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.712 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -63.17 -53.73 48.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.334 -0.854 . . . . 0.34 111.327 -178.884 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.65 -72.03 0.18 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.928 -1.107 . . . . 0.47 110.371 -179.159 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -39.49 -61.84 0.75 Allowed 'General case' 0 C--N 1.291 -1.937 0 O-C-N 121.697 -0.627 . . . . 0.47 110.494 178.959 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.548 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -45.62 -37.99 6.17 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 118.795 -1.162 . . . . 0.25 108.291 178.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.536 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.2 OUTLIER -70.37 -37.83 74.66 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 109.029 -0.73 . . . . 0.35 109.029 178.457 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.463 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.1 ttpt -55.38 -40.66 71.64 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.358 -0.839 . . . . 0.7 108.754 179.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.413 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 24.1 t -68.5 -44.84 82.79 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 O-C-N 121.69 -0.632 . . . . 0.61 109.342 179.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.66 ' HH2' HG21 ' A' ' 262' ' ' ILE . 29.1 t-105 -56.3 -41.5 76.04 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.424 -0.797 . . . . 0.39 109.161 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.54 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.5 OUTLIER -71.11 -34.42 71.06 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.288 -0.883 . . . . 0.35 108.858 178.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 1.1 m-20 -57.41 -41.64 80.76 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.602 -0.686 . . . . 0.36 109.625 179.346 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.589 HG22 ' O ' ' A' ' 145' ' ' TRP . 28.4 m -78.24 -29.86 15.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 O-C-N 121.372 -0.83 . . . . 0.5 110.116 179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.541 HG21 HG12 ' A' ' 262' ' ' ILE . 13.4 t -152.27 141.91 14.59 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.94 -1.1 . . . . 0.51 110.586 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -71.37 58.0 2.33 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.895 1.471 . . . . 0.31 110.313 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.619 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.3 OUTLIER -77.01 138.41 39.57 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.18 110.265 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -100.16 120.52 40.0 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.187 -0.946 . . . . 0.17 109.995 179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.51 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 6.0 p90 -137.57 141.01 41.35 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.16 -0.963 . . . . 0.14 110.389 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.912 ' O ' HG22 ' A' ' 119' ' ' THR . 2.6 m -139.58 134.5 32.22 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.327 -0.858 . . . . 0.15 110.011 179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.599 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 1.1 mtm180 -92.64 89.63 6.77 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.048 -1.033 . . . . 0.2 109.731 -179.859 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 3.6 mt -88.23 107.65 18.9 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.233 -0.917 . . . . 0.22 110.52 -179.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 9.0 p-80 -66.61 -11.9 55.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.171 -0.955 . . . . 0.32 109.79 179.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -54.53 -21.73 11.02 Favored 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.649 -0.657 . . . . 0.33 109.515 179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 121.56 15.78 4.39 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.477 -1.449 . . . . 0.28 109.477 -179.847 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.53 ' O ' ' HB ' ' A' ' 119' ' ' THR . 24.3 mm -106.22 78.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.119 -1.224 . . . . 0.3 108.943 179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.77 124.78 45.94 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 121.532 -0.73 . . . . 0.2 111.018 -178.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.684 ' HB2' HD12 ' A' ' 118' ' ' LEU . 14.8 t70 -94.08 -46.31 7.18 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.372 -0.83 . . . . 0.1 109.393 179.264 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.004 HD13 HD22 ' A' ' 228' ' ' LEU . 12.2 pt -128.56 177.94 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.498 -0.751 . . . . 0.1 109.302 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.78 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 4.0 ptt? -177.28 154.62 1.05 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.598 -1.314 . . . . 0.11 111.242 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.609 HG23 ' N ' ' A' ' 124' ' ' ASN . 3.0 tt -102.55 119.81 51.44 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.403 -0.811 . . . . 0.1 109.547 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.971 ' HB3' HG23 ' A' ' 123' ' ' VAL . 5.1 p -160.57 148.23 16.04 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.774 -1.204 . . . . 0.1 111.176 -179.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.667 ' CD1' ' CD1' ' A' ' 125' ' ' TYR . 3.2 p90 -68.95 116.35 9.31 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.594 -0.691 . . . . 0.09 109.523 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.465 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -74.42 113.38 4.06 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 110.367 -1.093 . . . . 0.2 110.367 -178.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.568 ' O ' ' C ' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -111.04 99.84 9.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.427 -1.043 . . . . 0.55 109.585 179.04 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.634 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.26 83.01 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.346 0 CA-C-O 121.365 0.602 . . . . 0.85 112.553 -179.401 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.7 pp20? -130.59 -3.51 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.32 -0.863 . . . . 0.71 110.192 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 19.8 m-70 -75.62 -80.28 0.09 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.156 -0.965 . . . . 0.42 110.042 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 135.57 -39.57 1.65 Allowed Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.587 -1.405 . . . . 0.33 109.587 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -77.46 -88.0 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.231 -1.158 . . . . 0.33 110.33 -179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.482 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.1 OUTLIER -88.21 136.12 33.12 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.21 -0.932 . . . . 0.27 110.274 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -93.94 108.46 35.26 Favored Pre-proline 0 N--CA 1.492 1.65 0 O-C-N 121.24 -0.912 . . . . 0.34 109.745 179.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.482 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 45.2 Cg_endo -77.51 -68.69 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.998 1.525 . . . . 0.47 110.581 -179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.634 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 6.3 p90 -40.81 136.8 1.33 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.309 -0.87 . . . . 0.35 110.749 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.497 ' OD1' ' HB2' ' A' ' 182' ' ' SER . 11.1 p30 179.21 78.75 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.157 -0.964 . . . . 0.2 110.759 178.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.55 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 43.17 -158.06 0.1 OUTLIER Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.421 -1.472 . . . . 0.25 109.421 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.473 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.6 Cg_endo -77.04 8.52 3.14 Favored 'Trans proline' 0 C--N 1.302 -1.913 0 O-C-N 124.101 1.58 . . . . 0.44 110.304 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.497 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 58.3 m -44.67 172.18 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.258 -0.901 . . . . 0.57 110.444 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 184' ' ' LEU . . . -62.91 73.4 0.03 OUTLIER Glycine 0 N--CA 1.488 2.106 0 C-N-CA 120.393 -0.908 . . . . 0.49 110.893 -179.35 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.051 ' HA ' HG13 ' A' ' 1' ' ' HAV . 3.2 tt 179.82 87.39 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.014 -1.286 . . . . 0.41 111.002 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.509 HD13 ' CE2' ' A' ' 214' ' ' TYR . 8.3 tt -103.72 -22.61 13.53 Favored 'General case' 0 N--CA 1.492 1.643 0 C-N-CA 118.686 -1.205 . . . . 0.3 110.88 179.423 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.659 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.21 100.0 2.86 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 120.72 -1.237 . . . . 0.2 111.973 -179.044 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.563 ' NE2' ' CB ' ' A' ' 200' ' ' HIS . 1.2 p80 -100.8 127.38 47.27 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.958 -1.089 . . . . 0.16 109.111 178.43 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.94 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -115.0 126.22 54.51 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 120.961 -1.087 . . . . 0.23 110.651 -178.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.471 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 2.4 m-85 -71.85 155.93 91.57 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.268 -0.895 . . . . 0.38 110.185 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.521 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.5 Cg_endo -72.3 141.65 35.96 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 O-C-N 123.945 1.497 . . . . 0.4 109.93 179.641 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -70.48 64.99 2.23 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.028 1.541 . . . . 0.32 110.783 -179.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -100.47 -103.36 2.57 Favored Glycine 0 N--CA 1.49 2.285 0 N-CA-C 109.244 -1.543 . . . . 0.32 109.244 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -73.16 -159.8 0.09 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.925 1.487 . . . . 0.47 110.314 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 43.8 p-10 -65.02 -9.34 21.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.142 -0.974 . . . . 0.63 110.373 -179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.05 59.37 0.61 Allowed 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.34 -0.85 . . . . 0.53 110.147 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.521 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -137.16 164.81 25.27 Favored Glycine 0 N--CA 1.489 2.233 0 N-CA-C 109.073 -1.611 . . . . 0.25 109.073 -179.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.975 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 57.95 16.93 27.22 Favored Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.354 -1.498 . . . . 0.1 109.354 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.664 ' OD1' ' HE2' ' A' ' 164' ' ' MET . 8.4 m-20 -81.94 88.71 6.36 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.256 -1.144 . . . . 0.1 110.466 -179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.78 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.43 115.51 4.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.191 -0.943 . . . . 0.09 109.894 179.806 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.563 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 15.0 m170 -123.44 127.79 48.92 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.315 -0.865 . . . . 0.09 111.003 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 11.3 m-30 -96.76 132.41 42.49 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.311 -0.868 . . . . 0.1 110.223 179.311 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.821 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.3 OUTLIER -49.98 93.18 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 107.97 -1.122 . . . . 0.14 107.97 178.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 3.4 p30 -35.21 -28.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.599 -0.688 . . . . 0.18 112.267 -177.597 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.55 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.1 OUTLIER -78.61 3.31 16.6 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 120.427 -1.421 . . . . 0.24 110.971 -179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.549 ' HG3' ' CB ' ' A' ' 202' ' ' ASP . 18.0 mm-40 -97.99 -168.97 1.74 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.934 -1.104 . . . . 0.42 110.229 179.864 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.501 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 12.5 m -122.29 151.53 41.02 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.18 -0.95 . . . . 0.47 110.383 -179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.536 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.2 m-90 -148.09 141.02 24.79 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.306 -0.871 . . . . 0.27 109.67 179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.024 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -159.0 179.63 8.89 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.999 -1.063 . . . . 0.3 110.62 -179.999 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 3.9 t -125.28 49.84 1.85 Allowed 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 119.807 -0.757 . . . . 0.61 109.551 178.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 15.9 t -125.84 -144.62 0.31 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.564 -0.71 . . . . 0.78 109.962 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 56.6 p -101.95 -27.97 12.66 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.166 -0.959 . . . . 0.91 110.147 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.448 ' O ' ' O ' ' A' ' 213' ' ' GLY . 2.2 mppt? -93.01 -176.84 4.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.356 -0.84 . . . . 0.93 110.364 -179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.448 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 48.58 -176.47 0.02 OUTLIER Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.614 -1.394 . . . . 0.79 109.614 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.509 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.1 m-85 -79.79 118.09 21.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -1.081 . . . . 0.69 109.606 179.402 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.669 ' ND2' HG23 ' A' ' 247' ' ' THR . 7.8 p30 -83.13 124.77 30.81 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 120.933 -1.105 . . . . 0.4 108.818 179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.024 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -42.2 -36.92 1.32 Allowed 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.367 -0.833 . . . . 0.17 110.522 -179.273 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.575 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 2.8 m-85 -50.98 -47.12 61.46 Favored 'General case' 0 C--N 1.288 -2.068 0 C-N-CA 118.419 -1.312 . . . . 0.28 107.793 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.684 HD11 ' HH1' ' A' ' 3' ' ' MSB . 20.3 tp -77.65 -70.7 0.46 Allowed 'General case' 0 C--N 1.293 -1.861 0 CA-C-N 115.683 -0.689 . . . . 0.46 110.912 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.861 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -49.18 -63.42 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.035 -1.041 . . . . 0.39 109.903 -179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.904 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -50.93 -52.28 43.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.161 -0.962 . . . . 0.17 111.287 179.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.575 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.89 -35.06 66.11 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.183 -1.573 . . . . 0.1 108.912 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.649 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.6 t60 -69.11 -49.48 56.72 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.212 0.529 . . . . 0.21 109.738 179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.668 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.5 tp10 -64.1 -27.48 69.12 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.28 108.777 178.398 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.418 ' HE2' ' CD2' ' A' ' 142' ' ' PHE . 5.2 m-30 -70.2 -61.42 1.78 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 109.043 -0.725 . . . . 0.18 109.043 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -48.62 -27.72 6.28 Favored Glycine 0 N--CA 1.484 1.895 0 N-CA-C 108.802 -1.719 . . . . 0.21 108.802 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.528 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 1.8 m80 -81.41 -65.36 1.02 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.155 -1.203 . . . . 0.17 111.601 -179.841 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.94 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -58.32 -29.82 66.21 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.278 -0.889 . . . . 0.33 111.971 -178.381 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 1.004 HD22 HD13 ' A' ' 163' ' ' ILE . 7.0 tp -100.21 -39.72 7.91 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.098 -1.001 . . . . 0.53 111.623 -178.421 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.466 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -78.36 -79.07 0.78 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 110.211 -1.156 . . . . 0.41 110.211 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.819 HD12 ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -170.83 -166.79 0.51 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.127 -1.22 . . . . 0.45 110.846 -179.318 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.515 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 1.0 OUTLIER -55.12 -55.92 25.65 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.381 -0.824 . . . . 0.62 110.573 -179.766 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.596 ' CD2' ' HB3' ' A' ' 240' ' ' MET . 0.7 OUTLIER -167.25 -179.6 4.61 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.145 -0.972 . . . . 0.45 110.763 179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.471 ' O ' ' HB3' ' A' ' 257' ' ' ASP . 9.9 t 179.5 51.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.015 -0.735 . . . . 0.38 109.015 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.686 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -128.6 22.03 5.96 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.403 -0.811 . . . . 0.48 111.247 -179.056 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.55 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -40.96 -52.38 6.82 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.438 -0.905 . . . . 0.38 110.101 179.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.55 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -87.04 -49.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.614 1.323 . . . . 0.28 110.589 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.495 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.56 99.21 0.12 Allowed Glycine 0 N--CA 1.499 2.867 0 C-N-CA 119.435 -1.364 . . . . 0.24 111.543 -179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.865 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.82 162.8 35.11 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.189 -1.183 . . . . 0.28 110.103 178.655 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.598 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -72.5 58.92 0.42 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.242 -0.911 . . . . 0.4 108.823 179.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.649 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 1.4 mtt -142.74 -36.95 0.38 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.335 -0.853 . . . . 0.45 110.432 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.596 ' HB2' ' HD2' ' A' ' 242' ' ' PRO . 0.1 OUTLIER -46.01 174.98 0.03 OUTLIER Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 121.235 -0.916 . . . . 0.57 110.377 179.951 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.596 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 48.6 Cg_endo -78.43 22.57 0.63 Allowed 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 123.476 1.25 . . . . 0.76 111.127 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.714 HG22 HG22 ' A' ' 245' ' ' THR . 12.6 mm -127.76 140.79 48.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.085 -1.01 . . . . 0.89 109.107 179.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.671 ' HB2' HD21 ' A' ' 218' ' ' LEU . 54.3 p90 -126.29 -31.27 2.81 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 120.869 -1.145 . . . . 0.78 110.633 -179.158 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.714 HG22 HG22 ' A' ' 243' ' ' ILE . 0.0 OUTLIER 3.8 -78.52 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.441 0 N-CA-C 113.152 0.797 . . . . 0.61 113.152 -179.335 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.677 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -43.82 114.79 0.7 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.7 -1.25 . . . . 0.74 109.687 -179.472 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.669 HG23 ' ND2' ' A' ' 215' ' ' ASN . 6.1 m -72.6 172.86 9.82 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.317 -0.865 . . . . 0.81 110.306 -179.656 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.425 ' H ' HG22 ' A' ' 247' ' ' THR . . . -53.13 -22.35 13.44 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.351 -1.5 . . . . 0.56 109.351 179.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.19 48.1 1.68 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.314 -1.109 . . . . 0.37 110.193 179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.14 -61.03 1.87 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.228 -0.92 . . . . 0.44 110.465 -179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.676 ' CD2' ' CE2' ' A' ' 252' ' ' PHE . 0.1 OUTLIER -133.38 -77.16 0.48 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.19 -0.944 . . . . 0.53 110.649 -179.678 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.676 ' CE2' ' CD2' ' A' ' 251' ' ' HIS . 23.1 m-85 -151.17 -178.03 6.39 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.07 -1.019 . . . . 0.38 110.948 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.965 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.7 58.18 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.672 -0.642 . . . . 0.19 110.018 179.498 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.73 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 2.6 mp -44.32 -47.08 24.92 Favored Pre-proline 0 N--CA 1.486 1.365 0 N-CA-C 108.066 -1.087 . . . . 0.28 108.066 177.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.73 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 42.5 Cg_endo -72.49 46.34 0.97 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 O-C-N 123.894 1.47 . . . . 0.49 111.231 177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.56 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.5 m-20 -46.7 -32.74 3.77 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.576 -1.328 . . . . 0.49 110.367 -179.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.865 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.83 -54.62 40.02 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 118.948 -1.101 . . . . 0.31 109.241 -179.372 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.088 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.88 -33.69 76.43 Favored 'General case' 0 C--N 1.296 -1.74 0 C-N-CA 119.174 -1.01 . . . . 0.14 108.873 179.125 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.965 HG21 ' HB2' ' A' ' 253' ' ' MET . 74.2 t -67.41 -86.97 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.476 -0.765 . . . . 0.17 110.566 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.626 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.2 tt0 -52.84 -42.18 64.95 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.008 -1.058 . . . . 0.26 109.353 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.72 -70.91 0.45 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 110.368 -1.093 . . . . 0.19 110.368 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.088 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -72.82 -18.75 18.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.735 -1.45 . . . . 0.22 110.035 -179.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 1.083 ' N ' HD13 ' A' ' 262' ' ' ILE . 6.6 tt0 -64.37 -21.97 66.8 Favored 'General case' 0 C--N 1.296 -1.752 0 C-N-CA 118.854 -1.138 . . . . 0.39 108.355 178.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.3 p -103.7 -42.42 5.64 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 120.222 -0.591 . . . . 0.47 111.502 -179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.529 HD22 ' HE2' ' A' ' 112' ' ' LYS . 7.6 mp -86.15 -46.18 10.65 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.265 -0.897 . . . . 0.48 111.266 -178.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.619 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -77.95 -14.24 59.6 Favored 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.306 -0.871 . . . . 0.41 110.404 -179.425 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.484 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.33 -94.62 0.01 OUTLIER Glycine 0 N--CA 1.49 2.253 0 N-CA-C 108.889 -1.684 . . . . 0.46 108.889 179.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -77.43 109.73 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 O-C-N 124.083 1.57 . . . . 0.58 110.244 179.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.442 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -82.38 132.96 11.51 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.552 -1.419 . . . . 0.64 109.552 -179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.624 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -78.59 -66.42 0.86 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.261 -1.141 . . . . 0.95 110.283 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.533 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 27.5 tt0 58.03 21.66 8.07 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.16 -0.962 . . . . 1.2 110.032 -179.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 273' ' ' PRO . 0.6 OUTLIER -171.27 99.85 0.4 Allowed Pre-proline 0 N--CA 1.49 1.566 0 O-C-N 121.374 -0.829 . . . . 1.2 110.245 179.871 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 272' ' ' ASP . 45.0 Cg_endo -71.21 66.12 2.68 Favored 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 124.046 1.551 . . . . 1.06 110.417 179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 118.022 -0.989 . . . . 0.78 110.232 -179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.051 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.63 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.684 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.188 0.518 . . . . 0.41 110.319 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.475 ' C ' HG23 ' A' ' 106' ' ' VAL . 8.5 m-80 -141.09 131.07 24.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.273 -0.892 . . . . 0.26 110.129 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.475 HG23 ' C ' ' A' ' 105' ' ' ASN . 11.6 t -149.28 -62.56 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.17 -0.957 . . . . 0.33 110.648 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -110.37 99.09 39.06 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.65 110.896 -179.53 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.431 ' C ' ' HG3' ' A' ' 109' ' ' ARG . 47.7 Cg_endo -75.02 54.19 3.58 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.861 1.453 . . . . 0.84 109.966 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.679 ' O ' HD12 ' A' ' 230' ' ' LEU . 11.9 mtt180 -138.77 53.18 1.78 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.279 -0.888 . . . . 0.93 110.28 -179.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.685 ' HA ' HD12 ' A' ' 230' ' ' LEU . 4.8 p -119.97 -55.77 2.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.258 -0.901 . . . . 1.03 109.851 179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.509 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.5 mm? 39.12 47.69 1.38 Allowed 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.552 -0.718 . . . . 1.04 111.118 179.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.594 ' HB3' HD23 ' A' ' 265' ' ' LEU . 2.1 tptm -128.17 60.99 1.46 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.096 -1.003 . . . . 0.77 109.967 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.557 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 10.7 t90 -139.48 -65.55 0.47 Allowed 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.311 -0.868 . . . . 0.42 110.637 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.467 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 79.1 p -98.85 46.15 0.99 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.329 -0.857 . . . . 0.44 110.562 -179.475 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 6.9 mmpt? -130.09 76.41 1.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.184 -0.947 . . . . 0.49 110.248 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.403 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 8.5 tmm? -111.85 -3.4 14.91 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.095 -1.003 . . . . 0.3 110.173 179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.493 ' HA ' ' O ' ' A' ' 152' ' ' ASN . 3.4 p-10 -159.11 125.78 4.62 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.372 -0.83 . . . . 0.15 109.859 179.876 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.472 HD23 ' CB ' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.4 -177.06 5.55 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.237 -0.914 . . . . 0.13 110.751 -179.503 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.832 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -127.29 165.88 18.85 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.452 -0.78 . . . . 0.12 109.848 179.717 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.576 ' CB ' HG13 ' A' ' 163' ' ' ILE . 46.1 p90 -162.89 -176.77 5.1 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.025 -1.047 . . . . 0.33 111.367 -179.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.3 mtm180 -140.38 155.45 46.75 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.572 -0.705 . . . . 0.54 110.23 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.898 ' O ' HD13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -114.41 123.5 70.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.494 -0.754 . . . . 0.33 111.134 -179.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.888 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.2 m -165.86 39.81 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.875 . . . . 0.27 109.72 178.702 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.488 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 0.9 OUTLIER -39.68 -80.27 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.55 -0.718 . . . . 0.41 109.395 179.863 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.689 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.9 t80 -179.2 -159.54 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.602 0 O-C-N 121.432 -0.792 . . . . 0.4 109.527 179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -154.0 50.38 0.56 Allowed Pre-proline 0 N--CA 1.494 1.763 0 O-C-N 120.903 -1.123 . . . . 0.45 110.656 179.749 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.65 -85.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.807 1.425 . . . . 0.36 110.388 179.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -96.6 0.45 49.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.255 -0.903 . . . . 0.25 109.982 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.572 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -118.03 160.04 22.18 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.265 -0.897 . . . . 0.39 110.168 -179.809 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.405 ' O ' ' C ' ' A' ' 131' ' ' HIS . 1.7 m -106.33 168.86 8.87 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.185 -0.947 . . . . 0.48 110.254 179.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.405 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.9 OUTLIER -44.7 -32.13 1.4 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.258 -0.901 . . . . 0.4 109.806 179.674 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -66.28 -49.36 67.37 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.315 -0.865 . . . . 0.46 109.562 179.616 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.572 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 1.8 mp0 -60.79 -57.64 11.84 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.249 -0.907 . . . . 0.47 109.17 179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.689 HG21 ' O ' ' A' ' 125' ' ' TYR . 5.6 t -46.22 -36.89 2.77 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 107.761 -1.2 . . . . 0.31 107.761 178.156 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.494 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.6 OUTLIER -56.89 -42.38 79.74 Favored 'General case' 0 C--N 1.307 -1.24 0 N-CA-C 108.03 -1.1 . . . . 0.48 108.03 178.133 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.539 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.4 tttt -71.24 -49.98 37.63 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.65 -0.87 . . . . 0.64 108.65 178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.827 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.83 -57.39 4.36 Favored 'General case' 0 C--N 1.29 -1.993 0 O-C-N 120.96 -1.087 . . . . 0.42 109.749 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CD2' HG13 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.11 -56.29 13.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.34 -0.85 . . . . 0.34 110.734 -179.65 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.602 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.61 -73.17 0.14 Allowed 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.126 -0.984 . . . . 0.47 110.157 -179.494 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.539 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -36.87 -60.99 0.58 Allowed 'General case' 0 C--N 1.291 -1.951 0 O-C-N 121.823 -0.548 . . . . 0.47 110.667 178.788 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.46 -40.95 19.48 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.618 -1.301 . . . . 0.25 108.709 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.538 ' CD2' ' O ' ' A' ' 138' ' ' PHE . 2.5 m-85 -69.38 -32.97 72.35 Favored 'General case' 0 N--CA 1.488 1.429 0 O-C-N 121.104 -0.998 . . . . 0.35 108.774 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 17.1 tttm -56.15 -41.66 75.75 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.977 -1.119 . . . . 0.7 107.977 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.493 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.9 t -67.11 -41.91 87.64 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.341 0 N-CA-C 108.537 -0.912 . . . . 0.61 108.537 178.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.594 ' CH2' HG13 ' A' ' 262' ' ' ILE . 25.5 t-105 -54.9 -38.67 67.89 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 108.819 -0.808 . . . . 0.39 108.819 178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 149' ' ' THR . 0.7 OUTLIER -75.95 -41.23 52.18 Favored 'General case' 0 C--N 1.304 -1.383 0 O-C-N 121.347 -0.846 . . . . 0.35 108.74 178.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.493 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 3.0 m-20 -50.47 -33.3 20.72 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 108.968 -0.753 . . . . 0.36 108.968 178.851 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.539 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 27.0 m -91.16 -38.52 10.71 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 O-C-N 121.532 -0.73 . . . . 0.5 110.108 179.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.59 HG23 ' O ' ' A' ' 149' ' ' THR . 14.1 t -149.43 124.15 4.78 Favored Pre-proline 0 N--CA 1.491 1.61 0 O-C-N 121.078 -1.014 . . . . 0.51 110.136 179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.21 59.27 2.37 Favored 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.859 1.452 . . . . 0.31 110.599 -179.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.856 HD21 ' O ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -73.81 139.24 45.0 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.276 -0.89 . . . . 0.18 110.154 179.86 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.493 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 7.4 t-20 -76.62 105.49 7.71 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.196 -0.94 . . . . 0.17 109.912 179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.503 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 7.8 p90 -117.34 143.67 45.72 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.36 -0.838 . . . . 0.14 110.479 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.502 ' O ' ' HA ' ' A' ' 119' ' ' THR . 20.5 m -141.27 145.6 35.74 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.216 -0.927 . . . . 0.15 110.125 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.519 ' CG ' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -124.84 79.87 1.82 Allowed 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.706 -0.621 . . . . 0.2 110.152 -178.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 156' ' ' LEU . 0.1 OUTLIER -85.42 114.73 22.69 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.197 -0.939 . . . . 0.22 110.092 179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 12.3 p-80 -56.42 -18.0 9.79 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.232 -0.917 . . . . 0.32 109.98 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -52.42 -23.25 5.75 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.449 -0.782 . . . . 0.33 109.632 179.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 126.42 7.94 5.11 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.534 -1.426 . . . . 0.28 109.534 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.832 HG22 HG21 ' A' ' 119' ' ' THR . 8.7 mt -87.91 91.81 3.67 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 O-C-N 121.126 -1.22 . . . . 0.3 109.034 179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.466 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -154.98 107.07 2.7 Favored 'General case' 0 C--N 1.302 -1.473 0 C-N-CA 119.968 -0.693 . . . . 0.2 110.336 -179.3 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.472 ' CB ' HD23 ' A' ' 118' ' ' LEU . 0.5 OUTLIER -76.51 -42.74 42.22 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.249 -0.907 . . . . 0.1 109.808 179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.02 HG21 HD12 ' A' ' 228' ' ' LEU . 1.1 pt -118.09 171.91 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.322 -0.861 . . . . 0.1 109.546 179.381 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.873 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 1.8 ptp -170.08 157.28 6.41 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.715 -1.241 . . . . 0.11 111.188 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.61 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.0 tt -104.9 120.78 55.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.279 -0.888 . . . . 0.1 109.806 179.471 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.888 ' HB3' HG23 ' A' ' 123' ' ' VAL . 11.5 p -162.45 156.4 21.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.786 -1.196 . . . . 0.1 111.142 -179.825 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.576 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.9 p90 -73.17 118.43 16.12 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.493 -0.755 . . . . 0.09 109.272 179.554 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -76.9 131.66 11.54 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 110.46 -1.056 . . . . 0.2 110.46 -178.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.583 ' O ' ' C ' ' A' ' 170' ' ' LYS . 2.5 tp -126.34 93.36 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.614 -0.933 . . . . 0.55 109.154 179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.601 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 0.87 92.68 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 CA-C-O 121.358 0.599 . . . . 0.85 112.466 -179.153 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 10.5 tt0 -148.69 17.22 1.01 Allowed 'General case' 0 C--N 1.302 -1.458 0 O-C-N 121.343 -0.848 . . . . 0.71 109.861 179.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.403 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m170 -78.96 -68.84 0.62 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.39 -0.819 . . . . 0.42 110.306 -179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 130.72 34.86 0.42 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.446 -1.461 . . . . 0.33 109.446 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 54.1 t0 -149.06 -69.52 0.21 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.314 -1.11 . . . . 0.33 110.091 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 45.6 p90 -123.29 174.48 7.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.251 -0.906 . . . . 0.27 110.167 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.566 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 4.4 m-30 -98.57 110.34 56.49 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.218 -0.926 . . . . 0.34 110.237 179.917 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.514 ' HD2' ' HD2' ' A' ' 170' ' ' LYS . 41.9 Cg_endo -73.33 -72.64 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.765 0 O-C-N 123.968 1.51 . . . . 0.47 110.616 -179.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.601 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.6 OUTLIER -49.58 142.05 8.68 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.15 -0.969 . . . . 0.35 110.575 -179.901 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.506 ' O ' ' HB2' ' A' ' 182' ' ' SER . 5.5 p30 179.64 80.3 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.202 -0.936 . . . . 0.2 110.453 179.139 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 41.72 -155.4 0.09 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.606 -1.398 . . . . 0.25 109.606 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.461 ' O ' ' O ' ' A' ' 182' ' ' SER . 51.7 Cg_endo -77.34 8.65 3.18 Favored 'Trans proline' 0 C--N 1.303 -1.854 0 O-C-N 124.077 1.567 . . . . 0.44 110.573 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.509 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.2 t -42.75 166.64 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.166 -0.959 . . . . 0.57 110.318 -179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.555 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.45 73.53 0.01 OUTLIER Glycine 0 N--CA 1.489 2.186 0 N-CA-C 110.712 -0.955 . . . . 0.49 110.712 -179.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.002 ' HA ' HG13 ' A' ' 1' ' ' HAV . 1.0 OUTLIER 179.86 87.47 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.193 -1.181 . . . . 0.41 110.649 179.603 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.799 HD12 ' OE1' ' A' ' 205' ' ' GLU . 7.8 tt -103.85 -23.05 13.42 Favored 'General case' 0 N--CA 1.491 1.586 0 C-N-CA 118.616 -1.234 . . . . 0.3 110.969 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.631 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -151.94 106.2 3.18 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.524 -1.36 . . . . 0.2 112.333 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.541 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.2 OUTLIER -101.84 133.02 47.26 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.044 -1.035 . . . . 0.16 109.229 178.427 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.913 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -122.09 118.72 29.38 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.134 -0.978 . . . . 0.23 110.476 -179.068 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.464 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-85 -67.86 167.48 16.68 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.16 -0.963 . . . . 0.38 110.372 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.508 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.4 Cg_endo -72.89 136.65 25.54 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.145 1.603 . . . . 0.4 109.856 179.504 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -69.0 84.62 0.53 Allowed 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.903 1.475 . . . . 0.32 110.561 -179.53 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -129.9 -102.22 0.99 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.958 -1.257 . . . . 0.32 109.958 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -72.34 -163.6 0.15 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 124.011 1.532 . . . . 0.47 110.859 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -67.89 -7.28 26.94 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.404 -0.81 . . . . 0.63 110.152 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -110.46 48.13 0.93 Allowed 'General case' 0 C--N 1.3 -1.587 0 O-C-N 121.383 -0.823 . . . . 0.53 109.838 -179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.508 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -136.06 169.23 23.71 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.029 -1.629 . . . . 0.25 109.029 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.963 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 57.31 17.68 25.78 Favored Glycine 0 N--CA 1.486 1.977 0 N-CA-C 109.088 -1.605 . . . . 0.1 109.088 -179.733 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -77.86 91.31 4.14 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.429 -1.042 . . . . 0.1 110.508 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.873 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -73.47 95.93 2.32 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.247 -0.908 . . . . 0.09 109.866 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.541 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 28.7 m170 -111.93 134.45 53.48 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.09 110.887 -179.275 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.558 ' O ' ' N ' ' A' ' 203' ' ' ASP . 14.4 m-85 -104.51 137.6 42.13 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.154 -0.966 . . . . 0.1 110.59 179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.909 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -47.03 92.71 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 108.554 -0.906 . . . . 0.14 108.554 179.009 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.599 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 3.2 p30 -36.88 -27.32 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.607 0 O-C-N 121.516 -0.74 . . . . 0.18 112.046 -177.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.537 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 1.0 OUTLIER -78.79 2.93 18.17 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.488 -1.383 . . . . 0.24 110.848 179.978 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.799 ' OE1' HD12 ' A' ' 185' ' ' LEU . 11.6 mm-40 -95.91 -168.52 1.77 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.942 -1.099 . . . . 0.42 110.237 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.8 m -123.72 140.21 53.22 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.209 -0.932 . . . . 0.47 110.498 -179.755 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.599 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.8 OUTLIER -138.26 146.33 42.41 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.291 -0.881 . . . . 0.27 109.312 179.727 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.008 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -158.33 178.61 9.98 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 120.959 -1.088 . . . . 0.3 110.792 179.975 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 29.9 t -130.48 32.37 4.44 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-O 121.534 0.683 . . . . 0.61 109.285 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.503 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.3 t -103.98 -90.87 0.38 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.545 -0.722 . . . . 0.78 110.686 -179.268 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.503 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER -157.21 -33.97 0.08 Allowed 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.462 -0.774 . . . . 0.91 109.793 -179.779 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.415 ' O ' ' C ' ' A' ' 213' ' ' GLY . 3.5 pttt -87.91 -171.96 3.64 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.322 -0.861 . . . . 0.93 109.932 179.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 45.42 -155.59 0.44 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.243 -1.543 . . . . 0.79 109.243 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.595 ' CE2' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -94.13 126.24 39.24 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.172 -1.193 . . . . 0.69 109.931 179.69 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.616 ' O ' HG12 ' A' ' 219' ' ' VAL . 42.6 m-80 -89.65 121.4 31.8 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.018 -1.051 . . . . 0.4 108.879 179.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.008 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.59 -37.84 1.22 Allowed 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 119.611 -0.836 . . . . 0.17 110.375 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 3.1 m-30 -51.67 -46.91 63.98 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.382 -1.327 . . . . 0.28 107.585 179.662 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.834 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -76.26 -73.4 0.28 Allowed 'General case' 0 C--N 1.295 -1.773 0 CA-C-N 115.781 -0.645 . . . . 0.46 110.277 178.793 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.88 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.61 -65.31 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.091 -1.006 . . . . 0.39 110.302 -179.789 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -49.66 -48.87 49.17 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.366 -0.834 . . . . 0.17 111.737 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.57 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.99 -41.71 92.66 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.185 -1.572 . . . . 0.1 108.645 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.59 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 5.3 t60 -60.2 -51.26 70.33 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 121.377 0.608 . . . . 0.21 109.792 178.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.67 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.0 tp10 -64.8 -29.16 70.12 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.092 -1.005 . . . . 0.28 109.138 178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.528 ' CG ' ' O ' ' A' ' 220' ' ' ALA . 13.8 m-30 -66.12 -64.28 0.89 Allowed 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.447 -0.783 . . . . 0.18 109.177 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -49.84 -26.7 8.52 Favored Glycine 0 N--CA 1.486 1.972 0 N-CA-C 109.045 -1.622 . . . . 0.21 109.045 179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.622 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.6 OUTLIER -78.93 -58.7 3.11 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.081 -1.247 . . . . 0.17 111.557 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.913 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -69.22 -23.77 63.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.322 -0.861 . . . . 0.33 111.78 -178.074 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 1.02 HD12 HG21 ' A' ' 163' ' ' ILE . 0.8 OUTLIER -99.21 -43.82 6.48 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.028 -1.045 . . . . 0.53 111.258 -178.663 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.509 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -83.03 -70.86 1.33 Allowed Glycine 0 N--CA 1.49 2.238 0 C-N-CA 120.184 -1.008 . . . . 0.41 110.589 -178.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.685 HD12 ' HA ' ' A' ' 110' ' ' THR . 0.4 OUTLIER -165.01 -162.11 0.6 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.09 -1.241 . . . . 0.45 110.86 -178.897 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.565 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -75.01 -51.7 12.93 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.62 110.34 -179.95 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.622 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.8 OUTLIER -162.48 172.79 14.96 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.256 -0.903 . . . . 0.45 110.959 179.914 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.455 ' HB2' HD11 ' A' ' 230' ' ' LEU . 5.7 t 179.56 44.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.615 -0.678 . . . . 0.38 109.24 179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.673 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -117.19 20.26 13.8 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.421 -0.799 . . . . 0.48 111.005 -179.292 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.577 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -30.55 -53.81 0.38 Allowed Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 121.894 -0.503 . . . . 0.38 111.507 -179.72 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.7 Cg_endo -89.49 -47.44 0.03 OUTLIER 'Trans proline' 0 C--N 1.309 -1.544 0 O-C-N 123.4 1.21 . . . . 0.28 111.063 179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.12 100.54 0.13 Allowed Glycine 0 N--CA 1.498 2.786 0 C-N-CA 119.498 -1.334 . . . . 0.24 111.268 -179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.935 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -146.78 168.73 20.67 Favored 'General case' 0 N--CA 1.497 1.921 0 O-C-N 121.131 -1.217 . . . . 0.28 110.518 179.048 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.558 HD21 ' N ' ' A' ' 222' ' ' HIS . 0.7 OUTLIER -73.67 55.42 0.51 Allowed 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.301 -0.875 . . . . 0.4 109.011 179.465 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.576 ' HA ' ' NE2' ' A' ' 222' ' ' HIS . 1.9 mtt -140.87 -5.6 1.15 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.288 -0.882 . . . . 0.45 111.356 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.605 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -79.71 168.82 23.4 Favored Pre-proline 0 N--CA 1.501 2.079 0 O-C-N 120.932 -1.105 . . . . 0.57 110.134 179.903 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.4 Cg_endo -69.56 -4.27 13.56 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.848 1.447 . . . . 0.76 110.665 -179.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.605 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 50.2 mm -104.63 143.87 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.301 -0.874 . . . . 0.89 109.808 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.834 ' HB2' HD21 ' A' ' 218' ' ' LEU . 42.8 p90 -131.39 -28.95 1.83 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.948 -1.095 . . . . 0.78 110.913 -179.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.53 ' C ' ' O ' ' A' ' 244' ' ' TYR . 98.8 m 2.79 -69.63 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.397 0 N-CA-C 113.412 0.893 . . . . 0.61 113.412 -179.307 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.582 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -55.81 101.3 0.05 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 120.604 -1.31 . . . . 0.74 109.511 -179.395 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.51 ' N ' ' HB3' ' A' ' 250' ' ' SER . 0.2 OUTLIER -48.09 179.5 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.431 -0.793 . . . . 0.81 110.263 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -51.71 -29.25 25.16 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.446 -1.461 . . . . 0.56 109.446 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 16.6 tttt -143.1 31.24 1.39 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.223 -1.163 . . . . 0.37 110.084 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.51 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.4 OUTLIER -59.56 -23.03 62.56 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.268 -0.895 . . . . 0.44 110.186 -179.822 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.573 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 6.8 t-80 -156.21 -67.08 0.11 Allowed 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.29 -0.882 . . . . 0.53 110.004 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.573 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.1 m-85 -168.38 -178.36 3.54 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.267 -0.895 . . . . 0.38 110.164 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.974 ' HB2' HG21 ' A' ' 259' ' ' VAL . 5.6 ptt? -72.26 54.99 0.32 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.547 -0.72 . . . . 0.19 110.225 179.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.726 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 7.6 tp -45.03 -46.07 28.53 Favored Pre-proline 0 N--CA 1.485 1.298 0 N-CA-C 107.975 -1.12 . . . . 0.28 107.975 177.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.726 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -71.58 48.19 0.99 Allowed 'Trans proline' 0 C--N 1.316 -1.148 0 O-C-N 123.76 1.4 . . . . 0.49 110.944 177.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.673 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.2 m-20 -52.63 -27.14 15.86 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.855 -1.153 . . . . 0.49 110.575 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.935 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -57.15 -43.76 82.78 Favored 'General case' 0 C--N 1.303 -1.44 0 C-N-CA 118.578 -1.249 . . . . 0.31 109.454 -179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.944 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -79.57 -32.95 42.1 Favored 'General case' 0 C--N 1.298 -1.641 0 C-N-CA 119.184 -1.006 . . . . 0.14 108.548 178.844 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.974 HG21 ' HB2' ' A' ' 253' ' ' MET . 54.4 t -65.43 -75.12 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 CA-C-O 121.816 0.817 . . . . 0.17 110.019 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.628 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.0 OUTLIER -63.57 -34.1 77.07 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.472 -0.768 . . . . 0.26 109.612 179.623 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -49.53 -67.24 1.85 Allowed Glycine 0 N--CA 1.49 2.286 0 N-CA-C 110.124 -1.19 . . . . 0.19 110.124 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.944 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -70.35 -21.7 23.49 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 120.811 -1.405 . . . . 0.22 109.895 -179.567 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.674 ' N ' HD13 ' A' ' 262' ' ' ILE . 20.4 tp60 -67.31 -19.44 65.47 Favored 'General case' 0 C--N 1.296 -1.724 0 O-C-N 121.028 -1.045 . . . . 0.39 108.625 178.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.1 m -103.41 -38.6 7.12 Favored 'General case' 0 N--CA 1.491 1.607 0 C-N-CA 120.119 -0.633 . . . . 0.47 111.709 -179.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.594 HD23 ' HB3' ' A' ' 112' ' ' LYS . 8.5 mp -97.79 -42.51 7.56 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.179 -0.951 . . . . 0.48 111.166 -178.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.856 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -72.15 -21.48 61.45 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.37 -0.831 . . . . 0.41 109.808 -179.804 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -55.6 -97.6 0.01 OUTLIER Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.293 -1.523 . . . . 0.46 109.293 179.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.7 108.29 2.52 Favored 'Trans proline' 0 C--N 1.305 -1.744 0 O-C-N 124.044 1.549 . . . . 0.58 110.258 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.469 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.17 151.43 23.59 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.696 -1.362 . . . . 0.64 109.696 -179.755 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.557 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 6.8 t0 -95.05 -57.79 2.33 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.31 -1.112 . . . . 0.95 110.203 179.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.467 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 14.5 tt0 43.85 38.01 1.93 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.239 -0.913 . . . . 1.2 110.192 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -158.87 144.17 11.91 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.303 -0.873 . . . . 1.2 110.036 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -73.25 91.91 0.84 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.033 1.544 . . . . 1.06 110.32 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 118.08 -0.962 . . . . 0.78 110.262 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.002 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.606 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.631 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.464 ' CD1' ' N ' ' A' ' 104' ' ' TYR . 34.4 p90 . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.287 0.565 . . . . 0.41 110.204 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -151.85 85.18 1.29 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.26 110.17 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.1 t -92.25 -40.31 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.198 -0.939 . . . . 0.33 110.2 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.1 106.13 33.9 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.836 . . . . 0.65 110.217 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.441 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.9 Cg_endo -72.86 -159.06 0.07 OUTLIER 'Trans proline' 0 C--N 1.304 -1.787 0 O-C-N 123.927 1.488 . . . . 0.84 110.287 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' O ' HD12 ' A' ' 230' ' ' LEU . 47.5 mtt-85 64.99 75.24 0.37 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.213 -0.93 . . . . 0.93 110.304 179.731 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.521 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -158.21 -58.4 0.08 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.463 -0.773 . . . . 1.03 109.71 179.803 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.534 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 5.9 mp 32.08 37.05 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 CA-C-O 121.079 0.466 . . . . 1.04 111.454 179.426 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.477 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.0 OUTLIER -121.51 42.6 3.05 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.167 -0.958 . . . . 0.77 109.869 179.754 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.579 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 22.7 t90 -110.63 -65.94 1.12 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.336 -0.853 . . . . 0.42 110.106 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.517 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 31.9 t -102.36 60.18 0.82 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.372 -0.83 . . . . 0.44 110.267 -179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 0.0 OUTLIER -146.26 85.48 1.66 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.205 -0.935 . . . . 0.49 110.617 -179.953 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.412 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 ttt -119.82 -18.33 8.29 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.3 110.101 179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.427 ' O ' ' OD1' ' A' ' 117' ' ' ASN . 8.7 p30 -157.3 111.88 2.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.342 -0.849 . . . . 0.15 109.984 179.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.447 HD13 HD21 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -133.08 -160.29 1.04 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.169 -0.957 . . . . 0.13 110.466 -179.799 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.613 HG22 ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -137.91 155.35 49.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.288 -0.883 . . . . 0.12 110.275 180.0 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.856 ' HB3' HG23 ' A' ' 163' ' ' ILE . 13.2 p90 -152.73 -167.6 2.79 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.247 -0.908 . . . . 0.33 110.857 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.412 ' N ' ' CD2' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -139.36 155.94 47.33 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.252 -0.905 . . . . 0.54 110.662 -179.644 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.852 ' O ' HG13 ' A' ' 123' ' ' VAL . 5.6 pt -112.67 115.75 50.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.413 -0.805 . . . . 0.33 110.698 -179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.852 HG13 ' O ' ' A' ' 122' ' ' ILE . 1.1 m -165.72 42.15 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 O-C-N 121.201 -0.937 . . . . 0.27 110.301 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.518 ' OD1' ' N ' ' A' ' 125' ' ' TYR . 2.5 t-20 -42.28 -73.61 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.298 -0.876 . . . . 0.41 109.742 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.729 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.8 t80 -179.32 -155.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.428 -0.795 . . . . 0.4 109.497 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.558 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -161.26 51.47 0.36 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 120.942 -1.099 . . . . 0.45 110.583 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.558 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -78.14 -85.14 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.906 1.477 . . . . 0.36 109.963 179.627 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -92.93 -2.09 56.12 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.345 -0.847 . . . . 0.25 109.638 179.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.914 ' SD ' HD21 ' A' ' 216' ' ' LEU . 0.2 OUTLIER -121.06 160.75 22.98 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.379 -0.826 . . . . 0.39 110.137 179.986 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.14 -175.05 2.61 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.299 -0.875 . . . . 0.48 110.211 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.418 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.7 OUTLIER -48.46 -37.49 17.48 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.903 . . . . 0.4 109.978 179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.484 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t -60.47 -50.08 75.01 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.186 -0.946 . . . . 0.46 109.845 179.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 7.7 mp0 -64.88 -63.64 1.06 Allowed 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.194 -0.941 . . . . 0.47 109.92 179.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.729 HG21 ' O ' ' A' ' 125' ' ' TYR . 16.3 t -42.96 -37.64 0.84 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 N-CA-C 108.694 -0.854 . . . . 0.31 108.694 178.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.614 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 6.5 mt-10 -59.24 -43.23 92.4 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 108.387 -0.968 . . . . 0.48 108.387 178.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.563 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.5 tttp -70.33 -47.34 61.52 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.416 -0.957 . . . . 0.64 108.416 178.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.819 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -45.79 -60.71 2.07 Favored 'General case' 0 C--N 1.29 -2.018 0 O-C-N 121.31 -0.868 . . . . 0.42 110.101 179.693 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.709 ' CE2' HD12 ' A' ' 122' ' ' ILE . 0.2 OUTLIER -66.96 -52.31 44.37 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.3 -0.875 . . . . 0.34 110.897 -179.185 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 4.1 tttt -66.58 -73.53 0.13 Allowed 'General case' 0 N--CA 1.494 1.761 0 O-C-N 120.84 -1.162 . . . . 0.47 110.124 -179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.525 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.71 -60.8 0.79 Allowed 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.754 -0.592 . . . . 0.47 110.779 179.006 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.56 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.28 -38.93 13.42 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.54 -1.264 . . . . 0.25 108.341 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.517 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -70.08 -33.66 72.19 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 119.611 -0.836 . . . . 0.35 108.976 178.61 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.458 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.8 OUTLIER -56.31 -41.55 76.17 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 107.931 -1.137 . . . . 0.7 107.931 178.561 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.427 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 12.6 t -66.05 -41.73 90.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 N-CA-C 108.578 -0.897 . . . . 0.61 108.578 178.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.589 ' CH2' HG13 ' A' ' 262' ' ' ILE . 27.9 t-105 -56.88 -39.21 73.94 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 108.818 -0.808 . . . . 0.39 108.818 178.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 149' ' ' THR . 69.1 m -73.19 -37.05 66.62 Favored 'General case' 0 N--CA 1.486 1.342 0 O-C-N 121.427 -0.796 . . . . 0.35 108.854 178.852 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.427 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.5 OUTLIER -54.89 -37.51 66.39 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.586 -0.696 . . . . 0.36 109.359 179.076 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.552 HG22 ' O ' ' A' ' 145' ' ' TRP . 26.8 m -84.82 -34.86 9.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.447 0 O-C-N 121.394 -0.816 . . . . 0.5 110.195 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.577 ' OG1' HD13 ' A' ' 151' ' ' LEU . 14.4 t -152.12 131.63 6.87 Favored Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 121.033 -1.042 . . . . 0.51 110.264 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.41 59.05 3.15 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.965 1.508 . . . . 0.31 110.808 -179.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.009 HD21 ' CG ' ' A' ' 266' ' ' TYR . 3.6 mp -76.88 169.09 18.96 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.276 -0.89 . . . . 0.18 110.014 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.414 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 0.7 OUTLIER -114.64 116.42 28.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.147 -0.97 . . . . 0.17 110.568 -179.716 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.532 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.4 p90 -126.33 125.78 42.85 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.39 -0.819 . . . . 0.14 109.723 179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.613 ' O ' HG22 ' A' ' 119' ' ' THR . 10.7 m -125.72 133.08 52.24 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.197 -0.94 . . . . 0.15 110.62 -179.548 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.625 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.31 81.71 2.24 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.224 -0.923 . . . . 0.2 109.877 179.904 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.617 ' HG ' HD13 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -60.43 129.79 43.36 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.31 -0.869 . . . . 0.22 110.49 -179.764 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -91.79 40.61 1.04 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.44 -0.787 . . . . 0.32 109.921 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.607 ' OD2' HD11 ' A' ' 160' ' ' ILE . 3.2 t0 -135.55 -38.95 0.73 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.396 -0.815 . . . . 0.33 109.52 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 144.2 37.64 0.07 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.661 -1.376 . . . . 0.28 109.661 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.617 HD13 ' HG ' ' A' ' 156' ' ' LEU . 3.1 mp -123.82 69.45 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.197 -1.178 . . . . 0.3 109.6 179.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.45 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -144.47 156.29 44.12 Favored 'General case' 0 C--N 1.3 -1.565 0 C-N-CA 120.032 -0.667 . . . . 0.2 110.111 -179.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -121.39 -23.52 5.66 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.289 -0.882 . . . . 0.1 110.337 -179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.856 HG23 ' HB3' ' A' ' 120' ' ' TYR . 1.2 tt -125.49 168.51 18.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 121.178 -0.951 . . . . 0.1 110.142 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.851 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 11.9 ptp -177.3 151.47 0.79 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.522 -1.361 . . . . 0.11 111.645 -179.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.698 ' O ' HG23 ' A' ' 165' ' ' ILE . 5.4 tt -97.98 112.68 30.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.593 -0.692 . . . . 0.1 110.032 179.132 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.76 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.4 p -153.76 149.71 27.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.901 -1.125 . . . . 0.1 110.39 -179.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.5 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 8.0 p90 -68.64 127.53 33.37 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.09 109.758 179.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.67 120.99 6.07 Favored Glycine 0 N--CA 1.49 2.284 0 N-CA-C 110.235 -1.146 . . . . 0.2 110.235 -179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.743 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -113.33 102.47 13.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.384 0 O-C-N 121.445 -1.032 . . . . 0.55 109.135 178.834 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 26.1 tptp 1.07 84.08 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.367 0 CA-C-O 121.422 0.629 . . . . 0.85 112.532 -178.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -131.46 0.76 4.07 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.34 -0.85 . . . . 0.71 109.942 179.64 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.493 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 10.8 m-70 -74.01 -81.22 0.07 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.296 -0.878 . . . . 0.42 110.331 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 121.97 8.3 7.41 Favored Glycine 0 N--CA 1.488 2.163 0 N-CA-C 109.194 -1.562 . . . . 0.33 109.194 -179.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.417 ' OD2' ' CE2' ' A' ' 175' ' ' PHE . 3.1 t0 -126.3 -70.76 0.72 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.325 -1.103 . . . . 0.33 110.198 -179.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.461 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 98.3 m-85 -107.25 144.5 33.95 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.315 -0.866 . . . . 0.27 110.093 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -63.65 111.07 4.49 Favored Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.308 -0.87 . . . . 0.34 110.355 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.544 ' O ' HD22 ' A' ' 184' ' ' LEU . 49.7 Cg_endo -78.74 -62.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.625 0 O-C-N 123.976 1.514 . . . . 0.47 110.444 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -94.21 178.59 5.58 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.366 -0.834 . . . . 0.35 110.232 -179.79 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.465 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.3 p-10 -180.0 -53.4 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.224 -0.923 . . . . 0.2 110.804 178.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.574 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 146.39 -134.98 5.58 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.364 -1.494 . . . . 0.25 109.364 -179.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -73.11 -1.6 10.78 Favored 'Trans proline' 0 C--N 1.296 -2.192 0 O-C-N 124.053 1.554 . . . . 0.44 109.809 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.443 ' HB3' ' OD2' ' A' ' 179' ' ' ASP . 0.3 OUTLIER -57.02 -177.08 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.428 -0.795 . . . . 0.57 110.296 179.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.555 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -81.3 76.55 2.15 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 110.575 -1.01 . . . . 0.49 110.575 -179.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.943 ' HA ' HG13 ' A' ' 1' ' ' HAV . 5.5 tt 179.64 94.36 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.273 -1.133 . . . . 0.41 110.789 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.668 HD13 ' CE2' ' A' ' 214' ' ' TYR . 8.6 tt -112.13 -18.45 12.57 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.554 -1.258 . . . . 0.3 111.109 179.206 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.624 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.11 109.56 3.59 Favored 'General case' 0 N--CA 1.496 1.875 0 O-C-N 120.503 -1.373 . . . . 0.2 111.832 -179.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.572 ' CD2' ' O ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -121.35 135.59 55.07 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.193 -0.942 . . . . 0.16 109.971 179.248 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.83 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -123.78 160.8 26.54 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.096 -1.003 . . . . 0.23 110.454 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.493 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 1.1 m-30 -99.04 170.23 7.16 Favored Pre-proline 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.38 110.176 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.506 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.8 Cg_endo -71.74 128.3 14.08 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.067 1.562 . . . . 0.4 109.745 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.485 ' HA ' ' HA3' ' A' ' 196' ' ' GLY . 42.9 Cg_endo -69.05 68.3 1.29 Allowed 'Trans proline' 0 C--N 1.304 -1.795 0 O-C-N 123.873 1.459 . . . . 0.32 110.62 -179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -113.98 -83.67 1.2 Allowed Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.267 -1.533 . . . . 0.32 109.267 179.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -74.0 -159.57 0.09 OUTLIER 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 124.063 1.559 . . . . 0.47 110.042 179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -79.12 0.52 27.77 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.082 -1.011 . . . . 0.63 110.34 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -116.74 40.84 2.84 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.319 -0.863 . . . . 0.53 110.326 -179.855 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.51 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -108.63 -179.3 21.63 Favored Glycine 0 N--CA 1.488 2.128 0 N-CA-C 108.961 -1.656 . . . . 0.25 108.961 179.656 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 163' ' ' ILE . . . 38.91 27.13 0.05 OUTLIER Glycine 0 N--CA 1.493 2.492 0 N-CA-C 110.213 -1.155 . . . . 0.1 110.213 -179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.51 ' N ' ' O ' ' A' ' 196' ' ' GLY . 0.8 OUTLIER -77.59 88.23 3.9 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 120.938 -1.331 . . . . 0.1 109.25 179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.851 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -71.72 90.24 1.06 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.265 -0.897 . . . . 0.09 110.74 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.521 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 12.8 m170 -100.86 120.83 40.71 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.301 -0.874 . . . . 0.09 109.909 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.6 ' O ' ' N ' ' A' ' 203' ' ' ASP . 20.2 m-85 -89.6 135.24 33.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.156 -0.965 . . . . 0.1 110.722 -179.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.561 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 58.8 t0 -44.2 88.52 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 108.857 -0.794 . . . . 0.14 108.857 178.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.9 p30 -41.76 -31.64 0.33 Allowed 'General case' 0 C--N 1.298 -1.669 0 O-C-N 121.083 -1.01 . . . . 0.18 111.49 -177.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.574 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 17.1 t0 -71.15 -5.54 32.54 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.558 -1.338 . . . . 0.24 110.329 179.779 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.508 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 16.6 mm-40 -93.73 -164.71 1.21 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.96 -1.088 . . . . 0.42 109.878 179.602 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.559 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 33.3 m -127.37 159.08 35.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.895 -1.128 . . . . 0.47 110.769 -179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.592 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.2 m-90 -150.12 142.8 24.59 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.385 -0.822 . . . . 0.27 109.555 179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.993 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -153.93 173.65 15.66 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.853 -1.154 . . . . 0.3 110.795 179.797 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.447 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.8 t -128.21 29.79 5.31 Favored 'General case' 0 C--N 1.301 -1.509 0 CA-C-O 121.781 0.8 . . . . 0.61 108.945 178.727 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 1.1 t -104.6 -72.68 0.7 Allowed 'General case' 0 N--CA 1.488 1.432 0 CA-C-O 121.504 0.669 . . . . 0.78 110.108 -179.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 179.61 -32.86 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.132 -0.692 . . . . 0.91 109.132 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -86.43 133.17 33.79 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.548 -0.72 . . . . 0.93 109.553 179.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 89.18 -171.54 38.81 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.109 -1.596 . . . . 0.79 109.109 -179.447 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.668 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.1 m-85 -75.66 113.54 13.22 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.201 -1.176 . . . . 0.69 109.999 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.567 ' O ' HG12 ' A' ' 219' ' ' VAL . 34.5 m-80 -79.87 121.97 26.08 Favored 'General case' 0 C--N 1.304 -1.373 0 O-C-N 121.054 -1.028 . . . . 0.4 108.627 179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.993 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -40.56 -38.01 0.8 Allowed 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.329 -0.857 . . . . 0.17 110.504 -179.244 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.578 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 3.3 m-85 -52.97 -48.33 67.49 Favored 'General case' 0 C--N 1.287 -2.126 0 C-N-CA 118.529 -1.268 . . . . 0.28 107.594 179.557 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.779 HD21 ' HB2' ' A' ' 244' ' ' TYR . 40.9 tp -72.06 -71.36 0.28 Allowed 'General case' 0 C--N 1.295 -1.77 0 CA-C-N 115.978 -0.556 . . . . 0.46 110.185 178.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.869 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -51.32 -70.44 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.156 -0.965 . . . . 0.39 110.144 179.878 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.912 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -42.22 -50.21 4.91 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.876 -1.14 . . . . 0.17 111.565 179.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -60.86 -34.7 75.0 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 120.309 -1.494 . . . . 0.1 108.924 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.613 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.7 t60 -69.33 -50.83 42.86 Favored 'General case' 0 C--N 1.298 -1.643 0 CA-C-O 121.465 0.65 . . . . 0.21 109.792 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.807 ' OE2' ' HB2' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -60.9 -44.09 97.62 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.167 -0.958 . . . . 0.28 109.181 178.839 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.519 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 7.4 m-85 -55.08 -62.02 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.254 -0.904 . . . . 0.18 108.926 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.448 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.62 -32.03 1.9 Allowed Glycine 0 N--CA 1.486 1.989 0 N-CA-C 108.804 -1.718 . . . . 0.21 108.804 179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.578 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.41 -71.96 0.43 Allowed 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.205 -1.174 . . . . 0.17 111.068 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.83 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.05 -44.19 0.37 Allowed 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.613 -0.679 . . . . 0.33 112.006 -178.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.695 HD22 ' OH ' ' A' ' 266' ' ' TYR . 0.8 OUTLIER -100.37 -37.41 8.87 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.784 -1.197 . . . . 0.53 111.328 -178.856 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.534 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -67.66 -88.37 0.07 OUTLIER Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.173 -1.171 . . . . 0.41 110.173 -179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.606 HD23 ' N ' ' A' ' 230' ' ' LEU . 0.8 OUTLIER -169.21 -172.62 1.55 Allowed 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.219 -1.165 . . . . 0.45 110.936 -179.32 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.542 ' O ' ' CD2' ' A' ' 232' ' ' HIS . 1.9 m-20 -53.05 -58.04 8.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.467 -0.771 . . . . 0.62 110.172 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.578 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -163.67 179.63 7.04 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.189 -0.945 . . . . 0.45 111.017 179.739 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.515 ' N ' ' SD ' ' A' ' 240' ' ' MET . 1.8 t 179.53 54.35 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 109.083 -0.71 . . . . 0.38 109.083 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.92 ' HB3' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.31 23.89 2.97 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.48 111.351 -179.111 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.574 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -38.72 -47.01 3.35 Favored Pre-proline 0 N--CA 1.492 1.671 0 C-N-CA 119.36 -0.936 . . . . 0.38 109.346 -179.942 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.574 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 43.0 Cg_endo -92.1 -47.51 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.777 0 O-C-N 124.029 1.542 . . . . 0.28 110.968 178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.557 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.83 100.9 0.14 Allowed Glycine 0 N--CA 1.498 2.804 0 C-N-CA 118.725 -1.703 . . . . 0.24 112.506 179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.961 ' HB2' ' HB2' ' A' ' 257' ' ' ASP . . . -148.08 160.92 42.37 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 121.317 -1.108 . . . . 0.28 109.998 177.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.569 HD21 ' C ' ' A' ' 221' ' ' ALA . 1.0 OUTLIER -69.31 62.88 0.14 Allowed 'General case' 0 N--CA 1.492 1.647 0 CA-C-O 122.076 0.941 . . . . 0.4 108.596 179.737 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.613 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.7 mtt -146.56 -33.98 0.29 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.59 -0.694 . . . . 0.45 110.758 -179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.568 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -44.13 168.5 0.07 OUTLIER Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 120.911 -1.118 . . . . 0.57 110.325 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.46 ' HA ' ' HB2' ' A' ' 2' ' ' 3MP . 45.4 Cg_endo -72.66 -12.51 26.77 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.879 1.463 . . . . 0.76 109.817 179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.659 HG12 HG22 ' A' ' 245' ' ' THR . 5.9 tt -98.25 151.09 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.382 -0.824 . . . . 0.89 109.695 179.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.779 ' HB2' HD21 ' A' ' 218' ' ' LEU . 32.6 p90 -131.89 -28.28 1.79 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.155 -0.966 . . . . 0.78 111.038 -179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.748 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.45 -69.73 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 113.196 0.813 . . . . 0.61 113.196 -179.009 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.748 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -67.96 104.25 1.68 Allowed 'General case' 0 N--CA 1.487 1.393 0 O-C-N 120.547 -1.346 . . . . 0.74 109.554 -179.894 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.647 ' HA ' HD22 ' A' ' 218' ' ' LEU . 26.5 p -56.08 -170.09 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.246 -0.909 . . . . 0.81 110.352 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -69.4 -7.15 57.12 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.495 -1.442 . . . . 0.56 109.495 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 1.2 mttt -149.21 27.84 0.83 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.227 -1.16 . . . . 0.37 110.174 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.531 ' HB3' ' CD1' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -68.21 -13.93 62.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.206 -0.933 . . . . 0.44 110.339 -179.932 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.0 -61.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.272 -0.892 . . . . 0.53 110.326 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.588 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER -167.54 178.39 5.43 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.225 -0.922 . . . . 0.38 110.501 -179.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.938 ' HB2' HG21 ' A' ' 259' ' ' VAL . 4.7 ptp -68.23 53.98 0.07 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.393 -0.817 . . . . 0.19 110.61 179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.708 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.3 OUTLIER -43.97 -48.34 22.22 Favored Pre-proline 0 N--CA 1.487 1.385 0 N-CA-C 108.131 -1.063 . . . . 0.28 108.131 177.655 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.708 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -72.49 48.05 1.22 Allowed 'Trans proline' 0 C--N 1.312 -1.367 0 O-C-N 124.125 1.592 . . . . 0.49 111.251 177.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.632 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.3 m-20 -52.77 -30.86 35.22 Favored 'General case' 0 C--N 1.302 -1.466 0 O-C-N 120.763 -1.211 . . . . 0.49 109.761 179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.961 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 3.1 m-20 -50.47 -45.59 56.34 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 119.589 -0.844 . . . . 0.31 109.57 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.955 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -80.18 -32.31 38.71 Favored 'General case' 0 C--N 1.295 -1.781 0 N-CA-C 108.379 -0.971 . . . . 0.14 108.379 179.083 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.938 HG21 ' HB2' ' A' ' 253' ' ' MET . 83.6 t -60.35 -73.59 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.295 -0.878 . . . . 0.17 110.072 179.224 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.719 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 6.2 pt20 -72.52 -31.35 65.26 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 121.331 -0.855 . . . . 0.26 110.094 -179.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.525 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -47.73 -57.79 7.33 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 109.092 -1.603 . . . . 0.19 109.092 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.955 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -83.5 -21.71 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.113 -1.228 . . . . 0.22 110.674 -179.718 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.79 ' N ' HD13 ' A' ' 262' ' ' ILE . 29.6 tt0 -64.47 -20.01 65.92 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 120.493 -1.379 . . . . 0.39 108.348 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 260' ' ' GLN . 2.8 p -103.68 -38.98 6.87 Favored 'General case' 0 N--CA 1.49 1.554 0 C-N-CA 120.152 -0.619 . . . . 0.47 111.354 -179.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.474 ' HB3' ' HG2' ' A' ' 112' ' ' LYS . 4.9 mp -90.88 -44.57 9.3 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 121.103 -0.998 . . . . 0.48 111.343 -178.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 1.009 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -72.92 -10.91 60.32 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.157 -0.965 . . . . 0.41 110.057 -179.826 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.412 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -60.75 -92.17 0.02 OUTLIER Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.446 -1.461 . . . . 0.46 109.446 179.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.35 117.03 4.91 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.979 1.515 . . . . 0.58 110.332 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -97.06 123.72 7.88 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.446 -1.462 . . . . 0.64 109.446 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.579 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -69.22 -63.71 1.01 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.95 109.93 179.943 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.517 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 2.6 tt0 50.15 28.96 3.31 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.304 -0.873 . . . . 1.2 110.149 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -155.62 125.66 3.29 Favored Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 121.332 -0.855 . . . . 1.2 110.07 179.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.66 81.45 1.58 Allowed 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.843 1.443 . . . . 1.06 110.511 -179.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.491 1.622 0 CA-C-O 117.999 -1.001 . . . . 0.78 110.223 179.905 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.943 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.626 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.626 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 29.3 m-85 . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.278 0.561 . . . . 0.41 110.214 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -122.88 96.22 4.93 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.157 -0.965 . . . . 0.26 110.26 -179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 8.7 m -89.7 -179.7 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.147 -0.97 . . . . 0.33 110.196 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -60.84 131.51 91.49 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.197 -0.939 . . . . 0.65 110.194 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 48.2 Cg_endo -73.53 61.68 4.4 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.824 1.434 . . . . 0.84 110.565 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.755 ' C ' HD23 ' A' ' 230' ' ' LEU . 23.6 mtp180 -142.0 63.26 1.42 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.223 -0.923 . . . . 0.93 110.12 179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.539 ' CB ' ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -148.52 -64.91 0.24 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.377 -0.827 . . . . 1.03 109.944 -179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.499 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.2 OUTLIER 33.15 53.76 0.41 Allowed 'General case' 0 N--CA 1.495 1.808 0 O-C-N 121.909 -0.494 . . . . 1.04 111.881 179.464 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.779 ' HD2' HD13 ' A' ' 265' ' ' LEU . 17.4 pttt -140.75 78.57 1.66 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.103 -0.998 . . . . 0.77 109.688 179.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.584 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 11.6 t90 -142.27 -71.09 0.33 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.217 -0.927 . . . . 0.42 111.017 -179.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.548 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 95.4 p -101.13 60.67 0.93 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.184 -0.948 . . . . 0.44 110.489 -179.363 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 114' ' ' SER . 30.3 mttp -148.72 78.72 1.41 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.265 -0.897 . . . . 0.49 110.183 179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.582 ' O ' HD13 ' A' ' 151' ' ' LEU . 12.6 ttt -105.71 -13.01 15.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.292 -0.88 . . . . 0.3 109.956 179.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.483 ' OD1' ' HB3' ' A' ' 152' ' ' ASN . 6.4 t30 -151.86 124.64 8.49 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.34 -0.85 . . . . 0.15 109.993 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.458 ' HA ' HD12 ' A' ' 118' ' ' LEU . 3.2 tp -145.99 -170.2 3.42 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.227 -0.921 . . . . 0.13 110.258 -179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.906 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -122.05 158.05 30.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.29 -0.881 . . . . 0.12 110.161 179.791 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.756 ' CB ' HG23 ' A' ' 163' ' ' ILE . 37.0 p90 -151.06 169.2 22.4 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.367 -0.833 . . . . 0.33 110.704 -179.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -120.87 147.1 45.86 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.395 -0.816 . . . . 0.54 109.776 179.763 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.823 ' O ' HG13 ' A' ' 123' ' ' VAL . 1.7 pp -112.87 120.45 62.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.116 -0.99 . . . . 0.33 110.997 -179.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.919 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.0 OUTLIER -164.77 49.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.36 -0.838 . . . . 0.27 109.416 179.292 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.706 ' ND2' HD13 ' A' ' 165' ' ' ILE . 1.4 m120 -39.67 -84.1 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.696 -0.627 . . . . 0.41 109.843 -179.866 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.571 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 3.8 t80 179.89 -168.41 0.11 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.272 -0.893 . . . . 0.4 109.089 179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.608 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.2 OUTLIER -138.61 42.71 0.6 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 120.707 -1.246 . . . . 0.45 111.705 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.608 ' HD3' ' N ' ' A' ' 126' ' ' THR . 45.7 Cg_endo -76.96 -83.3 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.484 1.255 . . . . 0.36 110.506 178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 8.9 m-20 -107.83 -0.9 21.3 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.169 -0.957 . . . . 0.25 110.053 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.586 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -126.39 89.95 3.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.251 -0.906 . . . . 0.39 109.778 179.47 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.465 ' N ' ' OE1' ' A' ' 133' ' ' GLU . 0.2 OUTLIER -48.21 -179.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.534 -0.729 . . . . 0.48 110.939 -179.513 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -48.49 -39.27 22.54 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.375 -0.828 . . . . 0.4 110.032 179.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.523 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -53.68 -61.2 2.46 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.216 -0.927 . . . . 0.46 109.615 179.717 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.586 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 31.6 mp0 -54.01 -54.49 38.38 Favored 'General case' 0 C--N 1.301 -1.501 0 C-N-CA 119.565 -0.854 . . . . 0.47 109.43 179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.569 HG22 ' HB2' ' A' ' 124' ' ' ASN . 53.2 t -45.76 -34.41 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 N-CA-C 108.098 -1.075 . . . . 0.31 108.098 178.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.523 ' CB ' ' O ' ' A' ' 132' ' ' SER . 0.7 OUTLIER -61.38 -43.21 99.25 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 107.776 -1.194 . . . . 0.48 107.776 178.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.578 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 1.4 tttp -70.34 -56.98 5.38 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 108.337 -0.986 . . . . 0.64 108.337 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.861 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -43.75 -69.94 0.12 Allowed 'General case' 0 C--N 1.29 -2.009 0 O-C-N 121.186 -0.946 . . . . 0.42 110.189 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.724 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -52.81 -59.46 4.48 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.264 -0.898 . . . . 0.34 110.945 -179.564 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.634 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 5.1 tmtt? -65.56 -74.15 0.11 Allowed 'General case' 0 N--CA 1.498 1.949 0 O-C-N 120.978 -1.076 . . . . 0.47 110.893 -178.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.548 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.8 OUTLIER -38.24 -62.39 0.58 Allowed 'General case' 0 C--N 1.293 -1.885 0 O-C-N 121.679 -0.638 . . . . 0.47 110.669 179.14 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.619 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -45.89 -38.15 7.12 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.798 -1.161 . . . . 0.25 108.386 178.863 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.532 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -70.42 -34.87 73.0 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.362 -0.836 . . . . 0.35 108.892 178.301 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 10.6 ttmm -58.51 -42.4 87.58 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.303 -0.873 . . . . 0.7 108.961 179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 13.5 t -67.86 -46.72 81.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.535 -0.728 . . . . 0.61 109.094 178.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.627 ' HH2' HG21 ' A' ' 262' ' ' ILE . 13.3 t-105 -53.55 -41.66 66.7 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.456 -0.777 . . . . 0.39 108.967 178.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.536 ' HA ' ' O ' ' A' ' 149' ' ' THR . 14.5 m -71.76 -37.15 70.54 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.412 -0.805 . . . . 0.35 109.02 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -53.66 -41.61 66.99 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.595 -0.691 . . . . 0.36 109.549 179.256 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.805 HG23 HG22 ' A' ' 149' ' ' THR . 29.4 m -79.63 -30.81 13.67 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 O-C-N 121.339 -0.851 . . . . 0.5 110.071 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.815 ' OG1' HD23 ' A' ' 151' ' ' LEU . 3.6 t -144.22 127.33 8.7 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.108 -0.995 . . . . 0.51 110.339 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -71.99 59.76 2.95 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.748 1.394 . . . . 0.31 110.745 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.008 HD21 ' O ' ' A' ' 266' ' ' TYR . 1.4 mm? -88.72 156.01 19.25 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.224 -0.923 . . . . 0.18 110.158 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.483 ' HB3' ' OD1' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -103.38 146.35 28.62 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.249 -0.907 . . . . 0.17 110.381 -179.802 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.481 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.9 p90 -152.49 138.6 18.26 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.312 -0.868 . . . . 0.14 110.384 179.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.906 ' O ' HG22 ' A' ' 119' ' ' THR . 4.2 m -143.02 135.4 27.38 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.33 -0.856 . . . . 0.15 110.261 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.587 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -93.61 89.03 6.08 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.978 -1.076 . . . . 0.2 110.024 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.547 ' CB ' ' HB ' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -62.97 100.63 0.22 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.182 -0.949 . . . . 0.22 110.371 -180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.57 ' CD2' ' O ' ' A' ' 157' ' ' HIS . 53.6 p-80 -67.14 57.58 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.331 -0.856 . . . . 0.32 110.357 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.488 ' N ' ' O ' ' A' ' 156' ' ' LEU . 10.9 t0 -154.31 -51.53 0.09 Allowed 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.128 -0.983 . . . . 0.33 109.904 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 161.41 35.84 0.02 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 110.037 -1.225 . . . . 0.28 110.037 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.547 ' HB ' ' CB ' ' A' ' 156' ' ' LEU . 72.1 mt -128.83 65.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.194 -1.18 . . . . 0.3 109.289 179.472 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.461 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -126.01 150.16 48.29 Favored 'General case' 0 C--N 1.299 -1.605 0 C-N-CA 120.2 -0.6 . . . . 0.2 110.568 -179.166 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.434 ' OD2' ' HG ' ' A' ' 118' ' ' LEU . 1.2 m-20 -113.27 -34.22 5.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.356 -0.84 . . . . 0.1 109.883 179.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.756 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.9 OUTLIER -126.03 170.38 16.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.41 -0.806 . . . . 0.1 110.155 -179.948 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.729 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.5 ptm -168.93 139.12 2.3 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.891 -1.131 . . . . 0.11 110.95 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.706 HD13 ' ND2' ' A' ' 124' ' ' ASN . 4.2 tt -96.88 115.44 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.401 -0.812 . . . . 0.1 109.29 179.236 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.919 ' HB3' HG23 ' A' ' 123' ' ' VAL . 14.2 p -160.07 148.48 17.04 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.511 -1.368 . . . . 0.1 111.065 -179.569 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.622 ' CE2' HG21 ' A' ' 169' ' ' ILE . 2.0 p90 -64.55 114.75 4.58 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.53 -0.731 . . . . 0.09 109.354 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.511 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -72.52 148.42 42.01 Favored Glycine 0 N--CA 1.489 2.17 0 N-CA-C 109.441 -1.464 . . . . 0.2 109.441 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.622 HG21 ' CE2' ' A' ' 167' ' ' PHE . 10.3 pt -141.41 97.46 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.752 -0.852 . . . . 0.55 109.853 179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.64 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.07 78.18 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.426 0 CA-C-O 121.277 0.561 . . . . 0.85 112.127 -179.755 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -121.1 -5.57 9.49 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.443 -0.786 . . . . 0.71 110.266 -179.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.424 ' CD2' ' N ' ' A' ' 172' ' ' HIS . 19.9 m-70 -82.19 -150.28 0.09 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.212 -0.93 . . . . 0.42 110.011 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -144.97 30.31 1.79 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.704 -1.358 . . . . 0.33 109.704 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.491 ' OD1' ' N ' ' A' ' 175' ' ' PHE . 2.9 p30 -127.51 -148.21 0.38 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.121 -1.223 . . . . 0.33 110.176 179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.491 ' N ' ' OD1' ' A' ' 174' ' ' ASP . 0.2 OUTLIER -49.22 153.35 1.0 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.175 -0.953 . . . . 0.27 110.09 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.454 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 9.2 m-30 -80.96 112.23 30.57 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.312 -0.867 . . . . 0.34 110.314 -179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.877 ' O ' HD22 ' A' ' 184' ' ' LEU . 45.9 Cg_endo -78.41 -67.61 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.901 1.474 . . . . 0.47 110.631 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.64 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.1 OUTLIER -51.74 149.79 4.43 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.291 -0.881 . . . . 0.35 110.714 -179.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.481 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.6 p30 -174.21 -30.57 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 119.214 -0.994 . . . . 0.2 111.482 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.588 ' N ' ' HB2' ' A' ' 204' ' ' ASP . . . 120.43 -140.32 14.32 Favored Glycine 0 N--CA 1.491 2.32 0 N-CA-C 109.178 -1.569 . . . . 0.25 109.178 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -74.29 53.88 3.13 Favored 'Trans proline' 0 C--N 1.297 -2.165 0 O-C-N 124.103 1.58 . . . . 0.44 109.628 179.832 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.429 ' HB2' ' OD1' ' A' ' 179' ' ' ASP . 0.2 OUTLIER -114.4 -177.41 3.12 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.526 -0.733 . . . . 0.57 110.055 -179.664 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.554 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -72.03 65.18 1.23 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.482 -1.047 . . . . 0.49 110.482 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.982 ' HA ' HG13 ' A' ' 1' ' ' HAV . 2.6 tt 179.69 93.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.212 -1.17 . . . . 0.41 110.846 179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.853 HD12 ' CD ' ' A' ' 205' ' ' GLU . 4.1 tt -114.48 -13.3 12.22 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.606 -1.237 . . . . 0.3 111.352 179.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.672 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -156.32 102.62 2.11 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 120.488 -1.382 . . . . 0.2 111.671 -179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.54 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -117.26 122.77 44.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.068 -1.02 . . . . 0.16 109.51 178.889 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 1.041 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -110.52 158.66 18.29 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.172 -0.955 . . . . 0.23 110.207 -179.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.482 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.9 m-30 -96.0 166.79 13.69 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.112 -0.992 . . . . 0.38 110.545 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.518 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 46.5 Cg_endo -72.86 136.38 25.13 Favored 'Trans proline' 0 C--N 1.305 -1.718 0 O-C-N 124.091 1.574 . . . . 0.4 109.742 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -70.89 58.98 2.15 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.93 1.489 . . . . 0.32 110.611 -179.41 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -99.18 -94.62 2.06 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.464 -1.454 . . . . 0.32 109.464 179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -72.8 -165.89 0.26 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.965 1.508 . . . . 0.47 110.38 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -66.01 -9.07 26.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.227 -0.921 . . . . 0.63 110.279 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -108.0 54.56 0.66 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.42 -0.8 . . . . 0.53 110.226 -179.802 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.518 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -124.08 174.76 16.91 Favored Glycine 0 N--CA 1.487 2.069 0 N-CA-C 109.049 -1.621 . . . . 0.25 109.049 179.774 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.555 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.14 24.66 0.59 Allowed Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.716 -1.354 . . . . 0.1 109.716 -179.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.504 ' HA ' ' HG2' ' A' ' 164' ' ' MET . 1.5 m-20 -79.8 87.35 5.29 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.068 -1.254 . . . . 0.1 109.96 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.729 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -63.73 113.25 3.27 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.297 -0.877 . . . . 0.09 110.502 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.482 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 11.4 m170 -121.24 119.07 31.21 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.325 -0.859 . . . . 0.09 110.602 -179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.0 m-85 -90.5 141.78 28.41 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.228 -0.92 . . . . 0.1 110.677 179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.559 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 24.0 t0 -52.27 85.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.578 -0.701 . . . . 0.14 109.476 178.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.561 ' OD1' ' HB2' ' A' ' 178' ' ' PHE . 1.7 p-10 -35.78 -37.09 0.09 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.281 -0.887 . . . . 0.18 112.059 -178.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.588 ' HB2' ' N ' ' A' ' 180' ' ' GLY . 3.0 m-20 -65.62 -14.1 60.47 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 120.725 -1.234 . . . . 0.24 111.175 -179.311 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.853 ' CD ' HD12 ' A' ' 185' ' ' LEU . 0.5 OUTLIER -93.13 -156.99 0.51 Allowed 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.716 -1.24 . . . . 0.42 110.325 179.868 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.513 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 3.2 m -137.16 161.43 36.18 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.944 -1.098 . . . . 0.47 111.062 -179.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.514 ' NE1' ' HB3' ' A' ' 201' ' ' PHE . 1.1 m-90 -149.19 149.1 30.44 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 109.033 -0.728 . . . . 0.27 109.033 179.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.008 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.76 -174.45 4.94 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.804 -1.185 . . . . 0.3 110.708 -179.83 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.475 ' OG ' ' O ' ' A' ' 209' ' ' SER . 1.2 t -123.36 30.2 6.38 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.893 -0.723 . . . . 0.61 109.822 179.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.488 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -117.21 -172.49 2.23 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.41 -0.806 . . . . 0.78 110.161 -179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.488 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.4 OUTLIER -80.88 0.84 33.4 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.154 -0.967 . . . . 0.91 110.236 179.995 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 2.0 mmmt -113.79 149.67 34.6 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.158 -0.964 . . . . 0.93 110.184 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 68.46 -173.8 32.53 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.402 -1.479 . . . . 0.79 109.402 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.834 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 76.8 m-85 -77.16 114.26 15.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.185 -1.185 . . . . 0.69 110.157 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.622 ' O ' HG12 ' A' ' 219' ' ' VAL . 1.6 m120 -77.45 123.24 26.29 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.99 -1.069 . . . . 0.4 108.653 179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.008 HD22 ' O ' ' A' ' 208' ' ' THR . 0.6 OUTLIER -44.72 -35.18 2.55 Favored 'General case' 0 N--CA 1.488 1.464 0 C-N-CA 118.787 -1.165 . . . . 0.17 108.691 179.614 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.584 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 6.6 m-85 -55.74 -46.42 77.82 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 106.968 -1.493 . . . . 0.28 106.968 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.644 HD21 ' HB2' ' A' ' 244' ' ' TYR . 21.8 tp -74.19 -74.8 0.18 Allowed 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.901 -0.59 . . . . 0.46 110.742 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.732 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.2 p -48.19 -61.61 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.106 -0.996 . . . . 0.39 110.852 -179.63 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.952 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.6 -51.15 63.93 Favored 'General case' 0 C--N 1.297 -1.717 0 O-C-N 120.79 -1.194 . . . . 0.17 111.336 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.584 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.57 -26.45 63.62 Favored 'General case' 0 N--CA 1.498 1.934 0 O-C-N 120.247 -1.533 . . . . 0.1 108.682 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.628 ' CA ' HD21 ' A' ' 239' ' ' LEU . 5.9 t60 -77.08 -51.69 10.61 Favored 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 121.223 0.535 . . . . 0.21 109.647 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.586 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.1 tp10 -59.41 -44.08 92.9 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.987 -1.071 . . . . 0.28 108.341 178.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.48 ' CZ ' HD12 ' A' ' 165' ' ' ILE . 7.5 m-30 -53.38 -61.96 1.96 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.525 -0.734 . . . . 0.18 109.102 178.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.68 -32.72 2.16 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.925 -1.67 . . . . 0.21 108.925 179.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.639 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -81.97 -77.99 0.21 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.198 -1.178 . . . . 0.17 111.229 -179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 1.041 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.73 -39.84 0.16 Allowed 'General case' 0 N--CA 1.495 1.81 0 O-C-N 121.558 -0.714 . . . . 0.33 111.937 -178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.477 ' HG ' ' OH ' ' A' ' 266' ' ' TYR . 3.0 tp -96.41 -39.45 9.59 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 120.968 -1.082 . . . . 0.53 110.667 -179.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -74.73 -91.09 0.18 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 110.099 -1.201 . . . . 0.41 110.099 -179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.773 HD22 ' C ' ' A' ' 230' ' ' LEU . 0.0 OUTLIER -175.93 170.44 2.77 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.3 -1.118 . . . . 0.45 111.17 -179.348 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.572 ' N ' HD22 ' A' ' 230' ' ' LEU . 7.2 t70 -25.7 -70.82 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 120.992 0.425 . . . . 0.62 112.024 -178.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.728 ' O ' HD21 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -162.12 -179.83 7.39 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.01 -1.056 . . . . 0.45 111.176 -179.81 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.462 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.3 OUTLIER 179.46 32.13 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 CA-C-O 121.467 0.651 . . . . 0.38 109.401 179.467 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.686 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.7 OUTLIER -101.76 23.09 11.83 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.534 -0.729 . . . . 0.48 111.472 -179.197 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.613 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -37.3 -66.71 0.27 Allowed Pre-proline 0 N--CA 1.493 1.691 0 C-N-CA 119.81 -0.756 . . . . 0.38 110.381 -179.872 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.613 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 55.0 Cg_endo -76.87 -47.28 0.14 Allowed 'Trans proline' 0 C--N 1.31 -1.492 0 O-C-N 123.292 1.154 . . . . 0.28 110.578 179.222 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.575 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.79 101.17 0.14 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 118.981 -1.58 . . . . 0.24 111.936 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.7 ' HB2' ' HB3' ' A' ' 257' ' ' ASP . . . -144.57 160.25 41.45 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.401 -1.058 . . . . 0.28 110.207 178.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.628 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.2 OUTLIER -75.2 64.98 1.5 Allowed 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 122.23 1.015 . . . . 0.4 108.747 179.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.614 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.1 mtp -141.64 -37.73 0.41 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.411 -0.805 . . . . 0.45 110.011 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.582 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -47.99 170.25 0.11 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.07 -1.019 . . . . 0.57 109.795 179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.531 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.0 Cg_endo -70.69 -2.64 11.16 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.582 1.306 . . . . 0.76 110.512 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.548 HG22 HG22 ' A' ' 245' ' ' THR . 4.3 mt -98.64 145.12 10.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.233 -0.917 . . . . 0.89 110.054 179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.702 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 46.9 p90 -134.65 -33.62 0.95 Allowed 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.221 -0.925 . . . . 0.78 110.486 -179.492 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.692 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 3.15 -68.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 113.646 0.98 . . . . 0.61 113.646 -179.212 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.692 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -54.0 107.79 0.3 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.355 -1.466 . . . . 0.74 109.854 -179.298 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.613 HG23 ' OD1' ' A' ' 215' ' ' ASN . 53.3 m -58.38 172.57 0.46 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.32 -0.863 . . . . 0.81 110.363 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.604 ' N ' HG22 ' A' ' 247' ' ' THR . . . -43.15 -40.76 4.55 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.899 -1.28 . . . . 0.56 109.899 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.06 46.74 1.64 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.069 -1.254 . . . . 0.37 110.638 -179.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.498 ' HB2' ' HB ' ' A' ' 247' ' ' THR . 1.2 t -89.29 1.93 55.06 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.145 -0.972 . . . . 0.44 110.093 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -166.86 -69.3 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.222 -0.924 . . . . 0.53 110.238 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.468 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.2 OUTLIER 179.75 178.45 0.56 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.262 -0.899 . . . . 0.38 110.47 -179.778 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.909 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -69.04 56.16 0.09 Allowed 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.472 -0.768 . . . . 0.19 109.853 179.337 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.69 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -46.79 -46.12 50.44 Favored Pre-proline 0 C--N 1.308 -1.227 0 N-CA-C 108.0 -1.111 . . . . 0.28 108.0 177.588 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.69 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.2 Cg_endo -73.89 49.69 1.95 Allowed 'Trans proline' 0 C--N 1.315 -1.234 0 O-C-N 123.94 1.495 . . . . 0.49 111.499 178.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.581 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 4.3 m-20 -48.82 -34.11 11.79 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.889 -1.132 . . . . 0.49 110.689 179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.7 ' HB3' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -54.69 -53.28 56.91 Favored 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 118.615 -1.234 . . . . 0.31 108.79 -179.285 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.947 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -65.22 -36.43 84.13 Favored 'General case' 0 C--N 1.291 -1.954 0 C-N-CA 119.498 -0.881 . . . . 0.14 108.819 178.784 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.909 HG21 ' HB2' ' A' ' 253' ' ' MET . 78.3 t -64.73 -84.95 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 O-C-N 121.348 -0.845 . . . . 0.17 110.753 179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 11.0 tt0 -54.68 -43.59 72.6 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.028 -1.045 . . . . 0.26 109.395 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.531 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.0 -70.12 0.39 Allowed Glycine 0 N--CA 1.493 2.438 0 N-CA-C 110.518 -1.033 . . . . 0.19 110.518 -179.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.947 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -71.25 -24.93 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 120.594 -1.533 . . . . 0.22 110.005 -179.401 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.814 ' N ' HD13 ' A' ' 262' ' ' ILE . 5.4 tt0 -57.33 -23.36 48.25 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 118.998 -1.081 . . . . 0.39 108.554 179.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -103.07 -43.49 5.48 Favored 'General case' 0 N--CA 1.49 1.551 0 C-N-CA 120.155 -0.618 . . . . 0.47 110.784 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.779 HD13 ' HD2' ' A' ' 112' ' ' LYS . 7.0 mt -73.92 -53.45 10.1 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.4 -0.812 . . . . 0.48 110.876 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 1.008 ' O ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -75.37 -8.48 56.8 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.251 -0.905 . . . . 0.41 109.837 -179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.453 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -56.43 -106.08 0.01 OUTLIER Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.097 -1.601 . . . . 0.46 109.097 179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -74.81 115.42 4.29 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.878 1.462 . . . . 0.58 109.999 179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -87.08 143.13 18.69 Favored Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.66 -1.376 . . . . 0.64 109.66 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.584 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 12.2 t70 -80.83 -60.92 2.12 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.334 -1.098 . . . . 0.95 110.064 179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.548 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 14.9 tt0 42.88 26.6 0.08 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.282 -0.886 . . . . 1.2 110.259 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 270' ' ' ASP . 5.3 t0 -167.21 105.2 0.62 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 1.2 110.4 179.988 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.22 56.6 3.21 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 123.984 1.518 . . . . 1.06 110.435 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.993 -1.003 . . . . 0.78 110.242 179.956 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.982 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.559 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.702 ' HH2' ' CB ' ' A' ' 244' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.244 0.545 . . . . 0.41 110.138 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 14.1 p-10 -126.89 110.4 12.99 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.116 -0.99 . . . . 0.26 110.436 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 6.0 m -103.23 169.8 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.298 -0.876 . . . . 0.33 109.957 179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -46.01 129.88 7.2 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.181 -0.949 . . . . 0.65 109.939 179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.499 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 46.1 Cg_endo -73.46 66.4 4.55 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.914 1.481 . . . . 0.84 110.375 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.868 ' O ' HD12 ' A' ' 230' ' ' LEU . 79.7 mtt180 -155.23 71.21 0.77 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.312 -0.867 . . . . 0.93 109.727 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.494 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 1.6 p -135.34 -67.0 0.55 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.247 -0.908 . . . . 1.03 109.41 179.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.512 ' CD2' ' HG2' ' A' ' 191' ' ' PRO . 0.0 OUTLIER 36.64 48.69 0.66 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.783 -0.573 . . . . 1.04 111.363 179.128 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.51 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.8 OUTLIER -138.72 78.83 1.7 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.104 -0.997 . . . . 0.77 109.61 179.516 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.606 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 6.4 t90 -151.15 -67.95 0.18 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.27 -0.893 . . . . 0.42 111.176 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.552 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 35.9 t -87.79 40.68 0.95 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.291 -0.881 . . . . 0.44 110.86 -179.136 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.823 ' HD3' HD11 ' A' ' 118' ' ' LEU . 13.1 mmtt -143.31 83.69 1.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.956 -1.09 . . . . 0.49 110.807 179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . . . . . . . . . 6.1 ttp -100.26 -21.03 15.62 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.141 -0.974 . . . . 0.3 109.391 179.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.411 ' HA ' ' CB ' ' A' ' 152' ' ' ASN . 1.7 p-10 -138.52 137.83 37.45 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.537 -0.727 . . . . 0.15 109.455 179.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.003 HD13 HD11 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -151.07 167.56 27.32 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.975 -1.078 . . . . 0.13 110.824 -179.228 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.708 HG22 ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -110.17 168.45 9.43 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.372 -0.83 . . . . 0.12 109.604 179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.663 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 8.5 p90 -167.32 176.13 6.88 Favored 'General case' 0 C--N 1.304 -1.383 0 C-N-CA 118.934 -1.107 . . . . 0.33 111.486 -179.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.507 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 6.2 tpt85 -123.38 152.73 41.25 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.698 -0.626 . . . . 0.54 109.38 179.584 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.815 HG21 ' CD1' ' A' ' 138' ' ' PHE . 0.1 OUTLIER -121.32 95.05 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.084 -1.01 . . . . 0.33 111.16 -179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.989 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.5 m -141.53 50.33 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.708 0 O-C-N 121.134 -0.979 . . . . 0.27 110.257 179.151 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.707 ' OD1' HD21 ' A' ' 216' ' ' LEU . 1.8 t-20 -43.33 -86.72 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.249 -0.907 . . . . 0.41 109.404 179.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.485 ' HB2' ' O ' ' A' ' 124' ' ' ASN . 30.6 t80 179.89 175.54 0.78 Allowed 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.447 -0.783 . . . . 0.4 110.127 179.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.431 ' N ' ' CG ' ' A' ' 125' ' ' TYR . 0.0 OUTLIER -118.97 59.28 4.24 Favored Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.204 -0.935 . . . . 0.45 109.964 179.382 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.455 ' HD3' ' C ' ' A' ' 125' ' ' TYR . 44.8 Cg_endo -70.73 -89.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 124.109 1.584 . . . . 0.36 110.567 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 6.5 m-20 -112.19 4.39 17.82 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.313 -0.867 . . . . 0.25 109.795 179.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.605 ' SD ' HD11 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -115.41 139.9 49.61 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.518 -0.739 . . . . 0.39 109.83 179.953 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.401 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -78.53 167.52 21.16 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.302 -0.874 . . . . 0.48 110.378 -179.903 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.401 ' C ' ' O ' ' A' ' 130' ' ' THR . 22.3 t-80 -43.28 -39.21 2.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.376 -0.827 . . . . 0.4 109.751 179.717 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.504 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 8.4 t -59.32 -49.36 78.13 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.302 -0.874 . . . . 0.46 109.709 179.607 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.566 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 0.5 OUTLIER -58.25 -57.62 12.06 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.33 -0.857 . . . . 0.47 109.337 179.525 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.472 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.6 t -46.42 -35.55 2.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.608 -1.256 . . . . 0.31 107.608 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.611 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.8 OUTLIER -57.79 -42.37 84.01 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 108.013 -1.106 . . . . 0.48 108.013 178.217 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.59 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 7.8 tttt -69.31 -49.66 53.78 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.197 0.999 . . . . 0.64 108.397 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.85 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -48.12 -61.71 1.84 Allowed 'General case' 0 C--N 1.287 -2.138 0 O-C-N 121.245 -0.91 . . . . 0.42 110.816 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.815 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -68.34 -52.25 35.37 Favored 'General case' 0 C--N 1.299 -1.619 0 O-C-N 121.234 -0.916 . . . . 0.34 111.026 -178.742 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.631 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.2 -71.52 0.19 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.059 -1.026 . . . . 0.47 110.397 -179.393 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.556 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -41.99 -57.55 2.39 Favored 'General case' 0 C--N 1.29 -2.015 0 O-C-N 121.527 -0.733 . . . . 0.47 110.307 179.202 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.569 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.97 -38.51 17.04 Favored 'General case' 0 N--CA 1.491 1.622 0 C-N-CA 118.296 -1.362 . . . . 0.25 108.345 178.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.663 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 1.0 OUTLIER -71.57 -34.71 70.19 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.308 -0.87 . . . . 0.35 108.994 178.693 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.421 ' CD ' ' C ' ' A' ' 143' ' ' LYS . 0.1 OUTLIER -60.63 -41.25 94.52 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.797 -0.816 . . . . 0.7 108.797 179.044 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 72.6 t -66.99 -49.96 68.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 N-CA-C 108.661 -0.866 . . . . 0.61 108.661 178.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.68 ' HH2' HG21 ' A' ' 262' ' ' ILE . 29.4 t-105 -52.43 -36.24 53.97 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 108.682 -0.859 . . . . 0.39 108.682 178.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.556 ' HA ' ' O ' ' A' ' 149' ' ' THR . 57.8 m -75.24 -35.39 61.42 Favored 'General case' 0 N--CA 1.487 1.402 0 O-C-N 121.475 -0.766 . . . . 0.35 109.095 178.976 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -57.68 -40.15 78.75 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.429 -0.794 . . . . 0.36 109.375 179.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.48 HG23 HG22 ' A' ' 149' ' ' THR . 20.0 m -80.37 -31.23 12.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 C-N-CA 119.777 -0.769 . . . . 0.5 110.119 179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.696 ' CG2' HD23 ' A' ' 151' ' ' LEU . 12.8 t -150.59 131.9 7.53 Favored Pre-proline 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.047 . . . . 0.51 110.173 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -71.14 58.93 2.29 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 123.854 1.45 . . . . 0.31 110.545 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.935 HD21 ' HB3' ' A' ' 266' ' ' TYR . 2.1 mm? -77.2 134.89 38.51 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.184 -0.948 . . . . 0.18 110.284 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.411 ' CB ' ' HA ' ' A' ' 117' ' ' ASN . 1.7 m-20 -80.94 130.13 34.88 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.255 -0.903 . . . . 0.17 110.123 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.5 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.4 p90 -137.15 139.57 41.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.203 -0.936 . . . . 0.14 110.268 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.708 ' O ' HG22 ' A' ' 119' ' ' THR . 18.2 m -147.06 131.31 17.45 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.302 -0.874 . . . . 0.15 110.554 -179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.608 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -98.65 118.23 34.91 Favored 'General case' 0 C--N 1.301 -1.54 0 O-C-N 121.695 -0.628 . . . . 0.2 109.471 -179.966 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 1.5 tp -116.43 99.74 7.39 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.122 -0.986 . . . . 0.22 110.311 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.436 ' O ' ' C ' ' A' ' 158' ' ' ASP . 11.1 p-80 -54.03 -28.77 40.46 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.166 -0.959 . . . . 0.32 109.833 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.436 ' C ' ' O ' ' A' ' 157' ' ' HIS . 3.5 t0 -41.76 -57.21 2.41 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.475 0.655 . . . . 0.33 109.719 179.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 151.72 37.87 0.03 OUTLIER Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.616 -1.394 . . . . 0.28 109.616 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.645 ' O ' HG22 ' A' ' 160' ' ' ILE . 23.5 mm -128.26 67.4 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 O-C-N 121.146 -1.208 . . . . 0.3 109.373 179.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -120.8 127.94 52.41 Favored 'General case' 0 C--N 1.299 -1.615 0 O-C-N 121.78 -0.575 . . . . 0.2 110.356 -179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.819 ' OD2' HD23 ' A' ' 118' ' ' LEU . 29.5 m-20 -90.0 -45.16 9.38 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.257 -0.902 . . . . 0.1 110.058 179.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.0 HG22 ' HA3' ' A' ' 197' ' ' GLY . 1.4 pp -127.02 172.84 13.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.068 -1.02 . . . . 0.1 109.719 179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.759 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 4.3 ptt? -174.39 163.51 3.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.55 -1.344 . . . . 0.11 111.563 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.582 ' O ' HG23 ' A' ' 165' ' ' ILE . 4.0 tt -106.23 116.25 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 121.542 -0.724 . . . . 0.1 109.683 179.537 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.989 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.8 p -157.12 141.08 16.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.598 -1.314 . . . . 0.1 111.304 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.567 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.7 p90 -60.76 121.68 12.89 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.547 -0.72 . . . . 0.09 109.913 179.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -90.86 126.86 8.58 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 110.094 -1.203 . . . . 0.2 110.094 -179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.2 tt -122.88 97.9 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.609 -0.936 . . . . 0.55 109.457 179.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 7.0 tptt 0.28 88.2 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.365 0 CA-C-O 121.291 0.567 . . . . 0.85 112.401 -179.518 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -148.66 15.18 0.97 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.283 -0.885 . . . . 0.71 110.168 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.412 ' CE1' ' CE1' ' A' ' 200' ' ' HIS . 29.6 m-70 -85.08 -86.5 0.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.187 -0.946 . . . . 0.42 110.302 -179.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 154.48 41.72 0.02 OUTLIER Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.422 -1.471 . . . . 0.33 109.422 -179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -143.97 -89.83 0.12 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.31 -1.112 . . . . 0.33 110.355 -179.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.48 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 3.5 m-85 -116.66 -171.26 1.98 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.227 -0.921 . . . . 0.27 110.411 -179.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.573 ' CD1' ' HE2' ' A' ' 170' ' ' LYS . 4.2 m-30 -90.45 109.83 36.68 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.37 -0.831 . . . . 0.34 110.176 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.494 ' O ' HD22 ' A' ' 184' ' ' LEU . 42.9 Cg_endo -75.56 -72.52 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 124.042 1.548 . . . . 0.47 110.536 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CG ' ' OD2' ' A' ' 203' ' ' ASP . 2.1 p90 -64.85 177.61 0.93 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.196 -0.94 . . . . 0.35 109.936 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.526 ' N ' ' OD1' ' A' ' 202' ' ' ASP . 1.8 p-10 179.13 -51.05 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.164 -0.96 . . . . 0.2 111.022 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.587 ' CA ' ' HB3' ' A' ' 204' ' ' ASP . . . 138.29 -136.59 8.19 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.366 -1.494 . . . . 0.25 109.366 -179.276 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.404 ' HD2' ' HA3' ' A' ' 180' ' ' GLY . 55.2 Cg_endo -71.64 -5.41 16.99 Favored 'Trans proline' 0 C--N 1.296 -2.216 0 O-C-N 124.15 1.606 . . . . 0.44 109.392 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.474 ' HB2' ' OD2' ' A' ' 179' ' ' ASP . 1.8 m -55.04 -176.88 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.397 -0.814 . . . . 0.57 109.616 179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.551 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -82.63 76.34 2.24 Favored Glycine 0 N--CA 1.488 2.115 0 C-N-CA 120.038 -1.077 . . . . 0.49 110.672 -179.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.034 ' HA ' HG13 ' A' ' 1' ' ' HAV . 6.6 tt 179.77 90.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.252 -1.146 . . . . 0.41 110.841 179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.621 HD13 ' CE2' ' A' ' 214' ' ' TYR . 9.4 tt -109.43 -15.59 14.19 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.803 -1.186 . . . . 0.3 111.248 179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.638 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -154.28 109.16 3.08 Favored 'General case' 0 N--CA 1.497 1.914 0 O-C-N 120.437 -1.414 . . . . 0.2 111.8 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 200' ' ' HIS . 1.1 p80 -109.77 127.04 54.37 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.89 -1.131 . . . . 0.16 109.862 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.826 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -104.2 130.98 51.97 Favored 'General case' 0 C--N 1.305 -1.366 0 O-C-N 121.459 -0.775 . . . . 0.23 110.359 -179.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.458 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 0.4 OUTLIER -78.53 163.49 61.13 Favored Pre-proline 0 N--CA 1.487 1.397 0 O-C-N 121.085 -1.009 . . . . 0.38 110.42 179.985 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.504 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 45.2 Cg_endo -72.73 133.43 20.26 Favored 'Trans proline' 0 C--N 1.304 -1.816 0 O-C-N 124.105 1.582 . . . . 0.4 109.933 179.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.512 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.7 Cg_endo -70.55 70.07 2.03 Favored 'Trans proline' 0 C--N 1.305 -1.715 0 O-C-N 123.874 1.46 . . . . 0.32 110.399 -179.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -109.36 -105.5 2.96 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 109.564 -1.414 . . . . 0.32 109.564 -179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.74 -159.46 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 123.916 1.482 . . . . 0.47 110.223 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 24.6 t30 -63.17 -10.95 17.26 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.101 -1.0 . . . . 0.63 110.175 179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.63 68.79 0.8 Allowed 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.499 -0.75 . . . . 0.53 110.032 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -151.53 165.33 30.47 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.901 -1.68 . . . . 0.25 108.901 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 1.0 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 58.28 16.18 26.32 Favored Glycine 0 N--CA 1.49 2.293 0 N-CA-C 109.066 -1.614 . . . . 0.1 109.066 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -79.24 87.5 4.95 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.307 -1.113 . . . . 0.1 110.576 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.759 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.7 95.67 0.08 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.088 -1.008 . . . . 0.09 109.59 179.471 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.582 ' HB2' ' CE1' ' A' ' 187' ' ' HIS . 19.6 m170 -97.08 141.05 30.69 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.403 -0.81 . . . . 0.09 110.394 -179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.65 ' CZ ' HG22 ' A' ' 219' ' ' VAL . 5.4 m-30 -108.0 136.84 47.03 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.326 -0.859 . . . . 0.1 110.98 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.537 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 59.5 t0 -50.86 86.66 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 108.786 -0.82 . . . . 0.14 108.786 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.597 ' OD2' ' CG ' ' A' ' 178' ' ' PHE . 1.3 p30 -39.34 -32.8 0.12 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.141 -0.974 . . . . 0.18 111.844 -177.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.587 ' HB3' ' CA ' ' A' ' 180' ' ' GLY . 0.2 OUTLIER -78.81 3.0 17.97 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 120.645 -1.285 . . . . 0.24 110.715 -179.54 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.527 ' HG3' ' HB3' ' A' ' 202' ' ' ASP . 9.1 mm-40 -96.63 -162.83 0.99 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 121.012 -1.055 . . . . 0.42 110.126 179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -124.92 147.5 48.82 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.023 -1.048 . . . . 0.47 110.51 -179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.569 ' CZ2' ' HA ' ' A' ' 203' ' ' ASP . 1.4 m-90 -138.71 144.94 39.76 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.286 -0.884 . . . . 0.27 109.49 179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.764 ' O ' HD12 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.27 177.58 10.49 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 120.93 -1.106 . . . . 0.3 110.833 -179.931 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.2 t -128.61 41.19 3.53 Favored 'General case' 0 C--N 1.301 -1.514 0 CA-C-O 121.912 0.863 . . . . 0.61 109.109 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.533 ' OG ' ' N ' ' A' ' 211' ' ' SER . 4.0 t -122.19 -164.79 1.2 Allowed 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.502 -0.749 . . . . 0.78 109.955 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.533 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.0 OUTLIER -89.02 14.45 10.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.174 -0.954 . . . . 0.91 109.889 179.69 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 27.5 mttm -130.28 163.16 27.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.315 -0.866 . . . . 0.93 110.316 -179.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 58.76 -175.26 2.77 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.461 -1.456 . . . . 0.79 109.461 -179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.621 ' CE2' HD13 ' A' ' 185' ' ' LEU . 63.0 m-85 -74.62 117.76 16.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.315 -1.109 . . . . 0.69 110.144 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.615 ' O ' HG12 ' A' ' 219' ' ' VAL . 9.3 p30 -87.75 118.66 27.41 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.192 -0.943 . . . . 0.4 108.709 178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.956 ' O ' ' HB3' ' A' ' 220' ' ' ALA . 1.6 mp -41.83 -32.72 0.43 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.483 -0.76 . . . . 0.17 110.649 -179.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.595 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 2.1 m-85 -50.89 -47.64 60.6 Favored 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.297 -1.372 . . . . 0.28 107.297 178.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.72 HD21 ' HB2' ' A' ' 244' ' ' TYR . 42.1 tp -82.49 -70.16 0.57 Allowed 'General case' 0 N--CA 1.492 1.632 0 CA-C-N 115.423 -0.808 . . . . 0.46 110.976 179.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.948 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -47.43 -60.21 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.021 -1.049 . . . . 0.39 109.753 -179.719 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.956 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -54.8 -48.69 72.42 Favored 'General case' 0 C--N 1.294 -1.825 0 O-C-N 120.892 -1.13 . . . . 0.17 110.916 179.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.595 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -58.22 -29.99 66.13 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 120.328 -1.483 . . . . 0.1 108.846 179.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.653 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.4 t60 -74.75 -51.06 15.19 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.746 -0.661 . . . . 0.21 109.523 179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.624 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 2.9 tp10 -61.09 -32.9 72.56 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.309 -0.87 . . . . 0.28 109.042 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 225' ' ' GLY . 13.6 m-30 -65.85 -64.92 0.75 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.42 -0.8 . . . . 0.18 108.986 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.43 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -28.27 1.19 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.076 -1.61 . . . . 0.21 109.076 179.603 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.614 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.3 m80 -80.63 -70.68 0.51 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.124 -1.221 . . . . 0.17 111.657 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.826 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 5.0 p -51.77 -31.17 25.75 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.257 -0.902 . . . . 0.33 112.124 -178.223 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 1.003 HD11 HD13 ' A' ' 118' ' ' LEU . 9.8 tp -99.96 -41.83 7.03 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 120.89 -1.131 . . . . 0.53 111.157 -178.845 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.581 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -74.89 -83.93 0.36 Allowed Glycine 0 N--CA 1.49 2.275 0 N-CA-C 110.758 -0.937 . . . . 0.41 110.758 -179.277 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.868 HD12 ' O ' ' A' ' 109' ' ' ARG . 2.0 pt? -161.13 -157.73 0.53 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.031 -1.276 . . . . 0.45 110.785 -178.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.522 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.6 OUTLIER -70.74 -50.95 30.57 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.365 -0.834 . . . . 0.62 110.36 -179.907 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.614 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.6 OUTLIER -169.09 176.18 5.42 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.223 -0.923 . . . . 0.45 110.59 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.71 53.87 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.443 -0.785 . . . . 0.38 109.316 179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.961 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -138.98 22.22 2.63 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.295 -0.878 . . . . 0.48 110.889 -179.109 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.54 ' N ' ' CD ' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -38.78 -48.47 3.77 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.464 -0.772 . . . . 0.38 110.433 -179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.54 ' CD ' ' N ' ' A' ' 235' ' ' ASP . 45.6 Cg_endo -87.36 -48.55 0.03 OUTLIER 'Trans proline' 0 C--N 1.303 -1.845 0 O-C-N 123.846 1.445 . . . . 0.28 111.372 179.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.506 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.28 100.43 0.13 Allowed Glycine 0 N--CA 1.497 2.717 0 C-N-CA 118.962 -1.589 . . . . 0.24 111.979 -179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.961 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -144.89 -161.62 1.33 Allowed 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.257 -1.143 . . . . 0.28 109.808 178.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.619 HD11 HD12 ' A' ' 218' ' ' LEU . 0.3 OUTLIER -105.66 49.84 0.79 Allowed 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.341 -0.985 . . . . 0.4 108.341 179.483 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.653 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.4 mtt -134.37 -21.78 1.78 Allowed 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.374 -0.829 . . . . 0.45 111.157 -179.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.625 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -59.07 168.5 1.51 Allowed Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 120.793 -1.192 . . . . 0.57 111.035 -179.34 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.551 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.7 Cg_endo -71.23 -8.65 23.9 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 123.684 1.36 . . . . 0.76 109.93 179.49 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.672 HG22 HG22 ' A' ' 245' ' ' THR . 17.1 mm -101.06 139.08 23.21 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.452 -0.78 . . . . 0.89 109.647 179.533 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.72 ' HB2' HD21 ' A' ' 218' ' ' LEU . 48.2 p90 -125.6 -25.56 3.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.195 -0.94 . . . . 0.78 110.664 -179.33 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.743 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER 2.45 -67.37 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 N-CA-C 113.635 0.976 . . . . 0.61 113.635 -179.541 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.743 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -68.63 117.19 10.05 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.38 -1.45 . . . . 0.74 109.289 -179.728 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.482 ' OG1' ' N ' ' A' ' 250' ' ' SER . 49.3 p -47.13 170.48 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.222 -0.924 . . . . 0.81 110.206 -179.505 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.79 -21.16 3.36 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.432 -1.467 . . . . 0.56 109.432 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.434 ' HA ' ' OH ' ' A' ' 246' ' ' TYR . 1.1 ptmm? -162.5 49.03 0.17 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.082 -1.246 . . . . 0.37 110.665 -179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.488 ' OG ' ' CD1' ' A' ' 246' ' ' TYR . 1.4 m -43.77 -61.42 1.43 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.164 -0.96 . . . . 0.44 109.856 179.678 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.483 ' O ' ' HB2' ' A' ' 252' ' ' PHE . 0.7 OUTLIER -147.37 4.37 0.8 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.305 -0.872 . . . . 0.53 111.016 -179.983 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CE2' ' HG2' ' A' ' 253' ' ' MET . 92.7 t80 179.98 170.91 1.15 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.934 -1.104 . . . . 0.38 110.939 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.934 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -90.58 59.89 4.4 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.55 -0.719 . . . . 0.19 110.013 179.354 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.702 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.7 OUTLIER -44.41 -47.33 25.75 Favored Pre-proline 0 N--CA 1.486 1.326 0 N-CA-C 107.979 -1.119 . . . . 0.28 107.979 177.584 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.702 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.2 Cg_endo -73.34 50.58 1.95 Allowed 'Trans proline' 0 C--N 1.312 -1.384 0 O-C-N 124.143 1.602 . . . . 0.49 110.922 177.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.656 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.4 m-20 -55.54 -29.15 58.42 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.072 -1.017 . . . . 0.49 110.633 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.889 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 35.3 m-20 -54.7 -48.95 71.83 Favored 'General case' 0 C--N 1.307 -1.275 0 O-C-N 121.111 -0.993 . . . . 0.31 109.234 -179.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.949 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.98 -33.31 63.8 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.57 -0.9 . . . . 0.14 108.57 178.764 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.934 HG21 ' HB2' ' A' ' 253' ' ' MET . 72.8 t -62.23 -82.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.469 0 O-C-N 121.402 -0.811 . . . . 0.17 110.055 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.652 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 21.4 tm0? -59.84 -41.76 92.08 Favored 'General case' 0 C--N 1.303 -1.444 0 O-C-N 121.345 -0.847 . . . . 0.26 109.665 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.68 ' O ' HD12 ' A' ' 265' ' ' LEU . . . -40.69 -64.87 1.12 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.949 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -80.21 -21.66 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 120.744 -1.445 . . . . 0.22 110.278 -179.352 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.867 ' N ' HD13 ' A' ' 262' ' ' ILE . 6.3 tt0 -60.35 -22.67 63.54 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 118.788 -1.165 . . . . 0.39 108.158 179.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 31.2 t -104.09 -41.21 5.9 Favored 'General case' 0 N--CA 1.491 1.612 0 C-N-CA 120.268 -0.573 . . . . 0.47 111.092 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.68 HD12 ' O ' ' A' ' 261' ' ' GLY . 0.4 OUTLIER -79.75 -50.2 10.92 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.279 -0.888 . . . . 0.48 111.527 -178.562 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.935 ' HB3' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -78.7 -17.09 56.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.061 -1.024 . . . . 0.41 110.059 -179.48 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -52.88 -93.22 0.01 OUTLIER Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.815 -1.714 . . . . 0.46 108.815 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -74.57 128.49 11.88 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.017 1.535 . . . . 0.58 110.067 179.372 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.43 ' HA2' ' O ' ' A' ' 113' ' ' TRP . . . -101.02 147.7 17.91 Favored Glycine 0 N--CA 1.491 2.336 0 N-CA-C 109.583 -1.407 . . . . 0.64 109.583 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.606 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -99.03 -68.69 0.79 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.273 -1.134 . . . . 0.95 110.054 179.806 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.552 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 3.2 tm-20 57.01 35.69 26.77 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.33 -0.856 . . . . 1.2 110.263 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.45 ' OD1' ' HB3' ' A' ' 270' ' ' ASP . 11.6 p-10 -133.73 75.12 68.66 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.408 -0.808 . . . . 1.2 110.274 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -73.23 56.81 3.26 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.975 1.513 . . . . 1.06 110.364 179.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.006 -0.997 . . . . 0.78 110.249 -179.949 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.034 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.626 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.638 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 CA-C-O 121.233 0.54 . . . . 0.41 110.227 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 16.0 p30 -121.09 150.3 41.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.255 -0.903 . . . . 0.26 110.308 -179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 107' ' ' PHE . 53.0 t -84.13 -88.57 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.273 -0.892 . . . . 0.33 110.227 -179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.572 ' N ' HG12 ' A' ' 106' ' ' VAL . 2.3 m-85 -113.83 131.37 23.13 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.214 -0.929 . . . . 0.65 110.178 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.29 54.69 2.85 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 124.0 1.526 . . . . 0.84 110.305 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.71 ' O ' HD12 ' A' ' 230' ' ' LEU . 71.7 mtt-85 -145.13 52.13 1.21 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.208 -0.933 . . . . 0.93 110.233 -179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.549 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 6.7 p -121.49 -53.33 2.01 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 1.03 109.967 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.613 HD22 ' HD2' ' A' ' 191' ' ' PRO . 0.1 OUTLIER 45.06 23.2 0.09 Allowed 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.187 -0.945 . . . . 1.04 111.285 179.282 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.517 ' HG2' ' CD2' ' A' ' 266' ' ' TYR . 28.9 mtpt -123.64 74.45 1.26 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.051 -1.031 . . . . 0.77 109.598 179.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.577 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 5.9 t90 -145.44 -67.91 0.3 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.225 -0.922 . . . . 0.42 110.907 -179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.534 ' OG ' ' CG ' ' A' ' 271' ' ' GLU . 30.1 t -97.84 58.52 1.4 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.317 -0.865 . . . . 0.44 110.835 -179.067 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.516 ' CG ' ' O ' ' A' ' 114' ' ' SER . 9.5 mttm -160.03 61.11 0.35 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.197 -0.94 . . . . 0.49 110.43 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 7.3 tmm? -85.05 13.69 5.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.281 -0.887 . . . . 0.3 110.355 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 13.7 p-10 -171.82 126.38 0.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.293 -0.88 . . . . 0.15 110.278 179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.772 HD13 ' OD2' ' A' ' 162' ' ' ASP . 2.8 mt -151.3 -164.15 1.93 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.198 -0.939 . . . . 0.13 110.177 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 1.071 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -128.78 171.38 12.29 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.293 -0.88 . . . . 0.12 109.75 179.855 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.565 ' CD1' ' O ' ' A' ' 154' ' ' THR . 36.2 p90 -171.4 -172.97 1.15 Allowed 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.957 -1.09 . . . . 0.33 111.168 -179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.483 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 2.3 mtm-85 -127.98 164.84 21.45 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.48 -0.762 . . . . 0.54 110.196 -179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.557 HG21 ' CE1' ' A' ' 138' ' ' PHE . 6.6 pt -128.19 70.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.309 -0.869 . . . . 0.33 110.365 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.949 HG23 ' HB3' ' A' ' 166' ' ' SER . 4.8 m -120.67 50.12 0.38 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.202 -0.936 . . . . 0.27 110.793 179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.497 ' N ' HG23 ' A' ' 165' ' ' ILE . 6.8 t30 -44.13 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.127 -0.983 . . . . 0.41 109.267 179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.66 ' O ' HG21 ' A' ' 134' ' ' VAL . 7.5 t80 -178.99 174.43 1.08 Allowed 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.506 -0.746 . . . . 0.4 109.836 179.129 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.52 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -128.74 53.78 12.23 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.132 -0.98 . . . . 0.45 110.425 179.93 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.52 ' HD3' ' N ' ' A' ' 126' ' ' THR . 47.2 Cg_endo -77.14 -86.21 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.989 1.52 . . . . 0.36 110.609 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.02 -1.38 34.42 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.26 -0.9 . . . . 0.25 110.064 179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.723 ' HE3' HD21 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -112.19 150.52 30.73 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.276 -0.89 . . . . 0.39 110.111 -179.942 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.0 OUTLIER -98.03 166.24 11.53 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.215 -0.928 . . . . 0.48 110.069 179.792 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.432 ' C ' ' O ' ' A' ' 130' ' ' THR . 17.2 t-80 -41.3 -32.02 0.27 Allowed 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.395 -0.816 . . . . 0.4 110.194 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.6 OUTLIER -69.87 -46.32 65.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.313 -0.867 . . . . 0.46 110.261 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.54 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.8 OUTLIER -67.67 -58.11 5.22 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.083 -1.01 . . . . 0.47 109.528 179.774 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.66 HG21 ' O ' ' A' ' 125' ' ' TYR . 13.8 t -45.07 -37.78 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.535 0 N-CA-C 107.817 -1.179 . . . . 0.31 107.817 178.196 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.9 mt-10 -57.58 -45.95 84.6 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 107.887 -1.153 . . . . 0.48 107.887 178.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.536 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 3.3 tttt -63.2 -48.94 76.19 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.798 0.809 . . . . 0.64 109.011 178.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.821 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.67 -59.02 2.99 Favored 'General case' 0 C--N 1.291 -1.957 0 O-C-N 121.123 -0.986 . . . . 0.42 110.155 179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.624 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -66.71 -54.15 26.05 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.375 -0.828 . . . . 0.34 110.568 -179.25 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.624 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.3 OUTLIER -64.6 -74.46 0.1 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.099 -1.0 . . . . 0.47 109.942 -179.715 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.536 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.9 tmtt? -37.32 -62.7 0.49 Allowed 'General case' 0 C--N 1.29 -1.989 0 O-C-N 122.07 -0.394 . . . . 0.47 110.886 178.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.557 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.92 -36.94 8.18 Favored 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 118.686 -1.206 . . . . 0.25 108.585 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.541 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.83 -28.94 61.86 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.336 -0.852 . . . . 0.35 109.111 178.628 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.502 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.93 -43.73 97.99 Favored 'General case' 0 N--CA 1.488 1.427 0 N-CA-C 108.379 -0.971 . . . . 0.7 108.379 178.941 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.452 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 5.7 t -70.29 -49.66 52.55 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.362 0 N-CA-C 108.649 -0.871 . . . . 0.61 108.649 178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.618 ' CH2' HG13 ' A' ' 262' ' ' ILE . 51.3 t-105 -53.54 -31.52 46.74 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 108.755 -0.831 . . . . 0.39 108.755 178.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 149' ' ' THR . 67.6 m -78.95 -34.25 44.58 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.235 -1.024 . . . . 0.35 108.235 178.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.452 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.7 OUTLIER -57.9 -37.37 73.87 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 108.793 -0.818 . . . . 0.36 108.793 178.693 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.84 HG23 HG22 ' A' ' 149' ' ' THR . 27.1 m -80.67 -35.14 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.767 -0.773 . . . . 0.5 109.751 179.607 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.84 HG22 HG23 ' A' ' 148' ' ' VAL . 4.6 t -147.83 127.6 6.56 Favored Pre-proline 0 N--CA 1.494 1.739 0 O-C-N 121.109 -0.994 . . . . 0.51 110.389 179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 54.25 2.69 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 O-C-N 123.803 1.422 . . . . 0.31 110.601 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.575 HD21 ' CG ' ' A' ' 266' ' ' TYR . 4.1 tp -73.85 147.79 42.98 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.192 -0.943 . . . . 0.18 110.318 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.459 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.9 OUTLIER -88.22 117.62 27.25 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.211 -0.93 . . . . 0.17 110.204 179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.478 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 6.0 p90 -125.12 119.75 29.47 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.291 -0.881 . . . . 0.14 110.297 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.584 HG22 ' N ' ' A' ' 155' ' ' ARG . 23.0 m -120.45 170.75 9.09 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.28 -0.887 . . . . 0.15 110.256 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.584 ' N ' HG22 ' A' ' 154' ' ' THR . 2.3 ptt180 -156.64 114.52 3.24 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.902 -0.719 . . . . 0.2 110.481 -178.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -125.46 110.67 14.19 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.32 -0.863 . . . . 0.22 109.995 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.412 ' O ' ' C ' ' A' ' 158' ' ' ASP . 23.9 p-80 -51.86 -23.63 5.08 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.204 -0.935 . . . . 0.32 109.954 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.523 ' OD2' ' CD1' ' A' ' 160' ' ' ILE . 1.1 t70 -44.24 -26.16 0.29 Allowed 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.39 -0.819 . . . . 0.33 109.666 179.029 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.72 28.9 1.01 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.543 -1.423 . . . . 0.28 109.543 -179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 1.071 HG22 HG21 ' A' ' 119' ' ' THR . 7.2 mt -115.3 81.91 0.64 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.406 0 O-C-N 121.2 -1.176 . . . . 0.3 108.483 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.526 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -144.81 123.68 12.7 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 120.068 -0.653 . . . . 0.2 110.828 -178.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.772 ' OD2' HD13 ' A' ' 118' ' ' LEU . 39.4 t0 -92.29 -51.61 5.07 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.364 -0.835 . . . . 0.1 109.697 179.582 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.628 HG22 ' HA3' ' A' ' 197' ' ' GLY . 1.1 pt -115.82 179.43 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.848 0 O-C-N 121.307 -0.87 . . . . 0.1 109.05 179.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.811 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 8.2 ptp -177.82 151.6 0.71 Allowed 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.602 -1.311 . . . . 0.11 111.618 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.568 ' HB ' ' CE2' ' A' ' 224' ' ' PHE . 3.6 tt -93.98 117.6 37.97 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 O-C-N 121.57 -0.706 . . . . 0.1 109.374 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.949 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.1 p -159.31 150.57 20.04 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.74 -1.225 . . . . 0.1 110.587 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.592 ' CE2' ' HB ' ' A' ' 169' ' ' ILE . 6.7 p90 -72.94 117.74 15.04 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.499 -0.751 . . . . 0.09 110.168 -179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.477 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -67.75 118.82 10.18 Favored Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.051 -1.22 . . . . 0.2 110.051 -179.585 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.765 ' O ' HG23 ' A' ' 169' ' ' ILE . 19.7 tt -118.5 101.08 11.2 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.449 0 O-C-N 121.88 -0.776 . . . . 0.55 109.422 179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.584 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.9 OUTLIER 1.93 86.28 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 CA-C-O 121.331 0.586 . . . . 0.85 112.488 -179.355 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -132.22 -0.04 3.72 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.359 -0.838 . . . . 0.71 110.088 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 17.3 m-70 -91.36 -154.23 0.35 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.42 110.191 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -159.08 31.61 0.45 Allowed Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.434 -1.467 . . . . 0.33 109.434 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -131.47 -52.84 1.01 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.237 -1.155 . . . . 0.33 110.125 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 14.7 m-85 -136.87 175.98 9.13 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.305 -0.872 . . . . 0.27 110.231 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.424 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -95.09 110.15 48.49 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.269 -0.894 . . . . 0.34 110.255 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.534 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.2 Cg_endo -73.38 -37.96 2.91 Favored 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.984 1.518 . . . . 0.47 110.592 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.58 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 4.4 p90 -109.73 170.19 8.23 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.09 -1.006 . . . . 0.35 110.734 -179.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.509 ' OD2' HD23 ' A' ' 184' ' ' LEU . 0.7 OUTLIER -179.77 -54.04 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.218 -0.926 . . . . 0.2 111.142 178.991 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.588 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 159.2 -141.66 7.73 Favored Glycine 0 N--CA 1.494 2.516 0 N-CA-C 109.561 -1.415 . . . . 0.25 109.561 -179.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -71.65 -3.82 13.83 Favored 'Trans proline' 0 C--N 1.298 -2.107 0 O-C-N 124.236 1.65 . . . . 0.44 109.875 -179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -51.86 177.09 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.463 -0.773 . . . . 0.57 110.019 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.564 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -74.97 79.77 0.98 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 110.234 -1.146 . . . . 0.49 110.234 -179.691 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.009 HD12 ' CG1' ' A' ' 1' ' ' HAV . 15.1 tp 179.82 91.78 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.296 -1.12 . . . . 0.41 110.888 179.798 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.705 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.0 tt -113.83 -17.38 12.06 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 118.461 -1.296 . . . . 0.3 111.293 179.255 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.683 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.14 104.55 2.98 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 120.555 -1.341 . . . . 0.2 111.864 -179.363 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.658 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 0.4 OUTLIER -109.41 121.0 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.188 -0.945 . . . . 0.16 109.77 178.938 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.933 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -110.83 136.01 50.53 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.086 -1.009 . . . . 0.23 110.413 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.698 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 3.8 m-30 -85.57 159.36 55.72 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.323 -0.861 . . . . 0.38 110.216 179.854 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.52 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 43.8 Cg_endo -70.88 140.28 38.14 Favored 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 124.145 1.603 . . . . 0.4 109.588 179.27 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.613 ' HD2' HD22 ' A' ' 111' ' ' LEU . 42.0 Cg_endo -68.75 82.0 0.58 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.015 1.534 . . . . 0.32 110.836 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -121.61 -91.23 1.12 Allowed Glycine 0 N--CA 1.491 2.329 0 N-CA-C 109.17 -1.572 . . . . 0.32 109.17 179.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.28 -158.13 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 124.074 1.565 . . . . 0.47 109.981 179.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 23.5 p30 -82.51 12.26 4.77 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.087 -1.008 . . . . 0.63 110.323 179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.466 ' O ' ' HB2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -117.78 -3.34 11.24 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.249 -0.907 . . . . 0.53 109.982 179.675 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -68.54 171.31 37.52 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.331 -1.508 . . . . 0.25 109.331 179.624 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.628 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 48.22 21.76 2.0 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.775 -1.33 . . . . 0.1 109.775 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.466 ' HB2' ' O ' ' A' ' 195' ' ' TYR . 0.4 OUTLIER -81.71 85.55 6.57 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.96 -1.317 . . . . 0.1 110.096 179.833 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.811 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.17 101.78 0.25 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.204 -0.935 . . . . 0.09 110.033 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.572 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 0.2 OUTLIER -112.53 120.88 43.11 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.362 -0.837 . . . . 0.09 110.461 -179.613 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.552 ' O ' ' N ' ' A' ' 203' ' ' ASP . 22.6 m-85 -90.67 144.37 25.81 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.223 -0.923 . . . . 0.1 110.477 179.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.601 ' HB2' ' O ' ' A' ' 184' ' ' LEU . 15.1 t0 -52.84 85.81 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.593 -0.892 . . . . 0.14 108.593 178.384 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.567 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.8 p30 -38.19 -27.56 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.239 -0.913 . . . . 0.18 111.799 -177.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.588 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.4 OUTLIER -75.68 -0.65 21.5 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.792 -1.193 . . . . 0.24 110.929 -179.648 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.65 ' HG2' HD12 ' A' ' 185' ' ' LEU . 0.0 OUTLIER -101.98 -156.14 0.55 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.789 -1.194 . . . . 0.42 110.218 179.823 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.581 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 17.5 m -133.98 156.4 48.23 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.052 -1.03 . . . . 0.47 110.768 -179.666 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.581 ' CD1' ' O ' ' A' ' 206' ' ' THR . 0.9 OUTLIER -151.65 150.64 30.48 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.302 -0.874 . . . . 0.27 109.272 179.815 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.003 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -161.05 173.18 15.59 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.726 -1.234 . . . . 0.3 111.038 -179.934 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.46 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.0 OUTLIER -129.84 25.35 5.31 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.716 0.769 . . . . 0.61 108.993 178.62 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -90.34 -67.94 0.82 Allowed 'General case' 0 N--CA 1.489 1.501 0 CA-C-O 121.463 0.649 . . . . 0.78 110.525 -179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 179.75 -29.93 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.488 -0.757 . . . . 0.91 109.724 -179.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.99 -178.99 4.26 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.369 -0.832 . . . . 0.93 110.063 179.863 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.05 -174.7 0.17 Allowed Glycine 0 N--CA 1.491 2.354 0 N-CA-C 109.539 -1.424 . . . . 0.79 109.539 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.705 ' CE1' HD13 ' A' ' 185' ' ' LEU . 93.9 m-85 -67.36 120.13 13.35 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.315 -1.109 . . . . 0.69 109.814 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.611 ' O ' HG12 ' A' ' 219' ' ' VAL . 40.6 m-80 -88.17 119.5 28.63 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.974 -1.079 . . . . 0.4 108.8 179.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.003 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.84 -36.24 1.0 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.319 -0.863 . . . . 0.17 110.236 -179.303 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.612 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 4.6 m-85 -51.58 -44.11 62.67 Favored 'General case' 0 C--N 1.282 -2.35 0 C-N-CA 118.407 -1.317 . . . . 0.28 107.746 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.995 HD11 ' HH1' ' A' ' 3' ' ' MSB . 12.3 tp -83.65 -71.29 0.51 Allowed 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.894 -0.594 . . . . 0.46 111.106 179.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.837 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.4 p -46.31 -56.11 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.986 -1.071 . . . . 0.39 109.817 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.931 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.95 -48.92 79.73 Favored 'General case' 0 C--N 1.295 -1.794 0 O-C-N 121.101 -0.999 . . . . 0.17 110.873 179.586 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.612 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -57.36 -24.92 58.25 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.234 -1.541 . . . . 0.1 108.556 179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.843 ' HB2' HD21 ' A' ' 239' ' ' LEU . 3.8 t-160 -79.64 -54.89 5.44 Favored 'General case' 0 C--N 1.301 -1.526 0 CA-C-N 115.95 -0.568 . . . . 0.21 109.872 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.612 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.3 tp10 -59.51 -50.94 71.97 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.979 -1.076 . . . . 0.28 109.092 178.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.568 ' CE2' ' HB ' ' A' ' 165' ' ' ILE . 1.9 m-85 -52.82 -57.99 8.39 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.326 -0.859 . . . . 0.18 109.163 178.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.4 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.02 -32.58 4.84 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 109.251 -1.539 . . . . 0.21 109.251 179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.64 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.0 -72.14 0.45 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.09 -1.241 . . . . 0.17 111.001 -179.959 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.933 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -38.05 -42.65 0.67 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.421 -0.799 . . . . 0.33 111.9 -178.893 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.604 ' HB2' HD13 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -95.95 -38.49 10.22 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.878 -1.139 . . . . 0.53 111.335 -178.794 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.538 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -75.13 -87.09 0.27 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 110.653 -0.979 . . . . 0.41 110.653 -179.183 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.811 HD11 ' O ' ' A' ' 232' ' ' HIS . 0.3 OUTLIER -158.69 -167.72 2.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.17 -1.194 . . . . 0.45 110.855 -178.766 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.514 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -64.41 -55.43 21.0 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.27 -0.894 . . . . 0.62 109.75 179.535 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.811 ' O ' HD11 ' A' ' 230' ' ' LEU . 0.1 OUTLIER -157.38 179.98 8.73 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.264 -0.898 . . . . 0.45 110.62 179.487 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 14.2 t 179.24 50.24 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.561 -0.712 . . . . 0.38 109.381 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.739 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -131.06 21.56 4.9 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.216 -0.928 . . . . 0.48 111.13 -179.01 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.586 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -37.44 -52.86 2.41 Favored Pre-proline 0 N--CA 1.49 1.541 0 O-C-N 121.543 -0.723 . . . . 0.38 110.708 179.994 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.586 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.2 Cg_endo -90.12 -46.58 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.52 1.274 . . . . 0.28 110.873 179.435 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.01 96.11 0.1 Allowed Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.295 -1.431 . . . . 0.24 111.419 -179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.856 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -143.37 165.95 26.1 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.347 -1.09 . . . . 0.28 110.133 178.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.901 ' O ' HD23 ' A' ' 239' ' ' LEU . 7.0 tt -74.46 55.7 0.64 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.256 -0.903 . . . . 0.4 109.736 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.631 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 3.6 mmm -133.7 -34.72 1.01 Allowed 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.004 -1.06 . . . . 0.45 110.32 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.57 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -42.99 168.51 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.34 -0.85 . . . . 0.57 110.464 -179.54 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.476 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 45.9 Cg_endo -72.89 -2.43 11.94 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 123.89 1.468 . . . . 0.76 110.024 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.709 HG22 HG22 ' A' ' 245' ' ' THR . 26.1 mm -106.89 149.8 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.391 -0.818 . . . . 0.89 110.04 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.716 ' HB2' HD21 ' A' ' 218' ' ' LEU . 26.4 p90 -134.51 -28.3 1.28 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.78 110.922 -179.35 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.737 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.93 -69.52 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.495 0.924 . . . . 0.61 113.495 -179.148 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.737 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -55.17 104.19 0.11 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.309 -1.495 . . . . 0.74 109.628 -179.574 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.545 HG23 ' ND2' ' A' ' 215' ' ' ASN . 0.2 OUTLIER -52.52 -177.11 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.287 -0.883 . . . . 0.81 110.201 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.434 ' H ' HG22 ' A' ' 247' ' ' THR . . . -67.58 -8.31 51.31 Favored Glycine 0 N--CA 1.489 2.183 0 N-CA-C 109.317 -1.513 . . . . 0.56 109.317 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.87 29.11 0.37 Allowed 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.284 -1.127 . . . . 0.37 110.353 -179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.486 ' HB2' ' CB ' ' A' ' 247' ' ' THR . 0.9 OUTLIER -82.35 -10.62 59.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.056 -1.028 . . . . 0.44 109.746 179.612 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.555 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.9 OUTLIER -156.92 -75.86 0.09 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.42 -0.8 . . . . 0.53 109.785 179.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.555 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER 179.22 -172.27 0.15 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.235 -0.915 . . . . 0.38 110.407 -179.967 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.886 ' HB2' HG21 ' A' ' 259' ' ' VAL . 19.7 ptt? -66.31 53.4 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.547 -0.721 . . . . 0.19 110.825 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.715 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.6 OUTLIER -46.22 -47.39 45.06 Favored Pre-proline 0 N--CA 1.483 1.218 0 N-CA-C 107.933 -1.136 . . . . 0.28 107.933 177.271 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.715 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -72.92 50.32 1.75 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 124.076 1.567 . . . . 0.49 111.309 178.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.61 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.0 m-20 -48.51 -32.48 7.98 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.945 -1.097 . . . . 0.49 110.6 179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.856 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -53.89 -53.54 51.19 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 118.887 -1.125 . . . . 0.31 109.233 -179.388 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.074 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -67.46 -32.86 73.99 Favored 'General case' 0 C--N 1.297 -1.706 0 O-C-N 121.021 -1.05 . . . . 0.14 108.915 179.015 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.886 HG21 ' HB2' ' A' ' 253' ' ' MET . 59.2 t -66.54 -86.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.356 -0.84 . . . . 0.17 110.398 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.605 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 8.7 tt0 -53.9 -41.97 68.22 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.106 -0.996 . . . . 0.26 109.231 179.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.538 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.69 -71.66 0.37 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.091 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -71.54 -19.48 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.707 -1.466 . . . . 0.22 110.073 -179.46 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 1.091 ' N ' HD13 ' A' ' 262' ' ' ILE . 40.3 tt0 -59.6 -26.44 65.44 Favored 'General case' 0 C--N 1.301 -1.501 0 N-CA-C 107.543 -1.28 . . . . 0.39 107.543 178.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.7 t -104.59 -42.47 5.41 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-O 121.411 0.624 . . . . 0.47 110.887 179.387 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.422 ' HB2' ' HA ' ' A' ' 262' ' ' ILE . 26.5 mt -69.15 -55.02 11.91 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.286 -0.884 . . . . 0.48 111.223 -178.719 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.575 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.0 OUTLIER -81.33 -6.84 59.33 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.017 -1.052 . . . . 0.41 110.032 -179.547 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.29 -108.34 0.01 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.129 -1.588 . . . . 0.46 109.129 179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.4 Cg_endo -73.74 76.84 2.77 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.733 1.386 . . . . 0.58 110.325 179.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -48.19 161.04 0.51 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.554 -1.418 . . . . 0.64 109.554 -179.87 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.577 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -98.51 -68.46 0.8 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.345 -1.091 . . . . 0.95 110.125 179.896 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.534 ' CG ' ' OG ' ' A' ' 114' ' ' SER . 3.7 tt0 57.89 21.11 7.28 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.279 -0.888 . . . . 1.2 110.225 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -153.44 137.72 10.86 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.192 -0.942 . . . . 1.2 110.551 179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -73.13 56.07 3.05 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 124.025 1.54 . . . . 1.06 110.415 179.802 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.41 ' O ' ' ND2' ' A' ' 274' ' ' ASN . 1.7 t30 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.948 -1.025 . . . . 0.78 110.281 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.009 ' CG1' HD12 ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.599 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.995 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 121.238 0.542 . . . . 0.41 110.178 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.491 ' ND2' ' O ' ' A' ' 105' ' ' ASN . 2.7 p-10 -168.45 119.67 0.79 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.248 -0.907 . . . . 0.26 110.18 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.416 ' O ' ' C ' ' A' ' 107' ' ' PHE . 32.7 m -97.63 -154.29 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.252 -0.905 . . . . 0.33 110.099 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.416 ' C ' ' O ' ' A' ' 106' ' ' VAL . 0.2 OUTLIER -43.83 111.43 1.13 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.277 -0.889 . . . . 0.65 110.026 179.858 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.6 Cg_endo -71.85 -162.69 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.96 1.506 . . . . 0.84 110.631 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.619 ' C ' HD12 ' A' ' 230' ' ' LEU . 19.7 mtt180 69.55 76.63 0.22 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.522 -0.736 . . . . 0.93 109.963 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.591 ' CA ' HD12 ' A' ' 230' ' ' LEU . 0.9 OUTLIER -150.79 -72.21 0.17 Allowed 'General case' 0 C--N 1.303 -1.452 0 O-C-N 121.491 -0.755 . . . . 1.03 109.505 179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.46 ' C ' ' O ' ' A' ' 110' ' ' THR . 7.3 tp 35.53 30.23 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.817 -0.552 . . . . 1.04 111.18 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.519 ' N ' ' O ' ' A' ' 110' ' ' THR . 0.2 OUTLIER -108.59 51.53 0.74 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.189 -0.945 . . . . 0.77 110.239 179.891 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.525 ' NE1' ' HB3' ' A' ' 270' ' ' ASP . 8.0 t90 -139.79 -56.47 0.56 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.319 -0.863 . . . . 0.42 110.124 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.483 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 79.5 p -90.67 49.74 1.71 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.266 -0.896 . . . . 0.44 110.112 -179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.534 ' O ' ' CE1' ' A' ' 266' ' ' TYR . 6.4 mmtt -148.48 87.71 1.59 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.351 -0.843 . . . . 0.49 110.174 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.458 ' SD ' ' HA ' ' A' ' 268' ' ' PRO . 35.9 ttp -123.02 -8.81 8.27 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.162 -0.961 . . . . 0.3 110.098 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.441 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 7.0 p-10 -159.77 126.73 4.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.15 109.974 179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.665 HD22 ' HB3' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -152.98 -172.58 4.29 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.226 -0.921 . . . . 0.13 110.426 -179.65 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.804 HG21 HG22 ' A' ' 160' ' ' ILE . 1.2 p -127.59 139.14 52.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.245 -0.909 . . . . 0.12 110.557 179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.557 ' CB ' HG12 ' A' ' 163' ' ' ILE . 26.6 p90 -127.32 177.99 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.396 -0.815 . . . . 0.33 111.398 -179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.511 ' HB3' ' CB ' ' A' ' 164' ' ' MET . 7.2 tpt180 -133.08 150.39 52.09 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.56 -0.712 . . . . 0.54 109.508 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.846 ' O ' HG13 ' A' ' 123' ' ' VAL . 3.4 pt -112.62 118.21 57.28 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.096 -1.003 . . . . 0.33 111.771 -178.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.852 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.8 m -166.26 38.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.828 0 O-C-N 121.375 -0.828 . . . . 0.27 110.079 178.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.757 ' OD1' HG22 ' A' ' 134' ' ' VAL . 0.8 OUTLIER -42.89 -76.78 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 119.399 -0.92 . . . . 0.41 109.116 179.979 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.542 ' O ' HG21 ' A' ' 134' ' ' VAL . 4.7 t80 179.58 -171.87 0.16 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.285 -0.885 . . . . 0.4 109.991 178.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.554 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -140.8 53.02 3.47 Favored Pre-proline 0 N--CA 1.496 1.827 0 O-C-N 120.798 -1.189 . . . . 0.45 110.913 179.569 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.9 Cg_endo -80.38 -84.56 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.64 0 O-C-N 123.858 1.452 . . . . 0.36 110.571 179.571 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 17.3 m-20 -90.15 -3.96 57.57 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.324 -0.86 . . . . 0.25 109.95 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.533 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -123.0 160.38 26.39 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.303 -0.873 . . . . 0.39 110.369 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -106.26 179.51 4.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.317 -0.864 . . . . 0.48 109.759 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 6.2 t-160 -47.02 -39.26 12.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.109 -0.994 . . . . 0.4 110.208 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -59.96 -57.87 11.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.221 -0.925 . . . . 0.46 110.037 179.883 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.533 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 4.4 mp0 -53.69 -54.61 35.52 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.219 -0.925 . . . . 0.47 109.607 179.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.757 HG22 ' OD1' ' A' ' 124' ' ' ASN . 2.6 t -46.16 -36.05 2.46 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.655 0 N-CA-C 107.939 -1.134 . . . . 0.31 107.939 178.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.61 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 5.1 tt0 -61.2 -40.28 93.35 Favored 'General case' 0 C--N 1.307 -1.254 0 N-CA-C 108.242 -1.022 . . . . 0.48 108.242 178.379 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.584 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -72.44 -52.0 17.8 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.3 -0.96 . . . . 0.64 108.776 178.42 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.825 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -44.67 -62.63 1.13 Allowed 'General case' 0 C--N 1.29 -2.005 0 O-C-N 121.081 -1.012 . . . . 0.42 110.447 179.741 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.653 ' CE1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.32 -52.98 55.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.439 -0.788 . . . . 0.34 111.343 -178.903 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.645 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -68.78 -71.76 0.21 Allowed 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.905 -1.122 . . . . 0.47 110.328 -179.391 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.537 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.0 OUTLIER -38.54 -59.78 0.88 Allowed 'General case' 0 C--N 1.292 -1.9 0 O-C-N 121.933 -0.479 . . . . 0.47 110.33 178.994 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.551 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.22 -41.38 27.22 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 118.594 -1.242 . . . . 0.25 107.984 178.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.534 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -68.29 -27.47 66.34 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.432 -0.793 . . . . 0.35 109.11 178.469 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 2.6 tttt -65.8 -37.95 87.66 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 108.465 -0.939 . . . . 0.7 108.465 178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.473 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 13.4 t -73.14 -46.86 49.53 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.349 0 N-CA-C 108.905 -0.776 . . . . 0.61 108.905 178.707 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.745 ' HH2' HG21 ' A' ' 262' ' ' ILE . 42.3 t-105 -58.52 -42.53 87.95 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.9 -0.778 . . . . 0.39 108.9 178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.549 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.3 m -70.86 -32.06 68.94 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 108.431 -0.952 . . . . 0.35 108.431 178.766 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -55.65 -46.87 77.41 Favored 'General case' 0 C--N 1.305 -1.348 0 N-CA-C 109.107 -0.701 . . . . 0.36 109.107 179.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.971 HG23 HG22 ' A' ' 149' ' ' THR . 28.1 m -72.34 -34.62 49.59 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.369 0 C-N-CA 119.448 -0.901 . . . . 0.5 109.369 179.371 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 1.015 HG23 HD11 ' A' ' 151' ' ' LEU . 1.1 t -141.37 118.69 7.63 Favored Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.103 -0.998 . . . . 0.51 109.754 178.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -72.49 62.58 3.63 Favored 'Trans proline' 0 C--N 1.305 -1.74 0 O-C-N 123.68 1.358 . . . . 0.31 111.153 -179.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.015 HD11 HG23 ' A' ' 149' ' ' THR . 0.2 OUTLIER -76.48 174.2 10.58 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 121.003 -1.06 . . . . 0.18 109.931 179.668 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.441 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 12.5 t-20 -107.81 126.23 52.39 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.228 -0.92 . . . . 0.17 109.873 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.544 ' HE2' ' HG ' ' A' ' 146' ' ' SER . 9.3 p90 -131.37 143.03 50.18 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.034 -1.041 . . . . 0.14 110.925 -179.526 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.669 ' HB ' HG22 ' A' ' 119' ' ' THR . 33.0 m -143.61 141.51 30.65 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 121.337 -0.852 . . . . 0.15 110.38 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.456 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -117.35 88.24 2.87 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.29 -0.882 . . . . 0.2 109.935 -179.396 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.926 HD22 HD13 ' A' ' 160' ' ' ILE . 0.1 OUTLIER -79.81 129.07 34.18 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.197 -0.939 . . . . 0.22 110.461 -179.84 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . . . . . . . . . 45.8 p-80 -89.0 36.78 0.82 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.384 -0.823 . . . . 0.32 109.965 179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -128.03 -34.63 2.11 Favored 'General case' 0 C--N 1.303 -1.453 0 O-C-N 121.511 -0.743 . . . . 0.33 109.648 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 147.1 37.13 0.05 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.051 -1.22 . . . . 0.28 110.051 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.926 HD13 HD22 ' A' ' 156' ' ' LEU . 1.9 mp -126.02 70.74 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 O-C-N 121.073 -1.251 . . . . 0.3 108.983 179.23 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.516 ' HA ' ' CB ' ' A' ' 119' ' ' THR . . . -139.22 162.27 35.39 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 120.003 -0.679 . . . . 0.2 110.702 -179.165 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.665 ' HB3' HD22 ' A' ' 118' ' ' LEU . 7.0 t70 -134.18 -33.95 0.99 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.326 -0.859 . . . . 0.1 110.458 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.054 HG21 ' HG ' ' A' ' 228' ' ' LEU . 0.2 OUTLIER -127.5 173.29 13.13 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 121.04 -1.038 . . . . 0.1 109.77 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.824 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 2.9 ptt? -176.98 159.12 1.65 Allowed 'General case' 0 N--CA 1.497 1.917 0 O-C-N 120.605 -1.309 . . . . 0.11 111.754 -179.73 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.632 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.3 tt -103.0 116.5 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.575 -0.703 . . . . 0.1 109.301 178.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.852 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.3 p -157.32 154.58 29.23 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.789 -1.195 . . . . 0.1 111.035 -179.346 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 7.3 p90 -75.03 122.13 23.06 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.387 -0.821 . . . . 0.09 109.448 179.569 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.476 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -84.52 115.72 4.14 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.244 -1.142 . . . . 0.2 110.244 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.719 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -105.43 104.21 16.59 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.443 -1.034 . . . . 0.55 109.246 178.91 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.72 89.37 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.425 0 CA-C-O 121.42 0.628 . . . . 0.85 112.374 -179.145 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -130.15 -2.13 4.54 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.431 -0.793 . . . . 0.71 110.181 -179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.512 ' N ' ' CD2' ' A' ' 172' ' ' HIS . 10.3 m-70 -84.83 178.95 7.44 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.229 -0.919 . . . . 0.42 109.857 179.803 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . -125.74 28.38 4.96 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.683 -1.367 . . . . 0.33 109.683 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -121.77 -97.3 0.46 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.253 -1.145 . . . . 0.33 110.14 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -102.09 126.94 49.17 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.131 -0.98 . . . . 0.27 110.022 179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 4.9 m-30 -54.48 109.59 1.65 Allowed Pre-proline 0 N--CA 1.49 1.575 0 O-C-N 121.211 -0.93 . . . . 0.34 110.301 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.625 ' O ' HD23 ' A' ' 184' ' ' LEU . 42.7 Cg_endo -74.16 -66.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.015 1.534 . . . . 0.47 110.76 -179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -47.72 137.75 9.1 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.249 -0.907 . . . . 0.35 110.406 -179.981 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 179' ' ' ASP . 7.6 p30 179.14 81.44 0.01 OUTLIER 'General case' 0 C--N 1.303 -1.455 0 C-N-CA 119.402 -0.919 . . . . 0.2 110.584 178.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.51 ' H ' ' CB ' ' A' ' 204' ' ' ASP . . . 38.2 -152.01 0.04 OUTLIER Glycine 0 N--CA 1.492 2.423 0 N-CA-C 109.741 -1.343 . . . . 0.25 109.741 179.699 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.409 ' HA ' ' CD ' ' A' ' 205' ' ' GLU . 54.6 Cg_endo -82.49 23.8 0.77 Allowed 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.969 1.51 . . . . 0.44 110.584 179.656 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.507 ' O ' ' N ' ' A' ' 184' ' ' LEU . 1.4 t -58.39 176.13 0.2 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.143 -0.973 . . . . 0.57 110.354 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.541 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.49 70.49 0.04 OUTLIER Glycine 0 N--CA 1.488 2.146 0 N-CA-C 110.219 -1.153 . . . . 0.49 110.219 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.998 ' HA ' HG13 ' A' ' 1' ' ' HAV . 7.4 tp 179.9 81.5 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.349 -1.089 . . . . 0.41 110.175 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.882 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.4 tt -100.84 -24.34 14.39 Favored 'General case' 0 N--CA 1.49 1.544 0 C-N-CA 118.355 -1.338 . . . . 0.3 111.036 179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.633 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -149.01 101.71 3.19 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.723 -1.235 . . . . 0.2 112.254 -179.217 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.542 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 0.1 OUTLIER -102.97 133.35 48.24 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.16 -0.963 . . . . 0.16 109.236 178.441 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.957 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -121.37 130.93 53.89 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.081 -1.012 . . . . 0.23 110.595 -179.503 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.42 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -79.14 165.15 50.76 Favored Pre-proline 0 N--CA 1.49 1.568 0 O-C-N 121.323 -0.86 . . . . 0.38 110.341 179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.53 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.9 Cg_endo -73.41 141.27 31.46 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.974 1.512 . . . . 0.4 110.038 179.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 227' ' ' SER . 42.9 Cg_endo -70.08 83.25 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.762 0 O-C-N 123.911 1.48 . . . . 0.32 110.626 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -125.72 -101.52 1.28 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.589 -1.404 . . . . 0.32 109.589 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.4 -162.49 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 123.942 1.496 . . . . 0.47 110.539 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -62.0 -17.79 58.35 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.238 -0.914 . . . . 0.63 110.023 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -105.44 59.55 0.67 Allowed 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.532 -0.73 . . . . 0.53 110.377 -179.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.53 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -131.22 168.16 22.18 Favored Glycine 0 N--CA 1.486 2.016 0 N-CA-C 108.828 -1.709 . . . . 0.25 108.828 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 1.002 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 42.78 26.61 0.46 Allowed Glycine 0 N--CA 1.486 2.012 0 N-CA-C 109.67 -1.372 . . . . 0.1 109.67 -179.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.429 ' N ' ' O ' ' A' ' 196' ' ' GLY . 7.3 m-20 -79.06 86.18 4.92 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.265 -1.138 . . . . 0.1 109.914 179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.824 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.6 90.0 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.074 -1.016 . . . . 0.09 109.947 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.542 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 17.9 m170 -101.97 131.19 48.53 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.333 -0.855 . . . . 0.09 110.707 -179.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.544 ' O ' ' N ' ' A' ' 203' ' ' ASP . 42.4 m-85 -103.52 137.61 41.36 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.24 -0.913 . . . . 0.1 110.515 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -49.05 92.45 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.242 -0.911 . . . . 0.14 108.956 179.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.548 ' OD2' ' CB ' ' A' ' 178' ' ' PHE . 2.6 p30 -35.95 -29.75 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.732 0 O-C-N 121.653 -0.654 . . . . 0.18 111.772 -178.442 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.519 ' N ' ' O ' ' A' ' 202' ' ' ASP . 10.4 m-20 -79.12 2.27 21.4 Favored 'General case' 0 N--CA 1.486 1.358 0 O-C-N 120.607 -1.308 . . . . 0.24 111.457 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.882 ' OE1' HD12 ' A' ' 185' ' ' LEU . 9.8 mm-40 -93.65 -166.45 1.51 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.773 -1.204 . . . . 0.42 110.347 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -125.32 140.81 52.49 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.235 -0.916 . . . . 0.47 110.468 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.516 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -140.6 130.39 24.4 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.275 -0.89 . . . . 0.27 109.737 179.627 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.021 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -138.83 176.46 8.68 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.021 -1.05 . . . . 0.3 110.583 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.49 ' HB2' HD23 ' A' ' 216' ' ' LEU . 2.1 t -130.5 35.94 3.99 Favored 'General case' 0 C--N 1.3 -1.58 0 N-CA-C 108.873 -0.788 . . . . 0.61 108.873 178.743 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.517 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.9 t -115.26 -111.62 0.35 Allowed 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.702 -0.624 . . . . 0.78 110.065 -179.271 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.517 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 t -143.88 11.23 1.6 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.91 109.952 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.74 123.52 29.41 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.274 -0.891 . . . . 0.93 109.917 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 93.99 -171.7 31.62 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 109.175 -1.57 . . . . 0.79 109.175 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.607 ' CE1' HD13 ' A' ' 185' ' ' LEU . 64.8 m-85 -69.47 122.11 18.35 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.174 -1.192 . . . . 0.69 109.687 179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.606 ' O ' HG12 ' A' ' 219' ' ' VAL . 1.1 p-10 -95.73 119.82 34.89 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 120.986 -1.072 . . . . 0.4 108.965 179.036 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.021 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -38.45 -37.92 0.34 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.672 -0.643 . . . . 0.17 111.093 -178.834 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.584 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.6 m-30 -49.92 -48.39 51.73 Favored 'General case' 0 C--N 1.286 -2.166 0 C-N-CA 118.439 -1.304 . . . . 0.28 107.719 179.605 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.021 HD11 ' HH1' ' A' ' 3' ' ' MSB . 4.7 tp -79.79 -69.45 0.58 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-N 115.906 -0.588 . . . . 0.46 110.53 178.677 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.969 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.99 -65.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.07 -1.019 . . . . 0.39 109.786 -179.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.911 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -48.53 -50.27 32.65 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 120.832 -1.167 . . . . 0.17 111.564 179.308 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.555 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -63.52 -24.88 68.0 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.329 -1.482 . . . . 0.1 109.052 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.618 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.6 t60 -76.78 -54.5 6.54 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 109.281 -0.637 . . . . 0.21 109.281 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.613 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.2 tp10 -58.76 -47.9 83.07 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 121.181 -0.949 . . . . 0.28 108.538 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.57 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 0.8 OUTLIER -54.79 -55.76 26.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.345 -0.847 . . . . 0.18 109.049 178.81 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.407 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -46.53 -31.52 5.07 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 108.848 -1.701 . . . . 0.21 108.848 179.238 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.564 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.4 OUTLIER -82.07 -76.71 0.25 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.241 -1.152 . . . . 0.17 110.865 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.957 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -35.22 -35.22 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.832 -0.543 . . . . 0.33 111.834 -178.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 1.054 ' HG ' HG21 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -99.82 -41.23 7.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.009 -1.057 . . . . 0.53 110.731 -179.215 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.47 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -72.19 -79.32 0.45 Allowed Glycine 0 N--CA 1.489 2.189 0 N-CA-C 110.26 -1.136 . . . . 0.41 110.26 -179.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.619 HD12 ' C ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -173.54 -163.54 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.07 -1.253 . . . . 0.45 110.525 -179.694 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.517 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -61.55 -54.62 40.76 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.233 -0.917 . . . . 0.62 110.288 -179.753 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.564 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -167.77 177.14 5.92 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.176 -0.952 . . . . 0.45 111.056 179.801 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.415 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 27.7 t 179.26 51.23 0.0 OUTLIER 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.748 -0.834 . . . . 0.38 108.748 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.83 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -132.41 24.66 4.46 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.411 -0.805 . . . . 0.48 111.41 -178.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.554 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.1 OUTLIER -37.13 -53.61 2.03 Favored Pre-proline 0 C--N 1.3 -1.578 0 O-C-N 121.491 -0.756 . . . . 0.38 110.976 -179.273 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.554 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -84.27 -49.52 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.784 0 O-C-N 123.715 1.376 . . . . 0.28 111.202 179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.525 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.57 101.56 0.15 Allowed Glycine 0 N--CA 1.497 2.712 0 C-N-CA 119.361 -1.399 . . . . 0.24 111.357 -179.512 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.907 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -146.73 163.27 36.49 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.341 -1.094 . . . . 0.28 110.246 178.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.639 HD11 HD12 ' A' ' 218' ' ' LEU . 0.5 OUTLIER -69.64 58.41 0.13 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.998 -1.064 . . . . 0.4 109.026 179.16 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.618 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.8 mtp -144.17 -37.29 0.32 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.331 -0.856 . . . . 0.45 110.045 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.594 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -48.56 171.39 0.1 OUTLIER Pre-proline 0 N--CA 1.493 1.688 0 O-C-N 120.865 -1.147 . . . . 0.57 110.063 179.885 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 47.3 Cg_endo -74.25 3.91 4.8 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 O-C-N 123.578 1.304 . . . . 0.76 110.553 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . . . . . . . . . 93.8 mt -104.8 134.58 45.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.183 -0.948 . . . . 0.89 110.182 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.726 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 49.8 p90 -127.87 -36.53 1.99 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.334 -0.854 . . . . 0.78 109.72 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.554 ' C ' ' O ' ' A' ' 244' ' ' TYR . 53.7 m 1.41 -69.55 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.333 0 N-CA-C 112.977 0.732 . . . . 0.61 112.977 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.577 ' O ' ' CG ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER -60.14 101.78 0.14 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.899 -1.126 . . . . 0.74 109.33 -179.915 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.519 ' N ' ' HB2' ' A' ' 250' ' ' SER . 38.7 p -46.79 175.2 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.219 -0.925 . . . . 0.81 110.484 -179.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -52.28 -21.22 8.05 Favored Glycine 0 N--CA 1.489 2.198 0 N-CA-C 109.703 -1.359 . . . . 0.56 109.703 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -146.48 28.48 1.08 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.236 -1.156 . . . . 0.37 110.345 -179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.519 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.5 OUTLIER -58.52 -27.34 64.42 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.193 -0.942 . . . . 0.44 109.941 179.786 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 252' ' ' PHE . 6.9 t-160 -150.59 -55.54 0.16 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.286 -0.884 . . . . 0.53 110.03 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.563 ' CD2' ' O ' ' A' ' 251' ' ' HIS . 0.3 OUTLIER -176.94 -179.24 0.91 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.164 -0.96 . . . . 0.38 110.191 -179.918 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.882 ' HB2' HG21 ' A' ' 259' ' ' VAL . 1.5 ptt? -68.77 54.27 0.09 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.418 -0.801 . . . . 0.19 110.371 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.6 mp -44.75 -47.72 28.56 Favored Pre-proline 0 N--CA 1.487 1.392 0 N-CA-C 107.974 -1.121 . . . . 0.28 107.974 177.689 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.5 Cg_endo -72.89 50.13 1.71 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 123.962 1.506 . . . . 0.49 110.94 177.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.609 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 2.7 m-20 -52.51 -29.77 26.85 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.037 -1.039 . . . . 0.49 110.157 179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.907 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -54.07 -51.55 63.76 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 119.118 -1.033 . . . . 0.31 109.487 -179.286 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.066 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.32 -33.92 70.11 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 118.938 -1.105 . . . . 0.14 108.553 179.135 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.882 HG21 ' HB2' ' A' ' 253' ' ' MET . 72.2 t -62.51 -85.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 C-N-CA 119.573 -0.851 . . . . 0.17 110.22 179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.647 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.4 tt0 -58.04 -43.52 86.87 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.383 -0.823 . . . . 0.26 110.007 179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.537 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.1 -63.87 1.66 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 110.556 -1.018 . . . . 0.19 110.556 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.1 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -80.18 -19.19 12.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 120.755 -1.438 . . . . 0.22 109.994 -179.089 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 1.1 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.7 OUTLIER -59.33 -24.65 63.52 Favored 'General case' 0 C--N 1.297 -1.713 0 N-CA-C 107.849 -1.167 . . . . 0.39 107.849 178.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 8.4 p -103.9 -40.85 6.07 Favored 'General case' 0 N--CA 1.491 1.585 0 C-N-CA 120.273 -0.571 . . . . 0.47 111.806 -179.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.451 ' HB3' ' CG ' ' A' ' 112' ' ' LYS . 4.9 mp -83.96 -46.85 11.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.08 -1.012 . . . . 0.48 111.789 -178.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.936 ' OH ' HD22 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -76.08 -21.42 56.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.061 -1.025 . . . . 0.41 110.481 -179.303 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.467 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -57.7 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.49 2.291 0 N-CA-C 109.165 -1.574 . . . . 0.46 109.165 179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.458 ' HA ' ' SD ' ' A' ' 116' ' ' MET . 48.0 Cg_endo -75.19 95.68 1.0 Allowed 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.789 1.415 . . . . 0.58 110.062 179.816 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.8 178.26 43.78 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.558 -1.417 . . . . 0.64 109.558 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.525 ' HB3' ' NE1' ' A' ' 113' ' ' TRP . 27.9 t0 -115.4 -50.74 2.72 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.266 -1.138 . . . . 0.95 110.138 -179.934 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.483 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 13.5 tt0 59.02 48.41 10.82 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.241 -0.912 . . . . 1.2 110.3 179.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.92 132.68 0.25 Allowed Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.166 -0.958 . . . . 1.2 110.2 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.99 -1.84 11.11 Favored 'Trans proline' 0 C--N 1.306 -1.674 0 O-C-N 123.899 1.473 . . . . 1.06 110.326 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.492 1.651 0 CA-C-O 117.969 -1.015 . . . . 0.78 110.176 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.998 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.617 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 1.021 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 84.4 t80 . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.22 0.533 . . . . 0.41 110.186 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -142.67 80.11 1.68 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.256 -0.902 . . . . 0.26 110.106 -179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.4 t -110.75 -4.31 10.9 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.33 110.319 -179.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -130.23 75.08 79.76 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.159 -0.963 . . . . 0.65 110.185 -179.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.456 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.4 Cg_endo -71.4 -161.95 0.1 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 124.06 1.558 . . . . 0.84 110.703 179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.616 ' C ' HD12 ' A' ' 230' ' ' LEU . 30.7 mtt-85 65.21 70.34 0.46 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.342 -0.849 . . . . 0.93 110.515 -179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.442 ' O ' ' HG2' ' A' ' 112' ' ' LYS . 3.1 p -148.82 -68.97 0.22 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.445 -0.784 . . . . 1.03 109.407 179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.538 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.9 mp 49.2 18.36 0.24 Allowed 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.386 -0.821 . . . . 1.04 111.541 179.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.75 ' HB3' HD12 ' A' ' 265' ' ' LEU . 9.6 mttm -97.41 78.89 2.72 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.837 -1.164 . . . . 0.77 109.643 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.56 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 17.3 t90 -165.38 -68.33 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.207 -0.933 . . . . 0.42 111.36 -179.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.525 ' O ' ' CD ' ' A' ' 115' ' ' LYS . 79.9 p -104.69 84.47 2.17 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.265 -0.897 . . . . 0.44 110.952 -178.766 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.579 ' HB3' ' CE1' ' A' ' 266' ' ' TYR . 3.4 mptt -173.53 83.31 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.294 -0.879 . . . . 0.49 110.312 179.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.436 ' SD ' ' O ' ' A' ' 116' ' ' MET . 7.7 tmm? -123.75 -8.88 7.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.286 -0.884 . . . . 0.3 110.134 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.437 ' HA ' ' HB3' ' A' ' 152' ' ' ASN . 10.1 p30 -158.31 117.34 3.12 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.277 -0.889 . . . . 0.15 109.941 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.515 ' CD2' ' OD2' ' A' ' 162' ' ' ASP . 0.1 OUTLIER -141.88 -178.83 5.87 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.155 -0.966 . . . . 0.13 110.611 -179.581 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.538 ' HA ' ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -119.93 170.36 9.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.341 -0.85 . . . . 0.12 109.56 179.258 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.55 ' HB3' HG23 ' A' ' 163' ' ' ILE . 41.0 p90 -165.22 -158.54 0.39 Allowed 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.034 -1.041 . . . . 0.33 110.947 -179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 1.1 mtt180 -150.34 143.17 24.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.592 -0.692 . . . . 0.54 110.138 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.636 HG21 ' CE1' ' A' ' 138' ' ' PHE . 1.7 pp -103.81 108.25 24.14 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.371 -0.831 . . . . 0.33 110.866 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.939 HG23 ' HB3' ' A' ' 166' ' ' SER . 15.6 m -158.76 43.86 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.292 -0.88 . . . . 0.27 110.352 179.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.543 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 16.1 t-20 -42.68 -76.92 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.273 -0.892 . . . . 0.41 109.328 179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.563 ' O ' HG21 ' A' ' 134' ' ' VAL . 3.0 t80 -179.17 -168.98 0.14 Allowed 'General case' 0 C--N 1.299 -1.628 0 O-C-N 121.383 -0.823 . . . . 0.4 109.537 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.579 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -143.34 45.71 0.62 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 120.832 -1.167 . . . . 0.45 111.353 179.953 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.579 ' CD ' ' N ' ' A' ' 126' ' ' THR . 45.2 Cg_endo -75.49 -85.68 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 123.783 1.412 . . . . 0.36 110.041 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -92.24 -5.84 51.63 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.326 -0.858 . . . . 0.25 109.655 179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.713 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.9 ptt? -118.49 146.87 44.18 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.45 -0.781 . . . . 0.39 109.94 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.3 OUTLIER -104.07 -179.35 3.92 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.858 . . . . 0.48 110.149 -179.97 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.48 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.6 t-80 -43.43 -35.33 1.56 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.362 -0.836 . . . . 0.4 109.872 179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.528 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.2 OUTLIER -66.62 -59.99 3.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.392 -0.818 . . . . 0.46 110.096 179.785 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.531 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 1.3 mp0 -50.72 -61.21 2.34 Favored 'General case' 0 N--CA 1.486 1.374 0 O-C-N 121.206 -0.934 . . . . 0.47 109.409 179.643 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.563 HG21 ' O ' ' A' ' 125' ' ' TYR . 8.2 t -45.13 -37.1 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.653 0 N-CA-C 108.28 -1.007 . . . . 0.31 108.28 178.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.6 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -56.87 -41.05 77.29 Favored 'General case' 0 C--N 1.308 -1.239 0 N-CA-C 108.319 -0.993 . . . . 0.48 108.319 178.639 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.576 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 10.2 tttp -75.09 -51.63 13.0 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 122.05 0.928 . . . . 0.64 108.608 178.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.82 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -45.5 -63.47 0.95 Allowed 'General case' 0 C--N 1.29 -1.981 0 O-C-N 121.093 -1.005 . . . . 0.42 110.418 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.658 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -61.26 -54.31 45.69 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.401 -0.812 . . . . 0.34 111.289 -178.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.658 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -69.62 -72.89 0.17 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.87 -1.144 . . . . 0.47 110.485 -179.238 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.546 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.1 tmtp? -37.91 -61.59 0.63 Allowed 'General case' 0 C--N 1.292 -1.905 0 O-C-N 121.899 -0.5 . . . . 0.47 110.607 179.136 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.585 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -47.06 -40.32 14.78 Favored 'General case' 0 N--CA 1.49 1.561 0 C-N-CA 118.69 -1.204 . . . . 0.25 108.257 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.2 OUTLIER -68.28 -32.82 73.24 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 119.508 -0.877 . . . . 0.35 108.947 178.418 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.486 ' N ' ' O ' ' A' ' 140' ' ' LYS . 13.1 ttpp -59.53 -39.23 83.27 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 108.261 -1.014 . . . . 0.7 108.261 178.752 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 76.2 t -68.86 -41.81 82.3 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.409 0 N-CA-C 108.813 -0.81 . . . . 0.61 108.813 178.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.639 ' O ' HG22 ' A' ' 148' ' ' VAL . 20.6 t-105 -60.99 -39.74 90.81 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.047 -0.723 . . . . 0.39 109.047 179.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.542 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.6 m -73.46 -34.51 65.41 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.412 -0.805 . . . . 0.35 108.834 178.843 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -56.49 -41.55 76.83 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.595 -0.691 . . . . 0.36 109.291 179.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.791 HG23 HG22 ' A' ' 149' ' ' THR . 35.2 m -78.35 -31.7 16.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.392 -0.818 . . . . 0.5 110.11 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.791 HG22 HG23 ' A' ' 148' ' ' VAL . 5.7 t -148.12 135.21 10.38 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.101 -0.999 . . . . 0.51 110.56 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -72.98 59.65 3.62 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.84 1.442 . . . . 0.31 110.377 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 1.015 HD21 ' CD1' ' A' ' 266' ' ' TYR . 1.1 mp -80.8 163.43 23.47 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.26 -0.9 . . . . 0.18 110.5 -179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.437 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 0.5 OUTLIER -107.4 110.18 22.09 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.331 -0.856 . . . . 0.17 110.178 179.977 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.511 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.1 p90 -115.71 122.62 46.06 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.28 -0.887 . . . . 0.14 110.015 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.945 ' CG2' HD13 ' A' ' 156' ' ' LEU . 8.3 m -127.42 140.87 51.88 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.203 -0.936 . . . . 0.15 110.373 -179.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.547 ' HG3' ' CZ ' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -104.5 82.09 1.87 Allowed 'General case' 0 C--N 1.3 -1.58 0 O-C-N 121.421 -0.799 . . . . 0.2 109.622 -179.558 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.945 HD13 ' CG2' ' A' ' 154' ' ' THR . 1.3 mp -91.26 85.48 5.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.167 -0.958 . . . . 0.22 110.44 -179.754 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.425 ' O ' ' N ' ' A' ' 159' ' ' GLY . 36.6 p-80 -57.32 -19.72 24.16 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.206 -0.934 . . . . 0.32 109.789 179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.402 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.96 -26.66 0.15 Allowed 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.481 -0.762 . . . . 0.33 109.823 179.13 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.425 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 130.38 20.68 1.24 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.829 -1.308 . . . . 0.28 109.829 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.673 ' O ' HG22 ' A' ' 160' ' ' ILE . 12.1 mt -122.64 65.54 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.331 0 O-C-N 121.045 -1.268 . . . . 0.3 109.259 179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.475 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -118.96 141.45 48.65 Favored 'General case' 0 C--N 1.299 -1.604 0 C-N-CA 120.198 -0.601 . . . . 0.2 110.4 -179.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.515 ' OD2' ' CD2' ' A' ' 118' ' ' LEU . 0.4 OUTLIER -107.12 -47.55 3.66 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.242 -0.911 . . . . 0.1 109.961 179.797 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.001 ' CD1' HD11 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -116.34 173.16 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 O-C-N 121.216 -0.928 . . . . 0.1 109.824 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.54 ' N ' ' CG1' ' A' ' 163' ' ' ILE . 4.4 ptp -170.67 142.22 1.97 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.112 -0.993 . . . . 0.11 110.63 179.64 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.674 ' O ' HG23 ' A' ' 165' ' ' ILE . 3.8 tt -92.89 113.77 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.446 -0.784 . . . . 0.1 109.086 179.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.939 ' HB3' HG23 ' A' ' 123' ' ' VAL . 5.0 p -157.38 156.54 32.45 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.805 -1.184 . . . . 0.1 111.262 -179.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.578 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -74.23 118.48 17.24 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.692 -0.63 . . . . 0.09 109.665 179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.455 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -71.67 119.8 7.83 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 110.024 -1.231 . . . . 0.2 110.024 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.731 ' O ' HG23 ' A' ' 169' ' ' ILE . 6.9 tp -116.61 97.65 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.393 -1.063 . . . . 0.55 109.985 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.63 ' CG ' ' CE1' ' A' ' 178' ' ' PHE . 3.7 tmtt? 0.07 96.54 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.364 0 CA-C-O 121.289 0.566 . . . . 0.85 112.388 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -162.47 24.94 0.1 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.216 -0.928 . . . . 0.71 110.351 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.0 m-70 -97.11 -69.59 0.75 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.153 -0.967 . . . . 0.42 110.132 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 144.43 -35.82 1.51 Allowed Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.494 -1.442 . . . . 0.33 109.494 -179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 11.9 p-10 -75.29 -144.05 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.21 -1.171 . . . . 0.33 110.517 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.427 ' C ' ' CD1' ' A' ' 176' ' ' TYR . 58.3 m-85 -55.65 -173.07 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.25 -0.906 . . . . 0.27 110.509 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.508 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 5.4 m-30 -111.01 110.94 56.52 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.327 -0.858 . . . . 0.34 110.306 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . . . . . . . . . 41.5 Cg_endo -71.88 -68.95 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 123.929 1.489 . . . . 0.47 110.558 179.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.63 ' CE1' ' CG ' ' A' ' 170' ' ' LYS . 0.8 OUTLIER -51.21 137.58 22.24 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.164 -0.96 . . . . 0.35 110.417 179.736 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.48 ' HB3' ' O ' ' A' ' 178' ' ' PHE . 51.6 p-10 -178.44 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.34 -0.85 . . . . 0.2 110.624 179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.57 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 44.44 -158.73 0.15 Allowed Glycine 0 N--CA 1.49 2.271 0 N-CA-C 109.782 -1.327 . . . . 0.25 109.782 179.607 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.448 ' O ' ' O ' ' A' ' 182' ' ' SER . 50.8 Cg_endo -74.95 7.28 2.91 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.14 1.6 . . . . 0.44 110.725 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.484 ' O ' ' N ' ' A' ' 184' ' ' LEU . 6.4 t -42.58 165.94 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.152 -0.967 . . . . 0.57 110.36 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.541 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -61.98 76.51 0.02 OUTLIER Glycine 0 N--CA 1.488 2.14 0 N-CA-C 110.418 -1.073 . . . . 0.49 110.418 -179.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.04 ' HA ' HG13 ' A' ' 1' ' ' HAV . 3.3 tt 179.9 88.13 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.222 -1.163 . . . . 0.41 110.389 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.585 HD13 ' CE2' ' A' ' 214' ' ' TYR . 4.8 tt -103.84 -23.22 13.41 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.9 -1.125 . . . . 0.3 110.944 179.664 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.764 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -148.45 108.03 3.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.602 -1.311 . . . . 0.2 112.126 -179.352 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -105.7 118.76 37.42 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.258 -0.901 . . . . 0.16 109.529 178.713 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.863 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -107.8 141.02 40.01 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.998 -1.064 . . . . 0.23 110.202 -179.383 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.541 ' CE1' ' CE1' ' A' ' 187' ' ' HIS . 3.2 m-30 -91.04 161.51 35.12 Favored Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.193 -0.942 . . . . 0.38 110.32 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.531 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 45.5 Cg_endo -72.41 142.98 37.96 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.967 1.509 . . . . 0.4 109.409 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.3 Cg_endo -69.64 74.41 1.24 Allowed 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.849 1.447 . . . . 0.32 110.693 -179.053 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.84 -93.71 1.76 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.408 -1.477 . . . . 0.32 109.408 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -72.71 -158.94 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.981 1.516 . . . . 0.47 110.406 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -79.51 8.82 5.67 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.21 -0.931 . . . . 0.63 110.43 -179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.493 ' HA ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -114.67 6.98 15.84 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.324 -0.86 . . . . 0.53 109.717 179.827 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.531 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -80.89 168.8 51.4 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.594 -1.402 . . . . 0.25 109.594 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.568 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 51.84 18.65 4.38 Favored Glycine 0 N--CA 1.488 2.115 0 N-CA-C 109.658 -1.377 . . . . 0.1 109.658 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.493 ' OD2' ' HA ' ' A' ' 195' ' ' TYR . 0.2 OUTLIER -79.98 92.19 5.54 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.288 -1.125 . . . . 0.1 110.339 -179.746 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.504 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -72.44 97.44 2.07 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.192 -0.942 . . . . 0.09 109.952 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.468 ' CB ' ' NE2' ' A' ' 187' ' ' HIS . 1.4 m170 -111.13 131.99 54.65 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.331 -0.856 . . . . 0.09 110.328 -179.68 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.626 ' CE1' ' CG2' ' A' ' 219' ' ' VAL . 59.5 m-85 -103.27 136.61 42.73 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 120.992 -1.067 . . . . 0.1 110.678 179.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.955 ' OD1' HD22 ' A' ' 184' ' ' LEU . 1.0 OUTLIER -46.52 92.33 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 108.719 -0.845 . . . . 0.14 108.719 179.111 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.642 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 2.4 p30 -36.84 -27.85 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.475 -0.766 . . . . 0.18 111.674 -178.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.57 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 0.7 OUTLIER -77.69 -0.24 25.99 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 120.675 -1.266 . . . . 0.24 111.217 -179.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.524 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 12.6 mm-40 -94.82 -164.17 1.14 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.832 -1.168 . . . . 0.42 110.303 -179.85 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 1.5 m -125.58 140.48 52.71 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.197 -0.94 . . . . 0.47 110.582 -179.68 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.642 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.1 m-90 -135.56 142.81 45.42 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.383 -0.823 . . . . 0.27 109.43 179.721 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.035 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.0 OUTLIER -156.83 179.93 8.81 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.932 -1.105 . . . . 0.3 110.565 -179.975 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . . . . . . . . . 42.8 t -124.62 43.07 3.11 Favored 'General case' 0 C--N 1.297 -1.676 0 CA-C-O 121.686 0.755 . . . . 0.61 109.251 178.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.522 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.8 t -131.63 -165.9 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.697 -0.627 . . . . 0.78 110.076 -179.528 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.522 ' N ' ' OG ' ' A' ' 210' ' ' SER . 8.7 t -87.64 -0.51 56.98 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 0.91 110.14 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.47 149.75 28.37 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.212 -0.93 . . . . 0.93 109.969 179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 64.23 -164.25 33.27 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.35 -1.5 . . . . 0.79 109.35 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.585 ' CE2' HD13 ' A' ' 185' ' ' LEU . 66.8 m-85 -84.52 120.78 26.72 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.169 -1.195 . . . . 0.69 109.891 179.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.92 ' ND2' HG22 ' A' ' 247' ' ' THR . 7.3 p30 -87.62 121.7 30.39 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.067 -1.021 . . . . 0.4 108.852 179.433 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.035 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -39.89 -38.78 0.73 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.487 -0.758 . . . . 0.17 110.867 -179.134 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.576 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 4.0 m-85 -51.31 -48.87 62.22 Favored 'General case' 0 C--N 1.289 -2.036 0 C-N-CA 118.435 -1.306 . . . . 0.28 107.527 179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.874 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.5 OUTLIER -73.87 -72.6 0.26 Allowed 'General case' 0 C--N 1.296 -1.739 0 CA-C-N 115.726 -0.67 . . . . 0.46 110.151 178.678 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.916 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -47.93 -69.98 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.524 0 O-C-N 121.129 -0.982 . . . . 0.39 109.914 -179.752 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.906 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -42.27 -54.79 3.58 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.982 -1.074 . . . . 0.17 111.292 179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -57.58 -30.72 65.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.499 -1.376 . . . . 0.1 109.578 -179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.644 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.7 t60 -75.51 -43.78 47.24 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-O 121.353 0.597 . . . . 0.21 109.686 179.487 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.764 ' OE1' ' HB1' ' A' ' 186' ' ' ALA . 22.8 tp10 -64.4 -35.97 82.63 Favored 'General case' 0 N--CA 1.486 1.357 0 O-C-N 121.286 -0.884 . . . . 0.28 108.894 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.565 ' CE2' ' HB1' ' A' ' 220' ' ' ALA . 19.1 m-85 -66.93 -48.52 68.37 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 108.755 -0.831 . . . . 0.18 108.755 178.559 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . -52.47 -31.66 36.54 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 108.288 -1.925 . . . . 0.21 108.288 178.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.662 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 0.7 OUTLIER -80.62 -78.44 0.17 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.405 -1.056 . . . . 0.17 110.674 179.482 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.863 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.9 OUTLIER -38.5 -45.48 1.06 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.747 -0.596 . . . . 0.33 111.268 -178.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 1.001 HD11 ' CD1' ' A' ' 163' ' ' ILE . 6.0 mt -83.37 -46.3 12.72 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.162 -0.961 . . . . 0.53 110.878 -179.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.538 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -71.31 -85.14 0.19 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 110.363 -1.095 . . . . 0.41 110.363 -178.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.622 HD23 ' N ' ' A' ' 230' ' ' LEU . 2.6 pt? -176.62 -158.32 0.05 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.16 -1.2 . . . . 0.45 110.563 -179.286 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.52 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 7.4 t70 -49.88 -56.1 11.77 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.308 -0.87 . . . . 0.62 110.148 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.662 ' CD2' ' NE2' ' A' ' 226' ' ' HIS . 0.0 OUTLIER -164.69 -175.68 3.93 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.346 -0.846 . . . . 0.45 109.861 179.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.42 ' HB3' ' SD ' ' A' ' 240' ' ' MET . 0.2 OUTLIER -179.78 58.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.316 -0.865 . . . . 0.38 109.809 179.649 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 1.084 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -152.29 27.06 0.59 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.211 -0.93 . . . . 0.48 111.196 -179.272 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.545 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.7 OUTLIER -37.83 -48.89 2.89 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 121.483 -0.761 . . . . 0.38 110.674 -179.612 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 41.1 Cg_endo -86.81 -46.38 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.913 1.481 . . . . 0.28 112.289 -179.817 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.522 ' N ' ' OD2' ' A' ' 257' ' ' ASP . . . 177.32 99.58 0.12 Allowed Glycine 0 N--CA 1.5 2.94 0 C-N-CA 118.638 -1.744 . . . . 0.24 112.127 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 1.084 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -150.03 169.49 21.09 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.031 -1.276 . . . . 0.28 110.556 178.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.613 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -80.19 49.96 1.18 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.241 -0.912 . . . . 0.4 108.79 178.737 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.644 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.9 OUTLIER -133.99 -22.45 1.82 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.005 -1.059 . . . . 0.45 110.915 -179.377 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.591 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -60.72 172.09 0.91 Allowed Pre-proline 0 N--CA 1.499 1.983 0 O-C-N 120.873 -1.142 . . . . 0.57 110.204 179.883 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.588 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 40.6 Cg_endo -67.79 -2.73 9.1 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 O-C-N 123.413 1.217 . . . . 0.76 110.935 179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.569 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.6 mp -108.04 153.59 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.89 109.649 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.874 ' HB2' HD21 ' A' ' 218' ' ' LEU . 14.3 p90 -135.78 -22.93 1.41 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.991 -1.068 . . . . 0.78 111.685 -179.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.756 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 4.0 -70.51 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.394 0 N-CA-C 113.44 0.904 . . . . 0.61 113.44 -178.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.756 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -72.27 117.34 13.8 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 120.454 -1.404 . . . . 0.74 109.77 -179.667 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.92 HG22 ' ND2' ' A' ' 215' ' ' ASN . 47.6 p -62.17 -161.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.298 -0.876 . . . . 0.81 110.403 -179.661 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -67.58 -32.61 79.03 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.593 -1.403 . . . . 0.56 109.593 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -139.48 41.67 2.04 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.289 -1.124 . . . . 0.37 110.517 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 251' ' ' HIS . 0.1 OUTLIER -63.52 -20.87 65.98 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.087 -1.008 . . . . 0.44 109.751 179.679 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.581 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 20.4 m-70 -167.9 -48.9 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.443 -0.786 . . . . 0.53 109.911 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.581 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 3.9 m-85 -170.22 176.6 4.49 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.41 -0.806 . . . . 0.38 110.205 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.943 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -70.56 54.38 0.15 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.415 -0.803 . . . . 0.19 110.043 179.195 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.699 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 4.2 mm? -43.82 -47.56 20.83 Favored Pre-proline 0 N--CA 1.485 1.292 0 N-CA-C 108.176 -1.046 . . . . 0.28 108.176 177.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.699 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.21 49.81 1.42 Allowed 'Trans proline' 0 C--N 1.311 -1.42 0 O-C-N 124.015 1.534 . . . . 0.49 110.787 177.574 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.615 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 6.2 m-20 -54.19 -29.45 45.99 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.169 -0.957 . . . . 0.49 110.236 179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.913 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 55.4 m-20 -57.2 -41.2 78.92 Favored 'General case' 0 C--N 1.306 -1.317 0 C-N-CA 119.257 -0.977 . . . . 0.31 109.339 -179.235 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.056 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -78.43 -33.2 48.7 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 107.986 -1.116 . . . . 0.14 107.986 178.673 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.943 HG21 ' HB2' ' A' ' 253' ' ' MET . 83.5 t -65.55 -79.46 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 121.457 0.646 . . . . 0.17 109.906 179.248 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.622 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 4.4 tt0 -58.18 -42.37 85.9 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.29 -0.881 . . . . 0.26 109.446 179.37 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.46 -70.33 0.5 Allowed Glycine 0 N--CA 1.489 2.211 0 N-CA-C 110.178 -1.169 . . . . 0.19 110.178 -179.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.089 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -73.75 -18.94 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.963 -1.316 . . . . 0.22 110.392 -179.281 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 1.089 ' N ' HD13 ' A' ' 262' ' ' ILE . 44.9 tt0 -65.54 -20.3 66.28 Favored 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 118.9 -1.12 . . . . 0.39 108.163 178.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -103.37 -40.69 6.28 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.779 -0.576 . . . . 0.47 111.145 -179.811 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.75 HD12 ' HB3' ' A' ' 112' ' ' LYS . 4.3 mm? -86.71 -45.4 11.0 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.185 -0.947 . . . . 0.48 111.179 -178.698 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 1.015 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.2 OUTLIER -76.95 -13.68 59.95 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.41 110.53 -179.481 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . . . . . . . . . . . -62.7 -107.43 0.01 OUTLIER Glycine 0 N--CA 1.49 2.278 0 N-CA-C 108.953 -1.659 . . . . 0.46 108.953 179.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -73.1 95.07 0.82 Allowed 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 123.797 1.42 . . . . 0.58 110.079 179.399 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -89.87 171.04 37.08 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.825 -1.31 . . . . 0.64 109.825 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.56 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.9 OUTLIER -96.42 -70.32 0.72 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.325 -1.103 . . . . 0.95 110.13 179.898 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.433 ' HG2' ' O ' ' A' ' 271' ' ' GLU . 78.7 tt0 52.37 28.76 6.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 1.2 110.115 -179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.462 ' OD2' ' O ' ' A' ' 270' ' ' ASP . 2.0 p30 -168.21 131.98 1.37 Allowed Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 1.2 110.201 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_endo -71.84 -10.47 26.39 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.9 1.474 . . . . 1.06 110.416 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 50.3 p-10 . . . . . 0 N--CA 1.492 1.641 0 O-C-N 121.159 -0.963 . . . . 0.78 110.215 179.98 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.04 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.619 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.619 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.49 1.575 0 CA-C-O 121.272 0.558 . . . . 0.41 110.193 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -147.58 74.32 1.31 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.295 -0.878 . . . . 0.26 110.128 -179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.729 HG12 ' HD1' ' A' ' 107' ' ' PHE . 36.9 t -122.82 -37.29 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.245 -0.909 . . . . 0.33 110.263 -179.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.729 ' HD1' HG12 ' A' ' 106' ' ' VAL . 1.6 m-85 -134.48 52.61 8.0 Favored Pre-proline 0 N--CA 1.491 1.591 0 O-C-N 121.34 -0.85 . . . . 0.65 110.487 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.554 ' HD3' ' N ' ' A' ' 107' ' ' PHE . 51.6 Cg_endo -79.24 12.06 2.43 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 O-C-N 123.919 1.484 . . . . 0.84 110.693 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.672 ' O ' HD12 ' A' ' 230' ' ' LEU . 63.8 mtt180 -121.38 58.81 0.97 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.125 -0.985 . . . . 0.93 110.202 -179.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.529 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p -127.34 -39.81 1.85 Allowed 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.302 -0.874 . . . . 1.03 109.59 179.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.529 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 3.2 mm? 40.75 25.03 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.545 -0.722 . . . . 1.04 111.373 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 1.8 mttt -123.44 65.18 1.01 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.856 -1.153 . . . . 0.77 109.939 179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.632 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 19.3 t90 -123.03 -71.67 0.72 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.259 -0.9 . . . . 0.42 110.573 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.53 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 22.1 t -105.15 58.33 0.68 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.302 -0.874 . . . . 0.44 110.291 -179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HG3' ' C ' ' A' ' 114' ' ' SER . 39.0 mttp -141.72 59.49 1.49 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.177 -0.952 . . . . 0.49 110.489 -179.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.48 ' CG ' ' O ' ' A' ' 267' ' ' GLY . 0.6 OUTLIER -89.9 11.2 21.06 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.26 -0.9 . . . . 0.3 109.793 179.55 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.991 ' O ' HD22 ' A' ' 118' ' ' LEU . 0.9 OUTLIER -172.0 115.4 0.35 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.343 -0.848 . . . . 0.15 109.512 179.951 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.991 HD22 ' O ' ' A' ' 117' ' ' ASN . 1.2 mm? -137.48 178.01 7.43 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.184 -0.947 . . . . 0.13 110.72 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.636 HG21 HG22 ' A' ' 160' ' ' ILE . 0.0 OUTLIER -120.34 174.11 6.72 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.436 -0.79 . . . . 0.12 109.902 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.556 ' HB3' HG12 ' A' ' 163' ' ' ILE . 31.3 p90 -178.94 178.74 0.73 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.142 -0.974 . . . . 0.33 111.425 -179.793 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.469 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 1.3 ttp180 -121.05 158.51 27.68 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.616 -0.677 . . . . 0.54 109.654 179.424 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.726 HD13 ' CD2' ' A' ' 138' ' ' PHE . 1.6 pp -125.7 98.42 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.199 -0.938 . . . . 0.33 110.881 -179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.995 HG23 ' HB3' ' A' ' 166' ' ' SER . 3.4 m -145.57 53.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.12 -0.988 . . . . 0.27 110.334 179.469 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 17.9 t30 -43.39 -84.63 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.214 -0.929 . . . . 0.41 109.623 179.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.543 ' CD2' ' HD3' ' A' ' 127' ' ' PRO . 8.6 t80 -177.53 -175.07 0.51 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.292 -0.88 . . . . 0.4 109.917 179.362 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.547 HG22 ' HA ' ' A' ' 130' ' ' THR . 0.0 OUTLIER -139.03 52.52 4.28 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 120.974 -1.079 . . . . 0.45 110.716 -179.799 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.543 ' HD3' ' CD2' ' A' ' 125' ' ' TYR . 44.2 Cg_endo -76.26 -86.23 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.819 1.431 . . . . 0.36 109.767 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -91.77 -4.62 54.76 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.31 -0.869 . . . . 0.25 109.588 179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.957 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.8 ptm -119.76 170.71 8.97 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.469 -0.769 . . . . 0.39 109.955 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.547 ' HA ' HG22 ' A' ' 126' ' ' THR . 0.2 OUTLIER -121.91 -172.46 2.45 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.169 -0.957 . . . . 0.48 110.34 -179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.458 ' H ' HG22 ' A' ' 130' ' ' THR . 1.5 t60 -53.09 -36.4 60.65 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.268 -0.895 . . . . 0.4 110.03 179.803 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.471 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 6.9 t -60.83 -48.68 80.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.248 -0.907 . . . . 0.46 109.336 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.564 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 13.1 mp0 -62.79 -63.33 1.24 Allowed 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.34 -0.85 . . . . 0.47 109.527 179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.614 HG23 ' HE2' ' A' ' 129' ' ' MET . 13.4 t -43.68 -38.48 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.603 0 N-CA-C 108.611 -0.885 . . . . 0.31 108.611 178.738 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.611 ' HA ' ' CE2' ' A' ' 138' ' ' PHE . 3.0 mt-10 -56.68 -42.14 78.54 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 108.246 -1.02 . . . . 0.48 108.246 178.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.543 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 2.4 tttm -73.8 -50.13 22.0 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 108.471 -0.936 . . . . 0.64 108.471 178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.84 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.05 -60.79 2.07 Favored 'General case' 0 C--N 1.29 -2.02 0 O-C-N 121.19 -0.944 . . . . 0.42 110.225 179.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.726 ' CD2' HD13 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.74 -53.63 44.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.191 -0.943 . . . . 0.34 111.018 -179.157 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.649 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -67.82 -72.76 0.16 Allowed 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.857 -1.152 . . . . 0.47 110.347 -179.537 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.543 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 2.2 tmtm? -38.65 -61.16 0.74 Allowed 'General case' 0 C--N 1.292 -1.911 0 O-C-N 121.752 -0.593 . . . . 0.47 110.655 178.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.575 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -47.59 -38.59 14.75 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 118.611 -1.235 . . . . 0.25 108.374 178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.523 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -70.11 -32.76 70.94 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 121.335 -0.853 . . . . 0.35 109.15 178.634 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.456 ' N ' ' O ' ' A' ' 140' ' ' LYS . 4.6 tttp -59.82 -38.82 83.08 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 108.38 -0.971 . . . . 0.7 108.38 178.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.484 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 16.1 t -71.91 -44.34 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 N-CA-C 109.035 -0.728 . . . . 0.61 109.035 178.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.628 ' O ' HG22 ' A' ' 149' ' ' THR . 13.6 t-105 -56.63 -44.93 81.71 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.494 -0.754 . . . . 0.39 109.01 178.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.498 ' HA ' ' O ' ' A' ' 149' ' ' THR . 26.0 m -71.01 -35.05 71.88 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.32 -0.862 . . . . 0.35 108.739 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.484 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -53.06 -42.43 65.78 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.576 -0.703 . . . . 0.36 109.416 179.147 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.761 HG23 HG22 ' A' ' 149' ' ' THR . 31.1 m -80.47 -32.59 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 119.779 -0.768 . . . . 0.5 110.198 179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.761 HG22 HG23 ' A' ' 148' ' ' VAL . 2.5 t -137.94 124.59 13.27 Favored Pre-proline 0 N--CA 1.493 1.696 0 O-C-N 120.992 -1.068 . . . . 0.51 110.818 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -78.28 62.24 8.04 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 O-C-N 123.977 1.514 . . . . 0.31 110.341 179.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.851 ' O ' HD12 ' A' ' 151' ' ' LEU . 0.3 OUTLIER -101.0 156.31 17.47 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.101 -0.999 . . . . 0.18 110.127 179.792 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.5 ' HB3' ' ND2' ' A' ' 117' ' ' ASN . 0.3 OUTLIER -76.94 134.41 38.92 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.35 -0.844 . . . . 0.17 111.341 -178.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.536 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 7.7 p90 -135.19 121.99 21.01 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.55 -0.719 . . . . 0.14 109.618 179.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.55 ' HB ' HG23 ' A' ' 119' ' ' THR . 42.4 m -127.0 161.68 27.79 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.062 -1.024 . . . . 0.15 110.573 -179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.516 ' N ' ' CD ' ' A' ' 155' ' ' ARG . 0.0 OUTLIER -142.18 68.95 1.32 Allowed 'General case' 0 C--N 1.3 -1.572 0 O-C-N 121.655 -0.653 . . . . 0.2 110.09 -178.94 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -69.78 93.29 0.73 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.265 -0.897 . . . . 0.22 110.038 179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.418 ' O ' ' C ' ' A' ' 158' ' ' ASP . 50.4 p-80 -48.51 -28.15 3.17 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.288 -0.882 . . . . 0.32 110.083 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' A' ' 157' ' ' HIS . 4.3 t70 -42.36 -70.27 0.11 Allowed 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.576 -0.703 . . . . 0.33 109.819 179.318 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 179.39 30.68 0.06 OUTLIER Glycine 0 N--CA 1.492 2.395 0 N-CA-C 109.586 -1.406 . . . . 0.28 109.586 179.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.636 HG22 HG21 ' A' ' 119' ' ' THR . 20.9 mm -121.57 79.55 0.63 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.514 0 O-C-N 121.267 -1.137 . . . . 0.3 108.339 179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.502 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -136.14 112.02 9.53 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 120.097 -0.641 . . . . 0.2 110.714 -178.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.436 ' HB2' HD12 ' A' ' 118' ' ' LEU . 33.5 t70 -73.37 -54.36 8.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.1 109.97 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.942 HG22 ' HA3' ' A' ' 197' ' ' GLY . 5.4 pt -111.84 175.9 1.81 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.222 -0.924 . . . . 0.1 109.677 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.487 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 23.2 ptm -170.35 136.71 1.38 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.844 -1.16 . . . . 0.11 111.122 -179.676 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.645 HG22 ' HA ' ' A' ' 122' ' ' ILE . 1.6 tt -90.24 123.44 42.42 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.447 -0.783 . . . . 0.1 109.852 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.995 ' HB3' HG23 ' A' ' 123' ' ' VAL . 23.0 p -168.37 143.05 3.41 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 120.831 -1.168 . . . . 0.1 110.922 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.583 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 1.8 p90 -58.49 117.21 4.25 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.372 -0.83 . . . . 0.09 109.507 179.58 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.478 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -83.79 115.3 4.03 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.901 -1.28 . . . . 0.2 109.901 -179.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.686 ' O ' HG23 ' A' ' 169' ' ' ILE . 7.0 tt -106.63 100.26 10.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.573 -0.957 . . . . 0.55 109.781 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.574 ' C ' ' O ' ' A' ' 169' ' ' ILE . 0.0 OUTLIER 0.91 87.47 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 CA-C-O 121.33 0.586 . . . . 0.85 112.397 -179.545 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -130.06 -1.75 4.61 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.71 110.226 -179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 12.3 m-70 -77.18 -86.24 0.06 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.163 -0.961 . . . . 0.42 110.035 179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 129.28 58.8 0.1 Allowed Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.339 -1.504 . . . . 0.33 109.339 -179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -155.16 -80.9 0.08 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.322 -1.105 . . . . 0.33 110.377 -179.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 83.9 m-85 -115.67 103.67 10.92 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.194 -0.941 . . . . 0.27 110.335 -179.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.427 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.3 m-30 -40.32 98.82 0.18 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.543 -0.723 . . . . 0.34 110.156 179.851 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.868 ' O ' HD22 ' A' ' 184' ' ' LEU . 48.9 Cg_endo -82.67 -59.46 0.02 OUTLIER 'Trans proline' 0 C--N 1.303 -1.822 0 O-C-N 124.099 1.579 . . . . 0.47 110.775 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.546 ' CB ' ' OD1' ' A' ' 203' ' ' ASP . 10.8 p90 -50.7 163.4 0.19 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.323 -0.861 . . . . 0.35 110.209 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.517 ' OD1' ' N ' ' A' ' 180' ' ' GLY . 0.9 OUTLIER 179.48 -46.96 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.941 -1.099 . . . . 0.2 111.451 179.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.553 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 141.89 -123.55 2.26 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.157 -1.577 . . . . 0.25 109.157 -179.29 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -78.4 2.62 7.91 Favored 'Trans proline' 0 C--N 1.297 -2.175 0 O-C-N 123.919 1.484 . . . . 0.44 109.768 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.64 177.53 0.2 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.434 -0.791 . . . . 0.57 110.228 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.541 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -77.03 76.33 1.63 Allowed Glycine 0 N--CA 1.488 2.16 0 N-CA-C 110.594 -1.003 . . . . 0.49 110.594 -179.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.876 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.6 OUTLIER 179.77 98.49 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.283 -1.127 . . . . 0.41 110.288 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.702 HD12 ' CD ' ' A' ' 205' ' ' GLU . 1.4 tt -116.74 -17.6 10.47 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 118.746 -1.182 . . . . 0.3 111.334 179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.725 ' HB1' ' OE1' ' A' ' 223' ' ' GLU . . . -157.52 105.1 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.452 -1.405 . . . . 0.2 111.851 -179.872 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.4 OUTLIER -102.76 121.35 42.27 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.031 -1.043 . . . . 0.16 110.086 179.224 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.833 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -106.41 119.03 38.2 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.302 -0.874 . . . . 0.23 110.075 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 1.2 m-30 -69.7 170.25 10.18 Favored Pre-proline 0 N--CA 1.494 1.764 0 O-C-N 121.257 -0.902 . . . . 0.38 110.401 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.517 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 46.2 Cg_endo -73.15 130.73 15.68 Favored 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.101 1.579 . . . . 0.4 109.698 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 227' ' ' SER . 43.6 Cg_endo -69.88 74.8 1.31 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.956 1.503 . . . . 0.32 110.572 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -123.01 -91.45 1.02 Allowed Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.703 -1.359 . . . . 0.32 109.703 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -73.0 -163.57 0.16 Allowed 'Trans proline' 0 C--N 1.306 -1.683 0 O-C-N 123.991 1.521 . . . . 0.47 110.489 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -70.23 -6.58 35.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.235 -0.916 . . . . 0.63 110.047 179.768 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . 0.438 ' C ' ' OD2' ' A' ' 198' ' ' ASP . 0.1 OUTLIER -111.55 49.7 0.87 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.423 -0.798 . . . . 0.53 109.796 -179.995 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.517 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -123.89 174.62 16.81 Favored Glycine 0 N--CA 1.487 2.075 0 N-CA-C 109.36 -1.496 . . . . 0.25 109.36 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.942 ' HA3' HG22 ' A' ' 163' ' ' ILE . . . 41.59 27.63 0.32 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 110.081 -1.208 . . . . 0.1 110.081 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.438 ' OD2' ' C ' ' A' ' 195' ' ' TYR . 57.7 m-20 -79.53 90.07 5.09 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.057 -1.261 . . . . 0.1 110.031 179.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.803 ' HB1' ' HG2' ' A' ' 223' ' ' GLU . . . -68.59 89.97 0.38 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.053 -1.029 . . . . 0.09 109.81 179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.544 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 3.1 m170 -102.92 128.31 49.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.267 -0.895 . . . . 0.09 110.222 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.567 ' O ' ' N ' ' A' ' 203' ' ' ASP . 21.2 m-85 -96.73 132.13 42.73 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.158 -0.964 . . . . 0.1 111.173 -179.679 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.573 ' HB3' ' CG ' ' A' ' 205' ' ' GLU . 35.8 t0 -40.06 91.09 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.245 -0.65 . . . . 0.14 109.245 178.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.567 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -36.43 -38.89 0.17 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.293 -0.879 . . . . 0.18 112.161 -178.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.553 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 14.0 t0 -73.68 -6.65 48.09 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 120.642 -1.286 . . . . 0.24 111.225 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.702 ' CD ' HD12 ' A' ' 185' ' ' LEU . 14.7 mm-40 -84.79 -165.21 1.12 Allowed 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.847 -1.158 . . . . 0.42 110.176 179.681 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -130.55 148.26 52.33 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.087 -1.008 . . . . 0.47 110.441 -179.857 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.437 ' NE1' ' HB3' ' A' ' 201' ' ' PHE . 0.9 OUTLIER -142.24 140.36 32.26 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.267 -0.895 . . . . 0.27 109.57 179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.016 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -149.03 174.85 11.86 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.857 -1.152 . . . . 0.3 110.748 179.925 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -129.06 24.79 5.59 Favored 'General case' 0 C--N 1.302 -1.499 0 CA-C-O 121.794 0.807 . . . . 0.61 109.206 178.89 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.531 ' OG ' ' N ' ' A' ' 211' ' ' SER . 3.3 t -94.6 -111.46 0.12 Allowed 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.615 -0.678 . . . . 0.78 110.03 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.531 ' N ' ' OG ' ' A' ' 210' ' ' SER . 4.4 p -141.28 8.39 2.02 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.886 -1.134 . . . . 0.91 110.008 179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -130.07 -179.26 5.12 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.3 -0.875 . . . . 0.93 109.963 179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 52.76 -154.88 5.63 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.038 -1.625 . . . . 0.79 109.038 -179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.617 ' CE2' HD13 ' A' ' 185' ' ' LEU . 79.0 m-85 -90.16 109.94 20.99 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.073 -1.251 . . . . 0.69 110.066 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.61 ' O ' HG12 ' A' ' 219' ' ' VAL . 32.6 m-20 -79.15 120.92 24.36 Favored 'General case' 0 C--N 1.305 -1.357 0 O-C-N 121.097 -1.002 . . . . 0.4 108.866 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.016 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -41.26 -36.53 0.79 Allowed 'General case' 0 N--CA 1.489 1.482 0 C-N-CA 119.556 -0.858 . . . . 0.17 110.718 -179.223 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.576 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 4.1 m-85 -53.05 -46.92 68.74 Favored 'General case' 0 C--N 1.285 -2.196 0 C-N-CA 118.315 -1.354 . . . . 0.28 107.589 179.722 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 1.031 HD21 ' HB2' ' A' ' 244' ' ' TYR . 5.8 tp -77.27 -71.86 0.38 Allowed 'General case' 0 C--N 1.295 -1.777 0 CA-C-N 115.4 -0.818 . . . . 0.46 110.683 179.15 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.3 p -48.78 -61.87 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.39 110.385 -179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.92 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.06 -48.56 67.58 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.061 -1.024 . . . . 0.17 111.439 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -58.95 -29.11 66.9 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 120.201 -1.562 . . . . 0.1 108.743 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.66 ' CA ' HD21 ' A' ' 239' ' ' LEU . 4.0 t60 -77.0 -44.12 32.19 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.31 0.576 . . . . 0.21 109.747 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.803 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 17.8 tp10 -64.58 -45.61 86.3 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.069 -1.02 . . . . 0.28 108.667 178.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.531 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 18.4 m-30 -56.35 -60.51 3.41 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.362 -0.836 . . . . 0.18 109.029 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.451 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.07 -34.15 1.99 Allowed Glycine 0 N--CA 1.486 2.015 0 N-CA-C 108.971 -1.652 . . . . 0.21 108.971 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.62 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -80.87 -70.16 0.55 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.106 -1.232 . . . . 0.17 111.235 179.921 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.833 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -36.66 -44.33 0.46 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.607 -0.683 . . . . 0.33 112.017 -178.652 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.868 ' HG ' HG21 ' A' ' 163' ' ' ILE . 1.0 OUTLIER -101.09 -37.49 8.56 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 120.661 -1.274 . . . . 0.53 111.317 -179.276 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.529 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -65.01 -85.08 0.07 OUTLIER Glycine 0 N--CA 1.49 2.281 0 N-CA-C 110.316 -1.114 . . . . 0.41 110.316 -179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.672 HD12 ' O ' ' A' ' 109' ' ' ARG . 0.6 OUTLIER -172.54 -173.28 1.01 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.083 -1.245 . . . . 0.45 110.473 -179.132 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.519 ' O ' ' ND1' ' A' ' 232' ' ' HIS . 42.0 t0 -51.35 -59.72 3.91 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.247 -0.908 . . . . 0.62 109.975 179.689 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.62 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 1.6 m80 -163.82 -179.98 6.69 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.334 -0.854 . . . . 0.45 110.256 179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.492 ' N ' ' SD ' ' A' ' 240' ' ' MET . 0.1 OUTLIER 179.23 58.23 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.457 -0.777 . . . . 0.38 109.391 179.481 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.899 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -137.04 21.43 3.02 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 119.468 -0.893 . . . . 0.48 111.197 -179.165 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.535 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -35.58 -49.66 1.38 Allowed Pre-proline 0 N--CA 1.49 1.571 0 C-N-CA 120.055 -0.658 . . . . 0.38 110.635 179.806 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 52.5 Cg_endo -88.5 -48.93 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.701 1.369 . . . . 0.28 111.132 179.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.547 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.1 101.73 0.15 Allowed Glycine 0 N--CA 1.498 2.806 0 C-N-CA 119.409 -1.377 . . . . 0.24 111.401 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.899 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -147.47 163.16 37.41 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.372 -1.075 . . . . 0.28 110.463 178.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.66 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.18 56.5 1.04 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.074 -1.016 . . . . 0.4 108.818 179.11 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.657 ' HB2' ' HB3' ' A' ' 234' ' ' LYS . 50.6 mtt -135.9 -34.4 0.81 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.432 -0.793 . . . . 0.45 110.437 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.579 ' CE2' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -43.88 169.85 0.05 OUTLIER Pre-proline 0 N--CA 1.495 1.788 0 O-C-N 121.195 -0.941 . . . . 0.57 110.359 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.488 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 43.2 Cg_endo -69.35 -8.02 22.5 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.786 1.413 . . . . 0.76 110.198 179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.702 HG22 HG22 ' A' ' 245' ' ' THR . 16.0 mm -103.26 159.66 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.239 -0.913 . . . . 0.89 109.845 179.562 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 1.031 ' HB2' HD21 ' A' ' 218' ' ' LEU . 16.8 p90 -138.07 -24.69 0.99 Allowed 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.174 -0.954 . . . . 0.78 111.446 -178.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.731 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 3.19 -68.78 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.425 0 N-CA-C 113.824 1.046 . . . . 0.61 113.824 -179.085 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.731 ' H ' HG23 ' A' ' 245' ' ' THR . 0.1 OUTLIER -71.82 115.64 11.27 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.438 -1.413 . . . . 0.74 110.022 -179.127 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.746 ' HA ' HD13 ' A' ' 218' ' ' LEU . 2.9 m -54.04 -174.1 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.524 -0.735 . . . . 0.81 110.301 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.696 ' H ' HG22 ' A' ' 247' ' ' THR . . . -50.83 -25.29 9.25 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.719 -1.352 . . . . 0.56 109.719 -179.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.632 ' CD ' ' N ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -167.46 36.21 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.271 -1.135 . . . . 0.37 110.353 -179.663 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 22.2 t -58.54 -16.19 14.5 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.136 -0.977 . . . . 0.44 110.147 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 11.2 t60 -145.55 -48.7 0.23 Allowed 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.53 110.086 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.55 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.8 OUTLIER 179.99 172.75 1.02 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.253 -0.905 . . . . 0.38 110.122 -179.798 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.894 ' HB2' HG21 ' A' ' 259' ' ' VAL . 4.8 ptp -72.85 52.38 0.31 Allowed 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.122 -0.986 . . . . 0.19 110.055 179.427 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.677 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.1 OUTLIER -45.24 -47.39 33.45 Favored Pre-proline 0 N--CA 1.485 1.285 0 N-CA-C 108.014 -1.106 . . . . 0.28 108.014 177.695 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.677 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -73.76 51.9 2.41 Favored 'Trans proline' 0 C--N 1.312 -1.365 0 O-C-N 124.085 1.571 . . . . 0.49 110.905 177.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.63 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.7 m-20 -52.17 -31.44 31.41 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.129 -0.982 . . . . 0.49 110.151 179.608 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.892 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.6 OUTLIER -51.89 -51.5 56.37 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 118.945 -1.102 . . . . 0.31 109.346 -179.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.036 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -69.48 -35.6 75.74 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.074 -1.051 . . . . 0.14 108.553 178.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.894 HG21 ' HB2' ' A' ' 253' ' ' MET . 73.8 t -63.41 -86.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 C-N-CA 119.816 -0.754 . . . . 0.17 110.273 179.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 33.0 tt0 -54.03 -43.87 70.5 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.246 -0.909 . . . . 0.26 109.902 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.04 -69.04 0.55 Allowed Glycine 0 N--CA 1.49 2.261 0 N-CA-C 110.345 -1.102 . . . . 0.19 110.345 -179.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.085 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -76.37 -19.14 15.06 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 120.786 -1.42 . . . . 0.22 110.264 -179.295 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 1.085 ' N ' HD13 ' A' ' 262' ' ' ILE . 14.3 tt0 -61.54 -23.58 66.05 Favored 'General case' 0 C--N 1.299 -1.617 0 C-N-CA 118.863 -1.135 . . . . 0.39 107.94 179.019 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 5.6 p -103.87 -42.58 5.55 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.386 0.612 . . . . 0.47 110.691 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.539 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 75.3 mt -73.95 -52.11 13.89 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.422 -0.799 . . . . 0.48 111.319 -178.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.779 ' OH ' HD22 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -75.6 -11.82 60.09 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.034 -1.041 . . . . 0.41 110.146 -179.577 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.48 ' O ' ' CG ' ' A' ' 116' ' ' MET . . . -59.89 -102.91 0.01 OUTLIER Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.059 -1.617 . . . . 0.46 109.059 179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -74.52 101.65 1.46 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.86 1.452 . . . . 0.58 110.158 179.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -78.82 165.71 51.37 Favored Glycine 0 N--CA 1.492 2.422 0 N-CA-C 109.587 -1.405 . . . . 0.64 109.587 -179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.632 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -95.41 -68.75 0.78 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.29 -1.124 . . . . 0.95 110.254 179.898 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.53 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 2.9 tm-20 49.42 30.86 3.56 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.205 -0.934 . . . . 1.2 110.143 179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 69.7 m-20 -100.15 108.43 52.21 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.248 -0.908 . . . . 1.2 110.424 -179.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -72.75 56.58 2.93 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.976 1.514 . . . . 1.06 110.354 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 118.016 -0.992 . . . . 0.78 110.234 -179.819 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.876 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.569 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.644 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . 0.664 ' CE2' HG12 ' A' ' 106' ' ' VAL . 19.9 t80 . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.23 0.538 . . . . 0.41 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . 0.455 ' O ' ' OD1' ' A' ' 105' ' ' ASN . 13.3 p30 -62.35 88.63 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.303 -0.873 . . . . 0.26 110.241 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.664 HG12 ' CE2' ' A' ' 104' ' ' TYR . 22.1 m -62.25 -145.34 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.216 -0.928 . . . . 0.33 110.124 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.407 ' C ' ' O ' ' A' ' 106' ' ' VAL . 8.3 m-85 -43.26 113.5 1.42 Allowed Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.165 -0.96 . . . . 0.65 110.218 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 47.3 Cg_endo -73.01 -158.75 0.07 OUTLIER 'Trans proline' 0 C--N 1.307 -1.622 0 O-C-N 123.886 1.466 . . . . 0.84 110.757 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.891 ' O ' HD12 ' A' ' 230' ' ' LEU . 2.1 mtp180 64.96 71.44 0.45 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.528 -0.732 . . . . 0.93 110.241 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.421 ' O ' ' C ' ' A' ' 111' ' ' LEU . 1.5 p -138.32 -63.62 0.55 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.46 -0.775 . . . . 1.03 109.484 179.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.486 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.4 OUTLIER 39.09 30.76 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.643 -0.66 . . . . 1.04 111.428 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.479 ' HB3' ' HB3' ' A' ' 265' ' ' LEU . 0.0 OUTLIER -114.35 68.95 0.7 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.043 -1.036 . . . . 0.77 109.433 179.262 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.578 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 20.8 t90 -147.52 -66.85 0.26 Allowed 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.317 -0.864 . . . . 0.42 111.063 -179.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.503 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 24.0 p -97.1 51.75 1.12 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.342 -0.849 . . . . 0.44 110.952 -178.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.481 ' HD3' ' O ' ' A' ' 114' ' ' SER . 4.5 mmmt -148.48 85.77 1.52 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.192 -0.942 . . . . 0.49 109.91 179.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.478 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 9.6 tmm? -120.86 -15.72 8.27 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.025 -1.047 . . . . 0.3 110.473 -179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.594 ' O ' HD22 ' A' ' 118' ' ' LEU . 7.3 p-10 -153.46 114.28 4.07 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.174 -0.954 . . . . 0.15 110.211 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.594 HD22 ' O ' ' A' ' 117' ' ' ASN . 0.2 OUTLIER -141.0 -151.87 0.38 Allowed 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.304 -0.873 . . . . 0.13 110.201 179.923 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.881 HG22 ' O ' ' A' ' 154' ' ' THR . 0.7 OUTLIER -136.32 155.35 50.19 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.279 -0.888 . . . . 0.12 110.142 -179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.878 ' HB3' HG23 ' A' ' 163' ' ' ILE . 29.0 p90 -148.92 163.33 37.77 Favored 'General case' 0 N--CA 1.487 1.41 0 C-N-CA 119.496 -0.882 . . . . 0.33 111.055 -179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.79 151.38 35.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.48 -0.763 . . . . 0.54 109.881 179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.856 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.1 pp -116.91 111.66 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.284 -0.885 . . . . 0.33 111.163 -179.257 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.936 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.8 m -161.82 49.13 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.254 -0.904 . . . . 0.27 110.261 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.476 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.8 t30 -42.95 -81.39 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.309 -0.87 . . . . 0.41 109.451 179.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.58 ' O ' HG21 ' A' ' 134' ' ' VAL . 24.6 t80 -179.03 -176.27 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.37 -0.831 . . . . 0.4 110.042 179.518 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.434 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.4 OUTLIER -129.09 57.95 33.73 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 121.128 -0.982 . . . . 0.45 109.834 179.634 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.452 ' HD3' ' HB3' ' A' ' 125' ' ' TYR . 47.8 Cg_endo -75.1 -88.39 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.275 1.671 . . . . 0.36 110.688 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -102.37 -8.27 21.31 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.407 -0.808 . . . . 0.25 110.163 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.568 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -106.04 174.95 5.66 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.228 -0.92 . . . . 0.39 110.204 179.84 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.432 ' O ' ' N ' ' A' ' 132' ' ' SER . 3.0 m -115.17 167.03 11.19 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.407 -0.808 . . . . 0.48 109.302 179.225 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.423 ' C ' ' O ' ' A' ' 130' ' ' THR . 7.9 t-160 -43.38 -26.83 0.22 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.218 -0.926 . . . . 0.4 109.61 179.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.432 ' N ' ' O ' ' A' ' 130' ' ' THR . 0.2 OUTLIER -68.8 -45.57 70.94 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.37 -0.831 . . . . 0.46 110.116 179.6 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.568 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 0.1 OUTLIER -70.71 -50.54 35.21 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 120.938 -1.101 . . . . 0.47 109.248 179.675 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.58 HG21 ' O ' ' A' ' 125' ' ' TYR . 9.5 t -47.18 -36.61 3.9 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 107.242 -1.392 . . . . 0.31 107.242 177.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.595 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 1.4 tt0 -58.96 -45.88 89.42 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 107.474 -1.306 . . . . 0.48 107.474 177.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.547 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.31 -50.36 71.98 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-O 122.068 0.937 . . . . 0.64 108.704 178.164 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.793 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -46.33 -62.93 1.14 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.149 -0.969 . . . . 0.42 110.718 179.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.856 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.73 -52.53 56.57 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.123 -0.986 . . . . 0.34 110.7 -178.965 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.627 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -65.91 -74.82 0.1 Allowed 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.901 -1.124 . . . . 0.47 110.175 -179.816 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.2 OUTLIER -38.48 -61.6 0.68 Allowed 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.807 -0.558 . . . . 0.47 110.66 179.019 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.586 ' HB3' ' O ' ' A' ' 137' ' ' ALA . . . -46.96 -38.56 10.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 120.665 -1.272 . . . . 0.25 108.359 178.882 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -71.65 -28.92 64.09 Favored 'General case' 0 N--CA 1.487 1.4 0 O-C-N 121.309 -0.869 . . . . 0.35 109.156 178.563 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.505 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.0 OUTLIER -62.02 -42.2 98.9 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.416 -0.957 . . . . 0.7 108.416 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.491 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 4.4 t -72.31 -51.36 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 108.817 -0.809 . . . . 0.61 108.817 178.695 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.638 ' HH2' HG21 ' A' ' 262' ' ' ILE . 47.8 t-105 -50.85 -34.47 28.08 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.523 -0.917 . . . . 0.39 108.523 178.62 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.509 ' HA ' ' O ' ' A' ' 149' ' ' THR . 70.5 m -76.28 -36.02 58.6 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.45 -0.944 . . . . 0.35 108.45 178.567 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.491 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -54.31 -43.23 70.97 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 108.981 -0.748 . . . . 0.36 108.981 178.898 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' A' ' 145' ' ' TRP . 31.4 m -74.85 -35.61 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 C-N-CA 119.703 -0.799 . . . . 0.5 109.552 179.418 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 149' ' ' THR . 13.0 t -148.06 121.77 4.81 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.124 -0.985 . . . . 0.51 110.305 179.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.79 60.74 3.65 Favored 'Trans proline' 0 C--N 1.306 -1.685 0 O-C-N 123.819 1.431 . . . . 0.31 110.335 179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.976 HD11 ' O ' ' A' ' 266' ' ' TYR . 1.1 mp -73.9 173.86 9.33 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.3 -0.875 . . . . 0.18 110.815 -179.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.406 ' HB3' ' CB ' ' A' ' 117' ' ' ASN . 0.1 OUTLIER -110.25 121.83 46.22 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.464 -0.772 . . . . 0.17 109.95 179.696 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.573 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 9.0 p90 -138.8 131.23 28.69 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.23 -0.918 . . . . 0.14 110.266 -179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.881 ' O ' HG22 ' A' ' 119' ' ' THR . 7.8 m -136.84 130.58 32.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.278 -0.889 . . . . 0.15 110.22 -179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.603 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.4 OUTLIER -94.12 69.83 3.83 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.036 -1.04 . . . . 0.2 109.945 -179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -67.96 110.64 3.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.293 -0.879 . . . . 0.22 110.11 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.442 ' O ' ' C ' ' A' ' 158' ' ' ASP . 4.6 m-70 -67.74 -24.53 65.37 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.097 -1.002 . . . . 0.32 110.01 -179.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.458 ' OD1' ' O ' ' A' ' 158' ' ' ASP . 4.5 t0 -42.44 -27.71 0.17 Allowed 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.53 -0.731 . . . . 0.33 109.646 179.168 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . 0.43 ' N ' ' O ' ' A' ' 157' ' ' HIS . . . 125.86 26.52 1.25 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.614 -1.395 . . . . 0.28 109.614 179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.612 ' O ' HG22 ' A' ' 160' ' ' ILE . 8.0 mt -116.65 74.98 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.442 0 O-C-N 121.203 -1.175 . . . . 0.3 109.432 179.646 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.46 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -135.57 152.94 51.76 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 121.664 -0.648 . . . . 0.2 110.491 -179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -128.98 -35.27 1.86 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.266 -0.896 . . . . 0.1 110.185 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.075 HD12 ' O ' ' A' ' 197' ' ' GLY . 0.7 OUTLIER -115.21 163.21 12.7 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.997 0 O-C-N 121.291 -0.881 . . . . 0.1 109.335 179.747 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.793 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 0.0 OUTLIER -174.63 142.57 0.73 Allowed 'General case' 0 N--CA 1.495 1.789 0 O-C-N 120.375 -1.453 . . . . 0.11 111.71 -179.71 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.636 ' O ' HG23 ' A' ' 165' ' ' ILE . 6.7 tt -94.74 118.42 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.469 -0.769 . . . . 0.1 109.777 179.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.936 ' HB3' HG23 ' A' ' 123' ' ' VAL . 9.7 p -160.94 153.4 20.52 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 120.808 -1.183 . . . . 0.1 110.708 -179.8 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.0 p90 -68.81 120.46 14.78 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.514 -0.741 . . . . 0.09 109.727 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.495 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -81.95 129.92 9.37 Favored Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.529 -1.028 . . . . 0.2 110.529 -179.156 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.751 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -125.06 99.99 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.709 -0.877 . . . . 0.55 108.94 178.884 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.43 110.39 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.404 0 CA-C-O 121.42 0.629 . . . . 0.85 112.475 -179.004 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.0 pt-20 -163.3 24.12 0.09 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.375 -0.828 . . . . 0.71 109.94 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 189' ' ' PHE . 14.4 m-70 -93.29 -57.96 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.337 -0.852 . . . . 0.42 110.253 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.426 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 110.86 55.34 0.51 Allowed Glycine 0 N--CA 1.491 2.302 0 N-CA-C 109.65 -1.38 . . . . 0.33 109.65 179.847 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.426 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 8.0 p-10 -176.71 -37.73 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.366 -1.079 . . . . 0.33 110.202 179.907 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.468 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.6 OUTLIER -156.05 149.07 24.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.2 -0.938 . . . . 0.27 110.106 179.953 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.426 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.9 m-30 -77.34 112.24 22.33 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.354 -0.841 . . . . 0.34 110.138 179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.554 ' O ' ' CD2' ' A' ' 184' ' ' LEU . 47.1 Cg_endo -74.15 -55.23 0.09 OUTLIER 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.954 1.502 . . . . 0.47 110.625 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.6 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 3.3 p90 -79.64 162.44 25.27 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.04 -1.038 . . . . 0.35 110.528 -179.744 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.519 ' OD1' ' CB ' ' A' ' 182' ' ' SER . 0.7 OUTLIER -169.51 -47.41 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.07 -1.019 . . . . 0.2 110.989 179.068 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.611 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 160.48 -149.11 18.16 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.49 -1.444 . . . . 0.25 109.49 179.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -71.83 -2.05 10.85 Favored 'Trans proline' 0 C--N 1.297 -2.174 0 O-C-N 124.228 1.646 . . . . 0.44 109.765 -179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.519 ' CB ' ' OD1' ' A' ' 179' ' ' ASP . 20.2 t -49.88 175.76 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.375 -0.828 . . . . 0.57 110.184 179.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.563 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -68.61 76.53 0.28 Allowed Glycine 0 N--CA 1.489 2.217 0 N-CA-C 110.781 -0.928 . . . . 0.49 110.781 -179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.997 ' HA ' HG13 ' A' ' 1' ' ' HAV . 1.0 OUTLIER 179.35 85.94 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.199 -1.177 . . . . 0.41 110.575 179.591 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.644 HD13 ' CE1' ' A' ' 214' ' ' TYR . 8.6 tt -105.79 -21.4 13.18 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.612 -1.305 . . . . 0.3 111.664 -179.949 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.63 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -146.63 109.7 4.7 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.526 -1.359 . . . . 0.2 111.985 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.591 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -112.61 115.26 28.32 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.42 -0.8 . . . . 0.16 109.538 178.872 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.922 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -111.1 145.72 38.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.063 -1.023 . . . . 0.23 110.116 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 172' ' ' HIS . 2.2 m-30 -95.72 165.78 15.89 Favored Pre-proline 0 N--CA 1.489 1.482 0 O-C-N 121.233 -0.917 . . . . 0.38 110.757 -179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.54 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -71.04 150.58 60.67 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 124.069 1.562 . . . . 0.4 109.163 179.116 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.505 ' HD3' ' O ' ' A' ' 227' ' ' SER . 45.4 Cg_endo -72.89 76.27 2.53 Favored 'Trans proline' 0 C--N 1.302 -1.892 0 O-C-N 123.681 1.359 . . . . 0.32 110.5 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.07 -108.29 2.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.498 -1.441 . . . . 0.32 109.498 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -71.89 -158.25 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.632 0 O-C-N 123.935 1.492 . . . . 0.47 110.26 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -69.16 -3.42 13.44 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.161 -0.962 . . . . 0.63 110.554 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.36 27.51 8.66 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.242 -0.911 . . . . 0.53 110.227 -179.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.54 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -105.35 166.72 14.51 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 109.136 -1.586 . . . . 0.25 109.136 179.754 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 1.075 ' O ' HD12 ' A' ' 163' ' ' ILE . . . 51.43 21.04 5.85 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 108.937 -1.665 . . . . 0.1 108.937 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.427 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.9 OUTLIER -77.44 88.83 3.8 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.257 -1.143 . . . . 0.1 110.267 -179.835 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.793 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -72.96 84.98 1.26 Allowed 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.131 -0.98 . . . . 0.09 109.728 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.495 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 52.9 m170 -97.82 127.06 43.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.369 -0.832 . . . . 0.09 110.628 -179.317 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.578 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.3 m-85 -97.89 141.03 31.37 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.107 -0.995 . . . . 0.1 109.818 179.347 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.891 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.2 OUTLIER -51.76 87.15 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.373 -0.973 . . . . 0.14 108.373 178.773 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.596 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 1.7 p30 -34.86 -31.0 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.38 -0.825 . . . . 0.18 112.204 -177.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.611 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 18.5 t0 -80.18 10.12 4.82 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.683 -1.261 . . . . 0.24 110.744 -179.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.559 ' CG ' ' HB3' ' A' ' 202' ' ' ASP . 21.8 mm-40 -101.41 -162.15 0.91 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.949 -1.095 . . . . 0.42 109.961 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 89.0 m -128.41 141.85 51.29 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.036 -1.04 . . . . 0.47 110.381 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.596 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.7 OUTLIER -142.41 139.03 31.51 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.152 -0.968 . . . . 0.27 109.9 179.988 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.04 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -144.29 172.91 12.27 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.975 -1.078 . . . . 0.3 110.545 179.593 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.49 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.0 OUTLIER -128.2 27.5 5.62 Favored 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.951 0.882 . . . . 0.61 108.996 178.786 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.53 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.6 t -99.66 -99.8 0.23 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.69 -0.632 . . . . 0.78 110.15 -179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.53 ' N ' ' OG ' ' A' ' 210' ' ' SER . 13.2 t -153.0 15.03 0.54 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.033 -1.042 . . . . 0.91 110.328 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.429 ' O ' ' C ' ' A' ' 213' ' ' GLY . 0.0 OUTLIER -133.27 -172.12 2.87 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.244 -0.91 . . . . 0.93 109.93 179.903 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.429 ' C ' ' O ' ' A' ' 212' ' ' LYS . . . 42.69 -147.95 0.62 Allowed Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.179 -1.569 . . . . 0.79 109.179 -179.928 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.644 ' CE1' HD13 ' A' ' 185' ' ' LEU . 90.8 m-85 -93.24 103.1 15.39 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.106 -1.232 . . . . 0.69 109.738 179.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.593 ' O ' HG12 ' A' ' 219' ' ' VAL . 58.1 m-80 -71.65 120.27 17.0 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.094 -1.004 . . . . 0.4 108.933 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.04 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -42.03 -34.7 0.75 Allowed 'General case' 0 C--N 1.302 -1.464 0 C-N-CA 119.564 -0.854 . . . . 0.17 110.051 -179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.582 ' O ' ' CB ' ' A' ' 221' ' ' ALA . 7.2 m-85 -54.37 -46.09 72.93 Favored 'General case' 0 C--N 1.285 -2.218 0 N-CA-C 107.572 -1.27 . . . . 0.28 107.572 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.904 HD11 ' HH1' ' A' ' 3' ' ' MSB . 10.2 tp -78.08 -71.15 0.44 Allowed 'General case' 0 C--N 1.296 -1.753 0 CA-C-N 115.775 -0.648 . . . . 0.46 110.694 179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.836 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.9 OUTLIER -48.17 -62.06 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.035 -1.041 . . . . 0.39 110.141 -179.83 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.941 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -53.08 -53.63 47.42 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 120.994 -1.067 . . . . 0.17 111.391 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.582 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -56.44 -25.94 52.06 Favored 'General case' 0 N--CA 1.496 1.851 0 O-C-N 120.404 -1.435 . . . . 0.1 108.965 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.642 ' HA ' HD22 ' A' ' 239' ' ' LEU . 6.3 t60 -78.82 -46.79 17.95 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.767 -0.583 . . . . 0.21 109.748 179.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.628 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.7 tp10 -63.99 -38.3 90.58 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.319 -0.863 . . . . 0.28 109.244 179.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.602 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 6.8 m-30 -64.33 -63.08 1.23 Allowed 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.395 -0.816 . . . . 0.18 109.084 178.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.434 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -44.72 -31.68 2.7 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 108.86 -1.696 . . . . 0.21 108.86 179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.73 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.0 OUTLIER -77.36 -74.77 0.23 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.263 -1.139 . . . . 0.17 110.639 179.661 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.922 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 1.0 OUTLIER -39.35 -54.83 1.83 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.484 -0.76 . . . . 0.33 111.492 -179.029 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.552 HD23 ' OH ' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -78.79 -46.04 19.68 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 120.931 -1.106 . . . . 0.53 110.785 -179.099 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 111' ' ' LEU . . . -60.3 -78.77 0.13 Allowed Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.717 -1.353 . . . . 0.41 109.717 -179.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.891 HD12 ' O ' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -177.76 -162.5 0.07 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.216 -1.167 . . . . 0.45 110.08 -179.723 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.507 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.3 OUTLIER -55.8 -55.3 34.08 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.108 -0.995 . . . . 0.62 109.789 179.683 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.73 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -162.09 -179.96 7.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.487 -0.758 . . . . 0.45 109.385 179.468 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 67.3 p -178.97 48.59 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.015 -1.053 . . . . 0.38 110.569 179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.799 ' HB3' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -135.39 27.29 3.44 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.242 -0.911 . . . . 0.48 110.559 179.886 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.571 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -39.83 -50.76 5.6 Favored Pre-proline 0 N--CA 1.491 1.597 0 C-N-CA 119.595 -0.842 . . . . 0.38 109.622 -179.814 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.571 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 43.4 Cg_endo -90.53 -46.65 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.691 0 O-C-N 123.747 1.393 . . . . 0.28 110.462 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.555 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.57 96.31 0.1 Allowed Glycine 0 N--CA 1.498 2.795 0 C-N-CA 119.065 -1.541 . . . . 0.24 112.304 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.914 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -145.25 160.33 41.64 Favored 'General case' 0 N--CA 1.504 2.244 0 O-C-N 121.263 -1.14 . . . . 0.28 109.57 177.68 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.642 HD22 ' HA ' ' A' ' 222' ' ' HIS . 1.5 tt -68.18 57.13 0.07 Allowed 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.247 -0.908 . . . . 0.4 109.237 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.643 ' CG ' ' CE1' ' A' ' 226' ' ' HIS . 0.1 OUTLIER -141.72 -6.3 1.01 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.441 -0.787 . . . . 0.45 111.547 -178.762 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.604 ' CD1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -78.21 165.23 51.8 Favored Pre-proline 0 N--CA 1.502 2.143 0 O-C-N 120.556 -1.34 . . . . 0.57 110.987 -179.506 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.569 ' HA ' ' HB2' ' A' ' 2' ' ' 3MP . 41.1 Cg_endo -68.11 -18.34 45.62 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.78 1.41 . . . . 0.76 110.053 -179.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.604 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 2.1 mm -90.21 136.18 24.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.553 0 N-CA-C 108.934 -0.765 . . . . 0.89 108.934 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.7 ' HB2' HD21 ' A' ' 218' ' ' LEU . 38.5 p90 -126.96 -30.64 2.7 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.942 -1.099 . . . . 0.78 110.405 -179.314 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.758 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 2.49 -70.99 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 N-CA-C 113.203 0.816 . . . . 0.61 113.203 -179.631 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.758 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -53.41 105.21 0.12 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 120.556 -1.34 . . . . 0.74 109.321 -179.641 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.505 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 22.5 p -57.16 166.65 1.04 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.341 -0.849 . . . . 0.81 109.998 -179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -53.7 -19.8 10.85 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.092 -1.603 . . . . 0.56 109.092 179.727 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.95 31.87 2.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.279 -1.13 . . . . 0.37 110.631 -179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.492 ' HB3' ' N ' ' A' ' 247' ' ' THR . 1.9 t -83.76 -22.67 31.82 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.05 -1.031 . . . . 0.44 109.927 179.755 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 17.5 m-70 -152.41 -69.26 0.16 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.367 -0.833 . . . . 0.53 109.873 179.83 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.64 -176.01 0.29 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.244 -0.91 . . . . 0.38 110.47 179.812 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.964 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.1 55.29 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.593 -0.692 . . . . 0.19 110.702 179.844 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.724 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -45.83 -46.88 40.44 Favored Pre-proline 0 N--CA 1.485 1.3 0 N-CA-C 108.017 -1.105 . . . . 0.28 108.017 177.576 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.724 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.3 Cg_endo -71.82 48.91 1.15 Allowed 'Trans proline' 0 C--N 1.313 -1.313 0 O-C-N 123.954 1.502 . . . . 0.49 110.966 177.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.616 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 8.8 m-20 -47.39 -32.42 4.93 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 120.887 -1.133 . . . . 0.49 110.453 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.914 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 1.4 m-20 -50.49 -50.81 51.68 Favored 'General case' 0 C--N 1.304 -1.389 0 O-C-N 121.138 -0.976 . . . . 0.31 109.51 -179.379 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.06 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -73.35 -33.01 64.87 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.169 -1.012 . . . . 0.14 108.468 179.021 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.964 HG21 ' HB2' ' A' ' 253' ' ' MET . 84.8 t -60.56 -81.57 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 C-N-CA 119.252 -0.979 . . . . 0.17 110.153 179.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.65 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.3 OUTLIER -62.05 -42.85 99.62 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.238 -0.914 . . . . 0.26 109.786 179.716 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -40.65 -64.92 1.1 Allowed Glycine 0 N--CA 1.491 2.353 0 N-CA-C 110.396 -1.082 . . . . 0.19 110.396 -179.433 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.065 HD13 ' N ' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -77.49 -19.84 14.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 120.816 -1.402 . . . . 0.22 110.441 -179.273 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 1.065 ' N ' HD13 ' A' ' 262' ' ' ILE . 17.3 tt0 -64.37 -21.87 66.77 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 118.838 -1.145 . . . . 0.39 108.317 179.394 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 41.0 t -104.22 -41.52 5.77 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 120.157 -0.617 . . . . 0.47 111.487 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.479 ' HB3' ' HB3' ' A' ' 112' ' ' LYS . 9.2 mt -87.5 -45.86 10.1 Favored 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.227 -0.921 . . . . 0.48 111.669 -178.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.976 ' O ' HD11 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -73.85 -8.78 57.36 Favored 'General case' 0 C--N 1.298 -1.638 0 O-C-N 121.206 -0.934 . . . . 0.41 110.156 -179.544 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.478 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -73.73 -107.02 0.08 OUTLIER Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.032 -1.627 . . . . 0.46 109.032 179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . 0.433 ' O ' ' O ' ' A' ' 269' ' ' GLY . 46.3 Cg_endo -73.01 74.99 2.84 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 123.784 1.413 . . . . 0.58 110.112 179.439 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 268' ' ' PRO . . . -61.81 -137.94 0.01 OUTLIER Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.723 -1.351 . . . . 0.64 109.723 -179.788 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.578 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.3 OUTLIER -149.45 -63.72 0.22 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.285 -1.126 . . . . 0.95 110.139 -179.946 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.503 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 3.4 tt0 64.36 13.54 8.11 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.286 -0.883 . . . . 1.2 110.303 179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.451 ' HB3' ' OD1' ' A' ' 274' ' ' ASN . 1.2 m-20 -179.49 126.02 0.24 Allowed Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.278 -0.889 . . . . 1.2 110.03 179.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.68 73.01 2.99 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.877 1.462 . . . . 1.06 110.375 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.451 ' OD1' ' HB3' ' A' ' 272' ' ' ASP . 22.9 m120 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 118.001 -1.0 . . . . 0.78 110.162 179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.997 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.62 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.904 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 5.2 p90 . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.291 0.567 . . . . 0.41 110.223 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 6.5 m-20 -73.54 87.48 1.62 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.281 -0.887 . . . . 0.26 110.089 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.461 ' C ' ' HD3' ' A' ' 108' ' ' PRO . 12.9 t -115.05 2.91 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.246 -0.909 . . . . 0.33 110.385 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.478 ' N ' ' HD3' ' A' ' 108' ' ' PRO . 5.5 m-85 -129.24 59.86 47.13 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.278 -0.889 . . . . 0.65 110.053 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.478 ' HD3' ' N ' ' A' ' 107' ' ' PHE . 53.4 Cg_endo -81.92 31.81 0.52 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.854 1.449 . . . . 0.84 111.036 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.617 ' O ' HD13 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -143.54 74.85 1.45 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.062 -1.024 . . . . 0.93 109.898 179.891 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.526 ' O ' HD22 ' A' ' 230' ' ' LEU . 1.7 p -142.63 -56.81 0.43 Allowed 'General case' 0 C--N 1.301 -1.508 0 O-C-N 121.342 -0.849 . . . . 1.03 109.692 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.441 ' C ' ' O ' ' A' ' 110' ' ' THR . 0.7 OUTLIER 37.24 28.48 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.706 -0.621 . . . . 1.04 111.107 179.275 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.548 ' HD3' HD22 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -100.22 91.05 4.57 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.121 -0.987 . . . . 0.77 110.015 -179.837 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.602 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 21.7 t90 -164.08 -71.8 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.305 -0.872 . . . . 0.42 110.284 -179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.543 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 88.4 p -91.71 69.52 5.66 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.29 -0.881 . . . . 0.44 110.268 -179.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.574 ' O ' ' CD1' ' A' ' 266' ' ' TYR . 27.1 mttp -165.65 86.56 0.37 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.257 -0.902 . . . . 0.49 110.465 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.403 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 5.8 ttp -123.23 -12.79 7.82 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.289 -0.882 . . . . 0.3 110.149 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.477 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 20.3 p-10 -155.3 124.21 6.15 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.313 -0.867 . . . . 0.15 109.84 179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.516 HD22 ' HB3' ' A' ' 162' ' ' ASP . 0.2 OUTLIER -148.98 -177.82 6.02 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.159 -0.963 . . . . 0.13 110.424 -179.724 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.761 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -121.44 147.14 46.14 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.394 -0.816 . . . . 0.12 109.766 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.818 ' CB ' HG23 ' A' ' 163' ' ' ILE . 9.6 p90 -145.01 160.71 40.94 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 119.254 -0.978 . . . . 0.33 111.015 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.423 ' HB3' ' HB2' ' A' ' 164' ' ' MET . 0.0 OUTLIER -103.68 160.69 14.55 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.472 -0.768 . . . . 0.54 110.032 179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.689 HG21 ' CD1' ' A' ' 138' ' ' PHE . 7.6 pt -122.32 62.63 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.28 -0.888 . . . . 0.33 110.727 -179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 1.021 HG23 ' HB3' ' A' ' 166' ' ' SER . 12.1 m -110.39 48.67 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 O-C-N 120.995 -1.066 . . . . 0.27 110.727 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.52 ' ND2' ' HG ' ' A' ' 216' ' ' LEU . 41.6 t-20 -43.18 -87.61 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.946 . . . . 0.41 109.297 179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.623 ' O ' HG21 ' A' ' 134' ' ' VAL . 5.6 t80 -178.81 -175.1 0.39 Allowed 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.346 -0.846 . . . . 0.4 109.47 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.571 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.3 OUTLIER -136.36 48.29 2.44 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.051 -1.031 . . . . 0.45 110.805 179.775 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.571 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.8 Cg_endo -76.14 -85.76 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.814 1.429 . . . . 0.36 110.343 179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 128' ' ' ASP . 1.5 m-20 -95.53 2.85 54.49 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.248 -0.907 . . . . 0.25 109.638 179.606 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.558 ' HB2' ' CB ' ' A' ' 133' ' ' GLU . 0.1 OUTLIER -124.3 156.5 36.83 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.477 -0.764 . . . . 0.39 109.75 179.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.418 ' O ' ' C ' ' A' ' 131' ' ' HIS . 0.2 OUTLIER -110.41 176.48 5.03 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.221 -0.925 . . . . 0.48 109.95 179.98 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.438 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.0 OUTLIER -43.37 -34.07 1.18 Allowed 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.338 -0.851 . . . . 0.4 109.931 179.808 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 1.0 OUTLIER -68.87 -50.01 53.38 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.257 -0.902 . . . . 0.46 109.646 179.458 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.558 ' CB ' ' HB2' ' A' ' 129' ' ' MET . 5.2 mp0 -58.44 -62.09 2.11 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.364 -0.835 . . . . 0.47 109.41 179.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.623 HG21 ' O ' ' A' ' 125' ' ' TYR . 9.5 t -45.16 -39.7 2.23 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 N-CA-C 108.139 -1.06 . . . . 0.31 108.139 178.414 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.525 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -54.11 -40.48 67.37 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 108.057 -1.09 . . . . 0.48 108.057 178.294 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.568 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 17.0 tttt -74.54 -52.24 12.41 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.867 0.842 . . . . 0.64 108.846 178.422 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.82 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.31 -60.81 2.1 Favored 'General case' 0 C--N 1.29 -2.016 0 O-C-N 120.962 -1.086 . . . . 0.42 110.561 -179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.689 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -64.54 -54.17 36.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.248 -0.908 . . . . 0.34 111.004 -179.06 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.654 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 7.9 tttm -68.09 -72.76 0.16 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.94 -1.1 . . . . 0.47 110.28 -179.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.547 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.4 OUTLIER -38.48 -61.24 0.72 Allowed 'General case' 0 C--N 1.292 -1.897 0 O-C-N 121.731 -0.605 . . . . 0.47 110.709 179.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.609 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.43 -38.27 13.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.641 -1.287 . . . . 0.25 108.344 178.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.53 ' CE2' ' CE2' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -72.53 -28.58 62.94 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 121.31 -0.869 . . . . 0.35 109.068 178.467 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.506 ' N ' ' O ' ' A' ' 140' ' ' LYS . 58.7 tttt -63.4 -39.75 95.35 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.43 -0.952 . . . . 0.7 108.43 178.836 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.533 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 11.3 t -75.76 -51.73 19.84 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.329 0 N-CA-C 109.086 -0.709 . . . . 0.61 109.086 178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.731 ' HH2' HG21 ' A' ' 262' ' ' ILE . 45.2 t-105 -52.19 -34.18 44.16 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 108.441 -0.948 . . . . 0.39 108.441 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.506 ' HA ' ' O ' ' A' ' 149' ' ' THR . 41.5 m -77.38 -38.41 50.06 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 108.395 -0.965 . . . . 0.35 108.395 178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.533 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.3 OUTLIER -51.43 -43.88 62.14 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 108.862 -0.792 . . . . 0.36 108.862 178.84 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.699 HG23 HG22 ' A' ' 149' ' ' THR . 32.3 m -74.05 -38.52 49.29 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.477 -0.764 . . . . 0.5 109.55 179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.699 HG22 HG23 ' A' ' 148' ' ' VAL . 7.2 t -142.78 119.53 6.89 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.107 -0.996 . . . . 0.51 110.212 179.284 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -71.41 58.57 2.42 Favored 'Trans proline' 0 C--N 1.306 -1.676 0 O-C-N 123.663 1.349 . . . . 0.31 110.793 -179.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.515 HD11 ' CG ' ' A' ' 266' ' ' TYR . 59.4 mt -70.48 167.12 19.02 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.264 -0.898 . . . . 0.18 110.043 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 117' ' ' ASN . 3.1 t30 -105.89 103.08 12.5 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.274 -0.892 . . . . 0.17 110.22 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.428 ' O ' ' CD1' ' A' ' 153' ' ' PHE . 8.6 p90 -116.08 144.68 43.81 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.088 -1.008 . . . . 0.14 110.312 -179.856 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.761 ' O ' HG22 ' A' ' 119' ' ' THR . 27.7 m -147.9 130.55 15.94 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.168 -0.957 . . . . 0.15 110.439 -179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.612 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -99.62 84.4 2.94 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.2 109.904 -179.684 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.485 HD23 HG22 ' A' ' 154' ' ' THR . 0.5 OUTLIER -77.11 104.35 7.56 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.133 -0.98 . . . . 0.22 110.224 179.92 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.422 ' O ' ' C ' ' A' ' 158' ' ' ASP . 55.8 p-80 -56.06 -27.96 55.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.163 -0.96 . . . . 0.32 109.948 179.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.422 ' C ' ' O ' ' A' ' 157' ' ' HIS . 0.2 OUTLIER -42.12 -41.91 2.79 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.56 -0.712 . . . . 0.33 109.941 179.29 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.73 33.22 0.3 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.733 -1.347 . . . . 0.28 109.733 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.482 ' O ' ' HB ' ' A' ' 119' ' ' THR . 6.5 mt -121.13 71.79 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.064 -1.257 . . . . 0.3 109.542 179.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -125.3 137.6 54.07 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 120.029 -0.668 . . . . 0.2 110.411 -179.421 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.516 ' HB3' HD22 ' A' ' 118' ' ' LEU . 0.2 OUTLIER -102.52 -34.9 8.95 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.359 -0.838 . . . . 0.1 109.653 179.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.818 HG23 ' CB ' ' A' ' 120' ' ' TYR . 0.5 OUTLIER -122.72 173.11 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.458 -0.776 . . . . 0.1 109.052 179.347 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.772 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 3.5 ptp -177.05 144.63 0.44 Allowed 'General case' 0 N--CA 1.495 1.788 0 O-C-N 120.495 -1.378 . . . . 0.11 111.656 -179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.582 HG22 ' HA ' ' A' ' 122' ' ' ILE . 1.5 tt -93.31 120.87 43.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.489 -0.757 . . . . 0.1 109.272 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 1.021 ' HB3' HG23 ' A' ' 123' ' ' VAL . 4.3 p -163.62 142.56 8.03 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.735 -1.228 . . . . 0.1 110.702 -179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.62 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.8 p90 -67.03 112.3 4.31 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.324 -0.86 . . . . 0.09 109.618 179.706 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.5 ' O ' ' OD1' ' A' ' 203' ' ' ASP . . . -60.63 143.28 48.12 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.281 -1.527 . . . . 0.2 109.281 -179.636 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.734 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.7 tt -138.15 96.91 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.548 -0.972 . . . . 0.55 109.905 179.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.591 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.0 OUTLIER 1.06 86.56 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.318 0 CA-C-O 121.382 0.611 . . . . 0.85 112.363 -179.76 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -146.42 11.83 1.16 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.294 -0.879 . . . . 0.71 110.108 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.406 ' HE1' ' CE1' ' A' ' 189' ' ' PHE . 12.7 m-70 -80.25 -87.69 0.07 Allowed 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.236 -0.915 . . . . 0.42 110.031 179.843 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 148.58 -35.2 1.13 Allowed Glycine 0 N--CA 1.49 2.3 0 N-CA-C 109.485 -1.446 . . . . 0.33 109.485 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -66.52 -87.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.287 -1.125 . . . . 0.33 110.26 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -111.01 -170.01 1.56 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.244 -0.91 . . . . 0.27 110.569 -179.813 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . . . . . . . . . 6.6 m-30 -101.95 110.62 62.72 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.336 -0.852 . . . . 0.34 110.349 -179.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.445 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.1 Cg_endo -76.92 -71.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 123.829 1.437 . . . . 0.47 110.668 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.591 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -50.38 140.68 13.14 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.281 -0.887 . . . . 0.35 110.606 -179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.49 ' O ' ' HB2' ' A' ' 182' ' ' SER . 6.0 p30 -178.74 79.3 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 118.932 -1.107 . . . . 0.2 111.703 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 36.97 -157.54 0.01 OUTLIER Glycine 0 N--CA 1.495 2.601 0 N-CA-C 110.562 -1.015 . . . . 0.25 110.562 178.662 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.452 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 51.6 Cg_endo -78.62 43.74 1.5 Allowed 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.183 1.623 . . . . 0.44 110.535 179.837 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.528 ' O ' ' N ' ' A' ' 184' ' ' LEU . 0.5 OUTLIER -83.33 179.32 7.72 Favored 'General case' 0 C--N 1.305 -1.345 0 O-C-N 121.285 -0.885 . . . . 0.57 109.816 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.499 ' HA2' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.2 68.6 0.03 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 110.566 -1.013 . . . . 0.49 110.566 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.978 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.8 OUTLIER 179.64 84.1 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.635 0 O-C-N 121.132 -1.217 . . . . 0.41 110.954 179.805 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.552 HD12 ' CD ' ' A' ' 205' ' ' GLU . 0.5 OUTLIER -100.18 -24.17 14.64 Favored 'General case' 0 N--CA 1.491 1.601 0 C-N-CA 118.964 -1.094 . . . . 0.3 110.741 179.406 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.659 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.36 99.55 2.51 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.79 -1.194 . . . . 0.2 111.788 -179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.539 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 1.4 p80 -100.97 124.47 46.72 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.051 -1.031 . . . . 0.16 109.987 179.109 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.828 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -106.08 124.49 49.67 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.141 -0.974 . . . . 0.23 110.333 -179.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.439 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.4 OUTLIER -68.5 162.83 59.1 Favored Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.241 -0.912 . . . . 0.38 110.443 -179.971 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.532 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 44.4 Cg_endo -72.26 138.58 30.63 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 O-C-N 124.011 1.532 . . . . 0.4 109.772 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -71.56 72.88 2.34 Favored 'Trans proline' 0 C--N 1.303 -1.86 0 O-C-N 123.92 1.484 . . . . 0.32 110.575 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -111.59 -105.95 2.86 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.443 -1.463 . . . . 0.32 109.443 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -72.65 -159.56 0.08 OUTLIER 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.943 1.497 . . . . 0.47 110.396 179.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 7.7 p30 -63.61 -11.8 28.09 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.119 -0.988 . . . . 0.63 110.279 -179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.27 63.58 0.66 Allowed 'General case' 0 C--N 1.299 -1.592 0 O-C-N 121.45 -0.781 . . . . 0.53 109.997 -179.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.532 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -139.19 173.89 22.46 Favored Glycine 0 N--CA 1.487 2.078 0 N-CA-C 109.097 -1.601 . . . . 0.25 109.097 -179.971 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.549 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 44.28 25.5 0.76 Allowed Glycine 0 N--CA 1.489 2.175 0 N-CA-C 109.481 -1.448 . . . . 0.1 109.481 -179.687 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.439 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 12.5 m-20 -79.04 87.44 4.83 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.145 -1.209 . . . . 0.1 110.666 -179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.772 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -62.8 98.19 0.12 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.287 -0.883 . . . . 0.09 109.539 179.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.538 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 8.5 m170 -110.57 119.86 40.53 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.271 -0.893 . . . . 0.09 111.266 -178.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.56 ' O ' ' N ' ' A' ' 203' ' ' ASP . 13.7 m-30 -90.62 131.93 36.05 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.316 -0.865 . . . . 0.1 109.556 178.891 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.519 ' HB3' ' HG2' ' A' ' 205' ' ' GLU . 0.4 OUTLIER -49.33 92.09 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.973 -1.079 . . . . 0.14 108.717 179.281 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.56 ' N ' ' O ' ' A' ' 201' ' ' PHE . 1.6 p-10 -34.55 -32.82 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.566 -0.709 . . . . 0.18 111.738 -178.37 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.532 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 1.8 m-20 -64.1 -16.75 62.47 Favored 'General case' 0 C--N 1.304 -1.37 0 O-C-N 120.638 -1.289 . . . . 0.24 110.631 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.552 ' CD ' HD12 ' A' ' 185' ' ' LEU . 11.4 mm-40 -86.77 -176.02 5.63 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.002 . . . . 0.42 110.49 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.528 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 83.8 m -122.11 154.74 36.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.351 -0.843 . . . . 0.47 110.006 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.553 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 0.9 OUTLIER -149.49 147.28 28.03 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 0.27 109.756 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.013 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -156.32 177.55 11.31 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.02 -1.05 . . . . 0.3 110.595 179.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.463 ' O ' ' OG ' ' A' ' 209' ' ' SER . 0.1 OUTLIER -129.06 20.28 5.88 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-O 121.729 0.776 . . . . 0.61 109.553 178.985 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.415 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.1 OUTLIER -89.38 -69.81 0.69 Allowed 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.566 0.698 . . . . 0.78 110.078 179.797 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.415 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.1 OUTLIER 179.41 -30.79 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.548 0 O-C-N 121.58 -0.7 . . . . 0.91 109.543 179.925 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.56 177.61 7.33 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.548 -0.72 . . . . 0.93 109.98 179.893 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 50.11 -161.4 1.05 Allowed Glycine 0 N--CA 1.491 2.305 0 N-CA-C 109.432 -1.467 . . . . 0.79 109.432 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.465 ' CE2' ' CE2' ' A' ' 244' ' ' TYR . 80.1 m-85 -81.69 126.2 31.5 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.297 -1.119 . . . . 0.69 109.473 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.62 ' O ' HG12 ' A' ' 219' ' ' VAL . 16.8 m-80 -89.2 118.6 29.02 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.026 -1.046 . . . . 0.4 108.658 179.337 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.013 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.37 -36.98 0.92 Allowed 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.672 -0.811 . . . . 0.17 110.334 -179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.609 ' HA ' ' HB2' ' A' ' 141' ' ' ALA . 3.0 m-85 -51.24 -49.34 61.31 Favored 'General case' 0 C--N 1.289 -2.059 0 C-N-CA 118.574 -1.25 . . . . 0.28 107.833 179.702 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.68 HD21 ' HB2' ' A' ' 244' ' ' TYR . 12.7 tp -75.09 -70.42 0.42 Allowed 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.791 -0.64 . . . . 0.46 110.54 179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.893 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -49.96 -68.67 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.146 -0.971 . . . . 0.39 110.03 -179.94 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.909 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -44.46 -52.96 7.4 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.978 -1.076 . . . . 0.17 111.23 179.683 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.556 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -55.99 -47.71 77.21 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.275 -1.516 . . . . 0.1 108.722 179.897 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.673 ' N ' HD21 ' A' ' 239' ' ' LEU . 5.6 t60 -54.25 -52.18 62.17 Favored 'General case' 0 C--N 1.298 -1.65 0 CA-C-O 121.419 0.628 . . . . 0.21 109.942 178.748 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.642 ' HG2' ' HB1' ' A' ' 199' ' ' ALA . 3.4 tp10 -59.81 -43.7 94.35 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.207 -0.933 . . . . 0.28 108.87 179.025 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' A' ' 224' ' ' PHE . 11.6 m-30 -55.0 -62.35 1.71 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.218 -0.926 . . . . 0.18 109.091 178.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.437 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -42.59 -32.97 1.4 Allowed Glycine 0 N--CA 1.487 2.043 0 N-CA-C 108.786 -1.725 . . . . 0.21 108.786 179.461 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.624 ' NE2' ' CD2' ' A' ' 232' ' ' HIS . 1.4 m80 -79.83 -76.46 0.22 Allowed 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.195 -1.179 . . . . 0.17 111.052 179.707 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.828 ' CB ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -34.55 -42.57 0.15 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.83 -0.544 . . . . 0.33 112.336 -178.688 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.652 HD13 HG21 ' A' ' 163' ' ' ILE . 3.1 tp -101.17 -38.74 7.99 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.839 -1.163 . . . . 0.53 111.309 -178.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.437 ' HA3' ' O ' ' A' ' 225' ' ' GLY . . . -68.29 -89.12 0.07 OUTLIER Glycine 0 N--CA 1.489 2.221 0 N-CA-C 110.762 -0.935 . . . . 0.41 110.762 -178.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.625 HD12 ' H ' ' A' ' 232' ' ' HIS . 0.5 OUTLIER -160.45 -155.34 0.42 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.131 -1.217 . . . . 0.45 111.098 -178.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.468 ' HB2' ' CG ' ' A' ' 109' ' ' ARG . 37.3 m-20 -74.4 -48.34 28.37 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.341 -0.849 . . . . 0.62 110.712 -179.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.625 ' H ' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -174.82 157.82 2.5 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.101 -1.0 . . . . 0.45 111.098 -179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 24.1 p -162.71 47.3 0.15 Allowed 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.033 -0.728 . . . . 0.38 109.033 179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.714 ' CA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -127.06 23.09 6.57 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.449 -0.782 . . . . 0.48 111.001 -179.094 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.553 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.4 OUTLIER -43.86 -60.24 2.87 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.2 -0.937 . . . . 0.38 109.494 179.571 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.553 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 49.0 Cg_endo -75.97 -50.76 0.11 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.735 1.387 . . . . 0.28 110.681 179.215 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 178.06 95.03 0.1 OUTLIER Glycine 0 N--CA 1.496 2.674 0 C-N-CA 119.337 -1.411 . . . . 0.24 111.404 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.928 ' HB2' ' HB2' ' A' ' 257' ' ' ASP . . . -145.77 164.93 30.33 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.426 -1.044 . . . . 0.28 110.022 178.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.673 HD21 ' N ' ' A' ' 222' ' ' HIS . 1.1 tp -72.14 57.33 0.35 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.235 -0.916 . . . . 0.4 109.131 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.601 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 4.3 mmm -146.86 14.46 1.18 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.102 -0.998 . . . . 0.45 110.576 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.596 ' CE1' ' O ' ' A' ' 243' ' ' ILE . 0.1 OUTLIER -106.14 166.67 10.84 Favored Pre-proline 0 N--CA 1.496 1.837 0 O-C-N 121.007 -1.058 . . . . 0.57 110.704 179.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.52 ' HA ' ' HD2' ' A' ' 3' ' ' MSB . 45.3 Cg_endo -70.24 -7.53 21.42 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.008 1.53 . . . . 0.76 109.981 179.877 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.727 HD11 ' CG2' ' A' ' 245' ' ' THR . 0.0 OUTLIER -101.41 112.03 33.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 N-CA-C 109.137 -0.69 . . . . 0.89 109.137 179.451 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.68 ' HB2' HD21 ' A' ' 218' ' ' LEU . 52.1 p90 -116.6 -31.58 5.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.037 -1.04 . . . . 0.78 110.731 -178.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.762 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.5 OUTLIER 1.89 -68.24 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.42 0 N-CA-C 113.235 0.828 . . . . 0.61 113.235 -178.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.762 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -48.6 106.33 0.1 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.51 -1.369 . . . . 0.74 109.524 -179.849 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.567 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 70.0 p -53.8 171.77 0.09 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.263 -0.898 . . . . 0.81 110.164 -179.652 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -59.3 -15.23 29.98 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.27 -1.532 . . . . 0.56 109.27 179.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -136.7 20.09 3.08 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.276 -1.132 . . . . 0.37 110.441 179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.467 ' HB3' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -64.74 -17.88 64.54 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.207 -0.933 . . . . 0.44 109.795 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.421 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 0.0 OUTLIER -168.36 -64.39 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.427 -0.795 . . . . 0.53 110.187 179.909 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.506 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.1 OUTLIER 179.95 -172.68 0.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.25 -0.906 . . . . 0.38 110.605 -179.874 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 1.011 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -66.32 56.81 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.716 -0.615 . . . . 0.19 110.541 179.86 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.704 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.9 OUTLIER -44.01 -47.6 22.43 Favored Pre-proline 0 N--CA 1.487 1.401 0 N-CA-C 108.0 -1.111 . . . . 0.28 108.0 177.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.0 Cg_endo -72.65 50.67 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.3 0 O-C-N 124.101 1.579 . . . . 0.49 111.176 177.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.666 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 31.3 m-20 -53.54 -28.52 32.02 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.108 -0.995 . . . . 0.49 110.786 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.928 ' HB2' ' HB2' ' A' ' 238' ' ' ALA . 1.7 m-20 -54.25 -47.76 71.91 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.035 -1.041 . . . . 0.31 109.436 -178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.037 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -76.21 -31.82 58.63 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 119.277 -0.969 . . . . 0.14 108.442 178.507 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 1.011 HG21 ' HB2' ' A' ' 253' ' ' MET . 70.8 t -61.83 -79.88 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 C-N-CA 119.658 -0.817 . . . . 0.17 109.98 179.418 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.634 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 0.0 OUTLIER -61.41 -40.96 96.31 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.247 -0.908 . . . . 0.26 109.525 179.551 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.504 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -41.53 -66.71 0.92 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 110.355 -1.098 . . . . 0.19 110.355 -179.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.037 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -76.14 -20.17 15.33 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.752 0 O-C-N 120.912 -1.346 . . . . 0.22 110.613 -179.246 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.954 ' N ' HD13 ' A' ' 262' ' ' ILE . 13.4 tp60 -61.37 -23.86 66.07 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 118.648 -1.221 . . . . 0.39 107.969 178.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 1.2 t -103.12 -36.34 8.17 Favored 'General case' 0 N--CA 1.491 1.578 0 C-N-CA 119.936 -0.705 . . . . 0.47 111.672 -179.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.561 ' CD2' ' N ' ' A' ' 265' ' ' LEU . 4.3 mm? -90.76 -46.52 8.18 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.973 -1.079 . . . . 0.48 111.923 -178.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.644 ' OH ' HD23 ' A' ' 228' ' ' LEU . 0.1 OUTLIER -71.23 -18.09 62.47 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.964 -1.085 . . . . 0.41 109.904 -179.454 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -57.95 -88.94 0.02 OUTLIER Glycine 0 N--CA 1.49 2.235 0 N-CA-C 108.999 -1.64 . . . . 0.46 108.999 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_endo -76.9 114.24 3.79 Favored 'Trans proline' 0 C--N 1.305 -1.716 0 O-C-N 124.072 1.564 . . . . 0.58 110.001 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . . . . . . . . . . . -104.92 154.97 17.27 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.842 -1.303 . . . . 0.64 109.842 -179.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.602 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -105.04 -75.49 0.62 Allowed 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.279 -1.13 . . . . 0.95 109.986 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.543 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 35.2 tt0 60.3 12.94 3.66 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.282 -0.886 . . . . 1.2 110.53 179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.465 ' OD2' ' O ' ' A' ' 270' ' ' ASP . 1.7 p30 179.55 137.68 0.28 Allowed Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.162 -0.961 . . . . 1.2 110.363 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -73.56 61.69 4.42 Favored 'Trans proline' 0 C--N 1.306 -1.681 0 O-C-N 123.987 1.519 . . . . 1.06 110.331 179.854 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 52.2 m-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 117.948 -1.025 . . . . 0.78 110.204 -179.911 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.978 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.657 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.659 ' OB2' ' N ' ' A' ' 186' ' ' ALA . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 47.9 m-85 . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.26 0.553 . . . . 0.41 110.12 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -105.14 89.13 3.04 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.23 -0.919 . . . . 0.26 110.283 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.467 HG23 ' N ' ' A' ' 107' ' ' PHE . 17.3 m -68.59 -144.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.29 -0.881 . . . . 0.33 110.15 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.467 ' N ' HG23 ' A' ' 106' ' ' VAL . 14.1 m-30 -81.36 113.97 45.76 Favored Pre-proline 0 N--CA 1.49 1.536 0 O-C-N 121.219 -0.926 . . . . 0.65 110.137 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 44.8 Cg_endo -71.99 -170.69 0.57 Allowed 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 123.99 1.521 . . . . 0.84 110.265 179.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 108' ' ' PRO . 1.1 mtt85 59.97 82.32 0.16 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.383 -0.823 . . . . 0.93 110.096 -179.928 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.698 ' HA ' HD12 ' A' ' 230' ' ' LEU . 1.1 p -149.48 -60.57 0.21 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.552 -0.718 . . . . 1.03 109.204 179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.406 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 0.0 OUTLIER 48.11 32.66 3.09 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.242 -0.911 . . . . 1.04 111.469 178.963 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.559 ' CG ' ' O ' ' A' ' 110' ' ' THR . 1.2 mtpt -117.75 92.88 3.96 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.957 -1.089 . . . . 0.77 109.883 179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.614 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 9.9 t90 -160.91 -72.07 0.06 Allowed 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.009 -1.057 . . . . 0.42 111.307 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.556 ' HB2' ' CB ' ' A' ' 271' ' ' GLU . 87.6 p -102.23 69.23 1.13 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.104 -0.998 . . . . 0.44 110.865 -178.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.483 ' CG ' ' O ' ' A' ' 114' ' ' SER . 7.3 mttm -161.59 50.5 0.22 Allowed 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.224 -0.923 . . . . 0.49 110.352 179.541 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.493 ' HG3' ' O ' ' A' ' 267' ' ' GLY . 3.9 ttt -74.91 -5.16 42.27 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.247 -0.908 . . . . 0.3 110.427 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.453 ' CB ' ' HB3' ' A' ' 152' ' ' ASN . 29.7 p30 -156.78 149.13 23.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.391 -0.818 . . . . 0.15 110.502 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.728 HD23 HD11 ' A' ' 228' ' ' LEU . 9.3 tp -171.15 177.64 3.58 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.345 -0.847 . . . . 0.13 109.857 -179.971 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.91 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -110.36 158.84 18.01 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.088 -1.008 . . . . 0.12 110.458 179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.752 ' HB2' HG23 ' A' ' 163' ' ' ILE . 21.4 p90 -154.45 167.85 28.64 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.422 -0.799 . . . . 0.33 110.329 179.964 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.454 ' HG2' ' NH1' ' A' ' 121' ' ' ARG . 0.0 OUTLIER -130.06 144.21 51.21 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.391 -0.818 . . . . 0.54 110.102 179.752 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.839 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -105.18 123.85 59.61 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.346 -0.846 . . . . 0.33 110.704 -179.695 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.995 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.0 m -165.41 44.5 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.416 -0.802 . . . . 0.27 109.818 179.632 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.527 ' HA ' ' HA ' ' A' ' 166' ' ' SER . 6.3 t-20 -40.11 -80.32 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.439 -0.788 . . . . 0.41 109.539 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.616 ' CD1' ' CG ' ' A' ' 167' ' ' PHE . 7.8 t80 -179.11 178.46 0.73 Allowed 'General case' 0 C--N 1.3 -1.585 0 O-C-N 121.314 -0.866 . . . . 0.4 109.951 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.562 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.1 OUTLIER -131.9 55.71 19.71 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 121.139 -0.976 . . . . 0.45 110.576 179.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.562 ' HD3' ' N ' ' A' ' 126' ' ' THR . 48.6 Cg_endo -82.86 -81.61 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.538 0 O-C-N 123.789 1.415 . . . . 0.36 110.517 179.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -102.77 -4.03 25.55 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.234 -0.916 . . . . 0.25 110.048 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.552 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 1.0 OUTLIER -113.76 160.98 18.09 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.223 -0.923 . . . . 0.39 110.211 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 2.3 m -106.89 167.74 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.32 -0.862 . . . . 0.48 109.839 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.464 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 2.0 t60 -44.29 -29.98 0.74 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.198 -0.938 . . . . 0.4 109.845 179.742 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.483 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -66.71 -51.5 55.28 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.346 -0.846 . . . . 0.46 109.654 179.646 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.552 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 10.3 mt-10 -62.16 -58.0 9.42 Favored 'General case' 0 C--N 1.305 -1.353 0 O-C-N 121.249 -0.907 . . . . 0.47 109.18 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.554 HG21 ' O ' ' A' ' 125' ' ' TYR . 5.7 t -46.37 -34.76 2.25 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 N-CA-C 107.935 -1.135 . . . . 0.31 107.935 177.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.504 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 0.0 OUTLIER -59.0 -42.4 90.0 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 107.938 -1.134 . . . . 0.48 107.938 178.132 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.582 ' HG2' ' CZ ' ' A' ' 217' ' ' PHE . 47.1 tttt -68.97 -45.49 70.55 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.219 -1.03 . . . . 0.64 108.219 178.056 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.822 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -49.17 -59.71 3.43 Favored 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.321 -0.862 . . . . 0.42 109.739 179.272 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.717 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.0 OUTLIER -65.39 -55.79 16.17 Favored 'General case' 0 C--N 1.299 -1.611 0 O-C-N 121.542 -0.724 . . . . 0.34 110.509 -179.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.61 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.2 OUTLIER -64.27 -73.58 0.12 Allowed 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.221 -0.924 . . . . 0.47 110.603 -179.153 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.549 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.1 OUTLIER -39.64 -60.27 1.0 Allowed 'General case' 0 C--N 1.292 -1.933 0 O-C-N 121.633 -0.667 . . . . 0.47 110.73 179.225 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.561 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -48.11 -36.86 14.05 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 120.521 -1.362 . . . . 0.25 108.339 178.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.52 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -72.33 -31.41 65.63 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.9 -0.778 . . . . 0.35 108.9 178.609 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.475 ' N ' ' O ' ' A' ' 140' ' ' LYS . 0.6 OUTLIER -61.29 -42.32 98.46 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.254 -0.904 . . . . 0.7 108.655 179.062 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.494 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 10.3 t -73.22 -48.55 42.51 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.566 -0.709 . . . . 0.61 109.208 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.596 ' CH2' HG13 ' A' ' 262' ' ' ILE . 43.1 t-105 -54.72 -39.38 68.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.35 -0.844 . . . . 0.39 109.215 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 149' ' ' THR . 75.5 m -74.9 -35.18 62.25 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 108.508 -0.923 . . . . 0.35 108.508 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.494 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.2 OUTLIER -56.15 -38.41 70.82 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.524 0.678 . . . . 0.36 109.375 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.783 HG23 HG22 ' A' ' 149' ' ' THR . 27.2 m -82.29 -32.05 10.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.419 -0.801 . . . . 0.5 110.256 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.783 HG22 HG23 ' A' ' 148' ' ' VAL . 5.0 t -146.29 136.65 12.17 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 121.114 -0.991 . . . . 0.51 110.557 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.93 58.44 4.11 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.972 1.512 . . . . 0.31 110.542 179.866 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.796 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -75.63 129.54 37.33 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.21 -0.931 . . . . 0.18 110.431 -179.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.453 ' HB3' ' CB ' ' A' ' 117' ' ' ASN . 64.6 t-20 -87.25 123.59 32.42 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.216 -0.928 . . . . 0.17 109.841 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.591 ' HB2' ' CD1' ' A' ' 120' ' ' TYR . 7.5 p90 -133.11 152.97 51.92 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.29 -0.881 . . . . 0.14 110.467 -179.564 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.91 ' O ' HG22 ' A' ' 119' ' ' THR . 22.5 m -152.49 125.81 8.71 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.273 -0.892 . . . . 0.15 110.319 -179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.602 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -92.04 105.43 17.67 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.224 -0.923 . . . . 0.2 109.755 -179.753 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.691 HD12 ' HB3' ' A' ' 158' ' ' ASP . 0.3 OUTLIER -101.76 96.97 7.43 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.19 -0.944 . . . . 0.22 110.395 -179.989 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.433 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.3 p-80 -52.5 -28.34 20.05 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.269 -0.894 . . . . 0.32 109.954 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.691 ' HB3' HD12 ' A' ' 156' ' ' LEU . 3.3 t0 -41.42 -60.7 1.22 Allowed 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.587 -0.696 . . . . 0.33 109.752 179.184 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 159.99 35.23 0.02 OUTLIER Glycine 0 N--CA 1.489 2.226 0 N-CA-C 109.963 -1.255 . . . . 0.28 109.963 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.769 ' O ' HG22 ' A' ' 160' ' ' ILE . 50.4 mt -126.09 68.33 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.151 -1.205 . . . . 0.3 109.398 179.455 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -112.4 126.41 55.26 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.641 -0.662 . . . . 0.2 110.758 -179.289 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.539 ' CG ' HD21 ' A' ' 118' ' ' LEU . 0.3 OUTLIER -96.9 -51.07 4.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.1 109.798 179.642 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.752 HG23 ' HB2' ' A' ' 120' ' ' TYR . 18.5 tt -116.53 160.84 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.346 -0.846 . . . . 0.1 109.644 179.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.946 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 15.6 ptp -160.81 139.73 10.29 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.56 -1.338 . . . . 0.11 111.439 -179.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.547 ' O ' ' CG2' ' A' ' 165' ' ' ILE . 0.3 OUTLIER -93.6 113.97 29.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.524 -0.735 . . . . 0.1 109.292 179.112 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.995 ' HB3' HG23 ' A' ' 123' ' ' VAL . 63.6 p -162.23 166.4 25.54 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.777 -1.202 . . . . 0.1 111.36 -179.172 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.616 ' CG ' ' CD1' ' A' ' 125' ' ' TYR . 1.0 OUTLIER -79.99 136.56 36.64 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.55 -0.719 . . . . 0.09 109.979 179.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.512 ' HA3' ' HB3' ' A' ' 200' ' ' HIS . . . -90.72 128.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.793 -1.323 . . . . 0.2 109.793 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.704 ' O ' HG23 ' A' ' 169' ' ' ILE . 3.1 tt -118.29 100.87 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.437 -1.037 . . . . 0.55 109.737 179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.608 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 3.0 tmtt? -9.71 88.82 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 CA-C-O 121.284 0.564 . . . . 0.85 112.352 -179.626 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.462 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 9.3 tt0 -146.16 11.85 1.2 Allowed 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.351 -0.843 . . . . 0.71 110.278 179.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 9.1 m170 -74.78 -75.01 0.18 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.42 110.107 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . 0.439 ' O ' ' HB3' ' A' ' 174' ' ' ASP . . . 120.12 52.45 0.26 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.795 -1.322 . . . . 0.33 109.795 179.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . 0.439 ' HB3' ' O ' ' A' ' 173' ' ' GLY . 6.5 p-10 -177.1 -42.26 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.243 -1.151 . . . . 0.33 110.083 179.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.483 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 0.2 OUTLIER -132.03 154.72 49.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.239 -0.913 . . . . 0.27 110.083 179.795 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.58 ' CE1' ' HE2' ' A' ' 170' ' ' LYS . 3.0 m-30 -106.48 88.98 3.68 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.195 -0.941 . . . . 0.34 110.168 -179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 175' ' ' PHE . 44.3 Cg_endo -72.6 -58.83 0.06 OUTLIER 'Trans proline' 0 C--N 1.304 -1.78 0 O-C-N 123.836 1.44 . . . . 0.47 109.968 179.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.608 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 1.1 p90 -49.12 131.49 19.39 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.3 -0.875 . . . . 0.35 110.362 179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.479 ' O ' ' HB2' ' A' ' 182' ' ' SER . 14.8 p30 179.33 82.01 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.134 -0.979 . . . . 0.2 110.804 179.196 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.497 ' H ' ' CB ' ' A' ' 204' ' ' ASP . . . 35.71 -154.13 0.01 OUTLIER Glycine 0 N--CA 1.495 2.621 0 N-CA-C 110.094 -1.202 . . . . 0.25 110.094 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -78.96 43.74 1.54 Allowed 'Trans proline' 0 C--N 1.303 -1.865 0 O-C-N 123.965 1.508 . . . . 0.44 110.2 179.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.1 t -80.78 176.67 9.6 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.103 -0.998 . . . . 0.57 110.076 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.566 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -63.35 67.25 0.03 OUTLIER Glycine 0 N--CA 1.488 2.154 0 N-CA-C 110.664 -0.974 . . . . 0.49 110.664 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.025 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.3 OUTLIER 179.57 88.87 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.178 -1.189 . . . . 0.41 110.709 179.707 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.591 HD13 ' CZ ' ' A' ' 214' ' ' TYR . 4.9 tt -105.9 -19.11 13.84 Favored 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 118.759 -1.176 . . . . 0.3 110.919 179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.653 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.25 111.11 4.31 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.703 -1.248 . . . . 0.2 112.074 -179.265 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.52 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 0.0 OUTLIER -114.64 125.83 54.2 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.84 . . . . 0.16 109.414 178.696 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.959 ' HB1' ' HB3' ' A' ' 227' ' ' SER . . . -123.04 116.89 24.26 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.931 -1.106 . . . . 0.23 110.512 -179.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . . . . . . . . . 2.1 m-30 -58.57 167.68 1.68 Allowed Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.271 -0.893 . . . . 0.38 110.146 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.491 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 44.0 Cg_endo -72.19 145.87 44.85 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 124.027 1.541 . . . . 0.4 109.489 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.451 ' HD3' ' O ' ' A' ' 227' ' ' SER . 44.3 Cg_endo -72.48 86.43 1.01 Allowed 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.831 1.438 . . . . 0.32 110.35 -179.417 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -131.49 -98.55 0.76 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 109.591 -1.404 . . . . 0.32 109.591 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.6 Cg_endo -72.61 -166.39 0.28 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 124.096 1.577 . . . . 0.47 110.573 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 15.4 p30 -69.67 -6.58 32.48 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.296 -0.878 . . . . 0.63 110.343 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -107.84 26.46 10.3 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.33 -0.856 . . . . 0.53 109.891 -179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -106.34 176.94 22.02 Favored Glycine 0 N--CA 1.486 2.004 0 N-CA-C 109.082 -1.607 . . . . 0.25 109.082 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.533 ' O ' HG13 ' A' ' 163' ' ' ILE . . . 45.3 25.33 1.16 Allowed Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.226 -1.55 . . . . 0.1 109.226 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.4 ' N ' ' O ' ' A' ' 196' ' ' GLY . 10.7 m-20 -78.79 87.49 4.67 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.916 -1.344 . . . . 0.1 110.026 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.946 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -69.72 97.99 1.14 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.205 -0.934 . . . . 0.09 109.895 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.512 ' HB3' ' HA3' ' A' ' 168' ' ' GLY . 41.4 m170 -115.27 129.47 56.63 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.299 -0.876 . . . . 0.09 110.602 -179.315 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.556 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.9 m-85 -96.79 139.25 33.12 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.085 -1.009 . . . . 0.1 110.365 179.483 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.52 ' O ' ' N ' ' A' ' 204' ' ' ASP . 0.4 OUTLIER -47.78 93.53 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.154 -0.966 . . . . 0.14 108.544 179.027 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.556 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.7 p-10 -35.48 -30.06 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 120.013 -0.675 . . . . 0.18 111.985 -178.263 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 0.8 OUTLIER -76.66 -3.21 36.72 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 120.771 -1.205 . . . . 0.24 111.271 -179.561 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.515 ' HG3' ' HB2' ' A' ' 202' ' ' ASP . 14.5 mm-40 -91.22 -164.94 1.25 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.031 -1.043 . . . . 0.42 110.171 179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.446 ' C ' ' CG ' ' A' ' 207' ' ' TRP . 16.0 m -127.88 150.95 49.64 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.205 -0.934 . . . . 0.47 110.223 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.56 ' C ' HG22 ' A' ' 208' ' ' THR . 1.2 m-90 -145.9 146.25 31.01 Favored 'General case' 0 N--CA 1.495 1.813 0 O-C-N 121.225 -0.922 . . . . 0.27 109.56 179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.986 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -162.17 175.4 11.73 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.867 -1.145 . . . . 0.3 111.104 179.733 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.9 t -126.58 45.24 2.71 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-O 121.855 0.836 . . . . 0.61 109.037 178.589 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.512 ' OG ' ' N ' ' A' ' 211' ' ' SER . 11.0 t -127.38 -157.99 0.84 Allowed 'General case' 0 C--N 1.303 -1.438 0 O-C-N 121.618 -0.676 . . . . 0.78 110.035 -179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.512 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.1 p -97.62 27.92 4.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.2 -0.937 . . . . 0.91 110.349 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 28.6 tttt -145.09 150.13 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.264 -0.898 . . . . 0.93 110.013 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 65.1 -176.2 12.58 Favored Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.174 -1.57 . . . . 0.79 109.174 -179.803 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.591 ' CZ ' HD13 ' A' ' 185' ' ' LEU . 86.7 m-85 -65.33 139.6 58.6 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -1.178 . . . . 0.69 109.565 179.599 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.619 ' O ' HG12 ' A' ' 219' ' ' VAL . 0.6 OUTLIER -108.32 119.24 38.93 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.061 -1.024 . . . . 0.4 108.678 179.131 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.986 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -39.08 -38.76 0.5 Allowed 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 120.044 -0.662 . . . . 0.17 110.801 -178.874 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.582 ' CZ ' ' HG2' ' A' ' 136' ' ' LYS . 2.0 m-85 -50.62 -46.66 58.25 Favored 'General case' 0 C--N 1.286 -2.171 0 C-N-CA 118.302 -1.359 . . . . 0.28 107.592 179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.914 HD21 ' HB2' ' A' ' 244' ' ' TYR . 13.4 tp -80.72 -72.86 0.4 Allowed 'General case' 0 C--N 1.297 -1.676 0 CA-C-N 115.707 -0.678 . . . . 0.46 110.908 179.05 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.819 HG13 ' HA ' ' A' ' 216' ' ' LEU . 1.5 p -46.1 -57.13 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.098 -1.001 . . . . 0.39 110.395 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.942 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -59.36 -49.56 77.33 Favored 'General case' 0 C--N 1.298 -1.663 0 O-C-N 121.336 -0.852 . . . . 0.17 111.385 -179.859 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.574 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.23 -27.07 65.41 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.338 -1.476 . . . . 0.1 108.998 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.632 ' CA ' HD21 ' A' ' 239' ' ' LEU . 4.0 t60 -76.53 -56.17 4.87 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-O 121.305 0.574 . . . . 0.21 109.768 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.643 ' OE1' ' HB1' ' A' ' 199' ' ' ALA . 34.7 tt0 -58.43 -39.28 79.36 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.126 -0.983 . . . . 0.28 109.015 178.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.509 ' HB2' ' O ' ' A' ' 220' ' ' ALA . 0.4 OUTLIER -60.47 -62.39 1.9 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.279 -0.888 . . . . 0.18 109.005 178.648 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -42.83 -29.71 0.86 Allowed Glycine 0 N--CA 1.486 2.014 0 N-CA-C 108.701 -1.76 . . . . 0.21 108.701 179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.48 ' CE1' ' HA ' ' A' ' 232' ' ' HIS . 0.2 OUTLIER -82.43 -66.05 0.94 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.292 -1.122 . . . . 0.17 110.884 179.652 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.959 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.0 OUTLIER -40.78 -42.91 1.89 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.443 -0.786 . . . . 0.33 111.691 -178.945 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.75 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.9 OUTLIER -100.27 -37.87 8.72 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.772 -1.205 . . . . 0.53 110.942 -179.186 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.477 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -67.91 -85.74 0.1 OUTLIER Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.255 -1.138 . . . . 0.41 110.255 -179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.698 HD12 ' HA ' ' A' ' 110' ' ' THR . 0.7 OUTLIER -170.23 -163.4 0.35 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.066 -1.255 . . . . 0.45 111.05 -179.139 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.451 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.1 OUTLIER -59.03 -55.78 30.76 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.477 -0.765 . . . . 0.62 110.329 -179.952 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.48 ' HA ' ' CE1' ' A' ' 226' ' ' HIS . 0.7 OUTLIER -161.72 -179.69 7.44 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.202 -0.937 . . . . 0.45 110.802 179.841 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.497 ' O ' ' CB ' ' A' ' 238' ' ' ALA . 1.2 t 179.35 56.22 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.714 -0.616 . . . . 0.38 109.474 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.672 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -139.25 26.36 2.4 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.184 -0.947 . . . . 0.48 110.862 -179.532 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.519 ' N ' ' HD2' ' A' ' 236' ' ' PRO . 0.5 OUTLIER -34.03 -52.6 0.89 Allowed Pre-proline 0 N--CA 1.493 1.699 0 C-N-CA 120.005 -0.678 . . . . 0.38 110.273 -179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.519 ' HD2' ' N ' ' A' ' 235' ' ' ASP . 50.2 Cg_endo -75.25 -56.76 0.06 OUTLIER 'Trans proline' 0 C--N 1.307 -1.643 0 O-C-N 123.634 1.334 . . . . 0.28 110.12 178.535 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 176.62 37.22 0.05 OUTLIER Glycine 0 N--CA 1.497 2.734 0 C-N-CA 119.328 -1.415 . . . . 0.24 111.655 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.672 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -69.9 171.97 8.49 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.389 -1.653 . . . . 0.28 111.009 179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.632 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -76.21 58.79 1.29 Allowed 'General case' 0 N--CA 1.494 1.734 0 CA-C-O 121.938 0.875 . . . . 0.4 109.148 179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.622 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 2.6 mmt -138.07 -33.53 0.69 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.494 -0.754 . . . . 0.45 110.519 -179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.642 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -52.62 169.93 0.26 Allowed Pre-proline 0 N--CA 1.494 1.767 0 O-C-N 121.153 -0.967 . . . . 0.57 110.344 179.988 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.533 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 44.7 Cg_endo -72.17 -1.42 10.06 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.592 1.312 . . . . 0.76 110.369 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.585 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 4.1 mt -111.97 141.96 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.292 -0.88 . . . . 0.89 109.965 179.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.914 ' HB2' HD21 ' A' ' 218' ' ' LEU . 22.4 p90 -130.15 -19.66 3.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.151 -0.968 . . . . 0.78 111.201 -179.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.694 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.0 OUTLIER 4.46 -76.77 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.428 0 N-CA-C 113.006 0.743 . . . . 0.61 113.006 -178.762 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.694 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -45.49 121.09 2.82 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.498 -1.376 . . . . 0.74 109.612 -179.683 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.55 ' O ' ' CD1' ' A' ' 246' ' ' TYR . 0.6 OUTLIER -71.14 157.96 37.27 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.374 -0.828 . . . . 0.81 110.228 -179.781 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -49.87 -22.09 4.16 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.528 -1.429 . . . . 0.56 109.528 179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.7 mtmt -131.07 31.56 4.42 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.238 -1.154 . . . . 0.37 110.744 -179.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.407 ' HB2' ' H ' ' A' ' 247' ' ' THR . 1.6 t -76.28 -69.5 0.5 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 120.806 -1.184 . . . . 0.44 110.114 179.795 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . 0.537 ' O ' ' CG ' ' A' ' 252' ' ' PHE . 2.4 t60 -116.73 -60.09 1.89 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.53 110.338 179.86 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.537 ' CG ' ' O ' ' A' ' 251' ' ' HIS . 0.2 OUTLIER 179.85 -169.15 0.12 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.136 -0.977 . . . . 0.38 110.898 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.927 ' HB2' HG21 ' A' ' 259' ' ' VAL . 26.0 ptp -64.92 55.83 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.998 -0.439 . . . . 0.19 110.658 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.727 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 0.2 OUTLIER -45.38 -46.96 35.16 Favored Pre-proline 0 N--CA 1.484 1.238 0 N-CA-C 107.897 -1.149 . . . . 0.28 107.897 177.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.3 Cg_endo -71.42 48.72 1.0 Allowed 'Trans proline' 0 C--N 1.314 -1.26 0 O-C-N 123.901 1.474 . . . . 0.49 111.194 177.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.588 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 7.7 m-20 -49.29 -32.54 11.13 Favored 'General case' 0 C--N 1.302 -1.493 0 O-C-N 120.887 -1.133 . . . . 0.49 110.325 179.865 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.626 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.96 -50.69 70.09 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 118.966 -1.093 . . . . 0.31 108.974 -179.539 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.023 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -68.54 -35.13 77.0 Favored 'General case' 0 C--N 1.296 -1.744 0 C-N-CA 119.257 -0.977 . . . . 0.14 108.672 178.546 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.927 HG21 ' HB2' ' A' ' 253' ' ' MET . 53.6 t -66.49 -86.1 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.273 -0.892 . . . . 0.17 110.543 179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.587 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 10.0 tt0 -53.77 -39.62 65.53 Favored 'General case' 0 C--N 1.3 -1.571 0 O-C-N 121.051 -1.03 . . . . 0.26 109.631 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.612 ' O ' HD12 ' A' ' 265' ' ' LEU . . . -45.9 -70.83 0.58 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 110.354 -1.098 . . . . 0.19 110.354 -179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.023 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -69.96 -20.65 23.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 120.638 -1.507 . . . . 0.22 109.89 -179.538 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.968 ' N ' HD13 ' A' ' 262' ' ' ILE . 3.4 tp-100 -58.87 -25.99 63.83 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 118.722 -1.191 . . . . 0.39 107.821 178.627 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 25.5 t -103.07 -43.05 5.6 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.308 0.575 . . . . 0.47 110.857 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.612 HD12 ' O ' ' A' ' 261' ' ' GLY . 1.6 mt -72.52 -53.06 13.08 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.364 -0.835 . . . . 0.48 111.054 -179.002 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.796 ' CD1' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -80.13 -8.1 59.24 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.26 -0.9 . . . . 0.41 110.291 -179.625 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.493 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -53.0 -100.2 0.01 OUTLIER Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.103 -1.599 . . . . 0.46 109.103 179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -76.33 132.74 13.98 Favored 'Trans proline' 0 C--N 1.303 -1.818 0 O-C-N 123.967 1.509 . . . . 0.58 110.088 179.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.481 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -98.37 140.88 15.28 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.737 -1.345 . . . . 0.64 109.737 -179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.614 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.6 OUTLIER -89.81 -64.63 1.11 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.244 -1.15 . . . . 0.95 109.903 179.873 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.556 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 5.1 tm-20 45.35 24.35 0.16 Allowed 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 1.2 110.146 179.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -152.25 84.98 4.69 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.27 -0.894 . . . . 1.2 110.235 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . 0.448 ' O ' ' HB2' ' A' ' 274' ' ' ASN . 44.5 Cg_endo -72.98 -1.21 10.15 Favored 'Trans proline' 0 C--N 1.305 -1.722 0 O-C-N 124.048 1.552 . . . . 1.06 110.515 -179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 273' ' ' PRO . 2.9 m-20 . . . . . 0 N--CA 1.493 1.678 0 CA-C-O 118.013 -0.994 . . . . 0.78 110.239 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.025 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.566 ' HE1' ' CA ' ' A' ' 183' ' ' GLY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.858 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 26.8 p90 . . . . . 0 N--CA 1.492 1.629 0 CA-C-O 121.345 0.593 . . . . 0.41 110.263 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -145.95 138.7 25.68 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.299 -0.876 . . . . 0.26 110.169 -179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.8 m -133.87 155.38 39.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.17 -0.956 . . . . 0.33 110.193 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.5 m-85 -52.29 152.07 6.5 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.65 110.237 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -72.57 -85.97 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.143 1.602 . . . . 0.84 110.807 -179.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.476 ' O ' ' CD1' ' A' ' 230' ' ' LEU . 18.8 mtp180 48.26 65.37 1.34 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.242 -0.911 . . . . 0.93 109.825 -179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.528 ' HA ' HD13 ' A' ' 230' ' ' LEU . 0.6 OUTLIER -141.93 -58.05 0.47 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.507 -0.746 . . . . 1.03 109.439 179.912 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.461 ' HB3' ' O ' ' A' ' 229' ' ' GLY . 3.6 mt 40.05 31.53 0.09 Allowed 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.585 -0.697 . . . . 1.04 111.017 179.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.798 ' NZ ' HG22 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -119.97 76.68 1.18 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.097 -1.002 . . . . 0.77 109.74 179.455 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.578 ' NE1' ' CB ' ' A' ' 270' ' ' ASP . 23.5 t90 -140.92 -71.16 0.36 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.338 -0.851 . . . . 0.42 110.54 -179.721 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.465 ' CB ' ' HA ' ' A' ' 271' ' ' GLU . 4.6 t -103.48 54.0 0.76 Allowed 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.411 -0.805 . . . . 0.44 110.326 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.743 ' HD3' HD11 ' A' ' 118' ' ' LEU . 59.6 mmtt -136.54 46.65 2.23 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.191 -0.943 . . . . 0.49 110.311 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.573 ' O ' ' HE3' ' A' ' 116' ' ' MET . 1.1 ttp -82.47 -15.34 52.86 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 121.296 -0.878 . . . . 0.3 109.989 179.833 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.442 ' OD1' ' N ' ' A' ' 117' ' ' ASN . 17.3 p30 -140.17 115.52 9.93 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.37 -0.831 . . . . 0.15 110.077 179.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 1.0 HD22 HD11 ' A' ' 228' ' ' LEU . 0.2 OUTLIER -138.76 176.2 8.9 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.362 -0.836 . . . . 0.13 110.108 -179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.567 HG22 ' O ' ' A' ' 154' ' ' THR . 0.9 OUTLIER -123.64 162.04 23.84 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.094 -1.004 . . . . 0.12 109.992 179.451 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.784 ' HB2' HD13 ' A' ' 163' ' ' ILE . 16.0 p90 -164.66 167.7 18.85 Favored 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.199 -1.0 . . . . 0.33 111.285 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 6.1 mtp180 -120.45 151.83 38.8 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.416 -0.803 . . . . 0.54 109.875 179.645 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.801 HG21 ' CD1' ' A' ' 138' ' ' PHE . 1.5 pp -109.47 101.24 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 O-C-N 121.32 -0.862 . . . . 0.33 110.989 -179.461 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.952 HG23 ' HB3' ' A' ' 166' ' ' SER . 2.8 m -143.63 43.1 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.202 -0.936 . . . . 0.27 110.396 179.333 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.473 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 4.0 t30 -42.04 -77.11 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.281 -0.887 . . . . 0.41 109.303 179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.691 ' O ' HG21 ' A' ' 134' ' ' VAL . 2.9 t80 -179.69 -167.06 0.09 Allowed 'General case' 0 C--N 1.301 -1.538 0 O-C-N 121.395 -0.815 . . . . 0.4 109.68 179.12 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.546 ' N ' ' HD3' ' A' ' 127' ' ' PRO . 0.7 OUTLIER -150.97 50.07 0.66 Allowed Pre-proline 0 N--CA 1.492 1.658 0 O-C-N 121.08 -1.012 . . . . 0.45 110.533 179.893 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.546 ' HD3' ' N ' ' A' ' 126' ' ' THR . 44.0 Cg_endo -75.76 -84.67 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.63 0 O-C-N 123.838 1.441 . . . . 0.36 110.508 179.845 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -95.71 -0.25 51.73 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.204 -0.935 . . . . 0.25 109.998 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.554 ' HB3' ' CB ' ' A' ' 133' ' ' GLU . 0.9 OUTLIER -115.99 163.57 15.71 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.298 -0.876 . . . . 0.39 110.007 179.821 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.17 168.68 9.42 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.323 -0.861 . . . . 0.48 110.049 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -43.6 -32.83 1.03 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 0.4 110.04 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -64.4 -46.32 83.82 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.25 -0.906 . . . . 0.46 109.512 179.611 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.554 ' CB ' ' HB3' ' A' ' 129' ' ' MET . 12.5 mt-10 -67.23 -57.5 6.6 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.138 -0.976 . . . . 0.47 109.66 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.691 HG21 ' O ' ' A' ' 125' ' ' TYR . 17.5 t -45.33 -32.47 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.568 0 N-CA-C 107.95 -1.13 . . . . 0.31 107.95 178.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.511 ' O ' ' HB2' ' A' ' 139' ' ' LYS . 1.7 mt-10 -63.55 -44.54 93.87 Favored 'General case' 0 C--N 1.308 -1.238 0 N-CA-C 108.078 -1.082 . . . . 0.48 108.078 178.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.535 ' O ' ' CB ' ' A' ' 140' ' ' LYS . 1.2 ttmt -68.56 -49.07 62.23 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 119.24 -0.984 . . . . 0.64 108.651 178.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.831 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -46.39 -59.75 2.76 Favored 'General case' 0 C--N 1.289 -2.036 0 O-C-N 121.212 -0.93 . . . . 0.42 110.245 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.801 ' CD1' HG21 ' A' ' 122' ' ' ILE . 0.1 OUTLIER -66.68 -53.78 30.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.236 -0.915 . . . . 0.34 110.825 -179.327 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.63 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 0.0 OUTLIER -66.18 -73.3 0.13 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.886 -1.134 . . . . 0.47 110.335 -179.529 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.535 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 1.8 tmtt? -38.63 -60.63 0.8 Allowed 'General case' 0 C--N 1.292 -1.909 0 O-C-N 121.865 -0.522 . . . . 0.47 110.603 179.144 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.575 ' HB2' ' HA ' ' A' ' 217' ' ' PHE . . . -47.38 -38.71 13.67 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.676 -1.265 . . . . 0.25 108.528 178.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.526 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.4 OUTLIER -71.68 -29.68 64.87 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.368 -0.832 . . . . 0.35 109.079 178.797 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.471 ' N ' ' O ' ' A' ' 140' ' ' LYS . 6.1 ttmm -61.24 -44.91 96.5 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 108.19 -1.041 . . . . 0.7 108.19 178.652 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.481 ' O ' ' HB2' ' A' ' 147' ' ' ASP . 6.5 t -63.61 -43.35 98.16 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.7 -0.852 . . . . 0.61 108.7 178.497 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.628 ' O ' HG22 ' A' ' 148' ' ' VAL . 46.2 t-105 -56.35 -44.4 80.05 Favored 'General case' 0 N--CA 1.488 1.437 0 N-CA-C 108.79 -0.819 . . . . 0.39 108.79 178.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.537 ' HA ' ' O ' ' A' ' 149' ' ' THR . 9.6 m -64.66 -32.12 73.65 Favored 'General case' 0 C--N 1.305 -1.334 0 N-CA-C 108.886 -0.783 . . . . 0.35 108.886 178.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 144' ' ' VAL . 0.6 OUTLIER -62.72 -36.57 83.41 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.521 -0.737 . . . . 0.36 109.334 179.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 145' ' ' TRP . 35.3 m -89.17 -11.56 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.34 -0.85 . . . . 0.5 110.534 -179.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.537 ' O ' ' HA ' ' A' ' 146' ' ' SER . 14.9 t -175.92 132.67 0.42 Allowed Pre-proline 0 N--CA 1.498 1.953 0 O-C-N 120.927 -1.108 . . . . 0.51 110.247 179.633 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.04 60.1 3.03 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.866 1.456 . . . . 0.31 110.804 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.885 HD21 ' CG ' ' A' ' 266' ' ' TYR . 0.1 OUTLIER -72.32 129.63 38.85 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.259 -0.901 . . . . 0.18 109.879 179.619 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.444 ' HB2' ' O ' ' A' ' 116' ' ' MET . 0.1 OUTLIER -87.19 124.73 33.61 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.196 -0.94 . . . . 0.17 110.191 -179.898 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.535 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 0.8 OUTLIER -136.27 155.85 49.5 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.247 -0.908 . . . . 0.14 110.508 -179.77 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.567 ' O ' HG22 ' A' ' 119' ' ' THR . 34.5 m -152.81 132.11 12.81 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.362 -0.836 . . . . 0.15 110.222 -179.807 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.57 ' HD3' HG23 ' A' ' 122' ' ' ILE . 0.8 OUTLIER -101.55 91.21 4.34 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.134 -0.978 . . . . 0.2 110.123 -179.91 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -95.5 94.32 7.71 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.309 -0.87 . . . . 0.22 110.286 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.434 ' O ' ' C ' ' A' ' 158' ' ' ASP . 14.3 p-80 -52.71 -25.85 12.28 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.156 -0.965 . . . . 0.32 109.867 179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.434 ' C ' ' O ' ' A' ' 157' ' ' HIS . 1.5 t70 -41.53 -62.79 0.81 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 121.468 0.652 . . . . 0.33 109.679 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 168.58 34.1 0.02 OUTLIER Glycine 0 N--CA 1.489 2.223 0 N-CA-C 109.888 -1.285 . . . . 0.28 109.888 179.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.55 ' O ' ' HB ' ' A' ' 119' ' ' THR . 22.6 mm -126.5 69.2 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 O-C-N 121.065 -1.256 . . . . 0.3 109.108 179.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . . . . . . . . . . . -127.91 136.9 51.99 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 120.001 -0.68 . . . . 0.2 110.572 -179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -118.33 -35.81 3.7 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.318 -0.864 . . . . 0.1 110.269 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 1.047 HG21 HD13 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -126.82 163.29 29.65 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.04 0 O-C-N 121.294 -0.879 . . . . 0.1 109.511 -179.93 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.806 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 6.5 ptm -172.77 156.19 3.41 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.208 -1.558 . . . . 0.11 111.727 -179.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.678 HG22 ' HA ' ' A' ' 122' ' ' ILE . 4.5 tt -98.43 114.74 36.85 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 O-C-N 121.654 -0.654 . . . . 0.1 109.447 179.166 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.952 ' HB3' HG23 ' A' ' 123' ' ' VAL . 80.9 p -155.85 151.61 27.35 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.651 -1.281 . . . . 0.1 110.92 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.563 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 2.5 p90 -72.45 119.15 16.26 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.522 -0.736 . . . . 0.09 109.826 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.466 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -77.87 129.31 9.39 Favored Glycine 0 N--CA 1.488 2.134 0 N-CA-C 110.219 -1.152 . . . . 0.2 110.219 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.566 ' O ' ' C ' ' A' ' 170' ' ' LYS . 3.5 tt -126.18 98.55 4.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 O-C-N 121.614 -0.933 . . . . 0.55 109.634 179.336 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.596 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 1.2 tmtt? 1.15 96.55 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.398 0 N-CA-C 112.589 0.588 . . . . 0.85 112.589 -179.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -158.68 20.21 0.21 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.31 -0.869 . . . . 0.71 110.282 179.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 28.4 m-70 -93.31 -88.44 0.22 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.182 -0.949 . . . . 0.42 110.268 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 156.29 -20.96 0.48 Allowed Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.325 -1.51 . . . . 0.33 109.325 -179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 2.3 t0 -75.68 -66.91 0.72 Allowed 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.395 -1.062 . . . . 0.33 110.339 -179.954 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.465 ' CD1' ' C ' ' A' ' 175' ' ' PHE . 23.4 p90 -148.24 163.51 36.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.236 -0.915 . . . . 0.27 110.422 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.539 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 7.0 m-30 -69.24 114.95 27.37 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.338 -0.851 . . . . 0.34 110.186 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.5 ' O ' HD23 ' A' ' 184' ' ' LEU . 44.1 Cg_endo -77.07 -72.28 0.01 OUTLIER 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.857 1.451 . . . . 0.47 110.784 -179.858 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.596 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.4 OUTLIER -54.2 146.87 14.17 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.164 -0.96 . . . . 0.35 110.422 -179.86 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.503 ' OD1' ' O ' ' A' ' 179' ' ' ASP . 44.4 p-10 -178.08 76.82 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.162 -0.961 . . . . 0.2 110.459 178.777 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.537 ' N ' ' HB3' ' A' ' 204' ' ' ASP . . . 53.18 -169.39 0.88 Allowed Glycine 0 N--CA 1.487 2.077 0 N-CA-C 109.121 -1.591 . . . . 0.25 109.121 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.513 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.3 Cg_endo -78.28 10.05 2.88 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 124.042 1.548 . . . . 0.44 110.478 179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.465 ' O ' ' N ' ' A' ' 184' ' ' LEU . 28.5 t -47.59 177.24 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.221 -0.924 . . . . 0.57 110.915 -179.619 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.538 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.02 76.36 0.02 OUTLIER Glycine 0 N--CA 1.49 2.246 0 N-CA-C 110.479 -1.048 . . . . 0.49 110.479 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.889 ' HA ' HG13 ' A' ' 1' ' ' HAV . 5.0 tp 179.47 87.68 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 O-C-N 121.369 -1.077 . . . . 0.41 109.767 179.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.859 HD12 ' OE1' ' A' ' 205' ' ' GLU . 6.4 tt -109.84 -23.47 11.36 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 120.901 -1.124 . . . . 0.3 111.42 -179.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.602 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -152.5 101.84 2.69 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.517 -1.365 . . . . 0.2 111.935 -179.617 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.57 ' O ' ' CG ' ' A' ' 187' ' ' HIS . 2.2 p80 -100.76 120.84 40.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.014 -1.054 . . . . 0.16 110.016 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.78 ' HB1' ' CA ' ' A' ' 227' ' ' SER . . . -102.64 132.45 48.74 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.306 -0.871 . . . . 0.23 110.179 -179.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.468 ' HB3' ' HA2' ' A' ' 196' ' ' GLY . 1.6 m-30 -78.91 168.92 23.19 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.124 -0.985 . . . . 0.38 110.421 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.509 ' O ' ' HA3' ' A' ' 196' ' ' GLY . 48.0 Cg_endo -73.68 125.47 10.05 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.994 1.523 . . . . 0.4 109.553 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -69.25 68.22 1.41 Allowed 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 123.897 1.472 . . . . 0.32 110.6 -179.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -114.36 -86.23 1.4 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.366 -1.494 . . . . 0.32 109.366 179.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -73.17 -164.46 0.19 Allowed 'Trans proline' 0 C--N 1.304 -1.794 0 O-C-N 124.072 1.564 . . . . 0.47 110.367 179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . 0.434 ' N ' ' ND2' ' A' ' 194' ' ' ASN . 3.4 m120 -74.22 -0.89 18.29 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.221 -0.924 . . . . 0.63 110.386 -179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -115.89 48.67 1.19 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.303 -0.873 . . . . 0.53 110.162 -179.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 190' ' ' PRO . . . -124.32 177.37 16.79 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 109.313 -1.515 . . . . 0.25 109.313 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.529 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 46.79 22.74 1.22 Allowed Glycine 0 N--CA 1.49 2.27 0 N-CA-C 109.902 -1.279 . . . . 0.1 109.902 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -80.88 86.58 6.02 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.142 -1.211 . . . . 0.1 109.745 179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.806 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -61.58 97.6 0.08 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.143 -0.973 . . . . 0.09 110.057 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 14.1 m170 -107.34 126.73 52.82 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.352 -0.842 . . . . 0.09 110.341 -179.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.561 ' O ' ' N ' ' A' ' 203' ' ' ASP . 24.5 m-85 -99.0 132.58 44.2 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.173 -0.954 . . . . 0.1 110.529 179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.651 ' OD1' HD23 ' A' ' 184' ' ' LEU . 0.6 OUTLIER -46.74 91.67 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.834 -0.802 . . . . 0.14 108.834 178.884 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.561 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.9 p30 -37.52 -27.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.423 -0.798 . . . . 0.18 111.638 -178.05 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.537 ' HB3' ' N ' ' A' ' 180' ' ' GLY . 19.6 m-20 -77.17 3.15 13.34 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.622 -1.299 . . . . 0.24 110.731 179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.859 ' OE1' HD12 ' A' ' 185' ' ' LEU . 17.2 mm-40 -98.41 -167.06 1.45 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.934 -1.104 . . . . 0.42 110.41 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . 0.532 ' O ' ' CD1' ' A' ' 207' ' ' TRP . 0.3 OUTLIER -124.94 151.72 45.07 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.257 -0.902 . . . . 0.47 110.177 -179.932 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.532 ' CD1' ' O ' ' A' ' 206' ' ' THR . 1.1 m-90 -148.95 144.52 26.86 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.324 -0.86 . . . . 0.27 109.911 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.986 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -160.57 170.17 21.42 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 120.958 -1.089 . . . . 0.3 110.638 179.482 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.464 ' HB2' HD23 ' A' ' 216' ' ' LEU . 1.1 t -129.58 26.98 5.3 Favored 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 108.822 -0.807 . . . . 0.61 108.822 178.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.483 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -95.26 -94.72 0.18 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.715 -0.615 . . . . 0.78 110.296 -179.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.483 ' N ' ' OG ' ' A' ' 210' ' ' SER . 18.0 p -156.78 20.96 0.33 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.166 -0.959 . . . . 0.91 109.8 179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 213' ' ' GLY . 5.4 mttm -141.94 -177.16 5.08 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.439 -0.788 . . . . 0.93 110.134 -179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . 0.457 ' O ' ' O ' ' A' ' 212' ' ' LYS . . . 43.68 -166.43 0.02 OUTLIER Glycine 0 N--CA 1.492 2.369 0 N-CA-C 109.385 -1.486 . . . . 0.79 109.385 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.476 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 73.7 m-85 -73.75 120.54 19.48 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.191 -1.182 . . . . 0.69 109.793 179.702 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.589 ' O ' HG12 ' A' ' 219' ' ' VAL . 57.2 m-80 -84.52 120.05 25.88 Favored 'General case' 0 C--N 1.304 -1.397 0 O-C-N 120.963 -1.086 . . . . 0.4 108.856 179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.986 HD22 ' O ' ' A' ' 208' ' ' THR . 0.5 OUTLIER -41.33 -37.2 0.94 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.321 -0.862 . . . . 0.17 110.439 -179.255 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.594 ' O ' ' HB2' ' A' ' 221' ' ' ALA . 3.1 m-30 -51.33 -47.79 62.59 Favored 'General case' 0 C--N 1.287 -2.144 0 C-N-CA 118.619 -1.232 . . . . 0.28 107.696 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.946 HD11 ' HH1' ' A' ' 3' ' ' MSB . 7.3 tp -77.0 -70.04 0.49 Allowed 'General case' 0 C--N 1.296 -1.725 0 CA-C-N 115.9 -0.591 . . . . 0.46 110.605 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.894 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.7 OUTLIER -48.89 -66.96 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 120.944 -1.097 . . . . 0.39 109.808 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.902 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -46.57 -48.55 19.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.111 -0.993 . . . . 0.17 111.077 179.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.594 ' HB2' ' O ' ' A' ' 217' ' ' PHE . . . -58.59 -45.43 89.12 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 120.323 -1.485 . . . . 0.1 108.764 179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.851 ' HB2' HD11 ' A' ' 239' ' ' LEU . 2.7 t-160 -58.08 -54.52 45.99 Favored 'General case' 0 C--N 1.299 -1.606 0 CA-C-O 121.415 0.626 . . . . 0.21 109.811 178.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.511 ' OE2' ' N ' ' A' ' 188' ' ' ALA . 24.6 tp10 -58.5 -57.12 14.33 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.244 -0.91 . . . . 0.28 109.156 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.835 ' CE1' HD11 ' A' ' 163' ' ' ILE . 3.3 m-85 -43.73 -57.89 2.98 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.263 -0.898 . . . . 0.18 109.016 178.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.799 ' HA3' ' HE1' ' A' ' 240' ' ' MET . . . -46.96 -35.04 7.76 Favored Glycine 0 N--CA 1.486 2.028 0 N-CA-C 109.421 -1.472 . . . . 0.21 109.421 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.755 ' HE2' ' CE1' ' A' ' 232' ' ' HIS . 0.1 OUTLIER -81.8 -67.59 0.77 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.095 -1.238 . . . . 0.17 111.08 179.979 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.78 ' CA ' ' HB1' ' A' ' 188' ' ' ALA . 0.1 OUTLIER -38.08 -42.95 0.7 Allowed 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.46 -0.775 . . . . 0.33 111.726 -179.058 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 1.047 HD13 HG21 ' A' ' 163' ' ' ILE . 2.1 tp -99.95 -36.72 9.29 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.815 -1.178 . . . . 0.53 110.753 -179.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.59 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -64.99 -79.71 0.17 Allowed Glycine 0 N--CA 1.489 2.218 0 N-CA-C 110.3 -1.12 . . . . 0.41 110.3 -179.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.609 HD11 ' O ' ' A' ' 232' ' ' HIS . 0.8 OUTLIER -177.37 -152.11 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.126 -1.22 . . . . 0.45 110.896 -179.17 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.87 -50.67 47.77 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.412 -0.805 . . . . 0.62 110.199 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.755 ' CE1' ' HE2' ' A' ' 226' ' ' HIS . 0.2 OUTLIER -175.19 169.15 3.32 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.339 -0.851 . . . . 0.45 110.017 179.864 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . . . . . . . . . 48.9 p -169.31 53.52 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.36 -0.837 . . . . 0.38 109.229 179.488 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.99 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.2 OUTLIER -139.33 25.14 2.46 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.281 -0.887 . . . . 0.48 111.525 -178.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.545 ' HB3' ' HD3' ' A' ' 236' ' ' PRO . 0.0 OUTLIER -39.39 -51.06 4.8 Favored Pre-proline 0 N--CA 1.491 1.624 0 O-C-N 121.354 -0.841 . . . . 0.38 110.428 -179.426 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.545 ' HD3' ' HB3' ' A' ' 235' ' ' ASP . 53.2 Cg_endo -81.03 -52.18 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.831 0 O-C-N 123.571 1.301 . . . . 0.28 110.687 179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.508 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 176.75 101.72 0.15 Allowed Glycine 0 N--CA 1.497 2.758 0 C-N-CA 119.2 -1.476 . . . . 0.24 111.508 179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.99 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -139.4 177.4 7.95 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.261 -1.141 . . . . 0.28 109.65 178.439 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.851 HD11 ' HB2' ' A' ' 222' ' ' HIS . 2.0 tp -67.8 -3.98 11.15 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.065 -1.022 . . . . 0.4 109.86 179.986 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.799 ' HE1' ' HA3' ' A' ' 225' ' ' GLY . 6.4 mmt -94.91 -6.81 41.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.133 -0.979 . . . . 0.45 111.709 -179.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.655 ' N ' ' CD1' ' A' ' 241' ' ' PHE . 0.0 OUTLIER -53.8 169.39 0.35 Allowed Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.768 -1.208 . . . . 0.57 110.681 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.532 ' O ' ' CG1' ' A' ' 243' ' ' ILE . 49.5 Cg_endo -80.22 43.0 1.43 Allowed 'Trans proline' 0 C--N 1.308 -1.565 0 O-C-N 123.662 1.349 . . . . 0.76 110.055 179.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.532 ' CG1' ' O ' ' A' ' 242' ' ' PRO . 9.0 mt -161.01 144.38 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 N-CA-C 108.797 -0.816 . . . . 0.89 108.797 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.607 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 53.7 p90 -124.97 -34.15 2.83 Favored 'General case' 0 C--N 1.3 -1.579 0 O-C-N 120.965 -1.084 . . . . 0.78 110.057 -179.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.558 ' C ' ' O ' ' A' ' 244' ' ' TYR . 15.7 m 2.9 -70.3 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.418 0 N-CA-C 112.831 0.678 . . . . 0.61 112.831 -179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.581 ' CE2' ' HD3' ' A' ' 255' ' ' PRO . 0.0 OUTLIER -61.34 106.96 0.69 Allowed 'General case' 0 N--CA 1.49 1.562 0 O-C-N 120.632 -1.292 . . . . 0.74 108.977 179.691 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.455 ' N ' ' HB2' ' A' ' 250' ' ' SER . 0.2 OUTLIER -47.03 174.4 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.217 -0.927 . . . . 0.81 110.263 -179.553 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . . . . . . . . . . . -58.31 -16.5 27.87 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.037 -1.625 . . . . 0.56 109.037 179.783 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.445 ' HD2' ' O ' ' A' ' 249' ' ' LYS . 0.0 OUTLIER -146.89 31.29 0.95 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.313 -1.11 . . . . 0.37 110.374 -179.995 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.455 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.1 OUTLIER -56.56 -19.22 14.73 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.029 -1.044 . . . . 0.44 110.144 179.967 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 3.6 t-80 -170.97 -41.46 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.261 -0.899 . . . . 0.53 110.501 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.491 ' O ' ' CZ ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER -177.92 177.13 1.09 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.151 -0.968 . . . . 0.38 111.019 -179.84 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.991 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -71.32 56.68 0.24 Allowed 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.64 -0.663 . . . . 0.19 110.903 -179.999 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.729 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.0 OUTLIER -43.82 -47.07 20.79 Favored Pre-proline 0 N--CA 1.486 1.368 0 N-CA-C 108.019 -1.104 . . . . 0.28 108.019 177.182 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.729 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 39.5 Cg_endo -71.29 50.89 1.3 Allowed 'Trans proline' 0 C--N 1.315 -1.206 0 O-C-N 123.983 1.518 . . . . 0.49 111.085 177.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.629 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 15.1 m-20 -54.56 -28.77 48.17 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 121.021 -1.05 . . . . 0.49 111.192 -179.709 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.94 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.3 OUTLIER -54.38 -46.3 73.04 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 120.726 -1.234 . . . . 0.31 109.396 -179.062 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.025 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -77.07 -32.02 56.5 Favored 'General case' 0 C--N 1.296 -1.745 0 N-CA-C 108.297 -1.001 . . . . 0.14 108.297 179.183 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.991 HG21 ' HB2' ' A' ' 253' ' ' MET . 66.7 t -61.25 -76.68 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 C-N-CA 119.661 -0.816 . . . . 0.17 110.269 179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.632 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 2.3 tt0 -65.78 -42.26 90.98 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.101 -0.999 . . . . 0.26 109.434 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -39.38 -63.44 1.14 Allowed Glycine 0 N--CA 1.491 2.301 0 N-CA-C 110.129 -1.189 . . . . 0.19 110.129 -179.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.025 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -77.75 -20.49 13.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.762 -1.434 . . . . 0.22 110.395 -179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.844 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -59.72 -25.98 65.25 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 120.795 -1.19 . . . . 0.39 108.028 178.791 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 3.0 m -104.38 -33.54 8.59 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 120.145 -0.622 . . . . 0.47 111.764 -179.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.625 HD12 ' HB3' ' A' ' 112' ' ' LYS . 2.2 mm? -90.08 -44.99 9.44 Favored 'General case' 0 N--CA 1.498 1.927 0 O-C-N 121.075 -1.015 . . . . 0.48 111.563 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.885 ' CG ' HD21 ' A' ' 151' ' ' LEU . 0.1 OUTLIER -85.09 -11.28 55.6 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.41 110.647 -179.359 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.464 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.3 -110.47 0.01 OUTLIER Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.311 -1.516 . . . . 0.46 109.311 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -73.66 93.78 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.809 1.426 . . . . 0.58 110.353 179.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.417 ' CA ' ' O ' ' A' ' 113' ' ' TRP . . . -79.18 156.08 41.13 Favored Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.44 -1.464 . . . . 0.64 109.44 179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.578 ' CB ' ' NE1' ' A' ' 113' ' ' TRP . 38.0 t0 -76.34 -66.08 0.85 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.244 -1.151 . . . . 0.95 110.396 -179.962 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.465 ' HA ' ' CB ' ' A' ' 114' ' ' SER . 6.9 tt0 56.12 27.39 11.42 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.18 -0.95 . . . . 1.2 110.229 -179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -153.32 161.68 28.5 Favored Pre-proline 0 N--CA 1.489 1.494 0 O-C-N 121.275 -0.891 . . . . 1.2 110.051 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . 0.432 ' O ' ' O ' ' A' ' 274' ' ' ASN . 44.7 Cg_endo -72.68 66.49 3.85 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 123.97 1.511 . . . . 1.06 110.332 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . 0.432 ' O ' ' O ' ' A' ' 273' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.553 0 CA-C-O 118.025 -0.988 . . . . 0.78 110.221 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.889 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.568 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.946 ' HH1' HD11 ' A' ' 218' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 121.239 0.543 . . . . 0.41 110.177 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -120.25 99.83 6.82 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.238 -0.913 . . . . 0.26 110.213 -179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 54.6 t -125.1 -37.05 0.99 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.575 0 O-C-N 121.235 -0.916 . . . . 0.33 110.222 -179.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.0 m-85 -121.41 87.89 45.49 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.275 -0.89 . . . . 0.65 110.324 -179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.48 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 45.7 Cg_endo -73.1 -159.03 0.07 OUTLIER 'Trans proline' 0 C--N 1.306 -1.708 0 O-C-N 124.003 1.528 . . . . 0.84 110.296 -179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.774 ' O ' HD12 ' A' ' 230' ' ' LEU . 0.0 OUTLIER 67.73 82.29 0.18 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.404 -0.81 . . . . 0.93 110.201 -179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.491 ' O ' ' HB3' ' A' ' 230' ' ' LEU . 1.6 p -143.36 -60.07 0.42 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 1.03 109.568 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.543 ' CB ' ' O ' ' A' ' 229' ' ' GLY . 0.3 OUTLIER 38.21 42.53 0.51 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.577 . . . . 1.04 111.126 179.244 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.867 ' CD ' HD23 ' A' ' 265' ' ' LEU . 1.2 ptpt -134.3 66.36 1.54 Allowed 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.226 -0.921 . . . . 0.77 109.303 179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.616 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 12.3 t90 -140.37 -65.15 0.46 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.392 -0.817 . . . . 0.42 110.822 -179.184 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.522 ' OG ' ' CB ' ' A' ' 271' ' ' GLU . 36.1 t -103.69 56.41 0.74 Allowed 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.359 -0.838 . . . . 0.44 111.09 -178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HD3' ' O ' ' A' ' 114' ' ' SER . 30.4 mmtt -150.9 45.18 0.84 Allowed 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.028 -1.045 . . . . 0.49 110.476 179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.556 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 2.0 ttp -81.66 -1.9 48.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.205 -0.934 . . . . 0.3 110.458 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.566 ' O ' HD12 ' A' ' 118' ' ' LEU . 1.4 p30 -148.51 119.53 7.68 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.32 -0.862 . . . . 0.15 110.012 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.862 HD22 HD11 ' A' ' 228' ' ' LEU . 1.5 tp -152.13 174.3 13.88 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.13 110.493 -179.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.642 HG22 ' O ' ' A' ' 154' ' ' THR . 0.6 OUTLIER -118.2 159.46 23.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.367 -0.833 . . . . 0.12 110.256 179.963 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.864 ' HB3' HG23 ' A' ' 163' ' ' ILE . 20.1 p90 -154.35 170.22 21.86 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.616 -0.834 . . . . 0.33 110.591 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.6 147.39 49.9 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.261 -0.899 . . . . 0.54 110.12 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.863 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -107.09 125.05 63.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.362 -0.836 . . . . 0.33 110.929 -179.448 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.907 HG23 ' HB3' ' A' ' 166' ' ' SER . 1.3 m -167.19 43.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.399 -0.813 . . . . 0.27 109.768 179.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.514 ' OD1' ' CE ' ' A' ' 129' ' ' MET . 1.0 OUTLIER -40.07 -84.19 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.473 -0.767 . . . . 0.41 109.429 -179.981 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.538 ' CD1' ' CD1' ' A' ' 167' ' ' PHE . 19.9 t80 -178.46 -178.62 0.62 Allowed 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.434 -0.791 . . . . 0.4 109.641 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.581 ' N ' ' CD ' ' A' ' 127' ' ' PRO . 0.0 OUTLIER -119.7 48.2 1.12 Allowed Pre-proline 0 N--CA 1.497 1.91 0 O-C-N 120.917 -1.114 . . . . 0.45 110.664 -179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -71.28 -87.95 0.0 OUTLIER 'Trans proline' 0 C--N 1.304 -1.808 0 O-C-N 124.11 1.584 . . . . 0.36 110.52 179.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -108.41 -15.09 14.54 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.31 -0.869 . . . . 0.25 109.909 -179.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.583 ' CB ' ' CB ' ' A' ' 133' ' ' GLU . 0.0 OUTLIER -111.24 104.95 13.49 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.254 -0.904 . . . . 0.39 109.548 179.625 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.457 ' O ' ' O ' ' A' ' 129' ' ' MET . 0.3 OUTLIER -51.46 -172.72 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.448 -0.782 . . . . 0.48 110.593 -179.52 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -56.58 -39.35 73.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.369 -0.832 . . . . 0.4 110.209 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.52 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.3 OUTLIER -55.45 -57.82 10.29 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.122 -0.986 . . . . 0.46 109.668 179.661 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.583 ' CB ' ' CB ' ' A' ' 129' ' ' MET . 2.2 mp0 -55.72 -56.75 16.8 Favored 'General case' 0 C--N 1.304 -1.382 0 O-C-N 121.351 -0.843 . . . . 0.47 109.256 179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.504 HG21 ' O ' ' A' ' 125' ' ' TYR 0.253 5.1 t -44.47 -35.46 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.595 0 N-CA-C 108.016 -1.105 . . . . 0.31 108.016 178.15 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.52 ' CB ' ' O ' ' A' ' 132' ' ' SER . 5.0 tt0 -59.47 -44.43 93.02 Favored 'General case' 0 C--N 1.307 -1.259 0 N-CA-C 107.888 -1.153 . . . . 0.48 107.888 178.261 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.561 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 8.8 tttp -68.22 -44.0 76.71 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 108.581 -0.896 . . . . 0.64 108.581 177.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.798 ' HB1' ' HB3' ' A' ' 216' ' ' LEU . . . -47.96 -58.53 4.3 Favored 'General case' 0 C--N 1.291 -1.955 0 O-C-N 121.205 -0.934 . . . . 0.42 109.893 179.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -69.92 -51.76 30.28 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 119.704 -0.798 . . . . 0.34 110.701 -179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.623 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 10.8 tttt -64.22 -73.66 0.12 Allowed 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.939 -1.101 . . . . 0.47 109.993 -179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.541 ' CB ' ' O ' ' A' ' 136' ' ' LYS . 0.6 OUTLIER -39.14 -60.84 0.83 Allowed 'General case' 0 C--N 1.291 -1.953 0 O-C-N 121.837 -0.539 . . . . 0.47 110.693 178.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.547 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -46.88 -37.4 8.78 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.665 -1.214 . . . . 0.25 108.519 178.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 224' ' ' PHE . 0.4 OUTLIER -73.23 -34.27 65.8 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.45 -0.781 . . . . 0.35 109.217 178.827 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . 0.436 ' N ' ' O ' ' A' ' 140' ' ' LYS . 1.0 OUTLIER -56.36 -40.68 74.91 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 108.269 -1.011 . . . . 0.7 108.269 178.957 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.438 ' HA ' ' HB2' ' A' ' 147' ' ' ASP . 4.1 t -69.25 -44.58 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.416 0 N-CA-C 108.893 -0.78 . . . . 0.61 108.893 178.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.652 ' O ' HG22 ' A' ' 148' ' ' VAL . 27.4 t-105 -54.71 -42.66 71.76 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.464 -0.773 . . . . 0.39 109.173 179.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 149' ' ' THR . 20.0 m -70.37 -33.41 71.39 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.403 -0.81 . . . . 0.35 108.929 178.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . 0.438 ' HB2' ' HA ' ' A' ' 144' ' ' VAL . 0.1 OUTLIER -58.1 -36.48 72.94 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.612 -0.68 . . . . 0.36 109.457 179.267 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.827 HG23 HG22 ' A' ' 149' ' ' THR . 34.7 m -86.9 -29.37 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.482 0 O-C-N 121.375 -0.828 . . . . 0.5 110.634 -179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.827 HG22 HG23 ' A' ' 148' ' ' VAL . 5.2 t -153.04 135.93 9.57 Favored Pre-proline 0 N--CA 1.495 1.784 0 O-C-N 120.869 -1.144 . . . . 0.51 110.526 179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -71.88 58.1 2.66 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.986 1.519 . . . . 0.31 110.644 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.44 HD21 ' CD1' ' A' ' 266' ' ' TYR . 0.2 OUTLIER -80.15 136.52 36.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.213 -0.929 . . . . 0.18 110.076 179.779 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.43 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 9.3 t30 -88.08 126.11 34.93 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.26 -0.9 . . . . 0.17 110.391 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . . . . . . . . . 7.9 p90 -134.79 139.52 45.18 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.38 -0.825 . . . . 0.14 110.207 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.642 ' O ' HG22 ' A' ' 119' ' ' THR . 11.5 m -141.47 137.57 32.24 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.17 -0.956 . . . . 0.15 110.369 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.549 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 0.0 OUTLIER -101.6 130.77 47.98 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.242 -0.911 . . . . 0.2 109.677 -179.782 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.803 ' CD2' HD12 ' A' ' 160' ' ' ILE . 0.2 OUTLIER -128.43 105.7 8.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.179 -0.951 . . . . 0.22 110.193 179.978 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.507 ' CD2' ' N ' ' A' ' 158' ' ' ASP . 4.7 p-80 -54.54 -33.8 60.68 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.193 -0.942 . . . . 0.32 110.075 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.602 ' OD2' HD11 ' A' ' 160' ' ' ILE . 1.3 t70 -42.25 -42.38 3.06 Favored 'General case' 0 C--N 1.298 -1.657 0 O-C-N 121.589 -0.694 . . . . 0.33 109.869 179.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 129.57 33.77 0.51 Allowed Glycine 0 N--CA 1.491 2.312 0 N-CA-C 109.442 -1.463 . . . . 0.28 109.442 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.803 HD12 ' CD2' ' A' ' 156' ' ' LEU . 6.7 mt -116.15 75.63 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.428 0 O-C-N 121.286 -1.126 . . . . 0.3 109.631 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.5 ' HB1' ' HA ' ' A' ' 120' ' ' TYR . . . -143.6 147.78 34.89 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.528 -0.732 . . . . 0.2 110.403 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -105.67 -18.22 14.14 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.263 -0.898 . . . . 0.1 110.285 -179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.864 HG23 ' HB3' ' A' ' 120' ' ' TYR . 1.2 tt -136.07 166.93 25.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.153 -0.967 . . . . 0.1 110.077 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.746 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 6.9 ptp -171.38 146.38 2.27 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.64 -1.288 . . . . 0.11 111.065 -179.792 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.641 ' O ' HG23 ' A' ' 165' ' ' ILE . 2.4 tt -98.72 119.49 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 O-C-N 121.423 -0.798 . . . . 0.1 110.082 179.659 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.907 ' HB3' HG23 ' A' ' 123' ' ' VAL . 14.9 p -161.8 158.58 25.87 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.965 -1.084 . . . . 0.1 110.82 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.548 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 18.6 p90 -76.41 122.46 24.54 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.382 -0.824 . . . . 0.09 110.061 179.869 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.462 ' O ' ' OD2' ' A' ' 203' ' ' ASP . . . -78.19 134.8 14.82 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.023 -1.231 . . . . 0.2 110.023 -179.625 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.682 ' O ' HG23 ' A' ' 169' ' ' ILE . 1.3 tt -130.17 98.36 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.472 0 O-C-N 121.538 -0.977 . . . . 0.55 109.702 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.61 ' HG3' ' CE1' ' A' ' 178' ' ' PHE . 0.4 OUTLIER 1.09 86.36 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.403 0 CA-C-O 121.359 0.6 . . . . 0.85 112.266 -179.59 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -141.52 7.0 1.9 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.285 -0.884 . . . . 0.71 110.215 -179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.411 ' CE1' ' CE1' ' A' ' 189' ' ' PHE . 12.8 m-70 -77.98 -51.61 10.11 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.194 -0.941 . . . . 0.42 110.002 179.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 94.65 39.38 4.7 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.433 -1.467 . . . . 0.33 109.433 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -168.24 -51.1 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.339 -1.095 . . . . 0.33 110.036 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -108.86 159.28 16.92 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.339 -0.851 . . . . 0.27 110.135 179.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.402 ' CD1' ' N ' ' A' ' 176' ' ' TYR . 14.5 m-30 -113.0 85.27 7.75 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.215 -0.928 . . . . 0.34 110.097 179.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.474 ' O ' ' OD1' ' A' ' 202' ' ' ASP . 46.3 Cg_endo -73.69 -57.08 0.07 OUTLIER 'Trans proline' 0 C--N 1.303 -1.825 0 O-C-N 123.993 1.523 . . . . 0.47 110.386 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.61 ' CE1' ' HG3' ' A' ' 170' ' ' LYS . 0.5 OUTLIER -57.96 135.37 56.92 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.254 -0.904 . . . . 0.35 110.698 -179.694 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.483 ' N ' ' OD2' ' A' ' 204' ' ' ASP . 3.2 p30 179.97 79.08 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 119.206 -0.997 . . . . 0.2 111.602 178.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.573 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.2 -161.33 0.01 OUTLIER Glycine 0 N--CA 1.494 2.52 0 N-CA-C 110.247 -1.141 . . . . 0.25 110.247 179.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.511 ' HA ' ' OE2' ' A' ' 205' ' ' GLU . 49.6 Cg_endo -80.11 44.01 1.64 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.086 1.572 . . . . 0.44 110.157 179.652 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.515 ' O ' ' N ' ' A' ' 184' ' ' LEU . 4.7 m -81.08 177.66 8.9 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.095 -1.003 . . . . 0.57 110.231 -179.715 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.513 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -62.74 71.32 0.03 OUTLIER Glycine 0 N--CA 1.487 2.098 0 N-CA-C 109.892 -1.283 . . . . 0.49 109.892 -179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 0.992 ' HA ' HG13 ' A' ' 1' ' ' HAV . 0.7 OUTLIER 179.58 95.31 0.02 OUTLIER 'General case' 0 C--N 1.295 -1.801 0 O-C-N 121.303 -1.116 . . . . 0.41 110.202 -179.798 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.484 ' HB3' ' OB2' ' A' ' 3' ' ' MSB . 6.7 tt -114.0 -18.41 11.73 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.708 -1.245 . . . . 0.3 111.375 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.934 ' HB1' ' CG ' ' A' ' 223' ' ' GLU . . . -151.0 105.76 3.28 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.493 -1.379 . . . . 0.2 112.001 -179.426 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.604 ' CD2' ' HB2' ' A' ' 200' ' ' HIS . 0.5 OUTLIER -115.08 119.81 37.7 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.365 -0.835 . . . . 0.16 109.485 178.797 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.877 ' HB2' ' CD ' ' A' ' 223' ' ' GLU . . . -109.68 142.03 41.43 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.981 -1.075 . . . . 0.23 110.691 -179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.463 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 0.3 OUTLIER -72.56 168.94 19.34 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.239 -0.913 . . . . 0.38 110.327 179.641 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.453 ' HD2' ' CD2' ' A' ' 189' ' ' PHE . 46.6 Cg_endo -74.69 137.87 23.07 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.04 1.547 . . . . 0.4 109.502 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.473 ' HG2' ' CD2' ' A' ' 111' ' ' LEU . 43.3 Cg_endo -70.8 82.1 1.01 Allowed 'Trans proline' 0 C--N 1.303 -1.82 0 O-C-N 123.85 1.447 . . . . 0.32 110.569 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -124.64 -99.72 1.29 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.396 -1.482 . . . . 0.32 109.396 179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -71.94 -162.96 0.12 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 123.996 1.524 . . . . 0.47 110.241 179.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -65.58 -11.82 47.55 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.103 -0.998 . . . . 0.63 109.991 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -106.42 60.89 0.64 Allowed 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.557 -0.714 . . . . 0.53 110.058 -179.855 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.473 ' O ' ' N ' ' A' ' 198' ' ' ASP . . . -134.33 177.07 19.46 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 108.559 -1.816 . . . . 0.25 108.559 179.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.53 ' HA2' ' HB2' ' A' ' 227' ' ' SER . . . 41.83 25.88 0.25 Allowed Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.808 -1.317 . . . . 0.1 109.808 -179.766 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.473 ' N ' ' O ' ' A' ' 196' ' ' GLY . 72.7 m-20 -79.71 91.77 5.32 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.962 -1.316 . . . . 0.1 109.898 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.746 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -67.38 111.69 4.19 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.302 -0.874 . . . . 0.09 110.421 -179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.604 ' HB2' ' CD2' ' A' ' 187' ' ' HIS . 31.2 m170 -121.6 126.43 49.07 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.386 -0.821 . . . . 0.09 110.2 -179.758 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.536 ' O ' ' N ' ' A' ' 203' ' ' ASP . 23.2 m-85 -98.1 137.63 36.61 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.939 -1.1 . . . . 0.1 110.674 179.751 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.731 ' OD1' HD23 ' A' ' 184' ' ' LEU . 1.1 m-20 -49.19 92.38 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.324 -0.86 . . . . 0.14 108.889 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.576 ' HA ' ' CH2' ' A' ' 207' ' ' TRP . 1.4 p30 -35.94 -30.19 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.464 -0.772 . . . . 0.18 111.663 -178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.573 ' CB ' ' N ' ' A' ' 180' ' ' GLY . 9.4 m-20 -79.06 2.07 21.92 Favored 'General case' 0 N--CA 1.487 1.425 0 O-C-N 120.59 -1.319 . . . . 0.24 111.245 -179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.52 ' N ' ' O ' ' A' ' 202' ' ' ASP . 29.4 mm-40 -95.95 -162.51 0.96 Allowed 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.982 -1.074 . . . . 0.42 110.155 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 29.8 m -125.81 148.53 49.1 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.112 -0.992 . . . . 0.47 110.529 -179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.576 ' CH2' ' HA ' ' A' ' 203' ' ' ASP . 1.5 m-90 -142.27 142.85 32.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.267 -0.896 . . . . 0.27 109.785 179.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 1.028 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -155.37 174.3 15.42 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.954 -1.091 . . . . 0.3 110.722 179.61 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.437 ' O ' ' OG ' ' A' ' 209' ' ' SER . 1.1 t -129.27 21.97 5.66 Favored 'General case' 0 C--N 1.303 -1.454 0 N-CA-C 108.649 -0.871 . . . . 0.61 108.649 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.454 ' OG ' ' N ' ' A' ' 211' ' ' SER . 0.4 OUTLIER -99.2 -81.47 0.45 Allowed 'General case' 0 C--N 1.302 -1.459 0 CA-C-O 121.712 0.767 . . . . 0.78 110.376 -179.547 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.454 ' N ' ' OG ' ' A' ' 210' ' ' SER . 1.7 p -171.77 -35.32 0.02 OUTLIER 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 108.958 -0.756 . . . . 0.91 108.958 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . 0.442 ' HG3' ' O ' ' A' ' 212' ' ' LYS . 0.0 OUTLIER -80.06 139.81 36.77 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.469 -0.769 . . . . 0.93 109.538 179.241 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.04 -154.96 32.48 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 108.935 -1.666 . . . . 0.79 108.935 -179.527 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.491 ' CE2' ' CE1' ' A' ' 244' ' ' TYR . 60.0 m-85 -93.77 117.25 29.85 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.087 -1.243 . . . . 0.69 109.555 179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.62 ' O ' HG12 ' A' ' 219' ' ' VAL . 46.9 m-80 -81.4 122.4 27.44 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 120.946 -1.096 . . . . 0.4 109.028 179.581 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 1.028 HD22 ' O ' ' A' ' 208' ' ' THR . 0.3 OUTLIER -42.28 -37.42 1.5 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.264 -0.898 . . . . 0.17 109.937 -179.539 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.582 ' N ' ' CD1' ' A' ' 217' ' ' PHE . 2.3 m-30 -51.98 -48.74 64.23 Favored 'General case' 0 C--N 1.291 -1.973 0 N-CA-C 107.423 -1.325 . . . . 0.28 107.423 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.817 HD21 ' HB2' ' A' ' 244' ' ' TYR . 0.2 OUTLIER -73.34 -73.57 0.21 Allowed 'General case' 0 C--N 1.296 -1.732 0 CA-C-N 115.819 -0.628 . . . . 0.46 109.906 178.464 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.913 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.6 OUTLIER -47.77 -71.67 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.195 -0.941 . . . . 0.39 110.043 179.958 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.91 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -41.61 -51.28 4.02 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.735 -1.228 . . . . 0.17 111.484 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.572 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -59.91 -33.51 71.96 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.249 -1.532 . . . . 0.1 109.045 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.638 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 5.3 t60 -71.63 -58.6 3.34 Favored 'General case' 0 C--N 1.299 -1.609 0 CA-C-O 121.311 0.577 . . . . 0.21 109.564 179.239 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.934 ' CG ' ' HB1' ' A' ' 186' ' ' ALA . 0.7 OUTLIER -55.87 -25.04 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 108.62 -0.882 . . . . 0.28 108.62 178.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.558 ' CE2' ' CE2' ' A' ' 142' ' ' PHE . 3.7 m-30 -72.11 -67.65 0.52 Allowed 'General case' 0 N--CA 1.49 1.561 0 CA-C-O 121.6 0.714 . . . . 0.18 109.261 179.001 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.43 ' O ' ' HA3' ' A' ' 229' ' ' GLY . . . -43.98 -27.25 0.99 Allowed Glycine 0 N--CA 1.488 2.125 0 N-CA-C 108.646 -1.782 . . . . 0.21 108.646 179.5 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.584 ' CE1' ' HG2' ' A' ' 240' ' ' MET . 0.0 OUTLIER -80.98 -58.41 3.09 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.355 -1.085 . . . . 0.17 110.348 179.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.772 ' HB3' ' HB1' ' A' ' 188' ' ' ALA . 0.4 OUTLIER -47.74 -45.39 28.92 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.668 -0.645 . . . . 0.33 111.794 -178.833 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.862 HD11 HD22 ' A' ' 118' ' ' LEU . 0.4 OUTLIER -100.54 -38.15 8.49 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.067 -1.02 . . . . 0.53 111.044 -178.75 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.543 ' O ' ' CB ' ' A' ' 111' ' ' LEU . . . -63.96 -77.2 0.24 Allowed Glycine 0 N--CA 1.49 2.243 0 N-CA-C 110.043 -1.223 . . . . 0.41 110.043 -179.506 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 0.774 HD12 ' O ' ' A' ' 109' ' ' ARG . 1.7 pt? -177.14 -162.82 0.08 Allowed 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.183 -1.187 . . . . 0.45 110.488 -179.398 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.5 ' N ' ' HG ' ' A' ' 230' ' ' LEU . 0.2 OUTLIER -62.5 -54.6 37.62 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.353 -0.842 . . . . 0.62 109.904 179.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.63 ' O ' HD11 ' A' ' 230' ' ' LEU . 2.2 m80 -163.71 178.26 8.04 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.364 -0.835 . . . . 0.45 110.379 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.464 ' HB2' ' O ' ' A' ' 232' ' ' HIS . 2.5 t 179.59 60.2 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.484 -0.76 . . . . 0.38 109.122 179.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.881 ' CB ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -144.61 22.13 1.64 Allowed 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 119.589 -0.844 . . . . 0.48 111.174 -178.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.525 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.8 OUTLIER -37.12 -49.13 2.19 Favored Pre-proline 0 N--CA 1.492 1.632 0 C-N-CA 119.759 -0.776 . . . . 0.38 110.775 -179.583 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.525 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 47.1 Cg_endo -89.41 -46.69 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.738 1.389 . . . . 0.28 111.586 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 257' ' ' ASP . . . 177.66 98.88 0.12 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 118.971 -1.585 . . . . 0.24 111.91 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.881 ' HB3' ' CB ' ' A' ' 234' ' ' LYS . . . -149.22 165.5 31.69 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.39 -1.065 . . . . 0.28 110.012 178.468 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.617 HD21 ' CA ' ' A' ' 222' ' ' HIS . 0.3 OUTLIER -79.32 55.63 1.93 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.077 -1.015 . . . . 0.4 108.837 179.189 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.638 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 14.0 mtt -137.96 -24.41 1.01 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.403 -0.81 . . . . 0.45 110.998 -179.46 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.583 ' CZ ' ' O ' ' A' ' 238' ' ' ALA . 0.1 OUTLIER -60.05 171.35 0.93 Allowed Pre-proline 0 N--CA 1.501 2.118 0 O-C-N 120.7 -1.25 . . . . 0.57 109.962 179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.553 ' HD2' ' HB2' ' A' ' 241' ' ' PHE . 42.8 Cg_endo -69.48 -4.69 14.34 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 O-C-N 123.377 1.198 . . . . 0.76 110.128 179.512 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.582 ' O ' ' CD1' ' A' ' 241' ' ' PHE . 10.2 mm -100.43 148.47 6.79 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.305 -0.872 . . . . 0.89 109.689 179.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.84 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 35.0 p90 -133.35 -27.46 1.57 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.095 -1.003 . . . . 0.78 111.174 -179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.729 HG23 ' H ' ' A' ' 246' ' ' TYR . 0.1 OUTLIER 3.27 -69.26 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.413 0 N-CA-C 113.642 0.978 . . . . 0.61 113.642 -179.055 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.729 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -66.32 129.82 41.11 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 120.348 -1.47 . . . . 0.74 109.676 -179.487 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.99 -161.17 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.461 -0.774 . . . . 0.81 110.202 -179.757 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.474 ' O ' ' CG ' ' A' ' 249' ' ' LYS . . . -86.93 10.89 66.39 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.427 -1.469 . . . . 0.56 109.427 179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . 0.474 ' CG ' ' O ' ' A' ' 248' ' ' GLY . 0.0 OUTLIER -177.59 30.92 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.234 -1.156 . . . . 0.37 110.37 179.949 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.59 -32.88 73.08 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.054 -1.029 . . . . 0.44 110.167 -179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 9.7 t-160 -125.79 -88.42 0.58 Allowed 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.248 -0.907 . . . . 0.53 110.174 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.521 ' O ' ' CG ' ' A' ' 253' ' ' MET . 0.0 OUTLIER -164.18 92.59 0.66 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.363 -0.836 . . . . 0.38 110.387 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.762 ' HB2' HG21 ' A' ' 259' ' ' VAL . 3.1 ptt? 36.09 47.77 0.48 Allowed 'General case' 0 C--N 1.294 -1.821 0 O-C-N 121.544 -0.722 . . . . 0.19 111.596 179.24 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.704 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.9 tp -47.65 -44.69 56.84 Favored Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 118.862 -1.135 . . . . 0.28 107.958 177.693 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.704 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 40.0 Cg_endo -73.1 49.62 1.67 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 O-C-N 123.646 1.34 . . . . 0.49 111.055 178.082 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.604 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 3.6 m-20 -47.48 -32.41 5.16 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 120.754 -1.216 . . . . 0.49 110.318 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.875 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.4 OUTLIER -55.57 -49.81 71.72 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 121.131 -0.981 . . . . 0.31 109.821 -179.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 1.011 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.0 OUTLIER -73.66 -32.08 63.8 Favored 'General case' 0 C--N 1.298 -1.672 0 C-N-CA 119.448 -0.901 . . . . 0.14 108.615 179.197 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.762 HG21 ' HB2' ' A' ' 253' ' ' MET . 71.1 t -66.72 -82.75 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.616 -0.677 . . . . 0.17 110.061 179.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.61 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 5.0 tt0 -55.92 -40.9 73.76 Favored 'General case' 0 C--N 1.301 -1.509 0 O-C-N 121.306 -0.871 . . . . 0.26 109.247 179.571 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.513 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -42.29 -70.65 0.45 Allowed Glycine 0 N--CA 1.489 2.219 0 N-CA-C 110.113 -1.195 . . . . 0.19 110.113 -179.831 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 1.011 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.0 OUTLIER -74.24 -21.01 17.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.952 -1.322 . . . . 0.22 110.342 -179.326 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 1.006 ' N ' HD13 ' A' ' 262' ' ' ILE . 47.7 tt0 -64.05 -20.36 65.88 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.904 -1.118 . . . . 0.39 108.422 179.111 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 18.8 t -103.42 -42.45 5.7 Favored 'General case' 0 N--CA 1.49 1.564 0 C-N-CA 120.249 -0.58 . . . . 0.47 111.347 -179.572 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.867 HD23 ' CD ' ' A' ' 112' ' ' LYS . 4.2 mp -87.32 -45.64 10.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.141 -0.974 . . . . 0.48 111.202 -178.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.655 ' OH ' HD12 ' A' ' 228' ' ' LEU . 0.0 OUTLIER -79.08 -5.11 53.26 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.209 -0.932 . . . . 0.41 109.948 -179.823 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.51 ' O ' ' HG3' ' A' ' 116' ' ' MET . . . -58.65 -72.28 0.63 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.608 -1.397 . . . . 0.46 109.608 -179.844 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -86.9 142.54 6.64 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.987 1.52 . . . . 0.58 110.761 -179.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.556 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -105.46 121.76 6.95 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.498 -1.441 . . . . 0.64 109.498 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.616 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.2 OUTLIER -86.63 -69.62 0.66 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.107 -1.231 . . . . 0.95 110.149 179.932 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.522 ' CB ' ' OG ' ' A' ' 114' ' ' SER . 0.5 OUTLIER 54.38 30.97 13.61 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.213 -0.929 . . . . 1.2 110.087 179.874 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.4 t0 -101.61 113.36 65.85 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 1.2 109.829 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -71.92 75.16 2.24 Favored 'Trans proline' 0 C--N 1.306 -1.694 0 O-C-N 123.966 1.508 . . . . 1.06 110.576 -179.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 . . . . . 0 N--CA 1.492 1.636 0 CA-C-O 117.986 -1.007 . . . . 0.78 110.179 179.931 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 0.992 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.569 ' CG ' ' HB ' ' A' ' 1' ' ' HAV . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.84 ' HH2' ' CB ' ' A' ' 244' ' ' TYR . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.656 0 CA-C-O 121.286 0.565 . . . . 0.41 110.263 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -121.24 73.74 1.06 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.268 -0.895 . . . . 0.26 110.126 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.541 HG12 ' H ' ' A' ' 107' ' ' PHE . 11.9 t -96.95 176.98 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.22 -0.925 . . . . 0.33 110.3 -179.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . 0.541 ' H ' HG12 ' A' ' 106' ' ' VAL . 50.1 m-85 -45.29 107.71 0.68 Allowed Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.257 -0.902 . . . . 0.65 110.304 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' PRO . . . . . 0.475 ' O ' ' HG3' ' A' ' 109' ' ' ARG . 47.1 Cg_endo -73.83 114.49 4.05 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.994 1.523 . . . . 0.84 110.558 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 230' ' ' LEU . 10.8 mtp180 -142.62 -48.49 0.34 Allowed 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.394 -0.816 . . . . 0.93 109.852 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' THR . . . . . 0.679 HG22 ' HE2' ' A' ' 112' ' ' LYS . 1.0 OUTLIER -28.9 -57.34 0.13 Allowed 'General case' 0 N--CA 1.5 2.046 0 CA-C-O 121.482 0.658 . . . . 1.03 111.488 -179.915 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.705 HD23 ' CG ' ' A' ' 191' ' ' PRO . 0.7 OUTLIER 40.73 48.49 2.65 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.268 -0.895 . . . . 1.04 111.471 179.768 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.679 ' HE2' HG22 ' A' ' 110' ' ' THR . 4.1 pttt -146.82 79.07 1.51 Allowed 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.263 -0.898 . . . . 0.77 109.113 179.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TRP . . . . . 0.616 ' CD1' ' HB2' ' A' ' 270' ' ' ASP . 7.6 t90 -143.89 -70.1 0.31 Allowed 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.175 -0.953 . . . . 0.42 111.398 -178.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' SER . . . . . 0.555 ' O ' ' CG ' ' A' ' 115' ' ' LYS . 93.6 p -96.95 63.0 1.89 Allowed 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.115 -0.99 . . . . 0.44 111.015 -178.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.555 ' CG ' ' O ' ' A' ' 114' ' ' SER . 14.2 mttm -159.59 53.56 0.37 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.361 -0.837 . . . . 0.49 110.082 179.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' MET . . . . . 0.464 ' HB2' ' HA3' ' A' ' 269' ' ' GLY . 0.0 OUTLIER -60.79 -19.89 60.37 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.224 -0.922 . . . . 0.3 110.408 -179.858 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -138.34 156.2 47.84 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.089 -1.007 . . . . 0.15 110.446 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.514 ' O ' ' HA ' ' A' ' 153' ' ' PHE . 0.0 OUTLIER -166.09 -174.61 3.03 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.13 110.127 179.807 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' THR . . . . . 0.88 HG22 ' O ' ' A' ' 154' ' ' THR . 0.2 OUTLIER -128.47 149.26 50.65 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.181 -0.949 . . . . 0.12 110.11 179.963 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' TYR . . . . . 0.663 ' HB3' HG23 ' A' ' 163' ' ' ILE . 23.1 p90 -149.87 165.12 33.51 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.225 -0.922 . . . . 0.33 111.18 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.5 ' HB2' ' HB3' ' A' ' 164' ' ' MET . 0.2 OUTLIER -118.08 150.91 38.54 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.34 -0.85 . . . . 0.54 109.89 179.651 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ILE . . . . . 0.897 ' O ' HG13 ' A' ' 123' ' ' VAL . 0.2 OUTLIER -115.65 124.76 72.43 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.74 0 O-C-N 121.282 -0.886 . . . . 0.33 110.543 -179.871 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' VAL . . . . . 0.897 HG13 ' O ' ' A' ' 122' ' ' ILE . 0.4 OUTLIER -168.76 43.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 121.306 -0.871 . . . . 0.27 109.932 179.589 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASN . . . . . 0.477 ' O ' ' HB2' ' A' ' 125' ' ' TYR . 5.3 t-20 -40.79 -79.51 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.419 -0.801 . . . . 0.41 109.501 179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TYR . . . . . 0.685 ' O ' HG21 ' A' ' 134' ' ' VAL . 3.7 t80 -179.35 -164.92 0.07 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.385 -0.822 . . . . 0.4 109.553 179.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' THR . . . . . 0.592 HG23 ' HA ' ' A' ' 130' ' ' THR . 1.8 m -148.12 46.78 0.48 Allowed Pre-proline 0 N--CA 1.492 1.669 0 O-C-N 120.913 -1.117 . . . . 0.45 110.864 179.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 126' ' ' THR . 44.1 Cg_endo -74.03 -85.92 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.896 1.472 . . . . 0.36 110.109 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -89.26 -4.46 58.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.173 -0.955 . . . . 0.25 109.689 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' MET . . . . . 0.781 ' SD ' HD21 ' A' ' 216' ' ' LEU . 1.2 ptm -122.85 171.87 8.88 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.363 -0.836 . . . . 0.39 110.107 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' THR . . . . . 0.592 ' HA ' HG23 ' A' ' 126' ' ' THR . 0.2 OUTLIER -119.66 171.63 8.25 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.353 -0.842 . . . . 0.48 109.768 179.848 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' HIS . . . . . 0.406 ' C ' ' O ' ' A' ' 130' ' ' THR . 0.1 OUTLIER -45.74 -28.23 0.99 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.036 -1.04 . . . . 0.4 109.715 179.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.531 ' O ' ' CB ' ' A' ' 135' ' ' GLU . 0.4 OUTLIER -67.31 -58.28 5.1 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.327 -0.858 . . . . 0.46 109.464 179.418 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' GLU . . . . . 0.529 ' O ' ' N ' ' A' ' 136' ' ' LYS . 25.4 mp0 -55.82 -55.32 33.84 Favored 'General case' 0 C--N 1.305 -1.344 0 O-C-N 121.24 -0.913 . . . . 0.47 108.775 179.266 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' VAL . . . . . 0.685 HG21 ' O ' ' A' ' 125' ' ' TYR . 4.9 t -46.19 -34.77 2.12 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.646 0 N-CA-C 107.826 -1.176 . . . . 0.31 107.826 178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' GLU . . . . . 0.579 ' HA ' ' CD2' ' A' ' 138' ' ' PHE . 8.1 tt0 -59.37 -42.48 91.73 Favored 'General case' 0 N--CA 1.485 1.294 0 N-CA-C 107.782 -1.192 . . . . 0.48 107.782 178.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.575 ' HG2' ' CE1' ' A' ' 217' ' ' PHE . 23.4 tttt -70.65 -47.59 59.22 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.185 0.993 . . . . 0.64 108.456 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.872 ' HB1' ' CB ' ' A' ' 216' ' ' LEU . . . -49.26 -62.22 1.66 Allowed 'General case' 0 C--N 1.289 -2.046 0 O-C-N 121.566 -0.709 . . . . 0.42 110.217 179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.636 ' CG ' ' N ' ' A' ' 139' ' ' LYS . 0.1 OUTLIER -66.89 -52.51 42.45 Favored 'General case' 0 C--N 1.298 -1.661 0 O-C-N 121.41 -0.806 . . . . 0.34 110.842 -179.267 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' LYS . . . . . 0.636 ' N ' ' CG ' ' A' ' 138' ' ' PHE . 1.0 OUTLIER -64.52 -72.9 0.13 Allowed 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.976 -1.077 . . . . 0.47 110.555 -179.403 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' LYS . . . . . 0.557 ' HD3' ' CE1' ' A' ' 217' ' ' PHE . 0.0 OUTLIER -41.5 -58.68 1.83 Allowed 'General case' 0 C--N 1.291 -1.971 0 O-C-N 121.581 -0.699 . . . . 0.47 110.383 179.254 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ALA . . . . . 0.581 ' CB ' ' O ' ' A' ' 137' ' ' ALA . . . -47.81 -35.4 10.09 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 118.564 -1.254 . . . . 0.25 108.351 178.772 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' PHE . . . . . 0.519 ' N ' ' O ' ' A' ' 139' ' ' LYS . 0.3 OUTLIER -73.63 -39.35 64.58 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.443 -0.786 . . . . 0.35 109.117 178.823 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' LYS . . . . . . . . . . . . . 6.5 tttt -56.03 -38.82 71.06 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.08 -1.012 . . . . 0.7 108.455 178.89 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 69.9 t -68.92 -45.28 80.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 109.112 -0.699 . . . . 0.61 109.112 178.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' TRP . . . . . 0.866 ' HH2' HG21 ' A' ' 262' ' ' ILE . 50.4 t-105 -57.11 -35.31 69.29 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.439 -0.788 . . . . 0.39 108.895 179.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 149' ' ' THR . 1.7 m -75.73 -39.64 56.94 Favored 'General case' 0 C--N 1.303 -1.416 0 O-C-N 121.327 -0.858 . . . . 0.35 108.788 178.71 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -55.7 -40.74 72.81 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.567 -0.708 . . . . 0.36 109.51 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' VAL . . . . . 0.564 HG23 HG22 ' A' ' 149' ' ' THR . 27.6 m -75.78 -33.38 25.81 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.392 -0.817 . . . . 0.5 109.781 179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . 0.626 HG22 ' O ' ' A' ' 145' ' ' TRP . 9.9 t -147.2 147.33 28.44 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.168 -0.958 . . . . 0.51 110.621 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -75.67 58.69 5.39 Favored 'Trans proline' 0 C--N 1.306 -1.688 0 O-C-N 123.948 1.499 . . . . 0.31 110.222 179.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . 0.946 HD13 ' N ' ' A' ' 152' ' ' ASN . 1.4 tm? -84.0 139.46 32.52 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.288 -0.882 . . . . 0.18 110.341 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ASN . . . . . 0.946 ' N ' HD13 ' A' ' 151' ' ' LEU . 1.2 m-20 -104.26 139.2 39.61 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.325 -0.859 . . . . 0.17 110.118 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' PHE . . . . . 0.59 ' HB2' ' CE1' ' A' ' 120' ' ' TYR . 2.1 p90 -151.24 155.95 39.87 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.25 -0.906 . . . . 0.14 110.593 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.88 ' O ' HG22 ' A' ' 119' ' ' THR . 7.3 m -152.9 131.05 11.92 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.406 -0.809 . . . . 0.15 109.943 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ARG . . . . . 0.572 ' HG3' ' CE1' ' A' ' 120' ' ' TYR . 5.2 mtm180 -96.62 82.47 3.33 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.145 -0.972 . . . . 0.2 110.595 -179.514 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.673 HD23 HD13 ' A' ' 160' ' ' ILE . 1.6 mp -74.98 83.34 2.23 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.155 -0.965 . . . . 0.22 109.71 179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' HIS . . . . . 0.432 ' O ' ' C ' ' A' ' 158' ' ' ASP . 7.7 p-80 -42.82 -26.84 0.15 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.194 -0.941 . . . . 0.32 110.16 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.515 ' OD1' ' CD1' ' A' ' 160' ' ' ILE . 0.2 OUTLIER -41.14 -37.87 0.97 Allowed 'General case' 0 C--N 1.3 -1.567 0 O-C-N 121.616 -0.677 . . . . 0.33 109.768 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' GLY . . . . . . . . . . . . . . . 134.38 33.71 0.3 Allowed Glycine 0 N--CA 1.489 2.186 0 N-CA-C 109.879 -1.288 . . . . 0.28 109.879 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ILE . . . . . 0.673 HD13 HD23 ' A' ' 156' ' ' LEU . 2.7 mp -127.83 65.67 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 121.12 -1.223 . . . . 0.3 109.507 179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ALA . . . . . 0.503 ' HA ' ' HB ' ' A' ' 119' ' ' THR . . . -122.36 144.38 49.06 Favored 'General case' 0 C--N 1.299 -1.609 0 C-N-CA 120.232 -0.587 . . . . 0.2 110.364 -179.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' ASP . . . . . 0.426 ' HB2' HD23 ' A' ' 118' ' ' LEU . 0.7 OUTLIER -107.6 -36.54 6.42 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.283 -0.885 . . . . 0.1 110.205 179.982 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ILE . . . . . 0.972 HD12 ' HB2' ' A' ' 227' ' ' SER . 0.4 OUTLIER -127.57 156.87 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 121.132 -0.98 . . . . 0.1 110.001 179.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' MET . . . . . 0.818 ' O ' ' HB3' ' A' ' 199' ' ' ALA . 13.7 ptm -163.94 160.45 22.0 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.42 -1.425 . . . . 0.11 111.564 -179.501 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . 0.671 ' O ' HG23 ' A' ' 165' ' ' ILE . 0.8 OUTLIER -106.75 119.41 56.26 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.46 -0.775 . . . . 0.1 109.985 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' SER . . . . . 0.872 ' HB3' HG23 ' A' ' 123' ' ' VAL . 11.6 p -158.68 146.01 17.7 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.001 -1.062 . . . . 0.1 110.389 179.861 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' PHE . . . . . 0.599 ' O ' ' CG ' ' A' ' 167' ' ' PHE . 10.4 p90 -66.34 114.24 5.24 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.326 -0.859 . . . . 0.09 109.667 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' GLY . . . . . 0.459 ' O ' ' HB3' ' A' ' 203' ' ' ASP . . . -73.49 119.81 6.74 Favored Glycine 0 N--CA 1.489 2.201 0 N-CA-C 110.225 -1.15 . . . . 0.2 110.225 -179.209 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ILE . . . . . 0.748 ' O ' HG23 ' A' ' 169' ' ' ILE . 0.0 OUTLIER -110.05 103.25 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 O-C-N 121.48 -1.012 . . . . 0.55 109.311 179.013 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . 0.597 ' HB2' ' CE1' ' A' ' 178' ' ' PHE . 2.0 tmtt? 1.26 85.41 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 CA-C-O 121.32 0.581 . . . . 0.85 112.317 -179.248 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.475 ' O ' ' CG ' ' A' ' 171' ' ' GLU . 1.9 tm-20 -137.17 5.21 2.75 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.305 -0.872 . . . . 0.71 110.218 179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -87.14 -87.99 0.14 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.134 -0.978 . . . . 0.42 110.284 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' GLY . . . . . . . . . . . . . . . 134.13 -34.86 2.32 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.165 -1.574 . . . . 0.33 109.165 -179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ASP . . . . . . . . . . . . . 7.2 t70 -62.53 -31.25 72.0 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.307 -1.114 . . . . 0.33 110.153 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' PHE . . . . . 0.419 ' O ' ' HD3' ' A' ' 177' ' ' PRO . 2.4 t80 -172.52 116.34 0.32 Allowed 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.323 -0.861 . . . . 0.27 110.183 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' TYR . . . . . 0.414 ' N ' ' CD1' ' A' ' 176' ' ' TYR . 11.3 m-30 -47.14 105.72 0.51 Allowed Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.245 -0.909 . . . . 0.34 110.192 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' PRO . . . . . 0.472 ' O ' ' OD2' ' A' ' 179' ' ' ASP . 44.2 Cg_endo -74.18 -61.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.902 1.475 . . . . 0.47 110.422 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 170' ' ' LYS . 0.7 OUTLIER -55.23 144.49 24.38 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.276 -0.89 . . . . 0.35 110.64 179.994 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 182' ' ' SER . 2.7 p30 179.12 80.84 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.396 -0.815 . . . . 0.2 110.093 179.029 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.532 ' N ' ' CB ' ' A' ' 204' ' ' ASP . . . 39.82 -154.54 0.04 OUTLIER Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.335 -1.506 . . . . 0.25 109.335 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' PRO . . . . . 0.475 ' O ' ' O ' ' A' ' 182' ' ' SER . 53.3 Cg_endo -79.63 11.29 2.76 Favored 'Trans proline' 0 C--N 1.302 -1.88 0 O-C-N 123.994 1.523 . . . . 0.44 110.393 179.433 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' SER . . . . . 0.496 ' HB2' ' O ' ' A' ' 179' ' ' ASP . 0.8 OUTLIER -45.28 174.08 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.353 -0.842 . . . . 0.57 110.669 -179.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' GLY . . . . . 0.582 ' CA ' ' HE1' ' A' ' 2' ' ' 3MP . . . -64.71 72.34 0.07 OUTLIER Glycine 0 N--CA 1.487 2.066 0 N-CA-C 110.795 -0.922 . . . . 0.49 110.795 -179.414 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' LEU . . . . . 1.051 ' HA ' HG13 ' A' ' 1' ' ' HAV . 4.4 tt 179.52 92.32 0.02 OUTLIER 'General case' 0 C--N 1.299 -1.596 0 O-C-N 121.191 -1.182 . . . . 0.41 110.322 179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' LEU . . . . . 0.583 HD12 ' OE1' ' A' ' 205' ' ' GLU . 4.1 tt -110.15 -23.84 11.05 Favored 'General case' 0 N--CA 1.493 1.712 0 C-N-CA 118.561 -1.256 . . . . 0.3 111.471 179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' ALA . . . . . 0.622 ' N ' ' OB2' ' A' ' 3' ' ' MSB . . . -150.9 103.3 3.05 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 120.521 -1.362 . . . . 0.2 112.065 -179.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' HIS . . . . . 0.551 ' NE2' ' HB2' ' A' ' 200' ' ' HIS . 1.5 p80 -103.0 141.12 36.34 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.936 -1.103 . . . . 0.16 109.683 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ALA . . . . . 0.943 ' HB1' ' CB ' ' A' ' 227' ' ' SER . . . -123.78 128.04 48.97 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.068 -1.02 . . . . 0.23 110.478 -179.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 198' ' ' ASP . 1.0 OUTLIER -75.25 169.78 18.78 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.267 -0.896 . . . . 0.38 110.337 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.496 ' O ' ' CA ' ' A' ' 196' ' ' GLY . 47.8 Cg_endo -75.08 134.51 17.76 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.119 1.589 . . . . 0.4 109.792 179.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' PRO . . . . . 0.705 ' CG ' HD23 ' A' ' 111' ' ' LEU . 43.9 Cg_endo -70.62 73.53 1.76 Allowed 'Trans proline' 0 C--N 1.304 -1.774 0 O-C-N 123.962 1.506 . . . . 0.32 110.431 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . . . . . . . . . . . -116.87 -98.09 2.02 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.632 -1.387 . . . . 0.32 109.632 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -72.04 -161.15 0.1 OUTLIER 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.988 1.52 . . . . 0.47 110.045 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -67.75 -9.41 43.74 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.097 -1.002 . . . . 0.63 110.237 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -107.53 55.86 0.64 Allowed 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.387 -0.821 . . . . 0.53 110.23 -179.634 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' GLY . . . . . 0.496 ' CA ' ' O ' ' A' ' 190' ' ' PRO . . . -130.07 174.87 19.41 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.185 -1.566 . . . . 0.25 109.185 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 227' ' ' SER . . . 43.55 24.63 0.43 Allowed Glycine 0 N--CA 1.489 2.171 0 N-CA-C 109.971 -1.252 . . . . 0.1 109.971 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.479 ' HB2' ' HB2' ' A' ' 189' ' ' PHE . 0.1 OUTLIER -78.18 92.02 4.4 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.126 -1.22 . . . . 0.1 110.604 -179.805 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' ALA . . . . . 0.818 ' HB3' ' O ' ' A' ' 164' ' ' MET . . . -73.36 99.47 2.94 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.324 -0.86 . . . . 0.09 109.779 179.614 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' HIS . . . . . 0.551 ' HB2' ' NE2' ' A' ' 187' ' ' HIS . 20.9 m170 -112.58 138.59 49.14 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.363 -0.836 . . . . 0.09 110.388 -179.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 203' ' ' ASP . 25.8 m-85 -105.74 137.52 43.48 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.28 -0.888 . . . . 0.1 110.526 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ASP . . . . . 0.862 ' OD1' HD22 ' A' ' 184' ' ' LEU . 0.5 OUTLIER -49.47 93.1 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 108.092 -1.077 . . . . 0.14 108.092 178.529 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' ASP . . . . . 0.554 ' N ' ' O ' ' A' ' 201' ' ' PHE . 2.5 p30 -36.07 -28.03 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.627 0 C-N-CA 120.1 -0.64 . . . . 0.18 111.967 -177.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 202' ' ' ASP . 32.0 m-20 -80.58 6.36 12.8 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 120.739 -1.225 . . . . 0.24 111.006 -179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' GLU . . . . . 0.583 ' OE1' HD12 ' A' ' 185' ' ' LEU . 16.8 mm-40 -97.91 -167.07 1.46 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.922 -1.111 . . . . 0.42 110.226 179.859 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -125.0 143.86 50.68 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.121 -0.987 . . . . 0.47 110.446 -179.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' TRP . . . . . 0.524 ' HB3' HD11 ' A' ' 216' ' ' LEU . 0.9 OUTLIER -143.17 131.38 21.97 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.213 -0.93 . . . . 0.27 109.409 179.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' THR . . . . . 0.974 ' O ' HD22 ' A' ' 216' ' ' LEU . 0.1 OUTLIER -145.08 170.5 16.08 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.832 -1.167 . . . . 0.3 111.114 -179.931 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' SER . . . . . 0.631 ' HB2' HD23 ' A' ' 216' ' ' LEU . 17.4 t -130.92 26.71 4.94 Favored 'General case' 0 C--N 1.299 -1.615 0 CA-C-O 121.81 0.814 . . . . 0.61 108.956 178.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' SER . . . . . 0.498 ' OG ' ' N ' ' A' ' 211' ' ' SER . 1.4 t -89.09 -93.53 0.11 Allowed 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.752 -0.592 . . . . 0.78 110.272 -179.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' SER . . . . . 0.498 ' N ' ' OG ' ' A' ' 210' ' ' SER . 0.3 OUTLIER -155.41 18.52 0.41 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.175 -0.953 . . . . 0.91 110.156 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -153.64 -176.3 5.76 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.197 -0.94 . . . . 0.93 110.221 179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 55.8 -172.24 1.62 Allowed Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.256 -1.537 . . . . 0.79 109.256 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' TYR . . . . . 0.54 ' CE1' ' CE1' ' A' ' 244' ' ' TYR . 75.6 m-85 -68.22 101.68 1.22 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.123 -1.222 . . . . 0.69 109.734 179.68 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' ASN . . . . . 0.596 ' ND2' HG23 ' A' ' 247' ' ' THR . 64.8 m-80 -76.1 117.77 18.15 Favored 'General case' 0 C--N 1.305 -1.361 0 O-C-N 121.047 -1.033 . . . . 0.4 108.857 179.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' LEU . . . . . 0.974 HD22 ' O ' ' A' ' 208' ' ' THR . 0.4 OUTLIER -40.17 -36.73 0.54 Allowed 'General case' 0 C--N 1.304 -1.399 0 C-N-CA 119.911 -0.716 . . . . 0.17 110.528 -179.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' PHE . . . . . 0.575 ' CE1' ' HG2' ' A' ' 136' ' ' LYS . 2.3 m-85 -49.45 -49.79 43.75 Favored 'General case' 0 C--N 1.288 -2.096 0 C-N-CA 118.335 -1.346 . . . . 0.28 107.736 179.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' LEU . . . . . 0.55 ' HG ' ' CH ' ' A' ' 3' ' ' MSB . 47.5 tp -76.83 -68.64 0.58 Allowed 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 115.7 -0.682 . . . . 0.46 110.778 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' VAL . . . . . 0.95 HG13 ' HA ' ' A' ' 216' ' ' LEU . 0.8 OUTLIER -50.89 -66.69 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.129 -0.982 . . . . 0.39 109.718 -179.645 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ALA . . . . . 0.922 ' HB3' ' O ' ' A' ' 216' ' ' LEU . . . -44.25 -49.69 9.18 Favored 'General case' 0 C--N 1.294 -1.836 0 O-C-N 120.727 -1.233 . . . . 0.17 110.653 178.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' ALA . . . . . 0.542 ' CB ' ' O ' ' A' ' 217' ' ' PHE . . . -64.73 -23.1 67.14 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.535 -1.353 . . . . 0.1 109.194 179.741 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.621 ' CE1' ' HA ' ' A' ' 240' ' ' MET . 6.0 t60 -79.97 -55.7 4.78 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.186 0.517 . . . . 0.21 109.778 -179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' GLU . . . . . 0.773 ' OE1' ' HB1' ' A' ' 199' ' ' ALA . 29.1 tt0 -58.75 -43.65 90.34 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.127 -0.983 . . . . 0.28 108.71 178.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.571 ' CZ ' ' HB ' ' A' ' 165' ' ' ILE . 2.7 m-85 -58.42 -60.36 3.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.325 -0.86 . . . . 0.18 109.46 178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.431 ' C ' ' O ' ' A' ' 224' ' ' PHE . . . -43.93 -31.33 1.94 Allowed Glycine 0 N--CA 1.487 2.052 0 N-CA-C 109.18 -1.568 . . . . 0.21 109.18 179.572 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' HIS . . . . . 0.529 ' CD2' ' O1 ' ' A' ' 1' ' ' HAV . 1.4 m80 -78.58 -74.77 0.26 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.107 -1.231 . . . . 0.17 110.679 179.879 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' SER . . . . . 0.972 ' HB2' HD12 ' A' ' 163' ' ' ILE . 0.0 OUTLIER -41.18 -36.67 0.78 Allowed 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.385 0.513 . . . . 0.33 112.385 -178.531 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' LEU . . . . . 0.682 ' HB2' HD13 ' A' ' 163' ' ' ILE . 0.3 OUTLIER -101.39 -35.06 9.35 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.81 -1.181 . . . . 0.53 112.172 -178.173 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' GLY . . . . . 0.433 ' HA2' ' CE2' ' A' ' 266' ' ' TYR . . . -85.36 -87.52 0.94 Allowed Glycine 0 N--CA 1.491 2.363 0 O-C-N 120.97 -1.081 . . . . 0.41 111.442 -178.443 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' LEU . . . . . 1.064 ' O ' HD13 ' A' ' 230' ' ' LEU . 0.0 OUTLIER -154.27 156.01 36.23 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.284 -1.127 . . . . 0.45 110.483 -178.335 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.897 ' N ' HD22 ' A' ' 230' ' ' LEU . 1.3 m-20 -37.08 -78.66 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.349 -0.844 . . . . 0.62 110.98 -178.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' HIS . . . . . 0.747 ' O ' HD21 ' A' ' 230' ' ' LEU . 6.3 m80 -143.12 161.39 38.34 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.247 -0.908 . . . . 0.45 110.588 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' SER . . . . . 0.44 ' HB2' HD11 ' A' ' 230' ' ' LEU . 1.0 OUTLIER -165.67 35.61 0.06 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.507 -0.746 . . . . 0.38 109.937 179.884 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' LYS . . . . . 0.61 ' CA ' ' HB3' ' A' ' 238' ' ' ALA . 0.0 OUTLIER -103.23 20.48 17.64 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.35 -0.844 . . . . 0.48 110.624 -179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' ASP . . . . . 0.611 ' CB ' ' HD3' ' A' ' 236' ' ' PRO . 0.2 OUTLIER -41.36 -60.15 1.95 Allowed Pre-proline 0 N--CA 1.492 1.649 0 C-N-CA 119.291 -0.964 . . . . 0.38 109.299 -179.898 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 235' ' ' ASP . 54.7 Cg_endo -81.07 -50.37 0.05 OUTLIER 'Trans proline' 0 C--N 1.307 -1.639 0 O-C-N 123.666 1.351 . . . . 0.28 109.742 178.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' GLY . . . . . 0.497 ' O ' ' HA ' ' A' ' 255' ' ' PRO . . . 177.37 93.49 0.09 OUTLIER Glycine 0 N--CA 1.496 2.691 0 C-N-CA 119.788 -1.196 . . . . 0.24 111.36 179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' ALA . . . . . 0.878 ' HB2' ' CB ' ' A' ' 257' ' ' ASP . . . -137.48 162.76 32.83 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 120.929 -1.336 . . . . 0.28 110.12 178.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' LEU . . . . . 0.586 ' N ' ' HB2' ' A' ' 255' ' ' PRO . 0.4 OUTLIER -73.22 57.36 0.49 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.195 -0.941 . . . . 0.4 109.275 -179.976 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' MET . . . . . 0.621 ' HA ' ' CE1' ' A' ' 222' ' ' HIS . 0.0 OUTLIER -140.37 -31.04 0.65 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.431 -0.793 . . . . 0.45 110.687 -179.753 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' PHE . . . . . 0.552 ' HB3' ' HG3' ' A' ' 234' ' ' LYS . 0.1 OUTLIER -42.0 167.22 0.06 OUTLIER Pre-proline 0 N--CA 1.498 1.938 0 O-C-N 120.953 -1.092 . . . . 0.57 110.553 179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 2' ' ' 3MP . 46.5 Cg_endo -74.23 -5.6 17.19 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.965 1.508 . . . . 0.76 109.605 179.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' ILE . . . . . 0.753 HG22 HG22 ' A' ' 245' ' ' THR . 19.4 mt -102.78 145.67 11.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.381 -0.824 . . . . 0.89 109.812 179.813 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' TYR . . . . . 0.596 ' CB ' ' HH2' ' A' ' 3' ' ' MSB . 45.8 p90 -128.65 -31.73 2.2 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.264 -0.898 . . . . 0.78 110.419 -179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' THR . . . . . 0.753 HG22 HG22 ' A' ' 243' ' ' ILE . 0.4 OUTLIER 2.17 -67.41 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 113.571 0.952 . . . . 0.61 113.571 -179.338 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' TYR . . . . . 0.745 ' H ' HG23 ' A' ' 245' ' ' THR . 0.0 OUTLIER -59.4 101.99 0.12 Allowed 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.478 -1.389 . . . . 0.74 109.415 -179.78 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.596 HG23 ' ND2' ' A' ' 215' ' ' ASN . 1.4 m -47.98 178.93 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.48 -0.763 . . . . 0.81 110.475 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' GLY . . . . . 0.488 ' H ' HG22 ' A' ' 247' ' ' THR . . . -52.1 -20.36 6.56 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.938 -1.265 . . . . 0.56 109.938 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -150.26 31.35 0.67 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.083 -1.245 . . . . 0.37 110.639 -179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' SER . . . . . 0.526 ' HB2' ' N ' ' A' ' 247' ' ' THR . 0.2 OUTLIER -49.65 -47.35 49.99 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.032 -1.043 . . . . 0.44 109.876 179.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -137.14 -47.65 0.59 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.295 -0.878 . . . . 0.53 110.022 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 254' ' ' LEU . 0.0 OUTLIER 179.46 -178.19 0.36 Allowed 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.287 -0.883 . . . . 0.38 110.494 -179.891 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' MET . . . . . 0.881 ' HB2' HG21 ' A' ' 259' ' ' VAL . 0.0 OUTLIER -68.32 55.52 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.591 -0.693 . . . . 0.19 110.595 179.722 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.727 ' N ' ' HD2' ' A' ' 255' ' ' PRO . 1.8 tp -43.99 -47.61 22.29 Favored Pre-proline 0 N--CA 1.486 1.343 0 N-CA-C 108.061 -1.088 . . . . 0.28 108.061 177.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' PRO . . . . . 0.727 ' HD2' ' N ' ' A' ' 254' ' ' LEU . 38.1 Cg_endo -71.1 48.52 0.89 Allowed 'Trans proline' 0 C--N 1.314 -1.269 0 O-C-N 124.054 1.555 . . . . 0.49 111.279 177.682 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ASP . . . . . 0.644 ' HA ' ' HB ' ' A' ' 259' ' ' VAL . 5.4 m-20 -52.64 -28.78 22.9 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 120.882 -1.136 . . . . 0.49 111.191 -179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' ASP . . . . . 0.878 ' CB ' ' HB2' ' A' ' 238' ' ' ALA . 0.5 OUTLIER -55.58 -52.67 62.97 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 118.875 -1.13 . . . . 0.31 109.523 -178.874 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ASP . . . . . 0.94 ' O ' HD12 ' A' ' 262' ' ' ILE . 0.1 OUTLIER -71.22 -32.29 68.62 Favored 'General case' 0 C--N 1.295 -1.794 0 C-N-CA 119.203 -0.999 . . . . 0.14 108.947 179.083 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' VAL . . . . . 0.881 HG21 ' HB2' ' A' ' 253' ' ' MET . 61.1 t -64.02 -82.68 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 C-N-CA 119.807 -0.757 . . . . 0.17 110.054 179.706 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' GLN . . . . . 0.644 ' HA ' ' HB3' ' A' ' 263' ' ' GLN . 1.8 tt0 -55.59 -42.43 74.8 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 0.26 108.951 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' GLY . . . . . 0.506 ' HA3' ' O ' ' A' ' 257' ' ' ASP . . . -38.95 -72.4 0.21 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 110.364 -1.094 . . . . 0.19 110.364 -179.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' ILE . . . . . 0.94 HD12 ' O ' ' A' ' 258' ' ' ASP . 0.1 OUTLIER -72.33 -22.59 20.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.921 -1.34 . . . . 0.22 110.082 -179.369 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLN . . . . . 0.829 ' N ' HD13 ' A' ' 262' ' ' ILE . 0.8 OUTLIER -57.25 -24.84 57.4 Favored 'General case' 0 C--N 1.3 -1.557 0 C-N-CA 118.843 -1.143 . . . . 0.39 108.424 179.298 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.0 -37.44 7.37 Favored 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 120.146 -0.622 . . . . 0.47 111.507 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' LEU . . . . . 0.488 ' N ' HD22 ' A' ' 265' ' ' LEU . 4.5 mm? -83.15 -47.98 11.02 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.108 -0.995 . . . . 0.48 111.951 -178.234 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' TYR . . . . . 0.506 ' CE2' ' CD2' ' A' ' 228' ' ' LEU . 0.0 OUTLIER -82.74 -9.94 59.13 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.005 -1.059 . . . . 0.41 110.691 -179.136 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' GLY . . . . . 0.407 ' O ' ' O ' ' A' ' 266' ' ' TYR . . . -54.62 -97.56 0.01 OUTLIER Glycine 0 N--CA 1.489 2.214 0 N-CA-C 109.009 -1.636 . . . . 0.46 109.009 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -75.05 116.75 4.67 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 124.097 1.577 . . . . 0.58 110.246 179.643 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLY . . . . . 0.464 ' HA3' ' HB2' ' A' ' 116' ' ' MET . . . -67.33 134.92 31.23 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.749 -1.34 . . . . 0.64 109.749 -179.791 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' ASP . . . . . 0.616 ' HB2' ' CD1' ' A' ' 113' ' ' TRP . 0.8 OUTLIER -89.44 -63.84 1.23 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.255 -1.144 . . . . 0.95 110.037 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' GLU . . . . . 0.528 ' CB ' ' HB2' ' A' ' 114' ' ' SER . 0.3 OUTLIER 43.09 31.35 0.34 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.392 -0.817 . . . . 1.2 110.25 179.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.75 79.07 47.36 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.175 -0.953 . . . . 1.2 110.297 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -72.62 59.53 3.35 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 124.04 1.547 . . . . 1.06 110.466 179.779 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' ASN . . . . . . . . . . . . . 22.6 t-20 . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.918 -1.039 . . . . 0.78 110.188 -179.925 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' HAV . . . . . 1.051 HG13 ' HA ' ' A' ' 184' ' ' LEU . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' 3MP . . . . . 0.638 ' HB2' ' CD2' ' A' ' 3' ' ' MSB . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MSB . . . . . 0.638 ' CD2' ' HB2' ' A' ' 2' ' ' 3MP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 stop_ save_